Citrus Sinensis ID: 027788

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------22
Protein Sequence
MMPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSWRRSCTMRITRSLWTYTRLGCAC
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccEEEcccEEcccccccEEEEEEcccccEEEEEEEEcccccccHHHHHHHHHHHHHHHccccccccEEEEEEEEccccEEEEEEEEEccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHccccccEEEccccccEEEEcccccEEEccccHHHHHcccccccEEcccccccccccccccccccEEccccEEEc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccEEEEEEEcccccEEEEEEEccccccEEEEEEEEHHHHccccccHHHHHHHHHHHHHcccccEEEEEEEEEcccccEEEEEEEEccccHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHccccEEccccccccEEEEccccEEEEccHHHHHHcccccccccccEEEEEccccHHHHccccEEEEEEEEEcc
Coil and Loop (DISEMBL)
mmpavnsdpsdkdsepfietdptgrygrynellgsGAVKKVYRAFDQEEGIEVAWNQVKlrtfcddpaMIERLFSEVRLLKTLANKNIISLHYvwrdedrntLNFITEVCtsgnlreyrkkHRHVSVKALKKWSKQILKGLNylhthepcvihrdlncsnvfvngntgqvkigdlGVAAIVGRAIRRIRCwgrrsswrrsctMRITRSLWTYTRLGCAC
Flexible Loop (DISEMBL)
mmpavnsdpsdkdsepfietdptgrygryneLLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLhyvwrdedrntLNFITEVctsgnlreyrkkhrHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGntgqvkigdlgVAAIVGRAirrircwgrrsswrrsctmritrslwtytrlgcac
Low Complexity Region (SEG)
MMPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLgvaaivgrairrircwgrrsswrrscTMRITRSLWTYTRLGCAC
Disordered region (IsUnstruct)
************************RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSWRRSCTMRITRSLWTYTRLGC**
Disordered Region (DISOPRED)
***********************GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVK****************EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI***RCWGRRSSWRRSCTMRITRSLWTYTRLGCAC
Disordered Region (DISEMBL)
***************PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYR**********LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSWRRSCTMRITRSLWTYTRLGCAC
Disordered Region (DISPRO)
**********************TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSWRRSCTMRITRSLWTYTRLGCAC
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MMPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSWRRSCTMRITRSLWTYTRLGCAC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	219	2.2.26 [Sep-21-2011]
Q6ICW6	314	Probable serine/threonine	yes	no	0.835	0.582	0.807	1e-86
Q0D541	327	Probable serine/threonine	yes	no	0.748	0.501	0.727	1e-69
Q9STK6	516	Probable serine/threonine	no	no	0.771	0.327	0.660	3e-61
Q65X23	621	Probable serine/threonine	no	no	0.785	0.276	0.635	5e-60
Q9CAV6	700	Serine/threonine-protein	no	no	0.826	0.258	0.582	2e-59
Q8S8Y9	568	Serine/threonine-protein	no	no	0.821	0.316	0.574	5e-59
Q2V338	492	Probable serine/threonine	no	no	0.771	0.343	0.591	2e-58
Q944Q0	563	Serine/threonine-protein	no	no	0.780	0.303	0.596	1e-57
Q0D598	704	Probable serine/threonine	no	no	0.867	0.269	0.552	1e-57
A2YMV6	704	Probable serine/threonine	N/A	no	0.867	0.269	0.552	1e-57

>sp|Q6ICW6|WNK11_ARATH Probable serine/threonine-protein kinase WNK11 OS=Arabidopsis thaliana GN=WNK11 PE=2 SV=1

 Score =  318 bits (816), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 151/187 (80%), Positives = 166/187 (88%), Gaps = 4/187 (2%)

Query: 1   MMPAVNSDPS----DKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWN 56
           MM   +SD +    DKDSE F+E DPTGRYGRY ELLGSGAVKKVYRAFDQEEGIEVAWN
Sbjct: 1   MMTCASSDDNESEKDKDSESFVEVDPTGRYGRYGELLGSGAVKKVYRAFDQEEGIEVAWN 60

Query: 57  QVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLR 116
           QVKLR F DDPAM ERL+SEVRLLK L N NII+L+ VWRDE  NTLNFITE+CTSGNLR
Sbjct: 61  QVKLRCFSDDPAMTERLYSEVRLLKNLKNSNIITLYKVWRDERNNTLNFITEICTSGNLR 120

Query: 117 EYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
           EYRKKHRHVS++ALKKWSKQILKGL+YLHTH+PC+IHRDLNCSN+FVNGN GQVKIGDLG
Sbjct: 121 EYRKKHRHVSMRALKKWSKQILKGLDYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLG 180

Query: 177 VAAIVGR 183
           +AAIVG+
Sbjct: 181 LAAIVGK 187

May regulate flowering time by modulating the photoperiod pathway.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q0D541|WNK5_ORYSJ Probable serine/threonine-protein kinase WNK5 OS=Oryza sativa subsp. japonica GN=WNK5 PE=2 SV=1

 Score =  262 bits (670), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 120/165 (72%), Positives = 144/165 (87%), Gaps = 1/165 (0%)

Query: 20  TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD-DPAMIERLFSEVR 78
            DPTGR+GRY ++LG G+VKKVYR FDQEEGIEVAWN+V+LR   D DPAM+ERL +EVR
Sbjct: 48  VDPTGRFGRYADVLGLGSVKKVYRGFDQEEGIEVAWNRVRLRALADRDPAMVERLHAEVR 107

Query: 79  LLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
           LL++L +++II  H VW D D   LNFITEVCTSG+LREYR +HRHVSVKALKKW++QIL
Sbjct: 108 LLRSLHHEHIIGFHKVWLDRDAGVLNFITEVCTSGSLREYRDRHRHVSVKALKKWARQIL 167

Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR 183
            GL++LHTH+PC+IHRDLNCSNVF+NGNTGQVKIGDLG+AAIV +
Sbjct: 168 LGLDHLHTHDPCIIHRDLNCSNVFINGNTGQVKIGDLGLAAIVDK 212

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9STK6|WNK3_ARATH Probable serine/threonine-protein kinase WNK3 OS=Arabidopsis thaliana GN=WNK3 PE=2 SV=1

 Score =  234 bits (597), Expect = 3e-61,   Method: Compositional matrix adjust.
 Identities = 113/171 (66%), Positives = 136/171 (79%), Gaps = 2/171 (1%)

Query: 15  EPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRT-FCDDPAMIERL 73
           E F+E DPTGRYGRY E+LG GA K+VYRAFDQ EGIEVAWNQVKL   FC    + +RL
Sbjct: 10  EEFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSSEDL-DRL 68

Query: 74  FSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKW 133
           +SEV LLKTL +K+II  +  W D    T+N ITEV TSGNLR+YRKKH+ V ++ALKKW
Sbjct: 69  YSEVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDLRALKKW 128

Query: 134 SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA 184
           S+QIL+GL YLH+H+P VIHRDL C N+F+NGN G+VKIGDLG+AAI+ RA
Sbjct: 129 SRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRA 179

May regulate flowering time by modulating the photoperiod pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1

 Score =  230 bits (587), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 110/173 (63%), Positives = 132/173 (76%), Gaps = 1/173 (0%)

Query: 13  DSEP-FIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE 71
           D+EP F E DPT RYGRY E+LG GA K VY+AFDQ EG+EVAWNQ+K+     +   +E
Sbjct: 13  DTEPEFAEVDPTARYGRYTEVLGKGAFKTVYKAFDQLEGLEVAWNQIKVGDILRNNDDLE 72

Query: 72  RLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
           RL SEVRLLKTL +KNII  +  W D+  N +NFITEV TSG LR+YR KH+ V V+ALK
Sbjct: 73  RLRSEVRLLKTLKHKNIIKFYNSWLDKKNNNINFITEVFTSGTLRQYRIKHKKVDVRALK 132

Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA 184
           KWS+QIL GL YLH+H+P VIHRDL C N+FVNGN G+VKIGDLG+A I+  A
Sbjct: 133 KWSRQILSGLVYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLATILDNA 185

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1

 Score =  228 bits (582), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 106/182 (58%), Positives = 135/182 (74%), Gaps = 1/182 (0%)

Query: 11  DKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMI 70
           + D   F+E DPTGRYGRYNE+LG GA K VYRAFD+ EGIEVAWNQVKL  F   P  +
Sbjct: 8   EPDYSEFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDL 67

Query: 71  ERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKAL 130
           ERL+ E+ LLKTL +KNI+  +  W D     +NF+TE+ TSG LR+YR +H+ V+++A+
Sbjct: 68  ERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAM 127

Query: 131 KKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRC 190
           K W +QIL+GL+YLH+H+P VIHRDL C N+FVNGN G+VKIGDLG+AAI+ R      C
Sbjct: 128 KHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-RKSHAAHC 186

Query: 191 WG 192
            G
Sbjct: 187 VG 188

Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8S8Y9|WNK2_ARATH Serine/threonine-protein kinase WNK2 OS=Arabidopsis thaliana GN=WNK2 PE=1 SV=1

 Score =  227 bits (578), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 104/181 (57%), Positives = 138/181 (76%), Gaps = 1/181 (0%)

Query: 12  KDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE 71
           +D   F+E DP+GRYGRY+E+LG GA K VYRAFD+ EGIEVAWNQVKLR F  +P  +E
Sbjct: 9   EDCSVFVEIDPSGRYGRYDEILGKGASKTVYRAFDEYEGIEVAWNQVKLRNFTRNPEELE 68

Query: 72  RLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
           + F E+ LLKTL ++NI+  +  W D +  ++NF+TE+ TSG LR+YR +HR V+++A+K
Sbjct: 69  KFFREIHLLKTLNHQNIMKFYTSWVDTNNLSINFVTELFTSGTLRQYRLRHRRVNIRAVK 128

Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCW 191
           +W KQILKGL YLH+  P +IHRDL C N+F+NGN G+VKIGDLG+AAI+ R    +RC 
Sbjct: 129 QWCKQILKGLLYLHSRSPPIIHRDLKCDNIFINGNQGEVKIGDLGLAAIL-RKSHAVRCV 187

Query: 192 G 192
           G
Sbjct: 188 G 188

Regulates flowering time by modulating the photoperiod pathway. Possesses kinase activity in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2V338|WNK9_ARATH Probable serine/threonine-protein kinase WNK9 OS=Arabidopsis thaliana GN=WNK9 PE=2 SV=1

 Score =  225 bits (574), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 100/169 (59%), Positives = 130/169 (76%)

Query: 11  DKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMI 70
           + D   ++E DPTGRYGRYNE+LG G+ K VYR FD+ +GIEVAWNQVKL  F   P  +
Sbjct: 9   ESDYSEYVEVDPTGRYGRYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYDFLQSPQEL 68

Query: 71  ERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKAL 130
           ERL+ E+ LLKTL +K+I+  +  W D D   +NF+TE+ TSG LR+YR KH+ V+++A+
Sbjct: 69  ERLYCEIHLLKTLKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHKRVNIRAV 128

Query: 131 KKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
           K W +QIL+GLNYLHTH+P VIHRDL C N+F+NGN G+VKIGDLG+AA
Sbjct: 129 KNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAA 177

May regulate flowering time by modulating the photoperiod pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q944Q0|WNK8_ARATH Serine/threonine-protein kinase WNK8 OS=Arabidopsis thaliana GN=WNK8 PE=1 SV=1

 Score =  223 bits (567), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 102/171 (59%), Positives = 127/171 (74%)

Query: 17  FIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSE 76
           F E DP+GRY RY+++LG GA K VY+AFD+ +GIEVAWN V +      P  +ERL+SE
Sbjct: 19  FAEKDPSGRYIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLVSIEDVMQMPGQLERLYSE 78

Query: 77  VRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQ 136
           V LLK L ++NII L Y W DE   T+N ITE+ TSG+LR YRKKHR V  KA+K W++Q
Sbjct: 79  VHLLKALKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVYRKKHRKVDPKAIKNWARQ 138

Query: 137 ILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR 187
           ILKGLNYLH+  P VIHRDL C N+FVNGNTG+VKIGDLG+A ++ +   R
Sbjct: 139 ILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLATVLQQPTAR 189

Regulates flowering time by modulating the photoperiod pathway. Phosphorylates the vacuolar ATPase subunit C (VATC).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1

 Score =  222 bits (566), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 106/192 (55%), Positives = 137/192 (71%), Gaps = 2/192 (1%)

Query: 1   MMPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKL 60
           M P  N+  +  D   + E DPTGRYGRYN++LG GA K VYRAFD+ +G+EVAWNQVKL
Sbjct: 2   MGPKANAAAA-GDLPEYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKL 60

Query: 61  RTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRK 120
             F   P  +ERL+ E+ LLKTL ++NI+  +  W D  R  +NFITE+ TSG LR+YR+
Sbjct: 61  HDFLQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQ 120

Query: 121 KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
           KH  V++ A+K W +QIL GL YLH+H+P +IHRDL C N+FVNGN G+VKIGDLG+AAI
Sbjct: 121 KHMRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 180

Query: 181 VGRAIRRIRCWG 192
           + R    + C G
Sbjct: 181 L-RKSHAVHCVG 191

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2

 Score =  222 bits (566), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 106/192 (55%), Positives = 137/192 (71%), Gaps = 2/192 (1%)

Query: 1   MMPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKL 60
           M P  N+  +  D   + E DPTGRYGRYN++LG GA K VYRAFD+ +G+EVAWNQVKL
Sbjct: 2   MGPKANAAAA-GDLPEYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKL 60

Query: 61  RTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRK 120
             F   P  +ERL+ E+ LLKTL ++NI+  +  W D  R  +NFITE+ TSG LR+YR+
Sbjct: 61  HDFLQSPEDLERLYCEIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQ 120

Query: 121 KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
           KH  V++ A+K W +QIL GL YLH+H+P +IHRDL C N+FVNGN G+VKIGDLG+AAI
Sbjct: 121 KHMRVNIWAVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 180

Query: 181 VGRAIRRIRCWG 192
           + R    + C G
Sbjct: 181 L-RKSHAVHCVG 191

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	219
30844109	295	MAP kinase-like protein [Gossypium hirsu	0.835	0.620	0.863	1e-91
356552725	299	PREDICTED: probable serine/threonine-pro	0.821	0.602	0.857	3e-90
356501610	299	PREDICTED: probable serine/threonine-pro	0.817	0.598	0.862	5e-90
357494805	305	MAP kinase-like protein [Medicago trunca	0.835	0.6	0.852	1e-89
356569661	298	PREDICTED: probable serine/threonine-pro	0.835	0.614	0.841	2e-89
357459941	340	MAP kinase-like protein [Medicago trunca	0.831	0.535	0.818	5e-88
356524330	298	PREDICTED: probable serine/threonine-pro	0.831	0.610	0.818	2e-86
357465193	295	MAP kinase-like protein [Medicago trunca	0.831	0.616	0.808	3e-86
225460775	297	PREDICTED: probable serine/threonine-pro	0.835	0.616	0.819	4e-86
255576306	298	ATP binding protein, putative [Ricinus c	0.835	0.614	0.797	3e-85

>gi|30844109|gb|AAP36697.1| MAP kinase-like protein [Gossypium hirsutum]

 Score =  341 bits (874), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 158/183 (86%), Positives = 171/183 (93%)

Query: 1   MMPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKL 60
           MMP+VN D SDKDSEPF+E DPTGRYGRY ELLGSGAVKKVYRAFDQEEGIEVAWNQVKL
Sbjct: 1   MMPSVNPDQSDKDSEPFVEADPTGRYGRYTELLGSGAVKKVYRAFDQEEGIEVAWNQVKL 60

Query: 61  RTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRK 120
           R F DDPAMI+RL+SEVRLL++L N NIISL+  WRDE+ NTLNFITEVCTSGNLREYRK
Sbjct: 61  RNFSDDPAMIDRLYSEVRLLRSLTNNNIISLYSFWRDEEHNTLNFITEVCTSGNLREYRK 120

Query: 121 KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
           KHR VS+KALKKWSKQILKGLNYLH+HEPC+IHRDLNCSNVFVNGNTGQVKIGDLG+AAI
Sbjct: 121 KHRQVSMKALKKWSKQILKGLNYLHSHEPCIIHRDLNCSNVFVNGNTGQVKIGDLGLAAI 180

Query: 181 VGR 183
           VG+
Sbjct: 181 VGK 183

Source: Gossypium hirsutum

Species: Gossypium hirsutum

Genus: Gossypium

Family: Malvaceae

Order: Malvales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356552725|ref|XP_003544713.1| PREDICTED: probable serine/threonine-protein kinase WNK11-like [Glycine max]

 Score =  337 bits (863), Expect = 3e-90,   Method: Compositional matrix adjust.
 Identities = 157/183 (85%), Positives = 173/183 (94%), Gaps = 3/183 (1%)

Query: 1   MMPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKL 60
           MMP+VN D   KDSEPF+ETDPTGRYGRY+ELLG GAVKKVYRAFDQEEGIEVAWNQVKL
Sbjct: 1   MMPSVNPD---KDSEPFVETDPTGRYGRYSELLGCGAVKKVYRAFDQEEGIEVAWNQVKL 57

Query: 61  RTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRK 120
           R FCDDPAM++RL+SEVRLL++L+NKNII+L+ VWRDE RNTLNFITEVCTSGNLREYRK
Sbjct: 58  RNFCDDPAMLDRLYSEVRLLRSLSNKNIIALYNVWRDEQRNTLNFITEVCTSGNLREYRK 117

Query: 121 KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
           KHRHVS+KALKKWSKQILKGLNYLH H+PC+IHRDLNCSNVFVNGNTGQVKIGDLG+A I
Sbjct: 118 KHRHVSIKALKKWSKQILKGLNYLHLHDPCIIHRDLNCSNVFVNGNTGQVKIGDLGLATI 177

Query: 181 VGR 183
           VG+
Sbjct: 178 VGK 180

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356501610|ref|XP_003519617.1| PREDICTED: probable serine/threonine-protein kinase WNK11-like [Glycine max]

 Score =  335 bits (860), Expect = 5e-90,   Method: Compositional matrix adjust.
 Identities = 157/182 (86%), Positives = 172/182 (94%), Gaps = 3/182 (1%)

Query: 2   MPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLR 61
           MP+VN D   KDSEPF+ETDPTGRYGRY+ELLG GAVKKVYRAFDQEEGIEVAWNQVKLR
Sbjct: 1   MPSVNPD---KDSEPFVETDPTGRYGRYSELLGCGAVKKVYRAFDQEEGIEVAWNQVKLR 57

Query: 62  TFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKK 121
            FCDDPAM++RL+SEVRLL++L NKNII+L+ VWRDE RNTLNFITEVCTSGNLREYRKK
Sbjct: 58  NFCDDPAMLDRLYSEVRLLRSLTNKNIIALYNVWRDEQRNTLNFITEVCTSGNLREYRKK 117

Query: 122 HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           HRHVS+KALKKWSKQILKGLNYLH H+PC+IHRDLNCSNVFVNGNTGQVKIGDLG+AAIV
Sbjct: 118 HRHVSIKALKKWSKQILKGLNYLHLHDPCIIHRDLNCSNVFVNGNTGQVKIGDLGLAAIV 177

Query: 182 GR 183
           G+
Sbjct: 178 GK 179

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357494805|ref|XP_003617691.1| MAP kinase-like protein [Medicago truncatula] gi|355519026|gb|AET00650.1| MAP kinase-like protein [Medicago truncatula]

 Score =  334 bits (857), Expect = 1e-89,   Method: Compositional matrix adjust.
 Identities = 156/183 (85%), Positives = 169/183 (92%)

Query: 1   MMPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKL 60
           MMP+VNS  SDKDSE F ETDPTGRYGRY ELLG GAVKKVYRAFDQEEGIEVAWNQVKL
Sbjct: 1   MMPSVNSGSSDKDSEAFAETDPTGRYGRYPELLGCGAVKKVYRAFDQEEGIEVAWNQVKL 60

Query: 61  RTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRK 120
           R FCD+PAM+ERL+SEVRLL++L NKNII L+ VW D+  NTLNFITEVCTSGNLREYRK
Sbjct: 61  RNFCDEPAMVERLYSEVRLLRSLTNKNIIELYSVWSDDRNNTLNFITEVCTSGNLREYRK 120

Query: 121 KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
           KHRHVS+KALKKWS+QILKGLNYLHTHEPC+IHRDLNCSNVFVNGN GQVKIGDLG+AAI
Sbjct: 121 KHRHVSMKALKKWSRQILKGLNYLHTHEPCIIHRDLNCSNVFVNGNVGQVKIGDLGLAAI 180

Query: 181 VGR 183
           VG+
Sbjct: 181 VGK 183

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356569661|ref|XP_003553016.1| PREDICTED: probable serine/threonine-protein kinase WNK11-like [Glycine max]

 Score =  334 bits (856), Expect = 2e-89,   Method: Compositional matrix adjust.
 Identities = 154/183 (84%), Positives = 172/183 (93%)

Query: 2   MPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLR 61
           MP+V SD SDKDSEPF+E DPT RYGRY+ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLR
Sbjct: 1   MPSVKSDASDKDSEPFVEVDPTRRYGRYSELLGSGAVKKVYRAFDQEEGIEVAWNQVKLR 60

Query: 62  TFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKK 121
            F DDPAM++RL+SEVRLL++L NKNIISL+ VWRDE  NTLNFITEVCTSGNLR+YRKK
Sbjct: 61  NFSDDPAMLDRLYSEVRLLRSLTNKNIISLYSVWRDEKHNTLNFITEVCTSGNLRKYRKK 120

Query: 122 HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           HRHVS++ALKKWSKQIL+GLNYLH H+PC+IHRDLNCSNVFVNGNTGQVKIGDLG+AAIV
Sbjct: 121 HRHVSMRALKKWSKQILEGLNYLHLHDPCIIHRDLNCSNVFVNGNTGQVKIGDLGLAAIV 180

Query: 182 GRA 184
           G++
Sbjct: 181 GKS 183

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357459941|ref|XP_003600252.1| MAP kinase-like protein [Medicago truncatula] gi|355489300|gb|AES70503.1| MAP kinase-like protein [Medicago truncatula]

 Score =  329 bits (844), Expect = 5e-88,   Method: Compositional matrix adjust.
 Identities = 149/182 (81%), Positives = 170/182 (93%)

Query: 2   MPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLR 61
           MP+V  +PSDKD+E F+ETDPTGRYGRY+ELLG+GA KKVY+AFD EEGIEVAWNQVKLR
Sbjct: 44  MPSVQQNPSDKDTETFVETDPTGRYGRYDELLGAGACKKVYKAFDNEEGIEVAWNQVKLR 103

Query: 62  TFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKK 121
            F +DPAMIERL+SEVRLLK + NKNII+L+ VWRD++ NTLNFITEVCTSGNLREYRKK
Sbjct: 104 NFSNDPAMIERLYSEVRLLKNMTNKNIIALYNVWRDKEHNTLNFITEVCTSGNLREYRKK 163

Query: 122 HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           H+HVS+KALKKWSKQIL+GLNYLH H+PC+IHRDLNCSNVFVNGNTGQVKIGDLG+AAIV
Sbjct: 164 HKHVSLKALKKWSKQILEGLNYLHVHDPCIIHRDLNCSNVFVNGNTGQVKIGDLGLAAIV 223

Query: 182 GR 183
           G+
Sbjct: 224 GK 225

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356524330|ref|XP_003530782.1| PREDICTED: probable serine/threonine-protein kinase WNK11-like [Glycine max]

 Score =  323 bits (829), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 149/182 (81%), Positives = 168/182 (92%)

Query: 2   MPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLR 61
           MP+V  D SDKDSEPF+E DPT RYGRY+ELLG GAVKKVYRAFDQEEGIEVAWNQVKLR
Sbjct: 1   MPSVKPDASDKDSEPFVEVDPTRRYGRYSELLGYGAVKKVYRAFDQEEGIEVAWNQVKLR 60

Query: 62  TFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKK 121
            F  DP+M++RL+SEVRLL++L NKNIISL+ VWR+E  NTLNFITEVCTSGNLREYRKK
Sbjct: 61  NFSYDPSMVDRLYSEVRLLRSLTNKNIISLYSVWREEKHNTLNFITEVCTSGNLREYRKK 120

Query: 122 HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           H+HVS++ALKKWSKQIL+GLNYLH H+PC+IHRDLNCSNVFVNGNTGQVKIGDLG+AAIV
Sbjct: 121 HKHVSMRALKKWSKQILEGLNYLHLHDPCIIHRDLNCSNVFVNGNTGQVKIGDLGLAAIV 180

Query: 182 GR 183
           G+
Sbjct: 181 GK 182

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357465193|ref|XP_003602878.1| MAP kinase-like protein [Medicago truncatula] gi|355491926|gb|AES73129.1| MAP kinase-like protein [Medicago truncatula]

 Score =  323 bits (829), Expect = 3e-86,   Method: Compositional matrix adjust.
 Identities = 148/183 (80%), Positives = 170/183 (92%), Gaps = 1/183 (0%)

Query: 2   MPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLR 61
           M +V  +P DKDSEPF+ETDPTGRYGRYNELLGSG+ KKVY+AFDQEEGIEVAWNQVKLR
Sbjct: 1   MKSVKPNPFDKDSEPFVETDPTGRYGRYNELLGSGSCKKVYKAFDQEEGIEVAWNQVKLR 60

Query: 62  TFCD-DPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRK 120
            F + DPAMI RL+SEVRLL+++ N+NII+L+YVWRDED N LNFITEVCTSGNLR+YRK
Sbjct: 61  NFSNNDPAMIHRLYSEVRLLRSMRNENIIALYYVWRDEDHNILNFITEVCTSGNLRDYRK 120

Query: 121 KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
           KH+HVS+KALKKWSKQIL+GLNYLH H+PC+IHRDLNCSNVF+NGNTGQVKIGDLG+AAI
Sbjct: 121 KHKHVSIKALKKWSKQILEGLNYLHVHDPCIIHRDLNCSNVFINGNTGQVKIGDLGLAAI 180

Query: 181 VGR 183
           VG+
Sbjct: 181 VGK 183

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225460775|ref|XP_002276368.1| PREDICTED: probable serine/threonine-protein kinase WNK11 [Vitis vinifera] gi|297737533|emb|CBI26734.3| unnamed protein product [Vitis vinifera]

 Score =  323 bits (827), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 150/183 (81%), Positives = 167/183 (91%)

Query: 2   MPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLR 61
           MPAV+ D SD+DSEPF+E DPT RYGRYNELLG GAVK+VYRAFDQEEGIEVAWNQVKLR
Sbjct: 1   MPAVSPDQSDRDSEPFVEVDPTRRYGRYNELLGCGAVKRVYRAFDQEEGIEVAWNQVKLR 60

Query: 62  TFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKK 121
            F DD  MI+RLFSEVRLLKTL +KNII+L+ VWR+ED NTLNFITEVCTSGNLREYRKK
Sbjct: 61  AFSDDKPMIDRLFSEVRLLKTLKDKNIIALYNVWRNEDHNTLNFITEVCTSGNLREYRKK 120

Query: 122 HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           HRHVS+KALKKWSKQILKGL+YLH HEPC+IHRDLNCSNVF+NGN G+VKIGD G+AA V
Sbjct: 121 HRHVSMKALKKWSKQILKGLDYLHRHEPCIIHRDLNCSNVFINGNVGKVKIGDFGLAATV 180

Query: 182 GRA 184
           G++
Sbjct: 181 GKS 183

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255576306|ref|XP_002529046.1| ATP binding protein, putative [Ricinus communis] gi|223531526|gb|EEF33357.1| ATP binding protein, putative [Ricinus communis]

 Score =  320 bits (820), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 146/183 (79%), Positives = 167/183 (91%)

Query: 2   MPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLR 61
           MP+   DPSD +SE F+E DPTGRYGRY+ELLG+GAVKKVYRAFDQEEGIEVAWNQV+LR
Sbjct: 1   MPSAKPDPSDTESEHFVEVDPTGRYGRYSELLGTGAVKKVYRAFDQEEGIEVAWNQVRLR 60

Query: 62  TFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKK 121
            F +DP +I+RL++EVRLL++L NKNIIS + VW DE+ NTLNFITEVCTSGNLREYRKK
Sbjct: 61  NFTNDPTIIDRLYAEVRLLRSLKNKNIISFYNVWHDEEHNTLNFITEVCTSGNLREYRKK 120

Query: 122 HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           HRHVS+KALKKWSKQILKGLNYLHTHEPC+IHRDLNCSN+ VNGN GQVKIGDLG+AAIV
Sbjct: 121 HRHVSMKALKKWSKQILKGLNYLHTHEPCIIHRDLNCSNLLVNGNIGQVKIGDLGLAAIV 180

Query: 182 GRA 184
           G++
Sbjct: 181 GKS 183

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	219
TAIR|locus:2176135	314	AT5G55560 [Arabidopsis thalian	0.776	0.541	0.835	5.5e-77
TAIR|locus:504955638	516	WNK3 "with no lysine (K) kinas	0.771	0.327	0.627	7.8e-55
TAIR|locus:2182039	492	WNK9 [Arabidopsis thaliana (ta	0.753	0.335	0.587	2.6e-54
TAIR|locus:2114845	700	WNK1 "with no lysine (K) kinas	0.753	0.235	0.6	5.5e-54
TAIR|locus:2165790	563	WNK8 "with no lysine (K) kinas	0.757	0.294	0.602	1.2e-51
TAIR|locus:2098242	549	WNK5 "with no lysine (K) kinas	0.767	0.306	0.591	1.3e-50
TAIR|locus:2093994	567	WNK6 "with no lysine (K) kinas	0.753	0.291	0.565	5.2e-49
TAIR|locus:2019404	524	WNK10 "with no lysine (K) kina	0.726	0.303	0.584	1.4e-48
TAIR|locus:2028521	557	WNK7 [Arabidopsis thaliana (ta	0.753	0.296	0.547	2.9e-48
TAIR|locus:2161278	571	WNK4 "with no lysine (K) kinas	0.726	0.278	0.572	3.7e-48

TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)]

 Score = 775 (277.9 bits), Expect = 5.5e-77, P = 5.5e-77
 Identities = 142/170 (83%), Positives = 153/170 (90%)

Query:     6 NSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD 65
             N    DKDSE F+E DPTGRYGRY ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLR F D
Sbjct:    10 NESEKDKDSESFVEVDPTGRYGRYGELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRCFSD 69

Query:    66 DPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV 125
             DPAM ERL+SEVRLLK L N NII+L+ VWRDE  NTLNFITE+CTSGNLREYRKKHRHV
Sbjct:    70 DPAMTERLYSEVRLLKNLKNSNIITLYKVWRDERNNTLNFITEICTSGNLREYRKKHRHV 129

Query:   126 SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             S++ALKKWSKQILKGL+YLHTH+PC+IHRDLNCSN+FVNGN GQVKIGDL
Sbjct:   130 SMRALKKWSKQILKGLDYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDL 179

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010260 "organ senescence" evidence=RCA

TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 566 (204.3 bits), Expect = 7.8e-55, P = 7.8e-55
 Identities = 108/172 (62%), Positives = 133/172 (77%)

Query:     5 VNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRT-F 63
             +  D ++ + E F+E DPTGRYGRY E+LG GA K+VYRAFDQ EGIEVAWNQVKL   F
Sbjct:     1 MRQDENNSEEE-FVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKF 59

Query:    64 CDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR 123
             C    + +RL+SEV LLKTL +K+II  +  W D    T+N ITEV TSGNLR+YRKKH+
Sbjct:    60 CSSEDL-DRLYSEVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHK 118

Query:   124 HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V ++ALKKWS+QIL+GL YLH+H+P VIHRDL C N+F+NGN G+VKIGDL
Sbjct:   119 CVDLRALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDL 170

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)]

 Score = 561 (202.5 bits), Expect = 2.6e-54, P = 2.6e-54
 Identities = 97/165 (58%), Positives = 126/165 (76%)

Query:    11 DKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMI 70
             + D   ++E DPTGRYGRYNE+LG G+ K VYR FD+ +GIEVAWNQVKL  F   P  +
Sbjct:     9 ESDYSEYVEVDPTGRYGRYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYDFLQSPQEL 68

Query:    71 ERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKAL 130
             ERL+ E+ LLKTL +K+I+  +  W D D   +NF+TE+ TSG LR+YR KH+ V+++A+
Sbjct:    69 ERLYCEIHLLKTLKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHKRVNIRAV 128

Query:   131 KKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             K W +QIL+GLNYLHTH+P VIHRDL C N+F+NGN G+VKIGDL
Sbjct:   129 KNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDL 173

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 558 (201.5 bits), Expect = 5.5e-54, P = 5.5e-54
 Identities = 99/165 (60%), Positives = 126/165 (76%)

Query:    11 DKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMI 70
             + D   F+E DPTGRYGRYNE+LG GA K VYRAFD+ EGIEVAWNQVKL  F   P  +
Sbjct:     8 EPDYSEFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPEDL 67

Query:    71 ERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKAL 130
             ERL+ E+ LLKTL +KNI+  +  W D     +NF+TE+ TSG LR+YR +H+ V+++A+
Sbjct:    68 ERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIRAM 127

Query:   131 KKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             K W +QIL+GL+YLH+H+P VIHRDL C N+FVNGN G+VKIGDL
Sbjct:   128 KHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 172

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007623 "circadian rhythm" evidence=IEP

GO:0016020 "membrane" evidence=IDA

TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 536 (193.7 bits), Expect = 1.2e-51, P = 1.2e-51
 Identities = 100/166 (60%), Positives = 122/166 (73%)

Query:    10 SDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
             S  +   F E DP+GRY RY+++LG GA K VY+AFD+ +GIEVAWN V +      P  
Sbjct:    12 SSMEEADFAEKDPSGRYIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLVSIEDVMQMPGQ 71

Query:    70 IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
             +ERL+SEV LLK L ++NII L Y W DE   T+N ITE+ TSG+LR YRKKHR V  KA
Sbjct:    72 LERLYSEVHLLKALKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVYRKKHRKVDPKA 131

Query:   130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             +K W++QILKGLNYLH+  P VIHRDL C N+FVNGNTG+VKIGDL
Sbjct:   132 IKNWARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDL 177

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004672 "protein kinase activity" evidence=IDA;TAS

GO:0006468 "protein phosphorylation" evidence=IDA;TAS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0048573 "photoperiodism, flowering" evidence=IMP

GO:0005634 "nucleus" evidence=IDA

GO:0009911 "positive regulation of flower development" evidence=IMP

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA;IMP

GO:0009909 "regulation of flower development" evidence=IMP

GO:0006865 "amino acid transport" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0016926 "protein desumoylation" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0050665 "hydrogen peroxide biosynthetic process" evidence=RCA

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 526 (190.2 bits), Expect = 1.3e-50, P = 1.3e-50
 Identities = 100/169 (59%), Positives = 127/169 (75%)

Query:     7 SDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD 66
             S  SD DS  ++ETDP+GRYGR+ E+LG GA+K VY+AFDQ  G+EVAWNQVKL      
Sbjct:     6 SSASD-DSIAYVETDPSGRYGRFREVLGKGAMKTVYKAFDQVLGMEVAWNQVKLNEVFRS 64

Query:    67 PAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVS 126
             P  ++RL+SEV LLK L +++II     W D +R T NFITE+ TSG LREYR+K++ V 
Sbjct:    65 PEPLQRLYSEVHLLKNLNHESIIRYCTSWIDVNRRTFNFITELFTSGTLREYRRKYQKVD 124

Query:   127 VKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             ++A+K W++QIL GL YLH H+P VIHRDL C N+FVNG+ GQVKIGDL
Sbjct:   125 IRAIKSWARQILNGLAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDL 173

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0043424 "protein histidine kinase binding" evidence=IPI

GO:0048573 "photoperiodism, flowering" evidence=IMP

TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 511 (184.9 bits), Expect = 5.2e-49, P = 5.2e-49
 Identities = 95/168 (56%), Positives = 123/168 (73%)

Query:     8 DPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDP 67
             +P D +    +E DPT RY RY E++G GA K VY+AFD+ +GIEVAWNQV++      P
Sbjct:    12 EPPDPE---VLEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDDVLQSP 68

Query:    68 AMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSV 127
               +ERL+SEVRLLK+L + NII  +  W D+   T+N ITE+ TSG+LR YRKKHR V++
Sbjct:    69 NCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKHRKVNM 128

Query:   128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             KA+K W++QIL GL YLH  EP +IHRDL C N+F+NGN G+VKIGDL
Sbjct:   129 KAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDL 176

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 507 (183.5 bits), Expect = 1.4e-48, P = 1.4e-48
 Identities = 93/159 (58%), Positives = 118/159 (74%)

Query:    17 FIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSE 76
             F++ DPTGRY RYN++LG GA K VY+AFD+ EGIEVAWN + +      P  ++RL+SE
Sbjct:     6 FVQKDPTGRYIRYNDVLGRGAFKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRLYSE 65

Query:    77 VRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQ 136
             V LL +L + NII L Y W D+   ++N ITE+ TSG+L  YRKKHR V  KA+  W++Q
Sbjct:    66 VHLLNSLKHDNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMNWARQ 125

Query:   137 ILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             ILKGL+YLH+  P VIHRDL C N+FVNGNTG+VKIGDL
Sbjct:   126 ILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDL 164

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0003700 "sequence-specific DNA binding transcription factor activity" evidence=ISS

TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)]

 Score = 504 (182.5 bits), Expect = 2.9e-48, P = 2.9e-48
 Identities = 92/168 (54%), Positives = 125/168 (74%)

Query:     8 DPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDP 67
             +P D +    +E DPT RY RY E++G GA K V++ FD+ +GIEVAWNQV++      P
Sbjct:    12 EPPDPE---VLEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRIDDLLQSP 68

Query:    68 AMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSV 127
               +ERL+SEVRLLK+L +KNII  +  W D+   T+N ITE+ TSG+LR+YRKKHR V++
Sbjct:    69 DCLERLYSEVRLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNM 128

Query:   128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             KA+K W++QIL GL YLH+ +P +IHRD+ C N+F+NGN G+VKIGDL
Sbjct:   129 KAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDL 176

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 503 (182.1 bits), Expect = 3.7e-48, P = 3.7e-48
 Identities = 91/159 (57%), Positives = 122/159 (76%)

Query:    17 FIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSE 76
             ++ETDPTGRYGR+ E+LG GA+K VY+A D++ GIEVAW+QVKL+        ++RL+SE
Sbjct:     9 YVETDPTGRYGRFAEILGRGAMKTVYKAIDEKLGIEVAWSQVKLKEVLRSSVDLQRLYSE 68

Query:    77 VRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQ 136
             V LL TL +K+II  +  W D   +TLNFITE+ TSG LR+Y+ K+  + ++A+K W++Q
Sbjct:    69 VHLLSTLNHKSIIRFYTSWIDVHNHTLNFITELFTSGTLRQYKNKYLRIDIRAIKSWARQ 128

Query:   137 ILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             IL+GL YLH H+P VIHRDL C N+FVNG+ GQVKIGDL
Sbjct:   129 ILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLGQVKIGDL 167

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0010260 "organ senescence" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q6ICW6	WNK11_ARATH	2, ., 7, ., 1, 1, ., 1	0.8074	0.8356	0.5828	yes	no
Q0D541	WNK5_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7272	0.7488	0.5015	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	219
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-35
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-34
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-31
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-30
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-27
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-26
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-25
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-25
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	9e-24
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-22
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-22
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-21
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-19
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-19
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-19
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-18
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-18
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-17
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-17
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-17
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-16
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-15
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-15
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-15
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-15
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-14
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-13
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-13
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-13
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-13
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-12
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-12
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-12
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-11
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-11
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-11
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	8e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-10
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-10
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-10
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-10
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	8e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-09
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-09
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-08
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-08
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-08
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-08
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-08
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-08
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-08
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-08
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-07
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-07
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-07
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-07
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-07
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-07
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	9e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-06
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-06
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-06
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-06
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-06
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-06
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-06
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-06
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-06
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	8e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-06
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-06
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-06
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-05
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-05
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-05
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-05
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-04
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-04
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-04
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-04
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-04
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-04
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-04
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-04
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-04
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-04
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-04
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-04
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	7e-04
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.001
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	0.001
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.002
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	0.002
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	0.003
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	0.003

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  124 bits (314), Expect = 1e-35
 Identities = 50/151 (33%), Positives = 86/151 (56%), Gaps = 8/151 (5%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G    VY A D++ G +VA   +K     D  +++E L  E+ +LK L + NI+ L+
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKE---DSSSLLEELLREIEILKKLNHPNIVKLY 57

Query: 93  YVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
            V+  ED N L  + E C  G+L++  ++    +S   + +   QIL+GL YLH++   +
Sbjct: 58  GVF--EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--I 113

Query: 152 IHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
           IHRDL   N+ ++ + G+VK+ D G++ ++ 
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLT 144

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  121 bits (305), Expect = 8e-34
 Identities = 52/152 (34%), Positives = 82/152 (53%), Gaps = 8/152 (5%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG G+  KVY A D++ G  VA   +K +    D   I R   E+++LK L + NI+ 
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILR---EIKILKKLKHPNIVR 61

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L+ V+  ED + L  + E C  G+L +  KK   +S    + + +QIL  L YLH+    
Sbjct: 62  LYDVF--EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK--G 117

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
           ++HRDL   N+ ++ + G VK+ D G+A  + 
Sbjct: 118 IVHRDLKPENILLDED-GHVKLADFGLARQLD 148

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  115 bits (291), Expect = 1e-31
 Identities = 55/152 (36%), Positives = 89/152 (58%), Gaps = 5/152 (3%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           ELLG G+   VY A D++ G  +A   V+L    D    +E L  E+R+L +L + NI+ 
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELS--GDSEEELEALEREIRILSSLQHPNIVR 63

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            +   RDE++NTLN   E  + G+L    KK   +    ++K+++QIL+GL YLH++   
Sbjct: 64  YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN--G 121

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
           ++HRD+  +N+ V+ + G VK+ D G A  +G
Sbjct: 122 IVHRDIKGANILVDSD-GVVKLADFGCAKRLG 152

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  112 bits (283), Expect = 2e-30
 Identities = 51/149 (34%), Positives = 80/149 (53%), Gaps = 7/149 (4%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
             LGSG+   VY+A  +  G  VA   +K R+  +     +    E+R+L+ L++ NI+ 
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS--EKSKKDQTARREIRILRRLSHPNIVR 62

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L   + D+D   L  + E C  G+L +Y  +   +S    KK + QIL+GL YLH++   
Sbjct: 63  LIDAFEDKDH--LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG-- 118

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
           +IHRDL   N+ ++   G VKI D G+A 
Sbjct: 119 IIHRDLKPENILLD-ENGVVKIADFGLAK 146

Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 1e-27
 Identities = 50/154 (32%), Positives = 77/154 (50%), Gaps = 7/154 (4%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           +L+G GA   VY+  + E G  VA  Q+ L         ++ +  E+ LLK L + NI+ 
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEK--IKEEALKSIMQEIDLLKNLKHPNIVK 63

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
             Y+   E  ++L  I E   +G+LR+  KK        +  +  Q+L+GL YL  HE  
Sbjct: 64  --YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYL--HEQG 119

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA 184
           VIHRD+  +N+    + G VK+ D GVA  +   
Sbjct: 120 VIHRDIKAANILTTKD-GVVKLADFGVATKLNDV 152

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  102 bits (256), Expect = 1e-26
 Identities = 48/155 (30%), Positives = 76/155 (49%), Gaps = 15/155 (9%)

Query: 30  NELLGSGAVKKVYRAF----DQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLA 84
            + LG GA  +VY+        ++ +EVA   VK L+        IE    E R+++ L 
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVA---VKTLKE-DASEQQIEEFLREARIMRKLD 59

Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNY 143
           + N++ L  V  +E+   L  + E    G+L  Y +K+R  +S+  L  ++ QI +G+ Y
Sbjct: 60  HPNVVKLLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117

Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           L +     IHRDL   N  V  N   VKI D G++
Sbjct: 118 LESK--NFIHRDLAARNCLVGEN-LVVKISDFGLS 149

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  101 bits (254), Expect = 3e-26
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 16/156 (10%)

Query: 30  NELLGSGAVKKVYRAF----DQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLA 84
            + LG GA  +VY+         + +EVA   VK L+        IE    E R+++ L 
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVA---VKTLKE-DASEQQIEEFLREARIMRKLD 59

Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH--VSVKALKKWSKQILKGLN 142
           + NI+ L  V  +E+   L  + E    G+L +Y +K+R   +S+  L  ++ QI +G+ 
Sbjct: 60  HPNIVKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117

Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           YL +     IHRDL   N  V  N   VKI D G++
Sbjct: 118 YLESK--NFIHRDLAARNCLVGEN-LVVKISDFGLS 150

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 99.5 bits (249), Expect = 2e-25
 Identities = 39/152 (25%), Positives = 75/152 (49%), Gaps = 11/152 (7%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           + +G G+  KVY    + +G      ++ L          E   +EV++LK L + NII 
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDL--SNMSEKEREDALNEVKILKKLNHPNIIK 63

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNL----REYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            +  +  E++  L  + E    G+L    ++ +K+ +    + +  W  Q+   L YLH+
Sbjct: 64  YYESF--EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121

Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            +  ++HRD+   N+F+  + G VK+GD G++
Sbjct: 122 RK--ILHRDIKPQNIFLT-SNGLVKLGDFGIS 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 98.7 bits (247), Expect = 3e-25
 Identities = 43/156 (27%), Positives = 69/156 (44%), Gaps = 13/156 (8%)

Query: 28  RYNELLGSGAVKKVYRAF----DQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL 83
              + LG GA  +VY+       +    +VA   VK           E    E  ++K L
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVA---VKTLKEGASEEEREEFLEEASIMKKL 58

Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLN 142
           ++ NI+ L  V    +   +  +TE    G+L ++ RK    +++K L + + QI KG+ 
Sbjct: 59  SHPNIVRLLGVCTQGEPLYI--VTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116

Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           YL +     +HRDL   N  V      VKI D G++
Sbjct: 117 YLESK--NFVHRDLAARNCLV-TENLVVKISDFGLS 149

Length = 258

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 95.2 bits (238), Expect = 9e-24
 Identities = 53/162 (32%), Positives = 80/162 (49%), Gaps = 17/162 (10%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS----EVRLLKTLANK 86
           E LG G    VY+A D++ G  VA  +++L          E + S    E+ LLK L + 
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKIRLDN------EEEGIPSTALREISLLKELKHP 58

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           NI+ L  V   E +  L F  E C   +L++Y  K    +S   +K    Q+L+GL Y H
Sbjct: 59  NIVKLLDVIHTERKLYLVF--EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115

Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR 187
           +H   ++HRDL   N+ +N   G +K+ D G+A   G  +R 
Sbjct: 116 SH--RILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLRT 154

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 92.8 bits (231), Expect = 1e-22
 Identities = 45/150 (30%), Positives = 77/150 (51%), Gaps = 7/150 (4%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +G G    VY+A D+  G  VA  ++KLR   +   + +    E++LLK L + NII L 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRF--ESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
            V+R +    L  + E   +   +  + + R +    +K +  Q+L+GL + H+H   ++
Sbjct: 65  DVFRHKGD--LYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--IL 120

Query: 153 HRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
           HRDL   N+ +N   G +K+ D G+A   G
Sbjct: 121 HRDLKPENLLINTE-GVLKLADFGLARSFG 149

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 91.9 bits (229), Expect = 1e-22
 Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 11/155 (7%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G+   VY+   +  G   A   +K      D    ++L  E++ L++  +  ++  +
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYA---LKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65

Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT--HEPC 150
             +       ++ + E    G+L +  KK   +    L   ++QILKGL+YLHT  H   
Sbjct: 66  GAF--YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--- 120

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI 185
           +IHRD+  SN+ +N + G+VKI D G++ ++   +
Sbjct: 121 IIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTL 154

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 89.1 bits (222), Expect = 1e-21
 Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 20/160 (12%)

Query: 31  ELLGSGAVKKVYRAF---DQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
           + LG GA  +VY+        +  EVA   VK           +    E R++K L + N
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVA---VKTLKEDASEEERKDFLKEARVMKKLGHPN 57

Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH---------VSVKALKKWSKQIL 138
           ++ L  V  +E+   L  + E    G+L +Y +K R          +S+K L  ++ QI 
Sbjct: 58  VVRLLGVCTEEEPLYL--VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115

Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           KG+ YL       +HRDL   N  V  +   VKI D G++
Sbjct: 116 KGMEYLA--SKKFVHRDLAARNCLVGED-LVVKISDFGLS 152

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.3 bits (219), Expect = 3e-21
 Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 12/155 (7%)

Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC-DDPAM---IERLFSEVRLLKTL 83
           R  +LLG GA  +VY  +D + G E+A  QV    F  D P     +  L  E++LLK L
Sbjct: 5   RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVP---FDPDSPETKKEVNALECEIQLLKNL 61

Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
            ++ I+   Y     D  TL+   E    G++++  K +  ++    +K+++QIL+G+ Y
Sbjct: 62  QHERIV--QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEY 119

Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           LH++   ++HRD+  +N+  +   G VK+GD G +
Sbjct: 120 LHSNM--IVHRDIKGANILRDSA-GNVKLGDFGAS 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 86.2 bits (213), Expect = 2e-20
 Identities = 47/154 (30%), Positives = 87/154 (56%), Gaps = 8/154 (5%)

Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM---IERLFSEVRLLKTLA 84
           R  +LLG GA  +VY  +D + G E+A  QV+     + P     +  L  E++LLK L 
Sbjct: 5   RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDP--ESPETSKEVNALECEIQLLKNLL 62

Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
           ++ I+  +   RD    TL+   E    G++++  K +  ++    +K+++QIL+G++YL
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           H++   ++HRD+  +N+  + + G VK+GD G +
Sbjct: 123 HSN--MIVHRDIKGANILRD-SVGNVKLGDFGAS 153

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 85.3 bits (212), Expect = 5e-20
 Identities = 41/151 (27%), Positives = 79/151 (52%), Gaps = 15/151 (9%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD--DPAMIERLFSEVRLLKTLANKNIIS 90
           +G G   +VY+A +++ G  VA  ++++    +      I     E++LL+ L + NI+ 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62

Query: 91  LHYVWRDEDRNTLNFITEVCT---SGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
           L  +   + + ++  + E      +G L     K    +   +K + KQ+L+GL YLH++
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIKCYMKQLLEGLQYLHSN 119

Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              ++HRD+  SN+ +N N G +K+ D G+A
Sbjct: 120 G--ILHRDIKGSNILIN-NDGVLKLADFGLA 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 84.6 bits (210), Expect = 1e-19
 Identities = 45/163 (27%), Positives = 79/163 (48%), Gaps = 25/163 (15%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD----------DPAMIERLFSEVRLL 80
           +++G G+   V  A ++E   E A   +K+    D              IE+   EV L 
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYA---IKI---LDKRQLIKEKKVKYVKIEK---EV-LT 56

Query: 81  KTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKG 140
           +   +  II L+Y ++DE+   L F+ E   +G L +Y +K+  +  K  + ++ +IL  
Sbjct: 57  RLNGHPGIIKLYYTFQDEEN--LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLA 114

Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR 183
           L YLH+    +IHRDL   N+ ++ +   +KI D G A ++  
Sbjct: 115 LEYLHSKG--IIHRDLKPENILLDKD-MHIKITDFGTAKVLDP 154

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 84.4 bits (207), Expect = 3e-19
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 16/157 (10%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVK--LRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
             LG G+  +VY A D++         +K   +        +ER   E+++L +L    N
Sbjct: 6   RKLGEGSFGEVYLARDRKLVA------LKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH---VSVKALKKWSKQILKGLNYL 144
           I+ L+  ++DE    L  + E    G+L +  KK      +S         QIL  L YL
Sbjct: 60  IVKLYDFFQDEGSLYL--VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           H+    +IHRD+   N+ ++ +   VK+ D G+A ++
Sbjct: 118 HSK--GIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152

Length = 384

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.4 bits (203), Expect = 4e-19
 Identities = 44/152 (28%), Positives = 85/152 (55%), Gaps = 4/152 (2%)

Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM-IERLFSEVRLLKTLANK 86
           R  +LLG GA  +VY  +D + G E+A  QV       + +  +  L  E++LLK L + 
Sbjct: 5   RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            I+  +   RD +   L+   E    G++++  K +  ++    +++++QIL+G++YLH+
Sbjct: 65  RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124

Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +   ++HRD+  +N+  + + G VK+GD G +
Sbjct: 125 N--MIVHRDIKGANILRD-SAGNVKLGDFGAS 153

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 81.3 bits (200), Expect = 1e-18
 Identities = 47/154 (30%), Positives = 86/154 (55%), Gaps = 8/154 (5%)

Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM---IERLFSEVRLLKTLA 84
           R  +LLG GA  +VY  +D + G E+A  QV+     + P     +  L  E++LLK L 
Sbjct: 5   RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDP--ESPETSKEVSALECEIQLLKNLQ 62

Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
           ++ I+  +   RD    TL    E    G++++  K +  ++    +K+++QIL+G++YL
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYL 122

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           H++   ++HRD+  +N+  + + G VK+GD G +
Sbjct: 123 HSN--MIVHRDIKGANILRD-SAGNVKLGDFGAS 153

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 80.5 bits (199), Expect = 2e-18
 Identities = 49/155 (31%), Positives = 77/155 (49%), Gaps = 6/155 (3%)

Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKL-RTFCDDPAMIERLFSEVRLLKTLANK 86
           R  ELLGSG+   VY   + ++G   A  +V L          +++L  E+ LL  L + 
Sbjct: 3   RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
           NI+      R+ED   L    E+   G+L +  KK+       ++ +++QIL GL YLH 
Sbjct: 63  NIVQYLGTEREEDN--LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
                +HRD+  +N+ V+   G VK+ D G+A  V
Sbjct: 121 RN--TVHRDIKGANILVD-TNGVVKLADFGMAKQV 152

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 3e-18
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 18/167 (10%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD--PAMIERLFSEVRLLKTL---AN 85
             +G GA   VY+A D   G  VA  +V++    ++  P    R   E+ LLK L    +
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPL-SEEGIPLSTLR---EIALLKQLESFEH 60

Query: 86  KNIISLH---YVWRDEDRNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKG 140
            NI+ L    +  R +    L  + E     +L  Y  K     +  + +K   +Q+L+G
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRG 119

Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR 187
           +++LH+H   ++HRDL   N+ V  + GQVKI D G+A I    +  
Sbjct: 120 VDFLHSH--RIVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMAL 163

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 79.6 bits (197), Expect = 5e-18
 Identities = 45/160 (28%), Positives = 84/160 (52%), Gaps = 10/160 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G   +VY+A  +  G EVA   +KL +        E++ +E+++LK   + NI+ 
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLES----KEKKEKIINEIQILKKCKHPNIVK 61

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV-SVKALKKWSKQILKGLNYLHTHEP 149
            +  +  +D   L  + E C+ G+L++  K      +   +    K++LKGL YLH++  
Sbjct: 62  YYGSYLKKDE--LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG- 118

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIR 189
            +IHRD+  +N+ +  + G+VK+ D G++A +     R  
Sbjct: 119 -IIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKARNT 156

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 79.1 bits (195), Expect = 8e-18
 Identities = 48/152 (31%), Positives = 78/152 (51%), Gaps = 10/152 (6%)

Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDP-----AMIERLFSEVRLLKTLANK 86
           L+GSG+   VY   +   G  +A  QV+L +          +M++ L  E+ LLK L ++
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
           NI+   Y+    D + LN   E    G++      +       ++ + +QILKGLNYLH 
Sbjct: 67  NIV--QYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
               +IHRD+  +N+ V+ N G +KI D G++
Sbjct: 125 RG--IIHRDIKGANILVD-NKGGIKISDFGIS 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 78.6 bits (194), Expect = 1e-17
 Identities = 44/148 (29%), Positives = 78/148 (52%), Gaps = 10/148 (6%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +G G    VY+A    +G  VA  +V++    D  A  +    E+ LLK L + N+I   
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR-QDCLKEIDLLKQLDHPNVIK-- 66

Query: 93  YVWRDEDRNTLNFITEVCTSGNL----REYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           Y+    + N LN + E+  +G+L    + ++K+ R +  + + K+  Q+   L ++H+  
Sbjct: 67  YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
             ++HRD+  +NVF+    G VK+GDLG
Sbjct: 127 --IMHRDIKPANVFITAT-GVVKLGDLG 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 78.2 bits (193), Expect = 2e-17
 Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 13/163 (7%)

Query: 25  RYGRYNELLGSGAVKKVYRA----FDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRL 79
           R+ ++ + LG G   KV            G +VA   VK L    ++    +    E+ +
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVA---VKSLNHSGEEQHRSD-FEREIEI 59

Query: 80  LKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQIL 138
           L+TL ++NI+    V       +L  I E   SG+LR+Y ++HR  +++K L  +S QI 
Sbjct: 60  LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQIC 119

Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           KG++YL +     IHRDL   N+ V  +   VKI D G+A ++
Sbjct: 120 KGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLAKVL 159

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 77.6 bits (192), Expect = 5e-17
 Identities = 56/163 (34%), Positives = 85/163 (52%), Gaps = 14/163 (8%)

Query: 25  RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVK--LRTFCDDPAMIERLFSEVRLLKT 82
           RY    + +GSGA   V  A D+  G +VA   +K     F DD    +R+  E++LL+ 
Sbjct: 1   RY-ELLKPIGSGAYGVVCSAVDKRTGRKVA---IKKISNVF-DDLIDAKRILREIKLLRH 55

Query: 83  LANKNIISLHYVWRDEDRNTLN---FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILK 139
           L ++NII L  + R       N    +TE+  + +L +  K  + ++   ++ +  QIL+
Sbjct: 56  LRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILR 114

Query: 140 GLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
           GL YLH+    VIHRDL  SN+ VN N   +KI D G+A  V 
Sbjct: 115 GLKYLHSAN--VIHRDLKPSNILVNSNC-DLKICDFGLARGVD 154

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 76.8 bits (189), Expect = 5e-17
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 9/154 (5%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
             +G G+   V++   + +    A  Q+ L     +    E    E R+L  L +  II 
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIR 63

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS--KQILKGLNYLHTHE 148
            +  + D+ +  LN + E   +G+L +  K  R   +   + W    QIL GL +LH+ +
Sbjct: 64  YYESFLDKGK--LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
             ++HRD+   N+F++     VKIGDLGVA ++ 
Sbjct: 122 --ILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLS 152

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 76.9 bits (190), Expect = 7e-17
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 24/173 (13%)

Query: 19  ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVR 78
           E DP   Y    E +G GA  +VY+A D+  G EVA  +++LR    +    E + +E+ 
Sbjct: 14  EGDPRELYKNL-EKIGEGASGEVYKATDRATGKEVAIKKMRLR--KQN---KELIINEIL 67

Query: 79  LLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE------YRKKHRHVS-VKALK 131
           ++K   + NI+   Y       + L  + E    G+L +       R     ++ V    
Sbjct: 68  IMKDCKHPNIVD--YYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV---- 121

Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA 184
              +++L+GL YLH+    VIHRD+   N+ ++   G VK+ D G AA + + 
Sbjct: 122 --CREVLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKE 169

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 76.2 bits (188), Expect = 7e-17
 Identities = 43/157 (27%), Positives = 86/157 (54%), Gaps = 7/157 (4%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +G G   KVY A + + G  +A  +++++   +DP  I+ +  E+++L+ L + N++  +
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQD--NDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
            V  +  R  +    E C+ G L E  +  R +    ++ ++ Q+L+GL YLH+H   ++
Sbjct: 66  GV--EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IV 121

Query: 153 HRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIR 189
           HRD+  +N+F++ N G +K+GD G A  +      + 
Sbjct: 122 HRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTMG 157

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 76.5 bits (189), Expect = 1e-16
 Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 10/164 (6%)

Query: 28  RYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER-LFSEVRLLKTLA 84
           RY   + LG G    VY+A D+E G  VA  ++KL    +    I      E++LL+ L 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA-LKKWSKQILKGLNY 143
           + NII L  V+     N +N + E     +L +  K    V   A +K +    L+GL Y
Sbjct: 61  HPNIIGLLDVF-GHKSN-INLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117

Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR 187
           LH++   ++HRDL  +N+ +  + G +K+ D G+A   G   R+
Sbjct: 118 LHSNW--ILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRK 158

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 75.2 bits (185), Expect = 2e-16
 Identities = 44/155 (28%), Positives = 76/155 (49%), Gaps = 15/155 (9%)

Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKNII 89
            LG G+   VY+     +    A  +V L +        ER  +  E+R+L ++ + NII
Sbjct: 7   KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK----EREDAVNEIRILASVNHPNII 62

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREY----RKKHRHVSVKALKKWSKQILKGLNYLH 145
           S    + D   N L  + E    G+L +     +KK + +  + + +   Q+L+GL  LH
Sbjct: 63  SYKEAFLDG--NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
             +  ++HRDL  +N+ +  N   VKIGDLG++ +
Sbjct: 121 EQK--ILHRDLKSANILLVAN-DLVKIGDLGISKV 152

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 75.5 bits (186), Expect = 2e-16
 Identities = 52/157 (33%), Positives = 84/157 (53%), Gaps = 9/157 (5%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    V++A ++E    VA  +V+L    DD  +      E+ LLK L +KNI+ 
Sbjct: 6   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVR 63

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTHEP 149
           L+ V   + + TL F  E C   +L++Y       +  + +K +  Q+LKGL + H+H  
Sbjct: 64  LYDVLHSDKKLTLVF--EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN- 119

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR 186
            V+HRDL   N+ +N N G++K+ D G+A   G  +R
Sbjct: 120 -VLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVR 154

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 75.3 bits (185), Expect = 2e-16
 Identities = 55/163 (33%), Positives = 80/163 (49%), Gaps = 16/163 (9%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPA--MIERLFSEVRLLKTLANKNI 88
           E+LG GA   VY      +G  +A  QV+L T     A    E+L  EV LLK+L + NI
Sbjct: 6   EVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           +   Y+    D NT++   E    G++     +   +      K++KQIL G+ YL  H 
Sbjct: 65  VQ--YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYL--HN 120

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCW 191
            CV+HRD+  +NV +  N G +K+ D G A       RR+  W
Sbjct: 121 NCVVHRDIKGNNVMLMPN-GIIKLIDFGCA-------RRL-AW 154

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 73.9 bits (181), Expect = 6e-16
 Identities = 48/155 (30%), Positives = 85/155 (54%), Gaps = 10/155 (6%)

Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
           R  + +G G   +VYRA    +G+ VA  +V++    D  A  +    E+ LLK L + N
Sbjct: 5   RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARAD-CIKEIDLLKQLNHPN 63

Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNL----REYRKKHRHVSVKALKKWSKQILKGLNY 143
           +I  +  + ++  N LN + E+  +G+L    + ++K+ R +  K + K+  Q+   L +
Sbjct: 64  VIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +H+    V+HRD+  +NVF+   TG VK+GDLG+ 
Sbjct: 122 MHSRR--VMHRDIKPANVFITA-TGVVKLGDLGLG 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 73.1 bits (180), Expect = 1e-15
 Identities = 42/160 (26%), Positives = 78/160 (48%), Gaps = 10/160 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G+   V +   + +G  + W ++            ++L SEV +L+ L + NI+ 
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVR 63

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNL----REYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            +    D    TL  + E C  G+L    ++ +K+ +++  + + +   Q+L  L   H 
Sbjct: 64  YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 147 HEPC---VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR 183
                  V+HRDL  +N+F++ N   VK+GD G+A I+G 
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKILGH 162

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 72.9 bits (179), Expect = 2e-15
 Identities = 47/155 (30%), Positives = 78/155 (50%), Gaps = 12/155 (7%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG G    VY+  ++  G  VA  ++ L      P+   R   E+ L+K L ++NI+ 
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHENIVR 62

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH---VSVKALKKWSKQILKGLNYLHTH 147
           LH V   E++  L F  E     +L++Y   H     +    +K ++ Q+LKG+ + H +
Sbjct: 63  LHDVIHTENKLMLVF--EYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
              V+HRDL   N+ +N   G++K+ D G+A   G
Sbjct: 120 R--VLHRDLKPQNLLINKR-GELKLADFGLARAFG 151

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 73.3 bits (180), Expect = 2e-15
 Identities = 47/167 (28%), Positives = 86/167 (51%), Gaps = 18/167 (10%)

Query: 27  GRYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA 84
            RY +L  LG G+   V+ A D +    VA  ++ L     DP  ++    E+++++ L 
Sbjct: 5   SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT----DPQSVKHALREIKIIRRLD 60

Query: 85  NKNIISLHYVWRD---EDRNTLNFITEVCTSGNLREYRK-------KHRHVSVKALKKWS 134
           + NI+ ++ V      +    +  +TE+ +   ++EY +       +   +S +  + + 
Sbjct: 61  HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFM 120

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
            Q+L+GL Y+H+    V+HRDL  +NVF+N     +KIGD G+A IV
Sbjct: 121 YQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIV 165

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 73.3 bits (180), Expect = 2e-15
 Identities = 55/160 (34%), Positives = 87/160 (54%), Gaps = 20/160 (12%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY +L  +G GA   V  A DQ  G  VA  ++ ++ F   P + +R + E++LLK L +
Sbjct: 11  RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-MKPF-STPVLAKRTYRELKLLKHLRH 68

Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK-----WSKQILKG 140
           +NIISL  ++       + F+TE+  +         HR ++ + L+K     +  QIL+G
Sbjct: 69  ENIISLSDIFISP-LEDIYFVTELLGT-------DLHRLLTSRPLEKQFIQYFLYQILRG 120

Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
           L Y+H+    V+HRDL  SN+ +N N   +KI D G+A I
Sbjct: 121 LKYVHS--AGVVHRDLKPSNILINENC-DLKICDFGLARI 157

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 3e-15
 Identities = 50/158 (31%), Positives = 81/158 (51%), Gaps = 14/158 (8%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +GSG    VY+A D   G  VA   +KL    DD  +I++   E+ +LK   + NI++  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKL-EPGDDFEIIQQ---EISMLKECRHPNIVAYF 66

Query: 93  --YVWRDEDRNTLNFITEVCTSGNLRE-YRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
             Y+ RD+    L  + E C  G+L++ Y+     +S   +    ++ LKGL YLH    
Sbjct: 67  GSYLRRDK----LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG- 121

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR 187
             IHRD+  +N+ +  + G VK+ D GV+A +   I +
Sbjct: 122 -KIHRDIKGANILLTED-GDVKLADFGVSAQLTATIAK 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 3e-15
 Identities = 39/155 (25%), Positives = 70/155 (45%), Gaps = 21/155 (13%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G+  +VY+A D+     VA   + L    D+   IE +  E++ L    +  I  
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE---IEDIQQEIQFLSQCRSPYITK 63

Query: 91  LH--YVWRDEDRNTLNFITEVCTSGN----LREYRKKHRHVSVKALKKWSKQILKGLNYL 144
            +  ++      + L  I E C  G+    L+  +    +++        +++L GL YL
Sbjct: 64  YYGSFL----KGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFIL-----REVLLGLEYL 114

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
           H      IHRD+  +N+ ++   G VK+ D GV+ 
Sbjct: 115 HEEG--KIHRDIKAANILLS-EEGDVKLADFGVSG 146

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 71.9 bits (176), Expect = 4e-15
 Identities = 37/109 (33%), Positives = 64/109 (58%), Gaps = 4/109 (3%)

Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVK 128
           I  L  E+ +L+ L ++NI+    +  ++  N +  I E   SG+L+EY  +++  +++K
Sbjct: 50  IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK 109

Query: 129 ALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV 177
              K++ QI KG++YL + +   +HRDL   NV V  +  QVKIGD G+
Sbjct: 110 QQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGL 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 72.0 bits (177), Expect = 4e-15
 Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 15/159 (9%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC---DDPAMIERLFSEVRLLKT 82
           +Y +L  +G G+   V++  ++E G  VA     ++ F    DDP + +    E+R+LK 
Sbjct: 2   KYEKLSKIGEGSYGVVFKCRNRETGQIVA-----IKKFVESEDDPVIKKIALREIRMLKQ 56

Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLN 142
           L + N+++L  V+R + +  L+ + E C    L E  K  R V    +KK   Q L+ +N
Sbjct: 57  LKHPNLVNLIEVFRRKRK--LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114

Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           + H H    IHRD+   N+ +    GQ+K+ D G A I+
Sbjct: 115 FCHKHN--CIHRDVKPENILITKQ-GQIKLCDFGFARIL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 70.5 bits (173), Expect = 1e-14
 Identities = 56/163 (34%), Positives = 77/163 (47%), Gaps = 21/163 (12%)

Query: 26  YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-- 83
           Y R  EL+G GA   VYR      G  VA   + L T  DD + I+R   EV LL  L  
Sbjct: 3   YQRL-ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR---EVALLSQLRQ 58

Query: 84  -ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRK----KHRHVSVKALKKWSKQIL 138
               NI   +  +    R  L  I E    G++R   K      +++SV       +++L
Sbjct: 59  SQPPNITKYYGSYLKGPR--LWIIMEYAEGGSVRTLMKAGPIAEKYISVII-----REVL 111

Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
             L Y+H     VIHRD+  +N+ V  NTG VK+ D GVAA++
Sbjct: 112 VALKYIH-KVG-VIHRDIKAANILVT-NTGNVKLCDFGVAALL 151

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 70.5 bits (173), Expect = 1e-14
 Identities = 43/150 (28%), Positives = 80/150 (53%), Gaps = 10/150 (6%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG GA   V +   +  G+  A   +K  T   +P + +++  E+ + K+  +  I+  +
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFA---LKTITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65

Query: 93  YVWRDEDRNTLNFITEVCTSGNL----REYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
             + DE  +++    E C  G+L    ++ +K+   +  K L K ++ +LKGL+YLH+ +
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             +IHRD+  SN+ +    GQVK+ D GV+
Sbjct: 126 --IIHRDIKPSNILLTRK-GQVKLCDFGVS 152

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 69.8 bits (171), Expect = 2e-14
 Identities = 44/148 (29%), Positives = 75/148 (50%), Gaps = 10/148 (6%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG GA  KVY+A  +E G+  A   +++         +E    E+ +L    + NI+ L+
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLY 68

Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA-LKKWSKQILKGLNYLHTHEPCV 151
             +  E++  L  + E C  G L     +      +  ++   +Q+L+ LN+LH+H+  V
Sbjct: 69  EAYFYENK--LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--V 124

Query: 152 IHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
           IHRDL   N+ +  + G VK+ D GV+A
Sbjct: 125 IHRDLKAGNILLTLD-GDVKLADFGVSA 151

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 69.9 bits (172), Expect = 2e-14
 Identities = 54/157 (34%), Positives = 79/157 (50%), Gaps = 16/157 (10%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISL 91
           LG G    VY A ++E G  VA  ++K + +  +  M  R   EV+ L+ L  + NI+ L
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR---EVKSLRKLNEHPNIVKL 63

Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREY--RKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
             V+R+ D   L F+ E    GNL +    +K +  S   ++    QIL+GL ++H H  
Sbjct: 64  KEVFREND--ELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG- 119

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR 186
              HRDL   N+ V+G    VKI D G+A    R IR
Sbjct: 120 -FFHRDLKPENLLVSG-PEVVKIADFGLA----REIR 150

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 70.2 bits (172), Expect = 3e-14
 Identities = 45/171 (26%), Positives = 82/171 (47%), Gaps = 16/171 (9%)

Query: 18  IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKL----------RTFCDDP 67
           +    + RY +    LG G   KV +A+D   G  VA  +VK+          R      
Sbjct: 2   MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMC 61

Query: 68  AMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSV 127
            +      E++++  + ++NI+ L  V+ + D   +N + ++  + +L++   +   ++ 
Sbjct: 62  GIHFTTLRELKIMNEIKHENIMGLVDVYVEGD--FINLVMDI-MASDLKKVVDRKIRLTE 118

Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             +K    QIL GLN LH      +HRDL+ +N+F+N + G  KI D G+A
Sbjct: 119 SQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLA 166

Length = 335

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 69.3 bits (170), Expect = 3e-14
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 10/158 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A D+  G  VA  +++L T  +D  +      E+ LLK L + NI+ 
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKIRLET--EDEGVPSTAIREISLLKELNHPNIVR 62

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA--LKKWSKQILKGLNYLHTHE 148
           L  V   E++  L F  E     +L++Y        +    +K +  Q+L+G+ Y H+H 
Sbjct: 63  LLDVVHSENKLYLVF--EFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR 119

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR 186
             V+HRDL   N+ ++   G +K+ D G+A   G  +R
Sbjct: 120 --VLHRDLKPQNLLID-REGALKLADFGLARAFGVPVR 154

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 69.0 bits (169), Expect = 4e-14
 Identities = 36/107 (33%), Positives = 58/107 (54%), Gaps = 4/107 (3%)

Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWS 134
           E+ +LK+L + NI+    V     R  L  + E    G+LR+Y +KHR  +  + L  ++
Sbjct: 55  EIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYA 114

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
            QI KG+ YL +     +HRDL   N+ V  +  +VKIGD G+  ++
Sbjct: 115 SQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVL 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 68.7 bits (169), Expect = 4e-14
 Identities = 37/149 (24%), Positives = 70/149 (46%), Gaps = 6/149 (4%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G+  KV     ++ G   A   +K +        +E   +E  +L  + +  I+ LH
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-KEVEHTLTERNILSRINHPFIVKLH 59

Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
           Y ++ E++  L  + E    G L  +  K    S +  + ++ +I+  L YLH+    +I
Sbjct: 60  YAFQTEEK--LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--II 115

Query: 153 HRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           +RDL   N+ ++   G +K+ D G+A  +
Sbjct: 116 YRDLKPENILLD-ADGHIKLTDFGLAKEL 143

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 68.0 bits (166), Expect = 1e-13
 Identities = 46/152 (30%), Positives = 81/152 (53%), Gaps = 8/152 (5%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKL--RTFCDDPAMIERLFSEVRLLKTLANKNI 88
           + LG+GA    Y+A D + G  +A  QV     T  +   ++E L  E+RL+  L + +I
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           I +      ED +  N   E    G++     K+       +  +++Q+L+GL+YLH ++
Sbjct: 66  IRMLGATC-EDSH-FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ 123

Query: 149 PCVIHRDLNCSNVFVNGNTGQ-VKIGDLGVAA 179
             +IHRD+  +N+ ++ +TGQ ++I D G AA
Sbjct: 124 --IIHRDVKGANLLID-STGQRLRIADFGAAA 152

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 67.3 bits (165), Expect = 1e-13
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 12/152 (7%)

Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
            E LG G+   VY+A  +E G  VA   V +         ++ +  E+ +LK   +  I+
Sbjct: 8   LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIV 61

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRK-KHRHVSVKALKKWSKQILKGLNYLHTHE 148
             +  +       L  + E C +G++ +  K  ++ ++ + +     Q LKGL YLH+++
Sbjct: 62  KYYGSYFKN--TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
              IHRD+   N+ +N   GQ K+ D GV+  
Sbjct: 120 --KIHRDIKAGNILLN-EEGQAKLADFGVSGQ 148

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 2e-13
 Identities = 52/177 (29%), Positives = 90/177 (50%), Gaps = 20/177 (11%)

Query: 21  DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           DPTG +    E++G G   KVY+A  ++ G  VA   +K+    +D    E +  E  +L
Sbjct: 3   DPTGIFELV-EVIGEGTYGKVYKARHKKTGQLVA---IKIMDIIED--EEEEIKEEYNIL 56

Query: 81  KTLAN-KNIISLHYVWRDED----RNTLNFITEVCTSGNLREYRKKHRHVSVKALKK-W- 133
           +  +N  NI + +  +  ++     + L  + E+C  G++ +  K  R    K LK+ W 
Sbjct: 57  RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-KRLKEEWI 115

Query: 134 ---SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR 187
               ++ L+GL YLH ++  VIHRD+   N+ +  N  +VK+ D GV+A +   + R
Sbjct: 116 AYILRETLRGLAYLHENK--VIHRDIKGQNILLTKN-AEVKLVDFGVSAQLDSTLGR 169

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 67.2 bits (164), Expect = 2e-13
 Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 11/148 (7%)

Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
           +LG G    VY A D    + +A  ++  R    D   ++ L  E+ L   L ++NI+  
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYLKHRNIV-- 68

Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVK--ALKKWSKQILKGLNYLHTHE 148
            Y+  D +        E    G+L    R K   +      +  ++KQIL+GL YLH ++
Sbjct: 69  QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
             ++HRD+   NV VN  +G VKI D G
Sbjct: 129 --IVHRDIKGDNVLVNTYSGVVKISDFG 154

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 67.0 bits (163), Expect = 2e-13
 Identities = 45/150 (30%), Positives = 80/150 (53%), Gaps = 10/150 (6%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +G G   +VYRA    +   VA  +V++    D  A  +    E+ LLK L + N+I   
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR-QDCVKEIDLLKQLNHPNVIK-- 66

Query: 93  YVWRDEDRNTLNFITEVCTSGNLRE----YRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           Y+    + N LN + E+  +G+L +    ++K+ R +  + + K+  Q+   + ++H+  
Sbjct: 67  YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             V+HRD+  +NVF+   TG VK+GDLG+ 
Sbjct: 127 --VMHRDIKPANVFITA-TGVVKLGDLGLG 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 3e-13
 Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 32/167 (19%)

Query: 34  GSGAVKKVYRAFDQE--EGIEVAWNQVKLRTFCDDPAMIERL----FSEVRLLKTLANKN 87
           G G   +VY+A  +   +G E A     ++ F  D      +      E+ LL+ L ++N
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYA-----IKKFKGDKEQYTGISQSACREIALLRELKHEN 63

Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREY----------RKKHRHVSVKALKKWSKQI 137
           ++SL  V+ +    ++  + +        E+          + K   +    +K    QI
Sbjct: 64  VVSLVEVFLEHADKSVYLLFDYA------EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117

Query: 138 LKGLNYLHTHEPCVIHRDLNCSNVFVNGN---TGQVKIGDLGVAAIV 181
           L G++YLH++   V+HRDL  +N+ V G     G VKIGDLG+A + 
Sbjct: 118 LNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 4e-13
 Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 14/161 (8%)

Query: 28  RYNELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL 83
              ++LGSGA   VY+     EG    I VA   ++  T    P   + +  E  ++ ++
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASV 66

Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLN 142
            + +++ L  +        +  IT++   G L +Y + H+ ++  + L  W  QI KG++
Sbjct: 67  DHPHVVRLLGICLSS---QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123

Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR 183
           YL      ++HRDL   NV V      VKI D G+A ++  
Sbjct: 124 YLEEKR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLDV 161

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 66.4 bits (162), Expect = 4e-13
 Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 18/163 (11%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN--- 87
           E +G G   KVY+A D+  G  VA  + +L    D+  +      E+ LL+ L+      
Sbjct: 7   EKIGEGTYGKVYKARDKNTGKLVALKKTRLEM--DEEGIPPTALREISLLQMLSESIYIV 64

Query: 88  -IISLHYVWRDEDRNTLNFITEVCTSGNLREY-----RKKHRHVSVKALKKWSKQILKGL 141
            ++ + +V     + +L  + E   S +L+++     R   R +  K +K +  Q+LKG+
Sbjct: 65  RLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123

Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA 184
            + H H   V+HRDL   N+ V+   G +KI DLG    +GRA
Sbjct: 124 AHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLG----LGRA 160

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 66.2 bits (162), Expect = 5e-13
 Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 11/154 (7%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLA 84
           RY  L  +G GA   V++A D+E G  VA  +V LR      P    R   E++ L+   
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR---EIKALQACQ 57

Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
           +  ++ L  V+       L    E   S      R + R +    +K + + +LKG+ Y+
Sbjct: 58  HPYVVKLLDVFPHGSGFVLVM--EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           H     ++HRDL  +N+ +    G +KI D G+A
Sbjct: 116 H--ANGIMHRDLKPANLLI-SADGVLKIADFGLA 146

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 65.7 bits (160), Expect = 6e-13
 Identities = 57/172 (33%), Positives = 84/172 (48%), Gaps = 15/172 (8%)

Query: 25  RYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRL 79
           RY +   +LG G   KV    Y   +   G  VA   VK L+  C           E+ +
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVA---VKTLKRECG-QQNTSGWKKEINI 59

Query: 80  LKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILK 139
           LKTL ++NI+       ++    L  I E    G+LR+Y  KH+ +++  L  +++QI +
Sbjct: 60  LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQQICE 118

Query: 140 GLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV--GRAIRRIR 189
           G+ YLH+     IHRDL   NV ++ N   VKIGD G+A  V  G    R+R
Sbjct: 119 GMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVR 167

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 65.6 bits (160), Expect = 8e-13
 Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 10/158 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 63

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRK--KHRHVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H 
Sbjct: 64  LLDVIHTE--NKLYLVFEF-LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR 186
             V+HRDL   N+ +N   G +K+ D G+A   G  +R
Sbjct: 121 --VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVR 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 64.4 bits (157), Expect = 2e-12
 Identities = 45/154 (29%), Positives = 77/154 (50%), Gaps = 13/154 (8%)

Query: 33  LGSGAVKK--VYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           LG GA  +  +YR    E+   V W +V L T   +    + L +E+ +L  L + NII+
Sbjct: 8   LGKGAFGEATLYRR--TEDDSLVVWKEVNL-TRLSEKERRDAL-NEIVILSLLQHPNIIA 63

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLRE--YRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
             Y     D NTL    E    G L +   R+K +    + +  +  QI+  ++Y+H  +
Sbjct: 64  --YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH--K 119

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
             ++HRD+   N+F+    G +K+GD G++ I+G
Sbjct: 120 AGILHRDIKTLNIFLT-KAGLIKLGDFGISKILG 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 64.3 bits (157), Expect = 2e-12
 Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 7/148 (4%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
            ++G GA   V +  ++  G  VA  + K     DD  + +    EV++L+ L ++NI++
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESE--DDEDVKKTALREVKVLRQLRHENIVN 64

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L   +R + R  L F  E      L         +   A++ +  Q+L+ + Y H+H   
Sbjct: 65  LKEAFRRKGRLYLVF--EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN-- 120

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +IHRD+   N+ V+  +G +K+ D G A
Sbjct: 121 IIHRDIKPENILVS-ESGVLKLCDFGFA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 64.2 bits (157), Expect = 2e-12
 Identities = 36/146 (24%), Positives = 68/146 (46%), Gaps = 10/146 (6%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISL 91
           +G G   +V +A  ++ G   A   +K          +  L  E++ L+ L+ + NI+ L
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKH--FKSLEQVNNL-REIQALRRLSPHPNILRL 63

Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
             V  D     L  + E+    NL E  + + R +  K +K +  Q+LK L+++H +   
Sbjct: 64  IEVLFDRKTGRLALVFEL-MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG-- 120

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLG 176
           + HRD+   N+ +  +   +K+ D G
Sbjct: 121 IFHRDIKPENILIKDDI--LKLADFG 144

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 63.7 bits (155), Expect = 3e-12
 Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 11/154 (7%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKL-RTFCDDP-----AMIERLFSEVRLLKTLA 84
           EL+G G   +VY A +   G  +A  QV+L  T           M++ L SE+  LK L 
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
           + NI+   Y+  +     L+   E    G++    + +     + ++ +++Q+L+GL YL
Sbjct: 67  HLNIVQ--YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           H+    ++HRDL   N+ V+ + G  KI D G++
Sbjct: 125 HSKG--ILHRDLKADNLLVDAD-GICKISDFGIS 155

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 64.0 bits (156), Expect = 3e-12
 Identities = 49/156 (31%), Positives = 82/156 (52%), Gaps = 17/156 (10%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNIISL 91
           +G G   +VY+A D++ G  VA  +V+L    +  P    R   E+++L+ L ++NI++L
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR---EIKILRQLNHRNIVNL 71

Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREY---------RKKHRHVSVKALKKWSKQILKGLN 142
             +  D+  + L+F  +      + EY              H S   +K + KQ+L+GLN
Sbjct: 72  KEIVTDKQ-DALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLN 130

Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           Y H      +HRD+ CSN+ +N N GQ+K+ D G+A
Sbjct: 131 YCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLA 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 64.3 bits (157), Expect = 3e-12
 Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 30/161 (18%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +GSGA   V  A D   G +VA  ++    F D P + +R   E+++L+   + NII+
Sbjct: 11  ENIGSGAYGVVCSAIDTRSGKKVAIKKIP-HAF-DVPTLAKRTLRELKILRHFKHDNIIA 68

Query: 91  LH-------------YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQI 137
           +              YV  D   + L+ I  + +   L E      H+       +  Q+
Sbjct: 69  IRDILRPPGADFKDVYVVMDLMESDLHHI--IHSDQPLTE-----EHIRY-----FLYQL 116

Query: 138 LKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           L+GL Y+H+    VIHRDL  SN+ VN +  +++IGD G+A
Sbjct: 117 LRGLKYIHS--ANVIHRDLKPSNLLVNED-CELRIGDFGMA 154

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 63.9 bits (156), Expect = 4e-12
 Identities = 54/163 (33%), Positives = 83/163 (50%), Gaps = 25/163 (15%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVK--LRTFCDDPAMIERLFSEVRLLKTL 83
           RY  L  +GSGA  +V  AFD + G +VA   +K   R F       +R + E+RLLK +
Sbjct: 16  RYQNLSPVGSGAYGQVCSAFDTKTGRKVA---IKKLSRPF-QSAIHAKRTYRELRLLKHM 71

Query: 84  ANKNIISLHYVW----RDEDRNTLNFITEVCTSGNLREYRKKHR----HVSVKALKKWSK 135
            ++N+I L  V+      ED   +  +T +  + +L    K  +    H+          
Sbjct: 72  DHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSDDHIQFLVY----- 125

Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           QIL+GL Y+H+    +IHRDL  SN+ VN +  ++KI D G+A
Sbjct: 126 QILRGLKYIHSAG--IIHRDLKPSNIAVNEDC-ELKILDFGLA 165

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 63.2 bits (154), Expect = 4e-12
 Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 12/150 (8%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD--PAMIERLFSEVRLLKTLANKNI 88
           + LG G+   V R      G +V    V ++    D    +++    E  ++ +L ++N+
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVI--PVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL 58

Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHT 146
           I L+ V        L  +TE+   G+L +  +K    H  +  L  ++ QI  G+ YL +
Sbjct: 59  IRLYGVVLTH---PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES 115

Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
                IHRDL   N+ +  +  +VKIGD G
Sbjct: 116 KR--FIHRDLAARNILLASDD-KVKIGDFG 142

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 62.8 bits (153), Expect = 5e-12
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 13/153 (8%)

Query: 30  NELLGSGAVKKVYRAF--DQE-EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
              +G G    VY+      E E I VA   VK    C  P++ E+   E  +++   + 
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVA---VKTCKNCTSPSVREKFLQEAYIMRQFDHP 67

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNYLH 145
           +I+ L  V  +   N +  + E+   G LR Y + +++ + + +L  +S Q+   L YL 
Sbjct: 68  HIVKLIGVITE---NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124

Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +    V HRD+   NV V+     VK+GD G++
Sbjct: 125 SKR-FV-HRDIAARNVLVSSPDC-VKLGDFGLS 154

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 62.7 bits (152), Expect = 1e-11
 Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 8/153 (5%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNIISL 91
           +G GA   VY+A D   G  VA   V+++T  D  P    R  + ++ L+   + NI+ L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 92  HYVWRD--EDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTH 147
             V      DR T   +       +LR Y  K     +  + +K   +Q L+GL++LH +
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127

Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
             C++HRDL   N+ V    GQVK+ D G+A I
Sbjct: 128 --CIVHRDLKPENILVTSG-GQVKLADFGLARI 157

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 62.4 bits (152), Expect = 1e-11
 Identities = 46/147 (31%), Positives = 67/147 (45%), Gaps = 7/147 (4%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNIISL 91
           +G G    VYRA D   G  VA  +V++    D  P    R   E+ LL  L + NI+ L
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR---EITLLLNLRHPNIVEL 71

Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
             V   +  +++  + E C               S   +K    Q+L+GL YLH +   +
Sbjct: 72  KEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN--FI 129

Query: 152 IHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           IHRDL  SN+ +    G +KI D G+A
Sbjct: 130 IHRDLKVSNLLLTD-KGCLKIADFGLA 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 62.1 bits (151), Expect = 1e-11
 Identities = 44/162 (27%), Positives = 72/162 (44%), Gaps = 19/162 (11%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQ---VKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
           LG+G   +V+      EG+   WN    V ++T        +   +E +++K L +  +I
Sbjct: 14  LGAGQFGEVW------EGL---WNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLI 64

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREY--RKKHRHVSVKALKKWSKQILKGLNYLHTH 147
            L+ V   E+   +  +TE+   G+L EY      R + +  L   + Q+  G+ YL   
Sbjct: 65  QLYAVCTLEE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ 122

Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIR 189
               IHRDL   NV V G     K+ D G+A ++   I   R
Sbjct: 123 N--YIHRDLAARNVLV-GENNICKVADFGLARVIKEDIYEAR 161

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 61.7 bits (149), Expect = 2e-11
 Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 15/161 (9%)

Query: 21  DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           DP  +Y RY E +G GA   V+ A D   G EVA  Q+ L+     P   E + +E+ ++
Sbjct: 16  DPKKKYTRY-EKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKK-ELIINEILVM 70

Query: 81  KTLANKNIISL--HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
           K L N NI++    ++  DE    L  + E    G+L +   +   +    +    ++ L
Sbjct: 71  KELKNPNIVNFLDSFLVGDE----LFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECL 125

Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
           + L +LH ++  VIHRD+   NV + G  G VK+ D G  A
Sbjct: 126 QALEFLHANQ--VIHRDIKSDNVLL-GMDGSVKLTDFGFCA 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 61.6 bits (149), Expect = 2e-11
 Identities = 49/155 (31%), Positives = 81/155 (52%), Gaps = 11/155 (7%)

Query: 33  LGSGAVKKVYRAFDQEEGIE-VAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNIIS 90
           +G GA  KV++A D + G   VA  +V+++T  +  P    R  + +R L+T  + N++ 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 91  LH---YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLH 145
           L     V R +    L  + E     +L  Y  K     V  + +K    Q+L+GL++LH
Sbjct: 69  LFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127

Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
           +H   V+HRDL   N+ V  ++GQ+K+ D G+A I
Sbjct: 128 SHR--VVHRDLKPQNILVT-SSGQIKLADFGLARI 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 2e-11
 Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 19/157 (12%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKTLANKN 87
             +G GA   V  A  +  G++VA  ++   + +TFC      +R   E+++L+   ++N
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFC------QRTLREIKILRRFKHEN 64

Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQILKGLNY 143
           II +  + R     + N   +V     L E   Y+  K +H+S   ++ +  QIL+GL Y
Sbjct: 65  IIGILDIIRPPSFESFN---DVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKY 121

Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
           +H+    V+HRDL  SN+ +N N   +KI D G+A I
Sbjct: 122 IHSAN--VLHRDLKPSNLLLNTNC-DLKICDFGLARI 155

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 61.2 bits (148), Expect = 3e-11
 Identities = 47/156 (30%), Positives = 78/156 (50%), Gaps = 10/156 (6%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG GA  KVY+A ++E G+  A   +  ++       +E    E+ +L +  + NI+ L 
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLL 68

Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYR-KKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
             +  E  N L  + E C  G +     +  R ++   ++   KQ L+ LNYLH ++  +
Sbjct: 69  DAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--I 124

Query: 152 IHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR 187
           IHRDL   N+    + G +K+ D GV+A   R I+R
Sbjct: 125 IHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQR 159

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 61.2 bits (149), Expect = 3e-11
 Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 21/164 (12%)

Query: 27  GRYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTL 83
             Y  L  LG G   +VY+A   + G  VA  ++ +    D  P    R   E+++LK L
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR---EIKILKKL 64

Query: 84  ANKNIISL---HYVWRDEDRNTLNFITEVCT------SGNLREYRKKHRHVSVKALKKWS 134
            + N++ L        D+ +     +  V        SG L         ++   +K + 
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV---KLTESQIKCYM 121

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            Q+L+G+NYLH +   ++HRD+  +N+ ++ N G +KI D G+A
Sbjct: 122 LQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLA 162

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 60.9 bits (148), Expect = 3e-11
 Identities = 47/159 (29%), Positives = 83/159 (52%), Gaps = 11/159 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+  +++ G  VA  +++L +  ++  +      E+ LLK L + NI+ 
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES--EEEGVPSTAIREISLLKELQHPNIVC 63

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYR---KKHRHVSVKALKKWSKQILKGLNYLHTH 147
           L  V   E R  L  I E   S +L++Y     K +++  + +K +  QIL+G+ + H+ 
Sbjct: 64  LQDVLMQESR--LYLIFEF-LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR 186
              V+HRDL   N+ ++ N G +K+ D G+A   G  +R
Sbjct: 121 R--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVR 156

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 61.0 bits (148), Expect = 4e-11
 Identities = 49/166 (29%), Positives = 76/166 (45%), Gaps = 25/166 (15%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A D+     +A  +++L    +D  +      E+ LLK + + NI+ 
Sbjct: 8   EKIGEGTYGVVYKARDRVTNETIALKKIRLEQ--EDEGVPSTAIREISLLKEMQHGNIVR 65

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYR----KKHRHVS------VKALKKWSKQILKG 140
           L  V   E R  L F           EY     KKH   S       + +K +  QIL+G
Sbjct: 66  LQDVVHSEKRLYLVF-----------EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRG 114

Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR 186
           + Y H+H   V+HRDL   N+ ++  T  +K+ D G+A   G  +R
Sbjct: 115 IAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158

Length = 294

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 60.4 bits (147), Expect = 4e-11
 Identities = 38/146 (26%), Positives = 73/146 (50%), Gaps = 8/146 (5%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG+G    V +   +  G  +A   ++L     + A+ +++  E+ +L    +  I+  +
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNYLHTHEPCV 151
             + +     ++   E    G+L +  K+ +  +  + L K +  +LKGL YLH  +  +
Sbjct: 66  GAFYNN--GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH-EKHKI 122

Query: 152 IHRDLNCSNVFVNGNTGQVKIGDLGV 177
           IHRD+  SN+ VN + GQ+K+ D GV
Sbjct: 123 IHRDVKPSNILVN-SRGQIKLCDFGV 147

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 60.6 bits (147), Expect = 4e-11
 Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 17/173 (9%)

Query: 17  FIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM--IERLF 74
           F + DP   +    E+ G G+   VY A D      VA   +K  ++    +    + + 
Sbjct: 8   FSKDDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVA---IKKMSYSGKQSNEKWQDII 63

Query: 75  SEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC---TSGNLREYRKKHRHVSVKALK 131
            EVR L+ L + N I     +  E  +T   + E C    S  L  ++K  + V + A+ 
Sbjct: 64  KEVRFLQQLRHPNTIEYKGCYLRE--HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI- 120

Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA 184
                 L+GL YLH+H    IHRD+   N+ +    G VK+ D G A++V  A
Sbjct: 121 --CHGALQGLAYLHSH--ERIHRDIKAGNILLTEP-GTVKLADFGSASLVSPA 168

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 59.9 bits (145), Expect = 6e-11
 Identities = 42/151 (27%), Positives = 70/151 (46%), Gaps = 11/151 (7%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD-DPAMIERLFSEVRLLKTLANKNIISL 91
           LG G+   VY   D++   E     +K     + +P    +   E +LL  L +  I+  
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 92  HYVWRDEDRNTLNFITEVCTSGNL----REYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
           H  + + D      ITE C   +L     E +   + +S   + +W  Q+L G++Y+H  
Sbjct: 68  HASFLERD--AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125

Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              ++HRDL   N+F+  N   +KIGD GV+
Sbjct: 126 R--ILHRDLKAKNIFLKNNL--LKIGDFGVS 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 59.7 bits (145), Expect = 8e-11
 Identities = 43/149 (28%), Positives = 75/149 (50%), Gaps = 10/149 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           + LG G+   VY+   +  G  VA  +++L      P    R   E  LLK L + NI++
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR---EASLLKDLKHANIVT 67

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEP 149
           LH +   +   TL  + E   + +L++Y       +S+  ++ +  Q+L+GL Y H    
Sbjct: 68  LHDIIHTKK--TLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR- 123

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            V+HRDL   N+ ++   G++K+ D G+A
Sbjct: 124 -VLHRDLKPQNLLIS-ERGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 58.5 bits (142), Expect = 2e-10
 Identities = 49/158 (31%), Positives = 70/158 (44%), Gaps = 18/158 (11%)

Query: 33  LGSG----AVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
           LG G     VK VY     +E +EVA   VK        A  +    E  ++  L +  I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKE-VEVA---VKTLKQEHIAAGKKEFLREASVMAQLDHPCI 58

Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           + L  V + E    L  + E+   G L +Y KK R + V  LK+ + Q+  G+ YL    
Sbjct: 59  VRLIGVCKGE---PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYL--ES 113

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR 186
              +HRDL   NV +  N  Q KI D G++    RA+ 
Sbjct: 114 KHFVHRDLAARNVLLV-NRHQAKISDFGMS----RALG 146

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 58.4 bits (141), Expect = 3e-10
 Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 9/155 (5%)

Query: 28  RYNELL--GSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY +L   GSGA   V  A D+  G +VA  ++  R F  +    +R + E+RLLK + +
Sbjct: 16  RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY-RPFQSE-LFAKRAYRELRLLKHMKH 73

Query: 86  KNIISLHYVWR-DEDRNTLN-FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
           +N+I L  V+  D   +  + F   +   G       KH  +S   ++    Q+LKGL Y
Sbjct: 74  ENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKY 133

Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +H     +IHRDL   N+ VN +  ++KI D G+A
Sbjct: 134 IHA--AGIIHRDLKPGNLAVNEDC-ELKILDFGLA 165

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 58.2 bits (140), Expect = 3e-10
 Identities = 49/161 (30%), Positives = 84/161 (52%), Gaps = 18/161 (11%)

Query: 24  GRYGRYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLK 81
           G+   Y +L  LG G+   VY+   +  G  VA   ++L+     P    R   E  LLK
Sbjct: 2   GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR---EASLLK 58

Query: 82  TLANKNIISLHYVWRDEDRNTLNFI---TEVCTSGNLREYRKKHR-HVSVKALKKWSKQI 137
            L + NI+ LH +   ++  TL F    T++C      +Y  KH   +  + +K +  Q+
Sbjct: 59  GLKHANIVLLHDIIHTKETLTLVFEYVHTDLC------QYMDKHPGGLHPENVKLFLFQL 112

Query: 138 LKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           L+GL+Y+  H+  ++HRDL   N+ ++ +TG++K+ D G+A
Sbjct: 113 LRGLSYI--HQRYILHRDLKPQNLLIS-DTGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 58.0 bits (140), Expect = 3e-10
 Identities = 47/151 (31%), Positives = 78/151 (51%), Gaps = 12/151 (7%)

Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
           +Y E+LG G    VY+A+       +A   VK+        + +++ SE+ +L    +  
Sbjct: 4   QYQEILGHGNGGTVYKAYHLLTRRILA---VKVIPLDITVELQKQIMSELEILYKCDSPY 60

Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
           II  +  +  E+R  ++  TE    G+L  YRK   HV    L + +  ++KGL YL + 
Sbjct: 61  IIGFYGAFFVENR--ISICTEFMDGGSLDVYRKIPEHV----LGRIAVAVVKGLTYLWSL 114

Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +  ++HRD+  SN+ VN   GQVK+ D GV+
Sbjct: 115 K--ILHRDVKPSNMLVN-TRGQVKLCDFGVS 142

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 58.1 bits (140), Expect = 4e-10
 Identities = 54/160 (33%), Positives = 85/160 (53%), Gaps = 19/160 (11%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 75

Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTS--GNLREYRK-KHRHVSVKALKKWSKQIL 138
           +N+I L  V+      E+ N +  +T +  +   N+ + +K    HV          QIL
Sbjct: 76  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY-----QIL 130

Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +GL Y+H+ +  +IHRDL  SN+ VN +  ++KI D G+A
Sbjct: 131 RGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGLA 167

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 58.0 bits (140), Expect = 4e-10
 Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 25/166 (15%)

Query: 21  DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           DP  +Y R+ E +G GA   VY A D   G EVA  Q+ L+     P   E + +E+ ++
Sbjct: 16  DPKKKYTRF-EKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKK-ELIINEILVM 70

Query: 81  KTLANKNIISL--HYVWRDEDRNTLNF-----ITEVCTSGNLREYRKKHRHVSVKALKKW 133
           +   + NI++    Y+  DE    + +     +T+V T   + E +       + A+   
Sbjct: 71  RENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-------IAAV--- 120

Query: 134 SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
            ++ L+ L +LH+++  VIHRD+   N+ + G  G VK+ D G  A
Sbjct: 121 CRECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCA 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 57.3 bits (138), Expect = 5e-10
 Identities = 42/150 (28%), Positives = 73/150 (48%), Gaps = 14/150 (9%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL- 91
           LG GA  KVY+A ++E G   A   ++ ++       +E    E+ +L T  +  I+ L 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYMVEIEILATCNHPYIVKLL 75

Query: 92  -HYVWRDEDRNTLNFITEVCTSGNLREYR-KKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
             + W       L  + E C  G +     +  R ++   ++   +Q+L+ L YLH+ + 
Sbjct: 76  GAFYW----DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK- 130

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
            +IHRDL   NV +  + G +K+ D GV+A
Sbjct: 131 -IIHRDLKAGNVLLTLD-GDIKLADFGVSA 158

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 57.3 bits (139), Expect = 5e-10
 Identities = 31/118 (26%), Positives = 62/118 (52%), Gaps = 5/118 (4%)

Query: 64  CDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR 123
           C +   +  + +E R+L+ L +  +++L Y ++DE+   +  + ++   G+LR +  +  
Sbjct: 38  CVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN--MYLVVDLLLGGDLRYHLSQKV 95

Query: 124 HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
             S + +K W  +I+  L YLH+    +IHRD+   N+ ++   G V I D  +A  V
Sbjct: 96  KFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKV 150

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 56.9 bits (137), Expect = 6e-10
 Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 8/150 (5%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           + +G G+  K+Y A  + +       ++ L          E    EV LL  + + NI++
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK--EASKKEVILLAKMKHPNIVT 63

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
               +++  R  L  + E C  G+L +   + R V  S   +  W  QI  GL   H H+
Sbjct: 64  FFASFQENGR--LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK--HIHD 119

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             ++HRD+   N+F++ N    K+GD G+A
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIA 149

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 57.3 bits (138), Expect = 6e-10
 Identities = 48/157 (30%), Positives = 80/157 (50%), Gaps = 14/157 (8%)

Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 69

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 70  HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL- 125

Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
             E  ++HRDL   NV V      VKI D G+A ++G
Sbjct: 126 -EERRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLG 160

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 57.0 bits (138), Expect = 6e-10
 Identities = 48/178 (26%), Positives = 79/178 (44%), Gaps = 29/178 (16%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E++G GA   VY A       +VA  ++ L         ++ L  EV+ +    + N++ 
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVK 63

Query: 91  LH--YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS-----KQILKGLNY 143
            +  +V  DE    L  +    + G+L +  K         L +       K++LKGL Y
Sbjct: 64  YYTSFVVGDE----LWLVMPYLSGGSLLDIMK--SSYPRGGLDEAIIATVLKEVLKGLEY 117

Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV---GRAIRRIR-------CW 191
           LH++    IHRD+   N+ +  + G VKI D GV+A +   G   R++R       CW
Sbjct: 118 LHSNG--QIHRDIKAGNILLGED-GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 57.0 bits (138), Expect = 7e-10
 Identities = 45/149 (30%), Positives = 79/149 (53%), Gaps = 9/149 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERL-FSEVRLLKTLANKNII 89
            L+G G+   V +   +E G  VA   +K     +D  M++++   E+R+LK L ++N++
Sbjct: 7   GLVGEGSYGMVMKCKHKETGQIVA---IKKFLESEDDKMVKKIAMREIRMLKQLRHENLV 63

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
           +L  V+R + R  L F  E      L +  K    +    ++K+  QIL+G+ + H+H  
Sbjct: 64  NLIEVFRRKKRLYLVF--EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN- 120

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            +IHRD+   N+ V+ + G VK+ D G A
Sbjct: 121 -IIHRDIKPENILVSQS-GVVKLCDFGFA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 56.8 bits (137), Expect = 8e-10
 Identities = 35/110 (31%), Positives = 59/110 (53%), Gaps = 6/110 (5%)

Query: 75  SEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH--VSVKALKK 132
           +E ++LK L++ NII  +Y    ED   L  + E    G L EY +K  +  +    +  
Sbjct: 48  NECQVLKLLSHPNIIE-YYENFLED-KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILH 105

Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
           +  QIL  L+++HT    ++HRDL   N+ ++ +   VKIGD G++ I+ 
Sbjct: 106 FFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 56.9 bits (137), Expect = 8e-10
 Identities = 36/108 (33%), Positives = 56/108 (51%), Gaps = 6/108 (5%)

Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL--REYRKKHRHVSVKALKKW 133
           E +LL  L + NI++    W  ED   L  +   C  G+L  +   +K + +    + +W
Sbjct: 49  EAQLLSQLKHPNIVAYRESWEGED-GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW 107

Query: 134 SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
             QI   L YLH  E  ++HRDL   NVF+   T  +K+GDLG+A ++
Sbjct: 108 FVQIAMALQYLH--EKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 57.0 bits (138), Expect = 9e-10
 Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 32/171 (18%)

Query: 31  ELLGSGAVKKVYRAF-----DQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLA 84
           + LG GA  +V +A      +  E   VA   VK L+    +  + + L SE+ ++K + 
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVA---VKMLKDDATEKDLSD-LVSEMEMMKMIG 73

Query: 85  -NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSV 127
            +KNII+L  V   E    L  + E    GNLR++ +  R                 ++ 
Sbjct: 74  KHKNIINLLGVCTQE--GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131

Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           K L  ++ Q+ +G+ +L + +   IHRDL   NV V      +KI D G+A
Sbjct: 132 KDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLV-TEDHVMKIADFGLA 179

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 57.0 bits (137), Expect = 9e-10
 Identities = 48/161 (29%), Positives = 80/161 (49%), Gaps = 15/161 (9%)

Query: 21  DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           DP  +Y R+ E +G GA   VY A D   G EVA  Q+ L+     P   E + +E+ ++
Sbjct: 16  DPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMNLQ---QQPKK-ELIINEILVM 70

Query: 81  KTLANKNIISL--HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
           +   N NI++    Y+  DE    L  + E    G+L +   +   +    +    ++ L
Sbjct: 71  RENKNPNIVNYLDSYLVGDE----LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECL 125

Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
           + L++LH+++  VIHRD+   N+ + G  G VK+ D G  A
Sbjct: 126 QALDFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCA 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 56.6 bits (136), Expect = 9e-10
 Identities = 51/186 (27%), Positives = 97/186 (52%), Gaps = 26/186 (13%)

Query: 21  DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           DP G +    EL+G+G   +VY+    + G   A   +K+     D    E +  E+ +L
Sbjct: 3   DPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAA---IKVMDVTGDEE--EEIKQEINML 56

Query: 81  KTLAN-KNIISLHYVWRDED----RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKW-- 133
           K  ++ +NI + +  +  ++     + L  + E C +G++ +  K  +  ++K  ++W  
Sbjct: 57  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK--EEWIA 114

Query: 134 --SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCW 191
              ++IL+GL++LH H+  VIHRD+   NV +  N  +VK+ D GV+A + R +      
Sbjct: 115 YICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTV------ 165

Query: 192 GRRSSW 197
           GRR+++
Sbjct: 166 GRRNTF 171

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 56.3 bits (135), Expect = 1e-09
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 15/161 (9%)

Query: 21  DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           DP  +Y R+ E +G GA   VY A D   G EVA  Q+ L+     P   E + +E+ ++
Sbjct: 17  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEILVM 71

Query: 81  KTLANKNIISL--HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
           +   N NI++    Y+  DE    L  + E    G+L +   +   +    +    ++ L
Sbjct: 72  RENKNPNIVNYLDSYLVGDE----LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECL 126

Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
           + L +LH+++  VIHRD+   N+ + G  G VK+ D G  A
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCA 164

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 56.2 bits (135), Expect = 1e-09
 Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 10/149 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG G    V++   +     VA  +++L      P    R   EV LLK L + NI++
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVT 68

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV-SVKALKKWSKQILKGLNYLHTHEP 149
           LH +   +   TL F        +L++Y     ++ S+  +K +  QIL+GL Y H  + 
Sbjct: 69  LHDIVHTDKSLTLVFEY---LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK- 124

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            V+HRDL   N+ +N   G++K+ D G+A
Sbjct: 125 -VLHRDLKPQNLLIN-ERGELKLADFGLA 151

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 55.9 bits (135), Expect = 2e-09
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 14/152 (9%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLF-SEVRLLKTLANKNIISL 91
           LGSG   +V+      EG+     +V ++    D  + ++ F  EV+ LK L +K++ISL
Sbjct: 14  LGSGYFGEVW------EGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREYRK--KHRHVSVKALKKWSKQILKGLNYLHTHEP 149
             V    +   +  ITE+   G+L  + +  + + + V +L   + Q+ +G+ YL   E 
Sbjct: 68  FAVCSVGE--PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL--EEQ 123

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
             IHRDL   N+ V  +    K+ D G+A ++
Sbjct: 124 NSIHRDLAARNILVGEDL-VCKVADFGLARLI 154

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 56.2 bits (135), Expect = 2e-09
 Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 10/147 (6%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G    VY+   +     VA  +++L      P    R   EV LLK L + NI++LH
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVTLH 70

Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
            +   E   TL F        +L++Y       +++  +K +  Q+L+GLNY H  +  V
Sbjct: 71  DIIHTEKSLTLVFEY---LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--V 125

Query: 152 IHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +HRDL   N+ +N   G++K+ D G+A
Sbjct: 126 LHRDLKPQNLLIN-ERGELKLADFGLA 151

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 55.8 bits (134), Expect = 2e-09
 Identities = 50/186 (26%), Positives = 94/186 (50%), Gaps = 26/186 (13%)

Query: 21  DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           DP G +    E++G+G   +VY+    + G   A   +K+    +D    E +  E+ +L
Sbjct: 13  DPAGIF-ELVEVVGNGTYGQVYKGRHVKTGQLAA---IKVMDVTEDEE--EEIKLEINML 66

Query: 81  KTLANKNIISLHY---VWRDE--DRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKW-- 133
           K  ++   I+ +Y   + +      + L  + E C +G++ +  K  +  ++K  + W  
Sbjct: 67  KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK--EDWIA 124

Query: 134 --SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCW 191
              ++IL+GL +LH H+  VIHRD+   NV +  N  +VK+ D GV+A + R +      
Sbjct: 125 YICREILRGLAHLHAHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTV------ 175

Query: 192 GRRSSW 197
           GRR+++
Sbjct: 176 GRRNTF 181

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 55.8 bits (134), Expect = 2e-09
 Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 10/147 (6%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G    V++   +     VA  +++L      P    R   EV LLK L + NI++LH
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR---EVSLLKNLKHANIVTLH 69

Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV-SVKALKKWSKQILKGLNYLHTHEPCV 151
            +   E   TL F  E   S +L++Y     ++ S+  +K +  Q+L+GL+Y H  +  +
Sbjct: 70  DIIHTERCLTLVF--EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--I 124

Query: 152 IHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +HRDL   N+ +N   G++K+ D G+A
Sbjct: 125 LHRDLKPQNLLIN-EKGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 55.4 bits (134), Expect = 2e-09
 Identities = 39/163 (23%), Positives = 66/163 (40%), Gaps = 27/163 (16%)

Query: 33  LGSGAVKKVYRAF-----DQEEGIEVAWNQVKLRTFCDDPAMIERL--FSEVRLLKTLAN 85
           LG G+   VY          E    VA     ++T  ++ +M ER+   +E  ++K    
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVA-----IKTVNENASMRERIEFLNEASVMKEFNC 68

Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-------VSVKALKK---WSK 135
            +++ L  V        +  + E+   G+L+ Y +  R        +    L+K    + 
Sbjct: 69  HHVVRLLGVVSTGQPTLV--VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126

Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +I  G+ YL       +HRDL   N  V  +   VKIGD G+ 
Sbjct: 127 EIADGMAYLA--AKKFVHRDLAARNCMVAED-LTVKIGDFGMT 166

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 55.3 bits (134), Expect = 2e-09
 Identities = 35/153 (22%), Positives = 61/153 (39%), Gaps = 10/153 (6%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD--PAMIERLFSEVRLLKTLANKNIIS 90
           LG G   +V     + +    A   VK R   +      I   FSE  +L+   +  I+ 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHI---FSEKEILEECNHPFIVK 57

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L+  ++D+    +  + E C  G L    +          + +   ++    YLH     
Sbjct: 58  LYRTFKDK--KYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG-- 113

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR 183
           +I+RDL   N+ ++ N G VK+ D G A  +  
Sbjct: 114 IIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKS 145

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 54.7 bits (131), Expect = 5e-09
 Identities = 54/190 (28%), Positives = 89/190 (46%), Gaps = 20/190 (10%)

Query: 3   PAVNSDPSDKD---SEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVK 59
           P+ +   S KD   +E F + DP   +    E+ G G+   VY A D      VA   +K
Sbjct: 1   PSTSRAGSLKDPEIAELFFKEDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVA---IK 56

Query: 60  LRTFCDDPAM--IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC--TSGNL 115
             ++    +    + +  EV+ L+ + + N I     +  E  +T   + E C  ++ +L
Sbjct: 57  KMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE--HTAWLVMEYCLGSASDL 114

Query: 116 REYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
            E  KK  + V + A+   +   L+GL YLH+H   +IHRD+   N+ +    GQVK+ D
Sbjct: 115 LEVHKKPLQEVEIAAI---THGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLAD 168

Query: 175 LGVAAIVGRA 184
            G A+I   A
Sbjct: 169 FGSASIASPA 178

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 54.6 bits (131), Expect = 5e-09
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 10/149 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG G+   VY+   +  G  VA   + ++T    P    R   E  LLK L + NI+ 
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR---EASLLKGLKHANIVL 67

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTHEP 149
           LH +     + TL F+ E   + +L +Y  +H   +    ++ +  Q+L+GL Y+H    
Sbjct: 68  LHDII--HTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH- 123

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            ++HRDL   N+ ++   G++K+ D G+A
Sbjct: 124 -ILHRDLKPQNLLIS-YLGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 54.3 bits (130), Expect = 6e-09
 Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 13/174 (7%)

Query: 14  SEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERL 73
           +E F + DP   +    E+ G G+   VY A D      VA  ++       +    + +
Sbjct: 5   AELFFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW-QDI 62

Query: 74  FSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC--TSGNLREYRKKH-RHVSVKAL 130
             EVR L+ L + N I     +  E  +T   + E C  ++ +L E  KK  + V + A+
Sbjct: 63  IKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 120

Query: 131 KKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA 184
              +   L+GL YLH+H   +IHRD+   N+ ++   G VK+GD G A+I+  A
Sbjct: 121 ---THGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPA 168

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 54.3 bits (131), Expect = 7e-09
 Identities = 39/144 (27%), Positives = 70/144 (48%), Gaps = 24/144 (16%)

Query: 37  AVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWR 96
           A+KK+  AFD         N++  +          R   E++LL+ L ++N+I++  +  
Sbjct: 34  AIKKIANAFD---------NRIDAK----------RTLREIKLLRHLDHENVIAIKDIMP 74

Query: 97  DEDRNTLN--FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHR 154
              R   N  +I       +L +  +  + +S    + +  Q+L+GL Y+H+    V+HR
Sbjct: 75  PPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHR 132

Query: 155 DLNCSNVFVNGNTGQVKIGDLGVA 178
           DL  SN+ +N N   +KI D G+A
Sbjct: 133 DLKPSNLLLNANC-DLKICDFGLA 155

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 53.9 bits (129), Expect = 8e-09
 Identities = 45/155 (29%), Positives = 76/155 (49%), Gaps = 9/155 (5%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +GSG    VY+A +   G   A   +KL    DD ++I++   E+ ++K   + NI++  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQ---EIFMVKECKHCNIVA-- 70

Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
           Y      R  L    E C  G+L++       +S   +    ++ L+GL YLH+     +
Sbjct: 71  YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK--M 128

Query: 153 HRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR 187
           HRD+  +N+ +  N G VK+ D GVAA +   I +
Sbjct: 129 HRDIKGANILLTDN-GDVKLADFGVAAKITATIAK 162

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 45/157 (28%), Positives = 80/157 (50%), Gaps = 13/157 (8%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL- 91
           +GSG    VY+A +   G   A   +KL    +D A++++   E+ ++K   + NI++  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQ---EIIMMKDCKHSNIVAYF 72

Query: 92  -HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
             Y+ RD+    L    E C  G+L++       +S   +   S++ L+GL YLH+    
Sbjct: 73  GSYLRRDK----LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK- 127

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR 187
            +HRD+  +N+ +  N G VK+ D GV+A +   I +
Sbjct: 128 -MHRDIKGANILLTDN-GHVKLADFGVSAQITATIAK 162

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 53.8 bits (129), Expect = 1e-08
 Identities = 55/189 (29%), Positives = 83/189 (43%), Gaps = 34/189 (17%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQ----VKLRTFCDDPAM--IERLFSEVRLLKTLA-N 85
           LG G   +V RA  +  GI+ +       V ++   D+     +  L SE+ L+K +  +
Sbjct: 20  LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKA 129
           KNII+L  V   E    L  I E    GNLRE+ +  R                 +S K 
Sbjct: 78  KNIINLLGVCTQE--GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIR 189
           L   + Q+ +G+ YL +     IHRDL   NV V  +   +KI D G+A    R +  I 
Sbjct: 136 LVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDN-VMKIADFGLA----RGVHDID 188

Query: 190 CWGRRSSWR 198
            + + S+ R
Sbjct: 189 YYKKTSNGR 197

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 53.6 bits (129), Expect = 1e-08
 Identities = 41/156 (26%), Positives = 75/156 (48%), Gaps = 8/156 (5%)

Query: 25  RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA 84
           RY +  E++G G+   V  A D   G +VA    K+    +  +   R+  E++LL+ L 
Sbjct: 1   RY-KIQEVIGKGSYGVVCSAIDTHTGEKVAIK--KINDVFEHVSDATRILREIKLLRLLR 57

Query: 85  NKNIISLHYVWRDEDRNTLNFITEV--CTSGNLREYRKKHRHVSVKALKKWSKQILKGLN 142
           + +I+ + ++     R     I  V      +L +  K +  ++ +  + +  Q+L+ L 
Sbjct: 58  HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117

Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           Y+HT    V HRDL   N+  N +  ++KI D G+A
Sbjct: 118 YIHTAN--VFHRDLKPKNILANADC-KLKICDFGLA 150

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 53.2 bits (128), Expect = 1e-08
 Identities = 34/125 (27%), Positives = 57/125 (45%), Gaps = 7/125 (5%)

Query: 56  NQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL 115
            +V ++   DD    +   +E  ++ TL + N++ L  V      N L  +TE    G+L
Sbjct: 30  QKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG--NPLYIVTEYMAKGSL 87

Query: 116 REY-RKKHRHVSVKA-LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIG 173
            +Y R + R V   A    ++  + +G+ YL       +HRDL   NV V+      K+ 
Sbjct: 88  VDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVS-EDLVAKVS 144

Query: 174 DLGVA 178
           D G+A
Sbjct: 145 DFGLA 149

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 14/156 (8%)

Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA   +K+      P        E  ++ ++ + 
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMASMDHP 69

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           +++ L  V       T+  +T++   G L +Y  +H+ ++  + L  W  QI KG+ YL 
Sbjct: 70  HLVRLLGVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126

Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
             E  ++HRDL   NV V  +   VKI D G+A ++
Sbjct: 127 --ERRLVHRDLAARNVLVK-SPNHVKITDFGLARLL 159

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 53.3 bits (128), Expect = 2e-08
 Identities = 24/44 (54%), Positives = 30/44 (68%), Gaps = 3/44 (6%)

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           KQIL+GL YLH     +IHRD+   N+F+N +  QV IGDLG A
Sbjct: 164 KQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAA 204

Length = 357

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 53.3 bits (129), Expect = 2e-08
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 43/152 (28%)

Query: 37  AVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN-KNIISLHYVW 95
           A+KK++ AF                    +    +R F E+  L+ L +  NI+ L  V 
Sbjct: 36  ALKKIFDAFR-------------------NATDAQRTFREIMFLQELGDHPNIVKLLNVI 76

Query: 96  R-DEDRNT-LNFITEVCTSGNLREYRKKHRHVSVKA--LKKWSK-----QILKGLNYLHT 146
           + + D++  L F           EY +   H  ++A  L+   K     Q+LK L Y+H+
Sbjct: 77  KAENDKDIYLVF-----------EYMETDLHAVIRANILEDVHKRYIMYQLLKALKYIHS 125

Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
               VIHRDL  SN+ +N +  +VK+ D G+A
Sbjct: 126 GN--VIHRDLKPSNILLNSDC-RVKLADFGLA 154

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 53.2 bits (128), Expect = 2e-08
 Identities = 44/177 (24%), Positives = 81/177 (45%), Gaps = 25/177 (14%)

Query: 20  TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRL 79
            DP      + ++ G G+   V  A D+  G +VA  ++ LR         E LF+EV +
Sbjct: 15  GDPRSYLDNFVKI-GEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVI 69

Query: 80  LKTLANKNIISLH--YVWRDEDRNTLNFI-----TEVCTSGNLREYRKKHRHVSVKALKK 132
           ++   + NI+ ++  Y+  DE    + F+     T++ T   + E          + +  
Sbjct: 70  MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE----------EQIAT 119

Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIR 189
               +LK L++LH     VIHRD+   ++ +  + G+VK+ D G  A V + + R +
Sbjct: 120 VCLAVLKALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRK 173

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 52.3 bits (126), Expect = 3e-08
 Identities = 24/108 (22%), Positives = 53/108 (49%), Gaps = 5/108 (4%)

Query: 69  MIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVK 128
            ++++ +E  +L    +  ++ L+Y ++ +    L  + E    G+L    +    +   
Sbjct: 36  QVDQVLTERDILSQAQSPYVVKLYYSFQGK--KNLYLVMEYLPGGDLASLLENVGSLDED 93

Query: 129 ALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
             + +  +I+  L YLH++   +IHRDL   N+ ++ N G +K+ D G
Sbjct: 94  VARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFG 138

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 52.2 bits (125), Expect = 3e-08
 Identities = 43/151 (28%), Positives = 67/151 (44%), Gaps = 12/151 (7%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G   +VY    ++  + VA     ++T  +D   +E    E  ++K + + N++ L 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68

Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA--LKKWSKQILKGLNYLHTHEPC 150
            V   E       ITE  T GNL +Y ++     V A  L   + QI   + YL      
Sbjct: 69  GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
            IHRDL   N  V G    VK+ D G++ ++
Sbjct: 125 FIHRDLAARNCLV-GENHLVKVADFGLSRLM 154

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 52.7 bits (126), Expect = 3e-08
 Identities = 53/187 (28%), Positives = 83/187 (44%), Gaps = 21/187 (11%)

Query: 4   AVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF 63
            V  DP   D   F + DP   +   +E+ G G+   VY A +      VA   VK  ++
Sbjct: 3   GVVKDPEIADL--FYKDDPEEIFVGLHEI-GHGSFGAVYFATNSHTNEVVA---VKKMSY 56

Query: 64  CDDPAMIER---LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC---TSGNLRE 117
                  E+   +  EV+ L+ L + N I     +  E  +T   + E C    S  L  
Sbjct: 57  -SGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE--HTAWLVMEYCLGSASDLLEV 113

Query: 118 YRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV 177
           ++K  + V + A+   +   L+GL YLH+H   +IHRD+   N+ +    GQVK+ D G 
Sbjct: 114 HKKPLQEVEIAAI---THGALQGLAYLHSH--NMIHRDIKAGNILLT-EPGQVKLADFGS 167

Query: 178 AAIVGRA 184
           A+    A
Sbjct: 168 ASKSSPA 174

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 52.2 bits (126), Expect = 3e-08
 Identities = 20/52 (38%), Positives = 32/52 (61%), Gaps = 3/52 (5%)

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR 186
            Q+L G+ +LH +   ++HRDL  SN+ +N N G +KI D G+A   G  ++
Sbjct: 113 LQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLK 161

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.3 bits (125), Expect = 4e-08
 Identities = 48/187 (25%), Positives = 85/187 (45%), Gaps = 26/187 (13%)

Query: 6   NSDPSDKDSEPFIETD---PTGRYGRYNELLGSGAVKKVYRA--FDQEEGIEVAWNQVKL 60
           N+   D+D E  I+ D      +  +   ++G+G+   VY A   D  E       +V +
Sbjct: 44  NNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSE-------KVAI 96

Query: 61  RTFCDDPAMIERLFSEVRLLKTLANKNIISL---HY---VWRDEDRNTLNFITEV---CT 111
           +    DP    R   E+ ++K L + NII L   +Y     ++E    LN + E      
Sbjct: 97  KKVLQDPQYKNR---ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTV 153

Query: 112 SGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVK 171
              ++ Y + +  + +  +K +S Q+ + L Y+H+   C  HRDL   N+ ++ NT  +K
Sbjct: 154 HKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFIC--HRDLKPQNLLIDPNTHTLK 211

Query: 172 IGDLGVA 178
           + D G A
Sbjct: 212 LCDFGSA 218

Length = 440

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 51.7 bits (124), Expect = 4e-08
 Identities = 27/112 (24%), Positives = 50/112 (44%), Gaps = 6/112 (5%)

Query: 71  ERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA- 129
           +    E +++  L++ N++ L+ V     +  +  +TE   +G L  Y ++ +       
Sbjct: 44  DDFIEEAKVMMKLSHPNLVQLYGVC--TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW 101

Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           L      + + + YL ++    IHRDL   N  V G    VK+ D G+A  V
Sbjct: 102 LLDMCSDVCEAMEYLESN--GFIHRDLAARNCLV-GEDNVVKVSDFGLARYV 150

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.4 bits (125), Expect = 4e-08
 Identities = 51/159 (32%), Positives = 85/159 (53%), Gaps = 17/159 (10%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RLFSEVRLLKTL 83
           RY  L  +GSGA   V  A+D     +VA  ++  R F    ++I   R + E+RLLK +
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLS-RPF---QSLIHARRTYRELRLLKHM 71

Query: 84  ANKNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILK 139
            ++N+I L  V+      E+ N +  +T +    +L    K  + +S + ++    Q+L+
Sbjct: 72  KHENVIGLLDVFTPATSIENFNEVYLVTNL-MGADLNNIVKCQK-LSDEHVQFLIYQLLR 129

Query: 140 GLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           GL Y+H+    +IHRDL  SNV VN +  +++I D G+A
Sbjct: 130 GLKYIHS--AGIIHRDLKPSNVAVNEDC-ELRILDFGLA 165

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 52.0 bits (124), Expect = 4e-08
 Identities = 40/147 (27%), Positives = 71/147 (48%), Gaps = 6/147 (4%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           +LLG G   KV    ++  G   A   +K         +   L +E R+LK   +  + S
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTL-TESRVLKNTRHPFLTS 59

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L Y ++ +DR  L F+ E    G L  +  + R  S    + +  +I+  L+YLH+ +  
Sbjct: 60  LKYSFQTKDR--LCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK-- 115

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGV 177
           +++RDL   N+ ++ + G +KI D G+
Sbjct: 116 IVYRDLKLENLMLDKD-GHIKITDFGL 141

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 52.0 bits (124), Expect = 5e-08
 Identities = 52/157 (33%), Positives = 80/157 (50%), Gaps = 14/157 (8%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY +L  +GSGA   V  AFD   GI VA  ++  R F  +    +R + E+ LLK + +
Sbjct: 22  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPF-QNQTHAKRAYRELVLLKCVNH 79

Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           KNIISL  V+      E+   +  + E+    NL +    H  +  + +     Q+L G+
Sbjct: 80  KNIISLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQV--IHMELDHERMSYLLYQMLCGI 136

Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            +LH+    +IHRDL  SN+ V  +   +KI D G+A
Sbjct: 137 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLA 170

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 51.7 bits (124), Expect = 5e-08
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 16/160 (10%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIE-VAWNQVKLRTFCDDPAMIER------LFSEVRLLK-T 82
           E LGSGA   VY+   +  G   +A  ++ +          ER      + SEV ++K  
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY----RKKHRHVSVKALKKWSKQIL 138
           L + NI+  +  + + DR  L  + ++     L E+    ++K +  + + +     Q++
Sbjct: 66  LRHPNIVRYYKTFLENDR--LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123

Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             L YLH  E  ++HRDL  +N+ + G   +V I D G+A
Sbjct: 124 LALRYLHK-EKRIVHRDLTPNNIML-GEDDKVTITDFGLA 161

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 51.5 bits (123), Expect = 6e-08
 Identities = 38/150 (25%), Positives = 69/150 (46%), Gaps = 6/150 (4%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LGSG    V +   + +  E       L+   +DPA+ + L  E  +++ L N  I+ + 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
            +   E   +   + E+   G L ++ +K++HV+ K + +   Q+  G+ YL       +
Sbjct: 63  GICEAE---SWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FV 117

Query: 153 HRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
           HRDL   NV +       KI D G++  +G
Sbjct: 118 HRDLAARNVLLV-TQHYAKISDFGLSKALG 146

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 51.7 bits (124), Expect = 6e-08
 Identities = 41/149 (27%), Positives = 74/149 (49%), Gaps = 9/149 (6%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +G GA   V+   D  +G  VA    K+     +    +R+F E+++L    + N++S  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALK--KMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65

Query: 93  YVWRDEDRN---TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
            + +    +    +  +TE+  S +L +     + +S   +K +  QIL+GL YLH+   
Sbjct: 66  DILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG- 123

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            ++HRD+   N+ VN N   +KI D G+A
Sbjct: 124 -ILHRDIKPGNLLVNSNC-VLKICDFGLA 150

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 51.3 bits (123), Expect = 7e-08
 Identities = 49/155 (31%), Positives = 80/155 (51%), Gaps = 18/155 (11%)

Query: 33  LGSGAVKKVYRA-----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN-K 86
           LG+GA  KV  A        +  ++VA   VK+       +  E L SE++++  L N +
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVA---VKMLKPTAHSSEREALMSELKIMSHLGNHE 99

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREY--RKKHRHVSVKALKKWSKQILKGLNYL 144
           NI++L  +        +  ITE C  G+L  +  RK+   ++++ L  +S Q+ KG+ +L
Sbjct: 100 NIVNL--LGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157

Query: 145 HTHEPCVIHRDLNCSNVFV-NGNTGQVKIGDLGVA 178
            + + C IHRDL   NV + +G    VKI D G+A
Sbjct: 158 AS-KNC-IHRDLAARNVLLTHGKI--VKICDFGLA 188

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 51.2 bits (123), Expect = 8e-08
 Identities = 40/176 (22%), Positives = 83/176 (47%), Gaps = 20/176 (11%)

Query: 13  DSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRT----FCDDPA 68
           D   F   D   +Y +  ++ G G   +V++A  ++    VA  +V +      F   P 
Sbjct: 1   DQYEFPFCDEVSKYEKLAKI-GQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF---PI 56

Query: 69  MIERLFSEVRLLKTLANKNIISLHYVWRDE------DRNTLNFITEVCTSGNLREYRKKH 122
              R   E+++L+ L ++N+++L  + R +       + +   + E C          K+
Sbjct: 57  TALR---EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKN 113

Query: 123 RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              ++  +KK  K +L GL Y+H ++  ++HRD+  +N+ +  + G +K+ D G+A
Sbjct: 114 VKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLADFGLA 166

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 51.1 bits (122), Expect = 8e-08
 Identities = 25/78 (32%), Positives = 45/78 (57%), Gaps = 4/78 (5%)

Query: 102 TLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSN 160
           +L  +T++   G+L ++ ++HR  +  + L  W  QI KG+ YL  H   ++HR+L   N
Sbjct: 82  SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH--RMVHRNLAARN 139

Query: 161 VFVNGNTGQVKIGDLGVA 178
           + +  ++  V+I D GVA
Sbjct: 140 ILLKSDS-IVQIADFGVA 156

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 50.5 bits (121), Expect = 1e-07
 Identities = 43/149 (28%), Positives = 65/149 (43%), Gaps = 10/149 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+    +   EVA   VK       P +  +   E  +LK   + NI+ 
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVA---VKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
           L  V     +  +  + E+   G+L  + RKK   ++VK L + S     G+ YL +   
Sbjct: 57  LIGV--CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK-- 112

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             IHRDL   N  V G    +KI D G++
Sbjct: 113 NCIHRDLAARNCLV-GENNVLKISDFGMS 140

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 50.8 bits (121), Expect = 1e-07
 Identities = 40/151 (26%), Positives = 70/151 (46%), Gaps = 13/151 (8%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG+G   +V+  +           +V ++T       ++    E  L+KTL +  ++ L+
Sbjct: 14  LGAGQFGEVWMGYYNNS------TKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLY 67

Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E+   +  ITE    G+L ++ K      V +  L  +S QI +G+ Y+      
Sbjct: 68  AVVTKEE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 123

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
            IHRDL  +NV V+  +   KI D G+A ++
Sbjct: 124 YIHRDLRAANVLVS-ESLMCKIADFGLARVI 153

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 51.0 bits (122), Expect = 1e-07
 Identities = 40/178 (22%), Positives = 77/178 (43%), Gaps = 19/178 (10%)

Query: 4   AVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF 63
           +  S  +   ++   E +   R       +GSGA   VY+   +  G   A   +K+   
Sbjct: 60  SSASGSAPSAAKSLSELERVNR-------IGSGAGGTVYKVIHRPTGRLYA---LKVIYG 109

Query: 64  CDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR 123
             +  +  ++  E+ +L+ + + N++  H ++  +    +  + E    G+L        
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVKCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADE 167

Query: 124 HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
                 L   ++QIL G+ YLH     ++HRD+  SN+ +N     VKI D GV+ I+
Sbjct: 168 Q----FLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAK-NVKIADFGVSRIL 218

Length = 353

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 50.4 bits (120), Expect = 1e-07
 Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 14/151 (9%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIE-RLFSEVRLLKTLANKNI 88
           ELLG G   +V++   +++        V ++T  +D P  ++ +  SE R+LK   + NI
Sbjct: 1   ELLGKGNFGEVFKGTLKDK------TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNI 54

Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYLHTH 147
           + L  V     R  +  + E+   G+   + RKK   +  K L K++     G+ YL + 
Sbjct: 55  VKLIGVC--TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112

Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
               IHRDL   N  V G    +KI D G++
Sbjct: 113 N--CIHRDLAARNCLV-GENNVLKISDFGMS 140

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 50.5 bits (121), Expect = 1e-07
 Identities = 26/64 (40%), Positives = 37/64 (57%), Gaps = 5/64 (7%)

Query: 118 YRKKH---RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
           Y+K +     +    L K +  I+K L YLH+    VIHRD+  SNV +N N GQVK+ D
Sbjct: 90  YKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS-VIHRDVKPSNVLINRN-GQVKLCD 147

Query: 175 LGVA 178
            G++
Sbjct: 148 FGIS 151

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 49.6 bits (118), Expect = 2e-07
 Identities = 46/175 (26%), Positives = 82/175 (46%), Gaps = 33/175 (18%)

Query: 21  DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           DPT  +    E +G G   KVY+  ++++G   A   VK+     D  + E + +E  +L
Sbjct: 19  DPTDTW-EIIETIGKGTYGKVYKVTNKKDGSLAA---VKILDPISD--VDEEIEAEYNIL 72

Query: 81  KTLANK-NIISLHYVWRDEDR---NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQ 136
           ++L N  N++  + ++   D+     L  + E+C  G++ E         VK L    ++
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTEL--------VKGLLICGQR 124

Query: 137 I------------LKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
           +            L GL +LH +   +IHRD+  +N+ +    G VK+ D GV+A
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGG-VKLVDFGVSA 176

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 49.4 bits (118), Expect = 3e-07
 Identities = 46/169 (27%), Positives = 70/169 (41%), Gaps = 23/169 (13%)

Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD--DPAMIERLFSEVRLLKTLAN 85
           R+ E LG GA  KVY+         ++   V ++T  +  +P + +    E  L+  L +
Sbjct: 8   RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH 67

Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLREY---RKKHRHVSVKALKKWSK------- 135
            NI+ L  V   E    + F  E    G+L E+      H  V  ++  +  K       
Sbjct: 68  PNIVCLLGVCTKEQPTCMLF--EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125

Query: 136 ------QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
                 QI  G+ YL +H    +HRDL   N  V G    VKI D G++
Sbjct: 126 FLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLTVKISDFGLS 171

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 49.5 bits (118), Expect = 3e-07
 Identities = 46/156 (29%), Positives = 77/156 (49%), Gaps = 12/156 (7%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  A D+  G +VA  ++  R F  +    +R + E+ LLK + +
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSE-IFAKRAYRELTLLKHMQH 73

Query: 86  KNIISLHYVWRDED--RNTLNF-ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLN 142
           +N+I L  V+          +F +       +L++       +S   ++    Q+L GL 
Sbjct: 74  ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG--HPLSEDKVQYLVYQMLCGLK 131

Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           Y+H+    +IHRDL   N+ VN +  ++KI D G+A
Sbjct: 132 YIHS--AGIIHRDLKPGNLAVNEDC-ELKILDFGLA 164

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 48.9 bits (117), Expect = 4e-07
 Identities = 30/108 (27%), Positives = 56/108 (51%), Gaps = 7/108 (6%)

Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKW 133
           E +++K L +  ++ L+ V  +E+   +  +TE  + G+L ++ K    + + +  L   
Sbjct: 51  EAQIMKKLRHDKLVQLYAVCSEEE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM 108

Query: 134 SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           + QI +G+ YL +     IHRDL   N+ V G     KI D G+A ++
Sbjct: 109 AAQIAEGMAYLESRN--YIHRDLAARNILV-GENLVCKIADFGLARLI 153

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 49.5 bits (118), Expect = 4e-07
 Identities = 28/118 (23%), Positives = 59/118 (50%), Gaps = 6/118 (5%)

Query: 75  SEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS 134
            E+ +LKT++++ II+L + +R   ++T+  +       +L  Y  +   + ++      
Sbjct: 135 REIDILKTISHRAIINLIHAYRW--KSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQ 191

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWG 192
           +++L+ L YLH     +IHRD+   N+F++       +GD G A  +       +C+G
Sbjct: 192 RRLLEALAYLH--GRGIIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYG 246

Length = 392

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 49.0 bits (117), Expect = 4e-07
 Identities = 34/147 (23%), Positives = 65/147 (44%), Gaps = 6/147 (4%)

Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
            +G+G   +V+   D+      A   + +          + + +E R+LK +++  II L
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR-LKQEQHVHNEKRVLKEVSHPFIIRL 66

Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
            +   D+    L  + E    G L  Y +     S      ++ +I+  L YLH+ E  +
Sbjct: 67  FWTEHDQ--RFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--I 122

Query: 152 IHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           ++RDL   N+ ++   G +K+ D G A
Sbjct: 123 VYRDLKPENILLD-KEGHIKLTDFGFA 148

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 49.3 bits (117), Expect = 4e-07
 Identities = 37/147 (25%), Positives = 72/147 (48%), Gaps = 7/147 (4%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG+G    V++   +  G+ +A   + L      PA+  ++  E+++L    +  I+  +
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 69

Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
             +  +    ++   E    G+L +  KK   +  + L K S  ++KGL YL      ++
Sbjct: 70  GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 126

Query: 153 HRDLNCSNVFVNGNTGQVKIGDLGVAA 179
           HRD+  SN+ VN + G++K+ D GV+ 
Sbjct: 127 HRDVKPSNILVN-SRGEIKLCDFGVSG 152

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 48.9 bits (116), Expect = 5e-07
 Identities = 49/167 (29%), Positives = 73/167 (43%), Gaps = 26/167 (15%)

Query: 33  LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
           LG G   +V  A     D+E+   V    VK+         +  L SE+ ++K +  +KN
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALK 131
           II+L      +    L  I E  + GNLREY +  R                 +S K L 
Sbjct: 86  IINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             + Q+ +G+ YL + +   IHRDL   NV V  +   +KI D G+A
Sbjct: 144 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLA 187

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 48.4 bits (115), Expect = 6e-07
 Identities = 33/108 (30%), Positives = 53/108 (49%), Gaps = 7/108 (6%)

Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH--VSVKALKKW 133
           E  LL  + + NI++    +  E    L  + E C  G+L +  K  R        + +W
Sbjct: 48  EAVLLAKMKHPNIVAFKESF--EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105

Query: 134 SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
             Q+  G+   H HE  V+HRD+   N+F+  N G+VK+GD G A ++
Sbjct: 106 FVQMCLGVQ--HIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLL 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 48.5 bits (115), Expect = 6e-07
 Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 5/147 (3%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           +LLG G   KV    ++  G   A   +K         +   L +E R+L+   +  + +
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFLTA 59

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L Y ++  DR  L F+ E    G L  +  + R  S    + +  +I+  L+YLH+ E  
Sbjct: 60  LKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS-EKN 116

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGV 177
           V++RDL   N+ ++ + G +KI D G+
Sbjct: 117 VVYRDLKLENLMLDKD-GHIKITDFGL 142

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 48.1 bits (114), Expect = 7e-07
 Identities = 38/151 (25%), Positives = 70/151 (46%), Gaps = 14/151 (9%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG+G   +V+ A   +        +V ++T       +E   +E  ++KTL +  ++ LH
Sbjct: 14  LGAGQFGEVWMATYNKH------TKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLH 67

Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPC 150
            V     +  +  ITE    G+L ++ K        +  L  +S QI +G+ ++      
Sbjct: 68  AV---VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 122

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
            IHRDL  +N+ V+ +    KI D G+A ++
Sbjct: 123 YIHRDLRAANILVSASL-VCKIADFGLARVI 152

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 48.5 bits (115), Expect = 7e-07
 Identities = 48/167 (28%), Positives = 73/167 (43%), Gaps = 26/167 (15%)

Query: 33  LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
           LG G   +V  A     D+++  E     VK+         +  L SE+ ++K +  +KN
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALK 131
           II+L      +    L  I E  + GNLREY +  R                 ++ K L 
Sbjct: 83  IINLLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             + Q+ +G+ YL + +   IHRDL   NV V  N   +KI D G+A
Sbjct: 141 SCTYQVARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLA 184

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 48.1 bits (114), Expect = 8e-07
 Identities = 35/132 (26%), Positives = 64/132 (48%), Gaps = 11/132 (8%)

Query: 55  WN---QVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCT 111
           WN   +V ++T      M E    E +++K L +  ++ L+ V  +E    +  +TE   
Sbjct: 27  WNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE---PIYIVTEFMG 83

Query: 112 SGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQ 169
            G+L ++ K+   +++ +  L   + QI  G+ Y+       IHRDL  +N+ V  N   
Sbjct: 84  KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNL-V 140

Query: 170 VKIGDLGVAAIV 181
            KI D G+A ++
Sbjct: 141 CKIADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 48.1 bits (114), Expect = 9e-07
 Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)

Query: 32  LLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
           +LGSGA   VY+     +G    I VA   ++  T    P   + +  E  ++  + +  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPY 70

Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHT 146
           +  L  +      +T+  +T++   G L +Y ++++  +  + L  W  QI KG++YL  
Sbjct: 71  VCRLLGICLT---STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL-- 125

Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
            E  ++HRDL   NV V  +   VKI D G+A ++
Sbjct: 126 EEVRLVHRDLAARNVLVK-SPNHVKITDFGLARLL 159

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 47.9 bits (114), Expect = 9e-07
 Identities = 33/120 (27%), Positives = 55/120 (45%), Gaps = 8/120 (6%)

Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKW 133
           EV +L  + + NI+   Y    E+   L  + + C  G+L +     R V      +  W
Sbjct: 49  EVAVLSNMKHPNIVQ--YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW 106

Query: 134 SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIR-CWG 192
             QI   L   H H+  ++HRD+   N+F+    G +K+GD G+A ++   +   R C G
Sbjct: 107 FVQICLALK--HVHDRKILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVELARTCIG 163

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 48.2 bits (115), Expect = 1e-06
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 14/161 (8%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  A+D   G  VA  ++  R F  +    +R + E+ L+K + +
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLS-RPF-QNVTHAKRAYRELVLMKLVNH 74

Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           KNII L  V+      E+   +  + E+  + NL +       +  + +     Q+L G+
Sbjct: 75  KNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQV--IQMDLDHERMSYLLYQMLCGI 131

Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
            +LH+    +IHRDL  SN+ V  +   +KI D G+A   G
Sbjct: 132 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAG 169

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 48.1 bits (114), Expect = 1e-06
 Identities = 38/162 (23%), Positives = 73/162 (45%), Gaps = 8/162 (4%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           +LLG G   KV    ++  G   A   ++         +   + +E R+L+   +  + +
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTRHPFLTA 59

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L Y ++  DR  L F+ E    G L  +  + R  + +  + +  +I+  L YLH+ +  
Sbjct: 60  LKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD-- 115

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVA--AIVGRAIRRIRC 190
           V++RD+   N+ ++   G +KI D G+    I   A  +  C
Sbjct: 116 VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFC 156

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 47.5 bits (113), Expect = 1e-06
 Identities = 30/113 (26%), Positives = 61/113 (53%), Gaps = 4/113 (3%)

Query: 66  DPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV 125
             ++ +++  E++++    +  I+S +  + +E  N +    E    G+L    KK   +
Sbjct: 43  KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICMCMEFMDCGSLDRIYKKGGPI 100

Query: 126 SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            V+ L K +  +++GL YL+ +   ++HRD+  SN+ VN   GQ+K+ D GV+
Sbjct: 101 PVEILGKIAVAVVEGLTYLY-NVHRIMHRDIKPSNILVNSR-GQIKLCDFGVS 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 47.5 bits (113), Expect = 1e-06
 Identities = 49/166 (29%), Positives = 64/166 (38%), Gaps = 28/166 (16%)

Query: 32  LLGSGAVKKVYRA------FDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLA 84
            LGSGA  +VY              I VA   VK LR    D    E    E  L+    
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVA---VKTLRKGATDQEKKE-FLKEAHLMSNFN 57

Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-------VSVKALKKWSKQI 137
           + NI+ L  V    +   +  I E+   G+L  Y +  R        +++K L      +
Sbjct: 58  HPNIVKLLGVCLLNEPQYI--IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115

Query: 138 LKGLNYLH-THEPCVIHRDLNCSNVFVNGNTGQ----VKIGDLGVA 178
            KG  YL   H    IHRDL   N  V+         VKIGD G+A
Sbjct: 116 AKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 47.5 bits (114), Expect = 1e-06
 Identities = 27/112 (24%), Positives = 59/112 (52%), Gaps = 5/112 (4%)

Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
           +E + +E R+L+++ +  +++L+  ++D+    L  + E    G L  + +K        
Sbjct: 45  VEHVLNEKRILQSIRHPFLVNLYGSFQDDSN--LYLVMEYVPGGELFSHLRKSGRFPEPV 102

Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
            + ++ Q++  L YLH+ +  +++RDL   N+ +  + G +KI D G A  V
Sbjct: 103 ARFYAAQVVLALEYLHSLD--IVYRDLKPENLLL-DSDGYIKITDFGFAKRV 151

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 47.2 bits (113), Expect = 2e-06
 Identities = 29/100 (29%), Positives = 50/100 (50%), Gaps = 8/100 (8%)

Query: 85  NKNIISLHYVWRDEDRNTL--NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLN 142
           N N I L+Y       + L  ++I +    G+L +  KK   +S   +KK  +Q+++ LN
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKD----GDLFDLLKKEGKLSEAEVKKIIRQLVEALN 123

Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
            LH H   +IH D+   NV  +    ++ + D G+  I+G
Sbjct: 124 DLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161

Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 47.4 bits (112), Expect = 2e-06
 Identities = 22/45 (48%), Positives = 31/45 (68%), Gaps = 3/45 (6%)

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
           K+ILKGL+YLH+ +   IHRD+  +NV ++   G VK+ D GVA 
Sbjct: 108 KEILKGLDYLHSEKK--IHRDIKAANVLLS-EQGDVKLADFGVAG 149

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 46.9 bits (111), Expect = 2e-06
 Identities = 28/91 (30%), Positives = 52/91 (57%), Gaps = 5/91 (5%)

Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
           I+ + Y +   D+  L FI ++   G+L  +  +H   S K ++ ++ +I+ GL   H H
Sbjct: 59  IVCMTYAFHTPDK--LCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE--HMH 114

Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              V++RDL  +N+ ++ + G V+I DLG+A
Sbjct: 115 NRFVVYRDLKPANILLDEH-GHVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 46.9 bits (111), Expect = 2e-06
 Identities = 27/91 (29%), Positives = 52/91 (57%), Gaps = 5/91 (5%)

Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
           I+ + Y +   D+  L+FI ++   G+L  +  +H   S   ++ ++ +I+ GL   H H
Sbjct: 59  IVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE--HMH 114

Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              V++RDL  +N+ ++ + G V+I DLG+A
Sbjct: 115 NRFVVYRDLKPANILLDEH-GHVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 47.4 bits (112), Expect = 2e-06
 Identities = 41/170 (24%), Positives = 78/170 (45%), Gaps = 22/170 (12%)

Query: 11  DKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMI 70
           D D E   E             LG+G    V +   +  G+ +A   + L      PA+ 
Sbjct: 4   DDDFERISE-------------LGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIR 47

Query: 71  ERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKAL 130
            ++  E+++L    +  I+  +  +  +    ++   E    G+L +  K+ + +  + L
Sbjct: 48  NQIIRELQVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKEAKRIPEEIL 105

Query: 131 KKWSKQILKGLNYL-HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
            K S  +L+GL YL   H+  ++HRD+  SN+ VN + G++K+ D GV+ 
Sbjct: 106 GKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVN-SRGEIKLCDFGVSG 152

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 47.0 bits (111), Expect = 2e-06
 Identities = 33/122 (27%), Positives = 64/122 (52%), Gaps = 6/122 (4%)

Query: 57  QVKLRTFCDDPAMIERLFSEVRLLKTLANKN-IISLHYVWRDEDRNTLNFITEVCTSGNL 115
           +V  +   +D   I+ + +E  + +  +N   ++ LH  ++ E R  L F+ E    G+L
Sbjct: 26  KVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR--LFFVIEYVNGGDL 83

Query: 116 REYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             + ++ R +  +  + +S +I   LNYL  HE  +I+RDL   NV ++ + G +K+ D 
Sbjct: 84  MFHMQRQRKLPEEHARFYSAEISLALNYL--HERGIIYRDLKLDNVLLD-SEGHIKLTDY 140

Query: 176 GV 177
           G+
Sbjct: 141 GM 142

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 47.0 bits (112), Expect = 2e-06
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 17/151 (11%)

Query: 32  LLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
           +LG G+  KV     +  D+   ++V    V L+   DD   +E   +E R+L  LA K+
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD--DD---VECTMTEKRVL-ALAGKH 55

Query: 88  --IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLH 145
             +  LH  ++ +DR  L F+ E    G+L  + ++         + ++ +I+ GL +LH
Sbjct: 56  PFLTQLHSCFQTKDR--LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113

Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
                +I+RDL   NV ++   G +KI D G
Sbjct: 114 ERG--IIYRDLKLDNVLLDSE-GHIKIADFG 141

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 46.5 bits (110), Expect = 3e-06
 Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 20/154 (12%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWN---QVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
           LG+G   +V+            WN   +V ++T        E    E +++K L +  ++
Sbjct: 14  LGNGQFGEVWMG---------TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV 64

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRK--KHRHVSVKALKKWSKQILKGLNYLHTH 147
            L+ V  +E    +  +TE  + G+L ++ K  + R + +  L   + Q+  G+ Y+   
Sbjct: 65  QLYAVVSEE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121

Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
               IHRDL  +N+ V G+    KI D G+A ++
Sbjct: 122 N--YIHRDLRSANILV-GDGLVCKIADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 46.5 bits (110), Expect = 3e-06
 Identities = 40/159 (25%), Positives = 79/159 (49%), Gaps = 20/159 (12%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPA--MIERLFSEVRLLKTLANK-N 87
           E +G G   KV++  +++ G + A   VK+     DP   + E + +E  +LK L++  N
Sbjct: 24  ETIGKGTYGKVFKVLNKKNGSKAA---VKIL----DPIHDIDEEIEAEYNILKALSDHPN 76

Query: 88  IISLHYVWRDEDRNT---LNFITEVCTSGNLRE----YRKKHRHVSVKALKKWSKQILKG 140
           ++  + ++  +D      L  + E+C  G++ +    + K+   +    +     + L G
Sbjct: 77  VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136

Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
           L +LH ++   IHRD+  +N+ +    G VK+ D GV+A
Sbjct: 137 LQHLHVNK--TIHRDVKGNNILLT-TEGGVKLVDFGVSA 172

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 46.2 bits (109), Expect = 3e-06
 Identities = 36/154 (23%), Positives = 70/154 (45%), Gaps = 20/154 (12%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWN---QVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
           LG G   +V+            WN   +V ++T        E    E +++K L ++ ++
Sbjct: 14  LGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 64

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTH 147
            L+ V  +E    +  +TE  + G+L ++ K    +++ +  L   + QI  G+ Y+   
Sbjct: 65  QLYAVVSEE---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121

Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
               +HRDL  +N+ V G     K+ D G+A ++
Sbjct: 122 N--YVHRDLRAANILV-GENLVCKVADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 46.3 bits (110), Expect = 3e-06
 Identities = 42/169 (24%), Positives = 67/169 (39%), Gaps = 31/169 (18%)

Query: 31  ELLGSGAVKKVYRA-----FDQEEGIEVAWNQVK-LRTFCDDPAMIERLFS-EVRLLKTL 83
             LG GA  KV+         + +   VA   VK L+    + A   + F  E  LL   
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVA---VKTLKETASNDA--RKDFEREAELLTNF 65

Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY--------------RKKHRHVSVKA 129
            ++NI+  + V  + D      + E    G+L ++                    +++  
Sbjct: 66  QHENIVKFYGVCTEGD--PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123

Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           L + + QI  G+ YL +     +HRDL   N  V G    VKIGD G++
Sbjct: 124 LLQIAVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLVVKIGDFGMS 169

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 46.1 bits (109), Expect = 4e-06
 Identities = 43/142 (30%), Positives = 60/142 (42%), Gaps = 33/142 (23%)

Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR------------ 123
           EV++L  L + NII L  V  DED   L  ITE   +G+L ++   H             
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDED--PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126

Query: 124 -------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
                   +S  +L   + QI  G+ YL +     +HRDL   N  V  N   +KI D G
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENL-TIKIADFG 183

Query: 177 VA---------AIVGRAIRRIR 189
           ++          I GRA+  IR
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIR 205

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 46.3 bits (110), Expect = 4e-06
 Identities = 24/66 (36%), Positives = 38/66 (57%), Gaps = 2/66 (3%)

Query: 113 GNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKI 172
           G+L +  KK   +    L K S  +L+GL YL   +  ++HRD+  SN+ VN   G++K+
Sbjct: 84  GSLDQVLKKAGRIPENILGKISIAVLRGLTYLR-EKHKIMHRDVKPSNILVNSR-GEIKL 141

Query: 173 GDLGVA 178
            D GV+
Sbjct: 142 CDFGVS 147

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 45.6 bits (108), Expect = 5e-06
 Identities = 36/153 (23%), Positives = 70/153 (45%), Gaps = 14/153 (9%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           + LG+G   +V+  +           +V +++        E   +E  L+K L +  ++ 
Sbjct: 12  KKLGAGQFGEVWMGYYNGH------TKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVR 65

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHE 148
           L+ V   E    +  ITE   +G+L ++ K      +++  L   + QI +G+ ++    
Sbjct: 66  LYAVVTQE---PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
              IHRDL  +N+ V+  T   KI D G+A ++
Sbjct: 123 --YIHRDLRAANILVS-ETLCCKIADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 46.0 bits (109), Expect = 5e-06
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 10/149 (6%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G    VY+   +  G+ +A  +++L     D +   ++  E+ +L    +  I+  +
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFY 65

Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVK---ALKKWSKQILKGLNYLHTHEP 149
             +  E    +    E   +G+L +               L++ +  ++KGL +L   E 
Sbjct: 66  GAFFIE--GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL-KEEH 122

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            +IHRD+  +NV VNGN GQVK+ D GV+
Sbjct: 123 NIIHRDVKPTNVLVNGN-GQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 7e-06
 Identities = 38/180 (21%), Positives = 79/180 (43%), Gaps = 21/180 (11%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE-----RLFSEVRLLKTLAN 85
           +LLG G V +V+    +  G   A   +K+    D   MI+     R+ +E  +L TL +
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFA---LKV---LDKKEMIKRNKVKRVLTEQEILATLDH 60

Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNY 143
             + +L+     +    L  + + C  G L    ++   + +S +  + ++ ++L  L Y
Sbjct: 61  PFLPTLY--ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118

Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV---AAIVGRAIRRIRCWGRRSSWRRS 200
           LH     +++RDL   N+ ++ + G + + D  +   + +    + +    G R S   S
Sbjct: 119 LHLLG--IVYRDLKPENILLHES-GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 45.2 bits (107), Expect = 8e-06
 Identities = 29/103 (28%), Positives = 54/103 (52%), Gaps = 5/103 (4%)

Query: 75  SEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS 134
           +E R+L+   +  + +L Y ++  DR  L F+ E    G L  +  + R  S    + + 
Sbjct: 44  TESRVLQNTRHPFLTALKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSEDRARFYG 101

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV 177
            +I+  L YLH+ +  V++RDL   N+ ++ + G +KI D G+
Sbjct: 102 AEIVSALGYLHSCD--VVYRDLKLENLMLDKD-GHIKITDFGL 141

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 45.2 bits (107), Expect = 8e-06
 Identities = 35/121 (28%), Positives = 58/121 (47%), Gaps = 26/121 (21%)

Query: 68  AMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY--------- 118
           AM+E+     R+L  + ++ I+SL Y +  + +  L  +  +   G+LR +         
Sbjct: 40  AMVEK-----RILAKVHSRFIVSLAYAF--QTKTDLCLVMTIMNGGDLRYHIYNVDEENP 92

Query: 119 -RKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV 177
              + R     A      QI+ GL +LH     +I+RDL   NV ++ N G V+I DLG+
Sbjct: 93  GFPEPRACFYTA------QIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGL 143

Query: 178 A 178
           A
Sbjct: 144 A 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 45.5 bits (108), Expect = 8e-06
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           QIL GL Y+H+    V+HRDL   N+ VN +  ++KI D G+A
Sbjct: 113 QILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLA 152

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 44.9 bits (106), Expect = 8e-06
 Identities = 28/112 (25%), Positives = 56/112 (50%), Gaps = 6/112 (5%)

Query: 71  ERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKA 129
           +    E +++  L+++ ++ L+ V   +    +  +TE  ++G L  Y ++H +      
Sbjct: 44  DEFIEEAKVMMKLSHEKLVQLYGVCTKQ--RPIYIVTEYMSNGCLLNYLREHGKRFQPSQ 101

Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           L +  K + +G+ YL + +   IHRDL   N  V+   G VK+ D G++  V
Sbjct: 102 LLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQ-GCVKVSDFGLSRYV 150

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 44.9 bits (106), Expect = 9e-06
 Identities = 40/151 (26%), Positives = 68/151 (45%), Gaps = 14/151 (9%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLF-SEVRLLKTLANKNIISL 91
           +GSG    V+  +  E+  +VA   ++      + AM E  F  E +++  L++  ++ L
Sbjct: 12  IGSGQFGLVWLGYWLEKR-KVAIKTIR------EGAMSEEDFIEEAQVMMKLSHPKLVQL 64

Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           + V  +  R+ +  + E    G L +Y R +    S + L      + +G+ YL      
Sbjct: 65  YGVCTE--RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE--SSN 120

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           VIHRDL   N  V G    VK+ D G+   V
Sbjct: 121 VIHRDLAARNCLV-GENQVVKVSDFGMTRFV 150

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 44.7 bits (105), Expect = 1e-05
 Identities = 21/45 (46%), Positives = 33/45 (73%), Gaps = 3/45 (6%)

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
           ++ILKGL+YLH+ +   IHRD+  +NV ++ + G+VK+ D GVA 
Sbjct: 108 REILKGLDYLHSEKK--IHRDIKAANVLLSEH-GEVKLADFGVAG 149

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 44.3 bits (104), Expect = 2e-05
 Identities = 37/122 (30%), Positives = 59/122 (48%), Gaps = 13/122 (10%)

Query: 76  EVRLLKTLANKNIISLHYVW-RDEDRNT-LNF------ITEVCTSGNLREYRKKHRHVSV 127
           E+ LL+ L + N+I+L  V+    DR   L F      +  +       +  KK   +  
Sbjct: 48  EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107

Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG---NTGQVKIGDLGVAAIVGRA 184
             +K    QIL G++YLH +   V+HRDL  +N+ V G     G+VKI D+G A +    
Sbjct: 108 SMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165

Query: 185 IR 186
           ++
Sbjct: 166 LK 167

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 37/123 (30%), Positives = 58/123 (47%), Gaps = 22/123 (17%)

Query: 73  LFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-------- 123
           L SE+ ++K +  +KNII+L      +    L  + E  + GNLREY +  R        
Sbjct: 64  LVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVLVEYASKGNLREYLRARRPPGMDYSF 121

Query: 124 --------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                    ++ K L   + Q+ +G+ YL + +   IHRDL   NV V  +   +KI D 
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDN-VMKIADF 178

Query: 176 GVA 178
           G+A
Sbjct: 179 GLA 181

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 44.3 bits (104), Expect = 2e-05
 Identities = 38/122 (31%), Positives = 59/122 (48%), Gaps = 13/122 (10%)

Query: 76  EVRLLKTLANKNIISLHYVWRDE-DRNT-LNF------ITEVCTSGNLREYRKKHRHVSV 127
           E+ LL+ L + N+ISL  V+    DR   L F      +  +       +  KK   +  
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107

Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG---NTGQVKIGDLGVAAIVGRA 184
             +K    QIL G++YLH +   V+HRDL  +N+ V G     G+VKI D+G A +    
Sbjct: 108 GMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165

Query: 185 IR 186
           ++
Sbjct: 166 LK 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 44.3 bits (104), Expect = 2e-05
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 14/161 (8%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  A+D      VA  ++  R F  +    +R + E+ L+K + +
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 75

Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           KNIISL  V+      E+   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY---QMLCGI 132

Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
            +LH+    +IHRDL  SN+ V  +   +KI D G+A   G
Sbjct: 133 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAG 170

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 43.5 bits (102), Expect = 3e-05
 Identities = 21/45 (46%), Positives = 30/45 (66%), Gaps = 3/45 (6%)

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
           ++ILKGL+YLH+     IHRD+  +NV ++   G VK+ D GVA 
Sbjct: 108 REILKGLDYLHSERK--IHRDIKAANVLLS-EQGDVKLADFGVAG 149

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 43.3 bits (102), Expect = 3e-05
 Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 17/153 (11%)

Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
            +LG G+  KV  A  +E G    ++V    V L+   DD   +E   +E R+L +LA  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD--DD---VECTMTEKRIL-SLARN 54

Query: 87  N--IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
           +  +  L+  ++  DR  L F+ E    G+L  + +K R       + ++ +I   L +L
Sbjct: 55  HPFLTQLYCCFQTPDR--LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFL 112

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV 177
           H  +  +I+RDL   NV ++ + G  K+ D G+
Sbjct: 113 H--DKGIIYRDLKLDNVLLD-HEGHCKLADFGM 142

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 43.3 bits (102), Expect = 3e-05
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 17/153 (11%)

Query: 31  ELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LG G+  KV  A     D+   I+V    V L+    D  M E+     R+L  LA K
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEK-----RIL-ALAAK 54

Query: 87  N--IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
           +  + +LH  ++ +DR  L F+ E    G+L    ++ R       + ++ ++   L +L
Sbjct: 55  HPFLTALHCCFQTKDR--LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFL 112

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV 177
           H H   VI+RDL   N+ ++   G  K+ D G+
Sbjct: 113 HRHG--VIYRDLKLDNILLDAE-GHCKLADFGM 142

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 43.3 bits (102), Expect = 4e-05
 Identities = 30/113 (26%), Positives = 59/113 (52%), Gaps = 12/113 (10%)

Query: 68  AMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE--YRKKHRHV 125
           A+ E+     ++L+ ++++ I+SL Y +  E ++ L  +  +   G+L+   Y       
Sbjct: 40  ALNEK-----KILEKVSSRFIVSLAYAF--ETKDDLCLVMTLMNGGDLKYHIYNVGEPGF 92

Query: 126 SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
                  ++ QI+ GL   H H+  +++RDL   NV ++ + G V+I DLG+A
Sbjct: 93  PEARAIFYAAQIICGL--EHLHQRRIVYRDLKPENVLLD-DHGNVRISDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 43.1 bits (101), Expect = 4e-05
 Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 14/161 (8%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  A+D      VA  ++  R F  +    +R + E+ L+K + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 82

Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           KNII L  V+      E+   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 139

Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
            +LH+    +IHRDL  SN+ V  +   +KI D G+A   G
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAG 177

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 43.1 bits (101), Expect = 5e-05
 Identities = 25/94 (26%), Positives = 50/94 (53%), Gaps = 5/94 (5%)

Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
           +N  ++ LH  ++   R  L  + E    G+L  + ++ R +  +  + ++ +I   LN+
Sbjct: 54  SNPFLVGLHSCFQTTSR--LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNF 111

Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV 177
           L  HE  +I+RDL   NV ++ + G +K+ D G+
Sbjct: 112 L--HERGIIYRDLKLDNVLLDAD-GHIKLTDYGM 142

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 42.9 bits (101), Expect = 5e-05
 Identities = 39/151 (25%), Positives = 76/151 (50%), Gaps = 15/151 (9%)

Query: 32  LLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
           ++G G+  KV     +   +   ++V    +K     DD   I+ + +E  + +T +N  
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKV----IKKELVNDDED-IDWVQTEKHVFETASNHP 56

Query: 88  -IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            ++ LH  ++ E R  L F+ E  + G+L  + ++ R +  +  + +S +I   LN+L  
Sbjct: 57  FLVGLHSCFQTESR--LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFL-- 112

Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV 177
           HE  +I+RDL   NV ++   G +K+ D G+
Sbjct: 113 HERGIIYRDLKLDNVLLDAE-GHIKLTDYGM 142

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 42.5 bits (100), Expect = 5e-05
 Identities = 31/112 (27%), Positives = 54/112 (48%), Gaps = 6/112 (5%)

Query: 71  ERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKA 129
           E    E +++  L++  ++ L+ V     +  L  +TE   +G L  Y R++   +S   
Sbjct: 44  EDFIEEAKVMMKLSHPKLVQLYGVC--TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDM 101

Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           L    + + +G+ YL  +    IHRDL   N  V+ +TG VK+ D G+   V
Sbjct: 102 LLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYV 150

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 42.7 bits (100), Expect = 5e-05
 Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 14/157 (8%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +G G+   V  A  +  G  VA  ++ LR         E LF+EV +++   ++N++ ++
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMY 83

Query: 93  --YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
             Y+  DE    L  + E    G L +    H  ++ + +      +LK L+ LH     
Sbjct: 84  NSYLVGDE----LWVVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLKALSVLHAQG-- 136

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR 187
           VIHRD+   ++ +  + G+VK+ D G  A V + + R
Sbjct: 137 VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPR 172

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 42.3 bits (99), Expect = 7e-05
 Identities = 29/113 (25%), Positives = 50/113 (44%), Gaps = 6/113 (5%)

Query: 67  PAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHV 125
           P +  +   E R+LK  ++ NI+ L  V     +  +  + E+   G+   + R +   +
Sbjct: 34  PDLKAKFLQEARILKQYSHPNIVRLIGVC--TQKQPIYIVMELVQGGDFLTFLRTEGPRL 91

Query: 126 SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            VK L +  +    G+ YL +     IHRDL   N  V      +KI D G++
Sbjct: 92  KVKELIQMVENAAAGMEYLESK--HCIHRDLAARNCLVT-EKNVLKISDFGMS 141

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 41.9 bits (98), Expect = 1e-04
 Identities = 35/151 (23%), Positives = 72/151 (47%), Gaps = 13/151 (8%)

Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           +++G G+  KV  A  + +G    ++V   ++ L        M ER      LLK + + 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV----LLKNVKHP 56

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            ++ LHY ++  ++  L F+ +    G L  + ++ R       + ++ +I   L YLH+
Sbjct: 57  FLVGLHYSFQTTEK--LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114

Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV 177
               +++RDL   N+ ++ + G V + D G+
Sbjct: 115 IN--IVYRDLKPENILLD-SQGHVVLTDFGL 142

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.5 bits (97), Expect = 2e-04
 Identities = 19/61 (31%), Positives = 35/61 (57%), Gaps = 3/61 (4%)

Query: 118 YRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV 177
           Y    R++++  +    + +L+ + YLH +   +IHRD+   N+F+N + G V +GD G 
Sbjct: 172 YLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGA 228

Query: 178 A 178
           A
Sbjct: 229 A 229

Length = 391

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 40.8 bits (95), Expect = 2e-04
 Identities = 34/147 (23%), Positives = 70/147 (47%), Gaps = 7/147 (4%)

Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
           ++G GA   V +   +E    VA    K +   ++  + E    E+++L+TL  +NI+ L
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIK--KFKDSEENEEVKETTLRELKMLRTLKQENIVEL 65

Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
              +R   R  L  + E      L    +    V  + ++ +  Q++K +++ H ++  +
Sbjct: 66  KEAFR--RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--I 121

Query: 152 IHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +HRD+   N+ ++ N   +K+ D G A
Sbjct: 122 VHRDIKPENLLISHND-VLKLCDFGFA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 41.1 bits (96), Expect = 2e-04
 Identities = 42/172 (24%), Positives = 71/172 (41%), Gaps = 31/172 (18%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RLFSEVRLLKTLANKNIIS 90
           LG G   KV +A          +  V ++   ++ +  E   L SE  LLK + + ++I 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV------------------------S 126
           L+     +    L  I E    G+LR + ++ R V                        +
Sbjct: 68  LYGACSQDG--PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 127 VKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +  L  ++ QI +G+ YL   E  ++HRDL   NV V     ++KI D G++
Sbjct: 126 MGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLV-AEGRKMKISDFGLS 174

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 40.7 bits (95), Expect = 3e-04
 Identities = 27/105 (25%), Positives = 54/105 (51%), Gaps = 7/105 (6%)

Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE--YRKKHRHVSVKALKKW 133
           E  +L+ + +  I++L Y +  E +  L  +  +   G+L+   Y    R + ++ +  +
Sbjct: 43  EKEILEKVNSPFIVNLAYAF--ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHY 100

Query: 134 SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           S QI  G+  LH H   +++RD+   NV ++   G  ++ DLG+A
Sbjct: 101 SAQITCGI--LHLHSMDIVYRDMKPENVLLDDQ-GNCRLSDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 40.4 bits (94), Expect = 3e-04
 Identities = 43/171 (25%), Positives = 78/171 (45%), Gaps = 29/171 (16%)

Query: 28  RYNELLGSGAVKKVYRAFDQEEGI--EVAWNQVKLRTFCDDPAMIERLFS-EVRLLKTLA 84
           ++ +++G G   +V +A  +++G+  + A  ++K     DD     R F+ E+ +L  L 
Sbjct: 10  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD----HRDFAGELEVLCKLG 65

Query: 85  -NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSV 127
            + NII  + +   E R  L    E    GNL ++ +K R                 +S 
Sbjct: 66  HHPNII--NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123

Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           + L  ++  + +G++YL   +   IHRDL   N+ V G     KI D G++
Sbjct: 124 QQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLS 171

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 40.6 bits (95), Expect = 3e-04
 Identities = 28/112 (25%), Positives = 56/112 (50%), Gaps = 5/112 (4%)

Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
           ++ +  E  +L  L++  I+++   ++DE+R  + F+ E    G L  + +K        
Sbjct: 62  VQHVAQEKSILMELSHPFIVNMMCSFQDENR--VYFLLEFVVGGELFTHLRKAGRFPNDV 119

Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
            K +  +++    YLH+ +  +I+RDL   N+ ++   G VK+ D G A  V
Sbjct: 120 AKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNK-GHVKVTDFGFAKKV 168

Length = 329

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 40.4 bits (94), Expect = 3e-04
 Identities = 43/169 (25%), Positives = 78/169 (46%), Gaps = 25/169 (14%)

Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS-EVRLLKTLANK 86
           ++ +++G G   +V RA  +++G+++      L+ F  +     R F+ E+ +L  L + 
Sbjct: 5   KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEND--HRDFAGELEVLCKLGHH 62

Query: 87  -NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKA 129
            NII+L  +   E+R  L    E    GNL ++ +K R                 ++ + 
Sbjct: 63  PNIINL--LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           L +++  +  G+ YL   +   IHRDL   NV V  N    KI D G++
Sbjct: 121 LLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLAS-KIADFGLS 166

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 40.1 bits (94), Expect = 4e-04
 Identities = 33/115 (28%), Positives = 54/115 (46%), Gaps = 16/115 (13%)

Query: 70  IERLFSEVRLLKTLANKNIIS-LHYVWRDEDRNTLNFITEVCTS-GNLREYRKKHRH--- 124
           +  L  E  LL  L+++NI+  LH    D +     F+     + GNL+ + ++ R    
Sbjct: 52  VTLLLQESCLLYGLSHQNILPILHVCIEDGEPP---FVLYPYMNWGNLKLFLQQCRLGEA 108

Query: 125 -----VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
                +S + L   + QI  G++YLH     VIH+D+   N  ++    QVKI D
Sbjct: 109 NNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EELQVKITD 160

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 40.1 bits (94), Expect = 4e-04
 Identities = 32/126 (25%), Positives = 60/126 (47%), Gaps = 12/126 (9%)

Query: 56  NQVKLRTFCDD----PAMIERLFSEVRLLKTLANKNIISLH--YVWRDEDRNTLNFITEV 109
            +V +RTF         +I+   +E++ L+ + + NI+ ++   +   +D   L+ I E 
Sbjct: 44  KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103

Query: 110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH--EPCVIHRDLNCSNVFVNGNT 167
           CT G LRE   K + +S K     +    KGL  L+ +  +P   +++L   +  V  N 
Sbjct: 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTEN- 159

Query: 168 GQVKIG 173
            ++KI 
Sbjct: 160 YKLKII 165

Length = 283

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 40.3 bits (94), Expect = 4e-04
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 7/148 (4%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRT-FCDDPAMIERLFSEVRLLKTLANKNII 89
           ++LG G+  KV  A  + +G   A   +K      DD   +E    E R+L  LA +N  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDD--VECTMVEKRVL-ALAWENPF 57

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
             H     + +  L F+ E    G+L  + +      +     ++ +I+ GL +LH+   
Sbjct: 58  LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG- 116

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGV 177
            +I+RDL   NV ++ + G +KI D G+
Sbjct: 117 -IIYRDLKLDNVMLDRD-GHIKIADFGM 142

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 40.0 bits (93), Expect = 5e-04
 Identities = 34/124 (27%), Positives = 61/124 (49%), Gaps = 7/124 (5%)

Query: 56  NQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL 115
           N+V ++   +D A  +   +E  ++  L + N++ L  V   E++  L  +TE    G+L
Sbjct: 30  NKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSL 87

Query: 116 REY-RKKHRHV-SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIG 173
            +Y R + R V     L K+S  + + + YL  +    +HRDL   NV V+ +    K+ 
Sbjct: 88  VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDN-VAKVS 144

Query: 174 DLGV 177
           D G+
Sbjct: 145 DFGL 148

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 39.6 bits (93), Expect = 5e-04
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 16/162 (9%)

Query: 20  TDPTGRYGRYNELLGSGAVKKVYRAFDQEEG---IEVAWNQVK-LRTFCDDPAMIERLFS 75
            DP+  Y    +++G G   +V R   +  G   I+VA   +K L+    D   ++ L +
Sbjct: 1   IDPS--YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVA---IKTLKAGSSDKQRLDFL-T 54

Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWS 134
           E  ++    + NII L  V        +  ITE   +G+L ++ +++    +V  L    
Sbjct: 55  EASIMGQFDHPNIIRLEGVV--TKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGML 112

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
           + I  G+ YL       +HRDL   N+ VN N    K+ D G
Sbjct: 113 RGIASGMKYLSEM--NYVHRDLAARNILVNSNL-VCKVSDFG 151

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 40.0 bits (93), Expect = 5e-04
 Identities = 34/152 (22%), Positives = 73/152 (48%), Gaps = 9/152 (5%)

Query: 31  ELLGSGAVKKVY---RAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
           ++LG+GA  KV+   +    + G   A   +K  T        E   +E ++L+ +    
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65

Query: 88  -IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            +++LHY ++ + +  L+ I +    G L  +  +      + ++ +S +I+  L   H 
Sbjct: 66  FLVTLHYAFQTDTK--LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE--HL 121

Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           H+  +I+RD+   N+ ++ N G V + D G++
Sbjct: 122 HKLGIIYRDIKLENILLDSN-GHVVLTDFGLS 152

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 39.8 bits (93), Expect = 5e-04
 Identities = 29/110 (26%), Positives = 58/110 (52%), Gaps = 5/110 (4%)

Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVK 128
           +E+   E  ++K  ++ N++SL  +    + + L  +  +   G+LR + R +  + +VK
Sbjct: 40  VEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK-HGDLRNFIRSETHNPTVK 98

Query: 129 ALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            L  +  Q+ KG+ YL + +   +HRDL   N  ++  +  VK+ D G+A
Sbjct: 99  DLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLD-ESFTVKVADFGLA 145

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 39.7 bits (92), Expect = 6e-04
 Identities = 40/166 (24%), Positives = 75/166 (45%), Gaps = 25/166 (15%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS-EVRLLKTLANK-NI 88
           +++G G   +V +A  +++G+ +     +++ +        R F+ E+ +L  L +  NI
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKLGHHPNI 58

Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALKK 132
           I+L  +   E R  L    E    GNL ++ +K R                 +S + L  
Sbjct: 59  INL--LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116

Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           ++  + +G++YL   +   IHRDL   N+ V  N    KI D G++
Sbjct: 117 FAADVARGMDYLS--QKQFIHRDLAARNILVGENYVA-KIADFGLS 159

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 39.8 bits (93), Expect = 7e-04
 Identities = 41/163 (25%), Positives = 72/163 (44%), Gaps = 15/163 (9%)

Query: 27  GRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA 84
            RY+   L+G G + +VY A+D      VA  +++     ++P + +R   E ++   L 
Sbjct: 2   QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIR-EDLSENPLLKKRFLREAKIAADLI 60

Query: 85  NKNIISLHYVWRDED--RNTLNFITEVCTSGNLREYRKK-------HRHVSVKALKKWSK 135
           +  I+ ++ +  D D    T+ +I        L+   +K           SV A      
Sbjct: 61  HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +I   + Y+H+    V+HRDL   N+ + G  G+V I D G A
Sbjct: 121 KICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWGAA 160

Length = 932

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 39.2 bits (91), Expect = 7e-04
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 16/157 (10%)

Query: 31  ELLGSGAVKKVYRAFDQEEG-IEVAWNQVKLRTFCDDPAMIER----LFSEVRLLKTLAN 85
           +++G+G   +V+R   +  G  EVA   V ++T    P   E+      SE  ++   ++
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVA---VAIKTL--KPGYTEKQRQDFLSEASIMGQFSH 65

Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYL 144
            NII L  V           ITE   +G L +Y + H    S   L    + I  G+ YL
Sbjct: 66  HNIIRLEGVV--TKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
              +   +HRDL   N+ VN N  + K+ D G++ ++
Sbjct: 124 S--DMNYVHRDLAARNILVNSNL-ECKVSDFGLSRVL 157

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 39.3 bits (91), Expect = 8e-04
 Identities = 17/44 (38%), Positives = 29/44 (65%), Gaps = 3/44 (6%)

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           KQ+L  + Y+H  +  +IHRD+   N+F+N + G++ +GD G A
Sbjct: 274 KQLLCAVEYIHDKK--LIHRDIKLENIFLNCD-GKIVLGDFGTA 314

Length = 501

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 39.0 bits (90), Expect = 0.001
 Identities = 37/132 (28%), Positives = 66/132 (50%), Gaps = 13/132 (9%)

Query: 72  RLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL-REYRKKHR---HVSV 127
           +L  EV +++ L +KNI+     + ++    L  + E C +G+L R  +K ++    +  
Sbjct: 58  QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117

Query: 128 KALKKWSKQILKGLNYLHTHEPC-----VIHRDLNCSNVFVNGNTGQVKIGDLGVAA--I 180
            A+   ++Q+L  L Y H  +       V+HRDL   N+F+  +TG   IG +   A  +
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL--STGIRHIGKITAQANNL 175

Query: 181 VGRAIRRIRCWG 192
            GR I +I  +G
Sbjct: 176 NGRPIAKIGDFG 187

Length = 1021

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 38.6 bits (90), Expect = 0.001
 Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 15/95 (15%)

Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNL-----REYRKKHRHVSVKALKKWSKQILKGLN 142
           +  LH  ++  DR  L F+ E    G+L     +  + K  H    A      +I  GL 
Sbjct: 63  LTQLHSCFQTMDR--LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYA-----AEIAIGLF 115

Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV 177
           +LH+    +I+RDL   NV ++   G +KI D G+
Sbjct: 116 FLHSKG--IIYRDLKLDNVMLDAE-GHIKIADFGM 147

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 38.3 bits (89), Expect = 0.002
 Identities = 17/48 (35%), Positives = 27/48 (56%), Gaps = 3/48 (6%)

Query: 134 SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           ++Q+L  ++Y+H     +IHRD+   NV VNG    + +GD G A   
Sbjct: 266 ARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPE-DICLGDFGAACFA 310

Length = 461

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 37.9 bits (88), Expect = 0.002
 Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 19/157 (12%)

Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
           +LGSGA   V  A    +G   A   V +       A   R  +EV  L      +I+  
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKC 96

Query: 92  H--YVWRDEDRNTLN-----FITEVCTSGNLREYRKKHRHVSVKALKKWSK-----QILK 139
           H  +  +D  RN  N      + +   +G+LR+   K R  + +  ++        Q+L 
Sbjct: 97  HEDFAKKDP-RNPENVLMIALVLDYANAGDLRQ-EIKSRAKTNRTFREHEAGLLFIQVLL 154

Query: 140 GLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
            ++  H H   +IHRD+  +N+ +  N G VK+GD G
Sbjct: 155 AVH--HVHSKHMIHRDIKSANILLCSN-GLVKLGDFG 188

Length = 496

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 37.6 bits (87), Expect = 0.003
 Identities = 31/152 (20%), Positives = 73/152 (48%), Gaps = 9/152 (5%)

Query: 31  ELLGSGAVKKVY---RAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
           ++LG+GA  KV+   +    + G   A   ++          +E   +E  +L+ +    
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 88  -IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            +++LHY ++ E +  L+ I +  + G +  +  +  + S   ++ +S +I+  L   H 
Sbjct: 66  FLVTLHYAFQTEAK--LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE--HL 121

Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           H+  +++RD+   N+ ++   G V + D G++
Sbjct: 122 HKLGIVYRDIKLENILLDSE-GHVVLTDFGLS 152

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 37.3 bits (86), Expect = 0.003
 Identities = 39/151 (25%), Positives = 69/151 (45%), Gaps = 15/151 (9%)

Query: 32  LLGSGAVKKVY----RAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
           +LG G+  KV     +  D+   I++    V ++   DD   +E    E R+L       
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD--DD---VECTMVEKRVLALQDKPP 61

Query: 88  IIS-LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            ++ LH  ++  DR  L F+ E    G+L  + ++           ++ +I  GL +LH 
Sbjct: 62  FLTQLHSCFQTVDR--LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH- 118

Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV 177
               +I+RDL   NV ++ + G +KI D G+
Sbjct: 119 -RRGIIYRDLKLDNVMLD-SEGHIKIADFGM 147

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	219
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.98
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.98
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.98
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.98
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.98
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.98
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.98
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.98
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.98
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.98
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.98
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.98
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.97
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.97
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.97
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.97
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.97
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.97
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.97
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.97
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.97
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.97
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.97
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.97
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.97
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.97
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.97
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.97
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.97
PTZ00283	496	serine/threonine protein kinase; Provisional	99.97
PTZ00267	478	NIMA-related protein kinase; Provisional	99.97
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.97
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.97
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.97
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.97
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.97
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.97
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.97
PHA03212	391	serine/threonine kinase US3; Provisional	99.97
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.97
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.97
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.97
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.97
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.97
PHA02988	283	hypothetical protein; Provisional	99.97
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.97
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.97
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.96
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.96
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.96
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.96
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.96
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.96
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.96
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.96
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.96
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.96
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.96
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.96
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.96
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.96
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.96
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.96
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.96
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.96
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.96
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.96
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.96
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.96
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.96
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.96
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.96
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.96
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.96
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.96
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.96
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.96
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.96
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.96
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.96
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.96
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.96
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.96
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.96
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.96
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.96
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.96
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.96
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.96
PTZ00284	467	protein kinase; Provisional	99.96
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.96
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.96
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.96
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.96
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.96
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.96
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.96
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.96
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.96
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.96
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.96
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.96
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.96
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.96
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.96
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.96
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.96
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.96
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.96
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.96
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.96
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.96
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.96
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.96
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.96
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.96
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.96
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.96
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.96
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.96
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.96
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.96
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.96
PHA03211	461	serine/threonine kinase US3; Provisional	99.96
PHA03209	357	serine/threonine kinase US3; Provisional	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.96
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.96
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.96
KOG0610	459	consensus Putative serine/threonine protein kinase	99.96
PHA03207	392	serine/threonine kinase US3; Provisional	99.96
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.96
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.96
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.96
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.96
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.96
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.96
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.96
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.96
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.96
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.96
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.96
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.96
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.96
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.96
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.96
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.96
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.96
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.96
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.96
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.96
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.96
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.96
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.96
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.96
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.96
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.96
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.96
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.96
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.96
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.96
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.96
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.96
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.96
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.96
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.96
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.96
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.96
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.96
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.96
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.96
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.96
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.96
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.96
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.96
PLN00009	294	cyclin-dependent kinase A; Provisional	99.96
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.95
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.95
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.95
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.95
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.95
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.95
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.95
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.95
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.95
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.95
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.95
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.95
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.95
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.95
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.95
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.95
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.95
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.95
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.95
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.95
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.95
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.95
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.95
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.95
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.95
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.95
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.95
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.95
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.95
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.95
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.95
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.95
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.95
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.95
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.95
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.95
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.95
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.95
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.95
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.95
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.95
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.95
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.95
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.95
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.95
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.95
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.95
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.95
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.95
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.95
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.95
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.95
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.95
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.95
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.95
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.95
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.95
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.95
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.95
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.95
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.95
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.95
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.95
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.95
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.95
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.95
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.95
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.95
PHA02882	294	putative serine/threonine kinase; Provisional	99.95
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.95
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.95
PHA03210	501	serine/threonine kinase US3; Provisional	99.95
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.95
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.95
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.94
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.94
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.94
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.94
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.94
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.94
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.94
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.94
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.94
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.94
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.94
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.94
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.94
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.94
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.94
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.94
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.94
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.94
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.94
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.93
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.93
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.93
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.93
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.92
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
KOG3653	534	consensus Transforming growth factor beta/activin	99.92
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.92
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.92
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.92
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.91
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.91
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.91
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.9
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.87
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.85
smart00090	237	RIO RIO-like kinase.	99.83
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.82
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.77
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.66
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.66
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.65
PLN00181	793	protein SPA1-RELATED; Provisional	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.57
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.56
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.51
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.47
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.47
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.42
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.39
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.37
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.27
KOG3087	229	consensus Serine/threonine protein kinase [General	99.27
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.22
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.19
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.15
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.14
KOG1243	690	consensus Protein kinase [General function predict	99.12
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.11
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.11
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.0
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.98
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.95
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.89
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	98.8
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.74
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.74
PRK09902	216	hypothetical protein; Provisional	98.67
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.57
PF01636	239	APH: Phosphotransferase enzyme family This family	98.48
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.46
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.45
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.43
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.36
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.33
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.22
PLN02876	822	acyl-CoA dehydrogenase	98.07
KOG2270	520	consensus Serine/threonine protein kinase involved	98.01
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.86
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.86
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.83
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.81
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.8
PRK10593	297	hypothetical protein; Provisional	97.72
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.71
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.6
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.58
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.47
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.47
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.11
PRK12396	409	5-methylribose kinase; Reviewed	97.07
PLN02756	418	S-methyl-5-thioribose kinase	97.03
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.02
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.95
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.8
PLN02236	344	choline kinase	96.79
KOG2137	700	consensus Protein kinase [Signal transduction mech	96.78
COG4248	637	Uncharacterized protein with protein kinase and he	96.77
KOG0606	1205	consensus Microtubule-associated serine/threonine	96.71
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.39
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.32
PRK05231	319	homoserine kinase; Provisional	96.28
KOG1290	590	consensus Serine/threonine protein kinase [Signal	95.86
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.67
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.42
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.35
PTZ00384	383	choline kinase; Provisional	95.2
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.02
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	94.69
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	94.57
KOG1236	565	consensus Predicted unusual protein kinase [Genera	94.23
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.11
PTZ00296	442	choline kinase; Provisional	92.58
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	92.27
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	92.22
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	92.2
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	91.18
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	90.88

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-42  Score=270.62  Aligned_cols=191  Identities=25%  Similarity=0.466  Sum_probs=164.3

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      ....++| .+.+.||+|+|+.||+|++++++..||||.+.....  ....++.+..|+.+|+.++||||+.+++++  +.
T Consensus         6 ~~~~~~y-~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~--~~   80 (429)
T KOG0595|consen    6 MRVVGDY-ELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCI--ED   80 (429)
T ss_pred             ccccccc-eehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEE--ec
Confidence            3445677 566889999999999999999999999999987654  456667888999999999999999999999  55


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC-C----CcEEEec
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN-T----GQVKIGD  174 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~-~----~~~~l~d  174 (219)
                      .+++|+|||||.||+|.++++..+.+++.+++.++.|++.|+++||+++  |+||||||+|||++.. .    ..+||+|
T Consensus        81 ~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   81 DDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             CCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecc
Confidence            6789999999999999999999999999999999999999999999999  9999999999999753 1    2479999


Q ss_pred             cccceeccccceeeeecccCc----cccCCCccccccceeeec--cccc
Q 027788          175 LGVAAIVGRAIRRIRCWGRRS----SWRRSCTMRITRSLWTYT--RLGC  217 (219)
Q Consensus       175 fg~a~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~diws~g--i~~~  217 (219)
                      ||+|+.+.......+.+|+|-    +......|+.|+|+||.|  +|.|
T Consensus       159 FGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~  207 (429)
T KOG0595|consen  159 FGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQC  207 (429)
T ss_pred             cchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHH
Confidence            999999998776555666543    223477799999999999  4443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-39  Score=254.40  Aligned_cols=192  Identities=22%  Similarity=0.345  Sum_probs=154.5

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCH---HHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDP---AMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      ..+|-+.+.+|+|+||.|-+|+..++++.||||+++.+......   .......+|+++|++|+||||++++++|  +..
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f--~~~  248 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF--EVP  248 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee--ecC
Confidence            45558999999999999999999999999999999987654321   1223457999999999999999999999  555


Q ss_pred             ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC--CcEEEeccccc
Q 027788          101 NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDLGVA  178 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~--~~~~l~dfg~a  178 (219)
                      .+.|+||||+.||+|.+++-.++.+.+.....+++|++.|+.|||+++  |.||||||+|||++.+.  -.+||+|||+|
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchh
Confidence            667899999999999999988888999999999999999999999999  99999999999997542  25799999999


Q ss_pred             eeccccce-----eeeecccCccccC-CCccc-cccceeeeccccccC
Q 027788          179 AIVGRAIR-----RIRCWGRRSSWRR-SCTMR-ITRSLWTYTRLGCAC  219 (219)
Q Consensus       179 ~~~~~~~~-----~~~~~~~~~~~~~-~~~~~-~~~diws~gi~~~~c  219 (219)
                      +..+....     ++..+.+|+-... ..++. .+-||||+|++-+-|
T Consensus       327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvc  374 (475)
T KOG0615|consen  327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVC  374 (475)
T ss_pred             hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEE
Confidence            98875443     3334444443322 22233 368999999554443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-39  Score=263.40  Aligned_cols=190  Identities=28%  Similarity=0.503  Sum_probs=168.8

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      ...|+..+.|...++||+|+|+++|.+++..+|..||+|++.++... .+.+.+.+.+||++++.|+||||++++++|  
T Consensus        11 ~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~-k~~~reKv~~EIeIHr~L~HpnIV~f~~~F--   87 (592)
T KOG0575|consen   11 VIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLK-KPKQREKVLNEIEIHRSLKHPNIVQFYHFF--   87 (592)
T ss_pred             eeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhc-CcchHHHHHHHHHHHHhcCCCcEEeeeeEe--
Confidence            45666678889999999999999999999999999999999875553 567788999999999999999999999999  


Q ss_pred             CCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                      ++.+++|++.|.|.+++|..+++....+++..++.++.||+.|+.|||+.+  |+|||||..|++++.+. ++||+|||+
T Consensus        88 EDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~-~VKIgDFGL  164 (592)
T KOG0575|consen   88 EDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENM-NVKIGDFGL  164 (592)
T ss_pred             ecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcC-cEEecccce
Confidence            788899999999999999999988789999999999999999999999999  99999999999999775 899999999


Q ss_pred             ceecccc-ceeeeecccCc----cccCCCccccccceeeec
Q 027788          178 AAIVGRA-IRRIRCWGRRS----SWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       178 a~~~~~~-~~~~~~~~~~~----~~~~~~~~~~~~diws~g  213 (219)
                      |..+..+ +...+.+|+|-    +.......+..+||||+|
T Consensus       165 At~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlG  205 (592)
T KOG0575|consen  165 ATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLG  205 (592)
T ss_pred             eeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhh
Confidence            9999865 55555566654    334466778889999999

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-39  Score=251.10  Aligned_cols=180  Identities=26%  Similarity=0.462  Sum_probs=157.0

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC  110 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  110 (219)
                      +.||+|+.|.||++.++.+++.+|+|.+....   ++...+.+.+|++++++.+||+|+.+++.|..+.. .+.++||||
T Consensus        85 ~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~---~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mEYM  160 (364)
T KOG0581|consen   85 GVLGSGNGGTVYKVRHKPTGKIYALKVILLNI---DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICMEYM  160 (364)
T ss_pred             hhcccCCCcEEEEEEEcCCCeEEEEEeecccC---CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehhhc
Confidence            68999999999999999999999999996443   57777889999999999999999999999987765 689999999


Q ss_pred             cCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---
Q 027788          111 TSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT-HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---  186 (219)
Q Consensus       111 ~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~-~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---  186 (219)
                      ++|+|.+++...+.+++.....++.+|+.||.|||. ..  |+||||||+|+|++.. |.+||+|||.+..+.....   
T Consensus       161 DgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNsk-GeVKicDFGVS~~lvnS~a~tf  237 (364)
T KOG0581|consen  161 DGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSK-GEVKICDFGVSGILVNSIANTF  237 (364)
T ss_pred             CCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccC-CCEEeccccccHHhhhhhcccc
Confidence            999999998887889999999999999999999996 67  9999999999999976 7999999999998876642   


Q ss_pred             -eeeecccCccccCCCccccccceeeec--ccccc
Q 027788          187 -RIRCWGRRSSWRRSCTMRITRSLWTYT--RLGCA  218 (219)
Q Consensus       187 -~~~~~~~~~~~~~~~~~~~~~diws~g--i~~~~  218 (219)
                       ++.++-+||.. ....|+.++||||||  +|.++
T Consensus       238 vGT~~YMsPERi-~g~~Ys~~sDIWSLGLsllE~a  271 (364)
T KOG0581|consen  238 VGTSAYMSPERI-SGESYSVKSDIWSLGLSLLELA  271 (364)
T ss_pred             cccccccChhhh-cCCcCCcccceecccHHHHHHh
Confidence             55555555443 445788889999999  76654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=246.33  Aligned_cols=187  Identities=18%  Similarity=0.275  Sum_probs=161.8

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      -.-+.+.+.||+|+||+||+++.+++++.+|+|+++++..... ...++..+|..++..++||+|++++..|+++  ..+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~--~kL  100 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRHTKAERNILSKIKHPFIVKLIYSFQTE--EKL  100 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHHHHHHHHHHHHhCCCCcEeeeEEecccC--CeE
Confidence            3445788999999999999999999999999999997765433 4568899999999999999999999999655  459


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      |+|+||++||.|...++.++.+++..+..++..++.||.|||+.+  |+||||||+|||++.+ |.++|+|||+|+..-.
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~-GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQ-GHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCC-CcEEEeccccchhccc
Confidence            999999999999999999999999999999999999999999999  9999999999999955 7999999999996655


Q ss_pred             cce-eeeecccCc----cccCCCccccccceeeecccc
Q 027788          184 AIR-RIRCWGRRS----SWRRSCTMRITRSLWTYTRLG  216 (219)
Q Consensus       184 ~~~-~~~~~~~~~----~~~~~~~~~~~~diws~gi~~  216 (219)
                      ... ..+.+|+++    +.....+|+...|-|||||+.
T Consensus       178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGill  215 (357)
T KOG0598|consen  178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILL  215 (357)
T ss_pred             CCCccccccCCccccChHHHhcCCCCcccchHhHHHHH
Confidence            543 333467765    344566899999999999654

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-38  Score=261.04  Aligned_cols=203  Identities=52%  Similarity=0.910  Sum_probs=187.8

Q ss_pred             CCCCCCCccccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCce
Q 027788           10 SDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII   89 (219)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   89 (219)
                      .+.+...+.+.++.+||.++...||+|+|-+||+|.+..+|.+||+-.++.+.....+..+++|..|+++|+.|+|+||+
T Consensus        25 ~e~~~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIi  104 (632)
T KOG0584|consen   25 SEPDESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNII  104 (632)
T ss_pred             hccccccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCcee
Confidence            34556678899999999999999999999999999999999999999999888888899999999999999999999999


Q ss_pred             EEEEEEecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCc
Q 027788           90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQ  169 (219)
Q Consensus        90 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~  169 (219)
                      +++++|.+.+...+.+++|.+..|+|..++.+++.++...+..|++||+.||.|||++.|||+|||||.+|||++.+.|.
T Consensus       105 rfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~  184 (632)
T KOG0584|consen  105 RFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGE  184 (632)
T ss_pred             eeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCc
Confidence            99999998888889999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEEeccccceeccccceeeeecccCcccc---CCCccccccceeeec
Q 027788          170 VKIGDLGVAAIVGRAIRRIRCWGRRSSWR---RSCTMRITRSLWTYT  213 (219)
Q Consensus       170 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~diws~g  213 (219)
                      |||.|+|+|.......... ..|+|+...   -...|+-..||||||
T Consensus       185 VKIGDLGLAtl~r~s~aks-vIGTPEFMAPEmYEE~YnE~VDVYaFG  230 (632)
T KOG0584|consen  185 VKIGDLGLATLLRKSHAKS-VIGTPEFMAPEMYEENYNELVDVYAFG  230 (632)
T ss_pred             eeecchhHHHHhhccccce-eccCccccChHHHhhhcchhhhhhhhh
Confidence            9999999999988877654 889988543   246788889999999

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-37  Score=231.83  Aligned_cols=183  Identities=22%  Similarity=0.335  Sum_probs=161.2

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      ...+.+|.|+||+|.+++.+.+|..+|+|++++...- ...++++..+|..+|+.+.||+++++++.++  +...++++|
T Consensus        47 e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vV-klKQveH~~nEk~vL~~v~~PFlv~l~~t~~--d~~~lymvm  123 (355)
T KOG0616|consen   47 ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVV-KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK--DNSNLYMVM  123 (355)
T ss_pred             hheeeeccCccceEEEEEEccCCceeehhhcCHHHHH-HHHHHHHHhhHHHHHhhccCceeEEEEEeec--cCCeEEEEE
Confidence            4457899999999999999999999999999876543 4678899999999999999999999999995  456799999


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccccee
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR  187 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~  187 (219)
                      ||.+||.|++++++.+++++...+.++.||+.|++|||+.+  |++|||||+|+|++.+ |.+||.|||+|+.....  .
T Consensus       124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~-G~iKitDFGFAK~v~~r--T  198 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQN-GHIKITDFGFAKRVSGR--T  198 (355)
T ss_pred             eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccC-CcEEEEeccceEEecCc--E
Confidence            99999999999999999999999999999999999999999  9999999999999966 79999999999987665  2


Q ss_pred             eeecccCc----cccCCCccccccceeeec--ccccc
Q 027788          188 IRCWGRRS----SWRRSCTMRITRSLWTYT--RLGCA  218 (219)
Q Consensus       188 ~~~~~~~~----~~~~~~~~~~~~diws~g--i~~~~  218 (219)
                      -+.+|+|+    +...+.+|+.+.|-||||  |+.+.
T Consensus       199 ~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMl  235 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEML  235 (355)
T ss_pred             EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHH
Confidence            34567766    345678888889999999  66554

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-36  Score=245.78  Aligned_cols=185  Identities=25%  Similarity=0.426  Sum_probs=153.8

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ..|.++ ++||+|+||.||+|++..+|+.||+|.+.....  ++.+..-..+||.+|++|+||||+++.+.........+
T Consensus       117 ~~feki-~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~--~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  117 DSFEKI-EKIGEGTYGQVYKARDLETGKIVALKKVRFDNE--KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             HHHHHH-HHhcCcchhheeEeeecccCcEEEEEEeecccC--CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            345444 789999999999999999999999998876653  45666777899999999999999999999988777889


Q ss_pred             EEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          104 NFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      |+|.|||+. +|..++... -.|++.++..++.|++.||.|+|.++  ++|||||..|||+|.+ |.+||+|||+|+.+.
T Consensus       194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~-G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNN-GVLKIADFGLARFYT  269 (560)
T ss_pred             EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCC-CCEEeccccceeecc
Confidence            999999974 888877653 47999999999999999999999999  9999999999999944 799999999999886


Q ss_pred             cccee--e----eecccCcc-ccCCCccccccceeeec-cc
Q 027788          183 RAIRR--I----RCWGRRSS-WRRSCTMRITRSLWTYT-RL  215 (219)
Q Consensus       183 ~~~~~--~----~~~~~~~~-~~~~~~~~~~~diws~g-i~  215 (219)
                      .....  +    +.|++|++ .+-+..|...-|+||.| |+
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl  310 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCIL  310 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHH
Confidence            65532  1    12333333 44566688889999999 44

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-38  Score=241.08  Aligned_cols=186  Identities=25%  Similarity=0.424  Sum_probs=156.8

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ..| ++.++||+|.||+||++....+|..+|.|.++-...  +....+....|+.+|++|+||||+++++.-..++...+
T Consensus        19 ~~y-~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m--d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl   95 (375)
T KOG0591|consen   19 ADY-QILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM--DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL   95 (375)
T ss_pred             HHH-HHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc--cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence            344 888999999999999999999999999999885443  56667889999999999999999999884444555668


Q ss_pred             EEEeccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCC--eeeeCCCCCceEEeCCCCcEEEecccc
Q 027788          104 NFITEVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHTHEPC--VIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~~~~~--i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                      +++||+|.+|+|...++.    ...+++..+++++.|++.||..+|..-+.  ++||||||.||+++.+ |.+||.|||+
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfGL  174 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFGL  174 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-Cceeeccchh
Confidence            899999999999987752    34689999999999999999999984333  9999999999999955 6999999999


Q ss_pred             ceeccccce-eeeecccCc----cccCCCccccccceeeec
Q 027788          178 AAIVGRAIR-RIRCWGRRS----SWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       178 a~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~diws~g  213 (219)
                      ++.+..... .++.+|+|-    +...+.+|+++|||||+|
T Consensus       175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslG  215 (375)
T KOG0591|consen  175 GRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLG  215 (375)
T ss_pred             HhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHH
Confidence            999887664 444566543    345677899999999999

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-36  Score=243.41  Aligned_cols=189  Identities=24%  Similarity=0.418  Sum_probs=154.5

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCH-HHHHHHHHHHHHHHhhC-CCCceEEEEEEecC
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDP-AMIERLFSEVRLLKTLA-NKNIISLHYVWRDE   98 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~   98 (219)
                      ...++| .+.+.||+|+||.|+.|.+..++..||+|+++.+...... ...+.+.+|+.+++.+. ||||+++++++..+
T Consensus        14 ~~~g~y-~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   14 LSIGKY-ELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             cccCce-eeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            344566 8889999999999999999999999999977754222111 34466778999999999 99999999999666


Q ss_pred             CCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      ..  ++++|||+.+|+|.+++...+.+.+..+.+++.|+++|+.|+|+++  |+||||||+|++++.+.+++||+|||++
T Consensus        93 ~~--~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   93 TK--IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             Ce--EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            54  8999999999999999988889999999999999999999999999  9999999999999976368999999999


Q ss_pred             eecc-ccceeeeecccCc----cccCCCc-cc-cccceeeecc
Q 027788          179 AIVG-RAIRRIRCWGRRS----SWRRSCT-MR-ITRSLWTYTR  214 (219)
Q Consensus       179 ~~~~-~~~~~~~~~~~~~----~~~~~~~-~~-~~~diws~gi  214 (219)
                      .... ........+|+|.    ++..... |. .++|+||+||
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GV  211 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGV  211 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHH
Confidence            9883 4333333344322    4444444 76 4599999993

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=236.60  Aligned_cols=192  Identities=22%  Similarity=0.376  Sum_probs=163.4

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      ..+.+....|.+...||.|..+.||+|+...++..||||+++.+...   ..++.+++|+..++.++||||++++.+|..
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~---~~ld~l~kE~~~msl~~HPNIv~~~~sFvv   95 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN---NDLDALRKEVQTMSLIDHPNIVTYHCSFVV   95 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh---hhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence            45566666778999999999999999999999999999999988753   236889999999999999999999999966


Q ss_pred             CCCceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      .  ..+|+||++|.+|++.+.+...  ..+++..+..++++++.||.|||+++  .+|||+|+.|||++.+ |.|||+||
T Consensus        96 ~--~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~d-G~VkLadF  170 (516)
T KOG0582|consen   96 D--SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSD-GTVKLADF  170 (516)
T ss_pred             c--ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCC-CcEEEcCc
Confidence            5  4599999999999999988754  35899999999999999999999999  9999999999999966 79999999


Q ss_pred             ccceeccccce----------eeeecccCcc-ccCCCccccccceeeeccccc
Q 027788          176 GVAAIVGRAIR----------RIRCWGRRSS-WRRSCTMRITRSLWTYTRLGC  217 (219)
Q Consensus       176 g~a~~~~~~~~----------~~~~~~~~~~-~~~~~~~~~~~diws~gi~~~  217 (219)
                      |.+..+.....          ++.+|-+|+- ...-.+|+.|+|||||||+||
T Consensus       171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~  223 (516)
T KOG0582|consen  171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITAC  223 (516)
T ss_pred             eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHH
Confidence            98877754332          2334444444 456777999999999999886

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.3e-36  Score=233.29  Aligned_cols=190  Identities=20%  Similarity=0.318  Sum_probs=159.3

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      .-....|.++ ..|++|+||.||+|.++++++.||+|.++.+..  ..++.--.++||.+|.+++||||+.+..+....+
T Consensus        72 Crsv~efe~l-nrI~EGtyGiVYRakdk~t~eIVALKr~kmeke--k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~  148 (419)
T KOG0663|consen   72 CRSVEEFEKL-NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE--KEGFPITSLREINILLKARHPNIVEVKEVVVGSN  148 (419)
T ss_pred             cccHHHHHHH-hhcccCcceeEEEeccCCcceeEEeeecccccc--cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence            3345666444 689999999999999999999999999886542  3444444678999999999999999999998888


Q ss_pred             CceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          100 RNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      .+.+|+|||||+ .+|.+++..- .++....+..++.|++.|+.|||.+.  |+|||||++|+|++.. |.+||+|||+|
T Consensus       149 ~d~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~-G~lKiaDFGLA  224 (419)
T KOG0663|consen  149 MDKIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHK-GILKIADFGLA  224 (419)
T ss_pred             cceeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccC-CcEEecccchh
Confidence            889999999997 5999988654 48999999999999999999999999  9999999999999844 78999999999


Q ss_pred             eecccccee------eeecccCccccCCCccccccceeeec-ccc
Q 027788          179 AIVGRAIRR------IRCWGRRSSWRRSCTMRITRSLWTYT-RLG  216 (219)
Q Consensus       179 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~diws~g-i~~  216 (219)
                      +.+.++...      +-.+++|+-...++.|+.+-|+||.| |+|
T Consensus       225 R~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~a  269 (419)
T KOG0663|consen  225 REYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFA  269 (419)
T ss_pred             hhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHH
Confidence            999988642      12333444456778899999999999 554

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.4e-36  Score=226.62  Aligned_cols=183  Identities=30%  Similarity=0.442  Sum_probs=149.3

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      +| ...+.+|+|.||.||+|++.++|+.||+|.++....  .+..-....+||+.|+.++|+||+.+.++|..  ...+.
T Consensus         3 rY-~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~--kdGi~~talREIK~Lqel~h~nIi~LiD~F~~--~~~l~   77 (318)
T KOG0659|consen    3 RY-EKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA--KDGINRTALREIKLLQELKHPNIIELIDVFPH--KSNLS   77 (318)
T ss_pred             hh-hhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc--ccCccHHHHHHHHHHHHccCcchhhhhhhccC--CCceE
Confidence            45 344899999999999999999999999999998754  23333456789999999999999999999954  45588


Q ss_pred             EEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          105 FITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +|.||++ .+|...++.. -.++...+..++.+++.|++|||++.  |+||||||.|+|++++ |.+||+|||+|+.+.+
T Consensus        78 lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   78 LVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSD-GQLKIADFGLARFFGS  153 (318)
T ss_pred             EEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCC-CcEEeecccchhccCC
Confidence            8999997 6999888754 46889999999999999999999999  9999999999999966 6999999999999987


Q ss_pred             cceee------eecccCccccCCCccccccceeeec-ccc
Q 027788          184 AIRRI------RCWGRRSSWRRSCTMRITRSLWTYT-RLG  216 (219)
Q Consensus       184 ~~~~~------~~~~~~~~~~~~~~~~~~~diws~g-i~~  216 (219)
                      +....      +.+++|+-...++.|...-||||.| |+|
T Consensus       154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~A  193 (318)
T KOG0659|consen  154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFA  193 (318)
T ss_pred             CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHH
Confidence            76532      2333333344455577778888888 543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=246.40  Aligned_cols=182  Identities=25%  Similarity=0.431  Sum_probs=156.7

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      |.+++.||+|+|++|++|++.+++++||||++.++... .+..++-+..|-++|.+| .||.|++++..|+++  ..+|+
T Consensus        75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Ii-ke~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~--~sLYF  151 (604)
T KOG0592|consen   75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYII-KEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE--ESLYF  151 (604)
T ss_pred             cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHH-hhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc--cceEE
Confidence            38899999999999999999999999999999876654 355567788899999999 899999999999665  45899


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ++||+++|+|.+++++.+.+++...+.++.+|+.+++|||+++  |+||||||+|||++.| ++++|.|||.|+.+++..
T Consensus       152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~d-mhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKD-GHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCC-CcEEEeeccccccCChhh
Confidence            9999999999999999999999999999999999999999999  9999999999999977 589999999999986644


Q ss_pred             ee--------------eeeccc----CccccCCCccccccceeeecc
Q 027788          186 RR--------------IRCWGR----RSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       186 ~~--------------~~~~~~----~~~~~~~~~~~~~~diws~gi  214 (219)
                      ..              .+.+|+    +++.+.....+..+|||+||+
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGC  275 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGC  275 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHH
Confidence            32              234444    224555666677799999994

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=9e-36  Score=227.42  Aligned_cols=182  Identities=24%  Similarity=0.426  Sum_probs=145.7

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+|.++ .++|+|+||.||+|+++.+|+.||||.+....  +++..-+-.++||..|++|.|+|++.+..+|  ..+..+
T Consensus         2 ekYE~L-gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese--dd~~VkKIAlREIrmLKqLkH~NLVnLiEVF--rrkrkl   76 (396)
T KOG0593|consen    2 EKYEKL-GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE--DDPVVKKIALREIRMLKQLKHENLVNLIEVF--RRKRKL   76 (396)
T ss_pred             cHHhhh-hccccCcceEEEEeccCCcccEEEEEeeccCC--ccHHHHHHHHHHHHHHHhcccchHHHHHHHH--Hhccee
Confidence            355555 68999999999999999999999999987543  2444446678999999999999999999999  455668


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      ++|.|||+..-|..+-.....++...+..+++|++.|+.|+|.++  ++||||||+||+++.+ +.+||+|||+|+.+..
T Consensus        77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQN-GVVKLCDFGFARTLSA  153 (396)
T ss_pred             EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecC-CcEEeccchhhHhhcC
Confidence            999999987655554333456899999999999999999999999  9999999999999966 6899999999999885


Q ss_pred             cce------eeeecccCccccCCCccccccceeeec
Q 027788          184 AIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +..      .++++++|+-......|..+-|||+.|
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiG  189 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIG  189 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhh
Confidence            433      222333333333334578888998888

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.1e-36  Score=236.16  Aligned_cols=185  Identities=22%  Similarity=0.402  Sum_probs=162.8

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      +.|.+.+.||+|.||.|-+|++...|+.||||.+.+.... +...+-++++||+++..|+||||+.++.+|  ++++-+.
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIk-deqDlvhIRREIeIMSsLNHPhII~IyEVF--ENkdKIv  129 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIK-DEQDLVHIRREIEIMSSLNHPHIIQIYEVF--ENKDKIV  129 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcc-cHHHHHHHHHHHHHHhhcCCCceeehhhhh--cCCceEE
Confidence            3347888999999999999999999999999999877664 456668899999999999999999999999  8888899


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      +||||..+|.|.++++..+.+++...+.+++||++|+.|+|.++  ++|||||.+|||++.+ +++||+|||++-.+...
T Consensus       130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N-~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQN-NNIKIADFGLSNLYADK  206 (668)
T ss_pred             EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCC-CCeeeeccchhhhhccc
Confidence            99999999999999999999999999999999999999999999  9999999999999977 58999999999988877


Q ss_pred             ceeeeecccCc----cccCCCccccc-cceeeeccc
Q 027788          185 IRRIRCWGRRS----SWRRSCTMRIT-RSLWTYTRL  215 (219)
Q Consensus       185 ~~~~~~~~~~~----~~~~~~~~~~~-~diws~gi~  215 (219)
                      .--++.+|+|-    +.....+|..+ -|-|||||+
T Consensus       207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvL  242 (668)
T KOG0611|consen  207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVL  242 (668)
T ss_pred             cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHH
Confidence            76666666543    44556666555 899999954

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-36  Score=242.08  Aligned_cols=184  Identities=32%  Similarity=0.407  Sum_probs=155.5

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCC
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDED   99 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~   99 (219)
                      ....|| .+.++||.|+||.||+|..+.++..||||..+.+...   ..-..=++|+..|++|+ ||||+++.+++.+.+
T Consensus         7 ~~m~RY-~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s---~ee~~nLREvksL~kln~hpniikL~Evi~d~~   82 (538)
T KOG0661|consen    7 IFMDRY-TVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNPHPNIIKLKEVIRDND   82 (538)
T ss_pred             hHHHHH-HHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc---HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence            345666 6779999999999999999999999999998866531   21123357999999999 999999999997655


Q ss_pred             CceEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          100 RNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      . .+++|||+|+ -+|.+++.. ...+++..+..|+.||++||.++|.+|  +.|||+||+|||+.... .+||+|||+|
T Consensus        83 ~-~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~-~iKiaDFGLA  157 (538)
T KOG0661|consen   83 R-ILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGND-VIKIADFGLA  157 (538)
T ss_pred             c-eEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccc-eeEecccccc
Confidence            3 8999999997 599998864 456999999999999999999999999  99999999999998553 7999999999


Q ss_pred             eeccccce-----eeeecccCccccCCCccccccceeeec
Q 027788          179 AIVGRAIR-----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       179 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +.+.+...     +++.+++|+-..++.-|+.+-|+|++|
T Consensus       158 Rev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~G  197 (538)
T KOG0661|consen  158 REVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVG  197 (538)
T ss_pred             cccccCCCcchhhhcccccchHHhhhccccCCchHHHHHH
Confidence            98866443     666677777777888899999999999

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-35  Score=236.09  Aligned_cols=183  Identities=22%  Similarity=0.373  Sum_probs=148.7

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      .+....+..++.+.||+|.||.||.|.... ...||+|.++....     ..+.|.+|+.++++|+|+||++++++|..+
T Consensus       200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m-----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~  273 (468)
T KOG0197|consen  200 PWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM-----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQ  273 (468)
T ss_pred             CeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc-----ChhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence            334555666888999999999999998753 35799999886432     225677999999999999999999999665


Q ss_pred             CCceEEEEeccccCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                      +  .++|||||++.|+|.++++.  ...++....+.++.|||+|++||.+++  ++||||..+|||++.+ ..+||+|||
T Consensus       274 ~--piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~-~~vKIsDFG  348 (468)
T KOG0197|consen  274 E--PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDED-LVVKISDFG  348 (468)
T ss_pred             C--ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccC-ceEEEcccc
Confidence            4  58999999999999999986  457899999999999999999999999  9999999999999966 589999999


Q ss_pred             cceeccccceeeeeccc--Ccccc-----CCCccccccceeeec
Q 027788          177 VAAIVGRAIRRIRCWGR--RSSWR-----RSCTMRITRSLWTYT  213 (219)
Q Consensus       177 ~a~~~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~diws~g  213 (219)
                      +|+.. .+...+...++  |..|+     ....++.+||+||||
T Consensus       349 LAr~~-~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFG  391 (468)
T KOG0197|consen  349 LARLI-GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFG  391 (468)
T ss_pred             ccccc-CCCceeecCCCCCCceecCHHHHhhCCcccccceeehh
Confidence            99943 33333333332  33343     344588899999999

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=241.10  Aligned_cols=189  Identities=24%  Similarity=0.408  Sum_probs=161.6

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      ...||..+|..+ .+||+|+.|.||.|....++..||+|.+.....    ...+.+.+|+.+++..+|+||+.+++.|..
T Consensus       267 ~~~dP~~~y~~~-~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q----~~keLilnEi~Vm~~~~H~NiVnfl~Sylv  341 (550)
T KOG0578|consen  267 SQGDPRSKYTDF-KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ----PKKELLLNEILVMRDLHHPNIVNFLDSYLV  341 (550)
T ss_pred             cCCChhhhhcch-hhhccccccceeeeeeccCCceEEEEEEEeccC----CchhhhHHHHHHHHhccchHHHHHHHHhcc
Confidence            457788888655 899999999999999999999999999987743    233778899999999999999999988865


Q ss_pred             CCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                      .  +.+|+||||+++|+|.+..... .+++.++..++++++.||.|||.++  |+|||||.+||+++.+ |.+||+|||+
T Consensus       342 ~--deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~-g~vKltDFGF  415 (550)
T KOG0578|consen  342 G--DELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMD-GSVKLTDFGF  415 (550)
T ss_pred             c--ceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccC-CcEEEeeeee
Confidence            5  5599999999999999977643 5999999999999999999999999  9999999999999866 6899999999


Q ss_pred             ceeccccc-eeeeecccCc----cccCCCccccccceeeeccccc
Q 027788          178 AAIVGRAI-RRIRCWGRRS----SWRRSCTMRITRSLWTYTRLGC  217 (219)
Q Consensus       178 a~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~diws~gi~~~  217 (219)
                      |..+.... .+.+.+|+|.    +......|..+.|||||||.++
T Consensus       416 caqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaI  460 (550)
T KOG0578|consen  416 CAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAI  460 (550)
T ss_pred             eeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHH
Confidence            99987766 4555667642    2345677899999999997664

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-34  Score=224.84  Aligned_cols=183  Identities=25%  Similarity=0.440  Sum_probs=150.2

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      ..+...+.||+|+||.||.+.+.++|...|+|.+....   ... .+.+.+|+.+|.+++||||+++++.........++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            33577799999999999999999999999999987652   222 67788999999999999999999864333224688


Q ss_pred             EEeccccCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          105 FITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      ++|||+++|+|.+++...+ .+++..+.++..|++.|+.|||+++  ++|+|||++|||++...+.+||+|||.++....
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            9999999999999998876 7999999999999999999999999  999999999999997335899999999987763


Q ss_pred             ---------cceeeeecccCccccCCCccccccceeeec
Q 027788          184 ---------AIRRIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       184 ---------~~~~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                               ...++..|-+|+.+........++||||+|
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlG  209 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLG  209 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcC
Confidence                     112455566666665533333479999999

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-34  Score=231.75  Aligned_cols=184  Identities=24%  Similarity=0.367  Sum_probs=151.3

Q ss_pred             eeeeeeccccceEEEEEEecCCCcE-EEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIE-VAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      .+.+.||+|+||.||+|...  |.. ||+|.+.....  ++...+.|..|+.++.+++||||+++++++..+.. .+.+|
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~--~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~iV  118 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDF--DDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCIV  118 (362)
T ss_pred             hhhhhcccCCceeEEEEEeC--CceeEEEEEecchhc--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEEE
Confidence            34456999999999999875  445 99999886544  23337899999999999999999999999965431 57899


Q ss_pred             eccccCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          107 TEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      |||+++|+|.+++..  ...++...+..++.+|+.|+.|||++++ |+|||||++|+|++.+...+||+|||+++.....
T Consensus       119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            999999999999876  5789999999999999999999999987 8999999999999966338999999999877653


Q ss_pred             c------eeeeecccCccccC-CCccccccceeeec--cccc
Q 027788          185 I------RRIRCWGRRSSWRR-SCTMRITRSLWTYT--RLGC  217 (219)
Q Consensus       185 ~------~~~~~~~~~~~~~~-~~~~~~~~diws~g--i~~~  217 (219)
                      .      .++..|.+|+-+.. ...|+.++|+||||  +|.+
T Consensus       198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl  239 (362)
T KOG0192|consen  198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWEL  239 (362)
T ss_pred             cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHH
Confidence            2      24445566554443 57899999999999  6654

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.4e-34  Score=223.55  Aligned_cols=177  Identities=25%  Similarity=0.394  Sum_probs=147.8

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc---e
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN---T  102 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~---~  102 (219)
                      .+.-.+++|+|+||.||+|....+++.||||.+-++..-        -.+|+++++++.||||+++..+|......   +
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~--------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY--------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc--------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            345568999999999999999999999999987654321        12699999999999999998888654433   6


Q ss_pred             EEEEeccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          103 LNFITEVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      +.+||||+|. +|...++.    ...++.-.+.-++.|++.|+.|||..+  |+||||||.|+|+|.+.|.+||+|||.|
T Consensus        97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcc
Confidence            6789999984 88887763    457888889999999999999999999  9999999999999999889999999999


Q ss_pred             eeccccce-----eeeecccCccccCCCccccccceeeec
Q 027788          179 AIVGRAIR-----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       179 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +.+.....     -++.+++||-.....+|+.+-||||.|
T Consensus       174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaG  213 (364)
T KOG0658|consen  174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAG  213 (364)
T ss_pred             eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhh
Confidence            99977664     333455566677888899999999999

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-35  Score=238.60  Aligned_cols=208  Identities=25%  Similarity=0.389  Sum_probs=175.2

Q ss_pred             CCCCCCCCCCCCCCC---ccccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHH
Q 027788            2 MPAVNSDPSDKDSEP---FIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVR   78 (219)
Q Consensus         2 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~   78 (219)
                      ||+.+...+.++++.   |..-||...|..+ +.||.|+||-||.|++..+.+.||||....... ......+.+.+|+.
T Consensus         1 ~pa~~r~GslKDPeiA~LF~k~DPEklf~dL-rEIGHGSFGAVYfArd~~n~evVAIKKMsySGK-Qs~EKWqDIlKEVr   78 (948)
T KOG0577|consen    1 MPAGGRPGSLKDPEIADLFFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDILKEVR   78 (948)
T ss_pred             CCCCCCCCCCCCchHHHHHccCCHHHHHHHH-HHhcCCccceeEEeeccCccceeeeeecccccc-ccHHHHHHHHHHHH
Confidence            677677777777654   6788888888777 899999999999999999999999998764433 24566789999999


Q ss_pred             HHHhhCCCCceEEEEEEecCCCceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCC
Q 027788           79 LLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLN  157 (219)
Q Consensus        79 ~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~  157 (219)
                      .|+.+.|||.+.+.++|..+.  ..|+|||||- |+..+++.-+ .++.+..+.-|+.+.+.||.|||+.+  .+|||||
T Consensus        79 FL~~l~HPntieYkgCyLre~--TaWLVMEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiK  153 (948)
T KOG0577|consen   79 FLRQLRHPNTIEYKGCYLREH--TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIK  153 (948)
T ss_pred             HHHhccCCCcccccceeeccc--hHHHHHHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhcc
Confidence            999999999999999986554  4788999996 6888888754 47889999999999999999999999  9999999


Q ss_pred             CCceEEeCCCCcEEEeccccceeccccce--eeeecccCccc--cCCCccccccceeeeccccc
Q 027788          158 CSNVFVNGNTGQVKIGDLGVAAIVGRAIR--RIRCWGRRSSW--RRSCTMRITRSLWTYTRLGC  217 (219)
Q Consensus       158 ~~nili~~~~~~~~l~dfg~a~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~diws~gi~~~  217 (219)
                      .-|||++. .|.|||+|||.|....+...  ++..|-+|+-.  +..+.|+.+.|||||||++|
T Consensus       154 AGNILLse-~g~VKLaDFGSAsi~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCI  216 (948)
T KOG0577|consen  154 AGNILLSE-PGLVKLADFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI  216 (948)
T ss_pred             ccceEecC-CCeeeeccccchhhcCchhcccCCccccchhHheeccccccCCccceeeccchhh
Confidence            99999984 47899999999988776543  56666666643  57888999999999998876

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=228.52  Aligned_cols=180  Identities=19%  Similarity=0.324  Sum_probs=144.2

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .-...||+|+||.||+|.- .++..||||.+.....   .. ..+|.+|++++.+++|||+++++++|.+.+. ..+||+
T Consensus        78 s~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~---~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LVY  151 (361)
T KOG1187|consen   78 SESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSG---QG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLVY  151 (361)
T ss_pred             chhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCC---cc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEEE
Confidence            4446899999999999984 5568999997764432   11 3559999999999999999999999975543 467899


Q ss_pred             ccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC-CCeeeeCCCCCceEEeCCCCcEEEeccccceeccc-
Q 027788          108 EVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE-PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR-  183 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~-~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~-  183 (219)
                      ||+++|+|.+++....  .++|..+.+|+.+++.||+|||... ++|+|||||+.|||+|.+. +.||+|||+|+..+. 
T Consensus       152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGLa~~~~~~  230 (361)
T KOG1187|consen  152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGLAKLGPEG  230 (361)
T ss_pred             EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccCcccCCcc
Confidence            9999999999886553  7899999999999999999999854 4799999999999999775 899999999976654 


Q ss_pred             ccee----eeec-ccCccccCCCccccccceeeecc
Q 027788          184 AIRR----IRCW-GRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~~----~~~~-~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ....    .... ...+++......+.++|+|||||
T Consensus       231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGV  266 (361)
T KOG1187|consen  231 DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGV  266 (361)
T ss_pred             ccceeeecCCCCccCChhhhccCCcCcccccccchH
Confidence            2221    1111 23345666677788999999994

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-33  Score=219.50  Aligned_cols=183  Identities=26%  Similarity=0.446  Sum_probs=149.7

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCC-ceEEEEEEecCC---
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN-IISLHYVWRDED---   99 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~~~~~~~~~~---   99 (219)
                      ..|.++ ++||+|+||.||+|+.+.+|+.||+|.+......  ++.-.-..+|+.++++++|+| |+.+++++...+   
T Consensus        11 ~~~~~~-eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~   87 (323)
T KOG0594|consen   11 FDYEKV-EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR   87 (323)
T ss_pred             HHHHHH-HHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence            345455 4599999999999999999999999999876542  222234568999999999999 999999997654   


Q ss_pred             -CceEEEEeccccCCChHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEec
Q 027788          100 -RNTLNFITEVCTSGNLREYRKKHR----HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD  174 (219)
Q Consensus       100 -~~~~~lv~e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~d  174 (219)
                       ...+++++|++. .+|..++...+    .++...+..+++|++.|+.|||+++  |+||||||+|++++++ |.+||+|
T Consensus        88 ~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~-G~lKlaD  163 (323)
T KOG0594|consen   88 GIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSS-GVLKLAD  163 (323)
T ss_pred             ccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCC-CcEeeec
Confidence             236889999996 69999887654    4777899999999999999999999  9999999999999965 7999999


Q ss_pred             cccceeccccce------eeeecccCccccCCCccccccceeeec
Q 027788          175 LGVAAIVGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       175 fg~a~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ||+|+....+..      .+-.+++|+-.+.+..|++.-||||+|
T Consensus       164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~G  208 (323)
T KOG0594|consen  164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLG  208 (323)
T ss_pred             cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHH
Confidence            999998875443      333444455566666799999999999

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.6e-33  Score=228.83  Aligned_cols=150  Identities=19%  Similarity=0.333  Sum_probs=137.2

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||+|+||.||+|..+.||..+|+|++++.... .-.+++++++|..+|....+|.+++++..|  ++..++||+
T Consensus       143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF--QD~~~LYLi  219 (550)
T KOG0605|consen  143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-KKNQVEHVRAERDILAEVDSPWVVKLYYSF--QDKEYLYLI  219 (550)
T ss_pred             chhheeeccccceeEEEEEEccCCcEEeeecccHHHHH-hhhhHHHHHHHHHHhhhcCCCcEEEEEEEe--cCCCeeEEE
Confidence            36678999999999999999999999999999976544 356789999999999999999999999999  456779999


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      |||+|||++.-++...+.++++.+.+++.+.+.|+..+|..+  ++||||||+|+|++.. |.+||+|||||..+.
T Consensus       220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAK-GHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCC-CCEeeccccccchhh
Confidence            999999999999999999999999999999999999999999  9999999999999965 799999999997653

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1e-32  Score=227.56  Aligned_cols=149  Identities=17%  Similarity=0.302  Sum_probs=131.3

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||+|+||.||+|.+..+++.||+|++...... .....+++..|+.+++.++|+||+++++.+..  .+.++++
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv   79 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV   79 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence            46778999999999999999999999999998754322 23455788999999999999999999999854  4568899


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      |||+++|+|.+++.....+++..+..++.|++.||.|||..+  ++||||||+||+++.+ +.++|+|||++..+
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~-~~~kL~DFGl~~~~  151 (381)
T cd05626          80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLD-GHIKLTDFGLCTGF  151 (381)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCC-CCEEEeeCcCCccc
Confidence            999999999999887778999999999999999999999999  9999999999999865 68999999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-33  Score=237.54  Aligned_cols=193  Identities=19%  Similarity=0.296  Sum_probs=157.4

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEe
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWR   96 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~   96 (219)
                      ......++..++++.|.+|+|+.||.|.+...+..+|+|..-..    +...++.+++||+++++|+ |+||+.+++...
T Consensus        30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~  105 (738)
T KOG1989|consen   30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSA  105 (738)
T ss_pred             eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Confidence            44445667779999999999999999999888899999976543    5677899999999999997 999999998432


Q ss_pred             ----cCC-CceEEEEeccccCCChHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCc
Q 027788           97 ----DED-RNTLNFITEVCTSGNLREYRK--KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQ  169 (219)
Q Consensus        97 ----~~~-~~~~~lv~e~~~~g~L~~~~~--~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~  169 (219)
                          ..+ ...++|+||||.+|.|.++++  .+..+++.++++|+.+++.|+.+||...++|+|||||.+|+|++.+ +.
T Consensus       106 ~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~-g~  184 (738)
T KOG1989|consen  106 INRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD-GN  184 (738)
T ss_pred             ccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC-CC
Confidence                122 346789999999999999987  3456999999999999999999999999999999999999999855 68


Q ss_pred             EEEeccccceeccccc-e--------------eeeecccCc--cccCCCccccccceeeeccc
Q 027788          170 VKIGDLGVAAIVGRAI-R--------------RIRCWGRRS--SWRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       170 ~~l~dfg~a~~~~~~~-~--------------~~~~~~~~~--~~~~~~~~~~~~diws~gi~  215 (219)
                      +||+|||.+.-....- .              .+..+++||  ..++.-+++.|+|||+||++
T Consensus       185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGcl  247 (738)
T KOG1989|consen  185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCL  247 (738)
T ss_pred             EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHH
Confidence            9999999765432222 1              233455555  35788889999999999954

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=6.6e-33  Score=227.31  Aligned_cols=150  Identities=17%  Similarity=0.318  Sum_probs=131.9

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||+|+||.||+|.+..+++.||+|++...... .......+..|+.++.+++|+||+++++.+..  ...++++
T Consensus         3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~lv   79 (363)
T cd05628           3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYLI   79 (363)
T ss_pred             ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEEE
Confidence            36779999999999999999999999999998754321 23445778899999999999999999999854  4568899


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      |||+++|+|.+++.....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||+++...
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~-~~vkL~DFGla~~~~  152 (363)
T cd05628          80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLK  152 (363)
T ss_pred             EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCC-CCEEEeeccCccccc
Confidence            999999999999988788999999999999999999999999  9999999999999865 689999999987653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=219.20  Aligned_cols=188  Identities=27%  Similarity=0.405  Sum_probs=155.7

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec---C
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD---E   98 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~   98 (219)
                      ...+| ...+.||+|+||.|..|.+..+|+.||+|.+....  ...-..++..+|+.+++.++|+||+.+.+++..   +
T Consensus        20 i~~~y-~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F--~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~   96 (359)
T KOG0660|consen   20 IPRYY-VLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF--ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD   96 (359)
T ss_pred             cccee-cccccccCcceeeEEEEEEcCCCCEeehhhhhhhh--hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence            33444 44689999999999999999999999999877333  245667999999999999999999999999865   3


Q ss_pred             CCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      +-+-+|+|+|+++ .+|.+.++.+..++...+..+++|++.|+.|+|+.+  ++||||||.|++++.+. .+||+|||+|
T Consensus        97 ~f~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c-~lKI~DFGLA  172 (359)
T KOG0660|consen   97 KFNDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADC-DLKICDFGLA  172 (359)
T ss_pred             ccceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCC-CEEeccccce
Confidence            4456899999994 799999988877999999999999999999999999  99999999999999775 7999999999


Q ss_pred             eecccc----c----eeeeecccCccccCCCccccccceeeec-ccc
Q 027788          179 AIVGRA----I----RRIRCWGRRSSWRRSCTMRITRSLWTYT-RLG  216 (219)
Q Consensus       179 ~~~~~~----~----~~~~~~~~~~~~~~~~~~~~~~diws~g-i~~  216 (219)
                      +.....    .    -.+..+++|+-.....+|+..-||||.| |+|
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~A  219 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILA  219 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHH
Confidence            988532    1    1344455555555566688888999998 654

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=226.73  Aligned_cols=148  Identities=20%  Similarity=0.302  Sum_probs=130.7

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||+|+||.||+|.+..+++.||+|.+...... .....+++.+|+.+++.++||||+++++++.  +...++++
T Consensus         3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~--~~~~~~lv   79 (377)
T cd05629           3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQ--DAQYLYLI   79 (377)
T ss_pred             ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEE--cCCeeEEE
Confidence            36779999999999999999999999999998753321 2345577889999999999999999999985  44678999


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      |||+++|+|.+++.....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||++..
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~-~~~kl~DfGla~~  150 (377)
T cd05629          80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRG-GHIKLSDFGLSTG  150 (377)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCC-CCEEEeecccccc
Confidence            999999999999887778999999999999999999999999  9999999999999865 6899999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-33  Score=226.31  Aligned_cols=150  Identities=19%  Similarity=0.336  Sum_probs=132.3

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|+||.||+|.+..+++.||+|++...... .......+..|+.+++.++||||+++++.+.  +...++++
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~--~~~~~~lv   79 (364)
T cd05599           3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQ--DENYLYLI   79 (364)
T ss_pred             ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEE--cCCeEEEE
Confidence            36779999999999999999999999999999854322 2344567889999999999999999999985  45678999


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      |||+++|+|.+++.....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||++..+.
T Consensus        80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~  152 (364)
T cd05599          80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLK  152 (364)
T ss_pred             ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEeecccceecc
Confidence            999999999999887778999999999999999999999999  9999999999999865 689999999997653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-32  Score=223.24  Aligned_cols=183  Identities=22%  Similarity=0.315  Sum_probs=151.2

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+| .+.+.||+|+||.||+|.+..+++.||+|+++..... .....+.+.+|+.++++++||||+++++.+..  .+.+
T Consensus        18 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~   93 (329)
T PTZ00263         18 SDF-EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRV   93 (329)
T ss_pred             hhe-EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEE
Confidence            444 7889999999999999999999999999998754322 23445778899999999999999999999854  4568


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++|||+++++|.+++.....+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.++|+|||+++....
T Consensus        94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNK-GHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCC-CCEEEeeccCceEcCC
Confidence            899999999999999888778999999999999999999999999  9999999999999865 6899999999987654


Q ss_pred             cce---eeeecccCccccCCCccccccceeeecc
Q 027788          184 AIR---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ...   ++..+.+| +......++.++|+||+|+
T Consensus       171 ~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~  203 (329)
T PTZ00263        171 RTFTLCGTPEYLAP-EVIQSKGHGKAVDWWTMGV  203 (329)
T ss_pred             CcceecCChhhcCH-HHHcCCCCCCcceeechHH
Confidence            321   12223333 3344555778899999993

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-32  Score=222.69  Aligned_cols=181  Identities=19%  Similarity=0.290  Sum_probs=150.5

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||+|+||.||+|.+..+++.||+|+++..... .......+..|+.++..++||||+++++.+.  +.+.++++
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~--~~~~~~lv   79 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLNEVRHVLTERDILTTTKSEWLVKLLYAFQ--DDEYLYLA   79 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhCCCCCCccEEEEEE--cCCEEEEE
Confidence            37889999999999999999999999999998855322 2334567889999999999999999999885  44678999


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc-
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI-  185 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~-  185 (219)
                      |||+++++|.+++.....+++..+..++.|++.++.|||+.+  ++||||||+||+++.+ +.++|+|||++....... 
T Consensus        80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~~~~  156 (333)
T cd05600          80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVTYAN  156 (333)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CCEEEEeCcCCcccccccC
Confidence            999999999999987778999999999999999999999999  9999999999999865 689999999998664421 


Q ss_pred             --eeeeecccCccccCCCccccccceeeecc
Q 027788          186 --RRIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       186 --~~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                        .++..+.+| +......++.++|+||+|+
T Consensus       157 ~~~gt~~y~aP-E~~~~~~~~~~~DvwslG~  186 (333)
T cd05600         157 SVVGSPDYMAP-EVLRGKGYDFTVDYWSLGC  186 (333)
T ss_pred             CcccCccccCh-hHhcCCCCCCccceecchH
Confidence              122233333 3444557888899999993

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.7e-32  Score=221.51  Aligned_cols=177  Identities=21%  Similarity=0.306  Sum_probs=145.7

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC  110 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  110 (219)
                      +.||+|+||.||+|.+..+++.||+|+++..... .......+.+|+.++++++||||+++.+.+..  .+.++++|||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~   77 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-AKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCC
Confidence            4699999999999999999999999998854322 23445678899999999999999999988844  45788999999


Q ss_pred             cCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce----
Q 027788          111 TSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR----  186 (219)
Q Consensus       111 ~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~----  186 (219)
                      ++++|..++.....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||+++.......    
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~  154 (323)
T cd05571          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCcccc
Confidence            99999998887788999999999999999999999999  9999999999999865 5899999999875432211    


Q ss_pred             --eeeecccCccccCCCccccccceeeecc
Q 027788          187 --RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 --~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                        ++..+.+| +......++.++|+||+|+
T Consensus       155 ~~gt~~y~aP-E~~~~~~~~~~~DiwSlG~  183 (323)
T cd05571         155 FCGTPEYLAP-EVLEDNDYGRAVDWWGLGV  183 (323)
T ss_pred             eecCccccCh-hhhcCCCCCccccCcccch
Confidence              22233333 3445566788899999993

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=230.04  Aligned_cols=188  Identities=25%  Similarity=0.439  Sum_probs=161.1

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      .++...|.++ ++||+|.||.||+|.+..+++.||+|++.....   ....+.+..|+.++..++++||.++++.+... 
T Consensus         9 ~~~~~~~~~~-~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~---~deIediqqei~~Ls~~~~~~it~yygsyl~g-   83 (467)
T KOG0201|consen    9 IDPELLYTKL-ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA---EDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-   83 (467)
T ss_pred             CCcccccccc-hhccccccceeeeeeeccccceEEEEEechhhc---chhhHHHHHHHHHHHhcCcchHHhhhhheeec-
Confidence            4455666555 899999999999999999999999999998763   44567788999999999999999999988654 


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                       ..++++||||.+|++.++++....+++..+..++++++.|+.|||.++  .+|||||+.|+++..+ |.+|++|||++.
T Consensus        84 -~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~-g~vkl~DfgVa~  159 (467)
T KOG0201|consen   84 -TKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSES-GDVKLADFGVAG  159 (467)
T ss_pred             -ccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEecc-CcEEEEecceee
Confidence             458999999999999999988877799999999999999999999999  9999999999999866 799999999999


Q ss_pred             eccccce------eeeecccCccccCCCccccccceeeeccccc
Q 027788          180 IVGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTRLGC  217 (219)
Q Consensus       180 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi~~~  217 (219)
                      .+.....      ++..|-+|+-.. ..+|+.+||||||||+|+
T Consensus       160 ql~~~~~rr~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITai  202 (467)
T KOG0201|consen  160 QLTNTVKRRKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAI  202 (467)
T ss_pred             eeechhhccccccccccccchhhhc-cccccchhhhhhhhHHHH
Confidence            8877654      333444443333 778999999999999875

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-33  Score=225.03  Aligned_cols=185  Identities=26%  Similarity=0.420  Sum_probs=149.7

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCC------CHH----HHHHHHHHHHHHHhhCCCCceEEEEEEe
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD------DPA----MIERLFSEVRLLKTLANKNIISLHYVWR   96 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~------~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~   96 (219)
                      |.+.+.||+|.||.|-+|++..+++.||+|++.......      ...    -.+..+.||.+++++.||||++++.+.-
T Consensus        99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD  178 (576)
T KOG0585|consen   99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD  178 (576)
T ss_pred             eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence            477789999999999999999999999999998654321      122    2357889999999999999999999998


Q ss_pred             cCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788           97 DEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus        97 ~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                      +...+.+|+|+|||..|.+...-.....+++++.+.+++.++.||.|||.++  |+||||||+|+|++.+ |++||+|||
T Consensus       179 DP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~~~-g~VKIsDFG  255 (576)
T KOG0585|consen  179 DPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLSSD-GTVKISDFG  255 (576)
T ss_pred             CcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEcCC-CcEEeeccc
Confidence            8888999999999998888653333333899999999999999999999999  9999999999999966 799999999


Q ss_pred             cceecc------ccceeeeecccCccccC----C---Ccc-ccccceeeecc
Q 027788          177 VAAIVG------RAIRRIRCWGRRSSWRR----S---CTM-RITRSLWTYTR  214 (219)
Q Consensus       177 ~a~~~~------~~~~~~~~~~~~~~~~~----~---~~~-~~~~diws~gi  214 (219)
                      .+....      .+..-...+|+|..+++    .   ..+ ..+.||||+||
T Consensus       256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGV  307 (576)
T KOG0585|consen  256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGV  307 (576)
T ss_pred             eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhh
Confidence            998762      22223336777664332    1   222 34489999994

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.6e-32  Score=224.72  Aligned_cols=148  Identities=16%  Similarity=0.272  Sum_probs=129.7

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+.+|+.++++++|+||+++++.+..  .+.++++
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv   79 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV   79 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEEE
Confidence            37779999999999999999999999999998743221 22345678899999999999999999999854  4678999


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      |||+++|+|.+++...+.+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||+|..
T Consensus        80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~-~~ikL~DFG~a~~  150 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTG  150 (376)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCC-CCEEEEeCCCCcc
Confidence            999999999999887778899999999999999999999999  9999999999999865 6899999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1e-33  Score=231.52  Aligned_cols=180  Identities=21%  Similarity=0.353  Sum_probs=155.7

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+-+.||+|.||+||+|+.+.+...||+|.+.+...  ....++.+.+|+++++.++||||++++++|  +....+|+|+
T Consensus         5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr--~~k~l~~l~~ev~i~r~lkHpniv~m~esf--Et~~~~~vVt   80 (808)
T KOG0597|consen    5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR--NEKELKNLRQEVRILRSLKHPNIVEMLESF--ETSAHLWVVT   80 (808)
T ss_pred             hHHHHhcCCccceeeecccccceeEEEEEEehhcCC--chHHHHHHHHHHHHHHhcCCcchhhHHHhh--cccceEEEEe
Confidence            566899999999999999999999999999986543  456678899999999999999999999999  7778899999


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce-
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR-  186 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~-  186 (219)
                      ||+.| +|..++...+.++++.+..+..++++|+.|||+.+  |+|||+||.||++.+. +.+|++|||+|+....... 
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t~v  156 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNTSV  156 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCC-CceeechhhhhhhcccCcee
Confidence            99975 99999998899999999999999999999999999  9999999999999866 6899999999998765332 


Q ss_pred             eeeecccC----ccccCCCccccccceeeeccc
Q 027788          187 RIRCWGRR----SSWRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       187 ~~~~~~~~----~~~~~~~~~~~~~diws~gi~  215 (219)
                      .++.-|+|    ++...+.+|+..+|+||+|++
T Consensus       157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGci  189 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCI  189 (808)
T ss_pred             eeeccCcccccCHHHHcCCCccchhhHHHHHHH
Confidence            22223332    245568889999999999943

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-33  Score=221.50  Aligned_cols=180  Identities=20%  Similarity=0.268  Sum_probs=149.1

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+.+|+.+++.++||||+++++++  .+...++++
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~~~lv   79 (291)
T cd05612           3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTE--HDQRFLYML   79 (291)
T ss_pred             ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCcHhhhHhhh--ccCCeEEEE
Confidence            36789999999999999999999999999998754321 233456788999999999999999998887  445678999


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      |||+++++|.+++...+.+++..+..++.|++.|+.|||+++  ++||||||+||+++.+ +.++|+|||++........
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~~~  156 (291)
T cd05612          80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDRTW  156 (291)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEEEecCcchhccCCcc
Confidence            999999999999888778999999999999999999999999  9999999999999855 6899999999987644321


Q ss_pred             ---eeeecccCccccCCCccccccceeeec
Q 027788          187 ---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                         ++..+.+| +......++.++||||+|
T Consensus       157 ~~~gt~~y~aP-E~~~~~~~~~~~DiwSlG  185 (291)
T cd05612         157 TLCGTPEYLAP-EVIQSKGHNKAVDWWALG  185 (291)
T ss_pred             cccCChhhcCH-HHHcCCCCCchhhHHHHH
Confidence               22223333 344555677889999999

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.4e-32  Score=224.48  Aligned_cols=148  Identities=18%  Similarity=0.289  Sum_probs=130.3

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||+|+||.||+|.+..+++.+|+|.+...... .......+.+|+.++++++|+||+++++.+..  .+.++++
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv   79 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL-LRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFV   79 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEE
Confidence            36679999999999999999999999999998754321 23455778899999999999999999999954  4568999


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      |||+++|+|.+++.....+++..+..++.|++.|+.|||+.+  |+||||||+||+++.+ +.++|+|||++..
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~-g~~kL~DFGla~~  150 (382)
T cd05625          80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTG  150 (382)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEEeECCCCcc
Confidence            999999999998887778899999999999999999999999  9999999999999865 6899999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-33  Score=230.71  Aligned_cols=185  Identities=21%  Similarity=0.330  Sum_probs=157.6

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      -|++++-||.|+.|.|-.|.+..||+..|||++...... .......+-+||.+++.+.|||+++++++|  +++..+|+
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~-s~s~~~~IerEIviMkLi~HpnVl~LydVw--e~~~~lyl   89 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL-SSSQPAGIEREIVIMKLIEHPNVLRLYDVW--ENKQHLYL   89 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeecccccc-ccccccchhhhhHHHHHhcCCCeeeeeeee--ccCceEEE
Confidence            359999999999999999999999999999999876433 334456677899999999999999999999  67778999


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      +.||+++|.|++++-.++++.+....+++.||+.|+.|+|..+  |+||||||+|++++.. +++||+|||+|..-..+.
T Consensus        90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~-~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVK-NNIKIADFGMASLEVPGK  166 (786)
T ss_pred             EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcc-cCEeeeccceeecccCCc
Confidence            9999999999999999999999999999999999999999999  9999999999999966 479999999998766655


Q ss_pred             eeeeecccCc----cccCCCccc-cccceeeecccc
Q 027788          186 RRIRCWGRRS----SWRRSCTMR-ITRSLWTYTRLG  216 (219)
Q Consensus       186 ~~~~~~~~~~----~~~~~~~~~-~~~diws~gi~~  216 (219)
                      --.+.+|+|-    +..++..|. .++|+||-||.-
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVIL  202 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVIL  202 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHH
Confidence            4444445432    344555554 459999999543

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-32  Score=225.05  Aligned_cols=190  Identities=22%  Similarity=0.382  Sum_probs=150.7

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCC----cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEe
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWR   96 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   96 (219)
                      ...+.--.+.++||+|+||.||+|.....+    ..||+|..+.... ....+..++.+|+.++++++||||++++|+..
T Consensus       153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~-~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE-LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccccc-ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            344555567789999999999999865432    2389998775322 24567799999999999999999999999997


Q ss_pred             cCCCceEEEEeccccCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788           97 DEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus        97 ~~~~~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      .+.+  ++++||+|+||+|.++++..+ .++..+...++.+.+.||+|||..+  ++||||..+|+|++.+ +.+||+||
T Consensus       232 ~~~P--l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~-~~vKISDF  306 (474)
T KOG0194|consen  232 LEEP--LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKK-GVVKISDF  306 (474)
T ss_pred             CCCc--cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCC-CeEEeCcc
Confidence            6654  788999999999999998876 4999999999999999999999999  9999999999999865 36799999


Q ss_pred             ccceeccccceee------eecccCccccCCCccccccceeeec--cccc
Q 027788          176 GVAAIVGRAIRRI------RCWGRRSSWRRSCTMRITRSLWTYT--RLGC  217 (219)
Q Consensus       176 g~a~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~diws~g--i~~~  217 (219)
                      |+++.-.......      ..|-+|+-+. ...|+.++|+||||  +|++
T Consensus       307 GLs~~~~~~~~~~~~~klPirWLAPEtl~-~~~~s~kTDV~sfGV~~~Ei  355 (474)
T KOG0194|consen  307 GLSRAGSQYVMKKFLKKLPIRWLAPETLN-TGIFSFKTDVWSFGVLLWEI  355 (474)
T ss_pred             ccccCCcceeeccccccCcceecChhhhc-cCccccccchhheeeeEEee
Confidence            9987654222222      2233333333 33788999999999  5554

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-32  Score=220.26  Aligned_cols=185  Identities=25%  Similarity=0.380  Sum_probs=158.3

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCCc
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRN  101 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~  101 (219)
                      ....|.+.+.||+|.||.||.|+.+.+|..+|+|.++++..... .....+.+|+.++++++ ||||+.+.++|  +...
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~-~~~~~v~~Ev~il~~l~~hpniv~l~~~~--e~~~  109 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK-EDREDVRREVAILQQLSGHPNIVQLKDAF--EDPD  109 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc-ccHHHHHHHHHHHHhccCCCCEEEEEEEE--EcCC
Confidence            34455898999999999999999999999999999987765332 24467889999999999 99999999999  5556


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC---CcEEEeccccc
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT---GQVKIGDLGVA  178 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~---~~~~l~dfg~a  178 (219)
                      .+++|||++.||.|.+.+... .+++.....++.|++.++.|||+.+  ++||||||+|+++....   +.++++|||++
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            799999999999999988665 4999999999999999999999999  99999999999986332   37999999999


Q ss_pred             eeccccceeeeecccCcc----ccCCCccccccceeeec
Q 027788          179 AIVGRAIRRIRCWGRRSS----WRRSCTMRITRSLWTYT  213 (219)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~diws~g  213 (219)
                      ............+|+|..    .....+|+...|+||+|
T Consensus       187 ~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~G  225 (382)
T KOG0032|consen  187 KFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIG  225 (382)
T ss_pred             eEccCCceEeeecCCccccCchhhcCCCCCcccchhHHH
Confidence            999886566666777653    33457788899999999

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=6.6e-32  Score=221.13  Aligned_cols=150  Identities=19%  Similarity=0.335  Sum_probs=131.6

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|+||.||+|.+..+++.||+|+++..... .......+..|+.++..++|++++++++.+.  +...++++
T Consensus         3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~~~~~lv   79 (360)
T cd05627           3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQ--DKRNLYLI   79 (360)
T ss_pred             ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEEE
Confidence            36779999999999999999999999999998753321 2334577889999999999999999999885  44678999


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      |||+++|+|.+++.....+++..+..++.|++.+|.|||+.+  ++||||||+||+++.+ +.++|+|||++....
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~-~~vkL~DfG~~~~~~  152 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLK  152 (360)
T ss_pred             EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCC-CCEEEeeccCCcccc
Confidence            999999999999887778999999999999999999999999  9999999999999865 689999999987653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.5e-32  Score=223.04  Aligned_cols=190  Identities=23%  Similarity=0.351  Sum_probs=161.6

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ..-..|.+.+.||+|.|+.|..|++..++..||+|.+++...  +...++.+.+|+.+++.|+||||++++.+...  +.
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--~~  128 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--EA  128 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeeeee--cc
Confidence            445556999999999999999999999999999999986654  34445568899999999999999999999844  45


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      .+|+||||+.+|.+++++..++...+......+.|+..+++|||++.  ++|||||++|++++.+. ++||+|||++..+
T Consensus       129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~m-nikIaDfgfS~~~  205 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENM-NIKIADFGFSTFF  205 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhccccccc-ceeeeccccceee
Confidence            69999999999999999999988888999999999999999999999  99999999999999775 7999999999998


Q ss_pred             cccceeeeecccCc----cccCCCccccc-cceeeec--ccccc
Q 027788          182 GRAIRRIRCWGRRS----SWRRSCTMRIT-RSLWTYT--RLGCA  218 (219)
Q Consensus       182 ~~~~~~~~~~~~~~----~~~~~~~~~~~-~diws~g--i~~~~  218 (219)
                      .....-.+.+|+|+    +.....+|..+ .|+||+|  ++++-
T Consensus       206 ~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV  249 (596)
T KOG0586|consen  206 DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALV  249 (596)
T ss_pred             cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeee
Confidence            87776666777655    34444445544 9999999  55543

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.5e-32  Score=219.19  Aligned_cols=183  Identities=18%  Similarity=0.300  Sum_probs=148.2

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCC-cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEG-IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      .+| .+.+.||+|+||.||+|.+..++ ..||+|.+...... .....+.+.+|+.+++.++||||+++++++..  ...
T Consensus        30 ~~y-~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~  105 (340)
T PTZ00426         30 EDF-NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPFCVNLYGSFKD--ESY  105 (340)
T ss_pred             hhc-EEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe--CCE
Confidence            445 78899999999999999876554 68999998754322 23445778899999999999999999999854  456


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++++|||+++|+|.+++.....+++..+..++.|++.+|.|||+.+  ++||||||+||+++.+ +.++|+|||++....
T Consensus       106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~-~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKD-GFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCC-CCEEEecCCCCeecC
Confidence            8899999999999999988788999999999999999999999999  9999999999999855 689999999998764


Q ss_pred             ccce---eeeecccCccccCCCccccccceeeecc
Q 027788          183 RAIR---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ....   ++..+.+| +......++.++|+||+|+
T Consensus       183 ~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwSlGv  216 (340)
T PTZ00426        183 TRTYTLCGTPEYIAP-EILLNVGHGKAADWWTLGI  216 (340)
T ss_pred             CCcceecCChhhcCH-HHHhCCCCCccccccchhh
Confidence            4221   22223333 3334455677899999994

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=9.3e-32  Score=217.68  Aligned_cols=177  Identities=21%  Similarity=0.321  Sum_probs=144.8

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC  110 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  110 (219)
                      +.||+|+||.||++.+..+++.||+|++...... .......+.+|+.+++.++||||+++.+.+.  ..+.++++|||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv~Ey~   77 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII-AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ--TKDRLCFVMEYV   77 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEE--cCCEEEEEEeCC
Confidence            4689999999999999999999999998854332 2344577889999999999999999998885  445688999999


Q ss_pred             cCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce----
Q 027788          111 TSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR----  186 (219)
Q Consensus       111 ~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~----  186 (219)
                      ++++|...+.....+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.++|+|||+++.......    
T Consensus        78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~  154 (328)
T cd05593          78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKT  154 (328)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCC-CcEEEecCcCCccCCCccccccc
Confidence            99999988887778999999999999999999999999  9999999999999865 6899999999876432221    


Q ss_pred             --eeeecccCccccCCCccccccceeeecc
Q 027788          187 --RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 --~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                        ++..+.+| +......++.++|+||+|+
T Consensus       155 ~~gt~~y~aP-E~~~~~~~~~~~DiwslGv  183 (328)
T cd05593         155 FCGTPEYLAP-EVLEDNDYGRAVDWWGLGV  183 (328)
T ss_pred             ccCCcCccCh-hhhcCCCCCccCCccccch
Confidence              12223333 3344556778899999993

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1e-31  Score=220.65  Aligned_cols=183  Identities=15%  Similarity=0.203  Sum_probs=146.8

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      ..|++.+.||+|+||.||++.+..+++.+|+|++...... .....+.+..|+.+++.++||||+++++.+.  +...++
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~--~~~~~~  119 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQ--DDKYLY  119 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEE
Confidence            3347889999999999999999999999999998753321 2233456788999999999999999999884  456789


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      ++|||+++|+|.+++... .+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.+||+|||++......
T Consensus       120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~-~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCC-CCEEEEecccceecccC
Confidence            999999999999988654 5889999999999999999999999  9999999999999855 68999999999876433


Q ss_pred             ce-------eeeecccCccccCC---Cccccccceeeecc
Q 027788          185 IR-------RIRCWGRRSSWRRS---CTMRITRSLWTYTR  214 (219)
Q Consensus       185 ~~-------~~~~~~~~~~~~~~---~~~~~~~diws~gi  214 (219)
                      ..       ++..+.+|+.+...   ..++.++|+||+|+
T Consensus       196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~  235 (370)
T cd05621         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV  235 (370)
T ss_pred             CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehH
Confidence            21       22233344433222   23667899999993

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.6e-31  Score=216.05  Aligned_cols=176  Identities=21%  Similarity=0.318  Sum_probs=144.2

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC  110 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  110 (219)
                      +.||+|+||.||++.+..+++.||+|+++..... .......+..|+.+++.++||||+++.+.+..  ...++++|||+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~   77 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYA   77 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence            4699999999999999999999999999864432 23345677889999999999999999988844  45688999999


Q ss_pred             cCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---
Q 027788          111 TSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT-HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---  186 (219)
Q Consensus       111 ~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~-~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---  186 (219)
                      ++++|..++.....+++..+..++.|++.||.|||+ .+  ++||||||+||+++.+ +.++|+|||+++.......   
T Consensus        78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~  154 (325)
T cd05594          78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMK  154 (325)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCC-CCEEEecCCCCeecCCCCcccc
Confidence            999999988877789999999999999999999997 68  9999999999999865 5899999999876432221   


Q ss_pred             ---eeeecccCccccCCCccccccceeeec
Q 027788          187 ---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                         ++..+.+| +......++.++|+||+|
T Consensus       155 ~~~gt~~y~aP-E~~~~~~~~~~~DiwslG  183 (325)
T cd05594         155 TFCGTPEYLAP-EVLEDNDYGRAVDWWGLG  183 (325)
T ss_pred             cccCCcccCCH-HHHccCCCCCcccccccc
Confidence               22223333 344556678889999999

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-32  Score=216.42  Aligned_cols=175  Identities=15%  Similarity=0.264  Sum_probs=144.1

Q ss_pred             eccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccccC
Q 027788           33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTS  112 (219)
Q Consensus        33 ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~  112 (219)
                      ||+|+||.||+|.+..+++.||+|.++..... .......+..|+.++++++||||+++++.+..  .+.++++|||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~   77 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFING   77 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCC
Confidence            69999999999999999999999998754322 23445778899999999999999999988854  4668899999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce------
Q 027788          113 GNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR------  186 (219)
Q Consensus       113 g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~------  186 (219)
                      ++|.+++.....+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.++|+|||+++.......      
T Consensus        78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~  154 (312)
T cd05585          78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTNTFC  154 (312)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCC-CcEEEEECcccccCccCCCcccccc
Confidence            999999887778999999999999999999999999  9999999999999865 5899999999976432221      


Q ss_pred             eeeecccCccccCCCccccccceeeecc
Q 027788          187 RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ++..+.+| +......++.++|+||+|+
T Consensus       155 gt~~y~aP-E~~~~~~~~~~~DvwslGv  181 (312)
T cd05585         155 GTPEYLAP-ELLLGHGYTKAVDWWTLGV  181 (312)
T ss_pred             CCcccCCH-HHHcCCCCCCccceechhH
Confidence            22223333 3444566788899999993

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.2e-31  Score=217.30  Aligned_cols=183  Identities=17%  Similarity=0.286  Sum_probs=146.7

Q ss_pred             eeeeeeeccccceEEEEEEec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCce
Q 027788           27 GRYNELLGSGAVKKVYRAFDQ---EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~  102 (219)
                      |++.+.||+|+||.||+++..   .++..||+|++............+.+..|+.+++.+ +|++|+++++++.  ..+.
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~~   79 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ--TEAK   79 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe--cCCE
Confidence            367899999999999998763   578999999987544333344557788999999999 4899999998884  4456


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++++|||+++++|.+++.....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||++....
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~  156 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSE-GHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCC-CCEEEeeCcCCcccc
Confidence            8899999999999998877778999999999999999999999999  9999999999999866 589999999998653


Q ss_pred             ccce-------eeeecccCccccCCCccccccceeeecc
Q 027788          183 RAIR-------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~-------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ....       ++..+.+|+.......++.++||||+|+
T Consensus       157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~  195 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGI  195 (332)
T ss_pred             ccCCCccccccCCccccCHHHhcCCCCCCCccccccchh
Confidence            3221       2222334443433344677899999993

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6.7e-32  Score=218.07  Aligned_cols=177  Identities=19%  Similarity=0.305  Sum_probs=145.1

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC  110 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  110 (219)
                      +.||+|+||.||++.+..++..||+|.++..... .......+.+|+.+++.++||||+++++.+..  ...++++|||+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~   77 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYA   77 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCC
Confidence            4699999999999999999999999998865332 23345677889999999999999999998854  45688999999


Q ss_pred             cCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce----
Q 027788          111 TSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR----  186 (219)
Q Consensus       111 ~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~----  186 (219)
                      ++++|..++.....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||++........    
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~  154 (323)
T cd05595          78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCC-CCEEecccHHhccccCCCCcccc
Confidence            99999988887778999999999999999999999999  9999999999999865 5899999999876432221    


Q ss_pred             --eeeecccCccccCCCccccccceeeecc
Q 027788          187 --RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 --~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                        ++..+.+| +......++.++|+||+|+
T Consensus       155 ~~gt~~y~aP-E~~~~~~~~~~~DiwSlGv  183 (323)
T cd05595         155 FCGTPEYLAP-EVLEDNDYGRAVDWWGLGV  183 (323)
T ss_pred             ccCCcCcCCc-ccccCCCCCchhchhhhHH
Confidence              22233333 3444556778899999993

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-33  Score=224.48  Aligned_cols=183  Identities=24%  Similarity=0.428  Sum_probs=156.5

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+| .+.+.+|+|+||.++...++.++..+++|.+......  .........|+.++++++||||+.+.+.|.. +..++
T Consensus         4 ~~Y-e~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t--~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~-~~~~l   79 (426)
T KOG0589|consen    4 DNY-EVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT--EPERRSAIQEMDLLSKLLHPNIVEYKDSFEE-DGQLL   79 (426)
T ss_pred             chh-hhhhhcCccccchhhhhhhccCCceEEEEEEeccccC--chhhHHHHHHHHHHHhccCCCeeeeccchhc-CCceE
Confidence            345 5568999999999999999999999999999877653  3333467789999999999999999999964 33568


Q ss_pred             EEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          104 NFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      +++|+||+||++.+.+...  ..++++.+..++.|++.|+.|||++.  |+|||||+.||+++++. .++|.|||+|+.+
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~-~VkLgDfGlaK~l  156 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDK-KVKLGDFGLAKIL  156 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccC-ceeecchhhhhhc
Confidence            9999999999999988654  35899999999999999999999888  99999999999999775 7899999999999


Q ss_pred             cccc-eeeeecccCc----cccCCCccccccceeeec
Q 027788          182 GRAI-RRIRCWGRRS----SWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~-~~~~~~~~~~----~~~~~~~~~~~~diws~g  213 (219)
                      ..+. ...+..|+|.    +.+..-+|+.++||||||
T Consensus       157 ~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLG  193 (426)
T KOG0589|consen  157 NPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLG  193 (426)
T ss_pred             CCchhhhheecCCCcccCHHHhCCCCCCccCcchhhc
Confidence            8887 3444555544    466788899999999999

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.98  E-value=2.3e-31  Score=211.25  Aligned_cols=181  Identities=17%  Similarity=0.271  Sum_probs=145.7

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|+||.||+|.+..+++.||+|.+...... .......+.+|+.++++++|++++++.+.+.  ..+.++++
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~--~~~~~~lv   78 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKRILEKVNSRFVVSLAYAYE--TKDALCLV   78 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc--cCCeEEEE
Confidence            46778999999999999999999999999998754332 1223355778999999999999999998884  44568899


Q ss_pred             eccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          107 TEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      |||+++|+|...+...  ..+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.++|+|||++......
T Consensus        79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDR-GHIRISDLGLAVQIPEG  155 (285)
T ss_pred             EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCC
Confidence            9999999998776532  35889999999999999999999999  9999999999999855 58999999999876443


Q ss_pred             cee-----eeecccCccccCCCccccccceeeecc
Q 027788          185 IRR-----IRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       185 ~~~-----~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ...     +..+.+ ++......++.++|+||+|+
T Consensus       156 ~~~~~~~g~~~y~a-PE~~~~~~~~~~~DvwslGv  189 (285)
T cd05631         156 ETVRGRVGTVGYMA-PEVINNEKYTFSPDWWGLGC  189 (285)
T ss_pred             CeecCCCCCCCccC-HhhhcCCCCCcccCchhHHH
Confidence            321     112223 34455667888899999993

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.98  E-value=2e-31  Score=215.86  Aligned_cols=182  Identities=17%  Similarity=0.252  Sum_probs=148.6

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||+|+||.||+|.+..+++.+|+|.++..... .....+.+..|+.+++.++|+||+++++.+.  +.+.++++
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~--~~~~~~lv   79 (330)
T cd05601           3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-AQETVSFFEEERDILSISNSPWIPQLQYAFQ--DKDNLYLV   79 (330)
T ss_pred             ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceeeEEe--cCCeEEEE
Confidence            47889999999999999999999999999999864321 2334567889999999999999999998884  44678899


Q ss_pred             eccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          107 TEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      |||+++++|.++++.. ..+++..+..++.|++.+|.|||+.+  ++||||||+||+++.+ +.++|+|||++..+....
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRT-GHIKLADFGSAARLTANK  156 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCC-CCEEeccCCCCeECCCCC
Confidence            9999999999998765 67999999999999999999999999  9999999999999855 689999999998765433


Q ss_pred             e-------eeeecccCccccC-----CCccccccceeeecc
Q 027788          186 R-------RIRCWGRRSSWRR-----SCTMRITRSLWTYTR  214 (219)
Q Consensus       186 ~-------~~~~~~~~~~~~~-----~~~~~~~~diws~gi  214 (219)
                      .       ++..+.+|+-...     ...++.++|+||+|+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~  197 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGV  197 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccc
Confidence            2       1222333433221     445677899999993

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=8.5e-32  Score=219.47  Aligned_cols=152  Identities=20%  Similarity=0.371  Sum_probs=133.3

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||+|+||.||+|.+..+++.||+|+++..... .......+..|+.+++.++|+|++++++.+.  +.+.++++
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv   79 (350)
T cd05573           3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSFQ--DEEHLYLV   79 (350)
T ss_pred             ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhhee--cCCeEEEE
Confidence            37789999999999999999999999999998854322 2234567889999999999999999998884  45678999


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||++......
T Consensus        80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKA  154 (350)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEeecCCCCccCccc
Confidence            999999999999887778999999999999999999999999  9999999999999866 58999999999876544

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.98  E-value=8.4e-32  Score=215.55  Aligned_cols=181  Identities=25%  Similarity=0.395  Sum_probs=144.0

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+| .+.+.||+|+||.||+|.+..+++.||+|.++....   ......+.+|+.+++.++||||+++++++..  ....
T Consensus         5 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~   78 (303)
T cd07869           5 DSY-EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDIIHT--KETL   78 (303)
T ss_pred             ccc-eEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeE
Confidence            445 777999999999999999999999999999875432   1222456789999999999999999999854  4568


Q ss_pred             EEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          104 NFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +++|||++ ++|.+++... ..+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.+||+|||++....
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~  154 (303)
T cd07869          79 TLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDT-GELKLADFGLARAKS  154 (303)
T ss_pred             EEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECCCCcceecc
Confidence            89999996 5777766543 56889999999999999999999999  9999999999999855 689999999987653


Q ss_pred             ccce------eeeecccCccccCCCccccccceeeecc
Q 027788          183 RAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ....      .+..+.+|+.+.....++.++|+||+|+
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  192 (303)
T cd07869         155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGC  192 (303)
T ss_pred             CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHH
Confidence            3221      1222344444455566777899999993

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.98  E-value=1.5e-31  Score=212.72  Aligned_cols=180  Identities=24%  Similarity=0.392  Sum_probs=144.8

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+| .+.+.||+|+||.||+|++..++..||+|.++....   ......+.+|+.++++++||||+++++++..  .+.+
T Consensus         5 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~   78 (288)
T cd07871           5 ETY-VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCL   78 (288)
T ss_pred             ccc-eEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeE
Confidence            345 667999999999999999999999999999875432   2223557789999999999999999999854  4568


Q ss_pred             EEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          104 NFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +++||+++ ++|.+++... ..++...+..++.|++.|+.|||+++  ++||||||+||+++.+ +.++|+|||+++...
T Consensus        79 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~  154 (288)
T cd07871          79 TLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEK-GELKLADFGLARAKS  154 (288)
T ss_pred             EEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEECcCcceeecc
Confidence            89999997 5888877654 34788999999999999999999999  9999999999999865 589999999997654


Q ss_pred             ccce------eeeecccCccccCCCccccccceeeec
Q 027788          183 RAIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ....      .+..+.+|+.+.....++.++|+||+|
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  191 (288)
T cd07871         155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVG  191 (288)
T ss_pred             CCCccccCceecccccChHHhcCCcccCcHHHHHHHH
Confidence            3221      223344454455556678889999999

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.98  E-value=3.8e-31  Score=217.40  Aligned_cols=185  Identities=15%  Similarity=0.215  Sum_probs=147.8

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      ..+-|.+.+.||+|+||.||+|.+..+++.+|+|++...... .....+.+..|+.+++.++||||+++++.+.  +...
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~--~~~~  117 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQ--DDRY  117 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--cCCE
Confidence            334457889999999999999999999999999998753321 2233456788999999999999999999885  4467


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++++|||+++++|.+++... .+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.++|+|||++....
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~-~~ikL~DfG~a~~~~  193 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMN  193 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCC-CCEEEEeCCceeEcC
Confidence            89999999999999988654 5888999999999999999999999  9999999999999865 689999999998765


Q ss_pred             ccce-------eeeecccCccccCC---Cccccccceeeecc
Q 027788          183 RAIR-------RIRCWGRRSSWRRS---CTMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~-------~~~~~~~~~~~~~~---~~~~~~~diws~gi  214 (219)
                      ....       ++..+.+|+.+...   ..++.++|+||+|+
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGv  235 (371)
T cd05622         194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV  235 (371)
T ss_pred             cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhH
Confidence            4321       22233344433222   23677899999993

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.98  E-value=2.9e-31  Score=214.35  Aligned_cols=177  Identities=20%  Similarity=0.327  Sum_probs=140.7

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHH-HHHhhCCCCceEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVR-LLKTLANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      +.||+|+||.||+|.+..+++.||+|++....... .....++..|.. +++.++||||+++++.+..  .+.++++|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~   77 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDY   77 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcC
Confidence            46999999999999999999999999987543321 222345555555 5678999999999988844  4568899999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---  186 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---  186 (219)
                      +++++|..++.....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||++........   
T Consensus        78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~  154 (323)
T cd05575          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTS  154 (323)
T ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCC-CcEEEeccCCCcccccCCCccc
Confidence            999999998887778999999999999999999999999  9999999999999865 6899999999875432221   


Q ss_pred             ---eeeecccCccccCCCccccccceeeecc
Q 027788          187 ---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                         ++..+.+| +......++.++|+||+|+
T Consensus       155 ~~~gt~~y~aP-E~~~~~~~~~~~DvwslG~  184 (323)
T cd05575         155 TFCGTPEYLAP-EVLRKQPYDRTVDWWCLGA  184 (323)
T ss_pred             cccCChhhcCh-hhhcCCCCCccccccccch
Confidence               12223333 3445566788899999993

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.98  E-value=1.6e-31  Score=216.94  Aligned_cols=181  Identities=24%  Similarity=0.366  Sum_probs=141.5

Q ss_pred             ceeeeeeeeccccceEEEEEEe-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecC
Q 027788           25 RYGRYNELLGSGAVKKVYRAFD-----QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDE   98 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~   98 (219)
                      +.+++.+.||+|+||.||+|.+     ..++..||+|.++...   .....+.+.+|+.+++.+ +||||+++++.+...
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA---TASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc---chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            3448899999999999999974     2445689999987432   234456788999999999 899999999988543


Q ss_pred             CCceEEEEeccccCCChHHHHHhC--------------------------------------------------------
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKH--------------------------------------------------------  122 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~--------------------------------------------------------  122 (219)
                       ...++++|||+++|+|.+++...                                                        
T Consensus        84 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          84 -NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             -CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence             34578899999999999887642                                                        


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccccee--------e
Q 027788          123 ------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR--------I  188 (219)
Q Consensus       123 ------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~--------~  188 (219)
                            ..+++..+..++.|++.|+.|||+++  ++||||||+||+++.+ +.++|+|||+++........        +
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccCCCCC
Confidence                  23667788899999999999999999  9999999999999865 58999999999876432210        1


Q ss_pred             eecccCccccCCCccccccceeeec
Q 027788          189 RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ..+.+| +......++.++||||+|
T Consensus       240 ~~y~aP-E~~~~~~~~~~sDiwslG  263 (338)
T cd05102         240 LKWMAP-ESIFDKVYTTQSDVWSFG  263 (338)
T ss_pred             ccccCc-HHhhcCCCCcccCHHHHH
Confidence            123333 333455678889999999

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.98  E-value=4e-31  Score=214.08  Aligned_cols=176  Identities=21%  Similarity=0.306  Sum_probs=144.2

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      +.||+|+||.||+|.+..+++.||+|+++..... .....+.+..|..+++.+ +||||+++++++..  .+.++++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~   77 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVN-DDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEF   77 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeC
Confidence            4689999999999999999999999999864432 334456788899999888 69999999998854  4568899999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---  186 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---  186 (219)
                      +++++|..++.....+++..+..++.|++.|+.|||+++  ++||||||+||+++.+ +.++|+|||+++.......   
T Consensus        78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~~  154 (329)
T cd05588          78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTS  154 (329)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEECcCccccccccCCCccc
Confidence            999999988877778999999999999999999999999  9999999999999865 5899999999875322111   


Q ss_pred             ---eeeecccCccccCCCccccccceeeec
Q 027788          187 ---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                         ++..+.+| +......++.++|+||+|
T Consensus       155 ~~~gt~~y~aP-E~~~~~~~~~~~DiwslG  183 (329)
T cd05588         155 TFCGTPNYIAP-EILRGEDYGFSVDWWALG  183 (329)
T ss_pred             cccCCccccCH-HHHcCCCCCCccceechH
Confidence               12223333 344556677889999999

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.98  E-value=3.9e-31  Score=217.30  Aligned_cols=183  Identities=15%  Similarity=0.247  Sum_probs=145.9

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+| .+.+.||+|+||.||+|.+..++..+|+|.++..... .....+.+..|+.+++.++||||+++++++.  +.+.+
T Consensus        43 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~--~~~~~  118 (370)
T cd05596          43 EDF-DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQ--DDKYL  118 (370)
T ss_pred             HHc-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCEE
Confidence            344 7779999999999999999999999999998743221 2233455778999999999999999998884  45678


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++|||+++|+|.+++... .+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||++.....
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~-~~~kL~DfG~~~~~~~  194 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDA  194 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCC-CCEEEEeccceeeccC
Confidence            9999999999999987653 5888999999999999999999999  9999999999999865 6899999999987643


Q ss_pred             cce-------eeeecccCccccCC---Cccccccceeeecc
Q 027788          184 AIR-------RIRCWGRRSSWRRS---CTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~-------~~~~~~~~~~~~~~---~~~~~~~diws~gi  214 (219)
                      ...       ++..+.+|+.+...   ..++.++|+||+|+
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGv  235 (370)
T cd05596         195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV  235 (370)
T ss_pred             CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhH
Confidence            321       22223334333322   23677899999993

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.98  E-value=5e-31  Score=213.67  Aligned_cols=182  Identities=16%  Similarity=0.213  Sum_probs=146.3

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|+||.||++.+..+++.||+|.+...... .......+..|+.++..++|++|+++++.+.  +.+.++++
T Consensus         3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~--~~~~~~lv   79 (331)
T cd05624           3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEML-KRAETACFREERNVLVNGDCQWITTLHYAFQ--DENYLYLV   79 (331)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-hhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEEE
Confidence            47889999999999999999999999999998753221 2333456788999999999999999999884  44678999


Q ss_pred             eccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          107 TEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      |||+++|+|.+++.. ...+++..+..++.|++.+|.|||+.+  ++||||||+||+++.+ +.++|+|||++.......
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCC-CCEEEEeccceeeccCCC
Confidence            999999999999876 457899999999999999999999999  9999999999999855 589999999998765433


Q ss_pred             e-------eeeecccCccccCC----Cccccccceeeecc
Q 027788          186 R-------RIRCWGRRSSWRRS----CTMRITRSLWTYTR  214 (219)
Q Consensus       186 ~-------~~~~~~~~~~~~~~----~~~~~~~diws~gi  214 (219)
                      .       ++..+.+|+.+...    ..++.++|+||+|+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGv  196 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGV  196 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeeh
Confidence            2       11223333332221    34667899999993

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.98  E-value=3.1e-31  Score=214.18  Aligned_cols=177  Identities=19%  Similarity=0.245  Sum_probs=142.8

Q ss_pred             eeeccccceEEEEEEec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           31 ELLGSGAVKKVYRAFDQ---EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      +.||+|+||.||++...   .+++.||+|.++.............+.+|+.+++.++||||+++++.+..  .+.++++|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv~   79 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLIL   79 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEEE
Confidence            67999999999999863   57889999998854432233445667899999999999999999998854  45688999


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce-
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR-  186 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~-  186 (219)
                      ||+++++|.+.+.....+.+..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||+++....... 
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~  156 (323)
T cd05584          80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTV  156 (323)
T ss_pred             eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEeeCcCCeecccCCCc
Confidence            99999999999887778899999999999999999999999  9999999999999865 6899999999875432221 


Q ss_pred             -----eeeecccCccccCCCccccccceeeec
Q 027788          187 -----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 -----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                           ++..+.+|+ ......++.++|+||+|
T Consensus       157 ~~~~~gt~~y~aPE-~~~~~~~~~~~DiwslG  187 (323)
T cd05584         157 THTFCGTIEYMAPE-ILMRSGHGKAVDWWSLG  187 (323)
T ss_pred             ccccCCCccccChh-hccCCCCCCcceecccH
Confidence                 222233333 33445567789999999

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4e-31  Score=214.22  Aligned_cols=182  Identities=16%  Similarity=0.229  Sum_probs=146.3

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|+||.||++.+..+++.||+|+++..... .....+.+..|+.+++.++|+||+++++++.  +...++++
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv   79 (331)
T cd05597           3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQ--DENNLYLV   79 (331)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEe--cCCeEEEE
Confidence            36789999999999999999999999999998743221 2334466888999999999999999999885  44678999


Q ss_pred             eccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          107 TEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      |||+++++|.+++.. ...+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.++|+|||++.......
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCC-CCEEEEECCceeecCCCC
Confidence            999999999998875 457899999999999999999999999  9999999999999855 689999999997764432


Q ss_pred             e-------eeeecccCccccC----CCccccccceeeecc
Q 027788          186 R-------RIRCWGRRSSWRR----SCTMRITRSLWTYTR  214 (219)
Q Consensus       186 ~-------~~~~~~~~~~~~~----~~~~~~~~diws~gi  214 (219)
                      .       ++..+.+|+.+..    ...++.++|+||+|+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~  196 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGV  196 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhh
Confidence            2       2222333433321    234567799999994

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.97  E-value=3.5e-31  Score=213.66  Aligned_cols=177  Identities=20%  Similarity=0.318  Sum_probs=140.0

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHH-HHHhhCCCCceEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVR-LLKTLANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      +.||+|+||.||+|++..+++.+|+|++....... ......+..|.. +++.++||||+++++.+.  +.+.++++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~--~~~~~~lv~e~   77 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ--TAEKLYFVLDY   77 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEEE--cCCEEEEEEcC
Confidence            46999999999999999999999999987543321 222344555554 678899999999998884  44568899999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---  186 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---  186 (219)
                      +++++|...+.....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||++........   
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~  154 (321)
T cd05603          78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTS  154 (321)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEccCCCCccCCCCCCccc
Confidence            999999988877778999999999999999999999999  9999999999999865 6899999999875422221   


Q ss_pred             ---eeeecccCccccCCCccccccceeeecc
Q 027788          187 ---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                         ++..+.+|+ ......++.++|+||+|+
T Consensus       155 ~~~gt~~y~aPE-~~~~~~~~~~~DiwslG~  184 (321)
T cd05603         155 TFCGTPEYLAPE-VLRKEPYDRTVDWWCLGA  184 (321)
T ss_pred             cccCCcccCCHH-HhcCCCCCCcCcccccch
Confidence               122233333 344556788899999993

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.97  E-value=4.2e-31  Score=213.55  Aligned_cols=177  Identities=20%  Similarity=0.314  Sum_probs=140.7

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHH-HHHhhCCCCceEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVR-LLKTLANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      +.||+|+||.||+|.+..+++.+|+|++...... .......+..|.. +++.++||||+++++.+..  .+.++++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~   77 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDF   77 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcC
Confidence            4699999999999999999999999998754322 2233345556655 4678999999999988844  4568899999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---  186 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---  186 (219)
                      +++++|...+.....+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.++|+|||++........   
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~  154 (325)
T cd05604          78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQSDTTT  154 (325)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEEeecCCcccCCCCCCCcc
Confidence            999999988887778999999999999999999999999  9999999999999865 6899999999875432221   


Q ss_pred             ---eeeecccCccccCCCccccccceeeecc
Q 027788          187 ---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                         ++..+.+ ++......++.++|+||+|+
T Consensus       155 ~~~gt~~y~a-PE~~~~~~~~~~~DvwslG~  184 (325)
T cd05604         155 TFCGTPEYLA-PEVIRKQPYDNTVDWWCLGA  184 (325)
T ss_pred             cccCChhhCC-HHHHcCCCCCCcCccccccc
Confidence               1112222 34445566788899999993

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.97  E-value=5.4e-31  Score=213.30  Aligned_cols=177  Identities=21%  Similarity=0.299  Sum_probs=144.3

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      +.||+|+||.||+|.+..+++.+|+|+++..... .....+.+..|+.++.++ +||||+++++++..  .+.++++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~   77 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEY   77 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc-chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeC
Confidence            4699999999999999999999999999865332 344456778899988776 79999999998854  4568899999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---  186 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---  186 (219)
                      +++++|..++.....+++..+..++.|++.|+.|||+++  ++||||||+||+++.+ +.++|+|||+++.......   
T Consensus        78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~~~~~  154 (329)
T cd05618          78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTS  154 (329)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCC-CCEEEeeCCccccccCCCCccc
Confidence            999999988887778999999999999999999999999  9999999999999866 5899999999875432221   


Q ss_pred             ---eeeecccCccccCCCccccccceeeecc
Q 027788          187 ---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                         ++..+.+| +......++.++|+||+|+
T Consensus       155 ~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~  184 (329)
T cd05618         155 TFCGTPNYIAP-EILRGEDYGFSVDWWALGV  184 (329)
T ss_pred             cccCCccccCH-HHHcCCCCCCccceecccH
Confidence               22223333 3445566788899999993

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.97  E-value=3.6e-31  Score=213.94  Aligned_cols=176  Identities=19%  Similarity=0.290  Sum_probs=139.0

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHH-HHHhhCCCCceEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVR-LLKTLANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      +.||+|+||.||+|.+..+++.+|+|++....... ......+..|.. +++.++|+||+++++.+..  .+.++++|||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~   77 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDY   77 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh-hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeC
Confidence            46999999999999999999999999987543221 122234444444 5678999999999998854  4568899999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---  186 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---  186 (219)
                      +++++|.+++.....+.+..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||++........   
T Consensus        78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~~~~~  154 (325)
T cd05602          78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTS  154 (325)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEEccCCCCcccccCCCCcc
Confidence            999999998887778899999999999999999999999  9999999999999865 5899999999876432221   


Q ss_pred             ---eeeecccCccccCCCccccccceeeec
Q 027788          187 ---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                         ++..+.+| +......++.++|+||+|
T Consensus       155 ~~~gt~~y~aP-E~~~~~~~~~~~DiwslG  183 (325)
T cd05602         155 TFCGTPEYLAP-EVLHKQPYDRTVDWWCLG  183 (325)
T ss_pred             cccCCccccCH-HHHcCCCCCCcccccccc
Confidence               12222333 344556678889999999

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.97  E-value=5.7e-31  Score=212.69  Aligned_cols=181  Identities=20%  Similarity=0.235  Sum_probs=144.7

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCC-CceEEEEEEecCCCceEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK-NIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~-~i~~~~~~~~~~~~~~~~l  105 (219)
                      |.+.+.||+|+||.||+|.+..+++.||+|++...... .....+.+..|+.+++.++|+ +++++++++..  .+.+++
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l   78 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF   78 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence            36789999999999999999999999999998854322 233456788899999999875 47777777744  456889


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      +|||+++++|..++.....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||++.......
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGG  155 (324)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCC-CCEEEeecCcceecCCCC
Confidence            9999999999998887778999999999999999999999999  9999999999999865 689999999987543221


Q ss_pred             e------eeeecccCccccCCCccccccceeeecc
Q 027788          186 R------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       186 ~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .      ++..+.+ ++......++.++|+||+|+
T Consensus       156 ~~~~~~~gt~~y~a-PE~~~~~~~~~~~DiwslGv  189 (324)
T cd05587         156 KTTRTFCGTPDYIA-PEIIAYQPYGKSVDWWAFGV  189 (324)
T ss_pred             CceeeecCCccccC-hhhhcCCCCCcccchhhhHH
Confidence            1      1122222 34445556778899999993

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-31  Score=221.75  Aligned_cols=184  Identities=21%  Similarity=0.274  Sum_probs=157.7

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCCce
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~  102 (219)
                      -.-+++.++||+|+||+|++|..+.+++.+|||++++.....+ +.++..+.|..++.... ||.++.++.+|+++  +.
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~-d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~--~~  443 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQR-DEVESLMCEKRIFELANRHPFLVNLFSCFQTK--EH  443 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecc-ccHHHHHHHHHHHHHhccCCeEeecccccccC--Ce
Confidence            3456888999999999999999999999999999998776643 44677888999888775 99999999999654  66


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +|+||||+.||++.. ++....+++..+..++..|+.||.|||+++  |++||||.+|||+|.+ |.+||+|||+++...
T Consensus       444 l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTE-GHVKIADFGLCKEGM  519 (694)
T ss_pred             EEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEccc-CcEEecccccccccC
Confidence            999999999999544 444568999999999999999999999999  9999999999999976 699999999999876


Q ss_pred             -ccceeeeecccCc----cccCCCccccccceeeecc
Q 027788          183 -RAIRRIRCWGRRS----SWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       183 -~~~~~~~~~~~~~----~~~~~~~~~~~~diws~gi  214 (219)
                       .+....+.+|+|+    +......|+..-|=||||+
T Consensus       520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGV  556 (694)
T KOG0694|consen  520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGV  556 (694)
T ss_pred             CCCCccccccCChhhcChhhhccCcccchhhHHHHHH
Confidence             3334556688877    3567888999999999994

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=7.3e-33  Score=205.09  Aligned_cols=183  Identities=22%  Similarity=0.302  Sum_probs=156.3

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      +.+++.||+|-||.||.|+.++++--||+|++.++... .......+.+|+++...|+||||++++++|.++  ..+|++
T Consensus        24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~-~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~--~riyLi  100 (281)
T KOG0580|consen   24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQIL-KTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS--KRIYLI  100 (281)
T ss_pred             ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHH-HhcchhhhhheeEeecccCCccHHhhhhheecc--ceeEEE
Confidence            47889999999999999999999999999998765432 233346688999999999999999999999654  568999


Q ss_pred             eccccCCChHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          107 TEVCTSGNLREYRK--KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       107 ~e~~~~g~L~~~~~--~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      +||.++|++...++  ....+++.....+..|++.|+.|+|..+  ++|||+||+|+|++.+ +.+|++|||.+..-+..
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~p~~  177 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHAPSN  177 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCC-CCeeccCCCceeecCCC
Confidence            99999999999888  5567999999999999999999999999  9999999999999866 58999999999877643


Q ss_pred             ceeeeeccc----CccccCCCccccccceeeecccc
Q 027788          185 IRRIRCWGR----RSSWRRSCTMRITRSLWTYTRLG  216 (219)
Q Consensus       185 ~~~~~~~~~----~~~~~~~~~~~~~~diws~gi~~  216 (219)
                       .+.+.+|+    |++.-.+.+++..-|+|++||.+
T Consensus       178 -kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~  212 (281)
T KOG0580|consen  178 -KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLC  212 (281)
T ss_pred             -CceeeecccccCCHhhcCCCCccchhhHHHHHHHH
Confidence             34444444    56778888999999999999653

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.97  E-value=1e-30  Score=217.14  Aligned_cols=188  Identities=24%  Similarity=0.371  Sum_probs=150.8

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-C-----CCceEE
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-N-----KNIISL   91 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~-----~~i~~~   91 (219)
                      +..|-....|.+.+.||+|+||.|.+|++.++++.||||+++..     ......-..|+.+|..|+ |     -|++++
T Consensus       179 v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm  253 (586)
T KOG0667|consen  179 VVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDKYNIVRM  253 (586)
T ss_pred             EecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEe
Confidence            33333333446789999999999999999999999999999854     455566778999999997 3     489999


Q ss_pred             EEEEecCCCceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEe-CCCC
Q 027788           92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN-GNTG  168 (219)
Q Consensus        92 ~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~-~~~~  168 (219)
                      +++|...  +.+|||.|.+. .+|.+++..+  ..++...++.++.||+.+|.+||..+  |+|+||||+|||+. .+..
T Consensus       254 ~d~F~fr--~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~  328 (586)
T KOG0667|consen  254 LDYFYFR--NHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRS  328 (586)
T ss_pred             eeccccc--cceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcC
Confidence            9999654  56899999995 6999998754  46899999999999999999999999  99999999999985 3334


Q ss_pred             cEEEeccccceeccccce---eeeecccCccccCCCccccccceeeec-ccc
Q 027788          169 QVKIGDLGVAAIVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYT-RLG  216 (219)
Q Consensus       169 ~~~l~dfg~a~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~g-i~~  216 (219)
                      .+||+|||.|.......-   +.+.+++| +....-+|+.+-|||||| |+|
T Consensus       329 ~vKVIDFGSSc~~~q~vytYiQSRfYRAP-EVILGlpY~~~IDmWSLGCIlA  379 (586)
T KOG0667|consen  329 RIKVIDFGSSCFESQRVYTYIQSRFYRAP-EVILGLPYDTAIDMWSLGCILA  379 (586)
T ss_pred             ceeEEecccccccCCcceeeeeccccccc-hhhccCCCCCccceeehhhhHH
Confidence            799999999987655442   43445554 444455688889999999 543

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.97  E-value=9.3e-31  Score=211.38  Aligned_cols=181  Identities=20%  Similarity=0.225  Sum_probs=145.1

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      |++.+.||+|+||.||+|++..++..+|+|+++..... .......+..|..++..+ .|++++++++++..  .+.+++
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l   78 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF   78 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence            36779999999999999999999999999998854322 233345667788888777 47888888888844  456889


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      +|||+++|+|...+.....+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.++|+|||+++......
T Consensus        79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDG  155 (323)
T ss_pred             EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCC-CcEEEccCCCceecCCCC
Confidence            9999999999998887778999999999999999999999999  9999999999999866 589999999997643222


Q ss_pred             e------eeeecccCccccCCCccccccceeeecc
Q 027788          186 R------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       186 ~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .      ++..+.+ ++......++.++|+||+|+
T Consensus       156 ~~~~~~~gt~~y~a-PE~~~~~~~~~~~DiwSlGv  189 (323)
T cd05616         156 VTTKTFCGTPDYIA-PEIIAYQPYGKSVDWWAFGV  189 (323)
T ss_pred             CccccCCCChhhcC-HHHhcCCCCCCccchhchhH
Confidence            1      1222223 34445566888899999993

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=3.7e-31  Score=214.63  Aligned_cols=182  Identities=21%  Similarity=0.350  Sum_probs=144.6

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC---ceE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR---NTL  103 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~---~~~  103 (219)
                      |.+.+.||+|+||.||+|.+..++..||+|.++....  .......+.+|+.++++++||||+++++++.....   ..+
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE--HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc--cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            4788999999999999999999999999999874322  22334668899999999999999999988754332   357


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++|||++ ++|.+++.....+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.++|+|||+++....
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANAD-CKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CcEEEccCcccccccc
Confidence            89999995 689888887778999999999999999999999999  9999999999999865 6899999999976533


Q ss_pred             cce---------eeeecccCccccC-CCccccccceeeecc
Q 027788          184 AIR---------RIRCWGRRSSWRR-SCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~---------~~~~~~~~~~~~~-~~~~~~~~diws~gi  214 (219)
                      ...         ++..+.+|+-... ...++.++|+||+|+
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGv  196 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGC  196 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHH
Confidence            221         1122233332221 245677899999993

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.97  E-value=8.6e-31  Score=212.26  Aligned_cols=179  Identities=21%  Similarity=0.382  Sum_probs=148.7

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      .|.+.+.||+|+||.||++.+..++..+|+|.+....   .+...+.+.+|++++++++|||++++++++...  +.+++
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~l   80 (331)
T cd06649           6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISI   80 (331)
T ss_pred             cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEEEE
Confidence            3477799999999999999999999999999987542   345567789999999999999999999998544  56889


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH-EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~-~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      +|||+++++|.+++.....+++..+..++.|++.++.|||+. +  ++|+||||+||+++.+ +.++|+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCC-CcEEEccCccccccccc
Confidence            999999999999998777899999999999999999999975 6  9999999999999866 58999999999766443


Q ss_pred             ce----eeeecccCccccCCCccccccceeeec
Q 027788          185 IR----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ..    ++..+.+|+ ......++.++|+||+|
T Consensus       158 ~~~~~~g~~~y~aPE-~~~~~~~~~~~DiwslG  189 (331)
T cd06649         158 MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMG  189 (331)
T ss_pred             ccccCCCCcCcCCHh-HhcCCCCCchHhHHHHH
Confidence            22    222333333 34455678889999999

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.97  E-value=4.6e-31  Score=212.57  Aligned_cols=176  Identities=20%  Similarity=0.283  Sum_probs=140.8

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHh-hCCCCceEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKT-LANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~-l~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      +.||+|+||.||+|.+..+++.||+|.++..... .....+.+..|..++.. .+||||+++++++..  ...++++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~   77 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEY   77 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcC
Confidence            4699999999999999999999999999864322 22334555667777664 489999999998844  4578899999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---  186 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---  186 (219)
                      +++++|..++.....+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.++|+|||++........   
T Consensus        78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~  154 (316)
T cd05592          78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKAS  154 (316)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCC-CCEEEccCcCCeECCCCCCccc
Confidence            999999998887778999999999999999999999999  9999999999999866 5899999999986533221   


Q ss_pred             ---eeeecccCccccCCCccccccceeeec
Q 027788          187 ---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                         ++..+.+| +......++.++|+||+|
T Consensus       155 ~~~gt~~y~aP-E~~~~~~~~~~~DvwslG  183 (316)
T cd05592         155 TFCGTPDYIAP-EILKGQKYNESVDWWSFG  183 (316)
T ss_pred             cccCCccccCH-HHHcCCCCCCcccchhHH
Confidence               22223333 334455678889999999

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=9.4e-31  Score=210.90  Aligned_cols=175  Identities=20%  Similarity=0.298  Sum_probs=141.9

Q ss_pred             eeeccccceEEEEEEe---cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           31 ELLGSGAVKKVYRAFD---QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      +.||+|+||.||++.+   ..++..+|+|+++....  .......+..|++++++++||||+++++.+..  ...++++|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~   77 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLIL   77 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEE
Confidence            5799999999999875   35789999999986442  22334567789999999999999999999854  45688999


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccccee
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR  187 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~  187 (219)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+.+  ++|+||||+||+++.+ +.++|+|||++.........
T Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~  154 (318)
T cd05582          78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKK  154 (318)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCC-CcEEEeeccCCcccCCCCCc
Confidence            99999999998887778999999999999999999999999  9999999999999865 58999999999865443221


Q ss_pred             ------eeecccCccccCCCccccccceeeec
Q 027788          188 ------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       188 ------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                            +..+.+| +......++.++|+||+|
T Consensus       155 ~~~~~g~~~y~aP-E~~~~~~~~~~~DiwslG  185 (318)
T cd05582         155 AYSFCGTVEYMAP-EVVNRRGHTQSADWWSFG  185 (318)
T ss_pred             eecccCChhhcCH-HHHcCCCCCCccceeccc
Confidence                  1122223 334445567789999999

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=7.3e-32  Score=225.39  Aligned_cols=190  Identities=23%  Similarity=0.311  Sum_probs=155.5

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC----C
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED----R  100 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~----~  100 (219)
                      .-|...+.||+|+||.||+++++.+|+.||||.++...   ...-+++.-+|++++++|+|+||++++++--...    .
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~   89 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT   89 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence            34456688999999999999999999999999988654   2344577889999999999999999988763322    2


Q ss_pred             ceEEEEeccccCCChHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC-CCC--cEEEec
Q 027788          101 NTLNFITEVCTSGNLREYRKKH---RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG-NTG--QVKIGD  174 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~-~~~--~~~l~d  174 (219)
                      ..-.++||||++|+|...+++-   ..+++..++.++..++.|+.+||.++  |+||||||.||++-. ..|  -.||+|
T Consensus        90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtD  167 (732)
T KOG4250|consen   90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTD  167 (732)
T ss_pred             ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeec
Confidence            3346799999999999998753   35899999999999999999999999  999999999999642 213  259999


Q ss_pred             cccceeccccceeeeecccCcc----ccC-CCccccccceeeeccccccC
Q 027788          175 LGVAAIVGRAIRRIRCWGRRSS----WRR-SCTMRITRSLWTYTRLGCAC  219 (219)
Q Consensus       175 fg~a~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~diws~gi~~~~c  219 (219)
                      ||.|+.+.....-++.+|+++.    .+. ...|+...|.||+|++++-|
T Consensus       168 fG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~c  217 (732)
T KOG4250|consen  168 FGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYEC  217 (732)
T ss_pred             ccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHH
Confidence            9999999888877777877553    223 57888889999999766544

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.97  E-value=7.6e-31  Score=211.73  Aligned_cols=177  Identities=19%  Similarity=0.259  Sum_probs=143.1

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      +.||+|+||.||+|++..+++.||+|+++..... .....+.+..|..+++.+ +||||+++++++..  .+.++++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~   77 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-QDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEY   77 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeC
Confidence            4689999999999999999999999998854332 233446677888888765 79999999999854  4568899999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---  186 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---  186 (219)
                      +++++|...+.....+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.++|+|||++........   
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~  154 (321)
T cd05591          78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTT  154 (321)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEeecccceecccCCcccc
Confidence            999999998887778999999999999999999999999  9999999999999866 5899999999876432221   


Q ss_pred             ---eeeecccCccccCCCccccccceeeecc
Q 027788          187 ---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                         ++..+.+| +......++.++|+||+|+
T Consensus       155 ~~~gt~~y~aP-E~~~~~~~~~~~DvwslG~  184 (321)
T cd05591         155 TFCGTPDYIAP-EILQELEYGPSVDWWALGV  184 (321)
T ss_pred             ccccCccccCH-HHHcCCCCCCccceechhH
Confidence               12223333 3445566788899999993

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=1.2e-30  Score=211.55  Aligned_cols=181  Identities=16%  Similarity=0.228  Sum_probs=145.3

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|+||.||++....+++.+|+|++...... .......+..|+.++..++|++++++++.+..  .+.++++
T Consensus         3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv   79 (332)
T cd05623           3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLYLV   79 (332)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEEEE
Confidence            37789999999999999999999999999998743221 22334567889999999999999999998854  4568899


Q ss_pred             eccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          107 TEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      |||+++|+|.+++.. ...+++..+..++.|++.++.|||+.+  ++||||||+||+++.+ +.++|+|||++..+....
T Consensus        80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCC-CCEEEeecchheecccCC
Confidence            999999999999876 457899999999999999999999999  9999999999999855 589999999997654322


Q ss_pred             e-------eeeecccCcccc----CCCccccccceeeec
Q 027788          186 R-------RIRCWGRRSSWR----RSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~-------~~~~~~~~~~~~----~~~~~~~~~diws~g  213 (219)
                      .       ++..+.+|+-+.    ....++.++|+||+|
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlG  195 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLG  195 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeH
Confidence            1       222333344332    134567789999999

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.97  E-value=6.6e-32  Score=229.74  Aligned_cols=182  Identities=25%  Similarity=0.361  Sum_probs=148.3

Q ss_pred             eeeeeeccccceEEEEEEec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           28 RYNELLGSGAVKKVYRAFDQ-----EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      ++.+.||+|+||+||+|+..     .+...||||.++...   +..+.++|++|++++..|+||||++++++|...  +.
T Consensus       489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~--~P  563 (774)
T KOG1026|consen  489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNIVRLLGVCREG--DP  563 (774)
T ss_pred             eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC--Ce
Confidence            56688999999999999743     345679999988654   455789999999999999999999999999544  55


Q ss_pred             EEEEeccccCCChHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCC
Q 027788          103 LNFITEVCTSGNLREYRKKHR----------H----VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG  168 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~----------~----~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~  168 (219)
                      +++|.||+..|+|.+|+....          .    ++..+.+.|+.||+.|+.||.++.  ++||||..+|+|+..+. 
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~l-  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGENL-  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccce-
Confidence            888999999999999986432          2    678889999999999999999999  99999999999998664 


Q ss_pred             cEEEeccccceeccccceeeeecc--cCccccC-----CCccccccceeeec--cccc
Q 027788          169 QVKIGDLGVAAIVGRAIRRIRCWG--RRSSWRR-----SCTMRITRSLWTYT--RLGC  217 (219)
Q Consensus       169 ~~~l~dfg~a~~~~~~~~~~~~~~--~~~~~~~-----~~~~~~~~diws~g--i~~~  217 (219)
                      .|||+|||+++.+-+.+-......  -|-.|+.     -+.|+.+|||||+|  .|.+
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEI  698 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEI  698 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhh
Confidence            899999999998877653211111  1344543     55688999999999  5544

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.97  E-value=1.1e-30  Score=209.14  Aligned_cols=180  Identities=26%  Similarity=0.367  Sum_probs=141.7

Q ss_pred             CceeeeeeeeccccceEEEEEEecC----------------CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCC
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQE----------------EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN   87 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~----------------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   87 (219)
                      ++| ++.+.||+|+||.||+|....                ++..||+|.+....   .......+.+|+.++++++|||
T Consensus         5 ~~~-~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           5 GHL-LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             hhC-eeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCCCC
Confidence            444 788999999999999997532                34479999887432   3445577899999999999999


Q ss_pred             ceEEEEEEecCCCceEEEEeccccCCChHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 027788           88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-------------------HVSVKALKKWSKQILKGLNYLHTHE  148 (219)
Q Consensus        88 i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~-------------------~~~~~~~~~i~~qv~~~l~~lh~~~  148 (219)
                      |+++++++...  +.++++|||+++++|.+++....                   .+++..+..++.|++.|+.|||+.+
T Consensus        81 iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~  158 (304)
T cd05096          81 IIRLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN  158 (304)
T ss_pred             eeEEEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999654  45788999999999999875431                   3567788999999999999999999


Q ss_pred             CCeeeeCCCCCceEEeCCCCcEEEeccccceecccccee--------eeecccCccccCCCccccccceeeec
Q 027788          149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR--------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       149 ~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                        ++|+||||+||+++.+ +.++|+|||+++........        +..+.+| +......++.++|+||+|
T Consensus       159 --ivH~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Dv~slG  227 (304)
T cd05096         159 --FVHRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAW-ECILMGKFTTASDVWAFG  227 (304)
T ss_pred             --ccccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCH-HHHhcCCCCchhhhHHHH
Confidence              9999999999999865 58999999999876443321        1112233 333445678889999999

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=4.7e-31  Score=221.22  Aligned_cols=177  Identities=24%  Similarity=0.341  Sum_probs=140.3

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec------CC
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD------ED   99 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~   99 (219)
                      .|.+.+.||+|+||.||+|.+..+++.||+|.+....        ....+|+.+++.++||||+++.+++..      +.
T Consensus        67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            3488899999999999999999999999999875321        123469999999999999999877643      22


Q ss_pred             CceEEEEeccccCCChHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788          100 RNTLNFITEVCTSGNLREYRK----KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      ..+++++|||+++ ++.+++.    ....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+.+.+||+||
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeecc
Confidence            3467789999974 6665543    3456889999999999999999999999  9999999999999866557999999


Q ss_pred             ccceeccccce-----eeeecccCccccCCCccccccceeeec
Q 027788          176 GVAAIVGRAIR-----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       176 g~a~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |+|+.+.....     ++..+.+|+.+.....++.++|+||+|
T Consensus       216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG  258 (440)
T PTZ00036        216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLG  258 (440)
T ss_pred             ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHH
Confidence            99987654332     222344555455555688889999999

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.97  E-value=1.7e-30  Score=210.27  Aligned_cols=176  Identities=20%  Similarity=0.295  Sum_probs=144.1

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      +.||+|+||.||+|....+++.+|+|+++..... +....+.+..|+.++.++ +||+|+.+++++..  .+.++++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~   77 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-DDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEY   77 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeC
Confidence            4699999999999999999999999999854332 234557788999999888 59999999998854  4568899999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---  186 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---  186 (219)
                      +++++|..++.....+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.++|+|||+++.......   
T Consensus        78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~  154 (327)
T cd05617          78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTS  154 (327)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCC-CCEEEeccccceeccCCCCcee
Confidence            999999988887778999999999999999999999999  9999999999999866 5899999999975322211   


Q ss_pred             ---eeeecccCccccCCCccccccceeeec
Q 027788          187 ---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                         ++..+.+ ++......++.++|+||+|
T Consensus       155 ~~~gt~~y~a-PE~~~~~~~~~~~DiwslG  183 (327)
T cd05617         155 TFCGTPNYIA-PEILRGEEYGFSVDWWALG  183 (327)
T ss_pred             cccCCcccCC-HHHHCCCCCCchheeehhH
Confidence               1222223 3444566778889999999

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.97  E-value=7.3e-31  Score=211.78  Aligned_cols=176  Identities=21%  Similarity=0.264  Sum_probs=142.2

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      +.||+|+||.||+|.+..+++.||+|.++..... .....+.+..|..++..+ +||||+++++++.  ..+.++++|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~--~~~~~~iv~Ey   77 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLYCCFQ--TPDRLFFVMEF   77 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhccCCCchhceeeEEE--cCCEEEEEEcC
Confidence            4699999999999999999999999998754322 233446677888888766 6999999999884  44568899999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---  186 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---  186 (219)
                      +++++|..++.....+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.++|+|||+++.......   
T Consensus        78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~~  154 (320)
T cd05590          78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTS  154 (320)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCccc
Confidence            999999998887778999999999999999999999999  9999999999999866 5899999999876432211   


Q ss_pred             ---eeeecccCccccCCCccccccceeeec
Q 027788          187 ---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                         ++..+.+| +......++.++|+||+|
T Consensus       155 ~~~gt~~y~aP-E~~~~~~~~~~~DiwslG  183 (320)
T cd05590         155 TFCGTPDYIAP-EILQEMLYGPSVDWWAMG  183 (320)
T ss_pred             ccccCccccCH-HHHcCCCCCCccchhhhH
Confidence               12222233 344556677889999999

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.5e-30  Score=210.75  Aligned_cols=176  Identities=15%  Similarity=0.255  Sum_probs=140.5

Q ss_pred             eccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh---CCCCceEEEEEEecCCCceEEEEecc
Q 027788           33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL---ANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        33 ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      ||+|+||.||+|.+..+++.||+|++....... .........|..++..+   .||||+++++.+.  ....++++|||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~--~~~~~~lv~e~   77 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA-KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ--TDSDLYLVTDY   77 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh-hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe--cCCeEEEEEcC
Confidence            699999999999999999999999987543221 22334455677777655   6999999998884  44568899999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---  186 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---  186 (219)
                      +++++|...+.....+++..+..++.|++.|+.|||+++  ++||||||+||+++.+ +.++|+|||++........   
T Consensus        78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~  154 (330)
T cd05586          78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTN  154 (330)
T ss_pred             CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCC-CCEEEecCCcCcCCCCCCCCcc
Confidence            999999998887788999999999999999999999999  9999999999999865 5899999999876432221   


Q ss_pred             ---eeeecccCccccCCCccccccceeeecc
Q 027788          187 ---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                         ++..+.+|+.......++.++|+||+|+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGv  185 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGV  185 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceecccc
Confidence               2233444544444555778899999993

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.97  E-value=6.3e-31  Score=208.69  Aligned_cols=180  Identities=20%  Similarity=0.323  Sum_probs=145.5

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||+|+||.||+|++..+++.+|+|.++....  .....+.+.+|+.+++.++||||+++++++.  ....++++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv   78 (287)
T cd07848           3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAFR--RRGKLYLV   78 (287)
T ss_pred             ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhEe--cCCEEEEE
Confidence            4788999999999999999999999999999875432  2334567788999999999999999998884  44578899


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      |||++++.+..+......+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+ +.++|+|||++........
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEEeeccCccccccccc
Confidence            999998777665554557899999999999999999999999  9999999999999855 5899999999987643321


Q ss_pred             -------eeeecccCccccCCCccccccceeeecc
Q 027788          187 -------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 -------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                             ++..+.+| +......++.++|+||+|+
T Consensus       156 ~~~~~~~~~~~y~aP-E~~~~~~~~~~~DiwslGv  189 (287)
T cd07848         156 ANYTEYVATRWYRSP-ELLLGAPYGKAVDMWSVGC  189 (287)
T ss_pred             ccccccccccccCCc-HHHcCCCCCCchhHHhHHH
Confidence                   12223333 3334556778899999993

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=6.2e-31  Score=214.02  Aligned_cols=176  Identities=27%  Similarity=0.384  Sum_probs=150.5

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC  110 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  110 (219)
                      +.||+|.||.||-|.+.++|+.||||++.+..+..  .+-..+++|+.+|+++.||.|+.+..-|  +..+.+|+|||-+
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~--kqesqlR~EVaILq~l~HPGiV~le~M~--ET~ervFVVMEKl  645 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT--KQESQLRNEVAILQNLHHPGIVNLECMF--ETPERVFVVMEKL  645 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCC--chHHHHHHHHHHHHhcCCCCeeEEEEee--cCCceEEEEehhh
Confidence            57999999999999999999999999998766643  3347789999999999999999988777  6667799999999


Q ss_pred             cCCChHHHH-Hh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC--CCCcEEEeccccceeccccce
Q 027788          111 TSGNLREYR-KK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG--NTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       111 ~~g~L~~~~-~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~--~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      . |+.-..+ ++ .+.+++....+++.||+.||.|||-++  |+|+||||+|+|+.+  +..++||+|||+|++++...-
T Consensus       646 ~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF  722 (888)
T KOG4236|consen  646 H-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF  722 (888)
T ss_pred             c-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence            6 5655544 33 467999999999999999999999999  999999999999863  335799999999999988776


Q ss_pred             eeeecccCc----cccCCCccccccceeeec
Q 027788          187 RIRCWGRRS----SWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ~~~~~~~~~----~~~~~~~~~~~~diws~g  213 (219)
                      +.+.+|+|.    +..++..|+..=|+||.|
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVG  753 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVG  753 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeee
Confidence            767777765    457788899999999999

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=223.08  Aligned_cols=174  Identities=24%  Similarity=0.416  Sum_probs=149.0

Q ss_pred             eeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEecccc
Q 027788           32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCT  111 (219)
Q Consensus        32 ~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~  111 (219)
                      .+|+|.||+||-|++..++..+|||.+..+    +...++.++.||.+++.|.|.||+++++.+.  .+.++-++||-.|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek----dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s--enGf~kIFMEqVP  655 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK----DSREVQPLHEEIALHSTLRHKNIVRYLGSVS--ENGFFKIFMEQVP  655 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc----cchhhccHHHHHHHHHHHhhHhHHHHhhccC--CCCeEEEEeecCC
Confidence            699999999999999999999999998865    4566789999999999999999999999984  4457889999999


Q ss_pred             CCChHHHHHh-CCCC--CHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc---
Q 027788          112 SGNLREYRKK-HRHV--SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI---  185 (219)
Q Consensus       112 ~g~L~~~~~~-~~~~--~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~---  185 (219)
                      ||+|.+++++ ++++  ++.+...+..||++||.|||.+.  |+|||||-+|++++--.|.+||+|||.++++-.-.   
T Consensus       656 GGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T  733 (1226)
T KOG4279|consen  656 GGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT  733 (1226)
T ss_pred             CCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence            9999998864 5777  89999999999999999999999  99999999999998777889999999998874321   


Q ss_pred             ---eeeeecccCccc-cCCCccccccceeeec
Q 027788          186 ---RRIRCWGRRSSW-RRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ---~~~~~~~~~~~~-~~~~~~~~~~diws~g  213 (219)
                         +++--+-+|+.. ...++|..++||||||
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~G  765 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFG  765 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhcc
Confidence               233334455543 3466788889999999

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.97  E-value=1.2e-30  Score=211.64  Aligned_cols=179  Identities=22%  Similarity=0.385  Sum_probs=148.4

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      .|.+.+.||+|+||.||+|.+..++..+|+|.++...   .......+.+|+.+++.++|+||+++++++..  .+.+++
T Consensus         6 ~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l   80 (333)
T cd06650           6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI   80 (333)
T ss_pred             hhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEEEE
Confidence            3478899999999999999999999999999887543   34445778899999999999999999999865  456889


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH-EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~-~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      +|||+++++|.+++.....+++..+..++.|++.++.|||+. +  ++|+||||+||+++.+ +.++|+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCC-CCEEEeeCCcchhhhhh
Confidence            999999999999988777889999999999999999999974 6  9999999999999865 58999999999765432


Q ss_pred             ce----eeeecccCccccCCCccccccceeeec
Q 027788          185 IR----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ..    ++..+.+|+ ......++.++|+||+|
T Consensus       158 ~~~~~~~~~~y~aPE-~~~~~~~~~~~DvwslG  189 (333)
T cd06650         158 MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMG  189 (333)
T ss_pred             ccccCCCCccccCHH-HhcCCCCCcHHHHHHHH
Confidence            21    222334443 34455677889999999

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=216.48  Aligned_cols=188  Identities=26%  Similarity=0.363  Sum_probs=160.3

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      .+.+.|-| .+++-||+|.|..|-+|++.-+|+.||||++.+...  +...-.++..|+..++.+|||||+++|.+.  .
T Consensus        13 DgkIAGLY-DLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl--D~~st~hlfqEVRCMKLVQHpNiVRLYEVi--D   87 (864)
T KOG4717|consen   13 DGKIAGLY-DLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DTLSTGHLFQEVRCMKLVQHPNIVRLYEVI--D   87 (864)
T ss_pred             ccceeeee-hhhhhhcCCceehhhhhhhhcccceeEEEEeccccc--chhhhhHHHHHHHHHHHhcCcCeeeeeehh--c
Confidence            34455666 899999999999999999999999999999987654  344457788999999999999999999998  4


Q ss_pred             CCceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                      .+..+|++.|.=.+|+|.+++-++ ..++++....++.||+.|+.|+|...  ++||||||+|+.+....|-+||.|||+
T Consensus        88 TQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGF  165 (864)
T KOG4717|consen   88 TQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGF  165 (864)
T ss_pred             ccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccc
Confidence            455699999999999999998665 56999999999999999999999999  999999999999887888999999999


Q ss_pred             ceeccccceeeeeccc----CccccCCCccccc-cceeeec
Q 027788          178 AAIVGRAIRRIRCWGR----RSSWRRSCTMRIT-RSLWTYT  213 (219)
Q Consensus       178 a~~~~~~~~~~~~~~~----~~~~~~~~~~~~~-~diws~g  213 (219)
                      +-.+.+...-++.+|+    -++......|+++ -||||||
T Consensus       166 SNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLG  206 (864)
T KOG4717|consen  166 SNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLG  206 (864)
T ss_pred             cccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHH
Confidence            9999888765444443    2355666777766 7999999

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=1.5e-30  Score=210.16  Aligned_cols=180  Identities=21%  Similarity=0.238  Sum_probs=144.2

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCC-CCceEEEEEEecCCCceEEEE
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN-KNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      ++.+.||+|+||.||+|.+..+++.||+|+++..... .....+.+..|..+++.+.| ++++++.+++..  .+.++++
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv   79 (323)
T cd05615           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYFV   79 (323)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEEE
Confidence            5678999999999999999999999999998854322 23345667789999888865 677778888744  4568899


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      |||+++++|.+++.....+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.++|+|||+++.......
T Consensus        80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEeccccccccCCCCc
Confidence            999999999999888778999999999999999999999999  9999999999999866 5899999999876433221


Q ss_pred             ------eeeecccCccccCCCccccccceeeecc
Q 027788          187 ------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 ------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                            ++..+.+| +......++.++|+||+|+
T Consensus       157 ~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslGv  189 (323)
T cd05615         157 TTRTFCGTPDYIAP-EIIAYQPYGKSVDWWAYGV  189 (323)
T ss_pred             cccCccCCccccCH-HHHcCCCCCCccchhhhHH
Confidence                  12223333 3444556788899999993

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=1.6e-30  Score=210.15  Aligned_cols=179  Identities=20%  Similarity=0.252  Sum_probs=142.0

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHH---HhhCCCCceEEEEEEecCCCceE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL---KTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l---~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      |++.+.||+|+||.||+|.+..+++.||+|+++..... .....+.+..|+.++   +.++||||+++++++.  ..+.+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~--~~~~~   77 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVESLMCEKRIFETANSERHPFLVNLFACFQ--TEDHV   77 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccccCCCChhceeeEEE--cCCEE
Confidence            36779999999999999999999999999999854321 223345667776655   4667999999999884  44578


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++|||+++++|...+.. ..+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.++|+|||++.....
T Consensus        78 ~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          78 CFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMG  153 (324)
T ss_pred             EEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCC-CcEEeCcccCCccCCC
Confidence            899999999999887654 46899999999999999999999999  9999999999999866 5899999999875432


Q ss_pred             cce------eeeecccCccccCCCccccccceeeec
Q 027788          184 AIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...      ++..+.+| +......++.++|+||+|
T Consensus       154 ~~~~~~~~~g~~~y~aP-E~~~~~~~~~~~DiwslG  188 (324)
T cd05589         154 FGDRTSTFCGTPEFLAP-EVLTETSYTRAVDWWGLG  188 (324)
T ss_pred             CCCcccccccCccccCH-hHhcCCCCCcccchhhHH
Confidence            221      12223333 344556678889999999

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.2e-30  Score=204.04  Aligned_cols=180  Identities=17%  Similarity=0.279  Sum_probs=144.7

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|+||.||++.+..+++.||+|.+...... .......+.+|+.+++.++|||++++++.+.  ..+.++++
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv   78 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYE--TKDALCLV   78 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-hhhhHHHHHHHHHHHHhcCCCCEeeeeeeec--CCCeEEEE
Confidence            36678999999999999999999999999998754321 1222355678999999999999999998884  44578999


Q ss_pred             eccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          107 TEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      |||+++++|.+++...  ..+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDY-GHIRISDLGLAVEIPEG  155 (285)
T ss_pred             EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCC-CCEEEeeCCCceecCCC
Confidence            9999999998876543  45899999999999999999999999  9999999999999855 68999999999876433


Q ss_pred             cee-----eeecccCccccCCCccccccceeeec
Q 027788          185 IRR-----IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~~-----~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...     +..+.+ ++......++.++|+||+|
T Consensus       156 ~~~~~~~~~~~y~a-PE~~~~~~~~~~~Diws~G  188 (285)
T cd05605         156 ETIRGRVGTVGYMA-PEVVKNERYTFSPDWWGLG  188 (285)
T ss_pred             CccccccCCCCccC-cHHhcCCCCCccccchhHH
Confidence            221     122223 3444556678889999999

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=4.5e-30  Score=203.66  Aligned_cols=185  Identities=27%  Similarity=0.439  Sum_probs=149.6

Q ss_pred             CCceeeeeeeeccccceEEEEEEe----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFD----QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      .++++++.+.||+|+||.||.|..    ..++..||+|.++...   .....+.+.+|+.+++.++|||++++.+++...
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (284)
T cd05079           2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTED   78 (284)
T ss_pred             chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc---cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            356778899999999999999973    4678899999976442   344557789999999999999999999988766


Q ss_pred             CCceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                      +....+++|||+++++|.+++... ..+++..+..++.|++.++.|||+++  ++|+||||+||+++.+ +.++|+|||+
T Consensus        79 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~-~~~~l~dfg~  155 (284)
T cd05079          79 GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVKIGDFGL  155 (284)
T ss_pred             CCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCC-CCEEECCCcc
Confidence            567788999999999999988654 35889999999999999999999999  9999999999999865 5899999999


Q ss_pred             ceecccccee---------eeecccCccccCCCccccccceeeecc
Q 027788          178 AAIVGRAIRR---------IRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +..+......         ...+.+| +......+..++|+||+|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~ap-E~~~~~~~~~~~Di~slG~  200 (284)
T cd05079         156 TKAIETDKEYYTVKDDLDSPVFWYAP-ECLIQSKFYIASDVWSFGV  200 (284)
T ss_pred             ccccccCccceeecCCCCCCccccCH-HHhccCCCCccccchhhhh
Confidence            9876543221         1112222 3344556777899999993

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.97  E-value=3.7e-30  Score=218.43  Aligned_cols=185  Identities=22%  Similarity=0.309  Sum_probs=148.5

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC-
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR-  100 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~-  100 (219)
                      ..++| .+.+.||+|+||.||+|.+..+++.||+|.+.....  .......+.+|+.++..++|+|+++++..+...+. 
T Consensus        30 ~~~rY-~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         30 QAKKY-WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             cCCCE-EEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            33555 888999999999999999999999999999876543  34555778899999999999999998877643322 


Q ss_pred             -----ceEEEEeccccCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEE
Q 027788          101 -----NTLNFITEVCTSGNLREYRKKH----RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVK  171 (219)
Q Consensus       101 -----~~~~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~  171 (219)
                           ..++++|||+++|+|.+++...    ..+++..+..++.|++.+|.|||+.+  ++||||||+||+++.+ +.++
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~-~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSN-GLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCC-CCEE
Confidence                 2467899999999999887542    46889999999999999999999999  9999999999999866 5899


Q ss_pred             Eeccccceeccccce--------eeeecccCccccCCCccccccceeeec
Q 027788          172 IGDLGVAAIVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       172 l~dfg~a~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |+|||+++.+.....        ++..+.+| +......++.++||||+|
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aP-E~~~~~~~s~k~DVwSlG  232 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAP-EIWRRKPYSKKADMFSLG  232 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCH-HHhCCCCCCcHHHHHHHH
Confidence            999999987643221        12223333 334456688889999999

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=3.2e-30  Score=218.27  Aligned_cols=182  Identities=19%  Similarity=0.278  Sum_probs=147.0

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCC-CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEE-GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      +..+.|.+.+.||+|++|.||.|....+ +..|++|.+...    +......+.+|+.+++.++||||+++++.+..+  
T Consensus        64 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~--  137 (478)
T PTZ00267         64 PREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSD--  137 (478)
T ss_pred             CcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC--
Confidence            4455568999999999999999998877 788999876533    345556788899999999999999999998544  


Q ss_pred             ceEEEEeccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788          101 NTLNFITEVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                      +.++++|||+++|+|.+++..    ...+++..+..++.|++.||.|+|+.+  ++||||||+||+++.+ +.++|+|||
T Consensus       138 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~-~~~kL~DFg  214 (478)
T PTZ00267        138 DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPT-GIIKLGDFG  214 (478)
T ss_pred             CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCC-CcEEEEeCc
Confidence            568899999999999887642    346889999999999999999999999  9999999999999865 589999999


Q ss_pred             cceeccccce--------eeeecccCccccCCCccccccceeeec
Q 027788          177 VAAIVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       177 ~a~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +++.......        ++..+.+| +......++.++|+||+|
T Consensus       215 la~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Dv~slG  258 (478)
T PTZ00267        215 FSKQYSDSVSLDVASSFCGTPYYLAP-ELWERKRYSKKADMWSLG  258 (478)
T ss_pred             CceecCCccccccccccCCCccccCH-hHhCCCCCCcHHhHHHHH
Confidence            9987654321        11122233 334456678889999999

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.97  E-value=1.9e-30  Score=209.10  Aligned_cols=176  Identities=20%  Similarity=0.263  Sum_probs=143.1

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      +.||+|+||.||+|++..++..||+|+++..... .......+..|+.+++.+ +||||+++++++.  ..+.++++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~--~~~~~~lv~e~   77 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVIL-QDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ--TKDRLFFVMEY   77 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcC
Confidence            4699999999999999999999999999854322 233446677899998877 6999999999884  44578999999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---  186 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---  186 (219)
                      +++++|..++.....+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+ +.++|+|||++........   
T Consensus        78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~  154 (318)
T cd05570          78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTS  154 (318)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCC-CcEEecccCCCeecCcCCCccc
Confidence            999999998887778999999999999999999999999  9999999999999866 5899999999875322221   


Q ss_pred             ---eeeecccCccccCCCccccccceeeec
Q 027788          187 ---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                         ++..+.+ ++......++.++|+||+|
T Consensus       155 ~~~g~~~y~a-PE~~~~~~~~~~~DiwslG  183 (318)
T cd05570         155 TFCGTPDYIA-PEILSYQPYGPAVDWWALG  183 (318)
T ss_pred             ceecCccccC-HHHhcCCCCCcchhhhhHH
Confidence               1122223 3444556678889999999

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.97  E-value=2.9e-30  Score=212.52  Aligned_cols=179  Identities=26%  Similarity=0.418  Sum_probs=141.1

Q ss_pred             eeeeeeeeccccceEEEEEEe-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCC
Q 027788           26 YGRYNELLGSGAVKKVYRAFD-----QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDED   99 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~   99 (219)
                      -+++.+.||+|+||.||+|..     ..++..||+|.++...   .....+.+.+|+.+++.+ +||||+++++.+... 
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-  111 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIVNLLGACTVG-  111 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC-
Confidence            348899999999999999963     3556789999987432   233446788999999999 899999999998544 


Q ss_pred             CceEEEEeccccCCChHHHHHhCC--------------------------------------------------------
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHR--------------------------------------------------------  123 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~--------------------------------------------------------  123 (219)
                       ...+++|||+++|+|.+++....                                                        
T Consensus       112 -~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         112 -GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             -CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence             45788999999999998875321                                                        


Q ss_pred             -------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          124 -------------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       124 -------------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                                         .+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.++|+|||+++.....
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~-~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHG-RITKICDFGLARDIRND  267 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECC-CcEEEecCccceeccCc
Confidence                               3577788999999999999999999  9999999999999855 57999999999876443


Q ss_pred             ceee--------eecccCccccCCCccccccceeeec
Q 027788          185 IRRI--------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~~~--------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ....        ..+.+ ++......++.++|+||||
T Consensus       268 ~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~sDi~slG  303 (375)
T cd05104         268 SNYVVKGNARLPVKWMA-PESIFNCVYTFESDVWSYG  303 (375)
T ss_pred             ccccccCCCCCCcceeC-hhHhcCCCCCCCCCHHHHH
Confidence            2110        11223 3444556678889999999

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.97  E-value=2.7e-30  Score=208.11  Aligned_cols=176  Identities=21%  Similarity=0.291  Sum_probs=141.0

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHh-hCCCCceEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKT-LANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~-l~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      +.||+|+||.||+|++..++..||+|.++..... .....+....|..++.. ++|||++++++.+.  +.+.++++|||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~lv~E~   77 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQ--TKEHLFFVMEF   77 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEE--eCCEEEEEECC
Confidence            4699999999999999999999999998854321 12234556778887765 48999999999985  44678999999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---  186 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---  186 (219)
                      +++++|..++.....+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.++|+|||++........   
T Consensus        78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05620          78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRAS  154 (316)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCC-CCEEeCccCCCeecccCCCcee
Confidence            999999998887778999999999999999999999999  9999999999999866 5899999999875422211   


Q ss_pred             ---eeeecccCccccCCCccccccceeeec
Q 027788          187 ---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                         ++..+.+| +......++.++|+||+|
T Consensus       155 ~~~gt~~y~aP-E~~~~~~~~~~~DiwslG  183 (316)
T cd05620         155 TFCGTPDYIAP-EILQGLKYTFSVDWWSFG  183 (316)
T ss_pred             ccCCCcCccCH-HHHcCCCCCcccchhhhH
Confidence               12223333 334455678889999999

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.97  E-value=2.7e-30  Score=208.13  Aligned_cols=177  Identities=19%  Similarity=0.271  Sum_probs=141.5

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHh-hCCCCceEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKT-LANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~-l~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      +.||+|+||.||+|++..+++.||+|.++...... .........|..++.. ++||||+++++++..  ...++++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey   77 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEY   77 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-cchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeC
Confidence            46999999999999999999999999988643211 2233556677777765 589999999999854  4568899999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---  186 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---  186 (219)
                      +++|+|..++.....+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.++|+|||++........   
T Consensus        78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05619          78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTC  154 (316)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCC-CCEEEccCCcceECCCCCCcee
Confidence            999999999887778999999999999999999999999  9999999999999866 5899999999876432221   


Q ss_pred             ---eeeecccCccccCCCccccccceeeecc
Q 027788          187 ---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                         ++..+.+| +......++.++|+||+|+
T Consensus       155 ~~~gt~~y~aP-E~~~~~~~~~~~DvwslG~  184 (316)
T cd05619         155 TFCGTPDYIAP-EILLGQKYNTSVDWWSFGV  184 (316)
T ss_pred             eecCCccccCH-HHHcCCCCCchhhhhhHHH
Confidence               12223333 4445566788899999993

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=4.9e-30  Score=203.28  Aligned_cols=183  Identities=28%  Similarity=0.442  Sum_probs=148.3

Q ss_pred             CCceeeeeeeeccccceEEEEEE----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAF----DQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      .+||+++.+.||+|+||.||.+.    ...++..||+|.++...   .......+.+|++++++++|||++++++++...
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (283)
T cd05080           2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ   78 (283)
T ss_pred             ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            46788888999999999998764    34577899999987542   233456788999999999999999999988766


Q ss_pred             CCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      +...++++||++++++|.+++... .+++..+..++.|++.++.+||+++  ++|+||||+||+++.+ +.++|+|||++
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~  154 (283)
T cd05080          79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDND-RLVKIGDFGLA  154 (283)
T ss_pred             CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCC-CcEEEeecccc
Confidence            667789999999999999988654 5899999999999999999999999  9999999999999866 58999999999


Q ss_pred             eeccccce---------eeeecccCccccCCCccccccceeeec
Q 027788          179 AIVGRAIR---------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       179 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ........         ....+.+| +......++.++|+||+|
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~P-E~~~~~~~~~~~Di~slG  197 (283)
T cd05080         155 KAVPEGHEYYRVREDGDSPVFWYAV-ECLKENKFSYASDVWSFG  197 (283)
T ss_pred             cccCCcchhhccCCCCCCCceeeCH-hHhcccCCCcccccHHHH
Confidence            87654322         11112233 334455677889999999

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.97  E-value=1.7e-30  Score=213.61  Aligned_cols=180  Identities=23%  Similarity=0.349  Sum_probs=145.2

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC---CceEE
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED---RNTLN  104 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~---~~~~~  104 (219)
                      .+.+.||+|+||.||+|.+..+++.||+|.+.....  +....+++.+|+.+++.++|+||+++++++..++   ...++
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ--NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             cccceeeeCCCEEEEEEEECCCCCEEEEEecccccc--chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            567899999999999999999999999998764321  3345577889999999999999999999885443   12678


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      +++||+. ++|...+.....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||++......
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPD  156 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCC-CCEEeccccceeecccC
Confidence            9999996 578887776678999999999999999999999999  9999999999999865 58999999999865433


Q ss_pred             ce-------eeeecccCccccCCCccccccceeeec
Q 027788          185 IR-------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~-------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ..       .+..+.+|+.+.....++.++|+||+|
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  192 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVG  192 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHH
Confidence            21       112233444444445577789999999

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=7.5e-30  Score=202.22  Aligned_cols=181  Identities=25%  Similarity=0.449  Sum_probs=147.8

Q ss_pred             ceeeeeeeeccccceEEEEEE----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           25 RYGRYNELLGSGAVKKVYRAF----DQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      +.+++.+.||+|+||.||.|.    +..++..||+|.++..    .....+.+.+|+.+++.++|||++++.+++...+.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            345888999999999999997    4567889999987643    34556788999999999999999999998866666


Q ss_pred             ceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          101 NTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      ..+++++||+++++|.+++... ..+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+ +.++|+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~-~~~~l~dfg~~~  156 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESE-NRVKIGDFGLTK  156 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCC-CeEEECCCcccc
Confidence            7789999999999999988654 45889999999999999999999999  9999999999999865 589999999998


Q ss_pred             ecccccee---------eeecccCccccCCCccccccceeeec
Q 027788          180 IVGRAIRR---------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       180 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ........         ...+.+| +......++.++|+||+|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  198 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAP-ESLTESKFSVASDVWSFG  198 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCH-HHhccCCcChHHHHHHHH
Confidence            76543321         1112333 334455677789999999

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9.4e-30  Score=199.28  Aligned_cols=182  Identities=26%  Similarity=0.425  Sum_probs=148.5

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCC-CHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD-DPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      |.+.+.||+|++|.||.|.+..+++.+++|.+....... .....+.+.+|++++++++||||+++++++..  ...+++
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~   81 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETLSI   81 (263)
T ss_pred             ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeEEE
Confidence            478899999999999999999999999999987543211 12234678899999999999999999999854  457899


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ++|++++++|.+.+.....+++.....++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||+++......
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeecccceeccccc
Confidence            9999999999998887778899999999999999999999999  9999999999999855 589999999998764432


Q ss_pred             eee--------eecccCccccCCCccccccceeeec
Q 027788          186 RRI--------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~~~--------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...        .....++++.....++.++|+||+|
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  194 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVG  194 (263)
T ss_pred             cccccccCCCcCccccCcceeccCCCCchhhhHHHH
Confidence            111        1122334444555577889999999

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.97  E-value=7.3e-31  Score=216.07  Aligned_cols=186  Identities=24%  Similarity=0.352  Sum_probs=152.9

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      -++++......+...||+|.||+||+|..   ..+||||++++...  .+.+++.|++|+.++++-+|.||+-+.+++..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~w---hGdVAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRW---HGDVAVKLLNVDDP--TPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccc---ccceEEEEEecCCC--CHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            34555555557888999999999999976   35799999997764  56789999999999999999999999999954


Q ss_pred             CCCceEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                      +.   +.+++.+|+|.+|..++.- ...+.......|+.|+++|+.|||.++  |+|+|||..||++..+ ++|||.|||
T Consensus       460 p~---~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~-~kVkIgDFG  533 (678)
T KOG0193|consen  460 PP---LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHED-LKVKIGDFG  533 (678)
T ss_pred             Cc---eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccC-CcEEEeccc
Confidence            43   4789999999999998754 357899999999999999999999999  9999999999999855 699999999


Q ss_pred             cceeccccce--------eeeecccCcc--ccCCCccccccceeeecc
Q 027788          177 VAAIVGRAIR--------RIRCWGRRSS--WRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       177 ~a~~~~~~~~--------~~~~~~~~~~--~~~~~~~~~~~diws~gi  214 (219)
                      ++..-.....        +-.+|-+||-  .....+|+..||+|||||
T Consensus       534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGi  581 (678)
T KOG0193|consen  534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGI  581 (678)
T ss_pred             ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhH
Confidence            9976654422        2234555553  245667888899999993

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=3.3e-30  Score=213.05  Aligned_cols=171  Identities=19%  Similarity=0.270  Sum_probs=139.8

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      .|.+.+.||+|+||.||+|.+..+++.||+|...          ...+.+|+.++++++||||+++++++..  ....++
T Consensus        93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~l  160 (391)
T PHA03212         93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFTY--NKFTCL  160 (391)
T ss_pred             CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEEE--CCeeEE
Confidence            3488899999999999999999999999999643          1345689999999999999999999854  356788


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ++|++. ++|..++.....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||+++......
T Consensus       161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHP-GDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCC-CCEEEEeCCccccccccc
Confidence            999985 688888877778999999999999999999999999  9999999999999865 589999999997543211


Q ss_pred             e-------eeeecccCccccCCCccccccceeeec
Q 027788          186 R-------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~-------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .       ++..+.+| +......++.++|+||+|
T Consensus       237 ~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwSlG  270 (391)
T PHA03212        237 ANKYYGWAGTIATNAP-ELLARDPYGPAVDIWSAG  270 (391)
T ss_pred             ccccccccCccCCCCh-hhhcCCCCCcHHHHHHHH
Confidence            1       22223333 344455678889999999

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.97  E-value=4.8e-30  Score=209.64  Aligned_cols=175  Identities=21%  Similarity=0.395  Sum_probs=138.8

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.+.||+|+||.||+|.+..+++.||+|.+....   .......+.+|+++++.++|+||+++++++.  ....++++|
T Consensus        77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~  151 (353)
T PLN00034         77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFD--HNGEIQVLL  151 (353)
T ss_pred             hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEec--cCCeEEEEE
Confidence            56688999999999999999999999999986432   3445577889999999999999999999884  445688999


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce-
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR-  186 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~-  186 (219)
                      ||+++++|...    ....+..+..++.|++.||.|||+++  ++||||||+||+++.+ +.++|+|||+++....... 
T Consensus       152 e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        152 EFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             ecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC-CCEEEcccccceeccccccc
Confidence            99999988642    23567788899999999999999999  9999999999999865 5899999999987654321 


Q ss_pred             -----eeeecccCccccC----CCccccccceeeecc
Q 027788          187 -----RIRCWGRRSSWRR----SCTMRITRSLWTYTR  214 (219)
Q Consensus       187 -----~~~~~~~~~~~~~----~~~~~~~~diws~gi  214 (219)
                           ++..+.+|+.+..    ......++||||||+
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGv  261 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGV  261 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHH
Confidence                 2223344443321    122334799999993

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.97  E-value=4.7e-30  Score=203.27  Aligned_cols=174  Identities=21%  Similarity=0.316  Sum_probs=139.9

Q ss_pred             eccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccccC
Q 027788           33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTS  112 (219)
Q Consensus        33 ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~  112 (219)
                      ||+|+||.||++.+..+++.+|+|.+...... .....+.+..|+.+++.++|+|++++.+.+.  ....++++|||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~   77 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ--TKTDLCLVMTIMNG   77 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc--CCCeEEEEEeCCCC
Confidence            69999999999999999999999998754322 2233466788999999999999999988884  44568899999999


Q ss_pred             CChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce--
Q 027788          113 GNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR--  186 (219)
Q Consensus       113 g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~--  186 (219)
                      ++|...+..    ...+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|+|||++........  
T Consensus        78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~  154 (280)
T cd05608          78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKT  154 (280)
T ss_pred             CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEeeCccceecCCCCccc
Confidence            999877632    346899999999999999999999999  9999999999999855 6899999999987654322  


Q ss_pred             ----eeeecccCccccCCCccccccceeeec
Q 027788          187 ----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                          ++..+.+| +......++.++|+||+|
T Consensus       155 ~~~~g~~~y~aP-E~~~~~~~~~~~DvwslG  184 (280)
T cd05608         155 KGYAGTPGFMAP-ELLQGEEYDFSVDYFALG  184 (280)
T ss_pred             cccCCCcCccCH-HHhcCCCCCccccHHHHH
Confidence                11122333 344455677889999999

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=8e-30  Score=225.53  Aligned_cols=187  Identities=20%  Similarity=0.353  Sum_probs=150.3

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      .-|.+.+.||+|+||.||+|.+..++..+|+|.+.....  .......+..|+.+++.|+||||+++++.|.......+|
T Consensus        13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            344888999999999999999999999999999875543  344557788999999999999999999998777777899


Q ss_pred             EEeccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCeeeeCCCCCceEEeCC---------
Q 027788          105 FITEVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHTHE-----PCVIHRDLNCSNVFVNGN---------  166 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~~~-----~~i~h~dl~~~nili~~~---------  166 (219)
                      ++|||+++++|.+++..    ...+++..++.++.||+.||.|||..+     +.|+|+||||+|||++.+         
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            99999999999988764    246899999999999999999999843     239999999999999632         


Q ss_pred             -------CCcEEEeccccceeccccce-----eeeecccCccccC-CCccccccceeeec
Q 027788          167 -------TGQVKIGDLGVAAIVGRAIR-----RIRCWGRRSSWRR-SCTMRITRSLWTYT  213 (219)
Q Consensus       167 -------~~~~~l~dfg~a~~~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~diws~g  213 (219)
                             .+.++|+|||++........     ++..+.+|+.+.. ...++.++||||||
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG  230 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG  230 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHH
Confidence                   12489999999987643322     2333444443332 34577889999999

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=1.2e-29  Score=199.20  Aligned_cols=183  Identities=26%  Similarity=0.462  Sum_probs=149.3

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccC-CCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC-DDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      |++.+.||+|+||.||.|.+..++..|++|.+...... ......+.+.+|+.+++++.|||++++++.+.......+++
T Consensus         4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (265)
T cd06652           4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI   83 (265)
T ss_pred             ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence            37789999999999999999999999999988643221 12345678889999999999999999999887655667889


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      +||++++++|.+++.....+++..+..++.|++.++.+||+++  ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          84 FMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSV-GNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCC-CCEEECcCcccccccccc
Confidence            9999999999999887777899999999999999999999999  9999999999999855 589999999998654321


Q ss_pred             e---------eeeecccCccccCCCccccccceeeec
Q 027788          186 R---------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~---------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .         ++..+.+|+. .....++.++|+||+|
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~-~~~~~~~~~~Dv~slG  196 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEV-ISGEGYGRKADIWSVG  196 (265)
T ss_pred             ccccccccCCCCccccChhh-hcCCCCCcchhHHHHH
Confidence            1         1122333433 3345567789999999

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.97  E-value=3.9e-30  Score=206.46  Aligned_cols=180  Identities=26%  Similarity=0.400  Sum_probs=143.4

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+| .+.+.||+|+||.||+|++..++..+|+|.++....   ......+.+|+.++++++|||++++++++..+  +..
T Consensus         6 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~   79 (309)
T cd07872           6 ETY-IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIVHTD--KSL   79 (309)
T ss_pred             Cce-EEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc---CCcchhHHHHHHHHHhCCCCCcceEEEEEeeC--CeE
Confidence            445 777999999999999999999999999999875432   12224567899999999999999999998544  568


Q ss_pred             EEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          104 NFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +++|||+++ +|.+++... ..++...+..++.|++.|+.|||+++  ++||||||+||+++.+ +.++|+|||++....
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~  155 (309)
T cd07872          80 TLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINER-GELKLADFGLARAKS  155 (309)
T ss_pred             EEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECccccceecC
Confidence            889999974 777766543 45788999999999999999999999  9999999999999865 589999999997654


Q ss_pred             ccce------eeeecccCccccCCCccccccceeeec
Q 027788          183 RAIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ....      .+..+.+|+.......++.++|+||+|
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  192 (309)
T cd07872         156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVG  192 (309)
T ss_pred             CCccccccccccccccCCHHHhCCCCCCcHHHHHHHH
Confidence            3221      122233444444455677889999999

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-32  Score=225.48  Aligned_cols=184  Identities=22%  Similarity=0.362  Sum_probs=157.4

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      .+|.|...||.|+||.||+|..+.++..-|.|+|..+    ....++.++-||++|..++||+|+++++.|+.+++  +|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk----seEELEDylVEIeILa~CdHP~ivkLl~ayy~enk--Lw  105 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK----SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK--LW  105 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc----chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc--eE
Confidence            3457888999999999999999999999999998865    45567889999999999999999999998877755  89


Q ss_pred             EEeccccCCChHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          105 FITEVCTSGNLREYR-KKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       105 lv~e~~~~g~L~~~~-~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      ++.|+|+||-....+ .....+.+.++..+++|++.||.|||+++  |+|||||.-|||++.+ |.++|+|||++.....
T Consensus       106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~Tld-GdirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLD-GDIRLADFGVSAKNKS  182 (1187)
T ss_pred             EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEec-CcEeeecccccccchh
Confidence            999999998887654 45678999999999999999999999999  9999999999999976 6999999999988866


Q ss_pred             cce------eeeecccCcc----ccCCCccccccceeeeccccc
Q 027788          184 AIR------RIRCWGRRSS----WRRSCTMRITRSLWTYTRLGC  217 (219)
Q Consensus       184 ~~~------~~~~~~~~~~----~~~~~~~~~~~diws~gi~~~  217 (219)
                      ...      ++..|.+|+-    -....+|+.++|||||||+-|
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLI  226 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLI  226 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHH
Confidence            543      5555666653    346788999999999997643

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-32  Score=209.46  Aligned_cols=183  Identities=21%  Similarity=0.367  Sum_probs=153.9

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ...+.+..+||+|+||.||+|.++.+|..+|+|.+.+.      ..++++.+|+.++++++.++++++++.+....  -+
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s--DL  103 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS--DL  103 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccCC--ce
Confidence            45567788999999999999999999999999988754      34688999999999999999999998875433  38


Q ss_pred             EEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          104 NFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      |+|||||..|+..+.++. ..+++++.+..++...+.||+|||...  -+|||||.-|||++-+ |..||+|||+|-.+.
T Consensus       104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~-G~AKLADFGVAGQLT  180 (502)
T KOG0574|consen  104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTD-GIAKLADFGVAGQLT  180 (502)
T ss_pred             EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEccc-chhhhhhccccchhh
Confidence            999999999999998764 467999999999999999999999888  8999999999999966 689999999998887


Q ss_pred             ccce-eeeecccCc----cccCCCccccccceeeeccccc
Q 027788          183 RAIR-RIRCWGRRS----SWRRSCTMRITRSLWTYTRLGC  217 (219)
Q Consensus       183 ~~~~-~~~~~~~~~----~~~~~~~~~~~~diws~gi~~~  217 (219)
                      ..-. +.+..|+|.    +....-.|+.++|||||||.|+
T Consensus       181 DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaI  220 (502)
T KOG0574|consen  181 DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAI  220 (502)
T ss_pred             hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhh
Confidence            6544 333344432    2234566889999999999886

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=3.2e-30  Score=201.37  Aligned_cols=179  Identities=26%  Similarity=0.463  Sum_probs=146.8

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|+||.||++.+..++..+|+|.+.....  ..........|+.+++.++||||+++++++..  ...++++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v   76 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIV   76 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhccccccccccccccccccc--ccccccc
Confidence            4788999999999999999999999999999986542  22222334569999999999999999999965  4568899


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      ||++++++|.+++.....++...+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus        77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~~~~~  153 (260)
T PF00069_consen   77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDEN-GEVKLIDFGSSVKLSENNE  153 (260)
T ss_dssp             EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTT-SEEEESSGTTTEESTSTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc-ccccccccccccccccccc
Confidence            999998899999886678999999999999999999999999  9999999999999955 6899999999976311111


Q ss_pred             ------eeeecccCccccC-CCccccccceeeec
Q 027788          187 ------RIRCWGRRSSWRR-SCTMRITRSLWTYT  213 (219)
Q Consensus       187 ------~~~~~~~~~~~~~-~~~~~~~~diws~g  213 (219)
                            .+..+. ++++.. ...+..++|+||+|
T Consensus       154 ~~~~~~~~~~y~-aPE~~~~~~~~~~~~Di~slG  186 (260)
T PF00069_consen  154 NFNPFVGTPEYM-APEVLQQGKKYTRKSDIWSLG  186 (260)
T ss_dssp             EBSSSSSSGGGS-CHHHHTTTSSBSTHHHHHHHH
T ss_pred             cccccccccccc-ccccccccccccccccccccc
Confidence                  212223 334444 77788889999999

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.97  E-value=8.4e-30  Score=200.32  Aligned_cols=180  Identities=18%  Similarity=0.286  Sum_probs=143.5

Q ss_pred             ceeeeeeeeccccceEEEEEEec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQ---EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      +-+++.+.||+|+||.||+|...   ..+..||+|.++...   .......+.+|+.++++++|||++++++++..  +.
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~   79 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC---SDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GN   79 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CC
Confidence            34589999999999999999764   456789999887542   33445678899999999999999999999854  45


Q ss_pred             eEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          102 TLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      .++++|||+++++|.+++... ..+++..+..++.|++.|+.|||+++  ++|+||+|+|++++.+ +.++++|||.+..
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~-~~~~l~dfg~~~~  156 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSD-LVCKISGFRRLQE  156 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCC-CcEEECCCccccc
Confidence            688999999999999988764 46899999999999999999999999  9999999999999865 5899999998765


Q ss_pred             ccccce-------eeeecccCccccCCCccccccceeeec
Q 027788          181 VGRAIR-------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ......       .+..+.+|+ ......++.++|+||+|
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG  195 (266)
T cd05064         157 DKSEAIYTTMSGKSPVLWAAPE-AIQYHHFSSASDVWSFG  195 (266)
T ss_pred             ccccchhcccCCCCceeecCHH-HHhhCCccchhHHHHHH
Confidence            432211       111233333 33445677789999999

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.97  E-value=7.2e-30  Score=210.07  Aligned_cols=179  Identities=26%  Similarity=0.433  Sum_probs=141.1

Q ss_pred             eeeeeeeeccccceEEEEEEecC-----CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCC
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQE-----EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDED   99 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~   99 (219)
                      .+.+.+.||+|+||.||+|+...     ++..||+|.++...   .....+.+.+|+.+++.+ +|+||+++++.+... 
T Consensus        39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-  114 (374)
T cd05106          39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGACTHG-  114 (374)
T ss_pred             HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC-
Confidence            34888999999999999998543     34579999987543   234457788999999999 899999999998544 


Q ss_pred             CceEEEEeccccCCChHHHHHhC---------------------------------------------------------
Q 027788          100 RNTLNFITEVCTSGNLREYRKKH---------------------------------------------------------  122 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~---------------------------------------------------------  122 (219)
                       +.++++|||+++|+|.+++...                                                         
T Consensus       115 -~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         115 -GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             -CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence             4578899999999999887432                                                         


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccceee-
Q 027788          123 -------------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRI-  188 (219)
Q Consensus       123 -------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~~-  188 (219)
                                   ..+++..+..++.|++.|+.|||+++  ++||||||+||+++.+ +.++|+|||++.......... 
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCC-CeEEEeeceeeeeccCCcceee
Confidence                         13677888999999999999999999  9999999999999855 589999999998764432211 


Q ss_pred             -------eecccCccccCCCccccccceeeec
Q 027788          189 -------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       189 -------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                             ..+.+|+ ......++.++|+||+|
T Consensus       271 ~~~~~~~~~y~aPE-~~~~~~~~~~~DvwSlG  301 (374)
T cd05106         271 KGNARLPVKWMAPE-SIFDCVYTVQSDVWSYG  301 (374)
T ss_pred             ccCCCCccceeCHH-HhcCCCCCccccHHHHH
Confidence                   1123333 33455678899999999

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.97  E-value=1.1e-29  Score=204.57  Aligned_cols=177  Identities=28%  Similarity=0.471  Sum_probs=142.5

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcE----EEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIE----VAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      |++.+.||+|+||.||+|....++..    ||+|.++...   .....+++..|+.+++.++||||+++++.+...   .
T Consensus         9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~---~   82 (316)
T cd05108           9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T   82 (316)
T ss_pred             ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---C
Confidence            47889999999999999987666554    8999876432   345567888999999999999999999988643   2


Q ss_pred             EEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          103 LNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      .+++++++++|+|.+++... ..++...+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||+++..
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~-~~~kl~DfG~a~~~  159 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTP-QHVKITDFGLAKLL  159 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCC-CcEEEccccccccc
Confidence            56799999999999988764 45888999999999999999999999  9999999999999865 58999999999877


Q ss_pred             cccceeee--------ecccCccccCCCccccccceeeec
Q 027788          182 GRAIRRIR--------CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ........        .+.+ ++......++.++|+||||
T Consensus       160 ~~~~~~~~~~~~~~~~~y~a-pE~~~~~~~~~~~Di~slG  198 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMA-LESILHRIYTHQSDVWSYG  198 (316)
T ss_pred             cCCCcceeccCCccceeecC-hHHhccCCCCchhhhHHHH
Confidence            54332111        1222 2344556677889999999

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.97  E-value=1.2e-29  Score=197.67  Aligned_cols=175  Identities=20%  Similarity=0.354  Sum_probs=140.9

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC  110 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  110 (219)
                      +.||+|+||.||+|.+..+++.+|+|.+....   .......+.+|+++++.++||||+++++++..  ...++++|||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeec
Confidence            46899999999999999999999999876332   34455778999999999999999999999854  45578899999


Q ss_pred             cCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccceee-
Q 027788          111 TSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRI-  188 (219)
Q Consensus       111 ~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~~-  188 (219)
                      ++++|.+++... ..+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++++|||++.......... 
T Consensus        76 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             cCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCC-CcEEECccccCccccccccccc
Confidence            999999988654 45889999999999999999999999  9999999999999865 589999999987654321110 


Q ss_pred             ------eecccCccccCCCccccccceeeec
Q 027788          189 ------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       189 ------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                            .....+++......++.++|+||+|
T Consensus       153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG  183 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFG  183 (252)
T ss_pred             CCCCCCceeecCchhhcCCCCChHHHHHHHH
Confidence                  1112223344455577789999999

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PHA02988 hypothetical protein; Provisional

Probab=99.97  E-value=8.6e-30  Score=202.19  Aligned_cols=176  Identities=20%  Similarity=0.241  Sum_probs=143.6

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec--CCCceEEEEec
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD--EDRNTLNFITE  108 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~~~~lv~e  108 (219)
                      ..|++|+++.||+|..  +++.||+|.++.... ......+.+.+|+.++++++||||+++++++..  ++...++++||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence            4689999999999986  688999999875432 233445778899999999999999999999866  44567889999


Q ss_pred             cccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce-
Q 027788          109 VCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH-EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR-  186 (219)
Q Consensus       109 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~-~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~-  186 (219)
                      |+++|+|.+++.....+++.....++.|++.++.+||.. +  ++||||||+|++++.+ +.+|++|||+++....... 
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~-~~~kl~dfg~~~~~~~~~~~  179 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTEN-YKLKIICHGLEKILSSPPFK  179 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCC-CcEEEcccchHhhhcccccc
Confidence            999999999998777899999999999999999999974 7  7899999999999866 6899999999986544321 


Q ss_pred             --eeeecccCccccCC--Cccccccceeeec
Q 027788          187 --RIRCWGRRSSWRRS--CTMRITRSLWTYT  213 (219)
Q Consensus       187 --~~~~~~~~~~~~~~--~~~~~~~diws~g  213 (219)
                        ++..+.+| ++...  ..++.++||||||
T Consensus       180 ~~~~~~y~aP-E~~~~~~~~~~~k~Di~SlG  209 (283)
T PHA02988        180 NVNFMVYFSY-KMLNDIFSEYTIKDDIYSLG  209 (283)
T ss_pred             ccCcccccCH-HHhhhccccccchhhhhHHH
Confidence              22233333 44433  5788899999999

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.97  E-value=1.8e-29  Score=199.71  Aligned_cols=174  Identities=17%  Similarity=0.283  Sum_probs=139.1

Q ss_pred             eccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccccC
Q 027788           33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTS  112 (219)
Q Consensus        33 ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~  112 (219)
                      ||+|+||.||++....+++.+|+|.+....... ......+..|++++++++||||+++.+.+.  ....++++|||+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~g   77 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLAYAFE--SKTHLCLVMSLMNG   77 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-chhhHHHHHHHHHHHhcCCCcEEEEEEEEe--cCCeEEEEEecCCC
Confidence            699999999999999999999999987543221 122344567999999999999999998884  45678899999999


Q ss_pred             CChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccccee---
Q 027788          113 GNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR---  187 (219)
Q Consensus       113 g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~---  187 (219)
                      ++|..++...  ..+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|+|||++.........   
T Consensus        78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~  154 (277)
T cd05607          78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQR  154 (277)
T ss_pred             CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCC-CCEEEeeceeeeecCCCceeecc
Confidence            9998876543  35888999999999999999999999  9999999999999865 58999999999876543322   


Q ss_pred             --eeecccCccccCCCccccccceeeec
Q 027788          188 --IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       188 --~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                        +..+.+| +......++.++|+||+|
T Consensus       155 ~~~~~y~aP-E~~~~~~~~~~~DvwslG  181 (277)
T cd05607         155 AGTNGYMAP-EILKEEPYSYPVDWFAMG  181 (277)
T ss_pred             CCCCCccCH-HHHccCCCCCchhHHHHH
Confidence              1223333 344455588889999999

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-30  Score=218.76  Aligned_cols=189  Identities=22%  Similarity=0.357  Sum_probs=156.0

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCC---cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEe
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEG---IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWR   96 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   96 (219)
                      .++...+.++++.||.|.||.|++|+-+..+   ..||||-+|.-.   .+++...|+.|+.++-+++||||+++.++..
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy---tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT  700 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT  700 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc---cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence            3455678899999999999999999876555   579999998654   5778899999999999999999999999995


Q ss_pred             cCCCceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788           97 DEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus        97 ~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      .  ...+.+++|||++|+|..|++.+ +.+..-++.-+++.|+.|+.||.+.+  ++||||..+|||++.+. .+|++||
T Consensus       701 k--s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnL-vCKVsDF  775 (996)
T KOG0196|consen  701 K--SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNL-VCKVSDF  775 (996)
T ss_pred             c--CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccce-EEEeccc
Confidence            4  45588899999999999998754 67888999999999999999999999  99999999999999774 7899999


Q ss_pred             ccceeccccc-eeeeecc--cCcccc-----CCCccccccceeeec--ccc
Q 027788          176 GVAAIVGRAI-RRIRCWG--RRSSWR-----RSCTMRITRSLWTYT--RLG  216 (219)
Q Consensus       176 g~a~~~~~~~-~~~~~~~--~~~~~~-----~~~~~~~~~diws~g--i~~  216 (219)
                      |+++.+..+. ...+..|  .|..|.     .-+.++.+||+||+|  +|.
T Consensus       776 GLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWE  826 (996)
T KOG0196|consen  776 GLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE  826 (996)
T ss_pred             cceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEE
Confidence            9999885543 2222222  234443     344577789999999  564

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=2e-29  Score=206.45  Aligned_cols=183  Identities=27%  Similarity=0.355  Sum_probs=144.3

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC-
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR-  100 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~-  100 (219)
                      ...+| .+.+.||+|+||.||+|.+..++..||+|.+.....  .......+.+|+.+++.++||||+++++++...+. 
T Consensus        19 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   95 (359)
T cd07876          19 VLKRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ--NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSL   95 (359)
T ss_pred             hhhce-EEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc--chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCc
Confidence            34566 777999999999999999999999999999874432  33445778899999999999999999998854332 


Q ss_pred             ---ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788          101 ---NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus       101 ---~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                         ..++++|||+++ ++...+.  ..++...+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~-~~~kl~Dfg~  169 (359)
T cd07876          96 EEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL  169 (359)
T ss_pred             cccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEecCCC
Confidence               357899999974 5655553  25788999999999999999999999  9999999999999866 6899999999


Q ss_pred             ceeccccce-----eeeecccCccccCCCccccccceeeecc
Q 027788          178 AAIVGRAIR-----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +........     ++..+.+| +......++.++|+||+|+
T Consensus       170 a~~~~~~~~~~~~~~t~~y~aP-E~~~~~~~~~~~DiwSlG~  210 (359)
T cd07876         170 ARTACTNFMMTPYVVTRYYRAP-EVILGMGYKENVDIWSVGC  210 (359)
T ss_pred             ccccccCccCCCCcccCCCCCc-hhccCCCCCcchhhHHHHH
Confidence            976543221     12223333 3445566788899999993

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=2.1e-29  Score=202.14  Aligned_cols=178  Identities=22%  Similarity=0.400  Sum_probs=147.5

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|+||.||++.+..++..+++|.++...   .......+.+|++++++++||||+++++.+..  .+.++++
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv   77 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI---KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISIC   77 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEE
Confidence            478899999999999999999999999999887542   34455678899999999999999999999854  4568899


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT-HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~-~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      |||+++++|.+++.....+++..+..++.|++.++.|||+ .+  ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~  154 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSM  154 (308)
T ss_pred             eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecC-CcEEEccCCCcccccccc
Confidence            9999999999999877789999999999999999999997 57  9999999999999865 589999999987654332


Q ss_pred             e----eeeecccCccccCCCccccccceeeec
Q 027788          186 R----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .    ++..+.+|+ ......++.++|+||+|
T Consensus       155 ~~~~~~~~~~~aPE-~~~~~~~~~~~DiwslG  185 (308)
T cd06615         155 ANSFVGTRSYMSPE-RLQGTHYTVQSDIWSLG  185 (308)
T ss_pred             cccCCCCcCccChh-HhcCCCCCccchHHHHH
Confidence            2    122233333 34455677789999999

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.97  E-value=2.3e-29  Score=200.02  Aligned_cols=180  Identities=28%  Similarity=0.411  Sum_probs=138.7

Q ss_pred             eeeeeeeccccceEEEEEEecC-CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh---CCCCceEEEEEEec---CC
Q 027788           27 GRYNELLGSGAVKKVYRAFDQE-EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL---ANKNIISLHYVWRD---ED   99 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~~~~i~~~~~~~~~---~~   99 (219)
                      |++.+.||+|+||.||+|.+.. .+..||+|.++.....  ......+.+|+.+++.+   +||||+++++++..   ..
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC--CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            4778999999999999999854 4688999998765432  22234456677777665   69999999998852   23


Q ss_pred             CceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788          100 RNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                      ...++++||+++ ++|.+++...  ..+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+ +.++|+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~-~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCC-CCEEEccccc
Confidence            456889999996 6888887643  35889999999999999999999999  9999999999999866 5899999999


Q ss_pred             ceeccccce-----eeeecccCccccCCCccccccceeeec
Q 027788          178 AAIVGRAIR-----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       178 a~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +........     ++..+.+|+ ......++.++|+||+|
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~DiwslG  196 (290)
T cd07862         157 ARIYSFQMALTSVVVTLWYRAPE-VLLQSSYATPVDLWSVG  196 (290)
T ss_pred             eEeccCCcccccccccccccChH-HHhCCCCCCccchHHHH
Confidence            987654322     122233333 33455677889999999

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.97  E-value=9.6e-31  Score=197.76  Aligned_cols=178  Identities=24%  Similarity=0.400  Sum_probs=153.9

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCC----CHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceEEE
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD----DPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      +.+|.|..+.|-+|.++.++.++|+|++.......    .-...+....|+.+|+++ .||+|+++.+++  +...++++
T Consensus        23 eilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--es~sF~Fl  100 (411)
T KOG0599|consen   23 EILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--ESDAFVFL  100 (411)
T ss_pred             HHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--cCcchhhh
Confidence            56999999999999999999999999998744332    223456678899999988 599999999999  55677889


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      |.|.++.|.|++++.+.-.+++...++++.|+..++.|+|..+  |+||||||+||+++.+. +++|+|||+|..+.++.
T Consensus       101 VFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~-~i~isDFGFa~~l~~Ge  177 (411)
T KOG0599|consen  101 VFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNM-NIKISDFGFACQLEPGE  177 (411)
T ss_pred             hhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeecccc-ceEEeccceeeccCCch
Confidence            9999999999999998888999999999999999999999999  99999999999999775 89999999999999988


Q ss_pred             eeeeecccCcc---------c-cCCCccccccceeeec
Q 027788          186 RRIRCWGRRSS---------W-RRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~~~~~~~~~~~---------~-~~~~~~~~~~diws~g  213 (219)
                      .-...+|+|..         | -..++|+..-|+|+.|
T Consensus       178 kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~G  215 (411)
T KOG0599|consen  178 KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACG  215 (411)
T ss_pred             hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHH
Confidence            75555666542         3 3477788889999999

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=9e-30  Score=204.91  Aligned_cols=176  Identities=24%  Similarity=0.355  Sum_probs=138.1

Q ss_pred             eeeeccccceEEEEEEec--CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           30 NELLGSGAVKKVYRAFDQ--EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        30 ~~~ig~g~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      +++||+|+||.||+|.+.  .+++.+|+|.++....      ...+.+|+.++++++||||+++++.+.......+++++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence            468999999999999865  4678999998864321      23466899999999999999999998776677889999


Q ss_pred             ccccCCChHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEe---CCCCcEEEecc
Q 027788          108 EVCTSGNLREYRKKH---------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN---GNTGQVKIGDL  175 (219)
Q Consensus       108 e~~~~g~L~~~~~~~---------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~---~~~~~~~l~df  175 (219)
                      |+++ ++|.+++...         ..+++..+..++.|++.|+.|||+++  ++||||||+||+++   ...+.+||+||
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            9996 5777765422         24788999999999999999999999  99999999999994   23357999999


Q ss_pred             ccceeccccce---------eeeecccCccccCCCccccccceeeecc
Q 027788          176 GVAAIVGRAIR---------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       176 g~a~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      |+++.......         ++..+.+|+.+.....++.++|+||+|+
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  204 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC  204 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHH
Confidence            99987644321         1223444544545566778899999993

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=8.1e-30  Score=207.45  Aligned_cols=183  Identities=27%  Similarity=0.382  Sum_probs=145.0

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC---
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED---   99 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~---   99 (219)
                      ..+| .+.+.||+|+||.||+|.+..++..||+|.+.....  .....+.+.+|+.+++.++|+||+++++++....   
T Consensus        14 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          14 PERY-QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ--SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhh-hhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh--hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            3455 677999999999999999999999999998874322  2234466778999999999999999988774322   


Q ss_pred             -CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          100 -RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       100 -~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                       ....+++++++ +++|..++. ...+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||++
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~-~~~kl~Dfg~~  165 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNED-CELRILDFGLA  165 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCC-CCEEEcCCccc
Confidence             23467899988 678887765 346999999999999999999999999  9999999999999865 58999999999


Q ss_pred             eeccccce---eeeecccCccccCCCccccccceeeec
Q 027788          179 AIVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       179 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ........   ++..+.+|+.+.....++.++||||+|
T Consensus       166 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  203 (343)
T cd07878         166 RQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG  203 (343)
T ss_pred             eecCCCcCCccccccccCchHhcCCccCCchhhhHhHH
Confidence            87654322   223344444444445677789999999

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.97  E-value=1.7e-29  Score=198.46  Aligned_cols=183  Identities=25%  Similarity=0.399  Sum_probs=147.3

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      .+..+| .+.+.||+|+||.||+|.+..+++.+|+|.+....    ......+.+|+.++++++|||++++++.+..  .
T Consensus         6 ~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--~   78 (267)
T cd06646           6 NPQHDY-ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLS--R   78 (267)
T ss_pred             Cchhhc-chhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEe--C
Confidence            344455 78899999999999999999999999999987442    2233567889999999999999999998854  3


Q ss_pred             ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          101 NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      +.++++|||+++++|.+++.....+++..+..++.|++.++.|||+.+  ++|+||+|+|++++.+ +.++|+|||++..
T Consensus        79 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~-~~~~l~dfg~~~~  155 (267)
T cd06646          79 EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDN-GDVKLADFGVAAK  155 (267)
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CCEEECcCcccee
Confidence            568889999999999998877778899999999999999999999999  9999999999999855 5899999999987


Q ss_pred             ccccce------eeeecccCcccc--CCCccccccceeeec
Q 027788          181 VGRAIR------RIRCWGRRSSWR--RSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~------~~~~~~~~~~~~--~~~~~~~~~diws~g  213 (219)
                      ......      ++..+.+|+...  ....++.++|+||+|
T Consensus       156 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G  196 (267)
T cd06646         156 ITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVG  196 (267)
T ss_pred             ecccccccCccccCccccCHhHcccccCCCCcchhhHHHHH
Confidence            643321      112233333221  233456679999999

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.7e-29  Score=196.32  Aligned_cols=183  Identities=25%  Similarity=0.468  Sum_probs=149.0

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeeccc-CCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF-CDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      |++.+.||+|+||.||+|.+..++..+++|.+..... .........+.+|++++++++|+|++++++.+.......+++
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (264)
T cd06653           4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI   83 (264)
T ss_pred             eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence            4788999999999999999999999999998754321 113345578889999999999999999999887666677889


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ++|++++++|.+++.....+++.....++.|++.++.+||+++  ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        84 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          84 FVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEECcccccccccccc
Confidence            9999999999998877667899999999999999999999999  9999999999999865 589999999998654321


Q ss_pred             e---------eeeecccCccccCCCccccccceeeec
Q 027788          186 R---------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~---------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .         ++..+ .+++.......+.++|+||+|
T Consensus       161 ~~~~~~~~~~~~~~y-~aPE~~~~~~~~~~~Di~slG  196 (264)
T cd06653         161 MSGTGIKSVTGTPYW-MSPEVISGEGYGRKADVWSVA  196 (264)
T ss_pred             ccCccccccCCcccc-cCHhhhcCCCCCccccHHHHH
Confidence            1         11112 233444455567789999999

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=2.3e-29  Score=206.42  Aligned_cols=183  Identities=25%  Similarity=0.337  Sum_probs=144.7

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC--
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED--   99 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~--   99 (219)
                      ..++| ++.+.||+|+||.||+|++..+++.||+|.+.....  .....+.+.+|+.+++.++||||+++++++...+  
T Consensus        22 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~   98 (364)
T cd07875          22 VLKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL   98 (364)
T ss_pred             hhcce-eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc--CchhHHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence            34565 788999999999999999999999999999875432  3344567889999999999999999998875432  


Q ss_pred             --CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788          100 --RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus       100 --~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                        ...++++|||+++ +|...+..  .++...+..++.|++.||.|||+++  ++||||||+||+++.+ +.++|+|||+
T Consensus        99 ~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~  172 (364)
T cd07875          99 EEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL  172 (364)
T ss_pred             cccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCC-CcEEEEeCCC
Confidence              2357899999974 67666643  4788899999999999999999999  9999999999999866 5899999999


Q ss_pred             ceeccccce-----eeeecccCccccCCCccccccceeeecc
Q 027788          178 AAIVGRAIR-----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ++.......     ++..+.+ ++......++.++|+||+|+
T Consensus       173 a~~~~~~~~~~~~~~t~~y~a-PE~~~~~~~~~~~DiwSlG~  213 (364)
T cd07875         173 ARTAGTSFMMTPYVVTRYYRA-PEVILGMGYKENVDIWSVGC  213 (364)
T ss_pred             ccccCCCCcccCCcccCCcCC-HHHHhCCCCCchhhHHhHHH
Confidence            987644322     1222233 34445566788899999993

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.97  E-value=4.4e-29  Score=198.22  Aligned_cols=180  Identities=18%  Similarity=0.292  Sum_probs=144.3

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      +..+.||+|+||.||+|.+..+++.+|+|.+...... .......+.+|+.++++++|++++.+.+.+..  .+.++++|
T Consensus         3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~   79 (285)
T cd05630           3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVL   79 (285)
T ss_pred             eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-chHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEEE
Confidence            5668899999999999999999999999998754332 22333567789999999999999999988854  45688999


Q ss_pred             ccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          108 EVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       108 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ||+++++|.+++...  ..+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+ +.++|+|||++.......
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCC-CCEEEeeccceeecCCCc
Confidence            999999999887543  35889999999999999999999999  9999999999999865 589999999997654332


Q ss_pred             e-----eeeecccCccccCCCccccccceeeecc
Q 027788          186 R-----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       186 ~-----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .     ++..+.+| +......++.++|+||+|+
T Consensus       157 ~~~~~~g~~~y~aP-E~~~~~~~~~~~DiwslG~  189 (285)
T cd05630         157 TIKGRVGTVGYMAP-EVVKNERYTFSPDWWALGC  189 (285)
T ss_pred             cccCCCCCccccCh-HHHcCCCCCCccccHHHHH
Confidence            2     11222233 3444556788899999993

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=1.3e-29  Score=199.06  Aligned_cols=182  Identities=24%  Similarity=0.398  Sum_probs=147.2

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      ..+| .+.+.||+|+||.||+|.+..+++.+|+|.++...    ......+.+|+.+++.++|||++++++.+..  .+.
T Consensus         8 ~~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~   80 (267)
T cd06645           8 QEDF-ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDK   80 (267)
T ss_pred             HHHH-HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCE
Confidence            3455 77789999999999999999999999999987542    2334567889999999999999999998854  456


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +++++||+++++|.+++...+.+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~  157 (267)
T cd06645          81 LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDN-GHVKLADFGVSAQIT  157 (267)
T ss_pred             EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEECcceeeeEcc
Confidence            8889999999999999887778999999999999999999999999  9999999999999855 589999999987654


Q ss_pred             ccce------eeeecccCcccc--CCCccccccceeeecc
Q 027788          183 RAIR------RIRCWGRRSSWR--RSCTMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~------~~~~~~~~~~~~--~~~~~~~~~diws~gi  214 (219)
                      ....      ++..+.+|+...  ....++.++|+||+|+
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~  197 (267)
T cd06645         158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGI  197 (267)
T ss_pred             CcccccccccCcccccChhhhccccCCCCCchhhhHHHHH
Confidence            3221      112233333221  2344667899999993

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=5.3e-29  Score=197.75  Aligned_cols=180  Identities=17%  Similarity=0.290  Sum_probs=144.1

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      +..+.||+|+||.||.|.+..+++.+|+|.+...... .......+.+|+++++.++|+|++.+.+.+..  .+.++++|
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~   79 (285)
T cd05632           3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-KRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLVL   79 (285)
T ss_pred             eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEEE
Confidence            4558899999999999999999999999998754322 22334557789999999999999999888844  45688999


Q ss_pred             ccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          108 EVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       108 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ||+++++|..++...  ..+++..+..++.|++.++.|||+.+  ++|+||+|+|++++.+ +.++|+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCC-CCEEEecCCcceecCCCC
Confidence            999999998877543  36899999999999999999999999  9999999999999865 589999999997654322


Q ss_pred             e-----eeeecccCccccCCCccccccceeeecc
Q 027788          186 R-----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       186 ~-----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .     ++..+.+| +......++.++|+||+|+
T Consensus       157 ~~~~~~g~~~~~aP-E~~~~~~~~~~~Di~slG~  189 (285)
T cd05632         157 SIRGRVGTVGYMAP-EVLNNQRYTLSPDYWGLGC  189 (285)
T ss_pred             cccCCCCCcCccCh-HHhcCCCCCcccchHHHHH
Confidence            2     11222233 3444566788899999993

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.97  E-value=2.3e-29  Score=221.57  Aligned_cols=182  Identities=20%  Similarity=0.303  Sum_probs=144.4

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++| .+.++||+|+||.||+|++..+++.||+|.+..... ......+++.+|+.++++++|||++++++++..  .+..
T Consensus         2 grY-eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~l   77 (932)
T PRK13184          2 QRY-DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-ENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPV   77 (932)
T ss_pred             CCe-EEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEE
Confidence            455 788999999999999999999999999999875332 234556789999999999999999999998844  4568


Q ss_pred             EEEeccccCCChHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEE
Q 027788          104 NFITEVCTSGNLREYRKKH-----------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKI  172 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~-----------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l  172 (219)
                      +++|||+++++|.+++...           ...+...+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.++|
T Consensus        78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~d-g~vKL  154 (932)
T PRK13184         78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLF-GEVVI  154 (932)
T ss_pred             EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCC-CCEEE
Confidence            8999999999999887531           13456678889999999999999999  9999999999999865 68999


Q ss_pred             eccccceeccccce------------------------eeeecccCccccCCCccccccceeeec
Q 027788          173 GDLGVAAIVGRAIR------------------------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       173 ~dfg~a~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +|||+++.......                        ++..+.+| +......++.++|+||+|
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAP-E~l~g~~~S~kSDIWSLG  218 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP-ERLLGVPASESTDIYALG  218 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCH-HHhcCCCCCcHhHHHHHH
Confidence            99999987622110                        11112222 234455577789999999

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-30  Score=185.17  Aligned_cols=178  Identities=29%  Similarity=0.525  Sum_probs=147.3

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC  110 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  110 (219)
                      ++||+|.||+||+|++..+++.||+|.+.....  ++......++||-+++.++|.||++++++...+++  +-+|.|+|
T Consensus         8 ekigegtygtvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelkhknivrl~dvlhsdkk--ltlvfe~c   83 (292)
T KOG0662|consen    8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK--LTLVFEFC   83 (292)
T ss_pred             HhhcCCcceeeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCce--eEEeHHHh
Confidence            689999999999999999999999999876543  44444667889999999999999999999866554  77799999


Q ss_pred             cCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccceee-
Q 027788          111 TSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRI-  188 (219)
Q Consensus       111 ~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~~-  188 (219)
                      . .+|..+..+ .+.++.+.+..++.|++.|+.++|+++  ++||||||.|++++.+ |.+|++|||+++.++.+...- 
T Consensus        84 d-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~n-gelkladfglarafgipvrcys  159 (292)
T KOG0662|consen   84 D-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVRCYS  159 (292)
T ss_pred             h-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccC-CcEEecccchhhhcCCceEeee
Confidence            6 588887754 467999999999999999999999999  9999999999999977 689999999999888776421 


Q ss_pred             ----eecccCc-cccCCCccccccceeeec-ccc
Q 027788          189 ----RCWGRRS-SWRRSCTMRITRSLWTYT-RLG  216 (219)
Q Consensus       189 ----~~~~~~~-~~~~~~~~~~~~diws~g-i~~  216 (219)
                          +.|.+|+ -......|+.+-|+||-| |+|
T Consensus       160 aevvtlwyrppdvlfgakly~tsidmwsagcifa  193 (292)
T KOG0662|consen  160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFA  193 (292)
T ss_pred             ceeeeeeccCcceeeeeehhccchHhhhcchHHH
Confidence                1233333 234555688889999999 654

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.97  E-value=2.5e-29  Score=199.19  Aligned_cols=180  Identities=26%  Similarity=0.402  Sum_probs=146.4

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||+|++|.||+|.+..+++.||+|.+.....  .....+.+.+|+.+++.++|+|++++++.+..  ...++++
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v   78 (286)
T cd07847           3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLV   78 (286)
T ss_pred             eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEE
Confidence            4677899999999999999999999999999875432  22233567889999999999999999999854  4568889


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      |||+++++|..++.....+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++|+|||++........
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCC-CcEEECccccceecCCCcc
Confidence            999998888877766667999999999999999999999999  9999999999999865 5899999999987755431


Q ss_pred             ------eeeecccCccccCCCccccccceeeec
Q 027788          187 ------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                            ....+.+|+.......++.++|+||+|
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG  188 (286)
T cd07847         156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIG  188 (286)
T ss_pred             cccCcccccccCCHHHHhCCCCcCchhhhHHHH
Confidence                  222334444433334567789999999

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=4.1e-29  Score=198.76  Aligned_cols=180  Identities=19%  Similarity=0.296  Sum_probs=148.2

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||+|++|.||++.+..+++.+|+|.++..... .....+.+.+|++++++++||||+++++++..  ...++++
T Consensus         3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v   79 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYLV   79 (290)
T ss_pred             eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEEE
Confidence            46779999999999999999999999999998754321 23455778899999999999999999998854  4568899


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      |||+++++|.+++.....++...+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++........
T Consensus        80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~~~  156 (290)
T cd05580          80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGRTY  156 (290)
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCC-CCEEEeeCCCccccCCCCC
Confidence            999999999999887778999999999999999999999999  9999999999999865 6899999999987654421


Q ss_pred             ---eeeecccCccccCCCccccccceeeec
Q 027788          187 ---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                         ++..+.+|+ .......+.++|+||+|
T Consensus       157 ~~~~~~~y~aPE-~~~~~~~~~~~Di~slG  185 (290)
T cd05580         157 TLCGTPEYLAPE-IILSKGYGKAVDWWALG  185 (290)
T ss_pred             CCCCCccccChh-hhcCCCCCccccHHHHH
Confidence               112233333 33344566779999999

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.96  E-value=1.7e-29  Score=197.98  Aligned_cols=181  Identities=24%  Similarity=0.389  Sum_probs=141.0

Q ss_pred             eeeeeeccccceEEEEEEec----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           28 RYNELLGSGAVKKVYRAFDQ----EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++.+.||.|.||.||+|...    ..+..|+||.++...   .....+.+.+|++.+++++||||+++++++...+  .+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~--~~   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS---SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE--PL   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS---SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS--SE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc---ccccceeeeecccccccccccccccccccccccc--cc
Confidence            46789999999999999876    456789999986432   4455788999999999999999999999997433  37


Q ss_pred             EEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          104 NFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      ++++||+++|+|.+++...  ..++...+..++.|++.|+.|||+.+  ++|++|+++||+++.+ +.+||+|||++...
T Consensus        77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~  153 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSN-GQVKLSDFGLSRPI  153 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETT-TEEEEESTTTGEET
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccc-cccccccccccccc
Confidence            8899999999999998775  67899999999999999999999999  9999999999999966 58999999999887


Q ss_pred             cccce--------eeeecccCccccCCCccccccceeeec--cccc
Q 027788          182 GRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT--RLGC  217 (219)
Q Consensus       182 ~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g--i~~~  217 (219)
                      .....        ....+.+| +......++.++||||||  +|.+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~aP-E~~~~~~~~~ksDVysfG~~l~ei  198 (259)
T PF07714_consen  154 SEKSKYKNDSSQQLPLRYLAP-EVLKDGEYTKKSDVYSFGMLLYEI  198 (259)
T ss_dssp             TTSSSEEESTTSESGGGGS-H-HHHHHSEESHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccc-cccccccccccccccccccccccc
Confidence            32211        11112222 222334477889999999  5443

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.96  E-value=3.6e-29  Score=207.27  Aligned_cols=178  Identities=25%  Similarity=0.370  Sum_probs=139.1

Q ss_pred             eeeeeeeccccceEEEEEEecCC-----CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCC
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEE-----GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDR  100 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~  100 (219)
                      +.+.++||+|+||.||+|++...     +..||+|.++...   .....+.+.+|+.+++++. ||||+++++++..  .
T Consensus        39 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~--~  113 (400)
T cd05105          39 LVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA---RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK--S  113 (400)
T ss_pred             eehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--C
Confidence            37889999999999999986433     3479999886442   3344577899999999996 9999999999954  4


Q ss_pred             ceEEEEeccccCCChHHHHHhC----------------------------------------------------------
Q 027788          101 NTLNFITEVCTSGNLREYRKKH----------------------------------------------------------  122 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~----------------------------------------------------------  122 (219)
                      ..++++|||+++|+|.+++...                                                          
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            5688999999999998876432                                                          


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEe
Q 027788          123 --------------------------------------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN  164 (219)
Q Consensus       123 --------------------------------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~  164 (219)
                                                            ..+++..+..++.|++.|+.|||..+  ++|+||||+||+++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~  271 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEe
Confidence                                                  13567778899999999999999999  99999999999998


Q ss_pred             CCCCcEEEeccccceeccccceee--------eecccCccccCCCccccccceeeec
Q 027788          165 GNTGQVKIGDLGVAAIVGRAIRRI--------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       165 ~~~~~~~l~dfg~a~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .+ +.++|+|||+++.........        ..+.+|+ ......++.++|+||||
T Consensus       272 ~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~DiwSlG  326 (400)
T cd05105         272 QG-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE-SIFDNLYTTLSDVWSYG  326 (400)
T ss_pred             CC-CEEEEEeCCcceeccccccccccCCcCCCcceEChh-hhcCCCCCchhhHHHHH
Confidence            65 589999999998764332110        1123333 33445577789999999

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.96  E-value=8e-29  Score=193.18  Aligned_cols=179  Identities=24%  Similarity=0.387  Sum_probs=147.4

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.+.||+|++|.||+|....+++.+++|.+.....  .......+..|+.+++.++|||++++++.+..  ....+++|
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~   78 (256)
T cd08529           3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIVM   78 (256)
T ss_pred             eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEEE
Confidence            567899999999999999999999999999875543  34556788899999999999999999998854  45688999


Q ss_pred             ccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          108 EVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       108 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ||+++++|.+++...  ..++...+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++++|||++.......
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCC-CCEEEcccccceeccCcc
Confidence            999999999988653  56889999999999999999999999  9999999999999866 589999999998765543


Q ss_pred             eee-----eecccCccccCCCccccccceeeec
Q 027788          186 RRI-----RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~~~-----~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...     .....++++.....++.++|+||+|
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  188 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALG  188 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHH
Confidence            211     1112233445555677789999999

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.96  E-value=2.8e-29  Score=197.16  Aligned_cols=182  Identities=23%  Similarity=0.366  Sum_probs=147.9

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccC--CCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC--DDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      |+..+.||+|++|.||.+.+..++..+|+|.+......  ......+.+..|+.++++++|+|++++++.+.  +.+.++
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~   79 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC--EDSHFN   79 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec--cCCeEE
Confidence            36678999999999999999999999999998743321  12234578899999999999999999999984  445688


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      +++|++++++|.+++.....+++..+..++.|++.|+.+||+.+  ++|+||+|+||+++.+...++|+|||.+......
T Consensus        80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            89999999999999887778999999999999999999999999  9999999999999866446899999999877554


Q ss_pred             cee----------eeecccCccccCCCccccccceeeec
Q 027788          185 IRR----------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~~----------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...          +..+..| +......++.++|+||+|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~P-E~~~~~~~~~~~Dv~slG  195 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAP-EVLRGEQYGRSCDVWSVG  195 (268)
T ss_pred             cccCCccccccccccceeCH-hHhccCCCCcccchHHHH
Confidence            221          1122233 333445677889999999

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.96  E-value=6.6e-30  Score=209.80  Aligned_cols=185  Identities=22%  Similarity=0.317  Sum_probs=149.3

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .....+.++||+|-||.|.+|+- ..+..||+|.++...   .......|+.|+++|.+|+||||++++++|...+.  +
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a---~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP--i  610 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA---TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP--L  610 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCccc---chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc--h
Confidence            44457888999999999999984 446899999988553   33445889999999999999999999999976554  8


Q ss_pred             EEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          104 NFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      ++++||+++|+|.+++..+  +.........++.||++|++||.+.+  ++||||.+.|+|++.+. ++||+|||+++.+
T Consensus       611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~-~iKiadfgmsR~l  687 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEF-TIKIADFGMSRNL  687 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcc-cEEecCccccccc
Confidence            8899999999999999877  34455667779999999999999999  99999999999999874 8999999999977


Q ss_pred             cccceeee--ecccCcccc-----CCCccccccceeeec--cccc
Q 027788          182 GRAIRRIR--CWGRRSSWR-----RSCTMRITRSLWTYT--RLGC  217 (219)
Q Consensus       182 ~~~~~~~~--~~~~~~~~~-----~~~~~~~~~diws~g--i~~~  217 (219)
                      -+......  ...-|-.|+     -...++++||+|++|  +|.+
T Consensus       688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~  732 (807)
T KOG1094|consen  688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEV  732 (807)
T ss_pred             ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHH
Confidence            66543111  111233342     356688899999999  7764

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.96  E-value=3.2e-29  Score=204.86  Aligned_cols=183  Identities=25%  Similarity=0.343  Sum_probs=145.1

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC--
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED--   99 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~--   99 (219)
                      ..++| ++.+.||+|+||.||+|.+..+++.+|+|.+.....  .......+.+|+.+++.++||||+++++++....  
T Consensus        15 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   91 (355)
T cd07874          15 VLKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhce-eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc--ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence            34566 777999999999999999999999999998874432  3444577888999999999999999999885432  


Q ss_pred             --CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788          100 --RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus       100 --~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                        ...++++||++++ ++.+.+..  .++...+..++.|++.||.|||+++  ++||||||+||+++.+ +.++|+|||+
T Consensus        92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~-~~~kl~Dfg~  165 (355)
T cd07874          92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL  165 (355)
T ss_pred             cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCC-CCEEEeeCcc
Confidence              2357899999974 66665543  5788999999999999999999999  9999999999999866 5899999999


Q ss_pred             ceeccccce-----eeeecccCccccCCCccccccceeeecc
Q 027788          178 AAIVGRAIR-----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ++.......     ++..+.+| +......++.++|+||+|+
T Consensus       166 ~~~~~~~~~~~~~~~t~~y~aP-E~~~~~~~~~~~DiwslG~  206 (355)
T cd07874         166 ARTAGTSFMMTPYVVTRYYRAP-EVILGMGYKENVDIWSVGC  206 (355)
T ss_pred             cccCCCccccCCccccCCccCH-HHHcCCCCCchhhHHHHHH
Confidence            987644322     22223333 3445566788899999993

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.96  E-value=4.3e-29  Score=198.17  Aligned_cols=181  Identities=28%  Similarity=0.395  Sum_probs=139.7

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh---CCCCceEEEEEEecC---CC
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL---ANKNIISLHYVWRDE---DR  100 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~~~~i~~~~~~~~~~---~~  100 (219)
                      |.+.+.||+|+||.||+|.+..+++.||+|.++.....  ......+.+|+.+++.+   +||||+++++++...   ..
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE--DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC--CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            36779999999999999999999999999998764322  11123345677777655   799999999887532   23


Q ss_pred             ceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          101 NTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      ..+++++|+++ ++|.+++...  ..+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+ +.++|+|||++
T Consensus        80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~-~~~kl~dfg~~  155 (288)
T cd07863          80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG-GQVKLADFGLA  155 (288)
T ss_pred             ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECccCcc
Confidence            56789999997 5888777643  34899999999999999999999999  9999999999999865 58999999999


Q ss_pred             eeccccce-----eeeecccCccccCCCccccccceeeecc
Q 027788          179 AIVGRAIR-----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       179 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ........     ++..+.+|+ ......++.++|+||+|+
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~DiwslG~  195 (288)
T cd07863         156 RIYSCQMALTPVVVTLWYRAPE-VLLQSTYATPVDMWSVGC  195 (288)
T ss_pred             ccccCcccCCCccccccccCch-HhhCCCCCCcchhhhHHH
Confidence            87654322     122233343 334556788899999993

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.96  E-value=9.8e-29  Score=194.15  Aligned_cols=183  Identities=26%  Similarity=0.463  Sum_probs=148.3

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccC-CCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC-DDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      |.+.+.||+|+||.||+|.+..++..+++|.+...... ........+.+|+.+++.++|||++++++.+.......+++
T Consensus         4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   83 (266)
T cd06651           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI   83 (266)
T ss_pred             ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence            36778999999999999999999999999988754321 12344567889999999999999999999887655677889


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ++|++++++|.+++.....+++.....++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        84 ~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          84 FMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEccCCCcccccccc
Confidence            9999999999998887777899999999999999999999999  9999999999999865 589999999997654321


Q ss_pred             e---------eeeecccCccccCCCccccccceeeec
Q 027788          186 R---------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~---------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .         ....+.+| +......++.++|+||+|
T Consensus       161 ~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Dv~slG  196 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSP-EVISGEGYGRKADVWSLG  196 (266)
T ss_pred             ccCCccccCCccccccCH-HHhCCCCCCchhhhHHHH
Confidence            1         11112233 333445567789999999

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.96  E-value=3.3e-29  Score=200.34  Aligned_cols=180  Identities=25%  Similarity=0.403  Sum_probs=144.1

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+| .+.+.||+|+||.||+|.+..++..||+|.++....   ......+.+|+.+++.++||||+++++++.  ..+.+
T Consensus         6 ~~y-~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~--~~~~~   79 (301)
T cd07873           6 ETY-IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIH--TEKSL   79 (301)
T ss_pred             cce-EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc---cCchhHHHHHHHHHHhcCCCCcceEEEEEe--cCCeE
Confidence            344 677999999999999999999999999999875432   222345678999999999999999999985  44568


Q ss_pred             EEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          104 NFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +++|||++ ++|.+++.. ...+++..+..++.|++.|+.+||+.+  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~  155 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINER-GELKLADFGLARAKS  155 (301)
T ss_pred             EEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCC-CcEEECcCcchhccC
Confidence            89999997 588877654 346889999999999999999999999  9999999999999865 589999999997654


Q ss_pred             ccce------eeeecccCccccCCCccccccceeeec
Q 027788          183 RAIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ....      .+..+.+|+.+.....++.++|+||+|
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG  192 (301)
T cd07873         156 IPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVG  192 (301)
T ss_pred             CCCCcccccceeecccCcHHHhCCCCCccHHHHHHHH
Confidence            3221      222334444444455677789999999

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.96  E-value=8.9e-29  Score=196.94  Aligned_cols=182  Identities=24%  Similarity=0.434  Sum_probs=146.7

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      +.++| ++.+.||+|+||.||+|.+..++..+++|.+...    .....+.+..|+.+++.++|+|++++.+.+..+  .
T Consensus        10 ~~~~y-~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~   82 (292)
T cd06644          10 PNEVW-EIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD--G   82 (292)
T ss_pred             cchhh-hhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC--C
Confidence            44455 8889999999999999999999999999998744    455567888999999999999999999988544  4


Q ss_pred             eEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          102 TLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      .++++|||+++++|..++.. ...+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~dfg~~~~  159 (292)
T cd06644          83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLD-GDIKLADFGVSAK  159 (292)
T ss_pred             eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCC-CCEEEccCcccee
Confidence            68889999999999877643 456899999999999999999999999  9999999999999855 6899999999876


Q ss_pred             ccccce------eeeecccCcccc----CCCccccccceeeec
Q 027788          181 VGRAIR------RIRCWGRRSSWR----RSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~------~~~~~~~~~~~~----~~~~~~~~~diws~g  213 (219)
                      ......      ....+.+|+...    ....++.++|+||+|
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG  202 (292)
T cd06644         160 NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG  202 (292)
T ss_pred             ccccccccceecCCccccCceeeccccccCCCCCchhhhHhHH
Confidence            533221      112233443332    234456679999999

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=222.09  Aligned_cols=186  Identities=22%  Similarity=0.335  Sum_probs=148.2

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCc-----EEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGI-----EVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      -....++..||+|.||.||.|.......     .||+|.++...   +......|++|..++++++||||+++++++..+
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~---~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS---SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS  767 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence            3444677899999999999998764433     38888776443   567779999999999999999999999999875


Q ss_pred             CCceEEEEeccccCCChHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEE
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKH-------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVK  171 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~-------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~  171 (219)
                      ..  .++++|||++|+|.++++..       ..++....+.++.+|+.|+.||+++.  ++||||..+|+|++.. ..+|
T Consensus       768 ~~--~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~-r~VK  842 (1025)
T KOG1095|consen  768 GP--PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDER-RVVK  842 (1025)
T ss_pred             CC--cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeeccc-CcEE
Confidence            54  55699999999999999765       24788899999999999999999999  9999999999999966 4899


Q ss_pred             Eeccccceeccccce-eeeec-ccCcccc-----CCCccccccceeeec--cccc
Q 027788          172 IGDLGVAAIVGRAIR-RIRCW-GRRSSWR-----RSCTMRITRSLWTYT--RLGC  217 (219)
Q Consensus       172 l~dfg~a~~~~~~~~-~~~~~-~~~~~~~-----~~~~~~~~~diws~g--i~~~  217 (219)
                      |+|||+|+.+....- +.... .-|..|+     ...-++.++||||||  +|.+
T Consensus       843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEi  897 (1025)
T KOG1095|consen  843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEI  897 (1025)
T ss_pred             EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHH
Confidence            999999995543332 11111 1233443     346788999999999  6654

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.96  E-value=1.3e-28  Score=193.71  Aligned_cols=179  Identities=23%  Similarity=0.350  Sum_probs=144.6

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCc---EEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGI---EVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      .+++.+.||+|+||.||+|....+++   .||+|.++...   .....+.+..|+.+++.++|||++++++.+..  ...
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~   79 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SRP   79 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--CCc
Confidence            35899999999999999999876664   59999887442   35556789999999999999999999998844  455


Q ss_pred             EEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          103 LNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      .+++|||+++++|.+++.. .+.++...+..++.|++.|+.+||+++  ++|+||+|+|++++.+ +.++++|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~-~~~kl~dfg~~~~~  156 (269)
T cd05065          80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRFL  156 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCC-CcEEECCCcccccc
Confidence            7889999999999998865 356889999999999999999999999  9999999999999865 58999999998765


Q ss_pred             ccccee---e--------eecccCccccCCCccccccceeeec
Q 027788          182 GRAIRR---I--------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~~---~--------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ......   .        ..+.+ ++......++.++|+||+|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~-PE~~~~~~~~~~~DvwslG  198 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTA-PEAIAYRKFTSASDVWSYG  198 (269)
T ss_pred             ccCccccccccccCCCcceeecC-HhHhccCcccchhhhhhhH
Confidence            432210   0        01223 3444556677789999999

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.96  E-value=4.5e-29  Score=200.71  Aligned_cols=176  Identities=24%  Similarity=0.360  Sum_probs=137.3

Q ss_pred             eeeeeccccceEEEEEEec--CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           29 YNELLGSGAVKKVYRAFDQ--EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        29 ~~~~ig~g~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      .+.+||+|+||.||+|+..  .++..+|+|.+....      ....+.+|+.++++++|||++++++++.......++++
T Consensus         5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv   78 (317)
T cd07867           5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL   78 (317)
T ss_pred             eceEeccCCCeeEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence            3468999999999999864  356889999876332      12346789999999999999999999877677788999


Q ss_pred             eccccCCChHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEe---CCCCcEEEec
Q 027788          107 TEVCTSGNLREYRKKH---------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN---GNTGQVKIGD  174 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~---------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~---~~~~~~~l~d  174 (219)
                      +||++ ++|.+++...         ..+++..+..++.|++.||.|||+.+  ++||||||+||++.   .+.+.++|+|
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~D  155 (317)
T cd07867          79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIAD  155 (317)
T ss_pred             EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEee
Confidence            99996 4776665321         24788889999999999999999999  99999999999994   2335799999


Q ss_pred             cccceeccccce---------eeeecccCccccCCCccccccceeeec
Q 027788          175 LGVAAIVGRAIR---------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       175 fg~a~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ||+++.......         .+..+.+|+.+.....++.++|+||+|
T Consensus       156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG  203 (317)
T cd07867         156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG  203 (317)
T ss_pred             ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHH
Confidence            999987644321         122344555454556677889999999

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.96  E-value=4.1e-29  Score=197.91  Aligned_cols=179  Identities=25%  Similarity=0.420  Sum_probs=143.4

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      ++.+.||+|++|.||+|++..++..||+|.+.....  +......+.+|+.+++.++|||++++++.+..  +..++++|
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~   78 (285)
T cd07861           3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF   78 (285)
T ss_pred             eEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence            677899999999999999999999999999875432  22233667789999999999999999999854  45688999


Q ss_pred             ccccCCChHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          108 EVCTSGNLREYRKKH---RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       108 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      ||++ ++|.+++...   ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIP  154 (285)
T ss_pred             ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCC-CcEEECcccceeecCCC
Confidence            9997 6887776532   45889999999999999999999999  9999999999999865 68999999999765433


Q ss_pred             ce------eeeecccCccccCCCccccccceeeecc
Q 027788          185 IR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       185 ~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ..      .+..+.+|+.......++.++|+||+|+
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~  190 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGT  190 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHH
Confidence            21      1223344444444555677899999993

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.96  E-value=9.7e-29  Score=197.91  Aligned_cols=178  Identities=24%  Similarity=0.407  Sum_probs=138.3

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcE--EEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIE--VAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~  103 (219)
                      +.+.+.||+|+||.||+|.+..++..  +++|.++..   ........+.+|++++.++ +|+|++++++++..  .+.+
T Consensus         9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~~   83 (303)
T cd05088           9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYL   83 (303)
T ss_pred             ceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc---CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCCc
Confidence            47889999999999999998777765  466654422   1334457788999999999 89999999999844  4568


Q ss_pred             EEEeccccCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC
Q 027788          104 NFITEVCTSGNLREYRKKHR----------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT  167 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~----------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~  167 (219)
                      +++|||+++++|.+++....                .+++..+..++.|++.|+.|||+.+  ++|+||||+|++++.+ 
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~-  160 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN-  160 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCC-
Confidence            88999999999999886432                4678899999999999999999999  9999999999999866 


Q ss_pred             CcEEEeccccceeccccceee-----eecccCccccCCCccccccceeeec
Q 027788          168 GQVKIGDLGVAAIVGRAIRRI-----RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       168 ~~~~l~dfg~a~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +.++|+|||++..........     ..+.+| +......++.++|+||+|
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  210 (303)
T cd05088         161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI-ESLNYSVYTTNSDVWSYG  210 (303)
T ss_pred             CcEEeCccccCcccchhhhcccCCCcccccCH-HHHhccCCcccccchhhh
Confidence            589999999986432211111     112233 333445567789999999

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3.7e-29  Score=197.87  Aligned_cols=181  Identities=26%  Similarity=0.458  Sum_probs=147.3

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      ..+| .+.+.||+|++|.||++....++..+++|.+...    .....+.+..|++++++++|+|++++++.+..  ...
T Consensus         4 ~~~~-~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~   76 (280)
T cd06611           4 NDIW-EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFY--ENK   76 (280)
T ss_pred             hhHH-HHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--CCe
Confidence            3444 7778999999999999999889999999998754    45556788899999999999999999999854  456


Q ss_pred             EEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          103 LNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      ++++|||+++++|..++... ..+++..+..++.|++.++.|||+.+  ++|+||+|+|++++.+ +.++|+|||++...
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~-~~~~l~d~g~~~~~  153 (280)
T cd06611          77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLD-GDVKLADFGVSAKN  153 (280)
T ss_pred             EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCC-CCEEEccCccchhh
Confidence            88999999999999988653 46899999999999999999999999  9999999999999865 58999999988765


Q ss_pred             cccce------eeeecccCcccc----CCCccccccceeeec
Q 027788          182 GRAIR------RIRCWGRRSSWR----RSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~------~~~~~~~~~~~~----~~~~~~~~~diws~g  213 (219)
                      .....      ++..+.+|+...    ....++.++|+||+|
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG  195 (280)
T cd06611         154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLG  195 (280)
T ss_pred             cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHH
Confidence            44322      122233333221    233456679999999

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.96  E-value=1.1e-28  Score=194.01  Aligned_cols=179  Identities=23%  Similarity=0.364  Sum_probs=143.2

Q ss_pred             eeeeeeeeccccceEEEEEEecCCC---cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEG---IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      .+++.+.||+|+||.||+|+...++   ..+|+|.++...   .....+.+.+|+.+++.++|||++++++++..  .+.
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~   79 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKP   79 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCc
Confidence            3488899999999999999876444   368999876432   34456788999999999999999999998853  456


Q ss_pred             EEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          103 LNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      ++++||++++++|.+++... ..++...+..++.|++.++.+||+.+  ++|+||+|+|++++.+ +.++++|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~-~~~~l~dfg~~~~~  156 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSN-LVCKVSDFGLSRVL  156 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCC-CeEEeCCCCccccc
Confidence            88899999999999988754 46789999999999999999999999  9999999999999865 58999999999876


Q ss_pred             cccceee---------eecccCccccCCCccccccceeeec
Q 027788          182 GRAIRRI---------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .......         ..+.+ ++......++.++|+||+|
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~-pe~~~~~~~~~~~Dv~slG  196 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTA-PEAIAYRKFTSASDVWSYG  196 (267)
T ss_pred             ccccceeeecCCCccceeecC-HhHhccCccCchhhhHHHH
Confidence            5432211         11222 2334445677789999999

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.96  E-value=7e-29  Score=197.38  Aligned_cols=180  Identities=24%  Similarity=0.376  Sum_probs=139.9

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+| ++.+.||+|+||.||+|.+..++..+++|.+.....   ......+.+|+.+++.++|+|++++.+++..  ....
T Consensus         5 ~~y-~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~   78 (291)
T cd07870           5 TSY-LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDIIHT--KETL   78 (291)
T ss_pred             cee-EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeE
Confidence            445 788999999999999999999999999999875432   1222356789999999999999999998854  4568


Q ss_pred             EEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          104 NFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++++|+++ +++.+.+.. ...+....+..++.|++.||.|||+.+  ++|+||||+||+++.+ +.++|+|||+++...
T Consensus        79 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~  154 (291)
T cd07870          79 TFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYL-GELKLADFGLARAKS  154 (291)
T ss_pred             EEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCC-CcEEEeccccccccC
Confidence            88999996 566665543 345778888999999999999999999  9999999999999855 689999999987643


Q ss_pred             ccce------eeeecccCccccCCCccccccceeeec
Q 027788          183 RAIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ....      .+..+.+|+.+.....++.++|+||+|
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  191 (291)
T cd07870         155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAG  191 (291)
T ss_pred             CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHH
Confidence            3221      122233344333344567779999999

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.96  E-value=2.3e-28  Score=190.78  Aligned_cols=177  Identities=20%  Similarity=0.384  Sum_probs=144.8

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.+.||+|+||.||++.+..++..+++|.++...   .....+.+..|+.+++.++|+|++++.+.+.  ..+.+++++
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~   77 (255)
T cd08219           3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFE--ADGHLYIVM   77 (255)
T ss_pred             eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEE--ECCEEEEEE
Confidence            67799999999999999999999999999987543   2344577889999999999999999999884  446789999


Q ss_pred             ccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          108 EVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       108 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ||+++++|.+++...  ..++++.+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++++|||.+.......
T Consensus        78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCC-CcEEEcccCcceeecccc
Confidence            999999999887542  35789999999999999999999999  9999999999999855 589999999998765432


Q ss_pred             e------eeeecccCccccCCCccccccceeeec
Q 027788          186 R------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .      +...+.+|+ ......++.++|+||+|
T Consensus       155 ~~~~~~~~~~~~~aPE-~~~~~~~~~~~Dv~slG  187 (255)
T cd08219         155 AYACTYVGTPYYVPPE-IWENMPYNNKSDIWSLG  187 (255)
T ss_pred             cccccccCCccccCHH-HHccCCcCchhhhhhhc
Confidence            2      111233333 33444577789999999

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.96  E-value=3.8e-29  Score=203.10  Aligned_cols=182  Identities=24%  Similarity=0.363  Sum_probs=142.5

Q ss_pred             ceeeeeeeeccccceEEEEEEec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecC
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQ-----EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDE   98 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~   98 (219)
                      +.|++.+.||+|+||.||+|+..     .+++.||+|.++...   .....+.+..|+.+++++ +|+||+++++.+..+
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            34589999999999999999743     345789999887432   233446678899999999 799999999988644


Q ss_pred             CCceEEEEeccccCCChHHHHHhC--------------------------------------------------------
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKH--------------------------------------------------------  122 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~--------------------------------------------------------  122 (219)
                       ...+++++||+++++|.+++...                                                        
T Consensus        84 -~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          84 -GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             -CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             35677899999999999887532                                                        


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---e-----ee
Q 027788          123 -----RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---R-----IR  189 (219)
Q Consensus       123 -----~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---~-----~~  189 (219)
                           ..+++..+..++.|++.++.|||+++  ++||||||+||+++.+ +.++|+|||++..+.....   .     ..
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCCCCCc
Confidence                 24688889999999999999999999  9999999999999965 5899999999987643321   1     11


Q ss_pred             ecccCccccCCCccccccceeeecc
Q 027788          190 CWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .+.+ +++.....++.++|+||+|+
T Consensus       240 ~y~a-PE~~~~~~~~~~~Di~SlGv  263 (337)
T cd05054         240 KWMA-PESIFDKVYTTQSDVWSFGV  263 (337)
T ss_pred             cccC-cHHhcCCCCCccccHHHHHH
Confidence            1223 34455566788899999993

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.6e-28  Score=192.12  Aligned_cols=181  Identities=27%  Similarity=0.411  Sum_probs=148.0

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      ..+| .+.+.||+|+||.||+|....++..+++|.+....    ....+.+..|+.+++.++|||++++++.+..  .+.
T Consensus         2 ~~~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~   74 (262)
T cd06613           2 QEDY-ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLR--RDK   74 (262)
T ss_pred             ccce-EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEe--CCE
Confidence            3455 77799999999999999998899999999987543    2355788899999999999999999998844  456


Q ss_pred             EEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          103 LNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      ++++||++++++|..++... ..+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++|+|||++...
T Consensus        75 ~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~  151 (262)
T cd06613          75 LWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTED-GDVKLADFGVSAQL  151 (262)
T ss_pred             EEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCC-CCEEECccccchhh
Confidence            88999999999999988765 67999999999999999999999999  9999999999999855 68999999998776


Q ss_pred             cccce------eeeecccCccccCC--Cccccccceeeec
Q 027788          182 GRAIR------RIRCWGRRSSWRRS--CTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~------~~~~~~~~~~~~~~--~~~~~~~diws~g  213 (219)
                      .....      ....+.+|+.....  ..++.++|+||+|
T Consensus       152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG  191 (262)
T cd06613         152 TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALG  191 (262)
T ss_pred             hhhhhccccccCCccccCchhhcccccCCcCchhhhHHHH
Confidence            54321      12223444433222  3667789999999

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.96  E-value=1.6e-28  Score=192.85  Aligned_cols=179  Identities=21%  Similarity=0.313  Sum_probs=143.0

Q ss_pred             eeeeeeeccccceEEEEEEecCC---CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEE---GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      +++.+.||+|+||.||+|....+   ...||+|.++...   .......+.+|+.++++++|||++++++.+..  ....
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   80 (266)
T cd05033           6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRPV   80 (266)
T ss_pred             ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCce
Confidence            47889999999999999987543   4579999876442   34455778899999999999999999998854  4557


Q ss_pred             EEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          104 NFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +++||++++++|.+++... +.+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++++|||++....
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~-~~~~l~dfg~~~~~~  157 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-CCEEECccchhhccc
Confidence            8899999999999988654 46899999999999999999999999  9999999999999865 589999999998875


Q ss_pred             ccceeee-------ecccCccccCCCccccccceeeec
Q 027788          183 RAIRRIR-------CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~~~~-------~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .......       ....+++......++.++|+||+|
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG  195 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFG  195 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHH
Confidence            2221111       111223344455677789999999

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.96  E-value=1.8e-28  Score=191.32  Aligned_cols=178  Identities=22%  Similarity=0.376  Sum_probs=145.9

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      ++.+.||.|+||.||.+....++..+++|.+.....  .....+.+.+|++++++++|+|++++++++..  ...++++|
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~   78 (256)
T cd08221           3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM   78 (256)
T ss_pred             eEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence            666999999999999999999999999999875543  34555778899999999999999999999954  46788999


Q ss_pred             ccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          108 EVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       108 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ||+++++|.+++...  ..++...+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEY  155 (256)
T ss_pred             EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCC-CCEEECcCcceEEccccc
Confidence            999999999988654  45889999999999999999999999  9999999999999865 589999999998764433


Q ss_pred             e------eeeecccCccccCCCccccccceeeec
Q 027788          186 R------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .      ++..+.+| +......++.++|+||+|
T Consensus       156 ~~~~~~~~~~~y~ap-e~~~~~~~~~~~Dv~slG  188 (256)
T cd08221         156 SMAETVVGTPYYMSP-ELCQGVKYNFKSDIWALG  188 (256)
T ss_pred             ccccccCCCccccCH-hhcCCCCCCCcchhHHHH
Confidence            1      11222223 333344466779999999

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.96  E-value=1.5e-29  Score=200.39  Aligned_cols=179  Identities=28%  Similarity=0.457  Sum_probs=142.8

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.+.||+|++|.||+|.+..+|+.+++|.++....  .......+.+|++++++++|+|++++++++.  +...+++++
T Consensus         3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~--~~~~~~lv~   78 (284)
T cd07839           3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLH--SDKKLTLVF   78 (284)
T ss_pred             eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhc--cCCceEEEE
Confidence            667899999999999999999999999999875432  2223355778999999999999999999884  445688999


Q ss_pred             ccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          108 EVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       108 e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      ||++ ++|.+++.. ...+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|+|||+++.......
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          79 EYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVR  154 (284)
T ss_pred             ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCC-CcEEECccchhhccCCCCC
Confidence            9997 577776643 456899999999999999999999999  9999999999999866 5899999999986543321


Q ss_pred             ------eeeecccCccccCCCccccccceeeecc
Q 027788          187 ------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 ------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                            .+..+.+|+.+.....++.++|+||+|+
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  188 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGC  188 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHH
Confidence                  1222334443444455677899999993

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.96  E-value=1e-28  Score=193.87  Aligned_cols=180  Identities=24%  Similarity=0.400  Sum_probs=145.8

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||+|+||.||+|+...++..||+|.++.... .+......+.+|+.+++.++|||++++++.+...  +..+++
T Consensus         4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v   80 (267)
T cd08228           4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED--NELNIV   80 (267)
T ss_pred             eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC--CeEEEE
Confidence            3788999999999999999999999999998765332 2345557788999999999999999999988543  567889


Q ss_pred             eccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          107 TEVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +|++++++|.+++..    ...+++..+..++.|++.|+.|||+++  ++|+||+|+||+++.+ +.++++|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~-~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCC-CCEEECccccceecc
Confidence            999999999887742    234788999999999999999999999  9999999999999865 589999999998765


Q ss_pred             ccce------eeeecccCccccCCCccccccceeeec
Q 027788          183 RAIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ....      +...+.+| +......++.++|+||+|
T Consensus       158 ~~~~~~~~~~~~~~~~aP-E~~~~~~~~~~~Di~slG  193 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSP-ERIHENGYNFKSDIWSLG  193 (267)
T ss_pred             chhHHHhcCCCCccccCh-hhhccCCCCchhhHHHHH
Confidence            4332      11223333 334445567789999999

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.96  E-value=1.2e-28  Score=195.08  Aligned_cols=174  Identities=26%  Similarity=0.421  Sum_probs=141.8

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      +++.+.||+|+||.||+|.+..++..+|+|.+....   .....+.+.+|+.++++++|||++++++.+...  +..+++
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv   77 (279)
T cd06619           3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE--NRISIC   77 (279)
T ss_pred             chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--CEEEEE
Confidence            367789999999999999999999999999886442   334456788999999999999999999998554  557789


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      |||+++++|..+    ..+++..+..++.|++.|+.|||+.+  ++|+||+|+|++++.+ +.++|+|||++........
T Consensus        78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~~~  150 (279)
T cd06619          78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNSIA  150 (279)
T ss_pred             EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCC-CCEEEeeCCcceecccccc
Confidence            999999988654    24788889999999999999999999  9999999999999866 6899999999987644322


Q ss_pred             ----eeeecccCccccCCCccccccceeeec
Q 027788          187 ----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                          ++..+.+| +......++.++|+||+|
T Consensus       151 ~~~~~~~~y~aP-E~~~~~~~~~~~DvwslG  180 (279)
T cd06619         151 KTYVGTNAYMAP-ERISGEQYGIHSDVWSLG  180 (279)
T ss_pred             cCCCCChhhcCc-eeecCCCCCCcchHHHHH
Confidence                22223333 344455677889999999

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.96  E-value=1e-28  Score=195.62  Aligned_cols=178  Identities=25%  Similarity=0.363  Sum_probs=142.3

Q ss_pred             eeeeeeeccccceEEEEEEecCCC-----cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEG-----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      +++.+.||+|+||.||+|.....+     ..+++|.++...   .......+.+|+.+++.++|||++++++++..  ..
T Consensus         7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~   81 (283)
T cd05048           7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--EQ   81 (283)
T ss_pred             cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC--CC
Confidence            367789999999999999876554     679999876432   34556778999999999999999999998854  34


Q ss_pred             eEEEEeccccCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC
Q 027788          102 TLNFITEVCTSGNLREYRKKH----------------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG  165 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~----------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~  165 (219)
                      ..++++||+++++|.+++...                ..+++..+..++.|++.|+.|||..+  ++|+||||+||+++.
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~  159 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGE  159 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcC
Confidence            578899999999999988654                34778889999999999999999999  999999999999986


Q ss_pred             CCCcEEEeccccceeccccce--------eeeecccCccccCCCccccccceeeec
Q 027788          166 NTGQVKIGDLGVAAIVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       166 ~~~~~~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      + +.++|+|||++........        .+..+.+| +......++.++|+||+|
T Consensus       160 ~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~sDv~slG  213 (283)
T cd05048         160 G-LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPP-EAILYGKFTTESDIWSFG  213 (283)
T ss_pred             C-CcEEECCCcceeeccccccccccCCCcccccccCH-HHhccCcCchhhhHHHHH
Confidence            5 5899999999986543321        11123333 334445678889999999

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.96  E-value=7.7e-29  Score=200.49  Aligned_cols=179  Identities=18%  Similarity=0.272  Sum_probs=141.6

Q ss_pred             eeeeeccc--cceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           29 YNELLGSG--AVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        29 ~~~~ig~g--~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      +.++||+|  +|+.||++.+..+++.||+|.++....  .....+.+.+|+.+++.++||||+++++++..+  +..+++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv   77 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVV   77 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CEEEEE
Confidence            45789999  789999999999999999999875532  344556778899999999999999999998654  568899


Q ss_pred             eccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          107 TEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||+.+  ++|+||||+||+++.+ +.+++.||+.+......
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~  154 (327)
T cd08227          78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMINH  154 (327)
T ss_pred             EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecC-CcEEEcccchhhccccc
Confidence            9999999999988643  45889999999999999999999999  9999999999999865 58999999765443221


Q ss_pred             ce-------------eeeecccCccccCC-Cccccccceeeecc
Q 027788          185 IR-------------RIRCWGRRSSWRRS-CTMRITRSLWTYTR  214 (219)
Q Consensus       185 ~~-------------~~~~~~~~~~~~~~-~~~~~~~diws~gi  214 (219)
                      ..             ....+.+|+..... ..++.++|+||+|+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~  198 (327)
T cd08227         155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI  198 (327)
T ss_pred             cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHH
Confidence            11             11223344433322 45778899999993

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.96  E-value=1.7e-28  Score=194.12  Aligned_cols=180  Identities=24%  Similarity=0.401  Sum_probs=143.0

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCc----EEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGI----EVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      .+.+++.+.||+|+||.||+|....++.    .||+|.++...   .......+.+|+.+++.++|+|++++++.+... 
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence            3445778999999999999998776665    47889876432   344557788999999999999999999988543 


Q ss_pred             CceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          100 RNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                        ..+++++++++|+|.+++... ..+++..+..++.|++.|+.|||+++  ++|+||||+||+++.+ +.++|+|||++
T Consensus        82 --~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~-~~~kL~dfG~~  156 (279)
T cd05109          82 --TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSP-NHVKITDFGLA  156 (279)
T ss_pred             --CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCC-CcEEECCCCce
Confidence              356799999999999988653 46899999999999999999999999  9999999999999755 58999999999


Q ss_pred             eeccccceee--------eecccCccccCCCccccccceeeec
Q 027788          179 AIVGRAIRRI--------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       179 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +.........        ..+.+ ++......++.++|+||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~-PE~~~~~~~~~~~Di~slG  198 (279)
T cd05109         157 RLLDIDETEYHADGGKVPIKWMA-LESILHRRFTHQSDVWSYG  198 (279)
T ss_pred             eecccccceeecCCCccchhhCC-HHHhccCCCCchhHHHHHH
Confidence            8775433211        11222 3334455577789999999

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.96  E-value=1.2e-28  Score=192.78  Aligned_cols=173  Identities=23%  Similarity=0.416  Sum_probs=140.1

Q ss_pred             eeccccceEEEEEEe--cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEecc
Q 027788           32 LLGSGAVKKVYRAFD--QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        32 ~ig~g~~g~V~~a~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      .||+|+||.||+|..  ..++..+|+|+++...  ......+.+.+|+.+++.++|+|++++++.+..   ...+++||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEec
Confidence            689999999999964  4667899999987543  245566889999999999999999999988742   346789999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccccee--
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR--  187 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~--  187 (219)
                      +++++|.+++.....+++..+..++.|++.++.++|.++  ++|+||||.|++++.+ +.++|+|||++.........  
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCC-CeEEECCCccccccCCCCCeee
Confidence            999999999887778999999999999999999999999  9999999999999865 58999999999876544321  


Q ss_pred             --e-----eecccCccccCCCccccccceeeec
Q 027788          188 --I-----RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       188 --~-----~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                        .     ..+.+| +......++.++|+||||
T Consensus       154 ~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  185 (257)
T cd05116         154 AKTHGKWPVKWYAP-ECMNYYKFSSKSDVWSFG  185 (257)
T ss_pred             ecCCCCCCccccCH-hHhccCCcCchhHHHHHH
Confidence              0     112222 233445567789999999

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.96  E-value=5.3e-29  Score=194.69  Aligned_cols=181  Identities=20%  Similarity=0.349  Sum_probs=149.6

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||.|+||.||+|.+..++..+++|.+...... .....+.+.+|++++++++|||++++++.+  ++...++++
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv   78 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSVRNVLNERRILQELNHPFLVNLWYSF--QDEENMYLV   78 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-chhHHHHHHHHHHHHHhCCCCChHHHHHhh--cCCCeEEEE
Confidence            47789999999999999999999999999998854332 334567899999999999999999998888  455678999


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      +|++++++|..++.....+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++|+|||++........
T Consensus        79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~  155 (258)
T cd05578          79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTL  155 (258)
T ss_pred             EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCC-CCEEEeecccccccCCCcc
Confidence            999999999999877778999999999999999999999999  9999999999999865 6899999999987655422


Q ss_pred             -----eeeecccCccccCCCccccccceeeecc
Q 027788          187 -----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 -----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                           +...+.+| +......++.++|+||+|+
T Consensus       156 ~~~~~~~~~y~~P-E~~~~~~~~~~~Di~slG~  187 (258)
T cd05578         156 TTSTSGTPGYMAP-EVLCRQGYSVAVDWWSLGV  187 (258)
T ss_pred             ccccCCChhhcCH-HHHcccCCCCcccchhhHH
Confidence                 11222233 3334444677899999993

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.96  E-value=5.6e-29  Score=202.60  Aligned_cols=180  Identities=25%  Similarity=0.365  Sum_probs=140.4

Q ss_pred             eeeeeeeeccccceEEEEEEe-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCC
Q 027788           26 YGRYNELLGSGAVKKVYRAFD-----QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDED   99 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~   99 (219)
                      .|++.+.||+|+||.||+|.+     ..+++.||+|.++...   .......+.+|+.+++++ +|+|++++++++..++
T Consensus         8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            348999999999999999974     3567889999987543   233456788999999999 6899999998875443


Q ss_pred             CceEEEEeccccCCChHHHHHhC---------------------------------------------------------
Q 027788          100 RNTLNFITEVCTSGNLREYRKKH---------------------------------------------------------  122 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~---------------------------------------------------------  122 (219)
                       ..++++|||+++|+|.+++...                                                         
T Consensus        85 -~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          85 -GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             -CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             4678899999999999887542                                                         


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccccee-----
Q 027788          123 ----------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR-----  187 (219)
Q Consensus       123 ----------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~-----  187 (219)
                                ..++......++.|++.|+.|||+.+  ++|+||||+||+++.+ +.++++|||++.........     
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCC-CcEEEEecccccccccCcchhhcCC
Confidence                      12566778889999999999999999  9999999999999865 58999999999875432210     


Q ss_pred             ---eeecccCccccCCCccccccceeeec
Q 027788          188 ---IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       188 ---~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                         +..+.+ ++......++.++|+||+|
T Consensus       241 ~~~~~~y~a-PE~~~~~~~~~~~Di~slG  268 (343)
T cd05103         241 ARLPLKWMA-PETIFDRVYTIQSDVWSFG  268 (343)
T ss_pred             CCCCcceEC-cHHhcCCCCCchhhHHHHH
Confidence               011222 3344455677889999999

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=2.1e-28  Score=193.59  Aligned_cols=183  Identities=28%  Similarity=0.443  Sum_probs=147.7

Q ss_pred             CceeeeeeeeccccceEEEEEEec----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQ----EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      .+++++.+.||+|+||.||+|...    .++..+|+|.++....   ....+.+.+|+++++.++|+|++++++++....
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            455677799999999999999854    4578999999875432   235678999999999999999999999887656


Q ss_pred             CceEEEEeccccCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      ....+++||++++++|.+++.... .+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++++|||++
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~  156 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESE-DLVKISDFGLA  156 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC-CCEEEcccccc
Confidence            677899999999999999887653 5899999999999999999999999  9999999999999866 68999999999


Q ss_pred             eecccccee---------eeecccCccccCCCccccccceeeec
Q 027788          179 AIVGRAIRR---------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       179 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .........         ...+.+|+ ......++.++|+||+|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe-~~~~~~~~~~~Di~slG  199 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPE-CLRTSKFSSASDVWSFG  199 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcH-HHccCCCCcccchHHHh
Confidence            887633211         11123333 23344567789999999

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.96  E-value=3.6e-28  Score=189.69  Aligned_cols=180  Identities=22%  Similarity=0.412  Sum_probs=145.9

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||+|++|.||.+.+..+++.+++|.+.....  .....+.+.+|++++++++|+|++++.+.+.. ....++++
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv   78 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYIV   78 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEEE
Confidence            3788999999999999999999999999999875432  23445678899999999999999999887743 33567899


Q ss_pred             eccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          107 TEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      ||++++++|.+++...  ..+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~  155 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecC-CcEEEecccceEEeccc
Confidence            9999999999887653  45899999999999999999999999  9999999999999855 58999999999876433


Q ss_pred             ce------eeeecccCccccCCCccccccceeeec
Q 027788          185 IR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ..      +...+ .+++......++.++|+||+|
T Consensus       156 ~~~~~~~~~~~~y-~aPE~~~~~~~~~~~Dv~slG  189 (257)
T cd08223         156 CDMASTLIGTPYY-MSPELFSNKPYNYKSDVWALG  189 (257)
T ss_pred             CCccccccCCcCc-cChhHhcCCCCCchhhhHHHH
Confidence            21      11122 233455556677789999999

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.96  E-value=9.7e-29  Score=197.14  Aligned_cols=182  Identities=26%  Similarity=0.416  Sum_probs=147.6

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCC-CHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD-DPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      |.+.+.||+|++|.||+|.+..+++.|++|.+....... .......+..|++++++++|+|++++++++..  .+.+++
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l   79 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNINL   79 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEEE
Confidence            366789999999999999999899999999987654321 12234567789999999999999999999855  567889


Q ss_pred             EeccccCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          106 ITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      +||++ +++|.+++.... .+++..+..++.|++.+|.|||+.+  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASD-GVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCC-CCEEEccceeeeeccCC
Confidence            99999 889999887665 7899999999999999999999999  9999999999999865 68999999999877554


Q ss_pred             ce------eeeecccCccccCCCccccccceeeecc
Q 027788          185 IR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       185 ~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ..      ....+.+|+.......++.++|+||+|+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~  191 (298)
T cd07841         156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGC  191 (298)
T ss_pred             CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHH
Confidence            32      1122344443434455677899999993

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=1.3e-28  Score=193.35  Aligned_cols=181  Identities=27%  Similarity=0.442  Sum_probs=145.9

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCC-----HHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-----PAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      |.+.+.||+|++|.||+|.+..++..+|+|.+........     ....+.+.+|+.++++++|||++++++.+..  ..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~   79 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--AD   79 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CC
Confidence            3577899999999999999988999999998875433211     1234678899999999999999999998854  45


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      ..++++||+++++|.+++.....++...+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||.++..
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~-~~~~l~dfg~~~~~  156 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNK-GGIKISDFGISKKL  156 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCC-CCEEecccCCCccc
Confidence            67889999999999999987778899999999999999999999999  9999999999999865 58999999999877


Q ss_pred             cccce------------eeeecccCccccCCCccccccceeeec
Q 027788          182 GRAIR------------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~------------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .....            +...+.+ ++......++.++|+||+|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~-pe~~~~~~~~~~~Dv~slG  199 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMA-PEVVKQTSYTRKADIWSLG  199 (267)
T ss_pred             ccccccCCccccccccCCCcCccC-hhHhccCCCCchhhhHHHH
Confidence            53221            0111222 2333445567789999999

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.96  E-value=1.5e-28  Score=195.75  Aligned_cols=180  Identities=24%  Similarity=0.326  Sum_probs=143.6

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCC----------------cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCC
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEG----------------IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN   87 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   87 (219)
                      ++| ++.+.||+|+||.||+|.+...+                ..+|+|.+....   .....+.+.+|+.++++++|||
T Consensus         5 ~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           5 QPL-NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             hhC-cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCCCC
Confidence            344 78899999999999999876543                457999877443   3455678899999999999999


Q ss_pred             ceEEEEEEecCCCceEEEEeccccCCChHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCC
Q 027788           88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-----------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDL  156 (219)
Q Consensus        88 i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~-----------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl  156 (219)
                      ++++++++...  ..+++++|++++++|.+++....           .+++..+..++.|++.|+.|||+.+  ++|+||
T Consensus        81 i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dl  156 (296)
T cd05051          81 IARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDL  156 (296)
T ss_pred             EeEEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccccc
Confidence            99999988544  56788999999999999887654           6889999999999999999999999  999999


Q ss_pred             CCCceEEeCCCCcEEEeccccceeccccceee--------eecccCccccCCCccccccceeeec
Q 027788          157 NCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRI--------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       157 ~~~nili~~~~~~~~l~dfg~a~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ||+||+++.+ +.++++|||++..........        ..+.+| +......++.++|+||+|
T Consensus       157 kp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Dv~slG  219 (296)
T cd05051         157 ATRNCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAW-ESVLLGKFTTKSDVWAFG  219 (296)
T ss_pred             chhceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCH-HHhhcCCCCccchhhhhH
Confidence            9999999866 689999999998654432111        112222 333344577889999999

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.96  E-value=2.2e-28  Score=191.89  Aligned_cols=176  Identities=25%  Similarity=0.389  Sum_probs=143.7

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      +.+.+.||+|++|.||+|...+++..+++|.+...     ......+.+|+.+++.++|+|++++++.+..+  ..++++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv   80 (263)
T cd05052           8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--PPFYII   80 (263)
T ss_pred             eEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcCC--CCcEEE
Confidence            47788999999999999999999999999987632     23346788999999999999999999988544  457889


Q ss_pred             eccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          107 TEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      |||+++++|.+++...  ..+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~df~~~~~~~~~  157 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCC-CcEEeCCCccccccccc
Confidence            9999999999988653  35788999999999999999999999  9999999999999855 58999999999876543


Q ss_pred             ceee-------eecccCccccCCCccccccceeeec
Q 027788          185 IRRI-------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~~~-------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ....       ..+.+| +......++.++|+||||
T Consensus       158 ~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Dv~slG  192 (263)
T cd05052         158 TYTAHAGAKFPIKWTAP-ESLAYNKFSIKSDVWAFG  192 (263)
T ss_pred             eeeccCCCCCccccCCH-HHhccCCCCchhHHHHHH
Confidence            3211       112233 344455677789999999

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.96  E-value=1e-28  Score=194.37  Aligned_cols=181  Identities=19%  Similarity=0.256  Sum_probs=139.9

Q ss_pred             eeeeeeccccceEEEEEEecCCCc--EEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC----Cc
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGI--EVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED----RN  101 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~----~~  101 (219)
                      .+++.||+|+||.||+|....++.  .+|+|.++....  .....+.+..|+.+++.++|+|++++++.+....    ..
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC--TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            467899999999999999876665  689998775432  3455678889999999999999999998764321    23


Q ss_pred             eEEEEeccccCCChHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788          102 TLNFITEVCTSGNLREYRKK------HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~------~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      ..++++||+++++|.+++..      ...+++.....++.|++.|+.|||+++  ++|+||||+||+++.+ +.++|+||
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Df  156 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNEN-MNVCVADF  156 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCC-CCEEECCC
Confidence            46789999999999887632      124789999999999999999999999  9999999999999865 58999999


Q ss_pred             ccceecccccee---ee----ecccCccccCCCccccccceeeec
Q 027788          176 GVAAIVGRAIRR---IR----CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       176 g~a~~~~~~~~~---~~----~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |++.........   ..    ....+++......++.++|+||+|
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG  201 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFG  201 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHH
Confidence            999876443211   01    011112334455677889999999

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.96  E-value=2e-28  Score=192.60  Aligned_cols=181  Identities=20%  Similarity=0.294  Sum_probs=142.0

Q ss_pred             eeeeeeeccccceEEEEEEecC---CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC---
Q 027788           27 GRYNELLGSGAVKKVYRAFDQE---EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR---  100 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~---  100 (219)
                      +++.+.||+|+||.||.|....   ++..+|+|.++....  .......+.+|++.++.++|||++++++.+.....   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence            3678899999999999998654   347899999875432  34455778999999999999999999988754332   


Q ss_pred             -ceEEEEeccccCCChHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEe
Q 027788          101 -NTLNFITEVCTSGNLREYRKKH------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIG  173 (219)
Q Consensus       101 -~~~~lv~e~~~~g~L~~~~~~~------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~  173 (219)
                       ...++++||+++++|..++...      ..+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+ +.++|+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLRED-MTVCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCC-CeEEEC
Confidence             3478899999999999877432      25788999999999999999999999  9999999999999865 589999


Q ss_pred             ccccceecccccee--------eeecccCccccCCCccccccceeeec
Q 027788          174 DLGVAAIVGRAIRR--------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       174 dfg~a~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |||+++........        ...+.+| +......++.++|+||+|
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~p-e~~~~~~~~~~~Dv~SlG  202 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAI-ESLADRVYTSKSDVWAFG  202 (273)
T ss_pred             CccceeeccccccccccccccCCccccCH-hhcccCCCCcccchHHHH
Confidence            99999876543311        0112222 334455677789999999

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.96  E-value=2.9e-28  Score=191.16  Aligned_cols=180  Identities=24%  Similarity=0.421  Sum_probs=146.5

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|++|.||+|....++..+++|.++.... .+....+.+.+|++++++++|+|++++++.+..  .+..+++
T Consensus         4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~lv   80 (267)
T cd08224           4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELNIV   80 (267)
T ss_pred             eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEEE
Confidence            3788999999999999999998999999999875332 234446788999999999999999999999854  4568899


Q ss_pred             eccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          107 TEVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      |||+++++|..++..    ...++...+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++++|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~-~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITAT-GVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCC-CcEEEeccceeeecc
Confidence            999999999988753    235789999999999999999999999  9999999999999865 589999999987654


Q ss_pred             ccce------eeeecccCccccCCCccccccceeeec
Q 027788          183 RAIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ....      ....+.+ ++......++.++|+||+|
T Consensus       158 ~~~~~~~~~~~~~~y~a-pE~~~~~~~~~~~Di~slG  193 (267)
T cd08224         158 SKTTAAHSLVGTPYYMS-PERIHENGYNFKSDIWSLG  193 (267)
T ss_pred             CCCcccceecCCccccC-HHHhccCCCCchhcHHHHH
Confidence            3321      1112223 3344556677789999999

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.96  E-value=2e-28  Score=193.50  Aligned_cols=181  Identities=22%  Similarity=0.332  Sum_probs=140.3

Q ss_pred             CceeeeeeeeccccceEEEEEEec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQ-----EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      .+.+++.+.||+|+||.||.|.+.     .++..+|+|.++...   .......+.+|+.+++.++|||++++++.+.  
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--   79 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVS--   79 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--
Confidence            344588899999999999999754     345679999875322   2334567889999999999999999999884  


Q ss_pred             CCceEEEEeccccCCChHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCC
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKHR----------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG  168 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~~----------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~  168 (219)
                      .....+++|||+++++|.+++....          .++...+..++.|++.++.|||+.+  ++|+||||+||+++.+ +
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~-~  156 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED-F  156 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCC-C
Confidence            3455788999999999999876422          2467788899999999999999999  9999999999999865 5


Q ss_pred             cEEEeccccceecccccee--------eeecccCccccCCCccccccceeeec
Q 027788          169 QVKIGDLGVAAIVGRAIRR--------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       169 ~~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .++++|||++.........        +..+.+| +......++.++|+||||
T Consensus       157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  208 (277)
T cd05062         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP-ESLKDGVFTTYSDVWSFG  208 (277)
T ss_pred             CEEECCCCCccccCCcceeecCCCCccCHhhcCh-hHhhcCCcCchhHHHHHH
Confidence            8999999998765433221        1113333 333445577789999999

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PTZ00284 protein kinase; Provisional

Probab=99.96  E-value=2.4e-28  Score=206.46  Aligned_cols=179  Identities=19%  Similarity=0.270  Sum_probs=137.8

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCC------CceEEEEEEecC
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK------NIISLHYVWRDE   98 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~------~i~~~~~~~~~~   98 (219)
                      +.|++.++||+|+||.||+|.+..+++.||+|+++..     .........|+.+++.++|.      +++++.+++..+
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            3458889999999999999999999999999998632     22234456788888777654      477888877643


Q ss_pred             CCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeCCCCCceEEeCCCC---------
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT-HEPCVIHRDLNCSNVFVNGNTG---------  168 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~-~~~~i~h~dl~~~nili~~~~~---------  168 (219)
                       ...++++|+++ +++|.+++.....+++..+..++.|++.||.|||. .+  |+||||||+||+++.+..         
T Consensus       204 -~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        204 -TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             -CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccccc
Confidence             35678899988 57888888777789999999999999999999997 58  999999999999975421         


Q ss_pred             ------cEEEeccccceeccccce---eeeecccCccccCCCccccccceeeec
Q 027788          169 ------QVKIGDLGVAAIVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       169 ------~~~l~dfg~a~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                            .+||+|||.+........   ++..+.+|+ ......++.++||||||
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE-~~~~~~~~~~~DiwSlG  332 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPE-VVLGLGWMYSTDMWSMG  332 (467)
T ss_pred             cCCCCceEEECCCCccccCccccccccCCccccCcH-HhhcCCCCcHHHHHHHH
Confidence                  489999998865432221   222334443 33455688889999999

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.96  E-value=2.2e-28  Score=194.38  Aligned_cols=179  Identities=24%  Similarity=0.317  Sum_probs=142.9

Q ss_pred             ceeeeeeeeccccceEEEEEEe-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           25 RYGRYNELLGSGAVKKVYRAFD-----QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      +-+.+.+.||+|+||.||++..     ..++..+|+|.+...    .....+.+.+|++++++++|||++++++++..  
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   78 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--   78 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence            4458889999999999999974     335567899987643    34455778999999999999999999999854  


Q ss_pred             CceEEEEeccccCCChHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHR-------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN  166 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~-------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~  166 (219)
                      ...+++++||+++++|.+++...+             .+++..+..++.|++.++.|||+++  ++||||||+||+++.+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~  156 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN  156 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccC
Confidence            456788999999999999886443             3789999999999999999999999  9999999999999865


Q ss_pred             CCcEEEeccccceecccccee--------eeecccCccccCCCccccccceeeec
Q 027788          167 TGQVKIGDLGVAAIVGRAIRR--------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       167 ~~~~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                       +.++++|||++.........        ...+.+| +......++.++|+||||
T Consensus       157 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~sDiwslG  209 (288)
T cd05093         157 -LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP-ESIMYRKFTTESDVWSLG  209 (288)
T ss_pred             -CcEEeccCCccccccCCceeecCCCCCccccccCH-HHhccCCCCchhhHHHHH
Confidence             58999999999866433211        1123333 334445677789999999

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=1.3e-28  Score=196.29  Aligned_cols=179  Identities=23%  Similarity=0.324  Sum_probs=140.2

Q ss_pred             eeeeeeeeccccceEEEEEEecCC--------------CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEE--------------GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL   91 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   91 (219)
                      .|++.+.||+|+||.||+|+...+              ...||+|.++...   .......+.+|++++++++|+|++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            348889999999999999986543              2358999877432   34455678899999999999999999


Q ss_pred             EEEEecCCCceEEEEeccccCCChHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCC
Q 027788           92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHR------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCS  159 (219)
Q Consensus        92 ~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~  159 (219)
                      ++.+..  ...++++|||+++++|.+++....            .+++..+..++.|++.|+.|||+.+  ++|+||+|+
T Consensus        83 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~  158 (295)
T cd05097          83 LGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATR  158 (295)
T ss_pred             EEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChh
Confidence            999854  456788999999999999875431            3678889999999999999999999  999999999


Q ss_pred             ceEEeCCCCcEEEeccccceecccccee--------eeecccCccccCCCccccccceeeec
Q 027788          160 NVFVNGNTGQVKIGDLGVAAIVGRAIRR--------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       160 nili~~~~~~~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |++++.+ +.++++|||++.........        ...+.+| +......++.++|+||||
T Consensus       159 Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~DvwSlG  218 (295)
T cd05097         159 NCLVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAW-ESILLGKFTTASDVWAFG  218 (295)
T ss_pred             hEEEcCC-CcEEecccccccccccCcceeccCcCcCceeecCh-hhhccCCcCchhhHHHHH
Confidence            9999855 58999999999765433211        1112233 333445577889999999

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.96  E-value=1.9e-28  Score=195.74  Aligned_cols=184  Identities=24%  Similarity=0.401  Sum_probs=148.9

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      ..+++..+| .+.+.||+|++|.||+|.+..++..||+|.+....    ....+.+.+|+.+++.++|+|++++++.+. 
T Consensus        13 ~~~~~~~~y-~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-   86 (297)
T cd06656          13 SVGDPKKKY-TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYL-   86 (297)
T ss_pred             ccCChhhhc-eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc----cchHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            456677777 67799999999999999999999999999987543    223466888999999999999999999884 


Q ss_pred             CCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                       .....+++|||+++++|.+++.. ..+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++++|||+
T Consensus        87 -~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~-~~~~l~Dfg~  161 (297)
T cd06656          87 -VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGF  161 (297)
T ss_pred             -cCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEECcCcc
Confidence             44568899999999999998764 45788999999999999999999999  9999999999999855 6899999999


Q ss_pred             ceecccccee------eeecccCccccCCCccccccceeeec
Q 027788          178 AAIVGRAIRR------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       178 a~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +.........      +..+.+| +......++.++|+||+|
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  202 (297)
T cd06656         162 CAQITPEQSKRSTMVGTPYWMAP-EVVTRKAYGPKVDIWSLG  202 (297)
T ss_pred             ceEccCCccCcCcccCCccccCH-HHHcCCCCCcHHHHHHHH
Confidence            9876443221      1122222 334445567789999999

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.96  E-value=1.8e-28  Score=194.31  Aligned_cols=178  Identities=24%  Similarity=0.328  Sum_probs=140.9

Q ss_pred             eeeeeeeccccceEEEEEEe----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           27 GRYNELLGSGAVKKVYRAFD----QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      +++.+.||+|+||.||+|..    ..++..+++|.+....   .......+.+|+.+++.++|||++++++++...  ..
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~   81 (283)
T cd05090           7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE--QP   81 (283)
T ss_pred             ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--Cc
Confidence            47889999999999999984    3456789999887432   344557788999999999999999999988544  45


Q ss_pred             EEEEeccccCCChHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC
Q 027788          103 LNFITEVCTSGNLREYRKKH-----------------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG  165 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~-----------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~  165 (219)
                      .+++|||+++++|.+++...                 ..+++..+..++.|++.++.|||+++  ++|+||||+|++++.
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~  159 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGE  159 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcC
Confidence            78899999999999987532                 23678888999999999999999999  999999999999986


Q ss_pred             CCCcEEEeccccceeccccce--------eeeecccCccccCCCccccccceeeec
Q 027788          166 NTGQVKIGDLGVAAIVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       166 ~~~~~~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      + +.++++|||++........        .+..+.+| ++.....++.++|+||+|
T Consensus       160 ~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Dv~slG  213 (283)
T cd05090         160 Q-LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP-EAIMYGKFSSDSDIWSFG  213 (283)
T ss_pred             C-CcEEeccccccccccCCcceecccCCCccceecCh-HHhccCCCCchhhhHHHH
Confidence            5 5899999999987643321        11112333 344445577889999999

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.96  E-value=2.2e-28  Score=193.69  Aligned_cols=179  Identities=26%  Similarity=0.455  Sum_probs=144.6

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      +|++.+.||+|+||.||+|.+..++..+++|.+...    .....+.+.+|+++++.++|+|++++++.+..  .+..++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~   79 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWI   79 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEE
Confidence            356778999999999999999999999999987643    34556788899999999999999999998854  456888


Q ss_pred             EeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          106 ITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      ++||+++++|..++.. ...+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++++|||++......
T Consensus        80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~  156 (282)
T cd06643          80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRT  156 (282)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccC-CCEEEcccccccccccc
Confidence            9999999999887654 457899999999999999999999999  9999999999999865 58999999998765432


Q ss_pred             ce------eeeecccCcccc----CCCccccccceeeec
Q 027788          185 IR------RIRCWGRRSSWR----RSCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~------~~~~~~~~~~~~----~~~~~~~~~diws~g  213 (219)
                      ..      ++..+.+|+...    ....++.++|+||+|
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG  195 (282)
T cd06643         157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLG  195 (282)
T ss_pred             ccccccccccccccCHhhccccCCCCCCCCccchhhhHH
Confidence            21      222233343321    234456689999999

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-29  Score=186.77  Aligned_cols=188  Identities=20%  Similarity=0.255  Sum_probs=151.4

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec---C
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD---E   98 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~   98 (219)
                      +.++.|++.+++|+|+|+-||.+....+++.+|+|.+....    ....+..++|++..++++|||++++++....   .
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D   93 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD   93 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence            34566699999999999999999999999999999988663    4556888999999999999999998765532   2


Q ss_pred             CCceEEEEeccccCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEec
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKH----RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD  174 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~d  174 (219)
                      .+...|++.+|+..|+|.+.++..    ..+++.+++.++.+++.|+.+||...+++.||||||.||++..+ +.+++.|
T Consensus        94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~-~~~vl~D  172 (302)
T KOG2345|consen   94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS-GLPVLMD  172 (302)
T ss_pred             CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC-CceEEEe
Confidence            346789999999999999877532    35899999999999999999999999899999999999999854 5899999


Q ss_pred             cccceeccccce---------------eeeecccCccc--cCCCccccccceeeecc
Q 027788          175 LGVAAIVGRAIR---------------RIRCWGRRSSW--RRSCTMRITRSLWTYTR  214 (219)
Q Consensus       175 fg~a~~~~~~~~---------------~~~~~~~~~~~--~~~~~~~~~~diws~gi  214 (219)
                      ||.+...+-...               .+..+++|+-|  .....++.+.||||||+
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGC  229 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGC  229 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhH
Confidence            999877654432               22223334322  23444677899999993

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.3e-28  Score=191.05  Aligned_cols=173  Identities=25%  Similarity=0.416  Sum_probs=140.5

Q ss_pred             eeeccccceEEEEEEecCCC---cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           31 ELLGSGAVKKVYRAFDQEEG---IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      ++||+|+||.||+|......   ..+|+|.+.....   ....+.+.+|+.+++.+.|+|++++++++..   +..+++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEE
Confidence            47999999999999765544   7899999875542   2345678899999999999999999998743   3468899


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccccee
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR  187 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~  187 (219)
                      |++++++|.+++.....+++..+..++.|++.++.+||..+  ++|+||+|+|++++.+ +.++|+|||+++........
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          75 ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             EeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCC-CcEEeccccccceeecCCcc
Confidence            99999999999987778999999999999999999999999  9999999999999865 58999999999876443321


Q ss_pred             e---------eecccCccccCCCccccccceeeec
Q 027788          188 I---------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       188 ~---------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .         ..+.+ ++......++.++|+||||
T Consensus       152 ~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG  185 (257)
T cd05060         152 YRATTAGRWPLKWYA-PECINYGKFSSKSDVWSYG  185 (257)
T ss_pred             cccccCccccccccC-HHHhcCCCCCccchHHHHH
Confidence            0         11222 3344555677889999999

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.96  E-value=2e-28  Score=193.84  Aligned_cols=177  Identities=23%  Similarity=0.370  Sum_probs=138.1

Q ss_pred             eeeeeeccccceEEEEEEecCCCcE----EEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIE----VAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++.+.||+|+||.||+|....++..    +++|.+....   ......++..|+..++.++||||+++++++..   ...
T Consensus        10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~~   83 (279)
T cd05111          10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---ASL   83 (279)
T ss_pred             eeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc---chHHHHHHHHHHHHHhcCCCCCcceEEEEECC---Ccc
Confidence            6778999999999999998777764    6666654221   23344667788889999999999999998743   336


Q ss_pred             EEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          104 NFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++++|++++|+|.+++... ..+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+ +.++|+|||+++...
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~-~~~kl~Dfg~~~~~~  160 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSD-SIVQIADFGVADLLY  160 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCC-CcEEEcCCccceecc
Confidence            6799999999999998654 56899999999999999999999999  9999999999999865 589999999998764


Q ss_pred             cccee-------eeecccCccccCCCccccccceeeec
Q 027788          183 RAIRR-------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~~-------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .....       ......++++.....++.++|+||||
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG  198 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG  198 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHH
Confidence            43221       01111223444556678889999999

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.96  E-value=3.2e-28  Score=190.55  Aligned_cols=179  Identities=25%  Similarity=0.400  Sum_probs=142.4

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      ..+.+++.++||+|++|.||+|... ++..+|+|.+....     ...+.+..|+.+++.++|+|++++++.+..  .+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~   75 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEP   75 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCC
Confidence            3445688899999999999999854 56779999876432     234678899999999999999999988844  455


Q ss_pred             EEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          103 LNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      .++++|++++++|.+++...  ..+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++++|||++..
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~  152 (261)
T cd05072          76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSES-LMCKIADFGLARV  152 (261)
T ss_pred             cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCC-CcEEECCCcccee
Confidence            78899999999999988643  45788899999999999999999999  9999999999999865 5899999999987


Q ss_pred             cccccee-------eeecccCccccCCCccccccceeeec
Q 027788          181 VGRAIRR-------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .......       ...+.+| +......++.++|+||+|
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  191 (261)
T cd05072         153 IEDNEYTAREGAKFPIKWTAP-EAINFGSFTIKSDVWSFG  191 (261)
T ss_pred             cCCCceeccCCCccceecCCH-HHhccCCCChhhhhhhhH
Confidence            6543211       0112223 334445577789999999

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.96  E-value=5.7e-29  Score=197.19  Aligned_cols=180  Identities=24%  Similarity=0.369  Sum_probs=145.7

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||+|+||.||+|.+..+++.+|+|.+.....  .....+.+.+|+++++.++|||++++++++.  .....+++
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv   78 (286)
T cd07846           3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVFR--RKKRLYLV   78 (286)
T ss_pred             eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhcc--cCCeEEEE
Confidence            3677999999999999999988999999998764432  2234467888999999999999999999884  45678899


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      +||+++++|..+......+++..+..++.|++.++.|||+.+  ++|+||+|+|++++.+ +.++++|||++........
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCcc
Confidence            999998888887665556899999999999999999999999  9999999999999865 5899999999887644321


Q ss_pred             ------eeeecccCccccCCCccccccceeeec
Q 027788          187 ------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                            +...+.+|+.......++.++|+||+|
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  188 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVG  188 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHH
Confidence                  222334444444344466779999999

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.96  E-value=1.4e-28  Score=195.88  Aligned_cols=180  Identities=22%  Similarity=0.316  Sum_probs=146.3

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.+.||+|++|.||+|.+..+++.+++|.++.....  ......+.+|+.++++++|||++++.+++...+...+++++
T Consensus         8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            6678999999999999999999999999998765432  23334567899999999999999999988766557899999


Q ss_pred             ccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          108 EVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       108 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      |+++ ++|.+++... ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++|+|||++........
T Consensus        86 e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          86 EYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNR-GILKICDFGLAREYGSPLK  161 (293)
T ss_pred             hhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCC-CcEEEeecCceeeccCCcc
Confidence            9997 5888877654 35899999999999999999999999  9999999999999865 6899999999987765421


Q ss_pred             ------eeeecccCccccCCCccccccceeeec
Q 027788          187 ------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                            ....+.+|+.......++.++|+||+|
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG  194 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVG  194 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHH
Confidence                  122233444344444567789999999

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.96  E-value=3.6e-28  Score=190.07  Aligned_cols=180  Identities=24%  Similarity=0.423  Sum_probs=148.1

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.+.||.|+||.||++.+..++..+++|.++....  .....+.+..|+.+++.++|+|++++++.+..+....++++|
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            677899999999999999999999999999875433  345557788999999999999999999988766667789999


Q ss_pred             ccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          108 EVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLH-----THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       108 e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh-----~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      ||+++++|.+++..    ...+++..++.++.|++.++.+||     +.+  ++|+||+|+||+++.+ +.++++|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~-~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDAN-NNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecC-CCEEEeccccc
Confidence            99999999988764    356889999999999999999999     777  9999999999999865 68999999999


Q ss_pred             eeccccce------eeeecccCccccCCCccccccceeeec
Q 027788          179 AIVGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       179 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ........      +...+.. ++......++.++|+||+|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~-pE~~~~~~~~~~~Dv~slG  197 (265)
T cd08217         158 KILGHDSSFAKTYVGTPYYMS-PEQLNHMSYDEKSDIWSLG  197 (265)
T ss_pred             ccccCCcccccccccCCCccC-hhhhcCCCCCchhHHHHHH
Confidence            87755432      1111222 3334445567779999999

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.96  E-value=2.8e-28  Score=190.84  Aligned_cols=172  Identities=22%  Similarity=0.382  Sum_probs=136.4

Q ss_pred             eeccccceEEEEEEec--CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEecc
Q 027788           32 LLGSGAVKKVYRAFDQ--EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        32 ~ig~g~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      .||+|+||.||+|...  ..+..||+|.++...   .....+.+.+|+.++++++|+|++++++++..   ...+++|||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEe
Confidence            4899999999999764  445679999887542   34445778999999999999999999998742   357889999


Q ss_pred             ccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccccee-
Q 027788          110 CTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR-  187 (219)
Q Consensus       110 ~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~-  187 (219)
                      +++++|.+++.. ...+++..+..++.|++.++.+||.++  ++|+||||+||+++.+ +.++++|||++......... 
T Consensus        76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCC-CcEEeccCCccccccCCccce
Confidence            999999998864 456899999999999999999999999  9999999999999865 58999999999865443211 


Q ss_pred             -e-------eecccCccccCCCccccccceeeec
Q 027788          188 -I-------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       188 -~-------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                       .       ..+.+| +......++.++|+||||
T Consensus       153 ~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  185 (257)
T cd05115         153 KARSAGKWPLKWYAP-ECINFRKFSSRSDVWSYG  185 (257)
T ss_pred             eccCCCCCCcccCCH-HHHccCCCCchhhHHHHH
Confidence             0       112222 333344567789999999

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.96  E-value=2.9e-28  Score=194.53  Aligned_cols=181  Identities=25%  Similarity=0.436  Sum_probs=147.0

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      ++..+| .+.+.||.|++|.||+|.+..+++.|++|.+....    ....+.+.+|+.+++.++|+|++++++.+..  .
T Consensus        16 ~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~   88 (296)
T cd06655          16 DPKKKY-TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELKNPNIVNFLDSFLV--G   88 (296)
T ss_pred             CCcceE-EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHHHHHHHHHHHhcCCCceeeeeeeEec--C
Confidence            344455 77799999999999999999999999999887542    2334678899999999999999999998854  4


Q ss_pred             ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          101 NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      +.+++++||+++++|..++... .+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        89 ~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~-~~~kl~dfg~~~~  164 (296)
T cd06655          89 DELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMD-GSVKLTDFGFCAQ  164 (296)
T ss_pred             ceEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEccCccchh
Confidence            5688999999999999987643 6899999999999999999999999  9999999999999855 6899999999886


Q ss_pred             cccccee------eeecccCccccCCCccccccceeeec
Q 027788          181 VGRAIRR------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .......      +..+. +++......++.++|+||+|
T Consensus       165 ~~~~~~~~~~~~~~~~y~-aPE~~~~~~~~~~~Dv~slG  202 (296)
T cd06655         165 ITPEQSKRSTMVGTPYWM-APEVVTRKAYGPKVDIWSLG  202 (296)
T ss_pred             cccccccCCCcCCCcccc-CcchhcCCCCCchhhHHHHH
Confidence            6443221      11122 23444455567789999999

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=2.8e-28  Score=190.99  Aligned_cols=178  Identities=24%  Similarity=0.352  Sum_probs=142.4

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      +.+++.+.||+|++|.||+|.+. ++..||+|.++...     ...+.+.+|+.++++++|+|++++++++..  .+.++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~   77 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPIY   77 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-----ccHHHHHHHHHHHHHCCCCCccceeEEEec--CCCee
Confidence            34588899999999999999864 45789999887432     123568889999999999999999998854  45578


Q ss_pred             EEeccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          105 FITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++||++++++|.+++....  .+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~  154 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGEN-NICKVADFGLARVIK  154 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCC-CCEEECCcceEEEcc
Confidence            8999999999999886543  6889999999999999999999999  9999999999999865 589999999998775


Q ss_pred             ccceeee------ecccCccccCCCccccccceeeec
Q 027788          183 RAIRRIR------CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~~~~------~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .......      ....+++......++.++|+||+|
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  191 (261)
T cd05068         155 EDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFG  191 (261)
T ss_pred             CCcccccCCCcCceeccCccccccCCCCchhhHHHHH
Confidence            4321111      112223444455667789999999

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.96  E-value=4.6e-28  Score=192.79  Aligned_cols=180  Identities=25%  Similarity=0.357  Sum_probs=141.8

Q ss_pred             ceeeeeeeeccccceEEEEEEecCC-----CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecC
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEE-----GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDE   98 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~   98 (219)
                      ..+++.+.||+|+||.||++.....     ...+|+|.+....   .......+.+|+++++++ +|+|++++++++.. 
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-   87 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-   87 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC-
Confidence            3447889999999999999987543     3789999877432   334456788999999999 79999999998854 


Q ss_pred             CCceEEEEeccccCCChHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceE
Q 027788           99 DRNTLNFITEVCTSGNLREYRKK----------------HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVF  162 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~----------------~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nil  162 (219)
                       ...++++|||+++++|..++..                ...+++..+..++.|++.|+.|||+.+  ++|+||+|+||+
T Consensus        88 -~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil  164 (293)
T cd05053          88 -EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVL  164 (293)
T ss_pred             -CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEE
Confidence             3458889999999999998853                235788899999999999999999999  999999999999


Q ss_pred             EeCCCCcEEEeccccceeccccceee--------eecccCccccCCCccccccceeeec
Q 027788          163 VNGNTGQVKIGDLGVAAIVGRAIRRI--------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       163 i~~~~~~~~l~dfg~a~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ++.+ +.++++|||+++.........        ..+.+ ++......++.++|+||+|
T Consensus       165 ~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG  221 (293)
T cd05053         165 VTED-HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMA-PEALFDRVYTHQSDVWSFG  221 (293)
T ss_pred             EcCC-CeEEeCccccccccccccceeccCCCCCCccccC-HHHhccCCcCcccceeehh
Confidence            9865 689999999998765432110        11222 3334455577789999999

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.96  E-value=3e-28  Score=191.45  Aligned_cols=180  Identities=22%  Similarity=0.327  Sum_probs=143.2

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCc---EEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGI---EVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      .+...+.||+|+||.||+|....++.   .+++|.++...   .....+.+..|++++++++|+|++++.+++...  ..
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~   80 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF--KP   80 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC--CC
Confidence            44677999999999999999876554   78999876442   344457788999999999999999999998544  45


Q ss_pred             EEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          103 LNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      .+++||++++++|.+++... ..+++..+..++.|++.|+.+||+.+  ++|+||+|+|++++.+ +.++++|||++...
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~  157 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSN-LECKVSDFGLSRVL  157 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCC-CcEEECCCccceec
Confidence            78899999999999988653 56899999999999999999999999  9999999999999865 58999999999876


Q ss_pred             cccceeeee--------cccCccccCCCccccccceeeec
Q 027788          182 GRAIRRIRC--------WGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~~~~~--------~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .........        ...+++......++.++|+||+|
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG  197 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFG  197 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHH
Confidence            543221100        11223334445677789999999

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.96  E-value=1.7e-28  Score=196.94  Aligned_cols=185  Identities=25%  Similarity=0.379  Sum_probs=147.4

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      +..+| ++.+.||+|+||.||+|.+..+++.||+|.++.....  ......+.+|+.++++++|+|++++++++..+..+
T Consensus         5 ~~~~y-~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (309)
T cd07845           5 SVTEF-EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLD   81 (309)
T ss_pred             cccce-eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC--CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence            44555 7779999999999999999999999999998754422  22223456799999999999999999998766656


Q ss_pred             eEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          102 TLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      .++++||+++ ++|.+++.. ...+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        82 ~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~kL~dfg~~~~  157 (309)
T cd07845          82 SIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDK-GCLKIADFGLART  157 (309)
T ss_pred             eEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECccceeee
Confidence            7899999996 578777664 356899999999999999999999999  9999999999999855 6899999999987


Q ss_pred             cccccee------eeecccCccccCCCccccccceeeec
Q 027788          181 VGRAIRR------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .......      +..+.+|+.......++.++|+||+|
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG  196 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVG  196 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHH
Confidence            7543211      11233444344445677889999999

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.96  E-value=3.3e-28  Score=194.25  Aligned_cols=186  Identities=24%  Similarity=0.380  Sum_probs=149.7

Q ss_pred             ccccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEe
Q 027788           17 FIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWR   96 (219)
Q Consensus        17 ~~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   96 (219)
                      ...+++..+| .+.+.||+|++|.||+|.+..++..+++|.+.....    ...+.+..|+.+++.+.|+|++++++.+.
T Consensus        13 ~~~~~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~   87 (296)
T cd06654          13 VSVGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYL   87 (296)
T ss_pred             cccCCcccce-eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            3456677777 666999999999999999999999999998875432    23466888999999999999999999885


Q ss_pred             cCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788           97 DEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus        97 ~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                      .  ....+++|||+++++|.+++.. ..++...+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++|+|||
T Consensus        88 ~--~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~-~~~kl~dfg  161 (296)
T cd06654          88 V--GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFG  161 (296)
T ss_pred             e--CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC-CCEEECccc
Confidence            4  4568899999999999998764 35789999999999999999999999  9999999999999855 589999999


Q ss_pred             cceeccccce------eeeecccCccccCCCccccccceeeecc
Q 027788          177 VAAIVGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       177 ~a~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ++........      ++..+.+| +......++.++|+||+|+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Dv~s~Gv  204 (296)
T cd06654         162 FCAQITPEQSKRSTMVGTPYWMAP-EVVTRKAYGPKVDIWSLGI  204 (296)
T ss_pred             cchhccccccccCcccCCccccCH-HHHcCCCCCccchHHHHHH
Confidence            9876543321      11122333 3344455677899999993

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.96  E-value=4.7e-28  Score=188.87  Aligned_cols=179  Identities=22%  Similarity=0.337  Sum_probs=146.4

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.+.||+|++|.||+|.+..++..+++|.+.....  .....+.+..|+.+++.++|||++++++.+.  ..+..++++
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~   78 (256)
T cd08220           3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFL--EDKALMIVM   78 (256)
T ss_pred             eEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEe--cCCEEEEEE
Confidence            677899999999999999999999999999875543  2344678899999999999999999998884  446788999


Q ss_pred             ccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          108 EVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       108 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      |++++++|.+++...  ..+++..+..++.|++.++.+||+++  ++|+||+|+||+++.+.+.++++|||++.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            999999999988653  34889999999999999999999999  99999999999998665567999999998775543


Q ss_pred             ee-----eeecccCccccCCCccccccceeeec
Q 027788          186 RR-----IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~~-----~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ..     ...+.+| +......++.++|+||+|
T Consensus       157 ~~~~~~~~~~y~aP-E~~~~~~~~~~~Dv~slG  188 (256)
T cd08220         157 KAYTVVGTPCYISP-ELCEGKPYNQKSDIWALG  188 (256)
T ss_pred             cccccccCCcccCc-hhccCCCCCcccchHHHH
Confidence            21     1123333 333445567789999999

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.96  E-value=3.9e-28  Score=194.68  Aligned_cols=189  Identities=24%  Similarity=0.383  Sum_probs=149.1

Q ss_pred             ccccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEe
Q 027788           17 FIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWR   96 (219)
Q Consensus        17 ~~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   96 (219)
                      ....++..+| ++.+.||+|+||.||+|....+++.|++|.+..... ......+.+.+|+++++.++|||++++.+++.
T Consensus         8 ~~~~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~   85 (307)
T cd06607           8 FSKDDPEKLF-TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL   85 (307)
T ss_pred             hcCCCcchhh-hhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence            3345566665 777999999999999999988999999998864322 23445577889999999999999999999986


Q ss_pred             cCCCceEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788           97 DEDRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus        97 ~~~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      ..  +..++++||++ |++.+++.. ...+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++|+||
T Consensus        86 ~~--~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~-~~~kL~df  159 (307)
T cd06607          86 RE--HTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEP-GTVKLADF  159 (307)
T ss_pred             eC--CeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCC-CCEEEeec
Confidence            54  45788999997 566666543 456899999999999999999999999  9999999999999865 58999999


Q ss_pred             ccceeccccce--eeeecccCcccc--CCCccccccceeeec
Q 027788          176 GVAAIVGRAIR--RIRCWGRRSSWR--RSCTMRITRSLWTYT  213 (219)
Q Consensus       176 g~a~~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~diws~g  213 (219)
                      |++........  +...+.+|+.+.  ....++.++|+||+|
T Consensus       160 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G  201 (307)
T cd06607         160 GSASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG  201 (307)
T ss_pred             CcceecCCCCCccCCccccCceeeeccCCCCCCcccchHHHH
Confidence            99976644322  222344454442  245577789999999

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.96  E-value=2.7e-28  Score=193.26  Aligned_cols=179  Identities=23%  Similarity=0.412  Sum_probs=147.5

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|++|.||+|.+..++..+++|.+.....  .......+.+|+.+++.++|||++++++++..  ...++++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v   77 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLV   77 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEE
Confidence            3788999999999999999999999999999876542  23445778899999999999999999999854  4668899


Q ss_pred             eccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          107 TEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      +|++ +++|.+++.. ...+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++++|||++.......
T Consensus        78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISAD-GVLKIADFGLARLFSEEE  153 (286)
T ss_pred             eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCC-CcEEEeeeeecccccCCC
Confidence            9999 8999998754 356899999999999999999999999  9999999999999865 589999999998775543


Q ss_pred             e-------eeeecccCccccCCCccccccceeeec
Q 027788          186 R-------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~-------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .       ++..+.+|+.+.....++.++|+||+|
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG  188 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVG  188 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHH
Confidence            1       122233444444455567789999999

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.96  E-value=1.1e-28  Score=194.92  Aligned_cols=174  Identities=16%  Similarity=0.235  Sum_probs=134.6

Q ss_pred             eeccccceEEEEEEecC------------------------CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCC
Q 027788           32 LLGSGAVKKVYRAFDQE------------------------EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN   87 (219)
Q Consensus        32 ~ig~g~~g~V~~a~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   87 (219)
                      .||+|+||.||+|....                        ....|++|.++..    .......+..|+.+++.++|||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~~~~l~h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS----HRDIALAFFETASLMSQVSHIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH----HHHHHHHHHHHHHHHhcCCCCC
Confidence            68999999999987422                        2245888887643    2334467888999999999999


Q ss_pred             ceEEEEEEecCCCceEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC
Q 027788           88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN  166 (219)
Q Consensus        88 i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~  166 (219)
                      |+++++++...  ...+++|||+++++|..++.. .+.+++..+..++.|++.|+.|||+++  ++||||||+||+++..
T Consensus        78 iv~~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~  153 (274)
T cd05076          78 LAFVHGVCVRG--SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARL  153 (274)
T ss_pred             eeeEEEEEEeC--CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEecc
Confidence            99999998654  457789999999999988765 456889999999999999999999999  9999999999999743


Q ss_pred             C------CcEEEeccccceeccccce--eeeecccCccccCCCccccccceeeec
Q 027788          167 T------GQVKIGDLGVAAIVGRAIR--RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       167 ~------~~~~l~dfg~a~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .      ..++++|||++........  .+..+.+|+.......++.++|+||||
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG  208 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFG  208 (274)
T ss_pred             CcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHH
Confidence            1      2379999998865533222  223344554444446678889999999

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.96  E-value=5.4e-28  Score=190.07  Aligned_cols=176  Identities=24%  Similarity=0.390  Sum_probs=141.7

Q ss_pred             eeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEecc
Q 027788           30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        30 ~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      ...||+|+||.||+|.+..++..|++|.++..    .....+.+.+|+.+++.++|+||+++++.+..  .+.+++++|+
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~   86 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGFFKIFMEQ   86 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCEEEEEEec
Confidence            35899999999999999999999999987744    23445778899999999999999999998854  4568899999


Q ss_pred             ccCCChHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          110 CTSGNLREYRKKH-RHV--SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       110 ~~~g~L~~~~~~~-~~~--~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      +++++|.+++... ..+  ++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+.+.++|+|||++........
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            9999999988653 345  78888999999999999999999  999999999999986556899999999876543221


Q ss_pred             ------eeeecccCccccCC-Cccccccceeeec
Q 027788          187 ------RIRCWGRRSSWRRS-CTMRITRSLWTYT  213 (219)
Q Consensus       187 ------~~~~~~~~~~~~~~-~~~~~~~diws~g  213 (219)
                            ++..+.+|+.+... ..++.++|+||+|
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slG  198 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLG  198 (268)
T ss_pred             ccccCCCCccccChhhhccccccCCchhhhHHHH
Confidence                  22233344443332 3467789999999

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.96  E-value=2.4e-28  Score=194.85  Aligned_cols=181  Identities=23%  Similarity=0.363  Sum_probs=140.1

Q ss_pred             CCceeeeeeeeccccceEEEEEEec----------------CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCC
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQ----------------EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK   86 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~----------------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   86 (219)
                      .++| .+.+.||+|+||.||++.+.                .+...+|+|.+....   .....+.+.+|+.+++.++|+
T Consensus         4 ~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~~   79 (296)
T cd05095           4 RKRL-TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKDP   79 (296)
T ss_pred             hhhc-eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCC
Confidence            3454 78899999999999998543                234578999877442   344557889999999999999


Q ss_pred             CceEEEEEEecCCCceEEEEeccccCCChHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeC
Q 027788           87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-----------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRD  155 (219)
Q Consensus        87 ~i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~-----------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~d  155 (219)
                      |++++++++...  ...+++||++++++|.+++....           .+++..+..++.|++.|+.+||+.+  ++|+|
T Consensus        80 ~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~d  155 (296)
T cd05095          80 NIIRLLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRD  155 (296)
T ss_pred             CcceEEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eeccc
Confidence            999999988554  45788999999999999886532           3567789999999999999999999  99999


Q ss_pred             CCCCceEEeCCCCcEEEeccccceecccccee--e------eecccCccccCCCccccccceeeec
Q 027788          156 LNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR--I------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       156 l~~~nili~~~~~~~~l~dfg~a~~~~~~~~~--~------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |||+||+++.+ +.++++|||++..+......  .      ..+.+|+ ......++.++|+||+|
T Consensus       156 lkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe-~~~~~~~~~~~DiwSlG  219 (296)
T cd05095         156 LATRNCLVGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWE-SILLGKFTTASDVWAFG  219 (296)
T ss_pred             CChheEEEcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHH-HHhcCCccchhhhhHHH
Confidence            99999999855 58999999999866443210  0      1122222 22334577789999999

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.96  E-value=2.4e-28  Score=195.03  Aligned_cols=178  Identities=24%  Similarity=0.409  Sum_probs=139.1

Q ss_pred             eeeeeeeccccceEEEEEEecCCCc--EEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGI--EVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~  103 (219)
                      +.+.+.||+|+||.||+|....++.  .+++|.++...   .....+.+..|+.++.++ +|||++++++.+..  ...+
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~   78 (297)
T cd05089           4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA---SENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYL   78 (297)
T ss_pred             ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC---CHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcc
Confidence            3788999999999999999877664  46888766322   334457788999999999 79999999998854  4557


Q ss_pred             EEEeccccCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC
Q 027788          104 NFITEVCTSGNLREYRKKHR----------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT  167 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~----------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~  167 (219)
                      ++++||+++++|.+++....                .+++..+..++.|++.|+.+||+.+  ++|+||||+|++++.+ 
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~-  155 (297)
T cd05089          79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGEN-  155 (297)
T ss_pred             eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCC-
Confidence            88999999999999886432                4778899999999999999999999  9999999999999865 


Q ss_pred             CcEEEeccccceecccccee----ee-ecccCccccCCCccccccceeeec
Q 027788          168 GQVKIGDLGVAAIVGRAIRR----IR-CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       168 ~~~~l~dfg~a~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +.++|+|||++.........    .. .+.+ ++......++.++|+||||
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~DvwSlG  205 (297)
T cd05089         156 LASKIADFGLSRGEEVYVKKTMGRLPVRWMA-IESLNYSVYTTKSDVWSFG  205 (297)
T ss_pred             CeEEECCcCCCccccceeccCCCCcCccccC-chhhccCCCCchhhHHHHH
Confidence            58999999998654322111    11 1223 3344455577889999999

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9.3e-30  Score=196.65  Aligned_cols=186  Identities=20%  Similarity=0.322  Sum_probs=159.6

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.++||+|.||+|.+++.+.+++.+|+|++++...-. -+.+.+.+.|..+|+..+||.+..+...|+.  ++.+|+||
T Consensus       171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviia-kdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt--~drlCFVM  247 (516)
T KOG0690|consen  171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIA-KDEVAHTLTENRVLQNCRHPFLTSLKYSFQT--QDRLCFVM  247 (516)
T ss_pred             hHHHHhcCCccceEEEEeecccCceeehhhhhhhheee-hHHhhhhhhHHHHHHhccCcHHHHhhhhhcc--CceEEEEE
Confidence            55678999999999999999999999999999776543 3456888999999999999999999888854  46699999


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce-
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR-  186 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~-  186 (219)
                      ||..||.|+-.++..+.+++...+.+-..|++||.|||+++  |++||||.+|++++++ |.+||.|||+++--..... 
T Consensus       248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkD-GHIKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKD-GHIKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccC-CceEeeecccchhcccccce
Confidence            99999999998998889999999999999999999999999  9999999999999977 6999999999987655443 


Q ss_pred             eeeecccCcc----ccCCCccccccceeeec--cccccC
Q 027788          187 RIRCWGRRSS----WRRSCTMRITRSLWTYT--RLGCAC  219 (219)
Q Consensus       187 ~~~~~~~~~~----~~~~~~~~~~~diws~g--i~~~~c  219 (219)
                      -.+.+|+|+.    ......|...-|-|++|  ++.+-|
T Consensus       325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmC  363 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMC  363 (516)
T ss_pred             eccccCChhhcCchhhccccccceeehhhhhHHHHHHHh
Confidence            4456788764    35567788889999999  444433

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3e-28  Score=196.01  Aligned_cols=150  Identities=20%  Similarity=0.373  Sum_probs=130.3

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|++|.||+|.+..++..+|+|.+...... .....+.+..|+++++.++|+||+++++.+.  .....+++
T Consensus         3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv   79 (316)
T cd05574           3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHPFLPTLYASFQ--TETYLCLV   79 (316)
T ss_pred             eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-hHHHHHHHHHHHHHHHhCCCCCchhheeeee--cCCEEEEE
Confidence            47779999999999999999999999999998865432 2235577899999999999999999998884  45678899


Q ss_pred             eccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          107 TEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ||++.+++|.+++...  ..+++.....++.|++.++.|||..+  ++|+||||+||+++.+ +.++|+|||++....
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~  154 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHES-GHIMLSDFDLSKQSD  154 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCC-CCEEEeecchhhccc
Confidence            9999999999988654  46889999999999999999999999  9999999999999865 689999999987654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.96  E-value=3.4e-28  Score=192.18  Aligned_cols=182  Identities=20%  Similarity=0.268  Sum_probs=143.0

Q ss_pred             ceeeeeeeeccccceEEEEEEecC-----CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQE-----EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      +.+.+.+.||+|++|.||+|....     ++..|++|.+....   .......+.+|+.+++.++|+|++++++++... 
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-   81 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER-   81 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-
Confidence            445788999999999999999876     67889999876432   233446688999999999999999999988544 


Q ss_pred             CceEEEEeccccCCChHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC--CcE
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHR-------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT--GQV  170 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~-------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~--~~~  170 (219)
                       ...+++||++++++|.+++....       .+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+.  ..+
T Consensus        82 -~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          82 -LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             -CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcce
Confidence             44678999999999999886542       4788999999999999999999999  99999999999997442  258


Q ss_pred             EEeccccceecccccee--e-----eecccCccccCCCccccccceeeec
Q 027788          171 KIGDLGVAAIVGRAIRR--I-----RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       171 ~l~dfg~a~~~~~~~~~--~-----~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +++|||+++........  .     .....+++......++.++||||||
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  208 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFG  208 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHH
Confidence            99999999876332210  0     0112233444556678889999999

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.96  E-value=3.8e-28  Score=191.27  Aligned_cols=182  Identities=24%  Similarity=0.386  Sum_probs=145.0

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCC------CHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD------DPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      |.+.+.||+|++|.||+|.+..+++.+|+|.++......      .....+.+..|+.+++.++|+|++++++++.  ..
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~   80 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--TE   80 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec--cC
Confidence            367789999999999999998899999999886532211      1123456888999999999999999999884  44


Q ss_pred             ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          101 NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      +.++++|||+++++|.+++.....++...+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++++|||++..
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~-~~~~l~d~~~~~~  157 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDAD-GICKISDFGISKK  157 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCC-CeEEEeecccccc
Confidence            668889999999999999887778999999999999999999999999  9999999999999865 5899999999976


Q ss_pred             ccccce--------eeeecccCccccCC-Cccccccceeeec
Q 027788          181 VGRAIR--------RIRCWGRRSSWRRS-CTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~--------~~~~~~~~~~~~~~-~~~~~~~diws~g  213 (219)
                      ......        +...+.+|+..... ..++.++|+||+|
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG  199 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLG  199 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHH
Confidence            543211        11122334333322 2467789999999

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=4.2e-28  Score=191.38  Aligned_cols=179  Identities=20%  Similarity=0.315  Sum_probs=141.2

Q ss_pred             eeeeeeeeccccceEEEEEEecCC-----CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEE-----GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      .+.+.+.||+|+||.||+|.....     +..+|+|.+....   .......+.+|+.+++.++|+|++++++++..  .
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~   81 (277)
T cd05032           7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVST--G   81 (277)
T ss_pred             HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC--C
Confidence            347889999999999999987643     4789999876432   33445678899999999999999999999854  4


Q ss_pred             ceEEEEeccccCCChHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcE
Q 027788          101 NTLNFITEVCTSGNLREYRKKHR----------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQV  170 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~~----------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~  170 (219)
                      ...+++|||+++++|.+++....          .+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~-~~~  158 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAED-LTV  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCC-CCE
Confidence            56788999999999999875432          3577889999999999999999999  9999999999999866 689


Q ss_pred             EEeccccceeccccce--------eeeecccCccccCCCccccccceeeec
Q 027788          171 KIGDLGVAAIVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       171 ~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +|+|||+++.......        .+..+.+| +......++.++|+||||
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  208 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP-ESLKDGVFTTKSDVWSFG  208 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCH-HHHhcCCCCcccchHHHH
Confidence            9999999876543321        11122333 333445577789999999

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.96  E-value=2.8e-28  Score=191.35  Aligned_cols=181  Identities=28%  Similarity=0.399  Sum_probs=144.9

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccC--CCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC--DDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      |++.+.||+|+||.||+|.. .++..+|+|.++.....  ........+.+|+++++.++|+|++++.+++..  ...++
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~   78 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTIS   78 (265)
T ss_pred             ccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeEE
Confidence            36778999999999999985 57889999998754321  123344678899999999999999999999854  46788


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      +++|++++++|.+++.....+++..+..++.|++.++.+||+.+  ++|+||+|+|++++.+ +.++|+|||++......
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCC-CeEEeccchhhHhhhhc
Confidence            99999999999999887778899999999999999999999999  9999999999999855 68999999998765321


Q ss_pred             ce------------eeeecccCccccCCCccccccceeeecc
Q 027788          185 IR------------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       185 ~~------------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ..            ++..+ .+++......++.++|+||+|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~-~~pe~~~~~~~~~~~Dv~slG~  196 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYW-MAPEVINESGYGRKSDIWSIGC  196 (265)
T ss_pred             cccccccccccccCCCccc-cChhhhcCCCCcchhhHHHHHH
Confidence            10            11112 2334445555678899999993

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.96  E-value=5e-28  Score=193.88  Aligned_cols=180  Identities=18%  Similarity=0.272  Sum_probs=145.2

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||+|+||.||++.+..+++.|++|.+...... .....+.+.+|+.+++.++||||+++++.+.  ....++++
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv   79 (305)
T cd05609           3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI-LRNQIQQVFVERDILTFAENPFVVSMFCSFE--TKRHLCMV   79 (305)
T ss_pred             ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh-hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe--cCCEEEEE
Confidence            36779999999999999999999999999998754321 2334567889999999999999999998884  45678899


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc-
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI-  185 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~-  185 (219)
                      ||++++++|.+++...+.+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++++|||+++...... 
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCC-CCEEEeeCCCccccCcCcc
Confidence            999999999999987778999999999999999999999999  9999999999999855 689999999886421100 


Q ss_pred             --------------------eeeeecccCccccCCCccccccceeeec
Q 027788          186 --------------------RRIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 --------------------~~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                                          .+...+.+| +......++.++|+||+|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  203 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAP-EVILRQGYGKPVDWWAMG  203 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCc-hhccCCCCCchhhHHHHH
Confidence                                011112223 333445677889999999

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.96  E-value=1.9e-28  Score=193.66  Aligned_cols=179  Identities=22%  Similarity=0.286  Sum_probs=143.2

Q ss_pred             eeeeeeeeccccceEEEEEEec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQ-----EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      .+.+.+.||+|+||.||+|...     .++..+|+|.++...   .....+.+.+|+++++.++|+|++++++.+...  
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--   80 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARKDFEREAELLTNFQHENIVKFYGVCTEG--   80 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC---CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC--
Confidence            3477789999999999999764     346789999887543   233457889999999999999999999998544  


Q ss_pred             ceEEEEeccccCCChHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC
Q 027788          101 NTLNFITEVCTSGNLREYRKKH--------------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN  166 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~--------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~  166 (219)
                      ...+++|||+++++|.+++...              ..+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~  158 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYD  158 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCC
Confidence            5688999999999999988653              23678889999999999999999999  9999999999999866


Q ss_pred             CCcEEEeccccceeccccce--------eeeecccCccccCCCccccccceeeec
Q 027788          167 TGQVKIGDLGVAAIVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       167 ~~~~~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                       +.++|+|||++........        ....+.+| +......++.++|+||+|
T Consensus       159 -~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  211 (280)
T cd05049         159 -LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPP-ESIMYRKFTTESDVWSFG  211 (280)
T ss_pred             -CeEEECCcccceecccCcceecCCCCcccceecCh-hhhccCCcchhhhHHHHH
Confidence             6899999999986533221        01123333 444556678889999999

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=1.5e-28  Score=206.27  Aligned_cols=170  Identities=19%  Similarity=0.264  Sum_probs=137.4

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||+|+||.||+|.+..+++.||+|....          ..+.+|+.++++++|+||+++++++...  ...+++
T Consensus       171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~--~~~~lv  238 (461)
T PHA03211        171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVG--GLTCLV  238 (461)
T ss_pred             eEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEEC--CEEEEE
Confidence            4888999999999999999999999999995321          2345799999999999999999988554  457789


Q ss_pred             eccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          107 TEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ||++. ++|..++... ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.+ +.++|+|||+++......
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGP-EDICLGDFGAACFARGSW  314 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCC-CCEEEcccCCceeccccc
Confidence            99995 6887776543 46899999999999999999999999  9999999999999865 589999999998764322


Q ss_pred             e--------eeeecccCccccCCCccccccceeeec
Q 027788          186 R--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .        ++..+.+|+ ......++.++|+||||
T Consensus       315 ~~~~~~~~~GT~~Y~APE-~~~~~~~~~~sDvwSlG  349 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPE-VLAGDPYTPSVDIWSAG  349 (461)
T ss_pred             ccccccccCCCcCCcCHH-HHcCCCCCchHHHHHHH
Confidence            1        222233333 33455678889999999

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=1.3e-28  Score=201.56  Aligned_cols=171  Identities=23%  Similarity=0.272  Sum_probs=137.2

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|+||.||+|.+..++..||+|.....          ....|+.++++++|+||+++++++...  ...+++
T Consensus        68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv  135 (357)
T PHA03209         68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSG--AITCMV  135 (357)
T ss_pred             cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeC--CeeEEE
Confidence            48889999999999999999999999999974321          134699999999999999999998644  457889


Q ss_pred             eccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          107 TEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      +|++. ++|.+++.. ...+++..+..++.|++.||.|||..+  ++||||||+||+++.+ +.++|+|||+++......
T Consensus       136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDV-DQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEecCccccccccCc
Confidence            99995 577776643 457899999999999999999999999  9999999999999865 589999999997543222


Q ss_pred             e-----eeeecccCccccCCCccccccceeeecc
Q 027788          186 R-----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       186 ~-----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .     ++..+.+|+ ......++.++|+||+|+
T Consensus       212 ~~~~~~gt~~y~aPE-~~~~~~~~~~~DiwSlGv  244 (357)
T PHA03209        212 AFLGLAGTVETNAPE-VLARDKYNSKADIWSAGI  244 (357)
T ss_pred             ccccccccccccCCe-ecCCCCCCchhhHHHHHH
Confidence            1     222334443 344456788899999993

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=4.1e-28  Score=192.15  Aligned_cols=177  Identities=19%  Similarity=0.311  Sum_probs=136.4

Q ss_pred             eeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHh---hCCCCceEEEEEEecCCCceEEEEec
Q 027788           32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKT---LANKNIISLHYVWRDEDRNTLNFITE  108 (219)
Q Consensus        32 ~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~---l~~~~i~~~~~~~~~~~~~~~~lv~e  108 (219)
                      .||+|+||.||++.+..+++.+|+|.+........ .....+..|..+++.   ..||+++.+.+.+..+  +..+++||
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e   77 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILD   77 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEe
Confidence            48999999999999999999999999875443211 112333445444433   4789999998888544  45788999


Q ss_pred             cccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce--
Q 027788          109 VCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR--  186 (219)
Q Consensus       109 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~--  186 (219)
                      |+++++|.+++.....+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+ +.++++|||++........  
T Consensus        78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~  154 (279)
T cd05633          78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKPHA  154 (279)
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCC-CCEEEccCCcceeccccCccC
Confidence            9999999998887778999999999999999999999999  9999999999999855 5899999999876543221  


Q ss_pred             --eeeecccCccccCCCccccccceeeecc
Q 027788          187 --RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 --~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                        ++..+.+|+.......++.++|+||+|+
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~  184 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGC  184 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHH
Confidence              2223334443434455778899999993

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.96  E-value=2.5e-28  Score=194.13  Aligned_cols=180  Identities=24%  Similarity=0.405  Sum_probs=142.3

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+| .+.+.||+|++|.||+|.+..+++.||+|.+......   .....+.+|++++++++|+||+++++++.  +.+..
T Consensus         5 ~~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~   78 (291)
T cd07844           5 ETY-KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFTAIREASLLKDLKHANIVTLHDIIH--TKKTL   78 (291)
T ss_pred             cce-eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchhHHHHHHHHhhCCCcceeeEEEEEe--cCCeE
Confidence            345 6779999999999999999989999999998754321   11234668999999999999999999985  44678


Q ss_pred             EEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          104 NFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +++|||++ ++|.+++... ..+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        79 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~  154 (291)
T cd07844          79 TLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISER-GELKLADFGLARAKS  154 (291)
T ss_pred             EEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCC-CCEEECccccccccC
Confidence            89999997 4888877653 46789999999999999999999999  9999999999999865 589999999987643


Q ss_pred             ccce------eeeecccCccccCCCccccccceeeec
Q 027788          183 RAIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ....      .+..+.+|+.......++.++|+||+|
T Consensus       155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG  191 (291)
T cd07844         155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVG  191 (291)
T ss_pred             CCCccccccccccccCCcHHhhcCcccCcHHHHHHHH
Confidence            2211      112233344334445577789999999

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=7.3e-30  Score=195.95  Aligned_cols=184  Identities=25%  Similarity=0.358  Sum_probs=144.2

Q ss_pred             eeeeeeeccccceEEEEEEecCCC----cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      |++..+||+|+||.||+|...++.    +++|+|.++....  ..+.....-+|+.+++.++|||++.+..+|... ...
T Consensus        26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd--~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~  102 (438)
T KOG0666|consen   26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD--GTGISMSACREIALLRELKHPNVISLVKVFLSH-DKK  102 (438)
T ss_pred             hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC--CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cce
Confidence            367789999999999999765443    3789998886543  223334456799999999999999999888754 467


Q ss_pred             EEEEeccccCCChHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC---CCcEEEec
Q 027788          103 LNFITEVCTSGNLREYRKKH-----RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN---TGQVKIGD  174 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~---~~~~~l~d  174 (219)
                      +++++||.+ .+|...+.-+     ..++...+..++.|++.|+.|||++.  ++||||||.||++..+   .|.|||+|
T Consensus       103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeec
Confidence            899999997 4887776533     35888999999999999999999999  9999999999999744   36899999


Q ss_pred             cccceecccccee---------eeecccCccccCCCccccccceeeec-ccc
Q 027788          175 LGVAAIVGRAIRR---------IRCWGRRSSWRRSCTMRITRSLWTYT-RLG  216 (219)
Q Consensus       175 fg~a~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~diws~g-i~~  216 (219)
                      ||+++.+..+...         +..+++|+-...++-|+.+-|+|+.| |+|
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfa  231 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFA  231 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHH
Confidence            9999999877642         23344444455556678888888888 554

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.96  E-value=4.1e-28  Score=192.84  Aligned_cols=179  Identities=20%  Similarity=0.312  Sum_probs=138.7

Q ss_pred             eeeeeeeeccccceEEEEEEec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQ-----EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      .|.+.+.||+|+||.||+|...     ..+..||+|.++...   .......+.+|+.+++.++|+|++++++.+...  
T Consensus         7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--   81 (288)
T cd05061           7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG--   81 (288)
T ss_pred             HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC--
Confidence            3478899999999999998754     235589999876432   233445678899999999999999999988544  


Q ss_pred             ceEEEEeccccCCChHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcE
Q 027788          101 NTLNFITEVCTSGNLREYRKKH----------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQV  170 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~----------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~  170 (219)
                      ...+++|||+++|+|.+++...          .......+..++.|++.|+.|||+++  ++|+||||+||+++.+ +.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~-~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHD-FTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCC-CcE
Confidence            4578899999999999998642          22456778889999999999999999  9999999999999865 589


Q ss_pred             EEeccccceecccccee--------eeecccCccccCCCccccccceeeec
Q 027788          171 KIGDLGVAAIVGRAIRR--------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       171 ~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +++|||+++........        ...+.+ ++......++.++|+||+|
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~-pE~~~~~~~~~~~DvwslG  208 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMA-PESLKDGVFTTSSDMWSFG  208 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccC-HHHhccCCCChHhHHHHHH
Confidence            99999998865432210        111222 3344455677789999999

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.96  E-value=6e-28  Score=192.17  Aligned_cols=177  Identities=25%  Similarity=0.330  Sum_probs=141.0

Q ss_pred             eeeeeeeccccceEEEEEEec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           27 GRYNELLGSGAVKKVYRAFDQ-----EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      +.+.+.||+|+||.||+|...     .++..+++|.+...    .....+.+.+|+.++++++|+|++++++++..  ..
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~   80 (291)
T cd05094           7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEHIVKFYGVCGD--GD   80 (291)
T ss_pred             eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--CC
Confidence            578899999999999999743     34567888887633    34445678899999999999999999999854  45


Q ss_pred             eEEEEeccccCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC
Q 027788          102 TLNFITEVCTSGNLREYRKKHR----------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG  165 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~----------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~  165 (219)
                      ..+++|||+++++|.+++..+.                .+++..+..++.|++.++.+||+++  ++|+||||+||+++.
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~  158 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGA  158 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEcc
Confidence            5788999999999999986532                3788899999999999999999999  999999999999986


Q ss_pred             CCCcEEEeccccceecccccee--------eeecccCccccCCCccccccceeeec
Q 027788          166 NTGQVKIGDLGVAAIVGRAIRR--------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       166 ~~~~~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      + +.++|+|||++.........        ...+.+ ++......++.++|+||+|
T Consensus       159 ~-~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG  212 (291)
T cd05094         159 N-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP-PESIMYRKFTTESDVWSFG  212 (291)
T ss_pred             C-CcEEECCCCcccccCCCceeecCCCCCcceeecC-hHHhccCCCCchhhHHHHH
Confidence            6 58999999999765443211        111223 3344455677789999999

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=1.2e-28  Score=195.25  Aligned_cols=153  Identities=22%  Similarity=0.344  Sum_probs=136.5

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      .-+.+++.+.||+|..|+||+|+...++..+|+|++.+.... ....+.+...|.++|+.++||.+..++..|  +..++
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~-~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f--et~~~  151 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA-SRKKLKRAQTEREILSLLDHPFLPTLYASF--ETDKY  151 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh-hhhHHHHHHHHHHHHHhcCCCccchhhhee--eccce
Confidence            344557788999999999999999999999999999876654 355678889999999999999999999999  55678


Q ss_pred             EEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          103 LNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      .+++||||+||+|..+++++  ..++++.+++++..|+.||+|||..|  |++|||||+|||+-.+ |.+.|+||.++..
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvred-GHIMLsDFDLS~~  228 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVRED-GHIMLSDFDLSLR  228 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecC-CcEEeeecccccc
Confidence            99999999999999988765  46999999999999999999999999  9999999999999855 7999999998876


Q ss_pred             c
Q 027788          181 V  181 (219)
Q Consensus       181 ~  181 (219)
                      .
T Consensus       229 ~  229 (459)
T KOG0610|consen  229 C  229 (459)
T ss_pred             C
Confidence            6

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=3.5e-28  Score=201.27  Aligned_cols=172  Identities=19%  Similarity=0.274  Sum_probs=137.8

Q ss_pred             eeeeeeeeccccceEEEEEEec--CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQ--EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .|.+.+.||+|+||.||+|...  .++..|++|.+...         ....+|+.++++++||||+++++.+..  ...+
T Consensus        93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~  161 (392)
T PHA03207         93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRW--KSTV  161 (392)
T ss_pred             ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEee--CCEE
Confidence            3488899999999999999753  45678999976532         223479999999999999999998854  4568


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++||++. ++|..++.....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||++.....
T Consensus       162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~-~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEP-ENAVLGDFGAACKLDA  237 (392)
T ss_pred             EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCC-CCEEEccCccccccCc
Confidence            88999995 688888876778999999999999999999999999  9999999999999865 5899999999977654


Q ss_pred             cce--------eeeecccCccccCCCccccccceeeec
Q 027788          184 AIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...        ++..+.+| +......++.++|+||+|
T Consensus       238 ~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DvwslG  274 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSP-ELLALDPYCAKTDIWSAG  274 (392)
T ss_pred             ccccccccccccccCccCH-hHhcCCCCCchhhHHHHH
Confidence            322        11122233 344455677889999999

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.96  E-value=2e-28  Score=191.27  Aligned_cols=173  Identities=19%  Similarity=0.314  Sum_probs=136.7

Q ss_pred             eeeccccceEEEEEEecCCC----------cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           31 ELLGSGAVKKVYRAFDQEEG----------IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      +.||+|+||.||+|....++          ..+++|.+....     .....+.+|+.+++.++|||++++++.+..   
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   72 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR---   72 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec---
Confidence            46899999999999987766          357777665332     115778899999999999999999998865   


Q ss_pred             ceEEEEeccccCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCC------cEEEe
Q 027788          101 NTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG------QVKIG  173 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~------~~~l~  173 (219)
                      ...++++||+++++|.+++.... .++...+..++.|++.|+.|||+++  ++|+||||+||+++.+..      .++++
T Consensus        73 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          73 DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeC
Confidence            33578999999999999987665 6899999999999999999999999  999999999999985531      58999


Q ss_pred             ccccceeccccce--eeeecccCccccCC-Cccccccceeeec
Q 027788          174 DLGVAAIVGRAIR--RIRCWGRRSSWRRS-CTMRITRSLWTYT  213 (219)
Q Consensus       174 dfg~a~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~diws~g  213 (219)
                      |||++........  ....+.+|+.+... ..++.++|+||+|
T Consensus       151 Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG  193 (259)
T cd05037         151 DPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFG  193 (259)
T ss_pred             CCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHH
Confidence            9999987654221  22233444433333 3677789999999

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.96  E-value=1.3e-28  Score=193.30  Aligned_cols=180  Identities=26%  Similarity=0.439  Sum_probs=144.9

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|++|.||+|....++..+++|.+..... .+.....++.+|+.+++.++|+|++++++.+...  +..+++
T Consensus         4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~~v   80 (267)
T cd08229           4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NELNIV   80 (267)
T ss_pred             hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC--CeEEEE
Confidence            3677899999999999999999999999998775332 1334457788999999999999999999988544  467889


Q ss_pred             eccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          107 TEVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ||++++++|.+++..    ...+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++++|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEECcchhhhccc
Confidence            999999999988753    245789999999999999999999999  9999999999999865 589999999987664


Q ss_pred             ccce------eeeecccCccccCCCccccccceeeec
Q 027788          183 RAIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ....      +...+.+ +++.....++.++|+||+|
T Consensus       158 ~~~~~~~~~~~~~~~~a-pe~~~~~~~~~~~Dv~slG  193 (267)
T cd08229         158 SKTTAAHSLVGTPYYMS-PERIHENGYNFKSDIWSLG  193 (267)
T ss_pred             cCCcccccccCCcCccC-HHHhcCCCccchhhHHHHH
Confidence            4321      1111222 3344455677789999999

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.96  E-value=4.9e-28  Score=189.03  Aligned_cols=177  Identities=21%  Similarity=0.353  Sum_probs=144.4

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+.+++.+.||.|++|.||+|...  ++.+|+|.++...     ...+++.+|+.+++.++|+|++++++.+..  ....
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~   75 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPL   75 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCe
Confidence            445588899999999999999764  7889999987432     245788999999999999999999999854  4567


Q ss_pred             EEEeccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          104 NFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      +++||++++++|.+++....  .+++..+..++.|++.++.|||..+  ++|+||+|+||+++.+ +.++|+|||.++..
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~-~~~~l~d~g~~~~~  152 (256)
T cd05039          76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSED-LVAKVSDFGLAKEA  152 (256)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCC-CCEEEccccccccc
Confidence            88999999999999987654  6899999999999999999999999  9999999999999855 58999999999877


Q ss_pred             ccccee---eeecccCccccCCCccccccceeeec
Q 027788          182 GRAIRR---IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~~---~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ......   ...+.+| +......++.++|+||+|
T Consensus       153 ~~~~~~~~~~~~~~ap-e~~~~~~~~~~~Di~slG  186 (256)
T cd05039         153 SQGQDSGKLPVKWTAP-EALREKKFSTKSDVWSFG  186 (256)
T ss_pred             ccccccCCCcccccCc-hhhcCCcCCcHHHHHHHH
Confidence            443321   1112233 334455677789999999

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.96  E-value=5.3e-28  Score=194.52  Aligned_cols=180  Identities=29%  Similarity=0.408  Sum_probs=141.1

Q ss_pred             CceeeeeeeeccccceEEEEEEec-------CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQ-------EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVW   95 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~   95 (219)
                      .++ .+.+.||+|+||.||+|.+.       .....+|+|.++...   .......+..|+.+++++ +||||+++++++
T Consensus        12 ~~~-~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          12 DRL-VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA---TDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             HHe-eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC---ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            445 78899999999999999753       234579999877432   344567788999999999 699999999988


Q ss_pred             ecCCCceEEEEeccccCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCC
Q 027788           96 RDEDRNTLNFITEVCTSGNLREYRKKH----------------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCS  159 (219)
Q Consensus        96 ~~~~~~~~~lv~e~~~~g~L~~~~~~~----------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~  159 (219)
                      ..  ...++++|||+++++|.+++...                ..++...+..++.|++.++.|||+++  ++|+||||+
T Consensus        88 ~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~  163 (314)
T cd05099          88 TQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAAR  163 (314)
T ss_pred             cc--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccce
Confidence            54  45688999999999999988643                24778889999999999999999999  999999999


Q ss_pred             ceEEeCCCCcEEEeccccceecccccee------e--eecccCccccCCCccccccceeeec
Q 027788          160 NVFVNGNTGQVKIGDLGVAAIVGRAIRR------I--RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       160 nili~~~~~~~~l~dfg~a~~~~~~~~~------~--~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |++++.+ +.++|+|||+++........      .  ..+.+| +......++.++|+||+|
T Consensus       164 Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~DiwslG  223 (314)
T cd05099         164 NVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAP-EALFDRVYTHQSDVWSFG  223 (314)
T ss_pred             eEEEcCC-CcEEEccccccccccccccccccccCCCCccccCH-HHHccCCcCccchhhHHH
Confidence            9999865 58999999999866432210      0  123333 333445677789999999

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.96  E-value=5.3e-28  Score=188.90  Aligned_cols=176  Identities=22%  Similarity=0.313  Sum_probs=139.4

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      +.+.+.||+|+||.||++... ++..+|+|.+....     ...+.+.+|+.++++++|||++++++++.  ....++++
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~iv   77 (256)
T cd05114           6 LTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-----MSEEDFIEEAKVMMKLSHPKLVQLYGVCT--QQKPLYIV   77 (256)
T ss_pred             cEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-----ccHHHHHHHHHHHHHCCCCCceeEEEEEc--cCCCEEEE
Confidence            367789999999999999864 56689999876332     12356788999999999999999999884  44568899


Q ss_pred             eccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          107 TEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      |||+++++|.+++.. ...+++..+..++.|++.++.|||+.+  ++|+||+|+|++++.+ +.++++|||.+.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSST-GVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCC-CeEEECCCCCccccCCCc
Confidence            999999999998864 346889999999999999999999999  9999999999999855 589999999998654332


Q ss_pred             eeee------ecccCccccCCCccccccceeeec
Q 027788          186 RRIR------CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~~~~------~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ....      ....+++......++.++|+||+|
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G  188 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFG  188 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHH
Confidence            2111      112223344455677889999999

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.96  E-value=5.3e-28  Score=189.06  Aligned_cols=175  Identities=21%  Similarity=0.346  Sum_probs=139.4

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      ++.+.||+|+||.||.|... .+..+|+|.+.....     ..+.+.+|+.++++++||||+++++++..  ...++++|
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~   78 (256)
T cd05113           7 TFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYIVT   78 (256)
T ss_pred             EEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEEEE
Confidence            67789999999999999764 345699998774321     23568889999999999999999999854  34578899


Q ss_pred             ccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          108 EVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       108 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      ||+++++|.+++... ..+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|+|||.++.......
T Consensus        79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCC-CCEEECCCccceecCCCce
Confidence            999999999988653 46899999999999999999999999  9999999999999865 5899999999886644321


Q ss_pred             eee------ecccCccccCCCccccccceeeec
Q 027788          187 RIR------CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ~~~------~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...      ....+++......++.++|+||||
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG  188 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFG  188 (256)
T ss_pred             eecCCCccChhhCCHHHHhcCcccchhHHHHHH
Confidence            110      112233444445677789999999

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.96  E-value=5.7e-28  Score=195.95  Aligned_cols=185  Identities=25%  Similarity=0.345  Sum_probs=143.9

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCC-------CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEE
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEE-------GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISL   91 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~   91 (219)
                      ....+..+++.+.||+|+||.||.|++...       +..+|+|.++...   .....+.+.+|+.+++++ +|+||+++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA---TDKDLSDLVSEMEMMKMIGKHKNIINL   83 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc---CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence            344455668999999999999999986432       2368999877432   344567889999999999 79999999


Q ss_pred             EEEEecCCCceEEEEeccccCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeC
Q 027788           92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKH----------------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRD  155 (219)
Q Consensus        92 ~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~----------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~d  155 (219)
                      ++.+..  ...+++++||+++++|.+++...                ..++...+..++.|++.|+.|||..+  ++|+|
T Consensus        84 ~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~d  159 (334)
T cd05100          84 LGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRD  159 (334)
T ss_pred             eEEEcc--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccc
Confidence            999854  45688899999999999988642                23677888899999999999999999  99999


Q ss_pred             CCCCceEEeCCCCcEEEeccccceeccccce------e--eeecccCccccCCCccccccceeeec
Q 027788          156 LNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR------R--IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       156 l~~~nili~~~~~~~~l~dfg~a~~~~~~~~------~--~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |+|+||+++.+ +.++|+|||+++.......      .  ...+.+| +......++.++|+||+|
T Consensus       160 lkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  223 (334)
T cd05100         160 LAARNVLVTED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAP-EALFDRVYTHQSDVWSFG  223 (334)
T ss_pred             cccceEEEcCC-CcEEECCcccceecccccccccccCCCcCceEcCH-HHhccCCcCchhhhHHHH
Confidence            99999999866 5899999999986643221      0  0112333 334455677789999999

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.96  E-value=5.3e-28  Score=188.66  Aligned_cols=181  Identities=28%  Similarity=0.443  Sum_probs=146.6

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccC-CCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC-DDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      +..+.||+|++|.||+|....++..|++|.+...... ......+.+..|+.+++.++|+|++++.+.+.  +...++++
T Consensus         3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv   80 (258)
T cd06632           3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER--EEDNLYIF   80 (258)
T ss_pred             cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe--cCCeEEEE
Confidence            5678999999999999999889999999998754321 12345577889999999999999999999884  44568889


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      +||+++++|.+++.....+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~~  157 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSF  157 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEccCccceecccccc
Confidence            999999999999887777899999999999999999999999  9999999999999865 5899999999887644331


Q ss_pred             -----eeeecccCccccCCCccccccceeeec
Q 027788          187 -----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 -----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                           ++..+.+|+.......++.++|+||+|
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG  189 (258)
T cd06632         158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLG  189 (258)
T ss_pred             ccccCCCcceeCHHHhcCCCCCCchhhhHHHH
Confidence                 112233333333222367789999999

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.96  E-value=4.6e-28  Score=193.92  Aligned_cols=184  Identities=27%  Similarity=0.382  Sum_probs=142.8

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEec-------CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEE
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQ-------EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLH   92 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~   92 (219)
                      +....-+.+.+.||+|+||.||.|...       ..+..+|+|.++...   .....+.+.+|+.+++.+ +||||++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc---chHHHHHHHHHHHHHHhhccCCCchhee
Confidence            344555588899999999999999742       234579999876432   234457788999999999 899999999


Q ss_pred             EEEecCCCceEEEEeccccCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCC
Q 027788           93 YVWRDEDRNTLNFITEVCTSGNLREYRKKH----------------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDL  156 (219)
Q Consensus        93 ~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~----------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl  156 (219)
                      +.+...  ..++++|||+++++|.+++...                ..++...+..++.|++.|+.|||+.+  ++|+||
T Consensus        88 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dl  163 (304)
T cd05101          88 GACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDL  163 (304)
T ss_pred             EEEecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeeccc
Confidence            998544  5678899999999999988653                23677788999999999999999999  999999


Q ss_pred             CCCceEEeCCCCcEEEeccccceecccccee--------eeecccCccccCCCccccccceeeec
Q 027788          157 NCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR--------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       157 ~~~nili~~~~~~~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ||+||+++.+ +.++|+|||+++........        ...+.+|+ ......++.++|+||+|
T Consensus       164 kp~Nili~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG  226 (304)
T cd05101         164 AARNVLVTEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFG  226 (304)
T ss_pred             ccceEEEcCC-CcEEECCCccceecccccccccccCCCCCceeeCch-hhccCCCCchhhHHHHH
Confidence            9999999855 58999999999876542211        01123333 33445577789999999

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.96  E-value=7.2e-29  Score=194.14  Aligned_cols=175  Identities=19%  Similarity=0.299  Sum_probs=137.5

Q ss_pred             eeeccccceEEEEEEecCCCc-------EEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           31 ELLGSGAVKKVYRAFDQEEGI-------EVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      +.||+|+||.||+|.....+.       .+++|.+...    .....+.+..|+.+++.++|||++++++.+...  ...
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~   74 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG--DES   74 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC--CCc
Confidence            368999999999998765443       3788876533    234456788899999999999999999998654  346


Q ss_pred             EEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCC-------cEEEecc
Q 027788          104 NFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG-------QVKIGDL  175 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~-------~~~l~df  175 (219)
                      +++|||+++|+|..++... ..+++..+..++.|++.++.|||+.+  ++|+||||+||+++.+..       .++++||
T Consensus        75 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          75 IMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             EEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccc
Confidence            7899999999999988754 45889999999999999999999999  999999999999975532       2689999


Q ss_pred             ccceeccccce--eeeecccCccccCCCccccccceeeec
Q 027788          176 GVAAIVGRAIR--RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       176 g~a~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |++........  ++..+.+|+.+.....++.++|+||+|
T Consensus       153 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  192 (258)
T cd05078         153 GISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFG  192 (258)
T ss_pred             ccccccCCchhccccCCccCchhccCCCCCCchhhHHHHH
Confidence            99876654322  223344555555445677889999999

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.96  E-value=3.4e-28  Score=190.03  Aligned_cols=176  Identities=20%  Similarity=0.293  Sum_probs=139.7

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      +.+.+.||+|+||.||++.+. ++..+|+|.+.....     ....+.+|++++++++|+|++++++++.  .....+++
T Consensus         6 ~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv   77 (256)
T cd05059           6 LTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVCT--KQRPIFIV   77 (256)
T ss_pred             cchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEEc--CCCceEEE
Confidence            467889999999999999865 567899998764322     1245778999999999999999999884  44568889


Q ss_pred             eccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          107 TEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ||++++++|.+++... ..+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++++|||+++......
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGED-NVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCC-CcEEECCcccceeccccc
Confidence            9999999999988653 46889999999999999999999999  9999999999999855 689999999997664332


Q ss_pred             eeee------ecccCccccCCCccccccceeeec
Q 027788          186 RRIR------CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~~~~------~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ....      ....+++......++.++|+||+|
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG  188 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFG  188 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHH
Confidence            1110      012223444455677789999999

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=2.4e-28  Score=193.81  Aligned_cols=179  Identities=22%  Similarity=0.424  Sum_probs=143.8

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      +.+.+.||+|+||.||++.+..++..+|+|.++...   .......+.+|+.++++++|+|++++++.+..  .+.++++
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv   77 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL---DESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMC   77 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc---CHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEE
Confidence            366789999999999999999899999999887542   34445778899999999999999999998854  4668899


Q ss_pred             eccccCCChHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          107 TEVCTSGNLREYRKKH---RHVSVKALKKWSKQILKGLNYLHT-HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qv~~~l~~lh~-~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      |||+++++|..++...   ..+++..+..++.|++.++.|||. .+  ++|+||+|+||+++.+ +.++|+|||++..+.
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~  154 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLV  154 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCC-CCEEEeecCCccccc
Confidence            9999999998887653   368999999999999999999996 47  9999999999999865 689999999997664


Q ss_pred             ccce----eeeecccCccccC-----CCccccccceeeec
Q 027788          183 RAIR----RIRCWGRRSSWRR-----SCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~----~~~~~~~~~~~~~-----~~~~~~~~diws~g  213 (219)
                      ....    +...+.+|+.+..     ...++.++|+||+|
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG  194 (286)
T cd06622         155 ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLG  194 (286)
T ss_pred             CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHH
Confidence            3322    1122334443321     22346779999999

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.96  E-value=3.3e-28  Score=191.54  Aligned_cols=184  Identities=26%  Similarity=0.468  Sum_probs=145.7

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCC
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDED   99 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~   99 (219)
                      ++.+.| .+.+.||+|+||.||+|....+++.+|+|.+....     .....+..|+.+++++ +|+|++++.+.+...+
T Consensus         3 ~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (272)
T cd06637           3 DPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   76 (272)
T ss_pred             Chhhhh-hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence            456667 67789999999999999999999999999987432     2235678899999988 6999999999886533


Q ss_pred             ----CceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEe
Q 027788          100 ----RNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIG  173 (219)
Q Consensus       100 ----~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~  173 (219)
                          .+.++++|||+++++|.+++...  ..+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++|+
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~-~~~~l~  153 (272)
T cd06637          77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLV  153 (272)
T ss_pred             CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCC-CCEEEc
Confidence                34688999999999999988753  35889999999999999999999999  9999999999999865 589999


Q ss_pred             ccccceeccccce------eeeecccCccccC----CCccccccceeeec
Q 027788          174 DLGVAAIVGRAIR------RIRCWGRRSSWRR----SCTMRITRSLWTYT  213 (219)
Q Consensus       174 dfg~a~~~~~~~~------~~~~~~~~~~~~~----~~~~~~~~diws~g  213 (219)
                      |||++........      ++..+.+|+....    ...++.++|+||+|
T Consensus       154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG  203 (272)
T cd06637         154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG  203 (272)
T ss_pred             cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHH
Confidence            9999986543221      1112233332221    33567789999999

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.96  E-value=8.8e-28  Score=189.99  Aligned_cols=178  Identities=25%  Similarity=0.425  Sum_probs=142.9

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCc----EEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGI----EVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      .+++.+.||+|+||.||+|....++.    .+|+|.++...   .......+.+|+.++++++|+|++++++++..   .
T Consensus         8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~   81 (279)
T cd05057           8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS---S   81 (279)
T ss_pred             HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---C
Confidence            34788999999999999999776654    58888776442   24455778899999999999999999998865   4


Q ss_pred             eEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          102 TLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      ..++++|++++++|.+++... ..+++..+..++.|++.|+.|||+++  ++|+||+|+||+++.+ +.++|+|||+++.
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~-~~~kL~dfg~~~~  158 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTP-QHVKITDFGLAKL  158 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCC-CeEEECCCccccc
Confidence            578899999999999988653 46899999999999999999999999  9999999999999855 5899999999987


Q ss_pred             ccccceee--------eecccCccccCCCccccccceeeec
Q 027788          181 VGRAIRRI--------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ........        ..+.+| +......++.++|+||+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~P-E~~~~~~~~~~~Di~slG  198 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMAL-ESILHRIYTHKSDVWSYG  198 (279)
T ss_pred             ccCcccceecCCCcccccccCH-HHhhcCCcCchhhHHHHH
Confidence            65433211        112233 233445567789999999

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=3.1e-28  Score=193.10  Aligned_cols=180  Identities=22%  Similarity=0.355  Sum_probs=147.1

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      +-+++.+.||+|+||.||++.+..+++.+|+|.+....   .....+.+.+|+++++.++|||++++++.+...  +.++
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA---KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC---cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEE
Confidence            33477789999999999999999999999999887543   344457889999999999999999999999654  5688


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT-HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~-~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      ++|||+++++|.+++...+.+++..+..++.+++.++.|||+ .+  ++|+||+|+|++++.+ +.++|+|||++.....
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~~  156 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSR-GQIKLCDFGVSGELIN  156 (284)
T ss_pred             EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCC-CcEEEccCCcccchhh
Confidence            999999999999988877789999999999999999999996 57  9999999999999855 6899999999876533


Q ss_pred             cce----eeeecccCccccCCCccccccceeeec
Q 027788          184 AIR----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...    ++..+.+|+ ......++.++|+||+|
T Consensus       157 ~~~~~~~~~~~~~aPE-~~~~~~~~~~~Di~slG  189 (284)
T cd06620         157 SIADTFVGTSTYMSPE-RIQGGKYTVKSDVWSLG  189 (284)
T ss_pred             hccCccccCcccCCHH-HHccCCCCccchHHHHH
Confidence            221    122223333 33445677789999999

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.96  E-value=6.6e-28  Score=190.16  Aligned_cols=177  Identities=20%  Similarity=0.293  Sum_probs=140.7

Q ss_pred             eeeeeeccccceEEEEEEecC-----CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           28 RYNELLGSGAVKKVYRAFDQE-----EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      ++.+.||+|+||.||+|....     +...+++|.+....   .....+.+.+|+.++++++|+|++++++.+.  +...
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~   82 (275)
T cd05046           8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLCR--EAEP   82 (275)
T ss_pred             eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEEC--CCCc
Confidence            677899999999999998643     34678888765432   2335578999999999999999999999884  4456


Q ss_pred             EEEEeccccCCChHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEe
Q 027788          103 LNFITEVCTSGNLREYRKKHR---------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIG  173 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~---------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~  173 (219)
                      .+++||++++++|.+++....         .+++..+..++.|++.++.|||+++  ++|+||||+|++++.+ +.++++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~-~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQ-REVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCC-CcEEEc
Confidence            788999999999999987654         6899999999999999999999999  9999999999999865 589999


Q ss_pred             ccccceeccccce-------eeeecccCccccCCCccccccceeeec
Q 027788          174 DLGVAAIVGRAIR-------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       174 dfg~a~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |||++........       ....+.+| ++........++|+||+|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~P-E~~~~~~~~~~~Di~slG  205 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAP-EAVQEDDFSTKSDVWSFG  205 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecCh-hhhccCCCCchhhHHHHH
Confidence            9999875432211       11223333 344445566789999999

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.96  E-value=8.4e-28  Score=192.41  Aligned_cols=183  Identities=26%  Similarity=0.421  Sum_probs=142.9

Q ss_pred             CCCceeeeeeeeccccceEEEEEEe-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEE
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFD-----QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVW   95 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~   95 (219)
                      ...+.+.+.+.||+|+||.||+|..     ..++..+|+|.++...   .....+.+.+|+.+++++ +|+||+++++.+
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            3344458889999999999999975     3455689999876432   234457789999999999 799999999988


Q ss_pred             ecCCCceEEEEeccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEe
Q 027788           96 RDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIG  173 (219)
Q Consensus        96 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~  173 (219)
                      ...  +.++++|||+++++|.+++....  .+++..+..++.|++.++.|||+++  ++|+||+|+||+++.+ +.++++
T Consensus       109 ~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~~l~  183 (302)
T cd05055         109 TIG--GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHG-KIVKIC  183 (302)
T ss_pred             ecC--CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCC-CeEEEC
Confidence            554  45788999999999999886543  3889999999999999999999999  9999999999999855 589999


Q ss_pred             ccccceeccccceee--------eecccCccccCCCccccccceeeec
Q 027788          174 DLGVAAIVGRAIRRI--------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       174 dfg~a~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |||++..........        ..+.+| +......++.++|+||+|
T Consensus       184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~DiwslG  230 (302)
T cd05055         184 DFGLARDIMNDSNYVVKGNARLPVKWMAP-ESIFNCVYTFESDVWSYG  230 (302)
T ss_pred             CCcccccccCCCceeecCCCCcccccCCH-hhhccCCCCcHhHHHHHH
Confidence            999998665432110        112222 333344467789999999

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.96  E-value=4.2e-28  Score=191.75  Aligned_cols=180  Identities=21%  Similarity=0.279  Sum_probs=142.2

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCCceEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      |++.+.||+|+||.||+|.+..++..+|+|.++....  +... .....|+..++++. |+|++++++++.......+++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence            3677899999999999999999999999998875432  1222 23457888888885 999999999987654467899


Q ss_pred             EeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          106 ITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      ++||++ +++.+.+.. ...+++..+..++.|++.|+.+||+.+  ++|+||+|+||+++.  +.++|+|||++......
T Consensus        78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          78 VFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD--DILKLADFGSCRGIYSK  152 (282)
T ss_pred             EEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC--CCeEEEecccccccccC
Confidence            999997 577776654 356899999999999999999999999  999999999999986  68999999999876443


Q ss_pred             ce-----eeeecccCccccCCCccccccceeeecc
Q 027788          185 IR-----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       185 ~~-----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ..     .+..+.+|+.+.....++.++|+||+|+
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv  187 (282)
T cd07831         153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGC  187 (282)
T ss_pred             CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHH
Confidence            32     2223444544444555677899999993

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.96  E-value=4.8e-28  Score=190.01  Aligned_cols=175  Identities=18%  Similarity=0.278  Sum_probs=136.1

Q ss_pred             eeeccccceEEEEEEecC------------CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           31 ELLGSGAVKKVYRAFDQE------------EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~------------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      +.||+|+||.||+|....            ....+++|.+...    .......+..|+.+++.++||||+++++++...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            368999999999997421            2235888876543    233446788899999999999999999998644


Q ss_pred             CCceEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCC------cEE
Q 027788           99 DRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG------QVK  171 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~------~~~  171 (219)
                        ...+++|||+++++|..++.. ...+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+..      .++
T Consensus        77 --~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          77 --VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             --CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeE
Confidence              446789999999999888764 356899999999999999999999999  999999999999974421      279


Q ss_pred             Eeccccceeccccce--eeeecccCccccCCCccccccceeeec
Q 027788          172 IGDLGVAAIVGRAIR--RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       172 l~dfg~a~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ++|||++........  .+..+.+|+.+.....++.++|+||+|
T Consensus       153 l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  196 (262)
T cd05077         153 LSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFG  196 (262)
T ss_pred             eCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHH
Confidence            999999876644322  233455565454456677889999999

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.96  E-value=1.6e-27  Score=185.95  Aligned_cols=179  Identities=19%  Similarity=0.395  Sum_probs=146.0

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|+||.+|.+.+..+++.+++|.+.....  .....+.+.+|+.++++++|||++++.+.+  +..+..+++
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv   77 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESF--EENGNLYIV   77 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeee--cCCCeEEEE
Confidence            3677999999999999999999999999999875433  234456788999999999999999999988  445678899


Q ss_pred             eccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          107 TEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      +|++++++|.+++...  ..+++..+..++.|++.++.+||+++  ++|+||+|+||+++.+ +.++++|||++......
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNST  154 (256)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEEeeccceeecCcc
Confidence            9999999999887653  25788999999999999999999999  9999999999999865 58999999999876543


Q ss_pred             ce------eeeecccCccccCCCccccccceeeec
Q 027788          185 IR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ..      +...+. +++...+...+.++|+||+|
T Consensus       155 ~~~~~~~~~~~~~~-~pe~~~~~~~~~~~Dv~slG  188 (256)
T cd08218         155 VELARTCIGTPYYL-SPEICENRPYNNKSDIWALG  188 (256)
T ss_pred             hhhhhhccCCcccc-CHHHhCCCCCCCccchhHHH
Confidence            22      111222 23444455667789999999

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.96  E-value=1e-27  Score=187.79  Aligned_cols=179  Identities=25%  Similarity=0.474  Sum_probs=147.4

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|++|.||+|....++..+++|.++....  .....+.+..|+.+++.++|+||+++++.+.  +.+.++++
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~lv   77 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLKHPNLVKYYGVEV--HREKVYIF   77 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHHHHHHHHHHHHhCCCCChhheeeeEe--cCCEEEEE
Confidence            3778999999999999999988999999999876543  2456788999999999999999999999874  45668899


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      +||+++++|.+++.....+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++........
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEcccccccccCCCCC
Confidence            999999999999887767889999999999999999999999  9999999999999865 6899999999987754332


Q ss_pred             e----------eeecccCccccCCC---ccccccceeeec
Q 027788          187 R----------IRCWGRRSSWRRSC---TMRITRSLWTYT  213 (219)
Q Consensus       187 ~----------~~~~~~~~~~~~~~---~~~~~~diws~g  213 (219)
                      .          ...+..| ++....   .+..++|+||+|
T Consensus       155 ~~~~~~~~~~~~~~~~~P-E~~~~~~~~~~~~~~Dv~s~G  193 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAP-EVITGGKGKGHGRAADIWSLG  193 (264)
T ss_pred             cccccccCCcCCcCccCh-hhccCCCCCCCCcccchHHHH
Confidence            1          1112222 333222   267789999999

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.96  E-value=7.5e-28  Score=188.03  Aligned_cols=175  Identities=22%  Similarity=0.355  Sum_probs=139.9

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      -+++.+.||+|+||.||++..  .+..+++|.++..      ...+.+.+|+.++++++|+|++++++.+... .+..++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~l   77 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI   77 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEE
Confidence            347889999999999999965  4778999987632      2246788999999999999999999876433 355788


Q ss_pred             EeccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          106 ITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      ++||+++++|.+++....  .+++..+..++.|++.++.+||+++  ++|+||+|+||+++.+ +.++++|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~  154 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASS  154 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCC-CcEEecCCccceeccc
Confidence            999999999999886543  4788999999999999999999999  9999999999999865 5899999999886544


Q ss_pred             cce---eeeecccCccccCCCccccccceeeec
Q 027788          184 AIR---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...   ....+.+| +......++.++|+||+|
T Consensus       155 ~~~~~~~~~~y~aP-E~~~~~~~~~~~Dv~slG  186 (256)
T cd05082         155 TQDTGKLPVKWTAP-EALREKKFSTKSDVWSFG  186 (256)
T ss_pred             cCCCCccceeecCH-HHHccCCCCchhhhHHHH
Confidence            321   11123333 444556677889999999

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.96  E-value=6.1e-28  Score=190.09  Aligned_cols=174  Identities=24%  Similarity=0.408  Sum_probs=135.5

Q ss_pred             eeeccccceEEEEEEecCCCc--EEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceEEEEe
Q 027788           31 ELLGSGAVKKVYRAFDQEEGI--EVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      +.||+|+||.||+|....++.  .+++|.++...   .....+.+..|+++++++ +|||++++++.+...  ..++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC---CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC--CCceEEE
Confidence            368999999999999887775  45777766322   344557788999999999 799999999998544  4578899


Q ss_pred             ccccCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEE
Q 027788          108 EVCTSGNLREYRKKHR----------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVK  171 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~----------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~  171 (219)
                      |++++++|.+++....                .+++..+..++.|++.|+.|||+.+  ++|+||||+|++++.+ +.++
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~-~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN-YVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCC-CeEE
Confidence            9999999999876432                3678899999999999999999999  9999999999999865 5899


Q ss_pred             Eeccccceeccccceee----e-ecccCccccCCCccccccceeeec
Q 027788          172 IGDLGVAAIVGRAIRRI----R-CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       172 l~dfg~a~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ++|||++..........    . .+.+| +......++.++|+||||
T Consensus       153 l~dfgl~~~~~~~~~~~~~~~~~~y~ap-E~~~~~~~~~~~Di~slG  198 (270)
T cd05047         153 IADFGLSRGQEVYVKKTMGRLPVRWMAI-ESLNYSVYTTNSDVWSYG  198 (270)
T ss_pred             ECCCCCccccchhhhccCCCCccccCCh-HHHccCCCCchhhHHHHH
Confidence            99999986433221111    1 12233 344455677789999999

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=8.6e-28  Score=190.14  Aligned_cols=176  Identities=19%  Similarity=0.320  Sum_probs=135.6

Q ss_pred             eeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHH---HHHhhCCCCceEEEEEEecCCCceEEEEec
Q 027788           32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVR---LLKTLANKNIISLHYVWRDEDRNTLNFITE  108 (219)
Q Consensus        32 ~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~---~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e  108 (219)
                      .||+|+||.||+|.+..+++.||+|.+......... ....+..|..   .++...||+++++.+.+..  .+.++++||
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e   77 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ-GETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILD   77 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccch-hHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEe
Confidence            479999999999999999999999998754332111 1122333433   3444578999999988854  456888999


Q ss_pred             cccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce--
Q 027788          109 VCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR--  186 (219)
Q Consensus       109 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~--  186 (219)
                      |+++++|..++.....+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++|+|||++........  
T Consensus        78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~~~~~  154 (278)
T cd05606          78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKKKPHA  154 (278)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCC-CCEEEccCcCccccCccCCcC
Confidence            9999999998877778999999999999999999999999  9999999999999866 5899999999876543322  


Q ss_pred             --eeeecccCccccCCCccccccceeeec
Q 027788          187 --RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 --~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                        ++..+.+|+.......++.++|+||+|
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G  183 (278)
T cd05606         155 SVGTHGYMAPEVLQKGVAYDSSADWFSLG  183 (278)
T ss_pred             cCCCcCCcCcHHhcCCCCCCcccchHhHH
Confidence              222233344333344577789999999

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=4.3e-28  Score=196.95  Aligned_cols=184  Identities=23%  Similarity=0.355  Sum_probs=146.9

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC---
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR---  100 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~---  100 (219)
                      .+| ++.+.||+|+||.||+|.+..++..||+|.++....  ......++.+|+.+++.++|+|++++++++.....   
T Consensus         5 ~~y-~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           5 TKY-VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD--NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             cce-eEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence            445 777899999999999999999999999999875432  22334667789999999999999999887754321   


Q ss_pred             ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          101 NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      ..+++++||+. ++|.+++.....+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~  157 (337)
T cd07858          82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNAN-CDLKICDFGLART  157 (337)
T ss_pred             CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC-CCEEECcCccccc
Confidence            35789999996 688888877778999999999999999999999999  9999999999999865 5899999999987


Q ss_pred             ccccce------eeeecccCccccCCCccccccceeeecc
Q 027788          181 VGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       181 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ......      .+..+.+|+.......++.++|+||+|+
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  197 (337)
T cd07858         158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGC  197 (337)
T ss_pred             cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHH
Confidence            654321      2222334443444345778899999993

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.96  E-value=3.9e-28  Score=192.54  Aligned_cols=180  Identities=22%  Similarity=0.337  Sum_probs=145.6

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|++|.||+|.+..++..|++|.++....  .....+.+.+|++++++++|+|++++.+.+..  .+.++++
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv   78 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLV   78 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEE
Confidence            4788999999999999999999999999998875432  23345778899999999999999999999854  4568899


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      |||++++.+..+......++...+..++.|++.++.+||..+  ++|+||+|+||+++.+ +.++|+|||++........
T Consensus        79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSES-GVLKLCDFGFARALRARPA  155 (288)
T ss_pred             EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEEeeecccccCCCcc
Confidence            999998777766665567899999999999999999999999  9999999999999865 6899999999887655432


Q ss_pred             -------eeeecccCccccCCCccccccceeeec
Q 027788          187 -------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 -------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                             ....+..|+.......++.++|+||+|
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG  189 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIG  189 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHH
Confidence                   111122333223333677789999999

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.96  E-value=3.6e-28  Score=195.19  Aligned_cols=183  Identities=25%  Similarity=0.396  Sum_probs=144.6

Q ss_pred             eeeeeeeccccceEEEEEEecC--CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQE--EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      |++.+.||+|++|.||+|.+..  ++..||+|.+..... ......+.+.+|+.+++.++|||++++++.+...+...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3677899999999999999988  899999999886431 1233346677899999999999999999999777567899


Q ss_pred             EEeccccCCChHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC---CCCcEEEeccc
Q 027788          105 FITEVCTSGNLREYRKKH-----RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG---NTGQVKIGDLG  176 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~---~~~~~~l~dfg  176 (219)
                      ++||++++ ++.+++...     ..+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.   ..+.++++|||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg  157 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLG  157 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence            99999974 666655422     25789999999999999999999999  999999999999986   13589999999


Q ss_pred             cceeccccce---------eeeecccCccccCCCccccccceeeec
Q 027788          177 VAAIVGRAIR---------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       177 ~a~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ++........         .+..+.+|+.+.....++.++|+||+|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  203 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG  203 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHH
Confidence            9987644322         112234444444445677789999999

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.96  E-value=7e-28  Score=188.02  Aligned_cols=174  Identities=26%  Similarity=0.401  Sum_probs=143.7

Q ss_pred             eeeccccceEEEEEEecCC---CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           31 ELLGSGAVKKVYRAFDQEE---GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      +.||+|+||.||+|.....   +..+++|.++....   ....+.+.+|+..++.++|+|++++++++..  ...++++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS---EEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccc---hhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEE
Confidence            4689999999999998866   89999999875432   2246788999999999999999999998854  56688999


Q ss_pred             ccccCCChHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          108 EVCTSGNLREYRKKH---------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       108 e~~~~g~L~~~~~~~---------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      ||+++++|.+++...         ..+++..+..++.|++.|+.+||+++  ++|+||+|+||+++.+ +.++|+|||.+
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~-~~~~l~dfg~~  152 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGED-LVVKISDFGLS  152 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCC-CcEEEcccccc
Confidence            999999999998764         67899999999999999999999999  9999999999999866 68999999999


Q ss_pred             eeccccce--------eeeecccCccccCCCccccccceeeec
Q 027788          179 AIVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       179 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ........        .+..+.+|+ ......++.++|+||+|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG  194 (262)
T cd00192         153 RDVYDDDYYRKKTGGKLPIRWMAPE-SLKDGIFTSKSDVWSFG  194 (262)
T ss_pred             cccccccccccccCCCcCccccCHH-HhccCCcchhhccHHHH
Confidence            87765421        112233333 33344677789999999

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.96  E-value=1.6e-27  Score=189.06  Aligned_cols=184  Identities=22%  Similarity=0.400  Sum_probs=143.9

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEec--
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRD--   97 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~--   97 (219)
                      ++..+| .+.+.||+|+||.||+|.+..+++.+|+|.+....     .....+.+|+.+++.+ +|+|++++++++..  
T Consensus        15 ~~~~~~-~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          15 DPSDTW-EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             Ccccce-eeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            455677 67799999999999999999999999999876321     1125577899999999 69999999988743  


Q ss_pred             -CCCceEEEEeccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEE
Q 027788           98 -EDRNTLNFITEVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKI  172 (219)
Q Consensus        98 -~~~~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l  172 (219)
                       ++.+.++++|||+++++|.+++..    ...+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.+++
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~-~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTE-GGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCC-CCEEE
Confidence             344678999999999999987642    346888999999999999999999999  9999999999999866 57999


Q ss_pred             eccccceeccccce------eeeecccCcccc----CCCccccccceeeec
Q 027788          173 GDLGVAAIVGRAIR------RIRCWGRRSSWR----RSCTMRITRSLWTYT  213 (219)
Q Consensus       173 ~dfg~a~~~~~~~~------~~~~~~~~~~~~----~~~~~~~~~diws~g  213 (219)
                      +|||++........      ++..+.+|+...    ....++.++|+||+|
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG  216 (286)
T cd06638         166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLG  216 (286)
T ss_pred             ccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHH
Confidence            99999987644221      112233333221    123467789999999

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.96  E-value=7.4e-28  Score=191.43  Aligned_cols=182  Identities=20%  Similarity=0.298  Sum_probs=144.5

Q ss_pred             eeeeeeeccccceEEEEEEec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCce
Q 027788           27 GRYNELLGSGAVKKVYRAFDQ---EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~  102 (219)
                      |++.+.||+|+||.||.|.+.   .+|..||+|.++...........+++.+|+.+++.+ +|+||+++++.+.  ....
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~~   79 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--TDTK   79 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee--cCCe
Confidence            367799999999999999864   478999999987543333344457788999999999 5899999988884  4456


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +++++|++++++|.+++.....+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~  156 (290)
T cd05613          80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCC-CCEEEeeCccceecc
Confidence            8899999999999999887778899999999999999999999999  9999999999999865 689999999998764


Q ss_pred             ccce-------eeeecccCccccCC-Cccccccceeeec
Q 027788          183 RAIR-------RIRCWGRRSSWRRS-CTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~-------~~~~~~~~~~~~~~-~~~~~~~diws~g  213 (219)
                      ....       +...+.+|+..... ..++.++|+||+|
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG  195 (290)
T cd05613         157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMG  195 (290)
T ss_pred             cccccccccccCCcccCChhhccCCCCCCCccccHHHHH
Confidence            4321       11223334333322 2355679999999

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.96  E-value=8.8e-28  Score=190.01  Aligned_cols=183  Identities=21%  Similarity=0.269  Sum_probs=144.4

Q ss_pred             CCceeeeeeeeccccceEEEEEEecC----CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQE----EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      ....+.+.+.||+|+||.||+|.+..    .+..|++|.+....   .....+.+.+|+.++++++|+|++++++++...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA---SEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            34455888999999999999999765    35789999876332   455668889999999999999999999887543


Q ss_pred             CCceEEEEeccccCCChHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcE
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKH--------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQV  170 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~--------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~  170 (219)
                       ....+++++++++++|.+++...        ..+++..+..++.|++.|+.|||+.+  ++|+||+|+|++++.+ +.+
T Consensus        81 -~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~-~~~  156 (280)
T cd05043          81 -GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEE-LQV  156 (280)
T ss_pred             -CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCC-CcE
Confidence             35567899999999999987653        34789999999999999999999999  9999999999999865 589


Q ss_pred             EEeccccceecccccee--------eeecccCccccCCCccccccceeeec
Q 027788          171 KIGDLGVAAIVGRAIRR--------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       171 ~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +++|||+++.+......        ...+.+|+ ......++.++||||+|
T Consensus       157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE-~~~~~~~~~~~Di~slG  206 (280)
T cd05043         157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALE-SLVNKEYSSASDVWSFG  206 (280)
T ss_pred             EECCCCCcccccCCceEEeCCCCCcchhccCHH-HHhcCCCCchhhHHHhH
Confidence            99999999866433211        11123333 33445567789999999

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.96  E-value=4.6e-28  Score=190.57  Aligned_cols=175  Identities=20%  Similarity=0.282  Sum_probs=131.8

Q ss_pred             eeeccccceEEEEEEec--CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEec
Q 027788           31 ELLGSGAVKKVYRAFDQ--EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITE  108 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e  108 (219)
                      +.||+|+||.||+|...  .....+++|.+....   .......+.+|+.+++.++|+||+++++.+..  ...++++||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEE
Confidence            36899999999999643  234567888765332   23344667889999999999999999998854  455888999


Q ss_pred             cccCCChHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          109 VCTSGNLREYRKKHR-----HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       109 ~~~~g~L~~~~~~~~-----~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      |+++++|.+++....     ..++.....++.|++.|+.|||+.+  ++||||||+|++++.+ +.++++|||++.....
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~  152 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTAD-LSVKIGDYGLALEQYP  152 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCC-CcEEEecccccccccc
Confidence            999999999886542     2457778899999999999999999  9999999999999865 5899999999876433


Q ss_pred             cce--------eeeecccCcccc------CCCccccccceeeec
Q 027788          184 AIR--------RIRCWGRRSSWR------RSCTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~--------~~~~~~~~~~~~------~~~~~~~~~diws~g  213 (219)
                      ...        ....+.+|+.+.      ....++.++|+||+|
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG  196 (269)
T cd05042         153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLG  196 (269)
T ss_pred             chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHH
Confidence            211        011123333221      123456689999999

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=8.3e-28  Score=192.54  Aligned_cols=188  Identities=19%  Similarity=0.371  Sum_probs=145.1

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      ..+..++| .+.+.||+|+||.||+|.+..++..||+|.+.....  .......+.+|+.++++++|||++++++++...
T Consensus         7 ~~~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   83 (310)
T cd07865           7 FCDEVSKY-EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTK   83 (310)
T ss_pred             ccchhhhe-EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence            34455666 677999999999999999999999999998865432  122224556799999999999999999988654


Q ss_pred             C------CceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEE
Q 027788           99 D------RNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVK  171 (219)
Q Consensus        99 ~------~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~  171 (219)
                      +      ....+++|||++ ++|.+.+... ..+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~k  159 (310)
T cd07865          84 ATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILK  159 (310)
T ss_pred             cccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCC-CcEE
Confidence            3      235688999996 5777766543 36899999999999999999999999  9999999999999855 6899


Q ss_pred             Eeccccceecccccee----------eeecccCccccCCCccccccceeeec
Q 027788          172 IGDLGVAAIVGRAIRR----------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       172 l~dfg~a~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |+|||++.........          ...+.+|+.......++.++|+||+|
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG  211 (310)
T cd07865         160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG  211 (310)
T ss_pred             ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHH
Confidence            9999999766433211          11233344333344466789999999

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.96  E-value=2.1e-27  Score=188.89  Aligned_cols=185  Identities=23%  Similarity=0.383  Sum_probs=145.4

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecC
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDE   98 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~   98 (219)
                      +++.++| .+.+.||+|+||.||++....+++.+|+|.+....     .....+.+|+.+++++ +|||++++++++...
T Consensus        18 ~~~~~~y-~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          18 GDPTDTW-EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             CCCCCCe-EEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            3456667 77789999999999999999999999999876431     1235567899999988 899999999988643


Q ss_pred             C---CceEEEEeccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEE
Q 027788           99 D---RNTLNFITEVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVK  171 (219)
Q Consensus        99 ~---~~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~  171 (219)
                      +   ...+++++||+++++|.+++..    ...+++..+..++.|++.++.+||+.+  ++|+||+|+|++++.+ +.++
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~-~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTE-GGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC-CCEE
Confidence            3   2467899999999999987652    346889999999999999999999999  9999999999999865 5899


Q ss_pred             Eeccccceeccccce------eeeecccCccccCCC----ccccccceeeec
Q 027788          172 IGDLGVAAIVGRAIR------RIRCWGRRSSWRRSC----TMRITRSLWTYT  213 (219)
Q Consensus       172 l~dfg~a~~~~~~~~------~~~~~~~~~~~~~~~----~~~~~~diws~g  213 (219)
                      |+|||++........      ++..+.+|+......    .++.++|+||+|
T Consensus       169 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG  220 (291)
T cd06639         169 LVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLG  220 (291)
T ss_pred             EeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHH
Confidence            999999886543221      222344444332222    256789999999

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9.6e-30  Score=221.44  Aligned_cols=182  Identities=17%  Similarity=0.252  Sum_probs=155.1

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.+.||+|+||.|...+.+.+++.||+|++++......+ ....|+.|..++..-+.+=|+.++..|+  +.+++|+||
T Consensus        78 eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~-~tA~F~EERDimv~~ns~Wiv~LhyAFQ--D~~~LYlVM  154 (1317)
T KOG0612|consen   78 EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRA-ETACFREERDIMVFGNSEWIVQLHYAFQ--DERYLYLVM  154 (1317)
T ss_pred             HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhch-hHHHHHHHhHHHHcCCcHHHHHHHHHhc--CccceEEEE
Confidence            6778999999999999999999999999999863322122 2366889999999888888899988885  456799999


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc--
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI--  185 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~--  185 (219)
                      ||++||+|-.++++...+++.-+++++..|+.||.-+|+.|  ++||||||+|+|++.. |.++|+|||.|..+..+.  
T Consensus       155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~-GHikLADFGsClkm~~dG~V  231 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKS-GHIKLADFGSCLKMDADGTV  231 (1317)
T ss_pred             ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEeccc-CcEeeccchhHHhcCCCCcE
Confidence            99999999999998888999999999999999999999999  9999999999999966 799999999998887554  


Q ss_pred             eeeeecccCcccc--------C-CCccccccceeeeccc
Q 027788          186 RRIRCWGRRSSWR--------R-SCTMRITRSLWTYTRL  215 (219)
Q Consensus       186 ~~~~~~~~~~~~~--------~-~~~~~~~~diws~gi~  215 (219)
                      .+..++|+|....        . ...|...+|-||+||+
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~  270 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVF  270 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHH
Confidence            3667788876432        1 3678888999999943

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.96  E-value=8.5e-28  Score=188.27  Aligned_cols=174  Identities=21%  Similarity=0.322  Sum_probs=143.4

Q ss_pred             eccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccccC
Q 027788           33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTS  112 (219)
Q Consensus        33 ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~  112 (219)
                      ||.|++|.||+|++..++..+++|.+...... .....+.+.+|+.+++.++|||++++++.+.  +...+++++||+++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~   77 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-ETGQQEHIFSEKEILEECNHPFIVKLYRTFK--DKKYIYMLMEYCLG   77 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcch-hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE--cCCccEEEEecCCC
Confidence            68999999999999999999999998754322 2334577899999999999999999999884  44568889999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce-----e
Q 027788          113 GNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR-----R  187 (219)
Q Consensus       113 g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~-----~  187 (219)
                      ++|.+++.....++...+..++.|++.++.+||+++  ++|+||+|+||+++.+ +.++|+|||++........     +
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~~~~~~~~  154 (262)
T cd05572          78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCG  154 (262)
T ss_pred             CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCC-CCEEEeeCCcccccCcccccccccC
Confidence            999999887777899999999999999999999999  9999999999999865 6899999999987755321     1


Q ss_pred             eeecccCccccCCCccccccceeeec
Q 027788          188 IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...+..| +......++.++|+||+|
T Consensus       155 ~~~~~~P-E~~~~~~~~~~~Di~slG  179 (262)
T cd05572         155 TPEYVAP-EIILNKGYDFSVDYWSLG  179 (262)
T ss_pred             CcCccCh-hHhcCCCCCChhhhhhhH
Confidence            1222233 334455677789999999

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.96  E-value=9.8e-28  Score=192.36  Aligned_cols=180  Identities=28%  Similarity=0.405  Sum_probs=140.8

Q ss_pred             CceeeeeeeeccccceEEEEEEecC-------CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQE-------EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVW   95 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~   95 (219)
                      ++| .+.+.||+|+||.||.|.+..       +...+|+|.++...   .......+..|+++++++ +|+|++++++++
T Consensus        18 ~~~-~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          18 DRL-VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             HHe-EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            444 888999999999999997643       23569999887432   233446788899999999 799999999998


Q ss_pred             ecCCCceEEEEeccccCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCC
Q 027788           96 RDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCS  159 (219)
Q Consensus        96 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~----------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~  159 (219)
                      ...  +.++++|||+++++|.+++....                .++...+..++.|++.++.|||+.+  ++|+||||+
T Consensus        94 ~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~  169 (307)
T cd05098          94 TQD--GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAAR  169 (307)
T ss_pred             ecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHH
Confidence            544  45788999999999999986532                3778889999999999999999999  999999999


Q ss_pred             ceEEeCCCCcEEEeccccceeccccce--ee------eecccCccccCCCccccccceeeec
Q 027788          160 NVFVNGNTGQVKIGDLGVAAIVGRAIR--RI------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       160 nili~~~~~~~~l~dfg~a~~~~~~~~--~~------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ||+++.+ +.++|+|||++........  ..      ..+.+| +......++.++|+||+|
T Consensus       170 Nill~~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~DvwslG  229 (307)
T cd05098         170 NVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP-EALFDRIYTHQSDVWSFG  229 (307)
T ss_pred             heEEcCC-CcEEECCCcccccccccchhhccccCCCccceeCh-HHhccCCCCcHHHHHHHH
Confidence            9999866 5899999999976643221  00      112223 334445677789999999

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.96  E-value=4.1e-28  Score=196.82  Aligned_cols=188  Identities=24%  Similarity=0.393  Sum_probs=147.6

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCH----------HHHHHHHHHHHHHHhhCCCCce
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDP----------AMIERLFSEVRLLKTLANKNII   89 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~----------~~~~~~~~E~~~l~~l~~~~i~   89 (219)
                      .+...+|..+.+.||+|+||.||+|.+..+++.||+|.+.........          .....+.+|+++++.++|+|++
T Consensus         4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   83 (335)
T PTZ00024          4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM   83 (335)
T ss_pred             cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence            356688888888999999999999999999999999998754321100          0112467899999999999999


Q ss_pred             EEEEEEecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCc
Q 027788           90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQ  169 (219)
Q Consensus        90 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~  169 (219)
                      ++++++.  ..+.++++||+++ ++|.+++.....+++.....++.|++.++.+||+.+  ++|+||+|+||+++.+ +.
T Consensus        84 ~~~~~~~--~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~-~~  157 (335)
T PTZ00024         84 GLVDVYV--EGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSK-GI  157 (335)
T ss_pred             eeeEEEe--cCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCC-CC
Confidence            9999985  4457889999996 689888877778999999999999999999999999  9999999999999865 58


Q ss_pred             EEEeccccceeccccc--------------e------eeeecccCccccCCCccccccceeeec
Q 027788          170 VKIGDLGVAAIVGRAI--------------R------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       170 ~~l~dfg~a~~~~~~~--------------~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ++++|||++.......              .      .+..+..|+.......++.++|+||+|
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  221 (335)
T PTZ00024        158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG  221 (335)
T ss_pred             EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHH
Confidence            9999999998765111              0      111122333333333467789999999

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=194.10  Aligned_cols=184  Identities=23%  Similarity=0.354  Sum_probs=152.1

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      ...| .+-+.||+|.|+.|+++.+..+|+.+|+|+++...+..  ...+.+.+|+.+-+.|+||||+++.+....  ..+
T Consensus        10 ~d~y-~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~--~~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~   84 (355)
T KOG0033|consen   10 SDNY-DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQE--ESF   84 (355)
T ss_pred             chhh-hHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc--ccHHHHHHHHHHHHhcCCCcEeehhhhhcc--cce
Confidence            3444 67789999999999999999999999999998877643  355888999999999999999999999854  456


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC--CcEEEecccccee
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDLGVAAI  180 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~--~~~~l~dfg~a~~  180 (219)
                      .|+|.|.+.|++|..-+-...-+++..+...+.|++.++.|+|.++  |+|||+||.|+++.+..  .-+|++|||+|..
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEE
Confidence            7889999999999865433356888889999999999999999999  99999999999986332  3589999999999


Q ss_pred             ccccceeeeecccCc----cccCCCccccccceeeec
Q 027788          181 VGRAIRRIRCWGRRS----SWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~diws~g  213 (219)
                      +.....-....|+|.    +..+..+|+-+.||||-|
T Consensus       163 l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cG  199 (355)
T KOG0033|consen  163 VNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG  199 (355)
T ss_pred             eCCccccccccCCCcccCHHHhhcCCCCCcchhhhhh
Confidence            985554444455554    345677788889999999

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.96  E-value=6.2e-28  Score=190.74  Aligned_cols=174  Identities=19%  Similarity=0.300  Sum_probs=139.6

Q ss_pred             eccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccccC
Q 027788           33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTS  112 (219)
Q Consensus        33 ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~  112 (219)
                      ||+|+||.||+|.+..+++.+++|.+...... .......+..|+++++.++|||++++.+.+.  ..+.++++|||+++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~   77 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-KRKGEQMALNEKKILEKVSSRFIVSLAYAFE--TKDDLCLVMTLMNG   77 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe--cCCeEEEEEecCCC
Confidence            68999999999999999999999998754322 2223456678999999999999999998884  34568899999999


Q ss_pred             CChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce----
Q 027788          113 GNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR----  186 (219)
Q Consensus       113 g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~----  186 (219)
                      ++|.+++....  .+++..+..++.|++.++.|||..+  ++|+||+|+||+++.+ +.++|+|||.+........    
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~  154 (277)
T cd05577          78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGR  154 (277)
T ss_pred             CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEccCcchhhhccCCccccc
Confidence            99998886554  6899999999999999999999999  9999999999999865 5899999999876543221    


Q ss_pred             -eeeecccCccccCCCccccccceeeec
Q 027788          187 -RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 -~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                       ....+.. ++......++.++|+||+|
T Consensus       155 ~~~~~y~~-PE~~~~~~~~~~~Di~slG  181 (277)
T cd05577         155 AGTPGYMA-PEVLQGEVYDFSVDWFALG  181 (277)
T ss_pred             cCCCCcCC-HHHhcCCCCCchhhhHHHH
Confidence             1112222 3334445577789999999

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=5.4e-28  Score=190.85  Aligned_cols=178  Identities=27%  Similarity=0.389  Sum_probs=145.2

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC---CCCceEEEEEEecCCCceE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA---NKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---~~~i~~~~~~~~~~~~~~~  103 (219)
                      |.+.+.||+|+||.||+|.+..++..+++|.++...   .....+.+.+|+.+++.++   |||++++++.+.  +....
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~--~~~~~   77 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL--KGPRL   77 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee--eCCEE
Confidence            466688999999999999999999999999987543   2344567888999999996   999999999884  34568


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++|||+++++|.++++.. .+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++++|||++.....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~  153 (277)
T cd06917          78 WIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNT-GNVKLCDFGVAALLNQ  153 (277)
T ss_pred             EEEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCC-CCEEEccCCceeecCC
Confidence            8999999999999987654 7889999999999999999999999  9999999999999865 6899999999987755


Q ss_pred             cce------eeeecccCccccCCCccccccceeeec
Q 027788          184 AIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...      ++..+.+|+.......++.++|+||+|
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  189 (277)
T cd06917         154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLG  189 (277)
T ss_pred             CccccccccCCcceeCHHHhccCCccccchhHHHHH
Confidence            432      111233444444444567789999999

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=1.6e-27  Score=189.34  Aligned_cols=179  Identities=25%  Similarity=0.421  Sum_probs=146.0

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      ...+.||.|++|.||++.+..++..+|+|.+....   .......+.+|+++++.++||||+++++++..+....++++|
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            56689999999999999999999999999987542   234457788999999999999999999998777767789999


Q ss_pred             ccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          108 EVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       108 e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      ||+++++|.+++..    ...+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRK-GQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecC-CeEEEeeccccccccc
Confidence            99999999887542    345889999999999999999999999  9999999999999865 5899999999876543


Q ss_pred             cce----eeeecccCccccCCCccccccceeeec
Q 027788          184 AIR----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...    ....+.+| +......++.++|+||+|
T Consensus       158 ~~~~~~~~~~~y~~p-E~~~~~~~~~~~Dv~slG  190 (287)
T cd06621         158 SLAGTFTGTSFYMAP-ERIQGKPYSITSDVWSLG  190 (287)
T ss_pred             cccccccCCccccCH-HHhcCCCCCchhhHHHHH
Confidence            221    12222233 334455677789999999

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.96  E-value=2.4e-28  Score=191.19  Aligned_cols=176  Identities=24%  Similarity=0.381  Sum_probs=142.7

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||.|+||.||+|.+.. +..+++|.+....    ......+..|+.+++.++|+|++++++++..  ...++++
T Consensus         8 y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv   80 (261)
T cd05148           8 FTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSV--GEPVYII   80 (261)
T ss_pred             HHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEec--CCCeEEE
Confidence            3677999999999999999877 8899999987542    3335678899999999999999999998854  4557889


Q ss_pred             eccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          107 TEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      |||+++++|.+++...  ..++...+..++.|++.|+.+||+.+  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGED-LVCKVADFGLARLIKED  157 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCC-ceEEEccccchhhcCCc
Confidence            9999999999998753  35789999999999999999999999  9999999999999865 58999999999876543


Q ss_pred             ceeee------ecccCccccCCCccccccceeeec
Q 027788          185 IRRIR------CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~~~~------~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .....      .+.. ++......++.++|+||+|
T Consensus       158 ~~~~~~~~~~~~~~~-PE~~~~~~~~~~~DiwslG  191 (261)
T cd05148         158 VYLSSDKKIPYKWTA-PEAASHGTFSTKSDVWSFG  191 (261)
T ss_pred             cccccCCCCceEecC-HHHHccCCCCchhhHHHHH
Confidence            22111      1222 3333445677789999999

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.96  E-value=6e-28  Score=189.38  Aligned_cols=176  Identities=22%  Similarity=0.371  Sum_probs=139.3

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++ |++.++||+|+||.||+|.+..+ ..||+|.++....     ..+.+.+|+.+++.++|+|++++++.+..   ...
T Consensus         6 ~~-~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~   75 (262)
T cd05071           6 ES-LRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPI   75 (262)
T ss_pred             HH-eeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEECC---CCc
Confidence            44 48999999999999999987655 4699998874321     22568889999999999999999887632   336


Q ss_pred             EEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          104 NFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      +++||++++++|.+++...  ..+++..+..++.|++.++.++|+.+  ++|+||+|+||+++.+ +.++|+|||.+...
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~  152 (262)
T cd05071          76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLI  152 (262)
T ss_pred             EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCC-CcEEeccCCceeec
Confidence            7899999999999988753  35789999999999999999999999  9999999999999855 58999999999876


Q ss_pred             cccceee-------eecccCccccCCCccccccceeeec
Q 027788          182 GRAIRRI-------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .......       ..+.+ ++......++.++|+||+|
T Consensus       153 ~~~~~~~~~~~~~~~~y~~-PE~~~~~~~~~~~DvwslG  190 (262)
T cd05071         153 EDNEYTARQGAKFPIKWTA-PEAALYGRFTIKSDVWSFG  190 (262)
T ss_pred             cccccccccCCcccceecC-HhHhccCCCCchhhHHHHH
Confidence            4433110       11222 3344455577789999999

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.96  E-value=1.5e-27  Score=186.69  Aligned_cols=178  Identities=22%  Similarity=0.413  Sum_probs=149.2

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      +.+.+.||+|++|.||+|.+..+++.+++|.+.....   ....+.+.+|+..+++++|+|++++++.+..  .+.++++
T Consensus         3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv   77 (264)
T cd06623           3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEISIV   77 (264)
T ss_pred             ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEE
Confidence            3677999999999999999999999999999875532   2455788999999999999999999999854  4668889


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT-HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~-~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      +||+++++|.+++.....+++..+..++.|++.++.+||+ .+  ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSK-GEVKIADFGISKVLENTL  154 (264)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCC-CCEEEccCccceecccCC
Confidence            9999999999998877789999999999999999999999 99  9999999999999866 589999999998775433


Q ss_pred             ee------eeecccCccccCCCccccccceeeec
Q 027788          186 RR------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~~------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ..      ...+.+| +......++.++|+||||
T Consensus       155 ~~~~~~~~~~~y~~p-E~~~~~~~~~~~Dv~slG  187 (264)
T cd06623         155 DQCNTFVGTVTYMSP-ERIQGESYSYAADIWSLG  187 (264)
T ss_pred             CcccceeecccccCH-hhhCCCCCCchhhHHHHH
Confidence            22      1222333 344455677789999999

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.96  E-value=5.8e-28  Score=196.06  Aligned_cols=183  Identities=26%  Similarity=0.419  Sum_probs=144.4

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC---
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED---   99 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~---   99 (219)
                      .++| .+.+.||+|+||.||+|.+..++..||+|.+....   .......+..|+.++++++|+|++++++++....   
T Consensus         4 ~~~y-~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (336)
T cd07849           4 GPRY-QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE---HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES   79 (336)
T ss_pred             ccce-EEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence            3455 78899999999999999999999999999886422   2334566788999999999999999988765332   


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      ...+++++|+++ ++|...+.. ..+++..+..++.|++.|+.+||+.+  ++|+||||+||+++.+ +.++|+|||++.
T Consensus        80 ~~~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~-~~~kl~dfg~~~  154 (336)
T cd07849          80 FNDVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTN-CDLKICDFGLAR  154 (336)
T ss_pred             cceEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCC-CCEEECccccee
Confidence            245789999996 578776653 46899999999999999999999999  9999999999999865 589999999998


Q ss_pred             eccccce---------eeeecccCccccCCCccccccceeeecc
Q 027788          180 IVGRAIR---------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .......         ++..+.+|+.......++.++|+||+|+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv  198 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGC  198 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHH
Confidence            7644322         1122334443444455677899999993

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.96  E-value=1.7e-27  Score=187.42  Aligned_cols=179  Identities=22%  Similarity=0.367  Sum_probs=141.9

Q ss_pred             ceeeeeeeeccccceEEEEEEecCC---CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEE---GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ..+.+.+.||+|+||.||+|.+...   ...+++|......   .....+.+.+|+.+++.++|||++++++++..+   
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC---
Confidence            3357889999999999999987543   3568999876442   245567889999999999999999999988532   


Q ss_pred             eEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          102 TLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      ..+++||++++++|.+++... ..+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++++|||++..
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~-~~~~l~d~g~~~~  156 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSP-DCVKLGDFGLSRY  156 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecC-CCeEEccCceeee
Confidence            357899999999999998754 35899999999999999999999999  9999999999999865 5899999999987


Q ss_pred             ccccceeee-------ecccCccccCCCccccccceeeec
Q 027788          181 VGRAIRRIR-------CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~~~~-------~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .........       .+.+| +......++.++|+||+|
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  195 (270)
T cd05056         157 LEDESYYKASKGKLPIKWMAP-ESINFRRFTSASDVWMFG  195 (270)
T ss_pred             cccccceecCCCCccccccCh-hhhccCCCCchhhhHHHH
Confidence            644321111       12223 334455577789999999

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.96  E-value=6.3e-28  Score=191.88  Aligned_cols=179  Identities=25%  Similarity=0.346  Sum_probs=138.3

Q ss_pred             eeeeeeeccccceEEEEEEecC-----CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           27 GRYNELLGSGAVKKVYRAFDQE-----EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      +++.+.||+|+||.||+|+...     ....+++|.+....   .......+.+|+.+++.++||||+++++.+...  .
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~   76 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD--G   76 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC--C
Confidence            3677899999999999998653     23568888776432   344457788999999999999999999988544  4


Q ss_pred             eEEEEeccccCCChHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCC
Q 027788          102 TLNFITEVCTSGNLREYRKKH------------------------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLN  157 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~------------------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~  157 (219)
                      ..++++||+++++|.+++...                        ..++...+..++.|++.++.|||+.+  ++|+||+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dik  154 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLA  154 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhh
Confidence            577899999999999987532                        23678889999999999999999999  9999999


Q ss_pred             CCceEEeCCCCcEEEeccccceeccccce-------eeeecccCccccCCCccccccceeeec
Q 027788          158 CSNVFVNGNTGQVKIGDLGVAAIVGRAIR-------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       158 ~~nili~~~~~~~~l~dfg~a~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |+||+++.+ +.++|+|||++........       .......+++......++.++|+||||
T Consensus       155 p~nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG  216 (290)
T cd05045         155 ARNVLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFG  216 (290)
T ss_pred             hheEEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHH
Confidence            999999855 5899999999976533221       111111222333455577889999999

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.96  E-value=1.5e-27  Score=190.06  Aligned_cols=180  Identities=24%  Similarity=0.387  Sum_probs=141.1

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||+|.+|.||+|.+..+++.|++|.+.....  .....+.+.+|+++++.++|+|++++++++..  ....+++
T Consensus         4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv   79 (294)
T PLN00009          4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRLYLV   79 (294)
T ss_pred             eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeEEEE
Confidence            3677999999999999999999999999998865432  22334667889999999999999999999854  4568899


Q ss_pred             eccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          107 TEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      |||++ ++|.+++....  .+++..+..++.|++.|+.|||+++  ++|+||+|+||+++.+.+.++++|||++......
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            99996 57777665433  3578888899999999999999999  9999999999999865557899999999765432


Q ss_pred             ce------eeeecccCccccCCCccccccceeeec
Q 027788          185 IR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ..      .+..+..|+.......++.++|+||+|
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG  191 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVG  191 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHH
Confidence            21      112233333333445567789999999

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=7.2e-28  Score=189.94  Aligned_cols=176  Identities=23%  Similarity=0.396  Sum_probs=146.0

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.+.||.|++|.||+|.+..++..+++|.+....   .......+.+|+.+++.++|+|++++.+.+..+  ..+++++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~   78 (274)
T cd06609           4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWIIM   78 (274)
T ss_pred             hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEEEE
Confidence            66789999999999999999999999999987543   234456788999999999999999999988544  6788999


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce-
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR-  186 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~-  186 (219)
                      |++++++|.+++... .+++..+..++.|++.++.+||+.+  ++|+||+|+|++++.+ +.++++|||++........ 
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~  154 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSK  154 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCC-CCEEEcccccceeecccccc
Confidence            999999999988765 7899999999999999999999999  9999999999999865 5899999999988765421 


Q ss_pred             -----eeeecccCccccCCCccccccceeeec
Q 027788          187 -----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 -----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                           ++..+.+ ++......++.++|+||+|
T Consensus       155 ~~~~~~~~~y~~-PE~~~~~~~~~~sDv~slG  185 (274)
T cd06609         155 RNTFVGTPFWMA-PEVIKQSGYDEKADIWSLG  185 (274)
T ss_pred             cccccCCccccC-hhhhccCCCCchhhHHHHH
Confidence                 1111223 3344444577889999999

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.95  E-value=3.7e-27  Score=206.42  Aligned_cols=181  Identities=18%  Similarity=0.246  Sum_probs=145.0

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.++||+|+||.||+|++..+++.||+|+++.... ........+..|+.+++.++|+||+++++++..  ...++++
T Consensus         6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~lV   82 (669)
T cd05610           6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVYLV   82 (669)
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEEEE
Confidence            4788999999999999999999999999999875433 234555778899999999999999999988854  4568999


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      |||+++++|.+++.....+++..++.++.|++.||.|||..+  |+||||||+|||++.+ +.++|+|||+++.......
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~-g~vkL~DFGls~~~~~~~~  159 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNE-GHIKLTDFGLSKVTLNREL  159 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCC-CCEEEEeCCCCccccCCcc
Confidence            999999999999887778899999999999999999999999  9999999999999865 6899999999987654332


Q ss_pred             ------eeeecccCccccCCCccccccceeeec
Q 027788          187 ------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                            .+..+..|+..+....-...+++||+|
T Consensus       160 ~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g  192 (669)
T cd05610         160 NMMDILTTPSMAKPKNDYSRTPGQVLSLISSLG  192 (669)
T ss_pred             cccccccCccccCccccccCCCCceeeeeeecC
Confidence                  112222333332222223346777777

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.95  E-value=8.9e-28  Score=198.92  Aligned_cols=179  Identities=25%  Similarity=0.387  Sum_probs=138.4

Q ss_pred             eeeeeeeeccccceEEEEEEe-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCC
Q 027788           26 YGRYNELLGSGAVKKVYRAFD-----QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDED   99 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~   99 (219)
                      .+.+.+.||+|+||.||+|..     ..+++.||+|.++...   .....+.+..|+.++.++. ||||+++++.+..+ 
T Consensus        38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~-  113 (401)
T cd05107          38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG-  113 (401)
T ss_pred             HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-
Confidence            346779999999999999984     3456789999987543   2333457889999999997 99999999999654 


Q ss_pred             CceEEEEeccccCCChHHHHHhCC--------------------------------------------------------
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHR--------------------------------------------------------  123 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~--------------------------------------------------------  123 (219)
                       ..++++|||+++|+|.+++....                                                        
T Consensus       114 -~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         114 -GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             -CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence             45788999999999998875321                                                        


Q ss_pred             ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCce
Q 027788          124 ------------------------------------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNV  161 (219)
Q Consensus       124 ------------------------------------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~ni  161 (219)
                                                                .++...+..++.|++.|+.|||+.+  ++|+||||+||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~Ni  270 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNV  270 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceE
Confidence                                                      2456677889999999999999998  99999999999


Q ss_pred             EEeCCCCcEEEeccccceeccccce---eee-----ecccCccccCCCccccccceeeec
Q 027788          162 FVNGNTGQVKIGDLGVAAIVGRAIR---RIR-----CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       162 li~~~~~~~~l~dfg~a~~~~~~~~---~~~-----~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +++.+ +.++++|||+++.......   ...     .+.+| +......++.++|+||+|
T Consensus       271 Ll~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~DvwslG  328 (401)
T cd05107         271 LICEG-KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAP-ESIFNNLYTTLSDVWSFG  328 (401)
T ss_pred             EEeCC-CEEEEEecCcceecccccccccCCCcCCCCceeCh-HHhcCCCCCcHhHHHHHH
Confidence            99865 5899999999987543221   111     12222 223344567789999999

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.95  E-value=9.1e-28  Score=189.76  Aligned_cols=177  Identities=22%  Similarity=0.336  Sum_probs=144.5

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      ...+.||+|+||.||.|.+..++..+|+|.++...   .....+.+.+|+.+++.++|+|++++++.+..  .+..+++|
T Consensus         7 ~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~   81 (277)
T cd06640           7 TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWIIM   81 (277)
T ss_pred             hhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEEE
Confidence            55588999999999999998899999999987542   24456788999999999999999999999854  45788999


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccccee
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR  187 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~  187 (219)
                      ||+++++|.+++.. .++++..+..++.|++.++.++|+.+  ++|+||+|+||+++.+ +.++++|||++.........
T Consensus        82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06640          82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCC-CCEEEcccccceeccCCccc
Confidence            99999999998764 46889999999999999999999999  9999999999999865 58999999999776543321


Q ss_pred             e-----eecccCccccCCCccccccceeeec
Q 027788          188 I-----RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       188 ~-----~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .     .....+++.......+.++|+||+|
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG  188 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLG  188 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHHHHHH
Confidence            1     1112223334445567789999999

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.95  E-value=1.5e-27  Score=187.70  Aligned_cols=175  Identities=19%  Similarity=0.283  Sum_probs=132.3

Q ss_pred             eeeccccceEEEEEEec--CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEec
Q 027788           31 ELLGSGAVKKVYRAFDQ--EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITE  108 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e  108 (219)
                      +.||+|+||.||+|...  .++..+++|.+....   .......+.+|+.++++++|||++++++.+.  +...++++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT--EVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--CCCCcEEEEE
Confidence            36899999999999753  455679999876443   2233356888999999999999999999884  3455788999


Q ss_pred             cccCCChHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          109 VCTSGNLREYRKKHR-----HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       109 ~~~~g~L~~~~~~~~-----~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      |+++++|.+++....     ..+...+..++.|++.++.|||+.+  ++|+||||+|++++.+ +.++++|||++.....
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~  152 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYK  152 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCC-CcEEECCccccccccC
Confidence            999999999886432     3466778889999999999999999  9999999999999865 5899999999975443


Q ss_pred             cceee--------eecccCccccCC------Cccccccceeeec
Q 027788          184 AIRRI--------RCWGRRSSWRRS------CTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~~~--------~~~~~~~~~~~~------~~~~~~~diws~g  213 (219)
                      .....        ..+.+|+-....      ..++.++|+||+|
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG  196 (269)
T cd05087         153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLG  196 (269)
T ss_pred             cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHH
Confidence            32111        112333322111      1246689999999

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.95  E-value=1.9e-27  Score=191.54  Aligned_cols=188  Identities=22%  Similarity=0.364  Sum_probs=147.8

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      ...++...| ...+.||+|+||.||++.+..++..+|+|.+...... .......+.+|+.++++++|+|++++++++..
T Consensus        19 ~~~~~~~~f-~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   96 (317)
T cd06635          19 FKEDPEKLF-TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR   96 (317)
T ss_pred             cCCCchhhh-hhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC-chHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            445555554 7778999999999999999999999999988754322 34455778899999999999999999998854


Q ss_pred             CCCceEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                        .+..+++|||++ |++.+.+.. ...+++..+..++.|++.++.|||..+  ++|+||+|+||+++.+ +.++|+|||
T Consensus        97 --~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~-~~~kl~dfg  170 (317)
T cd06635          97 --EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEP-GQVKLADFG  170 (317)
T ss_pred             --CCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCC-CCEEEecCC
Confidence              355788999997 467666543 456899999999999999999999999  9999999999999855 589999999


Q ss_pred             cceeccccce--eeeecccCcccc--CCCccccccceeeec
Q 027788          177 VAAIVGRAIR--RIRCWGRRSSWR--RSCTMRITRSLWTYT  213 (219)
Q Consensus       177 ~a~~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~diws~g  213 (219)
                      ++........  ++..+.+|+.+.  ....++.++|+||+|
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slG  211 (317)
T cd06635         171 SASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG  211 (317)
T ss_pred             CccccCCcccccCCccccChhhhhcCCCCCCCccccHHHHH
Confidence            9876544322  222344444432  344577789999999

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.95  E-value=1.4e-27  Score=185.79  Aligned_cols=173  Identities=25%  Similarity=0.414  Sum_probs=137.2

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC  110 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  110 (219)
                      +.||+|+||.||+|.. .++..+|+|.++...   .......+.+|+++++.++|||++++++.+...  ...+++|||+
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR--QPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC--CccEEEEECC
Confidence            3689999999999985 468899999877443   234445688999999999999999999998544  4578899999


Q ss_pred             cCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccceee-
Q 027788          111 TSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRI-  188 (219)
Q Consensus       111 ~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~~-  188 (219)
                      ++++|.+++... ..+++..+..++.|++.++.++|..+  ++|+||+|+|++++.+ +.++++|||++.......... 
T Consensus        75 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~  151 (250)
T cd05085          75 PGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSS  151 (250)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCC-CeEEECCCccceeccccccccC
Confidence            999999987643 45789999999999999999999999  9999999999999855 589999999997644322111 


Q ss_pred             ------eecccCccccCCCccccccceeeec
Q 027788          189 ------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       189 ------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                            ..+.+ ++......++.++|+||+|
T Consensus       152 ~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG  181 (250)
T cd05085         152 GLKQIPIKWTA-PEALNYGRYSSESDVWSYG  181 (250)
T ss_pred             CCCCCcccccC-HHHhccCCCCchhHHHHHH
Confidence                  11222 2333445567789999999

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.95  E-value=4.8e-28  Score=197.06  Aligned_cols=185  Identities=25%  Similarity=0.400  Sum_probs=145.7

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC-
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED-   99 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~-   99 (219)
                      +..++| .+.+.||.|+||.||+|.+..++..|++|.+....    ....+.+.+|++++++++|||++++++.+.... 
T Consensus         2 ~~~~~y-~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~----~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~   76 (342)
T cd07854           2 DLGSRY-MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD----PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS   76 (342)
T ss_pred             CcCcce-EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC----CchHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence            345666 77799999999999999999999999999987553    233467888999999999999999987664332 


Q ss_pred             -----------CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCC
Q 027788          100 -----------RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG  168 (219)
Q Consensus       100 -----------~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~  168 (219)
                                 ...+++++||++ ++|.+++.. ..+++..+..++.|++.|+.|||+.+  ++|+||+|+|++++.+.+
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~  152 (342)
T cd07854          77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDL  152 (342)
T ss_pred             ccccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCc
Confidence                       235789999997 588877653 46899999999999999999999999  999999999999986655


Q ss_pred             cEEEeccccceeccccce---------eeeecccCccccCCCccccccceeeecc
Q 027788          169 QVKIGDLGVAAIVGRAIR---------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       169 ~~~l~dfg~a~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .++++|||.+........         ++..+.+|+.......++.++|+||+|+
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGv  207 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGC  207 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHH
Confidence            789999999976533221         1122334443444456777899999993

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.95  E-value=4.6e-28  Score=196.52  Aligned_cols=182  Identities=24%  Similarity=0.400  Sum_probs=145.7

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC--CCceE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE--DRNTL  103 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~--~~~~~  103 (219)
                      .|.+.+.||+|++|.||+|.+..++..||+|.+.....  .....+.+.+|+.++++++||||+++++++...  ....+
T Consensus         6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            34777999999999999999999999999999875432  233456778899999999999999998877432  34578


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      ++++||+. ++|.+++.....+++..+..++.|++.|+.|||..+  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~  159 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNED-CELRIGDFGMARGLSS  159 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEecccccceeecc
Confidence            89999996 689888877777999999999999999999999999  9999999999999865 6899999999977643


Q ss_pred             cce----------eeeecccCccccCCCccccccceeeec
Q 027788          184 AIR----------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~----------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...          ++..+..|+.......++.++|+||+|
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG  199 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVG  199 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCCcccccccchHHHH
Confidence            221          111222333333335577889999999

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.95  E-value=6e-28  Score=191.24  Aligned_cols=180  Identities=26%  Similarity=0.412  Sum_probs=143.0

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||.|++|.||+|.+..++..+++|.++....  .......+.+|++++++++|||++++++++.  +....+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~~v   77 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIH--TENKLYLV   77 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhcc--cCCcEEEE
Confidence            3677899999999999999999999999998875432  2233457888999999999999999999884  45568899


Q ss_pred             eccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          107 TEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      |||++ ++|.+++...  ..+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++++|||++......
T Consensus        78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVP  153 (284)
T ss_pred             eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEeeccchhhcccC
Confidence            99996 5888877543  46889999999999999999999999  9999999999999866 58999999998766443


Q ss_pred             ce------eeeecccCccccCCCccccccceeeecc
Q 027788          185 IR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       185 ~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ..      ....+.+|+.......++.++|+||+|+
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~  189 (284)
T cd07860         154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC  189 (284)
T ss_pred             ccccccccccccccCCeEEecCCCCCcHHHHHHHHH
Confidence            22      1112334443333444567799999993

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.95  E-value=1.6e-27  Score=185.83  Aligned_cols=177  Identities=28%  Similarity=0.457  Sum_probs=143.8

Q ss_pred             eeeeeeccccceEEEEEEecCCC----cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+.+.||.|+||.||+|.....+    ..+|+|.++...   .....+.+..|+..++.++|+|++++++.+...  ...
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~   76 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE--EPL   76 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--Cee
Confidence            45688999999999999988766    889999986442   222567889999999999999999999988544  568


Q ss_pred             EEEeccccCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          104 NFITEVCTSGNLREYRKKHRH--VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~--~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      +++||++++++|.+++.....  +++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++++|||++...
T Consensus        77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~  153 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGEN-LVVKISDFGLSRDL  153 (258)
T ss_pred             EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccC-CeEEEcccCCceec
Confidence            889999999999998875543  899999999999999999999999  9999999999999865 58999999999877


Q ss_pred             cccceeee-------ecccCccccCCCccccccceeeec
Q 027788          182 GRAIRRIR-------CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ........       .+.+| +......++.++|+||+|
T Consensus       154 ~~~~~~~~~~~~~~~~y~~P-e~~~~~~~~~~~Di~slG  191 (258)
T smart00219      154 YDDDYYKKKGGKLPIRWMAP-ESLKDGKFTSKSDVWSFG  191 (258)
T ss_pred             ccccccccccCCCcccccCh-HHhccCCCCcchhHHHHH
Confidence            65422111       12222 333455677789999999

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.95  E-value=1.3e-27  Score=188.28  Aligned_cols=185  Identities=20%  Similarity=0.232  Sum_probs=140.3

Q ss_pred             eeeeeeeccccceEEEEEEec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC---
Q 027788           27 GRYNELLGSGAVKKVYRAFDQ---EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR---  100 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~---  100 (219)
                      |++.+.||+|+||.||+|...   .++..+|+|.+.....  .....+.+.+|+.+++.++|||++++++++...+.   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF--SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC--ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence            357789999999999999854   3578999999875432  34456778899999999999999999998754322   


Q ss_pred             -ceEEEEeccccCCChHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEe
Q 027788          101 -NTLNFITEVCTSGNLREYRKKH------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIG  173 (219)
Q Consensus       101 -~~~~lv~e~~~~g~L~~~~~~~------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~  173 (219)
                       ...+++++++++++|..++...      ..++...+..++.|++.++.|||+.+  ++|+||||+||+++.+ +.++++
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~-~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNEN-MTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCC-CCEEEC
Confidence             2346788999999998776422      24788899999999999999999999  9999999999999855 589999


Q ss_pred             ccccceecccccee-e-ee-----cccCccccCCCccccccceeeec--ccc
Q 027788          174 DLGVAAIVGRAIRR-I-RC-----WGRRSSWRRSCTMRITRSLWTYT--RLG  216 (219)
Q Consensus       174 dfg~a~~~~~~~~~-~-~~-----~~~~~~~~~~~~~~~~~diws~g--i~~  216 (219)
                      |||+++........ . ..     ...+++......++.++|+||+|  +|+
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~e  207 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWE  207 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHH
Confidence            99999876433210 0 01     11112233444567789999999  444

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.95  E-value=2.1e-27  Score=194.05  Aligned_cols=182  Identities=25%  Similarity=0.360  Sum_probs=144.6

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC---
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED---   99 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~---   99 (219)
                      .++| ++.+.||+|+||.||+|.+..++..||+|.+.....  .......+.+|+.+++.++|+|++++++++....   
T Consensus        15 ~~~y-~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (353)
T cd07850          15 LKRY-QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ--NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE   91 (353)
T ss_pred             hcce-EEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc--ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence            4555 777999999999999999999999999998864322  3344567778999999999999999999885432   


Q ss_pred             -CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          100 -RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       100 -~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                       ....+++||+++ ++|.+.+...  ++...+..++.|++.|+.+||..+  ++|+||||+||+++.+ +.++|+|||++
T Consensus        92 ~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~-~~~kL~Dfg~~  165 (353)
T cd07850          92 EFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA  165 (353)
T ss_pred             ccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEccCccc
Confidence             235789999996 5787766543  889999999999999999999999  9999999999999866 58999999999


Q ss_pred             eeccccce-----eeeecccCccccCCCccccccceeeecc
Q 027788          179 AIVGRAIR-----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       179 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ........     .+..+.+ ++......++.++|+||+|+
T Consensus       166 ~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~DvwslG~  205 (353)
T cd07850         166 RTAGTSFMMTPYVVTRYYRA-PEVILGMGYKENVDIWSVGC  205 (353)
T ss_pred             eeCCCCCCCCCCcccccccC-HHHHhCCCCCCchhhHhHHH
Confidence            87654332     1112223 33445566788899999993

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.95  E-value=7e-28  Score=195.60  Aligned_cols=182  Identities=25%  Similarity=0.360  Sum_probs=145.7

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCce
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~  102 (219)
                      ++| .+.+.||+|+||.||+|.+..++..+|+|.+.....  .......+..|+.+++++ +|+||+++++++...+...
T Consensus         7 ~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           7 RKY-EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR--NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hHH-HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC--cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            444 677899999999999999988999999998764322  223345677899999999 9999999999987666667


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++++||+++ ++|..++... .+++.....++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~  158 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSD-CRVKLADFGLARSLS  158 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CcEEEeeccchhccc
Confidence            899999997 5888877654 7788889999999999999999999  9999999999999865 689999999998765


Q ss_pred             ccce-----------eeeecccCccccCCCccccccceeeec
Q 027788          183 RAIR-----------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~-----------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ....           ++..+..|+.......++.++|+||+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG  200 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVG  200 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHH
Confidence            4321           111233343333445566789999999

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.95  E-value=1.7e-27  Score=188.51  Aligned_cols=179  Identities=22%  Similarity=0.274  Sum_probs=140.3

Q ss_pred             eeeeeeeeccccceEEEEEEe-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           26 YGRYNELLGSGAVKKVYRAFD-----QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      -+++.++||+|+||.||++..     ..++..+++|.+...    .....+.+.+|+++++.++|+||+++++++..  .
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~   79 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCTE--G   79 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec--C
Confidence            346778999999999999964     335678899886633    34555788999999999999999999998854  4


Q ss_pred             ceEEEEeccccCCChHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC
Q 027788          101 NTLNFITEVCTSGNLREYRKKHR---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG  165 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~~---------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~  165 (219)
                      ...++++||+++++|.+++....               .+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~  157 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQ  157 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcC
Confidence            55788999999999999886542               3788899999999999999999999  999999999999985


Q ss_pred             CCCcEEEeccccceeccccceee-------eecccCccccCCCccccccceeeec
Q 027788          166 NTGQVKIGDLGVAAIVGRAIRRI-------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       166 ~~~~~~l~dfg~a~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      + +.++|+|||++..........       .....+++......++.++|+||||
T Consensus       158 ~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  211 (280)
T cd05092         158 G-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFG  211 (280)
T ss_pred             C-CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHH
Confidence            5 589999999997654322110       0111222334445577789999999

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.3e-27  Score=186.99  Aligned_cols=177  Identities=16%  Similarity=0.237  Sum_probs=137.8

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHH-HhhCCCCceEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL-KTLANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l-~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      +.||+|++|.||+|.+..+++.||+|.+...... .......+..|...+ ...+|+|++++++.+.  ..+.+++++||
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~   78 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-AKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ--SKDYLYLVMEY   78 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhh-HHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE--cCCeEEEEEec
Confidence            5689999999999999999999999998643321 112223344555444 4558999999999984  44678899999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce--e
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR--R  187 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~--~  187 (219)
                      +++++|.++++....+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|+|||++........  +
T Consensus        79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~  155 (260)
T cd05611          79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLENKKFVG  155 (260)
T ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CcEEEeecccceeccccccCCC
Confidence            999999999987778999999999999999999999999  9999999999999865 5899999999876543221  2


Q ss_pred             eeecccCccccCCCccccccceeeecc
Q 027788          188 IRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       188 ~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ...+.+|+ ......++.++|+||+|+
T Consensus       156 ~~~y~~pe-~~~~~~~~~~~Dv~slG~  181 (260)
T cd05611         156 TPDYLAPE-TILGVGDDKMSDWWSLGC  181 (260)
T ss_pred             CcCccChh-hhcCCCCcchhhhHHHHH
Confidence            22233333 344444778899999993

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.95  E-value=9.6e-28  Score=191.68  Aligned_cols=181  Identities=25%  Similarity=0.429  Sum_probs=142.7

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC-------
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED-------   99 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~-------   99 (219)
                      |.+.+.||+|+||.||+|....+++.||+|.++....  .......+.+|+.+++.++|||++++++++....       
T Consensus         9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~   86 (302)
T cd07864           9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE--KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK   86 (302)
T ss_pred             hheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc--ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence            4778999999999999999999999999999875432  1222355678999999999999999998885443       


Q ss_pred             -CceEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788          100 -RNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus       100 -~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                       ...+++++|++++ ++..++.. ...+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        87 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~-~~~kl~dfg~  162 (302)
T cd07864          87 DKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNK-GQIKLADFGL  162 (302)
T ss_pred             cCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CcEEeCcccc
Confidence             3478899999975 66666554 346899999999999999999999999  9999999999999865 5899999999


Q ss_pred             ceeccccce-------eeeecccCccccCCCccccccceeeec
Q 027788          178 AAIVGRAIR-------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       178 a~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +........       ....+.+|+.......++.++|+||+|
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG  205 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG  205 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHH
Confidence            987644321       122234444343444567789999999

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.9e-27  Score=186.01  Aligned_cols=183  Identities=24%  Similarity=0.449  Sum_probs=146.6

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCC-
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDED-   99 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~-   99 (219)
                      +.++| .+.+.||+|++|.||+|.+..++..+++|.+....     ...+.+.+|+.+++++ +|+|++++++.+.... 
T Consensus         4 ~~~~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (275)
T cd06608           4 PTGIF-ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP   77 (275)
T ss_pred             chhhe-eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence            44566 78899999999999999998899999999887442     2336688999999999 6999999999986533 


Q ss_pred             ---CceEEEEeccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEE
Q 027788          100 ---RNTLNFITEVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKI  172 (219)
Q Consensus       100 ---~~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l  172 (219)
                         ...++++|||+++++|.+++..    ...+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.+++
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~-~~~~l  154 (275)
T cd06608          78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKN-AEVKL  154 (275)
T ss_pred             CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccC-CeEEE
Confidence               4568899999999999988754    246889999999999999999999999  9999999999999865 58999


Q ss_pred             eccccceeccccce------eeeecccCcccc----CCCccccccceeeec
Q 027788          173 GDLGVAAIVGRAIR------RIRCWGRRSSWR----RSCTMRITRSLWTYT  213 (219)
Q Consensus       173 ~dfg~a~~~~~~~~------~~~~~~~~~~~~----~~~~~~~~~diws~g  213 (219)
                      +|||++........      ++..+.+|+.+.    ....++.++|+||+|
T Consensus       155 ~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG  205 (275)
T cd06608         155 VDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG  205 (275)
T ss_pred             CCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhH
Confidence            99999876543222      122234444332    234466789999999

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.95  E-value=1.7e-27  Score=189.80  Aligned_cols=184  Identities=23%  Similarity=0.395  Sum_probs=147.3

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      ..+++.++| .+.+.||+|+||.||++.+..++..+++|.+....    ....+.+.+|+.+++.++|||++++++.+..
T Consensus        13 ~~~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~   87 (293)
T cd06647          13 SVGDPKKKY-TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYLV   87 (293)
T ss_pred             eccCchhhc-eeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheeee
Confidence            345566666 67799999999999999988889999999876432    2334678899999999999999999998854


Q ss_pred             CCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                        .+..++++||+++++|.+++... .++...+..++.|++.++.+||+.+  ++|+||+|+|++++.+ +.++|+|||+
T Consensus        88 --~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~-~~~kL~dfg~  161 (293)
T cd06647          88 --GDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGF  161 (293)
T ss_pred             --CCcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCC-CCEEEccCcc
Confidence              35578899999999999987643 5788899999999999999999999  9999999999999865 5899999998


Q ss_pred             ceecccccee------eeecccCccccCCCccccccceeeec
Q 027788          178 AAIVGRAIRR------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       178 a~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +.........      +..+..| +......++.++|+||+|
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~~P-E~~~~~~~~~~~Dv~slG  202 (293)
T cd06647         162 CAQITPEQSKRSTMVGTPYWMAP-EVVTRKAYGPKVDIWSLG  202 (293)
T ss_pred             eecccccccccccccCChhhcCc-hhhccCCCCchhhHHHHH
Confidence            8765443321      1112333 333445567789999999

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.95  E-value=2.6e-27  Score=185.68  Aligned_cols=179  Identities=24%  Similarity=0.422  Sum_probs=145.8

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||.|+||.||+|....++..+++|++.....   ....+.+.+|+++++.++|+|++++++.+..  .+..+++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv   77 (267)
T cd06610           3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLV   77 (267)
T ss_pred             ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEE
Confidence            4778999999999999999888999999999875432   2256788999999999999999999988844  4568899


Q ss_pred             eccccCCChHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          107 TEVCTSGNLREYRKKH---RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +|++++++|.+++...   ..+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++..+..
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~  154 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGED-GSVKIADFGVSASLAD  154 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCC-CCEEEcccchHHHhcc
Confidence            9999999999988653   35899999999999999999999999  9999999999999865 5899999999877755


Q ss_pred             ccee----------eeecccCccccCCCccccccceeeec
Q 027788          184 AIRR----------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~~----------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ....          +..+..|+.......++.++|+||+|
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG  194 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFG  194 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHh
Confidence            4322          11122333333333677789999999

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.95  E-value=7.1e-28  Score=190.82  Aligned_cols=178  Identities=26%  Similarity=0.360  Sum_probs=139.5

Q ss_pred             eeeeeeeccccceEEEEEEecC-----CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           27 GRYNELLGSGAVKKVYRAFDQE-----EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      +++.+.||+|+||.||+|....     .+..||+|.++...   .....+.+.+|+.++..++||||+++++.+...  .
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--~   81 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE--Q   81 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--C
Confidence            4677899999999999998653     35789999987442   334457788999999999999999999998544  4


Q ss_pred             eEEEEeccccCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC
Q 027788          102 TLNFITEVCTSGNLREYRKKH----------------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG  165 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~----------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~  165 (219)
                      .+++++||+++++|.+++...                ..+++..+..++.|++.|+.|+|+.+  ++||||||+||+++.
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~  159 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFD  159 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecC
Confidence            578899999999999887421                23678888999999999999999999  999999999999985


Q ss_pred             CCCcEEEeccccceecccccee--------eeecccCccccCCCccccccceeeec
Q 027788          166 NTGQVKIGDLGVAAIVGRAIRR--------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       166 ~~~~~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      + +.++|+|||+++........        +..+.+|+. .....++.++|+||+|
T Consensus       160 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~-~~~~~~~~~~Dv~slG  213 (283)
T cd05091         160 K-LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEA-IMYGKFSIDSDIWSYG  213 (283)
T ss_pred             C-CceEecccccccccccchheeeccCccCCccccCHHH-HhcCCCCcchhHHHHH
Confidence            5 58999999998866433211        112333332 3344567789999999

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=202.19  Aligned_cols=167  Identities=29%  Similarity=0.455  Sum_probs=140.7

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC  110 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  110 (219)
                      +-+|+|+-|.||+|+..  ++.||||.++.-.           -.+|+=|++|+|+||+.+.++|  ...+.++++||||
T Consensus       130 eWlGSGaQGAVF~Grl~--netVAVKKV~elk-----------ETdIKHLRkLkH~NII~FkGVC--tqsPcyCIiMEfC  194 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH--NETVAVKKVRELK-----------ETDIKHLRKLKHPNIITFKGVC--TQSPCYCIIMEFC  194 (904)
T ss_pred             hhhccCcccceeeeecc--CceehhHHHhhhh-----------hhhHHHHHhccCcceeeEeeee--cCCceeEEeeecc
Confidence            35899999999999753  5789999765321           1578889999999999999999  4557899999999


Q ss_pred             cCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce----
Q 027788          111 TSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR----  186 (219)
Q Consensus       111 ~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~----  186 (219)
                      +.|-|...++....+.......|..+|+.|+.|||.+.  |+|||||.-||||..++ .+||+|||.++-.....+    
T Consensus       195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSF  271 (904)
T KOG4721|consen  195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSF  271 (904)
T ss_pred             ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhh
Confidence            99999999998889999999999999999999999999  99999999999999775 799999999988766554    


Q ss_pred             -eeeecccCccccCCCccccccceeeec--ccc
Q 027788          187 -RIRCWGRRSSWRRSCTMRITRSLWTYT--RLG  216 (219)
Q Consensus       187 -~~~~~~~~~~~~~~~~~~~~~diws~g--i~~  216 (219)
                       ++.+|.+|+ ..++.+.+-|-||||||  .|.
T Consensus       272 aGTVaWMAPE-vIrnePcsEKVDIwSfGVVLWE  303 (904)
T KOG4721|consen  272 AGTVAWMAPE-VIRNEPCSEKVDIWSFGVVLWE  303 (904)
T ss_pred             hhhHhhhCHH-HhhcCCcccccceehhHHHHHH
Confidence             444555553 44555666789999999  554

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.95  E-value=1.4e-27  Score=189.07  Aligned_cols=178  Identities=27%  Similarity=0.454  Sum_probs=141.9

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||.|++|.||+|++..++..||+|.++....   ......+.+|+.++++++|+|++++++.+...  +..+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv   76 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHTE--NKLMLV   76 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC--CcEEEE
Confidence            3677899999999999999999999999999876532   22235677899999999999999999998654  457889


Q ss_pred             eccccCCChHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          107 TEVCTSGNLREYRKKH---RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      ||++++ +|.+++...   ..+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++++|||++.....
T Consensus        77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~  152 (284)
T cd07836          77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKR-GELKLADFGLARAFGI  152 (284)
T ss_pred             EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCC-CcEEEeecchhhhhcC
Confidence            999974 787776543   35899999999999999999999999  9999999999999855 6899999999976543


Q ss_pred             cce------eeeecccCccccCCCccccccceeeec
Q 027788          184 AIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...      .+..+..|+.......++.++|+||+|
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG  188 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVG  188 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHH
Confidence            221      111233343344445567789999999

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.6e-27  Score=186.58  Aligned_cols=178  Identities=23%  Similarity=0.381  Sum_probs=142.2

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ...+.+.+.||+|++|.||+|... .+..+++|.+....     ...+.+.+|+.++++++|+|++++++.+..  ...+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   76 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEPI   76 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-----cCHHHHHHHHHHHhhCCCCCEeeeeeeeec--CCce
Confidence            344588899999999999999865 45779999887432     223668899999999999999999998844  3557


Q ss_pred             EEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          104 NFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      +++||++++++|.+++...  ..++...+..++.|++.++.+||+++  ++|+||+|+||+++.+ +.++++|||++...
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~-~~~~l~d~g~~~~~  153 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGEN-LVCKIADFGLARLI  153 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCC-CCEEECccccceec
Confidence            8899999999999988654  36889999999999999999999999  9999999999999866 68999999999876


Q ss_pred             ccccee-------eeecccCccccCCCccccccceeeec
Q 027788          182 GRAIRR-------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ......       ...+.+ ++......++.++|+||+|
T Consensus       154 ~~~~~~~~~~~~~~~~y~~-PE~~~~~~~~~~~Di~slG  191 (261)
T cd05034         154 EDDEYTAREGAKFPIKWTA-PEAANYGRFTIKSDVWSFG  191 (261)
T ss_pred             cchhhhhhhccCCCccccC-HHHhccCCcCchhHHHHHH
Confidence            532210       011223 3334445567789999999

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.95  E-value=1.2e-27  Score=191.59  Aligned_cols=178  Identities=25%  Similarity=0.438  Sum_probs=139.7

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCc----EEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGI----EVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      .++..+.||+|+||.||+|....++.    .+|+|.+....   .......+.+|+.+++.++|||++++++.+....  
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--   82 (303)
T cd05110           8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT--   82 (303)
T ss_pred             hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC--
Confidence            34677899999999999999877775    46888766432   2344456889999999999999999999885432  


Q ss_pred             eEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          102 TLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                       .++++|++++|+|.+++... ..+++..+..++.|++.|+.|||+++  ++|+||||+||+++.+ +.+||+|||+++.
T Consensus        83 -~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~-~~~kL~Dfg~~~~  158 (303)
T cd05110          83 -IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSP-NHVKITDFGLARL  158 (303)
T ss_pred             -ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCC-CceEEcccccccc
Confidence             46799999999999988654 35889999999999999999999999  9999999999999855 5899999999987


Q ss_pred             ccccceeee--------ecccCccccCCCccccccceeeec
Q 027788          181 VGRAIRRIR--------CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~~~~--------~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .........        .+.+ ++......++.++|+||+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~-PE~~~~~~~~~~~DiwslG  198 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMA-LECIHYRKFTHQSDVWSYG  198 (303)
T ss_pred             ccCcccccccCCCccccccCC-HHHhccCCCChHHHHHHHH
Confidence            654332111        1222 2334455677789999999

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.95  E-value=2e-27  Score=188.20  Aligned_cols=180  Identities=21%  Similarity=0.393  Sum_probs=145.9

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.+.||+|++|.||+|....++..+|+|.+....  ........+.+|+.+++.++|+|++++++++........++++
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             eeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            56789999999999999999999999999998654  2334446788899999999999999999998655346788999


Q ss_pred             ccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          108 EVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       108 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      ||++ ++|..++... ..+++..+..++.|++.|+.+||..+  ++|+||+|+||+++.+ +.++++|||++........
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINND-GVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCC-CCEEEccccceeeccCCCc
Confidence            9997 4888877654 57899999999999999999999999  9999999999999865 6899999999987765431


Q ss_pred             -------eeeecccCccccCCCccccccceeeec
Q 027788          187 -------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 -------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                             .+..+.+|+.......++.++|+||+|
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG  189 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVG  189 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHH
Confidence                   111233343333344567789999999

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.95  E-value=4.2e-28  Score=191.63  Aligned_cols=176  Identities=24%  Similarity=0.373  Sum_probs=143.8

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      ...+.||+|+||.||+|.+..++..||+|.++...   .....+.+.+|+.+++.++|||++++++.+.  ..+.+++++
T Consensus         7 ~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~   81 (277)
T cd06642           7 TKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYL--KGTKLWIIM   81 (277)
T ss_pred             HHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccc--cCCceEEEE
Confidence            45578999999999999999899999999887442   2344577889999999999999999999884  445688999


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce-
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR-  186 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~-  186 (219)
                      ||+++++|.+++.. ..+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++++|||++..+..... 
T Consensus        82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06642          82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCC-CCEEEccccccccccCcchh
Confidence            99999999988764 46889999999999999999999999  9999999999999865 6899999999977654321 


Q ss_pred             -----eeeecccCccccCCCccccccceeeec
Q 027788          187 -----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 -----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                           +...+.+| +......++.++|+||+|
T Consensus       158 ~~~~~~~~~y~aP-E~~~~~~~~~~~Dv~slG  188 (277)
T cd06642         158 RNTFVGTPFWMAP-EVIKQSAYDFKADIWSLG  188 (277)
T ss_pred             hhcccCcccccCH-HHhCcCCCchhhhHHHHH
Confidence                 11122333 334445677789999999

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.95  E-value=1.9e-27  Score=189.35  Aligned_cols=183  Identities=26%  Similarity=0.399  Sum_probs=141.9

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCC---ce
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDR---NT  102 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~---~~  102 (219)
                      |++.+.||+|+||.||+|.+..+++.||+|.++....  .......+.+|+.+++.+. |+|++++++++...+.   ..
T Consensus         3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            3677899999999999999999999999998775432  2223356778999999995 5999999988865432   24


Q ss_pred             EEEEeccccCCChHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788          103 LNFITEVCTSGNLREYRKKH-----RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                      ++++|||+++ +|.+++...     ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+.+.++|+|||+
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~  157 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGL  157 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeeccc
Confidence            7899999985 787776432     34789999999999999999999999  999999999999996456899999999


Q ss_pred             ceeccccce------eeeecccCccccCCCccccccceeeecc
Q 027788          178 AAIVGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +..+.....      ....+.+|+.......++.++|+||+|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~  200 (295)
T cd07837         158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC  200 (295)
T ss_pred             ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHH
Confidence            986644322      1112333333334455677899999993

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.95  E-value=2.5e-27  Score=187.56  Aligned_cols=184  Identities=25%  Similarity=0.449  Sum_probs=145.1

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecC-
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDE-   98 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~-   98 (219)
                      ++.+.| .+.+.||+|+||.||+|.+..+++.+|+|.+...     ......+..|+.+++++ +|+|++++++.+... 
T Consensus        13 ~~~~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636          13 DPAGIF-ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             Chhhhh-hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            455666 7779999999999999999999999999987643     23345678899999888 699999999988532 


Q ss_pred             ---CCceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEe
Q 027788           99 ---DRNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIG  173 (219)
Q Consensus        99 ---~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~  173 (219)
                         ..+.++++|||+++++|.+++...  ..+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++|+
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~-~~~~l~  163 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTEN-AEVKLV  163 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEe
Confidence               346789999999999999988653  35788889999999999999999999  9999999999999855 589999


Q ss_pred             ccccceeccccce------eeeecccCccccC----CCccccccceeeec
Q 027788          174 DLGVAAIVGRAIR------RIRCWGRRSSWRR----SCTMRITRSLWTYT  213 (219)
Q Consensus       174 dfg~a~~~~~~~~------~~~~~~~~~~~~~----~~~~~~~~diws~g  213 (219)
                      |||++........      ++..+.+|+....    ...++.++|+||+|
T Consensus       164 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG  213 (282)
T cd06636         164 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLG  213 (282)
T ss_pred             eCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHH
Confidence            9999876543221      2222333433221    34567789999999

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.95  E-value=2.3e-27  Score=185.14  Aligned_cols=173  Identities=23%  Similarity=0.403  Sum_probs=138.7

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      +.+.+.||+|+||.||++.  .+++.+|+|.++..      ...+.+.+|+.++++++|||++++++++....   .+++
T Consensus         8 ~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---~~~v   76 (254)
T cd05083           8 LTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD------VTAQAFLEETAVMTKLHHKNLVRLLGVILHNG---LYIV   76 (254)
T ss_pred             ceeeeeeccCCCCceEecc--cCCCceEEEeecCc------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC---cEEE
Confidence            4788999999999999985  46788999987643      22367889999999999999999999885432   6789


Q ss_pred             eccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          107 TEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      |||+++++|.+++....  .++...+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSED-GVAKVSDFGLARVGSMG  153 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCC-CcEEECCCccceecccc
Confidence            99999999999886543  4789999999999999999999999  9999999999999865 58999999999765433


Q ss_pred             ceee--eecccCccccCCCccccccceeeec
Q 027788          185 IRRI--RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~~~--~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ....  .....+++......++.++|+||+|
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG  184 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYG  184 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHH
Confidence            2211  1112233444556677789999999

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.95  E-value=1.9e-27  Score=188.88  Aligned_cols=178  Identities=24%  Similarity=0.299  Sum_probs=140.6

Q ss_pred             eeeeeeeccccceEEEEEEec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           27 GRYNELLGSGAVKKVYRAFDQ-----EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      +++.+.||+|+||.||+|.+.     .++..+|+|.+....   .....+.+.+|+.++++++|||++++++++...  .
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~--~   81 (288)
T cd05050           7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAVG--K   81 (288)
T ss_pred             ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--C
Confidence            478899999999999999864     367889999887432   344557788999999999999999999988544  4


Q ss_pred             eEEEEeccccCCChHHHHHhC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCC
Q 027788          102 TLNFITEVCTSGNLREYRKKH----------------------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCS  159 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~----------------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~  159 (219)
                      .+++++|++++++|.+++...                      ..+++..+..++.|++.++.+||+.+  ++|+||+|+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~  159 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATR  159 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHh
Confidence            578899999999999988632                      13677888999999999999999999  999999999


Q ss_pred             ceEEeCCCCcEEEeccccceeccccce--------eeeecccCccccCCCccccccceeeec
Q 027788          160 NVFVNGNTGQVKIGDLGVAAIVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       160 nili~~~~~~~~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |++++.+ +.++++|||++........        ....+.+| +......++.++|+||+|
T Consensus       160 nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Dv~slG  219 (288)
T cd05050         160 NCLVGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPP-ESIFYNRYTTESDVWAYG  219 (288)
T ss_pred             heEecCC-CceEECccccceecccCccccccCCCccChhhcCH-HHHhcCCCCchhHHHHHH
Confidence            9999855 6899999999986543321        00112222 333445677789999999

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.95  E-value=1.9e-27  Score=186.26  Aligned_cols=175  Identities=21%  Similarity=0.351  Sum_probs=135.4

Q ss_pred             eeeccccceEEEEEEecC---CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           31 ELLGSGAVKKVYRAFDQE---EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      +.||+|+||.||+|....   ....+|+|.+....   .....+.+..|+.+++.++|||++++++.+... .+..++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT---DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC---CHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEE
Confidence            468999999999998643   34579999875321   344567888999999999999999999977533 34567899


Q ss_pred             ccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          108 EVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       108 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      ||+++++|.+++... .......+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|+|||+++.......
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCC-CcEEECCccccccccCCcc
Confidence            999999999998654 34667788889999999999999999  9999999999999865 5899999999976543211


Q ss_pred             ----------eeeecccCccccCCCccccccceeeec
Q 027788          187 ----------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ----------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                                ....+.+|+ ......++.++|+||||
T Consensus       154 ~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG  189 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALE-SLQTQKFTTKSDVWSFG  189 (262)
T ss_pred             eeecccccCcCCccccChh-HhccCccchHHHHHHHH
Confidence                      111223333 33445677789999999

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=5.3e-27  Score=200.12  Aligned_cols=189  Identities=23%  Similarity=0.374  Sum_probs=154.7

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEec--
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRD--   97 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~--   97 (219)
                      ||...+ .+...||.|.+|.||++...++++..|+|+.+....     .-+++..|.++++.. .|||+..+++++..  
T Consensus        16 dp~d~~-ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   16 DPADIF-EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             CCCCcc-EEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-----ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            344444 788999999999999999999999999998775432     226677889999877 58999999988854  


Q ss_pred             -CCCceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEec
Q 027788           98 -EDRNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD  174 (219)
Q Consensus        98 -~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~d  174 (219)
                       ...+-+|||||+|.+|+..++.+..  ..+.+..+..|++.++.|+..||.+.  ++|||+|-.|||++.+ +.||+.|
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e-~~VKLvD  166 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTEN-AEVKLVD  166 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEecc-CcEEEee
Confidence             3346799999999999999988643  56889999999999999999999988  9999999999999977 5899999


Q ss_pred             cccceeccccce------eeeecccCcc----ccCCCccccccceeeecccccc
Q 027788          175 LGVAAIVGRAIR------RIRCWGRRSS----WRRSCTMRITRSLWTYTRLGCA  218 (219)
Q Consensus       175 fg~a~~~~~~~~------~~~~~~~~~~----~~~~~~~~~~~diws~gi~~~~  218 (219)
                      ||++..+.+...      ++.+|-+|+-    -.....|+..+|+|||||+|+.
T Consensus       167 FGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIE  220 (953)
T KOG0587|consen  167 FGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIE  220 (953)
T ss_pred             eeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeeh
Confidence            999999877664      3334444442    2356668888999999999874

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.95  E-value=3.3e-27  Score=186.58  Aligned_cols=177  Identities=22%  Similarity=0.357  Sum_probs=143.5

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|+||.||+|.+..++..+|+|.+....   .....+.+.+|+.++++++|||++++++.+..  .+..+++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv   80 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWII   80 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEEEE
Confidence            466788999999999999998899999999876432   23455778899999999999999999998844  4568899


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      |||+++++|..++.. ..+++..+..++.|++.++.+||+.+  ++|+||+|+|++++.+ +.++++|||++........
T Consensus        81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCC-CCEEEeecccceecccchh
Confidence            999999999988764 36889999999999999999999999  9999999999999855 6899999999877654321


Q ss_pred             ------eeeecccCccccCCCccccccceeeec
Q 027788          187 ------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                            .+..+.+| +.......+.++|+||+|
T Consensus       157 ~~~~~~~~~~y~~P-E~~~~~~~~~~~Dv~slG  188 (277)
T cd06641         157 KRNTFVGTPFWMAP-EVIKQSAYDSKADIWSLG  188 (277)
T ss_pred             hhccccCCccccCh-hhhccCCCCchhhHHHHH
Confidence                  11112223 333344566789999999

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.95  E-value=6.1e-27  Score=185.31  Aligned_cols=178  Identities=22%  Similarity=0.328  Sum_probs=136.1

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHH-HHhhCCCCceEEEEEEecCCCceEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRL-LKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~-l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      |.+.+.||+|+||.||++.+..+++.||+|.++....  ... ...+..|+.. ++.++|||++++++.+..  ...+++
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~l   77 (283)
T cd06617           3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQE-QKRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWI   77 (283)
T ss_pred             ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEE
Confidence            3677899999999999999999999999999875432  122 2344556664 667789999999999854  345888


Q ss_pred             EeccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          106 ITEVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHTH-EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~~-~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      +|||++ ++|.+++..    ...+++..+..++.|++.|+.|||++ +  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~-~~~kl~dfg~~~~  153 (283)
T cd06617          78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRN-GQVKLCDFGISGY  153 (283)
T ss_pred             Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCC-CCEEEeecccccc
Confidence            999996 678776643    24688999999999999999999986 8  9999999999999865 5899999999987


Q ss_pred             ccccce-----eeeecccCccccC---CCccccccceeeec
Q 027788          181 VGRAIR-----RIRCWGRRSSWRR---SCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~diws~g  213 (219)
                      ......     ++..+.+|+.+..   ...++.++|+||+|
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG  194 (283)
T cd06617         154 LVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLG  194 (283)
T ss_pred             cccccccccccCCccccChhhcCCcccccccCccccchhhH
Confidence            644322     1222334443322   13456789999999

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.95  E-value=2.7e-27  Score=192.74  Aligned_cols=187  Identities=26%  Similarity=0.385  Sum_probs=145.6

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      +...++| .+.+.||+|+||.||+|.+..++..||+|.++...  ......+.+.+|+.++++++||||+++.+++....
T Consensus        11 ~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880          11 WEVPDRY-RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             hccccce-EEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            3455666 67799999999999999999999999999886432  13334467889999999999999999999885433


Q ss_pred             C----ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788          100 R----NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus       100 ~----~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      .    ..++++||++ +++|..++.. ..+++..+..++.|++.|+.+||+.+  ++|+||+|+||+++.+ +.++++||
T Consensus        88 ~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~-~~~kl~df  162 (343)
T cd07880          88 SLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNED-CELKILDF  162 (343)
T ss_pred             cccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeec
Confidence            2    2468899998 6788887654 46899999999999999999999999  9999999999999855 68999999


Q ss_pred             ccceeccccce---eeeecccCccccCCCccccccceeeecc
Q 027788          176 GVAAIVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       176 g~a~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      |++........   .+..+.+|+.......++.++|+||+|+
T Consensus       163 g~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~  204 (343)
T cd07880         163 GLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGC  204 (343)
T ss_pred             ccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHH
Confidence            99986644322   1112223333332234667799999993

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.95  E-value=4.1e-27  Score=183.20  Aligned_cols=174  Identities=25%  Similarity=0.393  Sum_probs=139.3

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC  110 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  110 (219)
                      ++||+|++|.||+|.+.. ++.|++|.+....   .......+.+|++++++++|+|++++++++...  ...++++|++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTL---PPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK--QPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CCeEEEEEcC
Confidence            468999999999999877 9999999877543   224557889999999999999999999988544  5578899999


Q ss_pred             cCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccccee--
Q 027788          111 TSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR--  187 (219)
Q Consensus       111 ~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~--  187 (219)
                      ++++|.+++.. ...++...+..++.+++.++.+||+++  ++|+||+|+||+++.+ +.++|+|||++.........  
T Consensus        75 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~  151 (251)
T cd05041          75 PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVS  151 (251)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCC-CcEEEeeccccccccCCcceec
Confidence            99999998864 346789999999999999999999999  9999999999999865 58999999999865422110  


Q ss_pred             -----eeecccCccccCCCccccccceeeec
Q 027788          188 -----IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       188 -----~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                           ......+++......++.++|+||+|
T Consensus       152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG  182 (251)
T cd05041         152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYG  182 (251)
T ss_pred             cccCcceeccCChHhhccCCCCcchhHHHHH
Confidence                 01112223344445677789999999

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.95  E-value=7.3e-27  Score=182.92  Aligned_cols=178  Identities=23%  Similarity=0.375  Sum_probs=140.1

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ...+++.++||+|+||.||++... .+..+++|.+...     ....+.+.+|+.+++.++|+|++++++.+..   ...
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~   75 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPI   75 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCe
Confidence            344589999999999999999754 5567999987632     2234678889999999999999999988854   447


Q ss_pred             EEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          104 NFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      +++|||+++++|.+++...  ..++...+..++.|++.++.+||+.+  ++|+||+|+|++++.+ +.++++|||.+...
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~  152 (260)
T cd05073          76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS-LVCKIADFGLARVI  152 (260)
T ss_pred             EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCC-CcEEECCCcceeec
Confidence            8899999999999988653  35788889999999999999999999  9999999999999865 68999999999766


Q ss_pred             cccceee------eecccCccccCCCccccccceeeec
Q 027788          182 GRAIRRI------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~~~------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .......      .....+++......++.++|+||+|
T Consensus       153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG  190 (260)
T cd05073         153 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFG  190 (260)
T ss_pred             cCCCcccccCCcccccccCHhHhccCCcCccccchHHH
Confidence            4322110      0112223344455677789999999

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.95  E-value=7.8e-27  Score=181.72  Aligned_cols=179  Identities=23%  Similarity=0.445  Sum_probs=147.8

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||.|++|.||++.+..++..+++|.+.....  .....+.+..|+++++.++|+|++++.+.+...  ...+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv   77 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIV   77 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEE
Confidence            3677899999999999999998999999999876543  334557788999999999999999999988544  678899


Q ss_pred             eccccCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          107 TEVCTSGNLREYRKKH----RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +|++++++|..++...    ..+++..+..++.+++.++.+||+.+  ++|+||+|+|++++.+ +.++|+|||++....
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~  154 (258)
T cd08215          78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSN-GLVKLGDFGISKVLS  154 (258)
T ss_pred             EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCC-CcEEECCccceeecc
Confidence            9999999999988653    56899999999999999999999999  9999999999999865 589999999998765


Q ss_pred             ccce------eeeecccCccccCCCccccccceeeec
Q 027788          183 RAIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ....      ++..+.+| +......++.++|+||+|
T Consensus       155 ~~~~~~~~~~~~~~y~~p-e~~~~~~~~~~~Dv~slG  190 (258)
T cd08215         155 STVDLAKTVVGTPYYLSP-ELCQNKPYNYKSDIWSLG  190 (258)
T ss_pred             cCcceecceeeeecccCh-hHhccCCCCccccHHHHH
Confidence            5431      22223333 334445577789999999

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.95  E-value=3.9e-27  Score=183.67  Aligned_cols=178  Identities=24%  Similarity=0.432  Sum_probs=146.2

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+| .+.+.||+|++|.||+|....++..+++|.+....      ..+.+.+|+.++++++|+|++++++.+...  ..+
T Consensus         3 ~~y-~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~   73 (256)
T cd06612           3 EVF-DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE------DLQEIIKEISILKQCDSPYIVKYYGSYFKN--TDL   73 (256)
T ss_pred             ccc-hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH------HHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CcE
Confidence            344 67789999999999999998889999999887432      257889999999999999999999988544  668


Q ss_pred             EEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          104 NFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++++|++++++|.+++.. ...+++..+..++.|++.++.+||..+  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        74 ~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~  150 (256)
T cd06612          74 WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEE-GQAKLADFGVSGQLT  150 (256)
T ss_pred             EEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCC-CcEEEcccccchhcc
Confidence            899999999999998865 356899999999999999999999999  9999999999999865 589999999998765


Q ss_pred             ccce------eeeecccCccccCCCccccccceeeecc
Q 027788          183 RAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ....      +...+.+| +......++.++|+||+|+
T Consensus       151 ~~~~~~~~~~~~~~y~~P-E~~~~~~~~~~~Di~s~G~  187 (256)
T cd06612         151 DTMAKRNTVIGTPFWMAP-EVIQEIGYNNKADIWSLGI  187 (256)
T ss_pred             cCccccccccCCccccCH-HHHhcCCCCchhhHHHHHH
Confidence            5431      11122233 3344456777899999993

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.95  E-value=1.4e-27  Score=189.03  Aligned_cols=178  Identities=28%  Similarity=0.439  Sum_probs=143.1

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.+.||.|++|.||+|.+..+|..|++|.+.....  .....+.+.+|+++++.++|||++++++.+.  +....++++
T Consensus         2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~--~~~~~~iv~   77 (283)
T cd07835           2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVH--SENKLYLVF   77 (283)
T ss_pred             chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheec--cCCeEEEEE
Confidence            566899999999999999999999999999875532  2233356788999999999999999999885  446788999


Q ss_pred             ccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          108 EVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ||++ ++|.+++....  .+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++.......
T Consensus        78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPV  153 (283)
T ss_pred             eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCC-CcEEEeecccccccCCCc
Confidence            9995 68988887654  6899999999999999999999999  9999999999999865 689999999997654322


Q ss_pred             e------eeeecccCccccCCCccccccceeeec
Q 027788          186 R------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .      ....+.+|+.......++.++|+||+|
T Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG  187 (283)
T cd07835         154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIG  187 (283)
T ss_pred             cccCccccccCCCCCceeecCcccCcHHHHHHHH
Confidence            1      111233344344444567789999999

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.95  E-value=1.4e-27  Score=191.32  Aligned_cols=185  Identities=21%  Similarity=0.364  Sum_probs=142.8

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC---
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED---   99 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~---   99 (219)
                      .++| .+.+.||+|++|.||+|.+..++..+++|.+......  ......+.+|+++++.++|+||+++++.+....   
T Consensus         7 ~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           7 LRDY-EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             cccE-EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC--CCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            3555 7889999999999999999999999999998754321  122245668999999999999999988775433   


Q ss_pred             ---CceEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788          100 ---RNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus       100 ---~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                         ...+++++||+++ ++...+.. ...+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++|+||
T Consensus        84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~-~~~~l~df  159 (311)
T cd07866          84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQ-GILKIADF  159 (311)
T ss_pred             cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEECcC
Confidence               2357899999964 66665543 457999999999999999999999999  9999999999999865 58999999


Q ss_pred             ccceecccccee-----------------eeecccCccccCCCccccccceeeecc
Q 027788          176 GVAAIVGRAIRR-----------------IRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       176 g~a~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      |++.........                 +..+.+|+.......++.++|+||+|+
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~  215 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGC  215 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHH
Confidence            999866443221                 111333333333445677899999993

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.95  E-value=2.8e-27  Score=186.17  Aligned_cols=175  Identities=18%  Similarity=0.276  Sum_probs=129.3

Q ss_pred             eeeccccceEEEEEEecCC--CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEec
Q 027788           31 ELLGSGAVKKVYRAFDQEE--GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITE  108 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e  108 (219)
                      +.||+|+||.||+|.....  ...+++|.++...   .....+.+.+|+.+++.++|||++++++.+..  ....+++||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA---SSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC---ChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEe
Confidence            3699999999999964322  2345566554332   23445788999999999999999999999854  456788999


Q ss_pred             cccCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          109 VCTSGNLREYRKKH----RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       109 ~~~~g~L~~~~~~~----~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      |+++++|.+++...    ...+...+..++.|++.|+.|||+.+  ++|+||||+||+++.+ +.++|+|||++......
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~  152 (268)
T cd05086          76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKE  152 (268)
T ss_pred             cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCC-ccEEecccccccccCcc
Confidence            99999999988643    23566778889999999999999999  9999999999999865 58999999998643221


Q ss_pred             ce--------eeeecccCccccC------CCccccccceeeec
Q 027788          185 IR--------RIRCWGRRSSWRR------SCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~--------~~~~~~~~~~~~~------~~~~~~~~diws~g  213 (219)
                      ..        .+..+.+|+....      ...++.++|+||+|
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG  195 (268)
T cd05086         153 DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALG  195 (268)
T ss_pred             hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHH
Confidence            10        1112333332211      12345679999999

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.95  E-value=1.9e-27  Score=185.66  Aligned_cols=173  Identities=26%  Similarity=0.439  Sum_probs=139.4

Q ss_pred             eeeccccceEEEEEEecC-CC--cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           31 ELLGSGAVKKVYRAFDQE-EG--IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      +.||+|++|.||+|.+.. .+  ..+|+|.+.....   ....+.+.+|+.++++++|||++++++.+..   ..+++++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL---SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc---HHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEE
Confidence            468999999999998755 23  3689998876542   1566889999999999999999999998854   6688999


Q ss_pred             ccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          108 EVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      |++++++|.+.+....  .+++..+..++.|++.|+.+||..+  ++|+||+|+|++++.+ +.++|+|||++.......
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~  151 (257)
T cd05040          75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASD-DKVKIGDFGLMRALPQNE  151 (257)
T ss_pred             EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecC-CEEEeccccccccccccc
Confidence            9999999999886543  6889999999999999999999999  9999999999999966 689999999998775532


Q ss_pred             e---------eeeecccCccccCCCccccccceeeec
Q 027788          186 R---------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~---------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .         ....+ .+++......++.++|+||+|
T Consensus       152 ~~~~~~~~~~~~~~y-~~pE~~~~~~~~~~~Di~slG  187 (257)
T cd05040         152 DHYVMEEHLKVPFAW-CAPESLRTRTFSHASDVWMFG  187 (257)
T ss_pred             cceecccCCCCCcee-cCHHHhcccCcCchhhhHHHH
Confidence            1         00112 223344455677789999999

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.95  E-value=7.4e-27  Score=181.78  Aligned_cols=181  Identities=31%  Similarity=0.515  Sum_probs=149.9

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|++|.||+|.+..++..+++|.+.....  .....+.+.+|++++++++|+|++++++.+........+++
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            3677899999999999999998999999999875532  24556888999999999999999999998865433678899


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      +|++++++|.+++.....+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCC-CCEEEcccccEEecccccc
Confidence            999999999999887778999999999999999999999999  9999999999999865 5899999999988766532


Q ss_pred             --------eeeecccCccccCCCccccccceeeec
Q 027788          187 --------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 --------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                              ....+. +++.......+.++|+||+|
T Consensus       157 ~~~~~~~~~~~~y~-~pE~~~~~~~~~~~Dv~slG  190 (260)
T cd06606         157 GEGTGSVRGTPYWM-APEVIRGEEYGRAADIWSLG  190 (260)
T ss_pred             cccccCCCCCcccc-CHhhhcCCCCCchhhHHHHH
Confidence                    111122 23333444477789999999

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.95  E-value=8.8e-28  Score=188.30  Aligned_cols=177  Identities=23%  Similarity=0.429  Sum_probs=146.4

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.+.||+|++|.||++.+..+++.+++|.+....   .....+.+.+|+++++.++|||++++++.+...  +..++++
T Consensus         4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~   78 (265)
T cd06605           4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISICM   78 (265)
T ss_pred             hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEEE
Confidence            56678999999999999999999999999987543   234557788999999999999999999988544  6788999


Q ss_pred             ccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          108 EVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHT-HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       108 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~-~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      |++++++|.+++... ..+++..+..++.|++.++.++|+ .+  ++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCC-CCEEEeecccchhhHHHH
Confidence            999999999988765 678999999999999999999999 88  9999999999999865 689999999987664332


Q ss_pred             e----eeeecccCccccCCCccccccceeeec
Q 027788          186 R----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .    ....+..| ++.....++.++|+||+|
T Consensus       156 ~~~~~~~~~y~~P-E~~~~~~~~~~~Dv~slG  186 (265)
T cd06605         156 AKTFVGTSSYMAP-ERIQGNDYSVKSDIWSLG  186 (265)
T ss_pred             hhcccCChhccCH-HHHcCCCCCchhhHHHHH
Confidence            2    22223333 344445677889999999

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.95  E-value=5.2e-27  Score=186.33  Aligned_cols=172  Identities=23%  Similarity=0.411  Sum_probs=141.0

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC  110 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  110 (219)
                      +.||+|++|.||++.+..+++.+++|.++..    .....+.+.+|+.+++.++|+|++++++.+..  .+..++++|++
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~e~~   98 (285)
T cd06648          25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLR----KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVMEFL   98 (285)
T ss_pred             eEeccCCCeEEEEEEECCCCCEEEEEEEecc----chhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEEecc
Confidence            7999999999999999999999999987643    23344668899999999999999999998854  45678899999


Q ss_pred             cCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce----
Q 027788          111 TSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR----  186 (219)
Q Consensus       111 ~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~----  186 (219)
                      ++++|.+++.. ..++...+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++++|||++........    
T Consensus        99 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~  174 (285)
T cd06648          99 EGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRKS  174 (285)
T ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCC-CcEEEcccccchhhccCCccccc
Confidence            99999998876 57899999999999999999999999  9999999999999865 5899999998876543321    


Q ss_pred             --eeeecccCccccCCCccccccceeeec
Q 027788          187 --RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 --~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                        ++..+.+| +......++.++|+||+|
T Consensus       175 ~~~~~~y~aP-E~~~~~~~~~~~Dv~slG  202 (285)
T cd06648         175 LVGTPYWMAP-EVISRLPYGTEVDIWSLG  202 (285)
T ss_pred             ccCCccccCH-HHhcCCCCCCcccHHHHH
Confidence              11122233 334445577889999999

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=7.7e-27  Score=181.58  Aligned_cols=178  Identities=28%  Similarity=0.474  Sum_probs=147.6

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.+.||+|++|.||++.+..+++.+++|.+.....  .......+.+|++++++++|+|++++.+++..  .+..++++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~   78 (254)
T cd06627           3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIIL   78 (254)
T ss_pred             eeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEE
Confidence            677999999999999999998999999999876542  23456789999999999999999999988854  46788999


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce-
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR-  186 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~-  186 (219)
                      |++++++|.+++.....+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++........ 
T Consensus        79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCC-CCEEEeccccceecCCCccc
Confidence            99999999999887778999999999999999999999999  9999999999999865 6899999999987755432 


Q ss_pred             -----eeeecccCccccCCCccccccceeeec
Q 027788          187 -----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 -----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                           ....+..|+ .......+.++|+||+|
T Consensus       156 ~~~~~~~~~y~~pe-~~~~~~~~~~~Dv~~lG  186 (254)
T cd06627         156 DASVVGTPYWMAPE-VIEMSGASTASDIWSLG  186 (254)
T ss_pred             ccccccchhhcCHh-hhcCCCCCcchhHHHHH
Confidence                 111222333 33333467789999999

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.3e-28  Score=194.88  Aligned_cols=194  Identities=26%  Similarity=0.423  Sum_probs=157.2

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCC---HHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD---PAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      .+| .+..+||+|+|+.||+|.+....+.||+|+-.......+   ....++..+|..+.+.|+||.|++++++|.-. .
T Consensus       463 ~RY-LlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD-t  540 (775)
T KOG1151|consen  463 DRY-LLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD-T  540 (775)
T ss_pred             HHH-HHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-c
Confidence            455 566899999999999999999999999998765443332   34557778999999999999999999999753 4


Q ss_pred             ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC--CCcEEEeccccc
Q 027788          101 NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN--TGQVKIGDLGVA  178 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~--~~~~~l~dfg~a  178 (219)
                      +.+|-|+|||+|.+|.-++..+..+++...+.|+.||+.+|.||....++|+|=||||.|||+-..  .|.+||.|||++
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            668889999999999999998888999999999999999999999999999999999999998522  256899999999


Q ss_pred             eeccccce------ee------eecccCcc-c---cCCCccccccceeeeccccccC
Q 027788          179 AIVGRAIR------RI------RCWGRRSS-W---RRSCTMRITRSLWTYTRLGCAC  219 (219)
Q Consensus       179 ~~~~~~~~------~~------~~~~~~~~-~---~~~~~~~~~~diws~gi~~~~c  219 (219)
                      ++...+..      ..      +.|.-|++ +   ...|.++.+.|+||.|+.=+.|
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQC  677 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQC  677 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhh
Confidence            99866442      11      22333332 1   2356688899999999665555

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.95  E-value=8.1e-28  Score=192.09  Aligned_cols=175  Identities=21%  Similarity=0.384  Sum_probs=141.4

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .....||+|+||.||+|.+..++..||+|.++....    ...+.+.+|+.+++.++|||++++++.+..  .+..++++
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv~   97 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVLM   97 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEEE
Confidence            344689999999999999988999999999875432    234667889999999999999999998854  45688899


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce-
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR-  186 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~-  186 (219)
                      |++++++|..++.. ..+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++........ 
T Consensus        98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~~~~  173 (297)
T cd06659          98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPK  173 (297)
T ss_pred             ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccC-CcEEEeechhHhhccccccc
Confidence            99999999887654 46899999999999999999999999  9999999999999866 6899999999876543322 


Q ss_pred             -----eeeecccCccccCCCccccccceeeec
Q 027788          187 -----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 -----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                           ++..+.+ ++......++.++|+||+|
T Consensus       174 ~~~~~~~~~y~a-PE~~~~~~~~~~~Dv~slG  204 (297)
T cd06659         174 RKSLVGTPYWMA-PEVISRTPYGTEVDIWSLG  204 (297)
T ss_pred             ccceecCccccC-HHHHccCCCCchhhHHHHH
Confidence                 1112222 3444455677889999999

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.95  E-value=8.6e-28  Score=191.50  Aligned_cols=184  Identities=21%  Similarity=0.391  Sum_probs=145.8

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      ...++...+.. ...||+|+||.||++.+..++..||+|.+...    .....+.+.+|+.+++.++|+|++++++.+..
T Consensus        16 ~~~~~~~~~~~-~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~   90 (292)
T cd06658          16 SPGDPREYLDS-FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLV   90 (292)
T ss_pred             ccCchHHHHhh-hhcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheec
Confidence            34445455543 47899999999999999889999999988643    23445678899999999999999999988843


Q ss_pred             CCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                        .+..+++||++++++|.+++.. ..+++..+..++.|++.++.|||+.+  ++|+||+|+|++++.+ +.++|+|||+
T Consensus        91 --~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~-~~~kL~dfg~  164 (292)
T cd06658          91 --GDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSD-GRIKLSDFGF  164 (292)
T ss_pred             --CCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCC-CCEEEccCcc
Confidence              4568899999999999987754 46889999999999999999999999  9999999999999866 5899999999


Q ss_pred             ceeccccce------eeeecccCccccCCCccccccceeeec
Q 027788          178 AAIVGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       178 a~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +........      ++..+.+| +......++.++|+||+|
T Consensus       165 ~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Dv~slG  205 (292)
T cd06658         165 CAQVSKEVPKRKSLVGTPYWMAP-EVISRLPYGTEVDIWSLG  205 (292)
T ss_pred             hhhcccccccCceeecCccccCH-HHHccCCCCchhhHHHHH
Confidence            876543322      11122233 333445567789999999

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.95  E-value=4.3e-27  Score=184.14  Aligned_cols=177  Identities=23%  Similarity=0.380  Sum_probs=140.2

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ...+++.++||+|+||.||+|.. +++..+|+|.+.....     ....+.+|+.++++++|+|++++++++..   ...
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   75 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM-----SPEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPI   75 (260)
T ss_pred             hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC-----cHHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCc
Confidence            34458889999999999999985 4678899998874332     23568889999999999999999987632   347


Q ss_pred             EEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          104 NFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      +++||++++++|.+++...  ..++......++.|++.++.+||+.+  ++|+||+|+|++++.+ +.++++|||++...
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~  152 (260)
T cd05067          76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSET-LCCKIADFGLARLI  152 (260)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCC-CCEEEccCcceeec
Confidence            8899999999999987643  35788999999999999999999999  9999999999999865 58999999999876


Q ss_pred             ccccee-------eeecccCccccCCCccccccceeeec
Q 027788          182 GRAIRR-------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ......       ...+.+ ++......++.++|+||+|
T Consensus       153 ~~~~~~~~~~~~~~~~y~~-pe~~~~~~~~~~~Di~slG  190 (260)
T cd05067         153 EDNEYTAREGAKFPIKWTA-PEAINYGTFTIKSDVWSFG  190 (260)
T ss_pred             CCCCcccccCCcccccccC-HHHhccCCcCcccchHHHH
Confidence            532211       011222 3344455567789999999

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.95  E-value=5e-27  Score=191.27  Aligned_cols=184  Identities=28%  Similarity=0.407  Sum_probs=143.0

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC--
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED--   99 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~--   99 (219)
                      ...+| .+.+.||+|+||.||+|.+..++..||+|.++....  .....+.+.+|+.++++++|+||+++.+++....  
T Consensus        15 ~~~~y-~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~   91 (345)
T cd07877          15 VPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL   91 (345)
T ss_pred             ccCce-EEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccc
Confidence            33555 677999999999999999999999999998874321  2333466788999999999999999998875322  


Q ss_pred             --CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788          100 --RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus       100 --~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                        ...++++++++ +++|.++++. ..+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        92 ~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~-~~~kl~dfg~  166 (345)
T cd07877          92 EEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGL  166 (345)
T ss_pred             cccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCC-CCEEEecccc
Confidence              23467788877 6789887654 36899999999999999999999999  9999999999999865 5899999999


Q ss_pred             ceeccccce---eeeecccCccccCCCccccccceeeec
Q 027788          178 AAIVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       178 a~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +........   ++..+.+|+.......++.++|+||+|
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG  205 (345)
T cd07877         167 ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG  205 (345)
T ss_pred             cccccccccccccCCCccCHHHHhCccCCCchhhHHHHH
Confidence            886543321   122233343333334567789999999

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.95  E-value=3.3e-28  Score=185.92  Aligned_cols=181  Identities=19%  Similarity=0.225  Sum_probs=142.5

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEe--cC
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWR--DE   98 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~--~~   98 (219)
                      ....|.-=.++||-|-.|.|-.|+++.+|+.+|+|++.-     .    ...++|++++=+. .||||+.+++++.  ..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----S----PKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----C----HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            445553333569999999999999999999999998762     1    2345788887555 6999999999883  23


Q ss_pred             CCceEEEEeccccCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC--CcEEEec
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKHRH--VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGD  174 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~~~--~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~--~~~~l~d  174 (219)
                      +...+.+|||.++||.|++.++..+.  +.+..+..|+.||+.|+.|||+.+  |.||||||+|+|.....  ..+||+|
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecc
Confidence            44578899999999999999987654  999999999999999999999999  99999999999986332  3579999


Q ss_pred             cccceeccccceeeeecccC----ccccCCCccccccceeeec
Q 027788          175 LGVAAIVGRAIRRIRCWGRR----SSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       175 fg~a~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~diws~g  213 (219)
                      ||+|+.-.....-.+.+.+|    ++......|+-..|+||+|
T Consensus       208 fGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlg  250 (400)
T KOG0604|consen  208 FGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLG  250 (400)
T ss_pred             cccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchh
Confidence            99999877544433333332    2344555588889999999

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.95  E-value=1.5e-27  Score=186.50  Aligned_cols=174  Identities=19%  Similarity=0.335  Sum_probs=141.3

Q ss_pred             eccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccccC
Q 027788           33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTS  112 (219)
Q Consensus        33 ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~  112 (219)
                      ||.|+||.||++++..+++.+++|.+...... .....+.+.+|+.++++++|+|++++++.+.  ....+++++|++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~~   77 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMI-RKNQVDQVLTERDILSQAQSPYVVKLYYSFQ--GKKNLYLVMEYLPG   77 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhh-hhhHHHHHHHHHHHHHhCCCcchhHHHHhee--cCcEEEEEEecCCC
Confidence            68999999999999989999999998754332 2345677889999999999999999988774  45668899999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce------
Q 027788          113 GNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR------  186 (219)
Q Consensus       113 g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~------  186 (219)
                      ++|.+++.....+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++........      
T Consensus        78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCC-CCEEEEecccchhcccCcccccccc
Confidence            999999887778999999999999999999999999  9999999999999866 5899999999876543311      


Q ss_pred             --------eeeecccCccccCCCccccccceeeec
Q 027788          187 --------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 --------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                              ....+.. ++.......+.++|+||+|
T Consensus       155 ~~~~~~~~~~~~~~~-Pe~~~~~~~~~~~Dv~slG  188 (265)
T cd05579         155 EKEDKRIVGTPDYIA-PEVILGQGHSKTVDWWSLG  188 (265)
T ss_pred             cccccCcccCccccC-HHHhcCCCCCcchhhHHHH
Confidence                    1111222 2333344467789999999

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=216.97  Aligned_cols=183  Identities=22%  Similarity=0.390  Sum_probs=154.5

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .-.+....+||.|.||.||.|.+..+|+..|+|.++....  .......+..|..++..++|||+++++++-.+.+.  +
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~--~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek--v 1309 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDS--DHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK--V 1309 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCcc--ccccCcchHHHHHHHHhccCccccccCceeecHHH--H
Confidence            3344677899999999999999999999999999887543  34556778899999999999999999999876554  6


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      ++.||||.+|+|.++++..+..++.....+..|++.|+.|||.++  |+|||+||.||+++.+ |-+|..|||.|..+..
T Consensus      1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFN-GLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecC-CcEEeecccceeEecC
Confidence            779999999999999887777888888889999999999999999  9999999999999966 6899999999998866


Q ss_pred             cce----------eeeecccCccccCC--Cccccccceeeec
Q 027788          184 AIR----------RIRCWGRRSSWRRS--CTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~----------~~~~~~~~~~~~~~--~~~~~~~diws~g  213 (219)
                      ...          ++..+-+|+.+..+  .+...++||||+|
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslG 1428 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLG 1428 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhccc
Confidence            541          55666667655433  3455679999999

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-28  Score=207.90  Aligned_cols=182  Identities=28%  Similarity=0.454  Sum_probs=151.2

Q ss_pred             eeeeeeeccccceEEEEEEecCCC----cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      .+..++||+|+||+||+|.....|    .+||+|++....   .+....+++.|+.++.+|+|||++++++++....   
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t---~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT---SPKASIELLDEALRMASLDHPNLLRLLGVCMLST---  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC---CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch---
Confidence            356689999999999999765444    467777765432   4555688999999999999999999999997655   


Q ss_pred             EEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          103 LNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      +.|+++++|.|.|.++.+.+ .++..+..+.|..||++|+.|||.++  ++||||..+|+|+..-. .+|+.|||+++.+
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~-hvkitdfgla~ll  848 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPN-HVKITDFGLAKLL  848 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCC-eEEEEecchhhcc
Confidence            67799999999999998765 47889999999999999999999999  99999999999998553 7999999999999


Q ss_pred             cccceeeeecc--cCccc-----cCCCccccccceeeec--cccc
Q 027788          182 GRAIRRIRCWG--RRSSW-----RRSCTMRITRSLWTYT--RLGC  217 (219)
Q Consensus       182 ~~~~~~~~~~~--~~~~~-----~~~~~~~~~~diws~g--i~~~  217 (219)
                      .++...-.+.+  .|..|     .+-+.|++++|+||||  ||.+
T Consensus       849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWEl  893 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWEL  893 (1177)
T ss_pred             CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHH
Confidence            88776433333  24455     4688899999999999  8865

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.95  E-value=5.5e-27  Score=190.02  Aligned_cols=182  Identities=24%  Similarity=0.296  Sum_probs=143.0

Q ss_pred             eeeeeeeccccceEEEEEEecCC--CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEec--CCCc
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEE--GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRD--EDRN  101 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~--~~~~  101 (219)
                      |.+.+.||+|+||.||++.+..+  +..+|+|.+.....  .....+.+.+|+.+++++ +||||+++++.+..  ....
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS--KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            47789999999999999999888  89999998774322  233456778899999999 59999999876532  2334


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      .+++++++++ ++|.+.+.....+++..+..++.|++.||.|||+.+  ++|+||||+||+++.+ +.++|+|||++...
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~-~~~kl~Dfg~a~~~  155 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGLARGF  155 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCC-CCEEeCcCCCceec
Confidence            5788999886 689888877778999999999999999999999999  9999999999999865 58999999999876


Q ss_pred             cccce----------eeeecccCccccCCCccccccceeeecc
Q 027788          182 GRAIR----------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       182 ~~~~~----------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .....          ++..+.+|+.......++.++|+||+|+
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv  198 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGC  198 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHH
Confidence            53321          1112333333333345677899999993

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.95  E-value=5e-27  Score=183.80  Aligned_cols=174  Identities=22%  Similarity=0.377  Sum_probs=138.5

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      +++.++||+|++|.||+|... .+..+|+|.+.....  .   .+.+.+|+.++++++|+|++++++.+..   ...+++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv   78 (260)
T cd05070           8 LQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--S---PESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYIV   78 (260)
T ss_pred             hhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--C---HHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEEE
Confidence            478899999999999999754 567799998875332  1   2458899999999999999999987732   336789


Q ss_pred             eccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          107 TEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      ||++++++|.+++...  ..+++..+..++.|++.++.|||+.+  ++|+||+|+|++++.+ +.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDG-LVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCC-ceEEeCCceeeeeccCc
Confidence            9999999999988653  35889999999999999999999999  9999999999999865 58999999999876443


Q ss_pred             ceee-------eecccCccccCCCccccccceeeec
Q 027788          185 IRRI-------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~~~-------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ....       ..+.+| +......++.++|+||||
T Consensus       156 ~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  190 (260)
T cd05070         156 EYTARQGAKFPIKWTAP-EAALYGRFTIKSDVWSFG  190 (260)
T ss_pred             ccccccCCCCCccccCh-HHHhcCCCcchhhhHHHH
Confidence            2111       112333 333445567789999999

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-27  Score=173.26  Aligned_cols=178  Identities=21%  Similarity=0.291  Sum_probs=144.2

Q ss_pred             eeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHH-hhCCCCceEEEEEEecCCCceEEEEec
Q 027788           30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLK-TLANKNIISLHYVWRDEDRNTLNFITE  108 (219)
Q Consensus        30 ~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~-~l~~~~i~~~~~~~~~~~~~~~~lv~e  108 (219)
                      ...||+|++|.|-+-++..+|...|+|.+....   ..+..++.+.|+.+.. ...+|.++.+++....+..  +++.||
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tv---n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd--vwIcME  125 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV---NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD--VWICME  125 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhc---ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc--EEEeHH
Confidence            357999999999999999999999999988654   2444577888998775 5578999999998876655  889999


Q ss_pred             cccCCChHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          109 VCTSGNLREYR----KKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       109 ~~~~g~L~~~~----~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      .+. .+|..+-    ......++..+.+++..|+.|+.+||++-+ ++|||+||.|||++.+ |++|++|||.+-.+...
T Consensus       126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~-vIHRDvKPsNiLIn~~-GqVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS-VIHRDVKPSNILINYD-GQVKICDFGISGYLVDS  202 (282)
T ss_pred             Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh-hhhccCCcceEEEccC-CcEEEcccccceeehhh
Confidence            995 6888763    345679999999999999999999998733 9999999999999966 79999999999988877


Q ss_pred             ceeeeec-----ccCcc---ccCCCccccccceeeeccc
Q 027788          185 IRRIRCW-----GRRSS---WRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       185 ~~~~~~~-----~~~~~---~~~~~~~~~~~diws~gi~  215 (219)
                      ...+...     -+|+.   ...+..|+-+||+|||||.
T Consensus       203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGIt  241 (282)
T KOG0984|consen  203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGIT  241 (282)
T ss_pred             hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhh
Confidence            7654322     23442   2345578999999999943

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.95  E-value=5.1e-28  Score=212.09  Aligned_cols=179  Identities=25%  Similarity=0.423  Sum_probs=142.8

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEe--------------
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWR--------------   96 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--------------   96 (219)
                      +.||+|+||.||+++++-+|+.||||.|....   +......+.+|+.++++|+|||+++++..|.              
T Consensus       485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~  561 (1351)
T KOG1035|consen  485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVAS  561 (1351)
T ss_pred             HHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccccc
Confidence            47999999999999999999999999998765   4566678899999999999999999874442              


Q ss_pred             --------------------------------------------------------------cC----------------
Q 027788           97 --------------------------------------------------------------DE----------------   98 (219)
Q Consensus        97 --------------------------------------------------------------~~----------------   98 (219)
                                                                                    ++                
T Consensus       562 ~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~  641 (1351)
T KOG1035|consen  562 DSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVI  641 (1351)
T ss_pred             chhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccc
Confidence                                                                          00                


Q ss_pred             -------------------------CCceEEEEeccccCCChHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCCCee
Q 027788           99 -------------------------DRNTLNFITEVCTSGNLREYRKKHRHV-SVKALKKWSKQILKGLNYLHTHEPCVI  152 (219)
Q Consensus        99 -------------------------~~~~~~lv~e~~~~g~L~~~~~~~~~~-~~~~~~~i~~qv~~~l~~lh~~~~~i~  152 (219)
                                               ....+|+.||||+..++.+++..+... ..+..++++++|+.|+.|+|+.+  ++
T Consensus       642 ~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g--iI  719 (1351)
T KOG1035|consen  642 LDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG--II  719 (1351)
T ss_pred             cCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc--ee
Confidence                                     014688999999987777777654333 58889999999999999999999  99


Q ss_pred             eeCCCCCceEEeCCCCcEEEeccccceecc----ccc--------------------eeeeecccCccccCCC--ccccc
Q 027788          153 HRDLNCSNVFVNGNTGQVKIGDLGVAAIVG----RAI--------------------RRIRCWGRRSSWRRSC--TMRIT  206 (219)
Q Consensus       153 h~dl~~~nili~~~~~~~~l~dfg~a~~~~----~~~--------------------~~~~~~~~~~~~~~~~--~~~~~  206 (219)
                      ||||||.||+++.+ ..|||.|||+|....    ...                    .++..+.+|+-.-...  .|+.|
T Consensus       720 HRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K  798 (1351)
T KOG1035|consen  720 HRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK  798 (1351)
T ss_pred             eccCCcceeEEcCC-CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence            99999999999966 489999999998721    000                    1444455555443444  69999


Q ss_pred             cceeeeccc
Q 027788          207 RSLWTYTRL  215 (219)
Q Consensus       207 ~diws~gi~  215 (219)
                      .|||||||+
T Consensus       799 iDmYSLGIV  807 (1351)
T KOG1035|consen  799 IDMYSLGIV  807 (1351)
T ss_pred             hhhHHHHHH
Confidence            999999954

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.95  E-value=2e-27  Score=187.51  Aligned_cols=152  Identities=27%  Similarity=0.472  Sum_probs=132.7

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCCceEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      |.+.+.||+|++|.||+|....++..+++|+++..... .....+.+..|++++++++ |+|++++++++  .+...+++
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~--~~~~~~~l   79 (280)
T cd05581           3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF--QDEENLYF   79 (280)
T ss_pred             ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-chHHHHHHHHHHHHHHhcccCCCchhHHHHh--cCCceEEE
Confidence            37789999999999999999999999999998754332 2334467888999999999 99999998887  44567889


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      +||++++++|.+++...+.+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++++|||++......
T Consensus        80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~~  155 (280)
T cd05581          80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKD-MHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCC-CCEEecCCccccccCCc
Confidence            9999999999999988778999999999999999999999999  9999999999999865 68999999999876543

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.95  E-value=7.1e-28  Score=199.43  Aligned_cols=179  Identities=23%  Similarity=0.456  Sum_probs=146.7

Q ss_pred             eeeeccccceEEEEEEecCC--C--cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEE
Q 027788           30 NELLGSGAVKKVYRAFDQEE--G--IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        30 ~~~ig~g~~g~V~~a~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      .++||.|-||.||.|++...  |  .-||||.-+...   +++..+.|+.|..++++++||||++++++|.++.   .|+
T Consensus       394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P---~Wi  467 (974)
T KOG4257|consen  394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP---MWI  467 (974)
T ss_pred             HHhhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc---eeE
Confidence            44799999999999987433  3  357888766432   4555688999999999999999999999996544   799


Q ss_pred             EeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          106 ITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      +||.++-|.|..+++.. ..++..+...++.|++.++.|||+.+  ++||||..+||++.+.. .+|++|||+++.+...
T Consensus       468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~-CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQ-CVKLADFGLSRYLEDD  544 (974)
T ss_pred             EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcc-eeeecccchhhhcccc
Confidence            99999999999998754 56889999999999999999999999  99999999999998775 8999999999988776


Q ss_pred             ceeeeeccc-CccccCCCc-----cccccceeeec--cccc
Q 027788          185 IRRIRCWGR-RSSWRRSCT-----MRITRSLWTYT--RLGC  217 (219)
Q Consensus       185 ~~~~~~~~~-~~~~~~~~~-----~~~~~diws~g--i~~~  217 (219)
                      .-.....+. |-.|+....     ++.+||+|=||  +|.+
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEI  585 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEI  585 (974)
T ss_pred             chhhccccccceeecCccccchhcccchhhHHHHHHHHHHH
Confidence            654444443 556765444     56779999999  6654

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-27  Score=196.55  Aligned_cols=181  Identities=26%  Similarity=0.311  Sum_probs=149.0

Q ss_pred             eeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCH----HHHHHHHHHHHHHHhhC---CCCceEEEEEEecCCCc
Q 027788           29 YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDP----AMIERLFSEVRLLKTLA---NKNIISLHYVWRDEDRN  101 (219)
Q Consensus        29 ~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~E~~~l~~l~---~~~i~~~~~~~~~~~~~  101 (219)
                      ..+.+|+|+||.|+.|.+++....|++|.+.+....-+.    ..+.-+-.||.+++.|+   |+||++++++|  ++++
T Consensus       565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF--Eddd  642 (772)
T KOG1152|consen  565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF--EDDD  642 (772)
T ss_pred             eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee--ecCC
Confidence            348899999999999999999999999999876544322    22333557999999998   99999999999  8888


Q ss_pred             eEEEEeccc-cCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          102 TLNFITEVC-TSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       102 ~~~lv~e~~-~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      ++|++||.. ++.+|++++..++.+++.....|+.||+.|+..||+++  |+|||||-+|+.++.+ |.+||+|||.|..
T Consensus       643 ~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~-g~~klidfgsaa~  719 (772)
T KOG1152|consen  643 YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSN-GFVKLIDFGSAAY  719 (772)
T ss_pred             eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecC-CeEEEeeccchhh
Confidence            999999987 46699999999999999999999999999999999999  9999999999999977 6899999998876


Q ss_pred             ccccc----eeeeecccCccccCCCccccc-cceeeeccc
Q 027788          181 VGRAI----RRIRCWGRRSSWRRSCTMRIT-RSLWTYTRL  215 (219)
Q Consensus       181 ~~~~~----~~~~~~~~~~~~~~~~~~~~~-~diws~gi~  215 (219)
                      ....-    .++.-+.+| +......|-.+ .|||++||+
T Consensus       720 ~ksgpfd~f~gtv~~aap-evl~g~~y~gk~qdiwalgil  758 (772)
T KOG1152|consen  720 TKSGPFDVFVGTVDYAAP-EVLGGEKYLGKPQDIWALGIL  758 (772)
T ss_pred             hcCCCcceeeeeccccch-hhhCCCccCCCcchhhhhhhe
Confidence            64322    244445554 44444455444 899999964

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-29  Score=204.96  Aligned_cols=182  Identities=20%  Similarity=0.299  Sum_probs=160.6

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      +...-||-|+||+|-+.........+|+|++++...- +..+.+++..|-.++.....|.|++++.+|  .+..++|++|
T Consensus       423 ~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV-dtkQqeHv~sEr~Im~~~~s~fIvrLYrTf--rd~kyvYmLm  499 (732)
T KOG0614|consen  423 KRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIV-DTKQQEHVFSERNIMMECRSDFIVRLYRTF--RDSKYVYMLM  499 (732)
T ss_pred             hhhhhcccCccceEEEEEecccchHHHHHHHhHhhcc-chhHHHHHHhHHHHHHhcCchHHHHHHHHh--ccchhhhhhH
Confidence            3446799999999999876665556899999887765 456779999999999999999999999999  5667899999


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccccee
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR  187 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~  187 (219)
                      |-|-||.|+..++..+.++..+..+++.++++|++|||+++  |++|||||+|++++.+ |.+||.|||+|+.+......
T Consensus       500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~~g~KT  576 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNR-GYLKLVDFGFAKKIGSGRKT  576 (732)
T ss_pred             HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccC-CceEEeehhhHHHhccCCce
Confidence            99999999999999999999999999999999999999999  9999999999999855 79999999999999998887


Q ss_pred             eeecccCcc----ccCCCccccccceeeeccc
Q 027788          188 IRCWGRRSS----WRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       188 ~~~~~~~~~----~~~~~~~~~~~diws~gi~  215 (219)
                      -+.+|+|+.    ...+...+.+.|+|||||+
T Consensus       577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIl  608 (732)
T KOG0614|consen  577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGIL  608 (732)
T ss_pred             eeecCCcccccchhhhccCcchhhHHHHHHHH
Confidence            778888774    4557777888999999965

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.95  E-value=9.2e-27  Score=183.28  Aligned_cols=168  Identities=21%  Similarity=0.277  Sum_probs=133.4

Q ss_pred             eccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceEEEEecccc
Q 027788           33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTLNFITEVCT  111 (219)
Q Consensus        33 ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~~~  111 (219)
                      +|+|+||.||.++...++..+++|.+.......         .|+.....+ +|+|++++++.+..+  +.++++|||++
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---------~e~~~~~~~~~h~~iv~~~~~~~~~--~~~~iv~e~~~   92 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---------IEPMVHQLMKDNPNFIKLYYSVTTL--KGHVLIMDYIK   92 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---------hhHHHHHHhhcCCCEEEEEEEEecC--CeeEEEEEcCC
Confidence            599999999999999999999999987543211         123222222 699999999999654  46889999999


Q ss_pred             CCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce--eee
Q 027788          112 SGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR--RIR  189 (219)
Q Consensus       112 ~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~--~~~  189 (219)
                      +++|.+++.....+++..+..++.|++.++.+||+.+  ++|+||+|+|++++.+.+.++++|||++........  ++.
T Consensus        93 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  170 (267)
T PHA03390         93 DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTL  170 (267)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCCC
Confidence            9999999887778999999999999999999999999  999999999999986643799999999887654332  222


Q ss_pred             ecccCccccCCCccccccceeeecc
Q 027788          190 CWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       190 ~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .+.+ ++......++.++|+||+|+
T Consensus       171 ~y~a-PE~~~~~~~~~~~DvwslG~  194 (267)
T PHA03390        171 DYFS-PEKIKGHNYDVSFDWWAVGV  194 (267)
T ss_pred             cccC-hhhhcCCCCCchhhHHHHHH
Confidence            2333 34445566778899999993

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.95  E-value=9.5e-27  Score=182.28  Aligned_cols=176  Identities=23%  Similarity=0.353  Sum_probs=137.1

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      +.+...||+|++|.||+|....+ ..+++|.+....     ...+.+.+|+.+++.++|+|++++++++..   +..+++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v   78 (260)
T cd05069           8 LRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-----MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYIV   78 (260)
T ss_pred             eeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-----ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEEE
Confidence            47889999999999999986544 468999876432     123567889999999999999999887732   346789


Q ss_pred             eccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          107 TEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      ||++++++|.+++...  ..+++..+..++.|++.|+.|||+.+  ++|+||+|+|++++.+ +.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDN-LVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCC-CeEEECCCccceEccCC
Confidence            9999999999988653  34789999999999999999999999  9999999999999855 58999999999766433


Q ss_pred             ceee------eecccCccccCCCccccccceeeecc
Q 027788          185 IRRI------RCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       185 ~~~~------~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ....      .....+++......++.++|+||+|+
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~  191 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI  191 (260)
T ss_pred             cccccCCCccchhhCCHHHhccCCcChHHHHHHHHH
Confidence            2110      01112223444455677899999993

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.95  E-value=4.3e-27  Score=183.51  Aligned_cols=180  Identities=21%  Similarity=0.379  Sum_probs=144.4

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||+|+||.||++....++..+|+|.+.....  .....+.+.+|+.+++.++|+|++++++.+.  .....+++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~--~~~~~~lv   77 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQ--ENGRLFIV   77 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheec--cCCeEEEE
Confidence            3677899999999999999999999999999876432  2233466788999999999999999999884  45678899


Q ss_pred             eccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          107 TEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      +||+++++|.+++....  .+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+...++++|||.+......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            99999999999876543  4789999999999999999999999  9999999999999866445799999998876543


Q ss_pred             cee------eeecccCccccCCCccccccceeeec
Q 027788          185 IRR------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~~------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...      +..+.+| ++.....++.++|+||+|
T Consensus       156 ~~~~~~~~~~~~~~ap-e~~~~~~~~~~~Dv~slG  189 (257)
T cd08225         156 MELAYTCVGTPYYLSP-EICQNRPYNNKTDIWSLG  189 (257)
T ss_pred             cccccccCCCccccCH-HHHcCCCCCchhhHHHHH
Confidence            321      1112222 334444567789999999

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=3e-28  Score=187.73  Aligned_cols=175  Identities=25%  Similarity=0.350  Sum_probs=141.8

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      +.||+|+|+.|-.|....++.++|||++.+.    ......++.+|++++...+ |+||+.++++|  ++...+|+|+|-
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq----~gHsR~RvfREVe~f~~Cqgh~nilqLiefF--Edd~~FYLVfEK  157 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ----PGHSRSRVFREVETFYQCQGHKNILQLIEFF--EDDTRFYLVFEK  157 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcC----CchHHHHHHHHHHHHHHhcCCccHHHHHHHh--cccceEEEEEec
Confidence            3599999999999999999999999999865    3556788999999998875 99999999999  666779999999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC--CcEEEeccccceecccccee
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDLGVAAIVGRAIRR  187 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~--~~~~l~dfg~a~~~~~~~~~  187 (219)
                      +.||+|-+.+.....+++....+++..|+.||.+||.++  |.||||||+|||-..-.  .-+||+||.+...+.....-
T Consensus       158 m~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  158 MRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             ccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            999999999998889999999999999999999999999  99999999999975222  24799999887654322210


Q ss_pred             --------eeecccCccc----------cCCCccccccceeeecc
Q 027788          188 --------IRCWGRRSSW----------RRSCTMRITRSLWTYTR  214 (219)
Q Consensus       188 --------~~~~~~~~~~----------~~~~~~~~~~diws~gi  214 (219)
                              .+.+|+- ++          -.+.-|+-+.|.||||+
T Consensus       236 spastP~L~tPvGSA-EfMAPEVVd~fv~qA~~YDKrCDlwSLGv  279 (463)
T KOG0607|consen  236 SPASTPELLTPVGSA-EFMAPEVVDVFVDQATFYDKRCDLWSLGV  279 (463)
T ss_pred             CCCCCccccCcccch-hhcchhHHhhhccccccccccccHHHHHH
Confidence                    1111211 11          12444777799999993

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.95  E-value=1.3e-26  Score=183.96  Aligned_cols=183  Identities=26%  Similarity=0.460  Sum_probs=149.8

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      ..++...| ...+.||+|++|.||++.+..++..+++|.++...    . ..+.+.+|++.++.++|+|++++++.+..+
T Consensus        14 ~~~~~~~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   87 (286)
T cd06614          14 EGDPRELY-KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK----Q-NKELIINEILIMKDCKHPNIVDYYDSYLVG   87 (286)
T ss_pred             CCCccccc-hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCc----h-hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence            34455555 67789999999999999998889999999987542    1 456788999999999999999999988654


Q ss_pred             CCceEEEEeccccCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                        ...++++||+++++|.+++.... .++...+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        88 --~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~-~~~~l~d~~~  162 (286)
T cd06614          88 --DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKD-GSVKLADFGF  162 (286)
T ss_pred             --CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCC-CCEEECccch
Confidence              56888999999999999988765 7999999999999999999999999  9999999999999865 5899999998


Q ss_pred             ceeccccce------eeeecccCccccCCCccccccceeeec
Q 027788          178 AAIVGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       178 a~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +........      +...+. +++......++.++|+||+|
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~-~PE~~~~~~~~~~~Dv~slG  203 (286)
T cd06614         163 AAQLTKEKSKRNSVVGTPYWM-APEVIKRKDYGPKVDIWSLG  203 (286)
T ss_pred             hhhhccchhhhccccCCcccC-CHhHhcCCCCCCccccHHHH
Confidence            876654321      111222 33444555678889999999

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.95  E-value=1.4e-26  Score=187.39  Aligned_cols=183  Identities=30%  Similarity=0.436  Sum_probs=144.2

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ...+| .+.+.||.|+||.||+|.+..++..+|+|.+.....  .....+.+..|+++++.++|||++++.+++... ..
T Consensus         8 ~~~~y-~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~   83 (328)
T cd07856           8 ITNRY-VDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LE   83 (328)
T ss_pred             cccce-EEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CC
Confidence            44555 778999999999999999999999999998764332  233446788899999999999999999988543 34


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      ..++++|++. ++|..+++. ..++...+..++.|++.++.+||+.+  ++|+||+|+|++++.+ +.++|+|||.+...
T Consensus        84 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~  158 (328)
T cd07856          84 DIYFVTELLG-TDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINEN-CDLKICDFGLARIQ  158 (328)
T ss_pred             cEEEEeehhc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCC-CCEEeCcccccccc
Confidence            5778999984 688877654 35788888899999999999999999  9999999999999855 68999999999765


Q ss_pred             cccce---eeeecccCccccCCCccccccceeeec
Q 027788          182 GRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .....   .+..+..|+.......++.++|+||+|
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  193 (328)
T cd07856         159 DPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAG  193 (328)
T ss_pred             CCCcCCCcccccccCceeeeccCCcCcHHHHHHHH
Confidence            43321   122234444333335677789999999

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.95  E-value=3.6e-27  Score=190.81  Aligned_cols=181  Identities=30%  Similarity=0.400  Sum_probs=147.3

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC---CceE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED---RNTL  103 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~---~~~~  103 (219)
                      |++.+.||+|++|.||+|.+..++..+++|.+.....  +....+.+.+|+.+++.++|+|++++.+++...+   ...+
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD--DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc--cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            4788999999999999999988899999999875432  2444577889999999999999999998885543   2367


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++||+++ ++|.+++.....+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~  155 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSN-CDLKICDFGLARGVDP  155 (330)
T ss_pred             EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEcccCceEeecc
Confidence            89999997 588888877678999999999999999999999999  9999999999999966 6899999999998765


Q ss_pred             cce---------eeeecccCccccCCCccccccceeeec
Q 027788          184 AIR---------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~---------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...         .+..+.+|+.......++.++|+||+|
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG  194 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVG  194 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHH
Confidence            531         111233343333333677789999999

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-27  Score=190.38  Aligned_cols=191  Identities=23%  Similarity=0.340  Sum_probs=144.2

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHH--hhCCCCceEEEEEE
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLK--TLANKNIISLHYVW   95 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~--~l~~~~i~~~~~~~   95 (219)
                      .-.....+...+.+.||+|.||.||+|...  |+.||||++...    ++   ..+.+|.++++  .|+|+||+.+++.-
T Consensus       204 LVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr----dE---~SWfrEtEIYqTvmLRHENILgFIaaD  274 (513)
T KOG2052|consen  204 LVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR----DE---RSWFRETEIYQTVMLRHENILGFIAAD  274 (513)
T ss_pred             HhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc----ch---hhhhhHHHHHHHHHhccchhhhhhhcc
Confidence            333455677789999999999999999774  889999998744    22   34667888886  77999999886543


Q ss_pred             ecCCC--ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeeeeCCCCCceEEeCCC
Q 027788           96 RDEDR--NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH------EPCVIHRDLNCSNVFVNGNT  167 (219)
Q Consensus        96 ~~~~~--~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~------~~~i~h~dl~~~nili~~~~  167 (219)
                      ...+.  .-+||+++|.+.|||.++++. ..++.+...+++..++.||++||..      .|.|.|||||..|||+.++ 
T Consensus       275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn-  352 (513)
T KOG2052|consen  275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-  352 (513)
T ss_pred             ccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC-
Confidence            22211  248999999999999999987 4799999999999999999999974      2569999999999999866 


Q ss_pred             CcEEEeccccceeccccce-----eeeecc-----cCccccC----CCcccc-ccceeeec--cccccC
Q 027788          168 GQVKIGDLGVAAIVGRAIR-----RIRCWG-----RRSSWRR----SCTMRI-TRSLWTYT--RLGCAC  219 (219)
Q Consensus       168 ~~~~l~dfg~a~~~~~~~~-----~~~~~~-----~~~~~~~----~~~~~~-~~diws~g--i~~~~c  219 (219)
                      +.+-|+|+|+|...+.+-.     .+..+|     +|+-.-.    ..--+. .+||||||  .|.++|
T Consensus       353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            6899999999998877632     222233     3332111    111122 28999999  888764

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.95  E-value=1.5e-26  Score=184.58  Aligned_cols=191  Identities=17%  Similarity=0.125  Sum_probs=133.3

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCC---CcEEEEEEeeecccCCCHHH-------HHHHHHHHHHHHhhCCCCc
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEE---GIEVAWNQVKLRTFCDDPAM-------IERLFSEVRLLKTLANKNI   88 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~-------~~~~~~E~~~l~~l~~~~i   88 (219)
                      ..+..++.|++.++||+|+||.||+|....+   +..+++|.............       ......+...++.++|+++
T Consensus         6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i   85 (294)
T PHA02882          6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI   85 (294)
T ss_pred             eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence            4455666679999999999999999998776   66777776443321100000       0111223344566789999


Q ss_pred             eEEEEEEecCCC--ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC
Q 027788           89 ISLHYVWRDEDR--NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN  166 (219)
Q Consensus        89 ~~~~~~~~~~~~--~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~  166 (219)
                      +++++.+.....  .+.+++++++. .++.+.+......++..+..++.|++.|+.|||+.+  ++||||||+||+++.+
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~~  162 (294)
T PHA02882         86 PKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDGN  162 (294)
T ss_pred             CcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC
Confidence            999887654432  24467788774 466666665555678889999999999999999999  9999999999999865


Q ss_pred             CCcEEEeccccceeccccce-------------eeeecccCccccCCCccccccceeeecc
Q 027788          167 TGQVKIGDLGVAAIVGRAIR-------------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       167 ~~~~~l~dfg~a~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                       +.++|+|||+|+.+.....             ++..+ .+++......++.++|+||+|+
T Consensus       163 -~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y-~ape~~~~~~~~~~~DiwSlG~  221 (294)
T PHA02882        163 -NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYY-AGLDAHNGACVTRRGDLESLGY  221 (294)
T ss_pred             -CcEEEEEcCCceeeccCCcccccccccccccCCCccc-cCHHHhCCCCCCcHHHHHHHHH
Confidence             5899999999987643211             11111 2223344566788899999993

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.95  E-value=6.7e-27  Score=189.25  Aligned_cols=176  Identities=22%  Similarity=0.304  Sum_probs=137.8

Q ss_pred             eeeccc--cceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEec
Q 027788           31 ELLGSG--AVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITE  108 (219)
Q Consensus        31 ~~ig~g--~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e  108 (219)
                      ..||+|  +||.||.|.+..+++.||+|.+.....  .....+.+.+|+.+++.++||||+++++++..  ...+++++|
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e   79 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISP   79 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEe
Confidence            457776  999999999999999999999875432  34456788999999999999999999999955  456888999


Q ss_pred             cccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          109 VCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       109 ~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      +++++++.+++...  ..+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.+++.||+.+........
T Consensus        80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~  156 (328)
T cd08226          80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQ  156 (328)
T ss_pred             cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCc
Confidence            99999999987653  35889999999999999999999999  9999999999999865 5899999975543322111


Q ss_pred             -------------eeeecccCccccCC-Cccccccceeeec
Q 027788          187 -------------RIRCWGRRSSWRRS-CTMRITRSLWTYT  213 (219)
Q Consensus       187 -------------~~~~~~~~~~~~~~-~~~~~~~diws~g  213 (219)
                                   ....+.+|+..... ..++.++|+||+|
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG  197 (328)
T cd08226         157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVG  197 (328)
T ss_pred             cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHH
Confidence                         01113344333322 3466789999999

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.95  E-value=4.6e-27  Score=184.72  Aligned_cols=176  Identities=24%  Similarity=0.322  Sum_probs=136.1

Q ss_pred             eeeccccceEEEEEEecCCC------cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           31 ELLGSGAVKKVYRAFDQEEG------IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      +.||+|+||.||+|......      ..+++|.+....   .......+.+|+.+++.++||||+++++++..  ....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeE
Confidence            36899999999999876443      679999876432   22345678899999999999999999998844  45578


Q ss_pred             EEeccccCCChHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC----CcEEEe
Q 027788          105 FITEVCTSGNLREYRKKH-------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT----GQVKIG  173 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~-------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~----~~~~l~  173 (219)
                      ++||++++++|.+++...       ..+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+.    ..++++
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~  153 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIG  153 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEEC
Confidence            899999999999987642       23678899999999999999999999  99999999999998542    168999


Q ss_pred             ccccceecccccee----e---eecccCccccCCCccccccceeeec
Q 027788          174 DLGVAAIVGRAIRR----I---RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       174 dfg~a~~~~~~~~~----~---~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |||++.........    .   .....+++......++.++|+||||
T Consensus       154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG  200 (269)
T cd05044         154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFG  200 (269)
T ss_pred             CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHH
Confidence            99999765432210    0   1112233444556678889999999

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=4.2e-27  Score=200.23  Aligned_cols=181  Identities=20%  Similarity=0.270  Sum_probs=129.5

Q ss_pred             eeeeeeeeccccceEEEEEEecCCC-cEEEEEEee-------------ecccCCCHHHHHHHHHHHHHHHhhCCCCceEE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEG-IEVAWNQVK-------------LRTFCDDPAMIERLFSEVRLLKTLANKNIISL   91 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~-~~vavK~~~-------------~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   91 (219)
                      .|++.+.||+|+||.||+|...... ...+.|.++             .+...........+.+|+.++++++|+||+++
T Consensus       149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  228 (501)
T PHA03210        149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI  228 (501)
T ss_pred             ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence            3488899999999999998754322 112222110             01111123345667899999999999999999


Q ss_pred             EEEEecCCCceEEEEeccccCCChHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC
Q 027788           92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKH-----RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN  166 (219)
Q Consensus        92 ~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~  166 (219)
                      ++++..+  +..+++++++. ++|..++...     .......+..++.|++.||.|||+++  ++||||||+||+++.+
T Consensus       229 ~~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~~~  303 (501)
T PHA03210        229 EEILRSE--ANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLNCD  303 (501)
T ss_pred             eEEEEEC--CeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC
Confidence            9998654  45778999985 5666655322     22345677889999999999999999  9999999999999865


Q ss_pred             CCcEEEeccccceeccccce-------eeeecccCccccCCCccccccceeeec
Q 027788          167 TGQVKIGDLGVAAIVGRAIR-------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       167 ~~~~~l~dfg~a~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                       +.+||+|||++..+.....       ++..+.+| +......++.++||||+|
T Consensus       304 -~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwSlG  355 (501)
T PHA03210        304 -GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSP-EILAGDGYCEITDIWSCG  355 (501)
T ss_pred             -CCEEEEeCCCceecCcccccccccccCCcCCCCc-hhhcCCCCCcHHHHHHHH
Confidence             6899999999987654322       22223333 344456678889999999

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.95  E-value=1.9e-26  Score=179.96  Aligned_cols=175  Identities=22%  Similarity=0.352  Sum_probs=139.0

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      +.+.+.||+|+||.||+|.+. ++..+|+|.+.....     ....+..|++++++++|||++++++++..  ....+++
T Consensus         6 ~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v   77 (256)
T cd05112           6 LTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVCTE--RSPICLV   77 (256)
T ss_pred             eEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEEcc--CCceEEE
Confidence            367799999999999999875 467899998764322     12457789999999999999999998844  4567889


Q ss_pred             eccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          107 TEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      +|++++++|.+++... ..+++..+..++.|++.++.+||+.+  ++|+||+|+|++++.+ +.++|+|||++.......
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCC-CeEEECCCcceeecccCc
Confidence            9999999999988654 45889999999999999999999999  9999999999999855 589999999998664432


Q ss_pred             eee-------eecccCccccCCCccccccceeeec
Q 027788          186 RRI-------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~~~-------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...       ..+.+ ++......++.++|+||+|
T Consensus       155 ~~~~~~~~~~~~~~a-Pe~~~~~~~~~~~Dv~slG  188 (256)
T cd05112         155 YTSSTGTKFPVKWSS-PEVFSFSKYSSKSDVWSFG  188 (256)
T ss_pred             ccccCCCccchhhcC-HhHhccCCcChHHHHHHHH
Confidence            110       11222 3344455677789999999

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.95  E-value=1.1e-26  Score=181.06  Aligned_cols=179  Identities=24%  Similarity=0.400  Sum_probs=145.6

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |.+.+.||+|++|.||++.+..++..+++|.+.....  .......+..|+.+++.++|+|++++.+++..  ....+++
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v   77 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIV   77 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEE
Confidence            3677899999999999999999999999999875432  23445677889999999999999999988854  3668889


Q ss_pred             eccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          107 TEVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +|++++++|..++..    ...+++..+..++.|++.|+.+||+.+  ++|+||+|+||+++.+ +.++++|||++....
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~  154 (256)
T cd08530          78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVAN-DLVKIGDLGISKVLK  154 (256)
T ss_pred             ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecC-CcEEEeeccchhhhc
Confidence            999999999988755    346889999999999999999999999  9999999999999865 689999999998775


Q ss_pred             ccce----eeeecccCccccCCCccccccceeeec
Q 027788          183 RAIR----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ....    +...+. ++++.....++.++|+||+|
T Consensus       155 ~~~~~~~~~~~~~~-~Pe~~~~~~~~~~~D~~slG  188 (256)
T cd08530         155 KNMAKTQIGTPHYM-APEVWKGRPYSYKSDIWSLG  188 (256)
T ss_pred             cCCcccccCCcccc-CHHHHCCCCCCchhhHHHHH
Confidence            5422    111222 23344455677789999999

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.94  E-value=3.4e-26  Score=184.03  Aligned_cols=187  Identities=22%  Similarity=0.351  Sum_probs=145.0

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      ..++...+ ...+.||+|+||.||+|.+..++..+++|.+...... .......+..|+.+++.++|||++++.+++.. 
T Consensus        16 ~~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-   92 (313)
T cd06633          16 KDDPEEIF-VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ-TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-   92 (313)
T ss_pred             cCCHHHHh-hcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-
Confidence            33444444 5557899999999999999999999999998754332 33445678889999999999999999999854 


Q ss_pred             CCceEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                       .+..+++|||++ +++.+++.. ...+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        93 -~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~-~~~kL~dfg~  167 (313)
T cd06633          93 -EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEP-GQVKLADFGS  167 (313)
T ss_pred             -CCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCC-CCEEEeecCC
Confidence             456889999996 567666543 456889999999999999999999999  9999999999999855 5899999999


Q ss_pred             ceeccccce--eeeecccCcccc--CCCccccccceeeec
Q 027788          178 AAIVGRAIR--RIRCWGRRSSWR--RSCTMRITRSLWTYT  213 (219)
Q Consensus       178 a~~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~diws~g  213 (219)
                      +........  ++..+.+|+.+.  ....++.++|+||+|
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slG  207 (313)
T cd06633         168 ASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG  207 (313)
T ss_pred             CcccCCCCCccccccccChhhccccCCCCCCchhhHHHHH
Confidence            875433221  222334444432  245577789999999

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.94  E-value=1.2e-26  Score=186.22  Aligned_cols=189  Identities=24%  Similarity=0.392  Sum_probs=145.7

Q ss_pred             ccccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEe
Q 027788           17 FIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWR   96 (219)
Q Consensus        17 ~~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   96 (219)
                      .....+...| ...+.||+|++|.||+|.+..++..+++|.+...... .......+.+|+++++.++|+|++++.+++.
T Consensus         8 ~~~~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   85 (308)
T cd06634           8 FFKDDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL   85 (308)
T ss_pred             hhcCCcHHHH-HHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence            3344444444 5668899999999999999999999999988643222 3344567888999999999999999999885


Q ss_pred             cCCCceEEEEeccccCCChHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788           97 DEDRNTLNFITEVCTSGNLREYRK-KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus        97 ~~~~~~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      .  .+..++++||+. +++.+.+. ....+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++++||
T Consensus        86 ~--~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~-~~~kl~df  159 (308)
T cd06634          86 R--EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDF  159 (308)
T ss_pred             c--CCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCC-CcEEECCc
Confidence            4  456788999997 57766654 3446889999999999999999999999  9999999999999865 58999999


Q ss_pred             ccceeccccce--eeeecccCcccc--CCCccccccceeeec
Q 027788          176 GVAAIVGRAIR--RIRCWGRRSSWR--RSCTMRITRSLWTYT  213 (219)
Q Consensus       176 g~a~~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~diws~g  213 (219)
                      |++........  ++..+.+|+...  ....++.++|+||+|
T Consensus       160 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG  201 (308)
T cd06634         160 GSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG  201 (308)
T ss_pred             ccceeecCcccccCCccccCHHHHhhcccCCCCcccchHHHH
Confidence            99887654322  222233343332  234567789999999

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.94  E-value=1.1e-26  Score=184.55  Aligned_cols=182  Identities=19%  Similarity=0.292  Sum_probs=142.3

Q ss_pred             eeeeeeeccccceEEEEEEec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCce
Q 027788           27 GRYNELLGSGAVKKVYRAFDQ---EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~  102 (219)
                      |++.+.||+|++|.||++...   .++..+|+|.++...........+.+.+|+.+++.+ +|+|++++.+.+.  ....
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~--~~~~   79 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ--TDTK   79 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee--cCCE
Confidence            367789999999999998753   467889999987543322344456788999999999 5999999998884  4456


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++++|||+++++|.+.+.....+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++++|||++....
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~  156 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSE-GHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCC-CCEEEEECccccccc
Confidence            8899999999999998876667899999999999999999999999  9999999999999865 589999999987754


Q ss_pred             ccce-------eeeecccCccccCC-Cccccccceeeec
Q 027788          183 RAIR-------RIRCWGRRSSWRRS-CTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~-------~~~~~~~~~~~~~~-~~~~~~~diws~g  213 (219)
                      ....       +...+.+|+..... +..+.++|+||+|
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG  195 (288)
T cd05583         157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG  195 (288)
T ss_pred             cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHH
Confidence            4321       11122233322221 2356679999999

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=8.2e-28  Score=199.26  Aligned_cols=178  Identities=26%  Similarity=0.427  Sum_probs=148.5

Q ss_pred             eeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEecc
Q 027788           30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        30 ~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      ..+||-|.||.||.|+.++-...||||-++.     +...+++|++|..+++.+.|||+++++++|..+..  +|+++||
T Consensus       272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKE-----DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP--FYIiTEf  344 (1157)
T KOG4278|consen  272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP--FYIITEF  344 (1157)
T ss_pred             eeccCCCcccceeeeeeeccceeeehhhhhh-----cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC--eEEEEec
Confidence            3579999999999999999889999998884     45667999999999999999999999999976654  7889999


Q ss_pred             ccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccccee
Q 027788          110 CTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR  187 (219)
Q Consensus       110 ~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~  187 (219)
                      |..|+|-++++.+.  -++.-..+.++.||.+++.||..++  ++||||..+|+|+..+. .+|++|||+++.+..+- .
T Consensus       345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnh-iVKvADFGLsRlMtgDT-Y  420 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENH-IVKVADFGLSRLMTGDT-Y  420 (1157)
T ss_pred             ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccc-eEEeeccchhhhhcCCc-e
Confidence            99999999987653  3667778889999999999999999  99999999999998664 78999999999887653 4


Q ss_pred             eeecccC--ccccCC-----Cccccccceeeec--ccccc
Q 027788          188 IRCWGRR--SSWRRS-----CTMRITRSLWTYT--RLGCA  218 (219)
Q Consensus       188 ~~~~~~~--~~~~~~-----~~~~~~~diws~g--i~~~~  218 (219)
                      +...|+.  ..|...     ..++.++|+|+||  .|.|+
T Consensus       421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIA  460 (1157)
T KOG4278|consen  421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIA  460 (1157)
T ss_pred             ecccCccCcccccCcccccccccccchhhHHHHHHHHHHH
Confidence            4445542  234332     2356789999999  78765

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=5.6e-29  Score=188.45  Aligned_cols=180  Identities=24%  Similarity=0.390  Sum_probs=148.7

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc---eEEEEe
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN---TLNFIT  107 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~---~~~lv~  107 (219)
                      +-||.|+||.||..++.++|+.||+|.+....  .....-+++.+|+..+..++|.|++..++..+-...+   .+|+++
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf--q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T  136 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF--QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT  136 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHH--HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence            57999999999999999999999999766332  2445568899999999999999999988777544433   246788


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccccee
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR  187 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~  187 (219)
                      |.+. .+|.+.+-+-..++.+.+.-+++||+.|+.|||+.+  |+||||||-|++++++. .+||+|||+++....+...
T Consensus       137 ELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  137 ELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             HHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCc-eEEecccccccccchhhhh
Confidence            8884 688877766667999999999999999999999999  99999999999999875 6899999999987666542


Q ss_pred             e-------eecccCccccCCCccccccceeeec-ccc
Q 027788          188 I-------RCWGRRSSWRRSCTMRITRSLWTYT-RLG  216 (219)
Q Consensus       188 ~-------~~~~~~~~~~~~~~~~~~~diws~g-i~~  216 (219)
                      .       ..+++|+-.+.++-|+..-||||.| |++
T Consensus       213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFa  249 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFA  249 (449)
T ss_pred             hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHH
Confidence            2       2456677777888899999999999 654

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.94  E-value=5.3e-26  Score=176.26  Aligned_cols=177  Identities=25%  Similarity=0.456  Sum_probs=145.7

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.+.||+|++|.||++.+..++..+++|.+....    ....+.+.+|++.++.++|++++++.+.+...  ...++++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~~   76 (253)
T cd05122           3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES----KEKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIVM   76 (253)
T ss_pred             eeeeeeccCCceEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEE
Confidence            56789999999999999998899999999987543    23557888999999999999999999988544  5578899


Q ss_pred             ccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          108 EVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       108 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      |++++++|.+++... ..+++..+..++.|++.++.+||..+  ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccC-CeEEEeecccccccccccc
Confidence            999999999988765 57899999999999999999999999  9999999999999865 6899999999988765431


Q ss_pred             ----eeeecccCccccCCCccccccceeeec
Q 027788          187 ----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                          .......+++......++.++|+||+|
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG  184 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLG  184 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHH
Confidence                111111233344444567789999999

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-27  Score=199.19  Aligned_cols=181  Identities=23%  Similarity=0.348  Sum_probs=148.4

Q ss_pred             eeeeeeccccceEEEEEEecCC---CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           28 RYNELLGSGAVKKVYRAFDQEE---GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      ++-++||+|.||.|++|.....   ...||||.+.....   ......|++|+.++.+|+|+|++++|++..+..   +.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l---~~~mddflrEas~M~~L~H~hliRLyGvVl~qp---~m  186 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL---NAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP---AM  186 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc---chhHHHHHHHHHHHHhccCcceeEEeeeeccch---hh
Confidence            5558999999999999976543   34699999886653   225688999999999999999999999997533   67


Q ss_pred             EEeccccCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          105 FITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +|+|.++.|+|-+.+.+  ...+-......++.||+.|+.||..++  ++||||..+|+++.... .+||+|||+.+.+.
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllaspr-tVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPR-TVKICDFGLMRALG  263 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccc-eeeeecccceeccC
Confidence            89999999999998876  345778889999999999999999999  99999999999998664 79999999999997


Q ss_pred             ccce-e--------eeecccCccccCCCccccccceeeec--ccccc
Q 027788          183 RAIR-R--------IRCWGRRSSWRRSCTMRITRSLWTYT--RLGCA  218 (219)
Q Consensus       183 ~~~~-~--------~~~~~~~~~~~~~~~~~~~~diws~g--i~~~~  218 (219)
                      ..+. .        ..+|++| +-.+.+.++.+||+|++|  ||.+.
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaP-EsLrh~kFShaSDvWmyGVTiWEMF  309 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAP-ESLRHRKFSHASDVWMYGVTIWEMF  309 (1039)
T ss_pred             CCCcceEecCCCcCcccccCH-hHhccccccccchhhhhhhhHHhhh
Confidence            7664 1        1134433 224567788899999999  88763

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.94  E-value=1.4e-26  Score=183.29  Aligned_cols=178  Identities=29%  Similarity=0.414  Sum_probs=142.1

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCCceEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      |.+.+.||+|++|.||+|....+++.+++|.+......   .......+|+..+++++ |+|++++++.+..  ....++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc---hhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEE
Confidence            36778999999999999999888999999988754321   11233456899999999 9999999988844  566889


Q ss_pred             EeccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          106 ITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +||++ +++|.+.+....  .+++..+..++.|++.++.|||+++  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~  151 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGP-EVVKIADFGLAREIRS  151 (283)
T ss_pred             EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCC-CCEEEeecccceeccC
Confidence            99999 678888776543  6899999999999999999999999  9999999999999865 5899999999987654


Q ss_pred             cce-----eeeecccCccccCCCccccccceeeec
Q 027788          184 AIR-----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~-----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...     ++..+.+|+.......++.++|+||+|
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G  186 (283)
T cd07830         152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALG  186 (283)
T ss_pred             CCCcCCCCCcccccCceeeecCcCcCCccchhhHH
Confidence            322     122233444444555567789999999

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.94  E-value=7.2e-26  Score=179.32  Aligned_cols=180  Identities=27%  Similarity=0.407  Sum_probs=140.8

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh---CCCCceEEEEEEecCCC---
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL---ANKNIISLHYVWRDEDR---  100 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~~~~i~~~~~~~~~~~~---  100 (219)
                      |++.+.||+|+||.||+|.+..++..+|+|.++....  .......+.+|+.+++++   +|+|++++++.+...+.   
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   78 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE   78 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence            3677899999999999999988899999999875543  223335566788877766   59999999999865432   


Q ss_pred             ceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          101 NTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      ..++++||+++ ++|.+++...  ..+++..+..++.|++.|+.+||+.+  ++|+||+|+|++++.+ +.++|+|||++
T Consensus        79 ~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~-~~~~l~dfg~~  154 (287)
T cd07838          79 LKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSD-GQVKIADFGLA  154 (287)
T ss_pred             ceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccC-CCEEEeccCcc
Confidence            24788999997 5788877653  35899999999999999999999999  9999999999999976 68999999999


Q ss_pred             eecccccee-----eeecccCccccCCCccccccceeeec
Q 027788          179 AIVGRAIRR-----IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       179 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .........     ...+.+| +......++.++|+||+|
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~P-E~~~~~~~~~~~Di~s~G  193 (287)
T cd07838         155 RIYSFEMALTSVVVTLWYRAP-EVLLQSSYATPVDMWSVG  193 (287)
T ss_pred             eeccCCcccccccccccccCh-HHhccCCCCCcchhhhHH
Confidence            887544321     1112233 334445567789999999

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-27  Score=190.80  Aligned_cols=186  Identities=19%  Similarity=0.292  Sum_probs=153.1

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      .+.++++.-+.||+|+||.|+-|.-..+|+-+|.|.+.++..... ..-...++|-.++.+++.+.|+.+-..|  +.++
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr-~ge~maLnEk~iL~kV~s~FiVslaYAf--eTkd  258 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKR-KGETMALNEKQILEKVSSPFIVSLAYAF--ETKD  258 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHh-hhhHHhhHHHHHHHHhccCcEEEEeeee--cCCC
Confidence            345666777899999999999999999999999999876543221 1224567899999999999999998777  6667


Q ss_pred             eEEEEeccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          102 TLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      .+++|+..|+||+|.-++...+  .+++....+++.+|+.||+.||+.+  |++|||||+|||+| +.|++.|+|+|+|.
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLD-d~GhvRISDLGLAv  335 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLD-DHGHVRISDLGLAV  335 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeec-cCCCeEeeccceEE
Confidence            7999999999999998776554  7999999999999999999999999  99999999999999 55899999999999


Q ss_pred             eccccceeeeecccCc----cccCCCccccccceeeec
Q 027788          180 IVGRAIRRIRCWGRRS----SWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       180 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~diws~g  213 (219)
                      .++....-...+|+..    +...+..|+.+.|-||||
T Consensus       336 ei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lG  373 (591)
T KOG0986|consen  336 EIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLG  373 (591)
T ss_pred             ecCCCCccccccCcccccCHHHHcCCcccCCccHHHHH
Confidence            9877654333234322    334455599999999999

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.94  E-value=2.3e-26  Score=183.27  Aligned_cols=172  Identities=23%  Similarity=0.386  Sum_probs=140.3

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC  110 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  110 (219)
                      ..||+|+||.||++....++..+|+|.+...    .......+.+|+.+++.++|+|++++++.+..  .+..+++|||+
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~   99 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVMEFL   99 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEecC
Confidence            6799999999999999999999999987543    23345678899999999999999999998854  45688899999


Q ss_pred             cCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce----
Q 027788          111 TSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR----  186 (219)
Q Consensus       111 ~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~----  186 (219)
                      ++++|.+++. ...+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++++|||++........    
T Consensus       100 ~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~~~~~  175 (292)
T cd06657         100 EGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKS  175 (292)
T ss_pred             CCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CCEEEcccccceecccccccccc
Confidence            9999988764 346889999999999999999999999  9999999999999866 5899999999876654322    


Q ss_pred             --eeeecccCccccCCCccccccceeeec
Q 027788          187 --RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 --~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                        ++..+.. +++.....++.++|+||+|
T Consensus       176 ~~~~~~y~~-pE~~~~~~~~~~~Dv~slG  203 (292)
T cd06657         176 LVGTPYWMA-PELISRLPYGPEVDIWSLG  203 (292)
T ss_pred             cccCccccC-HHHhcCCCCCchhhHHHHH
Confidence              1111223 3344455567789999999

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.4e-26  Score=178.58  Aligned_cols=174  Identities=21%  Similarity=0.332  Sum_probs=143.0

Q ss_pred             eccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccccC
Q 027788           33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTS  112 (219)
Q Consensus        33 ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~  112 (219)
                      ||+|++|.||++.+..+++.+++|.+..... ........+..|+.++++++|+|++++++.+  +.....+++||++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~~v~e~~~~   77 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLHYAF--QTEEKLYLVLEYAPG   77 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHHHHHHHHHHHHHcCCCcHHHHHHHe--ecCCeeEEEEecCCC
Confidence            6899999999999988899999999876543 2334567889999999999999999998887  455678899999999


Q ss_pred             CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc------e
Q 027788          113 GNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI------R  186 (219)
Q Consensus       113 g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~------~  186 (219)
                      ++|.+++.....+++..+..++.|++.++.++|..+  ++|+||+|+||+++.+ +.++++|||++.......      .
T Consensus        78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~  154 (250)
T cd05123          78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFC  154 (250)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCC-CcEEEeecCcceecccCCCcccCCc
Confidence            999999887777899999999999999999999999  9999999999999865 589999999998765431      1


Q ss_pred             eeeecccCccccCCCccccccceeeec
Q 027788          187 RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +...+.+|+ .......+.++|+||+|
T Consensus       155 ~~~~~~~Pe-~~~~~~~~~~~D~~slG  180 (250)
T cd05123         155 GTPEYLAPE-VLLGKGYGKAVDWWSLG  180 (250)
T ss_pred             CCccccChH-HhCCCCCCchhhHHHHH
Confidence            222233333 33334456679999999

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.94  E-value=3.8e-26  Score=185.88  Aligned_cols=183  Identities=25%  Similarity=0.352  Sum_probs=141.2

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC--
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR--  100 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~--  100 (219)
                      ..+| .+.+.||+|+||.||+|.+..+++.||+|.++....  .......+.+|+.+++.++|+||+++++++.....  
T Consensus        14 ~~~y-~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~   90 (342)
T cd07879          14 PERY-TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD   90 (342)
T ss_pred             ccce-EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc--cccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence            3555 677999999999999999999999999998874322  22334567889999999999999999988754322  


Q ss_pred             --ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          101 --NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       101 --~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                        ..+++++|++. .+|...+.  ..+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|+|||++
T Consensus        91 ~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~-~~~kL~dfg~~  164 (342)
T cd07879          91 EFQDFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNED-CELKILDFGLA  164 (342)
T ss_pred             CCceEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEeeCCCC
Confidence              34688999986 46766542  36889999999999999999999999  9999999999999866 68999999999


Q ss_pred             eeccccce---eeeecccCccccCCCccccccceeeecc
Q 027788          179 AIVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       179 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +.......   .+..+.+|+.......++.++|+||+|+
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGv  203 (342)
T cd07879         165 RHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGC  203 (342)
T ss_pred             cCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHH
Confidence            76543322   1122333433333345677899999993

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.94  E-value=5e-26  Score=178.90  Aligned_cols=182  Identities=20%  Similarity=0.299  Sum_probs=141.3

Q ss_pred             eeeeeeeccccceEEEEEEecC-CCcEEEEEEeeecccC------CCHHHHHHHHHHHHHHHh-hCCCCceEEEEEEecC
Q 027788           27 GRYNELLGSGAVKKVYRAFDQE-EGIEVAWNQVKLRTFC------DDPAMIERLFSEVRLLKT-LANKNIISLHYVWRDE   98 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~~~E~~~l~~-l~~~~i~~~~~~~~~~   98 (219)
                      |.+.+.||+|+||.||.+.... .+..+|+|.+......      ........+..|+.++.+ ++|||++++++.+.  
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~--   79 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL--   79 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc--
Confidence            3667899999999999999877 6789999988653321      123445667788888864 79999999999884  


Q ss_pred             CCceEEEEeccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeCCCCCceEEeCCCCcEEEe
Q 027788           99 DRNTLNFITEVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHT-HEPCVIHRDLNCSNVFVNGNTGQVKIG  173 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~-~~~~i~h~dl~~~nili~~~~~~~~l~  173 (219)
                      ..+..+++|||+++++|.+++..    ...+++..++.++.|++.++.+||. .+  ++|+||+|+||+++.+ +.++|+
T Consensus        80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~-~~~~l~  156 (269)
T cd08528          80 ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGED-DKVTIT  156 (269)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCC-CcEEEe
Confidence            44678899999999999887642    3468899999999999999999996 67  9999999999999865 589999


Q ss_pred             ccccceeccccceeeeec----ccCccccCCCccccccceeeec
Q 027788          174 DLGVAAIVGRAIRRIRCW----GRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       174 dfg~a~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |||.+.............    ..+++......++.++|+||+|
T Consensus       157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG  200 (269)
T cd08528         157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFG  200 (269)
T ss_pred             cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHH
Confidence            999998765543211111    1223444455677889999999

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.94  E-value=1.4e-26  Score=182.92  Aligned_cols=179  Identities=28%  Similarity=0.461  Sum_probs=144.9

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.+.||+|.+|.||+|....+++.+++|.++....  +....+.+..|+.+++.++|+|++++++.+..  ...+++++
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~   77 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE--EEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVF   77 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEeccccc--cccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEe
Confidence            456889999999999999999999999999886542  23344677889999999999999999988844  46688899


Q ss_pred             ccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          108 EVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       108 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      |+++ ++|.+++... ..+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++........
T Consensus        78 e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          78 EYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             cCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCC-CCEEEecCCcccccCCCcc
Confidence            9997 5899988765 57999999999999999999999999  9999999999999865 6899999999987654332


Q ss_pred             ------eeeecccCccccCCCccccccceeeecc
Q 027788          187 ------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 ------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                            ....+.+|+.+.....++.++|+||+|+
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~  187 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGC  187 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHH
Confidence                  1112333443434446777899999993

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.94  E-value=2.3e-26  Score=181.88  Aligned_cols=179  Identities=28%  Similarity=0.452  Sum_probs=143.0

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      ++.+.||+|++|.||+|.+..++..+++|.++....  .+.....+..|+.++++++|+|++++++.+..  +..+++++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~   77 (283)
T cd05118           2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KGDLYLVF   77 (283)
T ss_pred             ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCCEEEEE
Confidence            456889999999999999988999999999875543  22345678889999999999999999988854  45688899


Q ss_pred             ccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          108 EVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       108 e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      ||+++ ++.+++.. ...+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||.+........
T Consensus        78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCcc
Confidence            99975 77777655 357899999999999999999999999  9999999999999865 5899999999987755431


Q ss_pred             ------eeeecccCccccCCCccccccceeeecc
Q 027788          187 ------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 ------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                            ....+.+|+.......++.++|+||+|+
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~  187 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGC  187 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHH
Confidence                  1112333333333336777899999993

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.94  E-value=6.8e-26  Score=182.06  Aligned_cols=170  Identities=17%  Similarity=0.260  Sum_probs=132.1

Q ss_pred             cceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccccCCChH
Q 027788           37 AVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLR  116 (219)
Q Consensus        37 ~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~g~L~  116 (219)
                      +++.||.+....+++.||+|.++....  .....+.+..|+.+++.++|+||+++++++..  ....+++|||+++++|.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~   87 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYGSCE   87 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEeccCCCCHH
Confidence            445555555567899999999875422  34566889999999999999999999998854  45678899999999999


Q ss_pred             HHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce--------
Q 027788          117 EYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR--------  186 (219)
Q Consensus       117 ~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~--------  186 (219)
                      +++...  ..+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++++|||.+........        
T Consensus        88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~  164 (314)
T cd08216          88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHDF  164 (314)
T ss_pred             HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecC-CceEEecCccceeeccccccccccccc
Confidence            988653  45889999999999999999999999  9999999999999855 6899999998876543221        


Q ss_pred             -----eeeecccCccccCC-Cccccccceeeec
Q 027788          187 -----RIRCWGRRSSWRRS-CTMRITRSLWTYT  213 (219)
Q Consensus       187 -----~~~~~~~~~~~~~~-~~~~~~~diws~g  213 (219)
                           .+..+.+|+.+... ..++.++|+||+|
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G  197 (314)
T cd08216         165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVG  197 (314)
T ss_pred             cccccccccccCHHHhcCCCCCCCcchhHHHHH
Confidence                 11123333333322 3467789999999

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.94  E-value=4.2e-26  Score=181.11  Aligned_cols=177  Identities=20%  Similarity=0.293  Sum_probs=136.7

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCCceEEEE
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      ...+.||+|+||.||++.+..+++.+|+|.+.....   ......+.+|+.++.++. |+|++++++.+..+  +..+++
T Consensus         7 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~~   81 (288)
T cd06616           7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD---EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWIC   81 (288)
T ss_pred             HHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC---hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEEE
Confidence            344689999999999999999999999998875432   244567889999999986 99999999988554  446779


Q ss_pred             eccccCCChHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          107 TEVCTSGNLREYRK-----KHRHVSVKALKKWSKQILKGLNYLHTH-EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       107 ~e~~~~g~L~~~~~-----~~~~~~~~~~~~i~~qv~~~l~~lh~~-~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      ||+++ +++.++..     ....+++..+..++.|++.|+.|||+. +  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~  157 (288)
T cd06616          82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRN-GNIKLCDFGISGQ  157 (288)
T ss_pred             Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccC-CcEEEeecchhHH
Confidence            99986 45554322     235689999999999999999999974 7  9999999999999865 5899999999976


Q ss_pred             ccccce-----eeeecccCccccCC--Cccccccceeeec
Q 027788          181 VGRAIR-----RIRCWGRRSSWRRS--CTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~-----~~~~~~~~~~~~~~--~~~~~~~diws~g  213 (219)
                      ......     ++..+.+|+.....  ..++.++|+||+|
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG  197 (288)
T cd06616         158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLG  197 (288)
T ss_pred             hccCCccccccCccCccCHHHhccccccCCcchhhhhHHH
Confidence            544322     22223344433333  3577789999999

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=2.8e-26  Score=187.53  Aligned_cols=182  Identities=23%  Similarity=0.316  Sum_probs=143.3

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCC
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDR  100 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~  100 (219)
                      ..++-|.+.++||+|+.++||++.... .+.+|+|.+....  .+...+.-+.+|+++|.+|+ |.+|++++++...+  
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~--~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d--  432 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLE--ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD--  432 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhh--cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC--
Confidence            456667788999999999999998544 3456666554333  47888899999999999995 89999999998664  


Q ss_pred             ceEEEEeccccCCChHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          101 NTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~~~-~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      .++|+|||+= ..+|.+.++.... .....+..+..|++.++.++|..+  |+|.||||.|+++= . |.+||+|||.|.
T Consensus       433 ~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-k-G~LKLIDFGIA~  507 (677)
T KOG0596|consen  433 GYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-K-GRLKLIDFGIAN  507 (677)
T ss_pred             ceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-e-eeEEeeeechhc
Confidence            5799999975 4699998876543 444578889999999999999999  99999999999985 3 589999999999


Q ss_pred             eccccce--------eeeecccCccc-----cCCCc-----cccccceeeec
Q 027788          180 IVGRAIR--------RIRCWGRRSSW-----RRSCT-----MRITRSLWTYT  213 (219)
Q Consensus       180 ~~~~~~~--------~~~~~~~~~~~-----~~~~~-----~~~~~diws~g  213 (219)
                      .+..+-.        ++..+-+|+-.     .+..+     ...++||||+|
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLG  559 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLG  559 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhh
Confidence            8877654        44445555532     12222     67889999999

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.94  E-value=3.1e-26  Score=186.51  Aligned_cols=185  Identities=28%  Similarity=0.407  Sum_probs=143.4

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC-
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR-  100 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~-  100 (219)
                      ..++| .+.+.||+|++|.||+|.+..++..+|+|.+.....  .....+.+.+|+.++++++|+|++++.+++...+. 
T Consensus        13 ~~~~y-~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07851          13 VPDRY-QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ--SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL   89 (343)
T ss_pred             ccCce-EEEEEeccCCceEEEEEEECCCCcEEEEEecccccc--hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence            44565 677999999999999999999999999998764321  23345667889999999999999998876643321 


Q ss_pred             ---ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788          101 ---NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus       101 ---~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                         ..+++++|++ +++|.+++.. ..+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        90 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~-~~~kL~dfg~  164 (343)
T cd07851          90 EDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNED-CELKILDFGL  164 (343)
T ss_pred             cccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCC-CCEEEccccc
Confidence               3478899998 5699887765 46899999999999999999999999  9999999999999865 6899999999


Q ss_pred             ceeccccce---eeeecccCccccCCCccccccceeeecc
Q 027788          178 AAIVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +........   .+..+.+|+.......++.++|+||+|+
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv  204 (343)
T cd07851         165 ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC  204 (343)
T ss_pred             cccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHH
Confidence            987644321   1112223332222235567899999993

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.94  E-value=6.5e-26  Score=175.44  Aligned_cols=164  Identities=15%  Similarity=0.251  Sum_probs=130.5

Q ss_pred             ccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccccCCCh
Q 027788           36 GAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL  115 (219)
Q Consensus        36 g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~g~L  115 (219)
                      |.+|.||++.+..+++.+|+|.+....         ....|...+....|||++++++.+..  ....+++|||+++++|
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L   72 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKL   72 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCH
Confidence            899999999999999999999987542         12234555556679999999998854  4568899999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---eeeecc
Q 027788          116 REYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---RIRCWG  192 (219)
Q Consensus       116 ~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---~~~~~~  192 (219)
                      .+++.....+++..+..++.|++.++.|||+.+  ++|+||||+|++++.+ +.++++|||.+........   ....+.
T Consensus        73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~y~  149 (237)
T cd05576          73 WSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDSCDGEAVENMYC  149 (237)
T ss_pred             HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCC-CCEEEecccchhccccccccCCcCcccc
Confidence            998877777999999999999999999999999  9999999999999866 5899999998876654322   112233


Q ss_pred             cCccccCCCccccccceeeecc
Q 027788          193 RRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       193 ~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +|+ ......++.++|+||+|+
T Consensus       150 aPE-~~~~~~~~~~~DvwslG~  170 (237)
T cd05576         150 APE-VGGISEETEACDWWSLGA  170 (237)
T ss_pred             CCc-ccCCCCCCchhhHHHHHH
Confidence            443 333445667899999993

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.93  E-value=1.7e-25  Score=178.52  Aligned_cols=178  Identities=20%  Similarity=0.294  Sum_probs=137.9

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCCceEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      +.+.+.||+|++|.||+|.+..++..+|+|.++...   .......+..|+.++.+.. |+|++++++++..  ...+++
T Consensus        17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~   91 (296)
T cd06618          17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDVFI   91 (296)
T ss_pred             heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC---ChHHHHHHHHHHHHHHhccCCCchHhhheeeec--CCeEEE
Confidence            478899999999999999998889999999987542   2233456667787676665 9999999999854  456888


Q ss_pred             EeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          106 ITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHT-HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~-~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +||+++ +++.+++.. ...+++..+..++.|++.++.|||+ .+  ++|+||+|+||+++.+ +.++|+|||++..+..
T Consensus        92 v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~~-~~~kL~dfg~~~~~~~  167 (296)
T cd06618          92 CMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDAS-GNVKLCDFGISGRLVD  167 (296)
T ss_pred             EeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcCC-CCEEECccccchhccC
Confidence            999985 577776654 3568899999999999999999997 57  9999999999999855 6899999999976643


Q ss_pred             ccee-----eeecccCccccCC---Cccccccceeeec
Q 027788          184 AIRR-----IRCWGRRSSWRRS---CTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~~-----~~~~~~~~~~~~~---~~~~~~~diws~g  213 (219)
                      ....     ...+.+|+.+...   ..++.++|+||+|
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG  205 (296)
T cd06618         168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLG  205 (296)
T ss_pred             CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHH
Confidence            3221     1223344444322   3467789999999

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.93  E-value=7.4e-27  Score=172.76  Aligned_cols=182  Identities=18%  Similarity=0.319  Sum_probs=149.3

Q ss_pred             ccccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEE
Q 027788           17 FIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVW   95 (219)
Q Consensus        17 ~~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~   95 (219)
                      ++.++....| .+.+++|+|-++.||.|....+.+.+++|+++.       ..-+.+.+|+.+|+.|. +|||++++++.
T Consensus        31 ~i~wg~~ddY-eivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-------VkkkKIkREikIL~nL~gg~NIi~L~DiV  102 (338)
T KOG0668|consen   31 VIDWGNQDDY-EIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-------VKKKKIKREIKILQNLRGGPNIIKLLDIV  102 (338)
T ss_pred             eeeccccchH-HHHHHHcCccHhhHhcccccCCCceEEEeeech-------HHHHHHHHHHHHHHhccCCCCeeehhhhh
Confidence            4566666677 788999999999999999999999999999883       33467889999999997 99999999999


Q ss_pred             ecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788           96 RDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus        96 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      .++.....-++.|+.++.+...+-   +.++...+...+.+++.||.|+|+.|  |.|||+||.|++++.....++|+|+
T Consensus       103 ~Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDW  177 (338)
T KOG0668|consen  103 KDPESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDW  177 (338)
T ss_pred             cCccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeec
Confidence            888777777899999887776543   46788889999999999999999999  9999999999999977667899999


Q ss_pred             ccceeccccceeeeecccCccccCCC-------ccccccceeeec
Q 027788          176 GVAAIVGRAIRRIRCWGRRSSWRRSC-------TMRITRSLWTYT  213 (219)
Q Consensus       176 g~a~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~diws~g  213 (219)
                      |+|-.+.+.......+.  +.+..+|       .|+-+=|+||||
T Consensus       178 GLAEFYHp~~eYnVRVA--SRyfKGPELLVdy~~YDYSLD~WS~G  220 (338)
T KOG0668|consen  178 GLAEFYHPGKEYNVRVA--SRYFKGPELLVDYQMYDYSLDMWSLG  220 (338)
T ss_pred             chHhhcCCCceeeeeee--hhhcCCchheeechhccccHHHHHHH
Confidence            99998877665433222  2333333       366667888888

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=1.2e-28  Score=184.52  Aligned_cols=188  Identities=22%  Similarity=0.459  Sum_probs=146.9

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec-
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD-   97 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-   97 (219)
                      -.+..+.|.++ .+||+|.||.||+|+..++++.||+|.+-...  ...++-....+|+.+++.|.|+|++.+...|.. 
T Consensus        12 ~~~~~~~yek~-~kigqGtfgeVFkAr~~n~~kkvalkkvlmen--eKeGfpitalreikiL~~lkHenv~nliEic~tk   88 (376)
T KOG0669|consen   12 FCDEVSKYEKL-AKIGQGTFGEVFKARSKNTGKKVALKKVLMEN--EKEGFPITALREIKILQLLKHENVVNLIEICRTK   88 (376)
T ss_pred             ceecchHHHHH-HhcCCchHHHHHHHhhcCccchhHHHHHHHhc--cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence            44566778776 79999999999999999999999998654322  133444556789999999999999887766632 


Q ss_pred             -----CCCceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEE
Q 027788           98 -----EDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVK  171 (219)
Q Consensus        98 -----~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~  171 (219)
                           .....+++|+.+|+ .+|..++... -.++...+.+++.++..||.|+|+..  |+|||+|++|++|+.+ +.++
T Consensus        89 ~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~d-gilk  164 (376)
T KOG0669|consen   89 ATPTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKD-GILK  164 (376)
T ss_pred             cCCcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCC-ceEE
Confidence                 12235889999997 5888877654 57999999999999999999999999  9999999999999966 6899


Q ss_pred             Eeccccceeccccce--ee-------eecccCcc-ccCCCccccccceeeec
Q 027788          172 IGDLGVAAIVGRAIR--RI-------RCWGRRSS-WRRSCTMRITRSLWTYT  213 (219)
Q Consensus       172 l~dfg~a~~~~~~~~--~~-------~~~~~~~~-~~~~~~~~~~~diws~g  213 (219)
                      |+|||+++.+.....  +.       +.|..|++ ....++|.++-|||+-|
T Consensus       165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAg  216 (376)
T KOG0669|consen  165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAG  216 (376)
T ss_pred             eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHH
Confidence            999999976654432  11       22333333 45677789999999988

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.93  E-value=8.5e-26  Score=176.75  Aligned_cols=180  Identities=22%  Similarity=0.378  Sum_probs=138.5

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccC-CCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC-DDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      |.+.+.||+|+||.||++.+...+..+++|.++..... ........+..|+.+++.++|||++++++.+..+  ...++
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l   79 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER--DAFCI   79 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC--CceEE
Confidence            37789999999999999998887777777776542221 1222334566799999999999999999888543  45788


Q ss_pred             EeccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          106 ITEVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      ++||+++++|.+++..    ...+++..+..++.|++.++.+||+.+  ++|+||+|+|++++.  +.++++|||++...
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~--~~~~l~d~g~~~~~  155 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN--NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec--CCEeecccCceeec
Confidence            9999999999987653    346899999999999999999999999  999999999999974  36999999999876


Q ss_pred             cccce------eeeecccCccccCCCccccccceeeec
Q 027788          182 GRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .....      ++..+.+| +......++.++|+||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~p-e~~~~~~~~~~~Dv~slG  192 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSP-EALKHQGYDSKSDIWSLG  192 (260)
T ss_pred             CCCcccccCCCCCcCccCH-HHHccCCCCchhhHHHHH
Confidence            44322      11122223 333445567789999999

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.93  E-value=6.4e-27  Score=176.30  Aligned_cols=177  Identities=20%  Similarity=0.275  Sum_probs=142.7

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHh-hCCCCceEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKT-LANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~-l~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      ..||.|+||.|++..++.+|+..|||.+....   .....++++.|.++..+ =+.|||+++++....++.  .|+.||.
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n---~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd--cWiCMEL  144 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN---IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD--CWICMEL  144 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeecc---chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc--eeeeHHH
Confidence            46999999999999999999999999988654   35566888999987654 468999999998876654  7889999


Q ss_pred             ccCCChHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          110 CTSGNLREYRK-----KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       110 ~~~g~L~~~~~-----~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      +. .+|..+-.     ....++++.+..+....+.||.||...-. ++|||+||+|||++. .|.+||+|||.+-.+...
T Consensus       145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk-iIHRDvKPSNILldr-~G~vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK-IIHRDVKPSNILLDR-HGDVKLCDFGICGQLVDS  221 (361)
T ss_pred             Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh-hhhccCChhheEEec-CCCEeeecccchHhHHHH
Confidence            95 67776532     23468899999999999999999986532 999999999999994 479999999999888766


Q ss_pred             ceee-----eecccCccccCCCc-cccccceeeeccc
Q 027788          185 IRRI-----RCWGRRSSWRRSCT-MRITRSLWTYTRL  215 (219)
Q Consensus       185 ~~~~-----~~~~~~~~~~~~~~-~~~~~diws~gi~  215 (219)
                      ..++     .-+-+|+...++.. |+-+||+|||||+
T Consensus       222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGIT  258 (361)
T KOG1006|consen  222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGIT  258 (361)
T ss_pred             HHhhhccCCccccChhccCCccCCcchhhhhhhhcce
Confidence            6533     34445666665555 8999999999964

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=3.2e-24  Score=173.92  Aligned_cols=158  Identities=16%  Similarity=0.141  Sum_probs=118.2

Q ss_pred             CCCCCccccCCCCceeeeeeeeccccceEEEEEEecC-CCcEEEEEEeeeccc-CCCHHHHHHHHHHHHHHHhhCCCCce
Q 027788           12 KDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQE-EGIEVAWNQVKLRTF-CDDPAMIERLFSEVRLLKTLANKNII   89 (219)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~~~~i~   89 (219)
                      ..+.+.....+....|.+.+.||+|+||.||+|++.. ++..+|+|.+..... .......+.+.+|++++++++|+|++
T Consensus         5 ~~~~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv   84 (365)
T PRK09188          5 DVPLPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVV   84 (365)
T ss_pred             CCCCcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCC
Confidence            3444444444555556899999999999999998876 677789998652211 01234456789999999999999998


Q ss_pred             EEEEEEecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCC-CCCceEEeCCCC
Q 027788           90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDL-NCSNVFVNGNTG  168 (219)
Q Consensus        90 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl-~~~nili~~~~~  168 (219)
                      ..+..+     ...+++|||+++++|.. +..   ..   ...++.|++.++.+||+.+  ++|||| ||+||+++.+ +
T Consensus        85 ~~l~~~-----~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~-~  149 (365)
T PRK09188         85 PQLLAT-----GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPD-G  149 (365)
T ss_pred             cEEEEc-----CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCC-C
Confidence            533222     12588999999999963 221   11   1467889999999999999  999999 9999999755 5


Q ss_pred             cEEEeccccceecccc
Q 027788          169 QVKIGDLGVAAIVGRA  184 (219)
Q Consensus       169 ~~~l~dfg~a~~~~~~  184 (219)
                      .++|+|||+|+.+...
T Consensus       150 ~ikLiDFGlA~~~~~~  165 (365)
T PRK09188        150 EAAVIDFQLASVFRRR  165 (365)
T ss_pred             CEEEEECccceecccC
Confidence            8999999999977553

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.92  E-value=3.4e-25  Score=167.76  Aligned_cols=177  Identities=19%  Similarity=0.285  Sum_probs=140.0

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      ..||.|+.|.|++++.+.+|...|||......   .....++++..+.++.+- ++|.|++.+++|.....  +++.||.
T Consensus        98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~---Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d--V~IcMel  172 (391)
T KOG0983|consen   98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD--VFICMEL  172 (391)
T ss_pred             HhhcCCCccceEEEEEcccceEEEEEeecccC---CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch--HHHHHHH
Confidence            46999999999999999999999999876332   344558888888877554 48999999999976544  6678888


Q ss_pred             ccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccceee
Q 027788          110 CTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRI  188 (219)
Q Consensus       110 ~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~~  188 (219)
                      +. ..+..++.. .+++++..+..+..-++.||.||..+. .++|||+||+|||++ +.|++|++|||.+-++......+
T Consensus       173 Ms-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlD-e~GniKlCDFGIsGrlvdSkAht  249 (391)
T KOG0983|consen  173 MS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKAHT  249 (391)
T ss_pred             HH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEc-cCCCEEeecccccceeecccccc
Confidence            84 566666543 567999999999999999999999653 299999999999999 55799999999999887766533


Q ss_pred             e-----ecccCccccC--CCccccccceeeeccc
Q 027788          189 R-----CWGRRSSWRR--SCTMRITRSLWTYTRL  215 (219)
Q Consensus       189 ~-----~~~~~~~~~~--~~~~~~~~diws~gi~  215 (219)
                      .     .+-+|+....  .+.|+-.+|+|||||.
T Consensus       250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGIT  283 (391)
T KOG0983|consen  250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGIT  283 (391)
T ss_pred             cccCCccccCccccCCCCCCccchhhhhhhhccc
Confidence            3     3444554432  4668888999999954

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=5.2e-27  Score=195.25  Aligned_cols=189  Identities=25%  Similarity=0.408  Sum_probs=158.9

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      ..+|..+|+ +.+.+|+|+||.||+|++..+++..|+|+++...    .+.++-+..|+-.++..+||||+.+++.+...
T Consensus        10 rrnP~ddye-llqrvgsgTygdvyKaRd~~s~elaavkvVkLep----~dd~~~iqqei~~~~dc~h~nivay~gsylr~   84 (829)
T KOG0576|consen   10 RRNPQDDYE-LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP----GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR   84 (829)
T ss_pred             hcCCccchh-heeeecCCcccchhhhcccccCchhhheeeeccC----CccccccccceeeeecCCCcChHHHHhhhhhh
Confidence            346778885 5599999999999999999999999999999763    33456677899999999999999999998654


Q ss_pred             CCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      +  .+|+.||||.+|+|.+.-...+++++.++..+++..+.++.|||+.+  -+|||+|-.||+++.. |.+|+.|||.+
T Consensus        85 d--klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~-gDvklaDfgvs  159 (829)
T KOG0576|consen   85 D--KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDE-GDVKLADFGVS  159 (829)
T ss_pred             c--CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeeccc-CceeecccCch
Confidence            4  48899999999999987666778999999999999999999999999  8999999999999844 79999999999


Q ss_pred             eeccccce------eeeecccCcc--ccCCCccccccceeeeccccc
Q 027788          179 AIVGRAIR------RIRCWGRRSS--WRRSCTMRITRSLWTYTRLGC  217 (219)
Q Consensus       179 ~~~~~~~~------~~~~~~~~~~--~~~~~~~~~~~diws~gi~~~  217 (219)
                      ..+.-...      ++..|-+|+-  .-+...|.-.+|+|++||.|+
T Consensus       160 aqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAi  206 (829)
T KOG0576|consen  160 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAI  206 (829)
T ss_pred             hhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchh
Confidence            88866553      3333444432  246777888899999999886

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.92  E-value=9.7e-25  Score=171.52  Aligned_cols=185  Identities=17%  Similarity=0.250  Sum_probs=145.5

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCC------CceEE
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK------NIISL   91 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~------~i~~~   91 (219)
                      ..+|.....|.+.+.+|+|.||.|-.+.+..++..||+|+++.-     ....+..+.|+++++++.+.      -++.+
T Consensus        82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m  156 (415)
T KOG0671|consen   82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-----DKYREAALIEIEVLQKINESDPNGKFRCVQM  156 (415)
T ss_pred             EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-----HHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence            45666444457889999999999999999999999999998732     33445567899999999542      24555


Q ss_pred             EEEEecCCCceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC---
Q 027788           92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN---  166 (219)
Q Consensus        92 ~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~---  166 (219)
                      .++|  +-.+.++++.|.+ |.++.+++..+  .+++...+..+..|++.++.+||+.+  ++|-||||+||++-+.   
T Consensus       157 ~~wF--dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~  231 (415)
T KOG0671|consen  157 RDWF--DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYF  231 (415)
T ss_pred             ehhh--hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceE
Confidence            5666  4456689999998 56999998654  46899999999999999999999999  9999999999997211   


Q ss_pred             ----------------CCcEEEeccccceeccccc---eeeeecccCccccCCCccccccceeeec
Q 027788          167 ----------------TGQVKIGDLGVAAIVGRAI---RRIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       167 ----------------~~~~~l~dfg~a~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                                      ...++++|||.|.......   .++..+++|+ ...+-+++.++|+||.|
T Consensus       232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPE-ViLgLGwS~pCDvWSiG  296 (415)
T KOG0671|consen  232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPE-VILGLGWSQPCDVWSIG  296 (415)
T ss_pred             EEeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCch-heeccCcCCccCceeee
Confidence                            1258999999998776655   3666777764 44455677789999999

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.92  E-value=6.1e-25  Score=188.64  Aligned_cols=149  Identities=20%  Similarity=0.236  Sum_probs=104.1

Q ss_pred             ceeeeeeeeccccceEEEEEEecCC----CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEE----Ee
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEE----GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYV----WR   96 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~----~~   96 (219)
                      ..|.+.+.||+|+||.||+|++..+    +..||+|.++...    .  .+....|  .++...+.++..+...    ..
T Consensus       132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----A--VEIWMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----h--hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            3448889999999999999999888    8999999876321    1  1111111  1111112222211111    11


Q ss_pred             cCCCceEEEEeccccCCChHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCC
Q 027788           97 DEDRNTLNFITEVCTSGNLREYRKKHRH--------------------VSVKALKKWSKQILKGLNYLHTHEPCVIHRDL  156 (219)
Q Consensus        97 ~~~~~~~~lv~e~~~~g~L~~~~~~~~~--------------------~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl  156 (219)
                      ......+++++||+++++|.+++.....                    .....+..++.|++.+|.|||+.+  |+||||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDL  281 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDV  281 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcC
Confidence            1344568899999999999988764321                    112345678999999999999999  999999


Q ss_pred             CCCceEEeCCCCcEEEeccccceeccc
Q 027788          157 NCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       157 ~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      ||+|||++.+.+.+||+|||+|+.+..
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~  308 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRV  308 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCcccccc
Confidence            999999986556899999999986543

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=9.1e-26  Score=170.60  Aligned_cols=192  Identities=19%  Similarity=0.322  Sum_probs=145.8

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEe
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWR   96 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~   96 (219)
                      ...+....| .+++.+|+|.||.+-+|+++.++..+++|.++..     ....++|.+|...--.|. |.||+..+++-.
T Consensus        18 ~kv~l~d~y-~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF   91 (378)
T KOG1345|consen   18 KKVDLEDVY-TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-----QTTQADFVREFHYSFFLSPHQHIIDTYEVAF   91 (378)
T ss_pred             cccchhhhh-hHHHHhcccceeeEEeeeccCCceEEEeeccCcc-----hhhHHHHHHHhccceeeccchhhhHHHHHHh
Confidence            344455555 8999999999999999999999999999988743     344577888887666664 789998776543


Q ss_pred             cCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEe-CCCCcEEEecc
Q 027788           97 DEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN-GNTGQVKIGDL  175 (219)
Q Consensus        97 ~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~-~~~~~~~l~df  175 (219)
                       +..++.++++|++|.|+|.+-+.. ..+.+.-..+++.|+++|+.|+|+.+  ++|||||.+|||+. .+..++|++||
T Consensus        92 -qt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen   92 -QTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             -hcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeec
Confidence             334567789999999999876654 35778889999999999999999999  99999999999964 56668999999


Q ss_pred             ccceeccccceee---eecccCccc--cCCC--ccccccceeeeccccccC
Q 027788          176 GVAAIVGRAIRRI---RCWGRRSSW--RRSC--TMRITRSLWTYTRLGCAC  219 (219)
Q Consensus       176 g~a~~~~~~~~~~---~~~~~~~~~--~~~~--~~~~~~diws~gi~~~~c  219 (219)
                      |++...+......   ..+..|+..  ..+.  ...+..|+|.|||+-+-|
T Consensus       168 G~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~c  218 (378)
T KOG1345|consen  168 GLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYC  218 (378)
T ss_pred             ccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeee
Confidence            9998876654321   122233321  1222  245669999999765544

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=2.8e-25  Score=178.68  Aligned_cols=179  Identities=21%  Similarity=0.252  Sum_probs=137.1

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHH--hhCCCCceEEEEEEecCC--CceE
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLK--TLANKNIISLHYVWRDED--RNTL  103 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~--~l~~~~i~~~~~~~~~~~--~~~~  103 (219)
                      .+.++||+|.||.||+|..  +++.||||++...       ..+.+.+|-+++.  .++|+||+++++.-....  .-.+
T Consensus       213 ~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~-------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ-------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             hhHHHhhcCccceeehhhc--cCceeEEEecCHH-------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            5558999999999999964  4589999998743       3366788888886  558999999876653222  2367


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE-------PCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~-------~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                      +||++|.+.|+|.+++..+ ..++....+++..++.||+|||+..       |+|.|||||.+|||+..| ++..|+|||
T Consensus       284 wLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D-lTccIaDFG  361 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND-LTCCIADFG  361 (534)
T ss_pred             eEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-CcEEeeccc
Confidence            8999999999999999865 7899999999999999999999753       469999999999999855 689999999


Q ss_pred             cceeccccce--------eeeecccCcccc-----CCCccccccceeeec--cccc
Q 027788          177 VAAIVGRAIR--------RIRCWGRRSSWR-----RSCTMRITRSLWTYT--RLGC  217 (219)
Q Consensus       177 ~a~~~~~~~~--------~~~~~~~~~~~~-----~~~~~~~~~diws~g--i~~~  217 (219)
                      +|.++.....        ++..+-+|+-.-     ..+.-=...||+|+|  .|.+
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi  417 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEI  417 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHH
Confidence            9999976553        333333444211     111111237999999  6655

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=1.7e-24  Score=187.45  Aligned_cols=183  Identities=26%  Similarity=0.360  Sum_probs=146.2

Q ss_pred             CCCceeeeeeeeccccceEEEEEEec----C---CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEE
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQ----E---EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHY   93 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~----~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~   93 (219)
                      .......+.+.+|+|.||.|++|...    .   ....||||.++...   .....+.+..|+++++.+. |+|++.+.+
T Consensus       293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA---SSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             echhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc---CcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            33344467779999999999999732    1   24679999887554   3356688999999999885 999999999


Q ss_pred             EEecCCCceEEEEeccccCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCC
Q 027788           94 VWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLN  157 (219)
Q Consensus        94 ~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~----------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~  157 (219)
                      .+..  ...+++++||+..|+|.++++..+                .++....+.++.||+.|++||++..  ++||||.
T Consensus       370 ~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLA  445 (609)
T KOG0200|consen  370 ACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLA  445 (609)
T ss_pred             eecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhh
Confidence            9966  456788999999999999987654                3788899999999999999999999  9999999


Q ss_pred             CCceEEeCCCCcEEEeccccceeccccceee---------eecccCccccCCCccccccceeeec
Q 027788          158 CSNVFVNGNTGQVKIGDLGVAAIVGRAIRRI---------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       158 ~~nili~~~~~~~~l~dfg~a~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .+||++..+ ..+||+|||+|+.........         ..|.+|+.+.. ..|+.++|+||+|
T Consensus       446 aRNVLi~~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfG  508 (609)
T KOG0200|consen  446 ARNVLITKN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFG  508 (609)
T ss_pred             hhhEEecCC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHH
Confidence            999999866 478999999999765544321         12444433333 7789999999999

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=9e-26  Score=179.50  Aligned_cols=182  Identities=21%  Similarity=0.266  Sum_probs=150.1

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCCceEEEE
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      ++...||+|+||.|-+|+.+.+.+.+|||++++.....++ .++-.+.|-.+|+... -|.++.++.+|+.  .+.+|+|
T Consensus       352 nFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdD-Dvectm~EKrvLAL~~kppFL~qlHScFQT--mDRLyFV  428 (683)
T KOG0696|consen  352 NFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDD-DVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDRLYFV  428 (683)
T ss_pred             ceEEEeccCccceeeeecccCcchhhhhhhhccceeeecC-cccceehhhhheecCCCCchHHHHHHHhhh--hhheeeE
Confidence            5667899999999999999999999999999987765433 3466677888887665 4678888888854  4558899


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      |||+.||+|...++.-+.+.+..+..++..|+.||-+||+++  |++||||.+|++++.+ |.+||.|||+++....+..
T Consensus       429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~e-GHiKi~DFGmcKEni~~~~  505 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENIFDGV  505 (683)
T ss_pred             EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccC-CceEeeecccccccccCCc
Confidence            999999999999998889999999999999999999999999  9999999999999977 6999999999998766554


Q ss_pred             -eeeecccCccc----cCCCccccccceeeeccc
Q 027788          187 -RIRCWGRRSSW----RRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       187 -~~~~~~~~~~~----~~~~~~~~~~diws~gi~  215 (219)
                       ..+.+|+|...    ..=.+|.-+.|-||+|++
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVL  539 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL  539 (683)
T ss_pred             ceeeecCCCcccccceEEecccccchhHHHHHHH
Confidence             33456665532    233456677899999943

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.92  E-value=7.4e-24  Score=161.68  Aligned_cols=178  Identities=29%  Similarity=0.458  Sum_probs=145.6

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.+.||+|++|.||++....+++.+++|.+......   ...+.+.+|++.+++++|+|++++++.+...  ...++++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~   76 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDP--EPLYLVM   76 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecC--CceEEEE
Confidence            5678999999999999999888999999998855321   2567889999999999999999999887543  5577899


Q ss_pred             ccccCCChHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc-
Q 027788          108 EVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI-  185 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~-~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~-  185 (219)
                      |++++++|.+++..... +++..+..++.+++.++.+||..+  ++|+|+++.|++++.+ +.++|+|||.+....... 
T Consensus        77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       77 EYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             eccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeeCceeeEecCccc
Confidence            99998899999877655 899999999999999999999998  9999999999999866 589999999998876643 


Q ss_pred             -e-----eeeecccCccccCCCccccccceeeec
Q 027788          186 -R-----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 -~-----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                       .     ....+..|+.......++.++|+||+|
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG  187 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLG  187 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHH
Confidence             1     111122233222555666789999999

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.91  E-value=4.5e-24  Score=194.67  Aligned_cols=170  Identities=17%  Similarity=0.266  Sum_probs=130.5

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      +..+.||+|+||.||+|....++..||+|.++....        ....|++.+++++||||+++++++..+  ...+++|
T Consensus       693 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~~--~~~~lv~  762 (968)
T PLN00113        693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRSE--KGAYLIH  762 (968)
T ss_pred             CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEcC--CCCEEEE
Confidence            455789999999999999988999999998763221        112468889999999999999999654  4577899


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc-
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH-EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI-  185 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~-~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~-  185 (219)
                      ||+++|+|.+++.   .+++..+..++.|++.|+.|||.. .+.++|||+||+||+++.+ ...++. |+......... 
T Consensus       763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~~~~  837 (968)
T PLN00113        763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCTDTK  837 (968)
T ss_pred             eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-eccccccccCCC
Confidence            9999999999886   378899999999999999999944 2339999999999999855 355554 55543332211 


Q ss_pred             -eeeeecccCccccCCCccccccceeeec
Q 027788          186 -RRIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 -~~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                       ..+..|.+|| ......++.++||||+|
T Consensus       838 ~~~t~~y~aPE-~~~~~~~~~~sDv~S~G  865 (968)
T PLN00113        838 CFISSAYVAPE-TRETKDITEKSDIYGFG  865 (968)
T ss_pred             ccccccccCcc-cccCCCCCcccchhhHH
Confidence             1223445554 44556688899999999

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.1e-24  Score=180.96  Aligned_cols=174  Identities=19%  Similarity=0.309  Sum_probs=140.7

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      |.+...+|.|+|+.+-.+.+..++...++|++..+...        ..+|+.++.+. +|||++++.+++  .+...+|+
T Consensus       324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~--------~~~e~~~~~~~~~h~niv~~~~v~--~~~~~~~~  393 (612)
T KOG0603|consen  324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD--------NQDEIPISLLVRDHPNIVKSHDVY--EDGKEIYL  393 (612)
T ss_pred             hccccccCCCCccceeeeeccccccchhheeccccccc--------cccccchhhhhcCCCcceeeccee--cCCceeee
Confidence            36777899999999999999999999999999866321        12477665544 799999999999  56677899


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      |||.+.++.+.+.+...+.+. ..+..|+.+++.++.|||.++  ++||||||+|||++.+.++++|+|||.++......
T Consensus       394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~  470 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC  470 (612)
T ss_pred             eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchhh
Confidence            999999888887776655455 777789999999999999999  99999999999995355789999999999887763


Q ss_pred             e---eeeecccCccccCCCccccccceeeecc
Q 027788          186 R---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       186 ~---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .   -+..+.+|+ .....+|+..+|+||||+
T Consensus       471 ~tp~~t~~y~APE-vl~~~~yt~acD~WSLGv  501 (612)
T KOG0603|consen  471 DTPALTLQYVAPE-VLAIQEYTEACDWWSLGV  501 (612)
T ss_pred             cccchhhcccChh-hhccCCCCcchhhHHHHH
Confidence            2   233344554 444888999999999994

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=7.4e-25  Score=170.43  Aligned_cols=184  Identities=22%  Similarity=0.298  Sum_probs=155.6

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceEE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      -+++.+.||+|+|.+|..++.+++.+.+|+|++++..+.++ ....-...|-.++.+. +||.++-++.+|+.+.  .++
T Consensus       251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndd-edidwvqtek~vfe~asn~pflvglhscfqtes--rlf  327 (593)
T KOG0695|consen  251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES--RLF  327 (593)
T ss_pred             cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCc-ccchhHHhhHHHHHhccCCCeEEehhhhhcccc--eEE
Confidence            34777899999999999999999999999999997776543 3345667788888655 6899999998886654  477


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      +|.||.+||+|.-.++.+++++++.++.+...|+.+|.|||+.+  |++||||.+|++++.+ |.+|+.|+|+++.--.+
T Consensus       328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldae-ghikltdygmcke~l~~  404 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccC-CceeecccchhhcCCCC
Confidence            89999999999988888899999999999999999999999999  9999999999999977 69999999999876544


Q ss_pred             ce-eeeecccCc----cccCCCccccccceeeeccc
Q 027788          185 IR-RIRCWGRRS----SWRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       185 ~~-~~~~~~~~~----~~~~~~~~~~~~diws~gi~  215 (219)
                      .. ..+.+|+|-    +..+..+|..+.|-|+||++
T Consensus       405 gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvl  440 (593)
T KOG0695|consen  405 GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVL  440 (593)
T ss_pred             CcccccccCCCcccchhhhcccccCceehHHHHHHH
Confidence            43 334466654    56788999999999999943

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=5.2e-24  Score=177.02  Aligned_cols=148  Identities=16%  Similarity=0.293  Sum_probs=131.9

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      ...+-||-|+||.|-++....+...+|+|-+.+..+. .-.++.+.+.|..+|...+++=+++++..|  ++++.+|+||
T Consensus       632 vkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl-~rnQvaHVKAERDILAEADn~WVVrLyySF--QDkdnLYFVM  708 (1034)
T KOG0608|consen  632 VKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVL-MRNQVAHVKAERDILAEADNEWVVRLYYSF--QDKDNLYFVM  708 (1034)
T ss_pred             EEEeeecccccceeEEEeecchhhHHHHhhhHHHHHH-hhhhhhhhhhhhhhHhhcCCcceEEEEEEe--ccCCceEEEE
Confidence            3448899999999999998899999999988755433 234668899999999999999999999999  4556799999


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      +|++||++.+++-..+-|.+...++++..+..|+++.|..+  ++||||||+|||||.+ |.+||.|||||..+
T Consensus       709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrd-GHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRD-GHIKLTDFGLCTGF  779 (1034)
T ss_pred             eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccC-Cceeeeeccccccc
Confidence            99999999999888889999999999999999999999999  9999999999999966 79999999999765

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=3.4e-23  Score=154.81  Aligned_cols=146  Identities=19%  Similarity=0.196  Sum_probs=110.1

Q ss_pred             eeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCH--H--------------------HHHHHHHHHHHHHhhCCCC
Q 027788           30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDP--A--------------------MIERLFSEVRLLKTLANKN   87 (219)
Q Consensus        30 ~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~--~--------------------~~~~~~~E~~~l~~l~~~~   87 (219)
                      ...||+|++|.||+|.+. +|+.||+|+++........  .                    .......|+.++.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999986 8999999999764321110  0                    0122345999999998777


Q ss_pred             ceEEEEEEecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeeeeCCCCCceEEeCC
Q 027788           88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL-HTHEPCVIHRDLNCSNVFVNGN  166 (219)
Q Consensus        88 i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~l-h~~~~~i~h~dl~~~nili~~~  166 (219)
                      +........ .+   .+++|||++++++.........++...+..++.|++.++.++ |+.+  ++||||||+||+++ +
T Consensus        81 v~~p~~~~~-~~---~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-~  153 (190)
T cd05147          81 IPCPEPILL-KS---HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCCcEEEe-cC---CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE-C
Confidence            643322221 22   268999998877765433345789999999999999999999 6889  99999999999998 3


Q ss_pred             CCcEEEeccccceecccc
Q 027788          167 TGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       167 ~~~~~l~dfg~a~~~~~~  184 (219)
                       +.++|+|||+|.....+
T Consensus       154 -~~v~LiDFG~a~~~~~~  170 (190)
T cd05147         154 -GKLYIIDVSQSVEHDHP  170 (190)
T ss_pred             -CcEEEEEccccccCCCc
Confidence             47999999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.90  E-value=4e-23  Score=174.12  Aligned_cols=155  Identities=19%  Similarity=0.249  Sum_probs=111.7

Q ss_pred             eeeeeeeeccccceEEEEEEec----------------CCCcEEEEEEeeecccCCCHH----------HHHHHHHHHHH
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQ----------------EEGIEVAWNQVKLRTFCDDPA----------MIERLFSEVRL   79 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~----------------~~~~~vavK~~~~~~~~~~~~----------~~~~~~~E~~~   79 (219)
                      .|.+.++||+|+||.||+|...                ..++.||||.++.........          ..+....|+..
T Consensus       146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~  225 (507)
T PLN03224        146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM  225 (507)
T ss_pred             CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence            4488899999999999999742                345679999987532110000          11223346666


Q ss_pred             HHhhCCCCc-----eEEEEEEecC------CCceEEEEeccccCCChHHHHHhCC------------------------C
Q 027788           80 LKTLANKNI-----ISLHYVWRDE------DRNTLNFITEVCTSGNLREYRKKHR------------------------H  124 (219)
Q Consensus        80 l~~l~~~~i-----~~~~~~~~~~------~~~~~~lv~e~~~~g~L~~~~~~~~------------------------~  124 (219)
                      +.+++|.++     +++.++|...      .....++|+||+++++|.+++....                        .
T Consensus       226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~  305 (507)
T PLN03224        226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK  305 (507)
T ss_pred             HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence            677766543     4555555321      2245789999999999998875321                        2


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          125 VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       125 ~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      .++..+..++.|++.++.|+|..+  ++||||||+||+++.+ +.++|+|||++.....
T Consensus       306 ~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~  361 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCT  361 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCC-CcEEEEeCcCcccccc
Confidence            345678889999999999999999  9999999999999866 5899999999976543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=5e-23  Score=156.34  Aligned_cols=170  Identities=12%  Similarity=0.088  Sum_probs=128.1

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHH------HHHHHHHHHhhCCCCceEEEEEEe
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER------LFSEVRLLKTLANKNIISLHYVWR   96 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~------~~~E~~~l~~l~~~~i~~~~~~~~   96 (219)
                      .++| +..+.+|.|+||.||.+..  ++..+++|++..... ..+...+.      +.+|+..+.+++|+++..+.+++.
T Consensus        30 ~~~y-~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~-~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         30 SYNI-KTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVK-RTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             hCce-EEEEEecCCCceEEEEEec--CCCcEEEEEechhcC-chHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            3555 8999999999999999754  466899999875443 33444444      568999999999999999887765


Q ss_pred             cCC------CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcE
Q 027788           97 DED------RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQV  170 (219)
Q Consensus        97 ~~~------~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~  170 (219)
                      ...      ....+++|||++|.+|.+...    .++    ....+++.++..+|+.+  ++|+|++|.|++++++ + +
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~~~-g-i  173 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNFIVSKN-G-L  173 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHEEEeCC-C-E
Confidence            332      134678999999989977632    233    24568899999999999  9999999999999865 5 9


Q ss_pred             EEeccccceeccccceeeeecccCccccCCCccccccceeeeccc
Q 027788          171 KIGDLGVAAIVGRAIRRIRCWGRRSSWRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       171 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~diws~gi~  215 (219)
                      +++|||...........       ..+...+.|..++|+||||++
T Consensus       174 ~liDfg~~~~~~e~~a~-------d~~vler~y~~~~di~~lg~~  211 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK-------DRIDLERHYGIKNEIKDLGYY  211 (232)
T ss_pred             EEEECCCcccccchhhH-------HHHHHHhHhcccccccceeEe
Confidence            99999988765433211       124445556678999999954

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.90  E-value=2e-22  Score=151.54  Aligned_cols=175  Identities=29%  Similarity=0.514  Sum_probs=139.5

Q ss_pred             eccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccccC
Q 027788           33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTS  112 (219)
Q Consensus        33 ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~  112 (219)
                      ||+|.+|.||++....++..+++|.+......   ...+.+.+|+..++.++|++++++++.+...  ...++++|++++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS---SLLEELLREIEILKKLNHPNIVKLYGVFEDE--NHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccch---hHHHHHHHHHHHHHhcCCCCeeeEeeeeecC--CeEEEEEecCCC
Confidence            68999999999999888999999998855321   1357788999999999999999999988543  567889999998


Q ss_pred             CChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce-----
Q 027788          113 GNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR-----  186 (219)
Q Consensus       113 g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~-----  186 (219)
                      ++|.+++... ..++...+..++.+++.++.+||..+  ++|+||+|.||+++...+.++++|||.+........     
T Consensus        76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (215)
T cd00180          76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI  153 (215)
T ss_pred             CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence            9999988765 46899999999999999999999999  999999999999986235899999999987755421     


Q ss_pred             -eeeecccCccccCCCccccccceeeecc
Q 027788          187 -RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 -~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                       ....+..|+........+.+.|+|++|+
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~  182 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGV  182 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHH
Confidence             1111222222222226667799999993

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=1.8e-22  Score=151.12  Aligned_cols=146  Identities=20%  Similarity=0.219  Sum_probs=111.8

Q ss_pred             eeeeccccceEEEEEEecCCCcEEEEEEeeecccCCC--------------------HH-H-HHHHHHHHHHHHhhCCCC
Q 027788           30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD--------------------PA-M-IERLFSEVRLLKTLANKN   87 (219)
Q Consensus        30 ~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~--------------------~~-~-~~~~~~E~~~l~~l~~~~   87 (219)
                      ...||+|++|.||+|.+. +|+.||+|+++.......                    .. . ...+..|...+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999976 899999999886521100                    00 0 123457899999999988


Q ss_pred             ceEEEEEEecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeCCCCCceEEeCC
Q 027788           88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT-HEPCVIHRDLNCSNVFVNGN  166 (219)
Q Consensus        88 i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~-~~~~i~h~dl~~~nili~~~  166 (219)
                      +.........+    .+++|||++++++.........++......++.|++.++.++|. .+  ++|+||||+||+++ +
T Consensus        81 i~~p~~~~~~~----~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-~  153 (190)
T cd05145          81 VPVPEPILLKK----NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCCceEEEecC----CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE-C
Confidence            75443333222    26899999877554332233467888999999999999999999 89  99999999999998 4


Q ss_pred             CCcEEEeccccceecccc
Q 027788          167 TGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       167 ~~~~~l~dfg~a~~~~~~  184 (219)
                       +.++|+|||++.....+
T Consensus       154 -~~~~liDFG~a~~~~~~  170 (190)
T cd05145         154 -GKPYIIDVSQAVELDHP  170 (190)
T ss_pred             -CCEEEEEcccceecCCC
Confidence             58999999999887664

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.90  E-value=4.7e-23  Score=158.59  Aligned_cols=168  Identities=29%  Similarity=0.457  Sum_probs=136.8

Q ss_pred             cceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccccCCChH
Q 027788           37 AVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLR  116 (219)
Q Consensus        37 ~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~g~L~  116 (219)
                      +||.||+|....++..+++|.+......   ...+.+..|+..+++++|+|++++.+.+...  ...++++|++++++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheeeC--CEEEEEEeCCCCCCHH
Confidence            5899999999888999999998755421   1157888999999999999999999888543  5678899999988999


Q ss_pred             HHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce-----eeeec
Q 027788          117 EYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR-----RIRCW  191 (219)
Q Consensus       117 ~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~-----~~~~~  191 (219)
                      .++.....++...+..++.+++.++.+||..+  ++|+||+|+|++++.+ +.++++|||.+........     ....+
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  152 (244)
T smart00220       76 DLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEY  152 (244)
T ss_pred             HHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCC
Confidence            98877656899999999999999999999999  9999999999999866 6899999999988766421     11122


Q ss_pred             ccCccccCCCccccccceeeec
Q 027788          192 GRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       192 ~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .. ++......++.++|+||+|
T Consensus       153 ~~-pE~~~~~~~~~~~Di~slG  173 (244)
T smart00220      153 MA-PEVLLGKGYGKAVDVWSLG  173 (244)
T ss_pred             CC-HHHHccCCCCchhhHHHHH
Confidence            22 2333355567789999999

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=1.6e-22  Score=150.80  Aligned_cols=154  Identities=19%  Similarity=0.318  Sum_probs=123.8

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCC-CceEEEEEEecCCC
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK-NIISLHYVWRDEDR  100 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~-~i~~~~~~~~~~~~  100 (219)
                      ..++| ++.++||+|+||-+|.|....+|++||+|+-......      -.+..|..++..|++. .|..+..+.  .+.
T Consensus        13 v~gky-~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h------pqL~yEskvY~iL~~g~GiP~i~~y~--~e~   83 (341)
T KOG1163|consen   13 VGGKY-KLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH------PQLLYESKVYRILQGGVGIPHIRHYG--TEK   83 (341)
T ss_pred             eccce-EEEEeecCCchhheeeeeeccCCceEEEEeecccCCC------cchhHHHHHHHHhccCCCCchhhhhc--ccc
Confidence            34555 8899999999999999999999999999986644332      2356799999999874 444444444  334


Q ss_pred             ceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC--CcEEEecccc
Q 027788          101 NTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDLGV  177 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~--~~~~l~dfg~  177 (219)
                      ++-.+||+.+ |.+|.++++-+ ..++..+++.++.|++..++|+|.++  ++||||||+|+++.-+.  .++.++|||+
T Consensus        84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGL  160 (341)
T KOG1163|consen   84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGL  160 (341)
T ss_pred             ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccc
Confidence            5566799998 78999998754 57999999999999999999999999  99999999999986332  3688999999


Q ss_pred             ceecccccee
Q 027788          178 AAIVGRAIRR  187 (219)
Q Consensus       178 a~~~~~~~~~  187 (219)
                      |+.+.+..+.
T Consensus       161 aKky~d~~t~  170 (341)
T KOG1163|consen  161 AKKYRDIRTR  170 (341)
T ss_pred             hhhhcccccc
Confidence            9998776543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=2.3e-21  Score=150.59  Aligned_cols=181  Identities=19%  Similarity=0.233  Sum_probs=137.7

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCC
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDR  100 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~  100 (219)
                      .+|-.|+++++||+|+||.++.|.+.-+++.||||.-..++..  +    .++-|...++.|. .++|...+.+.+ ++.
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--P----QLrdEYr~YKlL~g~~GIP~vYYFGq-eG~   97 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--P----QLRDEYRTYKLLGGTEGIPQVYYFGQ-EGK   97 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccCCc--c----hHHHHHHHHHHHcCCCCCCceeeecc-ccc
Confidence            5677779999999999999999999999999999986655432  2    2455777777775 578877765443 333


Q ss_pred             ceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEe----CCCCcEEEecc
Q 027788          101 NTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN----GNTGQVKIGDL  175 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~----~~~~~~~l~df  175 (219)
                       +-.+|+|.+ |.+|.+++..+ +.|+..+++.++.|++.-++++|++.  +++|||||+|+||.    ++...+.++||
T Consensus        98 -~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDF  173 (449)
T KOG1165|consen   98 -YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDF  173 (449)
T ss_pred             -hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEec
Confidence             334688988 78999998765 57999999999999999999999999  99999999999995    22235789999


Q ss_pred             ccceeccccceeeeecccCc-------cc-----cCCCccccccceeeec
Q 027788          176 GVAAIVGRAIRRIRCWGRRS-------SW-----RRSCTMRITRSLWTYT  213 (219)
Q Consensus       176 g~a~~~~~~~~~~~~~~~~~-------~~-----~~~~~~~~~~diws~g  213 (219)
                      |+|+.+.++.++.....+.-       .+     -..++-+..-|+=|||
T Consensus       174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLG  223 (449)
T KOG1165|consen  174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALG  223 (449)
T ss_pred             cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhh
Confidence            99999998886443322210       11     1245555556777777

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.87  E-value=7.8e-22  Score=160.83  Aligned_cols=176  Identities=25%  Similarity=0.334  Sum_probs=140.7

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCC------CCceEEEEEEecCCC
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN------KNIISLHYVWRDEDR  100 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~------~~i~~~~~~~~~~~~  100 (219)
                      |.+....|+|-|+.|-+|.+...|..||||+|...     .-+.+.=+.|+++|++|+.      -||++++..|  ...
T Consensus       434 Y~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-----E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F--~hk  506 (752)
T KOG0670|consen  434 YEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-----EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF--KHK  506 (752)
T ss_pred             eEEEeccccceeeeeeeccccCCCCeeEEEEeecc-----hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh--hhc
Confidence            36667899999999999999999999999999854     3445666789999999974      4788887777  445


Q ss_pred             ceEEEEeccccCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788          101 NTLNFITEVCTSGNLREYRKKHR---HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                      +.+|||.|.+ ..+|...+...+   .+....+..++.|+..||..|..++  ++|.||||+|||++.....+||+|||.
T Consensus       507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccCcc
Confidence            7799999998 478988887654   3677888899999999999999999  999999999999997666679999999


Q ss_pred             ceeccccce----eeeecccCccccCCCccccccceeeec
Q 027788          178 AAIVGRAIR----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       178 a~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |........    -...+.+| +...+-+|+.+-|+||.|
T Consensus       584 A~~~~eneitPYLVSRFYRaP-EIiLG~~yd~~iD~WSvg  622 (752)
T KOG0670|consen  584 ASFASENEITPYLVSRFYRAP-EIILGLPYDYPIDTWSVG  622 (752)
T ss_pred             ccccccccccHHHHHHhccCc-ceeecCcccCCccceeec
Confidence            987655432    11223333 344455577788999998

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.87  E-value=1.3e-22  Score=156.52  Aligned_cols=183  Identities=27%  Similarity=0.351  Sum_probs=145.0

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      +....||..+ +.+|.|.- .|-.|.+.-.++.||+|..-.+..  .....++..+|..++..++|+|+++++.+|.-..
T Consensus        13 ftv~~Ry~nL-~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~--n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~   88 (369)
T KOG0665|consen   13 FTVPKRYVNL-KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ--NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK   88 (369)
T ss_pred             eeeeeeeeee-cccCCCCc-eEEecchhhccCceehhhhcCccc--cCccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence            3445677666 78998888 888899999999999998765532  2334477889999999999999999999885322


Q ss_pred             ----CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788          100 ----RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus       100 ----~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                          ...+|++||++. .+|...+..  .++-.++..++.|++.|+.+||+.+  |+||||||+||+++.+ ..+||.||
T Consensus        89 ~l~~~~e~y~v~e~m~-~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~-~~lKi~df  162 (369)
T KOG0665|consen   89 TLEEFQEVYLVMELMD-ANLCQVILM--ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSD-CTLKILDF  162 (369)
T ss_pred             cHHHHHhHHHHHHhhh-hHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecch-hheeeccc
Confidence                124678999995 688877663  4778899999999999999999999  9999999999999877 48999999


Q ss_pred             ccceeccccce-----eeeecccCccccCCCccccccceeeec
Q 027788          176 GVAAIVGRAIR-----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       176 g~a~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |+|+.-.....     -++.+++|+-.+... |....||||.|
T Consensus       163 g~ar~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvG  204 (369)
T KOG0665|consen  163 GLARTEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVG  204 (369)
T ss_pred             hhhcccCcccccCchhheeeccCchheeccC-Ccccchhhhhh
Confidence            99987666522     344555555544444 88889999999

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=2.4e-20  Score=140.99  Aligned_cols=138  Identities=18%  Similarity=0.210  Sum_probs=105.8

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-----CCCCceEEEEEEecCCC-ce-E
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-----ANKNIISLHYVWRDEDR-NT-L  103 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~~~~i~~~~~~~~~~~~-~~-~  103 (219)
                      +.||+|+|+.||.  ++.++.. +||++....    ....+.+.+|+.+++.+     +||||+++++++.++.+ .. +
T Consensus         8 ~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~----~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          8 SPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG----DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             ceecCCCceEEEE--CCCCcCe-EEEEEeccc----cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            6899999999995  6666655 688876532    22346789999999999     57999999999966532 33 3


Q ss_pred             EEEecc--ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCeeeeCCCCCceEEeCC---CCcEEEec-cc
Q 027788          104 NFITEV--CTSGNLREYRKKHRHVSVKALKKWSKQILKGL-NYLHTHEPCVIHRDLNCSNVFVNGN---TGQVKIGD-LG  176 (219)
Q Consensus       104 ~lv~e~--~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l-~~lh~~~~~i~h~dl~~~nili~~~---~~~~~l~d-fg  176 (219)
                      .+++||  +++++|.++++.. .+.+.  ..++.|++.++ .|||+++  |+||||||+||+++..   ...++|+| ||
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            478999  5578999999754 45555  35677888777 9999999  9999999999999732   23699999 55


Q ss_pred             ccee
Q 027788          177 VAAI  180 (219)
Q Consensus       177 ~a~~  180 (219)
                      .+..
T Consensus       156 ~~~~  159 (210)
T PRK10345        156 ESTF  159 (210)
T ss_pred             Ccce
Confidence            5544

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=1.3e-20  Score=152.26  Aligned_cols=180  Identities=21%  Similarity=0.172  Sum_probs=134.2

Q ss_pred             eeeeeeeeccccceEEEEEEecCCC-cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCC----CCceEEEEEEecCCC
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEG-IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN----KNIISLHYVWRDEDR  100 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~----~~i~~~~~~~~~~~~  100 (219)
                      .|++.++||+|+||.||.+.+..++ ..+|+|..........    ..+..|..++..++.    +++..+.+... ...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC----ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCC
Confidence            4589999999999999999987774 6789998765422111    146679999988873    58888887774 334


Q ss_pred             ceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC----CcEEEec
Q 027788          101 NTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT----GQVKIGD  174 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~----~~~~l~d  174 (219)
                      .+-++||+.+ |.+|.++....  +.++..+...++.|++.+|.++|+.+  ++||||||+|+.+....    ..+++.|
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEe
Confidence            5667899988 68999987543  57999999999999999999999999  99999999999997442    3589999


Q ss_pred             cccce--ecccccee---------eeeccc----CccccCCCccccccceeeec
Q 027788          175 LGVAA--IVGRAIRR---------IRCWGR----RSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       175 fg~a~--~~~~~~~~---------~~~~~~----~~~~~~~~~~~~~~diws~g  213 (219)
                      ||+++  .+......         ....|+    +.......+.+...|+||++
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~  224 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLF  224 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHH
Confidence            99999  43222111         011121    22234566677789999977

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.85  E-value=8.7e-21  Score=161.77  Aligned_cols=173  Identities=23%  Similarity=0.318  Sum_probs=127.9

Q ss_pred             eeeeeeeeccccce-EEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceE
Q 027788           26 YGRYNELLGSGAVK-KVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        26 ~~~~~~~ig~g~~g-~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+.-.+.+|.|+-| .||+|.+.  ++.||||.+-..       ......+|+.+|+.- +||||+++++.-  .+..++
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e-------~~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~  578 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE-------FFDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFL  578 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH-------hHHHHHHHHHHHHhccCCCceEEEEeec--cCCceE
Confidence            33344568899885 57899874  679999976533       234567899999866 599999987655  667789


Q ss_pred             EEEeccccCCChHHHHHhCC-C---CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC---C-CcEEEecc
Q 027788          104 NFITEVCTSGNLREYRKKHR-H---VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN---T-GQVKIGDL  175 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~-~---~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~---~-~~~~l~df  175 (219)
                      |+..|.|. -+|.+++.... .   ...-..+.++.|++.|++.||+.+  |+||||||.||||+..   . .+++|+||
T Consensus       579 YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDf  655 (903)
T KOG1027|consen  579 YIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDF  655 (903)
T ss_pred             EEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccc
Confidence            99999996 59999987641 1   111345678899999999999999  9999999999999852   2 36799999


Q ss_pred             ccceeccccce---------eeeecccCccccCCCccccccceeeec
Q 027788          176 GVAAIVGRAIR---------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       176 g~a~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |+++++..+..         ++.-|.+|+-....+. ..+.||+|+|
T Consensus       656 glsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslG  701 (903)
T KOG1027|consen  656 GLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLG  701 (903)
T ss_pred             ccccccCCCcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcC
Confidence            99999977654         2333445544333333 3368999999

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=9.4e-20  Score=140.65  Aligned_cols=154  Identities=19%  Similarity=0.182  Sum_probs=116.3

Q ss_pred             CCceeeeeeeeccccceEEEEEE-ecCCCcEEEEEEeeecccCC------------------CHH--HHHHHHHHHHHHH
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAF-DQEEGIEVAWNQVKLRTFCD------------------DPA--MIERLFSEVRLLK   81 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~-~~~~~~~vavK~~~~~~~~~------------------~~~--~~~~~~~E~~~l~   81 (219)
                      .|+.+.+.+.||+|++|.||+|+ +..+|+.||+|.++......                  .+.  ....+..|+.+++
T Consensus        26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~  105 (237)
T smart00090       26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ  105 (237)
T ss_pred             cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            46567899999999999999998 77889999999987543210                  010  1133568999999


Q ss_pred             hhCCC--CceEEEEEEecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCC
Q 027788           82 TLANK--NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCS  159 (219)
Q Consensus        82 ~l~~~--~i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~  159 (219)
                      ++.+.  .+.+++..   ..   .+++||++++.++.................++.|++.++.+||..+. ++|+||||+
T Consensus       106 ~L~~~~i~~p~~~~~---~~---~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~-iiH~Dikp~  178 (237)
T smart00090      106 RLYEAGVPVPKPIAW---RR---NVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGE-LVHGDLSEY  178 (237)
T ss_pred             HHHhcCCCCCeeeEe---cC---ceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCC-EEeCCCChh
Confidence            99753  33444432   22   36899999987876654333456666778899999999999998763 899999999


Q ss_pred             ceEEeCCCCcEEEeccccceeccccc
Q 027788          160 NVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       160 nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ||+++ + +.++++|||.+.....+.
T Consensus       179 NIli~-~-~~i~LiDFg~a~~~~~~~  202 (237)
T smart00090      179 NILVH-D-GKVVIIDVSQSVELDHPM  202 (237)
T ss_pred             hEEEE-C-CCEEEEEChhhhccCCcc
Confidence            99998 4 579999999998766655

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=3.7e-19  Score=144.19  Aligned_cols=141  Identities=28%  Similarity=0.397  Sum_probs=114.6

Q ss_pred             CccccC-CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCC--------C
Q 027788           16 PFIETD-PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN--------K   86 (219)
Q Consensus        16 ~~~~~~-~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~--------~   86 (219)
                      ++..+| ..+..|.+.++||.|.|++||+|++....+.||+|+.+.     .....+...-||.+|+++..        .
T Consensus        68 pV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-----AqhYtEaAlDEIklL~~v~~~Dp~~~~~~  142 (590)
T KOG1290|consen   68 PVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-----AQHYTEAALDEIKLLQQVREGDPNDPGKK  142 (590)
T ss_pred             eeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-----hhHHHHHHHHHHHHHHHHHhcCCCCCCCc
Confidence            455555 443455888999999999999999999999999999873     23333556779999998842        4


Q ss_pred             CceEEEEEEec--CCCceEEEEeccccCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeCCCCCce
Q 027788           87 NIISLHYVWRD--EDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTH-EPCVIHRDLNCSNV  161 (219)
Q Consensus        87 ~i~~~~~~~~~--~~~~~~~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qv~~~l~~lh~~-~~~i~h~dl~~~ni  161 (219)
                      +|+++++.|..  .++..+++|.|++ |.+|-.+|..  .+.++...+..|++||+.||.|||+. +  |+|-||||+||
T Consensus       143 ~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENv  219 (590)
T KOG1290|consen  143 CVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENV  219 (590)
T ss_pred             eeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCccee
Confidence            78999998854  4556889999999 5677777754  35799999999999999999999964 7  99999999999


Q ss_pred             EEe
Q 027788          162 FVN  164 (219)
Q Consensus       162 li~  164 (219)
                      |+.
T Consensus       220 Ll~  222 (590)
T KOG1290|consen  220 LLC  222 (590)
T ss_pred             eee
Confidence            985

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.81  E-value=2.2e-20  Score=147.97  Aligned_cols=184  Identities=22%  Similarity=0.277  Sum_probs=144.0

Q ss_pred             eeeeeeeccccceEEEEEEec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           27 GRYNELLGSGAVKKVYRAFDQ-----EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      .++..++.+|.||+||.|...     .+.+.|-+|-++...   .+-++..++.|.-.+..+.|||+..+.+++.. +..
T Consensus       286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A---S~iQv~~~L~es~lly~~sH~nll~V~~V~ie-~~~  361 (563)
T KOG1024|consen  286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA---SQIQVNLLLQESMLLYGASHPNLLSVLGVSIE-DYA  361 (563)
T ss_pred             eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc---cHHHHHHHHHHHHHHhcCcCCCccceeEEEee-ccC
Confidence            466667899999999999432     234556667665443   56678889999999999999999999988875 345


Q ss_pred             eEEEEeccccCCChHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEe
Q 027788          102 TLNFITEVCTSGNLREYRKKH--------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIG  173 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~--------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~  173 (219)
                      ..++++.+..-|+|..++.-.        +.++..+...++.|++.|+.+||.++  ++|.||..+|++|+ +..++||+
T Consensus       362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId-d~LqVklt  438 (563)
T KOG1024|consen  362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID-DQLQVKLT  438 (563)
T ss_pred             cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh-hheeEEec
Confidence            566788999889999998722        23566678888999999999999999  99999999999998 44689999


Q ss_pred             ccccceeccccce--eeeecccCccccC-----CCccccccceeeec--cccc
Q 027788          174 DLGVAAIVGRAIR--RIRCWGRRSSWRR-----SCTMRITRSLWTYT--RLGC  217 (219)
Q Consensus       174 dfg~a~~~~~~~~--~~~~~~~~~~~~~-----~~~~~~~~diws~g--i~~~  217 (219)
                      |-.+++.+.+.+-  -.-...+|..|+.     +..|+..||+||||  .|.+
T Consensus       439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWEL  491 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWEL  491 (563)
T ss_pred             cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHH
Confidence            9999999876553  1123445666753     66788889999999  6653

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=3.7e-18  Score=129.76  Aligned_cols=141  Identities=19%  Similarity=0.258  Sum_probs=109.7

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCC----HHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD----PAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      +.||+|++|.||+|..  .+..+++|..........    ......+.+|+.++..+.++++.....++...+  ..+++
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv   77 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE--NFIIV   77 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC--CCEEE
Confidence            5789999999999986  677899997653322111    112245778999999999988876655554333  35679


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      |||++|++|.+++.....    ....++.+++.++.++|..+  ++|+|++|.||+++ + +.++++|||.+.....
T Consensus        78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~~~~  146 (211)
T PRK14879         78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-G-GKIYLIDFGLAEFSKD  146 (211)
T ss_pred             EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-C-CCEEEEECCcccCCCc
Confidence            999999999998765322    77888999999999999999  99999999999998 4 5799999999876443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=7.1e-18  Score=125.98  Aligned_cols=136  Identities=15%  Similarity=0.055  Sum_probs=103.0

Q ss_pred             eeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCC-CCceEEEEEEecCCCceEEEEe
Q 027788           29 YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN-KNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        29 ~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      ....|++|+||+||.+..  .+..++.+.+.........-....+.+|++++++|+| +++.+++++.      ..+++|
T Consensus         6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lvm   77 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLDR   77 (218)
T ss_pred             cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEEE
Confidence            457899999999998764  6677777766644332222223467899999999964 7788887752      257899


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCC-CCCceEEeCCCCcEEEeccccceecc
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDL-NCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl-~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +|+.|.+|......      . ...++.|++.++.++|+++  ++|+|| ||.||+++.+ +.++|+|||+|....
T Consensus        78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~  143 (218)
T PRK12274         78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQED-GSPAVIDFQLAVRGN  143 (218)
T ss_pred             eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCC-CCEEEEECCCceecC
Confidence            99998888653321      1 1346788999999999999  999999 7999999855 589999999998544

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=7.5e-18  Score=126.96  Aligned_cols=137  Identities=19%  Similarity=0.251  Sum_probs=103.9

Q ss_pred             eeccccceEEEEEEecCCCcEEEEEEeeecccCCCH----HHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDP----AMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        32 ~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .||+|++|.||+|.  .++..+++|...........    ....++.+|+.++..++++++......+..++  ..+++|
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~   76 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVM   76 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEE
Confidence            48999999999998  35788999986543322111    12366778999999998876544333333333  346799


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      |+++|++|.+++.....       .++.+++.++.++|+.+  ++|+|++|.|++++ + +.++++|||++.....
T Consensus        77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~-~~~~liDfg~a~~~~~  141 (199)
T TIGR03724        77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-D-DKLYLIDFGLGKYSDE  141 (199)
T ss_pred             EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-C-CcEEEEECCCCcCCCc
Confidence            99999999987654211       78899999999999999  99999999999998 4 5899999999877544

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=1.3e-17  Score=143.18  Aligned_cols=141  Identities=16%  Similarity=0.210  Sum_probs=107.6

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCC----CHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD----DPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ...+.||+|+||.||++.....  .+++|....+....    .....+++.+|+.+++.++|+++.....++..++.  .
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~--~  411 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE--K  411 (535)
T ss_pred             CccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC--C
Confidence            5678999999999999876433  34444432221111    11234678899999999999998877665544433  5


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++|||+++++|.+++.        ....++.+++.++.+||+.+  ++|||+||+||+++ + +.++++|||+++....
T Consensus       412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~-~-~~~~liDFGla~~~~~  479 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR-D-DRLYLIDFGLGKYSDL  479 (535)
T ss_pred             EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE-C-CcEEEEeCcccccCCc
Confidence            67999999999998765        34678899999999999999  99999999999995 4 4799999999987654


Q ss_pred             c
Q 027788          184 A  184 (219)
Q Consensus       184 ~  184 (219)
                      .
T Consensus       480 ~  480 (535)
T PRK09605        480 I  480 (535)
T ss_pred             h
Confidence            3

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.77  E-value=7e-19  Score=140.16  Aligned_cols=146  Identities=24%  Similarity=0.387  Sum_probs=124.1

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecC---CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEec
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQE---EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRD   97 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~   97 (219)
                      ...+.++.+++||+|.|+.||+|.+..   ..+.||+|.+....      ...++.+|++.+..+. +.||+++.+.+..
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~~rn  106 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGCFRN  106 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence            345667899999999999999999877   78899999877432      2367889999998885 7899999988844


Q ss_pred             CCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                      +  +...+++||++.....++..   .++...+..+++.++.||.++|.++  |+|||+||.|++.+...+.-.|.|||+
T Consensus       107 n--d~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  107 N--DQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             C--CeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechh
Confidence            4  45778999999888877765   4678889999999999999999999  999999999999997777778999999


Q ss_pred             cee
Q 027788          178 AAI  180 (219)
Q Consensus       178 a~~  180 (219)
                      |..
T Consensus       180 A~~  182 (418)
T KOG1167|consen  180 AQR  182 (418)
T ss_pred             HHH
Confidence            984

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.76  E-value=3.5e-17  Score=130.49  Aligned_cols=179  Identities=25%  Similarity=0.359  Sum_probs=139.8

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCC-CceEEEEEEecCCCceEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK-NIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~-~i~~~~~~~~~~~~~~~~l  105 (219)
                      +.+.+.||.|.|+.||.+.+.   ..+++|.+...... .......+.+|+.+++.+.|+ +++++.+.+...  ...++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~~   75 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLES-KSKEVERFLREIQILASLNHPPNIVKLYDFFQDE--GSLYL   75 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhcc-chhHHHHHHHHHHHHHHccCCcceeeEEEEEecC--CEEEE
Confidence            467789999999999999876   77899998865532 223467888999999999988 799999988433  34788


Q ss_pred             EeccccCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          106 ITEVCTSGNLREYRKKHR---HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +++++.++++.+++....   .+.......++.|++.++.++|..+  ++|||+||+|++++.....+++.|||.+....
T Consensus        76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            999999999997766554   6889999999999999999999999  99999999999998653258999999998665


Q ss_pred             ccce------------eeeecccCccccCC--Cccccccceeeec
Q 027788          183 RAIR------------RIRCWGRRSSWRRS--CTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~------------~~~~~~~~~~~~~~--~~~~~~~diws~g  213 (219)
                      ....            ++..+.+|+.....  ..+....|+||+|
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g  198 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLG  198 (384)
T ss_pred             CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHH
Confidence            4431            22222233333332  4666779999998

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=3e-18  Score=151.33  Aligned_cols=183  Identities=16%  Similarity=0.200  Sum_probs=132.2

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC---CCCceEEEEEE
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA---NKNIISLHYVW   95 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---~~~i~~~~~~~   95 (219)
                      .....+.-+.|.+.||+|+||.||+|...+ |+.||+|+-+......       |+.=..++.+|+   -+.|+.+....
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-------fYI~~q~~~RLk~~~~~~~~~~~~a~  763 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-------FYICLQVMERLKPQMLPSIMHISSAH  763 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-------eeehHHHHHhhchhhhcchHHHHHHH
Confidence            344456666899999999999999999876 9999999876544321       111122223333   12233333333


Q ss_pred             ecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEe------CCCCc
Q 027788           96 RDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN------GNTGQ  169 (219)
Q Consensus        96 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~------~~~~~  169 (219)
                      ...+.  =++++||.+.|+|.++++..+.+++..++.+..|++..+..||..+  |+|+||||+|+++.      .+..-
T Consensus       764 ~~~~~--S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  764 VFQNA--SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             ccCCc--ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccc
Confidence            22332  3569999999999999998888999999999999999999999999  99999999999984      12224


Q ss_pred             EEEeccccceeccccceeeee---cccCc----cccCCCccccccceeeec
Q 027788          170 VKIGDLGVAAIVGRAIRRIRC---WGRRS----SWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       170 ~~l~dfg~a~~~~~~~~~~~~---~~~~~----~~~~~~~~~~~~diws~g  213 (219)
                      ++|+|||.+..+..-..++..   |.+..    +...+++++...|.++++
T Consensus       840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlA  890 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLA  890 (974)
T ss_pred             eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHH
Confidence            899999999887544333222   22211    457788888899998887

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=1.2e-17  Score=125.77  Aligned_cols=144  Identities=19%  Similarity=0.162  Sum_probs=106.4

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCC-----H-------------HHHHHHHHHHHHHHhhCCC
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-----P-------------AMIERLFSEVRLLKTLANK   86 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-----~-------------~~~~~~~~E~~~l~~l~~~   86 (219)
                      ..+.+.+.||+|+||.||++.. .+|+.||+|++........     .             ........|+.++.++.++
T Consensus        15 ~~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   93 (198)
T cd05144          15 VVESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE   93 (198)
T ss_pred             chhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence            3457789999999999999986 4799999998765321000     0             0112356788889888877


Q ss_pred             C--ceEEEEEEecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEe
Q 027788           87 N--IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN  164 (219)
Q Consensus        87 ~--i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~  164 (219)
                      +  +.+.++.    .  ..+++|||+++++|......      .....++.+++.++.++|..+  ++|+||+|.|++++
T Consensus        94 ~i~v~~~~~~----~--~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~  159 (198)
T cd05144          94 GFPVPKPIDW----N--RHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVD  159 (198)
T ss_pred             CCCCCceeec----C--CceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEc
Confidence            4  3443332    1  24789999999888764321      345578889999999999999  99999999999998


Q ss_pred             CCCCcEEEeccccceecccc
Q 027788          165 GNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       165 ~~~~~~~l~dfg~a~~~~~~  184 (219)
                      .+ +.++|+|||.+......
T Consensus       160 ~~-~~~~liDfg~~~~~~~~  178 (198)
T cd05144         160 DD-EKIYIIDWPQMVSTDHP  178 (198)
T ss_pred             CC-CcEEEEECCccccCCCc
Confidence            65 58999999999766554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=9.8e-17  Score=119.64  Aligned_cols=141  Identities=21%  Similarity=0.211  Sum_probs=97.7

Q ss_pred             eeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHH---------------------HHHHHHHHHHhhCCCC-
Q 027788           30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE---------------------RLFSEVRLLKTLANKN-   87 (219)
Q Consensus        30 ~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~~~~-   87 (219)
                      .+.||+|+||.||.|.+. +++.||+|++........ ....                     ....|...+..+.+.. 
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFK-KRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchh-hhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            468999999999999876 889999999875322111 1101                     1135666666665443 


Q ss_pred             -ceEEEEEEecCCCceEEEEeccccCCChHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeCCCCCceEEe
Q 027788           88 -IISLHYVWRDEDRNTLNFITEVCTSGNLRE-YRKKHRHVSVKALKKWSKQILKGLNYLHT-HEPCVIHRDLNCSNVFVN  164 (219)
Q Consensus        88 -i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~-~~~~~~~~~~~~~~~i~~qv~~~l~~lh~-~~~~i~h~dl~~~nili~  164 (219)
                       +.+.+...      ..+++||+++++.+.. .+... .. ......++.+++.++.++|. .+  ++|+||+|+|++++
T Consensus        80 ~~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~  149 (187)
T cd05119          80 PVPKPIDLN------RHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD  149 (187)
T ss_pred             CCCceEecC------CCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE
Confidence             34444321      1478999998844321 11111 01 16678899999999999999 88  99999999999998


Q ss_pred             CCCCcEEEeccccceecccc
Q 027788          165 GNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       165 ~~~~~~~l~dfg~a~~~~~~  184 (219)
                       + +.++++|||.+.....+
T Consensus       150 -~-~~~~liDfg~a~~~~~~  167 (187)
T cd05119         150 -D-GKVYIIDVPQAVEIDHP  167 (187)
T ss_pred             -C-CcEEEEECcccccccCc
Confidence             4 58999999999766553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.66  E-value=1.1e-16  Score=125.28  Aligned_cols=193  Identities=16%  Similarity=0.201  Sum_probs=117.5

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCC----------CCceEE
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN----------KNIISL   91 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~----------~~i~~~   91 (219)
                      ...+....++.||.|+++.||.+++..+++.+|+|+..... .......+.+++|.-....+.+          -.++..
T Consensus         9 ~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P   87 (288)
T PF14531_consen    9 QRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP   87 (288)
T ss_dssp             --EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred             CCceEEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence            34556677788999999999999999999999999988766 3334456777777655544322          122222


Q ss_pred             EEEEecCCC----------c-----eEEEEeccccCCChHHHHH---hCCCC--C--HHHHHHHHHHHHHHHHHHHhCCC
Q 027788           92 HYVWRDEDR----------N-----TLNFITEVCTSGNLREYRK---KHRHV--S--VKALKKWSKQILKGLNYLHTHEP  149 (219)
Q Consensus        92 ~~~~~~~~~----------~-----~~~lv~e~~~~g~L~~~~~---~~~~~--~--~~~~~~i~~qv~~~l~~lh~~~~  149 (219)
                      ++....+++          .     ..+++|+.+. ++|.+++.   .....  .  ......+..|++..+++||..+ 
T Consensus        88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G-  165 (288)
T PF14531_consen   88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG-  165 (288)
T ss_dssp             SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             eEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc-
Confidence            222221111          1     2356777774 68877643   22122  1  2223445689999999999999 


Q ss_pred             CeeeeCCCCCceEEeCCCCcEEEeccccceecccccee-eee-cccCcccc--------CCCccccccceeeec--cccc
Q 027788          150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR-IRC-WGRRSSWR--------RSCTMRITRSLWTYT--RLGC  217 (219)
Q Consensus       150 ~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~-~~~-~~~~~~~~--------~~~~~~~~~diws~g--i~~~  217 (219)
                       ++|+||+|+|++++.+ |.++|.||+........... ... ..+|++..        ..-.++.+.|-|++|  |+.+
T Consensus       166 -lVHgdi~~~nfll~~~-G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  166 -LVHGDIKPENFLLDQD-GGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             -EEEST-SGGGEEE-TT-S-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             -eEecccceeeEEEcCC-CCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence             9999999999999976 68999999887766554431 111 22344322        123466678999999  5555


Q ss_pred             cC
Q 027788          218 AC  219 (219)
Q Consensus       218 ~c  219 (219)
                      -|
T Consensus       244 WC  245 (288)
T PF14531_consen  244 WC  245 (288)
T ss_dssp             HH
T ss_pred             HH
Confidence            44

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.66  E-value=4.7e-15  Score=114.74  Aligned_cols=143  Identities=15%  Similarity=0.158  Sum_probs=103.5

Q ss_pred             eeec-cccceEEEEEEecCCCcEEEEEEeeeccc-----C----CCHHHHHHHHHHHHHHHhhCCCCc--eEEEEEEecC
Q 027788           31 ELLG-SGAVKKVYRAFDQEEGIEVAWNQVKLRTF-----C----DDPAMIERLFSEVRLLKTLANKNI--ISLHYVWRDE   98 (219)
Q Consensus        31 ~~ig-~g~~g~V~~a~~~~~~~~vavK~~~~~~~-----~----~~~~~~~~~~~E~~~l~~l~~~~i--~~~~~~~~~~   98 (219)
                      ..|| .|+.|.||.+...  +..+++|.+.....     .    .+.....++.+|+.++..++++++  ++.++....+
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4576 7888888888653  67899998864211     0    011233567889999999998775  5666554322


Q ss_pred             CCc--eEEEEeccccC-CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788           99 DRN--TLNFITEVCTS-GNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus        99 ~~~--~~~lv~e~~~~-g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      ...  ..++++|++++ .+|.+++... .++...    +.+++.++.++|+.+  ++|+||||.||+++.+ +.++|+||
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~-~~v~LIDf  186 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-PLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLDPD-GKFWLIDF  186 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-CCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEcCC-CCEEEEEC
Confidence            221  12489999986 6888877543 455443    568899999999999  9999999999999865 47999999


Q ss_pred             ccceeccc
Q 027788          176 GVAAIVGR  183 (219)
Q Consensus       176 g~a~~~~~  183 (219)
                      |.+....+
T Consensus       187 g~~~~~~~  194 (239)
T PRK01723        187 DRGELRTP  194 (239)
T ss_pred             CCcccCCC
Confidence            99987653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=1.2e-16  Score=137.71  Aligned_cols=187  Identities=22%  Similarity=0.296  Sum_probs=136.7

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecc-cCCCHHHH-HHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRT-FCDDPAMI-ERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~-~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      ....|.+.+..+|.|++|.|+.+......+..+.|.+..+. ........ ..+..|..+-..+.|+|++.....++...
T Consensus       315 ~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~  394 (601)
T KOG0590|consen  315 FSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID  394 (601)
T ss_pred             cccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc
Confidence            34667788889999999999988877777767766554220 11122222 22666777788899999988766664433


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      .  ..-.||||++ +|..++.....+....+..++.|++.|+.|+|..+  +.|||+|++|+++..+ +.+||+|||.+.
T Consensus       395 ~--~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~-g~lki~Dfg~~~  468 (601)
T KOG0590|consen  395 G--ILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTEN-GILKIIDFGAAS  468 (601)
T ss_pred             c--chhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecC-CceEEeecCcce
Confidence            2  3335999998 99998877667888999999999999999999999  9999999999999966 589999999887


Q ss_pred             ecccccee-----eeecccC----ccccCCCccccc-cceeeecc
Q 027788          180 IVGRAIRR-----IRCWGRR----SSWRRSCTMRIT-RSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~~-----~~~~~~~----~~~~~~~~~~~~-~diws~gi  214 (219)
                      ...-+...     ....|+.    ++.+...+|++. .||||.||
T Consensus       469 vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~i  513 (601)
T KOG0590|consen  469 VFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGI  513 (601)
T ss_pred             eeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccc
Confidence            76444332     1122221    244555666555 99999993

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.64  E-value=7.8e-17  Score=144.41  Aligned_cols=108  Identities=11%  Similarity=0.121  Sum_probs=78.3

Q ss_pred             eEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC---------------
Q 027788          102 TLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG---------------  165 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~---------------  165 (219)
                      .++.++|++ +++|.+++.. ...+++..+..++.|++.||.|||+++  |+||||||+|||++.               
T Consensus        54 ~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~  130 (793)
T PLN00181         54 SIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVHNVRPSCFVMSSFNHVSFIESASCSDS  130 (793)
T ss_pred             hhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeeccCCchhEEEcccCcEEEeeccccCcc
Confidence            456678877 5699999865 346899999999999999999999999  999999999999953               


Q ss_pred             ---CCCcEEEeccccceeccccc----------------------eeeeecccCccccCCCccccccceeeec
Q 027788          166 ---NTGQVKIGDLGVAAIVGRAI----------------------RRIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       166 ---~~~~~~l~dfg~a~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                         ..+.+|++|||+++......                      .++..+.+| +......++.++||||+|
T Consensus       131 ~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP-E~~~~~~~~~~sDVwSlG  202 (793)
T PLN00181        131 GSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP-EEDNGSSSNCASDVYRLG  202 (793)
T ss_pred             cccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh-hhhccCCCCchhhhhhHH
Confidence               12356777787776432100                      011113333 333445578889999999

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=6.4e-15  Score=105.37  Aligned_cols=136  Identities=20%  Similarity=0.129  Sum_probs=105.6

Q ss_pred             eeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCC--CCceEEEEEEecCCCceEEEEe
Q 027788           30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN--KNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        30 ~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~--~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.||+|.++.||++....  ..+++|.......      ...+..|+..++.+++  .++.+++.....  ++..++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~   72 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLM   72 (155)
T ss_pred             ceecccccccceEEEEecC--CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEE
Confidence            4789999999999998643  6889998764321      3567889999999987  488888776643  35578899


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE-PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~-~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      |+++++.+..+       +......+..+++.++..+|... +.++|+|++|.|++++.. +.++++|||.+.....
T Consensus        73 e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~~~~~  141 (155)
T cd05120          73 EWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAGYGPP  141 (155)
T ss_pred             EecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEecccccCCCh
Confidence            99988777543       45566677889999999999742 239999999999999864 5899999999875443

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.57  E-value=3.5e-16  Score=130.68  Aligned_cols=175  Identities=18%  Similarity=0.241  Sum_probs=139.7

Q ss_pred             eccccceEEEEEE---ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCCceEEEEec
Q 027788           33 LGSGAVKKVYRAF---DQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITE  108 (219)
Q Consensus        33 ig~g~~g~V~~a~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~e  108 (219)
                      +|+|.||.|+.+.   ....+..+|+|+.+..........  +...|..++...+ ||.++++...++.+.+  ++++.+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~~k--l~l~ld   77 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTDGK--LYLILD   77 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeeccccc--hhHhhh
Confidence            6899999999653   345677899999887655433332  6677899999887 9999999988876665  666999


Q ss_pred             cccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccccee-
Q 027788          109 VCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR-  187 (219)
Q Consensus       109 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~-  187 (219)
                      +..+|.+...+.....+.+.........++.+++.+|..+  ++|+|+|++||+++.+ |.+++.|||+++........ 
T Consensus        78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~~~c  154 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKIAC  154 (612)
T ss_pred             hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeeccc-CccccCCchhhhHhHhhhhcc
Confidence            9999999988777778888888889999999999999999  9999999999999966 68999999999988766655 


Q ss_pred             -eeecccCccccCCCccccccceeeeccccc
Q 027788          188 -IRCWGRRSSWRRSCTMRITRSLWTYTRLGC  217 (219)
Q Consensus       188 -~~~~~~~~~~~~~~~~~~~~diws~gi~~~  217 (219)
                       +.-+.+|+...   +....+|-||+|+.++
T Consensus       155 gt~eymApEI~~---gh~~a~D~ws~gvl~f  182 (612)
T KOG0603|consen  155 GTYEYRAPEIIN---GHLSAADWWSFGVLAF  182 (612)
T ss_pred             cchhhhhhHhhh---ccCCcccchhhhhhHH
Confidence             34444444333   4556789999996653

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.56  E-value=3.1e-16  Score=119.52  Aligned_cols=182  Identities=14%  Similarity=0.229  Sum_probs=141.1

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+..+|.+...|.+|+|+...  -.+++|+++++..  .......|..|...++-+.||||+.+++.|..+  +.+.++.
T Consensus       193 nl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~--t~risrdfneefp~lrifshpnilpvlgacnsp--pnlv~is  266 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQG--NDIVAKILNVREV--TARISRDFNEEFPALRIFSHPNILPVLGACNSP--PNLVIIS  266 (448)
T ss_pred             hhhhhhccCCCcccccccccC--cchhhhhhhhhhc--chhhcchhhhhCcceeeecCCchhhhhhhccCC--CCceEee
Confidence            556788999999999998764  4688898887765  455567889999999999999999999999544  5678899


Q ss_pred             ccccCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEE--Eeccccceeccc
Q 027788          108 EVCTSGNLREYRKKHRH--VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVK--IGDLGVAAIVGR  183 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~--~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~--l~dfg~a~~~~~  183 (219)
                      .|+|.|+|...+.....  .+..+..+++..++.|+.|||+..+.+..--|+..+++++.+. +.+  .+|--++.. ..
T Consensus       267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfsfq-e~  344 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFSFQ-EV  344 (448)
T ss_pred             eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceeeee-cc
Confidence            99999999998875543  6778899999999999999999987777778999999998664 444  345444432 22


Q ss_pred             cceeeeecccCccccCCCc--cccccceeeec--cccc
Q 027788          184 AIRRIRCWGRRSSWRRSCT--MRITRSLWTYT--RLGC  217 (219)
Q Consensus       184 ~~~~~~~~~~~~~~~~~~~--~~~~~diws~g--i~~~  217 (219)
                      ......+|.+|+-..+.++  ....+|+|||+  +|.+
T Consensus       345 gr~y~pawmspealqrkped~n~raadmwsfaillwel  382 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWEL  382 (448)
T ss_pred             ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHh
Confidence            2346677888887666555  33459999999  6654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.51  E-value=7e-15  Score=129.58  Aligned_cols=180  Identities=18%  Similarity=0.185  Sum_probs=128.4

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ..+ .+.+.+|++.|=+|.+|.+. .| .|++|++-.+...-+-.....-..|+. ....++||++.+..+.  ......
T Consensus        23 ~e~-~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~--~t~kAA   96 (1431)
T KOG1240|consen   23 VEC-HYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL--VTDKAA   96 (1431)
T ss_pred             cce-eeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH--HhhHHH
Confidence            344 77789999999999999753 33 589999876543323333344444555 5677899999876553  333455


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      |++-+|.. .+|.+.++..+-+..-+..-++.|++.|+..+|..+  ++|||||.+|||+++- .++.|+||.--+.---
T Consensus        97 ylvRqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSW-NW~~LtDFAsFKPtYL  172 (1431)
T KOG1240|consen   97 YLVRQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSW-NWLYLTDFASFKPTYL  172 (1431)
T ss_pred             HHHHHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeee-chhhhhcccccCCccC
Confidence            66888884 699998876655667777789999999999999999  9999999999999855 5899999976554322


Q ss_pred             cc-------------eeeeecccCccccCCCc----------cccccceeeec
Q 027788          184 AI-------------RRIRCWGRRSSWRRSCT----------MRITRSLWTYT  213 (219)
Q Consensus       184 ~~-------------~~~~~~~~~~~~~~~~~----------~~~~~diws~g  213 (219)
                      ++             .+..++-+||.+....+          ..++=||+|+|
T Consensus       173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~G  225 (1431)
T KOG1240|consen  173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAG  225 (1431)
T ss_pred             CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhh
Confidence            22             15556778887655331          34445677776

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.47  E-value=2.5e-12  Score=95.92  Aligned_cols=145  Identities=17%  Similarity=0.117  Sum_probs=102.1

Q ss_pred             eeeeccccceEEEEEEecC------CCcEEEEEEeeecccC---------CC---------HHHHHHHH----HHHHHHH
Q 027788           30 NELLGSGAVKKVYRAFDQE------EGIEVAWNQVKLRTFC---------DD---------PAMIERLF----SEVRLLK   81 (219)
Q Consensus        30 ~~~ig~g~~g~V~~a~~~~------~~~~vavK~~~~~~~~---------~~---------~~~~~~~~----~E~~~l~   81 (219)
                      ...||.|--+.||.|....      .+..+|+|+.+.....         .+         ....+.+.    +|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999997543      3579999998753311         01         11123344    7999998


Q ss_pred             hhCC--CCceEEEEEEecCCCceEEEEeccccCCChHH-HHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCeeeeCCC
Q 027788           82 TLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLRE-YRKKHRHVSVKALKKWSKQILKGLNYL-HTHEPCVIHRDLN  157 (219)
Q Consensus        82 ~l~~--~~i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~-~~~~~~~~~~~~~~~i~~qv~~~l~~l-h~~~~~i~h~dl~  157 (219)
                      ++..  -++.+++++.  +    -+++||++.+..+.. .+.. ..++.+....+..+++.++..+ |..+  ++|+||+
T Consensus        82 rl~~~Gv~vP~pi~~~--~----~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs  152 (197)
T cd05146          82 RMQKAGIPCPEVVVLK--K----HVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLS  152 (197)
T ss_pred             HHHHcCCCCCeEEEec--C----CEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCC
Confidence            8864  4555666542  2    256999997644422 2222 2345556677889999999988 8899  9999999


Q ss_pred             CCceEEeCCCCcEEEeccccceeccccc
Q 027788          158 CSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       158 ~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      +.||++. + +.+.++|||.+.....+.
T Consensus       153 ~~NIL~~-~-~~v~iIDF~qav~~~hp~  178 (197)
T cd05146         153 EYNMLWH-D-GKVWFIDVSQSVEPTHPH  178 (197)
T ss_pred             HHHEEEE-C-CcEEEEECCCceeCCCCC
Confidence            9999997 3 479999999998776654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.47  E-value=6.9e-13  Score=111.08  Aligned_cols=147  Identities=20%  Similarity=0.204  Sum_probs=93.8

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCC---CH-----------------------HHHH----------HHH
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD---DP-----------------------AMIE----------RLF   74 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~---~~-----------------------~~~~----------~~~   74 (219)
                      +.||+|++|.||+|+ .++|+.||||+.+......   +.                       ...+          .+.
T Consensus       123 ~plasaSigQVh~A~-l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRAR-LVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEE-ecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            469999999999998 4689999999976432100   00                       0000          134


Q ss_pred             HHHHHHHhhC----CCCceEEEEEEecCCCceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 027788           75 SEVRLLKTLA----NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILK-GLNYLHTHE  148 (219)
Q Consensus        75 ~E~~~l~~l~----~~~i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~-~l~~lh~~~  148 (219)
                      +|...+.++.    +.+-+.+-.++..- ...-+++|||++|++|.+..... ...+.   ..++.+++. .+..+|..+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~~---~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLDR---KALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCCH---HHHHHHHHHHHHHHHHhCC
Confidence            4555555552    22222322222111 11246899999999998765432 12222   234444443 467789889


Q ss_pred             CCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       149 ~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                        ++|+|++|.|++++.+ +.++++|||++..+....
T Consensus       278 --~~H~D~hPgNilv~~~-g~i~liDfG~~~~l~~~~  311 (437)
T TIGR01982       278 --FFHADLHPGNIFVLKD-GKIIALDFGIVGRLSEED  311 (437)
T ss_pred             --ceeCCCCcccEEECCC-CcEEEEeCCCeeECCHHH
Confidence              9999999999999855 689999999999887643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.42  E-value=3.2e-13  Score=99.53  Aligned_cols=90  Identities=13%  Similarity=0.122  Sum_probs=69.6

Q ss_pred             CChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce-eeee
Q 027788          113 GNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR-RIRC  190 (219)
Q Consensus       113 g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~-~~~~  190 (219)
                      |+|.+++.. ...+++..+..++.|++.|+.|||+.+        ||+||+++.+ +.+++  ||++........ ++..
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~-~~~~~--fG~~~~~~~~~~~g~~~   69 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWD-GLLKL--DGSVAFKTPEQSRVDPY   69 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCc-cceee--ccceEeeccccCCCccc
Confidence            688888875 456999999999999999999999865        9999999855 57888  999987655432 2333


Q ss_pred             cccCccccCCCccccccceeeecc
Q 027788          191 WGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       191 ~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +.+| +......++.++||||+|+
T Consensus        70 y~aP-E~~~~~~~~~~~DiwSlG~   92 (176)
T smart00750       70 FMAP-EVIQGQSYTEKADIYSLGI   92 (176)
T ss_pred             ccCh-HHhcCCCCcchhhHHHHHH
Confidence            3343 4455667888999999993

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.39  E-value=3.5e-12  Score=93.47  Aligned_cols=131  Identities=21%  Similarity=0.124  Sum_probs=92.6

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCc-eEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI-ISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i-~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      +.++.|.++.||+++..  +..+++|.......     ....+.+|+.+++.+.+.++ .+++...  ...  -+++||+
T Consensus         4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~--~~lv~e~   72 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYFD--PET--GVLITEF   72 (170)
T ss_pred             eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCC--CeEEEEe
Confidence            56889999999998754  77899998653321     11235678999988865444 3454443  222  2579999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC---CeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP---CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~---~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +++.++...     .   ......+.+++.++..||..+.   .++|+|+++.|++++ + +.++++||+.+..-.
T Consensus        73 i~G~~l~~~-----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~~~~  138 (170)
T cd05151          73 IEGSELLTE-----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAGMND  138 (170)
T ss_pred             cCCCccccc-----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEecccccCCC
Confidence            998777542     0   1113356788899999998861   249999999999998 4 369999999987543

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.37  E-value=1.3e-12  Score=111.06  Aligned_cols=145  Identities=14%  Similarity=0.188  Sum_probs=89.3

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccC--------------------C-----C-H----HHHHH------HH
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC--------------------D-----D-P----AMIER------LF   74 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~--------------------~-----~-~----~~~~~------~~   74 (219)
                      +.||+|++|.||+|+...+|+.||||+.......                    +     + .    ...+.      +.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            5799999999999998777999999998743200                    0     0 0    11122      33


Q ss_pred             HHHHHHHhhC----CCCceEEEEEEecCCCceEEEEeccccCCChHHHH--HhCC----CCCHHHHHHHHHHHHHHHHHH
Q 027788           75 SEVRLLKTLA----NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYR--KKHR----HVSVKALKKWSKQILKGLNYL  144 (219)
Q Consensus        75 ~E~~~l~~l~----~~~i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~--~~~~----~~~~~~~~~i~~qv~~~l~~l  144 (219)
                      +|...+.++.    +.+.+.+-.++.+- ...-+++|||++|+.+.+.-  ...+    .+.+..+..++.|+       
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------  276 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------  276 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------
Confidence            4444444442    23223322222110 11246799999999997642  2222    12222233333443       


Q ss_pred             HhCCCCeeeeCCCCCceEEeCCC---CcEEEeccccceeccccc
Q 027788          145 HTHEPCVIHRDLNCSNVFVNGNT---GQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       145 h~~~~~i~h~dl~~~nili~~~~---~~~~l~dfg~a~~~~~~~  185 (219)
                      ...+  ++|+|+||.||+++.+.   +.++++|||+...+....
T Consensus       277 f~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~~  318 (537)
T PRK04750        277 FRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKED  318 (537)
T ss_pred             HhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHHH
Confidence            4568  99999999999998652   279999999999887654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.27  E-value=9.6e-13  Score=113.77  Aligned_cols=188  Identities=17%  Similarity=0.234  Sum_probs=135.4

Q ss_pred             CCceeeeeeeeccccceEEEEEEec-CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCC
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQ-EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDR  100 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~  100 (219)
                      ...| ++.+-||+|+|+.|-.+... .....+|+|.+....  .......+...|..+.+.+. |.|++.+++..  .+.
T Consensus        19 ~~~~-~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~~   93 (601)
T KOG0590|consen   19 NSQY-KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SSP   93 (601)
T ss_pred             cccc-cccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCcc--CCC
Confidence            3444 77788999999999988764 334557777665443  24455577778898888888 99999998877  445


Q ss_pred             ceEEEEeccccCCChHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788          101 NTLNFITEVCTSGNLREYR-KKHR-HVSVKALKKWSKQILKGLNYLH-THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~-~~~~-~~~~~~~~~i~~qv~~~l~~lh-~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                      ...++.+++..++++..-+ .... ..+....-..+.|+..++.|+| ..+  +.|+|++|+|.+++.....++++|||+
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~  171 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGL  171 (601)
T ss_pred             cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchh
Confidence            5677799999899998877 4333 5667777888999999999999 888  999999999999985522789999999


Q ss_pred             ceeccc-cce---eeeecc-cCc----cccCCCcc-ccccceeeeccccc
Q 027788          178 AAIVGR-AIR---RIRCWG-RRS----SWRRSCTM-RITRSLWTYTRLGC  217 (219)
Q Consensus       178 a~~~~~-~~~---~~~~~~-~~~----~~~~~~~~-~~~~diws~gi~~~  217 (219)
                      |..+.. ...   .....| .++    ++.....+ ..+-|+||.|+...
T Consensus       172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~  221 (601)
T KOG0590|consen  172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLS  221 (601)
T ss_pred             hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccccc
Confidence            988876 222   111222 222    23333233 34489999996543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.27  E-value=2.4e-10  Score=83.11  Aligned_cols=150  Identities=19%  Similarity=0.258  Sum_probs=104.4

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccC-C---CHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC-D---DPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~-~---~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      ..+-+|+-++|+++.+  .|+...||.=..+.+. +   ..=..++..+|+..+.++.--.|.-..-++.+...+  .+.
T Consensus        13 ~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~--~i~   88 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGG--QIY   88 (229)
T ss_pred             eeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCC--eEE
Confidence            5778999999999965  5777777752222221 1   112346778899999888654444333344444443  459


Q ss_pred             eccccC-CChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcE--EEeccccceec
Q 027788          107 TEVCTS-GNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQV--KIGDLGVAAIV  181 (219)
Q Consensus       107 ~e~~~~-g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~--~l~dfg~a~~~  181 (219)
                      ||++++ .++.+++...-  .........++.++-..+.-||.++  ++|+||..+|+++.++..++  .++|||++...
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999975 47778776542  2223333678888888899999999  99999999999998665544  78999999887


Q ss_pred             cccce
Q 027788          182 GRAIR  186 (219)
Q Consensus       182 ~~~~~  186 (219)
                      ..++.
T Consensus       167 ~~~ED  171 (229)
T KOG3087|consen  167 RLPED  171 (229)
T ss_pred             cCccc
Confidence            66654

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.22  E-value=3.8e-10  Score=82.19  Aligned_cols=138  Identities=17%  Similarity=0.213  Sum_probs=95.1

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccC-CCH--H-HHHHHHHHHHHHHhhCCC--CceEEEEEEecCCCceEE
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC-DDP--A-MIERLFSEVRLLKTLANK--NIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~--~-~~~~~~~E~~~l~~l~~~--~i~~~~~~~~~~~~~~~~  104 (219)
                      ..+.+|+-+.+|.+...  |..+.+|.=..+... +..  . ...+..+|+.++.++.--  +...++++.  ++.  ..
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~~~--~~   75 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--PDN--GL   75 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--CCC--CE
Confidence            35788999999988653  334666652222221 111  1 225567899999887643  333444443  332  45


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      ++|||.+|..|.+.+...       ...++..+-.-+.-||..+  |+|+||.++|+++..+  .+.++|||++......
T Consensus        76 I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~--~i~~IDfGLg~~s~~~  144 (204)
T COG3642          76 IVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGG--RIYFIDFGLGEFSDEV  144 (204)
T ss_pred             EEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCC--cEEEEECCcccccccH
Confidence            699999988888887754       2456666767788899999  9999999999999744  5999999999876554


Q ss_pred             c
Q 027788          185 I  185 (219)
Q Consensus       185 ~  185 (219)
                      +
T Consensus       145 E  145 (204)
T COG3642         145 E  145 (204)
T ss_pred             H
Confidence            4

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.19  E-value=7.7e-11  Score=94.66  Aligned_cols=126  Identities=21%  Similarity=0.245  Sum_probs=86.2

Q ss_pred             CCCCceEEEEEEecC-------------------------CCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHH
Q 027788           84 ANKNIISLHYVWRDE-------------------------DRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL  138 (219)
Q Consensus        84 ~~~~i~~~~~~~~~~-------------------------~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~  138 (219)
                      .||||+++...|.++                         ....+|++|..++ -+|..++... ..+......++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHH
Confidence            589999987666421                         2346788999886 4888877643 455666777899999


Q ss_pred             HHHHHHHhCCCCeeeeCCCCCceEEeCCC---CcEEEeccccceeccccc------------eeeeecccCccccCCCc-
Q 027788          139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNT---GQVKIGDLGVAAIVGRAI------------RRIRCWGRRSSWRRSCT-  202 (219)
Q Consensus       139 ~~l~~lh~~~~~i~h~dl~~~nili~~~~---~~~~l~dfg~a~~~~~~~------------~~~~~~~~~~~~~~~~~-  202 (219)
                      +++.+||.++  +.|||+|.+||++..+.   ..+.++|||.+-.-....            .+..+.-+|+....-+. 
T Consensus       352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp  429 (598)
T KOG4158|consen  352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP  429 (598)
T ss_pred             HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence            9999999999  99999999999985322   346789999764322211            13334444543322221 


Q ss_pred             ----cccccceeeec
Q 027788          203 ----MRITRSLWTYT  213 (219)
Q Consensus       203 ----~~~~~diws~g  213 (219)
                          .-.++|.|+-|
T Consensus       430 ~avvny~kAD~WA~G  444 (598)
T KOG4158|consen  430 NAVVNYEKADTWAAG  444 (598)
T ss_pred             ceeeccchhhhhhhh
Confidence                12368999888

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.15  E-value=7e-10  Score=84.57  Aligned_cols=147  Identities=18%  Similarity=0.227  Sum_probs=98.6

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCC--CceEEEEEEecCC-CceEEEEe
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK--NIISLHYVWRDED-RNTLNFIT  107 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~--~i~~~~~~~~~~~-~~~~~lv~  107 (219)
                      +.|+.|.++.+|+++.. +|..+++|.......   ......+..|.++++.+.+.  .+.+++.+..... .+..+++|
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~---~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~   79 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGAL---LPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM   79 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCccc---CcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence            56889999999999864 367899998654321   11235678899999998763  3456665553221 12457899


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH----------------------------------------  147 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~----------------------------------------  147 (219)
                      |++++.++...+.. ..++......++.+++..+..||+.                                        
T Consensus        80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99998777653321 2355555556666666666666632                                        


Q ss_pred             --------------CCCeeeeCCCCCceEEeCC-CCcEEEeccccceecc
Q 027788          148 --------------EPCVIHRDLNCSNVFVNGN-TGQVKIGDLGVAAIVG  182 (219)
Q Consensus       148 --------------~~~i~h~dl~~~nili~~~-~~~~~l~dfg~a~~~~  182 (219)
                                    ...++|+|+++.|++++.+ .+.+.++||+.+..-.
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g~  208 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLGD  208 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccCC
Confidence                          1247999999999999863 3457899999887543

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.14  E-value=1.7e-09  Score=80.40  Aligned_cols=132  Identities=24%  Similarity=0.232  Sum_probs=81.6

Q ss_pred             EEEEEecCCCcEEEEEEeeecccC---------------------CCH-HHHHHHHHHHHHHHhhCCC--CceEEEEEEe
Q 027788           41 VYRAFDQEEGIEVAWNQVKLRTFC---------------------DDP-AMIERLFSEVRLLKTLANK--NIISLHYVWR   96 (219)
Q Consensus        41 V~~a~~~~~~~~vavK~~~~~~~~---------------------~~~-~~~~~~~~E~~~l~~l~~~--~i~~~~~~~~   96 (219)
                      ||.|.. .+|..+|+|+.......                     ... -......+|...|.++..-  ++.+++++. 
T Consensus         2 Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    2 VYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             EEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            788875 46789999998763211                     011 1224467899999999765  466666543 


Q ss_pred             cCCCceEEEEecccc--CCChHHHHHhCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCeeeeCCCCCceEEeCCCCcEEEe
Q 027788           97 DEDRNTLNFITEVCT--SGNLREYRKKHRHVSVKALKKWSKQILKGLN-YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIG  173 (219)
Q Consensus        97 ~~~~~~~~lv~e~~~--~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~-~lh~~~~~i~h~dl~~~nili~~~~~~~~l~  173 (219)
                       ++    .++|||++  |..+..+....  ++.+....++.+++..+. .+|..+  ++|+||++.||+++.+  .+.++
T Consensus        80 -~~----~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~~--~~~iI  148 (188)
T PF01163_consen   80 -RN----VIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDDG--KVYII  148 (188)
T ss_dssp             -TT----EEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEETT--CEEE-
T ss_pred             -CC----EEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeecc--eEEEE
Confidence             32    57999998  65665543321  113344556666666444 457889  9999999999999854  79999


Q ss_pred             ccccceeccccc
Q 027788          174 DLGVAAIVGRAI  185 (219)
Q Consensus       174 dfg~a~~~~~~~  185 (219)
                      |||.+.....+.
T Consensus       149 Df~qav~~~~p~  160 (188)
T PF01163_consen  149 DFGQAVDSSHPN  160 (188)
T ss_dssp             -GTTEEETTSTT
T ss_pred             ecCcceecCCcc
Confidence            999998766543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.12  E-value=3.7e-10  Score=95.97  Aligned_cols=128  Identities=26%  Similarity=0.273  Sum_probs=100.6

Q ss_pred             EEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccccCCChHHHHHhC
Q 027788           43 RAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH  122 (219)
Q Consensus        43 ~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~  122 (219)
                      .|..+.++.+|.|..++....    ...+...+-++.++-++||||+++++.+  +....+|+++|.+.  .|...+.. 
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~----~~~~~~~~A~k~lKtlRHP~Il~yL~t~--e~~~~~ylvTErV~--Pl~~~lk~-  100 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG----EVTELAKRAVKRLKTLRHPNILSYLDTT--EEEGTLYLVTERVR--PLETVLKE-  100 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc----hhhHHHHHHHHHhhhccCchhhhhhhhh--cccCceEEEeeccc--cHHHHHHH-
Confidence            466678889999998875532    3335566788899999999999999988  44457899999983  56655553 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHH-hCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          123 RHVSVKALKKWSKQILKGLNYLH-THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       123 ~~~~~~~~~~i~~qv~~~l~~lh-~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                        +....+.-.+.||+.||.||| .++  ++|+++..+.++++.. |.-+|.+|.++......
T Consensus       101 --l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~-GeWkLggle~v~~~~~~  158 (690)
T KOG1243|consen  101 --LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNES-GEWKLGGLELVSKASGF  158 (690)
T ss_pred             --hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCC-CcEEEeeeEEEeccccC
Confidence              336667778999999999998 556  9999999999999966 68999999988665443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.11  E-value=9.3e-11  Score=97.89  Aligned_cols=130  Identities=20%  Similarity=0.366  Sum_probs=99.7

Q ss_pred             HhhCCCCceEEEEEEecCCCceEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCe-eeeCCCC
Q 027788           81 KTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCV-IHRDLNC  158 (219)
Q Consensus        81 ~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i-~h~dl~~  158 (219)
                      +.+.|.|+.++.+.+...  ..++++.++|..|+|.+.+.. ...++......+++.++.|+.|+|...  + .|+.|+.
T Consensus         2 ~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s   77 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS   77 (484)
T ss_pred             cccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence            567899999999999765  557789999999999998876 456888889999999999999999766  4 9999999


Q ss_pred             CceEEeCCCCcEEEeccccceeccccc--------eeeeecccCccccC---CC---ccccccceeeeccc
Q 027788          159 SNVFVNGNTGQVKIGDLGVAAIVGRAI--------RRIRCWGRRSSWRR---SC---TMRITRSLWTYTRL  215 (219)
Q Consensus       159 ~nili~~~~~~~~l~dfg~a~~~~~~~--------~~~~~~~~~~~~~~---~~---~~~~~~diws~gi~  215 (219)
                      .|++++... .+|++|||+........        .....|-+|+-...   ..   ..+.++|++|+||.
T Consensus        78 ~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii  147 (484)
T KOG1023|consen   78 SNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGII  147 (484)
T ss_pred             ccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHH
Confidence            999999776 79999999998875311        12223334432111   11   14556999999943

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.11  E-value=7e-12  Score=98.23  Aligned_cols=160  Identities=38%  Similarity=0.726  Sum_probs=111.8

Q ss_pred             CCCCccccCCCCceeeeeeeeccc---cceEEEEEEecCCCcEEEEEEeeecccCCCHHHH-HHHHHHHHHHHhhCCCCc
Q 027788           13 DSEPFIETDPTGRYGRYNELLGSG---AVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMI-ERLFSEVRLLKTLANKNI   88 (219)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~~ig~g---~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~-~~~~~E~~~l~~l~~~~i   88 (219)
                      +.....+..|.+++.+-....|+.   +.-.||.+.+...|.+|....+...... ++... +....-...+-++-|.|+
T Consensus        51 ~~~eIleesp~~rw~krreqv~qrdvPgid~v~lamd~e~g~evvwneVq~~~rK-~~~~qeek~~~vFdnllqlvHsnl  129 (458)
T KOG1266|consen   51 DESEILEESPCGRWGKRREQVGQRDVPGIDDVYLAMDTEEGVEVVWNEVQFSERK-NPKEQEEKRRAVFDNLLQLVHSNL  129 (458)
T ss_pred             chhhhhccCchhhhhhhhhhccCCCCCchHHHHHHhhhccCchhhHHHHHHHHhc-ChhhCHHHHHHHHHHHHHHHHHHH
Confidence            344455666777776666666653   3456777777777777776554432211 11111 111222334556678999


Q ss_pred             eEEEEEEec---CCCceEEEEeccccCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCce
Q 027788           89 ISLHYVWRD---EDRNTLNFITEVCTSGNLREYRKKH----RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNV  161 (219)
Q Consensus        89 ~~~~~~~~~---~~~~~~~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~ni  161 (219)
                      ++++.+|.+   ++.....+++||+..|++.++++..    ..+......+|+.||+.||.|||+..|+++|+++..+.+
T Consensus       130 vkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~ti  209 (458)
T KOG1266|consen  130 VKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTI  209 (458)
T ss_pred             HHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhhe
Confidence            999888854   3445667899999999999998643    347788899999999999999999999999999999999


Q ss_pred             EEeCCCCcEEEec
Q 027788          162 FVNGNTGQVKIGD  174 (219)
Q Consensus       162 li~~~~~~~~l~d  174 (219)
                      ++..+ |-+|+.-
T Consensus       210 fiq~n-gLIkig~  221 (458)
T KOG1266|consen  210 FIQHN-GLIKIGS  221 (458)
T ss_pred             eecCC-ceEEecc
Confidence            99855 5667643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.00  E-value=9.2e-10  Score=92.28  Aligned_cols=184  Identities=15%  Similarity=0.135  Sum_probs=129.4

Q ss_pred             CCceeeeeeeeccccceEEEEEEec-CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCC
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQ-EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDR  100 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~  100 (219)
                      .+.+ .+...||.+.|+.|+..... .++..|++|.+....... .+.+. -..|+-+...+ .|.+++..+..|..-++
T Consensus       264 ~~df-~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~-~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  264 LTDF-GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF-ASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             cCCc-ceeEEccCCccccceeeeecCCCCceEeChhhhccccch-Hhhhc-chhhhhHhhHhhcccccCCCCCCcccccc
Confidence            3455 45588999999999987644 678889999877554321 11111 12344444444 47777776666654433


Q ss_pred             ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          101 NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                        .++-.|+|.++++...+.....+++...+++..|++.++.++|...  ++|+|++|+||++..+.+..++.||+.+..
T Consensus       341 --~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  341 --GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             --ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccc
Confidence              4579999998888766544456888999999999999999999998  999999999999985435678999998875


Q ss_pred             ccccce--eeeeccc--CccccCCCccccccceeeec
Q 027788          181 VGRAIR--RIRCWGR--RSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~--~~~~~~~--~~~~~~~~~~~~~~diws~g  213 (219)
                      +.....  ....+..  .+......++..+.|++|||
T Consensus       417 ~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~  453 (524)
T KOG0601|consen  417 LAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLG  453 (524)
T ss_pred             cceecccccccccccccchhhcccccccccccccccc
Confidence            433221  2222222  34456677778889999999

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.98  E-value=2.7e-10  Score=100.92  Aligned_cols=141  Identities=18%  Similarity=0.285  Sum_probs=89.2

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      ...+.|..|+||.||..+++.+.+++|+|+ +++..         +.+.  ++....+|.                 +| 
T Consensus        86 ~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l---------ilRn--ilt~a~npf-----------------vv-  135 (1205)
T KOG0606|consen   86 NTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL---------ILRN--ILTFAGNPF-----------------VV-  135 (1205)
T ss_pred             ceeEeeccCCCCceeeeeccccccchhhcc-cccch---------hhhc--cccccCCcc-----------------ee-
Confidence            455899999999999999999999999954 42211         1110  111112221                 12 


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce-
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR-  186 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~-  186 (219)
                           |+-..++..-+.++.+.        +.+++|+|+.+  |+|||+||+|.+|+.- |.+|+.|||+++..--... 
T Consensus       136 -----gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT~m-GhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 -----GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLITSM-GHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             -----chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceeeec-ccccccchhhhhhhhhhccc
Confidence                 23333333333343333        67899999999  9999999999999855 7999999999875421110 


Q ss_pred             ---------------eeeecccCc----cccCCCccccccceeeecc
Q 027788          187 ---------------RIRCWGRRS----SWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 ---------------~~~~~~~~~----~~~~~~~~~~~~diws~gi  214 (219)
                                     ....+++|+    ++..-..|.-+-|-|+|||
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGi  246 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGI  246 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHH
Confidence                           111233333    2233445666789999993

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.95  E-value=4.7e-08  Score=76.81  Aligned_cols=140  Identities=14%  Similarity=0.078  Sum_probs=90.3

Q ss_pred             cceEEEEEEecCCCcEEEEEEeeecccCC---C---H-HHHHHHHHHHHHHHhhCCCCce--EEEEEEecC-C--CceEE
Q 027788           37 AVKKVYRAFDQEEGIEVAWNQVKLRTFCD---D---P-AMIERLFSEVRLLKTLANKNII--SLHYVWRDE-D--RNTLN  104 (219)
Q Consensus        37 ~~g~V~~a~~~~~~~~vavK~~~~~~~~~---~---~-~~~~~~~~E~~~l~~l~~~~i~--~~~~~~~~~-~--~~~~~  104 (219)
                      ....|.+.+  -.|+.+.+|.........   .   . .-...+.+|...+.++..-+|.  ++..+.... +  ...-+
T Consensus        34 ~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~  111 (268)
T PRK15123         34 EGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF  111 (268)
T ss_pred             CCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence            334455543  245678888653222100   0   0 0001366788888877543333  333333111 1  12346


Q ss_pred             EEeccccCC-ChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC------CCCcEEEecc
Q 027788          105 FITEVCTSG-NLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG------NTGQVKIGDL  175 (219)
Q Consensus       105 lv~e~~~~g-~L~~~~~~--~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~------~~~~~~l~df  175 (219)
                      ++||++++. +|.+++..  ....+......++.+++..+.-||..+  ++|+||++.||+++.      +...+.++||
T Consensus       112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl  189 (268)
T PRK15123        112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDL  189 (268)
T ss_pred             EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence            899999875 78888753  234566777789999999999999999  999999999999974      2347899999


Q ss_pred             cccee
Q 027788          176 GVAAI  180 (219)
Q Consensus       176 g~a~~  180 (219)
                      +.+..
T Consensus       190 ~r~~~  194 (268)
T PRK15123        190 HRAQI  194 (268)
T ss_pred             Ccccc
Confidence            98864

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.89  E-value=7.7e-10  Score=92.76  Aligned_cols=183  Identities=18%  Similarity=0.226  Sum_probs=130.1

Q ss_pred             Cceeeeeeeecc--ccceEEEEEEe--cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecC
Q 027788           24 GRYGRYNELLGS--GAVKKVYRAFD--QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDE   98 (219)
Q Consensus        24 ~~~~~~~~~ig~--g~~g~V~~a~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~   98 (219)
                      .+.+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+....  .+....+-++|....+.+. |+|.++.+..+  +
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s--~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--e  188 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS--PPLDSKRKLREFLSHHKIDSHENPVRDSPAW--E  188 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC--CccccccccchhhcccccCccccccccCccc--c
Confidence            344466678999  99999999887  78889999997443322  2333344456777776664 88888877777  5


Q ss_pred             CCceEEEEeccccCCChHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEe
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILK----GLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIG  173 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~~~-~~~~~~~~i~~qv~~----~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~  173 (219)
                      +...+++.+|.+. .+|..+...... +....+...+.+...    |+..+|...  ++|.|++|+|+++..+....++.
T Consensus       189 ~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~  265 (524)
T KOG0601|consen  189 GSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLT  265 (524)
T ss_pred             cCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecC
Confidence            6677888999985 677666543323 566666666666666    999999999  99999999999998775578999


Q ss_pred             ccccceeccccceeeeec--ccCc-------cccCCCccccccceeeec
Q 027788          174 DLGVAAIVGRAIRRIRCW--GRRS-------SWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       174 dfg~a~~~~~~~~~~~~~--~~~~-------~~~~~~~~~~~~diws~g  213 (219)
                      |||+...+.........-  -.++       +......+...+|++|+|
T Consensus       266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~  314 (524)
T KOG0601|consen  266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLG  314 (524)
T ss_pred             CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchh
Confidence            999988886655211111  0111       223455567779999999

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=98.80  E-value=9.1e-10  Score=91.10  Aligned_cols=108  Identities=22%  Similarity=0.346  Sum_probs=82.8

Q ss_pred             ceEEEEeccccCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788          101 NTLNFITEVCTSGNLREYRKKHR---HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                      .++++.|++|...+|.+++...+   .-+......+..|++.++.|   ++  .+|+|+||.||++..+ ..++|.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d-~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDD-DQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccccc-hhhhhhhhhh
Confidence            36889999999999999986432   45677888899999999999   67  8999999999998755 4799999999


Q ss_pred             ceeccccce-------eee----ecccCccccCCCccccccceeeecc
Q 027788          178 AAIVGRAIR-------RIR----CWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~-------~~~----~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ........+       .+.    .++..++......|..+.||+|||+
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGl  450 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGL  450 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHH
Confidence            987766551       111    1222223345566889999999994

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.74  E-value=8.9e-08  Score=72.56  Aligned_cols=111  Identities=20%  Similarity=0.198  Sum_probs=81.7

Q ss_pred             HHHHHHHHHHHhhCCCCc--eEEEEEEecCC--CceEEEEeccccCC-ChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 027788           71 ERLFSEVRLLKTLANKNI--ISLHYVWRDED--RNTLNFITEVCTSG-NLREYRKKHRHVSVKALKKWSKQILKGLNYLH  145 (219)
Q Consensus        71 ~~~~~E~~~l~~l~~~~i--~~~~~~~~~~~--~~~~~lv~e~~~~g-~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh  145 (219)
                      .+..+|...+..|..-.|  .+.+++.....  ...-++++|++++. +|.+++......+......++.+++..+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            456678888777754333  33444332211  12346899999864 78888876545677778889999999999999


Q ss_pred             hCCCCeeeeCCCCCceEEeCCC--CcEEEeccccceeccc
Q 027788          146 THEPCVIHRDLNCSNVFVNGNT--GQVKIGDLGVAAIVGR  183 (219)
Q Consensus       146 ~~~~~i~h~dl~~~nili~~~~--~~~~l~dfg~a~~~~~  183 (219)
                      ..+  ++|+|+++.|||++.+.  ..+.++||+.++....
T Consensus       136 ~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~~  173 (206)
T PF06293_consen  136 DAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRPS  173 (206)
T ss_pred             HCc--CCCCCCCcccEEEeCCCCceeEEEEcchhceeCCC
Confidence            999  99999999999998653  2578999998877553

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.74  E-value=1.4e-07  Score=78.57  Aligned_cols=142  Identities=15%  Similarity=0.214  Sum_probs=109.4

Q ss_pred             cceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec--CCCceEEEEeccccC-C
Q 027788           37 AVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD--EDRNTLNFITEVCTS-G  113 (219)
Q Consensus        37 ~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~~~~lv~e~~~~-g  113 (219)
                      ...+.|+|+...+|-.|++|.++-......    .....-++.++++.|+|++.+.++|..  -+...+++|++|+|+ +
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~----nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~  363 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST----NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP  363 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc----ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence            557899999999999999999954332221    111235778899999999999888862  233578899999975 4


Q ss_pred             ChHHH-HHh--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          114 NLREY-RKK--------------HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       114 ~L~~~-~~~--------------~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      +|.++ +..              ....++..++.++.|+..||.++|+.|  +..+-|.+.+|+++.+. +++|+..|..
T Consensus       364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~-RIriS~C~i~  440 (655)
T KOG3741|consen  364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKM-RIRISGCGIM  440 (655)
T ss_pred             hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcc-eEEEecccce
Confidence            66553 211              123678999999999999999999999  98999999999998764 7999998888


Q ss_pred             eeccccc
Q 027788          179 AIVGRAI  185 (219)
Q Consensus       179 ~~~~~~~  185 (219)
                      ..+..+.
T Consensus       441 Dvl~~d~  447 (655)
T KOG3741|consen  441 DVLQEDP  447 (655)
T ss_pred             eeecCCC
Confidence            7776654

>PRK09902 hypothetical protein; Provisional

Probab=98.67  E-value=1.3e-06  Score=65.80  Aligned_cols=145  Identities=14%  Similarity=0.128  Sum_probs=95.5

Q ss_pred             ccccceEEEEEEecCCCcEEEEEEeeecccC--CCHHHHHHHHHHHHHHHhhCCCC--ceEEE--EEEecCCCceEEEEe
Q 027788           34 GSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC--DDPAMIERLFSEVRLLKTLANKN--IISLH--YVWRDEDRNTLNFIT  107 (219)
Q Consensus        34 g~g~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~--i~~~~--~~~~~~~~~~~~lv~  107 (219)
                      |.|+.+.|++-...  |..+=+|.-......  .-+.-...|.+|...+++|..-+  +.++.  +.-.......-+||+
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            45777888876532  334666653311100  00222355788999888886433  33333  111222233456799


Q ss_pred             ccccC-CChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCc--EEEeccccceecc
Q 027788          108 EVCTS-GNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQ--VKIGDLGVAAIVG  182 (219)
Q Consensus       108 e~~~~-g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~--~~l~dfg~a~~~~  182 (219)
                      |.+++ .+|.+++...  .+.+......+..+++..+.-||+.+  +.|+|+.+.||+++.+ +.  ++++||+-++..-
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~-g~~~v~lIDlEk~r~~l  181 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRRRL  181 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCC-CCeeEEEEEhhccchhh
Confidence            98853 4888877543  34577777889999999999999999  9999999999999744 35  8999999887654


Q ss_pred             c
Q 027788          183 R  183 (219)
Q Consensus       183 ~  183 (219)
                      .
T Consensus       182 ~  182 (216)
T PRK09902        182 R  182 (216)
T ss_pred             h
Confidence            3

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.57  E-value=6.7e-07  Score=69.24  Aligned_cols=147  Identities=19%  Similarity=0.175  Sum_probs=99.1

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccC----------------CC--HHHHHHHHHHHHHHHhhCC
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC----------------DD--PAMIERLFSEVRLLKTLAN   85 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~----------------~~--~~~~~~~~~E~~~l~~l~~   85 (219)
                      +-...++..||-|--+.||.|.+. .|.++|+|.-..-...                .+  .-......+|.+.|++|..
T Consensus        90 ~~ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~  168 (304)
T COG0478          90 GIVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP  168 (304)
T ss_pred             ChHHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence            445577889999999999999865 7889999985432110                00  0122334578889988875


Q ss_pred             C--CceEEEEEEecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEE
Q 027788           86 K--NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFV  163 (219)
Q Consensus        86 ~--~i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili  163 (219)
                      .  .+.+.+++-      .-.++||+.+|-.|....     ++.+....++..|+..+.-+-..+  ++|+|++.-||++
T Consensus       169 ~G~~VP~P~~~n------RHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV  235 (304)
T COG0478         169 EGVKVPKPIAWN------RHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILV  235 (304)
T ss_pred             cCCCCCCccccc------cceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEE
Confidence            4  566665542      235699999887776532     122333334444555555555778  9999999999999


Q ss_pred             eCCCCcEEEeccccceeccccc
Q 027788          164 NGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       164 ~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      +.+ |.+.++||=-+.....+.
T Consensus       236 ~~d-g~~~vIDwPQ~v~~~hp~  256 (304)
T COG0478         236 TED-GDIVVIDWPQAVPISHPD  256 (304)
T ss_pred             ecC-CCEEEEeCcccccCCCCC
Confidence            966 589999997776655544

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.48  E-value=7.8e-06  Score=62.53  Aligned_cols=145  Identities=20%  Similarity=0.228  Sum_probs=80.6

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCC--ceEEEEEEecC-CCceEEEEe
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN--IISLHYVWRDE-DRNTLNFIT  107 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~--i~~~~~~~~~~-~~~~~~lv~  107 (219)
                      +.++.|..+.||+.....  ..+++|...      .......+..|..+++.+....  +.+++...... .....+++|
T Consensus         3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~------~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD--GRYVLKFYR------PPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEESSSSEEEEEEETT--SEEEEEEES------SHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             ccCCCCCeeeEEEEEECC--cEEEEEEeC------CCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            678899999999998654  488999855      2234567778999988886433  44555533222 233468899


Q ss_pred             ccccCCChHH----------------HHH---hC--C--CCCHHH------HHHH---------------HHHHHH-HHH
Q 027788          108 EVCTSGNLRE----------------YRK---KH--R--HVSVKA------LKKW---------------SKQILK-GLN  142 (219)
Q Consensus       108 e~~~~g~L~~----------------~~~---~~--~--~~~~~~------~~~i---------------~~qv~~-~l~  142 (219)
                      +++++..+..                .+.   ..  .  ......      ....               ...+.. .+.
T Consensus        75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            9998776655                111   11  0  011000      0000               001111 222


Q ss_pred             HHHh-----CCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          143 YLHT-----HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       143 ~lh~-----~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      .++.     ....++|+|+.+.|++++.+.+.+.++||+.+.....
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~~~  200 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWGDP  200 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEEET
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceECCH
Confidence            2221     2234899999999999984434668999998876543

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.46  E-value=2.4e-06  Score=72.84  Aligned_cols=151  Identities=17%  Similarity=0.221  Sum_probs=90.9

Q ss_pred             eeeee-eeeccccceEEEEEEecCCCcEEEEEEeeecccCC--------------------------CHH----HHHH--
Q 027788           26 YGRYN-ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD--------------------------DPA----MIER--   72 (219)
Q Consensus        26 ~~~~~-~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~--------------------------~~~----~~~~--   72 (219)
                      |..++ .-|+.++-|.||+|+ .++|+.||||+........                          ...    ..+.  
T Consensus       125 F~eF~~~PiAsASIaQVH~A~-L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~  203 (517)
T COG0661         125 FSEFEPEPIASASIAQVHRAV-LKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR  203 (517)
T ss_pred             HHHcCCCchhhhhHhhheeEE-ecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence            33444 468899999999999 5669999999976432100                          000    1111  


Q ss_pred             ----HHHHHHHHHhhC-----CCCceEEEEEEe-cCCCceEEEEeccccCCChHHHHH-hCCCCCHHHHHHHHHHHHHHH
Q 027788           73 ----LFSEVRLLKTLA-----NKNIISLHYVWR-DEDRNTLNFITEVCTSGNLREYRK-KHRHVSVKALKKWSKQILKGL  141 (219)
Q Consensus        73 ----~~~E~~~l~~l~-----~~~i~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~~~i~~qv~~~l  141 (219)
                          +.+|.....++.     .+++. +=.++- -...  -.++|||++|..+.+... .....+...+.....++.  +
T Consensus       204 ~ElDy~~EA~n~~~~~~nf~~~~~v~-VP~V~we~t~~--~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~  278 (517)
T COG0661         204 EELDYRREAANAERFRENFKDDPDVY-VPKVYWEYTTR--RVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--L  278 (517)
T ss_pred             HHhCHHHHHHHHHHHHHHcCCCCCeE-eceeehhccCC--cEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--H
Confidence                233333333332     12222 212221 1112  357999999988887632 124566555444433332  2


Q ss_pred             HHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       142 ~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ..+-..+  +.|.|.+|-|++++.+ +.+.+.|||....+.+..
T Consensus       279 ~q~~~dg--ffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~~~~  319 (517)
T COG0661         279 RQLLRDG--FFHADPHPGNILVRSD-GRIVLLDFGIVGRLDPKF  319 (517)
T ss_pred             HHHHhcC--ccccCCCccceEEecC-CcEEEEcCcceecCCHHH
Confidence            3333457  9999999999999977 689999999998877654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.45  E-value=4.9e-06  Score=63.97  Aligned_cols=137  Identities=17%  Similarity=0.155  Sum_probs=77.2

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCc--eEEEEEEecCCCceEEEEec
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI--ISLHYVWRDEDRNTLNFITE  108 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i--~~~~~~~~~~~~~~~~lv~e  108 (219)
                      ..||+|..+.||+.    .+..+++|......      ......+|..+++.+..-.+  .+.+.+.  +......++||
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~------~~~~i~~E~~~l~~l~~~glpvP~~~~~~--~~~~~~glv~e   74 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF------DKETIKREFDASRKVFSLGIPTPHPFDLV--EDGGRLGLIYE   74 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC------CHHHHHHHHHHHHHHHHcCCCCCceEEEE--ecCCeeeeeee
Confidence            47899999999974    24467788765321      12346789999988864333  4555555  33334567999


Q ss_pred             cccCCC-hH--------------HHH----H-hCC----CCCHHH-HHHHHHH----------HHHH-HHHHH--hCCCC
Q 027788          109 VCTSGN-LR--------------EYR----K-KHR----HVSVKA-LKKWSKQ----------ILKG-LNYLH--THEPC  150 (219)
Q Consensus       109 ~~~~g~-L~--------------~~~----~-~~~----~~~~~~-~~~i~~q----------v~~~-l~~lh--~~~~~  150 (219)
                      +++|.. +.              ..+    . -+.    ...... ...+..+          +... ..+|.  ...+.
T Consensus        75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            998753 11              100    0 010    111111 0011000          0111 11121  22234


Q ss_pred             eeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       151 i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      ++|+|+.|.|++++.+ + +.++||+.+..-
T Consensus       155 ~~HgD~~~~Nii~~~~-~-~~iIDwe~a~~G  183 (226)
T TIGR02172       155 CLHGDFQIGNLITSGK-G-TYWIDLGDFGYG  183 (226)
T ss_pred             eEecCCCCCcEEEcCC-C-cEEEechhcCcC
Confidence            7899999999999854 4 899999988643

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.43  E-value=1.5e-05  Score=61.14  Aligned_cols=151  Identities=17%  Similarity=0.128  Sum_probs=97.7

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCC------------------CHHHHH-H-HHHHHHHHHh
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD------------------DPAMIE-R-LFSEVRLLKT   82 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~------------------~~~~~~-~-~~~E~~~l~~   82 (219)
                      .+....+.-.|.+|--+.||.|.. .++..+|+|+++.....-                  ...+.. . ..+|...|.+
T Consensus        46 rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R  124 (268)
T COG1718          46 RGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKR  124 (268)
T ss_pred             CCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence            344445556888999999999974 678899999988654221                  111111 1 2467778877


Q ss_pred             hCC--CCceEEEEEEecCCCceEEEEeccccCC-ChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeCCCC
Q 027788           83 LAN--KNIISLHYVWRDEDRNTLNFITEVCTSG-NLREYRKKHRHVSVKALKKWSKQILKGLNYLHT-HEPCVIHRDLNC  158 (219)
Q Consensus        83 l~~--~~i~~~~~~~~~~~~~~~~lv~e~~~~g-~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~-~~~~i~h~dl~~  158 (219)
                      +..  -.+.+.+.+.  .+    .++||+++.. .-.-.++.- .........+..+++..+.-|-. .+  ++|+||+.
T Consensus       125 ~~eAGVrvP~Pi~~~--~n----VLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSE  195 (268)
T COG1718         125 AYEAGVRVPEPIAFR--NN----VLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSE  195 (268)
T ss_pred             HHHcCCCCCCceeec--CC----eEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcC--cccccchh
Confidence            753  3444555554  22    5699998532 111122211 12222455666677777766665 78  99999999


Q ss_pred             CceEEeCCCCcEEEeccccceeccccc
Q 027788          159 SNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       159 ~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      -|||+. + +.+.++|++-|.....+.
T Consensus       196 yNiL~~-~-~~p~iID~~QaV~~~hp~  220 (268)
T COG1718         196 YNILVH-D-GEPYIIDVSQAVTIDHPN  220 (268)
T ss_pred             hheEEE-C-CeEEEEECccccccCCCc
Confidence            999998 4 479999999998777655

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.36  E-value=5.8e-06  Score=70.46  Aligned_cols=145  Identities=14%  Similarity=0.157  Sum_probs=89.1

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCC---C------------------------HHHHHH------HHHHH
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD---D------------------------PAMIER------LFSEV   77 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~---~------------------------~~~~~~------~~~E~   77 (219)
                      +-|+.-+.|.|++|+ .++|+.||||+-+......   +                        +...+.      |.+|.
T Consensus       167 ~piaaASlaQVhrA~-L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRAR-LKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEE-ecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            469999999999998 5569999999866432110   0                        001111      22333


Q ss_pred             HHHHhh----CCCC------ceEEEEEEecCCCceEEEEeccccCCChHHH--HHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 027788           78 RLLKTL----ANKN------IISLHYVWRDEDRNTLNFITEVCTSGNLREY--RKKHRHVSVKALKKWSKQILKGLNYLH  145 (219)
Q Consensus        78 ~~l~~l----~~~~------i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~--~~~~~~~~~~~~~~i~~qv~~~l~~lh  145 (219)
                      +...++    .|-+      |.+++--+..    .-.|+|||++|..+.+.  +.+ ..++...+..-..+..  ...+-
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~--~~qIf  318 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAY--LEQIF  318 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHH--HHHHH
Confidence            333222    2323      3333322221    24689999998877654  333 3566666555554443  33344


Q ss_pred             hCCCCeeeeCCCCCceEEeC---CCCcEEEeccccceeccccc
Q 027788          146 THEPCVIHRDLNCSNVFVNG---NTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       146 ~~~~~i~h~dl~~~nili~~---~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ..|  ++|+|-+|-||++.+   ..+.+.+.|||+...+....
T Consensus       319 ~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~~  359 (538)
T KOG1235|consen  319 KTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHKT  359 (538)
T ss_pred             hcC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccHHH
Confidence            557  999999999999984   24578999999998876654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.33  E-value=8.7e-06  Score=61.63  Aligned_cols=138  Identities=12%  Similarity=0.107  Sum_probs=80.7

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHH------HHHHHHHHhhCCCCceE---EEEEE---
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERL------FSEVRLLKTLANKNIIS---LHYVW---   95 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~------~~E~~~l~~l~~~~i~~---~~~~~---   95 (219)
                      ++.+.+-...-..|.+-.  -++..+.+|........ .......|      .+++....+++...+..   ++.+.   
T Consensus        34 ~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk  110 (229)
T PF06176_consen   34 KIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK  110 (229)
T ss_pred             eEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence            555555555555555543  45678888876644321 12222211      23444444443322222   11111   


Q ss_pred             ecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788           96 RDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus        96 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      ..+-....+++|||++|..|.+...    +.+    .+...+...+.-+|..|  ++|+|.+|.|++++.+  .++++||
T Consensus       111 ~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~~~--~i~iID~  178 (229)
T PF06176_consen  111 IFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVSNN--GIRIIDT  178 (229)
T ss_pred             eccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEECC--cEEEEEC
Confidence            1111233467999999988866432    222    23455667789999999  9999999999999844  5999999


Q ss_pred             cccee
Q 027788          176 GVAAI  180 (219)
Q Consensus       176 g~a~~  180 (219)
                      +..+.
T Consensus       179 ~~k~~  183 (229)
T PF06176_consen  179 QGKRM  183 (229)
T ss_pred             ccccc
Confidence            76643

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.22  E-value=1.7e-05  Score=57.87  Aligned_cols=136  Identities=21%  Similarity=0.196  Sum_probs=88.6

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      -.+..+.|++|.+|.||++...  +..+|+|+-.      .++....+..|++++..++..++..=...+ +++    ++
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr------~ds~r~~l~kEakiLeil~g~~~~p~vy~y-g~~----~i   89 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEWR--GGEVALKVRR------RDSPRRNLEKEAKILEILAGEGVTPEVYFY-GED----FI   89 (201)
T ss_pred             hhhhhhhhhcccccEEEEeecc--CceEEEEEec------CCcchhhHHHHHHHHHHhhhcCCCceEEEe-chh----hh
Confidence            3356678999999999999753  5688988744      334456788999999999876665432222 232    44


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCC-CceEEeCCCCcEEEeccccceecccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNC-SNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~-~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      .|||+.|-.|.+.....   +...+..    ++....-|-..+  |-|+.|+. ...++..+ +.+.|+||.-|.....+
T Consensus        90 ~me~i~G~~L~~~~~~~---~rk~l~~----vlE~a~~LD~~G--I~H~El~~~~k~vlv~~-~~~~iIDFd~At~k~~p  159 (201)
T COG2112          90 RMEYIDGRPLGKLEIGG---DRKHLLR----VLEKAYKLDRLG--IEHGELSRPWKNVLVND-RDVYIIDFDSATFKKKP  159 (201)
T ss_pred             hhhhhcCcchhhhhhcc---cHHHHHH----HHHHHHHHHHhc--cchhhhcCCceeEEecC-CcEEEEEccchhhccCC
Confidence            69999887887754321   3334333    333433345567  88888864 33333334 37999999988754443

>PLN02876 acyl-CoA dehydrogenase

Probab=98.07  E-value=0.00016  Score=65.88  Aligned_cols=81  Identities=12%  Similarity=0.124  Sum_probs=51.7

Q ss_pred             eeeccccceEEEEEEecCCC--cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCc--eEEEEEEecCC-CceEE
Q 027788           31 ELLGSGAVKKVYRAFDQEEG--IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNI--ISLHYVWRDED-RNTLN  104 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i--~~~~~~~~~~~-~~~~~  104 (219)
                      +.++.|.++.+|+......+  ..+++|.......   ......+.+|..+++.+. |+++  .+++..+.+.. ....|
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~---~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL---LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc---CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            67899999999987654322  3677776442221   112245778999999986 5655  66666664321 12356


Q ss_pred             EEeccccCCC
Q 027788          105 FITEVCTSGN  114 (219)
Q Consensus       105 lv~e~~~~g~  114 (219)
                      ++||+++|..
T Consensus       121 lVME~v~G~~  130 (822)
T PLN02876        121 YIMEYLEGRI  130 (822)
T ss_pred             EEEEecCCcc
Confidence            8999998643

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.01  E-value=0.00022  Score=58.08  Aligned_cols=154  Identities=21%  Similarity=0.246  Sum_probs=101.2

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccC--------------------CCH-HHHHHH-HHHHHH
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC--------------------DDP-AMIERL-FSEVRL   79 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~--------------------~~~-~~~~~~-~~E~~~   79 (219)
                      ..|-...++-+|..|--+.||.|+ ..+|..+|||+++-.-..                    ..+ .+++-+ -.|+..
T Consensus       141 ~RG~i~~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RN  219 (520)
T KOG2270|consen  141 NRGVIVEINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRN  219 (520)
T ss_pred             hcCeeeecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHH
Confidence            456677888899999999999998 568889999998753211                    112 233333 257888


Q ss_pred             HHhhCCCCceEEEEEEecCCCceEEEEeccccCCChH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCeeeeCCC
Q 027788           80 LKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLR-EYRKKHRHVSVKALKKWSKQILKGLNYLH-THEPCVIHRDLN  157 (219)
Q Consensus        80 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~g~L~-~~~~~~~~~~~~~~~~i~~qv~~~l~~lh-~~~~~i~h~dl~  157 (219)
                      |+++....|....-.....    -.|||+++...... -.+. .-.++...+..+..|++.-+.-|- .+.  ++|.||+
T Consensus       220 LkRl~~aGIP~PePIlLk~----hVLVM~FlGrdgw~aPkLK-d~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLS  292 (520)
T KOG2270|consen  220 LKRLNNAGIPCPEPILLKN----HVLVMEFLGRDGWAAPKLK-DASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLS  292 (520)
T ss_pred             HHHHHhcCCCCCCceeeec----ceEeeeeccCCCCcCcccc-cccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchh
Confidence            8888765543221111111    25699998532221 1121 124566666666666666666554 556  9999999


Q ss_pred             CCceEEeCCCCcEEEeccccceeccccc
Q 027788          158 CSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       158 ~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      --|+|.. + |.++++|.+-+.-..++.
T Consensus       293 EfN~Lyh-d-G~lyiIDVSQSVE~DHP~  318 (520)
T KOG2270|consen  293 EFNLLYH-D-GKLYIIDVSQSVEHDHPH  318 (520)
T ss_pred             hhhheEE-C-CEEEEEEccccccCCChh
Confidence            9999986 4 579999999887766654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.86  E-value=0.00029  Score=54.66  Aligned_cols=74  Identities=15%  Similarity=0.047  Sum_probs=46.0

Q ss_pred             eeccccc-eEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCC-CCceEEEEEEecCCCceEEEEecc
Q 027788           32 LLGSGAV-KKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN-KNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        32 ~ig~g~~-g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      .|..|.+ ..||+....  +..+.+|......       ...+.+|+.+++.+.. .-+.+++......  +.-+++|++
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~   73 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSA   73 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEe
Confidence            3444555 889988643  4678888754221       2345678888888743 3344666655433  335679999


Q ss_pred             ccCCChH
Q 027788          110 CTSGNLR  116 (219)
Q Consensus       110 ~~~g~L~  116 (219)
                      ++|.++.
T Consensus        74 i~G~~l~   80 (244)
T cd05150          74 VPGVPAA   80 (244)
T ss_pred             eCCccHh
Confidence            9876665

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.86  E-value=0.0016  Score=54.21  Aligned_cols=79  Identities=22%  Similarity=0.184  Sum_probs=51.6

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccC-CC--HHHHHHHHHHHHHHHhhC---CCCceEEEEEEecCCCceEE
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC-DD--PAMIERLFSEVRLLKTLA---NKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~--~~~~~~~~~E~~~l~~l~---~~~i~~~~~~~~~~~~~~~~  104 (219)
                      +.||.|.+..||+......++.+.||.-...... .+  +-..++...|.+.|+.+.   ...+.+++.+-  ++.  -+
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~--~~  107 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EEL--AV  107 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCC--CE
Confidence            6799999999999987533358999985421110 01  224567788888888763   24566766553  322  45


Q ss_pred             EEeccccCC
Q 027788          105 FITEVCTSG  113 (219)
Q Consensus       105 lv~e~~~~g  113 (219)
                      ++||++++.
T Consensus       108 lVME~L~~~  116 (401)
T PRK09550        108 TVMEDLSDH  116 (401)
T ss_pred             EEEecCCCc
Confidence            799998753

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.83  E-value=0.0003  Score=54.30  Aligned_cols=32  Identities=22%  Similarity=0.297  Sum_probs=25.0

Q ss_pred             CeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       150 ~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      .++|+|+++.|++++.+ +...|+||+.+..-.
T Consensus       165 ~l~HGD~~~~Nvlv~~~-~i~giIDw~~a~~gD  196 (235)
T cd05155         165 VWFHGDLAPGNLLVQDG-RLSAVIDFGCLGVGD  196 (235)
T ss_pred             eEEeCCCCCCcEEEECC-CEEEEEeCcccCcCC
Confidence            38999999999999843 234699999886543

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.81  E-value=0.00018  Score=53.62  Aligned_cols=102  Identities=21%  Similarity=0.162  Sum_probs=77.3

Q ss_pred             HHHHHHHhhCC-CCceEEEEEEecCCCceEEEEeccccCCChHH---HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCC-
Q 027788           75 SEVRLLKTLAN-KNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRKKHRHVSVKALKKWSKQILKGLNYLHTHEP-  149 (219)
Q Consensus        75 ~E~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~---~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~-  149 (219)
                      .|.-+++.+++ +++.+++++|  .+    +++.|+.+.+++..   .+......++..+.+++.+++..+.+++.... 
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C--G~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC--GR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC--CC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            58888888887 6899999999  22    45889997665532   11222346899999999999999999987422 


Q ss_pred             CeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       150 ~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      .+.-.|++++|+.++.+ +++|+.|.........
T Consensus        82 ~~~lcDv~~~nfgv~~~-~~lk~iDld~v~~~~~  114 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDD-GRLKLIDLDDVFVEDK  114 (188)
T ss_pred             cEEEeecchHHeEEeCC-CcEEEEechhcchhHH
Confidence            17789999999999855 6899999987755443

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.80  E-value=0.0029  Score=47.48  Aligned_cols=133  Identities=17%  Similarity=0.286  Sum_probs=84.3

Q ss_pred             CCceeeeeeeeccccc-eEEEEEEecCCCcEEEEEEeeecccCCC-----------------HHHHHHHHHHHHHHHhhC
Q 027788           23 TGRYGRYNELLGSGAV-KKVYRAFDQEEGIEVAWNQVKLRTFCDD-----------------PAMIERLFSEVRLLKTLA   84 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~-g~V~~a~~~~~~~~vavK~~~~~~~~~~-----------------~~~~~~~~~E~~~l~~l~   84 (219)
                      .+.-.++.+.||.|.- |.||+++-  .|..+|+|+...-.....                 ......|..|...+.+|+
T Consensus        35 h~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk  112 (207)
T PF13095_consen   35 HGDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK  112 (207)
T ss_pred             CCCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence            3344567789999999 99999964  577999999332111110                 023456788888887775


Q ss_pred             C---CCc--eEEEEEEecCC-C---------------ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 027788           85 N---KNI--ISLHYVWRDED-R---------------NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY  143 (219)
Q Consensus        85 ~---~~i--~~~~~~~~~~~-~---------------~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~  143 (219)
                      .   .++  ++++++..-.. +               ...-+|-|+.+...         .+....    +.++..-+..
T Consensus       113 e~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~  179 (207)
T PF13095_consen  113 EAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKI  179 (207)
T ss_pred             hccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHH
Confidence            3   344  77777764321 1               11123444443211         122233    3456666888


Q ss_pred             HHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       144 lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      +|..+  |+-+|+++.|..   + |  +|.|||.+
T Consensus       180 ~~k~g--I~~~Dv~~~ny~---~-G--~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG--IVPRDVKPRNYR---G-G--KLVDFSSS  206 (207)
T ss_pred             HHHCC--eeeccCcccccc---C-C--EEEecccC
Confidence            99999  999999999965   3 3  78999865

>PRK10593 hypothetical protein; Provisional

Probab=97.72  E-value=0.0017  Score=52.03  Aligned_cols=77  Identities=13%  Similarity=0.062  Sum_probs=50.5

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCC---CCceEEEEEEecC-CCceEEEE
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN---KNIISLHYVWRDE-DRNTLNFI  106 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~---~~i~~~~~~~~~~-~~~~~~lv  106 (219)
                      +.||.|..+.||..... ++ .+.+|..+...   .   ...+.+|...++.|..   ..+.++++++..+ ..+.-+++
T Consensus        20 ~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~---~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         20 ECISEQPYAALWALYDS-QG-NPMPLMARSFS---T---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             eecCCccceeEEEEEcC-CC-CEEEEEecccc---c---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            57999999999997532 23 46667643211   1   1457789999988854   3566777766432 12335779


Q ss_pred             eccccCCCh
Q 027788          107 TEVCTSGNL  115 (219)
Q Consensus       107 ~e~~~~g~L  115 (219)
                      ||++++.++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999987643

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.71  E-value=1e-05  Score=69.43  Aligned_cols=170  Identities=15%  Similarity=0.162  Sum_probs=108.5

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCC-ceEEEEEEecCCCce
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN-IISLHYVWRDEDRNT  102 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~~~~~~~~~~~~~  102 (219)
                      .+++..-.-+++++++++++.+...+...+ .+++...         ....-++++|.+++||| .+..++-+  +...+
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~  308 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDY  308 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---------hhhHHHHHHHHHccCCCCcccccccC--Ccccc
Confidence            334444467889999999998766554433 5554422         23446899999999999 44444444  55567


Q ss_pred             EEEEeccccCC-ChHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          103 LNFITEVCTSG-NLREYRK-KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       103 ~~lv~e~~~~g-~L~~~~~-~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      .++.++++.++ +-...+. ....+.......+.+.-..+++++|+..  -+|+|    |++...  +..+..+|+....
T Consensus       309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~--~~~~~~~~~v~~~  380 (829)
T KOG0576|consen  309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE--EEVKLLDFAVPPQ  380 (829)
T ss_pred             cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc--cccccccccCCcc
Confidence            88899999765 2221111 1112444455556666778889999765  47877    777653  3689999999888


Q ss_pred             ccccceeeeecccCccc----cCCCccccccceeeec
Q 027788          181 VGRAIRRIRCWGRRSSW----RRSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~diws~g  213 (219)
                      +.......+..+.|+..    .....+...-|.||++
T Consensus       381 L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~  417 (829)
T KOG0576|consen  381 LTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLA  417 (829)
T ss_pred             cCcccccccCCCCCCCCCchhhcccccccCCCccCCC
Confidence            87765444444443322    2334566677889888

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.60  E-value=0.0048  Score=46.39  Aligned_cols=138  Identities=20%  Similarity=0.275  Sum_probs=87.8

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCC------------CHHHHHHHHHHHHHHHhhC------CCCceEEE
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD------------DPAMIERLFSEVRLLKTLA------NKNIISLH   92 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~~~E~~~l~~l~------~~~i~~~~   92 (219)
                      ..||+|+.=.+|.-  + .....+||+........            .....+...+|+..+..+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            56889999888863  3 34567899887554000            0123466778888887777      67889999


Q ss_pred             EEEecCCCceEEEEecccc------CCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC
Q 027788           93 YVWRDEDRNTLNFITEVCT------SGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN  166 (219)
Q Consensus        93 ~~~~~~~~~~~~lv~e~~~------~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~  166 (219)
                      ++..+..+..  +++|...      ..+|.+++... .++. .....+.++   ..+|-...  |+.+|++|.||++...
T Consensus        84 G~veT~~G~G--lv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~~L~~f---~~~l~~~~--Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   84 GFVETNLGLG--LVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQALDEF---KRYLLDHH--IVIRDLNPHNIVVQRR  154 (199)
T ss_pred             EEEecCCceE--EEEEEEECCCCCcCccHHHHHHcC-CccH-HHHHHHHHH---HHHHHHcC--CeecCCCcccEEEEec
Confidence            9986655433  3666542      23677776433 4555 444444443   55666777  9999999999998633


Q ss_pred             C-C--cEEEec-ccccee
Q 027788          167 T-G--QVKIGD-LGVAAI  180 (219)
Q Consensus       167 ~-~--~~~l~d-fg~a~~  180 (219)
                      . +  .+.++| ||....
T Consensus       155 ~~~~~~lvlIDG~G~~~~  172 (199)
T PF10707_consen  155 DSGEFRLVLIDGLGEKEL  172 (199)
T ss_pred             CCCceEEEEEeCCCCccc
Confidence            2 1  355554 455444

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.58  E-value=0.0032  Score=48.46  Aligned_cols=74  Identities=18%  Similarity=0.161  Sum_probs=44.8

Q ss_pred             eeeccccceEEEEEEecC-CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCC-ceEEEEEEecCCCceEEEEec
Q 027788           31 ELLGSGAVKKVYRAFDQE-EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN-IISLHYVWRDEDRNTLNFITE  108 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~~~~~~~~~~~~~~~lv~e  108 (219)
                      +.|..|-...+|+..... .+..+.+|+......    .. -...+|..+++.+...+ ..+++..+  ++    .++||
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~-~d~~~E~~~~~~l~~~gl~P~v~~~~--~~----~~l~e   72 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LI-IDRERELRIHKLLSKHGLAPKLYATF--QN----GLIYE   72 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ce-ecHHHHHHHHHHHHhCCCCCeEEEEe--CC----cEEEE
Confidence            567788889999986443 356888997653211    11 12236888888885433 34444433  22    25999


Q ss_pred             cccCCCh
Q 027788          109 VCTSGNL  115 (219)
Q Consensus       109 ~~~~g~L  115 (219)
                      |++|.++
T Consensus        73 ~i~G~~l   79 (235)
T cd05157          73 FIPGRTL   79 (235)
T ss_pred             eeCCCcC
Confidence            9887554

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.47  E-value=0.003  Score=51.70  Aligned_cols=78  Identities=15%  Similarity=0.118  Sum_probs=49.0

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccC---CCHHHHHHHHHHHHHHHhhCC--C-CceEEEEEEecCCCceEE
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC---DDPAMIERLFSEVRLLKTLAN--K-NIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~E~~~l~~l~~--~-~i~~~~~~~~~~~~~~~~  104 (219)
                      +.||.|...-||++.....++.++||.-......   +-+-...+...|.+.|+....  | .+.+++.+-  ++  .-.
T Consensus         1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~e--~~~   76 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--TE--MAV   76 (370)
T ss_pred             CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--cc--cce
Confidence            3689999999999997543368999985432211   113345667788888876542  3 455554432  32  234


Q ss_pred             EEeccccC
Q 027788          105 FITEVCTS  112 (219)
Q Consensus       105 lv~e~~~~  112 (219)
                      ++||+++.
T Consensus        77 ~vMEdL~~   84 (370)
T TIGR01767        77 TVMEDLSH   84 (370)
T ss_pred             ehHhhCcc
Confidence            69999854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.47  E-value=0.0011  Score=51.79  Aligned_cols=139  Identities=20%  Similarity=0.234  Sum_probs=74.6

Q ss_pred             eccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCc-eEEEEEEecCCCceEEEEecccc
Q 027788           33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI-ISLHYVWRDEDRNTLNFITEVCT  111 (219)
Q Consensus        33 ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i-~~~~~~~~~~~~~~~~lv~e~~~  111 (219)
                      +..|..+.+|+..  .++..+++|......    ....-...+|..+++.+....+ .+++...  ++    ++++|+++
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~----~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~~----~~v~e~i~   71 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVC----KALGVDRQREYQILQALSALGLAPKPILVN--EH----WLLVEWLE   71 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCccc----ccccCcHHHHHHHHHHHHhcCCCCceEEEe--CC----EEEEEecc
Confidence            4567788888876  456678888644221    1100123568888888865333 3444333  22    46899998


Q ss_pred             CCChHH--------------HHHh-C--C----CCCHH-HHHHHHHHH---------HHHHHHHHhC------CCCeeee
Q 027788          112 SGNLRE--------------YRKK-H--R----HVSVK-ALKKWSKQI---------LKGLNYLHTH------EPCVIHR  154 (219)
Q Consensus       112 ~g~L~~--------------~~~~-~--~----~~~~~-~~~~i~~qv---------~~~l~~lh~~------~~~i~h~  154 (219)
                      |..+..              .+.. +  .    +++.. .+.....++         ......+-..      .+.++|+
T Consensus        72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~  151 (256)
T TIGR02721        72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM  151 (256)
T ss_pred             CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence            754421              1111 1  0    11111 111111111         1111111111      1248999


Q ss_pred             CCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          155 DLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       155 dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      |+.+.|++++.+ + +.++||+.+..-.+..
T Consensus       152 Dl~~~Nil~~~~-~-~~lIDwE~a~~gdp~~  180 (256)
T TIGR02721       152 DVHAYNLVVTPQ-G-LKLIDWEYASDGDIAL  180 (256)
T ss_pred             CCCcCcEEEeCC-C-CEEEeccccCcCCHHH
Confidence            999999999855 3 7899999887654433

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.11  E-value=0.015  Score=46.15  Aligned_cols=33  Identities=18%  Similarity=0.352  Sum_probs=26.4

Q ss_pred             CeeeeCCCCCceEEeCCCCcE-EEeccccceeccc
Q 027788          150 CVIHRDLNCSNVFVNGNTGQV-KIGDLGVAAIVGR  183 (219)
Q Consensus       150 ~i~h~dl~~~nili~~~~~~~-~l~dfg~a~~~~~  183 (219)
                      .++|+|+++.|++++.+ +.+ .|+||+.+..-.+
T Consensus       186 ~lvHGD~~~~Nilv~~~-~~~~gviDWe~a~iGDP  219 (276)
T cd05152         186 VLVHGDLHPGHILIDED-ARVTGLIDWTEAKVGDP  219 (276)
T ss_pred             eeEeCCCCCCcEEEeCC-CCEEEEECcHhcccCCH
Confidence            48999999999999854 344 6999999876544

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.07  E-value=0.011  Score=49.19  Aligned_cols=78  Identities=15%  Similarity=0.135  Sum_probs=50.6

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccC--CCHHHHHHHHHHHHHHHhhCC--C-CceEEEEEEecCCCceEEE
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC--DDPAMIERLFSEVRLLKTLAN--K-NIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~E~~~l~~l~~--~-~i~~~~~~~~~~~~~~~~l  105 (219)
                      +.||.|...-||++.+...++.|+||.-......  +=+-..++...|.+.|+.+..  | .+.+++.+-  ++  .-.+
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~e--~~~~  110 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--SV--MNCC  110 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--cH--HhhH
Confidence            6899999999999987444567999985422111  113445777888888876642  3 455555432  32  2346


Q ss_pred             EeccccC
Q 027788          106 ITEVCTS  112 (219)
Q Consensus       106 v~e~~~~  112 (219)
                      +||+++.
T Consensus       111 vMEdL~~  117 (409)
T PRK12396        111 VMEDLSD  117 (409)
T ss_pred             HHHhCcc
Confidence            9999864

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.03  E-value=0.026  Score=47.10  Aligned_cols=76  Identities=14%  Similarity=0.082  Sum_probs=49.2

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCH---HHHHHHHHHHHHHHhhC---CCCceEEEEEEecCCCceEE
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDP---AMIERLFSEVRLLKTLA---NKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~E~~~l~~l~---~~~i~~~~~~~~~~~~~~~~  104 (219)
                      +.||.|....||+..+.  +..++||.-.........   ....+-..|...|+.+.   ...+.+++.++.  +.  -+
T Consensus        38 ~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~--~v  111 (418)
T PLN02756         38 KEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TM--AL  111 (418)
T ss_pred             EEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CC--CE
Confidence            68899999999998753  456889975522221111   13455566777776654   246778877763  32  35


Q ss_pred             EEeccccC
Q 027788          105 FITEVCTS  112 (219)
Q Consensus       105 lv~e~~~~  112 (219)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            58999965

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.02  E-value=0.0035  Score=49.99  Aligned_cols=141  Identities=17%  Similarity=0.097  Sum_probs=75.0

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCC--ceEEEEEE----ecCCCceEE
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN--IISLHYVW----RDEDRNTLN  104 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~--i~~~~~~~----~~~~~~~~~  104 (219)
                      +.+..|....+|+...  ++..+++|.....    .   ...+..|+.+++.+...+  +.+++...    .....+..+
T Consensus        20 ~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~----~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          20 EGISAGIENTNYFVTT--DSGRYVLTLFEKV----S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             ecccCccccceEEEEe--CCCcEEEEEcCCC----C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            5677788889998753  3446888876531    1   234556788777775332  33433211    001123356


Q ss_pred             EEeccccCCChHH-----------HHHh-C---CCCCH--------HHHH------------HHHHHHHHHHHHHHh---
Q 027788          105 FITEVCTSGNLRE-----------YRKK-H---RHVSV--------KALK------------KWSKQILKGLNYLHT---  146 (219)
Q Consensus       105 lv~e~~~~g~L~~-----------~~~~-~---~~~~~--------~~~~------------~i~~qv~~~l~~lh~---  146 (219)
                      +++++++|..+..           .+.. +   ..+..        .-..            .....+...+.++..   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            7999998754321           0100 0   00000        0000            001112223333332   


Q ss_pred             --CCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          147 --HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       147 --~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                        ....++|+|++|.|++++.+ +.+.|+||+.+..-
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~~g  206 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFDGD-ELSGVIDFYFACTD  206 (296)
T ss_pred             hcCCCcCCccCcCcccEEEeCC-ceEEEeehhhhcCc
Confidence              11238999999999999854 34579999988654

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.95  E-value=0.033  Score=44.60  Aligned_cols=36  Identities=22%  Similarity=0.263  Sum_probs=28.9

Q ss_pred             CeeeeCCCCCceEEeCC---CCcEEEeccccceeccccc
Q 027788          150 CVIHRDLNCSNVFVNGN---TGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       150 ~i~h~dl~~~nili~~~---~~~~~l~dfg~a~~~~~~~  185 (219)
                      .++|+|+.+.||+++.+   .+.+.++||+.|....+..
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~p~~  218 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNYRGF  218 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCCcHH
Confidence            48999999999999853   2479999999997665533

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.80  E-value=0.032  Score=45.05  Aligned_cols=33  Identities=15%  Similarity=0.272  Sum_probs=27.6

Q ss_pred             CeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       150 ~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++|+|+++.|++++.+. .+-++||+++..-.+
T Consensus       199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~lGDP  231 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATLGDP  231 (321)
T ss_pred             eeeeCCcccCCEEEeCCC-eeEEEeccccccCCc
Confidence            589999999999999665 488999999975444

>PLN02236 choline kinase

Probab=96.79  E-value=0.023  Score=46.62  Aligned_cols=147  Identities=18%  Similarity=0.182  Sum_probs=79.9

Q ss_pred             eeeeeeeeccccceEEEEEEecC----CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCce-EEEEEEecCCC
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQE----EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII-SLHYVWRDEDR  100 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~-~~~~~~~~~~~  100 (219)
                      ...+ +.+-.|-+..+|+.....    .+..+.+|+.....    ...+.+ .+|..+++.+..-++. ++++.+  ++.
T Consensus        38 ~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t----~~~idR-~~E~~~~~~l~~~gl~P~~~~~~--~~g  109 (344)
T PLN02236         38 ALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV----ELFFDR-DDEIRTFECMSRHGQGPRLLGRF--PNG  109 (344)
T ss_pred             cEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC----Ceeech-HHHHHHHHHHHHcCCCCceEEEE--CCc
Confidence            3345 355568889999986322    24678888765432    122222 5688888888654443 455555  322


Q ss_pred             ceEEEEeccccCCChHHH--------------HHh-C--C-C----CC-HHHHHHHHHHH-----------------HHH
Q 027788          101 NTLNFITEVCTSGNLREY--------------RKK-H--R-H----VS-VKALKKWSKQI-----------------LKG  140 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~--------------~~~-~--~-~----~~-~~~~~~i~~qv-----------------~~~  140 (219)
                          .+++|+++.++...              +.. +  . +    .. ...+..+..++                 ...
T Consensus       110 ----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~  185 (344)
T PLN02236        110 ----RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDE  185 (344)
T ss_pred             ----eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHH
Confidence                36777765444210              110 1  0 0    11 12222222111                 111


Q ss_pred             HHHHH----h--CCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          141 LNYLH----T--HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       141 l~~lh----~--~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      +..|.    .  ....++|+|+++.||+++.+.+.+.++||+.+......
T Consensus       186 ~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~~~  235 (344)
T PLN02236        186 INLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNPVA  235 (344)
T ss_pred             HHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccchH
Confidence            11121    1  11248999999999999854457999999998866543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=96.78  E-value=0.0014  Score=57.06  Aligned_cols=45  Identities=24%  Similarity=0.496  Sum_probs=37.7

Q ss_pred             HHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          137 ILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       137 v~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      ++.|+.++|+... ++|+++.|+++.++.+ +..|+..|+++.....
T Consensus       108 v~dgl~flh~sAk-~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~  152 (700)
T KOG2137|consen  108 VADGLAFLHRSAK-VVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANG  152 (700)
T ss_pred             ccchhhhhccCcc-eeecccchhheeeccC-cceeeccchhhhccCC
Confidence            4489999996532 9999999999999966 5899999998887766

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=96.77  E-value=0.014  Score=48.62  Aligned_cols=181  Identities=13%  Similarity=0.101  Sum_probs=100.0

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEE----EE-E
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH----YV-W   95 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~----~~-~   95 (219)
                      ++-+.-.-....||+|+-+.+|..-.-   ..-+.|+++.....   .+ .....|+  .+--.||-+..-.    .. +
T Consensus         7 ~~~ge~i~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa---~~-aqk~a~l--a~~p~~p~~~~rvaWPqa~L~   77 (637)
T COG4248           7 DVYGEPIPPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPA---AQ-AQKVAEL--AATPDAPLLNYRVAWPQATLH   77 (637)
T ss_pred             cccCcccCCCccccCCccceeeecchh---hchhheeecCCCch---HH-HHHHHHh--ccCCCCcchhhhhcccHHHhh
Confidence            333444456678999999999964322   23456777654321   11 1111111  1122344332200    00 1


Q ss_pred             ecCCCceEEEEeccccCC-ChHHH------HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCC
Q 027788           96 RDEDRNTLNFITEVCTSG-NLREY------RKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG  168 (219)
Q Consensus        96 ~~~~~~~~~lv~e~~~~g-~L~~~------~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~  168 (219)
                      -...+..+=+.|+.+++. .+..+      .++.+..+++..+++.+.++.+...||..+  ..-+|++++|+|++.+ +
T Consensus        78 G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~-~  154 (637)
T COG4248          78 GGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDD-S  154 (637)
T ss_pred             CCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecC-c
Confidence            112222244577777543 12222      223345789999999999999999999999  8889999999999844 6


Q ss_pred             cEEEeccccceeccccceeeeeccc----CccccC-----CCccccccceeeec
Q 027788          169 QVKIGDLGVAAIVGRAIRRIRCWGR----RSSWRR-----SCTMRITRSLWTYT  213 (219)
Q Consensus       169 ~~~l~dfg~a~~~~~~~~~~~~~~~----~~~~~~-----~~~~~~~~diws~g  213 (219)
                      .+.+.|-..-.....+.....-++.    |++..+     ..+-+...|.++||
T Consensus       155 ~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLa  208 (637)
T COG4248         155 KVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLA  208 (637)
T ss_pred             eEEEEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHH
Confidence            7888765333222222221112222    223222     33345567888888

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=96.71  E-value=0.00019  Score=64.98  Aligned_cols=146  Identities=16%  Similarity=0.164  Sum_probs=98.6

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.+-+-++.++.++.+....++...+.|+......... ...+..+.+-.++....+|-+++....+...  ...+|++
T Consensus       807 ~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r--sP~~L~~  883 (1205)
T KOG0606|consen  807 EITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-NDYESIRSKSNILITPRSPAVVRSFPSFPCR--SPLPLVG  883 (1205)
T ss_pred             eecccccCCCCcccccCCccccccccchhhhccchhhcc-ccccccCCccCccccCCCCceecccCCCCCC--CCcchhh
Confidence            344567789999999887766675555555432211100 0112233344444444456555544443222  3467899


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      +++.+++|...+...+..+.+-.+-....+....++||...  +.|+|++|.|.+...+ +..++.+|+...
T Consensus       884 ~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~-gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYD-GHRPLTDFGTLS  952 (1205)
T ss_pred             HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhccc-CCcccCcccccc
Confidence            99999999998887777777766677777888999999987  8999999999998755 578999997443

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.39  E-value=0.053  Score=43.59  Aligned_cols=31  Identities=32%  Similarity=0.335  Sum_probs=25.5

Q ss_pred             CeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       150 ~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      .++|+|+++.|++++.+ +.+.++||+.+..-
T Consensus       188 ~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~~~  218 (307)
T TIGR00938       188 GVIHADLFPDNVLFDGD-SVKGVIDFYFACTD  218 (307)
T ss_pred             ccCCCCCCcCcEEEECC-ceEEEeecccccCc
Confidence            39999999999999865 34589999988543

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.32  E-value=0.11  Score=42.28  Aligned_cols=36  Identities=22%  Similarity=0.329  Sum_probs=29.2

Q ss_pred             CeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       150 ~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      .+.|+|+.+.||+++.+.+.++++||+.|....+..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd~~f  218 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSYRGY  218 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCCCccHH
Confidence            379999999999997554579999999987765544

>PRK05231 homoserine kinase; Provisional

Probab=96.28  E-value=0.25  Score=39.82  Aligned_cols=31  Identities=32%  Similarity=0.276  Sum_probs=24.7

Q ss_pred             CeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       150 ~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      .++|+|+++.|++++.+ ....++||+.+..-
T Consensus       188 ~liHgD~~~~Nil~~~~-~~~~iIDf~~~~~~  218 (319)
T PRK05231        188 GVIHADLFRDNVLFEGD-RLSGFIDFYFACND  218 (319)
T ss_pred             ccCCCCCCCCcEEEECC-ceEEEEecccccCC
Confidence            39999999999999844 23479999988643

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=95.86  E-value=0.0019  Score=54.04  Aligned_cols=44  Identities=23%  Similarity=0.354  Sum_probs=32.5

Q ss_pred             cEEEeccccceeccccce---eeeecccCccccCCCccccccceeeec
Q 027788          169 QVKIGDLGVAAIVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       169 ~~~l~dfg~a~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ++||+|||-|.......+   ++.-+++| +......|..++||||++
T Consensus       392 ~vKIaDlGNACW~~khFT~DIQTRQYRap-EVllGsgY~~~ADiWS~A  438 (590)
T KOG1290|consen  392 RVKIADLGNACWVHKHFTEDIQTRQYRAP-EVLLGSGYSTSADIWSTA  438 (590)
T ss_pred             eEEEeeccchhhhhhhhchhhhhhhccCc-ceeecCCCCCchhHHHHH
Confidence            689999999887654443   44445554 556667788899999999

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.67  E-value=0.36  Score=38.60  Aligned_cols=72  Identities=18%  Similarity=0.134  Sum_probs=41.8

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC---CCCceEEEEEEecCCCceEEEEe
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA---NKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      +.++-|....+|+..  .++..+.+|.-. ..      ....+..|.+-|+.|.   ...+.+++.+....+..  ++++
T Consensus        23 ~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~--fLll   91 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD--TDGGSYFVKVNS-ES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA--FLLL   91 (288)
T ss_dssp             EEE--SSSSEEEEEE--TTS-EEEEEEEE-GG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC--EEEE
T ss_pred             EecCCCChhheEEEE--CCCccEEEEecC-hh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc--eEEE
Confidence            567789999999876  667788999755 21      1145667888888773   34566777766544433  6799


Q ss_pred             ccccCC
Q 027788          108 EVCTSG  113 (219)
Q Consensus       108 e~~~~g  113 (219)
                      |+++.+
T Consensus        92 e~l~~~   97 (288)
T PF03881_consen   92 EFLEMG   97 (288)
T ss_dssp             E-----
T ss_pred             EeecCC
Confidence            998654

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.42  E-value=0.3  Score=37.69  Aligned_cols=69  Identities=16%  Similarity=0.174  Sum_probs=43.1

Q ss_pred             eEEEEEEecCCC-cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCC---ceEEEEEEecCCCceEEEEeccccCCC
Q 027788           39 KKVYRAFDQEEG-IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN---IISLHYVWRDEDRNTLNFITEVCTSGN  114 (219)
Q Consensus        39 g~V~~a~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~---i~~~~~~~~~~~~~~~~lv~e~~~~g~  114 (219)
                      |.|-.|....+| .++.+|+ +      ...+...|..|+.-|..+...|   +.+++.  .......-|+|+||++-+.
T Consensus        27 G~inea~~v~dg~~~~FvK~-n------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~--~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          27 GDINEAWRLRDGTDPFFVKC-N------QREQLSMFTAEADGLELLARSNTITVPKVIA--VGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             ccccceeEeecCCcceEEEe-c------chhhHHHHHHHHHHHHHHHhcCCccccceEE--ecCCCCeeEEEEeeccCCC
Confidence            444444444444 3566664 2      3455678889999888776554   444443  3456677889999998654


Q ss_pred             hH
Q 027788          115 LR  116 (219)
Q Consensus       115 L~  116 (219)
                      +.
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            43

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.35  E-value=0.095  Score=43.13  Aligned_cols=78  Identities=14%  Similarity=0.133  Sum_probs=52.2

Q ss_pred             CCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                      .++.+.|+++++- |+++.. +.   .....++..++.+.+..+.-+.. .-+.-|||+...||+++ + |++.|+||-+
T Consensus       296 de~~y~yl~~kdh-gt~is~-ik---~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~-GnvtLIDfkl  367 (488)
T COG5072         296 DETLYLYLHFKDH-GTPISI-IK---ADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-E-GNVTLIDFKL  367 (488)
T ss_pred             CCceEEEEEEecC-Cceeee-ee---cccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-c-CceEEEEeee
Confidence            3456778888876 455542 11   23456666666665554444443 33478999999999998 5 6899999999


Q ss_pred             ceeccc
Q 027788          178 AAIVGR  183 (219)
Q Consensus       178 a~~~~~  183 (219)
                      ++...+
T Consensus       368 sRl~~~  373 (488)
T COG5072         368 SRLSYS  373 (488)
T ss_pred             eecccC
Confidence            985443

>PTZ00384 choline kinase; Provisional

Probab=95.20  E-value=0.26  Score=41.07  Aligned_cols=33  Identities=18%  Similarity=0.137  Sum_probs=26.5

Q ss_pred             eeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       151 i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ..|.|+.+.||+.+.+  .+.++||..|.......
T Consensus       229 fCHNDL~~gNIL~~~~--~l~lID~EYA~~n~~~f  261 (383)
T PTZ00384        229 FCHNDLFFTNILDFNQ--GIYFIDFDFAGFNYVGW  261 (383)
T ss_pred             eeeccCCcccEEecCC--CEEEEEeccccCCchHh
Confidence            7999999999997633  69999999887655543

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.02  E-value=0.029  Score=45.38  Aligned_cols=144  Identities=17%  Similarity=0.207  Sum_probs=87.4

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccC-------------CCHH---HHHH--HHHHHHHHHhhCCC-
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC-------------DDPA---MIER--LFSEVRLLKTLANK-   86 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~-------------~~~~---~~~~--~~~E~~~l~~l~~~-   86 (219)
                      .+.++..||-|--+-||.+.+ ..|.+.++|+-..-...             ....   .+.+  ..+|...++.|.-. 
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            446778899999999999875 46778888863321100             0000   1112  23567777766431 


Q ss_pred             -CceEEEEEEecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC
Q 027788           87 -NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG  165 (219)
Q Consensus        87 -~i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~  165 (219)
                       -+.+.++..      .-++|||.+.+-.|.....   -.+..   .+...+..-+.-|..++  ++|+|.+-=||++..
T Consensus       172 fpVPkpiD~~------RH~Vvmelv~g~Pl~~v~~---v~d~~---~ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  172 FPVPKPIDHN------RHCVVMELVDGYPLRQVRH---VEDPP---TLYDDLMGLIVRLANHG--LIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCCCccccc------ceeeHHHhhcccceeeeee---cCChH---HHHHHHHHHHHHHHHcC--ceecccchheeEEec
Confidence             122333332      2467999998877754321   11222   23334444466677889  999999999999985


Q ss_pred             CCCcEEEeccccceeccccc
Q 027788          166 NTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       166 ~~~~~~l~dfg~a~~~~~~~  185 (219)
                      + +.++++||=-+.....+.
T Consensus       238 d-~~i~vIDFPQmvS~sh~n  256 (465)
T KOG2268|consen  238 D-DKIVVIDFPQMVSTSHPN  256 (465)
T ss_pred             C-CCEEEeechHhhccCCCc
Confidence            5 579999996555444443

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=94.69  E-value=0.058  Score=50.25  Aligned_cols=141  Identities=20%  Similarity=0.277  Sum_probs=89.5

Q ss_pred             HHHHHHHHHHHhhCCCCceEEEEEEecCCCce--EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 027788           71 ERLFSEVRLLKTLANKNIISLHYVWRDEDRNT--LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE  148 (219)
Q Consensus        71 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~--~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~  148 (219)
                      ...-.|.+.+.+..|+|+..++.+-.......  +.+..++|..-++.+.++.-...+..+.+.+..+...|+.++|...
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            34445777888999999999876654332222  2234577877788888887778899999999999999999999886


Q ss_pred             CCeeeeCCCCC---ceEEeCCCCcEEEe--ccccceeccccceeeeecccCcc----ccCCCccccc--cceeeecc
Q 027788          149 PCVIHRDLNCS---NVFVNGNTGQVKIG--DLGVAAIVGRAIRRIRCWGRRSS----WRRSCTMRIT--RSLWTYTR  214 (219)
Q Consensus       149 ~~i~h~dl~~~---nili~~~~~~~~l~--dfg~a~~~~~~~~~~~~~~~~~~----~~~~~~~~~~--~diws~gi  214 (219)
                        ..|.-|...   +...+.+ +.+.+.  ||+..+..............+..    -........+  .|+|.+|.
T Consensus       307 --l~~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  307 --LEHVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             --cceeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence              655555444   2222333 234444  88887776665543222222211    1223333333  58998883

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=94.57  E-value=0.023  Score=39.01  Aligned_cols=45  Identities=33%  Similarity=0.504  Sum_probs=33.8

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL   83 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l   83 (219)
                      .-|+.|+.|.||+|+ .++|+.||||+.+       +...+.+..++.+++.+
T Consensus        17 ~PlasASiaQVh~a~-l~~g~~VaVKV~r-------P~i~~~i~~Dl~~l~~~   61 (119)
T PF03109_consen   17 EPLASASIAQVHRAR-LKDGEEVAVKVQR-------PGIEEQIEADLRILRRL   61 (119)
T ss_pred             chhhheehhhheeee-ecccchhhhhhcc-------hHHHHHHHHHHHHHHHH
Confidence            359999999999998 4569999999866       33345566677776554

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=94.23  E-value=0.3  Score=40.92  Aligned_cols=61  Identities=20%  Similarity=0.165  Sum_probs=37.7

Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCeeeeCCCCCceEEeCCC
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY-LHTHEPCVIHRDLNCSNVFVNGNT  167 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~-lh~~~~~i~h~dl~~~nili~~~~  167 (219)
                      .++-+|..|.++..++... ..++....+++.-.+.++.. +--.+  ++|.|++|.|+++-.+.
T Consensus       321 vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf~~  382 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRFNK  382 (565)
T ss_pred             eeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEecC
Confidence            3455677777887776543 34444455554444444333 33446  89999999999986443

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.11  E-value=0.058  Score=41.33  Aligned_cols=86  Identities=20%  Similarity=0.299  Sum_probs=53.4

Q ss_pred             HHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 027788           71 ERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC  150 (219)
Q Consensus        71 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~  150 (219)
                      ..+.++..+++++.  .|+++..    .+....=++.|+|-.....            ..-.+..+ +..+...|+..+.
T Consensus       103 ~~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~i~------------~~N~i~ag-i~~L~~fH~~~~~  163 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIKIN------------FSNFITAG-IKDLMDFHSENQH  163 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCcccc------------hhHHHHHh-HHHHHHhhccCCC
Confidence            44577888887764  2555541    1223333577887432111            01111222 3557788977667


Q ss_pred             eeeeCCCCCceEEeCCCCcEEEeccc
Q 027788          151 VIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus       151 i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                      .+|+|..|+||+-+++ |.+|+.|=+
T Consensus       164 ~lHGD~np~NiM~D~~-G~lKlVDP~  188 (308)
T PF07387_consen  164 CLHGDCNPDNIMCDKF-GYLKLVDPV  188 (308)
T ss_pred             eecCCCChhheeecCC-CCEEecChh
Confidence            9999999999999966 689988754

The function of this family is unknown.

>PTZ00296 choline kinase; Provisional

Probab=92.58  E-value=2.2  Score=36.30  Aligned_cols=33  Identities=18%  Similarity=0.193  Sum_probs=26.4

Q ss_pred             CeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       150 ~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      .+.|+|+.+.||+.+.+  .++++||..|....+.
T Consensus       285 VfCHNDl~~~NiL~~~~--~l~LIDfEYAg~ndpa  317 (442)
T PTZ00296        285 VFCHNDLQENNIINTNK--CLRLIDFEYSGYNFLA  317 (442)
T ss_pred             eEEeCCCCccceeecCC--CEEEEeecccccccHH
Confidence            37999999999987633  5999999988765543

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=92.27  E-value=0.81  Score=35.83  Aligned_cols=73  Identities=12%  Similarity=0.049  Sum_probs=47.9

Q ss_pred             eeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHH---HHHHhhCCCCceEEEEEEecCCCceEEEEec
Q 027788           32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEV---RLLKTLANKNIISLHYVWRDEDRNTLNFITE  108 (219)
Q Consensus        32 ~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~---~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e  108 (219)
                      .+..|..+.|+.++ ..+|...++|+......         ...|.   ..|+..+-...+++++.-..  .  -.+++|
T Consensus         9 ~~~~g~~s~V~pv~-~~dG~~avLKl~~p~~~---------~~~E~~g~~~L~~w~G~GaVrll~~d~~--~--~AlLLE   74 (253)
T PF04655_consen    9 PPAHGSSSLVVPVR-RADGTPAVLKLAPPHAE---------AEHEARGEAALRWWNGRGAVRLLAADPE--R--GALLLE   74 (253)
T ss_pred             CCCCCcceEEEEEE-cCCCCeEEEEecCCccc---------chhhhhHHhHhheeCCCCceeeeccccc--c--chhhhh
Confidence            45678899999997 56899999998653211         11233   45777777778888876422  2  245888


Q ss_pred             cc-cCCChHHH
Q 027788          109 VC-TSGNLREY  118 (219)
Q Consensus       109 ~~-~~g~L~~~  118 (219)
                      ++ ++.+|.+.
T Consensus        75 rl~~g~~L~~~   85 (253)
T PF04655_consen   75 RLDPGRSLASL   85 (253)
T ss_pred             hccCCCchhhc
Confidence            88 55566543

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=92.22  E-value=0.11  Score=39.28  Aligned_cols=36  Identities=36%  Similarity=0.540  Sum_probs=22.6

Q ss_pred             CeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       150 ~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      .+.|+|+.+.||+++...+.++++||..|.......
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~n~~~f  179 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGYNDRAF  179 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EEEEHHH
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhhccchh
Confidence            378999999999993344689999999997665433

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=92.20  E-value=0.46  Score=38.07  Aligned_cols=29  Identities=21%  Similarity=0.376  Sum_probs=24.4

Q ss_pred             CeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       150 ~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      .++|+|+++.|++++.  +.+.++||+.+..
T Consensus       188 ~liHgD~~~~Nil~~~--~~i~lIDfd~~~~  216 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD--NEVYVIDFDYCTI  216 (313)
T ss_pred             ceEcCCCCcccEEEeC--CcEEEEECccccc
Confidence            3899999999999985  3689999997654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=91.18  E-value=0.31  Score=39.83  Aligned_cols=54  Identities=19%  Similarity=0.249  Sum_probs=32.8

Q ss_pred             HHHHHHHHHHHHHHHHHHHh-----CCCCeeeeCCCCCceEEeCCCC-----------------cEEEeccccceeccc
Q 027788          127 VKALKKWSKQILKGLNYLHT-----HEPCVIHRDLNCSNVFVNGNTG-----------------QVKIGDLGVAAIVGR  183 (219)
Q Consensus       127 ~~~~~~i~~qv~~~l~~lh~-----~~~~i~h~dl~~~nili~~~~~-----------------~~~l~dfg~a~~~~~  183 (219)
                      .+-+..+..|++.  .|+--     +.+ .+|.||||+|||+.+...                 ..++-||.+|..-.-
T Consensus       274 ~~YvkfifLQiaL--LyikIYelp~c~n-F~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~i  349 (434)
T PF05445_consen  274 VEYVKFIFLQIAL--LYIKIYELPCCTN-FLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVANI  349 (434)
T ss_pred             HHHHHHHHHHHHH--HHeeeecCCCcce-eeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhccc
Confidence            4456667777743  44221     211 899999999999853321                 346667777665433

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=90.88  E-value=0.26  Score=36.95  Aligned_cols=35  Identities=23%  Similarity=0.312  Sum_probs=27.3

Q ss_pred             CeeeeCCCCCceEEeCCC-C---cEEEeccccceecccc
Q 027788          150 CVIHRDLNCSNVFVNGNT-G---QVKIGDLGVAAIVGRA  184 (219)
Q Consensus       150 ~i~h~dl~~~nili~~~~-~---~~~l~dfg~a~~~~~~  184 (219)
                      .++|||+.+.|+++..+. +   .+.++||..+..-.+.
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~g~p~  159 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHYGSPA  159 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccCCcCChH
Confidence            489999999999997542 2   5789999998765443

subfamily of choline kinases

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	219
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-28
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		9e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-08
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-08
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-08
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		9e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-07
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-07
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-07
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-07
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-07
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-07
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-07
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-07
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-07
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-06
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-06
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-06
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-06
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-06
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-06
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-06
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-06
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-06
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-06
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-06
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-06
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-06
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-06
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-06
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-06
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-06
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-06
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-06
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-06
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-06
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-06
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-06
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-06
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-06
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-06
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-06
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-06
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-06
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-06
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-06
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-06
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		8e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		9e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		9e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		9e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		9e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-05
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-05
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-05
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-05
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-05
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-05
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-05
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-05
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-05
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-05
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-05
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-05
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-05
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-05
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-05
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-05
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-05
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-05
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-05
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		9e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-04
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-04
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-04
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-04
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-04
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-04
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-04
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-04
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-04
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-04
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-04
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-04
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-04
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-04
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-04
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-04
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-04
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-04
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-04
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-04
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-04
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-04
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-04
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-04
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-04
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-04
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-04
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-04
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-04
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-04
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-04
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-04
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-04
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-04
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-04
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-04
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-04
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-04
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-04
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-04
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-04
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-04
3soa_A	444	Full-Length Human Camkii Length = 444		3e-04
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-04
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-04
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-04
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-04
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-04
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-04
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-04
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		6e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-04
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-04
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-04
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-04
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-04
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-04
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-04
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-04

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  122 bits (307), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 60/154 (38%), Positives = 90/154 (58%), Gaps = 4/154 (2%)
Query: 24  GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL 83
           GR+ +++  +G G+ K VY+  D E  +EVAW +++ R         +R   E   LK L
Sbjct: 25  GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER--QRFKEEAEXLKGL 82
Query: 84  ANKNIISLHYVWRD--EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
            + NI+  +  W    + +  +  +TE+ TSG L+ Y K+ +   +K L+ W +QILKGL
Sbjct: 83  QHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGL 142
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            +LHT  P +IHRDL C N+F+ G TG VKIGDL
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 11/177 (6%)
Query: 3   PAVNSDPSDKDSE--PFIETDP--TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQV 58
           P+ + DP     +  P +  DP    RY R    LG G   K Y   D +   EV   +V
Sbjct: 17  PSAHVDPKSAPLKEIPDVLVDPRTMKRYMR-GRFLGKGGFAKCYEITDMDTK-EVFAGKV 74
Query: 59  KLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY 118
             ++    P   E++ +E+ + K+L N +++  H  + D+D   +  + E+C   +L E 
Sbjct: 75  VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDD--FVYVVLEICRRRSLLEL 132
Query: 119 RKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            K+ + V+    + + +Q ++G+ YLH +   VIHRDL   N+F+N +   VKIGD 
Sbjct: 133 HKRRKAVTEPEARYFMRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM-DVKIGDF 186

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 11/177 (6%)
Query: 3   PAVNSDPSDKDSE--PFIETDP--TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQV 58
           P+ + DP     +  P +  DP    RY R    LG G   K Y   D +   EV   +V
Sbjct: 17  PSAHVDPKSAPLKEIPDVLVDPRTMKRYMR-GRFLGKGGFAKCYEITDMDTK-EVFAGKV 74
Query: 59  KLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY 118
             ++    P   E++ +E+ + K+L N +++  H  + D+D   +  + E+C   +L E 
Sbjct: 75  VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDD--FVYVVLEICRRRSLLEL 132
Query: 119 RKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            K+ + V+    + + +Q ++G+ YLH +   VIHRDL   N+F+N +   VKIGD 
Sbjct: 133 HKRRKAVTEPEARYFMRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM-DVKIGDF 186

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 11/177 (6%)
Query: 3   PAVNSDPSDKDSE--PFIETDP--TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQV 58
           P+ + DP     +  P +  DP    RY R    LG G   K Y   D +   EV   +V
Sbjct: 17  PSAHVDPKSAPLKEIPDVLVDPRTMKRYMR-GRFLGKGGFAKCYEITDMDTK-EVFAGKV 74
Query: 59  KLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY 118
             ++    P   E++ +E+ + K+L N +++  H  + D+D   +  + E+C   +L E 
Sbjct: 75  VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDD--FVYVVLEICRRRSLLEL 132
Query: 119 RKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            K+ + V+    + + +Q ++G+ YLH +   VIHRDL   N+F+N +   VKIGD 
Sbjct: 133 HKRRKAVTEPEARYFMRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM-DVKIGDF 186

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 85/173 (49%), Gaps = 14/173 (8%)
Query: 10  SDKDSEPFIE-----TDP--TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRT 62
           SD  S P  E      DP    RY R    LG G   K Y   D +   EV   +V  ++
Sbjct: 5   SDPKSAPLKEIPDVLVDPRTMKRYMR-GRFLGKGGFAKCYEITDMDTK-EVFAGKVVPKS 62
Query: 63  FCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH 122
               P   E++ +E+ + K+L N +++  H  + D+D   +  + E+C   +L E  K+ 
Sbjct: 63  MLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDD--FVYVVLEICRRRSLLELHKRR 120
Query: 123 RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           + V+    + + +Q ++G+ YLH +   VIHRDL   N+F+N +   VKIGD 
Sbjct: 121 KAVTEPEARYFMRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM-DVKIGDF 170

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 83/152 (54%), Gaps = 10/152 (6%)
Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
           R  + +G G   +VYRA    +G+ VA  +V++    D  A  +    E+ LLK L + N
Sbjct: 35  RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD-CIKEIDLLKQLNHPN 93
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNL----REYRKKHRHVSVKALKKWSKQILKGLNY 143
           +I  +Y    ED N LN + E+  +G+L    + ++K+ R +  + + K+  Q+   L +
Sbjct: 94  VIK-YYASFIED-NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +H+    V+HRD+  +NVF+   TG VK+GDL
Sbjct: 152 MHSRR--VMHRDIKPANVFITA-TGVVKLGDL 180

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 76/145 (52%), Gaps = 7/145 (4%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
           LLG G+   VYRA     G+EVA   +  +       M++R+ +EV++   L + +I+ L
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPC 150
           +  +  ED N +  + E+C +G +  Y K   +  S    + +  QI+ G+ YLH+H   
Sbjct: 77  YNYF--EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH--G 132
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
           ++HRDL  SN+ +  N   +KI D 
Sbjct: 133 ILHRDLTLSNLLLTRNM-NIKIADF 156

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 86/171 (50%), Gaps = 14/171 (8%)
Query: 13  DSEPFIETDPT---GRYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCD 65
           + +P  E DPT    R+ +    LG G   KV    Y       G +VA   +K  +  +
Sbjct: 6   EKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN 65
Query: 66  DPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH- 124
               I  L  E+ +L+ L ++NI+    +  ++  N +  I E   SG+L+EY  K+++ 
Sbjct: 66  H---IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK 122
Query: 125 VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +++K   K++ QI KG++YL + +   +HRDL   NV V     QVKIGD 
Sbjct: 123 INLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEH-QVKIGDF 170

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 13/170 (7%)
Query: 6   NSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD 65
           NS  S  D +P I     G Y R  + +G G   KV  A     G EVA   +       
Sbjct: 2   NSITSATDEQPHI-----GNY-RLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQL-- 53
Query: 66  DPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV 125
           +P  +++LF EVR++K L + NI+ L  V   E   TL  + E  + G + +Y   H  +
Sbjct: 54  NPTSLQKLFREVRIMKILNHPNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRM 111
Query: 126 SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             K  +   +QI+  + Y   H+  ++HRDL   N+ ++G+   +KI D 
Sbjct: 112 KEKEARAKFRQIVSAVQY--CHQKYIVHRDLKAENLLLDGDM-NIKIADF 158

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 79/151 (52%), Gaps = 15/151 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG+G    VY+  ++  G+ VA  +VKL +    P+   R   E+ L+K L ++NI+ 
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---EISLMKELKHENIVR 67
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKH------RHVSVKALKKWSKQILKGLNYL 144
           L+ V   E++ TL F        +L++Y          R + +  +K +  Q+L+GL + 
Sbjct: 68  LYDVIHTENKLTLVF---EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF- 123
Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             HE  ++HRDL   N+ +N   GQ+K+GD 
Sbjct: 124 -CHENKILHRDLKPQNLLIN-KRGQLKLGDF 152

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
            LG G   K +   D +   EV   ++  ++    P   E++  E+ + ++LA+++++  
Sbjct: 48  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
           H  +  ED + +  + E+C   +L E  K+ + ++    + + +QI+ G  YLH +   V
Sbjct: 107 HGFF--EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 162
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
           IHRDL   N+F+N +  +VKIGD 
Sbjct: 163 IHRDLKLGNLFLNEDL-EVKIGDF 185

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
            LG G   K +   D +   EV   ++  ++    P   E++  E+ + ++LA+++++  
Sbjct: 28  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 86
Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
           H  +  ED + +  + E+C   +L E  K+ + ++    + + +QI+ G  YLH +   V
Sbjct: 87  HGFF--EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 142
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
           IHRDL   N+F+N +  +VKIGD 
Sbjct: 143 IHRDLKLGNLFLNEDL-EVKIGDF 165

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
            LG G   K +   D +   EV   ++  ++    P   E++  E+ + ++LA+++++  
Sbjct: 46  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 104
Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
           H  +  ED + +  + E+C   +L E  K+ + ++    + + +QI+ G  YLH +   V
Sbjct: 105 HGFF--EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 160
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
           IHRDL   N+F+N +  +VKIGD 
Sbjct: 161 IHRDLKLGNLFLNEDL-EVKIGDF 183

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
            LG G   K +   D +   EV   ++  ++    P   E++  E+ + ++LA+++++  
Sbjct: 24  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
           H  +  ED + +  + E+C   +L E  K+ + ++    + + +QI+ G  YLH +   V
Sbjct: 83  HGFF--EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 138
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
           IHRDL   N+F+N +  +VKIGD 
Sbjct: 139 IHRDLKLGNLFLNEDL-EVKIGDF 161

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
            LG G   K +   D +   EV   ++  ++    P   E++  E+ + ++LA+++++  
Sbjct: 24  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
           H  +  ED + +  + E+C   +L E  K+ + ++    + + +QI+ G  YLH +   V
Sbjct: 83  HGFF--EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 138
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
           IHRDL   N+F+N +  +VKIGD 
Sbjct: 139 IHRDLKLGNLFLNEDL-EVKIGDF 161

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
            LG G   K +   D +   EV   ++  ++    P   E++  E+ + ++LA+++++  
Sbjct: 22  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
           H  +  ED + +  + E+C   +L E  K+ + ++    + + +QI+ G  YLH +   V
Sbjct: 81  HGFF--EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 136
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
           IHRDL   N+F+N +  +VKIGD 
Sbjct: 137 IHRDLKLGNLFLNEDL-EVKIGDF 159

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/145 (31%), Positives = 75/145 (51%), Gaps = 7/145 (4%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    V++A ++E    VA  +V+L    DD  +      E+ LLK L +KNI+ 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVR 65
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           LH V   + + TL F  E C     + +   +  +  + +K +  Q+LKGL + H+    
Sbjct: 66  LHDVLHSDKKLTLVF--EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN-- 121
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
           V+HRDL   N+ +N N G++K+ D 
Sbjct: 122 VLHRDLKPQNLLINRN-GELKLADF 145

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 79/170 (46%), Gaps = 13/170 (7%)
Query: 6   NSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD 65
           NS  S  D +P I     G Y R  + +G G   KV  A     G EVA   +       
Sbjct: 2   NSIASCADEQPHI-----GNY-RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-- 53
Query: 66  DPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV 125
           +P  +++LF EVR++K L + NI+ L  V   E   TL  I E  + G + +Y   H  +
Sbjct: 54  NPTSLQKLFREVRIMKILNHPNIVKLFEVI--ETEKTLYLIMEYASGGEVFDYLVAHGRM 111
Query: 126 SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             K  +   +QI+  + Y   H+  ++HRDL   N+ ++ +   +KI D 
Sbjct: 112 KEKEARSKFRQIVSAVQY--CHQKRIVHRDLKAENLLLDADM-NIKIADF 158

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 75/145 (51%), Gaps = 7/145 (4%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    V++A ++E    VA  +V+L    DD  +      E+ LLK L +KNI+ 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVR 65
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           LH V   + + TL F  E C     + +   +  +  + +K +  Q+LKGL + H+    
Sbjct: 66  LHDVLHSDKKLTLVF--EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN-- 121
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
           V+HRDL   N+ +N N G++K+ + 
Sbjct: 122 VLHRDLKPQNLLINRN-GELKLANF 145

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 78/148 (52%), Gaps = 11/148 (7%)
Query: 33  LGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
           LG G   KV    Y       G +VA   +K  +  +  A +++   E+ +L+ L ++NI
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENI 73
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNYLHTH 147
           +    +  ++  N +  I E   SG+L+EY  K+++ +++K   K++ QI KG++YL + 
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +   +HRDL   NV V     QVKIGD 
Sbjct: 134 Q--YVHRDLAARNVLVESEH-QVKIGDF 158

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/101 (38%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWS 134
           E+ +LK+L + NI+    V     R  L  I E    G+LREY +KH+  +    L +++
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYT 123
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            QI KG+ YL T     IHRDL   N+ V  N  +VKIGD 
Sbjct: 124 SQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 161

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 78/170 (45%), Gaps = 15/170 (8%)
Query: 14  SEPFIETDPTG---RYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDD 66
           S  F + DPT    R+ ++ + LG G    V    Y       G  VA  +++  T    
Sbjct: 1   SGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---- 56
Query: 67  PAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-V 125
              +     E+ +LK+L + NI+    V     R  L  I E    G+LR+Y +KH+  +
Sbjct: 57  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 116
Query: 126 SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
               L +++ QI KG+ YL T     IHRDL   N+ V  N  +VKIGD 
Sbjct: 117 DHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 163

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 78/170 (45%), Gaps = 15/170 (8%)
Query: 14  SEPFIETDPTG---RYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDD 66
           S  F + DPT    R+ ++ + LG G    V    Y       G  VA  +++  T    
Sbjct: 3   SGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---- 58
Query: 67  PAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-V 125
              +     E+ +LK+L + NI+    V     R  L  I E    G+LR+Y +KH+  +
Sbjct: 59  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 118
Query: 126 SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
               L +++ QI KG+ YL T     IHRDL   N+ V  N  +VKIGD 
Sbjct: 119 DHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 165

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 4   AVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVK 59
           A+ S   D+D   F E     R+ ++ + LG G    V    Y       G  VA  +++
Sbjct: 25  AMGSAFEDRDPTQFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ 79
Query: 60  LRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYR 119
             T       +     E+ +LK+L + NI+    V     R  L  I E    G+LR+Y 
Sbjct: 80  HST----EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 135
Query: 120 KKHRH-VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +KH+  +    L +++ QI KG+ YL T     IHRDL   N+ V  N  +VKIGD 
Sbjct: 136 QKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 189

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 77/167 (46%), Gaps = 15/167 (8%)
Query: 17  FIETDPTG---RYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
           F + DPT    R+ ++ + LG G    V    Y       G  VA  +++  T       
Sbjct: 3   FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEH 58
Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVK 128
           +     E+ +LK+L + NI+    V     R  L  I E    G+LR+Y +KH+  +   
Sbjct: 59  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 118
Query: 129 ALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            L +++ QI KG+ YL T     IHRDL   N+ V  N  +VKIGD 
Sbjct: 119 KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 162

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 77/167 (46%), Gaps = 15/167 (8%)
Query: 17  FIETDPTG---RYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
           F + DPT    R+ ++ + LG G    V    Y       G  VA  +++  T       
Sbjct: 5   FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEH 60
Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVK 128
           +     E+ +LK+L + NI+    V     R  L  I E    G+LR+Y +KH+  +   
Sbjct: 61  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 120
Query: 129 ALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            L +++ QI KG+ YL T     IHRDL   N+ V  N  +VKIGD 
Sbjct: 121 KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 164

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 76/164 (46%), Gaps = 15/164 (9%)
Query: 20  TDPTG---RYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAMIER 72
           +DPT    R+ ++ + LG G    V    Y       G  VA  +++  T       +  
Sbjct: 2   SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRD 57
Query: 73  LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALK 131
              E+ +LK+L + NI+    V     R  L  I E    G+LR+Y +KH+  +    L 
Sbjct: 58  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 117
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +++ QI KG+ YL T     IHRDL   N+ V  N  +VKIGD 
Sbjct: 118 QYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 158

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/146 (34%), Positives = 67/146 (45%), Gaps = 9/146 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E++G G   KVYRAF    G EVA    +     D    IE +  E +L   L + NII+
Sbjct: 13  EIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L  V   E    L  + E    G L       R +    L  W+ QI +G+NYLH     
Sbjct: 71  LRGVCLKEP--NLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 151 -VIHRDLNCSNVFVNGNTGQVKIGDL 175
            +IHRDL  SN+ +     +V+ GDL
Sbjct: 128 PIIHRDLKSSNILI---LQKVENGDL 150

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 76/164 (46%), Gaps = 15/164 (9%)
Query: 20  TDPTG---RYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAMIER 72
           +DPT    R+ ++ + LG G    V    Y       G  VA  +++  T       +  
Sbjct: 2   SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRD 57
Query: 73  LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALK 131
              E+ +LK+L + NI+    V     R  L  I E    G+LR+Y +KH+  +    L 
Sbjct: 58  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 117
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +++ QI KG+ YL T     IHRDL   N+ V  N  +VKIGD 
Sbjct: 118 QYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 158

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWS 134
           E+ +LK+L + NI+    V     R  L  I E    G+LR+Y +KH+  +    L +++
Sbjct: 59  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 118
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            QI KG+ YL T     IHRDL   N+ V  N  +VKIGD 
Sbjct: 119 SQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 156

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWS 134
           E+ +LK+L + NI+    V     R  L  I E    G+LR+Y +KH+  +    L +++
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 123
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            QI KG+ YL T     IHRDL   N+ V  N  +VKIGD 
Sbjct: 124 SQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 161

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 13/163 (7%)
Query: 13  DSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER 72
           D +P I     G Y R  + +G G   KV  A     G EVA   +       +P  +++
Sbjct: 6   DEQPHI-----GNY-RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQK 57
Query: 73  LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK 132
           LF EVR++K L + NI+ L  V   E   TL  I E  + G + +Y   H  +  K  + 
Sbjct: 58  LFREVRIMKILNHPNIVKLFEVI--ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS 115
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             +QI+  + Y   H+  ++HRDL   N+ ++ +   +KI D 
Sbjct: 116 KFRQIVSAVQY--CHQKRIVHRDLKAENLLLDADM-NIKIADF 155

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWS 134
           E+ +LK+L + NI+    V     R  L  I E    G+LR+Y +KH+  +    L +++
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            QI KG+ YL T     IHRDL   N+ V  N  +VKIGD 
Sbjct: 121 SQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 158

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWS 134
           E+ +LK+L + NI+    V     R  L  I E    G+LR+Y +KH+  +    L +++
Sbjct: 60  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 119
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            QI KG+ YL T     IHRDL   N+ V  N  +VKIGD 
Sbjct: 120 SQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 157

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWS 134
           E+ +LK+L + NI+    V     R  L  I E    G+LR+Y +KH+  +    L +++
Sbjct: 79  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 138
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            QI KG+ YL T     IHRDL   N+ V  N  +VKIGD 
Sbjct: 139 SQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 176

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWS 134
           E+ +LK+L + NI+    V     R  L  I E    G+LR+Y +KH+  +    L +++
Sbjct: 79  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 138
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            QI KG+ YL T     IHRDL   N+ V  N  +VKIGD 
Sbjct: 139 SQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 176

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 25  RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA 84
           RY R  +L G G   +VY+A D      VA  +++L    ++  +      EV LLK L 
Sbjct: 35  RYRRITKL-GEGTYGEVYKAIDTVTNETVAIKRIRLEH--EEEGVPGTAIREVSLLKELQ 91
Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
           ++NII L  V     R  L+ I E     +L++Y  K+  VS++ +K +  Q++ G+N+ 
Sbjct: 92  HRNIIELKSVIHHNHR--LHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFC 148
Query: 145 HTHEPCVIHRDLNCSNVFVN----GNTGQVKIGDL 175
           H+   C +HRDL   N+ ++      T  +KIGD 
Sbjct: 149 HSRR-C-LHRDLKPQNLLLSVSDASETPVLKIGDF 181

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 7/151 (4%)
Query: 15  EPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER-- 72
           EPF +      Y    E LGSG    V +  ++  G+E A   +K R        + R  
Sbjct: 3   EPFKQQKVEDFYD-IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 73  LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK 132
           +  EV +L+ + + N+I+LH V+  E+R  +  I E+ + G L ++  +   +S +    
Sbjct: 62  IEREVSILRQVLHHNVITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFV 163
           + KQIL G+NYLHT +  + H DL   N+ +
Sbjct: 120 FIKQILDGVNYLHTKK--IAHFDLKPENIML 148

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 7/151 (4%)
Query: 15  EPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER-- 72
           EPF +      Y    E LGSG    V +  ++  G+E A   +K R        + R  
Sbjct: 3   EPFKQQKVEDFYD-IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 73  LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK 132
           +  EV +L+ + + N+I+LH V+  E+R  +  I E+ + G L ++  +   +S +    
Sbjct: 62  IEREVSILRQVLHHNVITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFV 163
           + KQIL G+NYLHT +  + H DL   N+ +
Sbjct: 120 FIKQILDGVNYLHTKK--IAHFDLKPENIML 148

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 7/151 (4%)
Query: 15  EPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER-- 72
           EPF +      Y    E LGSG    V +  ++  G+E A   +K R        + R  
Sbjct: 3   EPFKQQKVEDFYD-IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 73  LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK 132
           +  EV +L+ + + N+I+LH V+  E+R  +  I E+ + G L ++  +   +S +    
Sbjct: 62  IEREVSILRQVLHHNVITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFV 163
           + KQIL G+NYLHT +  + H DL   N+ +
Sbjct: 120 FIKQILDGVNYLHTKK--IAHFDLKPENIML 148

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 7/151 (4%)
Query: 15  EPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMI--ER 72
           EPF +      Y    E LGSG    V +  ++  G+E A   +K R        +  E 
Sbjct: 3   EPFKQQKVEDFYD-IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 73  LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK 132
           +  EV +L+ + + N+I+LH V+  E+R  +  I E+ + G L ++  +   +S +    
Sbjct: 62  IEREVSILRQVLHHNVITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFV 163
           + KQIL G+NYLHT +  + H DL   N+ +
Sbjct: 120 FIKQILDGVNYLHTKK--IAHFDLKPENIML 148

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 70/135 (51%), Gaps = 6/135 (4%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMI--ERLFSEVRLLKTLANKNI 88
           E LGSG    V +  ++  G+E A   +K R        +  E +  EV +L+ + + NI
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           I+LH V+  E+R  +  I E+ + G L ++  +   +S +    + KQIL G+NYLHT +
Sbjct: 78  ITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 149 PCVIHRDLNCSNVFV 163
             + H DL   N+ +
Sbjct: 136 --IAHFDLKPENIML 148

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 7/151 (4%)
Query: 15  EPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER-- 72
           EPF +      Y    E LGSG    V +  ++  G+E A   +K R        + R  
Sbjct: 3   EPFKQQKVEDFYD-IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 73  LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK 132
           +  EV +L+ + + N+I+LH V+  E+R  +  I E+ + G L ++  +   +S +    
Sbjct: 62  IEREVSILRQVLHHNVITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFV 163
           + KQIL G+NYLHT +  + H DL   N+ +
Sbjct: 120 FIKQILDGVNYLHTKK--IAHFDLKPENIML 148

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWS 134
           E+ +LK+L + NI+    V     R  L  I E    G+LR+Y +KH+  +    L +++
Sbjct: 62  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 121
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            QI KG+ YL T     IHR+L   N+ V  N  +VKIGD 
Sbjct: 122 SQICKGMEYLGTKR--YIHRNLATRNILVE-NENRVKIGDF 159

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 75/167 (44%), Gaps = 15/167 (8%)
Query: 17  FIETDPTG---RYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
           F + DPT    R+ ++ + LG G    V    Y       G  VA  +++  T       
Sbjct: 2   FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEH 57
Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVK 128
           +     E+ +LK+L + NI+    V     R  L  I E    G+LR+Y + H   +   
Sbjct: 58  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHI 117
Query: 129 ALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            L +++ QI KG+ YL T     IHRDL   N+ V  N  +VKIGD 
Sbjct: 118 KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 161

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 10  SDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
           +  D +P I     G Y R  + +G G   KV  A     G EVA   +       + + 
Sbjct: 5   TSADEQPHI-----GNY-RLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQL--NSSS 56
Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
           +++LF EVR++K L + NI+ L  V   E   TL  + E  + G + +Y   H  +  K 
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE 114
Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            +   +QI+  + Y   H+  ++HRDL   N+ ++ +   +KI D 
Sbjct: 115 ARAKFRQIVSAVQY--CHQKFIVHRDLKAENLLLDADM-NIKIADF 157

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 10  SDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
           +  D +P I     G Y R  + +G G   KV  A     G EVA   +       + + 
Sbjct: 5   TSADEQPHI-----GNY-RLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQL--NSSS 56
Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
           +++LF EVR++K L + NI+ L  V   E   TL  + E  + G + +Y   H  +  K 
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE 114
Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            +   +QI+  + Y   H+  ++HRDL   N+ ++ +   +KI D 
Sbjct: 115 ARAKFRQIVSAVQY--CHQKFIVHRDLKAENLLLDADM-NIKIADF 157

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 10  SDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
           +  D +P I     G Y R  + +G G   KV  A     G EVA   +       + + 
Sbjct: 5   TSADEQPHI-----GNY-RLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQL--NSSS 56
Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
           +++LF EVR++K L + NI+ L  V   E   TL  + E  + G + +Y   H  +  K 
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE 114
Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            +   +QI+  + Y   H+  ++HRDL   N+ ++ +   +KI D 
Sbjct: 115 ARAKFRQIVSAVQY--CHQKFIVHRDLKAENLLLDADM-NIKIADF 157

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 10  SDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
           +  D +P I     G Y R  + +G G   KV  A     G EVA   +       + + 
Sbjct: 5   TSADEQPHI-----GNY-RLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQL--NSSS 56
Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
           +++LF EVR++K L + NI+ L  V   E   TL  + E  + G + +Y   H  +  K 
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE 114
Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            +   +QI+  + Y   H+  ++HRDL   N+ ++ +   +KI D 
Sbjct: 115 ARAKFRQIVSAVQY--CHQKFIVHRDLKAENLLLDADM-NIKIADF 157

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 75  SEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS 134
            E+ +L+TL +++II       D    +L  + E    G+LR+Y  +H  + +  L  ++
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFA 140
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +QI +G+ YLH      IHRDL   NV ++ N   VKIGD 
Sbjct: 141 QQICEGMAYLHAQH--YIHRDLAARNVLLD-NDRLVKIGDF 178

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 10  SDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
           +  D +P I     G Y R  + +G G   KV  A     G EVA   +       + + 
Sbjct: 5   TSADEQPHI-----GNY-RLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQL--NSSS 56
Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
           +++LF EVR++K L + NI+ L  V   E   TL  + E  + G + +Y   H  +  K 
Sbjct: 57  LQKLFREVRIMKVLNHPNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE 114
Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            +   +QI+  + Y   H+  ++HRDL   N+ ++ +   +KI D 
Sbjct: 115 ARAKFRQIVSAVQY--CHQKFIVHRDLKAENLLLDADM-NIKIADF 157

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 75  SEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS 134
            E+ +L+TL +++II       D+   +L  + E    G+LR+Y  +H  + +  L  ++
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFA 123
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +QI +G+ YLH+     IHR+L   NV ++ N   VKIGD 
Sbjct: 124 QQICEGMAYLHSQH--YIHRNLAARNVLLD-NDRLVKIGDF 161

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 15/163 (9%)
Query: 21  DPT---GRYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAMIERL 73
           DPT    R+ +Y   LG G    V    Y       G  VA  Q++       P      
Sbjct: 16  DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH----SGPDQQRDF 71
Query: 74  FSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKK 132
             E+++LK L +  I+    V     R +L  + E   SG LR++ ++HR  +    L  
Sbjct: 72  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +S QI KG+ YL +     +HRDL   N+ V  +   VKI D 
Sbjct: 132 YSSQICKGMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADF 171

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 15/163 (9%)
Query: 21  DPT---GRYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAMIERL 73
           DPT    R+ +Y   LG G    V    Y       G  VA  Q++       P      
Sbjct: 4   DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH----SGPDQQRDF 59
Query: 74  FSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKK 132
             E+++LK L +  I+    V     R +L  + E   SG LR++ ++HR  +    L  
Sbjct: 60  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 119
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +S QI KG+ YL +     +HRDL   N+ V  +   VKI D 
Sbjct: 120 YSSQICKGMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADF 159

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
           IE+++ E+ +LK L + N++ L  V  D + + L  + E+   G + E     + +S   
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-PTLKPLSEDQ 138
Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            + + + ++KG+ YLH  +  +IHRD+  SN+ V G  G +KI D 
Sbjct: 139 ARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLV-GEDGHIKIADF 181

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 15/163 (9%)
Query: 21  DPT---GRYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAMIERL 73
           DPT    R+ +Y   LG G    V    Y       G  VA  Q++       P      
Sbjct: 3   DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH----SGPDQQRDF 58
Query: 74  FSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKK 132
             E+++LK L +  I+    V     R +L  + E   SG LR++ ++HR  +    L  
Sbjct: 59  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 118
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +S QI KG+ YL +     +HRDL   N+ V  +   VKI D 
Sbjct: 119 YSSQICKGMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADF 158

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 4/101 (3%)
Query: 75  SEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS 134
            E+ +L+TL +++II       D+   +L  + E    G+LR+Y  +H  + +  L  ++
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFA 123
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +QI +G+ YLH      IHR+L   NV ++ N   VKIGD 
Sbjct: 124 QQICEGMAYLHAQH--YIHRNLAARNVLLD-NDRLVKIGDF 161

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 33  LGSGAVKKVYRAFDQEEGIE-VAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNIIS 90
           +G GA  KV++A D + G   VA  +V+++T  +  P    R  + +R L+T  + N++ 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 91  LH---YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLH 145
           L     V R +    L  + E     +L  Y  K     V  + +K    Q+L+GL++LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +H   V+HRDL   N+ V  ++GQ+K+ D 
Sbjct: 138 SHR--VVHRDLKPQNILVT-SSGQIKLADF 164

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 83/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKSQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN ++ ++KI D 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDS-ELKILDF 169

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 33  LGSGAVKKVYRAFDQEEGIE-VAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNIIS 90
           +G GA  KV++A D + G   VA  +V+++T  +  P    R  + +R L+T  + N++ 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 91  LH---YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLH 145
           L     V R +    L  + E     +L  Y  K     V  + +K    Q+L+GL++LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +H   V+HRDL   N+ V  ++GQ+K+ D 
Sbjct: 138 SHR--VVHRDLKPQNILVT-SSGQIKLADF 164

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 33  LGSGAVKKVYRAFDQEEGIE-VAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNIIS 90
           +G GA  KV++A D + G   VA  +V+++T  +  P    R  + +R L+T  + N++ 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 91  LH---YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLH 145
           L     V R +    L  + E     +L  Y  K     V  + +K    Q+L+GL++LH
Sbjct: 79  LFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +H   V+HRDL   N+ V  ++GQ+K+ D 
Sbjct: 138 SHR--VVHRDLKPQNILVT-SSGQIKLADF 164

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 68/135 (50%), Gaps = 6/135 (4%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +G G+   V++  +++ G  VA    K     DDP + +    E+R+LK L + N+++L 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIK--KFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
            V+R + R  L+ + E C    L E  +  R V    +K  + Q L+ +N+ H H    I
Sbjct: 69  EVFRRKRR--LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CI 124
Query: 153 HRDLNCSNVFVNGNT 167
           HRD+   N+ +  ++
Sbjct: 125 HRDVKPENILITKHS 139

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 68/143 (47%), Gaps = 7/143 (4%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +G G   KV  A     G EVA   +       + + +++LF EVR++K L + NI+ L 
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQL--NSSSLQKLFREVRIMKVLNHPNIVKLF 72
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
            V   E   TL  + E  + G + +Y   H  +  K  +   +QI+  + Y   H+  ++
Sbjct: 73  EVI--ETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQY--CHQKFIV 128
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
           HRDL   N+ ++ +   +KI D 
Sbjct: 129 HRDLKAENLLLDADM-NIKIADF 150

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 9/158 (5%)
Query: 23  TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLK 81
           T RY    E+ G GA   VY+A D   G  VA   V++    +  P    R  + +R L+
Sbjct: 3   TSRYEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 82  TLANKNIISLHYVWRDE--DRNTLNFITEVCTSGNLREYRKKHRHVSVKA--LKKWSKQI 137
              + N++ L  V      DR     +       +LR Y  K     + A  +K   +Q 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 138 LKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L+GL++LH +  C++HRDL   N+ V    G VK+ D 
Sbjct: 122 LRGLDFLHAN--CIVHRDLKPENILVTSG-GTVKLADF 156

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKXQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDX-ELKILDF 169

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 9/158 (5%)
Query: 23  TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLK 81
           T RY    E+ G GA   VY+A D   G  VA   V++    +  P    R  + +R L+
Sbjct: 3   TSRYEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 82  TLANKNIISLHYVWRDE--DRNTLNFITEVCTSGNLREYRKKHRHVSVKA--LKKWSKQI 137
              + N++ L  V      DR     +       +LR Y  K     + A  +K   +Q 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 138 LKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L+GL++LH +  C++HRDL   N+ V    G VK+ D 
Sbjct: 122 LRGLDFLHAN--CIVHRDLKPENILVTSG-GTVKLADF 156

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 9/158 (5%)
Query: 23  TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLK 81
           T RY    E+ G GA   VY+A D   G  VA   V++    +  P    R  + +R L+
Sbjct: 3   TSRYEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 82  TLANKNIISLHYVWRDE--DRNTLNFITEVCTSGNLREYRKKHRHVSVKA--LKKWSKQI 137
              + N++ L  V      DR     +       +LR Y  K     + A  +K   +Q 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 138 LKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L+GL++LH +  C++HRDL   N+ V    G VK+ D 
Sbjct: 122 LRGLDFLHAN--CIVHRDLKPENILVTSG-GTVKLADF 156

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 11/147 (7%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
           +LG G    VY   D    + +A  ++  R    D    + L  E+ L K L +KNI+  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPER----DSRYSQPLHEEIALHKHLKHKNIV-- 82
Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
            Y+    +   +    E    G+L    R K   +  + + +  ++KQIL+GL YLH ++
Sbjct: 83  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             ++HRD+   NV +N  +G +KI D 
Sbjct: 143 --IVHRDIKGDNVLINTYSGVLKISDF 167

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 83/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 86
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 144
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN ++ ++KI D 
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDS-ELKILDF 175

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 11/147 (7%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
           +LG G    VY   D    + +A  ++  R    D    + L  E+ L K L +KNI+  
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPER----DSRYSQPLHEEIALHKHLKHKNIV-- 68
Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
            Y+    +   +    E    G+L    R K   +  + + +  ++KQIL+GL YLH ++
Sbjct: 69  QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 128
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             ++HRD+   NV +N  +G +KI D 
Sbjct: 129 --IVHRDIKGDNVLINTYSGVLKISDF 153

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 83/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 82
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 140
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN ++ ++KI D 
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDS-ELKILDF 171

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKXQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 10  SDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
           +  D +P I     G Y R  + +G G   KV  A     G EVA   +       + + 
Sbjct: 5   TSADEQPHI-----GNY-RLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQL--NSSS 56
Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
           +++LF EVR+ K L + NI+ L  V   E   TL  + E  + G + +Y   H     K 
Sbjct: 57  LQKLFREVRIXKVLNHPNIVKLFEVI--ETEKTLYLVXEYASGGEVFDYLVAHGRXKEKE 114
Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            +   +QI+  + Y   H+  ++HRDL   N+ ++ +   +KI D 
Sbjct: 115 ARAKFRQIVSAVQY--CHQKFIVHRDLKAENLLLDADX-NIKIADF 157

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A ++  G  VA  +++L T  +  P+   R   E+ LLK L + NI+
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 68
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
            L  V   E  N L  + E   S +L+++        + +  +K +  Q+L+GL + H+H
Sbjct: 69  KLLDVIHTE--NKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V+HRDL   N+ +N   G +K+ D 
Sbjct: 126 R--VLHRDLKPQNLLIN-TEGAIKLADF 150

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 77
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 78  HVCRLLGICLT---STVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 135 DRR--LVHRDLAARNVLVK-TPQHVKITDF 161

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 66/156 (42%), Gaps = 12/156 (7%)
Query: 25  RYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           R+ +Y   LG G    V    Y       G  VA  Q++       P        E+++L
Sbjct: 7   RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH----SGPDQQRDFQREIQIL 62
Query: 81  KTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILK 139
           K L +  I+    V     R  L  + E   SG LR++ ++HR  +    L  +S QI K
Sbjct: 63  KALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 122
Query: 140 GLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           G+ YL +     +HRDL   N+ V  +   VKI D 
Sbjct: 123 GMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADF 155

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 28  RYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 85
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 143
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDX-ELKILDF 174

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 70/161 (43%), Gaps = 12/161 (7%)
Query: 23  TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD----PAMIERLFSEVR 78
           T RY    E+ G GA   VY+A D   G  VA   V++          P    R  + +R
Sbjct: 8   TSRYEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 79  LLKTLANKNIISLHYVWRDE--DRNTLNFITEVCTSGNLREYRKKHRHVSVKA--LKKWS 134
            L+   + N++ L  V      DR     +       +LR Y  K     + A  +K   
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +Q L+GL++LH +  C++HRDL   N+ V    G VK+ D 
Sbjct: 127 RQFLRGLDFLHAN--CIVHRDLKPENILVTSG-GTVKLADF 164

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A ++  G  VA  +++L T  +  P+   R   E+ LLK L + NI+
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 67
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
            L  V   E  N L  + E   S +L+++        + +  +K +  Q+L+GL + H+H
Sbjct: 68  KLLDVIHTE--NKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V+HRDL   N+ +N   G +K+ D 
Sbjct: 125 R--VLHRDLKPQNLLIN-TEGAIKLADF 149

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 65/134 (48%), Gaps = 5/134 (3%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G +  VY A D    I+VA   + +    +    ++R   EV     L+++NI+S+ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPP-REKEETLKRFEREVHNSSQLSHQNIVSM- 76
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
            +  DE+ +    + E      L EY + H  +SV     ++ QIL G+   H H+  ++
Sbjct: 77  -IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK--HAHDMRIV 133
Query: 153 HRDLNCSNVFVNGN 166
           HRD+   N+ ++ N
Sbjct: 134 HRDIKPQNILIDSN 147

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 91
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 149
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVNEDX-ELKILDF 180

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 80
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 81  HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 138 DRR--LVHRDLAARNVLVK-TPQHVKITDF 164

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 85
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 143
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDX-ELKILDF 174

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A ++  G  VA  +++L T  +  P+   R   E+ LLK L + NI+
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 68
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
            L  V   E  N L  + E   S +L+++        + +  +K +  Q+L+GL + H+H
Sbjct: 69  KLLDVIHTE--NKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V+HRDL   N+ +N   G +K+ D 
Sbjct: 126 R--VLHRDLKPENLLIN-TEGAIKLADF 150

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 80
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 81  HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 138 DRR--LVHRDLAARNVLVK-TPQHVKITDF 164

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 14/163 (8%)
Query: 20  TDPTGRYGRYNEL---LGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAMIER 72
           +DPT  + RY +    LG G   KV    Y   +   G  VA     L+  C  P +   
Sbjct: 1   SDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK--ALKEGCG-PQLRSG 57
Query: 73  LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK 132
              E+ +L+TL +++I+       D+   ++  + E    G+LR+Y  +H  V +  L  
Sbjct: 58  WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGLAQLLL 116
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +++QI +G+ YLH      IHR L   NV ++ N   VKIGD 
Sbjct: 117 FAQQICEGMAYLHAQH--YIHRALAARNVLLD-NDRLVKIGDF 156

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 84
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 85  HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 142 DRR--LVHRDLAARNVLVK-TPQHVKITDF 168

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 84
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 85  HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 142 DRR--LVHRDLAARNVLVK-TPQHVKITDF 168

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 99
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 157
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 158 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 188

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 100
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 158
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 189

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 102
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 103 HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 159
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 160 DRR--LVHRDLAARNVLVK-TPQHVKITDF 186

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 79
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 80  HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 137 DRR--LVHRDLAARNVLVK-TPQHVKITDF 163

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 79
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 80  HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 137 DRR--LVHRDLAARNVLVK-TPQHVKITDF 163

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 77
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 78  HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 135 DRR--LVHRDLAARNVLVK-TPQHVKITDF 161

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 67
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E  N L  + E   S +L+++        + +  +K +  Q+L+GL + H+H 
Sbjct: 68  LLDVIHTE--NKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V+HRDL   N+ +N   G +K+ D 
Sbjct: 125 --VLHRDLKPENLLIN-TEGAIKLADF 148

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 21  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 78
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 79  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 136
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 137 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 167

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 80
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 81  HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 138 DRR--LVHRDLAARNVLVK-TPQHVKITDF 164

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 86
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 144
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 175

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 77
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 78  HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 135 DRR--LVHRDLAARNVLVK-TPQHVKITDF 161

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 83
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 84  HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 140
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 141 DRR--LVHRDLAARNVLVK-TPQHVKITDF 167

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 80/154 (51%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA    KL          +R + E+RLLK + +
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSKPFQSIIHAKRTYRELRLLKHMKH 92
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 150
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 181

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 103
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 161
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 162 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 192

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 92
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 150
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 181

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 92
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 150
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 181

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 87
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 145
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 176

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 85
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 143
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 174

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 71
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 72  HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 129 DRR--LVHRDLAARNVLVK-TPQHVKITDF 155

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 91
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 149
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 180

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 77
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 135
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 166

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 87
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 145
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 176

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 4/100 (4%)
Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSK 135
           E+ +L+TL +++I+       D+   ++  + E    G+LR+Y  +H  V +  L  +++
Sbjct: 60  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGLAQLLLFAQ 118
Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           QI +G+ YLH      IHR L   NV ++ N   VKIGD 
Sbjct: 119 QICEGMAYLHAQH--YIHRALAARNVLLD-NDRLVKIGDF 155

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 77
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 135
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 166

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 76
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 134
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 165

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 87
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 145
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 176

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 86
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 144
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 175

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 103
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 161
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 162 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 192

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 82
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 140
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 171

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 87
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 88  HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 144
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 145 DRR--LVHRDLAARNVLVK-TPQHVKITDF 171

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 82
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 140
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 171

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 82
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 140
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 171

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 87
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 145
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 176

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 85
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 143
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 174

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 77
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 78  HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 135 DRR--LVHRDLAARNVLVK-TPQHVKITDF 161

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 22  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 79
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 80  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 137
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 138 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 168

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 82/153 (53%), Gaps = 13/153 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILD 168

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 82/153 (53%), Gaps = 13/153 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILD 168

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 82/153 (53%), Gaps = 13/153 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILD 168

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 82/153 (53%), Gaps = 13/153 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILD 168

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 10/148 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEG--IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
           ++LGSGA   VY+     EG  +++    ++LR     P   + +  E  ++ ++ N ++
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELRE-ATSPKANKEILDEAYVMASVDNPHV 113
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTH 147
             L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL   
Sbjct: 114 CRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 170
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              ++HRDL   NV V      VKI D 
Sbjct: 171 R--LVHRDLAARNVLVK-TPQHVKITDF 195

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 76/143 (53%), Gaps = 12/143 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVN 164
            Y+H+ +  +IHRDL  SN+ VN
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN 159

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26  YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
           Y    E LGSG    V +  ++  G++ A   +K R        + R  +  EV +LK +
Sbjct: 12  YYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
            + N+I+LH V+  E++  +  I E+   G L ++  +   ++ +   ++ KQIL G+ Y
Sbjct: 72  QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
           LH+ +  + H DL   N+ +   N    ++KI D 
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A ++  G  VA  +++L T  +  P+   R   E+ LLK L + NI+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 65
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
            L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL++ H+H
Sbjct: 66  KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSH 122
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V+HRDL   N+ +N   G +K+ D 
Sbjct: 123 R--VLHRDLKPQNLLIN-TEGAIKLADF 147

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26  YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
           Y    E LGSG    V +  ++  G++ A   +K R        + R  +  EV +LK +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
            + N+I+LH V+  E++  +  I E+   G L ++  +   ++ +   ++ KQIL G+ Y
Sbjct: 72  QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
           LH+ +  + H DL   N+ +   N    ++KI D 
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26  YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
           Y    E LGSG    V +  ++  G++ A   +K R        + R  +  EV +LK +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
            + N+I+LH V+  E++  +  I E+   G L ++  +   ++ +   ++ KQIL G+ Y
Sbjct: 72  QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
           LH+ +  + H DL   N+ +   N    ++KI D 
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26  YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
           Y    E LGSG    V +  ++  G++ A   +K R        + R  +  EV +LK +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
            + N+I+LH V+  E++  +  I E+   G L ++  +   ++ +   ++ KQIL G+ Y
Sbjct: 72  QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
           LH+ +  + H DL   N+ +   N    ++KI D 
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26  YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
           Y    E LGSG    V +  ++  G++ A   +K R        + R  +  EV +LK +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
            + N+I+LH V+  E++  +  I E+   G L ++  +   ++ +   ++ KQIL G+ Y
Sbjct: 72  QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
           LH+ +  + H DL   N+ +   N    ++KI D 
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26  YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
           Y    E LGSG    V +  ++  G++ A   +K R        + R  +  EV +LK +
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
            + N+I+LH V+  E++  +  I E+   G L ++  +   ++ +   ++ KQIL G+ Y
Sbjct: 71  QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
           LH+ +  + H DL   N+ +   N    ++KI D 
Sbjct: 129 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 161

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26  YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
           Y    E LGSG    V +  ++  G++ A   +K R        + R  +  EV +LK +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
            + N+I+LH V+  E++  +  I E+   G L ++  +   ++ +   ++ KQIL G+ Y
Sbjct: 72  QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
           LH+ +  + H DL   N+ +   N    ++KI D 
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26  YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
           Y    E LGSG    V +  ++  G++ A   +K R        + R  +  EV +LK +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
            + N+I+LH V+  E++  +  I E+   G L ++  +   ++ +   ++ KQIL G+ Y
Sbjct: 72  QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
           LH+ +  + H DL   N+ +   N    ++KI D 
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26  YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
           Y    E LGSG    V +  ++  G++ A   +K R        + R  +  EV +LK +
Sbjct: 12  YYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
            + N+I+LH V+  E++  +  I E+   G L ++  +   ++ +   ++ KQIL G+ Y
Sbjct: 72  QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
           LH+ +  + H DL   N+ +   N    ++KI D 
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 79/149 (53%), Gaps = 10/149 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G+GA   V  A  +  G +VA    K+    D     +R   E+++LK   + NII+
Sbjct: 61  ETIGNGAYGVVSSARRRLTGQQVAIK--KIPNAFDVVTNAKRTLRELKILKHFKHDNIIA 118
Query: 91  LHYVWRDE----DRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
           +  + R      +  ++  + ++  S +L +     + ++++ ++ +  Q+L+GL Y+H+
Sbjct: 119 IKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS 177
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            +  VIHRDL  SN+ VN N  ++KIGD 
Sbjct: 178 AQ--VIHRDLKPSNLLVNENC-ELKIGDF 203

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26  YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
           Y    E LGSG    V +  ++  G++ A   +K R        + R  +  EV +LK +
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
            + N+I+LH V+  E++  +  I E+   G L ++  +   ++ +   ++ KQIL G+ Y
Sbjct: 71  QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
           LH+ +  + H DL   N+ +   N    ++KI D 
Sbjct: 129 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 161

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A ++  G  VA  +++L T  +  P+   R   E+ LLK L + NI+
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 72
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
            L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H
Sbjct: 73  KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V+HRDL   N+ +N   G +K+ D 
Sbjct: 130 R--VLHRDLKPQNLLIN-TEGAIKLADF 154

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26  YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
           Y    E LGSG    V +  ++  G++ A   +K R        + R  +  EV +LK +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
            + N+I+LH V+  E++  +  I E+   G L ++  +   ++ +   ++ KQIL G+ Y
Sbjct: 72  QHPNVITLHEVY--ENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
           LH+ +  + H DL   N+ +   N    ++KI D 
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A ++  G  VA  +++L T  +  P+   R   E+ LLK L + NI+
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 72
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
            L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H
Sbjct: 73  KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V+HRDL   N+ +N   G +K+ D 
Sbjct: 130 R--VLHRDLKPQNLLIN-TEGAIKLADF 154

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 69/135 (51%), Gaps = 6/135 (4%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTLANKNI 88
           E LGSG    V +  ++  G++ A   +K R        + R  +  EV +LK + + N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           I+LH V+  E++  +  I E+   G L ++  +   ++ +   ++ KQIL G+ YLH+ +
Sbjct: 77  ITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 149 PCVIHRDLNCSNVFV 163
             + H DL   N+ +
Sbjct: 135 --IAHFDLKPENIML 147

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 9/150 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTLANKNI 88
           E LGSG    V +  ++  G++ A   +K R        + R  +  EV +LK + + N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           I+LH V+  E++  +  I E+   G L ++  +   ++ +   ++ KQIL G+ YLH+ +
Sbjct: 77  ITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 149 PCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
             + H DL   N+ +   N    ++KI D 
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDF 162

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 69
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H 
Sbjct: 70  LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V+HRDL   N+ +N   G +K+ D 
Sbjct: 127 --VLHRDLKPQNLLIN-TEGAIKLADF 150

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 66
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H 
Sbjct: 67  LLDVIHTE--NKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V+HRDL   N+ +N   G +K+ D 
Sbjct: 124 --VLHRDLKPENLLIN-TEGAIKLADF 147

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 68
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H 
Sbjct: 69  LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V+HRDL   N+ +N   G +K+ D 
Sbjct: 126 --VLHRDLKPQNLLIN-TEGAIKLADF 149

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A ++  G  VA  +++L T  +  P+   R   E+ LLK L + NI+
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 68
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
            L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H
Sbjct: 69  KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V+HRDL   N+ +N   G +K+ D 
Sbjct: 126 R--VLHRDLKPQNLLIN-TEGAIKLADF 150

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26  YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
           Y    E LGSG    V +  ++  G++ A   +K R        + R  +  EV +LK +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
            + N+I+LH V+  E++  +  I E+   G L ++  +   ++ +   ++ KQIL G+ Y
Sbjct: 72  QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
           LH+ +  + H DL   N+ +   N    ++KI D 
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 78
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  I ++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 79  HVCRLLGICLT---STVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 136 DRR--LVHRDLAARNVLVK-TPQHVKITDF 162

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 68
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H 
Sbjct: 69  LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V+HRDL   N+ +N   G +K+ D 
Sbjct: 126 --VLHRDLKPQNLLIN-TEGAIKLADF 149

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 15/150 (10%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF-----CDDPAMIER----LFSEVRLLKTL 83
           LGSGA  +V    ++    E A   +K   F      DD   IE+    +++E+ LLK+L
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE-YRKKHRHVSVKALKKWSKQILKGLN 142
            + NII L  V+  ED+     +TE    G L E    +H+     A     KQIL G+ 
Sbjct: 104 DHPNIIKLFDVF--EDKKYFYLVTEFYEGGELFEQIINRHKFDECDA-ANIMKQILSGIC 160
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKI 172
           YLH H   ++HRD+   N+ +      + I
Sbjct: 161 YLHKHN--IVHRDIKPENILLENKNSLLNI 188

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 21  DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           DP  +Y R+ E +G GA   VY A D   G EVA  Q+ L+     P   E + +E+ ++
Sbjct: 18  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEILVM 72
Query: 81  KTLANKNIISL--HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
           +   N NI++    Y+  DE    L  + E    G+L +   +   +    +    ++ L
Sbjct: 73  RENKNPNIVNYLDSYLVGDE----LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECL 127
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           + L +LH+++  VIHRD+   N+ + G  G VK+ D 
Sbjct: 128 QALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDF 161

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 67
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H 
Sbjct: 68  LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V+HRDL   N+ +N   G +K+ D 
Sbjct: 125 --VLHRDLKPQNLLIN-TEGAIKLADF 148

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 23  TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKT 82
           + RY R  +L GSGA  +V    D+  G E A   +K ++     +    L  EV +LK 
Sbjct: 20  SDRYQRVKKL-GSGAYGEVLLCKDKLTGAERAIKIIK-KSSVTTTSNSGALLDEVAVLKQ 77
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRKKHRHVSVKALKKWSKQILK 139
           L + NI+ L+  +  ED+     + EV   G L +    R+K   V    +    KQ+L 
Sbjct: 78  LDHPNIMKLYEFF--EDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI---MKQVLS 132
Query: 140 GLNYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDL 175
           G  YLH H   ++HRDL   N+ +   +    +KI D 
Sbjct: 133 GTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDF 168

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A ++  G  VA  +++L T  +  P+   R   E+ LLK L + NI+
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 69
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
            L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H
Sbjct: 70  KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V+HRDL   N+ +N   G +K+ D 
Sbjct: 127 R--VLHRDLKPQNLLIN-TEGAIKLADF 151

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A ++  G  VA  +++L T  +  P+   R   E+ LLK L + NI+
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 69
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
            L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H
Sbjct: 70  KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V+HRDL   N+ +N   G +K+ D 
Sbjct: 127 R--VLHRDLKPQNLLIN-TEGAIKLADF 151

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 74
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI +G+NYL 
Sbjct: 75  HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLE 131
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 132 DRR--LVHRDLAARNVLVK-TPQHVKITDF 158

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 68
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H 
Sbjct: 69  LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V+HRDL   N+ +N   G +K+ D 
Sbjct: 126 --VLHRDLKPENLLIN-TEGAIKLADF 149

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 66
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H 
Sbjct: 67  LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V+HRDL   N+ +N   G +K+ D 
Sbjct: 124 --VLHRDLKPQNLLIN-TEGAIKLADF 147

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 66
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H 
Sbjct: 67  LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V+HRDL   N+ +N   G +K+ D 
Sbjct: 124 --VLHRDLKPQNLLIN-TEGAIKLADF 147

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 67
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H 
Sbjct: 68  LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V+HRDL   N+ +N   G +K+ D 
Sbjct: 125 --VLHRDLKPENLLIN-TEGAIKLADF 148

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 21  DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           DP  +Y R+ E +G GA   VY A D   G EVA  Q+ L+     P   E + +E+ ++
Sbjct: 17  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEILVM 71
Query: 81  KTLANKNIISL--HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
           +   N NI++    Y+  DE    L  + E    G+L +   +   +    +    ++ L
Sbjct: 72  RENKNPNIVNYLDSYLVGDE----LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECL 126
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           + L +LH+++  VIHRD+   N+ + G  G VK+ D 
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDF 160

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A ++  G  VA  +++L T  +  P+   R   E+ LLK L + NI+
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 64
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
            L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H
Sbjct: 65  KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V+HRDL   N+ +N   G +K+ D 
Sbjct: 122 R--VLHRDLKPQNLLIN-TEGAIKLADF 146

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A ++  G  VA  +++L T  +  P+   R   E+ LLK L + NI+
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 66
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
            L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H
Sbjct: 67  KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V+HRDL   N+ +N   G +K+ D 
Sbjct: 124 R--VLHRDLKPQNLLIN-TEGAIKLADF 148

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 21  DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           DP  +Y R+ E +G GA   VY A D   G EVA  Q+ L+     P   E + +E+ ++
Sbjct: 17  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEILVM 71
Query: 81  KTLANKNIISL--HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
           +   N NI++    Y+  DE    L  + E    G+L +   +   +    +    ++ L
Sbjct: 72  RENKNPNIVNYLDSYLVGDE----LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECL 126
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           + L +LH+++  VIHRD+   N+ + G  G VK+ D 
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDF 160

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 79/149 (53%), Gaps = 10/149 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G+GA   V  A  +  G +VA    K+    D     +R   E+++LK   + NII+
Sbjct: 60  ETIGNGAYGVVSSARRRLTGQQVAIK--KIPNAFDVVTNAKRTLRELKILKHFKHDNIIA 117
Query: 91  LHYVWRDE----DRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
           +  + R      +  ++  + ++  S +L +     + ++++ ++ +  Q+L+GL Y+H+
Sbjct: 118 IKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS 176
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            +  VIHRDL  SN+ VN N  ++KIGD 
Sbjct: 177 AQ--VIHRDLKPSNLLVNENC-ELKIGDF 202

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 69
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E++  L F        +L+++        + +  +K +  Q+L+GL + H+H 
Sbjct: 70  LLDVIHTENKLYLVF---EHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V+HRDL   N+ +N   G +K+ D 
Sbjct: 127 --VLHRDLKPQNLLIN-TEGAIKLADF 150

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 66
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H 
Sbjct: 67  LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V+HRDL   N+ +N   G +K+ D 
Sbjct: 124 --VLHRDLKPQNLLIN-TEGAIKLADF 147

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 67
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H 
Sbjct: 68  LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V+HRDL   N+ +N   G +K+ D 
Sbjct: 125 --VLHRDLKPQNLLIN-TEGAIKLADF 148

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 66
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H 
Sbjct: 67  LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V+HRDL   N+ +N   G +K+ D 
Sbjct: 124 --VLHRDLKPQNLLIN-TEGAIKLADF 147

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LGSG    V + + Q + +        L+   +DPA+ + L +E  +++ L N  I+ + 
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
            +   E   +   + E+   G L +Y +++RHV  K + +   Q+  G+ YL   E   +
Sbjct: 437 GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 491
Query: 153 HRDLNCSNVFV 163
           HRDL   NV +
Sbjct: 492 HRDLAARNVLL 502

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 21  DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           DP  +Y R+ E +G GA   VY A D   G EVA  Q+ L+     P   E + +E+ ++
Sbjct: 17  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEILVM 71
Query: 81  KTLANKNIISL--HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
           +   N NI++    Y+  DE    L  + E    G+L +   +   +    +    ++ L
Sbjct: 72  RENKNPNIVNYLDSYLVGDE----LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECL 126
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           + L +LH+++  VIHRD+   N+ + G  G VK+ D 
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDF 160

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A ++  G  VA  +++L T  +  P+   R   E+ LLK L + NI+
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 64
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
            L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H
Sbjct: 65  KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V+HRDL   N+ +N   G +K+ D 
Sbjct: 122 R--VLHRDLKPQNLLIN-TEGAIKLADF 146

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LGSG    V + + Q + +        L+   +DPA+ + L +E  +++ L N  I+ + 
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
            +   E   +   + E+   G L +Y +++RHV  K + +   Q+  G+ YL   E   +
Sbjct: 438 GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 492
Query: 153 HRDLNCSNVFV 163
           HRDL   NV +
Sbjct: 493 HRDLAARNVLL 503

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A ++  G  VA  +++L T  +  P+   R   E+ LLK L + NI+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 65
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
            L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H
Sbjct: 66  KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V+HRDL   N+ +N   G +K+ D 
Sbjct: 123 R--VLHRDLKPQNLLIN-TEGAIKLADF 147

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 65
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H 
Sbjct: 66  LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V+HRDL   N+ +N   G +K+ D 
Sbjct: 123 --VLHRDLKPQNLLIN-TEGAIKLADF 146

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A ++  G  VA  +++L T  +  P+   R   E+ LLK L + NI+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 65
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
            L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H
Sbjct: 66  KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V+HRDL   N+ +N   G +K+ D 
Sbjct: 123 R--VLHRDLKPQNLLIN-TEGAIKLADF 147

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 81
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  I ++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 82  HVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 139 DRR--LVHRDLAARNVLVK-TPQHVKITDF 165

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 66
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H 
Sbjct: 67  LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V+HRDL   N+ +N   G +K+ D 
Sbjct: 124 --VLHRDLKPQNLLIN-TEGAIKLADF 147

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 65
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H 
Sbjct: 66  LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V+HRDL   N+ +N   G +K+ D 
Sbjct: 123 --VLHRDLKPQNLLIN-TEGAIKLADF 146

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLA 79
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 80  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 136
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 137 RGLKYIHSAN--VLHRDLKPSNLLLN-TTSDLKICDF 170

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 80
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  I ++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 81  HVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 138 DRR--LVHRDLAARNVLVK-TPQHVKITDF 164

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A ++  G  VA  +++L T  +  P+   R   E+ LLK L + NI+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 65
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
            L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H
Sbjct: 66  KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V+HRDL   N+ +N   G +K+ D 
Sbjct: 123 R--VLHRDLKPQNLLIN-TEGAIKLADF 147

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A ++  G  VA  +++L T  +  P+   R   E+ LLK L + NI+
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 64
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
            L  V   E  N L  + E     +L+++        + +  +K +  Q+L+GL + H+H
Sbjct: 65  KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V+HRDL   N+ +N   G +K+ D 
Sbjct: 122 R--VLHRDLKPQNLLIN-TEGAIKLADF 146

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 12/148 (8%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A ++  G  VA  +++L T  +  P+   R   E+ LLK L + NI+
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 68
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
            L  V   E  N L  + E     +L+ +        + +  +K +  Q+L+GL + H+H
Sbjct: 69  KLLDVIHTE--NKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V+HRDL   N+ +N   G +K+ D 
Sbjct: 126 R--VLHRDLKPQNLLIN-TEGAIKLADF 150

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 79
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  I ++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 80  HVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 137 DRR--LVHRDLAARNVLVK-TPQHVKITDF 163

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 81
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  I ++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 82  HVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 139 DRR--LVHRDLAARNVLVK-TPQHVKITDF 165

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 68/144 (47%), Gaps = 10/144 (6%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG GA  KVY+A ++E  +  A   +  ++       +E    E+ +L +  + NI+ L 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLL 100
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYR-KKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
             +  E  N L  + E C  G +     +  R ++   ++   KQ L  LNYLH ++  +
Sbjct: 101 DAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--I 156
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
           IHRDL   N+    + G +K+ D 
Sbjct: 157 IHRDLKAGNILFTLD-GDIKLADF 179

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 79
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  I ++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 80  HVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 137 DRR--LVHRDLAARNVLVK-TPQHVKITDF 163

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 21  DPTGRYGRYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER-LFSEV 77
           D   R  RY +L  LG G    VY+A D+     VA  ++KL    +    I R    E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 78  RLLKTLANKNIISLHYVWRDEDRNTLNF-----ITEVCTSGNLREYRKKHRHVSVKALKK 132
           +LL+ L++ NII L   +  +   +L F       EV    N       H       +K 
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSH-------IKA 116
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +    L+GL YLH H   ++HRDL  +N+ ++ N G +K+ D 
Sbjct: 117 YMLMTLQGLEYLHQH--WILHRDLKPNNLLLDEN-GVLKLADF 156

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 78
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  I ++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 79  HVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 136 DRR--LVHRDLAARNVLVK-TPQHVKITDF 162

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 77
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  I ++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 78  HVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 135 DRR--LVHRDLAARNVLVK-TPQHVKITDF 161

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 79
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  I ++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 80  HVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 137 DRR--LVHRDLAARNVLVK-TPQHVKITDF 163

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 68/144 (47%), Gaps = 10/144 (6%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG GA  KVY+A ++E  +  A   +  ++       +E    E+ +L +  + NI+ L 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLL 100
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYR-KKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
             +  E  N L  + E C  G +     +  R ++   ++   KQ L  LNYLH ++  +
Sbjct: 101 DAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--I 156
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
           IHRDL   N+    + G +K+ D 
Sbjct: 157 IHRDLKAGNILFTLD-GDIKLADF 179

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 68/144 (47%), Gaps = 10/144 (6%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG GA  KVY+A ++E  +  A   +  ++       +E    E+ +L +  + NI+ L 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLL 100
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYR-KKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
             +  E  N L  + E C  G +     +  R ++   ++   KQ L  LNYLH ++  +
Sbjct: 101 DAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--I 156
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
           IHRDL   N+    + G +K+ D 
Sbjct: 157 IHRDLKAGNILFTLD-GDIKLADF 179

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 23  TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKT 82
           + RY R  +L GSGA  +V    D+  G E A   +K ++     +    L  EV +LK 
Sbjct: 3   SDRYQRVKKL-GSGAYGEVLLCKDKLTGAERAIKIIK-KSSVTTTSNSGALLDEVAVLKQ 60
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRKKHRHVSVKALKKWSKQILK 139
           L + NI+ L+  +  ED+     + EV   G L +    R+K   V    +    KQ+L 
Sbjct: 61  LDHPNIMKLYEFF--EDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI---MKQVLS 115
Query: 140 GLNYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDL 175
           G  YLH H   ++HRDL   N+ +   +    +KI D 
Sbjct: 116 GTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDF 151

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G  VA  ++  R F       +R + E+RLLK + +
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 100
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 158
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 189

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G  VA  ++  R F       +R + E+RLLK + +
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 100
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 158
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 189

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LGSG    V + + Q + +        L+   +DPA+ + L +E  +++ L N  I+ + 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
            +   E   +   + E+   G L +Y +++RHV  K + +   Q+  G+ YL   E   +
Sbjct: 95  GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 149
Query: 153 HRDLNCSNVFV 163
           HRDL   NV +
Sbjct: 150 HRDLAARNVLL 160

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LGSG    V + + Q + +        L+   +DPA+ + L +E  +++ L N  I+ + 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
            +   E   +   + E+   G L +Y +++RHV  K + +   Q+  G+ YL   E   +
Sbjct: 95  GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 149
Query: 153 HRDLNCSNVFV 163
           HRDL   NV +
Sbjct: 150 HRDLAARNVLL 160

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LGSG    V + + Q + +        L+   +DPA+ + L +E  +++ L N  I+ + 
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
            +   E   +   + E+   G L +Y +++RHV  K + +   Q+  G+ YL   E   +
Sbjct: 93  GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 147
Query: 153 HRDLNCSNVFV 163
           HRDL   NV +
Sbjct: 148 HRDLAARNVLL 158

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G  VA  ++  R F       +R + E+RLLK + +
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 76
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 134
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 165

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G  VA  ++  R F       +R + E+RLLK + +
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 76
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 134
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 165

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G  VA  ++  R F       +R + E+RLLK + +
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 86
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 144
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 175

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G  VA  ++  R F       +R + E+RLLK + +
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 99
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 157
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 158 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 188

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++L SGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 84
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 85  HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 142 DRR--LVHRDLAARNVLVK-TPQHVKITDF 168

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LGSG    V + + Q + +        L+   +DPA+ + L +E  +++ L N  I+ + 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
            +   E   +   + E+   G L +Y +++RHV  K + +   Q+  G+ YL   E   +
Sbjct: 79  GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 133
Query: 153 HRDLNCSNVFV 163
           HRDL   NV +
Sbjct: 134 HRDLAARNVLL 144

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LGSG    V + + Q + +        L+   +DPA+ + L +E  +++ L N  I+ + 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
            +   E   +   + E+   G L +Y +++RHV  K + +   Q+  G+ YL   E   +
Sbjct: 79  GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 133
Query: 153 HRDLNCSNVFV 163
           HRDL   NV +
Sbjct: 134 HRDLAARNVLL 144

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LGSG    V + + Q + +        L+   +DPA+ + L +E  +++ L N  I+ + 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
            +   E   +   + E+   G L +Y +++RHV  K + +   Q+  G+ YL   E   +
Sbjct: 85  GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 139
Query: 153 HRDLNCSNVFV 163
           HRDL   NV +
Sbjct: 140 HRDLAARNVLL 150

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G  VA  ++  R F       +R + E+RLLK + +
Sbjct: 33  RYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 90
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 91  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 148
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 149 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 179

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 5/141 (3%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
           +LG G+  +V    D+  G E A   +  R         E L  EV+LLK L + NI+ L
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
           +  +  ED+     + EV T G L +     +  S     +  +Q+L G+ Y+H ++  +
Sbjct: 116 YEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--I 171
Query: 152 IHRDLNCSNVFVNGNTGQVKI 172
           +HRDL   N+ +   +    I
Sbjct: 172 VHRDLKPENLLLESKSKDANI 192

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G  VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G  VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 79/162 (48%), Gaps = 29/162 (17%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           EL+GSG   +V++A  + +G      +VK           E+   EV+ L  L + NI+ 
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVH 68
Query: 91  LHYVWR--DEDRNT------------LNFITEVCTSGNLREYRKKHRHVS---VKALKKW 133
            +  W   D D  T            L    E C  G L ++ +K R      V AL+ +
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 134 SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            +QI KG++Y+H+ +  +I+RDL  SN+F+  +T QVKIGD 
Sbjct: 129 -EQITKGVDYIHSKK--LINRDLKPSNIFLV-DTKQVKIGDF 166

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G  VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G  VA  ++  R F       +R + E+RLLK + +
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 5/141 (3%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
           +LG G+  +V    D+  G E A   +  R         E L  EV+LLK L + NI+ L
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
           +  +  ED+     + EV T G L +     +  S     +  +Q+L G+ Y+H ++  +
Sbjct: 115 YEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--I 170
Query: 152 IHRDLNCSNVFVNGNTGQVKI 172
           +HRDL   N+ +   +    I
Sbjct: 171 VHRDLKPENLLLESKSKDANI 191

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LGSG    V + + Q + +        L+   +DPA+ + L +E  +++ L N  I+ + 
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
            +   E   +   + E+   G L +Y +++RHV  K + +   Q+  G+ YL   E   +
Sbjct: 73  GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 127
Query: 153 HRDLNCSNVFV 163
           HRDL   NV +
Sbjct: 128 HRDLAARNVLL 138

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 5/141 (3%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
           +LG G+  +V    D+  G E A   +  R         E L  EV+LLK L + NI+ L
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
           +  +  ED+     + EV T G L +     +  S     +  +Q+L G+ Y+H ++  +
Sbjct: 98  YEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--I 153
Query: 152 IHRDLNCSNVFVNGNTGQVKI 172
           +HRDL   N+ +   +    I
Sbjct: 154 VHRDLKPENLLLESKSKDANI 174

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 5/141 (3%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
           +LG G+  +V    D+  G E A   +  R         E L  EV+LLK L + NI+ L
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
           +  +  ED+     + EV T G L +     +  S     +  +Q+L G+ Y+H ++  +
Sbjct: 92  YEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--I 147
Query: 152 IHRDLNCSNVFVNGNTGQVKI 172
           +HRDL   N+ +   +    I
Sbjct: 148 VHRDLKPENLLLESKSKDANI 168

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 83/154 (53%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  ++D + G+++A  ++  R F       +R + E+RLLK + +
Sbjct: 52  RYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 109
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 110 ENVIGLLDVFTPATSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 167
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 168 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 198

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LGSG    V + + Q + +        L+   +DPA+ + L +E  +++ L N  I+ + 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
            +   E   +   + E+   G L +Y +++RHV  K + +   Q+  G+ YL   E   +
Sbjct: 75  GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 129
Query: 153 HRDLNCSNVFV 163
           HRDL   NV +
Sbjct: 130 HRDLAARNVLL 140

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++L SGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 77
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 78  HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 135 DRR--LVHRDLAARNVLVK-TPQHVKITDF 161

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 65
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E++  L F        +L+ +        + +  +K +  Q+L+GL + H+H 
Sbjct: 66  LLDVIHTENKLYLVF---EHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V+HRDL   N+ +N   G +K+ D 
Sbjct: 123 --VLHRDLKPQNLLIN-TEGAIKLADF 146

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 6/135 (4%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTLANKNI 88
           E LGSG    V +   +  G E A   +K R        + R  +  EV +L+ + + NI
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           I+LH ++  E++  +  I E+ + G L ++  +   ++     ++ KQIL G++YLH+  
Sbjct: 71  ITLHDIF--ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR 128
Query: 149 PCVIHRDLNCSNVFV 163
             + H DL   N+ +
Sbjct: 129 --IAHFDLKPENIML 141

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA   +K+      P        E  ++ ++ + 
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMASMDHP 100
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           +++ L  V       T+  +T++   G L EY  +H+ ++  + L  W  QI KG+ YL 
Sbjct: 101 HLVRLLGVCLSP---TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 157
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V  +   VKI D 
Sbjct: 158 ERR--LVHRDLAARNVLVK-SPNHVKITDF 184

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLA 79
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 80  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 136
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 137 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 170

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G  VA  ++  R F       +R + E+RLLK + +
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 76
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +N+I L  V+      E+ N +  +T +    +L    K  + ++   ++    QIL+GL
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCAK-LTDDHVQFLIYQILRGL 134
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+ +  +IHRDL  SN+ VN +  ++KI D 
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 165

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 77
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 78  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLN-TTXDLKIXDF 168

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 6/135 (4%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTLANKNI 88
           E LGSG    V +   +  G E A   +K R        + R  +  EV +L+ + + NI
Sbjct: 18  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 77
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           I+LH ++  E++  +  I E+ + G L ++  +   ++     ++ KQIL G++YLH+  
Sbjct: 78  ITLHDIF--ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR 135
Query: 149 PCVIHRDLNCSNVFV 163
             + H DL   N+ +
Sbjct: 136 --IAHFDLKPENIML 148

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 77
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 78  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLN-TTXDLKICDF 168

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 7/145 (4%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +GSGA   V  A D   G +VA  ++  R F  +    +R + E+RLLK + ++N+I L 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSE-LFAKRAYRELRLLKHMRHENVIGLL 90
Query: 93  YVWRDEDR--NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            V+  ++   +  +F   +   G       KH  +    ++    Q+LKGL Y+H     
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA--G 148
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
           +IHRDL   N+ VN +  ++KI D 
Sbjct: 149 IIHRDLKPGNLAVNEDC-ELKILDF 172

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 6/135 (4%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTLANKNI 88
           E LGSG    V +   +  G E A   +K R        + R  +  EV +L+ + + NI
Sbjct: 32  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNI 91
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           I+LH ++  E++  +  I E+ + G L ++  +   ++     ++ KQIL G++YLH+  
Sbjct: 92  ITLHDIF--ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR 149
Query: 149 PCVIHRDLNCSNVFV 163
             + H DL   N+ +
Sbjct: 150 --IAHFDLKPENIML 162

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 16/180 (8%)
Query: 2   MPAVNSDPSDKD---SEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQV 58
           MPA     S KD   +E F + DP   +    E+ G G+   VY A D      VA  ++
Sbjct: 29  MPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKM 87
Query: 59  KLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC---TSGNL 115
                  +    + +  EVR L+ L + N I     +  E  +T   + E C    S  L
Sbjct: 88  SYSGKQSNEKW-QDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEYCLGSASDLL 144
Query: 116 REYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             ++K  + V + A+   +   L+GL YLH+H   +IHRD+   N+ ++   G VK+GD 
Sbjct: 145 EVHKKPLQEVEIAAV---THGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDF 198

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++LGSGA   VY+     EG    I VA   +K+      P        E  ++ ++ + 
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMASMDHP 77
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           +++ L  V       T+  +T++   G L EY  +H+ ++  + L  W  QI KG+ YL 
Sbjct: 78  HLVRLLGVCLSP---TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYL- 133
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             E  ++HRDL   NV V  +   VKI D 
Sbjct: 134 -EERRLVHRDLAARNVLVK-SPNHVKITDF 161

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 10/139 (7%)
Query: 28  RYNE--LLGSGAVKKVYRAFDQEEGIEVAWNQV-KLRTFCDDPAMIERLFSEVRLLKTLA 84
           RYN   +LG G+  +V +  D+    E A   + K      D + I R   EV LLK L 
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLD 79
Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
           + NI+ L  +   ED ++   + E+ T G L +   K +  S     +  KQ+  G+ Y+
Sbjct: 80  HPNIMKLFEIL--EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 145 HTHEPCVIHRDLNCSNVFV 163
           H H   ++HRDL   N+ +
Sbjct: 138 HKHN--IVHRDLKPENILL 154

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 77
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 78  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLN-TTXDLKICDF 168

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 81
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 82  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLN-TTXDLKICDF 172

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 11/153 (7%)
Query: 26  YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVR-LLKTLA 84
           Y   +ELLG GA  KV  A   + G E A   ++ +          R+F EV  L +   
Sbjct: 14  YKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQA----GHSRSRVFREVETLYQCQG 69
Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
           NKNI+ L   + D+ R  L F  E    G++  + +K +H + +   +  + +   L++L
Sbjct: 70  NKNILELIEFFEDDTRFYLVF--EKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFL 127
Query: 145 HTHEPCVIHRDLNCSNVFVNG--NTGQVKIGDL 175
           HT    + HRDL   N+          VKI D 
Sbjct: 128 HTKG--IAHRDLKPENILCESPEKVSPVKICDF 158

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 21  DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           DP  +Y R+ E +G GA   VY A D   G EVA  Q+ L+     P   E + +E+ ++
Sbjct: 18  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEILVM 72
Query: 81  KTLANKNIISL--HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
           +   N NI++    Y+  DE    L  + E    G+L +   +   +    +    ++ L
Sbjct: 73  RENKNPNIVNYLDSYLVGDE----LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECL 127
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           + L +LH+++  VIHR++   N+ + G  G VK+ D 
Sbjct: 128 QALEFLHSNQ--VIHRNIKSDNILL-GMDGSVKLTDF 161

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 79/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY +L  +G GA   V  A+D      VA  ++   + +T+C      +R   E+++L  
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYC------QRTLREIQILLR 97
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++N+I +  + R    +TL  + +V    +L E   Y+  K + +S   +  +  QIL
Sbjct: 98  FRHENVIGIRDILR---ASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQIL 154
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 155 RGLKYIHSAN--VLHRDLKPSNLLIN-TTCDLKICDF 188

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 77
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 78  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 168

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 85
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 86  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 142
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 143 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 176

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 77
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 78  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 168

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 79
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 80  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 136
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 137 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 170

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 97
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 98  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 154
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 155 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 188

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 10/139 (7%)
Query: 28  RYNE--LLGSGAVKKVYRAFDQEEGIEVAWNQV-KLRTFCDDPAMIERLFSEVRLLKTLA 84
           RYN   +LG G+  +V +  D+    E A   + K      D + I R   EV LLK L 
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLD 79
Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
           + NI+ L  +   ED ++   + E+ T G L +   K +  S     +  KQ+  G+ Y+
Sbjct: 80  HPNIMKLFEIL--EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 145 HTHEPCVIHRDLNCSNVFV 163
           H H   ++HRDL   N+ +
Sbjct: 138 HKHN--IVHRDLKPENILL 154

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 10/139 (7%)
Query: 28  RYNE--LLGSGAVKKVYRAFDQEEGIEVAWNQV-KLRTFCDDPAMIERLFSEVRLLKTLA 84
           RYN   +LG G+  +V +  D+    E A   + K      D + I R   EV LLK L 
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLD 79
Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
           + NI+ L  +   ED ++   + E+ T G L +   K +  S     +  KQ+  G+ Y+
Sbjct: 80  HPNIMKLFEIL--EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 145 HTHEPCVIHRDLNCSNVFV 163
           H H   ++HRDL   N+ +
Sbjct: 138 HKHN--IVHRDLKPENILL 154

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 75
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 76  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 132
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 133 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 166

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 81
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 82  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 172

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 82
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 83  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 139
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 140 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 173

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 70/144 (48%), Gaps = 10/144 (6%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G    VY+   +     VA  +++L      P    R   EV LLK L + NI++LH
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVTLH 66
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNYLHTHEPCV 151
            +   E   TL F        +L++Y     + +++  +K +  Q+L+GL Y H  +  V
Sbjct: 67  DIIHTEKSLTLVF---EYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--V 121
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
           +HRDL   N+ +N   G++K+ D 
Sbjct: 122 LHRDLKPQNLLIN-ERGELKLADF 144

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 42/175 (24%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           EL+GSG   +V++A  + +G      +VK           E+   EV+ L  L + NI+ 
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN--------EKAEREVKALAKLDHVNIVH 69
Query: 91  LHYVWRDED-----------------RNTLN---------FIT-EVCTSGNLREYRKKHR 123
            +  W   D                  N+ N         FI  E C  G L ++ +K R
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 124 HVS---VKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                 V AL+ + +QI KG++Y+H+ +  +IHRDL  SN+F+  +T QVKIGD 
Sbjct: 130 GEKLDKVLALELF-EQITKGVDYIHSKK--LIHRDLKPSNIFLV-DTKQVKIGDF 180

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 75
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 76  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 132
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 133 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 166

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 82
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 83  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 139
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 140 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 173

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 69/139 (49%), Gaps = 13/139 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G+G+   V+RA  +  G +VA   +  + F  +   +     EV ++K L + NI+ 
Sbjct: 43  EKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAE--RVNEFLREVAIMKRLRHPNIVL 98
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK-----WSKQILKGLNYLH 145
             ++        L+ +TE  + G+L  YR  H+  + + L +      +  + KG+NYLH
Sbjct: 99  --FMGAVTQPPNLSIVTEYLSRGSL--YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 146 THEPCVIHRDLNCSNVFVN 164
              P ++HRDL   N+ V+
Sbjct: 155 NRNPPIVHRDLKSPNLLVD 173

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 83
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 84  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 140
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 141 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 174

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 74
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 75  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 131
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 132 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 165

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 81
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 82  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 172

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYC------QRTLREIKILLR 81
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 82  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 172

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 15/154 (9%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 97
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRK-KHRHVSVKALKKWSKQILKGL 141
             ++NII ++ + R      +  +  V        Y+  K +H+S   +  +  QIL+GL
Sbjct: 98  FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGL 157
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 158 KYIHSAN--VLHRDLKPSNLLLN-TTXDLKICDF 188

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 8/153 (5%)
Query: 27  GRY--NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA 84
           G+Y   +LLG G+  KV    D E     A   +K +     P     +  E++LL+ L 
Sbjct: 5   GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR 64
Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRK--KHRHVSVKALKKWSKQILKGLN 142
           +KN+I L  V  +E++  +  + E C  G ++E       +   V     +  Q++ GL 
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           YLH+    ++H+D+   N+ +    G +KI  L
Sbjct: 124 YLHSQG--IVHKDIKPGNLLLT-TGGTLKISAL 153

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
           RY  L  +G GA   V  A+D    + VA  ++   + +T+C      +R   E+++L  
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 81
Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
             ++NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL
Sbjct: 82  FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQIL 138
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +GL Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 172

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 14/150 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++L SGA   VY+     EG    I VA  +++  T    P   + +  E  ++ ++ N 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 84
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
           ++  L  +      +T+  I ++   G L +Y ++H+ ++  + L  W  QI KG+NYL 
Sbjct: 85  HVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
                ++HRDL   NV V      VKI D 
Sbjct: 142 DRR--LVHRDLAARNVLVK-TPQHVKITDF 168

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 5/147 (3%)
Query: 29  YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
           Y +LLG G   KV    ++  G   A   +K         +   L +E R+L+   +  +
Sbjct: 14  YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFL 72
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
            +L Y ++  DR  L F+ E    G L  +  + R  S    + +  +I+  L+YLH+ E
Sbjct: 73  TALKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS-E 129
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V++RDL   N+ ++ + G +KI D 
Sbjct: 130 KNVVYRDLKLENLMLDKD-GHIKITDF 155

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G   +VY    ++  + VA     ++T  +D   +E    E  ++K + + N++ L 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E       ITE  T GNL +Y ++   + VS   L   + QI   + YL      
Sbjct: 81  GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 136
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHRDL   N  V G    VK+ D 
Sbjct: 137 FIHRDLAARNCLV-GENHLVKVADF 160

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 5/147 (3%)
Query: 29  YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
           Y +LLG G   KV    ++  G   A   +K         +   L +E R+L+   +  +
Sbjct: 13  YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFL 71
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
            +L Y ++  DR  L F+ E    G L  +  + R  S    + +  +I+  L+YLH+ E
Sbjct: 72  TALKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS-E 128
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V++RDL   N+ ++ + G +KI D 
Sbjct: 129 KNVVYRDLKLENLMLDKD-GHIKITDF 154

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 5/147 (3%)
Query: 29  YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
           Y +LLG G   KV    ++  G   A   +K         +   L +E R+L+   +  +
Sbjct: 12  YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFL 70
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
            +L Y ++  DR  L F+ E    G L  +  + R  S    + +  +I+  L+YLH+ E
Sbjct: 71  TALKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS-E 127
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V++RDL   N+ ++ + G +KI D 
Sbjct: 128 KNVVYRDLKLENLMLDKD-GHIKITDF 153

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G   +VY    ++  + VA     ++T  +D   +E    E  ++K + + N++ L 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E       ITE  T GNL +Y ++   + VS   L   + QI   + YL      
Sbjct: 74  GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 129
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHRDL   N  V G    VK+ D 
Sbjct: 130 FIHRDLAARNCLV-GENHLVKVADF 153

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 76/145 (52%), Gaps = 9/145 (6%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERL-FSEVRLLKTLANKNIIS 90
           L+G G+   V +  +++ G  VA   +K     DD  M++++   E++LLK L ++N+++
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVA---IKKFLESDDDKMVKKIAMREIKLLKQLRHENLVN 88
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L  V + + R  L F  E      L +       +  + ++K+  QI+ G+ + H+H   
Sbjct: 89  LLEVCKKKKRWYLVF--EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN-- 144
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
           +IHRD+   N+ V+  +G VK+ D 
Sbjct: 145 IIHRDIKPENILVS-QSGVVKLCDF 168

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G   +VY    ++  + VA     ++T  +D   +E    E  ++K + + N++ L 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E       ITE  T GNL +Y ++   + VS   L   + QI   + YL      
Sbjct: 76  GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 131
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHRDL   N  V G    VK+ D 
Sbjct: 132 FIHRDLAARNCLV-GENHLVKVADF 155

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 22/174 (12%)
Query: 9   PSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPA 68
           PS  +    + T  TG YGR          +K+ R  D   G  + W ++   +  +  A
Sbjct: 2   PSRAEDYEVLYTIGTGSYGR---------CQKIRRKSD---GKILVWKELDYGSMTE--A 47
Query: 69  MIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY----RKKHRH 124
             + L SEV LL+ L + NI+  +    D    TL  + E C  G+L        K+ ++
Sbjct: 48  EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY 107
Query: 125 VSVKALKKWSKQILKGLNYLHTHEP---CVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +  + + +   Q+   L   H        V+HRDL  +NVF++G    VK+GD 
Sbjct: 108 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDF 160

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 22/174 (12%)
Query: 9   PSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPA 68
           PS  +    + T  TG YGR          +K+ R  D   G  + W ++   +  +  A
Sbjct: 2   PSRAEDYEVLYTIGTGSYGR---------CQKIRRKSD---GKILVWKELDYGSMTE--A 47
Query: 69  MIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY----RKKHRH 124
             + L SEV LL+ L + NI+  +    D    TL  + E C  G+L        K+ ++
Sbjct: 48  EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY 107
Query: 125 VSVKALKKWSKQILKGLNYLHTHEP---CVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +  + + +   Q+   L   H        V+HRDL  +NVF++G    VK+GD 
Sbjct: 108 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDF 160

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 65/148 (43%), Gaps = 19/148 (12%)
Query: 29  YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
           + E+LG G   +  +   +E G EV   +  +R    D         EV++++ L + N+
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETG-EVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNV 69
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS------KQILKGLN 142
           +    V   + R  LNFITE    G LR   K     S+ +   WS      K I  G+ 
Sbjct: 70  LKFIGVLYKDKR--LNFITEYIKGGTLRGIIK-----SMDSQYPWSQRVSFAKDIASGMA 122
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQV 170
           YLH+    +IHRDLN  N  V  N   V
Sbjct: 123 YLHSMN--IIHRDLNSHNCLVRENKNVV 148

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 22/174 (12%)
Query: 9   PSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPA 68
           PS  +    + T  TG YGR          +K+ R  D   G  + W ++   +  +  A
Sbjct: 2   PSRAEDYEVLYTIGTGSYGR---------CQKIRRKSD---GKILVWKELDYGSMTE--A 47
Query: 69  MIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY----RKKHRH 124
             + L SEV LL+ L + NI+  +    D    TL  + E C  G+L        K+ ++
Sbjct: 48  EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY 107
Query: 125 VSVKALKKWSKQILKGLNYLHTHEP---CVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +  + + +   Q+   L   H        V+HRDL  +NVF++G    VK+GD 
Sbjct: 108 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDF 160

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G   +VY    ++  + VA     ++T  +D   +E    E  ++K + + N++ L 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E       ITE  T GNL +Y ++   + VS   L   + QI   + YL      
Sbjct: 76  GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 131
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHRDL   N  V G    VK+ D 
Sbjct: 132 FIHRDLAARNCLV-GENHLVKVADF 155

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G   +VY    ++  + VA     ++T  +D   +E    E  ++K + + N++ L 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E       ITE  T GNL +Y ++   + VS   L   + QI   + YL      
Sbjct: 74  GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 129
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHRDL   N  V G    VK+ D 
Sbjct: 130 FIHRDLAARNCLV-GENHLVKVADF 153

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 63/141 (44%), Gaps = 5/141 (3%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
           +LG G+  +V    D+  G E A   +  R         E L  EV+LLK L + NI  L
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 92  HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
           +  +  ED+     + EV T G L +     +  S     +  +Q+L G+ Y H ++  +
Sbjct: 92  YEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK--I 147
Query: 152 IHRDLNCSNVFVNGNTGQVKI 172
           +HRDL   N+ +   +    I
Sbjct: 148 VHRDLKPENLLLESKSKDANI 168

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 5/147 (3%)
Query: 29  YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
           Y +LLG G   KV    ++  G   A   +K         +   L +E R+L+   +  +
Sbjct: 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFL 210
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
            +L Y ++  DR  L F+ E    G L  +  + R  S    + +  +I+  L+YLH+ E
Sbjct: 211 TALKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS-E 267
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V++RDL   N+ ++ + G +KI D 
Sbjct: 268 KNVVYRDLKLENLMLDKD-GHIKITDF 293

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 5/147 (3%)
Query: 29  YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
           Y +LLG G   KV    ++  G   A   +K         +   L +E R+L+   +  +
Sbjct: 155 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFL 213
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
            +L Y ++  DR  L F+ E    G L  +  + R  S    + +  +I+  L+YLH+ E
Sbjct: 214 TALKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS-E 270
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V++RDL   N+ ++ + G +KI D 
Sbjct: 271 KNVVYRDLKLENLMLDKD-GHIKITDF 296

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 65/142 (45%), Gaps = 18/142 (12%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
           LLG GA   V  A  +  G  VA    K+  F D P    R   E+++LK   ++NII++
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIK--KIEPF-DKPLFALRTLREIKILKHFKHENIITI 74
Query: 92  HYVWRDEDRNTLN--FITEVCTSGNLREYRKKHRHVSVKAL-----KKWSKQILKGLNYL 144
             + R +     N  +I +     +L      HR +S + L     + +  Q L+ +  L
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQTDL------HRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 145 HTHEPCVIHRDLNCSNVFVNGN 166
           H     VIHRDL  SN+ +N N
Sbjct: 129 HGSN--VIHRDLKPSNLLINSN 148

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 72/144 (50%), Gaps = 11/144 (7%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY +L  +GSGA   V  AFD   GI VA  ++  R F  +    +R + E+ LLK + +
Sbjct: 23  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPF-QNQTHAKRAYRELVLLKCVNH 80
Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLREY---RKKHRHVSVKALKKWSKQILKGLN 142
           KNIISL  V+  +   TL    +V     L +    +  H  +  + +     Q+L G+ 
Sbjct: 81  KNIISLLNVFTPQ--KTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIK 138
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGN 166
           +LH+    +IHRDL  SN+ V  +
Sbjct: 139 HLHS--AGIIHRDLKPSNIVVKSD 160

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 65/142 (45%), Gaps = 18/142 (12%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
           LLG GA   V  A  +  G  VA    K+  F D P    R   E+++LK   ++NII++
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIK--KIEPF-DKPLFALRTLREIKILKHFKHENIITI 74
Query: 92  HYVWRDEDRNTLN--FITEVCTSGNLREYRKKHRHVSVKAL-----KKWSKQILKGLNYL 144
             + R +     N  +I +     +L      HR +S + L     + +  Q L+ +  L
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQTDL------HRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 145 HTHEPCVIHRDLNCSNVFVNGN 166
           H     VIHRDL  SN+ +N N
Sbjct: 129 HGSN--VIHRDLKPSNLLINSN 148

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 10/154 (6%)
Query: 24  GRYGRYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLK 81
           G   +Y +L  +G G    VY+A D +  I VA  +++L    +D  +      E+ LLK
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLD--AEDEGIPSTAIREISLLK 74
Query: 82  TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
            L + NI+SL  V   E    L  + E       +   +    +    +K +  Q+L+G+
Sbjct: 75  ELHHPNIVSLIDVIHSE--RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            + H H   ++HRDL   N+ +N + G +K+ D 
Sbjct: 133 AHCHQHR--ILHRDLKPQNLLINSD-GALKLADF 163

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 65/142 (45%), Gaps = 18/142 (12%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
           LLG GA   V  A  +  G  VA    K+  F D P    R   E+++LK   ++NII++
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIK--KIEPF-DKPLFALRTLREIKILKHFKHENIITI 74
Query: 92  HYVWRDEDRNTLN--FITEVCTSGNLREYRKKHRHVSVKAL-----KKWSKQILKGLNYL 144
             + R +     N  +I +     +L      HR +S + L     + +  Q L+ +  L
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQTDL------HRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 145 HTHEPCVIHRDLNCSNVFVNGN 166
           H     VIHRDL  SN+ +N N
Sbjct: 129 HGSN--VIHRDLKPSNLLINSN 148

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 14/156 (8%)
Query: 25  RYGRY--NELLGSGAVKKVYRAFDQEEGIEVA---WNQVKLRTFCDDPAMIERLFSEVRL 79
           + G Y   + LG G   KV     Q  G +VA    N+ K+R+      ++ ++  E++ 
Sbjct: 9   KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSL----DVVGKIKREIQN 64
Query: 80  LKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILK 139
           LK   + +II L+ V           + E  + G L +Y  KH  V     ++  +QIL 
Sbjct: 65  LKLFRHPHIIKLYQVISTP--TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122
Query: 140 GLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            ++Y H H   V+HRDL   NV ++ +    KI D 
Sbjct: 123 AVDYCHRH--MVVHRDLKPENVLLDAHM-NAKIADF 155

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 72/147 (48%), Gaps = 14/147 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG G+   VY+A  +E G  VA  QV + +       ++ +  E+ +++   + +++ 
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD------LQEIIKEISIMQQCDSPHVVK 88
Query: 91  LHYVWRDEDRNT-LNFITEVCTSGNLRE-YRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
            +  +    +NT L  + E C +G++ +  R +++ ++   +    +  LKGL YLH   
Sbjct: 89  YYGSYF---KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              IHRD+   N+ +N   G  K+ D 
Sbjct: 146 K--IHRDIKAGNILLN-TEGHAKLADF 169

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 79/160 (49%), Gaps = 18/160 (11%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY +L  LG G    V+ A D +    VA  ++ L     DP  ++    E+++++ L +
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDH 67
Query: 86  KNIISLHYVWR---DEDRNTLNFITEVCTSGNLREYRK-------KHRHVSVKALKKWSK 135
            NI+ +  +      +  + +  +TE+ +   ++EY +       +   +  +  + +  
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY 127
Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           Q+L+GL Y+H+    V+HRDL  +N+F+N     +KIGD 
Sbjct: 128 QLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDF 165

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 10/154 (6%)
Query: 24  GRYGRYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLK 81
           G   +Y +L  +G G    VY+A D +  I VA  +++L    +D  +      E+ LLK
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLD--AEDEGIPSTAIREISLLK 74
Query: 82  TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
            L + NI+SL  V   E    L  + E       +   +    +    +K +  Q+L+G+
Sbjct: 75  ELHHPNIVSLIDVIHSE--RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            + H H   ++HRDL   N+ +N + G +K+ D 
Sbjct: 133 AHCHQHR--ILHRDLKPQNLLINSD-GALKLADF 163

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQV--KLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           LG G+  KV  A+    G +VA   +  K+    D    IER  S +RLL+   + +II 
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR---HPHIIK 72
Query: 91  LHYVWRDEDRNTLNFITEVCTSGN-LREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
           L+ V + +D      I  +  +GN L +Y  +   +S +  +++ +QI+  + Y H H+ 
Sbjct: 73  LYDVIKSKDE----IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK- 127
Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDL 175
            ++HRDL   N+ ++ +   VKI D 
Sbjct: 128 -IVHRDLKPENLLLDEHL-NVKIADF 151

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 14/156 (8%)
Query: 25  RYGRY--NELLGSGAVKKVYRAFDQEEGIEVA---WNQVKLRTFCDDPAMIERLFSEVRL 79
           + G Y   + LG G   KV     Q  G +VA    N+ K+R+      ++ ++  E++ 
Sbjct: 9   KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSL----DVVGKIKREIQN 64
Query: 80  LKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILK 139
           LK   + +II L+ V           + E  + G L +Y  KH  V     ++  +QIL 
Sbjct: 65  LKLFRHPHIIKLYQVISTP--TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122
Query: 140 GLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            ++Y H H   V+HRDL   NV ++ +    KI D 
Sbjct: 123 AVDYCHRH--MVVHRDLKPENVLLDAHM-NAKIADF 155

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQV--KLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           LG G+  KV  A+    G +VA   +  K+    D    IER  S +RLL+   + +II 
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR---HPHIIK 78
Query: 91  LHYVWRDEDRNTLNFITEVCTSGN-LREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
           L+ V + +D      I  +  +GN L +Y  +   +S +  +++ +QI+  + Y H H+ 
Sbjct: 79  LYDVIKSKDE----IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK- 133
Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDL 175
            ++HRDL   N+ ++ +   VKI D 
Sbjct: 134 -IVHRDLKPENLLLDEHL-NVKIADF 157

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQV--KLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           LG G+  KV  A+    G +VA   +  K+    D    IER  S +RLL+   + +II 
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR---HPHIIK 68
Query: 91  LHYVWRDEDRNTLNFITEVCTSGN-LREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
           L+ V + +D      I  +  +GN L +Y  +   +S +  +++ +QI+  + Y H H+ 
Sbjct: 69  LYDVIKSKDE----IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK- 123
Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDL 175
            ++HRDL   N+ ++ +   VKI D 
Sbjct: 124 -IVHRDLKPENLLLDEHL-NVKIADF 147

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 72/144 (50%), Gaps = 11/144 (7%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY +L  +GSGA   V  AFD   GI VA  ++  R F  +    +R + E+ LLK + +
Sbjct: 25  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPF-QNQTHAKRAYRELVLLKCVNH 82
Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLREY---RKKHRHVSVKALKKWSKQILKGLN 142
           KNIISL  V+  +   TL    +V     L +    +  H  +  + +     Q+L G+ 
Sbjct: 83  KNIISLLNVFTPQ--KTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIK 140
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGN 166
           +LH+    +IHRDL  SN+ V  +
Sbjct: 141 HLHS--AGIIHRDLKPSNIVVKSD 162

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 14/156 (8%)
Query: 25  RYGRY--NELLGSGAVKKVYRAFDQEEGIEVA---WNQVKLRTFCDDPAMIERLFSEVRL 79
           + G Y   + LG G   KV     +  G +VA    N+ K+R+      ++ ++  E++ 
Sbjct: 14  KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSL----DVVGKIRREIQN 69
Query: 80  LKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILK 139
           LK   + +II L+ V      + +  + E  + G L +Y  K+  +  K  ++  +QIL 
Sbjct: 70  LKLFRHPHIIKLYQVISTP--SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS 127
Query: 140 GLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           G++Y H H   V+HRDL   NV ++ +    KI D 
Sbjct: 128 GVDYCHRH--MVVHRDLKPENVLLDAHMN-AKIADF 160

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQV--KLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           LG G+  KV  A+    G +VA   +  K+    D    IER  S +RLL+   + +II 
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR---HPHIIK 77
Query: 91  LHYVWRDEDRNTLNFITEVCTSGN-LREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
           L+ V + +D      I  +  +GN L +Y  +   +S +  +++ +QI+  + Y H H+ 
Sbjct: 78  LYDVIKSKDE----IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK- 132
Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDL 175
            ++HRDL   N+ ++ +   VKI D 
Sbjct: 133 -IVHRDLKPENLLLDEHL-NVKIADF 156

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 13/165 (7%)
Query: 14  SEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERL 73
           +E F + DP   +    E+ G G+   VY A D      VA  ++       +    + +
Sbjct: 5   AELFFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW-QDI 62
Query: 74  FSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC---TSGNLREYRKKHRHVSVKAL 130
             EVR L+ L + N I     +  E  +T   + E C    S  L  ++K  + V + A+
Sbjct: 63  IKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 120
Query: 131 KKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              +   L+GL YLH+H   +IHRD+   N+ ++   G VK+GD 
Sbjct: 121 ---THGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDF 159

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G   +VY    ++  + VA     ++T  +D   +E    E  ++K + + N++ L 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E       ITE  T GNL +Y ++   + V+   L   + QI   + YL      
Sbjct: 81  GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 136
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHRDL   N  V G    VK+ D 
Sbjct: 137 FIHRDLAARNCLV-GENHLVKVADF 160

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G   +VY    ++  + VA     ++T  +D   +E    E  ++K + + N++ L 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 79
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E       ITE  T GNL +Y ++   + V+   L   + QI   + YL      
Sbjct: 80  GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 135
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHRDL   N  V G    VK+ D 
Sbjct: 136 FIHRDLAARNCLV-GENHLVKVADF 159

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G   +VY    ++  + VA     ++T  +D   +E    E  ++K + + N++ L 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E       ITE  T GNL +Y ++   + V+   L   + QI   + YL      
Sbjct: 81  GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 136
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHRDL   N  V G    VK+ D 
Sbjct: 137 FIHRDLAARNCLV-GENHLVKVADF 160

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 69/139 (49%), Gaps = 13/139 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G+G+   V+RA  +  G +VA   +  + F  +   +     EV ++K L + NI+ 
Sbjct: 43  EKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAE--RVNEFLREVAIMKRLRHPNIVL 98
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK-----WSKQILKGLNYLH 145
             ++        L+ +TE  + G+L  YR  H+  + + L +      +  + KG+NYLH
Sbjct: 99  --FMGAVTQPPNLSIVTEYLSRGSL--YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 146 THEPCVIHRDLNCSNVFVN 164
              P ++HR+L   N+ V+
Sbjct: 155 NRNPPIVHRNLKSPNLLVD 173

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 77/154 (50%), Gaps = 15/154 (9%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +G GA   V  A+D    + VA  ++   +  +     +R   E+++L    +
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI---SPFEHQTYXQRTLREIKILLRFRH 84
Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQILKGL 141
           +NII ++ + R     T+  + +V    +L E   Y+  K +H+S   +  +  QIL+GL
Sbjct: 85  ENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 141
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y+H+    V+HRDL  SN+ +N  T  +KI D 
Sbjct: 142 KYIHSAN--VLHRDLKPSNLLLN-TTXDLKICDF 172

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 70/144 (48%), Gaps = 10/144 (6%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG GA  KVY+A ++E G   A   ++ ++  +    +E    E+ +L T  +  I+ L 
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE----LEDYIVEIEILATCDHPYIVKLL 74
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYR-KKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
             +  + +  L  + E C  G +     +  R ++   ++   +Q+L+ LN+LH+    +
Sbjct: 75  GAYYHDGK--LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--I 130
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
           IHRDL   NV +    G +++ D 
Sbjct: 131 IHRDLKAGNVLMTLE-GDIRLADF 153

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G   +VY    ++  + VA     ++T  +D   +E    E  ++K + + N++ L 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E       ITE  T GNL +Y ++   + V+   L   + QI   + YL      
Sbjct: 76  GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 131
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHRDL   N  V G    VK+ D 
Sbjct: 132 FIHRDLAARNCLV-GENHLVKVADF 155

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G   +VY    ++  + VA     ++T  +D   +E    E  ++K + + N++ L 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E       ITE  T GNL +Y ++   + V+   L   + QI   + YL      
Sbjct: 77  GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 132
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHRDL   N  V G    VK+ D 
Sbjct: 133 FIHRDLAARNCLV-GENHLVKVADF 156

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G   +VY    ++  + VA     ++T  +D   +E    E  ++K + + N++ L 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E       ITE  T GNL +Y ++   + V+   L   + QI   + YL      
Sbjct: 76  GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 131
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHRDL   N  V G    VK+ D 
Sbjct: 132 FIHRDLAARNCLV-GENHLVKVADF 155

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G   +VY    ++  + VA     ++T  +D   +E    E  ++K + + N++ L 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E       ITE  T GNL +Y ++   + V+   L   + QI   + YL      
Sbjct: 81  GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 136
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHRDL   N  V G    VK+ D 
Sbjct: 137 FIHRDLAARNCLV-GENHLVKVADF 160

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G   +VY    ++  + VA     ++T  +D   +E    E  ++K + + N++ L 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E       ITE  T GNL +Y ++   + V+   L   + QI   + YL      
Sbjct: 78  GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 133
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHRDL   N  V G    VK+ D 
Sbjct: 134 FIHRDLAARNCLV-GENHLVKVADF 157

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 70/144 (48%), Gaps = 10/144 (6%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG GA  KVY+A ++E G   A   ++ ++  +    +E    E+ +L T  +  I+ L 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE----LEDYIVEIEILATCDHPYIVKLL 82
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYR-KKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
             +  + +  L  + E C  G +     +  R ++   ++   +Q+L+ LN+LH+    +
Sbjct: 83  GAYYHDGK--LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--I 138
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
           IHRDL   NV +    G +++ D 
Sbjct: 139 IHRDLKAGNVLMTLE-GDIRLADF 161

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G   +VY    ++  + VA     ++T  +D   +E    E  ++K + + N++ L 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E       ITE  T GNL +Y ++   + V+   L   + QI   + YL      
Sbjct: 78  GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 133
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHRDL   N  V G    VK+ D 
Sbjct: 134 FIHRDLAARNCLV-GENHLVKVADF 157

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G   +VY    ++  + VA     ++T  +D   +E    E  ++K + + N++ L 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 88
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E       ITE  T GNL +Y ++   + V+   L   + QI   + YL      
Sbjct: 89  GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 144
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHRDL   N  V G    VK+ D 
Sbjct: 145 FIHRDLAARNCLV-GENHLVKVADF 168

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G   +VY    ++  + VA     ++T  +D   +E    E  ++K + + N++ L 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E       ITE  T GNL +Y ++   + V+   L   + QI   + YL      
Sbjct: 78  GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 133
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHRDL   N  V G    VK+ D 
Sbjct: 134 FIHRDLAARNCLV-GENHLVKVADF 157

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 79/187 (42%), Gaps = 30/187 (16%)
Query: 14  SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
           SE  +  DP   + R      + LG GA  +V  A     D+++  E     VK+     
Sbjct: 20  SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 79
Query: 66  DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
               +  L SE+ ++K +  +KNII+L      +    L  I E  + GNLREY +  R 
Sbjct: 80  TEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQD--GPLYVIVEYASKGNLREYLRARRP 137
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
                           ++ K L   + Q+ +G+ YL + +   IHRDL   NV V  N  
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 194
Query: 169 QVKIGDL 175
            +KI D 
Sbjct: 195 VMKIADF 201

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G   +VY    ++  + VA     ++T  +D   +E    E  ++K + + N++ L 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E       ITE  T GNL +Y ++   + VS   L   + QI   + YL      
Sbjct: 283 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 338
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHR+L   N  V G    VK+ D 
Sbjct: 339 FIHRNLAARNCLV-GENHLVKVADF 362

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 11/147 (7%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +GSGA   V  A+D     +VA  ++  R F        R + E+RLLK L ++N+I L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLS-RPF-QSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 93  YVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
            V+      ED + +  +T      +L    K  + +S + ++    Q+L+GL Y+H+  
Sbjct: 94  DVFTPATSIEDFSEVYLVT-TLMGADLNNIVKS-QALSDEHVQFLVYQLLRGLKYIHS-- 149
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             +IHRDL  SNV VN ++ +++I D 
Sbjct: 150 AGIIHRDLKPSNVAVNEDS-ELRILDF 175

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 47.8 bits (112), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG+G    V++   +  G+ +A   + L      PA+  ++  E+++L    +  I+  +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
             +  +    ++   E    G+L +  KK   +  + L K S  ++KGL YL      ++
Sbjct: 71  GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
           HRD+  SN+ VN + G++K+ D 
Sbjct: 128 HRDVKPSNILVN-SRGEIKLCDF 149

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 78/187 (41%), Gaps = 30/187 (16%)
Query: 14  SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
           SE  +  DP   + R      + LG GA  +V  A     D+++  E     VK+     
Sbjct: 20  SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 79
Query: 66  DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
               +  L SE+ ++K +  +KNII  H +        L  I E  + GNLREY +  R 
Sbjct: 80  TEKDLSDLVSEMEMMKMIGKHKNII--HLLGACTQDGPLYVIVEYASKGNLREYLRARRP 137
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
                           ++ K L   + Q+ +G+ YL + +   IHRDL   NV V  N  
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 194
Query: 169 QVKIGDL 175
            +KI D 
Sbjct: 195 VMKIADF 201

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG+G    V++   +  G+ +A   + L      PA+  ++  E+++L    +  I+  +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
             +  +    ++   E    G+L +  KK   +  + L K S  ++KGL YL      ++
Sbjct: 71  GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
           HRD+  SN+ VN + G++K+ D 
Sbjct: 128 HRDVKPSNILVN-SRGEIKLCDF 149

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG+G    V++   +  G+ +A   + L      PA+  ++  E+++L    +  I+  +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
             +  +    ++   E    G+L +  KK   +  + L K S  ++KGL YL      ++
Sbjct: 71  GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
           HRD+  SN+ VN + G++K+ D 
Sbjct: 128 HRDVKPSNILVN-SRGEIKLCDF 149

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG+G    V++   +  G+ +A   + L      PA+  ++  E+++L    +  I+  +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
             +  +    ++   E    G+L +  KK   +  + L K S  ++KGL YL      ++
Sbjct: 71  GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
           HRD+  SN+ VN + G++K+ D 
Sbjct: 128 HRDVKPSNILVN-SRGEIKLCDF 149

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG+G    V++   +  G+ +A   + L      PA+  ++  E+++L    +  I+  +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
             +  +    ++   E    G+L +  KK   +  + L K S  ++KGL YL      ++
Sbjct: 71  GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
           HRD+  SN+ VN + G++K+ D 
Sbjct: 128 HRDVKPSNILVN-SRGEIKLCDF 149

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 79/187 (42%), Gaps = 30/187 (16%)
Query: 14  SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
           SE  +  DP   + R      + LG GA  +V  A     D+++  E     VK+     
Sbjct: 20  SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 79
Query: 66  DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
               +  L SE+ ++K +  +KNII+L      +    L  I E  + GNLREY +  R 
Sbjct: 80  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRP 137
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
                           ++ K L   + Q+ +G+ YL + +   IHRDL   NV V  N  
Sbjct: 138 PGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 194
Query: 169 QVKIGDL 175
            +KI D 
Sbjct: 195 VMKIADF 201

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 71/144 (49%), Gaps = 9/144 (6%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG+G    V++   +  G+ +A   + L      PA+  ++  E+++L    +  I+  +
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 132
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL-HTHEPCV 151
             +  +    ++   E    G+L +  KK   +  + L K S  ++KGL YL   H+  +
Sbjct: 133 GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--I 188
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
           +HRD+  SN+ VN + G++K+ D 
Sbjct: 189 MHRDVKPSNILVN-SRGEIKLCDF 211

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 79/187 (42%), Gaps = 30/187 (16%)
Query: 14  SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
           SE  +  DP   + R      + LG GA  +V  A     D+++  E     VK+     
Sbjct: 20  SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 79
Query: 66  DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
               +  L SE+ ++K +  +KNII+L      +    L  I E  + GNLREY +  R 
Sbjct: 80  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRP 137
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
                           ++ K L   + Q+ +G+ YL + +   IHRDL   NV V  N  
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 194
Query: 169 QVKIGDL 175
            +KI D 
Sbjct: 195 VMKIADF 201

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC------DDPAMIERLFSEVRLLKTLANK 86
           LGSGA  +V  AF+++   +VA   +  R F        DPA+   + +E+ +LK L + 
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKLNHP 75
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            II +   +  ED      + E+   G L +    ++ +     K +  Q+L  + YLH 
Sbjct: 76  CIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH- 131
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQ--VKIGDL 175
            E  +IHRDL   NV ++       +KI D 
Sbjct: 132 -ENGIIHRDLKPENVLLSSQEEDCLIKITDF 161

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC------DDPAMIERLFSEVRLLKTLANK 86
           LGSGA  +V  AF+++   +VA   +  R F        DPA+   + +E+ +LK L + 
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKLNHP 75
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            II +   +  ED      + E+   G L +    ++ +     K +  Q+L  + YLH 
Sbjct: 76  CIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH- 131
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQ--VKIGDL 175
            E  +IHRDL   NV ++       +KI D 
Sbjct: 132 -ENGIIHRDLKPENVLLSSQEEDCLIKITDF 161

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC------DDPAMIERLFSEVRLLKTLANK 86
           LGSGA  +V  AF+++   +VA   +  R F        DPA+   + +E+ +LK L + 
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKLNHP 75
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            II +   +  ED      + E+   G L +    ++ +     K +  Q+L  + YLH 
Sbjct: 76  CIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH- 131
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQ--VKIGDL 175
            E  +IHRDL   NV ++       +KI D 
Sbjct: 132 -ENGIIHRDLKPENVLLSSQEEDCLIKITDF 161

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG+G    V++   +  G+ +A   + L      PA+  ++  E+++L    +  I+  +
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 73
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
             +  +    ++   E    G+L +  KK   +  + L K S  ++KGL YL      ++
Sbjct: 74  GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 130
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
           HRD+  SN+ VN + G++K+ D 
Sbjct: 131 HRDVKPSNILVN-SRGEIKLCDF 152

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 82/190 (43%), Gaps = 36/190 (18%)
Query: 14  SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQE---EGIEVAWNQVKLRT 62
           SE  +  DP   + R      + LG GA  +V  A     D++   E + VA   +K   
Sbjct: 20  SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 79
Query: 63  FCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKK 121
             +D   +  L SE+ ++K +  +KNII+L      +    L  I E  + GNLREY + 
Sbjct: 80  TEED---LSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRA 134
Query: 122 HR----------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG 165
            R                 ++ K L   + Q+ +G+ YL + +   IHRDL   NV V  
Sbjct: 135 RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTE 192
Query: 166 NTGQVKIGDL 175
           N   +KI D 
Sbjct: 193 NN-VMKIADF 201

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC------DDPAMIERLFSEVRLLKTLANK 86
           LGSGA  +V  AF+++   +VA   +  R F        DPA+   + +E+ +LK L + 
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKLNHP 81
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            II +   +  ED      + E+   G L +    ++ +     K +  Q+L  + YLH 
Sbjct: 82  CIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH- 137
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQ--VKIGDL 175
            E  +IHRDL   NV ++       +KI D 
Sbjct: 138 -ENGIIHRDLKPENVLLSSQEEDCLIKITDF 167

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 65/145 (44%), Gaps = 13/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG+G   +V+  +           +V ++T       ++    E  L+KTL +  ++ L+
Sbjct: 20  LGAGQFGEVWMGYYNNS------TKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLY 73
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E+   +  ITE    G+L ++ K      V +  L  +S QI +G+ Y+      
Sbjct: 74  AVVTKEE--PIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 129
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHRDL  +NV V+  +   KI D 
Sbjct: 130 YIHRDLRAANVLVS-ESLMCKIADF 153

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 79/187 (42%), Gaps = 30/187 (16%)
Query: 14  SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
           SE  +  DP   + R      + LG GA  +V  A     D+++  E     VK+     
Sbjct: 20  SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 79
Query: 66  DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
               +  L SE+ ++K +  +KNII+L      +    L  I E  + GNLREY +  R 
Sbjct: 80  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRP 137
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
                           ++ K L   + Q+ +G+ YL + +   IHRDL   NV V  N  
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 194
Query: 169 QVKIGDL 175
            +KI D 
Sbjct: 195 VMKIADF 201

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC------DDPAMIERLFSEVRLLKTLANK 86
           LGSGA  +V  AF+++   +VA   +  R F        DPA+   + +E+ +LK L + 
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKLNHP 74
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            II +   +  ED      + E+   G L +    ++ +     K +  Q+L  + YLH 
Sbjct: 75  CIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH- 130
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQ--VKIGDL 175
            E  +IHRDL   NV ++       +KI D 
Sbjct: 131 -ENGIIHRDLKPENVLLSSQEEDCLIKITDF 160

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG+G    V++   +  G+ +A   + L      PA+  ++  E+++L    +  I+  +
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 97
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
             +  +    ++   E    G+L +  KK   +  + L K S  ++KGL YL      ++
Sbjct: 98  GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 154
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
           HRD+  SN+ VN + G++K+ D 
Sbjct: 155 HRDVKPSNILVN-SRGEIKLCDF 176

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 6/147 (4%)
Query: 29  YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
           Y +LLG G   KV    ++  G   A   ++          +    +E R+L+   +  +
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHTVTESRVLQNTRHPFL 67
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
            +L Y ++  DR  L F+ E    G L  +  + R  + +  + +  +I+  L YLH+ +
Sbjct: 68  TALKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V++RD+   N+ ++ + G +KI D 
Sbjct: 126 --VVYRDIKLENLMLDKD-GHIKITDF 149

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 6/147 (4%)
Query: 29  YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
           Y +LLG G   KV    ++  G   A   ++          +    +E R+L+   +  +
Sbjct: 12  YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHTVTESRVLQNTRHPFL 70
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
            +L Y ++  DR  L F+ E    G L  +  + R  + +  + +  +I+  L YLH+ +
Sbjct: 71  TALKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 128
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V++RD+   N+ ++ + G +KI D 
Sbjct: 129 --VVYRDIKLENLMLDKD-GHIKITDF 152

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 6/147 (4%)
Query: 29  YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
           Y +LLG G   KV    ++  G   A   ++          +    +E R+L+   +  +
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHTVTESRVLQNTRHPFL 67
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
            +L Y ++  DR  L F+ E    G L  +  + R  + +  + +  +I+  L YLH+ +
Sbjct: 68  TALKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V++RD+   N+ ++ + G +KI D 
Sbjct: 126 --VVYRDIKLENLMLDKD-GHIKITDF 149

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 6/147 (4%)
Query: 29  YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
           Y +LLG G   KV    ++  G   A   ++          +    +E R+L+   +  +
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHTVTESRVLQNTRHPFL 67
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
            +L Y ++  DR  L F+ E    G L  +  + R  + +  + +  +I+  L YLH+ +
Sbjct: 68  TALKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V++RD+   N+ ++ + G +KI D 
Sbjct: 126 --VVYRDIKLENLMLDKD-GHIKITDF 149

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC------DDPAMIERLFSEVRLLKTLANK 86
           LGSGA  +V  AF+++   +VA   +  R F        DPA+   + +E+ +LK L + 
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL--NVETEIEILKKLNHP 200
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            II +   +  ED      + E+   G L +    ++ +     K +  Q+L  + YLH 
Sbjct: 201 CIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH- 256
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQ--VKIGDL 175
            E  +IHRDL   NV ++       +KI D 
Sbjct: 257 -ENGIIHRDLKPENVLLSSQEEDCLIKITDF 286

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 46.6 bits (109), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC------DDPAMIERLFSEVRLLKTLANK 86
           LGSGA  +V  AF+++   +VA   +  R F        DPA+   + +E+ +LK L + 
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL--NVETEIEILKKLNHP 214
Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            II +   +  ED      + E+   G L +    ++ +     K +  Q+L  + YLH 
Sbjct: 215 CIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH- 270
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQ--VKIGDL 175
            E  +IHRDL   NV ++       +KI D 
Sbjct: 271 -ENGIIHRDLKPENVLLSSQEEDCLIKITDF 300

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 84/164 (51%), Gaps = 20/164 (12%)
Query: 21  DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           DP G +    EL+G+G   +VY+    + G   A   +K+     D    E +  E+ +L
Sbjct: 21  DPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAA---IKVMDVTGDEE--EEIKQEINML 74
Query: 81  KTLAN-KNIISLHYVWRDEDRNTLN----FITEVCTSGNLREYRKKHRHVSVKALKKW-- 133
           K  ++ +NI + +  +  ++   ++     + E C +G++ +  K  +  ++K  ++W  
Sbjct: 75  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK--EEWIA 132
Query: 134 --SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              ++IL+GL++LH H+  VIHRD+   NV +  N  +VK+ D 
Sbjct: 133 YICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDF 173

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 68/150 (45%), Gaps = 18/150 (12%)
Query: 23  TGRYGRYNEL------LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSE 76
           T + G  +E+      LGSGA  +V    D+   +E A   ++  +         +L  E
Sbjct: 29  TSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN--SKLLEE 86
Query: 77  VRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRKKHRHVSVKALKKW 133
           V +LK L + NI+ L+  +  ED+     + E    G L +   +R K   V    +   
Sbjct: 87  VAVLKLLDHPNIMKLYDFF--EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI--- 141
Query: 134 SKQILKGLNYLHTHEPCVIHRDLNCSNVFV 163
            KQ+L G+ YLH H   ++HRDL   N+ +
Sbjct: 142 IKQVLSGVTYLHKHN--IVHRDLKPENLLL 169

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 6/147 (4%)
Query: 29  YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
           Y +LLG G   KV    ++  G   A   ++          +    +E R+L+   +  +
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHTVTESRVLQNTRHPFL 67
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
            +L Y ++  DR  L F+ E    G L  +  + R  + +  + +  +I+  L YLH+ +
Sbjct: 68  TALKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V++RD+   N+ ++ + G +KI D 
Sbjct: 126 --VVYRDIKLENLMLDKD-GHIKITDF 149

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +GSGA   V  A D+  G +VA  ++  R F  +    +R + E+ LLK + ++N+I L 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSE-IFAKRAYRELLLLKHMQHENVIGLL 107
Query: 93  YVWRDED--RNTLNF-ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
            V+      RN  +F +       +L++        S + ++    Q+LKGL Y+H+   
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHS--A 163
Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDL 175
            V+HRDL   N+ VN +  ++KI D 
Sbjct: 164 GVVHRDLKPGNLAVNEDC-ELKILDF 188

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG+G    V++   +  G+ +A   + L      PA+  ++  E+++L    +  I+  +
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 89
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
             +  +    ++   E    G+L +  KK   +  + L K S  ++KGL YL      ++
Sbjct: 90  GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 146
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
           HRD+  SN+ VN + G++K+ D 
Sbjct: 147 HRDVKPSNILVN-SRGEIKLCDF 168

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 20/171 (11%)
Query: 16  PFIETDPTGRYGRYN--------ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDP 67
           PF     T + G  N        E+LG G   +V++  +   G+++A   +K R   D  
Sbjct: 72  PFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK- 130
Query: 68  AMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSV 127
              E + +E+ ++  L + N+I L+  +  E +N +  + E    G L + R      ++
Sbjct: 131 ---EEVKNEISVMNQLDHANLIQLYDAF--ESKNDIVLVMEYVDGGELFD-RIIDESYNL 184
Query: 128 KALKK--WSKQILKGLNYLHTHEPCVIHRDLNCSNVF-VNGNTGQVKIGDL 175
             L    + KQI +G+   H H+  ++H DL   N+  VN +  Q+KI D 
Sbjct: 185 TELDTILFMKQICEGIR--HMHQMYILHLDLKPENILCVNRDAKQIKIIDF 233

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 6/147 (4%)
Query: 29  YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
           Y +LLG G   KV    ++  G   A   ++          +    +E R+L+   +  +
Sbjct: 14  YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHTVTESRVLQNTRHPFL 72
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
            +L Y ++  DR  L F+ E    G L  +  + R  + +  + +  +I+  L YLH+ +
Sbjct: 73  TALKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 130
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V++RD+   N+ ++ + G +KI D 
Sbjct: 131 --VVYRDIKLENLMLDKD-GHIKITDF 154

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 10/148 (6%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
           +E LG+GA   V+R  ++  G   A   V      D     E +  E++ +  L +  ++
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK----ETVRKEIQTMSVLRHPTLV 217
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLRE-YRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           +LH  +  ED N +  I E  + G L E    +H  +S     ++ +Q+ KGL   H HE
Sbjct: 218 NLHDAF--EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL--CHMHE 273
Query: 149 PCVIHRDLNCSNV-FVNGNTGQVKIGDL 175
              +H DL   N+ F    + ++K+ D 
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDF 301

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 10/148 (6%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
           +E LG+GA   V+R  ++  G   A   V      D     E +  E++ +  L +  ++
Sbjct: 56  HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK----ETVRKEIQTMSVLRHPTLV 111
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLRE-YRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           +LH  +  ED N +  I E  + G L E    +H  +S     ++ +Q+ KGL   H HE
Sbjct: 112 NLHDAF--EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL--CHMHE 167
Query: 149 PCVIHRDLNCSNV-FVNGNTGQVKIGDL 175
              +H DL   N+ F    + ++K+ D 
Sbjct: 168 NNYVHLDLKPENIMFTTKRSNELKLIDF 195

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 78/149 (52%), Gaps = 15/149 (10%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +GSGA   V  A+D     +VA  ++  R F        R + E+RLLK L ++N+I L 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLS-RPF-QSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 93  YVWRD----EDRNTLNFITEVCTS--GNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            V+      ED + +  +T +  +   N+     K + +S + ++    Q+L+GL Y+H+
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNI----VKCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
               +IHRDL  SNV VN ++ +++I D 
Sbjct: 150 --AGIIHRDLKPSNVAVNEDS-ELRILDF 175

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 75/178 (42%), Gaps = 29/178 (16%)
Query: 14  SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
           SE  +  DP   + R      + LG GA  +V  A     D+++  E     VK+     
Sbjct: 20  SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 79
Query: 66  DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
               +  L SE+ ++K +  +KNII+L      +    L  I E  + GNLREY +  R 
Sbjct: 80  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRP 137
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
                           ++ K L   + Q+ +G+ YL + +   IHRDL   NV V  N
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN 193

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 6/147 (4%)
Query: 29  YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
           Y +LLG G   KV    ++  G   A   ++          +    +E R+L+   +  +
Sbjct: 9   YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHTVTESRVLQNTRHPFL 67
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
            +L Y ++  DR  L F+ E    G L  +  + R  + +  + +  +I+  L YLH+ +
Sbjct: 68  TALKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             V++RD+   N+ ++ + G +KI D 
Sbjct: 126 --VVYRDIKLENLMLDKD-GHIKITDF 149

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 73/147 (49%), Gaps = 9/147 (6%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
           L+G G+   VY A+D+     VA  +V  R F +D    +R+  E+ +L  L +  II L
Sbjct: 35  LIGRGSYGYVYLAYDKNANKNVAIKKVN-RMF-EDLIDCKRILREITILNRLKSDYIIRL 92
Query: 92  HYVWRDEDR---NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           H +   ED    + L  + E+  S +L++  K    ++ + +K     +L G  ++H  E
Sbjct: 93  HDLIIPEDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEQHVKTILYNLLLGEKFIH--E 149
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             +IHRDL  +N  +N +   VKI D 
Sbjct: 150 SGIIHRDLKPANCLLNQDCS-VKICDF 175

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 16/158 (10%)
Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NK 86
           R   +L  G    VY A D   G E A      R   ++      +  EV  +K L+ + 
Sbjct: 31  RVRRVLAEGGFAFVYEAQDVGSGREYALK----RLLSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 87  NII---SLHYVWRDE-DRNTLNFI--TEVCTSGNLREYRKKHRH---VSVKALKKWSKQI 137
           NI+   S   + ++E D     F+  TE+C  G L E+ KK      +S   + K   Q 
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 138 LKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            + + ++H  +P +IHRDL   N+ ++ N G +K+ D 
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDF 182

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 62/136 (45%), Gaps = 13/136 (9%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG+G   +V+ A   +        +V ++T       +E   +E  ++KTL +  ++ LH
Sbjct: 23  LGAGQFGEVWMATYNKH------TKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLH 76
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E    +  ITE    G+L ++ K        +  L  +S QI +G+ ++      
Sbjct: 77  AVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 131
Query: 151 VIHRDLNCSNVFVNGN 166
            IHRDL  +N+ V+ +
Sbjct: 132 YIHRDLRAANILVSAS 147

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 62/136 (45%), Gaps = 13/136 (9%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG+G   +V+ A   +        +V ++T       +E   +E  ++KTL +  ++ LH
Sbjct: 196 LGAGQFGEVWMATYNKH------TKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLH 249
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E    +  ITE    G+L ++ K        +  L  +S QI +G+ ++      
Sbjct: 250 AVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 304
Query: 151 VIHRDLNCSNVFVNGN 166
            IHRDL  +N+ V+ +
Sbjct: 305 YIHRDLRAANILVSAS 320

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 65/145 (44%), Gaps = 13/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG+G   +V+  +           +V ++T       ++    E  L+KTL +  ++ L+
Sbjct: 21  LGAGQFGEVWMGYYNNS------TKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLY 74
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E+   +  ITE    G+L ++ K      V +  L  +S QI +G+ Y+      
Sbjct: 75  AVVTREE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 130
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHRDL  +NV V+  +   KI D 
Sbjct: 131 YIHRDLRAANVLVS-ESLMCKIADF 154

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 62/136 (45%), Gaps = 13/136 (9%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG+G   +V+ A   +        +V ++T       +E   +E  ++KTL +  ++ LH
Sbjct: 190 LGAGQFGEVWMATYNKH------TKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLH 243
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E    +  ITE    G+L ++ K        +  L  +S QI +G+ ++      
Sbjct: 244 AVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 298
Query: 151 VIHRDLNCSNVFVNGN 166
            IHRDL  +N+ V+ +
Sbjct: 299 YIHRDLRAANILVSAS 314

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 66/143 (46%), Gaps = 13/143 (9%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G+  +V+R  D++ G + A  +V+L  F      +E L +       L++  I+ L+
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVA----CAGLSSPRIVPLY 130
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
              R+     +N   E+   G+L +  K+   +       +  Q L+GL YLHT    ++
Sbjct: 131 GAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--IL 186
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
           H D+   NV ++ +  +  + D 
Sbjct: 187 HGDVKADNVLLSSDGSRAALCDF 209

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/106 (22%), Positives = 60/106 (56%), Gaps = 5/106 (4%)
Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
           +  +F E+++++ L +  +++L Y ++DE+   +  + ++   G+LR + +++ H   + 
Sbjct: 59  VRNVFKELQIMQGLEHPFLVNLWYSFQDEE--DMFMVVDLLLGGDLRYHLQQNVHFKEET 116
Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +K +  +++  L+YL      +IHRD+   N+ ++ + G V I D 
Sbjct: 117 VKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEH-GHVHITDF 159

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 78/187 (41%), Gaps = 30/187 (16%)
Query: 14  SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
           SE  +  DP   + R      + LG G   +V  A     D+++  E     VK+     
Sbjct: 7   SEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 66
Query: 66  DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
               +  L SE+ ++K +  +KNII+L      +    L  I E  + GNLREY +  R 
Sbjct: 67  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRP 124
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
                           ++ K L   + Q+ +G+ YL + +   IHRDL   NV V  N  
Sbjct: 125 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLTARNVLVTENN- 181
Query: 169 QVKIGDL 175
            +KI D 
Sbjct: 182 VMKIADF 188

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 72/169 (42%), Gaps = 15/169 (8%)
Query: 16  PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS 75
           P + T   G +    E LG+G    V R   Q+ G +VA  Q +       P   ER   
Sbjct: 6   PSLPTQTCGPW-EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCL 61
Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLN----FITEVCTSGNLREYRKKHRH---VSVK 128
           E++++K L + N++S   V     +   N       E C  G+LR+Y  +  +   +   
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 129 ALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQV--KIGDL 175
            ++     I   L YLH +   +IHRDL   N+ +     ++  KI DL
Sbjct: 122 PIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDL 168

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G   +VY    ++  + VA     ++T  +D   +E    E  ++K + + N++ L 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 321
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            V   E       ITE  T GNL +Y ++   + V+   L   + QI   + YL      
Sbjct: 322 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 377
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
            IHR+L   N  V G    VK+ D 
Sbjct: 378 FIHRNLAARNCLV-GENHLVKVADF 401

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 72/169 (42%), Gaps = 15/169 (8%)
Query: 16  PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS 75
           P + T   G +    E LG+G    V R   Q+ G +VA  Q +       P   ER   
Sbjct: 7   PSLPTQTCGPW-EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCL 62
Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLN----FITEVCTSGNLREYRKKHRH---VSVK 128
           E++++K L + N++S   V     +   N       E C  G+LR+Y  +  +   +   
Sbjct: 63  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 122
Query: 129 ALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQV--KIGDL 175
            ++     I   L YLH +   +IHRDL   N+ +     ++  KI DL
Sbjct: 123 PIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDL 169

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
           ++ LH  ++ E R  L F+ E    G+L  + ++ R +  +  + +S +I   LNYL  H
Sbjct: 115 LVGLHSCFQTESR--LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL--H 170
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGD 174
           E  +I+RDL   NV ++ + G +K+ D
Sbjct: 171 ERGIIYRDLKLDNVLLD-SEGHIKLTD 196

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +GSGA   V  A D+  G +VA  ++  R F  +    +R + E+ LLK + ++N+I L 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSE-IFAKRAYRELLLLKHMQHENVIGLL 89
Query: 93  YVWRDED--RNTLNF-ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
            V+      RN  +F +       +L++        S + ++    Q+LKGL Y+H+   
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHS--A 145
Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDL 175
            V+HRDL   N+ VN +  ++KI D 
Sbjct: 146 GVVHRDLKPGNLAVNEDC-ELKILDF 170

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 71/138 (51%), Gaps = 14/138 (10%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +GSGA   V  A+D     +VA  ++  R F        R + E+RLLK L ++N+I L 
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLS-RPF-QSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 93  YVWRD----EDRNTLNFITEVCTS--GNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            V+      ED + +  +T +  +   N+     K + +S + ++    Q+L+GL Y+H+
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNI----VKCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 147 HEPCVIHRDLNCSNVFVN 164
               +IHRDL  SNV VN
Sbjct: 142 --AGIIHRDLKPSNVAVN 157

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 67/143 (46%), Gaps = 6/143 (4%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G    VY A +++    +A  +V  ++  +   +  +L  E+ +   L + NI+ ++
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMAL-KVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 81
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
             +   DR  +  + E    G L +  +KH     +    + +++   L+Y   HE  VI
Sbjct: 82  NYF--HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHY--CHERKVI 137
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
           HRD+   N+ + G  G++KI D 
Sbjct: 138 HRDIKPENLLM-GYKGELKIADF 159

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
           ++ LH  ++ E R  L F+ E    G+L  + ++ R +  +  + +S +I   LNYL  H
Sbjct: 83  LVGLHSCFQTESR--LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL--H 138
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGD 174
           E  +I+RDL   NV ++ + G +K+ D
Sbjct: 139 ERGIIYRDLKLDNVLLD-SEGHIKLTD 164

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 78/187 (41%), Gaps = 30/187 (16%)
Query: 14  SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
           SE  +  DP   + R      + LG G   +V  A     D+++  E     VK+     
Sbjct: 66  SEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 125
Query: 66  DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
               +  L SE+ ++K +  +KNII+L      +    L  I E  + GNLREY +  R 
Sbjct: 126 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRP 183
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
                           ++ K L   + Q+ +G+ YL + +   IHRDL   NV V  N  
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-N 240
Query: 169 QVKIGDL 175
            +KI D 
Sbjct: 241 VMKIADF 247

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
           ++ LH  ++ E R  L F+ E    G+L  + ++ R +  +  + +S +I   LNYL  H
Sbjct: 68  LVGLHSCFQTESR--LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL--H 123
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGD 174
           E  +I+RDL   NV ++ + G +K+ D
Sbjct: 124 ERGIIYRDLKLDNVLLD-SEGHIKLTD 149

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
           ++ LH  ++ E R  L F+ E    G+L  + ++ R +  +  + +S +I   LNYL  H
Sbjct: 72  LVGLHSCFQTESR--LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL--H 127
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGD 174
           E  +I+RDL   NV ++ + G +K+ D
Sbjct: 128 ERGIIYRDLKLDNVLLD-SEGHIKLTD 153

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 67/143 (46%), Gaps = 6/143 (4%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G    VY A +++    +A  +V  ++  +   +  +L  E+ +   L + NI+ ++
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMAL-KVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
             +   DR  +  + E    G L +  +KH     +    + +++   L+Y   HE  VI
Sbjct: 81  NYF--HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHY--CHERKVI 136
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
           HRD+   N+ + G  G++KI D 
Sbjct: 137 HRDIKPENLLM-GYKGELKIADF 158

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 77/158 (48%), Gaps = 24/158 (15%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
           +LG GA  +V +A +  +    A  +++          +  + SEV LL +L ++ ++  
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR-----HTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 92  HYVWRD-----------EDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWS--KQI 137
           +  W +           + ++TL    E C +G L  Y   H  +++ +  + W   +QI
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL--YDLIHSENLNQQRDEYWRLFRQI 125
Query: 138 LKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L+ L+Y+H+    +IHRDL   N+F++  +  VKIGD 
Sbjct: 126 LEALSYIHSQ--GIIHRDLKPMNIFID-ESRNVKIGDF 160

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 78/187 (41%), Gaps = 30/187 (16%)
Query: 14  SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
           SE  +  DP   + R      + LG G   +V  A     D+++  E     VK+     
Sbjct: 9   SEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 68
Query: 66  DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
               +  L SE+ ++K +  +KNII+L      +    L  I E  + GNLREY +  R 
Sbjct: 69  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRP 126
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
                           ++ K L   + Q+ +G+ YL + +   IHRDL   NV V  N  
Sbjct: 127 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 183
Query: 169 QVKIGDL 175
            +KI D 
Sbjct: 184 VMKIADF 190

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 78/187 (41%), Gaps = 30/187 (16%)
Query: 14  SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
           SE  +  DP   + R      + LG G   +V  A     D+++  E     VK+     
Sbjct: 12  SEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 71
Query: 66  DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
               +  L SE+ ++K +  +KNII+L      +    L  I E  + GNLREY +  R 
Sbjct: 72  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRP 129
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
                           ++ K L   + Q+ +G+ YL + +   IHRDL   NV V  N  
Sbjct: 130 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 186
Query: 169 QVKIGDL 175
            +KI D 
Sbjct: 187 VMKIADF 193

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 11/152 (7%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM-IERLFSEVRLLKTLANKNII 89
           E++G GA   V R  ++E G + A   V +  F   P +  E L  E  +   L + +I+
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNL---REYRKKHRHVSVKALKK-WSKQILKGLNYLH 145
            L   +  +    L  + E     +L      R     V  +A+   + +QIL+ L Y H
Sbjct: 90  ELLETYSSD--GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 146 THEPCVIHRDLNCSNVFVNG--NTGQVKIGDL 175
            +   +IHRD+   NV +    N+  VK+GD 
Sbjct: 148 DNN--IIHRDVKPENVLLASKENSAPVKLGDF 177

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 15/154 (9%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
           + L+G G+  +V +A+D+   +E  W  V ++   +  A + +   EVRLL+ L NK+  
Sbjct: 59  DSLIGKGSFGQVVKAYDR---VEQEW--VAIKIIKNKKAFLNQAQIEVRLLE-LMNKHDT 112
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREY-------RKKHRHVSVKALKKWSKQILKGLN 142
            + Y      R+ + F   +C    +  Y           R VS+   +K+++Q+   L 
Sbjct: 113 EMKYYIVHLKRHFM-FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 143 YLHTHEPCVIHRDLNCSNVFV-NGNTGQVKIGDL 175
           +L T E  +IH DL   N+ + N     +KI D 
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 63/143 (44%), Gaps = 13/143 (9%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G+  +V+R  D++ G + A  +V+L  F  +         E+     L +  I+ L+
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE---------ELMACAGLTSPRIVPLY 151
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
              R+     +N   E+   G+L +  K+   +       +  Q L+GL YLH+    ++
Sbjct: 152 GAVREGP--WVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR--IL 207
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
           H D+   NV ++ +     + D 
Sbjct: 208 HGDVKADNVLLSSDGSHAALCDF 230

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 63/143 (44%), Gaps = 13/143 (9%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G+  +V+R  D++ G + A  +V+L  F  +         E+     L +  I+ L+
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE---------ELMACAGLTSPRIVPLY 132
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
              R+     +N   E+   G+L +  K+   +       +  Q L+GL YLH+    ++
Sbjct: 133 GAVREGP--WVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR--IL 188
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
           H D+   NV ++ +     + D 
Sbjct: 189 HGDVKADNVLLSSDGSHAALCDF 211

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 15/154 (9%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
           + L+G G+  +V +A+D+   +E  W  V ++   +  A + +   EVRLL+ L NK+  
Sbjct: 40  DSLIGKGSFGQVVKAYDR---VEQEW--VAIKIIKNKKAFLNQAQIEVRLLE-LMNKHDT 93
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREY-------RKKHRHVSVKALKKWSKQILKGLN 142
            + Y      R+ + F   +C    +  Y           R VS+   +K+++Q+   L 
Sbjct: 94  EMKYYIVHLKRHFM-FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 152
Query: 143 YLHTHEPCVIHRDLNCSNVFV-NGNTGQVKIGDL 175
           +L T E  +IH DL   N+ + N     +KI D 
Sbjct: 153 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 186

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 78/187 (41%), Gaps = 30/187 (16%)
Query: 14  SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
           SE  +  DP   + R      + LG GA  +V  A     D+++  E     VK+     
Sbjct: 20  SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 79
Query: 66  DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
               +  L SE+ ++K +  +KNII+L      +    L  I    + GNLREY +  R 
Sbjct: 80  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVAYASKGNLREYLRARRP 137
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
                           ++ K L   + Q+ +G+ YL + +   IHRDL   NV V  N  
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 194
Query: 169 QVKIGDL 175
            +KI D 
Sbjct: 195 VMKIADF 201

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 33  LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
           LG GA  +V  A     D+++   V    VK+         +  L SE+ ++K +  +KN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALK 131
           II+L      +    L  I E  + GNLREY +  R                 +S K L 
Sbjct: 96  IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             + Q+ +G+ YL + +   IHRDL   NV V  +   +KI D 
Sbjct: 154 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADF 194

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 33  LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
           LG GA  +V  A     D+++   V    VK+         +  L SE+ ++K +  +KN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALK 131
           II+L      +    L  I E  + GNLREY +  R                 +S K L 
Sbjct: 96  IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             + Q+ +G+ YL + +   IHRDL   NV V  +   +KI D 
Sbjct: 154 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADF 194

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 33  LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
           LG GA  +V  A     D+++   V    VK+         +  L SE+ ++K +  +KN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALK 131
           II+L      +    L  I E  + GNLREY +  R                 +S K L 
Sbjct: 96  IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             + Q+ +G+ YL + +   IHRDL   NV V  +   +KI D 
Sbjct: 154 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADF 194

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 33  LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
           LG GA  +V  A     D+++   V    VK+         +  L SE+ ++K +  +KN
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALK 131
           II+L      +    L  I E  + GNLREY +  R                 +S K L 
Sbjct: 89  IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             + Q+ +G+ YL + +   IHRDL   NV V  +   +KI D 
Sbjct: 147 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADF 187

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 33  LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
           LG GA  +V  A     D+++   V    VK+         +  L SE+ ++K +  +KN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALK 131
           II+L      +    L  I E  + GNLREY +  R                 +S K L 
Sbjct: 137 IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             + Q+ +G+ YL + +   IHRDL   NV V  +   +KI D 
Sbjct: 195 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADF 235

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 15/154 (9%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
           + L+G G+  +V +A+D+   +E  W  V ++   +  A + +   EVRLL+ L NK+  
Sbjct: 59  DSLIGKGSFGQVVKAYDR---VEQEW--VAIKIIKNKKAFLNQAQIEVRLLE-LMNKHDT 112
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREY-------RKKHRHVSVKALKKWSKQILKGLN 142
            + Y      R+ + F   +C    +  Y           R VS+   +K+++Q+   L 
Sbjct: 113 EMKYYIVHLKRHFM-FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 143 YLHTHEPCVIHRDLNCSNVFV-NGNTGQVKIGDL 175
           +L T E  +IH DL   N+ + N     +KI D 
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRXAIKIVDF 205

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 78/187 (41%), Gaps = 30/187 (16%)
Query: 14  SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
           SE  +  DP   + R      + LG GA  +V  A     D+++  E     VK+     
Sbjct: 20  SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 79
Query: 66  DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
               +  L SE+ ++K +  +KNII+L      +    L  I    + GNLREY +  R 
Sbjct: 80  TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVGYASKGNLREYLRARRP 137
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
                           ++ K L   + Q+ +G+ YL + +   IHRDL   NV V  N  
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 194
Query: 169 QVKIGDL 175
            +KI D 
Sbjct: 195 VMKIADF 201

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 33  LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
           LG GA  +V  A     D+++   V    VK+         +  L SE+ ++K +  +KN
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALK 131
           II+L      +    L  I E  + GNLREY +  R                 +S K L 
Sbjct: 81  IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             + Q+ +G+ YL + +   IHRDL   NV V  +   +KI D 
Sbjct: 139 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADF 179

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 33  LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
           LG GA  +V  A     D+++   V    VK+         +  L SE+ ++K +  +KN
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALK 131
           II+L      +    L  I E  + GNLREY +  R                 +S K L 
Sbjct: 88  IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             + Q+ +G+ YL + +   IHRDL   NV V  +   +KI D 
Sbjct: 146 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADF 186

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 33  LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
           LG GA  +V  A     D+++   V    VK+         +  L SE+ ++K +  +KN
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALK 131
           II+L      +    L  I E  + GNLREY +  R                 +S K L 
Sbjct: 85  IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             + Q+ +G+ YL + +   IHRDL   NV V  +   +KI D 
Sbjct: 143 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADF 183

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/143 (23%), Positives = 66/143 (46%), Gaps = 13/143 (9%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +G G+  +V+R  D++ G + A  +V+L  F      +E L +       L++  I+ L+
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVA----CAGLSSPRIVPLY 116
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
              R+     +N   E+   G+L +  K+   +       +  Q L+GL YLHT    ++
Sbjct: 117 GAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--IL 172
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
           H D+   NV ++ +  +  + D 
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDF 195

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 26/154 (16%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A     G   A  +++L    +D  +      E+ +LK L + NI+ 
Sbjct: 8   EKIGEGTYGVVYKA-QNNYGETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVK 64
Query: 91  LHYVWRDEDRNTLNF---------ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           L+ V   + R  L F         + +VC  G            SV A K +  Q+L G+
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----------LESVTA-KSFLLQLLNGI 113
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y H     V+HRDL   N+ +N   G++KI D 
Sbjct: 114 AYCHDRR--VLHRDLKPQNLLIN-REGELKIADF 144

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 26/154 (16%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A     G   A  +++L    +D  +      E+ +LK L + NI+ 
Sbjct: 8   EKIGEGTYGVVYKA-QNNYGETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVK 64
Query: 91  LHYVWRDEDRNTLNF---------ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           L+ V   + R  L F         + +VC  G            SV A K +  Q+L G+
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----------LESVTA-KSFLLQLLNGI 113
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y H     V+HRDL   N+ +N   G++KI D 
Sbjct: 114 AYCHDRR--VLHRDLKPQNLLIN-REGELKIADF 144

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 64/148 (43%), Gaps = 10/148 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF-CDDPAMIERLFSEVRLLKTLANKNII 89
           E LG GA   V R   +    E A   +  +     D   +ER   E R+ + L + NI+
Sbjct: 37  EELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER---EARICRLLKHPNIV 93
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
            LH    +E  + L F  ++ T G L E      + S         QIL+ +N++H H+ 
Sbjct: 94  RLHDSISEEGFHYLVF--DLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHD- 150
Query: 150 CVIHRDLNCSNVFVNGNT--GQVKIGDL 175
            ++HRDL   N+ +        VK+ D 
Sbjct: 151 -IVHRDLKPENLLLASKCKGAAVKLADF 177

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 26/154 (16%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A     G   A  +++L    +D  +      E+ +LK L + NI+ 
Sbjct: 8   EKIGEGTYGVVYKA-QNNYGETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVK 64
Query: 91  LHYVWRDEDRNTLNF---------ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           L+ V   + R  L F         + +VC  G            SV A K +  Q+L G+
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----------LESVTA-KSFLLQLLNGI 113
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            Y H     V+HRDL   N+ +N   G++KI D 
Sbjct: 114 AYCHDRR--VLHRDLKPQNLLIN-REGELKIADF 144

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/143 (23%), Positives = 66/143 (46%), Gaps = 13/143 (9%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +G G+  +V+R  D++ G + A  +V+L  F      +E L +       L++  I+ L+
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVA----CAGLSSPRIVPLY 132
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
              R+     +N   E+   G+L +  K+   +       +  Q L+GL YLHT    ++
Sbjct: 133 GAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--IL 188
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
           H D+   NV ++ +  +  + D 
Sbjct: 189 HGDVKADNVLLSSDGSRAALCDF 211

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 26/159 (16%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
            E++GSGA   V  A+   +  +VA  ++ L   C     ++ L  E++ +    + NI+
Sbjct: 20  QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQ--TSMDELLKEIQAMSQCHHPNIV 76
Query: 90  SLH--YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS-----------KQ 136
           S +  +V +DE    L  + ++ + G++ +  K   H+  K   K             ++
Sbjct: 77  SYYTSFVVKDE----LWLVMKLLSGGSVLDIIK---HIVAKGEHKSGVLDESTIATILRE 129
Query: 137 ILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +L+GL YLH +    IHRD+   N+ + G  G V+I D 
Sbjct: 130 VLEGLEYLHKNGQ--IHRDVKAGNILL-GEDGSVQIADF 165

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 26/159 (16%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
            E++GSGA   V  A+   +  +VA  ++ L   C     ++ L  E++ +    + NI+
Sbjct: 15  QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQ--TSMDELLKEIQAMSQCHHPNIV 71
Query: 90  SLH--YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS-----------KQ 136
           S +  +V +DE    L  + ++ + G++ +  K   H+  K   K             ++
Sbjct: 72  SYYTSFVVKDE----LWLVMKLLSGGSVLDIIK---HIVAKGEHKSGVLDESTIATILRE 124
Query: 137 ILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +L+GL YLH +    IHRD+   N+ + G  G V+I D 
Sbjct: 125 VLEGLEYLHKNGQ--IHRDVKAGNILL-GEDGSVQIADF 160

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 68/145 (46%), Gaps = 12/145 (8%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG GA   VYR   +++G +  +    L+   D     + + +E+ +L  L++ NII L 
Sbjct: 61  LGRGATSIVYRC--KQKGTQKPYALKVLKKTVDK----KIVRTEIGVLLRLSHPNIIKLK 114
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
            ++  E    ++ + E+ T G L +   +  + S +      KQIL+ + YL  HE  ++
Sbjct: 115 EIF--ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYL--HENGIV 170
Query: 153 HRDLNCSNVF--VNGNTGQVKIGDL 175
           HRDL   N+          +KI D 
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADF 195

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 66/145 (45%), Gaps = 13/145 (8%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQV-------KLRTFCDDPAMIERLFSEVRLLKTLA 84
            + SG+   V    D E GI VA  +V       +      D  + +R+  E+RLL    
Sbjct: 29  FISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 85  NKNIISLHYVW---RDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           + NI+ L  ++    +   + L  +TE+  +   +    +   +S + ++ +   IL GL
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
           + LH  E  V+HRDL+  N+ +  N
Sbjct: 148 HVLH--EAGVVHRDLHPGNILLADN 170

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 30/153 (19%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWN---QVKLRTFCDD-PAMIERLFSEVRLLKTLANKNI 88
           +GSG+   VY+           W+    VK+    D  P   +   +EV +L+   + NI
Sbjct: 44  IGSGSFGTVYKG---------KWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNI 94
Query: 89  I-SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKW-----SKQILKGLN 142
           +  + Y+ +D     L  +T+ C   +L     KH HV     + +     ++Q  +G++
Sbjct: 95  LLFMGYMTKD----NLAIVTQWCEGSSLY----KHLHVQETKFQMFQLIDIARQTAQGMD 146
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           YLH     +IHRD+  +N+F++     VKIGD 
Sbjct: 147 YLHAKN--IIHRDMKSNNIFLHEGL-TVKIGDF 176

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/144 (24%), Positives = 71/144 (49%), Gaps = 9/144 (6%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG+G    V +   +  G+ +A   + L      PA+  ++  E+++L    +  I+  +
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 80
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL-HTHEPCV 151
             +  +    ++   E    G+L +  K+ + +  + L K S  +L+GL YL   H+  +
Sbjct: 81  GAFYSD--GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ--I 136
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
           +HRD+  SN+ VN + G++K+ D 
Sbjct: 137 MHRDVKPSNILVN-SRGEIKLCDF 159

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 66/145 (45%), Gaps = 13/145 (8%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQV-------KLRTFCDDPAMIERLFSEVRLLKTLA 84
            + SG+   V    D E GI VA  +V       +      D  + +R+  E+RLL    
Sbjct: 29  FISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 85  NKNIISLHYVW---RDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           + NI+ L  ++    +   + L  +TE+  +   +    +   +S + ++ +   IL GL
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
           + LH  E  V+HRDL+  N+ +  N
Sbjct: 148 HVLH--EAGVVHRDLHPGNILLADN 170

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 49/88 (55%), Gaps = 5/88 (5%)
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
           I+ + Y +   D+  L+FI ++   G+L  +  +H   S   ++ ++ +I+ GL   H H
Sbjct: 254 IVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE--HMH 309
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V++RDL  +N+ ++ + G V+I DL
Sbjct: 310 NRFVVYRDLKPANILLDEH-GHVRISDL 336

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 63/148 (42%), Gaps = 10/148 (6%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF-CDDPAMIERLFSEVRLLKTLANKNII 89
           E LG GA   V R      G E A   +  +     D   +ER   E R+ + L + NI+
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLER---EARICRLLKHPNIV 84
Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
            LH    +E  + L F  ++ T G L E      + S        +QIL+ +  LH H+ 
Sbjct: 85  RLHDSISEEGHHYLIF--DLVTGGELFEDIVAREYYSEADASHCIQQILEAV--LHCHQM 140
Query: 150 CVIHRDLNCSNVFVNGNT--GQVKIGDL 175
            V+HRDL   N+ +        VK+ D 
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADF 168

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 49/88 (55%), Gaps = 5/88 (5%)
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
           I+ + Y +   D+  L+FI ++   G+L  +  +H   S   ++ ++ +I+ GL   H H
Sbjct: 253 IVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE--HMH 308
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V++RDL  +N+ ++ + G V+I DL
Sbjct: 309 NRFVVYRDLKPANILLDEH-GHVRISDL 335

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 49/88 (55%), Gaps = 5/88 (5%)
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
           I+ + Y +   D+  L+FI ++   G+L  +  +H   S   ++ ++ +I+ GL   H H
Sbjct: 254 IVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE--HMH 309
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V++RDL  +N+ ++ + G V+I DL
Sbjct: 310 NRFVVYRDLKPANILLDEH-GHVRISDL 336

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 25/88 (28%), Positives = 49/88 (55%), Gaps = 5/88 (5%)
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
           I+ + Y +   D+  L+FI ++   G+L  +  +H   S   ++ ++ +I+ GL   H H
Sbjct: 254 IVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE--HMH 309
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              V++RDL  +N+ ++ + G V+I DL
Sbjct: 310 NRFVVYRDLKPANILLDEH-GHVRISDL 336

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 64/147 (43%), Gaps = 8/147 (5%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG GA   V R   +  G+E A   +  +         ++L  E R+ + L + NI+ 
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD--FQKLEREARICRKLQHPNIVR 92
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           LH   ++E  + L F  ++ T G L E        S        +QIL+ + Y H++   
Sbjct: 93  LHDSIQEESFHYLVF--DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN--G 148
Query: 151 VIHRDLNCSNVFV--NGNTGQVKIGDL 175
           ++HR+L   N+ +        VK+ D 
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADF 175

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 7/145 (4%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS- 90
           +LG G+  KV  A  +E G   A   +K      D   +E   +E R+L    N   ++ 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDD-VECTMTEKRILSLARNHPFLTQ 88
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L   ++  DR  L F+ E    G+L  + +K R       + ++ +I+  L +L  H+  
Sbjct: 89  LFCCFQTPDR--LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFL--HDKG 144
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
           +I+RDL   NV ++ + G  K+ D 
Sbjct: 145 IIYRDLKLDNVLLD-HEGHCKLADF 168

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 64/147 (43%), Gaps = 8/147 (5%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG GA   V R   +  G+E A   +  +         ++L  E R+ + L + NI+ 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVR 69
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           LH   ++E  + L F  ++ T G L E        S        +QIL+ + Y H++   
Sbjct: 70  LHDSIQEESFHYLVF--DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN--G 125
Query: 151 VIHRDLNCSNVFVNGNT--GQVKIGDL 175
           ++HR+L   N+ +        VK+ D 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADF 152

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 64/147 (43%), Gaps = 8/147 (5%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG GA   V R   +  G+E A   +  +         ++L  E R+ + L + NI+ 
Sbjct: 11  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVR 68
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           LH   ++E  + L F  ++ T G L E        S        +QIL+ + Y H++   
Sbjct: 69  LHDSIQEESFHYLVF--DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN--G 124
Query: 151 VIHRDLNCSNVFV--NGNTGQVKIGDL 175
           ++HR+L   N+ +        VK+ D 
Sbjct: 125 IVHRNLKPENLLLASKAKGAAVKLADF 151

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 66/156 (42%), Gaps = 11/156 (7%)
Query: 23  TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF-CDDPAMIERLFSEVRLLK 81
           T  Y  + EL G GA   V R      G E A   +  +     D   +ER   E R+ +
Sbjct: 3   TDEYQLFEEL-GKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER---EARICR 58
Query: 82  TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
            L + NI+ LH    +E  + L F  ++ T G L E      + S        +QIL+ +
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVF--DLVTGGELFEDIVAREYYSEADASHCIQQILESV 116
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDL 175
           N  H H   ++HRDL   N+ +   +    VK+ D 
Sbjct: 117 N--HCHLNGIVHRDLKPENLLLASKSKGAAVKLADF 150

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 66/156 (42%), Gaps = 11/156 (7%)
Query: 23  TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF-CDDPAMIERLFSEVRLLK 81
           T  Y  + EL G GA   V R      G E A   +  +     D   +ER   E R+ +
Sbjct: 3   TDEYQLFEEL-GKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER---EARICR 58
Query: 82  TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
            L + NI+ LH    +E  + L F  ++ T G L E      + S        +QIL+ +
Sbjct: 59  LLKHPNIVRLHDSISEEGFHYLVF--DLVTGGELFEDIVAREYYSEADASHCIQQILESV 116
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDL 175
           N  H H   ++HRDL   N+ +   +    VK+ D 
Sbjct: 117 N--HCHLNGIVHRDLKPENLLLASKSKGAAVKLADF 150

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 64/147 (43%), Gaps = 8/147 (5%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG GA   V R   +  G+E A   +  +         ++L  E R+ + L + NI+ 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVR 69
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           LH   ++E  + L F  ++ T G L E        S        +QIL+ + Y H++   
Sbjct: 70  LHDSIQEESFHYLVF--DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN--G 125
Query: 151 VIHRDLNCSNVFV--NGNTGQVKIGDL 175
           ++HR+L   N+ +        VK+ D 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADF 152

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 63/131 (48%), Gaps = 10/131 (7%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +G G+  +V  A  +   I  A  ++  + F +D   ++R   E+ ++K+L + NII L+
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIP-KYFVED---VDRFKQEIEIMKSLDHPNIIRLY 72
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA-LKKWSKQILKGLNYLHTHEPCV 151
             +  ED   +  + E+CT G L E R  H+ V  ++   +  K +L  + Y H     V
Sbjct: 73  ETF--EDNTDIYLVMELCTGGELFE-RVVHKRVFRESDAARIMKDVLSAVAYCHKLN--V 127
Query: 152 IHRDLNCSNVF 162
            HRDL   N  
Sbjct: 128 AHRDLKPENFL 138

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 63/131 (48%), Gaps = 10/131 (7%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +G G+  +V  A  +   I  A  ++  + F +D   ++R   E+ ++K+L + NII L+
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIP-KYFVED---VDRFKQEIEIMKSLDHPNIIRLY 89
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA-LKKWSKQILKGLNYLHTHEPCV 151
             +  ED   +  + E+CT G L E R  H+ V  ++   +  K +L  + Y H     V
Sbjct: 90  ETF--EDNTDIYLVMELCTGGELFE-RVVHKRVFRESDAARIMKDVLSAVAYCHKLN--V 144
Query: 152 IHRDLNCSNVF 162
            HRDL   N  
Sbjct: 145 AHRDLKPENFL 155

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 9/147 (6%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
           L+G G+   VY A+D+     VA  +V  R F +D    +R+  E+ +L  L +  II L
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMF-EDLIDCKRILREITILNRLKSDYIIRL 90
Query: 92  HYVWRDEDR---NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           + +   +D    + L  + E+  S +L++  K    ++ + +K     +L G N++H  E
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIH--E 147
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             +IHRDL  +N  +N +   VK+ D 
Sbjct: 148 SGIIHRDLKPANCLLNQDCS-VKVCDF 173

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 72/153 (47%), Gaps = 17/153 (11%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
            +++G+G+   VY+A   + G  VA  +V         A   R   E+++++ L + NI+
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQGKAFKNR---ELQIMRKLDHCNIV 76
Query: 90  SLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKGLN 142
            L Y +      +D   LN + +   +   R    Y +  + + V  +K +  Q+ + L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 137 YIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 167

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/76 (30%), Positives = 42/76 (55%), Gaps = 4/76 (5%)
Query: 101 NTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCS 159
           ++L  +T+    G+L ++ ++HR  +  + L  W  QI KG+ YL  H   ++HR+L   
Sbjct: 105 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH--GMVHRNLAAR 162
Query: 160 NVFVNGNTGQVKIGDL 175
           NV +  +  QV++ D 
Sbjct: 163 NVLLK-SPSQVQVADF 177

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/76 (30%), Positives = 42/76 (55%), Gaps = 4/76 (5%)
Query: 101 NTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCS 159
           ++L  +T+    G+L ++ ++HR  +  + L  W  QI KG+ YL  H   ++HR+L   
Sbjct: 87  SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH--GMVHRNLAAR 144
Query: 160 NVFVNGNTGQVKIGDL 175
           NV +  +  QV++ D 
Sbjct: 145 NVLLK-SPSQVQVADF 159

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
            +++G+G+   VY+A   + G  VA  +V          + ++ F   E+++++ L + N
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 74
Query: 88  IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
           I+ L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + 
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 135 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 167

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 65/143 (45%), Gaps = 6/143 (4%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G    VY A +++    +A  +V  +T  +   +  +L  EV +   L + NI+ L+
Sbjct: 20  LGKGKFGNVYLARERQSKFILAL-KVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
             + D  R  L  I E    G +    +K      +    +  ++   L+Y H+    VI
Sbjct: 79  GYFHDATRVYL--ILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR--VI 134
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
           HRD+   N+ + G+ G++KI D 
Sbjct: 135 HRDIKPENLLL-GSNGELKIADF 156

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
            +++G+G+   VY+A   + G  VA  +V          + ++ F   E+++++ L + N
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 74
Query: 88  IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
           I+ L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + 
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 135 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 167

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
            +++G+G+   VY+A   + G  VA  +V          + ++ F   E+++++ L + N
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 74
Query: 88  IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
           I+ L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + 
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 135 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 167

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
            +++G+G+   VY+A   + G  VA  +V          + ++ F   E+++++ L + N
Sbjct: 29  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 78
Query: 88  IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
           I+ L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + 
Sbjct: 79  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 138
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 139 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 171

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
            +++G+G+   VY+A   + G  VA  +V          + ++ F   E+++++ L + N
Sbjct: 26  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 75
Query: 88  IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
           I+ L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + 
Sbjct: 76  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 135
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 136 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 168

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 65/143 (45%), Gaps = 6/143 (4%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           LG G    VY A +++    +A  +V  +T  +   +  +L  EV +   L + NI+ L+
Sbjct: 20  LGKGKFGNVYLARERQSKFILAL-KVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
             + D  R  L  I E    G +    +K      +    +  ++   L+Y H+    VI
Sbjct: 79  GYFHDATRVYL--ILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR--VI 134
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
           HRD+   N+ + G+ G++KI D 
Sbjct: 135 HRDIKPENLLL-GSNGELKIADF 156

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 22/157 (14%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
           +LG GA  +V +A +  +    A  +++          +  + SEV LL +L ++ ++  
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR-----HTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 92  HYVWRDEDRNTLNFITEVCTSGNL---REY---RKKHRHVSVKALKK-----WS--KQIL 138
           +  W  E RN +  +T V     L    EY   R  +  +  + L +     W   +QIL
Sbjct: 68  YAAWL-ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           + L+Y+H+    +IHRDL   N+F++  +  VKIGD 
Sbjct: 127 EALSYIHSQ--GIIHRDLKPMNIFID-ESRNVKIGDF 160

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 70/164 (42%), Gaps = 26/164 (15%)
Query: 33  LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
           LG GA  +V  A     D+++   V    VK+         +  L SE+ ++K +  +KN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRK----------------KHRHVSVKALK 131
           II+L      +    L  I E  + GNLREY +                    +S K L 
Sbjct: 96  IINLLGACTQD--GPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             + Q+ +G+ YL + +   IHRDL   NV V  +   +KI D 
Sbjct: 154 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADF 194

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
            +++G+G+   VY+A   + G  VA  +V          + ++ F   E+++++ L + N
Sbjct: 44  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 93
Query: 88  IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
           I+ L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + 
Sbjct: 94  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 153
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 154 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 186

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
            +++G+G+   VY+A   + G  VA  +V          + ++ F   E+++++ L + N
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 86
Query: 88  IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
           I+ L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + 
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 147 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 179

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 62/146 (42%), Gaps = 18/146 (12%)
Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS---EVRLLKTLA 84
            Y + +G G    V++    ++   VA   + L     +  MIE+      EV ++  L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQ------IL 138
           + NI+ L+ +  +  R  + F+      G+L      HR +      KWS +      I 
Sbjct: 82  HPNIVKLYGLMHNPPRMVMEFVP----CGDLY-----HRLLDKAHPIKWSVKLRLMLDIA 132
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVN 164
            G+ Y+    P ++HRDL   N+F+ 
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQ 158

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
            +++G+G+   VY+A   + G  VA  +V          + ++ F   E+++++ L + N
Sbjct: 38  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 87
Query: 88  IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
           I+ L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + 
Sbjct: 88  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 147
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 148 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 180

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 28/152 (18%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWN---QVK-LRTFCDDPAMIERLFSEVRLLKTLANKNI 88
           +GSG+   VY+           W+    VK L      P  ++   +EV +L+   + NI
Sbjct: 32  IGSGSFGTVYKG---------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVS-----VKALKKWSKQILKGLNY 143
           +          +  L  +T+ C   +L      H H S     +K L   ++Q  +G++Y
Sbjct: 83  LLFMGY---STKPQLAIVTQWCEGSSLYH----HLHASETKFEMKKLIDIARQTARGMDY 135
Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           LH     +IHRDL  +N+F++ +   VKIGD 
Sbjct: 136 LHAK--SIIHRDLKSNNIFLHEDN-TVKIGDF 164

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
            +++G+G+   VY+A   + G  VA  +V          + ++ F   E+++++ L + N
Sbjct: 33  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 82
Query: 88  IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
           I+ L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + 
Sbjct: 83  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 142
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 143 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 175

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 63/146 (43%), Gaps = 18/146 (12%)
Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS---EVRLLKTLA 84
            Y + +G G    V++    ++   VA   + L     +  MIE+      EV ++  L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQ------IL 138
           + NI+ L+ +  +  R  + F+   C  G+L      HR +      KWS +      I 
Sbjct: 82  HPNIVKLYGLMHNPPRMVMEFVP--C--GDLY-----HRLLDKAHPIKWSVKLRLMLDIA 132
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVN 164
            G+ Y+    P ++HRDL   N+F+ 
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQ 158

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 62/146 (42%), Gaps = 18/146 (12%)
Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS---EVRLLKTLA 84
            Y + +G G    V++    ++   VA   + L     +  MIE+      EV ++  L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQ------IL 138
           + NI+ L+ +  +  R  + F+      G+L      HR +      KWS +      I 
Sbjct: 82  HPNIVKLYGLMHNPPRMVMEFVP----CGDLY-----HRLLDKAHPIKWSVKLRLMLDIA 132
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVN 164
            G+ Y+    P ++HRDL   N+F+ 
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQ 158

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 28/152 (18%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWN---QVK-LRTFCDDPAMIERLFSEVRLLKTLANKNI 88
           +GSG+   VY+           W+    VK L      P  ++   +EV +L+   + NI
Sbjct: 20  IGSGSFGTVYKG---------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 70
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVS-----VKALKKWSKQILKGLNY 143
           +          +  L  +T+ C   +L      H H S     +K L   ++Q  +G++Y
Sbjct: 71  LLFMGY---STKPQLAIVTQWCEGSSLYH----HLHASETKFEMKKLIDIARQTARGMDY 123
Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           LH     +IHRDL  +N+F++ +   VKIGD 
Sbjct: 124 LHAK--SIIHRDLKSNNIFLHEDN-TVKIGDF 152

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
            +++G+G+   VY+A   + G  VA  +V          + ++ F   E+++++ L + N
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 86
Query: 88  IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
           I+ L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + 
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 147 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 179

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 71/153 (46%), Gaps = 17/153 (11%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
            +++G+G+   VY+A   + G  VA  +V         A   R   E+++++ L + NI+
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQGKAFKNR---ELQIMRKLDHCNIV 76
Query: 90  SLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKGLN 142
            L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 137 YIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 167

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
            +++G+G+   VY+A   + G  VA  +V          + ++ F   E+++++ L + N
Sbjct: 30  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 79
Query: 88  IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
           I+ L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + 
Sbjct: 80  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 139
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 140 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 172

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 75/164 (45%), Gaps = 16/164 (9%)
Query: 18  IETDPTGRYGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--L 73
           +E      Y  Y+  E LGSGA   V+R       +E A  +V +  F + P  +++  +
Sbjct: 42  VEVKQGSVYDYYDILEELGSGAFGVVHRC------VEKATGRVFVAKFINTPYPLDKYTV 95
Query: 74  FSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE-YRKKHRHVSVKALKK 132
            +E+ ++  L +  +I+LH  +  ED+  +  I E  + G L +    +   +S   +  
Sbjct: 96  KNEISIMNQLHHPKLINLHDAF--EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 153
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN-GNTGQVKIGDL 175
           + +Q  +GL ++H H   ++H D+   N+         VKI D 
Sbjct: 154 YMRQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDF 195

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
            +++G+G+   VY+A   + G  VA  +V          + ++ F   E+++++ L + N
Sbjct: 53  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 102
Query: 88  IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
           I+ L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + 
Sbjct: 103 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 162
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 163 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 195

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 71/153 (46%), Gaps = 17/153 (11%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
            +++G+G+   VY+A   + G  VA  +V         A   R   E+++++ L + NI+
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQGKAFKNR---ELQIMRKLDHCNIV 76
Query: 90  SLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKGLN 142
            L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 137 YIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 167

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
            +++G+G+   VY+A   + G  VA  +V          + ++ F   E+++++ L + N
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 108
Query: 88  IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
           I+ L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + 
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 169 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 201

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
            +++G+G+   VY+A   + G  VA  +V          + ++ F   E+++++ L + N
Sbjct: 61  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 110
Query: 88  IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
           I+ L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + 
Sbjct: 111 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 170
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 171 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 203

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
            +++G+G+   VY+A   + G  VA  +V          + ++ F   E+++++ L + N
Sbjct: 104 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 153
Query: 88  IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
           I+ L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + 
Sbjct: 154 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 213
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 214 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 246

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
            +++G+G+   VY+A   + G  VA  +V          + ++ F   E+++++ L + N
Sbjct: 63  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 112
Query: 88  IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
           I+ L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + 
Sbjct: 113 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 172
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 173 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 205

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
            +++G+G+   VY+A   + G  VA  +V          + ++ F   E+++++ L + N
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 108
Query: 88  IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
           I+ L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + 
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 169 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 201

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 14/153 (9%)
Query: 28  RYNELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL 83
           R  ++LGSGA   VY+     +G    I VA   ++  T    P   + +  E  ++  +
Sbjct: 20  RKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGV 76
Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLN 142
            +  +  L  +      +T+  +T++   G L ++ +++R  +  + L  W  QI KG++
Sbjct: 77  GSPYVSRLLGICL---TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMS 133
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           YL      ++HRDL   NV V  +   VKI D 
Sbjct: 134 YLEDVR--LVHRDLAARNVLVK-SPNHVKITDF 163

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 54/111 (48%), Gaps = 13/111 (11%)
Query: 76  EVRLLKTLANKNIISLHYVWRDE-DRNT-LNF------ITEVCTSGNLREYRKKHRHVSV 127
           E+ LL+ L + N+ISL  V+    DR   L F      +  +       +  KK   +  
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT---GQVKIGDL 175
             +K    QIL G++YLH +   V+HRDL  +N+ V G     G+VKI D+
Sbjct: 128 GMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADM 176

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
            +++G+G+   VY+A   + G  VA  +V          + ++ F   E+++++ L + N
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 74
Query: 88  IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
           I+ L Y +      +D   LN + +       R    Y +  + + V  +K +  Q+ + 
Sbjct: 75  IVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           L Y+H+   C  HRD+   N+ ++ +T  +K+ D 
Sbjct: 135 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 167

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG+G   +V+  +      +VA   +K  +   D        +E  L+K L ++ ++ 
Sbjct: 19  ERLGAGQAGEVWMGYYNGH-TKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 72
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
           L+ V   E    +  ITE   +G+L ++ K    +  ++  L   + QI +G+ ++   E
Sbjct: 73  LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 127
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              IHRDL  +N+ V+ +T   KI D 
Sbjct: 128 RNYIHRDLRAANILVS-DTLSCKIADF 153

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/121 (24%), Positives = 56/121 (46%), Gaps = 6/121 (4%)
Query: 56  NQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL 115
           ++V ++T  +     E    E  ++  L++  ++ L+ V  ++    +  +TE    G L
Sbjct: 33  DKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLVTEFMEHGCL 90
Query: 116 REYRKKHRHV-SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
            +Y +  R + + + L      + +G+ YL   E CVIHRDL   N  V G    +K+ D
Sbjct: 91  SDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLV-GENQVIKVSD 147
Query: 175 L 175
Sbjct: 148 F 148

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 66/156 (42%), Gaps = 11/156 (7%)
Query: 23  TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF-CDDPAMIERLFSEVRLLK 81
           T  Y  Y ++ G GA   V R      G E A   +  +     D   +ER   E R+ +
Sbjct: 3   TDEYQLYEDI-GKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLER---EARICR 58
Query: 82  TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
            L + NI+ LH    +E  + L F  ++ T G L E      + S        +QIL+ +
Sbjct: 59  LLKHSNIVRLHDSISEEGFHYLVF--DLVTGGELFEDIVAREYYSEADASHCIQQILEAV 116
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDL 175
             LH H+  V+HRDL   N+ +        VK+ D 
Sbjct: 117 --LHCHQMGVVHRDLKPENLLLASKCKGAAVKLADF 150

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG+G   +V+  +      +VA   +K  +   D        +E  L+K L ++ ++ 
Sbjct: 14  ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDA-----FLAEANLMKQLQHQRLVR 67
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
           L+ V   E    +  ITE   +G+L ++ K    +  ++  L   + QI +G+ ++   E
Sbjct: 68  LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 122
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              IHRDL  +N+ V+ +T   KI D 
Sbjct: 123 RNYIHRDLRAANILVS-DTLSCKIADF 148

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG+G   +V+  +      +VA   +K  +   D        +E  L+K L ++ ++ 
Sbjct: 28  ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 81
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
           L+ V   E    +  ITE   +G+L ++ K    +  ++  L   + QI +G+ ++   E
Sbjct: 82  LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 136
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              IHRDL  +N+ V+ +T   KI D 
Sbjct: 137 RNYIHRDLRAANILVS-DTLSCKIADF 162

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG+G   +V+  +      +VA   +K  +   D        +E  L+K L ++ ++ 
Sbjct: 29  ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 82
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
           L+ V   E    +  ITE   +G+L ++ K    +  ++  L   + QI +G+ ++   E
Sbjct: 83  LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 137
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              IHRDL  +N+ V+ +T   KI D 
Sbjct: 138 RNYIHRDLRAANILVS-DTLSCKIADF 163

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG+G   +V+  +      +VA   +K  +   D        +E  L+K L ++ ++ 
Sbjct: 19  ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 72
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
           L+ V   E    +  ITE   +G+L ++ K    +  ++  L   + QI +G+ ++   E
Sbjct: 73  LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 127
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              IHRDL  +N+ V+ +T   KI D 
Sbjct: 128 RNYIHRDLRAANILVS-DTLSCKIADF 153

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG+G   +V+  +      +VA   +K  +   D        +E  L+K L ++ ++ 
Sbjct: 27  ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 80
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
           L+ V   E    +  ITE   +G+L ++ K    +  ++  L   + QI +G+ ++   E
Sbjct: 81  LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 135
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              IHRDL  +N+ V+ +T   KI D 
Sbjct: 136 RNYIHRDLRAANILVS-DTLSCKIADF 161

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG+G   +V+  +      +VA   +K  +   D        +E  L+K L ++ ++ 
Sbjct: 25  ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 78
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
           L+ V   E    +  ITE   +G+L ++ K    +  ++  L   + QI +G+ ++   E
Sbjct: 79  LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 133
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              IHRDL  +N+ V+ +T   KI D 
Sbjct: 134 RNYIHRDLRAANILVS-DTLSCKIADF 159

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 66/156 (42%), Gaps = 11/156 (7%)
Query: 23  TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF-CDDPAMIERLFSEVRLLK 81
           T  Y  + EL G GA   V R      G E A   +  +     D   +ER   E R+ +
Sbjct: 10  TEEYQLFEEL-GKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EARICR 65
Query: 82  TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
            L + NI+ LH    +E  + L F  ++ T G L E      + S        +QIL+ +
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIF--DLVTGGELFEDIVAREYYSEADASHCIQQILEAV 123
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDL 175
             LH H+  V+HR+L   N+ +        VK+ D 
Sbjct: 124 --LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADF 157

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 67/147 (45%), Gaps = 11/147 (7%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG G+  KV  A   +   +VA   +  R       M  R+  E+  LK L + +II 
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 91  LHYVWRDEDRNTLNFITEVC--TSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           L+ V       T   I  V     G L +Y  + + ++    +++ +QI+  + Y H H+
Sbjct: 74  LYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
             ++HRDL   N+ ++ N   VKI D 
Sbjct: 129 --IVHRDLKPENLLLDDNLN-VKIADF 152

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG+G   +V+  +      +VA   +K  +   D        +E  L+K L ++ ++ 
Sbjct: 21  ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 74
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
           L+ V   E    +  ITE   +G+L ++ K    +  ++  L   + QI +G+ ++   E
Sbjct: 75  LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 129
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              IHRDL  +N+ V+ +T   KI D 
Sbjct: 130 RNYIHRDLRAANILVS-DTLSCKIADF 155

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG+G   +V+  +      +VA   +K  +   D        +E  L+K L ++ ++ 
Sbjct: 25  ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 78
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
           L+ V   E    +  ITE   +G+L ++ K    +  ++  L   + QI +G+ ++   E
Sbjct: 79  LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 133
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              IHRDL  +N+ V+ +T   KI D 
Sbjct: 134 RNYIHRDLRAANILVS-DTLSCKIADF 159

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 28/152 (18%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWN---QVK-LRTFCDDPAMIERLFSEVRLLKTLANKNI 88
           +GSG+   VY+           W+    VK L      P  ++   +EV +L+   + NI
Sbjct: 32  IGSGSFGTVYKG---------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVS-----VKALKKWSKQILKGLNY 143
           +             L  +T+ C   +L      H H S     +K L   ++Q  +G++Y
Sbjct: 83  LLFMGY---STAPQLAIVTQWCEGSSLYH----HLHASETKFEMKKLIDIARQTARGMDY 135
Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           LH     +IHRDL  +N+F++ +   VKIGD 
Sbjct: 136 LHAK--SIIHRDLKSNNIFLHEDN-TVKIGDF 164

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 14/147 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG+G   +V+  +           +V +++        +   +E  L+K L ++ ++ 
Sbjct: 19  ERLGAGQFGEVWMGYYNGH------TKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
           L+ V   E    +  ITE   +G+L ++ K    +  ++  L   + QI +G+ ++   E
Sbjct: 73  LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 127
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              IHRDL  +N+ V+ +T   KI D 
Sbjct: 128 RNYIHRDLRAANILVS-DTLSCKIADF 153

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG+G   +V+  +      +VA   +K  +   D        +E  L+K L ++ ++ 
Sbjct: 24  ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 77
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
           L+ V   E    +  ITE   +G+L ++ K    +  ++  L   + QI +G+ ++   E
Sbjct: 78  LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 132
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              IHRDL  +N+ V+ +T   KI D 
Sbjct: 133 RNYIHRDLRAANILVS-DTLSCKIADF 158

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 14/147 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG+G   +V+  +           +V +++        +   +E  L+K L ++ ++ 
Sbjct: 19  ERLGAGQFGEVWMGYYNGH------TKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
           L+ V   E    +  ITE   +G+L ++ K    +  ++  L   + QI +G+ ++   E
Sbjct: 73  LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 127
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              IHRDL  +N+ V+ +T   KI D 
Sbjct: 128 RNYIHRDLRAANILVS-DTLSCKIADF 153

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 14/147 (9%)
Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG+G   +V+  +           +V +++        +   +E  L+K L ++ ++ 
Sbjct: 20  ERLGAGQFGEVWMGYYNGH------TKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 73
Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
           L+ V   E    +  ITE   +G+L ++ K    +  ++  L   + QI +G+ ++   E
Sbjct: 74  LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 128
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              IHRDL  +N+ V+ +T   KI D 
Sbjct: 129 RNYIHRDLRAANILVS-DTLSCKIADF 154

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 36/169 (21%), Positives = 83/169 (49%), Gaps = 20/169 (11%)
Query: 16  PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS 75
           PF   D   +Y +  ++ G G   +V++A  ++ G +VA  +V +    +          
Sbjct: 11  PF--CDEVSKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALR 65
Query: 76  EVRLLKTLANKNIISLHYVWRDED------RNTLNFITEVC---TSGNLREYRKKHRHVS 126
           E+++L+ L ++N+++L  + R +       + ++  + + C    +G L     K    +
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FT 122
Query: 127 VKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +  +K+  + +L GL Y+H ++  ++HRD+  +NV +  + G +K+ D 
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLADF 168

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 13/145 (8%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  A+D      VA  ++  R F +     +R + E+ L+K + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQ-THAKRAYRELVLMKXVNH 82
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           KNIISL  V+      E+   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL---LYQMLXGI 139
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
            +LH+    +IHRDL  SN+ V  +
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD 162

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 40.8 bits (94), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/160 (21%), Positives = 80/160 (50%), Gaps = 19/160 (11%)
Query: 27  GRYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA 84
            +Y +L  +G G   +V++A  ++ G +VA  +V +    +          E+++L+ L 
Sbjct: 18  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKILQLLK 75
Query: 85  NKNIISLHYVWRDED------RNTLNFITEVCT---SGNLREYRKKHRHVSVKALKKWSK 135
           ++N+++L  + R +       + ++  + + C    +G L     K    ++  +K+  +
Sbjct: 76  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQ 132
Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            +L GL Y+H ++  ++HRD+  +NV +  + G +K+ D 
Sbjct: 133 MLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLADF 169

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/169 (21%), Positives = 83/169 (49%), Gaps = 20/169 (11%)
Query: 16  PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS 75
           PF   D   +Y +  ++ G G   +V++A  ++ G +VA  +V +    +          
Sbjct: 12  PF--CDEVSKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALR 66
Query: 76  EVRLLKTLANKNIISLHYVWRDED------RNTLNFITEVC---TSGNLREYRKKHRHVS 126
           E+++L+ L ++N+++L  + R +       + ++  + + C    +G L     K    +
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FT 123
Query: 127 VKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +  +K+  + +L GL Y+H ++  ++HRD+  +NV +  + G +K+ D 
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLADF 169

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  A+D      VA  ++  R F +     +R + E+ L+K + +
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQ-THAKRAYRELVLMKCVNH 75
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           KNIISL  V+      E+   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL---LYQMLXGI 132
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            +LH+    +IHRDL  SN+ V  +   +KI D 
Sbjct: 133 KHLHS--AGIIHRDLKPSNIVVKSDXT-LKILDF 163

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 55/121 (45%), Gaps = 6/121 (4%)
Query: 56  NQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL 115
           ++V ++T  +     E    E  ++  L++  ++ L+ V  ++    L F  E    G L
Sbjct: 30  DKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF--EFMEHGCL 87
Query: 116 REYRKKHRHV-SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
            +Y +  R + + + L      + +G+ YL   E CVIHRDL   N  V G    +K+ D
Sbjct: 88  SDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLV-GENQVIKVSD 144
Query: 175 L 175
Sbjct: 145 F 145

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  A+D      VA  ++  R F +     +R + E+ L+K + +
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQ-THAKRAYRELVLMKCVNH 82
Query: 86  KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           KNIISL  V+      E+   +  + E+  +   +  + +  H  +  L     Q+L G+
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL---LYQMLXGI 139
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            +LH+    +IHRDL  SN+ V  +   +KI D 
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDXT-LKILDF 170

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 36/169 (21%), Positives = 83/169 (49%), Gaps = 20/169 (11%)
Query: 16  PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS 75
           PF   D   +Y +  ++ G G   +V++A  ++ G +VA  +V +    +          
Sbjct: 12  PF--CDEVSKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALR 66
Query: 76  EVRLLKTLANKNIISLHYVWRDED------RNTLNFITEVC---TSGNLREYRKKHRHVS 126
           E+++L+ L ++N+++L  + R +       + ++  + + C    +G L     K    +
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK---FT 123
Query: 127 VKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
           +  +K+  + +L GL Y+H ++  ++HRD+  +NV +  + G +K+ D 
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLADF 169

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 55/121 (45%), Gaps = 6/121 (4%)
Query: 56  NQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL 115
           ++V ++T  +     E    E  ++  L++  ++ L+ V  ++    L F  E    G L
Sbjct: 32  DKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF--EFMEHGCL 89
Query: 116 REYRKKHRHV-SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
            +Y +  R + + + L      + +G+ YL   E CVIHRDL   N  V G    +K+ D
Sbjct: 90  SDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLV-GENQVIKVSD 146
Query: 175 L 175
Sbjct: 147 F 147

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 40/166 (24%), Positives = 74/166 (44%), Gaps = 40/166 (24%)
Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
           +LG GA  +V +A +  +    A  +++          +  + SEV LL +L ++ ++  
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIR-----HTEEKLSTILSEVXLLASLNHQYVVRY 67
Query: 92  HYVWRD-----------EDRNTLNFITEVCT---------SGNLREYRKKHRHVSVKALK 131
           +  W +           + ++TL    E C          S NL + R ++         
Sbjct: 68  YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY--------- 118
Query: 132 KWS--KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
            W   +QIL+ L+Y+H+    +IHR+L   N+F++  +  VKIGD 
Sbjct: 119 -WRLFRQILEALSYIHSQ--GIIHRNLKPXNIFID-ESRNVKIGDF 160

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 55/121 (45%), Gaps = 6/121 (4%)
Query: 56  NQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL 115
           ++V ++T  +     E    E  ++  L++  ++ L+ V  ++    L F  E    G L
Sbjct: 35  DKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF--EFMEHGCL 92
Query: 116 REYRKKHRHV-SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
            +Y +  R + + + L      + +G+ YL   E CVIHRDL   N  V G    +K+ D
Sbjct: 93  SDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLV-GENQVIKVSD 149
Query: 175 L 175
Sbjct: 150 F 150

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/145 (22%), Positives = 62/145 (42%), Gaps = 9/145 (6%)
Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
           +G G+  K       E+G +    ++ +           R   EV +L  + + NI+   
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR--REVAVLANMKHPNIV--Q 87
Query: 93  YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVK--ALKKWSKQILKGLNYLHTHEPC 150
           Y    E+  +L  + + C  G+L +     + V  +   +  W  QI   L   H H+  
Sbjct: 88  YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK--HVHDRK 145
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
           ++HRD+   N+F+  + G V++GD 
Sbjct: 146 ILHRDIKSQNIFLTKD-GTVQLGDF 169

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
           ++ ++LG G+   V  A +     E A   ++ R    +   +  +  E  ++  L +  
Sbjct: 38  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 96
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
            + L++ ++D+++  L F      +G L +Y +K         + ++ +I+  L YLH  
Sbjct: 97  FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              +IHRDL   N+ +N +   ++I D 
Sbjct: 155 --GIIHRDLKPENILLNEDM-HIQITDF 179

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 40.0 bits (92), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
           ++ ++LG G+   V  A +     E A   ++ R    +   +  +  E  ++  L +  
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 93
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
            + L++ ++D+++  L F      +G L +Y +K         + ++ +I+  L YLH  
Sbjct: 94  FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              +IHRDL   N+ +N +   ++I D 
Sbjct: 152 --GIIHRDLKPENILLNEDM-HIQITDF 176

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 40.0 bits (92), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
           ++ ++LG G+   V  A +     E A   ++ R    +   +  +  E  ++  L +  
Sbjct: 36  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 94
Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
            + L++ ++D+++  L F      +G L +Y +K         + ++ +I+  L YLH  
Sbjct: 95  FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
              +IHRDL   N+ +N +   ++I D 
Sbjct: 153 --GIIHRDLKPENILLNEDM-HIQITDF 177

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	219
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-82
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-34
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-32
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-30
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-30
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-30
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-28
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-28
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-27
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-27
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-27
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-26
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-26
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-26
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-26
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-24
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-23
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-23
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-23
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-23
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-23
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-23
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-22
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-22
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-22
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-22
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-22
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-22
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-22
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-22
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-21
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-21
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-21
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-21
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-21
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-21
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-21
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-21
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-21
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-20
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-20
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-20
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-20
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-20
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-20
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-20
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-20
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-20
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-20
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-19
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-19
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-19
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-19
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-19
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-19
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-19
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-19
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-19
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-19
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-19
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	9e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-18
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-18
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-18
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-18
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-18
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-18
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-18
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-18
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-18
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-18
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-18
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-18
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-18
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-18
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-18
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	9e-18
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-18
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-17
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-17
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-17
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-17
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-17
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-17
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-17
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-17
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-17
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-17
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-17
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-17
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-17
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-17
3pls_A	298	Macrophage-stimulating protein receptor; protein k	7e-17
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-17
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-16
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-16
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-16
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-16
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-16
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-16
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-16
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-16
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-16
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-16
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-16
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-16
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-16
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-16
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-16
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-16
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-16
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-15
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-15
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-15
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-15
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-15
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-15
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-15
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-15
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-15
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-15
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-15
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-15
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-15
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-14
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-14
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-14
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-14
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-14
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-14
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-14
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-14
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-14
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-14
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-14
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-14
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-13
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-10
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-10
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-09
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-08
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-08
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-08
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-07
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-07
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-06
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-06
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-06
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-05
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-05
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-05
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-05
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-05
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-05
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-04
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-05
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-04
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-04
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-04
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-04
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-04

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  246 bits (631), Expect = 1e-82
 Identities = 63/183 (34%), Positives = 103/183 (56%), Gaps = 4/183 (2%)

Query: 7   SDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD 66
            D  ++     +     GR+ +++  +G G+ K VY+  D E  +EVAW +++ R     
Sbjct: 8   QDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--T 65

Query: 67  PAMIERLFSEVRLLKTLANKNIISLHYVWRD--EDRNTLNFITEVCTSGNLREYRKKHRH 124
            +  +R   E  +LK L + NI+  +  W    + +  +  +TE+ TSG L+ Y K+ + 
Sbjct: 66  KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV 125

Query: 125 VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA 184
           + +K L+ W +QILKGL +LHT  P +IHRDL C N+F+ G TG VKIGDLG+A +   +
Sbjct: 126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185

Query: 185 IRR 187
             +
Sbjct: 186 FAK 188

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  120 bits (304), Expect = 9e-34
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 10/155 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
             +G+G+  +  +   + +G  + W ++   +     A  + L SEV LL+ L + NI+ 
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVR 69

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNL----REYRKKHRHVSVKALKKWSKQILKGLNYLH- 145
            +    D    TL  + E C  G+L     +  K+ +++  + + +   Q+   L   H 
Sbjct: 70  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129

Query: 146 --THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
                  V+HRDL  +NVF++G    VK+GD G+A
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLA 163

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  119 bits (300), Expect = 1e-32
 Identities = 33/152 (21%), Positives = 67/152 (44%), Gaps = 9/152 (5%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           + +G G+  K       E+G +    ++ +          E    EV +L  + + NI+ 
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQ 87

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREY--RKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
               +  E+  +L  + + C  G+L +    +K        +  W  QI   L ++H  +
Sbjct: 88  YRESF--EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
             ++HRD+   N+F+  + G V++GD G+A +
Sbjct: 146 --ILHRDIKSQNIFLTKD-GTVQLGDFGIARV 174

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  118 bits (297), Expect = 2e-32
 Identities = 48/183 (26%), Positives = 87/183 (47%), Gaps = 11/183 (6%)

Query: 3   PAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRT 62
           P V      K   P +  +    +    + +G G   +VYRA    +G+ VA  +V++  
Sbjct: 11  PPVPQFQPQKALRPDMGYNTLANFRIE-KKIGRGQFSEVYRAACLLDGVPVALKKVQIFD 69

Query: 63  FCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL----REY 118
              D         E+ LLK L + N+I  +  +   + N LN + E+  +G+L    + +
Sbjct: 70  -LMDAKARADCIKEIDLLKQLNHPNVIKYYASF--IEDNELNIVLELADAGDLSRMIKHF 126

Query: 119 RKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +K+ R +  + + K+  Q+   L ++H+    V+HRD+  +NVF+    G VK+GDLG+ 
Sbjct: 127 KKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLG 183

Query: 179 AIV 181
              
Sbjct: 184 RFF 186

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  113 bits (284), Expect = 1e-30
 Identities = 46/181 (25%), Positives = 76/181 (41%), Gaps = 11/181 (6%)

Query: 4   AVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF 63
           ++ S          +E D          +LG G    VY   D    + +A  ++  R  
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-- 58

Query: 64  CDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE-YRKKH 122
             D    + L  E+ L K L +KNI+   Y+    +   +    E    G+L    R K 
Sbjct: 59  --DSRYSQPLHEEIALHKHLKHKNIVQ--YLGSFSENGFIKIFMEQVPGGSLSALLRSKW 114

Query: 123 RHVSVK--ALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
             +      +  ++KQIL+GL YLH +   ++HRD+   NV +N  +G +KI D G +  
Sbjct: 115 GPLKDNEQTIGFYTKQILEGLKYLHDN--QIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172

Query: 181 V 181
           +
Sbjct: 173 L 173

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  112 bits (282), Expect = 3e-30
 Identities = 38/176 (21%), Positives = 73/176 (41%), Gaps = 22/176 (12%)

Query: 24  GRY-GRYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           GRY   +  +  LG G    V+ A ++ +    A  +++L    +     E++  EV+ L
Sbjct: 1   GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP---NRELAREKVMREVKAL 57

Query: 81  KTLANKNIISLHYVWRDEDRN----------TLNFITEVCTSGNLREY---RKKHRHVSV 127
             L +  I+     W +++             L    ++C   NL+++   R        
Sbjct: 58  AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117

Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR 183
                   QI + + +LH+    ++HRDL  SN+F   +   VK+GD G+   + +
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQ 170

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  112 bits (282), Expect = 3e-30
 Identities = 41/163 (25%), Positives = 76/163 (46%), Gaps = 20/163 (12%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
            +LG GA  +V +A +  +    A  +++          +  + SEV LL +L ++ ++ 
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRH-----TEEKLSTILSEVMLLASLNHQYVVR 66

Query: 91  LHYVWRDEDR-----------NTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQIL 138
            +  W +              +TL    E C +G L +    ++ +       +  +QIL
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126

Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           + L+Y+H+    +IHRDL   N+F++ +   VKIGD G+A  V
Sbjct: 127 EALSYIHSQG--IIHRDLKPMNIFIDES-RNVKIGDFGLAKNV 166

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  111 bits (280), Expect = 4e-30
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 27/173 (15%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           EL+GSG   +V++A  + +G      +VK           E+   EV+ L  L + NI+ 
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVH 68

Query: 91  LHYVWRDEDR--------------NTLNFITEVCTSGNLREY--RKKHRHVSVKALKKWS 134
            +  W   D                 L    E C  G L ++  +++   +      +  
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR 187
           +QI KG++Y+H+ +  +I+RDL  SN+F+     QVKIGD G+   +    +R
Sbjct: 129 EQITKGVDYIHSKK--LINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKR 178

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  108 bits (273), Expect = 1e-28
 Identities = 49/183 (26%), Positives = 87/183 (47%), Gaps = 13/183 (7%)

Query: 3   PAVNSDPSDKDSEPFIETDPTGRYGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKL 60
           P   +        P +  DP     RY     LG G   K +   D +     A    K+
Sbjct: 18  PGAPAAAPPAKEIPEVLVDPR-SRRRYVRGRFLGKGGFAKCFEISDADTKEVFA---GKI 73

Query: 61  --RTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY 118
             ++    P   E++  E+ + ++LA+++++  H  +  ED + +  + E+C   +L E 
Sbjct: 74  VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF--EDNDFVFVVLELCRRRSLLEL 131

Query: 119 RKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            K+ + ++    + + +QI+ G  YLH +   VIHRDL   N+F+N +  +VKIGD G+A
Sbjct: 132 HKRRKALTEPEARYYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNED-LEVKIGDFGLA 188

Query: 179 AIV 181
             V
Sbjct: 189 TKV 191

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  107 bits (270), Expect = 2e-28
 Identities = 35/184 (19%), Positives = 73/184 (39%), Gaps = 13/184 (7%)

Query: 6   NSDPSDKDSEPFIETDPTGRYG-RYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRT 62
                   S  +  + P   +   +     LG G+  +V++   +E+G   A  +     
Sbjct: 35  GEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF 94

Query: 63  FCDDPAMIERLFSEVRLLKTLAN-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKK 121
               P    R  +EV   + +      + L   W +     L   TE+C   +L+++ + 
Sbjct: 95  --RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI--LYLQTELC-GPSLQQHCEA 149

Query: 122 H-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
               +    +  + +  L  L +LH+    ++H D+  +N+F+    G+ K+GD G+   
Sbjct: 150 WGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPR-GRCKLGDFGLLVE 206

Query: 181 VGRA 184
           +G A
Sbjct: 207 LGTA 210

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  104 bits (263), Expect = 2e-27
 Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 13/170 (7%)

Query: 16  PFIETDPTGRYGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKL--RTFCDDPAMIE 71
           P +  DP     RY     LG G   K +   D +     A    K+  ++    P   E
Sbjct: 5   PEVLVDPR-SRRRYVRGRFLGKGGFAKCFEISDADTKEVFA---GKIVPKSLLLKPHQRE 60

Query: 72  RLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
           ++  E+ + ++LA+++++  H  +  ED + +  + E+C   +L E  K+ + ++    +
Sbjct: 61  KMSMEISIHRSLAHQHVVGFHGFF--EDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR 118

Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
            + +QI+ G  YLH +   VIHRDL   N+F+N +  +VKIGD G+A  V
Sbjct: 119 YYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNED-LEVKIGDFGLATKV 165

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  106 bits (266), Expect = 2e-27
 Identities = 36/154 (23%), Positives = 70/154 (45%), Gaps = 14/154 (9%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA--NKNI 88
           + +GSG   KV++  + E+    A   V L     D   ++   +E+  L  L   +  I
Sbjct: 62  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 118

Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           I L+          +  + E C + +L  + KK + +     K + K +L+ ++ +H H 
Sbjct: 119 IRLYDYE--ITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175

Query: 149 PCVIHRDLNCSN-VFVNGNTGQVKIGDLGVAAIV 181
             ++H DL  +N + V+G    +K+ D G+A  +
Sbjct: 176 --IVHSDLKPANFLIVDGM---LKLIDFGIANQM 204

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  104 bits (262), Expect = 3e-27
 Identities = 40/181 (22%), Positives = 79/181 (43%), Gaps = 16/181 (8%)

Query: 6   NSDPSDKDSEPFIETDPTGRYGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF 63
           +S   D  +E       + +   Y+  + +GSG   KV++  + E+    A   V L   
Sbjct: 7   HSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA 65

Query: 64  CDDPAMIERLFSEVRLLKTLA--NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKK 121
             D   ++   +E+  L  L   +  II L+          +  + E C + +L  + KK
Sbjct: 66  --DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE--ITDQYIYMVME-CGNIDLNSWLKK 120

Query: 122 HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSN-VFVNGNTGQVKIGDLGVAAI 180
            + +     K + K +L+ ++ +H H   ++H DL  +N + V+G    +K+ D G+A  
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGM---LKLIDFGIANQ 175

Query: 181 V 181
           +
Sbjct: 176 M 176

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  104 bits (260), Expect = 9e-27
 Identities = 36/154 (23%), Positives = 70/154 (45%), Gaps = 14/154 (9%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA--NKNI 88
           + +GSG   KV++  + E+    A   V L     D   ++   +E+  L  L   +  I
Sbjct: 15  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKI 71

Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           I L+          +  + E C + +L  + KK + +     K + K +L+ ++ +H H 
Sbjct: 72  IRLYDYE--ITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128

Query: 149 PCVIHRDLNCSN-VFVNGNTGQVKIGDLGVAAIV 181
             ++H DL  +N + V+G    +K+ D G+A  +
Sbjct: 129 --IVHSDLKPANFLIVDGM---LKLIDFGIANQM 157

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  103 bits (259), Expect = 1e-26
 Identities = 37/172 (21%), Positives = 74/172 (43%), Gaps = 13/172 (7%)

Query: 10  SDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
           ++K      E      +  +   +G G+  +V+R  D++ G + A  +V+L  F  +   
Sbjct: 43  TEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--- 99

Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
                 E+     L++  I+ L+   R+     +N   E+   G+L +  K+   +    
Sbjct: 100 ------ELVACAGLSSPRIVPLYGAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDR 151

Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
              +  Q L+GL YLHT    ++H D+   NV ++ +  +  + D G A  +
Sbjct: 152 ALYYLGQALEGLEYLHTR--RILHGDVKADNVLLSSDGSRAALCDFGHALCL 201

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  101 bits (255), Expect = 2e-26
 Identities = 26/151 (17%), Positives = 54/151 (35%), Gaps = 9/151 (5%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLANKNII 89
             L      ++++   Q  G ++    VK L+              E   L+  ++ N++
Sbjct: 16  TKLNENHSGELWKGRWQ--GNDIV---VKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREY--RKKHRHVSVKALKKWSKQILKGLNYLHTH 147
            +    +         IT     G+L        +  V      K++  + +G+ +LHT 
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130

Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           EP +    LN  +V ++ +    +I    V 
Sbjct: 131 EPLIPRHALNSRSVMIDED-MTARISMADVK 160

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  102 bits (257), Expect = 2e-26
 Identities = 33/178 (18%), Positives = 56/178 (31%), Gaps = 13/178 (7%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           + LG G    V       +G   A    K R  C +    E    E  + +   + NI+ 
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYAL---K-RILCHEQQDREEAQREADMHRLFNHPNILR 90

Query: 91  L--HYVWRDEDRNTLNFITEVCTSGNLREY----RKKHRHVSVKALKKWSKQILKGLNYL 144
           L  + +     ++    +      G L       + K   ++   +      I +GL  +
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSWRRSCT 202
             H     HRDL  +N+ +    GQ  + DLG        +   R       W     
Sbjct: 151 --HAKGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  101 bits (253), Expect = 3e-26
 Identities = 33/158 (20%), Positives = 62/158 (39%), Gaps = 12/158 (7%)

Query: 29  YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERL---FSEVRLLKTLAN 85
           Y + +G G    V++    ++   VA   + L     +  MIE+      EV ++  L +
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82

Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYL 144
            NI+ L+ +  +        + E    G+L      K   +      +    I  G+ Y+
Sbjct: 83  PNIVKLYGLMHNP----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQ----VKIGDLGVA 178
               P ++HRDL   N+F+           K+ D G++
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  100 bits (251), Expect = 9e-26
 Identities = 39/152 (25%), Positives = 66/152 (43%), Gaps = 12/152 (7%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLANKNII 89
           E +G+G+   V+RA     G +VA   VK L         +     EV ++K L + NI+
Sbjct: 43  EKIGAGSFGTVHRAEWH--GSDVA---VKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREY---RKKHRHVSVKALKKWSKQILKGLNYLHT 146
                        L+ +TE  + G+L            +  +     +  + KG+NYLH 
Sbjct: 98  LFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155

Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             P ++HR+L   N+ V+     VK+ D G++
Sbjct: 156 RNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLS 186

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 99.7 bits (249), Expect = 2e-25
 Identities = 35/177 (19%), Positives = 62/177 (35%), Gaps = 29/177 (16%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN-KNII 89
           E +GSG    V++   + +G   A  + K           +    EV     L    +++
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL--AGSVDEQNALREVYAHAVLGQHSHVV 74

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNL----REYRKKHRHVSVKALKKWSKQILKGLNYLH 145
                W   + + +    E C  G+L     E  +   +     LK    Q+ +GL Y+H
Sbjct: 75  RYFSAW--AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 146 THEPCVIHRDLNCSNVFVNGN------------------TGQVKIGDLGVAAIVGRA 184
           +    ++H D+  SN+F++                        KIGDLG    +   
Sbjct: 133 SMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 97.0 bits (242), Expect = 6e-24
 Identities = 42/192 (21%), Positives = 83/192 (43%), Gaps = 27/192 (14%)

Query: 2   MPAVNSDPSDKDSEPFIETDPTGRYG-----RYNEL--LGSGAVKKVYRAFDQEEGIEVA 54
           +  V  +P D  ++        G+ G      Y     +G+G+   V++A   E   EVA
Sbjct: 10  LNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESD-EVA 68

Query: 55  WNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWR----DEDRNTLNFITEVC 110
             +V       D     R   E+++++ + + N++ L   +      +D   LN + E  
Sbjct: 69  IKKVLQ-----DKRFKNR---ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE-Y 119

Query: 111 TSGNL----REYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
               +    R Y K  + + +  +K +  Q+L+ L Y+H+    + HRD+   N+ ++  
Sbjct: 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPP 177

Query: 167 TGQVKIGDLGVA 178
           +G +K+ D G A
Sbjct: 178 SGVLKLIDFGSA 189

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 93.8 bits (234), Expect = 2e-23
 Identities = 48/165 (29%), Positives = 85/165 (51%), Gaps = 13/165 (7%)

Query: 20  TDPTGRYGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKL--RTFCDDPAMIERLFS 75
           T    +   +    LLG G+   VYRA     G+EVA   +K+  +       M++R+ +
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVA---IKMIDKKAMYKAGMVQRVQN 60

Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWS 134
           EV++   L + +I+ L+  +  ED N +  + E+C +G +  Y + + +  S    + + 
Sbjct: 61  EVKIHCQLKHPSILELYNYF--EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM 118

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
            QI+ G+ YLH+H   ++HRDL  SN+ +  N   +KI D G+A 
Sbjct: 119 HQIITGMLYLHSH--GILHRDLTLSNLLLTRN-MNIKIADFGLAT 160

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 93.5 bits (233), Expect = 3e-23
 Identities = 40/153 (26%), Positives = 69/153 (45%), Gaps = 20/153 (13%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQ---VK-LRTFCDDPAMIERLFSEVRLLKTLANK 86
           + +GSG+   VY+           W+    VK L      P  ++   +EV +L+   + 
Sbjct: 30  QRIGSGSFGTVYKGK---------WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYLH 145
           NI+             L  +T+ C   +L  +         +K L   ++Q  +G++YLH
Sbjct: 81  NILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137

Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
                +IHRDL  +N+F++ +   VKIGD G+A
Sbjct: 138 AKS--IIHRDLKSNNIFLHED-NTVKIGDFGLA 167

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 93.5 bits (233), Expect = 4e-23
 Identities = 45/163 (27%), Positives = 76/163 (46%), Gaps = 14/163 (8%)

Query: 25  RYGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKL---RTFCDDPAMIERLFSEVRL 79
             G+Y   +LLG G+  KV    D E     A   VK+   +     P     +  E++L
Sbjct: 3   LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRA---VKILKKKKLRRIPNGEANVKKEIQL 59

Query: 80  LKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGN--LREYRKKHRHVSVKALKKWSKQI 137
           L+ L +KN+I L  V  +E++  +  + E C  G   + +   + R    +A   +  Q+
Sbjct: 60  LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF-CQL 118

Query: 138 LKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
           + GL YLH+    ++H+D+   N+ +    G +KI  LGVA  
Sbjct: 119 IDGLEYLHSQ--GIVHKDIKPGNLLLTTG-GTLKISALGVAEA 158

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 92.7 bits (231), Expect = 4e-23
 Identities = 50/156 (32%), Positives = 68/156 (43%), Gaps = 13/156 (8%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E++G G   KVYRAF    G EVA    +     D    IE +  E +L   L + NII+
Sbjct: 13  EIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L  V   E    L  + E    G L       + +    L  W+ QI +G+NYLH     
Sbjct: 71  LRGVCLKEP--NLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 151 -VIHRDLNCSNVFVNGNTGQ-------VKIGDLGVA 178
            +IHRDL  SN+ +             +KI D G+A
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 93.4 bits (233), Expect = 5e-23
 Identities = 37/150 (24%), Positives = 69/150 (46%), Gaps = 11/150 (7%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD-DPAMIERLFSEVRLLKTLANKNII 89
             +G G+   V++  +++ G  VA  +            +  R   E+R+LK L + N++
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR---EIRMLKQLKHPNLV 65

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           +L  V+R + R  L+ + E C    +     +  R V    +K  + Q L+ +N+ H H 
Sbjct: 66  NLLEVFRRKRR--LHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              IHRD+   N+ +  +   +K+ D G A
Sbjct: 123 --CIHRDVKPENILITKH-SVIKLCDFGFA 149

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 93.1 bits (232), Expect = 6e-23
 Identities = 54/173 (31%), Positives = 88/173 (50%), Gaps = 16/173 (9%)

Query: 15  EPFIETDPT---GRYGRYNELLGSGAVKKVYRA----FDQEEGIEVAWNQVK-LRTFCDD 66
           +P  E DPT    R+ +    LG G   KV            G +VA   VK L+     
Sbjct: 8   KPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVA---VKSLKPESGG 64

Query: 67  PAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-V 125
             + + L  E+ +L+ L ++NI+    +  ++  N +  I E   SG+L+EY  K+++ +
Sbjct: 65  NHIAD-LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI 123

Query: 126 SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           ++K   K++ QI KG++YL + +   +HRDL   NV V  +  QVKIGD G+ 
Sbjct: 124 NLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLV-ESEHQVKIGDFGLT 173

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 93.2 bits (232), Expect = 6e-23
 Identities = 34/153 (22%), Positives = 62/153 (40%), Gaps = 20/153 (13%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQ---VK-LRTFCDDPAMIERLFSEVRLLKTLANK 86
           EL+G G   +VY            W+    ++ +    D+   ++    EV   +   ++
Sbjct: 39  ELIGKGRFGQVYHGR---------WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYLH 145
           N++             L  IT +C    L    R     + V   ++ +++I+KG+ YLH
Sbjct: 90  NVVLFMGACMSPPH--LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147

Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
                ++H+DL   NVF +     V I D G+ 
Sbjct: 148 AKG--ILHKDLKSKNVFYDNGK--VVITDFGLF 176

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 93.2 bits (232), Expect = 7e-23
 Identities = 47/156 (30%), Positives = 70/156 (44%), Gaps = 13/156 (8%)

Query: 28  RYNELLGSGAVKKVYRA----FDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKT 82
           +    LG G   KV        +   G  VA   VK L+              E+ +L+T
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVA---VKALKADAGPQHRSG-WKQEIDILRT 89

Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLN 142
           L +++II       D    +L  + E    G+LR+Y  +H  + +  L  +++QI +G+ 
Sbjct: 90  LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMA 148

Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           YLH      IHRDL   NV +  N   VKIGD G+A
Sbjct: 149 YLHAQH--YIHRDLAARNVLL-DNDRLVKIGDFGLA 181

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 92.4 bits (230), Expect = 1e-22
 Identities = 37/152 (24%), Positives = 65/152 (42%), Gaps = 16/152 (10%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E++G GA   V +A  +    +VA   +K     +  +  +    E+R L  + + NI+ 
Sbjct: 14  EVVGRGAFGVVCKAKWR--AKDVA---IKQ---IESESERKAFIVELRQLSRVNHPNIVK 65

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREY---RKKHRHVSVKALKKWSKQILKGLNYLHTH 147
           L+        N +  + E    G+L       +   + +      W  Q  +G+ YLH+ 
Sbjct: 66  LYGACL----NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 148 EPC-VIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +P  +IHRDL   N+ +      +KI D G A
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 92.4 bits (230), Expect = 1e-22
 Identities = 47/157 (29%), Positives = 68/157 (43%), Gaps = 14/157 (8%)

Query: 28  RYNELLGSGAVKKVYRA----FDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKT 82
           +Y   LG G    V            G  VA   VK L+     P        E+++LK 
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVA---VKQLQH--SGPDQQRDFQREIQILKA 80

Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGL 141
           L +  I+    V     R +L  + E   SG LR++ ++HR  +    L  +S QI KG+
Sbjct: 81  LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140

Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            YL +     +HRDL   N+ V  +   VKI D G+A
Sbjct: 141 EYLGSR--RCVHRDLAARNILV-ESEAHVKIADFGLA 174

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 92.0 bits (229), Expect = 1e-22
 Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 12/153 (7%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLF-SEVRLLKTLANKNII 89
           E+LG G   +  +   +E G  +    +K           +R F  EV++++ L + N++
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMV---MK--ELIRFDEETQRTFLKEVKVMRCLEHPNVL 70

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
               V   + R  LNFITE    G LR   +             ++K I  G+ YLH+  
Sbjct: 71  KFIGVLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM- 127

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
             +IHRDLN  N  V  N   V + D G+A ++
Sbjct: 128 -NIIHRDLNSHNCLVREN-KNVVVADFGLARLM 158

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 94.0 bits (233), Expect = 2e-22
 Identities = 47/169 (27%), Positives = 67/169 (39%), Gaps = 18/169 (10%)

Query: 22  PTGRYGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRL 79
           PT   G +   E LG+G    V R   Q+ G +VA   +K       P   ER   E+++
Sbjct: 9   PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVA---IKQCRQELSPKNRERWCLEIQI 65

Query: 80  LKTLANKNIISLHYVWRDEDRNTLN----FITEVCTSGNLREYRKKHRHVS----VKALK 131
           +K L + N++S   V     +   N       E C  G+LR+Y  +  +           
Sbjct: 66  MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125

Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNV--FVNGNTGQVKIGDLGVA 178
                I   L YLH +   +IHRDL   N+           KI DLG A
Sbjct: 126 LL-SDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 92.1 bits (229), Expect = 2e-22
 Identities = 55/182 (30%), Positives = 79/182 (43%), Gaps = 17/182 (9%)

Query: 6   NSDPSDKDSEPFIETDPT---GRYGRYNELLGSGAVKKVYRA----FDQEEGIEVAWNQV 58
           N          F + DPT    R+ ++ + LG G    V            G  VA   V
Sbjct: 19  NLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVA---V 75

Query: 59  K-LRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE 117
           K L+        +     E+ +LK+L + NI+    V     R  L  I E    G+LR+
Sbjct: 76  KKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 133

Query: 118 YRKKHR-HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
           Y +KH+  +    L +++ QI KG+ YL T     IHRDL   N+ V  N  +VKIGD G
Sbjct: 134 YLQKHKERIDHIKLLQYTSQICKGMEYLGTK--RYIHRDLATRNILV-ENENRVKIGDFG 190

Query: 177 VA 178
           + 
Sbjct: 191 LT 192

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 92.6 bits (230), Expect = 3e-22
 Identities = 32/158 (20%), Positives = 63/158 (39%), Gaps = 11/158 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           ++LG GA   V+R   ++ G   A   +K+         ++    E  +LK L +KNI+ 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSV---KALKKWSKQILKGLNYLHTH 147
           L  +  +        I E C  G+L    ++  +             + ++ G+N+L  +
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 148 EPCVIHRDLNCSNVFVNGNT---GQVKIGDLGVAAIVG 182
              ++HR++   N+            K+ D G A  + 
Sbjct: 132 G--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 91.4 bits (227), Expect = 3e-22
 Identities = 32/158 (20%), Positives = 62/158 (39%), Gaps = 11/158 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           ++LG GA   V+R   ++ G   A       +F      ++    E  +LK L +KNI+ 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP---VDVQMREFEVLKKLNHKNIVK 71

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSV---KALKKWSKQILKGLNYLHTH 147
           L  +  +        I E C  G+L    ++  +             + ++ G+N+L  +
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131

Query: 148 EPCVIHRDLNCSNVFVNGNT---GQVKIGDLGVAAIVG 182
              ++HR++   N+            K+ D G A  + 
Sbjct: 132 G--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 92.5 bits (230), Expect = 4e-22
 Identities = 43/187 (22%), Positives = 79/187 (42%), Gaps = 28/187 (14%)

Query: 9   PSDKDSEPFIETDPTGRYG-------RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVK 59
             DKD         T   G        Y +   +G+G+   VY+A   + G  VA  +V 
Sbjct: 29  SRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 88

Query: 60  LRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWR----DEDRNTLNFITEVCTSGNL 115
                 D     R   E+++++ L + NI+ L Y +      +D   LN + +      +
Sbjct: 89  Q-----DKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TV 139

Query: 116 ----REYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVK 171
               R Y +  + + V  +K +  Q+ + L Y+H+    + HRD+   N+ ++ +T  +K
Sbjct: 140 YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLK 197

Query: 172 IGDLGVA 178
           + D G A
Sbjct: 198 LCDFGSA 204

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 90.4 bits (225), Expect = 4e-22
 Identities = 49/157 (31%), Positives = 71/157 (45%), Gaps = 14/157 (8%)

Query: 28  RYNELLGSGAVKKVYRA----FDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKT 82
           ++ + LG G    V            G  VA   VK L+        +     E+ +LK+
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVA---VKKLQH--STEEHLRDFEREIEILKS 67

Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGL 141
           L + NI+    V     R  L  I E    G+LR+Y +KH+  +    L +++ QI KG+
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127

Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            YL T     IHRDL   N+ V  N  +VKIGD G+ 
Sbjct: 128 EYLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLT 161

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 90.0 bits (224), Expect = 1e-21
 Identities = 36/150 (24%), Positives = 73/150 (48%), Gaps = 11/150 (7%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD-DPAMIERLFSEVRLLKTLANKNII 89
            L+G G+   V +  +++ G  VA  +            +  R   E++LLK L ++N++
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR---EIKLLKQLRHENLV 87

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNYLHTHE 148
           +L  V + + R     + E      + +  +   + +  + ++K+  QI+ G+ + H+H 
Sbjct: 88  NLLEVCKKKKR--WYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             +IHRD+   N+ V+  +G VK+ D G A
Sbjct: 145 --IIHRDIKPENILVS-QSGVVKLCDFGFA 171

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 90.1 bits (224), Expect = 1e-21
 Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 15/177 (8%)

Query: 6   NSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVK-LRTFC 64
           NS  S  D +P I     G Y R  + +G G   KV  A     G EVA   +K +    
Sbjct: 2   NSIASCADEQPHI-----GNY-RLLKTIGKGNFAKVKLARHILTGREVA---IKIIDKTQ 52

Query: 65  DDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH 124
            +P  +++LF EVR++K L + NI+ L  V   E   TL  I E  + G + +Y   H  
Sbjct: 53  LNPTSLQKLFREVRIMKILNHPNIVKLFEVI--ETEKTLYLIMEYASGGEVFDYLVAHGR 110

Query: 125 VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           +  K  +   +QI+  + Y H     ++HRDL   N+ ++ +   +KI D G +   
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQK--RIVHRDLKAENLLLDAD-MNIKIADFGFSNEF 164

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 89.4 bits (222), Expect = 2e-21
 Identities = 44/190 (23%), Positives = 71/190 (37%), Gaps = 18/190 (9%)

Query: 3   PAVNSDPSDKDSEPFIETDPT-GRYGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVK 59
           P      S +D   F+      G   R     +L  G    VY A D   G E A  ++ 
Sbjct: 4   PGSLGGASGRDQSDFVGQTVELGEL-RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL- 61

Query: 60  LRTFCDDPAMIERLFSEVRLLKTLAN-KNIISL--HYVWRDEDRNTLN---FITEVCTSG 113
                ++      +  EV  +K L+   NI+          E+ +T      +      G
Sbjct: 62  ---LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKG 118

Query: 114 NLREYRKKHRHV---SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQV 170
            L E+ KK       S   + K   Q  + + ++H  +P +IHRDL   N+ ++   G +
Sbjct: 119 QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTI 177

Query: 171 KIGDLGVAAI 180
           K+ D G A  
Sbjct: 178 KLCDFGSATT 187

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 88.9 bits (221), Expect = 2e-21
 Identities = 41/176 (23%), Positives = 78/176 (44%), Gaps = 22/176 (12%)

Query: 10  SDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
           S       ++ DP   + +  E +G G+  +V++  D      VA   + L    D+   
Sbjct: 8   SGLPGMQNLKADPEELFTKL-EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED 66

Query: 70  IERLFSEVRLLKTLANKNIISLH--YVWRDEDRNTLNFITEVCTSGNLREYRKKH----R 123
           I++   E+ +L    +  +   +  Y+   +    L  I E    G+  +  +       
Sbjct: 67  IQQ---EITVLSQCDSPYVTKYYGSYLKDTK----LWIIMEYLGGGSALDLLEPGPLDET 119

Query: 124 HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
            ++        ++ILKGL+YLH+ +   IHRD+  +NV ++ + G+VK+ D GVA 
Sbjct: 120 QIATI-----LREILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADFGVAG 167

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 88.7 bits (221), Expect = 2e-21
 Identities = 46/151 (30%), Positives = 78/151 (51%), Gaps = 12/151 (7%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A ++  G  VA  +++L T  +  P+   R   E+ LLK L + NI+
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 65

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREY--RKKHRHVSVKALKKWSKQILKGLNYLHTH 147
            L  V   E++  L F  E     +L+++        + +  +K +  Q+L+GL + H+H
Sbjct: 66  KLLDVIHTENKLYLVF--EFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122

Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              V+HRDL   N+ +N   G +K+ D G+A
Sbjct: 123 --RVLHRDLKPQNLLIN-TEGAIKLADFGLA 150

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 89.3 bits (222), Expect = 2e-21
 Identities = 39/162 (24%), Positives = 63/162 (38%), Gaps = 17/162 (10%)

Query: 28  RYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           R+    + G G    V    ++  G+ VA   +K +    DP    R    ++ L  L +
Sbjct: 24  RFQVERMAGQGTFGTVQLGKEKSTGMSVA---IK-KVI-QDPRFRNRELQIMQDLAVLHH 78

Query: 86  KNIISLHYVWRDEDRNT-----LNFITEVCTSGNL----REYRKKHRHVSVKALKKWSKQ 136
            NI+ L   +            LN + E      L    R Y ++        +K +  Q
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQ 137

Query: 137 ILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +++ +  LH     V HRD+   NV VN   G +K+ D G A
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 88.1 bits (219), Expect = 3e-21
 Identities = 39/180 (21%), Positives = 76/180 (42%), Gaps = 28/180 (15%)

Query: 25  RYGRYN--ELLGSGAVKKVYRAFDQEEGIEVA----------------------WNQVKL 60
           +  +Y   + +G G+   V  A+++ +    A                        +   
Sbjct: 11  QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70

Query: 61  RTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRK 120
                    IE+++ E+ +LK L + N++ L  V  D + + L  + E+   G + E   
Sbjct: 71  GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT 130

Query: 121 KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
               +S    + + + ++KG+ YLH  +  +IHRD+  SN+ V  + G +KI D GV+  
Sbjct: 131 LKP-LSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGED-GHIKIADFGVSNE 186

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 88.2 bits (219), Expect = 4e-21
 Identities = 42/179 (23%), Positives = 79/179 (44%), Gaps = 21/179 (11%)

Query: 11  DKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMI 70
            +DS     +     Y    E++GSGA   V  A+   +  +VA  ++ L         +
Sbjct: 2   SEDSSALPWSINRDDYELQ-EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS---M 57

Query: 71  ERLFSEVRLLKTLANKNIISLH--YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVK 128
           + L  E++ +    + NI+S +  +V +DE    L  + ++ + G++ +  K        
Sbjct: 58  DELLKEIQAMSQCHHPNIVSYYTSFVVKDE----LWLVMKLLSGGSVLDIIKHIVAKGEH 113

Query: 129 ALKKWS--------KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
                         +++L+GL YLH +    IHRD+   N+ +  + G V+I D GV+A
Sbjct: 114 KSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGED-GSVQIADFGVSA 169

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 88.6 bits (220), Expect = 4e-21
 Identities = 49/188 (26%), Positives = 77/188 (40%), Gaps = 14/188 (7%)

Query: 2   MPAVNSDPSDKD---SEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQV 58
           MPA     S KD   +E F + DP   +      +G G+   VY A D      VA  ++
Sbjct: 29  MPAGGRAGSLKDPDVAELFFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKM 87

Query: 59  KLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH--YVWRDEDRNTLNFITEVCTSGNLR 116
                  +    + +  EVR L+ L + N I     Y+           + E C      
Sbjct: 88  SYSGKQSNEK-WQDIIKEVRFLQKLRHPNTIQYRGCYLREHT----AWLVMEYCLGSASD 142

Query: 117 EYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
                 + +    +   +   L+GL YLH+H   +IHRD+   N+ ++   G VK+GD G
Sbjct: 143 LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFG 199

Query: 177 VAAIVGRA 184
            A+I+  A
Sbjct: 200 SASIMAPA 207

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 88.1 bits (219), Expect = 5e-21
 Identities = 54/182 (29%), Positives = 84/182 (46%), Gaps = 14/182 (7%)

Query: 2   MPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLR 61
           + A    P               RY R  +L G G   +VY+A D      VA  +++L 
Sbjct: 12  LEAQTQGPGSMSVSAAPSATSIDRYRRITKL-GEGTYGEVYKAIDTVTNETVAIKRIRLE 70

Query: 62  TFCDD-PAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRK 120
              +  P    R   EV LLK L ++NII L  V     R  L F  E   + +L++Y  
Sbjct: 71  HEEEGVPGTAIR---EVSLLKELQHRNIIELKSVIHHNHRLHLIF--EYAEN-DLKKYMD 124

Query: 121 KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN----GNTGQVKIGDLG 176
           K+  VS++ +K +  Q++ G+N+ H+     +HRDL   N+ ++      T  +KIGD G
Sbjct: 125 KNPDVSMRVIKSFLYQLINGVNFCHSR--RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182

Query: 177 VA 178
           +A
Sbjct: 183 LA 184

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 88.3 bits (219), Expect = 5e-21
 Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 19/157 (12%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLANKNII 89
           E +G G   +V+R   +  G EVA   VK   +  +     E    E+     L ++NI+
Sbjct: 48  ESIGKGRFGEVWRG--KWRGEEVA---VKIFSSREERSWFREA---EIYQTVMLRHENIL 99

Query: 90  SLHYVWRDEDRNTLNF--ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT- 146
                   ++        +++    G+L +Y  ++  V+V+ + K +     GL +LH  
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHME 158

Query: 147 -----HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
                 +P + HRDL   N+ V  N G   I DLG+A
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLA 194

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 86.9 bits (216), Expect = 6e-21
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 12/166 (7%)

Query: 19  ETDPTGRYGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKL--RTFCDDPAMIERLF 74
           + D   + G Y   + LG G   KV     Q  G +VA   VK+  R       ++ ++ 
Sbjct: 3   KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVA---VKILNRQKIRSLDVVGKIK 59

Query: 75  SEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS 134
            E++ LK   + +II L+ V           + E  + G L +Y  KH  V     ++  
Sbjct: 60  REIQNLKLFRHPHIIKLYQVI--STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF 117

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
           +QIL  ++Y H H   V+HRDL   NV ++ +    KI D G++ +
Sbjct: 118 QQILSAVDYCHRH--MVVHRDLKPENVLLDAH-MNAKIADFGLSNM 160

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 88.0 bits (218), Expect = 1e-20
 Identities = 33/179 (18%), Positives = 70/179 (39%), Gaps = 22/179 (12%)

Query: 20  TDPTGRYGRYNELLGSGAVK--KVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEV 77
               G Y     ++G G      V  A  +  G  V   ++ L    ++  M+  L  E+
Sbjct: 21  LPEGGCYELL-TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNE--MVTFLQGEL 77

Query: 78  RLLKTLANKNIISLH--YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS- 134
            + K   + NI+     ++  +E    L  +T     G+ ++    H       + + + 
Sbjct: 78  HVSKLFNHPNIVPYRATFIADNE----LWVVTSFMAYGSAKDLICTHFM---DGMNELAI 130

Query: 135 ----KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIR 189
               + +LK L+Y+H      +HR +  S++ ++ + G+V +  L     +    +R R
Sbjct: 131 AYILQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQR 186

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 87.0 bits (216), Expect = 1e-20
 Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 15/169 (8%)

Query: 14  SEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERL 73
                + DP   +      LG GA  KVY+A ++E G   A   ++ ++  +    +E  
Sbjct: 9   EHVRRDLDPNEVWEIV-GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE----LEDY 63

Query: 74  FSEVRLLKTLANKNIISLH--YVWRDEDRNTLNFITEVCTSGNLRE-YRKKHRHVSVKAL 130
             E+ +L T  +  I+ L   Y    +    L  + E C  G +     +  R ++   +
Sbjct: 64  IVEIEILATCDHPYIVKLLGAYYHDGK----LWIMIEFCPGGAVDAIMLELDRGLTEPQI 119

Query: 131 KKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
           +   +Q+L+ LN+LH+    +IHRDL   NV +    G +++ D GV+A
Sbjct: 120 QVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLE-GDIRLADFGVSA 165

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 87.0 bits (216), Expect = 1e-20
 Identities = 47/187 (25%), Positives = 93/187 (49%), Gaps = 20/187 (10%)

Query: 2   MPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLR 61
           M + +   S  + +     DP G +    EL+G+G   +VY+    + G   A   + + 
Sbjct: 2   MASDSPARSLDEIDLSALRDPAGIFELV-ELVGNGTYGQVYKGRHVKTGQLAAIKVMDV- 59

Query: 62  TFCDDPAMIERLFSEVRLLKTLAN-KNIISLH--YVWRDEDR--NTLNFITEVCTSGNLR 116
                    E +  E+ +LK  ++ +NI + +  ++ ++     + L  + E C +G++ 
Sbjct: 60  ----TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115

Query: 117 EYRKKHRHVSVKALKKW----SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKI 172
           +  K  +  ++K  ++W     ++IL+GL++LH H+  VIHRD+   NV +  N  +VK+
Sbjct: 116 DLIKNTKGNTLK--EEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKL 170

Query: 173 GDLGVAA 179
            D GV+A
Sbjct: 171 VDFGVSA 177

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 86.4 bits (215), Expect = 1e-20
 Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 11/150 (7%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    V++A ++E    VA  +V+L    +  P+   R   E+ LLK L +KNI+
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---EICLLKELKHKNIV 64

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV-SVKALKKWSKQILKGLNYLHTHE 148
            LH V   +    L  + E C   +L++Y          + +K +  Q+LKGL + H+  
Sbjct: 65  RLHDVLHSD--KKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             V+HRDL   N+ +N   G++K+ + G+A
Sbjct: 121 -NVLHRDLKPQNLLIN-RNGELKLANFGLA 148

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 86.9 bits (216), Expect = 1e-20
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 21/177 (11%)

Query: 8   DPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAF----DQEEGIEVAWNQVK-LRT 62
            P+        ET+         ++LGSGA   VY+       ++  I VA   +K LR 
Sbjct: 3   APNQALLRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELRE 54

Query: 63  FCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH 122
                A  E +  E  ++ ++ N ++  L  +       T+  IT++   G L +Y ++H
Sbjct: 55  ATSPKANKE-ILDEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREH 110

Query: 123 R-HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           + ++  + L  W  QI KG+NYL      ++HRDL   NV V      VKI D G+A
Sbjct: 111 KDNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQ-HVKITDFGLA 164

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 87.2 bits (216), Expect = 2e-20
 Identities = 38/157 (24%), Positives = 75/157 (47%), Gaps = 7/157 (4%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
             LG+G    V++   +  G+ +A    KL      PA+  ++  E+++L    +  I+ 
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 95

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            +  +  +    ++   E    G+L +  KK   +  + L K S  ++KGL YL   +  
Sbjct: 96  FYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE-KHK 152

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR 187
           ++HRD+  SN+ VN   G++K+ D GV+  +  ++  
Sbjct: 153 IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMAN 188

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 85.4 bits (212), Expect = 3e-20
 Identities = 47/180 (26%), Positives = 82/180 (45%), Gaps = 23/180 (12%)

Query: 6   NSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD 65
           + +  +K        DP  +Y R+ E +G GA   VY A D   G EVA  Q+ L+    
Sbjct: 2   DEEILEKLRSIVSVGDPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK 60

Query: 66  DPAMIERLFSEVRLLKTLANKNIISLH--YVWRDEDRNTLNFITEVCTSGNLREYRKKHR 123
                E + +E+ +++   N NI++    Y+  DE    L  + E    G+L +   +  
Sbjct: 61  ----KELIINEILVMRENKNPNIVNYLDSYLVGDE----LWVVMEYLAGGSLTDVVTETC 112

Query: 124 ----HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
                ++        ++ L+ L +LH+++  VIHRD+   N+ +  + G VK+ D G  A
Sbjct: 113 MDEGQIAAV-----CRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFCA 164

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 85.5 bits (212), Expect = 4e-20
 Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 17/172 (9%)

Query: 11  DKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMI 70
            K  E  +   P   +    E LG G+   VY+A  +E G  VA  QV +     D   I
Sbjct: 16  KKLDEDSLTKQPEEVFDVL-EKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEI 71

Query: 71  ERLFSEVRLLKTLANKNIISLH--YVWRDEDRNTLNFITEVCTSGNLRE-YRKKHRHVSV 127
            +   E+ +++   + +++  +  Y    +    L  + E C +G++ +  R +++ ++ 
Sbjct: 72  IK---EISIMQQCDSPHVVKYYGSYFKNTD----LWIVMEYCGAGSVSDIIRLRNKTLTE 124

Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
             +    +  LKGL YLH      IHRD+   N+ +N   G  K+ D GVA 
Sbjct: 125 DEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTE-GHAKLADFGVAG 173

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 86.8 bits (215), Expect = 4e-20
 Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 12/166 (7%)

Query: 19  ETDPTGRYGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKL--RTFCDDPAMIERLF 74
           + D   + G Y   + LG G   KV     +  G +VA   VK+  R       ++ ++ 
Sbjct: 8   KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVA---VKILNRQKIRSLDVVGKIR 64

Query: 75  SEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS 134
            E++ LK   + +II L+ V      + +  + E  + G L +Y  K+  +  K  ++  
Sbjct: 65  REIQNLKLFRHPHIIKLYQVI--STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF 122

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
           +QIL G++Y H H   V+HRDL   NV ++ +    KI D G++ +
Sbjct: 123 QQILSGVDYCHRH--MVVHRDLKPENVLLDAH-MNAKIADFGLSNM 165

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 85.5 bits (212), Expect = 5e-20
 Identities = 40/163 (24%), Positives = 74/163 (45%), Gaps = 15/163 (9%)

Query: 19  ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVR 78
           + DP      Y   +G G+   V  A ++  G +VA   + LR         E LF+EV 
Sbjct: 40  QGDPRLLLDSY-VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR----RELLFNEVV 94

Query: 79  LLKTLANKNIISLH--YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQ 136
           +++   + N++ ++  Y+  +E    L  + E    G L +       ++ + +    + 
Sbjct: 95  IMRDYQHFNVVEMYKSYLVGEE----LWVLMEFLQGGALTDIV-SQVRLNEEQIATVCEA 149

Query: 137 ILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
           +L+ L YLH     VIHRD+   ++ +  + G+VK+ D G  A
Sbjct: 150 VLQALAYLHAQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCA 189

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 85.2 bits (211), Expect = 7e-20
 Identities = 40/184 (21%), Positives = 76/184 (41%), Gaps = 18/184 (9%)

Query: 8   DPSDKDSEPFIETDPTGRYGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVK------ 59
           +P        +         +Y+    LGSGA   V+ A D+E+  EV    VK      
Sbjct: 5   EPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVV---VKFIKKEK 61

Query: 60  -LRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGN-LRE 117
            L     +   + ++  E+ +L  + + NII +  ++  E++     + E   SG  L  
Sbjct: 62  VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF--ENQGFFQLVMEKHGSGLDLFA 119

Query: 118 YRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV 177
           +  +H  +         +Q++  + YL      +IHRD+   N+ +  +   +K+ D G 
Sbjct: 120 FIDRHPRLDEPLASYIFRQLVSAVGYLRLK--DIIHRDIKDENIVIAED-FTIKLIDFGS 176

Query: 178 AAIV 181
           AA +
Sbjct: 177 AAYL 180

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 84.2 bits (209), Expect = 9e-20
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 12/152 (7%)

Query: 30  NELLGSGAVKKVYRAF--DQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++ LGSG    V + +   ++    VA   VK L+   +DPA+ + L +E  +++ L N 
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVA---VKILKNEANDPALKDELLAEANVMQQLDNP 78

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            I+ +  +   E   +   + E+   G L +Y +++RHV  K + +   Q+  G+ YL  
Sbjct: 79  YIVRMIGICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 135

Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
                +HRDL   NV +       KI D G++
Sbjct: 136 S--NFVHRDLAARNVLL-VTQHYAKISDFGLS 164

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 85.1 bits (211), Expect = 1e-19
 Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 11/158 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC----DDPAMIERLFSEVRLLKTLANK 86
           + LGSGA  +V  AF+++   +VA   +  R F      +      + +E+ +LK L + 
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            II +   +  ED      + E+   G L +    ++ +     K +  Q+L  + YLH 
Sbjct: 201 CIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 257

Query: 147 HEPCVIHRDLNCSNVFV--NGNTGQVKIGDLGVAAIVG 182
           +   +IHRDL   NV +        +KI D G + I+G
Sbjct: 258 NG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 84.0 bits (208), Expect = 2e-19
 Identities = 40/157 (25%), Positives = 67/157 (42%), Gaps = 19/157 (12%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLANKNII 89
           + +G G   +V+    +  G +VA   VK   T  +     E    E+     + ++NI+
Sbjct: 43  KQIGKGRYGEVWMG--KWRGEKVA---VKVFFTTEEASWFRET---EIYQTVLMRHENIL 94

Query: 90  SLHYVWRDEDRNTLNF--ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT- 146
                      +      IT+   +G+L +Y K    +  K++ K +   + GL +LHT 
Sbjct: 95  GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLHTE 153

Query: 147 -----HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
                 +P + HRDL   N+ V  N G   I DLG+A
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLA 189

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 83.6 bits (207), Expect = 2e-19
 Identities = 31/150 (20%), Positives = 68/150 (45%), Gaps = 8/150 (5%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVR-LLKTLANKNII 89
             +GSG   +V++   ++ G  +A  Q++      +    +R+  ++  +LK+     I+
Sbjct: 31  GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG---NKEENKRILMDLDVVLKSHDCPYIV 87

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
                +       +    E+  +   +  ++    +  + L K +  I+K L YL   + 
Sbjct: 88  QCFGTFITN--TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK-EKH 144

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
            VIHRD+  SN+ ++   GQ+K+ D G++ 
Sbjct: 145 GVIHRDVKPSNILLDER-GQIKLCDFGISG 173

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 83.6 bits (207), Expect = 2e-19
 Identities = 27/212 (12%), Positives = 71/212 (33%), Gaps = 29/212 (13%)

Query: 2   MPAVNSDPSDKDSEPFIETDPTGRYGRYN--ELLGSGAVKKVYRAFDQEEGIEVA----- 54
           M  + S+ S+         +       Y     L  G   K+     +++    A     
Sbjct: 6   MKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYE 63

Query: 55  --------WNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI 106
                                +  +   +E++++  + N+  ++   +    + + +  I
Sbjct: 64  KSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII--TNYDEVYII 121

Query: 107 TEVCTSGNLREYRKKHRHVSVKALKKWS--------KQILKGLNYLHTHEPCVIHRDLNC 158
            E   + ++ ++ +    +                 K +L   +Y+H  +  + HRD+  
Sbjct: 122 YEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK-NICHRDVKP 180

Query: 159 SNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRC 190
           SN+ ++ N G+VK+ D G +  +     +   
Sbjct: 181 SNILMDKN-GRVKLSDFGESEYMVDKKIKGSR 211

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 84.7 bits (210), Expect = 2e-19
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 7/153 (4%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
            +LG G+  +V    D+  G E A   +  R         E L  EV+LLK L + NI+ 
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQLDHPNIMK 90

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L+  +  ED+     + EV T G L +     +  S     +  +Q+L G+ Y+H +   
Sbjct: 91  LYEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN--K 146

Query: 151 VIHRDLNCSN-VFVNGNTG-QVKIGDLGVAAIV 181
           ++HRDL   N +  + +    ++I D G++   
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 83.0 bits (206), Expect = 3e-19
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 13/158 (8%)

Query: 24  GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVK-LRT-FCDDPAMIERLFSEVRLLK 81
            RY +  + LG G +  VY A D    I+VA   +K +     +    ++R   EV    
Sbjct: 11  ERY-KIVDKLGGGGMSTVYLAEDTILNIKVA---IKAIFIPPREKEETLKRFEREVHNSS 66

Query: 82  TLANKNIISLHYVWRDEDRNTLNFIT-EVCTSGNLREYRKKHRHVSVKALKKWSKQILKG 140
            L+++NI+S+  V  ++D     ++  E      L EY + H  +SV     ++ QIL G
Sbjct: 67  QLSHQNIVSMIDVDEEDD---CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDG 123

Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           + + H     ++HRD+   N+ +  +   +KI D G+A
Sbjct: 124 IKHAHDMR--IVHRDIKPQNILI-DSNKTLKIFDFGIA 158

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 83.2 bits (206), Expect = 3e-19
 Identities = 40/182 (21%), Positives = 80/182 (43%), Gaps = 17/182 (9%)

Query: 6   NSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVA---WNQVKLRT 62
                 K+ EP        +Y +   LLGSG    VY      + + VA     + ++  
Sbjct: 30  TKLAPGKEKEPLE-----SQY-QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 83

Query: 63  FCDDPAMIERLFSEVRLLKTLANK--NIISLHYVWRDEDRNTLNFITEVCT-SGNLREYR 119
           + + P    R+  EV LLK +++    +I L   +  E  ++   I E      +L ++ 
Sbjct: 84  WGELP-NGTRVPMEVVLLKKVSSGFSGVIRLLDWF--ERPDSFVLILERPEPVQDLFDFI 140

Query: 120 KKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
            +   +  +  + +  Q+L+ + + H     V+HRD+   N+ ++ N G++K+ D G  A
Sbjct: 141 TERGALQEELARSFFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGA 198

Query: 180 IV 181
           ++
Sbjct: 199 LL 200

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 83.1 bits (206), Expect = 3e-19
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 16/154 (10%)

Query: 31  ELLGSGAVKKVYRAF----DQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLAN 85
           ++LGSGA   VY+       ++  I VA   +K LR      A  E +  E  ++ ++ N
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKE-ILDEAYVMASVDN 76

Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYL 144
            ++  L  +       T+  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL
Sbjct: 77  PHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
                 ++HRDL   NV V      VKI D G+A
Sbjct: 134 EDR--RLVHRDLAARNVLVKTPQ-HVKITDFGLA 164

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 82.7 bits (205), Expect = 5e-19
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 14/151 (9%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD--PAMIERLFSEVRLLKTLANKNI 88
           + LG G    VY+   +     VA  +++L    ++  P    R   EV LLK L + NI
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIR---EVSLLKDLKHANI 62

Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYLHTH 147
           ++LH +   E   +L  + E     +L++Y       +++  +K +  Q+L+GL Y H  
Sbjct: 63  VTLHDIIHTE--KSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119

Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              V+HRDL   N+ +N   G++K+ D G+A
Sbjct: 120 --KVLHRDLKPQNLLIN-ERGELKLADFGLA 147

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 82.4 bits (204), Expect = 5e-19
 Identities = 33/183 (18%), Positives = 67/183 (36%), Gaps = 15/183 (8%)

Query: 9   PSDKDSEPFIETDPTGRYGRYN--ELLGSGAVKKVYRAFDQEEGIEVA---WNQVKLRTF 63
           P    + P    D       Y    LLG G    V+      + ++VA     + ++  +
Sbjct: 13  PPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGW 72

Query: 64  CDDPAMIERLFSEVRLLKTLANK----NIISLHYVWRDEDRNTLNFITE-VCTSGNLREY 118
                       EV LL  +        +I L   +  E +     + E    + +L +Y
Sbjct: 73  SPLS-DSVTCPLEVALLWKVGAGGGHPGVIRLLDWF--ETQEGFMLVLERPLPAQDLFDY 129

Query: 119 RKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             +   +     + +  Q++  + + H+    V+HRD+   N+ ++   G  K+ D G  
Sbjct: 130 ITEKGPLGEGPSRCFFGQVVAAIQHCHSR--GVVHRDIKDENILIDLRRGCAKLIDFGSG 187

Query: 179 AIV 181
           A++
Sbjct: 188 ALL 190

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 83.3 bits (206), Expect = 5e-19
 Identities = 44/168 (26%), Positives = 70/168 (41%), Gaps = 23/168 (13%)

Query: 25  RYGRYNELLGSGAVKKVYRAFDQEE--GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKT 82
            +      +G G    VY+A  ++     + A  Q++            R   E+ LL+ 
Sbjct: 21  LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACR---EIALLRE 74

Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA---------LKKW 133
           L + N+ISL  V+       +  + +     +L    K HR               +K  
Sbjct: 75  LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSL 133

Query: 134 SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG---NTGQVKIGDLGVA 178
             QIL G++YLH +   V+HRDL  +N+ V G     G+VKI D+G A
Sbjct: 134 LYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFA 179

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 82.2 bits (204), Expect = 6e-19
 Identities = 44/150 (29%), Positives = 76/150 (50%), Gaps = 12/150 (8%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A D +  I VA  +++L    +  P+   R   E+ LLK L + NI+
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIR---EISLLKELHHPNIV 82

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV-SVKALKKWSKQILKGLNYLHTHE 148
           SL  V   E    L  + E     +L++   +++       +K +  Q+L+G+ + H H 
Sbjct: 83  SLIDVIHSE--RCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH- 138

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             ++HRDL   N+ +N + G +K+ D G+A
Sbjct: 139 -RILHRDLKPQNLLIN-SDGALKLADFGLA 166

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 82.3 bits (204), Expect = 7e-19
 Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 11/158 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC----DDPAMIERLFSEVRLLKTLANK 86
           + LGSGA  +V  AF+++   +VA   +  R F      +      + +E+ +LK L + 
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            II +   +  ED      + E+   G L +    ++ +     K +  Q+L  + YLH 
Sbjct: 76  CIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 132

Query: 147 HEPCVIHRDLNCSNVFV--NGNTGQVKIGDLGVAAIVG 182
           +   +IHRDL   NV +        +KI D G + I+G
Sbjct: 133 NG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 82.7 bits (205), Expect = 7e-19
 Identities = 42/185 (22%), Positives = 74/185 (40%), Gaps = 10/185 (5%)

Query: 2   MPAVNSDPSDKDSEPFIETDPTGRYGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVK 59
           M ++           F+    T     Y+  E LG GA   V R   +  G+E A   + 
Sbjct: 4   MASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 63

Query: 60  LRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYR 119
            +         ++L  E R+ + L + NI+ LH     ++ +    + ++ T G L E  
Sbjct: 64  TKKLSARD--FQKLEREARICRKLQHPNIVRLHDSI--QEESFHYLVFDLVTGGELFEDI 119

Query: 120 KKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNV-FVN-GNTGQVKIGDLGV 177
                 S        +QIL+ + Y H++   ++HR+L   N+   +      VK+ D G+
Sbjct: 120 VAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGL 177

Query: 178 AAIVG 182
           A  V 
Sbjct: 178 AIEVN 182

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 83.2 bits (206), Expect = 8e-19
 Identities = 41/153 (26%), Positives = 69/153 (45%), Gaps = 8/153 (5%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           + LGSGA  +V    D+   +E A   ++  +     +   +L  EV +LK L + NI+ 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV--STSSNSKLLEEVAVLKLLDHPNIMK 100

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L+  +  ED+     + E    G L +        +        KQ+L G+ YLH H   
Sbjct: 101 LYDFF--EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH--N 156

Query: 151 VIHRDLNCSN-VFVNGNTG-QVKIGDLGVAAIV 181
           ++HRDL   N +  +      +KI D G++A+ 
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 83.2 bits (206), Expect = 8e-19
 Identities = 39/155 (25%), Positives = 67/155 (43%), Gaps = 12/155 (7%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
            +LG G+  +V +  D+    E A   +   +          +  EV LLK L + NI+ 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMK 85

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L  +   ED ++   + E+ T G L +   K +  S     +  KQ+  G+ Y+H H   
Sbjct: 86  LFEIL--EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH--N 141

Query: 151 VIHRDL---NCSNVFVN-GNTGQVKIGDLGVAAIV 181
           ++HRDL   N   +  +      +KI D G++   
Sbjct: 142 IVHRDLKPENI--LLESKEKDCDIKIIDFGLSTCF 174

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 81.9 bits (203), Expect = 8e-19
 Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 19/160 (11%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE----RLFSEVRLLKTLAN- 85
             +G GA   VY+A D   G  VA   V++         +     R   EV LL+ L   
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR---EVALLRRLEAF 71

Query: 86  --KNIISLHYV---WRDEDRNTLNFITEVCTSGNLREY--RKKHRHVSVKALKKWSKQIL 138
              N++ L  V    R +    +  + E     +LR Y  +     +  + +K   +Q L
Sbjct: 72  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFL 130

Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +GL++LH +  C++HRDL   N+ V  + G VK+ D G+A
Sbjct: 131 RGLDFLHAN--CIVHRDLKPENILVT-SGGTVKLADFGLA 167

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 82.0 bits (203), Expect = 9e-19
 Identities = 37/154 (24%), Positives = 70/154 (45%), Gaps = 16/154 (10%)

Query: 31  ELLGSGAVKKVYRAF----DQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLAN 85
           ++LGSG    V++       +   I V    +K +       +    +   +  + +L +
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVC---IKVIEDKSGRQSFQA-VTDHMLAIGSLDH 74

Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYL 144
            +I+ L  +       +L  +T+    G+L ++ ++HR  +  + L  W  QI KG+ YL
Sbjct: 75  AHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL 131

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             H   ++HR+L   NV +     QV++ D GVA
Sbjct: 132 EEH--GMVHRNLAARNVLLKSP-SQVQVADFGVA 162

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 82.2 bits (204), Expect = 9e-19
 Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 14/153 (9%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD----PAMIERLFSEVRLLKTLANK 86
           + LG G    VY+A D+     VA  ++KL    +          R   E++LL+ L++ 
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR---EIKLLQELSHP 72

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV-SVKALKKWSKQILKGLNYLH 145
           NII L   +  +    ++ + +   + +L    K +  V +   +K +    L+GL YLH
Sbjct: 73  NIIGLLDAFGHKSN--ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            H   ++HRDL  +N+ ++   G +K+ D G+A
Sbjct: 130 QH--WILHRDLKPNNLLLD-ENGVLKLADFGLA 159

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 81.5 bits (202), Expect = 1e-18
 Identities = 49/156 (31%), Positives = 86/156 (55%), Gaps = 19/156 (12%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD--PAMIERLFSEVRLLKTLANKNI 88
           E LG+G    VY+  ++  G+ VA  +VKL +  ++  P+   R   E+ L+K L ++NI
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIR---EISLMKELKHENI 65

Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREY------RKKHRHVSVKALKKWSKQILKGLN 142
           + L+ V   E++ TL F  E   + +L++Y          R + +  +K +  Q+L+GL 
Sbjct: 66  VRLYDVIHTENKLTLVF--EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122

Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           + H +   ++HRDL   N+ +N   GQ+K+GD G+A
Sbjct: 123 FCHEN--KILHRDLKPQNLLIN-KRGQLKLGDFGLA 155

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 81.1 bits (201), Expect = 1e-18
 Identities = 37/162 (22%), Positives = 66/162 (40%), Gaps = 12/162 (7%)

Query: 32  LLGSGAVKKVYRAFDQEEGIEVA---WNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
            LG G    VY A +++    +A     + +L        +  +L  EV +   L + NI
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG----VEHQLRREVEIQSHLRHPNI 71

Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           + L+  + D  R  +  I E    G +    +K      +    +  ++   L+Y H+  
Sbjct: 72  LRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 129

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRC 190
             VIHRD+   N+ +    G++KI D G +     + R   C
Sbjct: 130 --VIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSRRTDLC 168

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 81.6 bits (202), Expect = 1e-18
 Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 13/160 (8%)

Query: 25  RYGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKL--RTFCDDPAMIERLFSEVRLL 80
             G Y   E LG G+  KV  A   +   +VA   +K   R       M  R+  E+  L
Sbjct: 7   HIGPYIIRETLGEGSFGKVKLATHYKTQQKVA---LKFISRQLLKKSDMHMRVEREISYL 63

Query: 81  KTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKG 140
           K L + +II L+ V        +  + E    G L +Y  + + ++    +++ +QI+  
Sbjct: 64  KLLRHPHIIKLYDVI--TTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120

Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
           + Y H H   ++HRDL   N+ ++ N   VKI D G++ I
Sbjct: 121 IEYCHRH--KIVHRDLKPENLLLDDN-LNVKIADFGLSNI 157

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 80.7 bits (200), Expect = 1e-18
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 10/154 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
             +G G+  +V  A  +   I  A  ++      D    ++R   E+ ++K+L + NII 
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED----VDRFKQEIEIMKSLDHPNIIR 70

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L+  +  ED   +  + E+CT G L E     R        +  K +L  + Y H     
Sbjct: 71  LYETF--EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN-- 126

Query: 151 VIHRDLNCSNVFVNGNTG--QVKIGDLGVAAIVG 182
           V HRDL   N     ++    +K+ D G+AA   
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 82.5 bits (204), Expect = 1e-18
 Identities = 40/181 (22%), Positives = 69/181 (38%), Gaps = 22/181 (12%)

Query: 8   DPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDP 67
           +  D D E  +       +    ++LG GA   +       +  +VA   VK       P
Sbjct: 8   EQDDGDEETSVVIVGKISFCP-KDVLGHGAEGTIVYR-GMFDNRDVA---VK----RILP 58

Query: 68  AMIERLFSEVRLLKTLAN-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREY--RKKHRH 124
                   EV+LL+      N+I       ++DR       E+C    L+EY  +K   H
Sbjct: 59  ECFSFADREVQLLRESDEHPNVIRYFCT--EKDRQFQYIAIELCA-ATLQEYVEQKDFAH 115

Query: 125 VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFV----NGNTGQVKIGDLGVAAI 180
           + ++      +Q   GL +LH+    ++HRDL   N+ +         +  I D G+   
Sbjct: 116 LGLEP-ITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172

Query: 181 V 181
           +
Sbjct: 173 L 173

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 81.0 bits (201), Expect = 1e-18
 Identities = 42/150 (28%), Positives = 68/150 (45%), Gaps = 12/150 (8%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
           E +G G    VY+A +       A  +++L    +  P+   R   E+ +LK L + NI+
Sbjct: 8   EKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIR---EISILKELKHSNIV 63

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV-SVKALKKWSKQILKGLNYLHTHE 148
            L+ V   + R  L F  E     +L++              K +  Q+L G+ Y H   
Sbjct: 64  KLYDVIHTKKRLVLVF--EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             V+HRDL   N+ +N   G++KI D G+A
Sbjct: 120 -RVLHRDLKPQNLLIN-REGELKIADFGLA 147

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 80.3 bits (199), Expect = 3e-18
 Identities = 40/155 (25%), Positives = 67/155 (43%), Gaps = 10/155 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLANKNII 89
           E LG GA   V R   +  G+E A    K + T        ++L  E R+ + L + NI+
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFA---AKIINTKKLSARDFQKLEREARICRKLQHPNIV 68

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
            LH     ++ +    + ++ T G L E        S        +QIL+ + Y H++  
Sbjct: 69  RLHDSI--QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG- 125

Query: 150 CVIHRDLNCSNV-FVN-GNTGQVKIGDLGVAAIVG 182
            ++HR+L   N+   +      VK+ D G+A  V 
Sbjct: 126 -IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 80.8 bits (200), Expect = 3e-18
 Identities = 40/160 (25%), Positives = 66/160 (41%), Gaps = 11/160 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM-IERLFSEVRLLKTLANKNII 89
           E++G G    V R  ++E G + A   V +  F   P +  E L  E  +   L + +I+
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNL--REYRKKHRHV--SVKALKKWSKQILKGLNYLH 145
            L   +       L  + E     +L     ++       S      + +QIL+ L Y H
Sbjct: 90  ELLETY--SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147

Query: 146 THEPCVIHRDLNCSNV-FVN-GNTGQVKIGDLGVAAIVGR 183
            +   +IHRD+    V   +  N+  VK+G  GVA  +G 
Sbjct: 148 DNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 185

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 80.4 bits (199), Expect = 3e-18
 Identities = 45/166 (27%), Positives = 73/166 (43%), Gaps = 15/166 (9%)

Query: 24  GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVK-LRT-FCDDPAMIERLFSEVRLLK 81
            RY    E+LG G + +V+ A D  +  +VA   VK LR     DP+   R   E +   
Sbjct: 12  DRY-ELGEILGFGGMSEVHLARDLRDHRDVA---VKVLRADLARDPSFYLRFRREAQNAA 67

Query: 82  TLANKNIISLHYVWRDEDRN-TLNFIT-EVCTSGNLREYRKKHRHVSVKALKKWSKQILK 139
            L +  I++++     E     L +I  E      LR+       ++ K   +      +
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127

Query: 140 GLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI 185
            LN+ H +   +IHRD+  +N+ +   T  VK+ D G+A    RAI
Sbjct: 128 ALNFSHQNG--IIHRDVKPANIMI-SATNAVKVMDFGIA----RAI 166

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 80.0 bits (198), Expect = 3e-18
 Identities = 34/158 (21%), Positives = 65/158 (41%), Gaps = 11/158 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVA-----WNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           E+LG G    V R   +    E A            +  +   + E    EV +L+ ++ 
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 86  -KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
             NII L   +  E       + ++   G L +Y  +   +S K  +K  + +L+ +  L
Sbjct: 83  HPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICAL 140

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
           H     ++HRDL   N+ ++ +   +K+ D G +  + 
Sbjct: 141 HKLN--IVHRDLKPENILLDDDM-NIKLTDFGFSCQLD 175

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 80.1 bits (198), Expect = 4e-18
 Identities = 40/157 (25%), Positives = 63/157 (40%), Gaps = 19/157 (12%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLANKNII 89
           E +G G   +V+R     +G  VA   VK   +  +     E    E+     L ++NI+
Sbjct: 14  ECVGKGRYGEVWRG--SWQGENVA---VKIFSSRDEKSWFRET---ELYNTVMLRHENIL 65

Query: 90  SLHYVWRDEDRNTLNF--ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT- 146
                      ++     IT     G+L +Y +    +   +  +    I  GL +LH  
Sbjct: 66  GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIE 124

Query: 147 -----HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
                 +P + HRDL   N+ V  N GQ  I DLG+A
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLA 160

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 80.9 bits (199), Expect = 4e-18
 Identities = 31/206 (15%), Positives = 61/206 (29%), Gaps = 38/206 (18%)

Query: 9   PSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVK--LRTFCDD 66
           P + ++          R  +  E L  G    V+   D E   + A   +K       + 
Sbjct: 46  PQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA---LKVFTMGAENS 102

Query: 67  PAMIERLFSEVRLLKTLANKNIISLHYVWR----------------------DEDRNTLN 104
            + +ERL         L  ++        R                       +D    N
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162

Query: 105 -FITEVCTSGNLREYRK-------KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDL 156
             +     S +L                  + AL   + Q+++    L +    ++H   
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK--GLVHGHF 220

Query: 157 NCSNVFVNGNTGQVKIGDLGVAAIVG 182
              N+F+  + G++ +GD+     VG
Sbjct: 221 TPDNLFIMPD-GRLMLGDVSALWKVG 245

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 80.0 bits (198), Expect = 4e-18
 Identities = 46/157 (29%), Positives = 78/157 (49%), Gaps = 9/157 (5%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC--DDPAMIERLFSEVRLLKTLANKNI 88
           E LGSG    V +  ++  G+E A   +K R           E +  EV +L+ + + N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77

Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           I+LH V+  E+R  +  I E+ + G L ++  +   +S +    + KQIL G+NYLHT +
Sbjct: 78  ITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK 135

Query: 149 PCVIHRDLNCSNVFV---NGNTGQVKIGDLGVAAIVG 182
             + H DL   N+ +   N     +K+ D G+A  + 
Sbjct: 136 --IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 79.6 bits (197), Expect = 4e-18
 Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 15/154 (9%)

Query: 31  ELLGSGAVKKVYRAF---DQEEGIEVAWNQVK-LRTFCDDPAMIERLF-SEVRLLKTLAN 85
           E LG G+   V R        + + VA   VK L+            F  EV  + +L +
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVA---VKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYL 144
           +N+I L+ V        +  +TE+   G+L +  +KH+ H  +  L +++ Q+ +G+ YL
Sbjct: 81  RNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            +     IHRDL   N+ +      VKIGD G+ 
Sbjct: 138 ESK--RFIHRDLAARNLLLATR-DLVKIGDFGLM 168

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 79.6 bits (197), Expect = 4e-18
 Identities = 41/155 (26%), Positives = 68/155 (43%), Gaps = 10/155 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLANKNII 89
            +LG G+  +V +  D+    E A   VK +            +  EV LLK L + NI+
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYA---VKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
            L  +   ED ++   + E+ T G L +   K +  S     +  KQ+  G+ Y+H H  
Sbjct: 85  KLFEIL--EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN- 141

Query: 150 CVIHRDLNCSNV-FVN-GNTGQVKIGDLGVAAIVG 182
            ++HRDL   N+   +      +KI D G++    
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 79.5 bits (197), Expect = 4e-18
 Identities = 35/156 (22%), Positives = 71/156 (45%), Gaps = 10/156 (6%)

Query: 27  GRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA 84
             ++  + LG GA  +V  A ++     VA   V ++   D P  I++   E+ + K L 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLN 63

Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
           ++N++  +      + N      E C+ G L +  +    +     +++  Q++ G+ YL
Sbjct: 64  HENVVKFYGHR--REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
           H     + HRD+   N+ ++     +KI D G+A +
Sbjct: 122 HGIG--ITHRDIKPENLLLDER-DNLKISDFGLATV 154

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 80.1 bits (198), Expect = 5e-18
 Identities = 34/160 (21%), Positives = 72/160 (45%), Gaps = 16/160 (10%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVK-------LRTFCDDPAMIERLFSEVRLLKTL 83
           +++G G    V R   +  G E A   VK         +      + E    E  +L+ +
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFA---VKIMEVTAERLSPEQLEEVREATRRETHILRQV 156

Query: 84  AN-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLN 142
           A   +II+L   +  E  + +  + ++   G L +Y  +   +S K  +   + +L+ ++
Sbjct: 157 AGHPHIITLIDSY--ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214

Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
           +LH +   ++HRDL   N+ ++ N  Q+++ D G +  + 
Sbjct: 215 FLHANN--IVHRDLKPENILLDDNM-QIRLSDFGFSCHLE 251

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 80.9 bits (200), Expect = 5e-18
 Identities = 45/164 (27%), Positives = 68/164 (41%), Gaps = 19/164 (11%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVA---------WNQVKLRTFCDDPAMIERLFSEVRLLK 81
             LGSGA  +V    ++    E A                   +     E +++E+ LLK
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 82  TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           +L + NII L  V+  ED+     +TE    G L E                 KQIL G+
Sbjct: 102 SLDHPNIIKLFDVF--EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGI 159

Query: 142 NYLHTHEPCVIHRDL---NCSNVFVNGNTG-QVKIGDLGVAAIV 181
            YLH H   ++HRD+   N   +  N N+   +KI D G+++  
Sbjct: 160 CYLHKH--NIVHRDIKPENI--LLENKNSLLNIKIVDFGLSSFF 199

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 80.1 bits (198), Expect = 6e-18
 Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 9/157 (5%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC--DDPAMIERLFSEVRLLKTLANKNI 88
           E LGSG    V +  ++  G+E A   +K R           E +  EV +L+ + + NI
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77

Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           I+LH V+  E+R  +  I E+ + G L ++  +   +S +    + KQIL G+NYLHT +
Sbjct: 78  ITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK 135

Query: 149 PCVIHRDLNCSNVFV---NGNTGQVKIGDLGVAAIVG 182
             + H DL   N+ +   N     +K+ D G+A  + 
Sbjct: 136 --IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 80.6 bits (199), Expect = 6e-18
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 15/158 (9%)

Query: 28  RYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVK--LRTFCDDPAMIERLFSEVRLLKTL 83
           RY    L+G+G+   V  A+D+ E   VA   +K  LR F +D    +R+  E+ +L  L
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVA---IKKILRVF-EDLIDCKRILREIAILNRL 109

Query: 84  ANKNIISLHYVWRDEDRNTLN---FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKG 140
            + +++ +  +   +D    +    + E+  S + ++  +   +++   +K     +L G
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVG 168

Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           + Y+H+    ++HRDL  +N  VN +   VK+ D G+A
Sbjct: 169 VKYVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGLA 203

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 79.2 bits (196), Expect = 7e-18
 Identities = 43/182 (23%), Positives = 79/182 (43%), Gaps = 15/182 (8%)

Query: 2   MPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAF---DQEEGIEVAWNQV 58
           + A+N +         I          +NE++G G    VY      +  + I  A   V
Sbjct: 4   LSALNPELVQAVQHVVIGPSSL--IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---V 58

Query: 59  K-LRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE 117
           K L    D   + +   +E  ++K  ++ N++SL  +    + + L  +      G+LR 
Sbjct: 59  KSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRN 116

Query: 118 Y-RKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
           + R +  + +VK L  +  Q+ KG+ YL + +   +HRDL   N  ++     VK+ D G
Sbjct: 117 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEK-FTVKVADFG 173

Query: 177 VA 178
           +A
Sbjct: 174 LA 175

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 79.7 bits (197), Expect = 9e-18
 Identities = 44/191 (23%), Positives = 82/191 (42%), Gaps = 20/191 (10%)

Query: 3   PAVNSDPSDKDSEPFIETDPTGRYGRYN--------ELLGSGAVKKVYRAFDQEEGIEVA 54
            +  +        PF     T + G  N        E+LG G   +V++  +   G+++A
Sbjct: 59  TSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLA 118

Query: 55  WNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGN 114
              +K R   D     E + +E+ ++  L + N+I L+  +  E +N +  + E    G 
Sbjct: 119 AKIIKTRGMKD----KEEVKNEISVMNQLDHANLIQLYDAF--ESKNDIVLVMEYVDGGE 172

Query: 115 L--REYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNV-FVNGNTGQVK 171
           L  R   + +    +     + KQI +G+ ++H     ++H DL   N+  VN +  Q+K
Sbjct: 173 LFDRIIDESYNLTELDT-ILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIK 229

Query: 172 IGDLGVAAIVG 182
           I D G+A    
Sbjct: 230 IIDFGLARRYK 240

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 79.8 bits (197), Expect = 9e-18
 Identities = 41/187 (21%), Positives = 75/187 (40%), Gaps = 19/187 (10%)

Query: 6   NSDPSDKDSEPFIETDPTGR-----YGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQV 58
           + D   +D        P        Y  Y+  E LGSGA   V+R  ++  G       +
Sbjct: 25  DYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI 84

Query: 59  KLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL--R 116
                 D       + +E+ ++  L +  +I+LH  +  ED+  +  I E  + G L  R
Sbjct: 85  NTPYPLD----KYTVKNEISIMNQLHHPKLINLHDAF--EDKYEMVLILEFLSGGELFDR 138

Query: 117 EYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNV-FVNGNTGQVKIGDL 175
              + ++    +    + +Q  +GL ++H H   ++H D+   N+         VKI D 
Sbjct: 139 IAAEDYKMSEAEV-INYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDF 195

Query: 176 GVAAIVG 182
           G+A  + 
Sbjct: 196 GLATKLN 202

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 79.2 bits (196), Expect = 9e-18
 Identities = 33/154 (21%), Positives = 76/154 (49%), Gaps = 15/154 (9%)

Query: 33  LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNIISL 91
           +G G   +V++A  ++ G +VA  +V +    +  P    R   E+++L+ L ++N+++L
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR---EIKILQLLKHENVVNL 81

Query: 92  HYV------WRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYL 144
             +        +  + ++  + + C   +L           ++  +K+  + +L GL Y+
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 140

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           H +   ++HRD+  +NV +    G +K+ D G+A
Sbjct: 141 HRN--KILHRDMKAANVLIT-RDGVLKLADFGLA 171

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 79.9 bits (197), Expect = 1e-17
 Identities = 40/153 (26%), Positives = 72/153 (47%), Gaps = 10/153 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG+GA   V+R  ++  G   A   V      D     E +  E++ +  L +  +++
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD----KETVRKEIQTMSVLRHPTLVN 218

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
           LH  +  ED N +  I E  + G L E    +H  +S     ++ +Q+ KGL ++H +  
Sbjct: 219 LHDAF--EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN- 275

Query: 150 CVIHRDLNCSNV-FVNGNTGQVKIGDLGVAAIV 181
             +H DL   N+ F    + ++K+ D G+ A +
Sbjct: 276 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 79.2 bits (196), Expect = 1e-17
 Identities = 39/150 (26%), Positives = 63/150 (42%), Gaps = 11/150 (7%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLANKNII 89
           E +G G   +V+    + +   VA   VK  R         + L  E R+LK  ++ NI+
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVA---VKSCRETLPPDLKAKFL-QEARILKQYSHPNIV 175

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
            L  V   +    +  + E+   G+   + R +   + VK L +       G+ YL +  
Sbjct: 176 RLIGVCTQKQ--PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK- 232

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            C IHRDL   N  V      +KI D G++
Sbjct: 233 -CCIHRDLAARNCLVTEK-NVLKISDFGMS 260

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 78.9 bits (195), Expect = 1e-17
 Identities = 35/156 (22%), Positives = 71/156 (45%), Gaps = 10/156 (6%)

Query: 27  GRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA 84
             ++  + LG GA  +V  A ++     VA   V ++   D P  I++   E+ + K L 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLN 63

Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
           ++N++  +      + N      E C+ G L +  +    +     +++  Q++ G+ YL
Sbjct: 64  HENVVKFYGHR--REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI 180
           H     + HRD+   N+ ++     +KI D G+A +
Sbjct: 122 HGIG--ITHRDIKPENLLLDER-DNLKISDFGLATV 154

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 79.4 bits (196), Expect = 2e-17
 Identities = 44/150 (29%), Positives = 65/150 (43%), Gaps = 12/150 (8%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
             LG G   +VY    ++  + VA   VK  T  +D   +E    E  ++K + + N++ 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVA---VK--TLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 280

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E       ITE  T GNL +Y ++     VS   L   + QI   + YL    
Sbjct: 281 LLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK- 337

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              IHR+L   N  V G    VK+ D G++
Sbjct: 338 -NFIHRNLAARNCLV-GENHLVKVADFGLS 365

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 78.1 bits (193), Expect = 2e-17
 Identities = 34/165 (20%), Positives = 58/165 (35%), Gaps = 20/165 (12%)

Query: 28  RYNELLGSGAVKKVYRAF---DQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTL 83
               +LG G    V  A    +    ++VA   VK L+      + IE    E   +K  
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVA---VKMLKADIIASSDIEEFLREAACMKEF 82

Query: 84  ANKNIISLHYVWRDEDRNTLNF----ITEVCTSGNLREYRKKHRH------VSVKALKKW 133
            + ++  L  V               I      G+L  +    R       + ++ L ++
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 134 SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              I  G+ YL +     IHRDL   N  +  +   V + D G++
Sbjct: 143 MVDIACGMEYLSSRN--FIHRDLAARNCMLAED-MTVCVADFGLS 184

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 78.5 bits (194), Expect = 2e-17
 Identities = 35/155 (22%), Positives = 75/155 (48%), Gaps = 17/155 (10%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLA 84
            Y  +  LG G   +V+ A +     +V    VK L+     P   +++  E+++L+ L 
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVV---VKILK-----PVKKKKIKREIKILENLR 88

Query: 85  N-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
              NII+L  + +D    T   + E   + + ++  +    ++   ++ +  +ILK L+Y
Sbjct: 89  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDY 145

Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            H+    ++HRD+   NV ++    ++++ D G+A
Sbjct: 146 CHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLA 178

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 78.4 bits (193), Expect = 2e-17
 Identities = 25/120 (20%), Positives = 50/120 (41%), Gaps = 8/120 (6%)

Query: 65  DDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY---RKK 121
             P+ ++    ++R +   + KN +          +  L    ++C   NL+++   R  
Sbjct: 100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS--SPKVYLYIQMQLCRKENLKDWMNRRCS 157

Query: 122 HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
                         QI + + +LH+    ++HRDL  SN+F   +   VK+GD G+   +
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAM 214

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 78.6 bits (194), Expect = 2e-17
 Identities = 42/182 (23%), Positives = 79/182 (43%), Gaps = 15/182 (8%)

Query: 2   MPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAF---DQEEGIEVAWNQV 58
           + A+N +         I          +NE++G G    VY      +  + I  A   V
Sbjct: 68  LSALNPELVQAVQHVVIGPSSL--IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---V 122

Query: 59  K-LRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE 117
           K L    D   + +   +E  ++K  ++ N++SL  +    + + L  +      G+LR 
Sbjct: 123 KSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRN 180

Query: 118 Y-RKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
           + R +  + +VK L  +  Q+ KG+ +L + +   +HRDL   N  ++     VK+ D G
Sbjct: 181 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFG 237

Query: 177 VA 178
           +A
Sbjct: 238 LA 239

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 77.7 bits (192), Expect = 2e-17
 Identities = 41/180 (22%), Positives = 79/180 (43%), Gaps = 14/180 (7%)

Query: 9   PSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPA 68
            S      + +      +  +   LGSGA   V+   ++  G+E     +          
Sbjct: 7   HSSGRENLYFQGTIDDLF-IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-- 63

Query: 69  MIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL----REYRKKHRH 124
            +E++ +E+ +LK+L + NII +  V+  ED + +  + E C  G L       + + + 
Sbjct: 64  -MEQIEAEIEVLKSLDHPNIIKIFEVF--EDYHNMYIVMETCEGGELLERIVSAQARGKA 120

Query: 125 VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNV-FVN-GNTGQVKIGDLGVAAIVG 182
           +S   + +  KQ++  L Y H+    V+H+DL   N+ F +      +KI D G+A +  
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 77.7 bits (192), Expect = 2e-17
 Identities = 37/161 (22%), Positives = 68/161 (42%), Gaps = 11/161 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVR-LLKTLANKNII 89
             LG GA   V +      G  +A   VK      +    +RL  ++   ++T+     +
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMA---VKRIRATVNSQEQKRLLMDLDISMRTVDCPFTV 69

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGN---LREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
           + +     E    +    E+  +      ++   K + +    L K +  I+K L +LH 
Sbjct: 70  TFYGALFRE--GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH- 126

Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR 187
            +  VIHRD+  SNV +N   GQVK+ D G++  +   + +
Sbjct: 127 SKLSVIHRDVKPSNVLINAL-GQVKMCDFGISGYLVDDVAK 166

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 78.1 bits (193), Expect = 3e-17
 Identities = 41/164 (25%), Positives = 71/164 (43%), Gaps = 29/164 (17%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +G GA   V  A+D    + VA    K+  F +     +R   E+++L    +
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK--KISPF-EHQTYCQRTLREIKILLRFRH 84

Query: 86  KNIISLHYVWRDEDRNTLN---FITE--------VCTSGNLREYRKKHRHVSVKALKKWS 134
           +NII ++ + R      +     + +        +  + +L      +          + 
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------FL 134

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            QIL+GL Y+H+    V+HRDL  SN+ +N     +KI D G+A
Sbjct: 135 YQILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLA 175

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 78.2 bits (193), Expect = 3e-17
 Identities = 35/192 (18%), Positives = 64/192 (33%), Gaps = 51/192 (26%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           +Y+    LG+G+   V   FD E G   A   +K +    DP    R   E+ ++K L +
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFA---LK-KVL-QDPRYKNR---ELDIMKVLDH 59

Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGN------------------------------- 114
            NII L   +                                                  
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 115 --------LREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
                   L+ + +  R + +  +  +  Q+ + + ++H+    + HRD+   N+ VN  
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSK 177

Query: 167 TGQVKIGDLGVA 178
              +K+ D G A
Sbjct: 178 DNTLKLCDFGSA 189

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 77.6 bits (192), Expect = 3e-17
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 17/158 (10%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIE-VAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLAN--- 85
             +G GA  KV++A D + G   VA  +V+++T  +  P    R   EV +L+ L     
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR---EVAVLRHLETFEH 73

Query: 86  KNIISLHYV---WRDEDRNTLNFITEVCTSGNLREY--RKKHRHVSVKALKKWSKQILKG 140
            N++ L  V    R +    L  + E     +L  Y  +     V  + +K    Q+L+G
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG 132

Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           L++LH+H   V+HRDL   N+ V  ++GQ+K+ D G+A
Sbjct: 133 LDFLHSH--RVVHRDLKPQNILVT-SSGQIKLADFGLA 167

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 77.3 bits (191), Expect = 4e-17
 Identities = 39/167 (23%), Positives = 66/167 (39%), Gaps = 25/167 (14%)

Query: 28  RYNELLGSGAVKKVYRA-----FDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLK 81
             +  LG G+   VY          E    VA   +K +         IE   +E  ++K
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVA---IKTVNEAASMRERIE-FLNEASVMK 83

Query: 82  TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH----------VSVKALK 131
                +++ L  V        +  I E+ T G+L+ Y +  R            S+  + 
Sbjct: 84  EFNCHHVVRLLGVVSQGQPTLV--IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141

Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           + + +I  G+ YL+ ++   +HRDL   N  V  +   VKIGD G+ 
Sbjct: 142 QMAGEIADGMAYLNANK--FVHRDLAARNCMVAED-FTVKIGDFGMT 185

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 76.9 bits (190), Expect = 4e-17
 Identities = 37/161 (22%), Positives = 72/161 (44%), Gaps = 10/161 (6%)

Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKL--RTFCDDPAMIERLFSEVRLLKTLANKNII 89
            LG G    VY A +++    +A   +K+  ++  +   +  +L  E+ +   L + NI+
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMA---LKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNIL 77

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
            ++  + D  R  +  + E    G L +  +KH     +    + +++   L+Y H  + 
Sbjct: 78  RMYNYFHDRKR--IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK- 134

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRC 190
            VIHRD+   N+ +    G++KI D G +       RR  C
Sbjct: 135 -VIHRDIKPENLLMGYK-GELKIADFGWSVHAPSLRRRTMC 173

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 77.3 bits (191), Expect = 4e-17
 Identities = 37/164 (22%), Positives = 62/164 (37%), Gaps = 19/164 (11%)

Query: 28  RYNELLGSGAVKKVYRAF---DQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTL 83
              ++LG G    V       +    ++VA   VK ++        IE   SE   +K  
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVA---VKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 84  ANKNIISLHYVWRDEDRNTLNF---ITEVCTSGNLREYRKKHR------HVSVKALKKWS 134
           ++ N+I L  V  +     +     I      G+L  Y    R      H+ ++ L K+ 
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             I  G+ YL       +HRDL   N  +  +   V + D G++
Sbjct: 154 VDIALGMEYLSNRN--FLHRDLAARNCMLRDD-MTVCVADFGLS 194

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 78.4 bits (193), Expect = 4e-17
 Identities = 36/153 (23%), Positives = 67/153 (43%), Gaps = 15/153 (9%)

Query: 31  ELLGSGAVKKVYRAFDQEEG---IEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLANK 86
             +G G    V++          + VA   +K  +    D    + L  E   ++   + 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVA---IKTCKNCTSDSVREKFL-QEALTMRQFDHP 451

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNYLH 145
           +I+ L  V  +     +  I E+CT G LR + +  +  + + +L  ++ Q+   L YL 
Sbjct: 452 HIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508

Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +     +HRD+   NV V+ N   VK+GD G++
Sbjct: 509 SK--RFVHRDIAARNVLVSSN-DCVKLGDFGLS 538

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 78.1 bits (193), Expect = 4e-17
 Identities = 40/154 (25%), Positives = 61/154 (39%), Gaps = 10/154 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLANKNII 89
           E LG GA   V R      G E A      + T        ++L  E R+ + L + NI+
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYA---AMIINTKKLSARDHQKLEREARICRLLKHPNIV 73

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
            LH      +      I ++ T G L E      + S        +QIL+ + + H    
Sbjct: 74  RLHDSI--SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG- 130

Query: 150 CVIHRDLNCSNV-FVN-GNTGQVKIGDLGVAAIV 181
            V+HR+L   N+   +      VK+ D G+A  V
Sbjct: 131 -VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 77.3 bits (191), Expect = 4e-17
 Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 9/156 (5%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM--IERLFSEVRLLKTLANKNI 88
           E LGSG    V +  ++  G++ A   +K R           E +  EV +LK + + N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76

Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           I+LH V+  E++  +  I E+   G L ++  +   ++ +   ++ KQIL G+ YLH+ +
Sbjct: 77  ITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134

Query: 149 PCVIHRDLNCSNVFV---NGNTGQVKIGDLGVAAIV 181
             + H DL   N+ +   N    ++KI D G+A  +
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 77.4 bits (191), Expect = 6e-17
 Identities = 46/171 (26%), Positives = 82/171 (47%), Gaps = 16/171 (9%)

Query: 23  TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLK 81
             RY   + L+G G+  +V +A+D+ E   VA   +K ++   +  A + +   EVRLL+
Sbjct: 53  MDRY-EIDSLIGKGSFGQVVKAYDRVEQEWVA---IKIIK---NKKAFLNQAQIEVRLLE 105

Query: 82  TLANKNIISLHYVWRDED----RNTLNFITEVCTSGNLREYRKKHRH--VSVKALKKWSK 135
            +   +    +Y+   +     RN L  + E+  S NL +  +      VS+   +K+++
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQ 164

Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNV-FVNGNTGQVKIGDLGVAAIVGRAI 185
           Q+   L +L T E  +IH DL   N+   N     +KI D G +  +G+ I
Sbjct: 165 QMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI 215

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 76.1 bits (188), Expect = 7e-17
 Identities = 37/153 (24%), Positives = 69/153 (45%), Gaps = 15/153 (9%)

Query: 31  ELLGSGAVKKVYRA---FDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLANK 86
             +G G    V++      +   + VA   +K  +    D    + L  E   ++   + 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVA---IKTCKNCTSDSVREKFL-QEALTMRQFDHP 76

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNYLH 145
           +I+ L  V      N +  I E+CT G LR + +  ++ + + +L  ++ Q+   L YL 
Sbjct: 77  HIVKLIGVI---TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133

Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +     +HRD+   NV V+ N   VK+GD G++
Sbjct: 134 SK--RFVHRDIAARNVLVSSN-DCVKLGDFGLS 163

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 76.2 bits (188), Expect = 7e-17
 Identities = 34/156 (21%), Positives = 67/156 (42%), Gaps = 13/156 (8%)

Query: 28  RYNELLGSGAVKKVYRAF---DQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTL 83
             + ++G G    VY        +  I+ A   +K L    +   +      E  L++ L
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCA---IKSLSRITEMQQVEA-FLREGLLMRGL 79

Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLN 142
            + N+++L  +    +      +      G+L ++ R   R+ +VK L  +  Q+ +G+ 
Sbjct: 80  NHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME 138

Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           YL   +   +HRDL   N  ++ +   VK+ D G+A
Sbjct: 139 YLAEQK--FVHRDLAARNCMLDES-FTVKVADFGLA 171

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 76.1 bits (188), Expect = 7e-17
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 9/157 (5%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLR--TFCDDPAMIERLFSEVRLLKTLANKNI 88
           E LGSG    V +   +  G E A   +K R  +        E +  EV +L+ + + NI
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70

Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           I+LH ++  E++  +  I E+ + G L ++  +   ++     ++ KQIL G++YLH+  
Sbjct: 71  ITLHDIF--ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR 128

Query: 149 PCVIHRDLNCSNVFV---NGNTGQVKIGDLGVAAIVG 182
             + H DL   N+ +   N    ++K+ D G+A  + 
Sbjct: 129 --IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 76.5 bits (189), Expect = 8e-17
 Identities = 33/154 (21%), Positives = 67/154 (43%), Gaps = 13/154 (8%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG G    V+R  +           VK++    D  ++++   E+ +L    ++NI+ 
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKK---EISILNIARHRNILH 65

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYR--KKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           LH  +  E    L  I E  +  ++ E R       ++ + +  +  Q+ + L +LH+H 
Sbjct: 66  LHESF--ESMEELVMIFEFISGLDIFE-RINTSAFELNEREIVSYVHQVCEALQFLHSHN 122

Query: 149 PCVIHRDLNCSNV-FVNGNTGQVKIGDLGVAAIV 181
             + H D+   N+ +    +  +KI + G A  +
Sbjct: 123 --IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 76.2 bits (188), Expect = 1e-16
 Identities = 30/154 (19%), Positives = 64/154 (41%), Gaps = 12/154 (7%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVR-LLKTLANKNII 89
             +G GA   V +   +  G  +A   VK      D    ++L  ++  ++++     I+
Sbjct: 28  GEIGRGAYGSVNKMVHKPSGQIMA---VKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIV 84

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRK----KHRHVSVKALKKWSKQILKGLNYLH 145
             +     E         E+ ++   + Y+         +  + L K +   +K LN+L 
Sbjct: 85  QFYGALFRE--GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142

Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
                +IHRD+  SN+ ++ + G +K+ D G++ 
Sbjct: 143 -ENLKIIHRDIKPSNILLDRS-GNIKLCDFGISG 174

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 76.0 bits (187), Expect = 1e-16
 Identities = 45/201 (22%), Positives = 79/201 (39%), Gaps = 23/201 (11%)

Query: 14  SEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERL 73
           SEP ++ D      +  EL+G G    VY+     +   VA   VK+ +F +    I   
Sbjct: 6   SEPSLDLDNL----KLLELIGRGRYGAVYKG--SLDERPVA---VKVFSFANRQNFIN-- 54

Query: 74  FSEVRLLKTLANKNIISLH-YVWRDEDRNTLNF--ITEVCTSGNLREYRKKHRHVSVKAL 130
              +  +  + + NI        R      + +  + E   +G+L +Y   H      + 
Sbjct: 55  EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSS 113

Query: 131 KKWSKQILKGLNYLHT-------HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR 183
            + +  + +GL YLHT       ++P + HRDLN  NV V  + G   I D G++  +  
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGLSMRLTG 172

Query: 184 AIRRIRCWGRRSSWRRSCTMR 204
                      ++     T+R
Sbjct: 173 NRLVRPGEEDNAAISEVGTIR 193

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 75.8 bits (187), Expect = 1e-16
 Identities = 37/159 (23%), Positives = 65/159 (40%), Gaps = 14/159 (8%)

Query: 26  YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
               ++ LG G+     +   ++     A   VK         M      E+  LK    
Sbjct: 12  LDLKDKPLGEGSFSICRKCVHKKSNQAFA---VK----IISKRMEANTQKEITALKLCEG 64

Query: 86  -KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
             NI+ LH V+   D+     + E+   G L E  KK +H S        ++++  ++++
Sbjct: 65  HPNIVKLHEVF--HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 145 HTHEPCVIHRDLNCSNV-FVN-GNTGQVKIGDLGVAAIV 181
           H     V+HRDL   N+ F +  +  ++KI D G A + 
Sbjct: 123 HDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 75.8 bits (187), Expect = 1e-16
 Identities = 43/173 (24%), Positives = 72/173 (41%), Gaps = 38/173 (21%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY +L  LG G    V+ A D +    VA   +K      DP  ++    E+++++ L +
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVA---IKKIVL-TDPQSVKHALREIKIIRRLDH 67

Query: 86  KNIISLHYVWRDEDRNTLN------------FITE--------VCTSGNLREYRKKHRHV 125
            NI+ +  +         +             + E        V   G L E   +    
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL--- 124

Query: 126 SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
                  +  Q+L+GL Y+H+    V+HRDL  +N+F+N     +KIGD G+A
Sbjct: 125 -------FMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLA 168

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 75.4 bits (186), Expect = 1e-16
 Identities = 37/150 (24%), Positives = 64/150 (42%), Gaps = 14/150 (9%)

Query: 33  LGSGAVKKVYRAF--DQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLANKNII 89
           LG G    V +     +++ I+VA   +K L+   +     E +  E +++  L N  I+
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMM-REAQIMHQLDNPYIV 73

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
            L  V + E    L  + E+   G L ++   K   + V  + +   Q+  G+ YL    
Sbjct: 74  RLIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK- 129

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              +HRDL   NV +       KI D G++
Sbjct: 130 -NFVHRDLAARNVLLVNR-HYAKISDFGLS 157

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 75.7 bits (187), Expect = 2e-16
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 23/161 (14%)

Query: 28  RYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
            +    LLG GA   V  A  +  G  VA    K+  F D P    R   E+++LK   +
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK--KIEPF-DKPLFALRTLREIKILKHFKH 68

Query: 86  KNIISLHYVWRDEDRNTLN---FITEVCTSGNLREYRKKHRHVSVKALKKWSK-----QI 137
           +NII++  + R +     N    I E+  + +L      HR +S + L          Q 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQT-DL------HRVISTQMLSDDHIQYFIYQT 121

Query: 138 LKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           L+ +  LH     VIHRDL  SN+ +N N   +K+ D G+A
Sbjct: 122 LRAVKVLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFGLA 159

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 75.9 bits (187), Expect = 2e-16
 Identities = 39/165 (23%), Positives = 66/165 (40%), Gaps = 12/165 (7%)

Query: 19  ETDPTGRYGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSE 76
           +        RY+  + +GSG         D+     VA   VK        A+ E +  E
Sbjct: 12  DMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVA---VKY--IERGAAIDENVQRE 66

Query: 77  VRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQ 136
           +   ++L + NI+    V        L  I E  + G L E        S    + + +Q
Sbjct: 67  IINHRSLRHPNIVRFKEVI--LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ 124

Query: 137 ILKGLNYLHTHEPCVIHRDLNCSNVFVNGN-TGQVKIGDLGVAAI 180
           +L G++Y H+    + HRDL   N  ++G+   ++KI D G +  
Sbjct: 125 LLSGVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 75.0 bits (185), Expect = 2e-16
 Identities = 45/153 (29%), Positives = 68/153 (44%), Gaps = 12/153 (7%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
             LG G   +VY    ++  + VA   VK  T  +D   +E    E  ++K + + N++ 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVA---VK--TLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E    +  ITE  T GNL +Y ++     VS   L   + QI   + YL    
Sbjct: 74  LLGVCTREPPFYI--ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK- 130

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
              IHRDL   N  V  N   VK+ D G++ ++
Sbjct: 131 -NFIHRDLAARNCLVGEN-HLVKVADFGLSRLM 161

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 75.9 bits (187), Expect = 2e-16
 Identities = 46/197 (23%), Positives = 84/197 (42%), Gaps = 18/197 (9%)

Query: 28  RYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVK--LRTFCDDPAMIERLFSEVRLLKTL 83
            Y    L+G G+   VY A+D+     VA   +K   R F +D    +R+  E+ +L  L
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVA---IKKVNRMF-EDLIDCKRILREITILNRL 82

Query: 84  ANKNIISLHYVWRDEDRNTLN---FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKG 140
            +  II L+ +   +D    +    + E+  S +L++  K    ++ + +K     +L G
Sbjct: 83  KSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLG 141

Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSWRRS 200
            N++H     +IHRDL  +N  +N +   VK+ D G+A  +              +    
Sbjct: 142 ENFIHESG--IIHRDLKPANCLLNQD-CSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198

Query: 201 CTMRITRSLWT-Y--TR 214
              +  +   T +  TR
Sbjct: 199 PHNKNLKKQLTSHVVTR 215

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 75.9 bits (186), Expect = 2e-16
 Identities = 33/215 (15%), Positives = 64/215 (29%), Gaps = 41/215 (19%)

Query: 4   AVNSDPSDKDSEPFIETDPTGRYGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLR 61
            V++   +      +E++   R        +LG         A DQE G       V + 
Sbjct: 55  LVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFE---VHVP 111

Query: 62  TFCDDPA--MIERLFSEVRLLKTLAN----------------------KNIISLHYVWRD 97
            F + P    I+++  EV  L+ L                             +  V  D
Sbjct: 112 YFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD 171

Query: 98  EDRNT-----LNFITEVCTSGN----LREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           E           +             L  +   H+ +   A  + + Q+++ L  LH + 
Sbjct: 172 ERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY- 230

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR 183
             ++H  L   ++ ++   G V +         G 
Sbjct: 231 -GLVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGA 263

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 75.4 bits (186), Expect = 2e-16
 Identities = 40/154 (25%), Positives = 69/154 (44%), Gaps = 12/154 (7%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
             LG GA   VYR   +      A   +K           + + +E+ +L  L++ NII 
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKT------VDKKIVRTEIGVLLRLSHPNIIK 112

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L  ++  E    ++ + E+ T G L +   +  + S +      KQIL+ + YLH +   
Sbjct: 113 LKEIF--ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG-- 168

Query: 151 VIHRDLNCSNV-FVN-GNTGQVKIGDLGVAAIVG 182
           ++HRDL   N+ +        +KI D G++ IV 
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 75.5 bits (186), Expect = 2e-16
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 30/164 (18%)

Query: 28  RYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVK--LRTFCDDPAMIERLFSEVRLLKTL 83
           +Y   + LG GA   V+++ D+  G  VA   VK     F  +    +R F E+ +L  L
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVA---VKKIFDAF-QNSTDAQRTFREIMILTEL 65

Query: 84  AN-KNIISLHYVWRDEDRNTLNFITE--------VCTSGNLREYRKKHRHVSVKALKKWS 134
           +  +NI++L  V R ++   +  + +        V  +  L    K++            
Sbjct: 66  SGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY----------VV 115

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            Q++K + YLH+    ++HRD+  SN+ +N     VK+ D G++
Sbjct: 116 YQLIKVIKYLHSGG--LLHRDMKPSNILLNAE-CHVKVADFGLS 156

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 74.2 bits (183), Expect = 4e-16
 Identities = 35/158 (22%), Positives = 59/158 (37%), Gaps = 13/158 (8%)

Query: 24  GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKL--RTFCDDPAMIERLFSEVRLLK 81
           G Y R   L+G G +  VY A D      VA   +KL   T   DP    R+  E R   
Sbjct: 34  GPY-RLRRLVGRGGMGDVYEAEDTVRERIVA---LKLMSETLSSDPVFRTRMQREARTAG 89

Query: 82  TLANKNIISLHYVWRDEDRNTLNFIT-EVCTSGNLREYRKKHRHVSVKALKKWSKQILKG 140
            L   +++ +H     + +    ++   +    +L    ++   ++        +QI   
Sbjct: 90  RLQEPHVVPIHDFGEIDGQ---LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146

Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           L+  H       HRD+   N+ V        + D G+A
Sbjct: 147 LDAAHAAG--ATHRDVKPENILV-SADDFAYLVDFGIA 181

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 74.6 bits (184), Expect = 4e-16
 Identities = 37/153 (24%), Positives = 65/153 (42%), Gaps = 14/153 (9%)

Query: 31  ELLGSGAVKKVYRAFDQEEG---IEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLANK 86
           +++GSG   +V     +  G   + VA   +K L+    +    + L SE  ++    + 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVA---IKALKAGYTERQRRDFL-SEASIMGQFDHP 110

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNYLH 145
           NII L  V           +TE   +G+L  + + H    ++  L    + +  G+ YL 
Sbjct: 111 NIIRLEGVVTRGR--LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168

Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
                 +HRDL   NV V+ N    K+ D G++
Sbjct: 169 DL--GYVHRDLAARNVLVDSN-LVCKVSDFGLS 198

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 73.9 bits (182), Expect = 4e-16
 Identities = 36/167 (21%), Positives = 74/167 (44%), Gaps = 25/167 (14%)

Query: 28  RYNELLGSGAVKKVYRA-------FDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRL 79
            +NE LG G   K+++        + Q    EV    +K L          E  F    +
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVL---LKVLDK--AHRNYSESFFEAASM 65

Query: 80  LKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQIL 138
           +  L++K+++  + V    D N L  + E    G+L  Y KK+++ +++    + +KQ+ 
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENIL--VQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123

Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVN-------GNTGQVKIGDLGVA 178
             +++L  +   +IH ++   N+ +        GN   +K+ D G++
Sbjct: 124 AAMHFLEEN--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 74.7 bits (183), Expect = 5e-16
 Identities = 31/212 (14%), Positives = 62/212 (29%), Gaps = 35/212 (16%)

Query: 4   AVNSDPSDKDSEPFIETDPTGRYGRYN--ELLGSGAVKKVYRAFDQEEGIEVA------- 54
            V++   +      +E++   R        +LG         A DQE G           
Sbjct: 50  LVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT 109

Query: 55  -----------------WNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD 97
                               ++         +  R      L+K    K +I +    RD
Sbjct: 110 ERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERD 169

Query: 98  EDRNTLNFITEVCTS------GNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
               +  F+     S        L  +   H+ +   A  + + Q+++ L  LH +   +
Sbjct: 170 MWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GL 227

Query: 152 IHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR 183
           +H  L   ++ ++   G V +         G 
Sbjct: 228 VHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGA 258

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 73.8 bits (182), Expect = 5e-16
 Identities = 36/150 (24%), Positives = 64/150 (42%), Gaps = 14/150 (9%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           + +G G    V        G +VA   VK      + A  +   +E  ++  L + N++ 
Sbjct: 27  QTIGKGEFGDVMLG--DYRGNKVA---VKC---IKNDATAQAFLAEASVMTQLRHSNLVQ 78

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V  +E +  L  +TE    G+L +Y +      +    L K+S  + + + YL  + 
Sbjct: 79  LLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 136

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              +HRDL   NV V+ +    K+ D G+ 
Sbjct: 137 -NFVHRDLAARNVLVSED-NVAKVSDFGLT 164

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 73.8 bits (182), Expect = 5e-16
 Identities = 37/162 (22%), Positives = 71/162 (43%), Gaps = 10/162 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E+LGSGA  +V+    +  G   A   +K      D      L +E+ +LK + ++NI++
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD----SSLENEIAVLKKIKHENIVT 70

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L  ++  E       + ++ + G L +   +    + K      +Q+L  + YLH +   
Sbjct: 71  LEDIY--ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG-- 126

Query: 151 VIHRDLNCSNVFV--NGNTGQVKIGDLGVAAIVGRAIRRIRC 190
           ++HRDL   N+         ++ I D G++ +    I    C
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC 168

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 73.4 bits (181), Expect = 6e-16
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 15/153 (9%)

Query: 31  ELLGSGAVKKVYRAF---DQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLANK 86
            +LG G   +VY       + E I VA   VK  +  C      + + SE  ++K L + 
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVA---VKTCKKDCTLDNKEKFM-SEAVIMKNLDHP 73

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNYLH 145
           +I+ L  +    +      I E+   G L  Y +++++ + V  L  +S QI K + YL 
Sbjct: 74  HIVKLIGII---EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130

Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +     +HRD+   N+ V      VK+GD G++
Sbjct: 131 SI--NCVHRDIAVRNILVASP-ECVKLGDFGLS 160

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 74.3 bits (183), Expect = 7e-16
 Identities = 50/167 (29%), Positives = 74/167 (44%), Gaps = 33/167 (19%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVK--LRTFCDDPAMIERLFSEVRLLKTL 83
            Y +L  +GSGA   V  A D   G +VA   +K   R F       +R + E+RLLK +
Sbjct: 26  VYRDLQPVGSGAYGAVCSAVDGRTGAKVA---IKKLYRPF-QSELFAKRAYRELRLLKHM 81

Query: 84  ANKNIISLHYVWR-DEDRNTLN---FITE--------VCTSGNLREYRKKHRHVSVKALK 131
            ++N+I L  V+  DE  +       +          +     L E R +          
Sbjct: 82  RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF--------- 132

Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
               Q+LKGL Y+H     +IHRDL   N+ VN +  ++KI D G+A
Sbjct: 133 -LVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGLA 175

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 74.5 bits (183), Expect = 8e-16
 Identities = 33/165 (20%), Positives = 67/165 (40%), Gaps = 14/165 (8%)

Query: 24  GRYGRYNELLGSGAVKKVYRAFDQE-EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKT 82
           G+Y      +  G +  +Y A D+   G  V    +K      D        +E + L  
Sbjct: 80  GQY-EVKGCIAHGGLGWIYLALDRNVNGRPVV---LKGLVHSGDAEAQAMAMAERQFLAE 135

Query: 83  LANKNIISLHYVWRDEDR--NTLNFIT-EVCTSGNLREYRKKHRHVSVKALKKWSKQILK 139
           + + +I+ +       DR  + + +I  E     +L+  +   + + V     +  +IL 
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILP 193

Query: 140 GLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA 184
            L+YLH+    +++ DL   N+ +     Q+K+ DLG  + +   
Sbjct: 194 ALSYLHSIG--LVYNDLKPENIMLTE--EQLKLIDLGAVSRINSF 234

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 74.6 bits (183), Expect = 9e-16
 Identities = 37/149 (24%), Positives = 65/149 (43%), Gaps = 12/149 (8%)

Query: 33  LGSGAVKKVYRAF--DQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           LG G    V +     +++ I+VA   +K+     + A  E +  E +++  L N  I+ 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTHEP 149
           L  V + E    L  + E+   G L ++    R  + V  + +   Q+  G+ YL     
Sbjct: 401 LIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK-- 455

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             +HR+L   NV +  N    KI D G++
Sbjct: 456 NFVHRNLAARNVLL-VNRHYAKISDFGLS 483

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 73.4 bits (181), Expect = 1e-15
 Identities = 42/166 (25%), Positives = 71/166 (42%), Gaps = 17/166 (10%)

Query: 25  RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA 84
            Y   ++ LG G    V +   +  G E A   +K R    D      +  E+ +L+   
Sbjct: 29  FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD--CRAEILHEIAVLELAK 86

Query: 85  -NKNIISLHYVWRDEDRNTLNFITEVCTSGNL--REYRKKHRHVSVKALKKWSKQILKGL 141
               +I+LH V+  E+ + +  I E    G +      +    VS   + +  KQIL+G+
Sbjct: 87  SCPRVINLHEVY--ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144

Query: 142 NYLHTHEPCVIHRDL---N--CSNVFVNGNTGQVKIGDLGVAAIVG 182
            YLH +   ++H DL   N   S+       G +KI D G++  +G
Sbjct: 145 YYLHQNN--IVHLDLKPQNILLSS---IYPLGDIKIVDFGMSRKIG 185

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 73.7 bits (181), Expect = 1e-15
 Identities = 40/195 (20%), Positives = 70/195 (35%), Gaps = 46/195 (23%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQV-KLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
             +G G+   V  A + +     A   + K +    +P  +ER+ +EVRL+K L + NI 
Sbjct: 32  GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS--------------- 134
            L+ V+  ED   +  + E+C  G+L +        S                       
Sbjct: 92  RLYEVY--EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149

Query: 135 -------------------------KQILKGLNYLHTHEPCVIHRDLNCSNV-FVNGNTG 168
                                    +QI   L+YLH     + HRD+   N  F    + 
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSF 207

Query: 169 QVKIGDLGVAAIVGR 183
           ++K+ D G++    +
Sbjct: 208 EIKLVDFGLSKEFYK 222

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 73.2 bits (180), Expect = 1e-15
 Identities = 41/161 (25%), Positives = 66/161 (40%), Gaps = 19/161 (11%)

Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
           +  E+   G    V++A    E   VA   VK      D    +  + EV  L  + ++N
Sbjct: 27  QLLEVKARGRFGCVWKAQLLNE--YVA---VK-IFPIQDKQSWQNEY-EVYSLPGMKHEN 79

Query: 88  IISLH-YVWRDEDRNTLNF-ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLH 145
           I+       R    +   + IT     G+L ++ K +  VS   L   ++ + +GL YLH
Sbjct: 80  ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLH 138

Query: 146 T--------HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
                    H+P + HRD+   NV +  N     I D G+A
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLA 178

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 73.1 bits (180), Expect = 1e-15
 Identities = 43/174 (24%), Positives = 72/174 (41%), Gaps = 31/174 (17%)

Query: 28  RYNELLGSGAVKKVYRAF-----DQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLK 81
           +  + LG GA  +V  A             VA   VK L+           L SE+++L 
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVA---VKMLKEGATHSEHRA-LMSELKILI 85

Query: 82  TLAN-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH---------------- 124
            + +  N+++L           +  I E C  GNL  Y +  R+                
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLM-VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144

Query: 125 VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           ++++ L  +S Q+ KG+ +L + +   IHRDL   N+ ++     VKI D G+A
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLA 195

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 73.1 bits (180), Expect = 1e-15
 Identities = 35/162 (21%), Positives = 64/162 (39%), Gaps = 15/162 (9%)

Query: 25  RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKL--RTFCDDPAMIERLFSEVRLLKT 82
            Y    ++LG GA  +V    +     E A   VK+  +          R+F EV +L  
Sbjct: 13  VYQLQEDVLGEGAHARVQTCINLITSQEYA---VKIIEKQPGHI---RSRVFREVEMLYQ 66

Query: 83  LAN-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
               +N++ L   +  E+ +    + E    G++  +  K RH +        + +   L
Sbjct: 67  CQGHRNVLELIEFF--EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASAL 124

Query: 142 NYLHTHEPCVIHRDLNCSNV-FVN-GNTGQVKIGDLGVAAIV 181
           ++LH     + HRDL   N+   +      VKI D  + + +
Sbjct: 125 DFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 73.1 bits (180), Expect = 1e-15
 Identities = 38/154 (24%), Positives = 69/154 (44%), Gaps = 15/154 (9%)

Query: 31  ELLGSGAVKKVYRAF----DQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLAN 85
           +++G+G   +VY+        ++ + VA   +K L+    +   ++ L  E  ++   ++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVA---IKTLKAGYTEKQRVDFL-GEAGIMGQFSH 105

Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYL 144
            NII L  V        +  ITE   +G L ++ ++     SV  L    + I  G+ YL
Sbjct: 106 HNIIRLEGVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
                  +HRDL   N+ VN N    K+ D G++
Sbjct: 164 ANM--NYVHRDLAARNILVNSN-LVCKVSDFGLS 194

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 73.2 bits (180), Expect = 2e-15
 Identities = 44/181 (24%), Positives = 74/181 (40%), Gaps = 16/181 (8%)

Query: 3   PAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRA---FDQEEGIEVAWNQVK 59
           P    DP+    E   E D T      ++++G+G   +V         ++ I VA   +K
Sbjct: 25  PHTFEDPTQTVHEFAKELDAT--NISIDKVVGAGEFGEVCSGRLKLPSKKEISVA---IK 79

Query: 60  -LRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY 118
            L+    +    + L  E  ++    + NII L  V        +  +TE   +G+L  +
Sbjct: 80  TLKVGYTEKQRRDFL-GEASIMGQFDHPNIIRLEGVVTKSK--PVMIVTEYMENGSLDSF 136

Query: 119 RKKHRH-VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV 177
            +KH    +V  L    + I  G+ YL       +HRDL   N+ +N N    K+ D G+
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILINSN-LVCKVSDFGL 193

Query: 178 A 178
            
Sbjct: 194 G 194

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 73.2 bits (180), Expect = 2e-15
 Identities = 36/150 (24%), Positives = 65/150 (43%), Gaps = 14/150 (9%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           + +G G    V     +  G +VA   VK      + A  +   +E  ++  L + N++ 
Sbjct: 199 QTIGKGEFGDVMLGDYR--GNKVA---VKC---IKNDATAQAFLAEASVMTQLRHSNLVQ 250

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E++  L  +TE    G+L +Y +      +    L K+S  + + + YL  + 
Sbjct: 251 LLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 308

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              +HRDL   NV V+ +    K+ D G+ 
Sbjct: 309 -NFVHRDLAARNVLVSED-NVAKVSDFGLT 336

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 72.7 bits (179), Expect = 2e-15
 Identities = 44/162 (27%), Positives = 71/162 (43%), Gaps = 24/162 (14%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVK--LRTFCDDPAMIERLFSEVRLLKTL 83
            Y     +GSGA   V  A D+  G +VA   +K   R F       +R + E+ LLK +
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVA---IKKLSRPF-QSEIFAKRAYRELLLLKHM 80

Query: 84  ANKNIISLHYV----WRDEDRNTLNFITEVCTSGNLREYRKK---HRHVSVKALKKWSKQ 136
            ++N+I L  V        +      +     + +L++          +          Q
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY-----LVYQ 134

Query: 137 ILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +LKGL Y+H+    V+HRDL   N+ VN +  ++KI D G+A
Sbjct: 135 MLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLA 173

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 72.8 bits (179), Expect = 2e-15
 Identities = 40/169 (23%), Positives = 79/169 (46%), Gaps = 19/169 (11%)

Query: 27  GRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTL 83
            RY   +++G G+  +V +A+D +    VA   +K +R   ++     +   E+R+L+ L
Sbjct: 97  YRYEVLKVIGKGSFGQVVKAYDHKVHQHVA---LKMVR---NEKRFHRQAAEEIRILEHL 150

Query: 84  ANKNIISLHYVWRDED----RNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQI 137
             ++  +   V    +    RN +    E+  S NL E  KK++    S+  ++K++  I
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSI 209

Query: 138 LKGLNYLHTHEPCVIHRDLNCSNV-FVNGNTGQVKIGDLGVAAIVGRAI 185
           L+ L+ LH +   +IH DL   N+         +K+ D G +    + +
Sbjct: 210 LQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV 256

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 73.0 bits (179), Expect = 2e-15
 Identities = 36/150 (24%), Positives = 65/150 (43%), Gaps = 14/150 (9%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
             LG G   +V+          VA   +K  T        E    E +++K L ++ ++ 
Sbjct: 273 VKLGQGCFGEVWMGTWNGT-TRVA---IK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 326

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L+ V  +E    +  +TE  + G+L ++ K     ++ +  L   + QI  G+ Y+    
Sbjct: 327 LYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM- 382

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              +HRDL  +N+ V  N    K+ D G+A
Sbjct: 383 -NYVHRDLRAANILVGEN-LVCKVADFGLA 410

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 72.9 bits (179), Expect = 2e-15
 Identities = 36/150 (24%), Positives = 65/150 (43%), Gaps = 14/150 (9%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
             LG G   +V+          VA   +K  T        E    E +++K L ++ ++ 
Sbjct: 190 VKLGQGCFGEVWMGTWNGT-TRVA---IK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 243

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L+ V  +E    +  +TE  + G+L ++ K     ++ +  L   + QI  G+ Y+    
Sbjct: 244 LYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM- 299

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              +HRDL  +N+ V  N    K+ D G+A
Sbjct: 300 -NYVHRDLRAANILVGEN-LVCKVADFGLA 327

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 72.8 bits (179), Expect = 2e-15
 Identities = 49/175 (28%), Positives = 75/175 (42%), Gaps = 31/175 (17%)

Query: 27  GRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTL 83
            RY     LG G    V+ A D      VA   +K +R    D    E    E++LL+ +
Sbjct: 19  ARYILVRKLGWGHFSTVWLAKDMVNNTHVA---MKIVR---GDKVYTEAAEDEIKLLQRV 72

Query: 84  AN-----------KNIISL--HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVK 128
            +            +I+ L  H+  +  +   +  + EV    NL    KK+ H    + 
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLI 131

Query: 129 ALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFV-----NGNTGQVKIGDLGVA 178
            +K+ SKQ+L GL+Y+H     +IH D+   NV +       N  Q+KI DLG A
Sbjct: 132 YVKQISKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 72.4 bits (178), Expect = 3e-15
 Identities = 51/165 (30%), Positives = 80/165 (48%), Gaps = 29/165 (17%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           RY  L  +GSGA   V  AFD + G+ VA  ++  R F       +R + E+RLLK + +
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 87

Query: 86  KNIISLHYVWR----DEDRNTLNFITE--------VCTSGNLREYRKKHRHVSVKALKKW 133
           +N+I L  V+      E+ N +  +T         +     L +   +            
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF----------L 137

Query: 134 SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             QIL+GL Y+H+ +  +IHRDL  SN+ VN +  ++KI D G+A
Sbjct: 138 IYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLA 179

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 71.5 bits (176), Expect = 3e-15
 Identities = 35/149 (23%), Positives = 64/149 (42%), Gaps = 12/149 (8%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           + LGSG    V     + +  +VA   VK     +     +  F E + +  L++  ++ 
Sbjct: 14  KELGSGQFGVVKLGKWKGQ-YDVA---VK--MIKEGSMSEDEFFQEAQTMMKLSHPKLVK 67

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
            + V   E    +  +TE  ++G L  Y R   + +    L +    + +G+ +L +H  
Sbjct: 68  FYGVCSKEYPIYI--VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH-- 123

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             IHRDL   N  V+ +   VK+ D G+ 
Sbjct: 124 QFIHRDLAARNCLVDRD-LCVKVSDFGMT 151

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 71.9 bits (177), Expect = 4e-15
 Identities = 50/176 (28%), Positives = 77/176 (43%), Gaps = 34/176 (19%)

Query: 28  RYNELLGSGAVKKVYRA-------FDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRL 79
              + LG GA  +V  A          +E + VA   VK L+    +  + + L SE+ +
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA---VKMLKDDATEKDLSD-LVSEMEM 93

Query: 80  LKTLAN-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-------------- 124
           +K +   KNII+L      +    +  I E  + GNLREY +  R               
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151

Query: 125 --VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             ++ K L   + Q+ +G+ YL + +   IHRDL   NV V  N   +KI D G+A
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLA 204

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 72.0 bits (177), Expect = 4e-15
 Identities = 48/162 (29%), Positives = 75/162 (46%), Gaps = 24/162 (14%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVK--LRTFCDDPAMIERLFSEVRLLKTL 83
           RY  L  +GSGA   V  A+D      VA   +K   R F  +    +R + E+ L+K +
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAILERNVA---IKKLSRPF-QNQTHAKRAYRELVLMKCV 81

Query: 84  ANKNIISLHYVWR-DEDRNTLN---FITEVCTSGNLREYRKK---HRHVSVKALKKWSKQ 136
            +KNII L  V+   +          + E+  + NL +  +    H  +S         Q
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLY-----Q 135

Query: 137 ILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +L G+ +LH+    +IHRDL  SN+ V  +   +KI D G+A
Sbjct: 136 MLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA 174

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 71.5 bits (176), Expect = 5e-15
 Identities = 45/176 (25%), Positives = 72/176 (40%), Gaps = 34/176 (19%)

Query: 28  RYNELLGSGAVKKVYRA-----FDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLK 81
            + + LG+GA  KV  A        +  + VA   VK L+           L SE+++L 
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVA---VKMLKPSAHLTEREA-LMSELKVLS 81

Query: 82  TLAN-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------- 123
            L N  NI++L           +  ITE C  G+L  + ++ R                 
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 124 -HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             + ++ L  +S Q+ KG+ +L +     IHRDL   N+ +       KI D G+A
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHG-RITKICDFGLA 192

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 72.2 bits (177), Expect = 5e-15
 Identities = 50/162 (30%), Positives = 78/162 (48%), Gaps = 24/162 (14%)

Query: 28  RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVK--LRTFCDDPAMIERLFSEVRLLKTL 83
           RY  L  +GSGA   V  A+D      VA   +K   R F  +    +R + E+ L+K +
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVA---IKKLSRPF-QNQTHAKRAYRELVLMKCV 118

Query: 84  ANKNIISLHYVWR----DEDRNTLNFITEVCTSGNLREYRKK---HRHVSVKALKKWSKQ 136
            +KNIISL  V+      E+   +  + E+  + NL +  +    H  +S         Q
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLY-----Q 172

Query: 137 ILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +L G+ +LH+    +IHRDL  SN+ V  +   +KI D G+A
Sbjct: 173 MLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA 211

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 70.3 bits (173), Expect = 7e-15
 Identities = 36/149 (24%), Positives = 65/149 (43%), Gaps = 12/149 (8%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           + +GSG    V+  +   +  +VA   +K  T  +     E    E  ++  L++  ++ 
Sbjct: 14  QEIGSGQFGLVHLGYWLNK-DKVA---IK--TIREGAMSEEDFIEEAEVMMKLSHPKLVQ 67

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNYLHTHEP 149
           L+ V  ++    +  +TE    G L +Y +  R   + + L      + +G+ YL     
Sbjct: 68  LYGVCLEQA--PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-- 123

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           CVIHRDL   N  V  N   +K+ D G+ 
Sbjct: 124 CVIHRDLAARNCLVGEN-QVIKVSDFGMT 151

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 70.8 bits (174), Expect = 8e-15
 Identities = 31/168 (18%), Positives = 61/168 (36%), Gaps = 24/168 (14%)

Query: 25  RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMI---ERLFSEVRLLK 81
            Y    ++LG G   KV   F +  G + A   +K         ++    +   EV    
Sbjct: 29  DYQLSKQVLGLGVNGKVLECFHRRTGQKCA---LK---------LLYDSPKARQEVDHHW 76

Query: 82  TLAN-KNIISLHYVWRDEDRNTLNF--ITEVCTSGNL--REYRKKHRHVSVKALKKWSKQ 136
             +   +I+ +  V+ +          I E    G L  R   +  +  + +   +  + 
Sbjct: 77  QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRD 136

Query: 137 ILKGLNYLHTHEPCVIHRDLNCSN-VFVN-GNTGQVKIGDLGVAAIVG 182
           I   + +LH+H   + HRD+   N ++ +      +K+ D G A    
Sbjct: 137 IGTAIQFLHSH--NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 71.3 bits (175), Expect = 8e-15
 Identities = 33/192 (17%), Positives = 67/192 (34%), Gaps = 27/192 (14%)

Query: 3   PAVNSDPSDKDSEPFIETDPTGRYGRYN---ELLGSGAVKKVYRAFDQEEGIEVAWNQVK 59
           P           +  ++         Y    ++LG G   KV + F++    + A   +K
Sbjct: 37  PPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFA---LK 93

Query: 60  LRTFCDDPAMI---ERLFSEVRLLKTLAN-KNIISLHYVWRDEDRNTLNF--ITEVCTSG 113
                    M+    +   EV L    +   +I+ +  V+ +          + E    G
Sbjct: 94  ---------MLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 144

Query: 114 NL--REYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSN-VFVN-GNTGQ 169
            L  R   +  +  + +   +  K I + + YLH+    + HRD+   N ++ +      
Sbjct: 145 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAI 202

Query: 170 VKIGDLGVAAIV 181
           +K+ D G A   
Sbjct: 203 LKLTDFGFAKET 214

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 70.4 bits (173), Expect = 1e-14
 Identities = 36/166 (21%), Positives = 65/166 (39%), Gaps = 23/166 (13%)

Query: 28  RYNELLGSGAVKKVYRAF-----DQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLK 81
                LG GA  +VY        +    ++VA   VK L   C +   ++    E  ++ 
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVA---VKTLPEVCSEQDELD-FLMEALIIS 88

Query: 82  TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-------VSVKALKKWS 134
              ++NI+    V        +  + E+   G+L+ + ++ R        +++  L   +
Sbjct: 89  KFNHQNIVRCIGVSLQSLPRFI--LMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQ--VKIGDLGVA 178
           + I  G  YL  +    IHRD+   N  +         KIGD G+A
Sbjct: 147 RDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 70.9 bits (174), Expect = 1e-14
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 14/150 (9%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           + LG+G   +V+ A   +   +VA   VK  T       +E   +E  ++KTL +  ++ 
Sbjct: 194 KKLGAGQFGEVWMATYNKH-TKVA---VK--TMKPGSMSVEAFLAEANVMKTLQHDKLVK 247

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           LH V   E    +  ITE    G+L ++ K        +  L  +S QI +G+ ++    
Sbjct: 248 LHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR- 303

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              IHRDL  +N+ V+ +    KI D G+A
Sbjct: 304 -NYIHRDLRAANILVSAS-LVCKIADFGLA 331

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 70.5 bits (173), Expect = 1e-14
 Identities = 49/176 (27%), Positives = 76/176 (43%), Gaps = 34/176 (19%)

Query: 28  RYNELLGSGAVKKVYRA-------FDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRL 79
              + LG G   +V  A          +E + VA   VK L+    +  + + L SE+ +
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVA---VKMLKDDATEKDLSD-LVSEMEM 139

Query: 80  LKTLAN-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--------------- 123
           +K +   KNII+L      +    +  I E  + GNLREY +  R               
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197

Query: 124 -HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             ++ K L   + Q+ +G+ YL + +   IHRDL   NV V  N   +KI D G+A
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-NVMKIADFGLA 250

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 70.0 bits (172), Expect = 2e-14
 Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 30/172 (17%)

Query: 28  RYNELLGSGAVKKVYRA-----FDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLK 81
           ++ + LG+GA  KV  A       ++  ++VA   VK L++          L SE++++ 
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVA---VKMLKSTAHADEKEA-LMSELKIMS 104

Query: 82  TLAN-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--------------HVS 126
            L   +NI++L           +  ITE C  G+L  + ++                  S
Sbjct: 105 HLGQHENIVNLLGACTHGGPVLV--ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162

Query: 127 VKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            + L  +S Q+ +G+ +L +     IHRD+   NV +  N    KIGD G+A
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL-TNGHVAKIGDFGLA 211

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 70.1 bits (172), Expect = 2e-14
 Identities = 36/166 (21%), Positives = 65/166 (39%), Gaps = 23/166 (13%)

Query: 28  RYNELLGSGAVKKVYRAF-----DQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLK 81
                LG GA  +VY        +    ++VA   VK L   C +   ++    E  ++ 
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVA---VKTLPEVCSEQDELD-FLMEALIIS 129

Query: 82  TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-------VSVKALKKWS 134
              ++NI+    V        +  + E+   G+L+ + ++ R        +++  L   +
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFI--LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQ--VKIGDLGVA 178
           + I  G  YL  +    IHRD+   N  +         KIGD G+A
Sbjct: 188 RDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 69.4 bits (170), Expect = 2e-14
 Identities = 25/158 (15%), Positives = 46/158 (29%), Gaps = 13/158 (8%)

Query: 24  GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVK-LRT-FCDDPAMIERLFSEVRLLK 81
           GRY R     G     + ++A D     +VA   +  +         +++   S    L 
Sbjct: 31  GRY-RLLIFHGGVPPLQFWQALDTALDRQVA---LTFVDPQGVLPDDVLQETLSRTLRLS 86

Query: 82  TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
            +    +  +  V     R     + E    G+L+E        S     +  + +    
Sbjct: 87  RIDKPGVARVLDV--VHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAA 142

Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA 179
           +  H     V     + S V V    G V +       
Sbjct: 143 DAAHRAG--VALSIDHPSRVRV-SIDGDVVLAYPATMP 177

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 69.2 bits (170), Expect = 2e-14
 Identities = 38/150 (25%), Positives = 71/150 (47%), Gaps = 14/150 (9%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLF-SEVRLLKTLANKNII 89
           + LG+G    V     + +  +VA   +K+     + +M E  F  E +++  L+++ ++
Sbjct: 30  KELGTGQFGVVKYGKWRGQ-YDVA---IKM---IKEGSMSEDEFIEEAKVMMNLSHEKLV 82

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNYLHTHE 148
            L+ V   +    +  ITE   +G L  Y ++ RH    + L +  K + + + YL +  
Sbjct: 83  QLYGVCTKQRPIFI--ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK- 139

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              +HRDL   N  VN   G VK+ D G++
Sbjct: 140 -QFLHRDLAARNCLVNDQ-GVVKVSDFGLS 167

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 69.7 bits (171), Expect = 3e-14
 Identities = 49/176 (27%), Positives = 76/176 (43%), Gaps = 34/176 (19%)

Query: 28  RYNELLGSGAVKKVYRA-------FDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRL 79
              + LG GA  +V  A              +VA   VK L++   +  + + L SE+ +
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVA---VKMLKSDATEKDLSD-LISEMEM 127

Query: 80  LKTLAN-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--------------- 123
           +K +   KNII+L      +    +  I E  + GNLREY +  R               
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYV--IVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185

Query: 124 -HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             +S K L   + Q+ +G+ YL + +   IHRDL   NV V  +   +KI D G+A
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLA 238

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 69.6 bits (171), Expect = 3e-14
 Identities = 39/165 (23%), Positives = 72/165 (43%), Gaps = 20/165 (12%)

Query: 28  RYN--ELLGSGAVKKVYRAFDQEEGIEVA--------WNQVKLRTFCDDPAMIERLFSEV 77
            Y     + SG+   V    D E GI VA         +   +     D  + +R+  E+
Sbjct: 23  PYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNIL-SDSFLCKRVLREI 80

Query: 78  RLLKTLANKNIISLHYVWRDEDRNTLN---FITEVCTSGNLREY-RKKHRHVSVKALKKW 133
           RLL    + NI+ L  ++   +   ++    +TE+  + +L +    +   +S + ++ +
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF 139

Query: 134 SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              IL GL+ LH     V+HRDL+  N+ +  N   + I D  +A
Sbjct: 140 MYHILLGLHVLHEAG--VVHRDLHPGNILLADN-NDITICDFNLA 181

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 69.2 bits (170), Expect = 3e-14
 Identities = 35/180 (19%), Positives = 67/180 (37%), Gaps = 18/180 (10%)

Query: 9   PSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPA 68
           P  K      +      Y   +++LG G   KV + F++    + A   +K+     D  
Sbjct: 2   PHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFA---LKM---LQDCP 55

Query: 69  MIERLFSEVRLLKTLAN-KNIISLHYVWRDEDRNTLNF--ITEVCTSGNL--REYRKKHR 123
              R   EV L    +   +I+ +  V+ +          + E    G L  R   +  +
Sbjct: 56  KARR---EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 112

Query: 124 HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSN-VFVN-GNTGQVKIGDLGVAAIV 181
             + +   +  K I + + YLH+    + HRD+   N ++ +      +K+ D G A   
Sbjct: 113 AFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 69.4 bits (170), Expect = 3e-14
 Identities = 37/173 (21%), Positives = 67/173 (38%), Gaps = 33/173 (19%)

Query: 30  NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN-KNI 88
            ++LG G+   V       +G  VA   VK           +    E++LL    +  N+
Sbjct: 20  EKILGYGSSGTVVFQ-GSFQGRPVA---VK----RMLIDFCDIALMEIKLLTESDDHPNV 71

Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREY--RKKHRHVSVKALKKWS-----KQILKGL 141
           I  +    +     L    E+C   NL++    K     ++K  K+++     +QI  G+
Sbjct: 72  IRYYCS--ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128

Query: 142 NYLHTHEPCVIHRDLNCSNVFVN------------GNTGQVKIGDLGVAAIVG 182
            +LH+    +IHRDL   N+ V+                ++ I D G+   + 
Sbjct: 129 AHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 68.8 bits (169), Expect = 3e-14
 Identities = 44/173 (25%), Positives = 65/173 (37%), Gaps = 31/173 (17%)

Query: 28  RYNELLGSGAVKKVYRA-----FDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLK 81
           R+ E LG     KVY+         E+   VA   +K L+   + P   E    E  L  
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVA---IKTLKDKAEGPLREE-FRHEAMLRA 67

Query: 82  TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HV 125
            L + N++ L  V   +   ++  I   C+ G+L E+                      +
Sbjct: 68  RLQHPNVVCLLGVVTKDQPLSM--IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125

Query: 126 SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
                     QI  G+ YL +H   V+H+DL   NV V      VKI DLG+ 
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDK-LNVKISDLGLF 175

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 68.9 bits (169), Expect = 4e-14
 Identities = 39/190 (20%), Positives = 61/190 (32%), Gaps = 57/190 (30%)

Query: 28  RYNELLGSGAVKKVYRA-----FDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLK 81
            Y   +G GA  +V++A        E    VA   VK L+         +    E  L+ 
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVA---VKMLKEEASADMQAD-FQREAALMA 105

Query: 82  TLANKNIISL---------HYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--------- 123
              N NI+ L           +           + E    G+L E+ +            
Sbjct: 106 EFDNPNIVKLLGVCAVGKPMCL-----------LFEYMAYGDLNEFLRSMSPHTVCSLSH 154

Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
                           +S       ++Q+  G+ YL   +   +HRDL   N  V  N  
Sbjct: 155 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGEN-M 211

Query: 169 QVKIGDLGVA 178
            VKI D G++
Sbjct: 212 VVKIADFGLS 221

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 68.8 bits (169), Expect = 4e-14
 Identities = 41/181 (22%), Positives = 73/181 (40%), Gaps = 39/181 (21%)

Query: 28  RYNELLGSGAVKKVYRAF-----DQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLK 81
              + LG G   KV +A       +     VA   VK L+       + + L SE  +LK
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVA---VKMLKENASPSELRD-LLSEFNVLK 81

Query: 82  TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH----------------- 124
            + + ++I L+     +    L  I E    G+LR + ++ R                  
Sbjct: 82  QVNHPHVIKLYGACSQDGPLLL--IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139

Query: 125 -------VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV 177
                  +++  L  ++ QI +G+ YL   +  ++HRDL   N+ V     ++KI D G+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEG-RKMKISDFGL 196

Query: 178 A 178
           +
Sbjct: 197 S 197

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 68.9 bits (169), Expect = 4e-14
 Identities = 39/171 (22%), Positives = 64/171 (37%), Gaps = 29/171 (16%)

Query: 28  RYNELLGSGAVKKVYRA-----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKT 82
                LG GA  KV+ A       +++ + VA   VK      + A  +    E  LL  
Sbjct: 44  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVA---VKALKEASESARQD-FQREAELLTM 99

Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR---------------HVSV 127
           L +++I+    V  +     +  + E    G+L  + + H                 + +
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLM--VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157

Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             L   + Q+  G+ YL       +HRDL   N  V      VKIGD G++
Sbjct: 158 GQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVKIGDFGMS 205

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 68.8 bits (168), Expect = 5e-14
 Identities = 29/171 (16%), Positives = 57/171 (33%), Gaps = 34/171 (19%)

Query: 31  ELLGSGAVKKVYRA-----FDQEEGIEVAWNQVKLRTFCDDPAMI---ERLFSEVRLLKT 82
            LLG GA  +VY A      D +   +     +K       PA           +  LK 
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFV---LK----VQKPANPWEFYIGTQLMERLKP 123

Query: 83  LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKAL-----KKWSKQI 137
                 +  +       +N    + E+ + G L      +++   K +       ++ ++
Sbjct: 124 SMQHMFMKFYSAH--LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181

Query: 138 LKGLNYLHTHEPCVIHRDLNCSNVFVNG----------NTGQVKIGDLGVA 178
           L  +  +H  E  +IH D+   N  +             +  + + DLG +
Sbjct: 182 LYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 68.4 bits (168), Expect = 5e-14
 Identities = 46/175 (26%), Positives = 71/175 (40%), Gaps = 36/175 (20%)

Query: 28  RYNELLGSGAVKKVYRA-----FDQEEGIEVAWNQVK-LRTFCDDPAMIER--LFSEVRL 79
                LG GA  KV+ A        ++ + VA   VK L+    DP +  R     E  L
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVA---VKALK----DPTLAARKDFQREAEL 70

Query: 80  LKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR---------------- 123
           L  L +++I+  + V  D D   L  + E    G+L ++ + H                 
Sbjct: 71  LTNLQHEHIVKFYGVCGDGD--PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128

Query: 124 HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            + +  +   + QI  G+ YL +     +HRDL   N  V  N   VKIGD G++
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGAN-LLVKIGDFGMS 180

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 67.6 bits (166), Expect = 9e-14
 Identities = 38/150 (25%), Positives = 69/150 (46%), Gaps = 14/150 (9%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E LG+G   +V+  +      +VA   VK  +        +   +E  L+K L ++ ++ 
Sbjct: 19  ERLGAGQFGEVWMGYYNGH-TKVA---VK--SLKQGSMSPDAFLAEANLMKQLQHQRLVR 72

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
           L+ V   E    +  ITE   +G+L ++ K      +++  L   + QI +G+ ++    
Sbjct: 73  LYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              IHRDL  +N+ V+      KI D G+A
Sbjct: 130 --YIHRDLRAANILVSDT-LSCKIADFGLA 156

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 67.7 bits (166), Expect = 1e-13
 Identities = 40/159 (25%), Positives = 64/159 (40%), Gaps = 24/159 (15%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMI----ERLFSEVRLLKTLAN- 85
           E +G G+     R   +   +E A   VK         +I         E+ +L      
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFA---VK---------IIDKSKRDPTEEIEILLRYGQH 75

Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLH 145
            NII+L  V+  +D   +  +TE+   G L +   + +  S +        I K + YLH
Sbjct: 76  PNIITLKDVY--DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH 133

Query: 146 THEPCVIHRDLNCSNVFV---NGNTGQVKIGDLGVAAIV 181
                V+HRDL  SN+     +GN   ++I D G A  +
Sbjct: 134 AQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 66.6 bits (163), Expect = 3e-13
 Identities = 48/181 (26%), Positives = 73/181 (40%), Gaps = 39/181 (21%)

Query: 28  RYNELLGSGAVKKVYRA-----FDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLK 81
            + ++LGSGA  KV  A           I+VA   VK L+   D       L SE++++ 
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVA---VKMLKEKADSSEREA-LMSELKMMT 103

Query: 82  TLAN-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH---------------- 124
            L + +NI++L           L  I E C  G+L  Y +  R                 
Sbjct: 104 QLGSHENIVNLLGACTLSGPIYL--IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161

Query: 125 -------VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV 177
                  ++ + L  ++ Q+ KG+ +L       +HRDL   NV V      VKI D G+
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHG-KVVKICDFGL 218

Query: 178 A 178
           A
Sbjct: 219 A 219

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 66.5 bits (163), Expect = 3e-13
 Identities = 37/171 (21%), Positives = 70/171 (40%), Gaps = 29/171 (16%)

Query: 28  RYNELLGSGAVKKVYRAF--DQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLA 84
           ++ +++G G   +V +A        ++ A   +K ++ +       +    E+ +L  L 
Sbjct: 28  KFQDVIGEGNFGQVLKARIKKDGLRMDAA---IKRMKEYASKDDHRD-FAGELEVLCKLG 83

Query: 85  N-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSV 127
           +  NII+L           L    E    GNL ++ +K R                 +S 
Sbjct: 84  HHPNIINLLGACEHRGYLYL--AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141

Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           + L  ++  + +G++YL   +   IHRDL   N+ V  N    KI D G++
Sbjct: 142 QQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAKIADFGLS 189

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 58.1 bits (141), Expect = 2e-10
 Identities = 31/172 (18%), Positives = 60/172 (34%), Gaps = 34/172 (19%)

Query: 6   NSDPSDKDSEPFIETDPTGRY---------GRY--NELLGSGAVKKVYRAFDQEEGIEVA 54
           +   S +++  F   D    +           +     +G G   +V      +     A
Sbjct: 5   HHHSSGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYA 64

Query: 55  WNQVK-LRTFCDDPAMIERLFSEVRLLKTLA-----NKNIISL--HYVWRDEDRNTLNFI 106
              VK +R   +          E  +LK +      N NI+     +++     + +  I
Sbjct: 65  ---VKVVR---NIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY----DHMCLI 114

Query: 107 TEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHEPCVIHRDL 156
            E     +L E   ++ +    ++ +K +  +ILK LNYL      + H DL
Sbjct: 115 FEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDL 163

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 56.5 bits (137), Expect = 7e-10
 Identities = 32/142 (22%), Positives = 64/142 (45%), Gaps = 18/142 (12%)

Query: 23  TGRYGRYNELLGSGAVKKVYRAFDQEEGIE-VAWNQVK-LRTFCDDPAMIERLFSEVRLL 80
           + RY    + LG GA  KV    D + G   VA   VK ++   +     E   SE+++L
Sbjct: 13  SARY-EIVDTLGEGAFGKVVECIDHKAGGRHVA---VKIVK---NVDRYCEAARSEIQVL 65

Query: 81  KTLANKNIISLHYVWRDED----RNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWS 134
           + L   +  S     +  +       +  + E+    +  ++ K++  +   +  ++K +
Sbjct: 66  EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMA 124

Query: 135 KQILKGLNYLHTHEPCVIHRDL 156
            QI K +N+LH+++  + H DL
Sbjct: 125 YQICKSVNFLHSNK--LTHTDL 144

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.7 bits (137), Expect = 8e-10
 Identities = 40/199 (20%), Positives = 77/199 (38%), Gaps = 34/199 (17%)

Query: 4   AVNSDPSDKDSEPFIE----TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVK 59
            + ++     S PF E     D  G      + +GSG    +Y AF   +  + A + VK
Sbjct: 12  DLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK 71

Query: 60  LRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSG------ 113
           +     +      LFSE++  + +A K+ I     W +  +     I     SG      
Sbjct: 72  V-----EYQENGPLFSELKFYQRVAKKDCIKK---WIERKQLDYLGIPLFYGSGLTEFKG 123

Query: 114 -------------NLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSN 160
                        +L++   ++       + +   ++L  L Y+H +E   +H D+  +N
Sbjct: 124 RSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAAN 181

Query: 161 VFVN-GNTGQVKIGDLGVA 178
           + +   N  QV + D G++
Sbjct: 182 LLLGYKNPDQVYLADYGLS 200

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 56.2 bits (136), Expect = 1e-09
 Identities = 30/142 (21%), Positives = 52/142 (36%), Gaps = 18/142 (12%)

Query: 23  TGRYGRYNELLGSGAVKKVYRAFDQEEGIE-VAWNQVK-LRTFCDDPAMIERLFSEVRLL 80
             RY      LG G   KV    D   G   VA   +K +R   +     E    E+ +L
Sbjct: 18  QERY-EIVGNLGEGTFGKVVECLDHARGKSQVA---LKIIR---NVGKYREAARLEINVL 70

Query: 81  KTLANKNIISLHYVWRDED----RNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWS 134
           K +  K+  +        D       +    E+    N  E+ K++      +  ++  +
Sbjct: 71  KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMA 129

Query: 135 KQILKGLNYLHTHEPCVIHRDL 156
            Q+   L +LH ++  + H DL
Sbjct: 130 YQLCHALRFLHENQ--LTHTDL 149

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 53.5 bits (129), Expect = 1e-08
 Identities = 26/112 (23%), Positives = 65/112 (58%), Gaps = 5/112 (4%)

Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
           +  +F E+++++ L +  +++L Y ++DE+   +  + ++   G+LR + +++ H   + 
Sbjct: 59  VRNVFKELQIMQGLEHPFLVNLWYSFQDEED--MFMVVDLLLGGDLRYHLQQNVHFKEET 116

Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           +K +  +++  L+YL      +IHRD+   N+ ++ + G V I D  +AA++
Sbjct: 117 VKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEH-GHVHITDFNIAAML 165

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 52.2 bits (126), Expect = 2e-08
 Identities = 27/122 (22%), Positives = 58/122 (47%), Gaps = 5/122 (4%)

Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
           +  +  E  ++  L +   + L++ ++D+++  L F      +G L +Y +K        
Sbjct: 74  VPYVTRERDVMSRLDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETC 131

Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIR 189
            + ++ +I+  L YLH     +IHRDL   N+ +N +   ++I D G A ++    ++ R
Sbjct: 132 TRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQAR 188

Query: 190 CW 191
             
Sbjct: 189 AN 190

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 51.9 bits (124), Expect = 3e-08
 Identities = 33/159 (20%), Positives = 70/159 (44%), Gaps = 16/159 (10%)

Query: 24  GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL 83
            ++ R    +GSG+  ++Y   + +   EVA     ++T    P    +L  E ++ + L
Sbjct: 7   NKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHP----QLLYESKIYRIL 59

Query: 84  AN-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGL 141
                I ++ +   + D N L  + ++    +L +      R +S+K +   + Q++  +
Sbjct: 60  QGGTGIPNVRWFGVEGDYNVL--VMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRV 116

Query: 142 NYLHTHEPCVIHRDLNCSNVFV--NGNTGQVKIGDLGVA 178
            ++H+     +HRD+   N  +       QV I D G+A
Sbjct: 117 EFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 51.6 bits (124), Expect = 3e-08
 Identities = 38/159 (23%), Positives = 67/159 (42%), Gaps = 16/159 (10%)

Query: 24  GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL 83
            RY R    +GSG+   +Y   D   G EVA     ++T    P    +L  E ++ K +
Sbjct: 9   NRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHP----QLHIESKIYKMM 61

Query: 84  AN-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGL 141
                I ++ +   + D N +  + E+    +L +      R  S+K +   + Q++  +
Sbjct: 62  QGGVGIPTIRWCGAEGDYNVM--VMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRI 118

Query: 142 NYLHTHEPCVIHRDLNCSNVFV--NGNTGQVKIGDLGVA 178
            Y+H+     IHRD+   N  +        V I D G+A
Sbjct: 119 EYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 51.4 bits (123), Expect = 6e-08
 Identities = 30/114 (26%), Positives = 62/114 (54%), Gaps = 13/114 (11%)

Query: 68  AMIERLFSEVRLLKTLANKN---IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH 124
           A+ ER      +L  ++  +   I+ + Y +   D+  L+FI ++   G+L  +  +H  
Sbjct: 236 ALNER-----IMLSLVSTGDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGV 288

Query: 125 VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            S   ++ ++ +I+ GL ++H     V++RDL  +N+ ++ + G V+I DLG+A
Sbjct: 289 FSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLA 339

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 48.8 bits (117), Expect = 3e-07
 Identities = 26/113 (23%), Positives = 54/113 (47%), Gaps = 5/113 (4%)

Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
           IE   +E R+L+ +    ++ L + ++D     L  + E    G +  + ++    S   
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGRFSEPH 142

Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
            + ++ QI+    YLH+ +  +I+RDL   N+ ++   G +++ D G A  V 
Sbjct: 143 ARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVK 192

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 49.0 bits (117), Expect = 4e-07
 Identities = 29/115 (25%), Positives = 56/115 (48%), Gaps = 14/115 (12%)

Query: 68  AMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL----REYRKKHR 123
           AM+E+     ++L  + ++ I+SL Y +  +    L  +  +   G++        + + 
Sbjct: 232 AMVEK-----KILAKVHSRFIVSLAYAFETKTD--LCLVMTIMNGGDIRYHIYNVDEDNP 284

Query: 124 HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
                    ++ QI+ GL +LH     +I+RDL   NV ++ + G V+I DLG+A
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD-GNVRISDLGLA 336

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 46.8 bits (112), Expect = 1e-06
 Identities = 39/167 (23%), Positives = 66/167 (39%), Gaps = 42/167 (25%)

Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLF-SEVRLLKTLANKNIIS 90
           +LG G   KVY+     +G  VA   VK R   +     E  F +EV ++    ++N++ 
Sbjct: 37  ILGRGGFGKVYKGR-LADGTLVA---VK-RLKEERTQGGELQFQTEVEMISMAVHRNLLR 91

Query: 91  LH-YVWRDEDRNTLNFITEVCTSGNLR----EY-------RKKHRHVSVKALKKWS--KQ 136
           L  +                C +   R     Y                +    W   ++
Sbjct: 92  LRGF----------------CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135

Query: 137 IL----KGLNYLHTH-EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           I     +GL YLH H +P +IHRD+  +N+ ++    +  +GD G+A
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLA 181

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 46.7 bits (111), Expect = 2e-06
 Identities = 26/113 (23%), Positives = 55/113 (48%), Gaps = 12/113 (10%)

Query: 68  AMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE--YRKKHRHV 125
           A+ E+     ++L+ + ++ ++SL Y +  +D   L  +  +   G+L+   Y       
Sbjct: 231 ALNEK-----QILEKVNSRFVVSLAYAYETKDA--LCLVLTLMNGGDLKFHIYHMGQAGF 283

Query: 126 SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
                  ++ +I  GL  LH     +++RDL   N+ ++ + G ++I DLG+A
Sbjct: 284 PEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDH-GHIRISDLGLA 333

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 46.4 bits (111), Expect = 2e-06
 Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 26/157 (16%)

Query: 32  LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLF-SEVRLLKTLANKNIIS 90
           L+G G   KVY+     +G +VA   +K RT      + E  F +E+  L    + +++S
Sbjct: 46  LIGHGVFGKVYKGV-LRDGAKVA---LKRRTPESSQGIEE--FETEIETLSFCRHPHLVS 99

Query: 91  LH-YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK--WSK--QIL----KGL 141
           L  +   + +   L  I +   +GNL+     H + S        W +  +I     +GL
Sbjct: 100 LIGFCD-ERNEMIL--IYKYMENGNLKR----HLYGSDLPTMSMSWEQRLEICIGAARGL 152

Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +YLH     +IHRD+   N+ ++ N    KI D G++
Sbjct: 153 HYLH--TRAIIHRDVKSINILLDENF-VPKITDFGIS 186

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.8 bits (110), Expect = 2e-06
 Identities = 35/238 (14%), Positives = 67/238 (28%), Gaps = 74/238 (31%)

Query: 2   MPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSG-AVKKVYRAFD-----QEEGIEVA- 54
             A   +   KD +   ++  +      + ++ S  AV    R F      QEE ++   
Sbjct: 26  EDAFVDNFDCKDVQDMPKSILSKE--EIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFV 83

Query: 55  ---------WNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN-IISLHYVWRDEDRNTLN 104
                    +    ++T    P+M+ R++ E R    L N N + + + V R +      
Sbjct: 84  EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQR--DRLYNDNQVFAKYNVSRLQP----- 136

Query: 105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN 164
                                    L++     L  L                  NV ++
Sbjct: 137 ----------------------YLKLRQA----LLELR----PAK----------NVLID 156

Query: 165 GNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSW----RRSCTMRITRSLWT-YTRLGC 217
           G  G    G   VA  V  + +       +  W      +    +   L     ++  
Sbjct: 157 GVLG---SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDP 211

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 40.6 bits (94), Expect = 2e-04
 Identities = 21/154 (13%), Positives = 41/154 (26%), Gaps = 38/154 (24%)

Query: 5   VNSDPSDKDSEPFIET-DPTGRYGRYNELLGSGAVKKVYRAFDQEEGI-----EVAWNQV 58
           VN D      E  +   +P      ++ L    +V      F     I      + W  V
Sbjct: 350 VNCDKLTTIIESSLNVLEPAEYRKMFDRL----SV------FPPSAHIPTILLSLIWFDV 399

Query: 59  KLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY 118
                  D  ++     +  L++    ++ IS+  ++ +                 L   
Sbjct: 400 IK----SDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKV-------------KLENE 442

Query: 119 RKKHRHV-----SVKALKKWSKQILKGLNYLHTH 147
              HR +       K              Y ++H
Sbjct: 443 YALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH 476

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 45.8 bits (109), Expect = 3e-06
 Identities = 32/162 (19%), Positives = 62/162 (38%), Gaps = 20/162 (12%)

Query: 24  GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKL-RTFCDDPAMIERLFSEVRLLKT 82
             + R  + +G G   ++    +      VA   +KL       P    +L  E R  K 
Sbjct: 9   PNF-RVGKKIGCGNFGELRLGKNLYTNEYVA---IKLEPMKSRAP----QLHLEYRFYKQ 60

Query: 83  LAN-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKG 140
           L +   I  ++Y       N +  + E+    +L +      R  S+K +   + Q++  
Sbjct: 61  LGSGDGIPQVYYFGPCGKYNAM--VLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISR 117

Query: 141 LNYLHTHEPCVIHRDLNCSNVFV----NGNTGQVKIGDLGVA 178
           + Y+H+    +I+RD+   N  +    N     + I D  +A
Sbjct: 118 MEYVHSK--NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 45.2 bits (108), Expect = 4e-06
 Identities = 15/40 (37%), Positives = 23/40 (57%), Gaps = 3/40 (7%)

Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            G+N+LH  E   IHRD+  +N+ ++      KI D G+A
Sbjct: 144 NGINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLA 180

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 44.9 bits (106), Expect = 7e-06
 Identities = 49/249 (19%), Positives = 90/249 (36%), Gaps = 50/249 (20%)

Query: 8   DPSDKDSEPFIETDPTGRY---------GRYN--ELLGSGAVKKVYRAFDQEEGIEVAWN 56
              D + E   +    G +         GRY+    LG G    V+ ++D +    VA  
Sbjct: 9   GSDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVA-- 66

Query: 57  QVKLRTFCDDPAMIERLFSEVRLLKTLANKN--------IISLHYVWRDEDRNTLN---- 104
            +K+          E    E+RLLK++ N +        ++ L       D   ++    
Sbjct: 67  -MKVVK--SAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL------DDFKISGVNG 117

Query: 105 ----FITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNC 158
                + EV    +L ++  K  ++ + +  +KK  +Q+L+GL+YLHT +  +IH D+  
Sbjct: 118 THICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKP 175

Query: 159 SNVFVNGNTGQVKI--------GDLGVAAIVGRAIRRIRCWGRRSSWRRSCTMRITRSLW 210
            N+ ++ N   ++            G     G A+                     +   
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235

Query: 211 TYTRLGCAC 219
               LG AC
Sbjct: 236 KIADLGNAC 244

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 44.3 bits (105), Expect = 9e-06
 Identities = 35/162 (21%), Positives = 67/162 (41%), Gaps = 20/162 (12%)

Query: 24  GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL 83
             Y +    +G G+   ++   +     +VA      R+  D P    +L  E R  K L
Sbjct: 10  VHY-KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAP----QLRDEYRTYKLL 62

Query: 84  AN-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGL 141
           A    I +++Y  ++   N L  + ++    +L +      R  SVK +   +KQ+L  +
Sbjct: 63  AGCTGIPNVYYFGQEGLHNVL--VIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARV 119

Query: 142 NYLHTHEPCVIHRDLNCSNVFVNG-----NTGQVKIGDLGVA 178
             +H     +++RD+   N F+ G     N   + + D G+ 
Sbjct: 120 QSIHEK--SLVYRDIKPDN-FLIGRPNSKNANMIYVVDFGMV 158

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 44.4 bits (105), Expect = 1e-05
 Identities = 44/189 (23%), Positives = 71/189 (37%), Gaps = 35/189 (18%)

Query: 14  SEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQ---VKLRTFCDDPAMI 70
           +   I TD      +    +G G    +Y A D      V  +    VK+     +P+  
Sbjct: 24  AVGEIITDMAAAAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKV-----EPSDN 77

Query: 71  ERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSG----NLREYR------- 119
             LF+E++  +  A    I     W    +     + +   SG    N + YR       
Sbjct: 78  GPLFTELKFYQRAAKPEQI---QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF 134

Query: 120 ---------KKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN-GNTGQ 169
                       +  S K + + S +IL  L Y+H HE   +H D+  SN+ +N  N  Q
Sbjct: 135 GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQ 192

Query: 170 VKIGDLGVA 178
           V + D G+A
Sbjct: 193 VYLVDYGLA 201

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 44.1 bits (105), Expect = 1e-05
 Identities = 27/109 (24%), Positives = 51/109 (46%), Gaps = 5/109 (4%)

Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
           +E    E  +L  + +  II +   ++D  +  +  I +    G L    +K +      
Sbjct: 50  VEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPV 107

Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            K ++ ++   L YLH+ +  +I+RDL   N+ ++ N G +KI D G A
Sbjct: 108 AKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIKITDFGFA 153

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 43.9 bits (104), Expect = 1e-05
 Identities = 21/109 (19%), Positives = 49/109 (44%), Gaps = 6/109 (5%)

Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
               + E  ++    +  ++ L Y ++D+    L  + E    G+L      +  V  K 
Sbjct: 113 SAFFWEERDIMAFANSPWVVQLFYAFQDDRY--LYMVMEYMPGGDLVNLMSNYD-VPEKW 169

Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
            + ++ +++  L+ +H+     IHRD+   N+ ++  +G +K+ D G  
Sbjct: 170 ARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTC 215

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 43.0 bits (102), Expect = 3e-05
 Identities = 25/109 (22%), Positives = 54/109 (49%), Gaps = 8/109 (7%)

Query: 70  IERLFSEVRLLKTLANKN--IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSV 127
           +E    E R+L  LA ++  +  +   ++ ++   L F+ E    G+L  + +      +
Sbjct: 61  VECTMVEKRVLS-LAWEHPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDL 117

Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
                ++ +I+ GL +LH+    +++RDL   N+ ++ + G +KI D G
Sbjct: 118 SRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFG 163

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 42.3 bits (100), Expect = 5e-05
 Identities = 30/109 (27%), Positives = 56/109 (51%), Gaps = 8/109 (7%)

Query: 70  IERLFSEVRLLKTLANKN--IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSV 127
           I+ + +E  +    A+ +  ++ LH  ++ E R  L F+ E    G+L  + ++ R +  
Sbjct: 96  IDWVQTEKHVF-EQASNHPFLVGLHSCFQTESR--LFFVIEYVNGGDLMFHMQRQRKLPE 152

Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
           +  + +S +I   LNYLH     +I+RDL   NV ++   G +K+ D G
Sbjct: 153 EHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYG 198

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 42.2 bits (99), Expect = 5e-05
 Identities = 18/56 (32%), Positives = 31/56 (55%), Gaps = 3/56 (5%)

Query: 123 RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             ++++ L  +S Q+ KG+ +L + +   IHRDL   N+ +      VKI D G+A
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILL-SEKNVVKICDFGLA 240

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 38.8 bits (90), Expect = 8e-04
 Identities = 27/119 (22%), Positives = 46/119 (38%), Gaps = 5/119 (4%)

Query: 33  LGSGAVKKVYRA--FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN-KNII 89
           LG GA  +V  A  F  ++        VK+       +    L SE+++L  + +  N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           +L           L  I E C  GNL  Y +  R+      K    +  +G +Y+    
Sbjct: 90  NLLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRN-EFVPYKTKGARFRQGKDYVGAIP 146

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 41.8 bits (99), Expect = 8e-05
 Identities = 30/109 (27%), Positives = 56/109 (51%), Gaps = 8/109 (7%)

Query: 70  IERLFSEVRLLKTLANKN--IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSV 127
           I+ + +E  +    A+ +  ++ LH  ++ E R  L F+ E    G+L  + ++ R +  
Sbjct: 53  IDWVQTEKHVF-EQASNHPFLVGLHSCFQTESR--LFFVIEYVNGGDLMFHMQRQRKLPE 109

Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
           +  + +S +I   LNYLH     +I+RDL   NV ++   G +K+ D G
Sbjct: 110 EHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYG 155

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 41.4 bits (98), Expect = 1e-04
 Identities = 27/107 (25%), Positives = 55/107 (51%), Gaps = 5/107 (4%)

Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
           +    +E R+L+   +  + +L Y ++  DR  L F+ E    G L  +  + R  + + 
Sbjct: 49  VAHTVTESRVLQNTRHPFLTALKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEER 106

Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
            + +  +I+  L YLH+ +  V++RD+   N+ ++ + G +KI D G
Sbjct: 107 ARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFG 150

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 41.5 bits (97), Expect = 1e-04
 Identities = 30/109 (27%), Positives = 50/109 (45%), Gaps = 8/109 (7%)

Query: 70  IERLFSEVRLLKTLANKN--IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSV 127
           +E    E R+L  L  K   +  LH  ++  DR  L F+ E    G+L  + ++      
Sbjct: 385 VECTMVEKRVLA-LPGKPPFLTQLHSCFQTMDR--LYFVMEYVNGGDLMYHIQQVGRFKE 441

Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
                ++ +I  GL +L +    +I+RDL   NV ++   G +KI D G
Sbjct: 442 PHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFG 487

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 41.1 bits (97), Expect = 1e-04
 Identities = 30/109 (27%), Positives = 53/109 (48%), Gaps = 8/109 (7%)

Query: 70  IERLFSEVRLLKTLANKN--IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSV 127
           +E   +E R+L +LA  +  +  L   ++  DR  L F+ E    G+L  + +K R    
Sbjct: 67  VECTMTEKRIL-SLARNHPFLTQLFCCFQTPDR--LFFVMEFVNGGDLMFHIQKSRRFDE 123

Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
              + ++ +I+  L +LH     +I+RDL   NV ++   G  K+ D G
Sbjct: 124 ARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFG 169

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 40.3 bits (93), Expect = 2e-04
 Identities = 31/194 (15%), Positives = 54/194 (27%), Gaps = 46/194 (23%)

Query: 12  KDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF----CDDP 67
           K   PF    PT +  R  E +G G   +V++     +   VA   + +           
Sbjct: 8   KGPVPFSHCLPTEKLQRC-EKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQ 64

Query: 68  AMIERLFSEVRLLKTLANKNIISLHY-----------------------VWRDEDR---- 100
              E +  E+ + K L+  +    +                         W   +     
Sbjct: 65  KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124

Query: 101 ----------NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
                     + L  + E    G   E  +  +  S+   K    Q+   L         
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAE-ASLR 182

Query: 151 VIHRDLNCSNVFVN 164
             HRDL+  NV + 
Sbjct: 183 FEHRDLHWGNVLLK 196

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 40.5 bits (95), Expect = 2e-04
 Identities = 21/110 (19%), Positives = 47/110 (42%), Gaps = 6/110 (5%)

Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL-REYRKKHRHVSVK 128
           +     E  +L     + I  LH+ ++DE+   L  + E    G+L     K    +  +
Sbjct: 105 VSCFREERDVLVNGDRRWITQLHFAFQDENY--LYLVMEYYVGGDLLTLLSKFGERIPAE 162

Query: 129 ALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             + +  +I+  ++ +H      +HRD+   N+ ++   G +++ D G  
Sbjct: 163 MARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSC 209

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 40.3 bits (95), Expect = 3e-04
 Identities = 30/109 (27%), Positives = 50/109 (45%), Gaps = 8/109 (7%)

Query: 70  IERLFSEVRLLKTLANKN--IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSV 127
           +E    E R+L  L  K   +  LH  ++  DR  L F+ E    G+L  + ++      
Sbjct: 64  VECTMVEKRVL-ALPGKPPFLTQLHSCFQTMDR--LYFVMEYVNGGDLMYHIQQVGRFKE 120

Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG 176
                ++ +I  GL +L +    +I+RDL   NV ++   G +KI D G
Sbjct: 121 PHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFG 166

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 40.1 bits (94), Expect = 3e-04
 Identities = 21/110 (19%), Positives = 49/110 (44%), Gaps = 6/110 (5%)

Query: 70  IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVK 128
                 E  +L    +K I +LHY ++D++   L  + +    G+L     K    +  +
Sbjct: 118 TACFREERDVLVNGDSKWITTLHYAFQDDNN--LYLVMDYYVGGDLLTLLSKFEDRLPEE 175

Query: 129 ALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             + +  +++  ++ +H      +HRD+   N+ ++ N G +++ D G  
Sbjct: 176 MARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSC 222

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	219
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.98
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.98
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.98
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.98
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.98
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.98
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.98
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.98
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.98
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.98
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.98
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.98
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.98
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.98
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.98
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.98
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.98
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.98
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.98
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.98
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.98
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.98
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.98
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.98
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.98
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.98
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.98
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.98
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.98
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.98
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.98
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.98
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.98
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.98
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.98
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.98
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.98
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.98
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.98
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.97
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.97
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.97
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.97
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.97
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.97
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.97
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.97
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.97
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.97
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.97
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.97
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.97
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.97
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.97
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.97
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.97
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.97
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.97
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.97
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.97
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.97
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.97
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.97
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.97
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.97
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.97
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.97
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.97
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.97
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.97
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.97
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.97
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.97
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.97
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.97
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.97
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.97
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.97
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.97
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.97
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.97
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.97
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.97
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.97
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.97
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.97
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.97
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.97
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.97
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.97
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.97
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.97
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.97
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.97
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.97
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.97
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.97
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.97
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.97
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.97
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.97
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.97
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.97
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.96
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.96
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.96
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.96
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.96
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.96
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.96
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.96
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.71
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.17
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.09
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.77
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.72
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.64
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.57
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.33
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.25
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.25
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.93
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.61
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.53
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.46
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.37
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.21
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.93
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.84
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.84
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.79
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.49
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.48
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.33
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	87.84
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.8
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	83.16
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	82.48

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-45  Score=290.09  Aligned_cols=194  Identities=32%  Similarity=0.634  Sum_probs=163.7

Q ss_pred             ccccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEe
Q 027788           17 FIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWR   96 (219)
Q Consensus        17 ~~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   96 (219)
                      .....+.++|++++++||+|+||.||+|.+..++..||+|.+.....  .....+.+.+|+.++++++||||+++++++.
T Consensus        18 ~~~~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~   95 (290)
T 3fpq_A           18 AVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWE   95 (290)
T ss_dssp             EEEECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hcCcCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            34566789999999999999999999999999999999999986543  4556688999999999999999999999985


Q ss_pred             c--CCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEec
Q 027788           97 D--EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD  174 (219)
Q Consensus        97 ~--~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~d  174 (219)
                      .  .+...+++|||||++|+|.+++.....+++..+..++.|++.||.|||+++++|+||||||+|||++...+.+||+|
T Consensus        96 ~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~D  175 (290)
T 3fpq_A           96 STVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             EEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred             eccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEe
Confidence            4  34567899999999999999998888899999999999999999999998877999999999999985446899999


Q ss_pred             cccceeccccce----eeeecccCccccCCCccccccceeeecc
Q 027788          175 LGVAAIVGRAIR----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       175 fg~a~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ||+|+.......    ++..+.+||-+ . ..|+.++||||+||
T Consensus       176 FGla~~~~~~~~~~~~GTp~YmAPE~~-~-~~y~~~~DiwSlGv  217 (290)
T 3fpq_A          176 LGLATLKRASFAKAVIGTPEFMAPEMY-E-EKYDESVDVYAFGM  217 (290)
T ss_dssp             TTGGGGCCTTSBEESCSSCCCCCGGGG-G-TCCCTHHHHHHHHH
T ss_pred             CcCCEeCCCCccCCcccCccccCHHHc-C-CCCCcHHHHHHHHH
Confidence            999986544332    33344445433 3 35889999999993

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.5e-44  Score=285.75  Aligned_cols=183  Identities=20%  Similarity=0.347  Sum_probs=154.4

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|+||.||+|++..+++.||+|+++..... +....+.+.+|+.++++++||||+++++++.  +.+.+|+|
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~yiv  110 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQ--DDEKLYFG  110 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--eCCEEEEE
Confidence            48899999999999999999999999999999865332 1233577899999999999999999999995  45679999


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      ||||++|+|.+++...+.+++..+..++.|++.||.|||+++  |+||||||+|||++.+ +.+||+|||+|+.+.....
T Consensus       111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~-g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-MHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECCTTTT
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCC-CCEEEEEcCCceecCCCCC
Confidence            999999999999988889999999999999999999999999  9999999999999866 6899999999998754321


Q ss_pred             ---eeeecccCc----cccCCCccccccceeeeccc
Q 027788          187 ---RIRCWGRRS----SWRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       187 ---~~~~~~~~~----~~~~~~~~~~~~diws~gi~  215 (219)
                         ..+.+|+|.    +......|+.++||||+||+
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvi  223 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCI  223 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHH
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHH
Confidence               222344432    33445668889999999943

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.5e-43  Score=277.50  Aligned_cols=188  Identities=22%  Similarity=0.383  Sum_probs=139.8

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      +.-.++| ++.+.||+|+||.||+|++..+++.||+|+++..... +....+.+.+|+.++++++||||+++++++.+  
T Consensus         9 G~~ig~Y-~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--   84 (275)
T 3hyh_A            9 GAHIGNY-QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-KSDMQGRIEREISYLRLLRHPHIIKLYDVIKS--   84 (275)
T ss_dssp             -----CC-EEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred             CCEeeCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--
Confidence            3344677 7889999999999999999999999999999865432 23445778999999999999999999999954  


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      .+.+|++|||+ +|+|.+++...+.+++..+..++.|++.|+.|||+++  |+||||||+||+++.+ +.+||+|||+|+
T Consensus        85 ~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~-~~vkl~DFGla~  160 (275)
T 3hyh_A           85 KDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEH-LNVKIADFGLSN  160 (275)
T ss_dssp             SSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTT-CCEEECCSSCC-
T ss_pred             CCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCC-CCEEEeecCCCe
Confidence            46789999999 5799999888889999999999999999999999999  9999999999999866 689999999998


Q ss_pred             eccccceeeeeccc-----CccccCCCccccccceeeeccc
Q 027788          180 IVGRAIRRIRCWGR-----RSSWRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       180 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~diws~gi~  215 (219)
                      .........+..|+     ||-+...+.++.++||||+||+
T Consensus       161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvi  201 (275)
T 3hyh_A          161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVI  201 (275)
T ss_dssp             --------------CTTSCHHHHSSSSCCCTHHHHHHHHHH
T ss_pred             ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHH
Confidence            77655443333444     3333333334567999999943

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.6e-43  Score=285.32  Aligned_cols=183  Identities=18%  Similarity=0.374  Sum_probs=149.3

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      ..+| ++.+.||+|+||.||+|++..+|+.||+|+++....  .....+.+.+|+.++++++||||+++++++.+  .+.
T Consensus        23 me~Y-~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~--~~~   97 (350)
T 4b9d_A           23 MEKY-VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEE--NGS   97 (350)
T ss_dssp             CCCE-EEEEEC------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTE
T ss_pred             ccce-EEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--CCE
Confidence            3566 777999999999999999999999999999986543  45567889999999999999999999999954  456


Q ss_pred             EEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          103 LNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      +|+|||||++|+|.+++...  ..+++..++.++.|++.||.|||+++  |+||||||+|||++.+ +.+||+|||+|+.
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla~~  174 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTVQLGDFGIARV  174 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTT-CCEEECSTTEESC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCC-CCEEEccccccee
Confidence            89999999999999998654  35789999999999999999999999  9999999999999866 6899999999998


Q ss_pred             ccccce------eeeecccCccccCCCccccccceeeecc
Q 027788          181 VGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       181 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +.....      ++..+.+| +......|+.++||||+||
T Consensus       175 ~~~~~~~~~~~~GT~~YmAP-E~l~~~~y~~~~DiwSlGv  213 (350)
T 4b9d_A          175 LNSTVELARACIGTPYYLSP-EICENKPYNNKSDIWALGC  213 (350)
T ss_dssp             CCHHHHHHHHHHSCCTTCCH-HHHTTCCCCHHHHHHHHHH
T ss_pred             ecCCcccccccCCCccccCH-HHHCCCCCCcHHHHHHHHH
Confidence            765432      23333333 3455677899999999994

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.3e-43  Score=285.47  Aligned_cols=185  Identities=22%  Similarity=0.337  Sum_probs=153.9

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      +++..+| ++.++||+|+||.||+|++..+|+.||||+++.....    ..+.+.+|+.++++++||||+++++++..+ 
T Consensus        70 ~dp~~~y-~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~----~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-  143 (346)
T 4fih_A           70 GDPRSYL-DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ----RRELLFNEVVIMRDYQHENVVEMYNSYLVG-  143 (346)
T ss_dssp             SCGGGTE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS----SGGGGHHHHHHHHHCCCTTBCCEEEEEEET-
T ss_pred             CChhHhc-EEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh----HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-
Confidence            3444555 6678999999999999999999999999999865432    235678999999999999999999999654 


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                       +.+|+|||||++|+|.+++.. ..+++..+..++.|++.||.|||+++  |+||||||+|||++.+ +.+||+|||+|+
T Consensus       144 -~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla~  218 (346)
T 4fih_A          144 -DELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCA  218 (346)
T ss_dssp             -TEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCE
T ss_pred             -CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCC-CCEEEecCcCce
Confidence             568999999999999998875 47999999999999999999999999  9999999999999866 689999999999


Q ss_pred             eccccce-eeeecccCc----cccCCCccccccceeeeccc
Q 027788          180 IVGRAIR-RIRCWGRRS----SWRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       180 ~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~diws~gi~  215 (219)
                      .+..... ....+|+|.    +......|+.++||||+||+
T Consensus       219 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvi  259 (346)
T 4fih_A          219 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIM  259 (346)
T ss_dssp             ECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred             ecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHH
Confidence            8765432 223334432    34556778999999999943

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.5e-43  Score=288.33  Aligned_cols=185  Identities=22%  Similarity=0.341  Sum_probs=154.6

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      +|+..+| ++.++||+|+||.||+|++..+|+.||||+++....    ...+.+.+|+.+++.++||||++++++|..+ 
T Consensus       147 ~dp~~~y-~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-  220 (423)
T 4fie_A          147 GDPRSYL-DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVG-  220 (423)
T ss_dssp             SCGGGTE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC----SSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-
T ss_pred             CChhHhc-EeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-
Confidence            4455556 677999999999999999999999999999986532    2235688999999999999999999999654 


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                       +.+|+|||||++|+|.+++.. ..+++..+..++.|++.||.|||+++  |+||||||+|||++.+ +.+||+|||+|+
T Consensus       221 -~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~-g~vKl~DFGla~  295 (423)
T 4fie_A          221 -DELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHD-GRVKLSDFGFCA  295 (423)
T ss_dssp             -TEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTT-CCEEECCCTTCE
T ss_pred             -CEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCC-CCEEEecCccce
Confidence             568999999999999998865 46999999999999999999999999  9999999999999866 689999999999


Q ss_pred             eccccce-eeeecccCc----cccCCCccccccceeeeccc
Q 027788          180 IVGRAIR-RIRCWGRRS----SWRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       180 ~~~~~~~-~~~~~~~~~----~~~~~~~~~~~~diws~gi~  215 (219)
                      .+..... ....+|+|.    +......|+.++||||+||+
T Consensus       296 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvi  336 (423)
T 4fie_A          296 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIM  336 (423)
T ss_dssp             ECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred             ECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHH
Confidence            8765432 223344432    34556778999999999943

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.2e-42  Score=275.35  Aligned_cols=177  Identities=20%  Similarity=0.280  Sum_probs=147.9

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      -+++.+.++||+|+||.||+|++..+|+.||||+++.+..         ..+|+.+++.++||||+++++++.+  .+.+
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~--~~~~  125 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVRE--GPWV  125 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEE--TTEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEE--CCEE
Confidence            4566888999999999999999999999999999985432         1369999999999999999999954  4568


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      |+|||||++|+|.+++...+.+++..+..++.|++.||.|||+++  |+||||||+|||++.+...+||+|||+|+.+..
T Consensus       126 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          126 NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            999999999999999988888999999999999999999999999  999999999999986643699999999998755


Q ss_pred             cce-----------eeeecccCccccCCCccccccceeeecc
Q 027788          184 AIR-----------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~-----------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ...           ++..+.+| +......|+.++||||+||
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAP-E~~~~~~y~~~~DiwSlGv  244 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAP-EVVMGKPCDAKVDIWSSCC  244 (336)
T ss_dssp             ----------CCCCCCGGGCCH-HHHTTCCCCTHHHHHHHHH
T ss_pred             CCcccceecCCccccCccccCH-HHHCCCCCCcHHHHHHHHH
Confidence            331           22223333 3345667899999999994

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-41  Score=270.66  Aligned_cols=181  Identities=19%  Similarity=0.320  Sum_probs=143.1

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC------
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR------  100 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~------  100 (219)
                      |++.+.||+|+||.||+|++..+++.||+|.++...   .....+.+.+|+.++++++||||+++++++...+.      
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            478899999999999999999999999999987553   45556789999999999999999999999865432      


Q ss_pred             ----ceEEEEeccccCCChHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEe
Q 027788          101 ----NTLNFITEVCTSGNLREYRKKHRH---VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIG  173 (219)
Q Consensus       101 ----~~~~lv~e~~~~g~L~~~~~~~~~---~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~  173 (219)
                          .++|++||||++|+|.+++.....   ..+..+..++.|++.||.|||+++  |+||||||+|||++.+ +.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~-~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCC-CcEEEc
Confidence                357899999999999999986543   456678899999999999999999  9999999999999866 589999


Q ss_pred             ccccceeccccce------------------eeeecccCccccCCCccccccceeeecc
Q 027788          174 DLGVAAIVGRAIR------------------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       174 dfg~a~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      |||+|+.+.....                  ++..+.+| +......|+.++||||+||
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAP-E~~~~~~y~~~~DiwSlGv  218 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSP-EQIHGNSYSHKVDIFSLGL  218 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCH-HHHTTCCCCTHHHHHHHHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCH-HHHcCCCCCCHHHHHHHHH
Confidence            9999988755332                  22223333 3344567899999999994

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-41  Score=270.27  Aligned_cols=178  Identities=24%  Similarity=0.312  Sum_probs=145.2

Q ss_pred             eeeeeeeeccccceEEEEEEec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQ-----EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      -+.+.+.||+|+||.||+|+..     .++..||||.++..    .....+.|.+|+.++++++||||+++++++..  .
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~   87 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--G   87 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee--C
Confidence            3478899999999999999864     46789999998743    45566889999999999999999999999954  4


Q ss_pred             ceEEEEeccccCCChHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC
Q 027788          101 NTLNFITEVCTSGNLREYRKKH-------------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT  167 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~-------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~  167 (219)
                      +.+++|||||++|+|.+++...             ..+++..+..++.|++.|+.|||+++  |+||||||+|||++.+ 
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~-  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGEN-  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCC-
Confidence            5588999999999999998653             35899999999999999999999999  9999999999999866 


Q ss_pred             CcEEEeccccceeccccce--------eeeecccCccccCCCccccccceeeec
Q 027788          168 GQVKIGDLGVAAIVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       168 ~~~~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +.+||+|||+|+.......        ++..|-+| +......|+.++||||||
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP-E~~~~~~~~~k~DVwS~G  217 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP-ESIMYRKFTTESDVWSLG  217 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCH-HHHHHCCCCHHHHHHHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCH-HHHcCCCCCchhhHHHHH
Confidence            5899999999987655432        11123333 334456789999999999

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.6e-42  Score=275.19  Aligned_cols=182  Identities=20%  Similarity=0.264  Sum_probs=142.6

Q ss_pred             eeeeeeeccccceEEEEEEec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQ---EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      |++.+.||+|+||.||+|++.   .+++.||+|+++......  ....++.+|+.++++++||||+++++++.++  +.+
T Consensus        26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~  101 (304)
T 3ubd_A           26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV--RDRVRTKMERDILVEVNHPFIVKLHYAFQTE--GKL  101 (304)
T ss_dssp             EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE--EECC------CCCCCCCCTTEECEEEEEEET--TEE
T ss_pred             cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh--HHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC--CEE
Confidence            488899999999999999874   467899999997544321  1124577899999999999999999999654  568


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      |++||||++|+|.+++...+.+++..+..++.|++.||.|||+++  |+||||||+|||++.+ +.+||+|||+|+....
T Consensus       102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEE-GHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTT-SCEEEESSEEEEC---
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCC-CCEEecccccceeccC
Confidence            999999999999999988889999999999999999999999999  9999999999999866 6899999999987644


Q ss_pred             cce-eeeecccCc----cccCCCccccccceeeeccc
Q 027788          184 AIR-RIRCWGRRS----SWRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       184 ~~~-~~~~~~~~~----~~~~~~~~~~~~diws~gi~  215 (219)
                      ... ..+..|+|.    +......|+.++||||+||+
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvi  215 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVL  215 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHH
T ss_pred             CCccccccccCcccCCHHHhccCCCCCCCcccchHHH
Confidence            332 222334322    33456678889999999943

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=268.19  Aligned_cols=178  Identities=22%  Similarity=0.288  Sum_probs=140.9

Q ss_pred             eeeeeeeeccccceEEEEEEec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQ-----EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      -+.+.++||+|+||.||+|+..     .++..||||.++..    .....+.|.+|+.++++++||||++++++|..  .
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~  115 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVCTE--G  115 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--C
Confidence            3478899999999999999854     46889999998743    45566889999999999999999999999954  4


Q ss_pred             ceEEEEeccccCCChHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC
Q 027788          101 NTLNFITEVCTSGNLREYRKKH---------------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG  165 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~---------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~  165 (219)
                      +.+++|||||++|+|.+++...               .++++..+..++.|++.||.|||+++  |+||||||+|||++.
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEET
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECC
Confidence            5688999999999999998653               24889999999999999999999999  999999999999996


Q ss_pred             CCCcEEEeccccceeccccce--------eeeecccCccccCCCccccccceeeec
Q 027788          166 NTGQVKIGDLGVAAIVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       166 ~~~~~~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      + +.+||+|||+|+.......        ++..|.+| +......|+.++||||||
T Consensus       194 ~-~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAP-E~~~~~~~~~~sDvwS~G  247 (329)
T 4aoj_A          194 G-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPP-ESILYRKFTTESDVWSFG  247 (329)
T ss_dssp             T-TEEEECCCC----------------CCCCGGGCCH-HHHTTCCCCHHHHHHHHH
T ss_pred             C-CcEEEcccccceeccCCCcceecCcccccccccCh-hhhcCCCCCccccccchH
Confidence            6 5899999999987644332        11223333 345567789999999999

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-41  Score=267.11  Aligned_cols=179  Identities=23%  Similarity=0.372  Sum_probs=143.3

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      .-+.+.++||+|+||.||+|+..   ..||||+++...  ......+.|.+|+.++++++||||+++++++..   +.++
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~  107 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLA  107 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEE
Confidence            34478899999999999999854   369999987543  256667889999999999999999999998743   2378


Q ss_pred             EEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          105 FITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +|||||++|+|.+++... ..+++..+..++.|++.||.|||+++  |+||||||+|||++.+ +.+||+|||+|+....
T Consensus       108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEG-LTVKIGDFGLATVKSR  184 (307)
T ss_dssp             EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETT-EEEEECCCSSCBC---
T ss_pred             EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCC-CcEEEeeccCceeccc
Confidence            899999999999998654 57999999999999999999999999  9999999999999966 5899999999987654


Q ss_pred             cce--------eeeecccCcccc--CCCccccccceeeecc
Q 027788          184 AIR--------RIRCWGRRSSWR--RSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~--------~~~~~~~~~~~~--~~~~~~~~~diws~gi  214 (219)
                      ...        ++..|-+||-+.  ....|+.++|||||||
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gv  225 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGI  225 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHH
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHH
Confidence            321        222333444332  2345888999999993

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-40  Score=271.64  Aligned_cols=184  Identities=24%  Similarity=0.375  Sum_probs=151.8

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC----C
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE----D   99 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~----~   99 (219)
                      .+| ++.+.||+|+||.||+|++..+|+.||||+++....  .....+.+.+|+.+++.++||||+++++++...    +
T Consensus        54 ~~Y-~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~  130 (398)
T 4b99_A           54 DEY-EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD--VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE  130 (398)
T ss_dssp             SSE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred             CCe-EEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc--chHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence            455 788999999999999999999999999999875432  455567889999999999999999999988542    3


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      ...+|+|||||+ |+|.+++...+.+++..+..++.|++.||.|||+++  |+||||||+|||++.+ +.+||+|||+|+
T Consensus       131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~-~~~Ki~DFGla~  206 (398)
T 4b99_A          131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNEN-CELKIGDFGMAR  206 (398)
T ss_dssp             CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-CCEEECCCTTCB
T ss_pred             CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCC-CCEEEeecceee
Confidence            457899999996 689999988889999999999999999999999999  9999999999999866 689999999998


Q ss_pred             eccccc----------eeeeecccCccccCCCccccccceeeecc
Q 027788          180 IVGRAI----------RRIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .+....          .++..+.+|+-+.....++.++||||+|+
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~  251 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGC  251 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHH
Confidence            764322          12333444444445556788899999994

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=9e-41  Score=266.23  Aligned_cols=178  Identities=28%  Similarity=0.379  Sum_probs=143.5

Q ss_pred             eeeeeeeccccceEEEEEEe-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           27 GRYNELLGSGAVKKVYRAFD-----QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      .++.++||+|+||.||+|+.     ..+++.||||.++...   +....+.|.+|+.++++++||||+++++++..+  .
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~--~  102 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD--Q  102 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC--C
Confidence            47889999999999999985     3467899999987543   233457899999999999999999999999544  4


Q ss_pred             eEEEEeccccCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC
Q 027788          102 TLNFITEVCTSGNLREYRKKH----------------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG  165 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~----------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~  165 (219)
                      .+++|||||++|+|.+++...                ..+++..+..++.|++.||.|||+++  ++||||||+|||++.
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYD  180 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECG
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEECC
Confidence            578899999999999998542                24889999999999999999999999  999999999999996


Q ss_pred             CCCcEEEeccccceeccccce--------eeeecccCccccCCCccccccceeeec
Q 027788          166 NTGQVKIGDLGVAAIVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       166 ~~~~~~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      + +.+||+|||+|+.......        ++..|.+|| ......|+.++||||||
T Consensus       181 ~-~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE-~l~~~~~s~ksDVwSfG  234 (308)
T 4gt4_A          181 K-LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPE-AIMYGKFSIDSDIWSYG  234 (308)
T ss_dssp             G-GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHH-HHHHCCCCHHHHHHHHH
T ss_pred             C-CCEEECCcccceeccCCCceeEecccccCCcccCHH-HHhCCCCCccchhhhHH
Confidence            6 5899999999987654432        112233333 33456689999999999

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.9e-39  Score=277.06  Aligned_cols=184  Identities=18%  Similarity=0.302  Sum_probs=150.4

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccC--CCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC--DDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      |.+.+.||+|+||.||+|++..+|+.||+|+++.....  ...........++.+++.++||||++++++|.+  .+.+|
T Consensus       191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~--~~~ly  268 (689)
T 3v5w_A          191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLS  268 (689)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--SSEEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE--CCEEE
Confidence            48889999999999999999999999999999764322  122222333344666777899999999999954  46799


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      +||||++||+|..++...+.+++..+..++.||+.||.|||+++  |+||||||+|||++.+ |.+||+|||+|+.+...
T Consensus       269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~-G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDFSKK  345 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECSSC
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCC-CCEEecccceeeecCCC
Confidence            99999999999999988889999999999999999999999999  9999999999999966 69999999999987654


Q ss_pred             ce----eeeecccCccccCCCccccccceeeeccc
Q 027788          185 IR----RIRCWGRRSSWRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       185 ~~----~~~~~~~~~~~~~~~~~~~~~diws~gi~  215 (219)
                      ..    ++..+.+|+-+.....|+.++|+||+||+
T Consensus       346 ~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvi  380 (689)
T 3v5w_A          346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM  380 (689)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHH
T ss_pred             CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHH
Confidence            43    23333334334456678999999999943

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.3e-39  Score=255.53  Aligned_cols=180  Identities=23%  Similarity=0.278  Sum_probs=139.3

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC--ce
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR--NT  102 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~--~~  102 (219)
                      +.+.+.++||+|+||.||+|+.  +|+.||||.++...     ........|+..+.+++||||+++++++..++.  ..
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~   75 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence            4458999999999999999986  58899999987432     111222345666678899999999999976543  36


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH------EPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~------~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                      +++||||+++|+|.++++.. .++++.+..++.|++.||.|||++      .++|+||||||+|||++.+ +.+||+|||
T Consensus        76 ~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~-~~~Ki~DFG  153 (303)
T 3hmm_A           76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLG  153 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCCT
T ss_pred             EEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC-CCEEEEeCC
Confidence            78999999999999998764 689999999999999999999987      1239999999999999966 589999999


Q ss_pred             cceeccccce----------eeeecccCccccC-----CCccccccceeeec
Q 027788          177 VAAIVGRAIR----------RIRCWGRRSSWRR-----SCTMRITRSLWTYT  213 (219)
Q Consensus       177 ~a~~~~~~~~----------~~~~~~~~~~~~~-----~~~~~~~~diws~g  213 (219)
                      +|+.......          ++..|.+||-+..     ...++.++||||||
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~G  205 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG  205 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHH
Confidence            9987755432          2223333432221     22466789999999

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.5e-39  Score=260.16  Aligned_cols=182  Identities=24%  Similarity=0.334  Sum_probs=146.7

Q ss_pred             CceeeeeeeeccccceEEEEEEecCC-----CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCC-CCceEEEEEEec
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEE-----GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN-KNIISLHYVWRD   97 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~~~~~~~~   97 (219)
                      ...+++.+.||+|+||.||+|....+     ++.||+|.++...   .....+.+.+|+.++.+++| |||++++++|..
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            34458999999999999999987544     3679999887543   34556789999999999976 899999999864


Q ss_pred             CCCceEEEEeccccCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCce
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKH----------------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNV  161 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~----------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~ni  161 (219)
                      + ...+++|||||++|+|.+++...                ..+++..+..++.|++.||.|||+++  ++||||||+||
T Consensus       140 ~-~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NI  216 (353)
T 4ase_A          140 P-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNI  216 (353)
T ss_dssp             T-TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGE
T ss_pred             c-CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCccce
Confidence            3 34578899999999999998643                23789999999999999999999999  99999999999


Q ss_pred             EEeCCCCcEEEeccccceeccccce--------eeeecccCccccCCCccccccceeeec
Q 027788          162 FVNGNTGQVKIGDLGVAAIVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       162 li~~~~~~~~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |++.+ +.+||+|||+|+.+.....        ++..|.+|| ......|+.++||||||
T Consensus       217 Ll~~~-~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE-~l~~~~y~~ksDVwS~G  274 (353)
T 4ase_A          217 LLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE-TIFDRVYTIQSDVWSFG  274 (353)
T ss_dssp             EECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHH-HHHHCCCCHHHHHHHHH
T ss_pred             eeCCC-CCEEECcchhhhhcccCCCceeeccccccccccCHH-HHhcCCCCCcccEeehH
Confidence            99866 5899999999987754332        111233333 33456788999999999

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.3e-38  Score=259.17  Aligned_cols=177  Identities=15%  Similarity=0.264  Sum_probs=144.7

Q ss_pred             ceeeeeeeeccccceEEEEEEec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCC
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQ---EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDR  100 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~  100 (219)
                      +.|++.+.||+|+||.||+|++.   .+++.||+|.+....      ...++.+|+++++.+ +||||+++++++..  .
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~   92 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS------HPIRIAAELQCLTVAGGQDNVMGVKYCFRK--N   92 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS------CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--T
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc------CHHHHHHHHHHHHHhcCCCCCceEEEEEEE--C
Confidence            33489999999999999999874   467899999876432      124577899999988 69999999999954  4


Q ss_pred             ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          101 NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      +.+|++|||+++++|.++++   .+++..+..++.|++.||.|||+++  |+||||||+|||++.+.+.+||+|||+|+.
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            67899999999999999884   5899999999999999999999999  999999999999987767899999999986


Q ss_pred             ccccc----------------------------------eeeeecccCccccCCCccccccceeeecc
Q 027788          181 VGRAI----------------------------------RRIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       181 ~~~~~----------------------------------~~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .....                                  .++..+.+||-+...+.|+.++||||+|+
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~  235 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGV  235 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHH
Confidence            54321                                  12333444444455566888899999994

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.2e-37  Score=267.10  Aligned_cols=182  Identities=22%  Similarity=0.325  Sum_probs=155.0

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+| .+.+.||+|+||.||+|.+..+|+.||+|.+...    .....+.+.+|+.+++.++||||++++++|.  +...+
T Consensus       157 ~~Y-~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~  229 (573)
T 3uto_A          157 DHY-DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFE--DDNEM  229 (573)
T ss_dssp             GTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE--CSSEE
T ss_pred             ccc-EEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc----chhhHHHHHHHHHHHHhCCCCCCCeEEEEEE--ECCEE
Confidence            345 8889999999999999999999999999998754    3444577889999999999999999999995  45679


Q ss_pred             EEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC-CCcEEEeccccceec
Q 027788          104 NFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN-TGQVKIGDLGVAAIV  181 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~-~~~~~l~dfg~a~~~  181 (219)
                      +++||||++|+|.+++.. ...+++..+..++.|++.||.|||+++  |+||||||+|||++.+ .+.+||+|||+|+.+
T Consensus       230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            999999999999998854 457999999999999999999999999  9999999999999743 358999999999998


Q ss_pred             cccceeeeecccCc----cccCCCccccccceeeecc
Q 027788          182 GRAIRRIRCWGRRS----SWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       182 ~~~~~~~~~~~~~~----~~~~~~~~~~~~diws~gi  214 (219)
                      ..........|+|.    +......|+.++||||+||
T Consensus       308 ~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGv  344 (573)
T 3uto_A          308 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV  344 (573)
T ss_dssp             CTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHH
T ss_pred             cCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHH
Confidence            76665444555533    3345667888999999994

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.7e-36  Score=240.35  Aligned_cols=183  Identities=25%  Similarity=0.414  Sum_probs=152.0

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++| ++.+.||+|+||.||+|.+..+|+.||+|.+.....  .....+.+.+|+.+++.++||||+++++++..  ...+
T Consensus        15 ~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~   89 (328)
T 3fe3_A           15 GNY-RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVIET--EKTL   89 (328)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred             CCE-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEE
Confidence            455 888999999999999999999999999999886543  45666888999999999999999999999854  4568


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++|||+++++|.+++...+.+++..+..++.|++.|+.|||+++  ++||||||+||+++.+ +.+||+|||++.....
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDAD-MNIKIADFGFSNEFTV  166 (328)
T ss_dssp             EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSTTCCGGGSS
T ss_pred             EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCC-CCEEEeeccCceecCC
Confidence            899999999999999887788999999999999999999999999  9999999999999866 5899999999987654


Q ss_pred             cce-----eeeecccCccccCCCccccccceeeecc
Q 027788          184 AIR-----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~-----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ...     ++..+.+|+.+......+.++|+||+|+
T Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~  202 (328)
T 3fe3_A          167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGV  202 (328)
T ss_dssp             SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHH
T ss_pred             CCccccccCCcceeCcccccCCCcCCchhhhhhhHH
Confidence            432     2222333333333333346799999993

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1e-34  Score=241.88  Aligned_cols=200  Identities=22%  Similarity=0.328  Sum_probs=162.6

Q ss_pred             CCCCCCCCCCccccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCC
Q 027788            7 SDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK   86 (219)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   86 (219)
                      +.+.......+......++| .+.+.||+|+||.||+|.+..+++.||+|.++...  ......+++.+|+.+++.++||
T Consensus         9 ~~~~~~~~Q~~~~~~i~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~   85 (432)
T 3n9x_A            9 SGRENLYFQGIKNVHVPDNY-IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREITILNRLKSD   85 (432)
T ss_dssp             --CCCCCTTCGGGCCCCTTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT--TSHHHHHHHHHHHHHHHHCCCT
T ss_pred             ccchhhhhcCCCcceecCCE-EEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh--cChHHHHHHHHHHHHHHHcCCC
Confidence            34455666667777788888 78899999999999999999999999999987432  2455668899999999999999


Q ss_pred             CceEEEEEEecCCC---ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEE
Q 027788           87 NIISLHYVWRDEDR---NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFV  163 (219)
Q Consensus        87 ~i~~~~~~~~~~~~---~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili  163 (219)
                      ||+++++++.....   ..++++||+++ ++|.+++.....+++..+..++.|++.||.|||+.+  ++||||||+||++
T Consensus        86 nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl  162 (432)
T 3n9x_A           86 YIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLL  162 (432)
T ss_dssp             TBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE
T ss_pred             CcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEE
Confidence            99999999865432   56899999986 699999988778999999999999999999999999  9999999999999


Q ss_pred             eCCCCcEEEeccccceeccccce----------------------------eeeecccCccccCCCccccccceeeec
Q 027788          164 NGNTGQVKIGDLGVAAIVGRAIR----------------------------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       164 ~~~~~~~~l~dfg~a~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +.+ +.+||+|||+++.......                            ++..+.+|+-+.....++.++||||+|
T Consensus       163 ~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG  239 (432)
T 3n9x_A          163 NQD-CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG  239 (432)
T ss_dssp             CTT-CCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHH
T ss_pred             CCC-CCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHH
Confidence            866 5899999999998754321                            122233444445566688889999999

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.7e-35  Score=237.31  Aligned_cols=188  Identities=26%  Similarity=0.402  Sum_probs=153.7

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCC--HHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD--PAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      ...+| .+.+.||+|+||.||+|.+..+|..||+|.++.......  ....+.+.+|+.+++.++||||+++++++.  +
T Consensus        10 ~~~~y-~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~   86 (361)
T 2yab_A           10 VEDFY-DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE--N   86 (361)
T ss_dssp             GGGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE--C
T ss_pred             hhhce-EEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE--e
Confidence            33444 888999999999999999999999999999986543211  113467889999999999999999999995  4


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCC---cEEEeccc
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG---QVKIGDLG  176 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~---~~~l~dfg  176 (219)
                      ...++++|||+++++|.+++.....+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+..   .++|+|||
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            4678899999999999999987778999999999999999999999999  999999999999975532   69999999


Q ss_pred             cceeccccceeeeecccC----ccccCCCccccccceeeecc
Q 027788          177 VAAIVGRAIRRIRCWGRR----SSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       177 ~a~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~diws~gi  214 (219)
                      ++.............|+|    ++......++.++|+||+|+
T Consensus       165 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGv  206 (361)
T 2yab_A          165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV  206 (361)
T ss_dssp             SCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred             CceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHH
Confidence            998876544322223332    23344556788899999993

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.7e-35  Score=245.52  Aligned_cols=186  Identities=21%  Similarity=0.343  Sum_probs=145.0

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC-
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED-   99 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~-   99 (219)
                      ....+| ++.+.||+|+||.||+|.+..+++.||+|.+....  .+....+++.+|+.+++.++||||+++++++...+ 
T Consensus        50 ~~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  126 (458)
T 3rp9_A           50 QIPDRY-EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF--EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV  126 (458)
T ss_dssp             CSCTTE-EECCC-------CEEEEEECC--CEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred             ccCCCe-EEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh--cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence            344566 88899999999999999999999999999986432  24556688999999999999999999999985432 


Q ss_pred             --CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788          100 --RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus       100 --~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                        ...+|++||+++ ++|..++.....+++..+..++.|++.||.|||+.+  ++||||||+|||++.+ +.+||+|||+
T Consensus       127 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~-~~~kl~DFGl  202 (458)
T 3rp9_A          127 EKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGL  202 (458)
T ss_dssp             TTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-CCEEECCCTT
T ss_pred             ccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCC-CCEeeccccc
Confidence              356899999984 799998887778999999999999999999999999  9999999999999966 5899999999


Q ss_pred             ceeccccce---------------------------------eeeecccCccccCCCccccccceeeec
Q 027788          178 AAIVGRAIR---------------------------------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       178 a~~~~~~~~---------------------------------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ++.......                                 ++..+.+|+-+.....++.++||||+|
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG  271 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG  271 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHH
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHH
Confidence            987653221                                 122234444445566688889999999

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-34  Score=232.42  Aligned_cols=188  Identities=19%  Similarity=0.321  Sum_probs=153.4

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      ....++.|++.+.||+|+||.||+|.+..+++.||+|+++.....   ...+.+.+|+.++++++||||+++++++...+
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   80 (319)
T 4euu_A            4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETT   80 (319)
T ss_dssp             EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred             ccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCcceEEEEeecCC
Confidence            334456669999999999999999999999999999998754432   22466789999999999999999999998777


Q ss_pred             CceEEEEeccccCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEE----eCCCCcEEE
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHR---HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFV----NGNTGQVKI  172 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili----~~~~~~~~l  172 (219)
                      ...++++|||+++++|.+++....   .+++..+..++.|++.||.|||+.+  ++|+||||+||++    +.+ +.+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~-~~~kL  157 (319)
T 4euu_A           81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQ-SVYKL  157 (319)
T ss_dssp             TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSC-EEEEE
T ss_pred             CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCC-ceEEE
Confidence            668899999999999999987543   3899999999999999999999999  9999999999998    433 46899


Q ss_pred             eccccceeccccceeee-----ecccCcccc-------CCCccccccceeeec
Q 027788          173 GDLGVAAIVGRAIRRIR-----CWGRRSSWR-------RSCTMRITRSLWTYT  213 (219)
Q Consensus       173 ~dfg~a~~~~~~~~~~~-----~~~~~~~~~-------~~~~~~~~~diws~g  213 (219)
                      +|||++...........     .+.+|+.+.       ....++.++||||+|
T Consensus       158 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG  210 (319)
T 4euu_A          158 TDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG  210 (319)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHH
T ss_pred             ccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHH
Confidence            99999988765543222     233333222       146677889999999

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.4e-34  Score=224.96  Aligned_cols=196  Identities=32%  Similarity=0.627  Sum_probs=161.2

Q ss_pred             CCccccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEE
Q 027788           15 EPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYV   94 (219)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~   94 (219)
                      .........++++++.+.||+|+||.||+|.+..++..||+|.+.....  .....+.+.+|+.+++.++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   93 (290)
T 1t4h_A           16 TKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDS   93 (290)
T ss_dssp             --CCEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhhhhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh--CHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence            3345667789999999999999999999999999999999999886543  45566889999999999999999999998


Q ss_pred             Eec--CCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEE
Q 027788           95 WRD--EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKI  172 (219)
Q Consensus        95 ~~~--~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l  172 (219)
                      +..  .+...++++|||+++++|.+++.....+++..+..++.|++.|+.|||+.+++++|+||||+||+++.+.+.++|
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl  173 (290)
T 1t4h_A           94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI  173 (290)
T ss_dssp             EEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEE
T ss_pred             eccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEE
Confidence            854  345678999999999999999987778999999999999999999999987669999999999999744568999


Q ss_pred             eccccceeccccce----eeeecccCccccCCCccccccceeeecc
Q 027788          173 GDLGVAAIVGRAIR----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       173 ~dfg~a~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +|||++........    ++..+.+|+.+ . ..++.++|+||+|+
T Consensus       174 ~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~-~-~~~~~~~Di~slG~  217 (290)
T 1t4h_A          174 GDLGLATLKRASFAKAVIGTPEFMAPEMY-E-EKYDESVDVYAFGM  217 (290)
T ss_dssp             CCTTGGGGCCTTSBEESCSSCCCCCGGGG-G-TCCCTHHHHHHHHH
T ss_pred             eeCCCcccccccccccccCCcCcCCHHHH-h-ccCCCcchHHHHHH
Confidence            99999976544432    22233344432 2 34778899999993

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.6e-34  Score=237.91  Aligned_cols=183  Identities=21%  Similarity=0.284  Sum_probs=149.5

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceEE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      -|++.+.||+|+||.||+|++..+++.||+|+++..... .....+.+.+|..+++++ +||||+++++++..  ...++
T Consensus        53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~~  129 (396)
T 4dc2_A           53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLF  129 (396)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCEEE
Confidence            348889999999999999999999999999999865432 234446688899999877 89999999999964  45688


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      ++|||+++|+|..++.....+++..+..++.|++.||.|||+++  |+||||||+||+++.+ +.+||+|||+++.....
T Consensus       130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~-g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT
T ss_pred             EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCC-CCEEEeecceeeecccC
Confidence            99999999999999888788999999999999999999999999  9999999999999866 68999999999864332


Q ss_pred             c-eeeeecccC----ccccCCCccccccceeeecc
Q 027788          185 I-RRIRCWGRR----SSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       185 ~-~~~~~~~~~----~~~~~~~~~~~~~diws~gi  214 (219)
                      . ......|++    ++......++.++|+||+|+
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGv  241 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGV  241 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred             CCccccccCCcccCCchhhcCCCCChHHHHHHHHH
Confidence            2 222222322    23445567888999999993

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.2e-34  Score=232.64  Aligned_cols=183  Identities=19%  Similarity=0.313  Sum_probs=151.0

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++| ++.+.||+|+||.||+|.+..+++.||+|+++...... ......+.+|+.+++.++||||+++++++..  ...+
T Consensus         5 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~   80 (337)
T 1o6l_A            5 NDF-DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRL   80 (337)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEE
T ss_pred             HHe-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-hhHHHHHHHHHHHHHhCCCCcCcceEEEEEe--CCEE
Confidence            345 78899999999999999999999999999997543211 1234678899999999999999999999954  4568


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++|||+++|+|..++.....+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+++....
T Consensus        81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCC-CCEEEeeccchhhccc
Confidence            899999999999999887778999999999999999999999999  9999999999999866 6899999999986433


Q ss_pred             cce------eeeecccCccccCCCccccccceeeecc
Q 027788          184 AIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ...      ++..+.+| +......++.++|+||+|+
T Consensus       158 ~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~  193 (337)
T 1o6l_A          158 DGATMKTFCGTPEYLAP-EVLEDNDYGRAVDWWGLGV  193 (337)
T ss_dssp             TTCCBCCCEECGGGCCG-GGGSSSCBCTTHHHHHHHH
T ss_pred             CCCcccccccChhhCCh-hhhcCCCCCchhhcccchh
Confidence            221      22233333 3445567888999999993

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2e-34  Score=236.44  Aligned_cols=186  Identities=18%  Similarity=0.346  Sum_probs=153.3

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      ....|.+.+.||+|+||.||+|.+..+++.||+|.++..... .....+.+.+|+.+++.++||||+++++++..+  ..
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~   89 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV-ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE--ED   89 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--SE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc-cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--CE
Confidence            334458889999999999999999999999999998754321 122346788999999999999999999999644  56


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++++|||+++|+|..++.....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||++....
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEH-GHVHITDFNIAAMLP  166 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCC-CCEEEeccceeeecc
Confidence            8899999999999999988888999999999999999999999999  9999999999999866 689999999998875


Q ss_pred             ccceeee-----ecccCccccC--CCccccccceeeecc
Q 027788          183 RAIRRIR-----CWGRRSSWRR--SCTMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~~~~-----~~~~~~~~~~--~~~~~~~~diws~gi  214 (219)
                      .......     .+.+|+.+..  ...++.++|+||+|+
T Consensus       167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~  205 (384)
T 4fr4_A          167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGV  205 (384)
T ss_dssp             TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHH
T ss_pred             CCCceeccCCCccccCCeeeccCCCCCCCccceeechHH
Confidence            5443222     3334443332  345788899999993

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.6e-34  Score=230.98  Aligned_cols=183  Identities=21%  Similarity=0.299  Sum_probs=152.1

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCce
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~  102 (219)
                      .+| ++.+.||+|+||.||+|++..+++.||+|+++.... ......+.+.+|..+++++ +||||+++++++..  ...
T Consensus         9 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~   84 (345)
T 3a8x_A            9 QDF-DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR   84 (345)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS-CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred             hhe-EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh-cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCE
Confidence            445 788999999999999999999999999999986543 3455667888999999987 89999999999954  456


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++++|||+++++|..++.....+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+++...
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCGGGCBCSC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCC-CCEEEEecccccccc
Confidence            8899999999999999887778999999999999999999999999  9999999999999866 689999999998643


Q ss_pred             ccce------eeeecccCccccCCCccccccceeeecc
Q 027788          183 RAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ....      ++..+.+| +......++.++|+||+|+
T Consensus       162 ~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~  198 (345)
T 3a8x_A          162 RPGDTTSTFCGTPNYIAP-EILRGEDYGFSVDWWALGV  198 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCH-HHHTTCCBCTHHHHHHHHH
T ss_pred             CCCCcccccCCCccccCc-cccCCCCCChHHhHHHHHH
Confidence            3221      12222233 3344566788899999993

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.1e-34  Score=228.04  Aligned_cols=181  Identities=27%  Similarity=0.450  Sum_probs=148.0

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      +| ++.+.||+|+||.||+|.+..+++.||+|.++....  .....+.+.+|+.++++++||||+++++++..+  ..++
T Consensus         3 ~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~   77 (292)
T 3o0g_A            3 KY-EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--KKLT   77 (292)
T ss_dssp             SE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEE
T ss_pred             Cc-eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC--CEEE
Confidence            45 788999999999999999999999999999986543  344457788999999999999999999999654  5688


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      ++||+++++.+..+....+.+++..+..++.|++.|+.|||+++  ++||||||+||+++.+ +.++|+|||++......
T Consensus        78 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN-GELKLANFGLARAFGIP  154 (292)
T ss_dssp             EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCSC
T ss_pred             EEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEeecccceecCCc
Confidence            99999986444444444678999999999999999999999999  9999999999999866 58999999999876543


Q ss_pred             ce------eeeecccCccccCCCccccccceeeec
Q 027788          185 IR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ..      ++..+.+|+.+.....++.++||||+|
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  189 (292)
T 3o0g_A          155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG  189 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHH
T ss_pred             cccccCCccccCCcChHHHcCCCCcCchHHHHHHH
Confidence            32      222344444444555578889999999

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6e-34  Score=232.19  Aligned_cols=183  Identities=22%  Similarity=0.322  Sum_probs=151.9

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      .|.+.+.||+|+||.||+|.+..++..||+|+++....  .....+.+.+|+.+++.++||||+++++++..  ....++
T Consensus        30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~l  105 (362)
T 2bdw_A           30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL  105 (362)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred             CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence            34888999999999999999999999999999986543  44556788999999999999999999999954  456889


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC--CcEEEeccccceeccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDLGVAAIVGR  183 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~--~~~~l~dfg~a~~~~~  183 (219)
                      +||++++++|.+.+.....+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+.  +.+||+|||++.....
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            9999999999998887778999999999999999999999999  99999999999997542  3599999999987765


Q ss_pred             cceeeeeccc----CccccCCCccccccceeeecc
Q 027788          184 AIRRIRCWGR----RSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~~~~~~~~----~~~~~~~~~~~~~~diws~gi  214 (219)
                      ........++    +++......++.++||||+|+
T Consensus       184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  218 (362)
T 2bdw_A          184 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV  218 (362)
T ss_dssp             CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHH
T ss_pred             CcccccCCCCccccCHHHHccCCCCchhhHHHHHH
Confidence            4322222222    123344556888899999993

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.7e-34  Score=229.40  Aligned_cols=184  Identities=24%  Similarity=0.382  Sum_probs=151.7

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      .+++.++| ++.+.||+|+||.||+|.+..+++.||+|.+......    ..+.+.+|+.+++.++||||+++++++...
T Consensus        15 ~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (297)
T 3fxz_A           15 VGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVG   89 (297)
T ss_dssp             SSCGGGTB-CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cCChhhce-eeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc----HHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence            44556666 7889999999999999999999999999998755422    236678999999999999999999999654


Q ss_pred             CCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                        ..++++|||+++++|.+++... .+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.++|+|||++
T Consensus        90 --~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~  163 (297)
T 3fxz_A           90 --DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGFC  163 (297)
T ss_dssp             --TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTC
T ss_pred             --CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCC-CCEEEeeCCCc
Confidence              4588999999999999988764 6899999999999999999999999  9999999999999866 58999999999


Q ss_pred             eeccccce------eeeecccCccccCCCccccccceeeecc
Q 027788          179 AIVGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       179 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ........      ++..+.+| +......++.++||||+|+
T Consensus       164 ~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~  204 (297)
T 3fxz_A          164 AQITPEQSKRSTMVGTPYWMAP-EVVTRKAYGPKVDIWSLGI  204 (297)
T ss_dssp             EECCSTTCCBCCCCSCGGGCCH-HHHHCSCBCTHHHHHHHHH
T ss_pred             eecCCcccccCCccCCcCccCh-hhhcCCCCCcHHHHHHHHH
Confidence            87755432      11222222 3344556788999999993

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-34  Score=229.20  Aligned_cols=182  Identities=18%  Similarity=0.244  Sum_probs=150.8

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ..++| .+.+.||+|+||.||+|.+..++..+|+|.++..     ......+.+|+.+++.++||||+++++++..  ..
T Consensus         3 ~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~   74 (321)
T 1tki_A            3 LYEKY-MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFES--ME   74 (321)
T ss_dssp             CTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TT
T ss_pred             hhhce-EeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEec--CC
Confidence            34556 7889999999999999999999999999998743     2334668899999999999999999999954  45


Q ss_pred             eEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC-CCcEEEeccccce
Q 027788          102 TLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN-TGQVKIGDLGVAA  179 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~-~~~~~l~dfg~a~  179 (219)
                      .++++|||+++++|.+++... ..+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ .+.++|+|||++.
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~  152 (321)
T 1tki_A           75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence            688999999999999988754 46999999999999999999999999  9999999999999852 4689999999999


Q ss_pred             eccccceeeeecccCc----cccCCCccccccceeeec
Q 027788          180 IVGRAIRRIRCWGRRS----SWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       180 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~diws~g  213 (219)
                      ............++|.    +......++.++|+||+|
T Consensus       153 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  190 (321)
T 1tki_A          153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLG  190 (321)
T ss_dssp             ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHH
T ss_pred             ECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHH
Confidence            8766544333333322    233445577889999999

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.7e-34  Score=233.15  Aligned_cols=188  Identities=18%  Similarity=0.267  Sum_probs=154.9

Q ss_pred             ccCCCCceeeeeeeeccc--cceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEe
Q 027788           19 ETDPTGRYGRYNELLGSG--AVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWR   96 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g--~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   96 (219)
                      ...+.+..|++.+.||+|  +||.||+|.+..+++.||+|.++....  .....+.+.+|+.+++.++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   96 (389)
T 3gni_B           19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIVPYRATFI   96 (389)
T ss_dssp             CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence            344455555899999999  999999999999999999999986543  4566688899999999999999999999996


Q ss_pred             cCCCceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEec
Q 027788           97 DEDRNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD  174 (219)
Q Consensus        97 ~~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~d  174 (219)
                      ..  +.++++|||+++++|.+++...  ..+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.++|+|
T Consensus        97 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~d  171 (389)
T 3gni_B           97 AD--NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSG  171 (389)
T ss_dssp             ET--TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECC
T ss_pred             EC--CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCC-CCEEEcc
Confidence            54  5688999999999999998765  67999999999999999999999999  9999999999999866 5899999


Q ss_pred             cccceeccccce-------------eeeecccCccccCC-Cccccccceeeec
Q 027788          175 LGVAAIVGRAIR-------------RIRCWGRRSSWRRS-CTMRITRSLWTYT  213 (219)
Q Consensus       175 fg~a~~~~~~~~-------------~~~~~~~~~~~~~~-~~~~~~~diws~g  213 (219)
                      ||.+........             ++..+.+|+.+... ..++.++||||+|
T Consensus       172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG  224 (389)
T 3gni_B          172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG  224 (389)
T ss_dssp             GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHH
T ss_pred             cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHH
Confidence            999876543322             11123344433332 5688889999999

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.9e-34  Score=227.68  Aligned_cols=184  Identities=23%  Similarity=0.341  Sum_probs=151.4

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      .++| ++.+.||+|+||.||+|++..++..||+|.+..... ......+.+.+|+.++++++||||+++++++.  ..+.
T Consensus        10 ~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~~~   85 (294)
T 4eqm_A           10 NERY-KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDE--EDDC   85 (294)
T ss_dssp             ETTE-EEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE--CSSE
T ss_pred             hccE-EEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHHHHHHHHHHHhcCCCCCCceEEEeee--eCCe
Confidence            3455 888999999999999999999999999999875433 34566788999999999999999999999984  4466


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++++|||+++++|.+++...+.+++..+..++.|++.++.|||+++  ++|+||||+||+++.+ +.++|+|||++....
T Consensus        86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSN-KTLKIFDFGIAKALS  162 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCSSSTTC-
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CCEEEEeCCCccccc
Confidence            8899999999999999988778999999999999999999999999  9999999999999866 589999999998764


Q ss_pred             ccce-------eeeecccCccccCCCccccccceeeecc
Q 027788          183 RAIR-------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~-------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ....       ++..+.+| +......++.++|+||+|+
T Consensus       163 ~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG~  200 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSP-EQAKGEATDECTDIYSIGI  200 (294)
T ss_dssp             ------------CCSSCCH-HHHHTCCCCTTHHHHHHHH
T ss_pred             cccccccCccccCccccCH-hHhcCCCCCchHhHHHHHH
Confidence            4321       12222233 3344556777899999993

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.4e-34  Score=229.84  Aligned_cols=187  Identities=24%  Similarity=0.376  Sum_probs=152.5

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCC--HHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD--PAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ...|++.+.||+|+||.||+|.+..++..||+|.++.......  ....+.+.+|+.+++.++||||+++++++..  ..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~   87 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KT   87 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CC
Confidence            4455889999999999999999999999999999986543211  1234678899999999999999999999854  45


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC---CcEEEeccccc
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT---GQVKIGDLGVA  178 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~---~~~~l~dfg~a  178 (219)
                      .++++||++++++|.+++.....+++..+..++.|++.||.|||+.+  ++|+||||+||+++.+.   ..++|+|||++
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            68899999999999999987778999999999999999999999999  99999999999997542   16999999999


Q ss_pred             eeccccceeeeeccc----CccccCCCccccccceeeecc
Q 027788          179 AIVGRAIRRIRCWGR----RSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       179 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~diws~gi  214 (219)
                      .............++    +++......++.++|+||+|+
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  205 (326)
T 2y0a_A          166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV  205 (326)
T ss_dssp             EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHH
T ss_pred             eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHH
Confidence            887544322222222    223344566788899999993

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.1e-34  Score=235.70  Aligned_cols=184  Identities=21%  Similarity=0.284  Sum_probs=147.8

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCce
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~  102 (219)
                      ++| ++.+.||+|+||.||+|++..+++.||+|+++..... .....+.+.+|..+++.+ +||||+++++++..  ...
T Consensus        23 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~   98 (353)
T 3txo_A           23 DNF-EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDR   98 (353)
T ss_dssp             CCE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred             hhe-EEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-chhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCE
Confidence            445 8889999999999999999999999999999854321 123346778899999988 79999999999954  456


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++++|||+++|+|..++.....+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+++...
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~-g~ikL~DFG~a~~~~  175 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCSC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCC-CCEEEccccceeecc
Confidence            8899999999999999988788999999999999999999999999  9999999999999866 689999999998644


Q ss_pred             ccce-eeeecccC----ccccCCCccccccceeeecc
Q 027788          183 RAIR-RIRCWGRR----SSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~-~~~~~~~~----~~~~~~~~~~~~~diws~gi  214 (219)
                      .... .....|++    ++......++.++|+||+|+
T Consensus       176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  212 (353)
T 3txo_A          176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGV  212 (353)
T ss_dssp             C---------CCGGGCCHHHHHHHHCTTHHHHHHHHH
T ss_pred             cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchH
Confidence            3322 11222322    12333445788899999993

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.3e-34  Score=233.23  Aligned_cols=184  Identities=18%  Similarity=0.287  Sum_probs=149.4

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCce
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~  102 (219)
                      ++| .+.+.||+|+||.||+|++..+++.||+|.++...... ....+.+..|..+++.+ +||||+++++++..  ...
T Consensus        17 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~~   92 (345)
T 1xjd_A           17 EDF-ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KEN   92 (345)
T ss_dssp             TTE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSE
T ss_pred             HHe-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CCE
Confidence            455 78899999999999999999999999999998543211 12346677899999877 99999999999954  456


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++++|||+++|+|.+++.....+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.++|+|||+++...
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCC-CCEEEeEChhhhhcc
Confidence            8899999999999999987778999999999999999999999999  9999999999999866 689999999998653


Q ss_pred             ccce-eeeeccc----CccccCCCccccccceeeecc
Q 027788          183 RAIR-RIRCWGR----RSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~-~~~~~~~----~~~~~~~~~~~~~~diws~gi  214 (219)
                      .... .....|+    +++......++.++|+||+|+
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  206 (345)
T 1xjd_A          170 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGV  206 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred             cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHH
Confidence            3221 1122222    223344556888899999993

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-34  Score=230.64  Aligned_cols=183  Identities=20%  Similarity=0.291  Sum_probs=151.3

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+| ++.+.||+|+||.||+|.+..+++.||+|+++..... .....+.+.+|+.+++.++||||+++++++..  ...+
T Consensus         6 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~   81 (318)
T 1fot_A            6 QDF-QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQI   81 (318)
T ss_dssp             GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEE
T ss_pred             HHc-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe--CCEE
Confidence            445 7889999999999999999999999999999854321 11234677889999999999999999999954  4568


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++|||+++++|.+++.....+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+++....
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIKITDFGFAKYVPD  158 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTT-SCEEECCCSSCEECSS
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCC-CCEEEeecCcceecCC
Confidence            899999999999999988888999999999999999999999999  9999999999999866 6899999999987654


Q ss_pred             cce---eeeecccCccccCCCccccccceeeecc
Q 027788          184 AIR---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ...   ++..+.+| +......++.++|+||+|+
T Consensus       159 ~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~  191 (318)
T 1fot_A          159 VTYTLCGTPDYIAP-EVVSTKPYNKSIDWWSFGI  191 (318)
T ss_dssp             CBCCCCSCTTTCCH-HHHTTCCBCTTHHHHHHHH
T ss_pred             ccccccCCccccCH-hHhcCCCCCcccchhhhHH
Confidence            321   12222222 3445566888899999993

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.7e-34  Score=232.01  Aligned_cols=184  Identities=20%  Similarity=0.286  Sum_probs=147.5

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ..++| ++.+.||+|+||.||+|.+..+++.||+|++.....   ....+.+.+|+.+++.++||||+++++++.  +..
T Consensus         5 ~~~~y-~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~   78 (323)
T 3tki_A            5 FVEDW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRR--EGN   78 (323)
T ss_dssp             TTTCE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEE--CSS
T ss_pred             Hhhhc-eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCCCCeEEEEEe--cCC
Confidence            34556 888999999999999999999999999999875432   223366889999999999999999999985  446


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      ..+++|||+++++|.+++.....+++..+..++.|++.||.|||+.+  ++|+||||+||+++.+ +.++|+|||++...
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVF  155 (323)
T ss_dssp             EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEEC
T ss_pred             eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCC-CCEEEEEeecccee
Confidence            68899999999999998887778999999999999999999999999  9999999999999866 58999999999876


Q ss_pred             cccce--------eeeecccCccccCCCccccccceeeecc
Q 027788          182 GRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       182 ~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .....        ++..+.+|+.+.....++.++||||+|+
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~  196 (323)
T 3tki_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI  196 (323)
T ss_dssp             EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHH
T ss_pred             ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHH
Confidence            43322        1222333333333333466799999993

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=7.6e-34  Score=237.16  Aligned_cols=183  Identities=23%  Similarity=0.269  Sum_probs=150.8

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+| ++.+.||+|+||.||+|.+..++..+|+|.+.....  .....+.+.+|+.+++.++||||+++++++.  +...+
T Consensus        11 ~~Y-~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~   85 (444)
T 3soa_A           11 EEY-QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSIS--EEGHH   85 (444)
T ss_dssp             HHE-EEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE--CSSEE
T ss_pred             CCe-EEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE--ECCEE
Confidence            445 888999999999999999999999999999886543  3445577889999999999999999999995  44668


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC--CCCcEEEeccccceec
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG--NTGQVKIGDLGVAAIV  181 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~--~~~~~~l~dfg~a~~~  181 (219)
                      +++||++++|+|.+.+.....+++..+..++.|++.|+.|||+++  ++||||||+||+++.  +.+.+||+|||++...
T Consensus        86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            899999999999999888888999999999999999999999999  999999999999974  2357999999999877


Q ss_pred             cccce------eeeecccCccccCCCccccccceeeecc
Q 027788          182 GRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       182 ~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .....      ++..+.+| +......++.++||||+|+
T Consensus       164 ~~~~~~~~~~~gt~~Y~AP-E~l~~~~~~~~~DIwSlGv  201 (444)
T 3soa_A          164 EGEQQAWFGFAGTPGYLSP-EVLRKDPYGKPVDLWACGV  201 (444)
T ss_dssp             CTTCCBCCCSCSCGGGCCH-HHHTTCCBCTHHHHHHHHH
T ss_pred             cCCCceeecccCCcccCCH-HHhcCCCCCCccccHHHHH
Confidence            55432      22223333 3344556888999999993

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-33  Score=225.70  Aligned_cols=179  Identities=23%  Similarity=0.386  Sum_probs=148.8

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++| .+.+.||+|+||.||+|.+..+++.||+|.+...    +....+.+.+|+.++++++||||+++++++...  ..+
T Consensus        10 ~~~-~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~   82 (310)
T 3s95_A           10 SDL-IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF----DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KRL   82 (310)
T ss_dssp             GGE-EEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEE
T ss_pred             hHe-eccceecCCCCEEEEEEEECCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--Cee
Confidence            444 7889999999999999999999999999987532    456678899999999999999999999999654  558


Q ss_pred             EEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          104 NFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+  ++|+||||+||+++.+ +.++|+|||++....
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVREN-KNVVVADFGLARLMV  159 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTT-SCEEECCCTTCEECC
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCC-CCEEEeecccceecc
Confidence            889999999999999876 467999999999999999999999999  9999999999999865 589999999998775


Q ss_pred             cccee--------------------eeecccCccccCCCccccccceeeec
Q 027788          183 RAIRR--------------------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~~--------------------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .....                    +..+.+| +......++.++||||+|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG  209 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP-EMINGRSYDEKVDVFSFG  209 (310)
T ss_dssp             --------------------CCCCSCGGGCCH-HHHTTCCCCTHHHHHHHH
T ss_pred             cccccccccccccccccccccccCCCcceeCH-HHhcCCCCCcHHHHHHHH
Confidence            43321                    1112222 334456678889999999

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.3e-34  Score=229.42  Aligned_cols=185  Identities=26%  Similarity=0.445  Sum_probs=149.1

Q ss_pred             CCCCceeeeeeeeccccceEEEEEE----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEe
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAF----DQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWR   96 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   96 (219)
                      +...+.|++.+.||+|+||.||+|+    +..+++.||+|.++..    .....+.+.+|+.++++++||||+++++++.
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   81 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCY   81 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            3445666999999999999999998    5678999999998743    4556678999999999999999999999987


Q ss_pred             cCCCceEEEEeccccCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788           97 DEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus        97 ~~~~~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      ..+...++++|||+++++|.+++.... .+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+ +.++|+||
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~-~~~kl~Df  158 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVKIGDF  158 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCC-CeEEEccC
Confidence            655566889999999999999987653 5999999999999999999999999  9999999999999866 58999999


Q ss_pred             ccceeccccce---------eeeecccCccccCCCccccccceeeec
Q 027788          176 GVAAIVGRAIR---------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       176 g~a~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |++........         .+..+.+| +......++.++||||+|
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  204 (295)
T 3ugc_A          159 GLTKVLPQDKEFFKVKEPGESPIFWYAP-ESLTESKFSVASDVWSFG  204 (295)
T ss_dssp             CSCC-------------CTTCGGGGCCH-HHHHHCCCCHHHHHHHHH
T ss_pred             cccccccCCcceeeeccCCCCccceeCc-HHhcCCCCChHHHHHHHH
Confidence            99987654332         11112333 333445578889999999

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.6e-34  Score=232.53  Aligned_cols=183  Identities=19%  Similarity=0.289  Sum_probs=152.0

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++| ++.+.||+|+||.||+|.+..+++.||+|+++..... .....+.+.+|+.+++.++||||+++++++..  ...+
T Consensus        41 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~  116 (350)
T 1rdq_E           41 DQF-DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNL  116 (350)
T ss_dssp             GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred             HHC-EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc-cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEE
Confidence            455 7889999999999999999999999999998754321 12234678899999999999999999999954  4568


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++|||+++++|.+++.....+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.++|+|||+++....
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCC-CCEEEcccccceeccC
Confidence            899999999999999987778999999999999999999999999  9999999999999866 6899999999987754


Q ss_pred             cce---eeeecccCccccCCCccccccceeeecc
Q 027788          184 AIR---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ...   ++..+.+| +......++.++|+||+|+
T Consensus       194 ~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~  226 (350)
T 1rdq_E          194 RTWTLCGTPEALAP-EIILSKGYNKAVDWWALGV  226 (350)
T ss_dssp             CBCCCEECGGGCCH-HHHTTCCBCTHHHHHHHHH
T ss_pred             CcccccCCccccCH-HHhcCCCCCCcCCEecccH
Confidence            321   22223333 3344566888899999993

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1e-33  Score=227.30  Aligned_cols=181  Identities=18%  Similarity=0.312  Sum_probs=146.3

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC------
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR------  100 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~------  100 (219)
                      |++.+.||+|+||.||+|.+..+++.||+|.++...   .....+.+.+|+.++++++||||+++++++.....      
T Consensus         8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            378899999999999999999999999999987543   34455788999999999999999999998865432      


Q ss_pred             -------------------------------------------------ceEEEEeccccCCChHHHHHhCCC---CCHH
Q 027788          101 -------------------------------------------------NTLNFITEVCTSGNLREYRKKHRH---VSVK  128 (219)
Q Consensus       101 -------------------------------------------------~~~~lv~e~~~~g~L~~~~~~~~~---~~~~  128 (219)
                                                                       .+++++|||+++++|.+++.....   ..+.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                             248899999999999999876533   4566


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce------------------eeee
Q 027788          129 ALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR------------------RIRC  190 (219)
Q Consensus       129 ~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~------------------~~~~  190 (219)
                      .+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||++........                  ++..
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCC-CCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            78999999999999999999  9999999999999866 5899999999998765432                  1122


Q ss_pred             cccCccccCCCccccccceeeecc
Q 027788          191 WGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       191 ~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +.+| +......++.++|+||+|+
T Consensus       242 y~aP-E~~~~~~~~~~~Di~slG~  264 (332)
T 3qd2_B          242 YMSP-EQIHGNNYSHKVDIFSLGL  264 (332)
T ss_dssp             GSCH-HHHHCCCCCTHHHHHHHHH
T ss_pred             ccCh-HHhcCCCCcchhhHHHHHH
Confidence            2222 3334556788899999993

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5e-34  Score=229.60  Aligned_cols=185  Identities=18%  Similarity=0.205  Sum_probs=139.7

Q ss_pred             CceeeeeeeeccccceEEEEEEec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQ---EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      ...|++.+.||+|+||.||+|++.   .+++.||+|+++.............+.+|+.+++.++||||+++++++..  .
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~   93 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--G   93 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--C
Confidence            344588899999999999999875   68999999999865433333445667889999999999999999999954  4


Q ss_pred             ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          101 NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      ..++++|||+++++|.+++.....+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+++.
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~-~~~kl~Dfg~~~~  170 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQ-GHVKLTDFGLCKE  170 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTT-SCEEECCCSCC--
T ss_pred             CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCC-CcEEEEeCCcccc
Confidence            568899999999999999887778999999999999999999999999  9999999999999866 6899999999976


Q ss_pred             ccccce------eeeecccCccccCCCccccccceeeecc
Q 027788          181 VGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       181 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ......      ++..+.+| +......++.++|+||+|+
T Consensus       171 ~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~  209 (327)
T 3a62_A          171 SIHDGTVTHTFCGTIEYMAP-EILMRSGHNRAVDWWSLGA  209 (327)
T ss_dssp             --------CTTSSCCTTSCH-HHHTTSCCCTHHHHHHHHH
T ss_pred             cccCCccccccCCCcCccCH-hhCcCCCCCCcccchhHHH
Confidence            543322      22223333 3344556788899999993

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.1e-34  Score=225.74  Aligned_cols=190  Identities=27%  Similarity=0.428  Sum_probs=150.5

Q ss_pred             ccccCCCCceeeeeeeeccccceEEEEEE----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEE
Q 027788           17 FIETDPTGRYGRYNELLGSGAVKKVYRAF----DQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH   92 (219)
Q Consensus        17 ~~~~~~~~~~~~~~~~ig~g~~g~V~~a~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~   92 (219)
                      ........++|++.+.||+|+||.||+|+    +..+++.||+|.++...   .....+.+.+|+.+++.++||||++++
T Consensus        13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~   89 (302)
T 4e5w_A           13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYK   89 (302)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCeeeee
Confidence            33444556777999999999999999998    67789999999987543   223346788999999999999999999


Q ss_pred             EEEecCCCceEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEE
Q 027788           93 YVWRDEDRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVK  171 (219)
Q Consensus        93 ~~~~~~~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~  171 (219)
                      +++..++...++++||++++++|.+++.. ...+++..+..++.|++.++.+||+.+  ++|+||||+||+++.+ +.++
T Consensus        90 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~k  166 (302)
T 4e5w_A           90 GICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESE-HQVK  166 (302)
T ss_dssp             EEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEE
T ss_pred             eEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCC-CCEE
Confidence            99987766778999999999999999844 457999999999999999999999999  9999999999999866 5899


Q ss_pred             Eeccccceecccccee---------eeecccCccccCCCccccccceeeec
Q 027788          172 IGDLGVAAIVGRAIRR---------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       172 l~dfg~a~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |+|||++.........         +..+.+| +......++.++|+||+|
T Consensus       167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  216 (302)
T 4e5w_A          167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP-ECLMQSKFYIASDVWSFG  216 (302)
T ss_dssp             ECCCTTCEECCTTCCEEECCCCTTCCGGGCCH-HHHHHCEEEHHHHHHHHH
T ss_pred             ECcccccccccCCCcceeccCCCCCCccccCC-eeecCCCCCcchhHHHHH
Confidence            9999999887554321         1112222 223344567789999999

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.8e-34  Score=233.05  Aligned_cols=184  Identities=23%  Similarity=0.335  Sum_probs=148.3

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      .++| ++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.++||||+++++++..  ...
T Consensus         8 i~~Y-~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~   83 (336)
T 3h4j_B            8 IGPY-IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVEREISYLKLLRHPHIIKLYDVITT--PTD   83 (336)
T ss_dssp             ETTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred             cCCE-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCE
Confidence            3566 8889999999999999999999999999998754321 11223568899999999999999999999954  456


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++++|||+ +|+|.+++.....+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.+||+|||++....
T Consensus        84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDN-LNVKIADFGLSNIMT  159 (336)
T ss_dssp             EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTT-CCEEECCSSCTBTTT
T ss_pred             EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCC-CCEEEEEeccceecc
Confidence            88999999 6789888877778999999999999999999999999  9999999999999865 589999999998765


Q ss_pred             ccceee-----eecccCccccCCCccccccceeeecc
Q 027788          183 RAIRRI-----RCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~~~-----~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ......     ..+.+|+.+......+.++|+||+|+
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~  196 (336)
T 3h4j_B          160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGI  196 (336)
T ss_dssp             TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHH
T ss_pred             CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHH
Confidence            544322     22333433333333356799999993

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-33  Score=230.53  Aligned_cols=184  Identities=20%  Similarity=0.258  Sum_probs=150.7

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ..++ |++.+.||+|+||.||+|.+..+++.+|+|++...    .......+.+|+.+++.++||||+++++++..  ..
T Consensus        49 ~~~~-y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~  121 (387)
T 1kob_A           49 VYDY-YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFED--KY  121 (387)
T ss_dssp             GGGT-EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SS
T ss_pred             cccc-eEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc----chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe--CC
Confidence            3344 48889999999999999999999999999998754    23344678899999999999999999999954  46


Q ss_pred             eEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC-CCcEEEeccccce
Q 027788          102 TLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN-TGQVKIGDLGVAA  179 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~-~~~~~l~dfg~a~  179 (219)
                      .++++|||+++++|.+++... ..+++..+..++.|++.||.|||+++  ++||||||+||+++.+ .+.++|+|||++.
T Consensus       122 ~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~  199 (387)
T 1kob_A          122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLAT  199 (387)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             EEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccce
Confidence            688999999999999988654 36899999999999999999999999  9999999999999742 3579999999999


Q ss_pred             eccccceeeeeccc----CccccCCCccccccceeeecc
Q 027788          180 IVGRAIRRIRCWGR----RSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~diws~gi  214 (219)
                      ............++    +++......++.++||||+|+
T Consensus       200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~  238 (387)
T 1kob_A          200 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGV  238 (387)
T ss_dssp             ECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHH
T ss_pred             ecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhH
Confidence            87654432222232    223344556788899999993

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.3e-34  Score=231.28  Aligned_cols=183  Identities=20%  Similarity=0.246  Sum_probs=142.5

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      ...++| ++.+.||+|+||.||+|.+..+++.||+|.+......     .+.+.+|+.+++.++||||+++++++..  .
T Consensus        17 ~~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~--~   88 (361)
T 3uc3_A           17 HDSDRY-DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-----DENVQREIINHRSLRHPNIVRFKEVILT--P   88 (361)
T ss_dssp             CCTTTE-EEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-----CHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred             CCCCcE-EEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-----cHHHHHHHHHHHhCCCCCCCcEEEEEee--C
Confidence            344556 8889999999999999999999999999998754321     2557789999999999999999999954  4


Q ss_pred             ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC-CcEEEeccccce
Q 027788          101 NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT-GQVKIGDLGVAA  179 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~-~~~~l~dfg~a~  179 (219)
                      ..++++|||+++++|.+++...+.+++..+..++.|++.||.|||+++  ++||||||+||+++.+. +.+||+|||+++
T Consensus        89 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~  166 (361)
T 3uc3_A           89 THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSK  166 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence            568899999999999999887778999999999999999999999999  99999999999997542 249999999997


Q ss_pred             eccccceeee-----ecccCccccCCCccccc-cceeeecc
Q 027788          180 IVGRAIRRIR-----CWGRRSSWRRSCTMRIT-RSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~-~diws~gi  214 (219)
                      ..........     .+.+|+.. ....+..+ +||||+|+
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~~DiwslG~  206 (361)
T 3uc3_A          167 SSVLHSQPKSTVGTPAYIAPEVL-LRQEYDGKIADVWSCGV  206 (361)
T ss_dssp             --------------CTTSCHHHH-HCSSCCHHHHHHHHHHH
T ss_pred             cccccCCCCCCcCCCCcCChhhh-cCCCCCCCeeeeehhHH
Confidence            5443332222     22333322 33344444 89999993

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.3e-33  Score=225.48  Aligned_cols=185  Identities=22%  Similarity=0.317  Sum_probs=144.1

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      .....|++.+.||+|+||.||+|.+  ++..||+|++.....  .....+.+.+|+.++++++||||+++++++..  ..
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~  107 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ--PP  107 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--TT
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CC
Confidence            4444558999999999999999976  578999999875533  45566789999999999999999999999954  44


Q ss_pred             eEEEEeccccCCChHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          102 TLNFITEVCTSGNLREYRKKHRH---VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~---~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      .++++|||+++++|.+++.....   +++..+..++.|++.|+.|||+.+++++||||||+||+++.+ +.++|+|||++
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a  186 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLS  186 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT-CCEEECCCC--
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC-CcEEECCCCCC
Confidence            57889999999999999876543   899999999999999999999988779999999999999866 58999999999


Q ss_pred             eeccccce------eeeecccCccccCCCccccccceeeecc
Q 027788          179 AIVGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       179 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +.......      ++..+.+| +......++.++|+||+|+
T Consensus       187 ~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~  227 (309)
T 3p86_A          187 RLKASTFLSSKSAAGTPEWMAP-EVLRDEPSNEKSDVYSFGV  227 (309)
T ss_dssp             ---------------CCTTSCH-HHHTTCCCCTTHHHHHHHH
T ss_pred             ccccccccccccCCCCccccCh-hhhcCCCCCchhhHHHHHH
Confidence            76544322      22223333 3344556788899999993

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.3e-33  Score=225.65  Aligned_cols=185  Identities=25%  Similarity=0.416  Sum_probs=146.5

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      ....++| ++.+.||+|+||.||+|.+. +++.||+|.+.....  .....+.+.+|+.++++++||||+++++++.  +
T Consensus        17 q~l~~~y-~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~   90 (311)
T 3niz_A           17 QGLMEKY-QKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVIH--S   90 (311)
T ss_dssp             ECSSCEE-EEEEEEEECSSCEEEEEEET-TSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC--C
T ss_pred             cchHhhh-HhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeeeeeEEc--c
Confidence            3445666 78899999999999999974 589999999875432  3334577889999999999999999999994  4


Q ss_pred             CceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          100 RNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      ...++++|||+++ +|.+.+... ..+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~a  166 (311)
T 3niz_A           91 ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSD-GALKLADFGLA  166 (311)
T ss_dssp             SSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTC
T ss_pred             CCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCC-CCEEEccCcCc
Confidence            4568899999974 777766543 45999999999999999999999999  9999999999999866 58999999999


Q ss_pred             eeccccce------eeeecccCccccCCCccccccceeeecc
Q 027788          179 AIVGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       179 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ........      ++..+.+|+.+.....++.++|+||+|+
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  208 (311)
T 3niz_A          167 RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGC  208 (311)
T ss_dssp             EETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred             eecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHH
Confidence            87754332      2223344444445566888899999993

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-34  Score=236.39  Aligned_cols=188  Identities=20%  Similarity=0.350  Sum_probs=152.0

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      +...++.|++.+.||+|+||.||+|.+..+++.||+|+++.....   ...+.+.+|++++++++||||+++++++...+
T Consensus         4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~   80 (396)
T 4eut_A            4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETT   80 (396)
T ss_dssp             EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred             CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence            344566679999999999999999999999999999998754432   22466788999999999999999999998777


Q ss_pred             CceEEEEeccccCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEE----eCCCCcEEE
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHR---HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFV----NGNTGQVKI  172 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili----~~~~~~~~l  172 (219)
                      ...++++|||+++++|.+++....   .+++..+..++.|++.||.|||+++  ++||||||+||++    +.+ +.+||
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~-~~~kL  157 (396)
T 4eut_A           81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQ-SVYKL  157 (396)
T ss_dssp             TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSC-EEEEE
T ss_pred             CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCc-eeEEE
Confidence            667899999999999999886543   3899999999999999999999999  9999999999998    433 46899


Q ss_pred             eccccceeccccceeeeecc-----cCccccC-------CCccccccceeeec
Q 027788          173 GDLGVAAIVGRAIRRIRCWG-----RRSSWRR-------SCTMRITRSLWTYT  213 (219)
Q Consensus       173 ~dfg~a~~~~~~~~~~~~~~-----~~~~~~~-------~~~~~~~~diws~g  213 (219)
                      +|||+++............+     +|+.+..       ...++.++||||+|
T Consensus       158 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG  210 (396)
T 4eut_A          158 TDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG  210 (396)
T ss_dssp             CCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHH
T ss_pred             ecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHH
Confidence            99999988765543222223     3322211       14566789999999

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6.6e-34  Score=236.95  Aligned_cols=184  Identities=16%  Similarity=0.213  Sum_probs=148.4

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      +-|.+.+.||+|+||.||+|.+..+++.||+|+++...... ......+.+|+.++..++||||+++++++..  ...++
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~~  150 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQD--DNNLY  150 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEEE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCEEE
Confidence            34488899999999999999999999999999987532111 1112347889999999999999999999954  45689


Q ss_pred             EEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          105 FITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      ++|||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.+||+|||+++....
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~-g~vkL~DFGla~~~~~  227 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMN-GHIRLADFGSCLKLME  227 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCT
T ss_pred             EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCC-CCEEEcchhhhhhccc
Confidence            99999999999999876 467999999999999999999999999  9999999999999866 6899999999987755


Q ss_pred             cce-------eeeecccCcccc----CCCccccccceeeecc
Q 027788          184 AIR-------RIRCWGRRSSWR----RSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~-------~~~~~~~~~~~~----~~~~~~~~~diws~gi  214 (219)
                      ...       ++..+.+|+.+.    ....++.++|+||+|+
T Consensus       228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGv  269 (437)
T 4aw2_A          228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGV  269 (437)
T ss_dssp             TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHH
T ss_pred             CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHH
Confidence            432       122222333222    1455788899999993

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.7e-34  Score=224.84  Aligned_cols=186  Identities=22%  Similarity=0.404  Sum_probs=145.1

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCC----------------------HHHHHHHHHHHHHHH
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD----------------------PAMIERLFSEVRLLK   81 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~----------------------~~~~~~~~~E~~~l~   81 (219)
                      ++| ++.+.||+|+||.||+|++..+++.||+|++........                      ....+.+.+|+.+++
T Consensus        13 ~~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           13 NQY-TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             TTE-EEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             cce-EEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            455 888999999999999999999999999999875532111                      122456889999999


Q ss_pred             hhCCCCceEEEEEEecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCce
Q 027788           82 TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNV  161 (219)
Q Consensus        82 ~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~ni  161 (219)
                      +++||||+++++++...+...++++||++++++|.+++. ...+++..+..++.|++.||.|||+++  ++|+||||+||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Ni  168 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNL  168 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGE
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHE
Confidence            999999999999997766778999999999999987543 357999999999999999999999999  99999999999


Q ss_pred             EEeCCCCcEEEeccccceeccccce------eeeecccCccccCCCc--cccccceeeecc
Q 027788          162 FVNGNTGQVKIGDLGVAAIVGRAIR------RIRCWGRRSSWRRSCT--MRITRSLWTYTR  214 (219)
Q Consensus       162 li~~~~~~~~l~dfg~a~~~~~~~~------~~~~~~~~~~~~~~~~--~~~~~diws~gi  214 (219)
                      +++.+ +.+||+|||++........      ++..+.+|+.+.....  ++.++|+||+|+
T Consensus       169 l~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~  228 (298)
T 2zv2_A          169 LVGED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV  228 (298)
T ss_dssp             EECTT-SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHH
T ss_pred             EECCC-CCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHH
Confidence            99866 5899999999987754432      2223334443333222  355689999993

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-33  Score=230.89  Aligned_cols=182  Identities=21%  Similarity=0.346  Sum_probs=143.0

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCCce
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~  102 (219)
                      ++| ++.+.||+|+||.||+|.+..+++.||+|.+....  ......+++.+|+.+++.+. ||||+++++++..++...
T Consensus         9 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            9 RKY-ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF--QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             TTE-EEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             Cce-EEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc--cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            455 78899999999999999999999999999986432  24556678889999999997 999999999998777778


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++++|||++ ++|..++.. ..++...+..++.|++.||.|||+.+  ++||||||+||+++.+ +.+||+|||+|+...
T Consensus        86 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAE-CHVKVADFGLSRSFV  160 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEESS
T ss_pred             EEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCC-CCEEecCCccccccc
Confidence            999999997 688888765 47899999999999999999999999  9999999999999866 589999999998764


Q ss_pred             ccc---------------------------eeeeecccCccccCCCccccccceeeec
Q 027788          183 RAI---------------------------RRIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~---------------------------~~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...                           .++..+.+|+.+.....++.++||||+|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  218 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG  218 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHH
Confidence            311                           1222233444344446688889999999

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.2e-34  Score=235.41  Aligned_cols=183  Identities=15%  Similarity=0.217  Sum_probs=146.5

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      .-|.+.+.||+|+||.||+|.+..+++.||+|+++...... ....+.+.+|+.+++.++||||+++++++..  ...++
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~  145 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYLY  145 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEE
Confidence            34588899999999999999999999999999987532110 1112457789999999999999999999954  46689


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      ++|||+++|+|.+++... .+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.+||+|||+++.....
T Consensus       146 lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~-g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             EEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECCTT
T ss_pred             EEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCC-CCEEEeccceeEeeccC
Confidence            999999999999988754 6899999999999999999999999  9999999999999866 68999999999877554


Q ss_pred             ce-------eeeecccCccccCCC---ccccccceeeecc
Q 027788          185 IR-------RIRCWGRRSSWRRSC---TMRITRSLWTYTR  214 (219)
Q Consensus       185 ~~-------~~~~~~~~~~~~~~~---~~~~~~diws~gi  214 (219)
                      ..       ++..+.+|+.+...+   .++.++|+||+|+
T Consensus       222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGv  261 (410)
T 3v8s_A          222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGV  261 (410)
T ss_dssp             SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHH
T ss_pred             CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchH
Confidence            32       222222333222221   2777899999993

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.3e-33  Score=227.03  Aligned_cols=183  Identities=21%  Similarity=0.303  Sum_probs=147.5

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCc---EEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGI---EVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      .....|++.+.||+|+||.||+|.+..++.   .||+|.++...   .....+.+.+|+.+++.++||||+++++++.  
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--  120 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDHPNIIRLEGVVT--  120 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--
Confidence            344455899999999999999999875554   49999987432   4556678999999999999999999999994  


Q ss_pred             CCceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                      +...++++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||+
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~  197 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSN-LVCKVSDFGL  197 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCSS
T ss_pred             eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCC-CCEEECCCCc
Confidence            445678899999999999998654 57999999999999999999999999  9999999999999866 5899999999


Q ss_pred             ceeccccceee--e-------ecccCccccCCCccccccceeeec
Q 027788          178 AAIVGRAIRRI--R-------CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       178 a~~~~~~~~~~--~-------~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +..........  .       .+.+| +......++.++||||+|
T Consensus       198 a~~~~~~~~~~~~~~~~~~t~~y~aP-E~~~~~~~~~~~Di~slG  241 (325)
T 3kul_A          198 SRVLEDDPDAAYTTTGGKIPIRWTAP-EAIAFRTFSSASDVWSFG  241 (325)
T ss_dssp             CEECC----CCEECC---CCGGGSCH-HHHHHCEECHHHHHHHHH
T ss_pred             ccccccCccceeeccCCCCcccccCH-hHhcCCCCCcHHHHHHHH
Confidence            98875543211  1       12233 333445677889999999

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.2e-33  Score=223.86  Aligned_cols=183  Identities=23%  Similarity=0.408  Sum_probs=150.6

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++| ++.+.||+|+||.||+|.+..+++.||+|.+....  ......+.+.+|+.++++++||||+++++++...  ..+
T Consensus         3 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~   77 (311)
T 4agu_A            3 EKY-EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK--RRL   77 (311)
T ss_dssp             CCE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEE
T ss_pred             ccc-eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeecC--CeE
Confidence            455 78899999999999999999999999999886543  2445567788999999999999999999999654  568


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++||++++++|..++.....+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+ +.++|+|||++.....
T Consensus        78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKH-SVIKLCDFGFARLLTG  154 (311)
T ss_dssp             EEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECC-
T ss_pred             EEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCC-CCEEEeeCCCchhccC
Confidence            889999999999998887778999999999999999999999999  9999999999999866 5899999999987764


Q ss_pred             cce------eeeecccCccccCCCccccccceeeecc
Q 027788          184 AIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ...      ++..+.+|+.+.....++.++|+||+|+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~  191 (311)
T 4agu_A          155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGC  191 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHH
T ss_pred             cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHH
Confidence            332      2222334444444566788899999993

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.7e-34  Score=228.66  Aligned_cols=186  Identities=19%  Similarity=0.266  Sum_probs=149.4

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC-
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR-  100 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~-  100 (219)
                      ..++| ++.+.||+|+||.||+|.+..+++.||+|+++.... .+......+.+|+.++++++||||+++++++..... 
T Consensus        10 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   87 (311)
T 3ork_A           10 LSDRY-ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   87 (311)
T ss_dssp             ETTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT-TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred             ecCcE-EEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc-CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence            34555 888999999999999999999999999999875433 345666789999999999999999999998865433 


Q ss_pred             -ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          101 -NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       101 -~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                       ...+++|||+++++|.+++.....+++..+..++.|++.+|.|||+++  ++|+||||+||+++.+ +.+||+|||++.
T Consensus        88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~a~  164 (311)
T 3ork_A           88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT-NAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETT-SCEEECCCSCC-
T ss_pred             CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCC-CCEEEeeccCcc
Confidence             355889999999999999987778999999999999999999999999  9999999999999866 589999999998


Q ss_pred             eccccce---------eeeecccCccccCCCccccccceeeec
Q 027788          180 IVGRAIR---------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       180 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .......         ++..+.+| +......++.++||||+|
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG  206 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSP-EQARGDSVDARSDVYSLG  206 (311)
T ss_dssp             -----------------CCTTCCH-HHHHTCCCCHHHHHHHHH
T ss_pred             cccccccccccccccCcCcccCCH-HHhcCCCCCchHhHHHHH
Confidence            7654321         12222233 333455678889999999

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4e-34  Score=230.29  Aligned_cols=185  Identities=29%  Similarity=0.471  Sum_probs=146.3

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ..++| ++.+.||+|+||.||+|.+..+++.||+|.++....  .....+.+.+|+.++++++||||+++++++..+  .
T Consensus        32 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~  106 (329)
T 3gbz_A           32 SIDRY-RRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSVIHHN--H  106 (329)
T ss_dssp             CGGGE-EEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEET--T
T ss_pred             chhhE-EEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEEEecC--C
Confidence            44555 888999999999999999999999999999875532  333446678999999999999999999999654  5


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC----CCcEEEecccc
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN----TGQVKIGDLGV  177 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~----~~~~~l~dfg~  177 (219)
                      .++++|||++ ++|.+++...+.+++..+..++.|++.||.|||+++  ++|+||||+||+++.+    .+.++|+|||+
T Consensus       107 ~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          107 RLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            6889999997 599999988888999999999999999999999999  9999999999999532    23599999999


Q ss_pred             ceeccccce------eeeecccCccccCCCccccccceeeecc
Q 027788          178 AAIVGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +........      ++..+.+|+.+.....++.++||||+|+
T Consensus       184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  226 (329)
T 3gbz_A          184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIAC  226 (329)
T ss_dssp             HHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred             ccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHH
Confidence            987654332      2233445544555566888999999993

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.3e-34  Score=234.49  Aligned_cols=185  Identities=15%  Similarity=0.227  Sum_probs=149.4

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ...|++.+.||+|+||.||+|.+..+++.||+|+++..... .....+.+.+|+.++..++||||+++++++..  .+.+
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~  136 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRWITQLHFAFQD--ENYL  136 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEE
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEE
Confidence            34458889999999999999999999999999998753211 11223457889999999999999999999954  4568


Q ss_pred             EEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          104 NFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +++|||+++|+|.+++... ..+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.+||+|||+++...
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~-g~vkL~DFGla~~~~  213 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRC-GHIRLADFGSCLKLR  213 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECC
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCC-CCEEEeechhheecc
Confidence            9999999999999998764 47999999999999999999999999  9999999999999865 689999999998875


Q ss_pred             ccce-------eeeecccCccccC------CCccccccceeeecc
Q 027788          183 RAIR-------RIRCWGRRSSWRR------SCTMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~-------~~~~~~~~~~~~~------~~~~~~~~diws~gi  214 (219)
                      ....       ++..+.+|+.+..      ...++.++|+||+|+
T Consensus       214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGv  258 (412)
T 2vd5_A          214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGV  258 (412)
T ss_dssp             TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHH
T ss_pred             CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhH
Confidence            5432       1222333332221      356788899999993

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.3e-33  Score=224.99  Aligned_cols=186  Identities=24%  Similarity=0.379  Sum_probs=152.4

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCC--HHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD--PAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      .+.|++.+.||+|+||.||+|.+..++..||+|.++.......  ....+.+.+|+.++++++||||+++++++..  ..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~   88 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN--RT   88 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence            3445899999999999999999999999999999986543221  1134678899999999999999999999854  45


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCC---cEEEeccccc
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG---QVKIGDLGVA  178 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~---~~~l~dfg~a  178 (219)
                      .++++||++++++|.+++.....+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+..   .++|+|||++
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            68899999999999999988778999999999999999999999999  999999999999985532   6999999999


Q ss_pred             eecccccee-----eeecccCccccCCCccccccceeeecc
Q 027788          179 AIVGRAIRR-----IRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       179 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .........     +..+.+| +......++.++|+||+|+
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG~  206 (321)
T 2a2a_A          167 HEIEDGVEFKNIFGTPEFVAP-EIVNYEPLGLEADMWSIGV  206 (321)
T ss_dssp             EECCTTCCCCCCCSCGGGCCH-HHHTTCCCCTHHHHHHHHH
T ss_pred             eecCccccccccCCCCCccCc-ccccCCCCCCccccHHHHH
Confidence            887654322     2222233 3344566788899999993

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.2e-33  Score=217.79  Aligned_cols=185  Identities=22%  Similarity=0.342  Sum_probs=152.9

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ..++| ++.+.||+|+||.||+|.+..++..||+|.+.....  .....+.+.+|+.++++++||||+++++++.  ...
T Consensus         4 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~   78 (284)
T 3kk8_A            4 FSDNY-DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQ--EES   78 (284)
T ss_dssp             TTTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSS
T ss_pred             hhhhh-hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE--cCC
Confidence            44566 888999999999999999999999999999886543  4555678889999999999999999999985  445


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC--CcEEEeccccce
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDLGVAA  179 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~--~~~~l~dfg~a~  179 (219)
                      ..+++||++++++|.+.+.....+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+.  +.++|+|||++.
T Consensus        79 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            67889999999999988877778999999999999999999999999  99999999999997442  249999999998


Q ss_pred             eccccceeeeeccc----CccccCCCccccccceeeec
Q 027788          180 IVGRAIRRIRCWGR----RSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       180 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~diws~g  213 (219)
                      ............++    +++......++.++|+||+|
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  194 (284)
T 3kk8_A          157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG  194 (284)
T ss_dssp             ECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHH
T ss_pred             EcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHH
Confidence            77654432222222    22334455678889999999

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.2e-34  Score=240.38  Aligned_cols=184  Identities=23%  Similarity=0.347  Sum_probs=150.3

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++| .+.+.||+|+||.||+|.+..+|+.||+|+++..... .....+.+.+|+.+++.++||||+++++++..  ...+
T Consensus        16 ~~Y-~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~   91 (476)
T 2y94_A           16 GHY-ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--PSDI   91 (476)
T ss_dssp             TTE-EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred             cCE-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEE
Confidence            455 8889999999999999999999999999998754321 11234678899999999999999999999954  4568


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++|||+++++|.+++...+.+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ +.+||+|||++.....
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~-~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTT-CCEEECCCSSCEECCT
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecC-CCeEEEeccchhhccc
Confidence            899999999999999987778999999999999999999999999  9999999999999866 5899999999988755


Q ss_pred             cceeeee-----cccCccccCCCccccccceeeecc
Q 027788          184 AIRRIRC-----WGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~~~~~-----~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .......     +.+|+........+.++|+||+|+
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  204 (476)
T 2y94_A          169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGV  204 (476)
T ss_dssp             TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHH
T ss_pred             cccccccCCCcCeEChhhccCCCCCCCcceehhhHH
Confidence            4322222     233332333333356799999993

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.1e-33  Score=227.91  Aligned_cols=180  Identities=23%  Similarity=0.349  Sum_probs=137.5

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ...|++.+.||+|+||.||+|.+..+++.||+|+++...      ..+.+.+|+.++++++||||+++++++..  ...+
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~  123 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFET--PTEI  123 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEec--CCeE
Confidence            344588999999999999999999999999999987432      23567789999999999999999999954  4568


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC--CCCcEEEeccccceec
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG--NTGQVKIGDLGVAAIV  181 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~--~~~~~~l~dfg~a~~~  181 (219)
                      +++|||+++++|.+++.....+++..+..++.|++.||.|||+.+  ++||||||+||+++.  +.+.++|+|||++...
T Consensus       124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            899999999999999887778999999999999999999999999  999999999999974  2368999999999876


Q ss_pred             cccce-----eeeecccCccccCCCccccccceeeecc
Q 027788          182 GRAIR-----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       182 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .....     ++..+.+| +......++.++||||+|+
T Consensus       202 ~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~  238 (349)
T 2w4o_A          202 EHQVLMKTVCGTPGYCAP-EILRGCAYGPEVDMWSVGI  238 (349)
T ss_dssp             -----------CGGGSCH-HHHTTCCCCTHHHHHHHHH
T ss_pred             CcccccccccCCCCccCH-HHhcCCCCCcccchHHHHH
Confidence            54432     22223333 3445556888999999993

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.5e-33  Score=239.44  Aligned_cols=187  Identities=18%  Similarity=0.271  Sum_probs=152.2

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ...+.|++.+.||+|+||.||+|.+..+++.||+|.+....... ......+.+|+.+++.++||||+++++++..  ..
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~  257 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYET--KD  257 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEee--CC
Confidence            33445588899999999999999999999999999997543211 1223667899999999999999999999854  45


Q ss_pred             eEEEEeccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          102 TLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      .++++|||+++|+|..++....  .+++..+..++.|++.||.|||+++  |+||||||+||+++.+ +.+||+|||+++
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~-g~vKL~DFGla~  334 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDH-GHIRISDLGLAV  334 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTTCE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCC-CCeEEEecccce
Confidence            7899999999999999887643  4999999999999999999999999  9999999999999865 689999999998


Q ss_pred             eccccceeeeecccC----ccccCCCccccccceeeecc
Q 027788          180 IVGRAIRRIRCWGRR----SSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~diws~gi  214 (219)
                      ............|++    ++......++.++|+||+|+
T Consensus       335 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGv  373 (576)
T 2acx_A          335 HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGC  373 (576)
T ss_dssp             ECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHH
T ss_pred             ecccCccccccCCCccccCHHHHcCCCCCccchHHHHHH
Confidence            876544322233332    23344556888899999993

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.2e-33  Score=229.66  Aligned_cols=184  Identities=19%  Similarity=0.236  Sum_probs=149.5

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCce
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~  102 (219)
                      ++| ++.+.||+|+||.||+|.+..+++.||+|+++...... ....+.+..|..+++.+ +||+|+++++++..  ...
T Consensus        20 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~   95 (353)
T 2i0e_A           20 TDF-NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR   95 (353)
T ss_dssp             TTE-EEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSE
T ss_pred             HHc-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCE
Confidence            455 78899999999999999999999999999998643211 12346778899999887 79999999999954  456


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++++|||+++|+|.+++...+.+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+++...
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENI  172 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCC-CcEEEEeCCcccccc
Confidence            8899999999999999987778999999999999999999999999  9999999999999866 689999999998643


Q ss_pred             ccce-eeeecccC----ccccCCCccccccceeeecc
Q 027788          183 RAIR-RIRCWGRR----SSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~-~~~~~~~~----~~~~~~~~~~~~~diws~gi  214 (219)
                      .... .....|++    ++......++.++|+||+|+
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  209 (353)
T 2i0e_A          173 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV  209 (353)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHH
T ss_pred             cCCcccccccCCccccChhhhcCCCcCCcccccchHH
Confidence            3221 11222222    23344566788899999993

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-33  Score=228.79  Aligned_cols=185  Identities=25%  Similarity=0.385  Sum_probs=145.9

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      +..++| ++.+.||+|+||.||+|.+..+|+.||+|.+....  ......+++.+|+.+++.++||||+++++++...+.
T Consensus        22 ~~~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   98 (367)
T 1cm8_A           22 EVRAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET   98 (367)
T ss_dssp             CCBSSE-EEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred             eecceE-EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence            444555 78899999999999999999999999999986433  245566788999999999999999999999865432


Q ss_pred             ----ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788          101 ----NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus       101 ----~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                          ..++++||++ +++|.+++.. ..+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.+||+|||
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg  173 (367)
T 1cm8_A           99 LDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFG  173 (367)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCT
T ss_pred             cccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCC-CCEEEEeee
Confidence                3468899999 7899998876 47999999999999999999999999  9999999999999866 589999999


Q ss_pred             cceeccccce---eeeecccCccccCCCccccccceeeec
Q 027788          177 VAAIVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       177 ~a~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +++.......   .+..+.+|+.......++.++|+||+|
T Consensus       174 ~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  213 (367)
T 1cm8_A          174 LARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVG  213 (367)
T ss_dssp             TCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHH
T ss_pred             cccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHH
Confidence            9987654332   223344444444446688889999999

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.4e-33  Score=227.69  Aligned_cols=181  Identities=28%  Similarity=0.388  Sum_probs=146.4

Q ss_pred             CceeeeeeeeccccceEEEEEEec-------CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQ-------EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVW   95 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~   95 (219)
                      ...|.+.+.||+|+||.||+|++.       .++..||+|.++...   .....+.+.+|+.+++++ +||||+++++++
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC---BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc---CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            344588899999999999999864       345679999987542   455667899999999999 899999999999


Q ss_pred             ecCCCceEEEEeccccCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCC
Q 027788           96 RDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCS  159 (219)
Q Consensus        96 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~----------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~  159 (219)
                      ..  ...++++|||+++|+|.+++....                .++...+..++.|++.||.|||+++  ++||||||+
T Consensus       157 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~  232 (370)
T 2psq_A          157 TQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAAR  232 (370)
T ss_dssp             CS--SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGG
T ss_pred             cc--CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchh
Confidence            54  455788999999999999987542                4788999999999999999999999  999999999


Q ss_pred             ceEEeCCCCcEEEeccccceeccccce--------eeeecccCccccCCCccccccceeeec
Q 027788          160 NVFVNGNTGQVKIGDLGVAAIVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       160 nili~~~~~~~~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ||+++.+ +.+||+|||+++.......        .+..+.+| +......++.++|+||||
T Consensus       233 NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP-E~~~~~~~~~~~DvwslG  292 (370)
T 2psq_A          233 NVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP-EALFDRVYTHQSDVWSFG  292 (370)
T ss_dssp             GEEECTT-CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCH-HHHHTCCCCHHHHHHHHH
T ss_pred             hEEECCC-CCEEEccccCCcccCcccceecccCCCcccceECH-hHhcCCCCCcHHHHHHHH
Confidence            9999866 6899999999987654321        11123333 333455688889999999

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.2e-32  Score=222.08  Aligned_cols=185  Identities=24%  Similarity=0.370  Sum_probs=153.3

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      ..+.|.+.+.||+|+||.||+|.+..+++.+|+|++..... ......+.+.+|+.+++.++|+||+++++++..  ...
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~  115 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDF  115 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCe
Confidence            34455888999999999999999999999999999885543 245566888999999999999999999999954  467


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++++|||+++++|.+++.....+++..+..++.|++.+|.|||+++  ++|+||||+||+++.+ +.++|+|||++....
T Consensus       116 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKVE  192 (335)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCC-CCEEEeeccCceecc
Confidence            8899999999999998887778999999999999999999999999  9999999999999866 589999999998765


Q ss_pred             ccce------eeeecccCccccCCCccccccceeeecc
Q 027788          183 RAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ....      ++..+.+| +......++.++|+||+|+
T Consensus       193 ~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG~  229 (335)
T 2owb_A          193 YDGERKKVLCGTPNYIAP-EVLSKKGHSFEVDVWSIGC  229 (335)
T ss_dssp             STTCCBCCCCSCCSSCCH-HHHHTSCBCTHHHHHHHHH
T ss_pred             cCcccccccCCCccccCH-HHhccCCCCchhhHHHHHH
Confidence            3322      11122233 3334455777899999993

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.4e-34  Score=233.60  Aligned_cols=187  Identities=21%  Similarity=0.316  Sum_probs=150.8

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCC----HHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD----PAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      ..++| ++.+.||+|+||.||+|.+..+++.||+|.++.......    ....+.+.+|+.++++++||||+++++++. 
T Consensus        22 ~~~~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-   99 (335)
T 3dls_A           22 YSQKY-STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE-   99 (335)
T ss_dssp             HHHHE-EEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE-
T ss_pred             cccce-EEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            34555 788999999999999999999999999999986543211    112345678999999999999999999995 


Q ss_pred             CCCceEEEEeccccCC-ChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788           98 EDRNTLNFITEVCTSG-NLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g-~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                       +...++++||++.+| +|.+++.....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||
T Consensus       100 -~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~Dfg  175 (335)
T 3dls_A          100 -NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAED-FTIKLIDFG  175 (335)
T ss_dssp             -CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCT
T ss_pred             -eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCC-CcEEEeecc
Confidence             446688999999766 99999988888999999999999999999999999  9999999999999866 589999999


Q ss_pred             cceecccccee-----eeecccCccccCCCccccccceeeecc
Q 027788          177 VAAIVGRAIRR-----IRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       177 ~a~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ++.........     +..+.+|+.+.....++.++||||+|+
T Consensus       176 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~  218 (335)
T 3dls_A          176 SAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGV  218 (335)
T ss_dssp             TCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHH
T ss_pred             cceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHH
Confidence            99887655432     223333433333333467799999993

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.3e-32  Score=216.39  Aligned_cols=185  Identities=24%  Similarity=0.370  Sum_probs=153.2

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      ..+.|.+.+.||+|+||.||+|.+..+++.+|+|++..... ......+.+.+|+.+++.++||||+++++++..  .+.
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~   89 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDF   89 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--CCE
Confidence            34445888999999999999999999999999999875543 245566788999999999999999999999854  456


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++++||++++++|.+++.....+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|+|||++....
T Consensus        90 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           90 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKVE  166 (294)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCEECC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCC-CCEEEEeccCceecc
Confidence            8899999999999998887778999999999999999999999999  9999999999999866 589999999998765


Q ss_pred             ccce------eeeecccCccccCCCccccccceeeecc
Q 027788          183 RAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ....      ++..+.+| +......++.++|+||+|+
T Consensus       167 ~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG~  203 (294)
T 2rku_A          167 YDGERKKVLCGTPNYIAP-EVLSKKGHSFEVDVWSIGC  203 (294)
T ss_dssp             STTCCBCCCCSCCSSCCH-HHHTTSCBCTHHHHHHHHH
T ss_pred             cCccccccccCCCCcCCc-chhccCCCCchhhHHHHHH
Confidence            3322      11122233 3344556777899999993

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.2e-33  Score=229.64  Aligned_cols=183  Identities=18%  Similarity=0.292  Sum_probs=141.2

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHH-HHhhCCCCceEEEEEEecCCCceEE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRL-LKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~-l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      -|++.+.||+|+||.||+|++..+++.||+|+++..... .......+..|..+ ++.++||||+++++++..  ...+|
T Consensus        39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--~~~~~  115 (373)
T 2r5t_A           39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL-KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLY  115 (373)
T ss_dssp             GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEEC--SSEEE
T ss_pred             heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--CCEEE
Confidence            348889999999999999999999999999999865543 23334566777776 477899999999999954  45688


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      ++|||+++|+|.+++.....+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+++.....
T Consensus       116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCBCGGGBCC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCC-CCEEEeeCccccccccC
Confidence            99999999999999987778999999999999999999999999  9999999999999866 68999999999864332


Q ss_pred             ce-eeeecccC----ccccCCCccccccceeeecc
Q 027788          185 IR-RIRCWGRR----SSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       185 ~~-~~~~~~~~----~~~~~~~~~~~~~diws~gi  214 (219)
                      .. .....|++    ++......++.++|+||+|+
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  227 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA  227 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHH
T ss_pred             CCccccccCCccccCHHHhCCCCCCchhhhHHHHH
Confidence            21 11222322    23344566888899999993

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2e-33  Score=225.17  Aligned_cols=181  Identities=27%  Similarity=0.488  Sum_probs=135.8

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++| ++.+.||+|+||.||+|.+..+++.||+|.++....   ....+.+.+|+.++++++||||+++++++.  ..+.+
T Consensus         5 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~   78 (317)
T 2pmi_A            5 SQF-KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKELKHENIVRLYDVIH--TENKL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCST---TCSCHHHHHHHHHHTTCCBTTBCCEEEEEC--CTTEE
T ss_pred             cce-eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc---cccHHHHHHHHHHHHhcCCCCcceEEEEEE--ECCeE
Confidence            344 788999999999999999999999999999876542   222356778999999999999999999994  45678


Q ss_pred             EEEeccccCCChHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788          104 NFITEVCTSGNLREYRKKH------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                      +++|||++ ++|.+++...      ..+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~  154 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKR-GQLKLGDFGL  154 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCSS
T ss_pred             EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCC-CCEEECcCcc
Confidence            89999997 5888877542      35889999999999999999999999  9999999999999866 5899999999


Q ss_pred             ceeccccce------eeeecccCccccCCCccccccceeeecc
Q 027788          178 AAIVGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +........      ++..+.+|+.+.....++.++||||+|+
T Consensus       155 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  197 (317)
T 2pmi_A          155 ARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGC  197 (317)
T ss_dssp             CEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred             ceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHH
Confidence            987654321      2233444444444556788899999993

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6.2e-33  Score=218.38  Aligned_cols=184  Identities=19%  Similarity=0.306  Sum_probs=150.4

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCce
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~  102 (219)
                      ++| ++.+.||+|+||.||+|.+..+++.||+|.++....  .......+.+|+..+..+ +||||+++++++...  ..
T Consensus        11 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~   85 (289)
T 1x8b_A           11 TEF-HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA--GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DH   85 (289)
T ss_dssp             HHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT--TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TE
T ss_pred             chh-hhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--Ce
Confidence            445 788999999999999999999999999999885432  234457788899999998 999999999999654  56


Q ss_pred             EEEEeccccCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC------------
Q 027788          103 LNFITEVCTSGNLREYRKKH----RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN------------  166 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~------------  166 (219)
                      ++++||++++++|.+++...    ..+++..+..++.|++.||.|||+++  ++|+||||+||+++.+            
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~  163 (289)
T 1x8b_A           86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDE  163 (289)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC--------------
T ss_pred             EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCccccccccc
Confidence            88899999999999988654    56899999999999999999999999  9999999999999732            


Q ss_pred             ------CCcEEEeccccceeccccce--eeeecccCccccCCCccccccceeeecc
Q 027788          167 ------TGQVKIGDLGVAAIVGRAIR--RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       167 ------~~~~~l~dfg~a~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                            ...++|+|||.+........  ++..+.+|+.+.....++.++||||+|+
T Consensus       164 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~  219 (289)
T 1x8b_A          164 DDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALAL  219 (289)
T ss_dssp             ------CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHH
T ss_pred             ccccCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHH
Confidence                  23689999999988765443  3333445554555556667899999993

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.2e-32  Score=225.38  Aligned_cols=183  Identities=20%  Similarity=0.295  Sum_probs=143.2

Q ss_pred             Cceeee--eeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           24 GRYGRY--NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        24 ~~~~~~--~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ..++.+  .+.||+|+||.||+|.+..++..||+|+++..    .....+.+.+|+.++++++||||+++++++..  .+
T Consensus        86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~  159 (373)
T 2x4f_A           86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR----GMKDKEEVKNEISVMNQLDHANLIQLYDAFES--KN  159 (373)
T ss_dssp             GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SS
T ss_pred             ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc----ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CC
Confidence            334455  46799999999999999999999999998854    23455788999999999999999999999954  45


Q ss_pred             eEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEe-CCCCcEEEeccccce
Q 027788          102 TLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN-GNTGQVKIGDLGVAA  179 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~-~~~~~~~l~dfg~a~  179 (219)
                      .++++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+  ++||||||+||++. .+.+.+||+|||++.
T Consensus       160 ~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~  237 (373)
T 2x4f_A          160 DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLAR  237 (373)
T ss_dssp             EEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence            688999999999998877543 46899999999999999999999999  99999999999984 233579999999999


Q ss_pred             eccccceeeeecccC----ccccCCCccccccceeeecc
Q 027788          180 IVGRAIRRIRCWGRR----SSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~diws~gi  214 (219)
                      ............+++    ++......++.++|+||+|+
T Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  276 (373)
T 2x4f_A          238 RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGV  276 (373)
T ss_dssp             ECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHH
T ss_pred             ecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHH
Confidence            876554322222322    23344556777899999993

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.2e-33  Score=227.90  Aligned_cols=185  Identities=22%  Similarity=0.286  Sum_probs=147.6

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCC-HHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ..|++.+.||+|+||.||+|.+..+++.||+|+++....... ....+.+.+|+.+++.++||||+++++++..  ...+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~  101 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--DGML  101 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEE
Confidence            345888999999999999999999999999999875432211 1134678899999999999999999999965  4568


Q ss_pred             EEEeccccCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC--CcEEEecccc
Q 027788          104 NFITEVCTSGNLREYRKKH----RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDLGV  177 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~--~~~~l~dfg~  177 (219)
                      +++|||+++++|.+.+...    ..+++..+..++.|++.||.|||+++  ++||||||+||+++.+.  ..+||+|||+
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            8999999999998766432    35899999999999999999999999  99999999999997542  2499999999


Q ss_pred             ceeccccce------eeeecccCccccCCCccccccceeeecc
Q 027788          178 AAIVGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +........      ++..+.+| +......++.++||||+|+
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~  221 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAP-EVVKREPYGKPVDVWGCGV  221 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCH-HHHTTCCBCTHHHHHHHHH
T ss_pred             eeEecCCCeeecCCcCCcCccCH-HHHcCCCCCchHhhHHHHH
Confidence            988755432      22223333 3344556788899999993

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.5e-33  Score=238.01  Aligned_cols=187  Identities=23%  Similarity=0.368  Sum_probs=151.4

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      .+....+| ++.+.||+|+||.||+|.+..+++.||+|+++......  .....+.+|+.++++++||||+++++++.  
T Consensus        17 ~g~~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~--   91 (486)
T 3mwu_A           17 QGTFAERY-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEILE--   91 (486)
T ss_dssp             CCHHHHHE-EEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred             cCChhcce-EEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc--hHHHHHHHHHHHHHhCCCCCcCeEEEEEE--
Confidence            34455666 78899999999999999999999999999987544322  22467889999999999999999999995  


Q ss_pred             CCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC--CCcEEEeccc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN--TGQVKIGDLG  176 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~--~~~~~l~dfg  176 (219)
                      +...++++||++++++|.+.+.....+++..+..++.|++.|+.|||+.+  ++||||||+||+++..  .+.+||+|||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  169 (486)
T 3mwu_A           92 DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFG  169 (486)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred             cCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECC
Confidence            45678899999999999998877778999999999999999999999999  9999999999999632  2479999999


Q ss_pred             cceeccccce-----eeeecccCccccCCCccccccceeeecc
Q 027788          177 VAAIVGRAIR-----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       177 ~a~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ++........     ++..+.+|+.+.  ..++.++||||+|+
T Consensus       170 ~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~  210 (486)
T 3mwu_A          170 LSTCFQQNTKMKDRIGTAYYIAPEVLR--GTYDEKCDVWSAGV  210 (486)
T ss_dssp             CTTTBCCC----CCTTGGGGCCGGGGG--SCCCHHHHHHHHHH
T ss_pred             cCeECCCCCccCCCcCCCCCCCHHHhC--CCCCchhhHHHHHH
Confidence            9987654432     222333444332  34778899999993

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-33  Score=231.48  Aligned_cols=183  Identities=20%  Similarity=0.335  Sum_probs=149.4

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      .....+.+.+.||+|+||.||+|.+..++..||+|.++...   .....+.+.+|+.++++++||||+++++++..  ..
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~  185 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL---PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQ  185 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS---CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS--SS
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec--CC
Confidence            33455588899999999999999999899999999987432   34555678899999999999999999999954  34


Q ss_pred             eEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          102 TLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      .++++||++++++|.+++... ..++...+..++.|++.|+.|||+++  ++||||||+||+++.+ +.+||+|||+++.
T Consensus       186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~-~~~kl~DfG~s~~  262 (377)
T 3cbl_A          186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEK-NVLKISDFGMSRE  262 (377)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCGGGCEE
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCC-CcEEECcCCCcee
Confidence            578899999999999988654 46899999999999999999999999  9999999999999866 5899999999987


Q ss_pred             cccccee--------eeecccCccccCCCccccccceeeec
Q 027788          181 VGRAIRR--------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .......        +..+.+|+ ......++.++|+||||
T Consensus       263 ~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~DvwslG  302 (377)
T 3cbl_A          263 EADGVYAASGGLRQVPVKWTAPE-ALNYGRYSSESDVWSFG  302 (377)
T ss_dssp             CTTSEEECCSSCCEEEGGGSCHH-HHHHCEEEHHHHHHHHH
T ss_pred             cCCCceeecCCCCCCCcCcCCHh-HhccCCCCchhhHHHHH
Confidence            5443221        11133333 33345577889999999

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.1e-33  Score=226.82  Aligned_cols=187  Identities=20%  Similarity=0.394  Sum_probs=149.0

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC-
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED-   99 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~-   99 (219)
                      +..++| ++.+.||+|+||.||+|++..+++.||+|.+.....  .......+.+|+.+++.++||||+++++++.... 
T Consensus        14 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   90 (351)
T 3mi9_A           14 DEVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKAS   90 (351)
T ss_dssp             CBGGGE-EEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC--SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             ccccce-eEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc--cccchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence            445677 788999999999999999999999999999865543  2222356778999999999999999999987643 


Q ss_pred             -----CceEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEe
Q 027788          100 -----RNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIG  173 (219)
Q Consensus       100 -----~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~  173 (219)
                           ...++++|||+++ +|.+.+.. ...+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.++|+
T Consensus        91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~-~~~kl~  166 (351)
T 3mi9_A           91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLA  166 (351)
T ss_dssp             ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEEC
T ss_pred             ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCC-CCEEEc
Confidence                 3568899999975 66665544 457999999999999999999999999  9999999999999866 589999


Q ss_pred             ccccceeccccce----------eeeecccCccccCCCccccccceeeecc
Q 027788          174 DLGVAAIVGRAIR----------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       174 dfg~a~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      |||++........          ++..+.+|+.+.....++.++||||+|+
T Consensus       167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~  217 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGC  217 (351)
T ss_dssp             CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred             cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHH
Confidence            9999987653221          1223444444545566788999999993

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.5e-33  Score=227.72  Aligned_cols=189  Identities=24%  Similarity=0.332  Sum_probs=150.5

Q ss_pred             ccccCCCCceeeeeeeeccccceEEEEEE-----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceE
Q 027788           17 FIETDPTGRYGRYNELLGSGAVKKVYRAF-----DQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIIS   90 (219)
Q Consensus        17 ~~~~~~~~~~~~~~~~ig~g~~g~V~~a~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~   90 (219)
                      ....+...+.|++.+.||+|+||.||+|.     +..+++.||+|.++...   .....+.+.+|+.+++++ +||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC---CHHHHHHHHHHHHHHHhhcCCcceee
Confidence            34445555556899999999999999998     56677899999987442   345567899999999999 7899999


Q ss_pred             EEEEEecCCCceEEEEeccccCCChHHHHHhCCC----------------------------------------------
Q 027788           91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH----------------------------------------------  124 (219)
Q Consensus        91 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~----------------------------------------------  124 (219)
                      +++++...+ ..++++|||+++|+|.+++.....                                              
T Consensus        91 ~~~~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           91 LLGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             EEEEECSTT-SCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeecCC-CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            999986543 447789999999999999875432                                              


Q ss_pred             --------------------CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          125 --------------------VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       125 --------------------~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                                          +++..+..++.|++.||.|||+++  ++|+||||+||+++.+ +.++|+|||++......
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEK-NVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCC-CcEEEEeccceeeeccc
Confidence                                889999999999999999999999  9999999999999865 58999999999866433


Q ss_pred             ce--------eeeecccCccccCCCccccccceeeec
Q 027788          185 IR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ..        ++..+.+| +......++.++||||+|
T Consensus       247 ~~~~~~~~~~~t~~y~aP-E~~~~~~~~~~~Di~slG  282 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAP-ETIFDRVYTIQSDVWSFG  282 (359)
T ss_dssp             TTCEEC--CEECGGGCCH-HHHHHCCCCHHHHHHHHH
T ss_pred             ccchhccccCCCceeECh-hhhcCCCCCchhhhhhHH
Confidence            21        11112233 333455678889999999

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.5e-32  Score=220.71  Aligned_cols=179  Identities=19%  Similarity=0.327  Sum_probs=149.7

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCCc
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRN  101 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~  101 (219)
                      .++| ++.+.||+|+||.||+|.+..+++.||+|+++...       .+.+.+|+.++++++ ||||+++++++......
T Consensus        35 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~  106 (330)
T 3nsz_A           35 QDDY-QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSR  106 (330)
T ss_dssp             GGGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CCce-EEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence            3455 88899999999999999999999999999987321       256889999999997 99999999999876677


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      ..+++||++++++|.+++.   .+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+...++|+|||++...
T Consensus       107 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             ceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            7899999999999998875   4889999999999999999999999  9999999999999866557999999999876


Q ss_pred             cccce-----eeeecccCccccCCCccccccceeeecc
Q 027788          182 GRAIR-----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       182 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .....     ++..+.+|+.+.....++.++||||+|+
T Consensus       182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  219 (330)
T 3nsz_A          182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC  219 (330)
T ss_dssp             CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred             CCCCccccccccccccChhhhcCCCcCCchhhHHHHHH
Confidence            54433     2222334444444466888899999993

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.2e-32  Score=220.15  Aligned_cols=185  Identities=16%  Similarity=0.212  Sum_probs=149.0

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC--C
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE--D   99 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~--~   99 (219)
                      ..++.|++.+.||+|+||.||+|.+..+++.||+|.+...    .....+.+.+|+.+++.++||||+++++++..+  .
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA  101 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence            4455568999999999999999999999999999998753    455668889999999999999999999988532  3


Q ss_pred             CceEEEEeccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788          100 RNTLNFITEVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      ....+++||++++++|.+++..    ...+++..+..++.|++.||.|||+++  ++|+||||+||+++.+ +.++|+||
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~df  178 (317)
T 2buj_A          102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDE-GQPVLMDL  178 (317)
T ss_dssp             EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCC
T ss_pred             CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCC-CCEEEEec
Confidence            4578899999999999988764    356899999999999999999999999  9999999999999866 58999999


Q ss_pred             ccceeccccce---------------eeeecccCccccCC--Cccccccceeeec
Q 027788          176 GVAAIVGRAIR---------------RIRCWGRRSSWRRS--CTMRITRSLWTYT  213 (219)
Q Consensus       176 g~a~~~~~~~~---------------~~~~~~~~~~~~~~--~~~~~~~diws~g  213 (219)
                      |++........               ++..+.+|+.+...  ..++.++||||+|
T Consensus       179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG  233 (317)
T 2buj_A          179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG  233 (317)
T ss_dssp             SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHH
T ss_pred             CcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHH
Confidence            99887643221               12234444433322  2367789999999

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.9e-32  Score=226.16  Aligned_cols=181  Identities=18%  Similarity=0.234  Sum_probs=143.5

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHH-hhCCCCceEEEEEEec--C
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLK-TLANKNIISLHYVWRD--E   98 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~-~l~~~~i~~~~~~~~~--~   98 (219)
                      ..++|+.+.+.||+|+||.||+|.+..+++.||+|+++..         ..+.+|+.++. ..+||||+++++++..  .
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~  129 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYA  129 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence            4456755557899999999999999999999999998622         34567888874 5589999999998843  3


Q ss_pred             CCceEEEEeccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC--CCcEEEec
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN--TGQVKIGD  174 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~--~~~~~l~d  174 (219)
                      +...++++|||+++|+|.+++....  .+++..+..++.|++.||.|||+.+  ++||||||+||+++.+  .+.+||+|
T Consensus       130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEe
Confidence            4567899999999999999987643  5899999999999999999999999  9999999999999852  36899999


Q ss_pred             cccceecccccee-----eeecccCccccCCCccccccceeeecc
Q 027788          175 LGVAAIVGRAIRR-----IRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       175 fg~a~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ||+++........     +..+.+| +......++.++||||+|+
T Consensus       208 FG~a~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~  251 (400)
T 1nxk_A          208 FGFAKETTSHNSLTTPCYTPYYVAP-EVLGPEKYDKSCDMWSLGV  251 (400)
T ss_dssp             CTTCEECC-----------CTTCCG-GGSCCCCSSSHHHHHHHHH
T ss_pred             cccccccCCCCccccCCCCCCccCH-hhcCCCCCCCcccHHHHHH
Confidence            9999876544322     2223333 3445667888999999993

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.9e-33  Score=226.79  Aligned_cols=178  Identities=22%  Similarity=0.315  Sum_probs=142.6

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC-------
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE-------   98 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-------   98 (219)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+......        ..+|+.+++.++||||+++++++...       
T Consensus         8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            348889999999999999999999999999998754221        23699999999999999999988542       


Q ss_pred             -----------------------------CCceEEEEeccccCCChHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH
Q 027788           99 -----------------------------DRNTLNFITEVCTSGNLREYRK----KHRHVSVKALKKWSKQILKGLNYLH  145 (219)
Q Consensus        99 -----------------------------~~~~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~~~i~~qv~~~l~~lh  145 (219)
                                                   +..+++++|||++ ++|.+.+.    ....+++..+..++.|++.||.|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                         3346889999998 57665543    4567999999999999999999999


Q ss_pred             hCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccccee-----eeecccCccccCCCccccccceeeecc
Q 027788          146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR-----IRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       146 ~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +.+  ++||||||+||+++.+.+.+||+|||+++........     +..+.+|+.+.....++.++||||+|+
T Consensus       159 ~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  230 (383)
T 3eb0_A          159 SLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC  230 (383)
T ss_dssp             TTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             HCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence            999  9999999999999855568999999999877554432     222344444455566888999999993

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.2e-33  Score=222.74  Aligned_cols=184  Identities=27%  Similarity=0.431  Sum_probs=151.7

Q ss_pred             CCCceeeeeeeeccccceEEEEEE----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAF----DQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      ..++|+++.+.||+|+||.||++.    +..+++.||+|+++...   .....+.+.+|+.++++++||||+++++++..
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA---GPQHRSGWKQEIDILRTLYHEHIIKYKGCCED  104 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc---ChHHHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence            568888999999999999998774    34578999999987542   45666889999999999999999999999987


Q ss_pred             CCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                      .+...++++||++++++|.+++... .+++..+..++.|++.++.+||+.+  ++|+||||+||+++.+ +.++|+|||+
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~-~~~kl~Dfg~  180 (318)
T 3lxp_A          105 AGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDND-RLVKIGDFGL  180 (318)
T ss_dssp             TTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCGGG
T ss_pred             CCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCC-CCEEECCccc
Confidence            7677899999999999999988764 5999999999999999999999999  9999999999999866 5899999999


Q ss_pred             ceecccccee---------eeecccCccccCCCccccccceeeec
Q 027788          178 AAIVGRAIRR---------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       178 a~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +.........         +..+.+| +......++.++||||+|
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  224 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAP-ECLKEYKFYYASDVWSFG  224 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCH-HHHHHCEEEHHHHHHHHH
T ss_pred             cccccccccccccccCCCCCceeeCh-HHhcCCCCCcHHHHHHHH
Confidence            9887654321         1112222 233344567789999999

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.1e-33  Score=222.62  Aligned_cols=184  Identities=25%  Similarity=0.390  Sum_probs=152.7

Q ss_pred             CCCceeeeeeeeccccceEEEEEE----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAF----DQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      ...+.|++.+.||+|+||.||+|+    +..++..||+|.+...    .....+.+.+|+.++++++||||+++++++..
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   95 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGVSYG   95 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence            344555899999999999999998    5778999999998743    45566789999999999999999999999987


Q ss_pred             CCCceEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                      ++...++++|||+++++|.+++.. ...+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+ +.++|+|||
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg  172 (327)
T 3lxl_A           96 PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESE-AHVKIADFG  172 (327)
T ss_dssp             SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCGG
T ss_pred             CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCC-CCEEEcccc
Confidence            777889999999999999999875 346999999999999999999999999  9999999999999866 589999999


Q ss_pred             cceeccccceeee---------ecccCccccCCCccccccceeeec
Q 027788          177 VAAIVGRAIRRIR---------CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       177 ~a~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ++...........         .+.+| +......++.++||||+|
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  217 (327)
T 3lxl_A          173 LAKLLPLDKDYYVVREPGQSPIFWYAP-ESLSDNIFSRQSDVWSFG  217 (327)
T ss_dssp             GCEECCTTCSEEECSSCCCSCGGGSCH-HHHHHCEEEHHHHHHHHH
T ss_pred             cceecccCCccceeeccCCccccccCH-HHhccCCCChHHhHHHHH
Confidence            9987754432111         12222 233344567789999999

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.2e-33  Score=221.63  Aligned_cols=181  Identities=18%  Similarity=0.318  Sum_probs=147.6

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCC-------cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEe
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEG-------IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWR   96 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   96 (219)
                      .+.|.+.+.||+|+||.||+|.+..++       ..||+|.+....    ....+.+.+|+.++++++||||+++++++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH----RNYSESFFEAASMMSKLSHKHLVLNYGVCV   82 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG----GGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            334488899999999999999988777       479999986442    334577889999999999999999999995


Q ss_pred             cCCCceEEEEeccccCCChHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCc------
Q 027788           97 DEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQ------  169 (219)
Q Consensus        97 ~~~~~~~~lv~e~~~~g~L~~~~~~~~~-~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~------  169 (219)
                      ..  +..+++|||+++++|.+++..... +++..+..++.|++.||.|||+++  ++||||||+||+++.+. .      
T Consensus        83 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~-~~~~~~~  157 (289)
T 4fvq_A           83 CG--DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREE-DRKTGNP  157 (289)
T ss_dssp             CT--TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECC-BGGGTBC
T ss_pred             eC--CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCC-ccccccc
Confidence            44  456789999999999999876544 999999999999999999999999  99999999999998653 4      


Q ss_pred             --EEEeccccceeccccce--eeeecccCccccCCCccccccceeeec
Q 027788          170 --VKIGDLGVAAIVGRAIR--RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       170 --~~l~dfg~a~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                        ++|+|||++........  ++..+.+|+.+.....++.++|+||+|
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  205 (289)
T 4fvq_A          158 PFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFG  205 (289)
T ss_dssp             CEEEECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHH
T ss_pred             ceeeeccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHH
Confidence              99999999976644332  222344444444446688889999999

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1e-32  Score=234.00  Aligned_cols=186  Identities=25%  Similarity=0.381  Sum_probs=147.7

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCC---------HHHHHHHHHHHHHHHhhCCCCceEEE
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD---------PAMIERLFSEVRLLKTLANKNIISLH   92 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~---------~~~~~~~~~E~~~l~~l~~~~i~~~~   92 (219)
                      ...+| ++.+.||+|+||.||+|.+..++..||+|+++.......         ....+.+.+|+.+++.++||||++++
T Consensus        34 i~~~Y-~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           34 IGESY-FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             GGGTE-EEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             cccce-EEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            33444 788999999999999999999999999999986542210         12346788999999999999999999


Q ss_pred             EEEecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCC--cE
Q 027788           93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG--QV  170 (219)
Q Consensus        93 ~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~--~~  170 (219)
                      +++.  +...++++|||+++++|.+.+.....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+..  .+
T Consensus       113 ~~~~--~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          113 DVFE--DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EEEE--CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSE
T ss_pred             EEEE--cCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccE
Confidence            9995  45678899999999999998877778999999999999999999999999  999999999999985532  58


Q ss_pred             EEeccccceeccccceeee-----ecccCccccCCCccccccceeeecc
Q 027788          171 KIGDLGVAAIVGRAIRRIR-----CWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       171 ~l~dfg~a~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +|+|||++...........     .+.+|+.+ . ..++.++||||+|+
T Consensus       189 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~-~-~~~~~~~DiwslG~  235 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL-K-KKYNEKCDVWSCGV  235 (504)
T ss_dssp             EECCCTTCEECCTTSCBCCCCSCTTTCCHHHH-T-TCBCTHHHHHHHHH
T ss_pred             EEEECCCCEEcCCCCccccccCCcCCCCHHHh-c-cCCCchHHHHHHHH
Confidence            9999999988765433222     23333322 2 45788899999993

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.9e-33  Score=224.18  Aligned_cols=185  Identities=24%  Similarity=0.383  Sum_probs=150.0

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      +..+| .+.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+.+|+.++++++||||+++++++..+  +
T Consensus        52 ~~~~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~  127 (348)
T 1u5q_A           52 PEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--H  127 (348)
T ss_dssp             HHHHE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--T
T ss_pred             hhhhe-eeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--C
Confidence            33444 777999999999999999999999999999875432 2344557889999999999999999999999654  5


Q ss_pred             eEEEEeccccCCChHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          102 TLNFITEVCTSGNLREYRK-KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      ..+++|||++ |+|.+++. ....+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||++..
T Consensus       128 ~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~  203 (348)
T 1u5q_A          128 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT-TEEEECCCTTCBS
T ss_pred             eEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCC-CCEEEeeccCcee
Confidence            6888999997 57777664 4567999999999999999999999999  9999999999999965 5899999999987


Q ss_pred             ccccce--eeeecccCcccc--CCCccccccceeeecc
Q 027788          181 VGRAIR--RIRCWGRRSSWR--RSCTMRITRSLWTYTR  214 (219)
Q Consensus       181 ~~~~~~--~~~~~~~~~~~~--~~~~~~~~~diws~gi  214 (219)
                      ......  ++..+.+|+.+.  ....++.++||||+|+
T Consensus       204 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~  241 (348)
T 1u5q_A          204 MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  241 (348)
T ss_dssp             SSSBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHH
T ss_pred             cCCCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHH
Confidence            654332  333344444432  3566788899999993

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.3e-33  Score=221.71  Aligned_cols=180  Identities=26%  Similarity=0.404  Sum_probs=145.2

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      +| ++.+.||+|+||.||+|.+ .+++.||+|.+.....  +....+.+.+|+.++++++||||+++++++...  ..++
T Consensus         3 ~y-~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~   76 (288)
T 1ob3_A            3 KY-HGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRLV   76 (288)
T ss_dssp             SE-EEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCEE
T ss_pred             cc-hhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc--ccccchhHHHHHHHHHhcCCCCEeeeeeEEccC--CeEE
Confidence            45 7889999999999999998 6789999999875432  222235677899999999999999999999544  5688


Q ss_pred             EEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          105 FITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      ++||++++ +|.+++... ..+++..+..++.|++.|+.|||+++  ++||||||+||+++.+ +.+||+|||++.....
T Consensus        77 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~  152 (288)
T 1ob3_A           77 LVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINRE-GELKIADFGLARAFGI  152 (288)
T ss_dssp             EEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC
T ss_pred             EEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEEeECccccccCc
Confidence            99999974 888887654 57899999999999999999999999  9999999999999866 5899999999987643


Q ss_pred             cce------eeeecccCccccCCCccccccceeeecc
Q 027788          184 AIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ...      ++..+.+|+.+.....++.++|+||+|+
T Consensus       153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  189 (288)
T 1ob3_A          153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC  189 (288)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred             cccccccccccccccCchheeCCCCCCcHHHHHHHHH
Confidence            322      2233444544545566888899999993

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.2e-32  Score=231.19  Aligned_cols=181  Identities=25%  Similarity=0.332  Sum_probs=142.5

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC----
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED----   99 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~----   99 (219)
                      ++| ++.+.||+|+||.||+|.+..+++.||+|.+.....  .....+.+.+|+.+++.++||||+++++++...+    
T Consensus        62 ~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           62 KRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             TTE-EEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             CCe-EEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc--ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            455 778999999999999999999999999999875432  4556678899999999999999999999996543    


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      ...++++|||+++ ++.+.+..  .+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.+||+|||+++
T Consensus       139 ~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~-~~~kl~DFG~a~  212 (464)
T 3ttj_A          139 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLAR  212 (464)
T ss_dssp             CCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCCC-
T ss_pred             CCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCC-CCEEEEEEEeee
Confidence            2467899999975 56655543  5899999999999999999999999  9999999999999966 589999999998


Q ss_pred             eccccceeeeeccc----CccccCCCccccccceeeec
Q 027788          180 IVGRAIRRIRCWGR----RSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       180 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~diws~g  213 (219)
                      ........+...++    +++......++.++||||+|
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  250 (464)
T 3ttj_A          213 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG  250 (464)
T ss_dssp             ----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHH
T ss_pred             ecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHH
Confidence            77654332222222    22334455788899999999

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.7e-32  Score=220.57  Aligned_cols=171  Identities=21%  Similarity=0.300  Sum_probs=136.7

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      +.||+|+||.||+|.+..+++.||+|.+....       ...+.+|+.+++.+. ||||+++++++.  +....+++||+
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~l~~l~~h~niv~~~~~~~--~~~~~~lv~e~   87 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-------EANTQKEITALKLCEGHPNIVKLHEVFH--DQLHTFLVMEL   87 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-------HHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEEEEECC
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChhh-------hhhHHHHHHHHHHhcCCCCeeEEEEEEE--cCCEEEEEEEc
Confidence            67999999999999999999999999987432       255678999999997 999999999995  44668899999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCC--cEEEeccccceeccccce-
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG--QVKIGDLGVAAIVGRAIR-  186 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~--~~~l~dfg~a~~~~~~~~-  186 (219)
                      +++++|.+++.....+++..+..++.|++.|+.|||+++  ++||||||+||+++.+..  .++|+|||++........ 
T Consensus        88 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           88 LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             CCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            999999999988888999999999999999999999999  999999999999975422  689999999987654432 


Q ss_pred             -----eeeecccCccccCCCccccccceeeec
Q 027788          187 -----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 -----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                           ++..+.+| +......++.++|+||+|
T Consensus       166 ~~~~~~t~~y~aP-E~~~~~~~~~~~DiwslG  196 (325)
T 3kn6_A          166 LKTPCFTLHYAAP-ELLNQNGYDESCDLWSLG  196 (325)
T ss_dssp             -------------------CCCCHHHHHHHHH
T ss_pred             ccccCCCcCccCH-HHhcCCCCCCccchHHHH
Confidence                 12223333 344556678889999999

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.6e-32  Score=223.74  Aligned_cols=184  Identities=15%  Similarity=0.155  Sum_probs=142.7

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEE-----EecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC---CCCceE
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRA-----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA---NKNIIS   90 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a-----~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---~~~i~~   90 (219)
                      .....++.|.+.+.||+|+||.||+|     .+..+++.||+|.++..    .   ...+..|+.+++.+.   |+|+++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~---~~~~~~e~~~~~~l~~~~~~~iv~  131 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----N---PWEFYIGTQLMERLKPSMQHMFMK  131 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----C---HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----C---hhHHHHHHHHHHHhhhhhhhhhhh
Confidence            33445666799999999999999999     46778999999998743    2   245667788877776   899999


Q ss_pred             EEEEEecCCCceEEEEeccccCCChHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC
Q 027788           91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKK-----HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG  165 (219)
Q Consensus        91 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~-----~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~  165 (219)
                      +++++...  +..+++|||+++|+|.+++..     ...+++..+..++.|++.||.|||+++  ++||||||+||+++.
T Consensus       132 ~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~  207 (365)
T 3e7e_A          132 FYSAHLFQ--NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGN  207 (365)
T ss_dssp             EEEEEECS--SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECG
T ss_pred             hheeeecC--CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecc
Confidence            99998654  457889999999999999863     456999999999999999999999999  999999999999975


Q ss_pred             C----------CCcEEEeccccceeccccc---ee-----eeecccCccccCCCccccccceeeecc
Q 027788          166 N----------TGQVKIGDLGVAAIVGRAI---RR-----IRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       166 ~----------~~~~~l~dfg~a~~~~~~~---~~-----~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +          .+.+||+|||+|+......   ..     +..+.+| +......++.++||||+|+
T Consensus       208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~  273 (365)
T 3e7e_A          208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCV-EMLSNKPWNYQIDYFGVAA  273 (365)
T ss_dssp             GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCH-HHHTTCCBSTHHHHHHHHH
T ss_pred             cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCCh-HHhcCCCCCccccHHHHHH
Confidence            1          3689999999997654221   11     2222233 3344555888999999993

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.8e-33  Score=235.28  Aligned_cols=182  Identities=21%  Similarity=0.299  Sum_probs=140.9

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      .|++.+.||+|+||.||+|.+..+++.||+|+++..... .......+.+|+.+++.++||||+++++++...  +.+++
T Consensus       149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~l  225 (446)
T 4ejn_A          149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--DRLCF  225 (446)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC--------------CCCCCSCTTSCCEEEEEEET--TEEEE
T ss_pred             HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh-hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC--CEEEE
Confidence            348889999999999999999999999999999854322 233446778899999999999999999999654  46889


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT-HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~-~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      +|||+++++|..++.....+++..+..++.|++.||.|||+ .+  ++||||||+||+++.+ +.+||+|||+++.....
T Consensus       226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSS-SCEEECCCCCCCTTCC-
T ss_pred             EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCC-CCEEEccCCCceeccCC
Confidence            99999999999998877789999999999999999999998 88  9999999999999866 58999999999864333


Q ss_pred             ce------eeeecccCccccCCCccccccceeeecc
Q 027788          185 IR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       185 ~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ..      ++..+.+| +......++.++|+||+|+
T Consensus       303 ~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~  337 (446)
T 4ejn_A          303 GATMKTFCGTPEYLAP-EVLEDNDYGRAVDWWGLGV  337 (446)
T ss_dssp             ----CCSSSCGGGCCH-HHHHTSCCCTHHHHHHHHH
T ss_pred             CcccccccCCccccCH-hhcCCCCCCCccchhhhHH
Confidence            22      12222233 3345566888999999993

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-32  Score=219.65  Aligned_cols=179  Identities=18%  Similarity=0.276  Sum_probs=140.9

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~  103 (219)
                      +.|++.++||+|+||.||+|.+..+++.||+|.+.....  ..........|+..+.++ +||||+++++++..  ...+
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~  132 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR--GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGIL  132 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC--SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc--ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEE
Confidence            445888999999999999999999999999998764332  344445556666666555 89999999999954  4568


Q ss_pred             EEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          104 NFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +++||++ +++|.+++.. ...+++..+..++.|++.||.|||+.+  ++|+||||+||+++.+ +.+||+|||++....
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPR-GRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGG-GCEEECCCTTCEECC
T ss_pred             EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCC-CCEEEccceeeeecc
Confidence            8999999 5688877654 456999999999999999999999999  9999999999999866 589999999998775


Q ss_pred             cccee-----eeecccCccccCCCccccccceeeec
Q 027788          183 RAIRR-----IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~~-----~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .....     +..+.+|+.+ . ..++.++||||+|
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~-~-~~~~~~~DiwslG  242 (311)
T 3p1a_A          209 TAGAGEVQEGDPRYMAPELL-Q-GSYGTAADVFSLG  242 (311)
T ss_dssp             ------CCCCCGGGCCGGGG-G-TCCSTHHHHHHHH
T ss_pred             cCCCCcccCCCccccCHhHh-c-CCCCchhhHHHHH
Confidence            54432     2234444433 3 2578889999999

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.4e-32  Score=215.76  Aligned_cols=178  Identities=22%  Similarity=0.293  Sum_probs=147.7

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      +.|++.+.||+|+||.||+|.+..++..+|+|.+......    ..+.+.+|+.++++++||||+++++++.  +...++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~   82 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE----DVDRFKQEIEIMKSLDHPNIIRLYETFE--DNTDIY   82 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc----hHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCeEE
Confidence            3458889999999999999999999999999998754321    2467889999999999999999999995  445688


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEE---eCCCCcEEEeccccceec
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili---~~~~~~~~l~dfg~a~~~  181 (219)
                      ++||++++++|.+++.....+++..+..++.|++.|+.|||+++  ++|+||||+||++   +.+ +.++|+|||++...
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~-~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPD-SPLKLIDFGLAARF  159 (277)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTT-CCEEECCCTTCEEC
T ss_pred             EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCC-CcEEEEecccceec
Confidence            99999999999998887778999999999999999999999999  9999999999999   534 58999999999877


Q ss_pred             cccceeeee-----cccCccccCCCccccccceeeec
Q 027788          182 GRAIRRIRC-----WGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .........     +.+|+ ... ..++.++|+||+|
T Consensus       160 ~~~~~~~~~~~t~~y~aPE-~~~-~~~~~~~Di~slG  194 (277)
T 3f3z_A          160 KPGKMMRTKVGTPYYVSPQ-VLE-GLYGPECDEWSAG  194 (277)
T ss_dssp             CTTSCBCCCCSCTTTCCHH-HHT-TCBCTTHHHHHHH
T ss_pred             cCccchhccCCCCCccChH-Hhc-ccCCchhhehhHH
Confidence            654432222     22333 222 2377889999999

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8.9e-33  Score=220.43  Aligned_cols=185  Identities=23%  Similarity=0.342  Sum_probs=148.8

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEE
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQ-----EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYV   94 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~   94 (219)
                      .+...+.|.+.+.||+|+||.||+|.+.     .++..||+|.++...   .....+.+.+|+.+++.++||||++++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA---SPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            3445566699999999999999999873     455889999987432   45666889999999999999999999999


Q ss_pred             EecCCCceEEEEeccccCCChHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCC
Q 027788           95 WRDEDRNTLNFITEVCTSGNLREYRKKHRH------------------------VSVKALKKWSKQILKGLNYLHTHEPC  150 (219)
Q Consensus        95 ~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~------------------------~~~~~~~~i~~qv~~~l~~lh~~~~~  150 (219)
                      +..  ...++++|||+++++|.+++.....                        +++..+..++.|++.|+.|||+++  
T Consensus        95 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--  170 (314)
T 2ivs_A           95 CSQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--  170 (314)
T ss_dssp             ECS--SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             Eec--CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--
Confidence            854  4557889999999999999876432                        789999999999999999999999  


Q ss_pred             eeeeCCCCCceEEeCCCCcEEEeccccceeccccceee--------eecccCccccCCCccccccceeeec
Q 027788          151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRI--------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       151 i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ++|+||||+||+++.+ +.++|+|||++..........        ..+.+| +......++.++|+||+|
T Consensus       171 ivH~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  239 (314)
T 2ivs_A          171 LVHRDLAARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAI-ESLFDHIYTTQSDVWSFG  239 (314)
T ss_dssp             EECCCCSGGGEEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCH-HHHHHCEECHHHHHHHHH
T ss_pred             CcccccchheEEEcCC-CCEEEccccccccccccccceeccCCCCcccccCh-hhhcCCCcCchhhHHHHH
Confidence            9999999999999965 589999999998775433211        112222 222344577889999999

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.6e-32  Score=233.61  Aligned_cols=186  Identities=19%  Similarity=0.279  Sum_probs=151.3

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      ....|.+.+.||+|+||.||+|++..+++.||+|+++...... ....+.+.+|+.++++++||||+++++++..  ...
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~  259 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK-RKGYQGAMVEKKILAKVHSRFIVSLAYAFET--KTD  259 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh-hHHHHHHHHHHHHHHhcCCCCEeeEEEEEee--CCE
Confidence            3445578899999999999999999999999999997543211 1234678899999999999999999999854  456


Q ss_pred             EEEEeccccCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          103 LNFITEVCTSGNLREYRKKH----RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      ++++|||+++|+|..++...    ..+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||++
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~-g~vkL~DFGla  336 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDD-GNVRISDLGLA  336 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEECCCTTC
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCC-CCEEEeeccee
Confidence            89999999999999988653    36899999999999999999999999  9999999999999866 68999999999


Q ss_pred             eeccccceee-eecccC----ccccCCCccccccceeeecc
Q 027788          179 AIVGRAIRRI-RCWGRR----SSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       179 ~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~diws~gi  214 (219)
                      +......... ...|++    ++......++.++|+||+|+
T Consensus       337 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGv  377 (543)
T 3c4z_A          337 VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGV  377 (543)
T ss_dssp             EECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHH
T ss_pred             eeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchH
Confidence            8875543221 123332    23344567888999999993

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.6e-32  Score=214.54  Aligned_cols=186  Identities=17%  Similarity=0.298  Sum_probs=148.0

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHH---HHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMI---ERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      ..++| ++.+.||+|+||.||+|.+..+++.||+|.+............   +.+.+|+.++++++||||+++++++...
T Consensus        17 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           17 ADNEI-EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CSTTE-EEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhccc-eehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            34555 8889999999999999999999999999998765443333322   6788999999999999999999998443


Q ss_pred             CCceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCc-----EEE
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQ-----VKI  172 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~-----~~l  172 (219)
                        .  +++||++++++|.+++... ..+++..+..++.|++.|+.|||+.+++++|+||||+||+++.+ +.     ++|
T Consensus        96 --~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~-~~~~~~~~kl  170 (287)
T 4f0f_A           96 --P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL-DENAPVCAKV  170 (287)
T ss_dssp             --T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-CTTCSCCEEE
T ss_pred             --C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-CCCCceeEEe
Confidence              3  5799999999998877543 47999999999999999999999988779999999999999754 34     899


Q ss_pred             eccccceeccccce---eeeecccCcccc-CCCccccccceeeec
Q 027788          173 GDLGVAAIVGRAIR---RIRCWGRRSSWR-RSCTMRITRSLWTYT  213 (219)
Q Consensus       173 ~dfg~a~~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~diws~g  213 (219)
                      +|||++........   ++..+.+|+.+. ....++.++|+||+|
T Consensus       171 ~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG  215 (287)
T 4f0f_A          171 ADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFA  215 (287)
T ss_dssp             CCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHH
T ss_pred             CCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHH
Confidence            99999986554332   222334444332 344567789999999

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.3e-33  Score=218.96  Aligned_cols=186  Identities=22%  Similarity=0.387  Sum_probs=146.3

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      ..+...++| .+.+.||+|+||.||+|.+..++..+|+|.+.....   ....+.+.+|+.++++++||||+++++++. 
T Consensus        16 ~~g~i~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-   90 (285)
T 3is5_A           16 FQGTIDDLF-IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS---QVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-   90 (285)
T ss_dssp             ESSCHHHHE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---CSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-
T ss_pred             CCCChhhhe-eecceeccCCCeEEEEEEEccCCceEEEEEeecccc---chhHHHHHHHHHHHHhCCCchHHhHHHhee-
Confidence            444555666 888999999999999999999999999999886542   223467889999999999999999999995 


Q ss_pred             CCCceEEEEeccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC--CCcEE
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN--TGQVK  171 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~--~~~~~  171 (219)
                       +...++++||++++++|.+.+..    ...+++..+..++.|++.||.|||+.+  ++|+||||+||+++.+  .+.++
T Consensus        91 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~k  167 (285)
T 3is5_A           91 -DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIK  167 (285)
T ss_dssp             -CSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEE
T ss_pred             -cCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEE
Confidence             44568899999999999987743    367999999999999999999999999  9999999999999532  25799


Q ss_pred             Eeccccceeccccceeee-----ecccCccccCCCccccccceeeec
Q 027788          172 IGDLGVAAIVGRAIRRIR-----CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       172 l~dfg~a~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |+|||++...........     .+.+|+.+  ...++.++|+||+|
T Consensus       168 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~--~~~~~~~~Di~slG  212 (285)
T 3is5_A          168 IIDFGLAELFKSDEHSTNAAGTALYMAPEVF--KRDVTFKCDIWSAG  212 (285)
T ss_dssp             ECCCCCCCC----------CTTGGGCCHHHH--TTCCCHHHHHHHHH
T ss_pred             EEeeecceecCCcccCcCcccccCcCChHHh--ccCCCcccCeehHH
Confidence            999999987655433222     23333322  24567789999999

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-32  Score=223.81  Aligned_cols=183  Identities=27%  Similarity=0.353  Sum_probs=147.6

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecC-------CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEE
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQE-------EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHY   93 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~   93 (219)
                      ...+.+.+.+.||+|+||.||+|++..       .+..||+|.++...   .....+.+.+|+.+++++ +||||+++++
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  142 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLG  142 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc---CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence            334455899999999999999998653       33579999987542   456668899999999999 9999999999


Q ss_pred             EEecCCCceEEEEeccccCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCC
Q 027788           94 VWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLN  157 (219)
Q Consensus        94 ~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~----------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~  157 (219)
                      ++..  ...++++||++++++|.+++....                .+++..+..++.|++.||.|||+.+  ++|||||
T Consensus       143 ~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlk  218 (382)
T 3tt0_A          143 ACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLA  218 (382)
T ss_dssp             EECS--SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred             eecc--CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCC
Confidence            9954  445788999999999999987643                4899999999999999999999999  9999999


Q ss_pred             CCceEEeCCCCcEEEeccccceeccccce--------eeeecccCccccCCCccccccceeeec
Q 027788          158 CSNVFVNGNTGQVKIGDLGVAAIVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       158 ~~nili~~~~~~~~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |+||+++.+ +.+||+|||++........        .+..+.+| +......++.++||||+|
T Consensus       219 p~NIll~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP-E~~~~~~~~~~~DiwslG  280 (382)
T 3tt0_A          219 ARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP-EALFDRIYTHQSDVWSFG  280 (382)
T ss_dssp             GGGEEECTT-CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCH-HHHHSCCCCHHHHHHHHH
T ss_pred             cceEEEcCC-CcEEEcccCcccccccccccccccCCCCCcceeCH-HHhcCCCCCchhHHHHHH
Confidence            999999866 5899999999987654321        11122333 333455678889999999

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.1e-32  Score=233.12  Aligned_cols=181  Identities=23%  Similarity=0.340  Sum_probs=144.6

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      .|++.+.||+|+||.||+|++..++..||+|+++.....  ......+.+|+.+++.++||||+++++++.  +...+++
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~l  113 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS--TSSNSKLLEEVAVLKLLDHPNIMKLYDFFE--DKRNYYL  113 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred             CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHhCCCCCCCeEEEEEE--eCCEEEE
Confidence            458889999999999999999999999999998865432  222466889999999999999999999995  4466889


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC--CCcEEEeccccceeccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN--TGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~--~~~~~l~dfg~a~~~~~  183 (219)
                      +|||+++|+|.+.+.....+++..+..++.|++.||.|||+++  ++||||||+||+++..  .+.+||+|||++.....
T Consensus       114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            9999999999998877778999999999999999999999999  9999999999999743  23599999999988765


Q ss_pred             cceeee-----ecccCccccCCCccccccceeeecc
Q 027788          184 AIRRIR-----CWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~~~~-----~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ......     .+.+|+.+ . ..++.++||||+|+
T Consensus       192 ~~~~~~~~gt~~y~aPE~l-~-~~~~~~~DiwslG~  225 (494)
T 3lij_A          192 QKKMKERLGTAYYIAPEVL-R-KKYDEKCDVWSIGV  225 (494)
T ss_dssp             TBCBCCCCSCTTTCCHHHH-T-TCBCTHHHHHHHHH
T ss_pred             CccccccCCCcCeeCHHHH-c-ccCCCchhHHHHHH
Confidence            443222     23333322 2 45788899999993

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.3e-33  Score=222.14  Aligned_cols=188  Identities=19%  Similarity=0.270  Sum_probs=145.5

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEec
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRD   97 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~   97 (219)
                      .+....+|.-.++.||+|+||.||+|.+..+++.||+|+++...    ....+.+.+|+.++.++ +||||+++++++..
T Consensus         7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~   82 (316)
T 2ac3_A            7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE   82 (316)
T ss_dssp             CCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             CcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            34455667444688999999999999999999999999987542    22346788999999885 79999999999965


Q ss_pred             CCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCC--cEEEecc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG--QVKIGDL  175 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~--~~~l~df  175 (219)
                      +  +.++++||++++++|.+++.....+++..+..++.|++.||.|||+++  ++|+||||+||+++.+..  .++|+||
T Consensus        83 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Df  158 (316)
T 2ac3_A           83 E--DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDF  158 (316)
T ss_dssp             T--TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCT
T ss_pred             C--CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEc
Confidence            4  568899999999999999987778999999999999999999999999  999999999999985531  3899999


Q ss_pred             ccceeccccce-------------eeeecccCccccC----CCccccccceeeecc
Q 027788          176 GVAAIVGRAIR-------------RIRCWGRRSSWRR----SCTMRITRSLWTYTR  214 (219)
Q Consensus       176 g~a~~~~~~~~-------------~~~~~~~~~~~~~----~~~~~~~~diws~gi  214 (219)
                      |++........             ++..+.+|+.+..    ...++.++||||+|+
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~  214 (316)
T 2ac3_A          159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV  214 (316)
T ss_dssp             TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHH
T ss_pred             cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHH
Confidence            99976643211             1222333332221    134677899999993

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1e-32  Score=222.09  Aligned_cols=185  Identities=22%  Similarity=0.362  Sum_probs=148.7

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ..++| ++.+.||+|+||.||+|.+..+++.||+|.+....  ......+.+.+|+.++++++||||+++++++..  ..
T Consensus        23 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~   97 (331)
T 4aaa_A           23 SMEKY-ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK--KK   97 (331)
T ss_dssp             CGGGE-EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TT
T ss_pred             hhhhh-eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec--CC
Confidence            44666 78899999999999999999999999999987543  244555778899999999999999999999954  45


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      .++++||++++++|..++.....+++..+..++.|++.|+.+||+.+  ++|+||||+||+++.+ +.++|+|||++...
T Consensus        98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~  174 (331)
T 4aaa_A           98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQS-GVVKLCDFGFARTL  174 (331)
T ss_dssp             EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCTTC---
T ss_pred             EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCC-CcEEEEeCCCceee
Confidence            68899999999899888776778999999999999999999999999  9999999999999866 58999999999876


Q ss_pred             cccce------eeeecccCccccCCCccccccceeeecc
Q 027788          182 GRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       182 ~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .....      ++..+.+|+.+.....++.++|+||+|+
T Consensus       175 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~  213 (331)
T 4aaa_A          175 AAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGC  213 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHH
T ss_pred             cCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHH
Confidence            54322      2222334443444456788899999993

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.1e-33  Score=227.55  Aligned_cols=181  Identities=21%  Similarity=0.353  Sum_probs=139.8

Q ss_pred             CceeeeeeeeccccceEEEEEEec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQ---EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      ...+.+.+.||+|+||.||+|+..   .++..||+|.++...   .....+.+.+|+.++++++||||+++++++..  .
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~  118 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--S  118 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--C
Confidence            344588899999999999999876   467789999987542   45566789999999999999999999999954  4


Q ss_pred             ceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          101 NTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      ..++++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.+||+|||+++
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~  195 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSN-LVCKVSDFGLGR  195 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC----
T ss_pred             CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCC-CCEEECcCcccc
Confidence            5578899999999999998765 36899999999999999999999999  9999999999999866 589999999998


Q ss_pred             ecccccee--e-------eecccCccccCCCccccccceeeec
Q 027788          180 IVGRAIRR--I-------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       180 ~~~~~~~~--~-------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ........  .       ..+.+| +......++.++|+||||
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Dv~SlG  237 (373)
T 2qol_A          196 VLEDDPEAAYTTRGGKIPIRWTSP-EAIAYRKFTSASDVWSYG  237 (373)
T ss_dssp             ------------------CTTSCH-HHHHHCCCCHHHHHHHHH
T ss_pred             ccccCCccceeccCCCcCCCccCh-hhhccCCcCchhcHHHHH
Confidence            76543221  0       112233 333445678889999999

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-32  Score=221.62  Aligned_cols=184  Identities=21%  Similarity=0.336  Sum_probs=146.3

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCC--CCceEEEEEEecC
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN--KNIISLHYVWRDE   98 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~--~~i~~~~~~~~~~   98 (219)
                      ...++.|++.+.||+|+||.||+|.+ .++..||+|.++....  .....+.+.+|+.++++++|  +||+++++++.. 
T Consensus         5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-   80 (343)
T 3dbq_A            5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-   80 (343)
T ss_dssp             ESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-
T ss_pred             eeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc--chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-
Confidence            34567779999999999999999987 5688999999876542  45566889999999999987  999999999854 


Q ss_pred             CCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                       ...++++|| +.+++|.+++.....+++..+..++.|++.||.|||+.+  ++||||||+||+++ + +.+||+|||++
T Consensus        81 -~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~-~~~kl~DFG~a  154 (343)
T 3dbq_A           81 -DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-D-GMLKLIDFGIA  154 (343)
T ss_dssp             -SSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-T-TEEEECCCSSS
T ss_pred             -CCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-C-CcEEEeecccc
Confidence             457889999 457899999988888999999999999999999999999  99999999999997 4 47999999999


Q ss_pred             eeccccce--------eeeecccCcccc----------CCCccccccceeeecc
Q 027788          179 AIVGRAIR--------RIRCWGRRSSWR----------RSCTMRITRSLWTYTR  214 (219)
Q Consensus       179 ~~~~~~~~--------~~~~~~~~~~~~----------~~~~~~~~~diws~gi  214 (219)
                      ........        ++..+.+|+.+.          ....++.++||||+|+
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~  208 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC  208 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHH
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHH
Confidence            87654332        222233333221          1255777899999993

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-33  Score=226.64  Aligned_cols=195  Identities=21%  Similarity=0.283  Sum_probs=149.8

Q ss_pred             CCCccccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccC-CCHHHHHHHHHHHHHHHhhCCCCceEEE
Q 027788           14 SEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC-DDPAMIERLFSEVRLLKTLANKNIISLH   92 (219)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~~~   92 (219)
                      ..+....+..++| ++.+.||+|+||.||+|.+..++..||+|++...... ......+.+.+|+.++++++||||++++
T Consensus        16 ~q~~~~~~~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~   94 (345)
T 3hko_A           16 FQGGSLLELQKKY-HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLY   94 (345)
T ss_dssp             CCCBCHHHHHHHE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccCchhhhhhhhe-eecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceee
Confidence            3333334445666 8889999999999999999999999999998754321 1234567889999999999999999999


Q ss_pred             EEEecCCCceEEEEeccccCCChHHHHHhC----------------------------------------CCCCHHHHHH
Q 027788           93 YVWRDEDRNTLNFITEVCTSGNLREYRKKH----------------------------------------RHVSVKALKK  132 (219)
Q Consensus        93 ~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~----------------------------------------~~~~~~~~~~  132 (219)
                      +++..  ...++++|||+++++|.+++...                                        ..+++..+..
T Consensus        95 ~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (345)
T 3hko_A           95 EVYED--EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN  172 (345)
T ss_dssp             EEEEC--SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHH
T ss_pred             hhhcc--CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHH
Confidence            99954  46788999999999999987420                                        1135677888


Q ss_pred             HHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC-CcEEEeccccceeccccce----------eeeecccCccccC-C
Q 027788          133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT-GQVKIGDLGVAAIVGRAIR----------RIRCWGRRSSWRR-S  200 (219)
Q Consensus       133 i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~-~~~~l~dfg~a~~~~~~~~----------~~~~~~~~~~~~~-~  200 (219)
                      ++.|++.|+.|||+.+  ++|+||||+||+++.+. ..++|+|||++..+.....          ++..+.+|+.+.. .
T Consensus       173 i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  250 (345)
T 3hko_A          173 IMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN  250 (345)
T ss_dssp             HHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred             HHHHHHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence            9999999999999999  99999999999997442 2799999999987643221          2222334443332 3


Q ss_pred             Cccccccceeeec
Q 027788          201 CTMRITRSLWTYT  213 (219)
Q Consensus       201 ~~~~~~~diws~g  213 (219)
                      ..++.++||||+|
T Consensus       251 ~~~~~~~DiwslG  263 (345)
T 3hko_A          251 ESYGPKCDAWSAG  263 (345)
T ss_dssp             SCCCTHHHHHHHH
T ss_pred             CCCCcHHHHHHHH
Confidence            5677889999999

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.9e-32  Score=219.83  Aligned_cols=177  Identities=21%  Similarity=0.356  Sum_probs=146.4

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      +...+.||+|+||.||+|.+..+|+.||+|.+....    ....+.+.+|+.++++++||||+++++++...  ..++++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  120 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG--EELWVL  120 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEE
Confidence            466689999999999999999899999999987543    22346688999999999999999999999654  458889


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      |||+++++|.+++.. ..+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+ +.++|+|||++........
T Consensus       121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~  196 (321)
T 2c30_A          121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVP  196 (321)
T ss_dssp             ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSC
T ss_pred             EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCC-CcEEEeeeeeeeecccCcc
Confidence            999999999998764 46999999999999999999999999  9999999999999866 5899999999987755432


Q ss_pred             ------eeeecccCccccCCCccccccceeeecc
Q 027788          187 ------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 ------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                            ++..+.+| +......++.++|+||+|+
T Consensus       197 ~~~~~~gt~~y~aP-E~~~~~~~~~~~Dv~slG~  229 (321)
T 2c30_A          197 KRKSLVGTPYWMAP-EVISRSLYATEVDIWSLGI  229 (321)
T ss_dssp             CBCCCCSCGGGCCH-HHHTTCCBCTHHHHHHHHH
T ss_pred             ccccccCCccccCH-hhhcCCCCCchhhHHHHHH
Confidence                  12222333 3344566788899999993

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.9e-32  Score=214.76  Aligned_cols=181  Identities=20%  Similarity=0.302  Sum_probs=148.7

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++| ++.+.||+|+||.||+|.+..+++.||+|.++....   ....+.+.+|+.+++.++||||+++++++..  ....
T Consensus         7 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   80 (276)
T 2yex_A            7 EDW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQ   80 (276)
T ss_dssp             HHE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEE
T ss_pred             cce-EEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---hhhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEE
Confidence            344 788999999999999999999999999999875542   3345778899999999999999999999854  4567


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++||++++++|.+++.....+++..+..++.|++.++.+||+++  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRY  157 (276)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEECEE
T ss_pred             EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccC-CCEEEeeCCCccccCC
Confidence            889999999999998877778999999999999999999999999  9999999999999865 5899999999987643


Q ss_pred             cce--------eeeecccCccccCCCccccccceeeec
Q 027788          184 AIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...        ++..+.+|+.......++.++|+||+|
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG  195 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG  195 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHH
T ss_pred             CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHH
Confidence            321        222233444333333346679999999

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=9.5e-33  Score=233.00  Aligned_cols=183  Identities=23%  Similarity=0.352  Sum_probs=150.5

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      ..|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+.+|+.++++++||||+++++++.  +...++
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~  102 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPNIMKLYEFFE--DKGYFY  102 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-BSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc-cchHHHHHHHHHHHHHhCCCCCCCcEEEEEE--eCCEEE
Confidence            3448889999999999999999999999999998755432 1223477889999999999999999999995  456788


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC--CCCcEEEeccccceecc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG--NTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~--~~~~~~l~dfg~a~~~~  182 (219)
                      ++||++++++|.+.+.....+++..+..++.|++.|+.|||+++  ++||||||+||+++.  ..+.+||+|||++....
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999999888788999999999999999999999999  999999999999952  33589999999998765


Q ss_pred             ccce-----eeeecccCccccCCCccccccceeeecc
Q 027788          183 RAIR-----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~-----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ....     ++..+.+|+...  ..++.++||||+|+
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~  215 (484)
T 3nyv_A          181 ASKKMKDKIGTAYYIAPEVLH--GTYDEKCDVWSTGV  215 (484)
T ss_dssp             CCCSHHHHTTGGGTCCHHHHH--TCCCTHHHHHHHHH
T ss_pred             cccccccCCCCccccCceeec--CCCCCcceeHHHHH
Confidence            5433     222333343322  25788899999993

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.8e-33  Score=224.36  Aligned_cols=179  Identities=22%  Similarity=0.304  Sum_probs=143.6

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCc
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~  101 (219)
                      .++| .+.+.||+|+||.||+|.+..+++.||+|+++....        ...+|++++.++ +||||+++++++.  +..
T Consensus        21 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~--~~~   89 (342)
T 2qr7_A           21 TDGY-EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYD--DGK   89 (342)
T ss_dssp             HHHE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEE--CSS
T ss_pred             cccE-EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEE--cCC
Confidence            3445 788999999999999999999999999999875432        123688888887 7999999999984  456


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCC---cEEEeccccc
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG---QVKIGDLGVA  178 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~---~~~l~dfg~a  178 (219)
                      .++++|||+++|+|.+++.....+++..+..++.|++.|+.|||+.+  ++||||||+||++..+.+   .+||+|||++
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence            78999999999999999988888999999999999999999999999  999999999999854332   4999999999


Q ss_pred             eecccccee-eeecccC----ccccCCCccccccceeeecc
Q 027788          179 AIVGRAIRR-IRCWGRR----SSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       179 ~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~diws~gi  214 (219)
                      ......... ....+++    ++......++.++|+||+|+
T Consensus       168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  208 (342)
T 2qr7_A          168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGV  208 (342)
T ss_dssp             EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhH
Confidence            876544321 1112221    12223344777899999993

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.2e-32  Score=213.64  Aligned_cols=183  Identities=22%  Similarity=0.367  Sum_probs=148.6

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCC--HHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD--PAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .|++.+.||+|+||.||+|.+..+++.||+|.++.......  ....+.+.+|+.++++++||||+++++++..  ....
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~   83 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN--KTDV   83 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC--CCeE
Confidence            34888999999999999999999999999999886543221  1235778899999999999999999999854  4568


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC---CcEEEecccccee
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT---GQVKIGDLGVAAI  180 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~---~~~~l~dfg~a~~  180 (219)
                      +++||++++++|.+++.....+++..+..++.|++.|+.+||+.+  ++|+||+|+||+++.+.   ..++|+|||++..
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            899999999999999987778999999999999999999999999  99999999999997542   1699999999987


Q ss_pred             cccccee-----eeecccCccccCCCccccccceeeec
Q 027788          181 VGRAIRR-----IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .......     +..+.+| +......++.++|+||+|
T Consensus       162 ~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  198 (283)
T 3bhy_A          162 IEAGNEFKNIFGTPEFVAP-EIVNYEPLGLEADMWSIG  198 (283)
T ss_dssp             CC--------CCCGGGCCH-HHHTTCCCCTHHHHHHHH
T ss_pred             ccCCCcccccCCCcCccCc-ceecCCCCCcchhhhhHH
Confidence            7554322     1222233 344455677889999999

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.4e-32  Score=224.82  Aligned_cols=183  Identities=20%  Similarity=0.338  Sum_probs=145.4

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCC--CCceEEEEEEecCC
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN--KNIISLHYVWRDED   99 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~--~~i~~~~~~~~~~~   99 (219)
                      ..++.|++.+.||+|+||.||+|.+.. +..||+|.+.....  .....+.+.+|+.++++++|  |||+++++++..+ 
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-  128 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-  128 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-
Confidence            345667999999999999999999764 89999999876543  45667889999999999974  9999999988544 


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                       ..++++|| +.+++|.+++.....+++..+..++.|++.||.|||+.+  ++||||||+||+++ + +.+||+|||++.
T Consensus       129 -~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~-~~~kl~DFG~a~  202 (390)
T 2zmd_A          129 -QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-D-GMLKLIDFGIAN  202 (390)
T ss_dssp             -SEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-S-SCEEECCCSSSC
T ss_pred             -CEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-C-CeEEEEecCccc
Confidence             56889999 567899999988788999999999999999999999999  99999999999996 4 589999999998


Q ss_pred             eccccce--------eeeecccCccccC----------CCccccccceeeecc
Q 027788          180 IVGRAIR--------RIRCWGRRSSWRR----------SCTMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~--------~~~~~~~~~~~~~----------~~~~~~~~diws~gi  214 (219)
                      .......        ++..+.+|+.+..          ...++.++||||+|+
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGv  255 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC  255 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHH
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHH
Confidence            7654321        2223334433221          235777899999993

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-32  Score=217.02  Aligned_cols=184  Identities=25%  Similarity=0.378  Sum_probs=143.3

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCC-CHHHHHHHHHHHHHHHhhC---CCCceEEEEEEecCCC
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD-DPAMIERLFSEVRLLKTLA---NKNIISLHYVWRDEDR  100 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~---~~~i~~~~~~~~~~~~  100 (219)
                      ..|++.+.||+|+||.||+|.+..+++.||+|.++...... .......+.+|+.+++.++   ||||+++++++.....
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            34488899999999999999999999999999987543211 1111234556777776665   9999999999876443


Q ss_pred             c---eEEEEeccccCCChHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788          101 N---TLNFITEVCTSGNLREYRKKHRH--VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus       101 ~---~~~lv~e~~~~g~L~~~~~~~~~--~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      .   .++++||+++ ++|.+++.....  +++..+..++.|++.|+.|||+++  ++|+||||+||+++.+ +.++|+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~-~~~kl~Df  164 (308)
T 3g33_A           89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG-GTVKLADF  164 (308)
T ss_dssp             SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTT-SCEEECSC
T ss_pred             CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC-CCEEEeeC
Confidence            2   5789999997 699998876543  899999999999999999999999  9999999999999866 58999999


Q ss_pred             ccceeccccceeee-----ecccCccccCCCccccccceeeec
Q 027788          176 GVAAIVGRAIRRIR-----CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       176 g~a~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |++...........     .+.+| +......++.++||||+|
T Consensus       165 g~a~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG  206 (308)
T 3g33_A          165 GLARIYSYQMALTPVVVTLWYRAP-EVLLQSTYATPVDMWSVG  206 (308)
T ss_dssp             SCTTTSTTCCCSGGGGCCCSSCCH-HHHHTSCCCSTHHHHHHH
T ss_pred             ccccccCCCcccCCccccccccCc-hHHcCCCCCchHHHHHHH
Confidence            99987654433222     22333 333455578889999999

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.9e-32  Score=217.60  Aligned_cols=186  Identities=18%  Similarity=0.227  Sum_probs=144.9

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      ....++| ++.+.||+|+||.||+|.+..+++.||+|+++.... .+....+.+.+|+.++++++||||+++++++..+ 
T Consensus        30 ~~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-  106 (309)
T 2h34_A           30 GTQFGPY-RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-  106 (309)
T ss_dssp             ----CCE-EEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-
T ss_pred             CcEeccE-EEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-
Confidence            3344666 888999999999999999999999999999875432 2455568899999999999999999999998654 


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                       ..++++||++++++|.+++.....+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++|+|||++.
T Consensus       107 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~  182 (309)
T 2h34_A          107 -GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSAD-DFAYLVDFGIAS  182 (309)
T ss_dssp             -TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSCCC--
T ss_pred             -CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCC-CCEEEecCccCc
Confidence             568899999999999999987778999999999999999999999999  9999999999999866 589999999997


Q ss_pred             eccccce-------eeeecccCccccCCCccccccceeeec
Q 027788          180 IVGRAIR-------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       180 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .......       ++..+.+| +......++.++|+||+|
T Consensus       183 ~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  222 (309)
T 2h34_A          183 ATTDEKLTQLGNTVGTLYYMAP-ERFSESHATYRADIYALT  222 (309)
T ss_dssp             --------------CCGGGCCG-GGTCC----CCCHHHHHH
T ss_pred             cccccccccccccCCCcCccCH-HHHcCCCCCchHhHHHHH
Confidence            7654321       12223333 344455677889999999

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-33  Score=224.02  Aligned_cols=184  Identities=23%  Similarity=0.285  Sum_probs=148.5

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEE
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQ-----EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVW   95 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~   95 (219)
                      +...+.|++.+.||+|+||.||+|.+.     .++..||+|.++...   .....+.+.+|+.++++++||||+++++++
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            434445588899999999999999986     455899999987442   455667899999999999999999999999


Q ss_pred             ecCCCceEEEEeccccCCChHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 027788           96 RDEDRNTLNFITEVCTSGNLREYRKKH------------------------RHVSVKALKKWSKQILKGLNYLHTHEPCV  151 (219)
Q Consensus        96 ~~~~~~~~~lv~e~~~~g~L~~~~~~~------------------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i  151 (219)
                      ..  ...++++|||+++++|.+++...                        ..+++..+..++.|++.|+.|||+++  +
T Consensus       120 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--i  195 (343)
T 1luf_A          120 AV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--F  195 (343)
T ss_dssp             CS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred             cc--CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--e
Confidence            54  45578899999999999998753                        46889999999999999999999999  9


Q ss_pred             eeeCCCCCceEEeCCCCcEEEeccccceeccccce--------eeeecccCccccCCCccccccceeeec
Q 027788          152 IHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       152 ~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +|+||||+||+++.+ +.++|+|||++........        .+..+.+| +......++.++|+||+|
T Consensus       196 vH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP-E~~~~~~~~~~~Di~slG  263 (343)
T 1luf_A          196 VHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPP-ESIFYNRYTTESDVWAYG  263 (343)
T ss_dssp             CCSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCH-HHHHHCCCCHHHHHHHHH
T ss_pred             ecCCCCcceEEECCC-CeEEEeecCCCcccccCccccccCCCcccceecCh-hhhccCCcCcccccHHHH
Confidence            999999999999866 5899999999987644321        11113333 333344577889999999

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.3e-32  Score=232.87  Aligned_cols=182  Identities=25%  Similarity=0.371  Sum_probs=148.5

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      .....-+.+.+.||+|+||.||+|.+..++..||+|.++...     ...+.+.+|+.++++++||||+++++++...  
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--  288 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--  288 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-----cchHHHHHHHHHHHhcCCCCEeeEEEEEecC--
Confidence            334445588899999999999999999889999999987432     1247789999999999999999999999544  


Q ss_pred             ceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          101 NTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      ..++++|||+++|+|.+++...  ..+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||++
T Consensus       289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~a  365 (495)
T 1opk_A          289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGEN-HLVKVADFGLS  365 (495)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG-GCEEECCTTCE
T ss_pred             CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCC-CcEEEeecccc
Confidence            4578899999999999998753  45889999999999999999999999  9999999999999865 58999999999


Q ss_pred             eeccccceee-------eecccCccccCCCccccccceeeec
Q 027788          179 AIVGRAIRRI-------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       179 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +.........       ..+.+| +......++.++||||||
T Consensus       366 ~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~sDvwSlG  406 (495)
T 1opk_A          366 RLMTGDTYTAHAGAKFPIKWTAP-ESLAYNKFSIKSDVWAFG  406 (495)
T ss_dssp             ECCTTCCEECCTTCCCCGGGCCH-HHHHHCEECHHHHHHHHH
T ss_pred             eeccCCceeecCCCcCCcceeCH-hHHhcCCCCcHHhHHhHH
Confidence            8765433211       112233 223345577889999999

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.2e-32  Score=220.77  Aligned_cols=183  Identities=24%  Similarity=0.392  Sum_probs=150.3

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC---
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED---   99 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~---   99 (219)
                      .++| ++.+.||+|+||.||+|.+..++..||+|.+....   .....+.+.+|+.++++++||||+++++++....   
T Consensus        26 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  101 (364)
T 3qyz_A           26 GPRY-TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ  101 (364)
T ss_dssp             TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred             cccE-EEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc---CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence            3455 88899999999999999999999999999987432   4555678899999999999999999999885432   


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      ...++++||+++ ++|.+++.. ..+++..+..++.|++.||.|||+++  ++|+||||+||+++.+ +.++|+|||++.
T Consensus       102 ~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~  176 (364)
T 3qyz_A          102 MKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLAR  176 (364)
T ss_dssp             CCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCTTCE
T ss_pred             cceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCC-CCEEEEeCcceE
Confidence            246789999997 589888765 46999999999999999999999999  9999999999999866 589999999998


Q ss_pred             eccccce---------eeeecccCccccCCCccccccceeeecc
Q 027788          180 IVGRAIR---------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .......         ++..+.+|+.+.....++.++|+||+|+
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~  220 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC  220 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHH
Confidence            7765432         2222334443455566788899999993

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.4e-32  Score=216.37  Aligned_cols=184  Identities=20%  Similarity=0.319  Sum_probs=144.5

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      .......+.|++.+.||+|+||.||+|.+. ++..||+|.++....  .   .+.+.+|+.++++++||||+++++++. 
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-   89 (283)
T 3gen_A           17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--S---EDEFIEEAKVMMNLSHEKLVQLYGVCT-   89 (283)
T ss_dssp             CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB--C---HHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC--C---HHHHHHHHHHHhcCCCCCEeeEEEEEe-
Confidence            344455555688899999999999999865 677899999875432  1   256889999999999999999999994 


Q ss_pred             CCCceEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                       +...++++||++++++|.+++.. ...+++..+..++.|++.++.+||+++  ++|+||||+||+++.+ +.++|+|||
T Consensus        90 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg  165 (283)
T 3gen_A           90 -KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFG  165 (283)
T ss_dssp             -SSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTT-SCEEECSTT
T ss_pred             -cCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCC-CCEEEcccc
Confidence             44568899999999999998875 457999999999999999999999999  9999999999999865 589999999


Q ss_pred             cceecccccee-------eeecccCccccCCCccccccceeeec
Q 027788          177 VAAIVGRAIRR-------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       177 ~a~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ++.........       +..+.+| +......++.++|+||+|
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Dv~slG  208 (283)
T 3gen_A          166 LSRYVLDDEYTSSVGSKFPVRWSPP-EVLMYSKFSSKSDIWAFG  208 (283)
T ss_dssp             GGGGBCCHHHHSTTSTTSCGGGCCH-HHHHHCCCSHHHHHHHHH
T ss_pred             ccccccccccccccCCccCcccCCH-HHhccCCCCchhhHHHHH
Confidence            99866443321       1112233 333344577889999999

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.2e-32  Score=218.24  Aligned_cols=184  Identities=28%  Similarity=0.384  Sum_probs=145.9

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEec-------CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEE
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQ-------EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLH   92 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~   92 (219)
                      +...+.|.+.+.||+|+||.||+|.+.       .++..||+|.++...   .....+.+.+|+.+++++ +||||++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~  107 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLL  107 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence            333445588999999999999999875       467789999987442   455668899999999999 899999999


Q ss_pred             EEEecCCCceEEEEeccccCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCC
Q 027788           93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDL  156 (219)
Q Consensus        93 ~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~----------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl  156 (219)
                      +++..  ...++++||++++++|.+++....                .+++..+..++.|++.||.|||+.+  ++|+||
T Consensus       108 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dl  183 (334)
T 2pvf_A          108 GACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDL  183 (334)
T ss_dssp             EEECS--SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCC
T ss_pred             EEEcc--CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCC
Confidence            99854  456788999999999999987543                3789999999999999999999999  999999


Q ss_pred             CCCceEEeCCCCcEEEeccccceecccccee--------eeecccCccccCCCccccccceeeec
Q 027788          157 NCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR--------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       157 ~~~nili~~~~~~~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ||+||+++.+ +.+||+|||++.........        +..+.+| +......++.++|+||+|
T Consensus       184 kp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  246 (334)
T 2pvf_A          184 AARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP-EALFDRVYTHQSDVWSFG  246 (334)
T ss_dssp             SGGGEEECTT-CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCH-HHHHHCEECHHHHHHHHH
T ss_pred             ccceEEEcCC-CCEEEccccccccccccccccccCCCCcccceeCh-HHhcCCCcChHHHHHHHH
Confidence            9999999866 58999999999876543321        1112222 223344577889999999

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.5e-32  Score=215.95  Aligned_cols=182  Identities=20%  Similarity=0.288  Sum_probs=147.1

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++| ++.+.||+|+||.||+|.+..++..||+|++...... .......+.+|+.++++++||||+++++++..  ....
T Consensus         9 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   84 (279)
T 3fdn_A            9 EDF-EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRV   84 (279)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred             ccE-EEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccc-hhhHHHHHHHHHHHHHcCCCCCCcchhheEec--CCEE
Confidence            445 8889999999999999999999999999998754321 12224668899999999999999999999954  4568


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++|||+++++|.+++.....+++..+..++.|++.++.|||+.+  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHAPS  161 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTT-SCEEECSCCEESCC--
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCC-CCEEEEeccccccCCc
Confidence            899999999999999887778999999999999999999999999  9999999999999866 5899999999866544


Q ss_pred             cce----eeeecccCccccCCCccccccceeeec
Q 027788          184 AIR----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...    ++..+.+| +......++.++|+||+|
T Consensus       162 ~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  194 (279)
T 3fdn_A          162 SRRTDLCGTLDYLPP-EMIEGRMHDEKVDLWSLG  194 (279)
T ss_dssp             ------CCCCTTCCH-HHHTTCCCCTTHHHHHHH
T ss_pred             ccccccCCCCCccCH-hHhccCCCCccchhHhHH
Confidence            332    11222222 334455677789999999

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-32  Score=220.32  Aligned_cols=184  Identities=27%  Similarity=0.401  Sum_probs=144.5

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEe-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEE
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFD-----QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYV   94 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~   94 (219)
                      +...+.|.+.+.||+|+||.||+|.+     ..++..||+|.++...   .....+.+.+|+.+++++ +||||++++++
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  117 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGA  117 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            34445558999999999999999996     3456789999987543   233457788999999999 89999999999


Q ss_pred             EecCCCceEEEEeccccCCChHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCe
Q 027788           95 WRDEDRNTLNFITEVCTSGNLREYRKKHR-----------------------HVSVKALKKWSKQILKGLNYLHTHEPCV  151 (219)
Q Consensus        95 ~~~~~~~~~~lv~e~~~~g~L~~~~~~~~-----------------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i  151 (219)
                      +..  ...++++||++++++|.+++....                       .+++..+..++.|++.||.|||+.+  +
T Consensus       118 ~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i  193 (344)
T 1rjb_A          118 CTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--C  193 (344)
T ss_dssp             ECS--SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred             Eee--CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--c
Confidence            954  445788999999999999987543                       2788999999999999999999999  9


Q ss_pred             eeeCCCCCceEEeCCCCcEEEeccccceecccccee--------eeecccCccccCCCccccccceeeec
Q 027788          152 IHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR--------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       152 ~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +|+||||+||+++.+ +.++|+|||++.........        +..+.+| +......++.++||||+|
T Consensus       194 vH~Dikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP-E~~~~~~~~~~~Di~slG  261 (344)
T 1rjb_A          194 VHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP-ESLFEGIYTIKSDVWSYG  261 (344)
T ss_dssp             EETTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH-HHHHHCCCCHHHHHHHHH
T ss_pred             ccCCCChhhEEEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCH-HHhccCCCChhHhHHHHH
Confidence            999999999999966 58999999999876543321        1123333 333345578889999999

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9.3e-32  Score=213.14  Aligned_cols=187  Identities=19%  Similarity=0.291  Sum_probs=151.3

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCC-----CHHHHHHHHHHHHHHHhhC-CCCceEEEEE
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD-----DPAMIERLFSEVRLLKTLA-NKNIISLHYV   94 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~   94 (219)
                      ....+| ++.+.||+|+||.||+|.+..+++.||+|.++......     .....+.+.+|+.+++++. ||||++++++
T Consensus        14 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           14 GFYENY-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             -CTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             chhhcc-ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            345666 78899999999999999999999999999987543111     1234467889999999995 9999999999


Q ss_pred             EecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEec
Q 027788           95 WRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD  174 (219)
Q Consensus        95 ~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~d  174 (219)
                      +.  .....+++||++++++|.+++.....+++..+..++.|++.|+.+||+.+  ++|+||+|+||+++.+ +.++|+|
T Consensus        93 ~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~d  167 (298)
T 1phk_A           93 YE--TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD-MNIKLTD  167 (298)
T ss_dssp             EE--CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECC
T ss_pred             ec--cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCC-CcEEEec
Confidence            84  45678899999999999999987778999999999999999999999999  9999999999999866 5899999


Q ss_pred             cccceecccccee-----eeecccCcccc-----CCCccccccceeeec
Q 027788          175 LGVAAIVGRAIRR-----IRCWGRRSSWR-----RSCTMRITRSLWTYT  213 (219)
Q Consensus       175 fg~a~~~~~~~~~-----~~~~~~~~~~~-----~~~~~~~~~diws~g  213 (219)
                      ||++.........     +..+.+|+.+.     ....++.++|+||+|
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG  216 (298)
T 1phk_A          168 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG  216 (298)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHH
T ss_pred             ccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHH
Confidence            9999876544322     22233333221     244577789999999

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.98  E-value=1.3e-32  Score=223.76  Aligned_cols=185  Identities=21%  Similarity=0.376  Sum_probs=152.9

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      +.....|++.+.||+|+||.||+|.+..++..||+|+++...   .....+.+.+|+.+++.++||||+++++++...  
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--  103 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD--  103 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET--
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC--
Confidence            334444588899999999999999999999999999988543   456668899999999999999999999998654  


Q ss_pred             ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          101 NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH-EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~-~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      ..++++|||+++++|.+++.....+++..+..++.|++.++.|||+. +  ++|+||||+||+++.+ +.++|+|||++.
T Consensus       104 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~  180 (360)
T 3eqc_A          104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSG  180 (360)
T ss_dssp             TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTT-CCEEECCCCCCH
T ss_pred             CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCC-CCEEEEECCCCc
Confidence            56889999999999999998777899999999999999999999985 8  9999999999999866 589999999997


Q ss_pred             eccccce----eeeecccCccccCCCccccccceeeecc
Q 027788          180 IVGRAIR----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .......    ++..+.+| +......++.++|+||+|+
T Consensus       181 ~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG~  218 (360)
T 3eqc_A          181 QLIDSMANSFVGTRSYMSP-ERLQGTHYSVQSDIWSMGL  218 (360)
T ss_dssp             HHHHHC----CCCCTTCCH-HHHTTCCCSHHHHHHHHHH
T ss_pred             ccccccccCCCCCCCeECH-HHHcCCCCCchhhHHHHHH
Confidence            6543321    22222233 3344556788899999993

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.98  E-value=1.1e-31  Score=215.38  Aligned_cols=185  Identities=26%  Similarity=0.460  Sum_probs=145.5

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecC
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDE   98 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~   98 (219)
                      .++.++| ++.+.||+|+||.||+|.+..+++.||+|++.....     ..+.+.+|+.+++++ +||||+++++++...
T Consensus        20 ~~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           20 RDPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----EEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             CCCTTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             cCCCCcE-EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-----cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            3455666 888999999999999999999999999999875421     235678899999999 799999999998764


Q ss_pred             C----CceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEE
Q 027788           99 D----RNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKI  172 (219)
Q Consensus        99 ~----~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l  172 (219)
                      .    ...++++||++++++|.+++...  ..+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.+ +.++|
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~-~~~kl  170 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKL  170 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-CCEEE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCC-CCEEE
Confidence            3    46789999999999999998754  46899999999999999999999999  9999999999999865 58999


Q ss_pred             eccccceeccccce------eeeecccCcccc----CCCccccccceeeec
Q 027788          173 GDLGVAAIVGRAIR------RIRCWGRRSSWR----RSCTMRITRSLWTYT  213 (219)
Q Consensus       173 ~dfg~a~~~~~~~~------~~~~~~~~~~~~----~~~~~~~~~diws~g  213 (219)
                      +|||++........      ++..+.+|+.+.    ....++.++|+||+|
T Consensus       171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG  221 (326)
T 2x7f_A          171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG  221 (326)
T ss_dssp             CCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHH
T ss_pred             eeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHH
Confidence            99999987654321      222233343332    145577889999999

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.98  E-value=9.9e-32  Score=216.12  Aligned_cols=190  Identities=22%  Similarity=0.340  Sum_probs=148.1

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEec
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRD   97 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~   97 (219)
                      ..+..+..|++.+.||+|+||.||+|.+..+++.||+|.+...    .....+.+.+|+.+++++. ||||+++++++..
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~   97 (337)
T 3ll6_A           22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI   97 (337)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence            3445556669999999999999999999999999999988644    4555677899999999996 9999999998842


Q ss_pred             ------CCCceEEEEeccccCCChHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCC
Q 027788           98 ------EDRNTLNFITEVCTSGNLREYRKK---HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG  168 (219)
Q Consensus        98 ------~~~~~~~lv~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~  168 (219)
                            .....++++||+++ |+|.+++..   ...+++..+..++.|++.||.|||+.+++++|+||||+||+++.+ +
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~-~  175 (337)
T 3ll6_A           98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-G  175 (337)
T ss_dssp             CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT-S
T ss_pred             cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC-C
Confidence                  34456889999996 688887653   456999999999999999999999987679999999999999865 5


Q ss_pred             cEEEeccccceeccccce------------------eeeecccCcccc--CCCccccccceeeecc
Q 027788          169 QVKIGDLGVAAIVGRAIR------------------RIRCWGRRSSWR--RSCTMRITRSLWTYTR  214 (219)
Q Consensus       169 ~~~l~dfg~a~~~~~~~~------------------~~~~~~~~~~~~--~~~~~~~~~diws~gi  214 (219)
                      .++|+|||++........                  ++..+.+|+...  ....++.++||||+|+
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~  241 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGC  241 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHH
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHH
Confidence            899999999987654321                  222344444332  4556777899999993

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.98  E-value=2.7e-32  Score=214.34  Aligned_cols=184  Identities=26%  Similarity=0.488  Sum_probs=141.0

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ..++| ++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+.+|+.++++++||||+++++++..  .+
T Consensus         9 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~   84 (278)
T 3cok_A            9 KIEDF-KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELYNYFED--SN   84 (278)
T ss_dssp             SGGGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--SS
T ss_pred             ccccc-eeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--CC
Confidence            34555 8889999999999999999999999999998754321 11234678899999999999999999999854  46


Q ss_pred             eEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          102 TLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      ..+++||++++++|.+++... ..+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~-~~~kl~dfg~~~~  161 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRN-MNIKIADFGLATQ  161 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred             eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCC-CCEEEEeecceee
Confidence            788999999999999988764 57899999999999999999999999  9999999999999866 5899999999987


Q ss_pred             ccccce------eeeecccCccccCCCccccccceeeec
Q 027788          181 VGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ......      ++..+.+| +......++.++|+||+|
T Consensus       162 ~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  199 (278)
T 3cok_A          162 LKMPHEKHYTLCGTPNYISP-EIATRSAHGLESDVWSLG  199 (278)
T ss_dssp             CC-----------------------------CTHHHHHH
T ss_pred             ccCCCCcceeccCCCCcCCc-chhcCCCCCchhhHHHHH
Confidence            654332      22223333 334445567789999999

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.98  E-value=3e-32  Score=218.55  Aligned_cols=185  Identities=24%  Similarity=0.359  Sum_probs=146.1

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccC----CCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC----DDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      ++| .+.+.||+|+||.||+|.+..+++.||+|.++.....    ........+.+|+.++++++||||+++++++..++
T Consensus        10 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A           10 DEY-IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hce-eEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            344 8889999999999999999999999999998754321    11223345789999999999999999999985443


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC--CcEEEecccc
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDLGV  177 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~--~~~~l~dfg~  177 (219)
                         .+++||++++++|.+++.....+++..+..++.|++.||.|||+++  ++|+||||+||+++.+.  ..++|+|||+
T Consensus        89 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           89 ---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             ---EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             ---eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence               7889999999999998887778999999999999999999999999  99999999999998543  2499999999


Q ss_pred             ceeccccce-----eeeecccCccc--cCCCccccccceeeecc
Q 027788          178 AAIVGRAIR-----RIRCWGRRSSW--RRSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~-----~~~~~~~~~~~--~~~~~~~~~~diws~gi  214 (219)
                      +........     ++..+.+|+.+  .....++.++|+||+|+
T Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~  207 (322)
T 2ycf_A          164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV  207 (322)
T ss_dssp             CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHH
T ss_pred             ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHH
Confidence            988755432     22334444433  23556778899999993

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.98  E-value=3.7e-32  Score=214.23  Aligned_cols=183  Identities=20%  Similarity=0.281  Sum_probs=149.4

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      .-|++.+.||+|+||.||+|.+..++..||+|.+...... .....+.+.+|+.+++.++||||+++++++..  ...++
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~   90 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKRIY   90 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc-hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc--CCEEE
Confidence            3348889999999999999999999999999998754321 11223668899999999999999999999854  45688


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      ++||++++++|.+++.....+++..+..++.|++.|+.+||+++  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYK-GELKIADFGWSVHAPSL  167 (284)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECSSS
T ss_pred             EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCC-CCEEEecccccccCccc
Confidence            99999999999999887778999999999999999999999999  9999999999999865 58999999999766543


Q ss_pred             ce----eeeecccCccccCCCccccccceeeecc
Q 027788          185 IR----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       185 ~~----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ..    ++..+.+| +......++.++|+||+|+
T Consensus       168 ~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG~  200 (284)
T 2vgo_A          168 RRRTMCGTLDYLPP-EMIEGKTHDEKVDLWCAGV  200 (284)
T ss_dssp             CBCCCCSCGGGCCH-HHHTTCCBCTTHHHHHHHH
T ss_pred             ccccccCCCCcCCH-HHhccCCCCcccchhhHHH
Confidence            22    11222233 3444556778899999993

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.98  E-value=2.1e-32  Score=238.90  Aligned_cols=184  Identities=19%  Similarity=0.236  Sum_probs=150.1

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCce
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~  102 (219)
                      ++| .+.+.||+|+||.||+|.+..+++.||+|+++...... ....+.+..|..++..+ +||+|+++++++.  +...
T Consensus       341 ~~f-~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~--~~~~  416 (674)
T 3pfq_A          341 TDF-NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDR  416 (674)
T ss_dssp             TTE-EEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH-TTTTHHHHHHHHHHTCTTCCTTBCCEEEECB--CSSE
T ss_pred             cce-EEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEEE--eCCE
Confidence            344 78899999999999999999999999999998543211 12346678899999877 6899999999884  4567


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +|+||||+++|+|..++...+.+++..+..++.|++.||.|||+.+  |+||||||+|||++.+ +.+||+|||+++...
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~-g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSE-GHIKIADFGMCKENI  493 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSS-SCEEECCCTTCEECC
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCC-CcEEEeecceeeccc
Confidence            8999999999999999988778999999999999999999999999  9999999999999866 689999999998653


Q ss_pred             ccce-eeeecccC----ccccCCCccccccceeeecc
Q 027788          183 RAIR-RIRCWGRR----SSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~-~~~~~~~~----~~~~~~~~~~~~~diws~gi  214 (219)
                      .... .....|++    ++......++.++|+||||+
T Consensus       494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGv  530 (674)
T 3pfq_A          494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGV  530 (674)
T ss_dssp             CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHH
T ss_pred             cCCcccccccCCCcccCHhhhcCCCCCccceEechHH
Confidence            3322 22223332    23445667888999999993

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.98  E-value=1.1e-32  Score=228.91  Aligned_cols=185  Identities=23%  Similarity=0.344  Sum_probs=144.8

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCC----CHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD----DPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      ++| .+.+.||+|+||.||+|.+..+++.||+|++.......    .......+.+|+.++++++||||+++++++..+ 
T Consensus       135 ~~y-~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  212 (419)
T 3i6u_A          135 DEY-IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-  212 (419)
T ss_dssp             TTE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred             ccE-EEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            445 78899999999999999999999999999998654321    112223578899999999999999999988432 


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC--CcEEEecccc
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDLGV  177 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~--~~~~l~dfg~  177 (219)
                        .++++|||+++++|.+++.....+++..+..++.|++.||.|||+++  ++||||||+||+++.+.  ..+||+|||+
T Consensus       213 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          213 --DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             --EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             --ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeeccc
Confidence              36899999999999998877778999999999999999999999999  99999999999997432  3599999999


Q ss_pred             ceeccccce-----eeeecccCcccc--CCCccccccceeeecc
Q 027788          178 AAIVGRAIR-----RIRCWGRRSSWR--RSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~-----~~~~~~~~~~~~--~~~~~~~~~diws~gi  214 (219)
                      ++.......     ++..+.+|+.+.  ....++.++|+||+|+
T Consensus       289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~  332 (419)
T 3i6u_A          289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV  332 (419)
T ss_dssp             TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHH
T ss_pred             ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHH
Confidence            987755432     222334444332  2455677899999993

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.98  E-value=8.4e-32  Score=219.74  Aligned_cols=183  Identities=17%  Similarity=0.303  Sum_probs=149.3

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCC----HHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCc
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD----PAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~  101 (219)
                      |++.+.||+|+||.||+|.+..+|+.||||++........    ....+.+.+|+.+++++ +||||+++++++..  ..
T Consensus        96 y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~  173 (365)
T 2y7j_A           96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES--SS  173 (365)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--SS
T ss_pred             cccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--CC
Confidence            4788999999999999999998999999999875432211    22346678999999999 79999999999854  45


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      ..+++|||+++++|.+++.....+++..+..++.|++.||.|||+.+  ++|+||||+||+++.+ +.++|+|||++..+
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~-~~ikl~DfG~~~~~  250 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDN-MQIRLSDFGFSCHL  250 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEEC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC-CCEEEEecCccccc
Confidence            68899999999999999887778999999999999999999999999  9999999999999866 68999999999887


Q ss_pred             ccccee-----eeecccCcccc-----CCCccccccceeeecc
Q 027788          182 GRAIRR-----IRCWGRRSSWR-----RSCTMRITRSLWTYTR  214 (219)
Q Consensus       182 ~~~~~~-----~~~~~~~~~~~-----~~~~~~~~~diws~gi  214 (219)
                      ......     +..+.+|+.+.     ....++.++|+||+|+
T Consensus       251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~  293 (365)
T 2y7j_A          251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV  293 (365)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHH
T ss_pred             CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHH
Confidence            654332     22233343222     2345777899999993

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.98  E-value=1.2e-32  Score=221.13  Aligned_cols=181  Identities=20%  Similarity=0.190  Sum_probs=143.8

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC--
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED--   99 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~--   99 (219)
                      .....|++.+.||+|+||.||+|.+.  ++.||+|.++..     .........|+.++++++||||+++++++....  
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ-----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC-----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            33455589999999999999999865  789999998643     223344556888999999999999999997644  


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCeeeeCCCCCceEEeCCCCc
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH----------EPCVIHRDLNCSNVFVNGNTGQ  169 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~----------~~~i~h~dl~~~nili~~~~~~  169 (219)
                      ...++++|||+++|+|.+++... .+++..+..++.|++.|+.|||+.          +  ++|+||||+||+++.+ +.
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~~~-~~  169 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLKNN-LT  169 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEECTT-CC
T ss_pred             CceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEECCC-Ce
Confidence            34578999999999999998764 599999999999999999999998          8  9999999999999865 58


Q ss_pred             EEEeccccceeccccce--------eeeecccCccccC----CCccccccceeeec
Q 027788          170 VKIGDLGVAAIVGRAIR--------RIRCWGRRSSWRR----SCTMRITRSLWTYT  213 (219)
Q Consensus       170 ~~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~~----~~~~~~~~diws~g  213 (219)
                      +||+|||+++.......        ++..+.+|+.+..    ...++.++||||+|
T Consensus       170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG  225 (322)
T 3soc_A          170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMG  225 (322)
T ss_dssp             EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHH
T ss_pred             EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHH
Confidence            99999999987654332        2223334443332    13455678999999

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.98  E-value=3.4e-32  Score=218.67  Aligned_cols=184  Identities=26%  Similarity=0.442  Sum_probs=148.8

Q ss_pred             CCCceeeeeeeeccccceEEEEEE----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAF----DQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      ...+.+++.+.||+|+||.||+|.    +..+++.||+|.+...    .....+.+.+|+.++++++||||+++++++..
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  113 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS  113 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence            445566899999999999999998    4678999999998743    34556789999999999999999999999876


Q ss_pred             CCCceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                      .+...++++||++++++|.+++... ..+++..+..++.|++.||.+||+.+  ++|+||||+||+++.+ +.++|+|||
T Consensus       114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~-~~~kL~Dfg  190 (326)
T 2w1i_A          114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENE-NRVKIGDFG  190 (326)
T ss_dssp             ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCT
T ss_pred             cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCC-CcEEEecCc
Confidence            6656788999999999999998765 45899999999999999999999999  9999999999999866 589999999


Q ss_pred             cceeccccceee---------eecccCccccCCCccccccceeeec
Q 027788          177 VAAIVGRAIRRI---------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       177 ~a~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ++..........         ..+.+| +......++.++|+||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  235 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAP-ESLTESKFSVASDVWSFG  235 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCH-HHHHHCEEEHHHHHHHHH
T ss_pred             chhhccccccccccccCCCCceeEECc-hhhcCCCCCchhhHHHHH
Confidence            998875543211         112222 223334567789999999

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.98  E-value=4.3e-32  Score=215.07  Aligned_cols=181  Identities=23%  Similarity=0.393  Sum_probs=147.7

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC-----
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE-----   98 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-----   98 (219)
                      ++| ++.+.||+|+||.||+|.+..+++.||+|.++..     ....+.+.+|+.++++++||||+++++++...     
T Consensus         6 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            6 SDF-EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             ccc-hhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            344 7889999999999999999999999999998642     34557789999999999999999999988643     


Q ss_pred             ------CCceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEE
Q 027788           99 ------DRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVK  171 (219)
Q Consensus        99 ------~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~  171 (219)
                            ....++++||++++++|.+++... ..+++..+..++.|++.|+.|||+++  ++|+||+|+||+++.+ +.++
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~-~~~k  156 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDES-RNVK  156 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEE
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCC-CCEE
Confidence                  246788999999999999998754 35788999999999999999999999  9999999999999866 5899


Q ss_pred             Eeccccceeccccc--------------------eeeeecccCccccCCCccccccceeeec
Q 027788          172 IGDLGVAAIVGRAI--------------------RRIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       172 l~dfg~a~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |+|||++.......                    .++..+.+|+.+.....++.++|+||+|
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG  218 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLG  218 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHH
Confidence            99999998764321                    0222233444444445678889999999

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.98  E-value=5.8e-32  Score=219.92  Aligned_cols=184  Identities=18%  Similarity=0.234  Sum_probs=149.1

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-----CCCceEEEE
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-----NKNIISLHY   93 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----~~~i~~~~~   93 (219)
                      .+....+.|++.++||+|+||.||+|.+..+++.||+|+++.     .....+.+..|+.+++.++     ||||+++++
T Consensus        29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            444434455888999999999999999999999999999863     2344566788999999997     999999999


Q ss_pred             EEecCCCceEEEEeccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC------
Q 027788           94 VWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG------  165 (219)
Q Consensus        94 ~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~------  165 (219)
                      ++...  +.++++||++ +++|.+++....  .+++..+..++.|++.||.|||+++  ++||||||+||+++.      
T Consensus       104 ~~~~~--~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~  178 (360)
T 3llt_A          104 KFMYY--DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKS  178 (360)
T ss_dssp             EEEET--TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEE
T ss_pred             eeeEC--CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEcccccccc
Confidence            99654  5688999999 789999887653  5899999999999999999999999  999999999999963      


Q ss_pred             ------------------CCCcEEEeccccceeccccce---eeeecccCccccCCCccccccceeeec
Q 027788          166 ------------------NTGQVKIGDLGVAAIVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       166 ------------------~~~~~~l~dfg~a~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                                        ..+.++|+|||++........   ++..+.+| +......++.++||||+|
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG  246 (360)
T 3llt_A          179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAP-EVILNLGWDVSSDMWSFG  246 (360)
T ss_dssp             EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCH-HHHTTCCCCTTHHHHHHH
T ss_pred             ccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCc-HHHcCCCCCCccchHHHH
Confidence                              245899999999987654332   22233333 344455688899999999

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.98  E-value=2.1e-32  Score=214.63  Aligned_cols=183  Identities=22%  Similarity=0.305  Sum_probs=147.0

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      ..|++.+.||+|+||.||+|.+..+++.||+|.++..... .....+.+.+|+.+++.++||||+++++++..  ....+
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~   87 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR-SLDVVGKIKREIQNLKLFRHPHIIKLYQVIST--PTDFF   87 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc-chhHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCeEE
Confidence            3348889999999999999999999999999998754321 11234678899999999999999999999854  45688


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      ++||++++++|.+++.....+++..+..++.|++.|+.+||+.+  ++|+||+|+||+++.+ +.++|+|||++......
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTT-SCEEECCCCGGGCCCC-
T ss_pred             EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCC-CCEEEeecccccccCCC
Confidence            99999999999999987778999999999999999999999999  9999999999999866 58999999999876543


Q ss_pred             ce-----eeeecccCccccCCCccccccceeeec
Q 027788          185 IR-----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~-----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ..     ++..+.+|+........+.++|+||+|
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG  198 (276)
T 2h6d_A          165 EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCG  198 (276)
T ss_dssp             ------------CCTGGGTTSCCCHHHHHHHHHH
T ss_pred             cceecccCCccccCHHHHcCCCCCCccchHHHHH
Confidence            32     223344444443333345679999999

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.98  E-value=2.6e-32  Score=217.94  Aligned_cols=191  Identities=20%  Similarity=0.290  Sum_probs=143.1

Q ss_pred             ccccCCCCceeeeeeeeccccceEEEEEEecC---CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEE
Q 027788           17 FIETDPTGRYGRYNELLGSGAVKKVYRAFDQE---EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHY   93 (219)
Q Consensus        17 ~~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~   93 (219)
                      ........+.|.+.+.||+|+||.||+|....   ++..||+|.++....  .....+.+.+|+.++++++||||+++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~  103 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFSHPNVIRLLG  103 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC--CHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc--chhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence            34455566667999999999999999998765   456899999875532  4556678999999999999999999999


Q ss_pred             EEecCCCc---eEEEEeccccCCChHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEe
Q 027788           94 VWRDEDRN---TLNFITEVCTSGNLREYRK------KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN  164 (219)
Q Consensus        94 ~~~~~~~~---~~~lv~e~~~~g~L~~~~~------~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~  164 (219)
                      ++...+..   ..+++||++++++|.+++.      ....+++..+..++.|++.||.|||+++  ++|+||||+||+++
T Consensus       104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~  181 (313)
T 3brb_A          104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLR  181 (313)
T ss_dssp             EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEEC
T ss_pred             EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc
Confidence            98654432   4588999999999999873      2346899999999999999999999999  99999999999998


Q ss_pred             CCCCcEEEeccccceeccccce---eee-----ecccCccccCCCccccccceeeec
Q 027788          165 GNTGQVKIGDLGVAAIVGRAIR---RIR-----CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       165 ~~~~~~~l~dfg~a~~~~~~~~---~~~-----~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .+ +.++|+|||++........   ...     .+.+| +......++.++|+||+|
T Consensus       182 ~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  236 (313)
T 3brb_A          182 DD-MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI-ESLADRVYTSKSDVWAFG  236 (313)
T ss_dssp             TT-SCEEECSCSCC----------------CCGGGSCH-HHHHSSCCCHHHHHHHHH
T ss_pred             CC-CcEEEeecCcceecccccccCcccccCCCccccCc-hhhcCCCccchhhhHHHH
Confidence            66 5899999999987654321   111     12222 333455678889999999

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.98  E-value=1.1e-32  Score=221.81  Aligned_cols=178  Identities=17%  Similarity=0.189  Sum_probs=144.4

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCce
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~  102 (219)
                      ++| ++.+.||+|+||.||+|.+..+++.||+|.+......      +.+.+|+.+++++ +||||+++++++..  ...
T Consensus         9 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~   79 (330)
T 2izr_A            9 PNF-RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA------PQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKY   79 (330)
T ss_dssp             TTE-EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS------CCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTE
T ss_pred             CCe-EEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch------HHHHHHHHHHHHhhCCCCCCEEEEEEec--CCc
Confidence            444 8889999999999999999999999999998754321      3477899999999 99999999998865  456


Q ss_pred             EEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCc-----EEEeccc
Q 027788          103 LNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQ-----VKIGDLG  176 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~-----~~l~dfg  176 (219)
                      .+++||++ +++|.+++.. ...+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.     ++|+|||
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~-~~~~~~~~kl~DFg  155 (330)
T 2izr_A           80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRP-GNKTQQVIHIIDFA  155 (330)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCG-GGTCTTSEEECCCT
T ss_pred             cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccC-CCCCCceEEEEEcc
Confidence            88999999 8999999876 367999999999999999999999999  9999999999999855 35     9999999


Q ss_pred             cceecccccee--------eeeccc----CccccCCCccccccceeeecc
Q 027788          177 VAAIVGRAIRR--------IRCWGR----RSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       177 ~a~~~~~~~~~--------~~~~~~----~~~~~~~~~~~~~~diws~gi  214 (219)
                      +++.+......        ....++    +++......++.++|+||||+
T Consensus       156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~  205 (330)
T 2izr_A          156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGH  205 (330)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred             cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHH
Confidence            99987544321        111222    223344566788899999993

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.98  E-value=1.9e-31  Score=211.87  Aligned_cols=175  Identities=19%  Similarity=0.280  Sum_probs=146.3

Q ss_pred             CCCCCCccccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHH-HhhCCCCce
Q 027788           11 DKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL-KTLANKNII   89 (219)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l-~~l~~~~i~   89 (219)
                      .+....+......++|+.+.+.||+|+||.||+|.+..+++.||+|.++..         ..+.+|+.++ +.++||||+
T Consensus         4 ~~~~~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~   74 (299)
T 3m2w_A            4 VKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIV   74 (299)
T ss_dssp             CCCCCCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBC
T ss_pred             ccccccCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCch
Confidence            334455566777788877768899999999999999999999999998632         3456788887 666899999


Q ss_pred             EEEEEEec--CCCceEEEEeccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC
Q 027788           90 SLHYVWRD--EDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG  165 (219)
Q Consensus        90 ~~~~~~~~--~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~  165 (219)
                      ++++++..  .+...++++|||+++++|.+++....  .+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.
T Consensus        75 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~  152 (299)
T 3m2w_A           75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTS  152 (299)
T ss_dssp             CEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESS
T ss_pred             hHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEec
Confidence            99998854  34567899999999999999987653  6899999999999999999999999  999999999999986


Q ss_pred             C--CCcEEEeccccceeccccceeeeecccCccccCCCccccccceeeec
Q 027788          166 N--TGQVKIGDLGVAAIVGRAIRRIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       166 ~--~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +  .+.++|+|||++.....                 ..++.++|+||+|
T Consensus       153 ~~~~~~~kl~Dfg~a~~~~~-----------------~~~~~~~DiwslG  185 (299)
T 3m2w_A          153 KRPNAILKLTDFGFAKETTG-----------------EKYDKSCDMWSLG  185 (299)
T ss_dssp             SSTTCCEEECCCTTCEECTT-----------------CGGGGHHHHHHHH
T ss_pred             CCCCCcEEEecccccccccc-----------------ccCCchhhHHHHH
Confidence            2  35799999999975432                 4466789999999

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.98  E-value=7.4e-32  Score=214.55  Aligned_cols=180  Identities=20%  Similarity=0.314  Sum_probs=146.7

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++| .+.+.||+|+||.||+|.+..+++.||+|.++...    ....+.+.+|+.++++++||||+++++++..  ...+
T Consensus         9 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   81 (304)
T 2jam_A            9 KTF-IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP----AFRDSSLENEIAVLKKIKHENIVTLEDIYES--TTHY   81 (304)
T ss_dssp             HHE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred             ccc-eeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc----ccchHHHHHHHHHHHhCCCCCeeehhhhccc--CCEE
Confidence            444 88899999999999999999999999999988542    2223567899999999999999999999854  4568


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEE---eCCCCcEEEecccccee
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili---~~~~~~~~l~dfg~a~~  180 (219)
                      +++||++++++|.+++.....+++..+..++.|++.|+.|||+.+  ++|+||+|+||++   +.+ +.++|+|||++..
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~-~~~kl~Dfg~~~~  158 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEEN-SKIMITDFGLSKM  158 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTT-CCEEBCSCSTTCC
T ss_pred             EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCC-CCEEEccCCccee
Confidence            899999999999998877778999999999999999999999999  9999999999999   433 5899999999976


Q ss_pred             ccccce----eeeecccCccccCCCccccccceeeecc
Q 027788          181 VGRAIR----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       181 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ......    ++..+.+|+ ......++.++|+||+|+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~  195 (304)
T 2jam_A          159 EQNGIMSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGV  195 (304)
T ss_dssp             CCCBTTHHHHSCCCBCCTT-TBSSCSCCHHHHHHHHHH
T ss_pred             cCCCccccccCCCCccChH-HhccCCCCchhhHHHHHH
Confidence            544321    233344443 444556788899999993

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.98  E-value=1e-32  Score=221.14  Aligned_cols=188  Identities=19%  Similarity=0.253  Sum_probs=134.1

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCc---EEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEe
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGI---EVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWR   96 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   96 (219)
                      .....+.|++.+.||+|+||.||+|.+..++.   .||+|.++....  .....+.+.+|+.++++++||||+++++++.
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            33444455889999999999999999877765   899999875432  2344678999999999999999999999986


Q ss_pred             cCCCc----eEEEEeccccCCChHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC
Q 027788           97 DEDRN----TLNFITEVCTSGNLREYRKKHR------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN  166 (219)
Q Consensus        97 ~~~~~----~~~lv~e~~~~g~L~~~~~~~~------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~  166 (219)
                      ..+..    ..+++|||+++++|.+++....      .+++..+..++.|++.|+.|||+++  ++|+||||+||+++.+
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAED  173 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCC
Confidence            54432    2378999999999999875432      5899999999999999999999999  9999999999999866


Q ss_pred             CCcEEEeccccceeccccceee---e-----ecccCccccCCCccccccceeeec
Q 027788          167 TGQVKIGDLGVAAIVGRAIRRI---R-----CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       167 ~~~~~l~dfg~a~~~~~~~~~~---~-----~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                       +.++|+|||++..........   .     .+.+| +......++.++||||+|
T Consensus       174 -~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  226 (323)
T 3qup_A          174 -MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLAL-ESLADNLYTVHSDVWAFG  226 (323)
T ss_dssp             -SCEEECCCCC-----------------CCGGGCCH-HHHHHCCCCHHHHHHHHH
T ss_pred             -CCEEEeeccccccccccccccccccccCcccccCc-hhhcCCCCCCccchhhHH
Confidence             689999999998764433211   1     12222 223344577889999999

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.98  E-value=5.6e-33  Score=225.88  Aligned_cols=184  Identities=20%  Similarity=0.292  Sum_probs=144.6

Q ss_pred             eeeeeeeeccccceEEEEEEec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCc
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQ---EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~  101 (219)
                      .|++.+.||+|+||.||+|++.   .+++.||+|+++...........+.+.+|+.+++.+ +||||+++++++..+  .
T Consensus        55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--~  132 (355)
T 1vzo_A           55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE--T  132 (355)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--T
T ss_pred             ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC--c
Confidence            4488899999999999999974   588999999987543211122234566799999999 699999999998554  4


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      .++++|||+++++|.+++.....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.+||+|||+++..
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEESCSSEEEEC
T ss_pred             eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCC-CcEEEeeCCCCeec
Confidence            58889999999999999887778999999999999999999999999  9999999999999866 58999999999876


Q ss_pred             cccce-------eeeecccCccccC-CCccccccceeeecc
Q 027788          182 GRAIR-------RIRCWGRRSSWRR-SCTMRITRSLWTYTR  214 (219)
Q Consensus       182 ~~~~~-------~~~~~~~~~~~~~-~~~~~~~~diws~gi  214 (219)
                      .....       ++..+.+|+.+.. ...++.++|+||||+
T Consensus       210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~  250 (355)
T 1vzo_A          210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV  250 (355)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHH
T ss_pred             ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHH
Confidence            44322       2222333333332 234677899999993

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.98  E-value=1.9e-32  Score=216.56  Aligned_cols=193  Identities=22%  Similarity=0.337  Sum_probs=139.0

Q ss_pred             CCCCCCCccccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCce
Q 027788           10 SDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII   89 (219)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   89 (219)
                      ....+.....++..+..|++.+.||+|+||.||+|.+.   ..+|+|.++....  .....+.+.+|+.++++++||||+
T Consensus         9 ~~~~~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv   83 (289)
T 3og7_A            9 HHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNIL   83 (289)
T ss_dssp             ---------CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC--CHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred             ccCCCCCCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC--CHHHHHHHHHHHHHHHhCCCCcEE
Confidence            33344444555666666689999999999999999754   3599999875542  566678899999999999999999


Q ss_pred             EEEEEEecCCCceEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCC
Q 027788           90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG  168 (219)
Q Consensus        90 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~  168 (219)
                      +++++...   ..++++||++++++|.+++.. ...+++..+..++.|++.+|.|||+.+  ++|+||||+||+++.+ +
T Consensus        84 ~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~-~  157 (289)
T 3og7_A           84 LFMGYSTA---PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHED-N  157 (289)
T ss_dssp             CEEEEECS---SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-T
T ss_pred             EEEeeccC---CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCC-C
Confidence            99986632   346789999999999998854 356899999999999999999999999  9999999999999966 5


Q ss_pred             cEEEeccccceeccccce--------eeeecccCcccc--CCCccccccceeeec
Q 027788          169 QVKIGDLGVAAIVGRAIR--------RIRCWGRRSSWR--RSCTMRITRSLWTYT  213 (219)
Q Consensus       169 ~~~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~--~~~~~~~~~diws~g  213 (219)
                      .++|+|||++........        ++..+.+|+.+.  ....++.++||||+|
T Consensus       158 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG  212 (289)
T 3og7_A          158 TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG  212 (289)
T ss_dssp             EEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHH
T ss_pred             CEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHH
Confidence            899999999976543221        122233333222  245567789999999

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.98  E-value=3.3e-32  Score=212.63  Aligned_cols=185  Identities=16%  Similarity=0.256  Sum_probs=148.2

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      ..|++.+.||+|+||.||+|++.  +..+|+|+++....  .....+.+.+|+.++++++||||+++++++...+...++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW--STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT   85 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC--CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence            34488899999999999999874  88999999886532  455667899999999999999999999999776557788


Q ss_pred             EEeccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          105 FITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++||++++++|.+++....  .+++..+..++.|++.|+.|||+.+++++|+||||+||+++.+ +.+++.||+++....
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQ  164 (271)
T ss_dssp             EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT-SCEEEEGGGSCCTTS
T ss_pred             eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC-cceeEEeccceeeec
Confidence            9999999999999998654  4899999999999999999999988779999999999999865 578998888776544


Q ss_pred             ccce-eeeecccCccccCCC--ccccccceeeecc
Q 027788          183 RAIR-RIRCWGRRSSWRRSC--TMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~-~~~~~~~~~~~~~~~--~~~~~~diws~gi  214 (219)
                      .... ++..+.+|+.+....  .++.++|+||+|+
T Consensus       165 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~  199 (271)
T 3kmu_A          165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAV  199 (271)
T ss_dssp             CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHH
T ss_pred             ccCccCCccccChhhhccCCCCCCCchhhHHHHHH
Confidence            4332 333344444333221  2223699999993

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.98  E-value=5.3e-32  Score=216.23  Aligned_cols=183  Identities=23%  Similarity=0.405  Sum_probs=143.3

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec----
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD----   97 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~----   97 (219)
                      ..++| ++.+.||+|+||.||+|.+..+++.||+|.+...    +....+.+.+|+.+++.++||||+++++++..    
T Consensus         9 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   83 (320)
T 2i6l_A            9 LGSRY-MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ   83 (320)
T ss_dssp             ETTTE-EEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred             cCCce-eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence            44566 7889999999999999999999999999998744    45667889999999999999999999988743    


Q ss_pred             --------CCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCc
Q 027788           98 --------EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQ  169 (219)
Q Consensus        98 --------~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~  169 (219)
                              .....++++||+++ ++|.+++.. ..+++..+..++.|++.|+.|||+++  ++|+||||+||+++.+.+.
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             CCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTE
T ss_pred             cccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCe
Confidence                    23467889999997 699988764 56899999999999999999999999  9999999999999855568


Q ss_pred             EEEeccccceeccccce---------eeeecccCccccCCCccccccceeeec
Q 027788          170 VKIGDLGVAAIVGRAIR---------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       170 ~~l~dfg~a~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ++|+|||++........         .+..+.+|+.+.....++.++|+||+|
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG  212 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG  212 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHH
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHH
Confidence            99999999987643221         122233444344446678889999999

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.98  E-value=2.6e-32  Score=215.32  Aligned_cols=184  Identities=24%  Similarity=0.357  Sum_probs=150.4

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      ..+...+.|++.+.||+|+||.||+|.+..++..||+|.++..     ....+.+.+|+.+++.++||||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   80 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-   80 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-
Confidence            3344555568999999999999999999999999999998743     3345778899999999999999999999854 


Q ss_pred             CCceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                       ...++++||++++++|.+++...  ..+++..+..++.|++.++.+||+.+  ++|+||||+||+++.+ +.++|+|||
T Consensus        81 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~~l~Dfg  156 (288)
T 3kfa_A           81 -EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFG  156 (288)
T ss_dssp             -SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGG-GCEEECCCC
T ss_pred             -CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCC-CCEEEccCc
Confidence             45588899999999999998764  35899999999999999999999999  9999999999999866 589999999


Q ss_pred             cceeccccceee-------eecccCccccCCCccccccceeeec
Q 027788          177 VAAIVGRAIRRI-------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       177 ~a~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ++..........       ..+.+| +......++.++|+||+|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  199 (288)
T 3kfa_A          157 LSRLMTGDTYTAHAGAKFPIKWTAP-ESLAYNKFSIKSDVWAFG  199 (288)
T ss_dssp             GGGTSCSSSSEEETTEEECGGGCCH-HHHHHCCCCHHHHHHHHH
T ss_pred             cceeccCCccccccCCccccCcCCh-hhhccCCCCchhhHHHHH
Confidence            998765443211       112233 333444577789999999

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.98  E-value=7e-32  Score=215.15  Aligned_cols=184  Identities=26%  Similarity=0.391  Sum_probs=148.2

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEe-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEE
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFD-----QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYV   94 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~   94 (219)
                      ....+.|++.+.||+|+||.||+|++     ..++..||+|.++...   .....+.+.+|+.+++++ +||||++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            33344458889999999999999984     4677899999987442   345567899999999999 99999999999


Q ss_pred             EecCCCceEEEEeccccCCChHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCC
Q 027788           95 WRDEDRNTLNFITEVCTSGNLREYRKKHR------------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDL  156 (219)
Q Consensus        95 ~~~~~~~~~~lv~e~~~~g~L~~~~~~~~------------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl  156 (219)
                      +...  ...+++||++++++|.+++....                  .+++..+..++.|++.|+.|||+++  ++|+||
T Consensus        96 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl  171 (313)
T 1t46_A           96 CTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDL  171 (313)
T ss_dssp             ECSS--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred             EecC--CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCC
Confidence            9544  45788999999999999887543                  3899999999999999999999999  999999


Q ss_pred             CCCceEEeCCCCcEEEeccccceecccccee--------eeecccCccccCCCccccccceeeec
Q 027788          157 NCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR--------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       157 ~~~nili~~~~~~~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ||+||+++.+ +.++|+|||++.........        +..+.+| +......++.++|+||+|
T Consensus       172 kp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  234 (313)
T 1t46_A          172 AARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAP-ESIFNCVYTFESDVWSYG  234 (313)
T ss_dssp             SGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCH-HHHHHCCCCHHHHHHHHH
T ss_pred             ccceEEEcCC-CCEEEccccccccccccccceeccCCCCcceeeCh-HHhcCCCCChHHHHHHHH
Confidence            9999999866 58999999999877554321        1113333 333345677889999999

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.98  E-value=7.6e-32  Score=223.81  Aligned_cols=179  Identities=20%  Similarity=0.311  Sum_probs=141.8

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec----CCC
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD----EDR  100 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~----~~~  100 (219)
                      ..|.+.+.||+|+||.||+|.+..+++.||+|.+.....        ...+|+++++.++||||+++++++..    .+.
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            346888999999999999999999999999999874321        12369999999999999999988853    233


Q ss_pred             ceEEEEeccccCCChHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788          101 NTLNFITEVCTSGNLREYRK----KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                      .+++++|||+++ ++.+.+.    ....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+.+.+||+|||
T Consensus       126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccch
Confidence            467889999975 5555433    3467999999999999999999999999  99999999999999665578999999


Q ss_pred             cceecccccee-----eeecccCccccCCCccccccceeeecc
Q 027788          177 VAAIVGRAIRR-----IRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       177 ~a~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +++........     +..+.+|+.......++.++||||+|+
T Consensus       203 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~  245 (420)
T 1j1b_A          203 SAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC  245 (420)
T ss_dssp             TCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             hhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHH
Confidence            99876544332     222334443444456888899999993

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.98  E-value=1.3e-31  Score=213.61  Aligned_cols=184  Identities=25%  Similarity=0.444  Sum_probs=141.9

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ..++| ++.+.||+|+||.||+|.+..++..||+|.++.... .+....+.+.+|+.++++++||||+++++++...  +
T Consensus        30 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~  105 (310)
T 2wqm_A           30 TLANF-RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--N  105 (310)
T ss_dssp             SGGGE-EEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--T
T ss_pred             cccce-EEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--C
Confidence            34555 888999999999999999999999999999875332 2456668889999999999999999999999654  4


Q ss_pred             eEEEEeccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788          102 TLNFITEVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                      .++++||++++++|.+++..    ...+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|+|||+
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~-~~~kl~Dfg~  182 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGDLGL  182 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCC--
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCC-CCEEEEeccc
Confidence            68889999999999998753    456899999999999999999999999  9999999999999865 5899999999


Q ss_pred             ceeccccce------eeeecccCccccCCCccccccceeeec
Q 027788          178 AAIVGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       178 a~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +........      ++..+.+| +......++.++|+||+|
T Consensus       183 ~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Dv~slG  223 (310)
T 2wqm_A          183 GRFFSSKTTAAHSLVGTPYYMSP-ERIHENGYNFKSDIWSLG  223 (310)
T ss_dssp             ----------------CCSSCCH-HHHTTCCCCHHHHHHHHH
T ss_pred             eeeecCCCccccccCCCeeEeCh-HHhCCCCCCchhhHHHHH
Confidence            987654322      11222233 334455677889999999

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.98  E-value=2.3e-32  Score=219.15  Aligned_cols=180  Identities=21%  Similarity=0.271  Sum_probs=144.9

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+.|++.+.||+|+||.||+|.+ .++..||+|.+...    .....+.+.+|+.+++.++||||+++++++..  .+.+
T Consensus        38 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~  110 (321)
T 2qkw_B           38 TNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIGFCDE--RNEM  110 (321)
T ss_dssp             CCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC----CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC--TTCC
T ss_pred             HhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCeE
Confidence            34448889999999999999995 57899999987644    23345778999999999999999999999854  4557


Q ss_pred             EEEeccccCCChHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          104 NFITEVCTSGNLREYRKKHR----HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      +++|||+++++|.+++....    .+++..+..++.|++.|+.|||+++  ++|+||||+||+++.+ +.+||+|||++.
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~  187 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDEN-FVPKITDFGISK  187 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTT-CCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCC-CCEEEeeccccc
Confidence            88999999999999875432    4889999999999999999999999  9999999999999865 589999999998


Q ss_pred             eccccce--------eeeecccCccccCCCccccccceeeecc
Q 027788          180 IVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .......        ++..+.+| +......++.++|+||+|+
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG~  229 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDP-EYFIKGRLTEKSDVYSFGV  229 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCH-HHHHHCBCCTHHHHHHHHH
T ss_pred             ccccccccccccccCCCccccCH-HHhcCCCCCcccchHhHHH
Confidence            7543221        22223333 3333456788899999993

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.98  E-value=4e-32  Score=213.81  Aligned_cols=183  Identities=21%  Similarity=0.354  Sum_probs=137.5

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCC---CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEE---GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      +...+.|++.+.||+|+||.||+|.+..+   +..||+|.++..   ......+.+.+|+.++++++||||+++++++..
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   87 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE   87 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc
Confidence            33445558999999999999999998654   456999987643   245566789999999999999999999998843


Q ss_pred             CCCceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                         +..+++||++++++|.+++... ..+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+ +.++|+|||
T Consensus        88 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg  161 (281)
T 1mp8_A           88 ---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFG  161 (281)
T ss_dssp             ---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECC--
T ss_pred             ---CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCC-CCEEECccc
Confidence               3467899999999999998754 36899999999999999999999999  9999999999999866 589999999


Q ss_pred             cceeccccceeee-------ecccCccccCCCccccccceeeec
Q 027788          177 VAAIVGRAIRRIR-------CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       177 ~a~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ++...........       .+.+| +......++.++|+||+|
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  204 (281)
T 1mp8_A          162 LSRYMEDSTYYKASKGKLPIKWMAP-ESINFRRFTSASDVWMFG  204 (281)
T ss_dssp             -----------------CCGGGCCH-HHHHHCCCSHHHHHHHHH
T ss_pred             cccccCcccccccccCCCcccccCh-hhcccCCCCCccCchHHH
Confidence            9987654332111       12233 333345577789999999

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.98  E-value=7.1e-32  Score=210.84  Aligned_cols=178  Identities=20%  Similarity=0.306  Sum_probs=144.4

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+.|++.+.||+|+||.||+|... ++..||+|.++....     ..+.+.+|+.++++++||||+++++++.  +...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~   78 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLSHPKLVKFYGVCS--KEYPI   78 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-----CHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSE
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-----cHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCce
Confidence            344588899999999999999765 677899999875432     1256889999999999999999999984  44568


Q ss_pred             EEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          104 NFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +++||++++++|.+++... ..+++..+..++.|++.|+.+||+.+  ++|+||||+||+++.+ +.++|+|||++....
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~  155 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRD-LCVKVSDFGMTRYVL  155 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTT-CCEEECCTTCEEECC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCC-CCEEEccCccceecc
Confidence            8999999999999988754 35999999999999999999999999  9999999999999866 589999999998775


Q ss_pred             ccceeee-------ecccCccccCCCccccccceeeec
Q 027788          183 RAIRRIR-------CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~~~~-------~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .......       .+.+ ++......++.++|+||+|
T Consensus       156 ~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG  192 (268)
T 3sxs_A          156 DDQYVSSVGTKFPVKWSA-PEVFHYFKYSSKSDVWAFG  192 (268)
T ss_dssp             TTCEEECCSCCCCGGGCC-HHHHHHSEEETTHHHHHHH
T ss_pred             hhhhhcccCCCcCcccCC-HHHHhccCCchhhhhHHHH
Confidence            5432111       1222 2333444577889999999

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.98  E-value=1.9e-32  Score=220.29  Aligned_cols=183  Identities=26%  Similarity=0.450  Sum_probs=139.8

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEE----EEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEE
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEV----AWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVW   95 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~   95 (219)
                      .....+| ++.+.||+|+||.||+|.+..++..+    |+|.+....   .....+.+.+|+.++++++||||+++++++
T Consensus        11 ~l~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   86 (327)
T 3poz_A           11 ILKETEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGIC   86 (327)
T ss_dssp             ECCGGGE-EEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred             hcCHHHc-ccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            3344555 78899999999999999988777765    666654322   233457789999999999999999999999


Q ss_pred             ecCCCceEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEec
Q 027788           96 RDEDRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD  174 (219)
Q Consensus        96 ~~~~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~d  174 (219)
                      ...+   .+++++++++|+|.+++.. ...+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.+||+|
T Consensus        87 ~~~~---~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~-~~~kl~D  160 (327)
T 3poz_A           87 LTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKITD  160 (327)
T ss_dssp             ESSS---EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEECC
T ss_pred             ecCC---eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCC-CCEEEcc
Confidence            7543   6779999999999998876 457999999999999999999999999  9999999999999866 5899999


Q ss_pred             cccceeccccceeee--------ecccCccccCCCccccccceeeec
Q 027788          175 LGVAAIVGRAIRRIR--------CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       175 fg~a~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ||+++..........        .+.+| +......++.++||||+|
T Consensus       161 fg~a~~~~~~~~~~~~~~~~~t~~y~aP-E~~~~~~~~~~~Di~slG  206 (327)
T 3poz_A          161 FGLAKLLGAEEKEYHAEGGKVPIKWMAL-ESILHRIYTHQSDVWSYG  206 (327)
T ss_dssp             TTHHHHHTTTCC-------CCCGGGSCH-HHHHHCCCCHHHHHHHHH
T ss_pred             CcceeEccCCcccccccCCCccccccCh-HHhccCCCCchhhhhhhH
Confidence            999987655432111        12222 333445678889999999

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.98  E-value=7.5e-33  Score=222.42  Aligned_cols=180  Identities=24%  Similarity=0.390  Sum_probs=141.7

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      +| ++.+.||+|+||.||+|.+..+++.||+|.++....   ......+.+|+.+++.++||||+++++++..  ...++
T Consensus         3 ~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~   76 (324)
T 3mtl_A            3 TY-IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLT   76 (324)
T ss_dssp             SE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--SSCEE
T ss_pred             ce-EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc---cccchhHHHHHHHHHhcCCCCCCeeeeEEee--CCEEE
Confidence            45 788999999999999999999999999999875432   1112234579999999999999999999954  45588


Q ss_pred             EEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          105 FITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      ++|||++ ++|.+++... ..+++..+..++.|++.||.|||+.+  ++|+||||+||+++.+ +.++|+|||++.....
T Consensus        77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           77 LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINER-GELKLADFGLARAKSI  152 (324)
T ss_dssp             EEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTT-CCEEECSSSEEECC--
T ss_pred             EEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCC-CCEEEccCcccccccC
Confidence            8999997 5888877654 45899999999999999999999999  9999999999999866 5899999999986654


Q ss_pred             cce------eeeecccCccccCCCccccccceeeecc
Q 027788          184 AIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ...      ++..+.+|+.+.....++.++||||+|+
T Consensus       153 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  189 (324)
T 3mtl_A          153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGC  189 (324)
T ss_dssp             ----------CGGGCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred             CccccccccCcccccChhhhcCCCCCCcHHHHHHHHH
Confidence            332      2223444444555567888899999993

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.98  E-value=1e-32  Score=225.37  Aligned_cols=182  Identities=19%  Similarity=0.251  Sum_probs=142.5

Q ss_pred             CceeeeeeeeccccceEEEEEE-----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           24 GRYGRYNELLGSGAVKKVYRAF-----DQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      .+.|++.+.||+|+||.||+|.     +..++..||+|.++...   .......+.+|+.++++++||||+++++++...
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  146 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  146 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc---ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            3445888999999999999999     55678899999986432   345556788999999999999999999999544


Q ss_pred             CCceEEEEeccccCCChHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC--Cc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKH-------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT--GQ  169 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~-------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~--~~  169 (219)
                        ...+++|||+++++|.+++...       ..+++..+..++.|++.||.|||+++  ++||||||+||+++.+.  ..
T Consensus       147 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          147 --LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             --SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCC
T ss_pred             --CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCce
Confidence              4567899999999999988653       24889999999999999999999999  99999999999998332  25


Q ss_pred             EEEeccccceeccccce--------eeeecccCccccCCCccccccceeeec
Q 027788          170 VKIGDLGVAAIVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       170 ~~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +||+|||+++.......        .+..+.+| +......++.++|+||||
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP-E~~~~~~~~~~~DvwslG  273 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP-EAFMEGIFTSKTDTWSFG  273 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCH-HHHHHCCCCHHHHHHHHH
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECH-HHhcCCCCCcHHHHHHHH
Confidence            99999999976533221        11123333 333345678889999999

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.98  E-value=2.4e-32  Score=223.10  Aligned_cols=186  Identities=27%  Similarity=0.411  Sum_probs=135.5

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC-
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED-   99 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~-   99 (219)
                      +..++| ++.+.||+|+||.||+|.+..+++.||+|.+....  ......+.+.+|+.+++.++||||+++++++.... 
T Consensus        26 ~~~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  102 (367)
T 2fst_X           26 EVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS  102 (367)
T ss_dssp             EEETTE-EEEEECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             CCCCce-EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence            344666 77899999999999999999999999999986433  24556678899999999999999999999986432 


Q ss_pred             ---CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788          100 ---RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus       100 ---~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                         ...+++++|++ +++|.+++.. ..+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.+||+|||
T Consensus       103 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~-~~~kL~DFG  177 (367)
T 2fst_X          103 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFG  177 (367)
T ss_dssp             GGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECC--
T ss_pred             cccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCC-CCEEEeecc
Confidence               24578899999 5799887765 57999999999999999999999999  9999999999999866 589999999


Q ss_pred             cceeccccce---eeeecccCccccCCCccccccceeeecc
Q 027788          177 VAAIVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       177 ~a~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +++.......   ++..+.+|+.......++.++||||+|+
T Consensus       178 ~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  218 (367)
T 2fst_X          178 LARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC  218 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHH
T ss_pred             ccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHH
Confidence            9987654322   2233344444444466788899999993

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.98  E-value=7.3e-32  Score=212.13  Aligned_cols=176  Identities=28%  Similarity=0.427  Sum_probs=144.7

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec---------
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD---------   97 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---------   97 (219)
                      |++.+.||+|+||.||+|.+..+++.||+|.++...        +.+.+|+.++++++||||+++++++..         
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             EEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             cceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            478899999999999999999999999999987542        235689999999999999999988743         


Q ss_pred             -----CCCceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcE
Q 027788           98 -----EDRNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQV  170 (219)
Q Consensus        98 -----~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~  170 (219)
                           .....++++|||+++++|.+++...  ..+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDT-KQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEcCC-CCE
Confidence                 2245688999999999999998643  57899999999999999999999999  9999999999999866 589


Q ss_pred             EEeccccceeccccceeeeeccc----CccccCCCccccccceeeec
Q 027788          171 KIGDLGVAAIVGRAIRRIRCWGR----RSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       171 ~l~dfg~a~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~diws~g  213 (219)
                      +|+|||++.............++    +++......++.++|+||+|
T Consensus       162 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  208 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALG  208 (284)
T ss_dssp             EECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHH
T ss_pred             EECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHH
Confidence            99999999887654332222222    22334455678889999999

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.98  E-value=6.5e-32  Score=216.34  Aligned_cols=185  Identities=21%  Similarity=0.304  Sum_probs=147.6

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEE
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQ-----EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYV   94 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~   94 (219)
                      .....+.|++.+.||+|+||.||+|.+.     .++..||+|.++...   .......+.+|+.+++.++||||++++++
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            3444555589999999999999999876     457889999987432   34556778999999999999999999999


Q ss_pred             EecCCCceEEEEeccccCCChHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEe
Q 027788           95 WRDEDRNTLNFITEVCTSGNLREYRKKH----------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN  164 (219)
Q Consensus        95 ~~~~~~~~~~lv~e~~~~g~L~~~~~~~----------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~  164 (219)
                      +..  ....+++||++++++|.+++...          ..+++..+..++.|++.||.+||+++  ++|+||||+||+++
T Consensus        97 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~  172 (322)
T 1p4o_A           97 VSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA  172 (322)
T ss_dssp             ECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC
T ss_pred             Ecc--CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEc
Confidence            854  45578899999999999987642          35689999999999999999999999  99999999999998


Q ss_pred             CCCCcEEEeccccceecccccee--------eeecccCccccCCCccccccceeeec
Q 027788          165 GNTGQVKIGDLGVAAIVGRAIRR--------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       165 ~~~~~~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .+ +.++|+|||++.........        +..+.+| +......++.++|+||+|
T Consensus       173 ~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  227 (322)
T 1p4o_A          173 ED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP-ESLKDGVFTTYSDVWSFG  227 (322)
T ss_dssp             TT-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH-HHHHHCCCCHHHHHHHHH
T ss_pred             CC-CeEEECcCccccccccccccccccCCCCCCCccCh-hhhccCCCCchhhHHHHH
Confidence            66 58999999999866443311        1112233 333445577889999999

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.98  E-value=5e-32  Score=226.75  Aligned_cols=179  Identities=21%  Similarity=0.334  Sum_probs=143.7

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ...+.+++.+.||+|+||.||+|...  +..||+|.++...      ..+.+.+|+.++++++||||+++++++..++ .
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~  260 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-G  260 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-S
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-C
Confidence            34445588899999999999999864  7799999987432      2367889999999999999999999886543 4


Q ss_pred             eEEEEeccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          102 TLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      .++++|||+++|+|.+++...+  .++...+..++.|++.|+.|||+++  ++||||||+||+++.+ +.+||+|||+++
T Consensus       261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a~  337 (450)
T 1k9a_A          261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTK  337 (450)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-SCEEECCCTTCE
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCC-CCEEEeeCCCcc
Confidence            5789999999999999987643  3789999999999999999999999  9999999999999866 589999999998


Q ss_pred             eccccce---eeeecccCccccCCCccccccceeeec
Q 027788          180 IVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       180 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .......   .+..+.+| +......++.++|+||||
T Consensus       338 ~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~sDvwslG  373 (450)
T 1k9a_A          338 EASSTQDTGKLPVKWTAP-EALREKKFSTKSDVWSFG  373 (450)
T ss_dssp             ECC------CCCTTTSCH-HHHHSSCCCHHHHHHHHH
T ss_pred             cccccccCCCCCcceeCH-HHhcCCCCCcHHHHHHHH
Confidence            6544321   11123333 333456688899999999

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.98  E-value=2.1e-31  Score=215.92  Aligned_cols=184  Identities=26%  Similarity=0.405  Sum_probs=148.9

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC---
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE---   98 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~---   98 (219)
                      ..++| ++.+.||+|+||.||+|.+..+++.||+|.++..   ........+.+|+.+++.++||||+++++++...   
T Consensus         9 i~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   84 (353)
T 2b9h_A            9 ISSDF-QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE   84 (353)
T ss_dssp             SCTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred             cccce-EEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence            44555 8889999999999999999999999999998643   2455567788999999999999999999987542   


Q ss_pred             CCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      .....+++||+++ ++|.+++.. ..+++..+..++.|++.||.|||+++  ++|+||||+||+++.+ +.++|+|||++
T Consensus        85 ~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a  159 (353)
T 2b9h_A           85 NFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFGLA  159 (353)
T ss_dssp             TCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTC
T ss_pred             ccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCC-CcEEEEecccc
Confidence            2356889999997 689888765 47999999999999999999999999  9999999999999866 58999999999


Q ss_pred             eeccccce----------------eeeecccCccccCCCccccccceeeecc
Q 027788          179 AIVGRAIR----------------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       179 ~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ........                ++..+.+|+.+.....++.++|+||+|+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~  211 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGC  211 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHH
Confidence            87754321                1222334444445566788899999993

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.97  E-value=2.2e-31  Score=217.61  Aligned_cols=182  Identities=25%  Similarity=0.345  Sum_probs=142.6

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC---
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED---   99 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~---   99 (219)
                      .++| ++.+.||+|+||.||+|.+..+++.||+|.+....  ......+.+.+|+.+++.++||||+++++++...+   
T Consensus        24 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  100 (371)
T 2xrw_A           24 LKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE  100 (371)
T ss_dssp             ETTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred             hhhe-eEeeeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence            3555 78899999999999999999999999999987543  24556678889999999999999999999986543   


Q ss_pred             -CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          100 -RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       100 -~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                       ...++++||+++ ++|.+.+.  ..+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||++
T Consensus       101 ~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a  174 (371)
T 2xrw_A          101 EFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLA  174 (371)
T ss_dssp             TCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCCCC-
T ss_pred             cccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCC-CCEEEEEeecc
Confidence             236889999997 57777775  35899999999999999999999999  9999999999999866 58999999999


Q ss_pred             eeccccce-----eeeecccCccccCCCccccccceeeecc
Q 027788          179 AIVGRAIR-----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       179 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ........     ++..+.+| +......++.++||||+|+
T Consensus       175 ~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwslG~  214 (371)
T 2xrw_A          175 RTAGTSFMMTPYVVTRYYRAP-EVILGMGYKENVDIWSVGC  214 (371)
T ss_dssp             ---------------CTTCCH-HHHTTCCCCTTHHHHHHHH
T ss_pred             cccccccccCCceecCCccCH-HHhcCCCCCchHhHHHHHH
Confidence            87654432     22223333 3344556888999999993

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.97  E-value=2.5e-32  Score=214.52  Aligned_cols=186  Identities=23%  Similarity=0.376  Sum_probs=148.9

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++| ++.+.||+|+||.||+|.+..+++.||+|.++....  .....+.+.+|+.++++++||||+++++++..+....+
T Consensus         6 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            6 EDY-EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             GGE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred             hhe-eeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence            445 888999999999999999999999999999886543  45566789999999999999999999998876666788


Q ss_pred             EEEeccccCCChHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC---CCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788          104 NFITEVCTSGNLREYRKKH----RHVSVKALKKWSKQILKGLNYLHTHE---PCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qv~~~l~~lh~~~---~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                      +++|||+++++|.+++...    ..+++..+..++.|++.|+.+||+.+   .+++|+||+|+||+++.+ +.++|+|||
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~-~~~kl~dfg  161 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFG  161 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS-SCEEECCCC
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC-CCEEEecCc
Confidence            9999999999999987643    34899999999999999999999876   339999999999999865 589999999


Q ss_pred             cceeccccce------eeeecccCccccCCCccccccceeeecc
Q 027788          177 VAAIVGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       177 ~a~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ++........      ++..+.+|+ ......++.++|+||+|+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~Di~slG~  204 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPE-QMNRMSYNEKSDIWSLGC  204 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHH-HHHCC-CCHHHHHHHHHH
T ss_pred             hheeeccccccccccCCCccccChH-HhccCCCCchhhHHHHHH
Confidence            9987654321      222233333 334446777899999993

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.97  E-value=1.4e-31  Score=212.74  Aligned_cols=184  Identities=22%  Similarity=0.386  Sum_probs=151.2

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      ..++..+| .+.+.||+|+||.||+|.+..+++.||+|.++....   ....+.+.+|+.+++.++||||+++++++...
T Consensus        17 ~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   92 (303)
T 3a7i_A           17 KADPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD   92 (303)
T ss_dssp             EECGGGTE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC---STTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             CCChHHHH-HHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            34455556 777999999999999999999999999999875542   23357788999999999999999999998654


Q ss_pred             CCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                        ..++++||++++++|.+++.. ..+++..+..++.|++.++.+||+.+  ++|+||+|+||+++.+ +.++|+|||++
T Consensus        93 --~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~Dfg~~  166 (303)
T 3a7i_A           93 --TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEH-GEVKLADFGVA  166 (303)
T ss_dssp             --TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTC
T ss_pred             --CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCC-CCEEEeecccc
Confidence              468889999999999998864 47899999999999999999999999  9999999999999866 58999999999


Q ss_pred             eeccccce------eeeecccCccccCCCccccccceeeec
Q 027788          179 AIVGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       179 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ........      ++..+.+ ++......++.++|+||+|
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG  206 (303)
T 3a7i_A          167 GQLTDTQIKRNTFVGTPFWMA-PEVIKQSAYDSKADIWSLG  206 (303)
T ss_dssp             EECBTTBCCBCCCCSCGGGCC-HHHHTTCCBCTHHHHHHHH
T ss_pred             eecCccccccCccCCCcCccC-HHHHhcCCCCchhhhHHHH
Confidence            87654332      1112223 2344455677889999999

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.97  E-value=2.4e-33  Score=229.72  Aligned_cols=187  Identities=18%  Similarity=0.185  Sum_probs=140.5

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHH---HHHhhCCCCceEEE-------
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVR---LLKTLANKNIISLH-------   92 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~---~l~~l~~~~i~~~~-------   92 (219)
                      ..+.|++.+.||+|+||.||+|.+..+++.||+|+++..... .....+.+.+|+.   .++.++||||++++       
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C-CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc-chHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            345668899999999999999999899999999999854332 3445678899994   55566899999887       


Q ss_pred             EEEecCCC----------c-----eEEEEeccccCCChHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCCC
Q 027788           93 YVWRDEDR----------N-----TLNFITEVCTSGNLREYRKKHRHVSV-------KALKKWSKQILKGLNYLHTHEPC  150 (219)
Q Consensus        93 ~~~~~~~~----------~-----~~~lv~e~~~~g~L~~~~~~~~~~~~-------~~~~~i~~qv~~~l~~lh~~~~~  150 (219)
                      +++..++.          .     ..+++|||+ +|+|.+++.....+++       ..+..++.|++.||.|||+++  
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--  226 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--  226 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence            55543321          1     367899999 5799998875444444       778889999999999999999  


Q ss_pred             eeeeCCCCCceEEeCCCCcEEEeccccceecccccee--eeecccCccccCC----------Cccccccceeeecc
Q 027788          151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR--IRCWGRRSSWRRS----------CTMRITRSLWTYTR  214 (219)
Q Consensus       151 i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~--~~~~~~~~~~~~~----------~~~~~~~diws~gi  214 (219)
                      ++||||||+||+++.+ +.+||+|||+++........  ...+.+|+.+...          ..++.++||||||+
T Consensus       227 ivHrDikp~NIll~~~-~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             EECSCCCGGGEEECTT-CCEEECCGGGCEETTCEEECCCCTTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCC-CCEEEEechhheecCCcccCCCCcCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999966 68999999999875442210  1222333322222          26788899999993

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.97  E-value=6.2e-32  Score=213.72  Aligned_cols=180  Identities=22%  Similarity=0.373  Sum_probs=144.4

Q ss_pred             Cceeeeee-eeccccceEEEEEE--ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           24 GRYGRYNE-LLGSGAVKKVYRAF--DQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        24 ~~~~~~~~-~ig~g~~g~V~~a~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      .+| .+.+ .||+|+||.||+|.  ...++..||+|.++....  +....+.+.+|+.+++.++||||+++++++..   
T Consensus        16 ~~y-~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   89 (291)
T 1xbb_A           16 KLL-TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEA---   89 (291)
T ss_dssp             GGE-EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---
T ss_pred             hhh-hhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC---
Confidence            455 6666 99999999999994  456788999999875432  34456789999999999999999999999832   


Q ss_pred             ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          101 NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      +.++++||++++++|.+++.....+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+ +.++|+|||++..
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKA  166 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTCEE
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCC-CcEEEccCCccee
Confidence            347789999999999999988878999999999999999999999999  9999999999999866 5899999999987


Q ss_pred             ccccceee---------eecccCccccCCCccccccceeeec
Q 027788          181 VGRAIRRI---------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ........         ..+.+| +......++.++|+||+|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  207 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAP-ECINYYKFSSKSDVWSFG  207 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCH-HHHHHCEEEHHHHHHHHH
T ss_pred             eccCCCcccccccCCCCceeeCh-HHhccCCCChhhhHHHHH
Confidence            75543211         112222 233344567789999999

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.97  E-value=1.9e-31  Score=217.49  Aligned_cols=191  Identities=16%  Similarity=0.090  Sum_probs=142.1

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCC-----CcEEEEEEeeecccCC--CHHHH-----HHHHHHHHHHHhhCCC
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEE-----GIEVAWNQVKLRTFCD--DPAMI-----ERLFSEVRLLKTLANK   86 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~-----~~~vavK~~~~~~~~~--~~~~~-----~~~~~E~~~l~~l~~~   86 (219)
                      ..+...+.|++.+.||+|+||.||+|.+..+     ++.||+|++.......  .....     .....|+..++.++||
T Consensus        29 i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~  108 (364)
T 3op5_A           29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYL  108 (364)
T ss_dssp             EECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred             eeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence            3344455668999999999999999988664     5789999987432100  00000     1123344556677899


Q ss_pred             CceEEEEEEecCC--CceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEE
Q 027788           87 NIISLHYVWRDED--RNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFV  163 (219)
Q Consensus        87 ~i~~~~~~~~~~~--~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili  163 (219)
                      ||+++++++....  ..+++++|||+ +++|.+++... ..+++..+..++.|++.||.|||+.+  ++||||||+||++
T Consensus       109 ~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill  185 (364)
T 3op5_A          109 GVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLL  185 (364)
T ss_dssp             CSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE
T ss_pred             CCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEE
Confidence            9999999886543  36689999999 89999998765 57999999999999999999999999  9999999999999


Q ss_pred             e--CCCCcEEEeccccceeccccce-------------eeeecccCccccCCCccccccceeeecc
Q 027788          164 N--GNTGQVKIGDLGVAAIVGRAIR-------------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       164 ~--~~~~~~~l~dfg~a~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +  .+ +.+||+|||+++.+.....             ++..+.+| +......++.++||||||+
T Consensus       186 ~~~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG~  249 (364)
T 3op5_A          186 NYKNP-DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSI-DAHNGVAPSRRGDLEILGY  249 (364)
T ss_dssp             ESSCT-TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCH-HHHTTCCCCHHHHHHHHHH
T ss_pred             ecCCC-CeEEEEECCcceecccCCcccccccCcccccCCCCCccCH-HHhCCCCCCchhhHHHHHH
Confidence            8  44 5899999999987755432             11122222 3344556788899999993

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.97  E-value=1.1e-31  Score=214.35  Aligned_cols=179  Identities=22%  Similarity=0.454  Sum_probs=142.6

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      +..+| .+.+.||+|+||.||+|.+..+++.||+|.++...      ..+.+.+|+.+++.++||||+++++++...  .
T Consensus        27 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~   97 (314)
T 3com_A           27 PEEVF-DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYGSYFKN--T   97 (314)
T ss_dssp             ---CE-EEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHHHHHHHHHHHTCCCTTBCCEEEEEEET--T
T ss_pred             chhhh-hhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHHHHHHHHHHHhCCCCCCccEEEEEEeC--C
Confidence            44455 78899999999999999999999999999987432      135688899999999999999999998654  5


Q ss_pred             eEEEEeccccCCChHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          102 TLNFITEVCTSGNLREYRK-KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      .++++||++++++|.+++. ....+++..+..++.|++.|+.+||+.+  ++|+||+|+||+++.+ +.++|+|||++..
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~  174 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTE-GHAKLADFGVAGQ  174 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred             EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCC-CCEEEeecccchh
Confidence            6888999999999999886 4567999999999999999999999999  9999999999999866 5899999999987


Q ss_pred             ccccce------eeeecccCccccCCCccccccceeeec
Q 027788          181 VGRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ......      ++..+.+ ++......++.++|+||+|
T Consensus       175 ~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG  212 (314)
T 3com_A          175 LTDTMAKRNTVIGTPFWMA-PEVIQEIGYNCVADIWSLG  212 (314)
T ss_dssp             CBTTBSCBCCCCSCGGGCC-HHHHSSSCBCTTHHHHHHH
T ss_pred             hhhhccccCccCCCCCccC-hhhcCCCCCCccccHHHHH
Confidence            654432      1112222 3344455678889999999

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=9.9e-32  Score=216.68  Aligned_cols=183  Identities=21%  Similarity=0.341  Sum_probs=141.6

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCC----cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      .....+.+.+.||+|+||.||+|....++    ..||+|.++...   .......+.+|+.++++++||||+++++++. 
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-  116 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-  116 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-
Confidence            34445588899999999999999876543    459999987432   4555677899999999999999999999984 


Q ss_pred             CCCceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                       ....++++||++++++|.+++... ..+++..+..++.|++.||.+||+.+  ++|+||||+||+++.+ +.++|+|||
T Consensus       117 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kl~Dfg  192 (333)
T 1mqb_A          117 -KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN-LVCKVSDFG  192 (333)
T ss_dssp             -SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCCC
T ss_pred             -cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCC-CcEEECCCC
Confidence             445688999999999999998754 57999999999999999999999999  9999999999999866 589999999


Q ss_pred             cceecccccee---------eeecccCccccCCCccccccceeeec
Q 027788          177 VAAIVGRAIRR---------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       177 ~a~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ++.........         +..+.+| +......++.++|+||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  237 (333)
T 1mqb_A          193 LSRVLEDDPEATYTTSGGKIPIRWTAP-EAISYRKFTSASDVWSFG  237 (333)
T ss_dssp             C-----------------CCCGGGSCH-HHHHSCCCCHHHHHHHHH
T ss_pred             cchhhccccccccccCCCCccccccCc-hhcccCCCCchhhhHHHH
Confidence            99876543221         1113333 333455677889999999

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.97  E-value=6.2e-32  Score=214.82  Aligned_cols=186  Identities=24%  Similarity=0.407  Sum_probs=145.4

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++| ++.+.||+|+||.||+|.+..++..+|+|+++...........+.+.+|+.++++++||||+++++++..++...+
T Consensus         5 ~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            5 GKY-LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             CCB-CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             cce-eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            455 8889999999999999999999999999998865432223445778999999999999999999999876666778


Q ss_pred             EEEeccccCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          104 NFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      +++||+++++ |.+++..  ...+++..+..++.|++.|+.|||+++  ++|+||||+||+++.+ +.++|+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTG-GTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCC-CcEEeecccccccc
Confidence            9999999865 6666554  356899999999999999999999999  9999999999999866 58999999999876


Q ss_pred             cccce--------eeeecccCccccC-CCccccccceeeecc
Q 027788          182 GRAIR--------RIRCWGRRSSWRR-SCTMRITRSLWTYTR  214 (219)
Q Consensus       182 ~~~~~--------~~~~~~~~~~~~~-~~~~~~~~diws~gi  214 (219)
                      .....        ++..+.+|+.... ...++.++|+||+|+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~  201 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGV  201 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHH
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHH
Confidence            53221        1222333332222 222356799999993

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.97  E-value=4.1e-32  Score=222.01  Aligned_cols=182  Identities=25%  Similarity=0.352  Sum_probs=143.7

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc--
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN--  101 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~--  101 (219)
                      .+| .+.+.||+|+||.||+|.+..+++.||+|.++...  ......+.+.+|+.+++.++||||+++++++...+..  
T Consensus        42 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           42 KTY-VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred             ccE-EEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc--cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence            455 78899999999999999999999999999987543  2455668889999999999999999999999654432  


Q ss_pred             --eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          102 --TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       102 --~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                        .++++||+++ ++|.+.+.  ..+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+ +.++|+|||++.
T Consensus       119 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~-~~~kL~Dfg~a~  192 (371)
T 4exu_A          119 FYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLAR  192 (371)
T ss_dssp             CCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECSTTCC-
T ss_pred             ceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCC-CCEEEEecCccc
Confidence              2378999997 68877664  35999999999999999999999999  9999999999999866 589999999998


Q ss_pred             eccccce---eeeecccCccccCCCccccccceeeecc
Q 027788          180 IVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .......   ++..+.+|+.......++.++|+||+|+
T Consensus       193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  230 (371)
T 4exu_A          193 HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGC  230 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHH
T ss_pred             ccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHH
Confidence            7654432   2223334443444467888899999993

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.8e-32  Score=220.91  Aligned_cols=184  Identities=25%  Similarity=0.436  Sum_probs=141.4

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCC-CHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD-DPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      ++| ++.+.||+|+||.||+|.+..+++.||+|.++...... .....+.+.+|+.+++.++||||+++++++.  ....
T Consensus        10 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~   86 (346)
T 1ua2_A           10 KRY-EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG--HKSN   86 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC--CTTC
T ss_pred             ccc-EEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe--eCCc
Confidence            444 78899999999999999999999999999987543221 1122346788999999999999999999995  4456


Q ss_pred             EEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          103 LNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      ++++||++++ +|..++... ..+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+ +.+||+|||++...
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDEN-GVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCC-CCEEEEecccceec
Confidence            7889999975 888777654 46889999999999999999999999  9999999999999866 58999999999876


Q ss_pred             cccce------eeeecccCccccCCCccccccceeeecc
Q 027788          182 GRAIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       182 ~~~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .....      ++..+.+|+.......++.++||||+|+
T Consensus       163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  201 (346)
T 1ua2_A          163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC  201 (346)
T ss_dssp             TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHH
T ss_pred             cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHH
Confidence            54332      2222334444444455778899999993

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.97  E-value=4.9e-32  Score=216.33  Aligned_cols=188  Identities=24%  Similarity=0.336  Sum_probs=149.5

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEe-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEE
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFD-----QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISL   91 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~   91 (219)
                      .......+.|++.+.||+|+||.||+|.+     ..+++.||+|.++...   .....+.+.+|+.+++++ +||||+++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            34444555558999999999999999984     4567899999987542   445567889999999999 68999999


Q ss_pred             EEEEecCCCceEEEEeccccCCChHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCeeeeC
Q 027788           92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH----------------VSVKALKKWSKQILKGLNYLHTHEPCVIHRD  155 (219)
Q Consensus        92 ~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~----------------~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~d  155 (219)
                      ++++...+ ..++++||++++++|.+++.....                +++..+..++.|++.|+.|||+.+  ++|+|
T Consensus        97 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~d  173 (316)
T 2xir_A           97 LGACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRD  173 (316)
T ss_dssp             EEEECCTT-SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred             EEEEecCC-CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--ccccc
Confidence            99986443 457889999999999999876543                789999999999999999999999  99999


Q ss_pred             CCCCceEEeCCCCcEEEeccccceeccccce--------eeeecccCccccCCCccccccceeeec
Q 027788          156 LNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       156 l~~~nili~~~~~~~~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |||+||+++.+ +.++|+|||++........        .+..+.+| +......++.++|+||+|
T Consensus       174 ikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aP-E~~~~~~~~~~~Di~slG  237 (316)
T 2xir_A          174 LAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP-ETIFDRVYTIQSDVWSFG  237 (316)
T ss_dssp             CSGGGEEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCH-HHHHHCCCCHHHHHHHHH
T ss_pred             CccceEEECCC-CCEEECCCccccccccCccceeccCCCcceeecCc-hhhccccccchhHHHHHH
Confidence            99999999865 5899999999987644321        11112233 333445677889999999

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.97  E-value=2.4e-31  Score=214.02  Aligned_cols=185  Identities=25%  Similarity=0.407  Sum_probs=147.5

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCc-----EEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEE
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGI-----EVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHY   93 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~   93 (219)
                      .....+.|++.+.||+|+||.||+|.+..++.     .||+|.++...   .....+.+.+|+.+++.+ +||||+++++
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  117 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLG  117 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            33444555899999999999999999876654     79999887442   445567899999999999 8999999999


Q ss_pred             EEecCCCceEEEEeccccCCChHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCC
Q 027788           94 VWRDEDRNTLNFITEVCTSGNLREYRKKH--------------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCS  159 (219)
Q Consensus        94 ~~~~~~~~~~~lv~e~~~~g~L~~~~~~~--------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~  159 (219)
                      ++..  ...++++||++++++|.+++...              ..+++..+..++.|++.||.|||+.+  ++|+||||+
T Consensus       118 ~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~  193 (333)
T 2i1m_A          118 ACTH--GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAAR  193 (333)
T ss_dssp             EECS--SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred             EEec--CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccc
Confidence            9954  44578899999999999987642              35789999999999999999999999  999999999


Q ss_pred             ceEEeCCCCcEEEeccccceecccccee--------eeecccCccccCCCccccccceeeec
Q 027788          160 NVFVNGNTGQVKIGDLGVAAIVGRAIRR--------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       160 nili~~~~~~~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ||+++.+ +.++|+|||++.........        +..+.+| +......++.++||||+|
T Consensus       194 NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  253 (333)
T 2i1m_A          194 NVLLTNG-HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAP-ESIFDCVYTVQSDVWSYG  253 (333)
T ss_dssp             GCEEEGG-GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCH-HHHHHCCCCHHHHHHHHH
T ss_pred             eEEECCC-CeEEECccccccccccccceeecCCCCCCccccCH-HHhccCCCChHHHHHHHH
Confidence            9999866 58999999999876443221        1113333 333345577889999999

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=7.4e-32  Score=210.93  Aligned_cols=177  Identities=19%  Similarity=0.294  Sum_probs=143.5

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      .-|++.+.||+|+||.||+|.+. ++..||+|.+.....     ..+.+.+|+.++++++||||+++++++..  ...++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~   81 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPIC   81 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEE
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-----CHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCceE
Confidence            34588899999999999999976 577899999875432     12568899999999999999999999854  45588


Q ss_pred             EEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          105 FITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      ++||++++++|.+++... ..+++..+..++.|++.++.+||+.+  ++|+||||+||+++.+ +.++|+|||++.....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGG-GCEEECCTTGGGGBCC
T ss_pred             EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCC-CCEEeccccccccccc
Confidence            899999999999998654 45899999999999999999999999  9999999999999866 5899999999986644


Q ss_pred             cce-------eeeecccCccccCCCccccccceeeec
Q 027788          184 AIR-------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~-------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...       .+..+.+| +......++.++|+||+|
T Consensus       159 ~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  194 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASP-EVFSFSRYSSKSDVWSFG  194 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCH-HHHHHCCCCHHHHHHHHH
T ss_pred             cccccccCcccccccCCH-HHhcCCCCCchhhhHHHH
Confidence            331       11112333 333445577889999999

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.97  E-value=3.6e-32  Score=215.93  Aligned_cols=186  Identities=24%  Similarity=0.433  Sum_probs=148.0

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      ..++..+| ++.+.||+|+||.||+|.+..++..+|+|.+....    ....+.+.+|+.+++.++||||+++++++...
T Consensus        14 ~~~~~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (302)
T 2j7t_A           14 DLDPNEVW-EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYIVEIEILATCDHPYIVKLLGAYYHD   88 (302)
T ss_dssp             SSCGGGTE-EEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred             ccCCccce-eecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC----HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence            34555665 88899999999999999999999999999987542    23357788999999999999999999999654


Q ss_pred             CCceEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                        ..++++||++++++|.+++.. ...+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|+|||+
T Consensus        89 --~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~  163 (302)
T 2j7t_A           89 --GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLE-GDIRLADFGV  163 (302)
T ss_dssp             ---CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-SCEEECCCHH
T ss_pred             --CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCC-CCEEEEECCC
Confidence              457889999999999988764 467999999999999999999999999  9999999999999866 5899999998


Q ss_pred             ceeccccc------eeeeecccCcccc----CCCccccccceeeecc
Q 027788          178 AAIVGRAI------RRIRCWGRRSSWR----RSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~------~~~~~~~~~~~~~----~~~~~~~~~diws~gi  214 (219)
                      +.......      .++..+.+|+.+.    ....++.++|+||+|+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~  210 (302)
T 2j7t_A          164 SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGI  210 (302)
T ss_dssp             HHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHH
T ss_pred             CccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHH
Confidence            76442221      1222333443332    4556777899999993

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.97  E-value=1.1e-31  Score=212.77  Aligned_cols=188  Identities=20%  Similarity=0.362  Sum_probs=147.6

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCC---cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEE
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEG---IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYV   94 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~   94 (219)
                      ..+++....|++.+.||+|+||.||+|.+..++   ..+|+|.++..   ......+.+.+|+.++++++||||++++++
T Consensus        18 ~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   94 (298)
T 3f66_A           18 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGI   94 (298)
T ss_dssp             GBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             eecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC---CCHHHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence            345566777799999999999999999865433   35888887642   245667889999999999999999999998


Q ss_pred             EecCCCceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEe
Q 027788           95 WRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIG  173 (219)
Q Consensus        95 ~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~  173 (219)
                      +... ....+++||++++++|.+++... ..++...+..++.|++.|+.+||+++  ++|+||||+||+++.+ +.++|+
T Consensus        95 ~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~  170 (298)
T 3f66_A           95 CLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEK-FTVKVA  170 (298)
T ss_dssp             ECCS-SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEEC
T ss_pred             EEcC-CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCC-CCEEEC
Confidence            6543 34567899999999999998753 46889999999999999999999999  9999999999999865 589999


Q ss_pred             ccccceeccccce-----eee-----ecccCccccCCCccccccceeeec
Q 027788          174 DLGVAAIVGRAIR-----RIR-----CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       174 dfg~a~~~~~~~~-----~~~-----~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |||++........     ...     .+.+| +......++.++|+||+|
T Consensus       171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  219 (298)
T 3f66_A          171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMAL-ESLQTQKFTTKSDVWSFG  219 (298)
T ss_dssp             SCGGGCCCSCGGGCBC-----CCBCGGGSCH-HHHHHCCCCHHHHHHHHH
T ss_pred             cccccccccccchhccccccCCCCCccccCh-HHhcCCCCChHHHHHHHH
Confidence            9999987654332     111     12222 233445577889999999

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.97  E-value=1e-31  Score=233.20  Aligned_cols=175  Identities=23%  Similarity=0.402  Sum_probs=142.6

Q ss_pred             eeeeccccceEEEEEEe--cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           30 NELLGSGAVKKVYRAFD--QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        30 ~~~ig~g~~g~V~~a~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      .+.||+|+||.||+|.+  ..++..||||.++....  +....+.+.+|+.++++++||||+++++++..+   .++++|
T Consensus       374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~---~~~lv~  448 (635)
T 4fl3_A          374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVM  448 (635)
T ss_dssp             EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG--CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SEEEEE
T ss_pred             CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CEEEEE
Confidence            34799999999999954  46678999999875432  344557899999999999999999999998533   377899


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce-
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR-  186 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~-  186 (219)
                      ||+++|+|.+++.....+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+++.+..... 
T Consensus       449 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          449 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCTTHHHHTTC----
T ss_pred             EccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCC-CCEEEEEcCCccccccCccc
Confidence            99999999999988888999999999999999999999999  9999999999999966 5899999999987654332 


Q ss_pred             ---ee-----eecccCccccCCCccccccceeeec
Q 027788          187 ---RI-----RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ---~~-----~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                         ..     ..+.+| +......++.++||||||
T Consensus       526 ~~~~~~~~~t~~y~AP-E~~~~~~~~~~sDvwSlG  559 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAP-ECINYYKFSSKSDVWSFG  559 (635)
T ss_dssp             ---------CGGGSCH-HHHHHCCCCHHHHHHHHH
T ss_pred             cccccCCCCceeeeCh-hhhcCCCCCcHHHHHHHH
Confidence               11     112333 333445678889999999

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.97  E-value=1.3e-31  Score=215.45  Aligned_cols=187  Identities=22%  Similarity=0.336  Sum_probs=146.3

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCC
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDR  100 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~  100 (219)
                      ..++|....+.||+|+||.||+|.+..+++.||+|+++....  .......+.+|+.+++.+. ||||+++++++.  +.
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~--~~  101 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINLHEVYE--NT  101 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CS
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEEEEEEE--eC
Confidence            445664445899999999999999999999999999886543  2233467889999999985 599999999995  44


Q ss_pred             ceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC--CCCcEEEeccc
Q 027788          101 NTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG--NTGQVKIGDLG  176 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~--~~~~~~l~dfg  176 (219)
                      ..++++|||+++++|.+++...  ..+++..+..++.|++.||.|||+++  ++||||||+||+++.  ..+.++|+|||
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg  179 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFG  179 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred             CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence            5688999999999999887543  56899999999999999999999999  999999999999985  13589999999


Q ss_pred             cceeccccceeeeeccc----CccccCCCccccccceeeecc
Q 027788          177 VAAIVGRAIRRIRCWGR----RSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       177 ~a~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~diws~gi  214 (219)
                      ++.............++    +++......++.++|+||+|+
T Consensus       180 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  221 (327)
T 3lm5_A          180 MSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGI  221 (327)
T ss_dssp             GCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred             cccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHH
Confidence            99887654432222222    223445566788899999993

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.97  E-value=9.3e-32  Score=216.10  Aligned_cols=182  Identities=23%  Similarity=0.395  Sum_probs=143.2

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEE--EEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecC
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEV--AWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDE   98 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~v--avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~   98 (219)
                      ..++| ++.+.||+|+||.||+|.+..++..+  ++|.++...   .....+.+.+|+.+++++ +||||+++++++...
T Consensus        23 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~   98 (327)
T 1fvr_A           23 DWNDI-KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   98 (327)
T ss_dssp             CGGGC-EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             cHHHc-cceeeeecCCCceEEEEEEccCCcccceeeeeecccc---chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence            33555 88899999999999999998888865  888877432   233456788999999999 899999999999544


Q ss_pred             CCceEEEEeccccCCChHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceE
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVF  162 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~~----------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nil  162 (219)
                        ..++++||++++++|.+++....                .+++..+..++.|++.||.|||+++  ++|+||||+||+
T Consensus        99 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl  174 (327)
T 1fvr_A           99 --GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNIL  174 (327)
T ss_dssp             --TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred             --CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEE
Confidence              56889999999999999987543                6899999999999999999999999  999999999999


Q ss_pred             EeCCCCcEEEeccccceeccccceeeee-----cccCccccCCCccccccceeeec
Q 027788          163 VNGNTGQVKIGDLGVAAIVGRAIRRIRC-----WGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       163 i~~~~~~~~l~dfg~a~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ++.+ +.++|+|||++............     +.+| +......++.++|+||+|
T Consensus       175 ~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  228 (327)
T 1fvr_A          175 VGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI-ESLNYSVYTTNSDVWSYG  228 (327)
T ss_dssp             ECGG-GCEEECCTTCEESSCEECCC----CCTTTCCH-HHHHHCEECHHHHHHHHH
T ss_pred             EcCC-CeEEEcccCcCccccccccccCCCCCccccCh-hhhccccCCchhcchHHH
Confidence            9865 58999999999754433221111     2222 233344567789999999

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=2.8e-31  Score=209.87  Aligned_cols=166  Identities=15%  Similarity=0.098  Sum_probs=138.7

Q ss_pred             cccC--CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEE
Q 027788           18 IETD--PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVW   95 (219)
Q Consensus        18 ~~~~--~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~   95 (219)
                      ..++  ..++| ++.+.||+|+||.||+|++..+++.||+|+++.... .+....+.+.+|+..+++++||||+++++++
T Consensus        23 ~~g~~~~~~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~  100 (286)
T 3uqc_A           23 VPGARIANGRY-RLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV-LPDDVLQETLSRTLRLSRIDKPGVARVLDVV  100 (286)
T ss_dssp             CTTCEETTTTE-EEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC-SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCCCEEecCcE-EEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc-cCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence            4444  33555 888999999999999999999999999999885433 2355668899999999999999999999999


Q ss_pred             ecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788           96 RDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus        96 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      ...  +..|++|||+++++|.++++..  .....+..++.|++.||.|||+++  ++||||||+||+++.+ +.++|+++
T Consensus       101 ~~~--~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~-g~~kl~~~  173 (286)
T 3uqc_A          101 HTR--AGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSID-GDVVLAYP  173 (286)
T ss_dssp             EET--TEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETT-SCEEECSC
T ss_pred             EEC--CcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCC-CCEEEEec
Confidence            654  5688999999999999998643  466678899999999999999999  9999999999999966 68998855


Q ss_pred             ccceeccccceeeeecccCccccCCCccccccceeeecc
Q 027788          176 GVAAIVGRAIRRIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       176 g~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +..                      ..++.++||||+|+
T Consensus       174 ~~~----------------------~~~~~~~Di~slG~  190 (286)
T 3uqc_A          174 ATM----------------------PDANPQDDIRGIGA  190 (286)
T ss_dssp             CCC----------------------TTCCHHHHHHHHHH
T ss_pred             ccc----------------------CCCCchhHHHHHHH
Confidence            432                      13677899999993

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=3.4e-31  Score=209.06  Aligned_cols=181  Identities=22%  Similarity=0.349  Sum_probs=145.8

Q ss_pred             CCceeeeeeeeccccceEEEEEEec--CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQ--EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      .++|+.+++.||+|+||.||+|.+.  .++..||+|.++...   .....+.+.+|+.+++.++||||+++++++..   
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   81 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---   81 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc---chhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---
Confidence            4667666569999999999999854  467889999987542   45667889999999999999999999999843   


Q ss_pred             ceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          101 NTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      +.++++||++++++|.+++... ..+++..+..++.|++.|+.+||+.+  ++|+||+|+||+++.+ +.++|+|||++.
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~Dfg~~~  158 (287)
T 1u59_A           82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR-HYAKISDFGLSK  158 (287)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEET-TEEEECCCTTCE
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCC-CCEEECccccee
Confidence            3378899999999999988643 46999999999999999999999999  9999999999999866 589999999998


Q ss_pred             eccccceee---------eecccCccccCCCccccccceeeec
Q 027788          180 IVGRAIRRI---------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       180 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .........         ..+.+| +......++.++|+||+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  200 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAP-ECINFRKFSSRSDVWSYG  200 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCH-HHHHHCEECHHHHHHHHH
T ss_pred             eeccCcceeeccccccccccccCH-HHhccCCCCchhhHHHHH
Confidence            875433211         112222 233345577789999999

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.97  E-value=1.9e-31  Score=210.55  Aligned_cols=183  Identities=23%  Similarity=0.373  Sum_probs=148.7

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ..++| ++.+.||+|+||.||+|.+..+++.||+|++......  ....+.+.+|+.++++++||||+++++++..  ..
T Consensus        20 ~~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~   94 (287)
T 2wei_A           20 FAERY-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILED--SS   94 (287)
T ss_dssp             HHHHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SS
T ss_pred             Hhhcc-eeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHHHHHhccCCCccEEEEEEeC--CC
Confidence            33455 8889999999999999999999999999998755432  2234678899999999999999999999854  45


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC--CcEEEeccccce
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDLGVAA  179 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~--~~~~l~dfg~a~  179 (219)
                      .++++||++++++|.+.+.....+++..+..++.|++.|+.+||+.+  ++|+||+|+||+++.+.  +.++|+|||++.
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             eEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            68899999999999988876678999999999999999999999999  99999999999997432  369999999998


Q ss_pred             eccccce-----eeeecccCccccCCCccccccceeeec
Q 027788          180 IVGRAIR-----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       180 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .......     ++..+.+|+.. . ..++.++|+||+|
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~-~-~~~~~~~Di~slG  209 (287)
T 2wei_A          173 CFQQNTKMKDRIGTAYYIAPEVL-R-GTYDEKCDVWSAG  209 (287)
T ss_dssp             TBCCCSSCSCHHHHHTTCCHHHH-T-TCCCTHHHHHHHH
T ss_pred             eecCCCccccccCcccccChHHh-c-CCCCCchhhHhHH
Confidence            6654332     12223333322 2 2377789999999

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.97  E-value=1.6e-31  Score=216.36  Aligned_cols=198  Identities=14%  Similarity=0.084  Sum_probs=145.4

Q ss_pred             CCCCCccccCCCCceeeeeeeeccccceEEEEEEecC---CCcEEEEEEeeecccCC--CHH-----HHHHHHHHHHHHH
Q 027788           12 KDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQE---EGIEVAWNQVKLRTFCD--DPA-----MIERLFSEVRLLK   81 (219)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~---~~~~vavK~~~~~~~~~--~~~-----~~~~~~~E~~~l~   81 (219)
                      ..++.....+..++.|++.+.||+|+||.||+|.+..   ++..+|+|.+.......  ...     ....+.+|+..++
T Consensus        24 ~l~~g~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~  103 (345)
T 2v62_A           24 PFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK  103 (345)
T ss_dssp             -CCTTCEEECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred             cCCCCCeeccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhc
Confidence            3344444455556666999999999999999999887   78899999987542100  000     1123557888889


Q ss_pred             hhCCCCceEEEEEEec--CCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCC
Q 027788           82 TLANKNIISLHYVWRD--EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCS  159 (219)
Q Consensus        82 ~l~~~~i~~~~~~~~~--~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~  159 (219)
                      .++||||+++++++..  ++...++++||++ +++|.+++...+.+++..+..++.|++.||.|||+++  ++||||||+
T Consensus       104 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~  180 (345)
T 2v62_A          104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAA  180 (345)
T ss_dssp             TCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred             cccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHH
Confidence            9999999999999865  3356789999999 8999999877668999999999999999999999999  999999999


Q ss_pred             ceEEeCCC-CcEEEeccccceeccccce-------------eeeecccCccccCCCccccccceeeec
Q 027788          160 NVFVNGNT-GQVKIGDLGVAAIVGRAIR-------------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       160 nili~~~~-~~~~l~dfg~a~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ||+++.+. +.++|+|||+++.+.....             ++..+.+| +......++.++||||||
T Consensus       181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG  247 (345)
T 2v62_A          181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSL-DAHKGVALSRRSDVEILG  247 (345)
T ss_dssp             GEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCH-HHHHTCCCCHHHHHHHHH
T ss_pred             HEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCH-HHhcCCCCCchhhHHHHH
Confidence            99998552 2799999999987754321             11122222 233445678889999999

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.97  E-value=1.1e-31  Score=219.25  Aligned_cols=185  Identities=14%  Similarity=0.135  Sum_probs=132.6

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh--CCCCceEEE-------EE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL--ANKNIISLH-------YV   94 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l--~~~~i~~~~-------~~   94 (219)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|.++.... ......+.+.+|+.+++.+  +|||+++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-THHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence            3446888999999999999999999999999999986532 1344557788886666555  599988755       44


Q ss_pred             EecCCC---------------ceEEEEeccccCCChHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHhCCCCee
Q 027788           95 WRDEDR---------------NTLNFITEVCTSGNLREYRKKH-RHVSVKAL------KKWSKQILKGLNYLHTHEPCVI  152 (219)
Q Consensus        95 ~~~~~~---------------~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~------~~i~~qv~~~l~~lh~~~~~i~  152 (219)
                      +..++.               ..++++|||++ ++|.+++... ..+.....      ..++.|++.||.|||+++  ++
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--iv  216 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LV  216 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EE
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--Cc
Confidence            433332               44789999998 8999988653 23344444      577799999999999999  99


Q ss_pred             eeCCCCCceEEeCCCCcEEEeccccceeccccce---eeeecccCccccCC--Cccccccceeeecc
Q 027788          153 HRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---RIRCWGRRSSWRRS--CTMRITRSLWTYTR  214 (219)
Q Consensus       153 h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---~~~~~~~~~~~~~~--~~~~~~~diws~gi  214 (219)
                      ||||||+||+++.+ +.+||+|||+++.......   .+..+.+|+ ....  ..++.++||||+|+
T Consensus       217 HrDikp~NIll~~~-~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE-~~~~~~~~~~~~~DiwSlG~  281 (371)
T 3q60_A          217 HGHFTPDNLFIMPD-GRLMLGDVSALWKVGTRGPASSVPVTYAPRE-FLNASTATFTHALNAWQLGL  281 (371)
T ss_dssp             ETTCSGGGEEECTT-SCEEECCGGGEEETTCEEEGGGSCGGGCCHH-HHTCSEEECCHHHHHHHHHH
T ss_pred             cCcCCHHHEEECCC-CCEEEEecceeeecCCCccCccCCcCCcChh-hccCCCCCcCccccHHHHHH
Confidence            99999999999866 6899999999987755431   222233333 3333  56888899999993

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.97  E-value=1.2e-31  Score=212.35  Aligned_cols=179  Identities=16%  Similarity=0.179  Sum_probs=144.2

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCce
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~  102 (219)
                      ++.|++.+.||+|+||.||+|.+..+++.||+|.++....      .+.+.+|+.+++.+ +|+|++++++++..  ...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~   80 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLH   80 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc------cHHHHHHHHHHHHHhcCCCCCeEEeecCC--Cce
Confidence            4445888999999999999999999999999999874432      13467899999999 79999999988854  456


Q ss_pred             EEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC----CcEEEecccc
Q 027788          103 LNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT----GQVKIGDLGV  177 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~----~~~~l~dfg~  177 (219)
                      .+++||++ +++|.+++... ..+++..+..++.|++.|+.|||+++  ++|+||||+||+++.+.    ..++|+|||+
T Consensus        81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            78899999 89999998764 45999999999999999999999999  99999999999997542    1399999999


Q ss_pred             ceeccccce-------------eeeecccCccccCCCccccccceeeecc
Q 027788          178 AAIVGRAIR-------------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +........             ++..+.+| +......++.++|+||+|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG~  206 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSI-NTHLGREQSRRDDLEALGH  206 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCH-HHHTTCCCCHHHHHHHHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCc-hhhcCCCCChHHHHHHHHH
Confidence            988765432             11122222 3345556788899999993

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.97  E-value=1.9e-31  Score=208.63  Aligned_cols=183  Identities=30%  Similarity=0.437  Sum_probs=134.5

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      .|++.+.||+|+||.||+|.+.  +..+|+|+++...........+.+.+|+.+++.++||||+++++++..  ...+++
T Consensus         8 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l   83 (271)
T 3dtc_A            8 ELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK--EPNLCL   83 (271)
T ss_dssp             SEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC--C--CEE
T ss_pred             heeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--CCceEE
Confidence            3488899999999999999864  789999998765433223445778899999999999999999999954  455788


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCC-eeeeCCCCCceEEeCC-------CCcEEEecccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC-VIHRDLNCSNVFVNGN-------TGQVKIGDLGV  177 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~-i~h~dl~~~nili~~~-------~~~~~l~dfg~  177 (219)
                      +||++++++|.+++. ...+++..+..++.|++.|+.|||+++.. ++|+||||+||+++.+       .+.++|+|||+
T Consensus        84 v~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             EEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             EEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            999999999998875 45799999999999999999999998733 7899999999999752       35799999999


Q ss_pred             ceeccccce----eeeecccCccccCCCccccccceeeecc
Q 027788          178 AAIVGRAIR----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +........    ++..+.+| +......++.++|+||+|+
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG~  202 (271)
T 3dtc_A          163 AREWHRTTKMSAAGAYAWMAP-EVIRASMFSKGSDVWSYGV  202 (271)
T ss_dssp             -------------CCGGGSCH-HHHHHCCCSHHHHHHHHHH
T ss_pred             ccccccccccCCCCccceeCH-HHhccCCCCchhhHHHHHH
Confidence            987654432    11222222 3334455778899999993

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.97  E-value=1.3e-31  Score=211.49  Aligned_cols=184  Identities=20%  Similarity=0.234  Sum_probs=133.3

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ...+.|++.+.||+|+||.||+|.+..+++.||+|.++....  .....+.+..+...++.++||||+++++++..+  .
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--~   79 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN--SQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE--G   79 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C--HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS--S
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC--cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc--C
Confidence            334445888999999999999999999999999999875431  223334444555567889999999999999644  4


Q ss_pred             eEEEEeccccCCChHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788          102 TLNFITEVCTSGNLREYRK----KHRHVSVKALKKWSKQILKGLNYLHTH-EPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~----~~~~~~~~~~~~i~~qv~~~l~~lh~~-~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                      ..+++||+++ ++|.+++.    ....+++..+..++.|++.|+.|||++ +  ++|+||||+||+++.+ +.++|+|||
T Consensus        80 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg  155 (290)
T 3fme_A           80 DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINAL-GQVKMCDFG  155 (290)
T ss_dssp             SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTT-CCEEBCCC-
T ss_pred             CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCC-CCEEEeecC
Confidence            5788999997 57766553    346799999999999999999999998 9  9999999999999865 589999999


Q ss_pred             cceecccccee-----eeecccCccc---cCCCccccccceeeec
Q 027788          177 VAAIVGRAIRR-----IRCWGRRSSW---RRSCTMRITRSLWTYT  213 (219)
Q Consensus       177 ~a~~~~~~~~~-----~~~~~~~~~~---~~~~~~~~~~diws~g  213 (219)
                      ++.........     +..+.+|+.+   .....++.++|+||+|
T Consensus       156 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG  200 (290)
T 3fme_A          156 ISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLG  200 (290)
T ss_dssp             --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHH
T ss_pred             CcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHH
Confidence            99876554432     2223334333   3555677889999999

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=8.2e-32  Score=217.25  Aligned_cols=185  Identities=18%  Similarity=0.206  Sum_probs=142.1

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccC----CCHHHHHHHHHHHHHHHhhC---------CCC
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC----DDPAMIERLFSEVRLLKTLA---------NKN   87 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~---------~~~   87 (219)
                      ...++| ++.+.||+|+||.||+|++  +++.||+|+++.....    ......+.+.+|+.+++.++         |||
T Consensus        17 ~~~~~y-~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n   93 (336)
T 2vuw_A           17 LPTEKL-QRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG   93 (336)
T ss_dssp             SCHHHH-HTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred             cccccc-hheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence            344555 7889999999999999987  6899999999865421    12233467889999999886         888


Q ss_pred             ceEEEEEEecC----------------------------CCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHH
Q 027788           88 IISLHYVWRDE----------------------------DRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILK  139 (219)
Q Consensus        88 i~~~~~~~~~~----------------------------~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~  139 (219)
                      ++++.+++...                            +...++++|||+++|++.+.+.. ..+++..+..++.|++.
T Consensus        94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHH
T ss_pred             hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHH
Confidence            88887765311                            24678999999998865554433 46899999999999999


Q ss_pred             HHHHHH-hCCCCeeeeCCCCCceEEeCCC-------------------CcEEEeccccceeccccce-eeeecccCcccc
Q 027788          140 GLNYLH-THEPCVIHRDLNCSNVFVNGNT-------------------GQVKIGDLGVAAIVGRAIR-RIRCWGRRSSWR  198 (219)
Q Consensus       140 ~l~~lh-~~~~~i~h~dl~~~nili~~~~-------------------~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~  198 (219)
                      ||.||| +.+  ++||||||+|||++.+.                   ..+||+|||+|+....... ++..+.+|+-+.
T Consensus       173 aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          173 SLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGC
T ss_pred             HHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhc
Confidence            999999 899  99999999999998552                   1799999999988765432 344455555444


Q ss_pred             CCCccccccceeeec
Q 027788          199 RSCTMRITRSLWTYT  213 (219)
Q Consensus       199 ~~~~~~~~~diws~g  213 (219)
                      ...  +.++||||++
T Consensus       251 g~~--~~~~Diwsl~  263 (336)
T 2vuw_A          251 GDG--DYQFDIYRLM  263 (336)
T ss_dssp             CCS--SHHHHHHHHH
T ss_pred             CCC--ccceehhhhh
Confidence            333  6679999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.97  E-value=5.2e-32  Score=217.16  Aligned_cols=191  Identities=21%  Similarity=0.312  Sum_probs=148.2

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCC--HHHHHHHHHHHHHHHhhC--CCCceEEEEE
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD--PAMIERLFSEVRLLKTLA--NKNIISLHYV   94 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~--~~~i~~~~~~   94 (219)
                      +.++....|++.+.||+|+||.||+|.+..+++.||+|.++.......  ....+.+.+|+.++++++  |+|+++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            444444445899999999999999999999999999999986543210  011234567999999996  5999999999


Q ss_pred             EecCCCceEEEEeccccC-CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEe
Q 027788           95 WRDEDRNTLNFITEVCTS-GNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIG  173 (219)
Q Consensus        95 ~~~~~~~~~~lv~e~~~~-g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~  173 (219)
                      +..  ...+++++|++.+ ++|.+++.....+++..+..++.|++.||.|||+.+  ++|+||||+||+++.+.+.+||+
T Consensus       117 ~~~--~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          117 FER--PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             EEC--SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEEC
T ss_pred             Eec--CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEe
Confidence            954  4568889999975 899999887778999999999999999999999999  99999999999998555689999


Q ss_pred             ccccceeccccce----eeeecccCccccCCCccccccceeeec
Q 027788          174 DLGVAAIVGRAIR----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       174 dfg~a~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |||++........    ++..+.+|+.+.....++.++|+||||
T Consensus       193 Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG  236 (320)
T 3a99_A          193 DFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG  236 (320)
T ss_dssp             CCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHH
T ss_pred             eCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHH
Confidence            9999987755432    222233443333333346678999999

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.97  E-value=2.3e-32  Score=219.58  Aligned_cols=179  Identities=22%  Similarity=0.370  Sum_probs=140.8

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcE----EEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIE----VAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~----vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      .+| ++.+.||+|+||.||+|.+..++..    ||+|.+.....   ....+.+.+|+.+++.++||||+++++++..  
T Consensus        13 ~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--   86 (325)
T 3kex_A           13 TEL-RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG---RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG--   86 (325)
T ss_dssp             TTE-EEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS---CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB--
T ss_pred             hHc-eeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc---HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--
Confidence            444 8889999999999999999888776    66666543321   1222456689999999999999999998843  


Q ss_pred             CceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          100 RNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                       ...+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.++|+|||++
T Consensus        87 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~-~~~kl~Dfg~a  162 (325)
T 3kex_A           87 -SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSP-SQVQVADFGVA  162 (325)
T ss_dssp             -SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSS-SCEEECSCSGG
T ss_pred             -CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCC-CeEEECCCCcc
Confidence             3477899999999999988754 46899999999999999999999999  9999999999999865 58999999999


Q ss_pred             eecccccee---ee-----ecccCccccCCCccccccceeeec
Q 027788          179 AIVGRAIRR---IR-----CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       179 ~~~~~~~~~---~~-----~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +........   ..     .+.+| +......++.++|+||+|
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  204 (325)
T 3kex_A          163 DLLPPDDKQLLYSEAKTPIKWMAL-ESIHFGKYTHQSDVWSYG  204 (325)
T ss_dssp             GGSCCCTTCCC-----CCTTTSCH-HHHHHCCCCHHHHHHHHH
T ss_pred             cccCcccccccccCCCCcccccCh-HHhccCCCChhhHhHHhH
Confidence            876544321   11     12222 333445578889999999

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.97  E-value=3e-31  Score=215.89  Aligned_cols=186  Identities=23%  Similarity=0.338  Sum_probs=141.8

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccC-------CCHHHHHHHHHHHHHHHhhCCCCceEEEEEE
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC-------DDPAMIERLFSEVRLLKTLANKNIISLHYVW   95 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~   95 (219)
                      .++| ++.+.||+|+||.||+|.+.. +..||+|.+......       .+....+.+.+|+.+++.++||||+++++++
T Consensus        21 ~~~y-~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           21 QSPY-TVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TCSC-EEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             ccce-EEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            3455 888999999999999999754 899999998654321       1334457899999999999999999999988


Q ss_pred             ec---CCCceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEE
Q 027788           96 RD---EDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVK  171 (219)
Q Consensus        96 ~~---~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~  171 (219)
                      ..   +....++++||+++ ++|.+.+... ..+++..+..++.|++.|+.|||+++  ++|+||||+||+++.+ +.++
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~-~~~k  174 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADN-NDIT  174 (362)
T ss_dssp             EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEE
T ss_pred             EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEcCC-CCEE
Confidence            54   33457899999997 5777766543 46899999999999999999999999  9999999999999865 5899


Q ss_pred             Eeccccceeccccceeee-----ecccCccccCCCccccccceeeecc
Q 027788          172 IGDLGVAAIVGRAIRRIR-----CWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       172 l~dfg~a~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      |+|||++...........     .+.+|+.+.....++.++|+||+|+
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  222 (362)
T 3pg1_A          175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGC  222 (362)
T ss_dssp             ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHH
T ss_pred             EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHH
Confidence            999999986554433222     2334443444466788899999993

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.97  E-value=1.5e-31  Score=217.33  Aligned_cols=183  Identities=20%  Similarity=0.289  Sum_probs=133.3

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC----
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE----   98 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~----   98 (219)
                      .++| ++.+.||+|+||.||+|.+..++..||+|.+.....     .......++..++.++||||+++++++...    
T Consensus        22 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           22 MDRF-QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HTTE-EEC----------CEEEEETTTCCEEEEEEEECCTT-----CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             ccce-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-----ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            3556 888999999999999999999999999998864322     123456778888999999999999998542    


Q ss_pred             -CCceEEEEeccccCCChHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCeeeeCCCCCceEEeCCCCcEE
Q 027788           99 -DRNTLNFITEVCTSGNLREYR----KKHRHVSVKALKKWSKQILKGLNYLH--THEPCVIHRDLNCSNVFVNGNTGQVK  171 (219)
Q Consensus        99 -~~~~~~lv~e~~~~g~L~~~~----~~~~~~~~~~~~~i~~qv~~~l~~lh--~~~~~i~h~dl~~~nili~~~~~~~~  171 (219)
                       ...+++++|||+++ +|...+    .....+++..+..++.|++.++.|||  +.+  ++|+||||+||+++...+.++
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEE
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEE
Confidence             23357899999986 444332    34567899999999999999999999  888  999999999999986456899


Q ss_pred             Eeccccceecccccee-----eeecccCccccCCCccccccceeeecc
Q 027788          172 IGDLGVAAIVGRAIRR-----IRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       172 l~dfg~a~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      |+|||++.........     +..+.+|+.+.....++.++||||+|+
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~  220 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGC  220 (360)
T ss_dssp             ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHH
Confidence            9999999877654432     222334444445556788899999993

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.97  E-value=3e-31  Score=210.42  Aligned_cols=177  Identities=24%  Similarity=0.330  Sum_probs=138.1

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHh--hCCCCceEEEEEEec--CC
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKT--LANKNIISLHYVWRD--ED   99 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~--l~~~~i~~~~~~~~~--~~   99 (219)
                      .+.|++.+.||+|+||.||+|.+  +++.||+|.+....       ...+..|.+++..  ++||||+++++++..  ..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~   77 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-------EKSWFRETELYNTVMLRHENILGFIASDMTSRHS   77 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence            33448889999999999999986  68899999986431       2445667777766  799999999988653  33


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeeeeCCCCCceEEeCCCCcEE
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLH--------THEPCVIHRDLNCSNVFVNGNTGQVK  171 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh--------~~~~~i~h~dl~~~nili~~~~~~~~  171 (219)
                      ...++++|||+++++|.++++. ..+++..+..++.|++.|+.|||        +.+  ++||||||+||+++.+ +.+|
T Consensus        78 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~-~~~k  153 (301)
T 3q4u_A           78 STQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKN-GQCC  153 (301)
T ss_dssp             EEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTT-SCEE
T ss_pred             CceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCC-CCEE
Confidence            4568899999999999999864 47999999999999999999999        778  9999999999999866 5899


Q ss_pred             Eeccccceecccccee----------eeecccCccccCCC-----ccccccceeeec
Q 027788          172 IGDLGVAAIVGRAIRR----------IRCWGRRSSWRRSC-----TMRITRSLWTYT  213 (219)
Q Consensus       172 l~dfg~a~~~~~~~~~----------~~~~~~~~~~~~~~-----~~~~~~diws~g  213 (219)
                      |+|||+++........          +..+.+|+.+....     .++.++||||+|
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG  210 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG  210 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHH
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHH
Confidence            9999999876543321          12233333222221     344679999999

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=3.3e-31  Score=209.89  Aligned_cols=181  Identities=18%  Similarity=0.323  Sum_probs=144.2

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCc---EEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGI---EVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      -.+++.++||+|+||.||+|.+..++.   .+|+|.++..   ......+.+.+|+.++++++||||+++++++...+ .
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   96 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI---TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE-G   96 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-S
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc---ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-C
Confidence            345677999999999999998655544   7999987643   24566788999999999999999999999986443 3


Q ss_pred             eEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          102 TLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      ..+++||++.+++|.+++.. ...+++..+..++.|++.|+.|||+++  ++|+||||+||+++.+ +.++|+|||++..
T Consensus        97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg~~~~  173 (298)
T 3pls_A           97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDES-FTVKVADFGLARD  173 (298)
T ss_dssp             CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEECCTTSSCT
T ss_pred             CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCC-CcEEeCcCCCccc
Confidence            34789999999999998876 456889999999999999999999999  9999999999999865 5899999999986


Q ss_pred             ccccce----------eeeecccCccccCCCccccccceeeec
Q 027788          181 VGRAIR----------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~----------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ......          .+..+.+ ++......++.++|+||+|
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~a-PE~~~~~~~~~~~Di~slG  215 (298)
T 3pls_A          174 ILDREYYSVQQHRHARLPVKWTA-LESLQTYRFTTKSDVWSFG  215 (298)
T ss_dssp             TTTGGGGCSCCSSCTTCGGGGSC-HHHHTTCCCCHHHHHHHHH
T ss_pred             ccCCcccccccCcCCCCCccccC-hhhhccCCCChhhchhhHH
Confidence            544321          0111222 2333455677889999999

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.97  E-value=1.5e-31  Score=224.05  Aligned_cols=180  Identities=23%  Similarity=0.395  Sum_probs=144.9

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      ......+++.+.||+|+||.||+|... .+..||+|.++...     ...+.+.+|+.++++++||||+++++++..   
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---  254 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---  254 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-----BCHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred             eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-----ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC---
Confidence            344455689999999999999999875 56789999987432     224778999999999999999999998852   


Q ss_pred             ceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          101 NTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      ..++++|||+++|+|.+++...  ..++...+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||++
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DFG~a  331 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSAS-LVCKIADFGLA  331 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTT-CCEEECSTTGG
T ss_pred             CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCC-CcEEEeeCCCc
Confidence            3478899999999999998643  36889999999999999999999999  9999999999999865 58999999999


Q ss_pred             eeccccce-------eeeecccCccccCCCccccccceeeec
Q 027788          179 AIVGRAIR-------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       179 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +.......       .+..+.+|+ ......++.++|+||||
T Consensus       332 ~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~~DvwslG  372 (454)
T 1qcf_A          332 RVIEDNEYTAREGAKFPIKWTAPE-AINFGSFTIKSDVWSFG  372 (454)
T ss_dssp             GGBCCHHHHTTCSSSSCGGGSCHH-HHHHCCCCHHHHHHHHH
T ss_pred             eEcCCCceeccCCCcccccccCHH-HhccCCCCcHHHHHhHH
Confidence            87654321       111233333 33345578889999999

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.97  E-value=2.1e-31  Score=209.59  Aligned_cols=181  Identities=24%  Similarity=0.362  Sum_probs=142.4

Q ss_pred             CCceeeeeeeeccccceEEEEEEecC---CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQE---EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      ..+.|.+.+.||+|+||.||+|.+..   ++..||+|.++...   .....+.+.+|+.+++.++||||+++++++..+ 
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   85 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-   85 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence            34445888999999999999998653   34569999887542   455668899999999999999999999988533 


Q ss_pred             CceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          100 RNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                        ..+++||++++++|.+++... ..+++..+..++.|++.|+.+||+++  ++|+||||+||+++.+ +.++|+|||++
T Consensus        86 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~kl~Dfg~~  160 (281)
T 3cc6_A           86 --PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASP-ECVKLGDFGLS  160 (281)
T ss_dssp             --SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEET-TEEEECCCCGG
T ss_pred             --CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCC-CcEEeCccCCC
Confidence              257899999999999988654 45899999999999999999999999  9999999999999866 58999999999


Q ss_pred             eecccccee-------eeecccCccccCCCccccccceeeec
Q 027788          179 AIVGRAIRR-------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       179 ~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .........       +..+.+| +......++.++|+||+|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  201 (281)
T 3cc6_A          161 RYIEDEDYYKASVTRLPIKWMSP-ESINFRRFTTASDVWMFA  201 (281)
T ss_dssp             GCC---------CCCCCGGGCCH-HHHHHCCCCHHHHHHHHH
T ss_pred             cccccccccccccCCCCcceeCc-hhhccCCCCchhccHHHH
Confidence            876543321       1112233 333345577789999999

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.97  E-value=1e-31  Score=216.08  Aligned_cols=182  Identities=26%  Similarity=0.453  Sum_probs=138.3

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEE----EEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEe
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEV----AWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWR   96 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~v----avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   96 (219)
                      ...++| ++.+.||+|+||.||+|.+..++..+    ++|.+....   .....+.+.+|+.+++.++||||+++++++.
T Consensus        12 l~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   87 (327)
T 3lzb_A           12 LKETEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICL   87 (327)
T ss_dssp             CCTTTE-EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEE
T ss_pred             cCHhHc-eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEe
Confidence            344555 88899999999999999998888766    555443222   2334577889999999999999999999996


Q ss_pred             cCCCceEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788           97 DEDRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus        97 ~~~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      ...   .+++++++++++|.+++.. ...+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.++|+||
T Consensus        88 ~~~---~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~-~~~kL~Df  161 (327)
T 3lzb_A           88 TST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKITDF  161 (327)
T ss_dssp             SSS---EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEECCT
T ss_pred             cCC---ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCC-CCEEEccC
Confidence            543   6779999999999998865 356999999999999999999999999  9999999999999866 58999999


Q ss_pred             ccceeccccceeee--------ecccCccccCCCccccccceeeec
Q 027788          176 GVAAIVGRAIRRIR--------CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       176 g~a~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |+++..........        .+.+| +......++.++||||+|
T Consensus       162 G~a~~~~~~~~~~~~~~~~~t~~y~aP-E~~~~~~~~~~~Di~slG  206 (327)
T 3lzb_A          162 GLAKLLGAEEKEYHAEGGKVPIKWMAL-ESILHRIYTHQSDVWSYG  206 (327)
T ss_dssp             TC----------------CCCGGGSCH-HHHHHCCCCHHHHHHHHH
T ss_pred             cceeEccCccccccccCCCccccccCH-HHHcCCCCChHHHHHHHH
Confidence            99987754432111        12222 223345578889999999

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.97  E-value=2.9e-31  Score=209.92  Aligned_cols=176  Identities=23%  Similarity=0.391  Sum_probs=140.4

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEeccc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC  110 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~  110 (219)
                      ..||+|+||.||+|.+..++..||+|.++..    .....+.+.+|+.+++.++||||+++++++...  ..++++||++
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~  101 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPER----DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN--GFIKIFMEQV  101 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECC----CC---HHHHHHHHHHHTCCCTTBCCEEEEEEET--TEEEEEEECC
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCC----chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC--CcEEEEEEeC
Confidence            3899999999999999999999999998754    233457788999999999999999999999654  5688899999


Q ss_pred             cCCChHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce-
Q 027788          111 TSGNLREYRKKH---RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR-  186 (219)
Q Consensus       111 ~~g~L~~~~~~~---~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~-  186 (219)
                      ++++|.+++...   ..+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++...+.++|+|||++........ 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~  179 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC  179 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence            999999988754   24678899999999999999999999  999999999999986456899999999987654321 


Q ss_pred             -----eeeecccCccccCC-Cccccccceeeecc
Q 027788          187 -----RIRCWGRRSSWRRS-CTMRITRSLWTYTR  214 (219)
Q Consensus       187 -----~~~~~~~~~~~~~~-~~~~~~~diws~gi  214 (219)
                           ++..+.+|+.+... ..++.++|+||+|+
T Consensus       180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~  213 (295)
T 2clq_A          180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGC  213 (295)
T ss_dssp             -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHH
T ss_pred             ccccCCCccccChhhhcCCCCCCCcHHHHHHHHH
Confidence                 22223333333222 23677899999993

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.97  E-value=4e-31  Score=217.79  Aligned_cols=180  Identities=20%  Similarity=0.289  Sum_probs=139.6

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC----C
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE----D   99 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~----~   99 (219)
                      ...|++.+.||+|+||.||+|.+..++. +|+|.+......        ..+|+.+++.++||||+++++++...    +
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~  109 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD  109 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence            3345888999999999999999876665 888877643211        12699999999999999999988543    2


Q ss_pred             CceEEEEeccccCCChHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788          100 RNTLNFITEVCTSGNLREYR---KKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~---~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                      ..+++++|||++++.+....   .....+++..+..++.|++.||.|||+.+  ++||||||+||+++.+.+.+||+|||
T Consensus       110 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          110 EVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             CEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             ceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence            34578999999865443322   23467999999999999999999999999  99999999999998444689999999


Q ss_pred             cceecccccee-----eeecccCccccCCCccccccceeeecc
Q 027788          177 VAAIVGRAIRR-----IRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       177 ~a~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +++........     +..+.+|+.+.....++.++||||+|+
T Consensus       188 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~  230 (394)
T 4e7w_A          188 SAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGC  230 (394)
T ss_dssp             TCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             CcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHH
Confidence            99887554432     223444444445566888999999993

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.97  E-value=1.6e-31  Score=216.97  Aligned_cols=185  Identities=15%  Similarity=0.165  Sum_probs=144.7

Q ss_pred             CCccccCCCCceeeeeeeeccccceEEEEEEecC--------CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCC
Q 027788           15 EPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQE--------EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK   86 (219)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   86 (219)
                      .+....+..++.|++.+.||+|+||.||+|.+..        .++.||+|.+...         +.+.+|+.++++++||
T Consensus        32 ~g~~i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~  102 (352)
T 2jii_A           32 TGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKP  102 (352)
T ss_dssp             TTCEEECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCH
T ss_pred             CCceeecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhccc
Confidence            3334445556667999999999999999999887        4889999998733         3467899999999999


Q ss_pred             CceE---------------EEEEEecCCCceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 027788           87 NIIS---------------LHYVWRDEDRNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEP  149 (219)
Q Consensus        87 ~i~~---------------~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~  149 (219)
                      |+++               +++++.. +...++++||++ +++|.+++...  ..+++..+..++.|++.||.|||+++ 
T Consensus       103 niv~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-  179 (352)
T 2jii_A          103 LQVNKWKKLYSTPLLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE-  179 (352)
T ss_dssp             HHHHHHHHHTTCTTCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             chhhhhhhhccCCccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence            9887               4555543 346788999999 89999999875  67999999999999999999999999 


Q ss_pred             CeeeeCCCCCceEEeCCCC--cEEEeccccceeccccce-------------eeeecccCccccCCCccccccceeeecc
Q 027788          150 CVIHRDLNCSNVFVNGNTG--QVKIGDLGVAAIVGRAIR-------------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       150 ~i~h~dl~~~nili~~~~~--~~~l~dfg~a~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                       ++||||||+||+++.+ +  .++|+|||+++.+.....             ++..+.+| +......++.++||||||+
T Consensus       180 -ivH~Dikp~NIl~~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG~  256 (352)
T 2jii_A          180 -YVHGNVTAENIFVDPE-DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISM-DLHKGCGPSRRSDLQSLGY  256 (352)
T ss_dssp             -CBCSCCCGGGEEEETT-EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCH-HHHTTCCCCHHHHHHHHHH
T ss_pred             -ccCCCCCHHHEEEcCC-CCceEEEecCcceeeccCCCccccccccccccccCCccccCH-HHHccCCCCchhhHHHHHH
Confidence             9999999999999865 4  799999999987755432             11112222 3344556788899999993

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.97  E-value=2.2e-32  Score=217.00  Aligned_cols=185  Identities=21%  Similarity=0.407  Sum_probs=129.3

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      ....+.|++.+.||+|+||.||+|.+..+++.||+|.+.....   ....+.+.+|+.++++++||||+++++++...  
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--   85 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK--   85 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESS--
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEeec--
Confidence            3444455888999999999999999988999999998875432   23456788999999999999999999999654  


Q ss_pred             ceEEEEeccccCCChHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEE
Q 027788          101 NTLNFITEVCTSGNLREYRKK--------HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKI  172 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~--------~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l  172 (219)
                      +..+++||++++++|.+++..        ...+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+ +.++|
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~-~~~kl  162 (303)
T 2vwi_A           86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGED-GSVQI  162 (303)
T ss_dssp             SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTT-CCEEE
T ss_pred             CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCC-CCEEE
Confidence            457889999999999998763        345899999999999999999999999  9999999999999866 58999


Q ss_pred             eccccceeccccce-----------eeeecccCccccCCCccccccceeeec
Q 027788          173 GDLGVAAIVGRAIR-----------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       173 ~dfg~a~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +|||++........           ++..+.+|+.......++.++|+||+|
T Consensus       163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG  214 (303)
T 2vwi_A          163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG  214 (303)
T ss_dssp             CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHH
T ss_pred             EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHH
Confidence            99999876643221           111233333222224567789999999

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.97  E-value=5.3e-31  Score=216.43  Aligned_cols=180  Identities=27%  Similarity=0.401  Sum_probs=143.6

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC--------CCCceEEEEEE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA--------NKNIISLHYVW   95 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------~~~i~~~~~~~   95 (219)
                      ++| ++.++||+|+||.||+|.+..+++.||+|+++.     .....+.+.+|+.+++.++        |+||+++++.+
T Consensus        37 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           37 GRY-HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-----AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             CeE-EEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-----CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            455 888999999999999999999999999999873     3445677889999999996        77899999988


Q ss_pred             ecC--CCceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeCCCCCceEEeCCC---
Q 027788           96 RDE--DRNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTH-EPCVIHRDLNCSNVFVNGNT---  167 (219)
Q Consensus        96 ~~~--~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~-~~~i~h~dl~~~nili~~~~---  167 (219)
                      ...  +...++++||++. +++.+.+...  ..+++..+..++.|++.||.|||++ +  ++||||||+||+++.+.   
T Consensus       111 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          111 KISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHH
T ss_pred             eecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhh
Confidence            532  4567899999995 5665555433  4699999999999999999999998 9  99999999999998542   


Q ss_pred             ---------------------------------------------CcEEEeccccceeccccce---eeeecccCccccC
Q 027788          168 ---------------------------------------------GQVKIGDLGVAAIVGRAIR---RIRCWGRRSSWRR  199 (219)
Q Consensus       168 ---------------------------------------------~~~~l~dfg~a~~~~~~~~---~~~~~~~~~~~~~  199 (219)
                                                                   ..++|+|||++........   ++..+.+| +...
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aP-E~~~  266 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSL-EVLI  266 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCH-HHHH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCC-hhhc
Confidence                                                         2699999999987754432   22233333 3334


Q ss_pred             CCccccccceeeec
Q 027788          200 SCTMRITRSLWTYT  213 (219)
Q Consensus       200 ~~~~~~~~diws~g  213 (219)
                      ...++.++||||+|
T Consensus       267 ~~~~~~~~DiwslG  280 (397)
T 1wak_A          267 GSGYNTPADIWSTA  280 (397)
T ss_dssp             TSCCCTHHHHHHHH
T ss_pred             CCCCCcHHHHHHHH
Confidence            45588899999999

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.97  E-value=6.9e-31  Score=209.04  Aligned_cols=178  Identities=17%  Similarity=0.274  Sum_probs=143.1

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      ..++.||+|+||.||+|..  ++..||+|.+............+.+.+|+.+++.++||||+++++++..  ....+++|
T Consensus        34 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~  109 (307)
T 2nru_A           34 VGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD--GDDLCLVY  109 (307)
T ss_dssp             TTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEE
T ss_pred             ccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec--CCceEEEE
Confidence            4558899999999999985  5789999998754433344556789999999999999999999999954  44578899


Q ss_pred             ccccCCChHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          108 EVCTSGNLREYRKK---HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       108 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      |++++++|.+++..   ...+++..+..++.|++.||.|||+.+  ++|+||||+||+++.+ +.++|+|||++......
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~  186 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEA-FTAKISDFGLARASEKF  186 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECCSC
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCC-CcEEEeecccccccccc
Confidence            99999999998763   346899999999999999999999999  9999999999999865 58999999999876543


Q ss_pred             ce--------eeeecccCccccCCCccccccceeeecc
Q 027788          185 IR--------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       185 ~~--------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ..        ++..+.+|+.+ . ..++.++|+||+|+
T Consensus       187 ~~~~~~~~~~g~~~y~aPE~~-~-~~~~~~~Dv~slG~  222 (307)
T 2nru_A          187 AQTVMTSRIVGTTAYMAPEAL-R-GEITPKSDIYSFGV  222 (307)
T ss_dssp             SSCEECSSCCSCGGGCCHHHH-T-TEECTHHHHHHHHH
T ss_pred             cccccccccCCCcCcCChHHh-c-CCCCccchhHHHHH
Confidence            21        12223333322 2 34677899999993

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.97  E-value=5.7e-31  Score=219.09  Aligned_cols=179  Identities=22%  Similarity=0.348  Sum_probs=143.7

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh------CCCCceEEEEEEec
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL------ANKNIISLHYVWRD   97 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l------~~~~i~~~~~~~~~   97 (219)
                      ...|++.+.||+|+||.||+|.+..+++.||+|+++.     .......+..|+.+++.+      +|+||+++++.+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-----ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            3335888999999999999999999999999999873     234456677899998887      56799999999865


Q ss_pred             CCCceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCc--EEEe
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQ--VKIG  173 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~--~~l~  173 (219)
                      .  ..++++||+++ ++|.+++...  ..+++..+..++.|++.||.|||+.+  ++||||||+||+++.+ +.  +||+
T Consensus       171 ~--~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~-~~~~vkL~  244 (429)
T 3kvw_A          171 R--NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQ-GRSGIKVI  244 (429)
T ss_dssp             T--TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESST-TSCCEEEC
T ss_pred             C--CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccC-CCcceEEe
Confidence            4  56889999996 6888887654  35899999999999999999999999  9999999999999865 34  9999


Q ss_pred             ccccceeccccce---eeeecccCccccCCCccccccceeeecc
Q 027788          174 DLGVAAIVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       174 dfg~a~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      |||++........   ++..+.+| +......++.++||||+|+
T Consensus       245 DFG~a~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwSlG~  287 (429)
T 3kvw_A          245 DFGSSCYEHQRVYTYIQSRFYRAP-EVILGARYGMPIDMWSLGC  287 (429)
T ss_dssp             CCTTCEETTCCCCSSCSCGGGCCH-HHHHTBCCCTHHHHHHHHH
T ss_pred             ecccceecCCcccccCCCCCccCh-HHHhCCCCCchHHHHhHHH
Confidence            9999976544322   22223333 3334556788999999993

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.97  E-value=5.9e-32  Score=215.77  Aligned_cols=187  Identities=17%  Similarity=0.234  Sum_probs=140.7

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCC--HHHHHHHHHHHHHHHhh----CCCCceEEEEEEe
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD--PAMIERLFSEVRLLKTL----ANKNIISLHYVWR   96 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l----~~~~i~~~~~~~~   96 (219)
                      ..+.|++.+.||+|+||.||+|.+..+++.||+|.++.......  ......+.+|+.++.++    +|+||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            34445888999999999999999999999999999875432211  11223456799999999    8999999999985


Q ss_pred             cCCCceEEEEecc-ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788           97 DEDRNTLNFITEV-CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus        97 ~~~~~~~~lv~e~-~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      ..  ...++++|+ +++++|.+++.....+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+.+.++|+||
T Consensus       109 ~~--~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~df  184 (312)
T 2iwi_A          109 TQ--EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDF  184 (312)
T ss_dssp             ------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECCC
T ss_pred             cC--CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEEc
Confidence            44  456779998 788999999987778999999999999999999999999  9999999999999844468999999


Q ss_pred             ccceeccccce----eeeecccCccccCCCccccccceeeec
Q 027788          176 GVAAIVGRAIR----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       176 g~a~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |++........    ++..+.+|+.+........++|+||+|
T Consensus       185 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG  226 (312)
T 2iwi_A          185 GSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLG  226 (312)
T ss_dssp             SSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHH
T ss_pred             chhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHH
Confidence            99987755432    112223333222233334479999999

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.97  E-value=5.8e-32  Score=223.44  Aligned_cols=179  Identities=24%  Similarity=0.356  Sum_probs=133.1

Q ss_pred             eee-eeeeccccceEEEEEEec--CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           27 GRY-NELLGSGAVKKVYRAFDQ--EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        27 ~~~-~~~ig~g~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      |.+ +++||+|+||.||+|.+.  .++..||+|.++....      ...+.+|+.++++++||||+++++++..+....+
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            344 568999999999999955  5788999999874321      1457789999999999999999999987777889


Q ss_pred             EEEeccccCCChHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEe---CCCCcEE
Q 027788          104 NFITEVCTSGNLREYRKKH---------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN---GNTGQVK  171 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~---------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~---~~~~~~~  171 (219)
                      +++|||++ ++|.+++...         ..+++..+..++.|++.||.|||+.+  ++||||||+||++.   .+.+.+|
T Consensus        96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEE
Confidence            99999996 5777765421         14899999999999999999999999  99999999999993   2336899


Q ss_pred             Eeccccceeccccce---------eeeecccCccccCCCccccccceeeecc
Q 027788          172 IGDLGVAAIVGRAIR---------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       172 l~dfg~a~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      |+|||++........         ++..+.+|+.+.....++.++||||+|+
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~  224 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC  224 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHH
Confidence            999999987654321         2223444444444456888899999993

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2e-31  Score=218.04  Aligned_cols=186  Identities=20%  Similarity=0.349  Sum_probs=139.1

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCC---CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEe
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEE---GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWR   96 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   96 (219)
                      +++....+++.+.||+|+||.||+|....+   +..||+|.++..   .+....+.+.+|+.++++++||||+++++++.
T Consensus        84 i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~  160 (373)
T 3c1x_A           84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL  160 (373)
T ss_dssp             CCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC
T ss_pred             cChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            344455568889999999999999986543   246889987642   24456688999999999999999999999875


Q ss_pred             cCCCceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788           97 DEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus        97 ~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      .. ....+++|||+++++|.+++... ..+++..+..++.|++.|+.|||+++  ++||||||+||+++.+ +.+||+||
T Consensus       161 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~-~~~kL~DF  236 (373)
T 3c1x_A          161 RS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADF  236 (373)
T ss_dssp             CC-SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC
T ss_pred             cC-CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCC-CCEEEeec
Confidence            43 34567899999999999998754 45889999999999999999999999  9999999999999865 58999999


Q ss_pred             ccceecccccee-----ee-----ecccCccccCCCccccccceeeec
Q 027788          176 GVAAIVGRAIRR-----IR-----CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       176 g~a~~~~~~~~~-----~~-----~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |+++........     ..     .+.+| +......++.++|+||+|
T Consensus       237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~DvwSlG  283 (373)
T 3c1x_A          237 GLARDMYDKEFDSVHNKTGAKLPVKWMAL-ESLQTQKFTTKSDVWSFG  283 (373)
T ss_dssp             ---------------------CCGGGSCH-HHHHHCCCCHHHHHHHHH
T ss_pred             cccccccccccccccccCCCCCcccccCh-HHhcCCCCCcHHHHHHHH
Confidence            999866443211     11     12232 233345677889999999

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.97  E-value=5.2e-32  Score=217.34  Aligned_cols=183  Identities=17%  Similarity=0.254  Sum_probs=143.2

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      .....|.+.+.||+|+||.||+|.. .++..||+|.++.....   .....+.+|+.+++.++||||+++++++...  .
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~  100 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ---GGELQFQTEVEMISMAVHRNLLRLRGFCMTP--T  100 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS--S
T ss_pred             HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc---hHHHHHHHHHHHHHhccCCCccceEEEEecC--C
Confidence            4444458889999999999999974 56899999998754321   1123578899999999999999999999544  4


Q ss_pred             eEEEEeccccCCChHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCeeeeCCCCCceEEeCCCCcEEEec
Q 027788          102 TLNFITEVCTSGNLREYRKKHR----HVSVKALKKWSKQILKGLNYLHTH---EPCVIHRDLNCSNVFVNGNTGQVKIGD  174 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qv~~~l~~lh~~---~~~i~h~dl~~~nili~~~~~~~~l~d  174 (219)
                      ..+++|||+++++|.+++....    .+++..+..++.|++.|+.|||+.   +  ++|+||||+||+++.+ +.++|+|
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~-~~~kl~D  177 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEE-FEAVVGD  177 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTT-CCEEECC
T ss_pred             ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCC-CCEEecc
Confidence            5678999999999999887542    489999999999999999999999   8  9999999999999865 5899999


Q ss_pred             cccceeccccce-------eeeecccCccccCCCccccccceeeecc
Q 027788          175 LGVAAIVGRAIR-------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       175 fg~a~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ||++........       ++..+.+| +......++.++||||+|+
T Consensus       178 fg~~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG~  223 (326)
T 3uim_A          178 FGLAKLMDYKDTHVTTAVRGTIGHIAP-EYLSTGKSSEKTDVFGYGV  223 (326)
T ss_dssp             CSSCEECCSSSSCEECCCCSCGGGCCH-HHHHHSEECHHHHHHHHHH
T ss_pred             CccccccCcccccccccccCCcCccCH-HHhccCCCCccccchhHHH
Confidence            999987654332       11122222 2333445777899999993

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.97  E-value=4.6e-31  Score=214.24  Aligned_cols=182  Identities=25%  Similarity=0.355  Sum_probs=144.7

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC---
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR---  100 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~---  100 (219)
                      ++| .+.+.||+|+||.||+|.+..+|+.||+|.+....  ......+.+.+|+.+++.++||||+++++++...+.   
T Consensus        24 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  100 (353)
T 3coi_A           24 KTY-VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  100 (353)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             ceE-EEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence            455 78899999999999999999999999999987543  245556788999999999999999999999865432   


Q ss_pred             -ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          101 -NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       101 -~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                       ..++++||+++ ++|.+++..  .+++..+..++.|++.||.|||+++  ++|+||||+||+++.+ +.++|+|||++.
T Consensus       101 ~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~  174 (353)
T 3coi_A          101 FYDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGLAR  174 (353)
T ss_dssp             CCCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTT-CCEEECSTTCTT
T ss_pred             ceeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCC-CcEEEeeccccc
Confidence             13588999997 688776543  5899999999999999999999999  9999999999999866 589999999998


Q ss_pred             eccccce---eeeecccCccccCCCccccccceeeecc
Q 027788          180 IVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .......   ++..+.+|+.......++.++|+||+|+
T Consensus       175 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~  212 (353)
T 3coi_A          175 HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGC  212 (353)
T ss_dssp             C--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHH
T ss_pred             CCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHH
Confidence            7644322   2223334443444466788899999993

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.97  E-value=4e-31  Score=209.19  Aligned_cols=181  Identities=20%  Similarity=0.233  Sum_probs=143.3

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ..++| ++.+.||+|+||.||+|.+..+++.||+|++.....      .+.+.+|+.+++.++|++++..+..+.. ...
T Consensus         7 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~   78 (296)
T 3uzp_A            7 VGNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGA-EGD   78 (296)
T ss_dssp             ETTTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CCHHHHHHHHHHHHTTSTTCCCEEEEEE-ETT
T ss_pred             eccEE-EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hhHHHHHHHHHHHhhcCCCCCccccccC-CCC
Confidence            34556 888999999999999999999999999999875432      1347789999999999887766655543 345


Q ss_pred             eEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEe--CCCCcEEEeccccc
Q 027788          102 TLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN--GNTGQVKIGDLGVA  178 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~--~~~~~~~l~dfg~a  178 (219)
                      ..+++||++ +++|.+++.. ...+++..+..++.|++.|+.|||+++  ++|+||||+||+++  .+.+.++|+|||++
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  155 (296)
T 3uzp_A           79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             ceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence            678999999 8899998873 457999999999999999999999999  99999999999994  23358999999999


Q ss_pred             eeccccce-------------eeeecccCccccCCCccccccceeeecc
Q 027788          179 AIVGRAIR-------------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       179 ~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ........             ++..+.+| +......++.++||||+|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG~  203 (296)
T 3uzp_A          156 KKYRDARTHQHIPYRENKNLTGTARYASI-NTHLGIEQSRRDDLESLGY  203 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCTTTCCH-HHHTTCCCCHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCCh-hhhcCCCCCcchhhHHHHH
Confidence            87755432             11112222 3344555778899999993

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.97  E-value=4.7e-31  Score=228.35  Aligned_cols=180  Identities=22%  Similarity=0.351  Sum_probs=141.8

Q ss_pred             CceeeeeeeeccccceEEEEEEec--CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQ--EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      .+++.....||+|+||.||+|...  .++..||+|.++...   .....+.+.+|+.++++++||||+++++++..+   
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---  408 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---  408 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC---SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS---
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC---
Confidence            344334348999999999999765  456679999987543   233457789999999999999999999998643   


Q ss_pred             eEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          102 TLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      .++++|||+++|+|.+++... ..+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+++.
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~-~~vkL~DFGla~~  485 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNR-HYAKISDFGLSKA  485 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCCSTTTT
T ss_pred             CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCC-CcEEEeeccCccc
Confidence            378999999999999988654 45899999999999999999999999  9999999999999866 5899999999987


Q ss_pred             ccccceee---------eecccCccccCCCccccccceeeec
Q 027788          181 VGRAIRRI---------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ........         ..+.+| +......++.++||||||
T Consensus       486 ~~~~~~~~~~~~~~~~~~~y~AP-E~~~~~~~~~~sDvwSlG  526 (613)
T 2ozo_A          486 LGADDSYYTARSAGKWPLKWYAP-ECINFRKFSSRSDVWSYG  526 (613)
T ss_dssp             CC--------------CCTTSCH-HHHHHCCCCHHHHHHHHH
T ss_pred             ccCCCceeeeccCCCCccceeCH-hhhcCCCCCcHHHHHHHH
Confidence            65432210         113333 233445678889999999

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.97  E-value=7.2e-31  Score=209.37  Aligned_cols=175  Identities=21%  Similarity=0.293  Sum_probs=135.8

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      +.+++.+.||+|+||.||+|...  ++.||+|.+..      ....+.+.+|+.++++++||||+++++++.  +.  .+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~--~~   75 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES------ESERKAFIVELRQLSRVNHPNIVKLYGACL--NP--VC   75 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TT--TE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CC--cE
Confidence            34488899999999999999864  78899998762      234577889999999999999999999874  22  57


Q ss_pred             EEeccccCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          105 FITEVCTSGNLREYRKKHR---HVSVKALKKWSKQILKGLNYLHT---HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qv~~~l~~lh~---~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      ++|||+++++|.+++....   .++...+..++.|++.|+.|||+   ++  ++|+||||+||+++.+...+||+|||++
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~  153 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTA  153 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcccccc
Confidence            8999999999999987654   37889999999999999999999   67  9999999999999866434799999999


Q ss_pred             eeccccce---eeeecccCccccCCCccccccceeeecc
Q 027788          179 AIVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       179 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ........   ++..+.+| +......++.++||||+|+
T Consensus       154 ~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG~  191 (307)
T 2eva_A          154 CDIQTHMTNNKGSAAWMAP-EVFEGSNYSEKCDVFSWGI  191 (307)
T ss_dssp             -----------CCTTSSCH-HHHTCCCCCTHHHHHHHHH
T ss_pred             cccccccccCCCCCceECh-hhhCCCCCCcHHHHHHHHH
Confidence            76644322   22223333 3445566788899999993

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.97  E-value=2.6e-31  Score=213.49  Aligned_cols=183  Identities=19%  Similarity=0.256  Sum_probs=139.9

Q ss_pred             CCceeeeeeeeccccceEEEEEE-----ecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAF-----DQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~-----~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      ..+.|++.+.||+|+||.||+|.     +..++..||+|.+....   .......+.+|+.++++++||||+++++++..
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc---chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            34445888999999999999998     55678899999986332   44556778899999999999999999999854


Q ss_pred             CCCceEEEEeccccCCChHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC--CC
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKH-------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN--TG  168 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~-------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~--~~  168 (219)
                      .  ...+++||++++++|.+++...       ..+++..+..++.|++.|+.|||+.+  ++|+||||+||+++.+  ..
T Consensus       105 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          105 S--LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             S--SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTC
T ss_pred             C--CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcc
Confidence            3  4568899999999999998764       24889999999999999999999999  9999999999999832  23


Q ss_pred             cEEEeccccceeccccce--------eeeecccCccccCCCccccccceeeec
Q 027788          169 QVKIGDLGVAAIVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       169 ~~~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .++|+|||++........        .+..+.+| +......++.++|+||+|
T Consensus       181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  232 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP-EAFMEGIFTSKTDTWSFG  232 (327)
T ss_dssp             CEEECCCHHHHHHHC------CCGGGSCGGGCCH-HHHHHCCCCHHHHHHHHH
T ss_pred             eEEECccccccccccccccccCCCcCCCcceeCH-hHhcCCCCCchhhHHHHH
Confidence            699999999975533221        11123333 333345577889999999

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.97  E-value=6.8e-31  Score=207.76  Aligned_cols=180  Identities=21%  Similarity=0.238  Sum_probs=140.2

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ..++| ++.+.||+|+||.||+|.+..+++.||+|++......      ..+..|+.+++.++|++++..+..+.. ...
T Consensus         7 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~   78 (296)
T 4hgt_A            7 VGNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGA-EGD   78 (296)
T ss_dssp             ----C-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C------CCHHHHHHHHHHHTTSTTCCCEEEEEE-ETT
T ss_pred             cCCce-EEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc------hHHHHHHHHHHHhcCCCCCCeeeeecC-CCC
Confidence            44555 8889999999999999999999999999987654322      346789999999999887776666543 346


Q ss_pred             eEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEE---eCCCCcEEEecccc
Q 027788          102 TLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDLGV  177 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili---~~~~~~~~l~dfg~  177 (219)
                      ..+++||++ +++|.+++.. ...+++..+..++.|++.|+.|||+++  ++|+||||+||++   +.+ +.++|+|||+
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~-~~~kL~Dfg~  154 (296)
T 4hgt_A           79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKG-NLVYIIDFGL  154 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGT-TCEEECCCTT
T ss_pred             ceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCC-CeEEEecCcc
Confidence            678999999 8899998874 457999999999999999999999999  9999999999999   544 5899999999


Q ss_pred             ceeccccce-------------eeeecccCccccCCCccccccceeeecc
Q 027788          178 AAIVGRAIR-------------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +........             ++..+.+| +......++.++||||+|+
T Consensus       155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG~  203 (296)
T 4hgt_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASI-NTHLGIEQSRRDDLESLGY  203 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCGGGCCH-HHHTTCCCCHHHHHHHHHH
T ss_pred             ceeccCcccCccCCCCcccccCCCccccch-HHhcCCCCCchhHHHHHHH
Confidence            987755432             11122222 3334556778899999993

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.97  E-value=1.3e-31  Score=210.52  Aligned_cols=178  Identities=21%  Similarity=0.346  Sum_probs=136.3

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      ..+.|++.+.||+|+||.||+|.+  ++..||+|.++..      ...+.+.+|+.++++++||||+++++++..+ ...
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~   89 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGG   89 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---C
T ss_pred             ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch------hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCc
Confidence            344458889999999999999976  4789999998733      2346788999999999999999999987543 345


Q ss_pred             EEEEeccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          103 LNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      ++++||++++++|.+++....  .+++..+..++.|++.++.+||+++  ++|+||||+||+++.+ +.++|+|||++..
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~  166 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKE  166 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-SCEEECCCCC---
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCC-CcEEEeecccccc
Confidence            788999999999999886543  3789999999999999999999999  9999999999999865 5899999999986


Q ss_pred             ccccce---eeeecccCccccCCCccccccceeeec
Q 027788          181 VGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ......   .+..+.+| +......++.++|+||+|
T Consensus       167 ~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  201 (278)
T 1byg_A          167 ASSTQDTGKLPVKWTAP-EALREKKFSTKSDVWSFG  201 (278)
T ss_dssp             ---------CCTTTSCH-HHHHHCCCCHHHHHHHHH
T ss_pred             ccccccCCCccccccCH-HHhCCCCCCchhcHHHHH
Confidence            654332   11112233 333345577789999999

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=4.7e-31  Score=205.87  Aligned_cols=177  Identities=20%  Similarity=0.303  Sum_probs=143.3

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      ..|++.+.||+|+||.||+|.+. ++..||+|.++....     ..+.+.+|+.+++.++||||+++++++..  ...++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~   79 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPIC   79 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSCE
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCeE
Confidence            44588899999999999999975 678899999875432     12568899999999999999999999954  44578


Q ss_pred             EEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          105 FITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      ++||++++++|.+++... ..+++..+..++.|++.|+.+||+.+  ++|+||+|+||+++.+ +.++|+|||++.....
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGG-GCEEECCTTGGGGBCC
T ss_pred             EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCC-CCEEEccccccccccc
Confidence            899999999999988764 46899999999999999999999999  9999999999999865 5899999999987644


Q ss_pred             cce-------eeeecccCccccCCCccccccceeeec
Q 027788          184 AIR-------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~-------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...       .+..+.+| +......++.++|+||+|
T Consensus       157 ~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  192 (267)
T 3t9t_A          157 DQYTSSTGTKFPVKWASP-EVFSFSRYSSKSDVWSFG  192 (267)
T ss_dssp             HHHHSTTSTTCCGGGCCH-HHHHHCCCCHHHHHHHHH
T ss_pred             ccccccccccccccccCh-hhhcCCCccchhchhhhH
Confidence            321       11112232 333345567789999999

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.97  E-value=3.6e-31  Score=221.69  Aligned_cols=180  Identities=22%  Similarity=0.353  Sum_probs=141.0

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      ....+.+++.+.||+|+||.||+|.+.. +..||+|.++....     ..+.+.+|+.++++++||||+++++++..   
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---  250 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---  250 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC---
Confidence            3444556899999999999999999764 46799999875431     23678899999999999999999999854   


Q ss_pred             ceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          101 NTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      ..++++|||+++|+|.+++...  ..+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||++
T Consensus       251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~-~~~kl~DfG~a  327 (452)
T 1fmk_A          251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLA  327 (452)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCTT
T ss_pred             CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCC-CCEEECCCccc
Confidence            3478899999999999998642  46899999999999999999999999  9999999999999865 58999999999


Q ss_pred             eecccccee-------eeecccCccccCCCccccccceeeec
Q 027788          179 AIVGRAIRR-------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       179 ~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +........       +..+.+|+ ......++.++||||||
T Consensus       328 ~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~sDvwslG  368 (452)
T 1fmk_A          328 RLIEDNEYTARQGAKFPIKWTAPE-AALYGRFTIKSDVWSFG  368 (452)
T ss_dssp             C--------------CCGGGSCHH-HHHHCCCCHHHHHHHHH
T ss_pred             eecCCCceecccCCcccccccCHh-HHhcCCCCccccHHhHH
Confidence            876543211       11233333 23344578889999999

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.97  E-value=4.7e-31  Score=207.30  Aligned_cols=179  Identities=23%  Similarity=0.407  Sum_probs=142.8

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ...+.|++.+.||+|+||.||+|.+. ++..||+|.++....     ..+.+.+|+.+++.++||||+++++++..+   
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---   80 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVTQE---   80 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc-----cHHHHHHHHHHHHhCCCcCcceEEEEEcCC---
Confidence            33444588899999999999999864 567899999874321     236788999999999999999999988532   


Q ss_pred             eEEEEeccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          102 TLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      ..+++||++++++|.+++....  .+++..+..++.|++.|+.+||+.+  ++|+||||+||+++.+ +.++|+|||++.
T Consensus        81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~-~~~kl~Dfg~~~  157 (279)
T 1qpc_A           81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT-LSCKIADFGLAR  157 (279)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred             CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCC-CCEEECCCcccc
Confidence            3678999999999999886432  6899999999999999999999999  9999999999999855 589999999998


Q ss_pred             eccccceeee-------ecccCccccCCCccccccceeeec
Q 027788          180 IVGRAIRRIR-------CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       180 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ..........       .+.+| +......++.++|+||+|
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  197 (279)
T 1qpc_A          158 LIEDNEYTAREGAKFPIKWTAP-EAINYGTFTIKSDVWSFG  197 (279)
T ss_dssp             ECSSSCEECCTTCCCCTTTSCH-HHHHHCEECHHHHHHHHH
T ss_pred             cccCcccccccCCCCccCccCh-hhhccCCCCchhhhHHHH
Confidence            7755432111       12222 333345567789999999

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.97  E-value=2.1e-31  Score=215.51  Aligned_cols=182  Identities=15%  Similarity=0.283  Sum_probs=147.0

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCH-------------HHHHHHHHHHHHHHhhCCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDP-------------AMIERLFSEVRLLKTLANKNIIS   90 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~-------------~~~~~~~~E~~~l~~l~~~~i~~   90 (219)
                      ++| ++.+.||+|+||.||+|.+  +++.||+|.+.........             ...+.+.+|+.++++++||||++
T Consensus        31 ~~y-~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           31 NDY-RIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             TTE-EEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             Cce-EEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            445 8889999999999999998  8999999998865432111             11267889999999999999999


Q ss_pred             EEEEEecCCCceEEEEeccccCCChHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeCCCCCce
Q 027788           91 LHYVWRDEDRNTLNFITEVCTSGNLREY------RKK--HRHVSVKALKKWSKQILKGLNYLHT-HEPCVIHRDLNCSNV  161 (219)
Q Consensus        91 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~------~~~--~~~~~~~~~~~i~~qv~~~l~~lh~-~~~~i~h~dl~~~ni  161 (219)
                      +++++...  +.++++|||+++++|.++      +..  ...+++..+..++.|++.|+.|||+ .+  ++|+||+|+||
T Consensus       108 ~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Ni  183 (348)
T 2pml_X          108 CEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNI  183 (348)
T ss_dssp             CSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGE
T ss_pred             EEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhE
Confidence            99998554  568899999999999987      554  4678999999999999999999999 89  99999999999


Q ss_pred             EEeCCCCcEEEeccccceeccccce----eeeecccCccccCCCcccc-ccceeeec
Q 027788          162 FVNGNTGQVKIGDLGVAAIVGRAIR----RIRCWGRRSSWRRSCTMRI-TRSLWTYT  213 (219)
Q Consensus       162 li~~~~~~~~l~dfg~a~~~~~~~~----~~~~~~~~~~~~~~~~~~~-~~diws~g  213 (219)
                      +++.+ +.++|+|||++........    ++..+.+|+.......+.. ++|+||+|
T Consensus       184 l~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG  239 (348)
T 2pml_X          184 LMDKN-GRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLG  239 (348)
T ss_dssp             EECTT-SCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHH
T ss_pred             EEcCC-CcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHH
Confidence            99866 5899999999987654321    2333444544444435655 79999999

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.97  E-value=1.9e-30  Score=207.20  Aligned_cols=187  Identities=20%  Similarity=0.323  Sum_probs=147.8

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC--CCCceEEEEEE
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA--NKNIISLHYVW   95 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--~~~i~~~~~~~   95 (219)
                      ......++.|++.+.||+|+||.||+|.+. ++..||+|.+.....  .....+.+.+|+.++++++  |+||+++++++
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc--cccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            455566777799999999999999999975 588999999875532  4566788999999999998  49999999988


Q ss_pred             ecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788           96 RDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus        96 ~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      ..  ...++++|| +.+++|.+++.....+++..+..++.|++.||.|||+++  ++|+||||+||+++ + +.++|+||
T Consensus        98 ~~--~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~-~~~kL~Df  170 (313)
T 3cek_A           98 IT--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-D-GMLKLIDF  170 (313)
T ss_dssp             EC--SSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-T-TEEEECCC
T ss_pred             ec--CCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEE-C-CeEEEeec
Confidence            54  456889999 557899999988788999999999999999999999999  99999999999997 4 58999999


Q ss_pred             ccceeccccce--------eeeecccCccccC----------CCccccccceeeecc
Q 027788          176 GVAAIVGRAIR--------RIRCWGRRSSWRR----------SCTMRITRSLWTYTR  214 (219)
Q Consensus       176 g~a~~~~~~~~--------~~~~~~~~~~~~~----------~~~~~~~~diws~gi  214 (219)
                      |++........        ++..+.+|+.+..          ...++.++|+||+|+
T Consensus       171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~  227 (313)
T 3cek_A          171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC  227 (313)
T ss_dssp             SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHH
T ss_pred             cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHH
Confidence            99987654322        2223334433221          245677899999993

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.97  E-value=2.2e-30  Score=208.31  Aligned_cols=182  Identities=20%  Similarity=0.274  Sum_probs=144.8

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEe-cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCC------ceEEEE
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFD-QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN------IISLHY   93 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~------i~~~~~   93 (219)
                      +.....|++.+.||+|+||.||+|.+ ..+++.||+|+++.     .....+.+.+|+.+++.++|++      ++++++
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~   84 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-----VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE   84 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec-----CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence            33334448889999999999999998 56789999999863     2445577889999999998765      899999


Q ss_pred             EEecCCCceEEEEeccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC-----
Q 027788           94 VWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN-----  166 (219)
Q Consensus        94 ~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~-----  166 (219)
                      ++...  ..++++||++ +++|.+++....  .+++..+..++.|++.||.|||+++  ++|+||||+||+++.+     
T Consensus        85 ~~~~~--~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~  159 (339)
T 1z57_A           85 WFEHH--GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEA  159 (339)
T ss_dssp             EEEET--TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEE
T ss_pred             ccccC--CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccc
Confidence            88544  5688999999 789998887654  6889999999999999999999999  9999999999999752     


Q ss_pred             -------------CCcEEEeccccceeccccce---eeeecccCccccCCCccccccceeeec
Q 027788          167 -------------TGQVKIGDLGVAAIVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       167 -------------~~~~~l~dfg~a~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                                   .+.++|+|||++........   ++..+.+| +......++.++|+||+|
T Consensus       160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG  221 (339)
T 1z57_A          160 YNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAP-EVILALGWSQPCDVWSIG  221 (339)
T ss_dssp             EC----CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCH-HHHTTSCCCTHHHHHHHH
T ss_pred             cCCccccccccccCCCceEeeCcccccCccccccccCCccccCh-HHhhCCCCCcchhhHHHH
Confidence                         34799999999987654322   22223333 334455678889999999

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=5.1e-31  Score=230.81  Aligned_cols=179  Identities=19%  Similarity=0.304  Sum_probs=142.8

Q ss_pred             CceeeeeeeeccccceEEEEEEecC-CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC--
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQE-EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR--  100 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~--  100 (219)
                      ++| ++.+.||+|+||.||+|.+.. +++.||+|.+...   ........+.+|+.++++++||||+++++++...+.  
T Consensus        80 ~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           80 GQY-EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             TTE-EEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             Cce-EEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            445 888999999999999999876 7899999987643   245566788999999999999999999999865433  


Q ss_pred             -ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          101 -NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       101 -~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                       ...|+||||+++++|.+++..  .+++..+..++.|++.+|.|||+++  |+||||||+||+++.+  .+||+|||+++
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~--~~kl~DFG~a~  229 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE--QLKLIDLGAVS  229 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS--CEEECCCTTCE
T ss_pred             CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC--cEEEEecccch
Confidence             236899999999999887654  7999999999999999999999999  9999999999999854  79999999998


Q ss_pred             eccccce--eeeecccCccccCCCccccccceeeecc
Q 027788          180 IVGRAIR--RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .......  ++..+.+|+.+...  .+.++||||||+
T Consensus       230 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~  264 (681)
T 2pzi_A          230 RINSFGYLYGTPGFQAPEIVRTG--PTVATDIYTVGR  264 (681)
T ss_dssp             ETTCCSCCCCCTTTSCTTHHHHC--SCHHHHHHHHHH
T ss_pred             hcccCCccCCCccccCHHHHcCC--CCCceehhhhHH
Confidence            8765422  22334444433322  366799999993

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.97  E-value=2.5e-30  Score=208.75  Aligned_cols=184  Identities=17%  Similarity=0.261  Sum_probs=135.5

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec-
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD-   97 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-   97 (219)
                      .....++|..+.+.||+|+||.||+|.+..+++.||+|++...     ....+   .....++.++|||++++++++.. 
T Consensus        23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~   94 (336)
T 3fhr_A           23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQ---EVDHHWQASGGPHIVCILDVYENM   94 (336)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHH---HHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHH---HHHHHHHhcCCCChHHHHHHHhhc
Confidence            3445577754466799999999999999999999999998632     22212   22334567799999999998854 


Q ss_pred             -CCCceEEEEeccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC--CCcEEE
Q 027788           98 -EDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN--TGQVKI  172 (219)
Q Consensus        98 -~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~--~~~~~l  172 (219)
                       .+...++++|||+++++|.+++....  .+++..+..++.|++.|+.|||+++  ++|+||||+||+++.+  .+.++|
T Consensus        95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl  172 (336)
T 3fhr_A           95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKL  172 (336)
T ss_dssp             ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEE
T ss_pred             cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEE
Confidence             33456889999999999999987653  6899999999999999999999999  9999999999999743  245999


Q ss_pred             eccccceeccccce----eeeecccCccccCCCccccccceeeec
Q 027788          173 GDLGVAAIVGRAIR----RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       173 ~dfg~a~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +|||++........    ++..+.+| +......++.++|+||+|
T Consensus       173 ~Dfg~~~~~~~~~~~~~~~t~~y~aP-E~~~~~~~~~~~Di~slG  216 (336)
T 3fhr_A          173 TDFGFAKETTQNALQTPCYTPYYVAP-EVLGPEKYDKSCDMWSLG  216 (336)
T ss_dssp             CCCTTCEEC-----------------------CHHHHHHHHHHHH
T ss_pred             eccccceeccccccccCCCCcCccCh-hhhCCCCCCchhhHHHHH
Confidence            99999987654332    22223333 334555677789999999

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.97  E-value=5.1e-31  Score=212.72  Aligned_cols=177  Identities=24%  Similarity=0.326  Sum_probs=140.5

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHh--hCCCCceEEEEEEecCCC-
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKT--LANKNIISLHYVWRDEDR-  100 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~--l~~~~i~~~~~~~~~~~~-  100 (219)
                      .+.|++.+.||+|+||.||+|.+  +++.||+|.++...       ...+.+|+++++.  ++||||+++++++...+. 
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG-------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh-------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            34458889999999999999986  58899999986331       2557788888887  789999999999876543 


Q ss_pred             -ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCeeeeCCCCCceEEeCCCCcEE
Q 027788          101 -NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLH--------THEPCVIHRDLNCSNVFVNGNTGQVK  171 (219)
Q Consensus       101 -~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh--------~~~~~i~h~dl~~~nili~~~~~~~~  171 (219)
                       ..++++||++++++|.+++... .+++..+..++.|++.|+.|||        +.+  ++|+||||+||+++.+ +.++
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~~~-~~~k  187 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVKKN-GTCC  187 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEECTT-SCEE
T ss_pred             cceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEECCC-CCEE
Confidence             2688999999999999998764 6899999999999999999999        778  9999999999999866 5899


Q ss_pred             Eeccccceeccccce----------eeeecccCccccCCC-----ccccccceeeec
Q 027788          172 IGDLGVAAIVGRAIR----------RIRCWGRRSSWRRSC-----TMRITRSLWTYT  213 (219)
Q Consensus       172 l~dfg~a~~~~~~~~----------~~~~~~~~~~~~~~~-----~~~~~~diws~g  213 (219)
                      |+|||++........          ++..+.+|+.+....     .++.++|+||+|
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG  244 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG  244 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHH
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHH
Confidence            999999987655431          222233333332221     233579999999

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.97  E-value=3.8e-30  Score=206.67  Aligned_cols=186  Identities=18%  Similarity=0.269  Sum_probs=136.3

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHH-HHHhhCCCCceEEEEEEec
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVR-LLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~~~~~~~~   97 (219)
                      ..+.....|++.+.||+|+||.||+|.+..+++.||+|.++...   .......+..|+. +++.++||||+++++++..
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~   92 (327)
T 3aln_A           16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR   92 (327)
T ss_dssp             EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred             hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence            33444444588899999999999999999999999999987543   3344455666666 6778899999999999964


Q ss_pred             CCCceEEEEeccccCCChHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeCCCCCceEEeCCCCcEE
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKK-----HRHVSVKALKKWSKQILKGLNYLHTH-EPCVIHRDLNCSNVFVNGNTGQVK  171 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~-----~~~~~~~~~~~i~~qv~~~l~~lh~~-~~~i~h~dl~~~nili~~~~~~~~  171 (219)
                      +  +..+++||++++ +|.+++..     ...+++..+..++.|++.|+.+||+. +  ++|+||||+||+++.+ +.+|
T Consensus        93 ~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~-~~~k  166 (327)
T 3aln_A           93 E--GDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRS-GNIK  166 (327)
T ss_dssp             S--SEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETT-TEEE
T ss_pred             C--CceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCC-CCEE
Confidence            4  568889999974 77776642     46789999999999999999999998 9  9999999999999866 5899


Q ss_pred             Eeccccceeccccce-----eeeecccCcccc---CCCccccccceeeec
Q 027788          172 IGDLGVAAIVGRAIR-----RIRCWGRRSSWR---RSCTMRITRSLWTYT  213 (219)
Q Consensus       172 l~dfg~a~~~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~diws~g  213 (219)
                      |+|||++........     ++..+.+|+.+.   ....++.++|+||+|
T Consensus       167 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG  216 (327)
T 3aln_A          167 LCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLG  216 (327)
T ss_dssp             ECCCSSSCC------------------------------CCSHHHHHHHH
T ss_pred             EccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHH
Confidence            999999987654432     222344444332   345577889999999

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.97  E-value=5.6e-31  Score=207.87  Aligned_cols=183  Identities=25%  Similarity=0.410  Sum_probs=136.9

Q ss_pred             CCceeeeeeeeccccceEEEEEEecC-CCc--EEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQE-EGI--EVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      ..+.|++.+.||+|+||.||+|.+.. ++.  .||+|.++..... .....+.+.+|+.++++++||||+++++++..++
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence            34445888999999999999998543 333  6899998754332 3345688999999999999999999999986543


Q ss_pred             CceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          100 RNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                         .++++|++++++|.+++... ..+++..+..++.|++.|+.+||+++  ++|+||||+||+++.+ +.++|+|||++
T Consensus        95 ---~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~-~~~kl~Dfg~~  168 (291)
T 1u46_A           95 ---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR-DLVKIGDFGLM  168 (291)
T ss_dssp             ---CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCTTC
T ss_pred             ---ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCC-CCEEEcccccc
Confidence               67899999999999988653 56899999999999999999999999  9999999999999866 58999999999


Q ss_pred             eeccccceeee---------ecccCccccCCCccccccceeeec
Q 027788          179 AIVGRAIRRIR---------CWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       179 ~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...........         .+.+| +......++.++|+||+|
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  211 (291)
T 1u46_A          169 RALPQNDDHYVMQEHRKVPFAWCAP-ESLKTRTFSHASDTWMFG  211 (291)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCH-HHHHHCEEEHHHHHHHHH
T ss_pred             ccccccccchhhhccCCCCceeeCc-hhhcCCCCCchhhHHHHH
Confidence            88755432111         12222 333344567789999999

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.97  E-value=2.4e-30  Score=208.41  Aligned_cols=176  Identities=20%  Similarity=0.288  Sum_probs=134.7

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHH--HHhhCCCCceEEEEEE---ecC
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRL--LKTLANKNIISLHYVW---RDE   98 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~--l~~l~~~~i~~~~~~~---~~~   98 (219)
                      ++| ++.+.||+|+||.||+|..  +++.||+|+++...       ...+..|.++  +..++||||+++++.+   ...
T Consensus        13 ~~y-~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A           13 DNL-KLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             TSE-EEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             HHh-heeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-------hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence            455 8889999999999999975  68899999987432       1334444444  4468999999998754   234


Q ss_pred             CCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCeeeeCCCCCceEEeCCCCc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH---------EPCVIHRDLNCSNVFVNGNTGQ  169 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~---------~~~i~h~dl~~~nili~~~~~~  169 (219)
                      +...++++|||+++++|.+++... ..++..+..++.|++.||.|||+.         +  ++||||||+||+++.+ +.
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~~~-~~  158 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVKND-GT  158 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEECTT-SC
T ss_pred             CCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEcCC-Cc
Confidence            445678999999999999998765 458899999999999999999998         8  9999999999999865 58


Q ss_pred             EEEeccccceeccccce--------------eeeecccCccccCC------Cccccccceeeec
Q 027788          170 VKIGDLGVAAIVGRAIR--------------RIRCWGRRSSWRRS------CTMRITRSLWTYT  213 (219)
Q Consensus       170 ~~l~dfg~a~~~~~~~~--------------~~~~~~~~~~~~~~------~~~~~~~diws~g  213 (219)
                      +||+|||++........              ++..+.+|+.+...      ..++.++||||+|
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG  222 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG  222 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHH
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHH
Confidence            99999999987654221              22223333322221      3455679999999

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.97  E-value=2.3e-30  Score=207.56  Aligned_cols=182  Identities=27%  Similarity=0.411  Sum_probs=142.5

Q ss_pred             ceeeeeeeeccccceEEEEEEec-CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh---CCCCceEEEEEEec---
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQ-EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL---ANKNIISLHYVWRD---   97 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~~~~i~~~~~~~~~---   97 (219)
                      +.|++.+.||+|+||.||+|.+. .+++.||+|.++......  .....+.+|+.+++.+   +||||+++++++..   
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc--cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            33488899999999999999985 678999999987654321  1123455677777766   89999999998852   


Q ss_pred             CCCceEEEEeccccCCChHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                      .....++++||+++ ++|.+++....  .+++..+..++.|++.||.|||+.+  ++|+||||+||+++.+ +.++|+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~-~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCC-CCEEEecC
Confidence            24567889999997 69999887643  4899999999999999999999999  9999999999999866 58999999


Q ss_pred             ccceecccccee-----eeecccCccccCCCccccccceeeec
Q 027788          176 GVAAIVGRAIRR-----IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       176 g~a~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |++.........     +..+.+| +......++.++|+||+|
T Consensus       165 g~~~~~~~~~~~~~~~~~~~y~aP-E~~~~~~~~~~~Di~slG  206 (326)
T 1blx_A          165 GLARIYSFQMALTSVVVTLWYRAP-EVLLQSSYATPVDLWSVG  206 (326)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCH-HHHTTCCCCTHHHHHHHH
T ss_pred             cccccccCCCCccccccccceeCH-HHHhcCCCCcchhHHHHH
Confidence            999876544322     1222233 334455678889999999

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=3.4e-30  Score=207.40  Aligned_cols=179  Identities=22%  Similarity=0.295  Sum_probs=135.7

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHh--hCCCCceEEEEEEecC
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKT--LANKNIISLHYVWRDE   98 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~--l~~~~i~~~~~~~~~~   98 (219)
                      ....+.|++.+.||+|+||.||+|.+.  ++.||+|++....       ......|.+++..  ++||||+++++++...
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-------EASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-------cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            333344589999999999999999864  8899999986332       1334456666654  4899999999998765


Q ss_pred             CC--ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCeeeeCCCCCceEEeCCCC
Q 027788           99 DR--NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH--------EPCVIHRDLNCSNVFVNGNTG  168 (219)
Q Consensus        99 ~~--~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~--------~~~i~h~dl~~~nili~~~~~  168 (219)
                      ..  ..++++|||+++++|.+++... .+++..+..++.|++.|+.|||+.        +  ++||||||+||+++.+ +
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~~~-~  179 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVKKN-G  179 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEECTT-S
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEECCC-C
Confidence            43  5788999999999999998754 689999999999999999999998        7  9999999999999866 5


Q ss_pred             cEEEeccccceeccccce----------eeeecccCccccCCCcccc------ccceeeec
Q 027788          169 QVKIGDLGVAAIVGRAIR----------RIRCWGRRSSWRRSCTMRI------TRSLWTYT  213 (219)
Q Consensus       169 ~~~l~dfg~a~~~~~~~~----------~~~~~~~~~~~~~~~~~~~------~~diws~g  213 (219)
                      .+||+|||++........          ++..+.+|+.+. ......      ++||||+|
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~~~~~~DiwslG  239 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD-ESLNRNHFQSYIMADMYSFG  239 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHT-TCCCTTCTHHHHHHHHHHHH
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcc-cccCCccccCccccchHHHH
Confidence            899999999987654332          122233333222 222222      38999999

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.97  E-value=8.7e-31  Score=223.53  Aligned_cols=181  Identities=22%  Similarity=0.339  Sum_probs=144.8

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      .....+.+++.+.||+|+||.||+|.+.. +..||+|.++....     ..+.+.+|+.++++++|+||+++++++..  
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~--  333 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--  333 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEee--
Confidence            33445556899999999999999999764 46799999875431     23678899999999999999999999854  


Q ss_pred             CceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788          100 RNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                       ..++++|||+++|+|.+++...  ..+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+
T Consensus       334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~-~~~kl~DFG~  409 (535)
T 2h8h_A          334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGL  409 (535)
T ss_dssp             -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCTTS
T ss_pred             -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCC-CcEEEccccc
Confidence             3478899999999999998642  46899999999999999999999999  9999999999999865 5899999999


Q ss_pred             ceeccccce-------eeeecccCccccCCCccccccceeeec
Q 027788          178 AAIVGRAIR-------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       178 a~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ++.......       .+..+.+|+ ......++.++||||||
T Consensus       410 a~~~~~~~~~~~~~~~~~~~y~aPE-~~~~~~~~~~sDvwSlG  451 (535)
T 2h8h_A          410 ARLIEDNEYTARQGAKFPIKWTAPE-AALYGRFTIKSDVWSFG  451 (535)
T ss_dssp             TTTCCCHHHHTTCSTTSCGGGSCHH-HHHHCCCCHHHHHHHHH
T ss_pred             ceecCCCceecccCCcCcccccCHH-HhccCCCCchhhHHHHH
Confidence            987654321       111233333 22344578889999999

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=7.2e-31  Score=226.89  Aligned_cols=189  Identities=25%  Similarity=0.374  Sum_probs=148.6

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      ..+...++| ++.+.||+|+||.||+|.+..++..||+|.++...   .....+.+.+|+.++++++||||+++++++..
T Consensus         8 ~pg~~~grY-~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~   83 (676)
T 3qa8_A            8 LPTQTCGPW-EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCLEIQIMKKLNHPNVVSAREVPDG   83 (676)
T ss_dssp             ----------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC---CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTT
T ss_pred             CCCCCCCCe-EEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCceeeeecc
Confidence            334445666 88899999999999999999999999999887542   45666889999999999999999999988743


Q ss_pred             ----CCCceEEEEeccccCCChHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCC--
Q 027788           98 ----EDRNTLNFITEVCTSGNLREYRKKHR---HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG--  168 (219)
Q Consensus        98 ----~~~~~~~lv~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~--  168 (219)
                          ......+++|||+++++|.+++....   .+++..+..++.|++.|+.|||+.+  ++|+||+|+||+++.+..  
T Consensus        84 ~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~  161 (676)
T 3qa8_A           84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRL  161 (676)
T ss_dssp             TCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSC
T ss_pred             cccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCce
Confidence                22456788999999999999987643   5889999999999999999999999  999999999999985532  


Q ss_pred             cEEEeccccceeccccceee-----eecccCccccCCCccccccceeeec
Q 027788          169 QVKIGDLGVAAIVGRAIRRI-----RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       169 ~~~l~dfg~a~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .++|+|||++..........     ..+.+| +......++.++|+||+|
T Consensus       162 ~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~AP-E~l~~~~~s~ksDIwSLG  210 (676)
T 3qa8_A          162 IHKIIDLGYAKELDQGELCTEFVGTLQYLAP-ELLEQKKYTVTVDYWSFG  210 (676)
T ss_dssp             EEEECSCCCCCBTTSCCCCCCCCSCCTTCSS-CSSCCSCCSTTHHHHHHH
T ss_pred             eEEEcccccccccccccccccccCCcccCCh-HHhccCCCCchhHHHHHH
Confidence            38999999998875544322     223333 344556778889999999

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.97  E-value=1.5e-29  Score=220.30  Aligned_cols=181  Identities=21%  Similarity=0.351  Sum_probs=144.1

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCC---CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEE---GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      ....+++.+.||+|+||.||+|.+..+   +..||+|.++..   ......+.+.+|+.++++++||||+++++++..  
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--  462 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--  462 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST---TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--
Confidence            334458889999999999999987643   457899987643   245566889999999999999999999998843  


Q ss_pred             CceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          100 RNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                       +.++++|||+++|+|.+++... ..+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||++
T Consensus       463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~-~~vkL~DFG~a  538 (656)
T 2j0j_A          463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGLS  538 (656)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECCCCCC
T ss_pred             -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCC-CCEEEEecCCC
Confidence             3368899999999999998754 36899999999999999999999999  9999999999999966 58999999999


Q ss_pred             eeccccceee-------eecccCccccCCCccccccceeeec
Q 027788          179 AIVGRAIRRI-------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       179 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +.........       ..+.+|+ ......++.++||||+|
T Consensus       539 ~~~~~~~~~~~~~~~~t~~y~aPE-~~~~~~~~~~~DiwSlG  579 (656)
T 2j0j_A          539 RYMEDSTYYKASKGKLPIKWMAPE-SINFRRFTSASDVWMFG  579 (656)
T ss_dssp             CSCCC----------CCGGGCCHH-HHHHCCCCHHHHHHHHH
T ss_pred             eecCCCcceeccCCCCCcceeCHH-HhcCCCCCchhhHHHHH
Confidence            8765433211       1223332 33344677889999999

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.96  E-value=2e-29  Score=203.94  Aligned_cols=184  Identities=17%  Similarity=0.229  Sum_probs=141.8

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCC-cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCC------ceEEE
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEG-IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN------IISLH   92 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~------i~~~~   92 (219)
                      ++...+.|++.+.||+|+||.||+|.+..++ ..||+|+++.     .....+.+.+|+.+++.++|++      ++.+.
T Consensus        14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~   88 (355)
T 2eu9_A           14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKEKDKENKFLCVLMS   88 (355)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred             CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-----cccchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence            3333344488899999999999999998776 6899999863     3445577889999999998765      88888


Q ss_pred             EEEecCCCceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC-----
Q 027788           93 YVWRDEDRNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG-----  165 (219)
Q Consensus        93 ~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~-----  165 (219)
                      +++...  ..++++||+++ +++.+.+...  ..+++..+..++.|++.||.|||+++  ++|+||||+||+++.     
T Consensus        89 ~~~~~~--~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~  163 (355)
T 2eu9_A           89 DWFNFH--GHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFET  163 (355)
T ss_dssp             EEEEET--TEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEE
T ss_pred             eeeeeC--CeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccc
Confidence            888544  46889999995 5666655443  46899999999999999999999999  999999999999931     


Q ss_pred             -------------CCCcEEEeccccceeccccce---eeeecccCccccCCCccccccceeeecc
Q 027788          166 -------------NTGQVKIGDLGVAAIVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       166 -------------~~~~~~l~dfg~a~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                                   ..+.++|+|||++........   ++..+.+| +......++.++|+||+|+
T Consensus       164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~Di~slG~  227 (355)
T 2eu9_A          164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPP-EVILELGWAQPCDVWSIGC  227 (355)
T ss_dssp             EECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCH-HHHTTCCCCTHHHHHHHHH
T ss_pred             cccccccccccccCCCcEEEeecCccccccccccCCcCCCcccCC-eeeecCCCCCccchHHHHH
Confidence                         235899999999987554332   22223333 3344556788899999993

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.96  E-value=2e-29  Score=206.80  Aligned_cols=181  Identities=26%  Similarity=0.399  Sum_probs=142.4

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CC-----CceEEEEEEec
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NK-----NIISLHYVWRD   97 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~-----~i~~~~~~~~~   97 (219)
                      ++| ++.+.||+|+||.||+|.+..+++.||+|+++.     .......+..|+.+++.++ |+     +++++.+.+..
T Consensus        54 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           54 DRY-EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-----KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             TTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             eeE-EEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-----cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            455 888999999999999999999999999999873     2344567788999998886 44     38899998865


Q ss_pred             CCCceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC-CCCcEEEec
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG-NTGQVKIGD  174 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~-~~~~~~l~d  174 (219)
                      .  +.++++||+++ ++|.+++...  ..+++..+..++.|++.|+.|||.+...++||||||+||+++. +.+.+||+|
T Consensus       128 ~--~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          128 R--NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             T--TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             C--CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            4  56889999996 5999888654  4689999999999999999999953222999999999999953 335799999


Q ss_pred             cccceeccccce---eeeecccCccccCCCccccccceeeecc
Q 027788          175 LGVAAIVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       175 fg~a~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ||++........   ++..+.+| +......++.++||||+|+
T Consensus       205 FG~a~~~~~~~~~~~~t~~y~aP-E~~~~~~~~~~~DiwSlG~  246 (382)
T 2vx3_A          205 FGSSCQLGQRIYQYIQSRFYRSP-EVLLGMPYDLAIDMWSLGC  246 (382)
T ss_dssp             CTTCEETTCCCCSSCSCGGGCCH-HHHTTCCCCTHHHHHHHHH
T ss_pred             ccCceecccccccccCCccccCh-HHHcCCCCCcHHHHHHHHH
Confidence            999987754322   22233343 3344556888999999993

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.96  E-value=8.2e-30  Score=207.92  Aligned_cols=180  Identities=27%  Similarity=0.344  Sum_probs=144.4

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-----------CCCceEEE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-----------NKNIISLH   92 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------~~~i~~~~   92 (219)
                      ++| ++.+.||+|+||.||+|.+..+++.||+|++..     +....+.+.+|+.++++++           |+||++++
T Consensus        19 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           19 ARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             CeE-EEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            455 888999999999999999999999999999873     3344567888999999887           78999999


Q ss_pred             EEEecC--CCceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeCCCCCceEEeCC-
Q 027788           93 YVWRDE--DRNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTH-EPCVIHRDLNCSNVFVNGN-  166 (219)
Q Consensus        93 ~~~~~~--~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~-~~~i~h~dl~~~nili~~~-  166 (219)
                      +++...  +...++++||++ +++|.+++...  ..+++..+..++.|++.||.|||++ +  ++|+||||+||+++.+ 
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEE
T ss_pred             HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccC
Confidence            988653  334788999999 78999988753  4589999999999999999999998 9  9999999999999522 


Q ss_pred             ----CCcEEEeccccceeccccce---eeeecccCccccCCCccccccceeeec
Q 027788          167 ----TGQVKIGDLGVAAIVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       167 ----~~~~~l~dfg~a~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                          .+.++|+|||++........   ++..+.+| +......++.++||||+|
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aP-E~~~~~~~~~~~Di~slG  222 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEHYTNSIQTREYRSP-EVLLGAPWGCGADIWSTA  222 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCH-HHHHTCCCCTHHHHHHHH
T ss_pred             CCcCcceEEEcccccccccCCCCCCCCCCccccCc-HHHhCCCCCchHhHHHHH
Confidence                23689999999987754332   22223333 333445578889999999

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.96  E-value=1.2e-29  Score=213.73  Aligned_cols=180  Identities=17%  Similarity=0.244  Sum_probs=139.7

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++| ++.++||+|+||.||+|.+..+++.||||+++.....      ..+..|+.+++.++|++.+..+..+.. .....
T Consensus         7 ~~y-~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~-~~~~~   78 (483)
T 3sv0_A            7 NKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGV-EGDYN   78 (483)
T ss_dssp             TTE-ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEE-ETTEE
T ss_pred             CcE-EEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEe-eCCEE
Confidence            445 8899999999999999999999999999988755432      236789999999998554444333332 34567


Q ss_pred             EEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEe--CCCCcEEEecccccee
Q 027788          104 NFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN--GNTGQVKIGDLGVAAI  180 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~--~~~~~~~l~dfg~a~~  180 (219)
                      +++|||+ +++|.+++.. ...+++..++.++.|++.||.|||+++  |+||||||+|||++  .+.+.+||+|||+++.
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            8899999 8999999874 457999999999999999999999999  99999999999994  2335899999999988


Q ss_pred             ccccceee--------eeccc----CccccCCCccccccceeeecc
Q 027788          181 VGRAIRRI--------RCWGR----RSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       181 ~~~~~~~~--------~~~~~----~~~~~~~~~~~~~~diws~gi  214 (219)
                      +.......        ...++    +++......++.++||||||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGv  201 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGY  201 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHH
Confidence            76543211        11122    223344556788899999993

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.96  E-value=1.5e-29  Score=202.10  Aligned_cols=181  Identities=19%  Similarity=0.258  Sum_probs=127.8

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+| ++.+.||+|+||.||+|.+..+++.||+|.+.....  .....+.+..+..+++.++||||+++++++..  ...+
T Consensus        25 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~   99 (318)
T 2dyl_A           25 NDL-ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSHDCPYIVQCFGTFIT--NTDV   99 (318)
T ss_dssp             GGE-EEEEEC------CEEEEEETTTCCEEEEEEEETTSC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred             ccc-cccceeeecCCeeEEEEEEecCCeEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCcE
Confidence            444 777999999999999999999999999999875431  22233344455557888899999999999954  4568


Q ss_pred             EEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          104 NFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTH-EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~-~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      +++||++ ++.+..+... ...+++..+..++.|++.|+.|||+. +  ++|+||+|+||+++.+ +.++|+|||++...
T Consensus       100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDER-GQIKLCDFGISGRL  175 (318)
T ss_dssp             EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTT-SCEEECCCTTC---
T ss_pred             EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCC-CCEEEEECCCchhc
Confidence            8999999 4566655543 46799999999999999999999985 8  9999999999999866 58999999999776


Q ss_pred             cccce-----eeeecccCcccc----CCCccccccceeeec
Q 027788          182 GRAIR-----RIRCWGRRSSWR----RSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~-----~~~~~~~~~~~~----~~~~~~~~~diws~g  213 (219)
                      .....     ++..+.+|+.+.    ....++.++||||+|
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG  216 (318)
T 2dyl_A          176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG  216 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHH
T ss_pred             cCCccccccCCCccccChhhcccccccccCCccccchhhHH
Confidence            54332     222333343332    345677789999999

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.96  E-value=4.5e-30  Score=213.81  Aligned_cols=199  Identities=20%  Similarity=0.199  Sum_probs=133.0

Q ss_pred             CCCCCCCCCCCCCCCccccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHH
Q 027788            2 MPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLK   81 (219)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~   81 (219)
                      |+.+.+.+.+...+........+..|.+.+.||+|+||.|+. ....+++.||||.+.....       ..+.+|+.+++
T Consensus         1 M~ss~s~~~~~~~~~~~~~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~   72 (432)
T 3p23_A            1 MGSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-------SFADREVQLLR   72 (432)
T ss_dssp             -----------------CEEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-------EECHHHHHHHH
T ss_pred             CCCCcccccCcCcccCCcEEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-------HHHHHHHHHHH
Confidence            344444333333333333444455568889999999999764 3356789999999864322       22457999999


Q ss_pred             hh-CCCCceEEEEEEecCCCceEEEEeccccCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCC
Q 027788           82 TL-ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCS  159 (219)
Q Consensus        82 ~l-~~~~i~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~  159 (219)
                      .+ +||||+++++++..  ...++++||+++ ++|.+++.... ......+..++.|++.||.|||+.+  ++||||||+
T Consensus        73 ~l~~HpnIv~l~~~~~~--~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~  147 (432)
T 3p23_A           73 ESDEHPNVIRYFCTEKD--RQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPH  147 (432)
T ss_dssp             HSCCCTTBCCEEEEEEE--TTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTT
T ss_pred             hccCCCCcCeEEEEEec--CCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHH
Confidence            99 79999999998854  456889999996 69998886543 3555567789999999999999999  999999999


Q ss_pred             ceEEeCC----CCcEEEeccccceeccccce---------eeeecccCccccC--CCccccccceeeec
Q 027788          160 NVFVNGN----TGQVKIGDLGVAAIVGRAIR---------RIRCWGRRSSWRR--SCTMRITRSLWTYT  213 (219)
Q Consensus       160 nili~~~----~~~~~l~dfg~a~~~~~~~~---------~~~~~~~~~~~~~--~~~~~~~~diws~g  213 (219)
                      ||+++.+    ...++|+|||+++.......         ++..+.+|+.+..  ...++.++||||+|
T Consensus       148 NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG  216 (432)
T 3p23_A          148 NILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG  216 (432)
T ss_dssp             SEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHH
T ss_pred             HEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHH
Confidence            9999522    12578999999987754321         2223334443332  34455679999999

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.96  E-value=1e-30  Score=209.00  Aligned_cols=185  Identities=23%  Similarity=0.346  Sum_probs=140.7

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      ...+.....|++.+.||+|+||.||+|.+..   .+|+|.++....  .....+.+.+|+.++++++||||+++++++..
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC--CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC--CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            4555555555899999999999999998753   499999875432  22223556789999999999999999999965


Q ss_pred             CCCceEEEEeccccCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                      .  ..++++||++++++|.+++.... .+++..+..++.|++.|+.|||+.+  ++|+||||+||+++ + +.++|+|||
T Consensus       101 ~--~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~-~~~~l~Dfg  174 (319)
T 2y4i_B          101 P--PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-N-GKVVITDFG  174 (319)
T ss_dssp             S--SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC----CCEECCCS
T ss_pred             C--CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-C-CCEEEeecC
Confidence            4  45888999999999999987654 6899999999999999999999999  99999999999997 4 489999999


Q ss_pred             cceeccccce-----------eeeecccCccccC--------CCccccccceeeec
Q 027788          177 VAAIVGRAIR-----------RIRCWGRRSSWRR--------SCTMRITRSLWTYT  213 (219)
Q Consensus       177 ~a~~~~~~~~-----------~~~~~~~~~~~~~--------~~~~~~~~diws~g  213 (219)
                      ++........           ++..+.+|+.+..        ...++.++||||+|
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG  230 (319)
T 2y4i_B          175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG  230 (319)
T ss_dssp             CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHH
T ss_pred             CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHH
Confidence            9876532211           1122333332221        34567789999999

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.96  E-value=5.2e-29  Score=207.58  Aligned_cols=178  Identities=19%  Similarity=0.238  Sum_probs=134.1

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCc
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~  101 (219)
                      .++++.+.+.||+|+||+||.+. ..+|+.||||.+....       .+.+.+|+.+++++ +||||+++++++.  +..
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~~~~~~~--~~~   82 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF-------CDIALMEIKLLTESDDHPNVIRYYCSET--TDR   82 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG-------HHHHHHHHHHHHHHTTSTTBCCEEEEEE--CSS
T ss_pred             hhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEEe--cCC
Confidence            35556788999999999998754 5679999999987432       24567899999876 8999999999884  446


Q ss_pred             eEEEEeccccCCChHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC--------
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHV-------SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN--------  166 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~-------~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~--------  166 (219)
                      .++++||+++ ++|.+++......       .+..+..++.|++.||.|||+++  ++||||||+||+++.+        
T Consensus        83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~  159 (434)
T 2rio_A           83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQ  159 (434)
T ss_dssp             EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCT
T ss_pred             eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccc
Confidence            7899999996 6999988765332       22235679999999999999999  9999999999999743        


Q ss_pred             ----CCcEEEeccccceeccccce----------eeeecccCccccC------CCccccccceeeec
Q 027788          167 ----TGQVKIGDLGVAAIVGRAIR----------RIRCWGRRSSWRR------SCTMRITRSLWTYT  213 (219)
Q Consensus       167 ----~~~~~l~dfg~a~~~~~~~~----------~~~~~~~~~~~~~------~~~~~~~~diws~g  213 (219)
                          ...++|+|||+++.......          ++..+.+|+.+..      ...++.++||||+|
T Consensus       160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG  226 (434)
T 2rio_A          160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG  226 (434)
T ss_dssp             TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHH
T ss_pred             cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHH
Confidence                23799999999998765431          2223334443322      35678889999999

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=8.5e-29  Score=212.30  Aligned_cols=176  Identities=13%  Similarity=0.009  Sum_probs=118.0

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCC------CHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceE
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD------DPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ...+.|+.|....++..-.|+.+++|++.......      .....+++.+|+++|+++ .|+||+++++++  ++...+
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~--ed~~~~  317 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG--ENAQSG  317 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE--ECSSEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE--EECCEE
Confidence            34667777777777766778999999987653221      234557799999999999 699999999998  556679


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      ||||||++|++|.+++...+.++..   .|+.||+.||.|+|+++  |+||||||+|||++.+ +.+||+|||+|+....
T Consensus       318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~d-g~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDAR-QHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTT-SCEEECCCTTEESCC-
T ss_pred             EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCC-CCEEEeecccCeeCCC
Confidence            9999999999999999988888765   47899999999999999  9999999999999866 6899999999987765


Q ss_pred             cce-eeeecccCc----cccCCCccccccceeeeccc
Q 027788          184 AIR-RIRCWGRRS----SWRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       184 ~~~-~~~~~~~~~----~~~~~~~~~~~~diws~gi~  215 (219)
                      ... ..+..|+|.    +.. .+.+..++|+||+|+.
T Consensus       392 ~~~~~~t~vGTp~YmAPE~l-~g~~~~~~d~~s~g~~  427 (569)
T 4azs_A          392 DCSWPTNLVQSFFVFVNELF-AENKSWNGFWRSAPVH  427 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC-----------------
T ss_pred             CCccccCceechhhccHHHh-CCCCCCcccccccccc
Confidence            432 222233322    122 2345566899999943

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.95  E-value=1.8e-28  Score=203.16  Aligned_cols=187  Identities=20%  Similarity=0.186  Sum_probs=130.8

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCC-CCc---------e--
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN-KNI---------I--   89 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i---------~--   89 (219)
                      ...+.+++.+.||+|+||.||+|.+..+++.||||+++..... .....+.+.+|+.+++.++| .|.         +  
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~  153 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP  153 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCc-cHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence            3445568889999999999999999999999999998743321 22335778899999999887 211         1  


Q ss_pred             ----------EEEEEEecCC---CceEEEEeccccCCChHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 027788           90 ----------SLHYVWRDED---RNTLNFITEVCTSGNLREYRKK-------HRHVSVKALKKWSKQILKGLNYLHTHEP  149 (219)
Q Consensus        90 ----------~~~~~~~~~~---~~~~~lv~e~~~~g~L~~~~~~-------~~~~~~~~~~~i~~qv~~~l~~lh~~~~  149 (219)
                                .+...+....   ...++++|+.+ +++|.++++.       ...+++..+..++.|++.||.|||+++ 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-  231 (413)
T 3dzo_A          154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-  231 (413)
T ss_dssp             CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence                      1111111111   22356677766 5799888741       223667788899999999999999999 


Q ss_pred             CeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---eeeecccCcccc---------CCCccccccceeeecc
Q 027788          150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---RIRCWGRRSSWR---------RSCTMRITRSLWTYTR  214 (219)
Q Consensus       150 ~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---~~~~~~~~~~~~---------~~~~~~~~~diws~gi  214 (219)
                       ++||||||+||+++.+ +.+||+|||+++.......   + ..+.+|+.+.         ....++.++|+||||+
T Consensus       232 -iiHrDiKp~NILl~~~-~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          232 -LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             -EECSCCCGGGEEECTT-CCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             -cccCCcccceEEEecC-CeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence             9999999999999966 5899999999987654421   1 2233333221         4445777899999993

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=8.8e-25  Score=186.41  Aligned_cols=168  Identities=18%  Similarity=0.183  Sum_probs=118.4

Q ss_pred             eeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCC----HHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           29 YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD----PAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        29 ~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      -.+.||+|+||.||+|.  ..+..+++|..........    ....+++.+|+.++++++||||+++..++..++.  .+
T Consensus       340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~--~~  415 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN--KR  415 (540)
T ss_dssp             --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT--TE
T ss_pred             CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc--cE
Confidence            35689999999999994  4578899998654333211    1224568999999999999999943333333433  47


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      ++|||+++++|.+++..        ...++.|++.++.|||+++  ++||||||+||+++.   .+||+|||+++.....
T Consensus       416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~---~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK---DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS---SEEECCCTTCEECCCH
T ss_pred             EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC---eEEEEECccCEECCCc
Confidence            89999999999998764        5689999999999999999  999999999999985   7999999999988664


Q ss_pred             ce-------------eeeecccCccccC-CCccccccceeeec
Q 027788          185 IR-------------RIRCWGRRSSWRR-SCTMRITRSLWTYT  213 (219)
Q Consensus       185 ~~-------------~~~~~~~~~~~~~-~~~~~~~~diws~g  213 (219)
                      ..             ++..+.+|+-|.. ...|+...|+||..
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~v  525 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEII  525 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHH
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHH
Confidence            32             1112223332221 14466678899865

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=4.8e-24  Score=168.00  Aligned_cols=143  Identities=20%  Similarity=0.222  Sum_probs=110.0

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCC------H--------HHHHHHHHHHHHHHhhCCCCce
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD------P--------AMIERLFSEVRLLKTLANKNII   89 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~------~--------~~~~~~~~E~~~l~~l~~~~i~   89 (219)
                      +..+.+.+.||+|+||.||+|.+ .+|..||+|.++.......      .        .....+.+|+.++++++|+++.
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~  167 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVP  167 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSC
T ss_pred             CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcC
Confidence            33445669999999999999998 8899999999864321100      0        2356788999999999854444


Q ss_pred             EEEEEEecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCc
Q 027788           90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQ  169 (219)
Q Consensus        90 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~  169 (219)
                      .   ++..   +..+++|||+++++|.+ +..      .....++.|++.|+.+||+.+  ++||||||+||+++ + +.
T Consensus       168 ~---~~~~---~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~-~-~~  230 (282)
T 1zar_A          168 K---VYAW---EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EG  230 (282)
T ss_dssp             C---EEEE---ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TE
T ss_pred             e---EEec---cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE-C-Cc
Confidence            4   3322   23578999999999987 421      234569999999999999999  99999999999999 5 68


Q ss_pred             EEEeccccceecccc
Q 027788          170 VKIGDLGVAAIVGRA  184 (219)
Q Consensus       170 ~~l~dfg~a~~~~~~  184 (219)
                      ++|+|||+|+....+
T Consensus       231 vkl~DFG~a~~~~~~  245 (282)
T 1zar_A          231 IWIIDFPQSVEVGEE  245 (282)
T ss_dssp             EEECCCTTCEETTST
T ss_pred             EEEEECCCCeECCCC
Confidence            999999999876554

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=1.8e-21  Score=151.43  Aligned_cols=149  Identities=16%  Similarity=0.157  Sum_probs=110.8

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcE--EEEEEeeecccCCC--------------------HHHHHHHHHHHHHH
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIE--VAWNQVKLRTFCDD--------------------PAMIERLFSEVRLL   80 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~--vavK~~~~~~~~~~--------------------~~~~~~~~~E~~~l   80 (219)
                      .+..+.+.+.||+|+||.||+|.+..+|..  ||+|+++.......                    ......+.+|+.++
T Consensus        45 ~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  124 (258)
T 1zth_A           45 KGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL  124 (258)
T ss_dssp             TTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred             CCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence            355678889999999999999998778989  99998764321100                    01123578899999


Q ss_pred             HhhCCCCc--eEEEEEEecCCCceEEEEeccccC-C----ChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCee
Q 027788           81 KTLANKNI--ISLHYVWRDEDRNTLNFITEVCTS-G----NLREYRKKHRHVSVKALKKWSKQILKGLNYLH-THEPCVI  152 (219)
Q Consensus        81 ~~l~~~~i--~~~~~~~~~~~~~~~~lv~e~~~~-g----~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh-~~~~~i~  152 (219)
                      +++.|+++  ..++..   .   ..+++|||+++ |    +|.+....   .++..+..++.|++.++.+|| ..+  ++
T Consensus       125 ~~l~~~~i~~p~~~~~---~---~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--iv  193 (258)
T 1zth_A          125 ERAKEAGVSVPQPYTY---M---KNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LV  193 (258)
T ss_dssp             HHHHHTTCCCCCEEEE---E---TTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EE
T ss_pred             HHHHhCCCCCCeEEEc---C---CCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EE
Confidence            99988754  334432   1   24789999942 3    66655332   234467789999999999999 999  99


Q ss_pred             eeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          153 HRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       153 h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ||||||+|||++.   .++|+|||+|.....+.
T Consensus       194 HrDlkp~NILl~~---~~~liDFG~a~~~~~~~  223 (258)
T 1zth_A          194 HADLSEYNIMYID---KVYFIDMGQAVTLRHPM  223 (258)
T ss_dssp             CSSCSTTSEEESS---SEEECCCTTCEETTSTT
T ss_pred             eCCCCHHHEEEcC---cEEEEECcccccCCCcc
Confidence            9999999999974   69999999998775543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.71  E-value=2.2e-17  Score=134.30  Aligned_cols=146  Identities=14%  Similarity=0.153  Sum_probs=102.3

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccC-----------C--CH-H--HHHH--HHHHHHHHHhhCCC
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC-----------D--DP-A--MIER--LFSEVRLLKTLANK   86 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~-----------~--~~-~--~~~~--~~~E~~~l~~l~~~   86 (219)
                      ..|.+..+||+|.+|.||.|.+ .+|+.||||+++.....           .  .. .  ...+  ..+|...+.++.+.
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CEEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            3468999999999999999997 47999999987642210           0  00 0  0111  13577777777554


Q ss_pred             Cce--EEEEEEecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEe
Q 027788           87 NII--SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN  164 (219)
Q Consensus        87 ~i~--~~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~  164 (219)
                      ++.  ..++..  .    .+++|||+++++|..+..      ......++.|++.++.++|..+  ++||||||.|||++
T Consensus       174 gv~vp~p~~~~--~----~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~  239 (397)
T 4gyi_A          174 GFPVPEPIAQS--R----HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIR  239 (397)
T ss_dssp             TCSCCCEEEEE--T----TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE
T ss_pred             CCCCCeeeecc--C----ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEe
Confidence            432  333322  2    267999999888865422      1234567899999999999999  99999999999998


Q ss_pred             CCCC---------cEEEeccccceeccccc
Q 027788          165 GNTG---------QVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       165 ~~~~---------~~~l~dfg~a~~~~~~~  185 (219)
                      .+..         .+.|+||+-+.....+.
T Consensus       240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~hp~  269 (397)
T 4gyi_A          240 EEKDAEDPSSITLTPIIIXFPQMVSMDHPN  269 (397)
T ss_dssp             EEECSSCTTSEEEEEEECCCTTCEETTSTT
T ss_pred             CCCCcccccccccceEEEEeCCcccCCCCC
Confidence            5421         27899999887765554

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.31  E-value=2.4e-11  Score=94.07  Aligned_cols=142  Identities=16%  Similarity=0.099  Sum_probs=101.8

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCCCceEEEE
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      ++...++.|+.+.||++..  .+..+++|........ .   ...+.+|+.+++.+. +..+.++++++..  ....|++
T Consensus        17 ~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~-~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv   88 (263)
T 3tm0_A           17 RCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG-T---TYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLL   88 (263)
T ss_dssp             EEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT-S---TTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEE
T ss_pred             eeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC-C---HHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEEE
Confidence            6767788888899999874  3678999987643211 1   134778999999885 5667778877754  3557889


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE--------------------------------------  148 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~--------------------------------------  148 (219)
                      ||+++|.+|.+.+.     +......++.++..++..||+..                                      
T Consensus        89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99999988876421     11223466778888889999810                                      


Q ss_pred             -------------------CCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          149 -------------------PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       149 -------------------~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                                         +.++|+|+++.||+++.+ +.+.|+||+.+..-..
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~~gd~  216 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGRADK  216 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTCEEEEH
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhcccCCH
Confidence                               238999999999999743 3446999998865443

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.17  E-value=3.8e-10  Score=91.33  Aligned_cols=148  Identities=13%  Similarity=0.161  Sum_probs=102.1

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEee--ecccCCCHHHHHHHHHHHHHHHhhCC--CCceEEEEEEecCCC-ce
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVK--LRTFCDDPAMIERLFSEVRLLKTLAN--KNIISLHYVWRDEDR-NT  102 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~E~~~l~~l~~--~~i~~~~~~~~~~~~-~~  102 (219)
                      .+ +.++.|.++.+|+....  +..+++|...  ....   ......+.+|..+++.+..  ..+.+++..+..... ..
T Consensus        42 ~~-~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~---~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~  115 (359)
T 3dxp_A           42 SV-EQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL---LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR  115 (359)
T ss_dssp             EE-EECCC-CCSCEEEEECS--SCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred             eE-EEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC---CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence            44 67899999999998753  4578888654  2211   1123457789999999974  446777777744321 34


Q ss_pred             EEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------
Q 027788          103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH-----------------------------------  147 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~-----------------------------------  147 (219)
                      .|++||+++|..+.+.  ....++......++.+++..|..||..                                   
T Consensus       116 ~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          116 AFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             CEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             eEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            5789999998777431  123467788888899999999999973                                   


Q ss_pred             ---------------------CCCeeeeCCCCCceEEeCCCCc-EEEeccccceeccc
Q 027788          148 ---------------------EPCVIHRDLNCSNVFVNGNTGQ-VKIGDLGVAAIVGR  183 (219)
Q Consensus       148 ---------------------~~~i~h~dl~~~nili~~~~~~-~~l~dfg~a~~~~~  183 (219)
                                           .+.++|+|+++.||+++.+... +.++||+.+..-..
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~p  251 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGHP  251 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEECH
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCCH
Confidence                                 1348999999999999865433 58999999875433

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.09  E-value=7.2e-10  Score=85.26  Aligned_cols=137  Identities=15%  Similarity=0.105  Sum_probs=90.8

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCC--ceEEEEEEecCCCceEEE
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN--IISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~--i~~~~~~~~~~~~~~~~l  105 (219)
                      .+....+.|..+.||++. ..+|..+++|.....       ....+..|+.+++.+.+.+  +.+++.+....  ...++
T Consensus        23 ~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~~   92 (264)
T 1nd4_A           23 DWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWL   92 (264)
T ss_dssp             EEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEE
T ss_pred             ceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCEE
Confidence            453333456679999986 356778999986532       1134668999999886544  45577766433  44778


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE-------------------------------------  148 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~-------------------------------------  148 (219)
                      +||+++|.++.  ..   ..+.   ..++.+++..+..||...                                     
T Consensus        93 v~e~i~G~~l~--~~---~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           93 LLGEVPGQDLL--SS---HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             EEECCSSEETT--TS---CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             EEEecCCcccC--cC---cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            99999988874  11   1121   234555666666666532                                     


Q ss_pred             -------------------CCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          149 -------------------PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       149 -------------------~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                                         +.++|+|++|.||+++.+ +.+.|+||+.+.....
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~~g~~  217 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLGVADR  217 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCEEEET
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhcccCCh
Confidence                               128999999999999744 3456999999876544

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.72  E-value=1.1e-07  Score=75.06  Aligned_cols=140  Identities=20%  Similarity=0.234  Sum_probs=93.2

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCC--ceEEEEEEecCCC-ceEEEE
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN--IISLHYVWRDEDR-NTLNFI  106 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~--i~~~~~~~~~~~~-~~~~lv  106 (219)
                      +.++.|.+..||+..     ..+++|+..      .......+.+|..+++.+. +..  +.+++......+. ..-|++
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~------~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPK------HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEES------SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecC------CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            458899999999853     458888744      2344577889999998884 322  3344443322111 133678


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH---------------------------------------  147 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~---------------------------------------  147 (219)
                      |++++|.++.....  ..++......++.+++..+..||+.                                       
T Consensus        95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99999877764322  2356666666777777777777641                                       


Q ss_pred             -----------------CCCeeeeCCCCCceEEeCC-CCcEEEeccccceeccc
Q 027788          148 -----------------EPCVIHRDLNCSNVFVNGN-TGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       148 -----------------~~~i~h~dl~~~nili~~~-~~~~~l~dfg~a~~~~~  183 (219)
                                       .+.++|+|+++.|++++.+ .+.+.++||+.+..-..
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~  226 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP  226 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh
Confidence                             1237999999999999863 33568999999876543

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.64  E-value=1.9e-06  Score=68.06  Aligned_cols=140  Identities=23%  Similarity=0.181  Sum_probs=86.0

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCC---CceEEEEEEecCCCceEEEEe
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK---NIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~---~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      +.++.|....||+.     +..+++|+..      .......+.+|..+++.+.+.   .+.+++.+... .....+++|
T Consensus        25 ~~l~~G~~n~v~~v-----g~~~VlR~~~------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~   92 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----NGDWVFRFPK------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGY   92 (306)
T ss_dssp             EEEEECSSEEEEEE-----TTTEEEEEES------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEE
T ss_pred             eecCCCcceeEEEE-----CCEEEEEecC------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEE
Confidence            45788888999987     4678888732      344457788999999999753   24455555432 234456899


Q ss_pred             ccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 027788          108 EVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT-----------------------------------------  146 (219)
Q Consensus       108 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~-----------------------------------------  146 (219)
                      ++++|..+....-  ..++......+..++...+..||+                                         
T Consensus        93 e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           93 RKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             ECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             eccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            9999877754211  112222222222222222222221                                         


Q ss_pred             -----------------CCCCeeeeCCCCCceEEeCC--CCcE-EEeccccceecccc
Q 027788          147 -----------------HEPCVIHRDLNCSNVFVNGN--TGQV-KIGDLGVAAIVGRA  184 (219)
Q Consensus       147 -----------------~~~~i~h~dl~~~nili~~~--~~~~-~l~dfg~a~~~~~~  184 (219)
                                       ..+.++|+|+++.|++++.+  .+.+ .|+||+.+..-.+.
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~~  228 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDPD  228 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECGG
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCHH
Confidence                             22237999999999999851  2344 79999988765443

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.57  E-value=1.8e-06  Score=66.66  Aligned_cols=138  Identities=15%  Similarity=0.167  Sum_probs=90.2

Q ss_pred             eeccccce-EEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCC-CCceEEEEEEecCCCceEEEEecc
Q 027788           32 LLGSGAVK-KVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN-KNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        32 ~ig~g~~g-~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      .+..|..+ .||+......+..+.+|.-.       ......+..|...++.+.. --+.+++.++...  +.-+++||+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~-------~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~  101 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGK-------GSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTA  101 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEE-------THHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEEC
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECC-------CCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEe
Confidence            44456555 68988777777789999744       2234667889999988853 2245666666544  446789999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE-----------------------------------------  148 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~-----------------------------------------  148 (219)
                      +++.++.+.....    ......+..++...+.-||...                                         
T Consensus       102 l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (272)
T 4gkh_A          102 IPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE  177 (272)
T ss_dssp             CCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred             eCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence            9987776644321    1122234445555555555421                                         


Q ss_pred             ---------------CCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          149 ---------------PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       149 ---------------~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                                     +.++|+|+.+.|++++.+ +.+-|+||+.+..-..
T Consensus       178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~-~~~~viDwe~a~~gdp  226 (272)
T 4gkh_A          178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEG-KLIGCIDVGRVGIADR  226 (272)
T ss_dssp             HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEEEET
T ss_pred             HHHHHHHhcccccCCcEEEcCCCCCCeEEEECC-eEEEEEECcccccCCH
Confidence                           137899999999999854 3456999999876444

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.25  E-value=8.6e-06  Score=66.53  Aligned_cols=78  Identities=18%  Similarity=0.204  Sum_probs=46.8

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeeccc-CCC--HHHHHHHHHHHHHHHhhCC--C-CceEEEEEEecCCCceEE
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF-CDD--PAMIERLFSEVRLLKTLAN--K-NIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~--~~~~~~~~~E~~~l~~l~~--~-~i~~~~~~~~~~~~~~~~  104 (219)
                      +.+|.|.++.||++....+++.+++|....... ...  +....++..|.++++.+..  + .+.+++.+.  ++.  .+
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~--~~  111 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEM--AV  111 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTT--TE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCc--cE
Confidence            679999999999997655678899997653211 000  0122456779999887743  2 334555432  332  35


Q ss_pred             EEeccccC
Q 027788          105 FITEVCTS  112 (219)
Q Consensus       105 lv~e~~~~  112 (219)
                      ++||++++
T Consensus       112 lvmE~l~g  119 (397)
T 2olc_A          112 TVMEDLSH  119 (397)
T ss_dssp             EEECCCTT
T ss_pred             EEEEeCCC
Confidence            79999975

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.93  E-value=6.9e-05  Score=60.15  Aligned_cols=84  Identities=7%  Similarity=-0.009  Sum_probs=49.5

Q ss_pred             eee-ccccceEEEEEEec--C----CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCC---CCceEEEEEEecCC-
Q 027788           31 ELL-GSGAVKKVYRAFDQ--E----EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN---KNIISLHYVWRDED-   99 (219)
Q Consensus        31 ~~i-g~g~~g~V~~a~~~--~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~---~~i~~~~~~~~~~~-   99 (219)
                      +.| +.|....+|+....  .    ++..+++|.......... .....+.+|..+++.+..   ..+.+++.+....+ 
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~-~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPV-FPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCS-SSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcccc-CchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            567 88999999987642  0    256788887553220000 001335678888887743   24566776664321 


Q ss_pred             CceEEEEeccccCCCh
Q 027788          100 RNTLNFITEVCTSGNL  115 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L  115 (219)
                      ....+++||+++|..+
T Consensus       105 ~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TSSCEEEEECCCCBCC
T ss_pred             cCCceEEEEecCCCCh
Confidence            0234679999987544

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.61  E-value=0.001  Score=52.63  Aligned_cols=34  Identities=24%  Similarity=0.324  Sum_probs=27.4

Q ss_pred             CCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       149 ~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +.++|+|+++.|++++.+ +.+.++||+.+..-..
T Consensus       222 ~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~~g~~  255 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGEN-EQIWVIDLDTVSFDLP  255 (346)
T ss_dssp             CCEECSSCSTTSEEECGG-GCEEECCCTTCEECCT
T ss_pred             CceecCCCCcccEEEeCC-CcEEEEehhhcccCCh
Confidence            349999999999999755 4689999998865433

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.53  E-value=0.00053  Score=53.32  Aligned_cols=72  Identities=13%  Similarity=-0.005  Sum_probs=48.3

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCC---CceEEEEEEecCCCceEEEEe
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK---NIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~---~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      +.+|.|..+.||+.+ ..+|+.+.+|.......    .....+..|...|+.|...   -+.+++...  ..    +++|
T Consensus        21 ~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~~----~lv~   89 (288)
T 3f7w_A           21 AERGHSHRWHLYRVE-LADGTPLFVKALPDDAP----ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--DR----TLAM   89 (288)
T ss_dssp             EEEEEETTEEEEEEE-ETTSCEEEEEECCTTCC----CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--TT----EEEE
T ss_pred             EecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCc----chhhHHHHHHHHHHHHHhhCCCCcceEEecc--Cc----eEEE
Confidence            678999999999987 56889999997543221    1123467899999888532   234444432  22    5688


Q ss_pred             ccccCC
Q 027788          108 EVCTSG  113 (219)
Q Consensus       108 e~~~~g  113 (219)
                      |+++++
T Consensus        90 e~l~~~   95 (288)
T 3f7w_A           90 EWVDER   95 (288)
T ss_dssp             ECCCCC
T ss_pred             Eeeccc
Confidence            988654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.46  E-value=0.002  Score=50.90  Aligned_cols=74  Identities=18%  Similarity=0.073  Sum_probs=52.8

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCC---CCceEEEEEEecCCCceEEEEe
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN---KNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~---~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      +.|+.|.+..+|+...  ++..+++|.....       ....+..|...++.|..   ..+.+++.+....  ...+++|
T Consensus        42 ~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lvm  110 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND--EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLLL  110 (312)
T ss_dssp             EEECCSSSSEEEEEES--SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEEE
T ss_pred             EEeCCccceeeeEEEE--CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEEE
Confidence            5689999999999874  4678888875522       23567789998888742   4466777666433  4577899


Q ss_pred             ccccCCCh
Q 027788          108 EVCTSGNL  115 (219)
Q Consensus       108 e~~~~g~L  115 (219)
                      |++++..+
T Consensus       111 e~l~G~~~  118 (312)
T 3jr1_A          111 EALNKSKN  118 (312)
T ss_dssp             ECCCCCCC
T ss_pred             EeccCCCC
Confidence            99987643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.37  E-value=0.0038  Score=51.22  Aligned_cols=34  Identities=21%  Similarity=0.256  Sum_probs=27.7

Q ss_pred             CCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       149 ~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      +.++|+|+++.||+++.+  .+.++||+.+..-...
T Consensus       232 ~~liHGDl~~~Nil~~~~--~~~lID~e~a~~G~p~  265 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQD--STQVIDPEFSFYGPMG  265 (420)
T ss_dssp             CEEECSCCSGGGEEECSS--CEEECCCTTCEEECHH
T ss_pred             CeEEecCCCCCcEEEeCC--CCEEEeCcccccCchH
Confidence            349999999999999854  3999999998765543

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.21  E-value=0.0062  Score=47.50  Aligned_cols=71  Identities=13%  Similarity=-0.014  Sum_probs=41.7

Q ss_pred             eeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCc-eEEEEEEecCCCceEEEEec
Q 027788           30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI-ISLHYVWRDEDRNTLNFITE  108 (219)
Q Consensus        30 ~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i-~~~~~~~~~~~~~~~~lv~e  108 (219)
                      .+.|+.|....+|+.      ..+.+|+......    . .....+|..+++.+...++ .+++...  ++..  ++++|
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~--~~v~e   87 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----E-YINRANEAVAAREAAKAGVSPEVLHVD--PATG--VMVTR   87 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC---------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTC--CEEEE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCcc----c-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCC--EEEEe
Confidence            377888999999998      4588887653211    0 0112357877777653223 3555443  3222  45899


Q ss_pred             cc-cCCCh
Q 027788          109 VC-TSGNL  115 (219)
Q Consensus       109 ~~-~~g~L  115 (219)
                      ++ ++.++
T Consensus        88 ~i~~g~~l   95 (301)
T 3dxq_A           88 YIAGAQTM   95 (301)
T ss_dssp             CCTTCEEC
T ss_pred             ecCCCccC
Confidence            99 65443

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.93  E-value=0.0078  Score=49.62  Aligned_cols=72  Identities=15%  Similarity=0.147  Sum_probs=46.6

Q ss_pred             eeeeeeccccceEEEEEEecC-------CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCc-eEEEEEEecCC
Q 027788           28 RYNELLGSGAVKKVYRAFDQE-------EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI-ISLHYVWRDED   99 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i-~~~~~~~~~~~   99 (219)
                      .+ +.|+.|....+|++....       .+..+.+|+....   ..   ...+..|..+++.+...++ .++++.+  ++
T Consensus        77 ~v-~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~---~~~li~E~~~l~~L~~~g~~P~l~~~~--~~  147 (429)
T 1nw1_A           77 RI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET---ESHLVAESVIFTLLSERHLGPKLYGIF--SG  147 (429)
T ss_dssp             EE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE--TT
T ss_pred             EE-EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEe--CC
Confidence            44 578889999999997542       2578899986421   11   1334468888888754333 4666655  33


Q ss_pred             CceEEEEeccccC
Q 027788          100 RNTLNFITEVCTS  112 (219)
Q Consensus       100 ~~~~~lv~e~~~~  112 (219)
                          .++++|++|
T Consensus       148 ----g~v~e~l~G  156 (429)
T 1nw1_A          148 ----GRLEEYIPS  156 (429)
T ss_dssp             ----EEEECCCCE
T ss_pred             ----CEEEEEeCC
Confidence                258899875

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.84  E-value=0.012  Score=47.74  Aligned_cols=142  Identities=16%  Similarity=0.169  Sum_probs=78.1

Q ss_pred             eeeccccceEEEEEEecC-------CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCC-ceEEEEEEecCCCce
Q 027788           31 ELLGSGAVKKVYRAFDQE-------EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN-IISLHYVWRDEDRNT  102 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~~~~~~~~~~~~~  102 (219)
                      +.+..|-...+|++....       ++..+.+|+.-..     ........+|..+++.|...+ ..++++.+  ++.  
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~g--  126 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-----LQGVDSLVLESVMFAILAERSLGPQLYGVF--PEG--  126 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TTE--
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-----cchHHHHHHHHHHHHHHHhcCCCCeEEEEc--CCc--
Confidence            467678889999987542       3468888875321     111244557999888775322 34566655  332  


Q ss_pred             EEEEeccccCCChH--------------HHHH-hCC-------CCC--HHHHHHHHHHHHH-------------------
Q 027788          103 LNFITEVCTSGNLR--------------EYRK-KHR-------HVS--VKALKKWSKQILK-------------------  139 (219)
Q Consensus       103 ~~lv~e~~~~g~L~--------------~~~~-~~~-------~~~--~~~~~~i~~qv~~-------------------  139 (219)
                        ++||+++|..+.              ..+. -+.       ...  ...+.++..++..                   
T Consensus       127 --~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  204 (379)
T 3feg_A          127 --RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD  204 (379)
T ss_dssp             --EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred             --cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence              689999864332              1111 010       111  2344444433311                   


Q ss_pred             HHHHHH----hC--CCCeeeeCCCCCceEEeCC---CCcEEEeccccceeccc
Q 027788          140 GLNYLH----TH--EPCVIHRDLNCSNVFVNGN---TGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       140 ~l~~lh----~~--~~~i~h~dl~~~nili~~~---~~~~~l~dfg~a~~~~~  183 (219)
                      .+.+|.    ..  ...++|+|+.+.|++++.+   .+.+.++||+.+.....
T Consensus       205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~~~  257 (379)
T 3feg_A          205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYNYR  257 (379)
T ss_dssp             HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEEEH
T ss_pred             HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcCCh
Confidence            122222    11  1238999999999999865   24789999999876544

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.84  E-value=0.0044  Score=49.02  Aligned_cols=35  Identities=26%  Similarity=0.339  Sum_probs=27.7

Q ss_pred             CeeeeCCCCCceEEeCC---CCcEEEeccccceecccc
Q 027788          150 CVIHRDLNCSNVFVNGN---TGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       150 ~i~h~dl~~~nili~~~---~~~~~l~dfg~a~~~~~~  184 (219)
                      .++|+|+++.|++++.+   .+.+.++||+.+..-...
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~~  221 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHRA  221 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECTT
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCCH
Confidence            48999999999999753   136899999998765443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.79  E-value=0.039  Score=45.90  Aligned_cols=72  Identities=17%  Similarity=0.154  Sum_probs=45.0

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCc-eEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI-ISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i-~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      +.|+.|-...+|+......+..+.+|+......  .  ... ..+|..+++.|...++ .++++.+  ++  .  +++||
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~--~id-R~~E~~vl~~L~~~gl~P~ll~~~--~~--G--~v~e~  182 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--E--IIN-REREKKISCILYNKNIAKKIYVFF--TN--G--RIEEF  182 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CC--S--CSC-HHHHHHHHHHHTTSSSBCCEEEEE--TT--E--EEEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChh--h--hcC-HHHHHHHHHHHHhcCCCCCEEEEe--CC--e--EEEEe
Confidence            578889999999998654457888997643211  0  001 1478999998875444 4566665  32  2  38999


Q ss_pred             ccCC
Q 027788          110 CTSG  113 (219)
Q Consensus       110 ~~~g  113 (219)
                      ++|.
T Consensus       183 I~G~  186 (458)
T 2qg7_A          183 MDGY  186 (458)
T ss_dssp             CCSE
T ss_pred             eCCc
Confidence            8763

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.49  E-value=0.019  Score=45.15  Aligned_cols=75  Identities=11%  Similarity=0.121  Sum_probs=42.8

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCC--ceEEEEEEec----CCCceEE
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN--IISLHYVWRD----EDRNTLN  104 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~--i~~~~~~~~~----~~~~~~~  104 (219)
                      ..++ |....||+... .+|+.+++|.......  .   ...+..|..+++.+....  +.+++.. ..    ...+..+
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~--~---~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~  103 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW--T---ADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYF  103 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS--C---HHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC--C---HHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEE
Confidence            3455 78889998753 3566789998763211  1   244566888887775322  2333322 00    0123456


Q ss_pred             EEeccccCC
Q 027788          105 FITEVCTSG  113 (219)
Q Consensus       105 lv~e~~~~g  113 (219)
                      +++++++|.
T Consensus       104 ~l~~~i~G~  112 (328)
T 1zyl_A          104 AVFPSVGGR  112 (328)
T ss_dssp             EEEECCCCE
T ss_pred             EEEEecCCC
Confidence            789999764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.48  E-value=0.01  Score=46.57  Aligned_cols=142  Identities=20%  Similarity=0.130  Sum_probs=71.3

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCC--ceEEEEEEec----CCCceEE
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN--IISLHYVWRD----EDRNTLN  104 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~--i~~~~~~~~~----~~~~~~~  104 (219)
                      +.|+.|....+|+.... ++ .+++|......      ....+..|..+++.+...+  +.+++.....    ......+
T Consensus        28 ~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~------~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~   99 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTT-KD-PLILTLYEKRV------EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA   99 (322)
T ss_dssp             EEECC---EEEEEEEES-SC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred             eccCCCcccceEEEEeC-Cc-cEEEEEeCCCC------CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence            56788888999998643 33 67888876421      1133456777777664322  2222211000    0012356


Q ss_pred             EEeccccCCChH---------------HHHHhCCC--------CCHHHHHHH---------------HHHHHHHHHHHHh
Q 027788          105 FITEVCTSGNLR---------------EYRKKHRH--------VSVKALKKW---------------SKQILKGLNYLHT  146 (219)
Q Consensus       105 lv~e~~~~g~L~---------------~~~~~~~~--------~~~~~~~~i---------------~~qv~~~l~~lh~  146 (219)
                      +++++++|..+.               .+-.....        .........               ...+...+..+..
T Consensus       100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~  179 (322)
T 2ppq_A          100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  179 (322)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence            799999865421               01011001        111111000               0112233444442


Q ss_pred             C-----CCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          147 H-----EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       147 ~-----~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      .     ...++|+|+++.|++++.+ +.+.++||+.+..-
T Consensus       180 ~~~~~~~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~~g  218 (322)
T 2ppq_A          180 HWPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFACND  218 (322)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCEEE
T ss_pred             hCcccCCcccCCCCCCccCEEEeCC-ceEEEecchhccCc
Confidence            1     1238999999999999854 23479999988654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.33  E-value=0.021  Score=45.86  Aligned_cols=72  Identities=15%  Similarity=0.114  Sum_probs=40.7

Q ss_pred             eeeccccceEEEEEEecC--------CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCC-ceEEEEEEecCCCc
Q 027788           31 ELLGSGAVKKVYRAFDQE--------EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN-IISLHYVWRDEDRN  101 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~~~~~~~~~~~~  101 (219)
                      +.++.|....+|+.....        .+..+.+|+.....     ........|..+++.+...+ ..++++..  ++  
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--  109 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-----DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--  109 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-----GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-----cceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence            567788899999987542        12578888754321     11111346888888775433 34565544  22  


Q ss_pred             eEEEEeccccCC
Q 027788          102 TLNFITEVCTSG  113 (219)
Q Consensus       102 ~~~lv~e~~~~g  113 (219)
                        ++++++++|.
T Consensus       110 --~~v~e~i~G~  119 (369)
T 3c5i_A          110 --GRIEEWLYGD  119 (369)
T ss_dssp             --EEEEECCCSE
T ss_pred             --cEEEEEecCC
Confidence              4689998764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=87.84  E-value=0.58  Score=37.00  Aligned_cols=33  Identities=21%  Similarity=0.366  Sum_probs=27.0

Q ss_pred             CeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       150 ~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      .++|+|+.+.|++++.+ +.+.++||+.+..-..
T Consensus       207 ~~~HgD~~~~N~l~~~~-~~~~~iD~e~~~~~~~  239 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNE-ESIYIIDWDEPMLAPK  239 (339)
T ss_dssp             EEECSCCCGGGEEECGG-GCEEECCCSSCEEECT
T ss_pred             eeEeCCCCcCCEEEeCC-CeEEEEECCCCeeCCH
Confidence            48999999999999754 4689999988875544

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.80  E-value=0.029  Score=46.74  Aligned_cols=63  Identities=11%  Similarity=0.050  Sum_probs=16.2

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEE------EEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEE
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAW------NQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVW   95 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vav------K~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~   95 (219)
                      .+.+.+|   ||.||++.......+||+      |..+....  .......+.+|..+.+.++|||+++.+.+.
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~--~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV--SEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-------------------------------------CBCCCEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccc--cccccccccccccccccccccccCCCcceE
Confidence            3445666   999999987665567888      55443221  122335677888888899999998876544

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=83.16  E-value=0.73  Score=37.36  Aligned_cols=35  Identities=14%  Similarity=0.192  Sum_probs=27.4

Q ss_pred             eeeeCCCCCceEEeC-----CCCcEEEeccccceeccccc
Q 027788          151 VIHRDLNCSNVFVNG-----NTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       151 i~h~dl~~~nili~~-----~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ++|+|+.+.||++..     +...+.++||+.|.......
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n~~~f  285 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNYRGF  285 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEEEHHH
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCCCchH
Confidence            579999999999942     33468999999998765533

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	219
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-41
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-35
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-32
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-32
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-32
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-30
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-30
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-29
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-28
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-28
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-27
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-27
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-26
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-26
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-26
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-26
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-26
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-26
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-25
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-25
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-25
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-25
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-24
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-24
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-24
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-24
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-24
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-24
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-24
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-24
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-23
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-23
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-23
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-23
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-22
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-22
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-22
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-22
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-22
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-22
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-21
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-21
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-21
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-21
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-21
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-21
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-21
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-21
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-21
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-20
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-20
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-20
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-19
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-18
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-18
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-18
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-18
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-18
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-18
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-16
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-16
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-14
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-09

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 1e-41
 Identities = 62/175 (35%), Positives = 100/175 (57%), Gaps = 4/175 (2%)

Query: 18  IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEV 77
           +     GR+ +++  +G G+ K VY+  D E  +EVAW +++ R      +  +R   E 
Sbjct: 2   VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEA 59

Query: 78  RLLKTLANKNIISLHYVWRD--EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSK 135
            +LK L + NI+  +  W    + +  +  +TE+ TSG L+ Y K+ + + +K L+ W +
Sbjct: 60  EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR 119

Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRC 190
           QILKGL +LHT  P +IHRDL C N+F+ G TG VKIGDLG+A +   +  +   
Sbjct: 120 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI 174

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  123 bits (310), Expect = 8e-35
 Identities = 46/181 (25%), Positives = 75/181 (41%), Gaps = 9/181 (4%)

Query: 8   DPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDP 67
           DP    +E F + DP   +    E+ G G+   VY A D      VA  ++         
Sbjct: 1   DPDV--AELFFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSN 56

Query: 68  AMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSV 127
              + +  EVR L+ L + N I     +     +T   + E C            + +  
Sbjct: 57  EKWQDIIKEVRFLQKLRHPNTIQYRGCY--LREHTAWLVMEYCLGSASDLLEVHKKPLQE 114

Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR 187
             +   +   L+GL YLH+H   +IHRD+   N+ ++   G VK+GD G A+I+  A   
Sbjct: 115 VEIAAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPANSF 171

Query: 188 I 188
           +
Sbjct: 172 V 172

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 1e-32
 Identities = 38/160 (23%), Positives = 75/160 (46%), Gaps = 7/160 (4%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
             LG+G    V++   +  G+ +A    KL      PA+  ++  E+++L    +  I+ 
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
            +  +  +    ++   E    G+L +  KK   +  + L K S  ++KGL YL   +  
Sbjct: 69  FYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHK 125

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRC 190
           ++HRD+  SN+ VN   G++K+ D GV+  +  ++     
Sbjct: 126 IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMANSFV 164

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 2e-32
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 11/170 (6%)

Query: 19  ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVR 78
           + +P   +      LG GA  KVY+A ++E  +  A   +  +        +E    E+ 
Sbjct: 7   DLNPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK----SEEELEDYMVEID 61

Query: 79  LLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQI 137
           +L +  + NI+ L   +  E+   L  + E C  G +     +  R ++   ++   KQ 
Sbjct: 62  ILASCDHPNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 119

Query: 138 LKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR 187
           L  LNYLH +   +IHRDL   N+    + G +K+ D GV+A   R I+R
Sbjct: 120 LDALNYLHDN--KIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQR 166

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 9e-32
 Identities = 41/160 (25%), Positives = 74/160 (46%), Gaps = 10/160 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
             +G+G+  +  +   + +G  + W ++   +     A  + L SEV LL+ L + NI+ 
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVR 67

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREY----RKKHRHVSVKALKKWSKQILKGLNYLHT 146
            +    D    TL  + E C  G+L        K+ +++  + + +   Q+   L   H 
Sbjct: 68  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127

Query: 147 HEPC---VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR 183
                  V+HRDL  +NVF++G    VK+GD G+A I+  
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNH 166

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 3e-30
 Identities = 36/160 (22%), Positives = 66/160 (41%), Gaps = 6/160 (3%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
             LG G    VY A +++    +A   +  +   +   +  +L  EV +   L + NI+ 
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLF-KAQLEKAGVEHQLRREVEIQSHLRHPNILR 70

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L+  + D  R  +  I E    G +    +K      +    +  ++   L+Y H+    
Sbjct: 71  LYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK--R 126

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRC 190
           VIHRD+   N+ +    G++KI D G +     + R   C
Sbjct: 127 VIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSRRTTLC 165

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 8e-30
 Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 11/177 (6%)

Query: 21  DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           DP  +Y R+ E +G GA   VY A D   G EVA  Q+ L          E + +E+ ++
Sbjct: 17  DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNL----QQQPKKELIINEILVM 71

Query: 81  KTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKG 140
           +   N NI++    +   D   L  + E    G+L +   +        +    ++ L+ 
Sbjct: 72  RENKNPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQA 128

Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSW 197
           L +LH++   VIHRD+   N+ +  + G VK+ D G  A +     +         W
Sbjct: 129 LEFLHSN--QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  108 bits (272), Expect = 5e-29
 Identities = 39/181 (21%), Positives = 72/181 (39%), Gaps = 12/181 (6%)

Query: 18  IETDPTGRYGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS 75
           +E      Y  Y+  E LGSGA   V+R  ++  G       +        P     + +
Sbjct: 20  VEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT----PYPLDKYTVKN 75

Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWS 134
           E+ ++  L +  +I+LH  +  ED+  +  I E  + G L +    +   +S   +  + 
Sbjct: 76  EISIMNQLHHPKLINLHDAF--EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 133

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN-TGQVKIGDLGVAAIVGRAIRRIRCWGR 193
           +Q  +GL ++H H   ++H D+   N+         VKI D G+A  +            
Sbjct: 134 RQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT 191

Query: 194 R 194
            
Sbjct: 192 A 192

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 4e-28
 Identities = 35/160 (21%), Positives = 72/160 (45%), Gaps = 6/160 (3%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           ++LG G+   V  A +     E A   ++ R        +  +  E  ++  L +   + 
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKR-HIIKENKVPYVTRERDVMSRLDHPFFVK 72

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L++ ++D+++  L F      +G L +Y +K         + ++ +I+  L YL  H   
Sbjct: 73  LYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL--HGKG 128

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRC 190
           +IHRDL   N+ +N +   ++I D G A ++    ++ R 
Sbjct: 129 IIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARA 167

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  106 bits (265), Expect = 6e-28
 Identities = 40/171 (23%), Positives = 74/171 (43%), Gaps = 12/171 (7%)

Query: 28  RYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
            Y+  E LG+GA   V+R  ++  G   A   V         +  E +  E++ +  L +
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT----PHESDKETVRKEIQTMSVLRH 82

Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYL 144
             +++LH  +  ED N +  I E  + G L E    +H  +S     ++ +Q+ KGL ++
Sbjct: 83  PTLVNLHDAF--EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 145 HTHEPCVIHRDLNCSNVFVN-GNTGQVKIGDLGVAAIVGRAIRRIRCWGRR 194
           H +    +H DL   N+      + ++K+ D G+ A +          G  
Sbjct: 141 HEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA 189

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 2e-27
 Identities = 38/167 (22%), Positives = 75/167 (44%), Gaps = 14/167 (8%)

Query: 16  PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS 75
           PF+E      +    + LG GA  +V  A ++     VA   V ++   D P  I++   
Sbjct: 2   PFVE-----DW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK--- 52

Query: 76  EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSK 135
           E+ + K L ++N++  +   R+ +        E C+ G L +  +    +     +++  
Sbjct: 53  EICINKMLNHENVVKFYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH 110

Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
           Q++ G+ YLH     + HRD+   N+ ++     +KI D G+A +  
Sbjct: 111 QLMAGVVYLHGI--GITHRDIKPENLLLDER-DNLKISDFGLATVFR 154

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 3e-27
 Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 15/164 (9%)

Query: 22  PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLL 80
           P G+     + +GSG+   VY+     +   VA   VK L      P  ++   +EV +L
Sbjct: 6   PDGQI-TVGQRIGSGSFGTVYKGKWHGD---VA---VKMLNVTAPTPQQLQAFKNEVGVL 58

Query: 81  KTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILK 139
           +   + NI+             L  +T+ C   +L  +         +  L   ++Q  +
Sbjct: 59  RKTRHVNILLFMGY---STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 115

Query: 140 GLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR 183
           G++YLH     +IHRDL  +N+F++ +   VKIGD G+A +  R
Sbjct: 116 GMDYLHAK--SIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSR 156

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  102 bits (254), Expect = 1e-26
 Identities = 35/164 (21%), Positives = 71/164 (43%), Gaps = 10/164 (6%)

Query: 21  DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           D    Y  + ++LG+GA  +V  A D+     VA   +  +        +E    E+ +L
Sbjct: 6   DIRDIY-DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMEN---EIAVL 61

Query: 81  KTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKG 140
             + + NI++L  ++  E    L  I ++ + G L +   +    + +   +   Q+L  
Sbjct: 62  HKIKHPNIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119

Query: 141 LNYLHTHEPCVIHRDLNCSNVFVN--GNTGQVKIGDLGVAAIVG 182
           + YL  H+  ++HRDL   N+         ++ I D G++ +  
Sbjct: 120 VKYL--HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 1e-26
 Identities = 34/171 (19%), Positives = 69/171 (40%), Gaps = 13/171 (7%)

Query: 26  YGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL 83
           Y +Y   E LG G    V+R  +           VK++    D  ++++   E+ +L   
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKK---EISILNIA 58

Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLN 142
            ++NI+ LH  +  E    L  I E  +  ++ E        ++ + +  +  Q+ + L 
Sbjct: 59  RHRNILHLHESF--ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 143 YLHTHEPCVIHRDLNCSNVFV-NGNTGQVKIGDLGVAAIVGRAIRRIRCWG 192
           +LH+H   + H D+   N+      +  +KI + G A  +         + 
Sbjct: 117 FLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT 165

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  100 bits (251), Expect = 2e-26
 Identities = 38/175 (21%), Positives = 70/175 (40%), Gaps = 13/175 (7%)

Query: 26  YGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPA-----MIERLFSEVR 78
           Y  Y   E+LG G    V R   +    E A   + +       A     + E    EV 
Sbjct: 2   YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61

Query: 79  LLKTLAN-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQI 137
           +L+ ++   NII L   +  E       + ++   G L +Y  +   +S K  +K  + +
Sbjct: 62  ILRKVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119

Query: 138 LKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWG 192
           L+ +  LH     ++HRDL   N+ ++ +   +K+ D G +  +    +     G
Sbjct: 120 LEVICALHKL--NIVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCG 171

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  100 bits (249), Expect = 4e-26
 Identities = 35/166 (21%), Positives = 63/166 (37%), Gaps = 7/166 (4%)

Query: 17  FIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSE 76
           F +        +  +++G+G   +V     +  G    +  +K               SE
Sbjct: 19  FAKEIDISCV-KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSE 77

Query: 77  VRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSK 135
             ++    + N+I L  V        +  ITE   +G+L  + R+     +V  L    +
Sbjct: 78  ASIMGQFDHPNVIHLEGVVTKSTP--VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 135

Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
            I  G+ YL       +HRDL   N+ VN N    K+ D G++  +
Sbjct: 136 GIAAGMKYLADM--NYVHRDLAARNILVNSN-LVCKVSDFGLSRFL 178

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.4 bits (247), Expect = 5e-26
 Identities = 37/170 (21%), Positives = 70/170 (41%), Gaps = 9/170 (5%)

Query: 27  GRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD--DPAMIERLFSEVRLLKT 82
            +Y    LLGSG    VY      + + VA   V+     D  +     R+  EV LLK 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 83  L--ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKG 140
           +      +I L   +   D   L  +       +L ++  +   +  +  + +  Q+L+ 
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVL-ILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122

Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRC 190
           + + H     V+HRD+   N+ ++ N G++K+ D G  A++   +     
Sbjct: 123 VRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 170

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  101 bits (252), Expect = 5e-26
 Identities = 34/165 (20%), Positives = 70/165 (42%), Gaps = 7/165 (4%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD--DPAMIERLFSEVRLLKTLANKNI 88
            ++G G   +VY     + G   A   +  +         +       + L+ T     I
Sbjct: 10  RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69

Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           + + Y +   D+  L+FI ++   G+L  +  +H   S   ++ ++ +I+ GL ++H   
Sbjct: 70  VCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR- 126

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGR 193
             V++RDL  +N+ ++   G V+I DLG+A    +          
Sbjct: 127 -FVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTH 169

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.8 bits (245), Expect = 2e-25
 Identities = 34/177 (19%), Positives = 76/177 (42%), Gaps = 12/177 (6%)

Query: 21  DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           D   +Y      +G G   +V++A  ++ G +VA  +V +    +          E+++L
Sbjct: 7   DEVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKIL 63

Query: 81  KTLANKNIISLHYVWRD------EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS 134
           + L ++N+++L  + R         + ++  + + C               ++  +K+  
Sbjct: 64  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123

Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCW 191
           + +L GL Y+  H   ++HRD+  +NV +  + G +K+ D G+A     A       
Sbjct: 124 QMLLNGLYYI--HRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNR 177

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.7 bits (245), Expect = 2e-25
 Identities = 36/189 (19%), Positives = 72/189 (38%), Gaps = 13/189 (6%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           +LLG G   KV    ++  G   A   ++          +    +E R+L+   +  + +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           L Y ++  DR  L F+ E    G L  +  + R  + +  + +  +I+  L   + H   
Sbjct: 70  LKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE--YLHSRD 125

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSWRRSCTMRITRSLW 210
           V++RD+   N+ ++ + G +KI D G+        +     G            +   + 
Sbjct: 126 VVYRDIKLENLMLDKD-GHIKITDFGLC-------KEGISDGATMKTFCGTPEYLAPEVL 177

Query: 211 TYTRLGCAC 219
                G A 
Sbjct: 178 EDNDYGRAV 186

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.6 bits (242), Expect = 5e-25
 Identities = 39/162 (24%), Positives = 75/162 (46%), Gaps = 6/162 (3%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD-DPAMIERLFSEVRLLKTLANKNII 89
           + LG G    VY+A D+     VA  ++KL    +    +      E++LL+ L++ NII
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
            L   +    ++ ++ + +   +      +     ++   +K +    L+GL YL  H+ 
Sbjct: 64  GLLDAF--GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL--HQH 119

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCW 191
            ++HRDL  +N+ ++ N G +K+ D G+A   G   R     
Sbjct: 120 WILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQ 160

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 97.9 bits (243), Expect = 5e-25
 Identities = 37/178 (20%), Positives = 69/178 (38%), Gaps = 6/178 (3%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
             LG+G+  +V+    +  G   A   +K +        +E    E  +L  + +  II 
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           +   ++D  +  +  I +    G L    +K +       K ++ ++   L YL  H   
Sbjct: 69  MWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL--HSKD 124

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSWRRSCTMRITRS 208
           +I+RDL   N+ ++ N G +KI D G A  V      +       +     T    +S
Sbjct: 125 IIYRDLKPENILLDKN-GHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKS 181

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.2 bits (241), Expect = 1e-24
 Identities = 39/171 (22%), Positives = 77/171 (45%), Gaps = 17/171 (9%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           +++G+G+   VY+A   + G  VA  +V       D     R   E+++++ L + NI+ 
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNR---ELQIMRKLDHCNIVR 77

Query: 91  LHYVWRD----EDRNTLNFITEVCTSGN---LREYRKKHRHVSVKALKKWSKQILKGLNY 143
           L Y +      +D   LN + +          R Y +  + + V  +K +  Q+ + L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRR 194
           +H+    + HRD+   N+ ++ +T  +K+ D G A  + R    +     R
Sbjct: 138 IHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.4 bits (239), Expect = 2e-24
 Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 8/170 (4%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQ-VKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
           ++LGSGA   VY+     EG +V     +K       P   + +  E  ++ ++ N ++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTHE 148
            L  +        +  IT++   G L +Y ++H+ ++  + L  W  QI KG+NYL    
Sbjct: 75  RLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 130

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSWR 198
             ++HRDL   NV V      VKI D G+A ++G   +     G +   +
Sbjct: 131 -RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.8 bits (235), Expect = 4e-24
 Identities = 43/172 (25%), Positives = 79/172 (45%), Gaps = 11/172 (6%)

Query: 28  RYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF--CDDPAMIERLFSEVRLLKTL 83
            Y+  E LGSG    V +  ++  G++ A   +K R           E +  EV +LK +
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
            + N+I+LH V+  E++  +  I E+   G L ++  +   ++ +   ++ KQIL G+  
Sbjct: 71  QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY- 127

Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDLGVAAIVGRAIRRIRCWG 192
            + H   + H DL   N+ +   N    ++KI D G+A  +         +G
Sbjct: 128 -YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 178

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.5 bits (237), Expect = 5e-24
 Identities = 31/175 (17%), Positives = 61/175 (34%), Gaps = 18/175 (10%)

Query: 24  GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL 83
             Y   +++LG G   KV + F++    + A   ++            +   EV L    
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRA 61

Query: 84  AN-KNIISLHYVWRD--EDRNTLNFITEVCTSGNLREY--RKKHRHVSVKALKKWSKQIL 138
           +   +I+ +  V+ +    R  L  + E    G L      +  +  + +   +  K I 
Sbjct: 62  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 121

Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVN--GNTGQVKIGDLGVAAIVGRAIRRIRCW 191
           + + YLH+    + HRD+   N+          +K+ D G A             
Sbjct: 122 EAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 174

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 6e-24
 Identities = 43/176 (24%), Positives = 76/176 (43%), Gaps = 10/176 (5%)

Query: 21  DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
           D   RY      +G GA   V  A+D    + VA   +K  +  +     +R   E+++L
Sbjct: 5   DVGPRY-TNLSYIGEGAYGMVCSAYDNVNKVRVA---IKKISPFEHQTYCQRTLREIKIL 60

Query: 81  KTLANKNIISLHYVWRDEDRNTLN--FITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
               ++NII ++ + R      +   ++       +L +   K +H+S   +  +  QIL
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQIL 119

Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRR 194
           +GL Y+H+    V+HRDL  SN+ +N     +KI D G+A +              
Sbjct: 120 RGLKYIHSA--NVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEY 172

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.8 bits (235), Expect = 8e-24
 Identities = 46/208 (22%), Positives = 79/208 (37%), Gaps = 31/208 (14%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD--DPAMIERLFSEVRLLKTLAN-KN 87
           ++LGSGA  KV  A            QV ++   +  D +  E L SE++++  L + +N
Sbjct: 43  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102

Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH----------------------- 124
           I++L           +  I E C  G+L  Y +  R                        
Sbjct: 103 IVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160

Query: 125 VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA 184
           ++ + L  ++ Q+ KG+ +L       +HRDL   NV V      VKI D G+A  +   
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSD 217

Query: 185 IRRIRCWGRRSSWRRSCTMRITRSLWTY 212
              +     R   +      +   ++T 
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTI 245

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 93.7 bits (232), Expect = 8e-24
 Identities = 30/146 (20%), Positives = 59/146 (40%), Gaps = 6/146 (4%)

Query: 23  TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKT 82
           + RY    E+LG G + +V+ A D     +VA   ++      DP+   R   E +    
Sbjct: 6   SDRY-ELGEILGFGGMSEVHLARDLRLHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAA 63

Query: 83  LANKNIISLHYVWRDEDR--NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKG 140
           L +  I++++     E         + E      LR+       ++ K   +      + 
Sbjct: 64  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123

Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGN 166
           LN+ H +   +IHRD+  +N+ ++  
Sbjct: 124 LNFSHQN--GIIHRDVKPANIMISAT 147

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.6 bits (232), Expect = 9e-24
 Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 12/155 (7%)

Query: 30  NELLGSGAVKKVYRAFDQEE--GIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLANK 86
           ++ LGSG    V + + Q +     VA   VK L+   +DPA+ + L +E  +++ L N 
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVA---VKILKNEANDPALKDELLAEANVMQQLDNP 68

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
            I+ +  +   E       + E+   G L +Y +++RHV  K + +   Q+  G+ YL  
Sbjct: 69  YIVRMIGICEAES---WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 125

Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
                +HRDL   NV +       KI D G++  +
Sbjct: 126 S--NFVHRDLAARNVLLVTQ-HYAKISDFGLSKAL 157

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.0 bits (233), Expect = 1e-23
 Identities = 29/148 (19%), Positives = 66/148 (44%), Gaps = 5/148 (3%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           ++LG G+  KV+ A  ++     A   +K      D  +   +  +  L     +  +  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
           +   ++ ++   L F+ E    G+L  + +      +     ++ +I+ GL +LH+    
Sbjct: 68  MFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK--G 123

Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +++RDL   N+ ++ + G +KI D G+ 
Sbjct: 124 IVYRDLKLDNILLDKD-GHIKIADFGMC 150

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.2 bits (231), Expect = 2e-23
 Identities = 37/153 (24%), Positives = 64/153 (41%), Gaps = 12/153 (7%)

Query: 33  LGSGAVKKVYRAFDQE--EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           LG G    V +   +   + I+VA   +K+     + A  E +  E +++  L N  I+ 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
           L  V +      L  + E+   G L ++   K   + V  + +   Q+  G+ YL     
Sbjct: 74  LIGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK-- 128

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG 182
             +HRDL   NV +       KI D G++  +G
Sbjct: 129 NFVHRDLAARNVLLVNR-HYAKISDFGLSKALG 160

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 93.8 bits (232), Expect = 2e-23
 Identities = 33/175 (18%), Positives = 74/175 (42%), Gaps = 13/175 (7%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNII 89
             LG G   +V+ A +     +V    +K       P   +++  E+++L+ L    NII
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIKREIKILENLRGGPNII 93

Query: 90  SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
           +L  + +D    T   + E   + + ++    ++ ++   ++ +  +ILK L+Y H+   
Sbjct: 94  TLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSM-- 148

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSWRRSCTMR 204
            ++HRD+   NV ++    ++++ D G+A               R        + 
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 203

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 92.9 bits (230), Expect = 2e-23
 Identities = 43/162 (26%), Positives = 66/162 (40%), Gaps = 12/162 (7%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
             LG G   +VY    ++  + VA   +K     +D   +E    E  ++K + + N++ 
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQ 77

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREY--RKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           L  V   E       ITE  T GNL +Y      + VS   L   + QI   + YL   +
Sbjct: 78  LLGVCTREPP--FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EK 133

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRC 190
              IHRDL   N  V  N   VK+ D G++ ++         
Sbjct: 134 KNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHA 174

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.6 bits (224), Expect = 2e-22
 Identities = 48/209 (22%), Positives = 80/209 (38%), Gaps = 32/209 (15%)

Query: 28  RYNELLGSGAVKKVYRA-----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKT 82
            + + LG+GA  KV  A        +  + VA   VK+          E L SE+++L  
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVA---VKMLKPSAHLTEREALMSELKVLSY 82

Query: 83  LAN-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH----------------- 124
           L N  NI++L              ITE C  G+L  + ++ R                  
Sbjct: 83  LGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 125 -VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR 183
            + ++ L  +S Q+ KG+ +L +     IHRDL   N+ +       KI D G+A  +  
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNILLTHG-RITKICDFGLARDIKN 197

Query: 184 AIRRIRCWGRRSSWRRSCTMRITRSLWTY 212
               +     R   +      I   ++T+
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTF 226

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.6 bits (224), Expect = 2e-22
 Identities = 37/175 (21%), Positives = 72/175 (41%), Gaps = 5/175 (2%)

Query: 8   DPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDP 67
           +P    +   +   P+     +NE++G G    VY     +   +     VK      D 
Sbjct: 10  NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 69

Query: 68  AMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VS 126
             + +  +E  ++K  ++ N++SL  +    + + L  +      G+LR + +   H  +
Sbjct: 70  GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRNETHNPT 128

Query: 127 VKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           VK L  +  Q+ KG+          +HRDL   N  ++     VK+ D G+A  +
Sbjct: 129 VKDLIGFGLQVAKGMK--FLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDM 180

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 90.2 bits (223), Expect = 4e-22
 Identities = 36/178 (20%), Positives = 74/178 (41%), Gaps = 7/178 (3%)

Query: 1   MMPAVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKL 60
            +     D   K   P   T    ++    + LG+G+  +V     +E G   A   +  
Sbjct: 18  FLAKAKEDFLKKWETPSQNTAQLDQF-DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK 76

Query: 61  RTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRK 120
           +        IE   +E R+L+ +    ++ L + ++D   + L  + E    G +  + +
Sbjct: 77  QKV-VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFSHLR 133

Query: 121 KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
           +    S    + ++ QI+    YLH+    +I+RDL   N+ ++   G +++ D G A
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFEYLHSL--DLIYRDLKPENLLIDQQ-GYIQVTDFGFA 188

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.5 bits (219), Expect = 5e-22
 Identities = 36/150 (24%), Positives = 62/150 (41%), Gaps = 14/150 (9%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           + +G G    V        G +VA   VK      + A  +   +E  ++  L + N++ 
Sbjct: 13  QTIGKGEFGDVMLG--DYRGNKVA---VKC---IKNDATAQAFLAEASVMTQLRHSNLVQ 64

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREY--RKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
           L  V  +E    L  +TE    G+L +Y   +    +    L K+S  + + + YL    
Sbjct: 65  LLGVIVEEK-GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EG 121

Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
              +HRDL   NV V+ +    K+ D G+ 
Sbjct: 122 NNFVHRDLAARNVLVSED-NVAKVSDFGLT 150

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.2 bits (220), Expect = 5e-22
 Identities = 45/169 (26%), Positives = 77/169 (45%), Gaps = 8/169 (4%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G    VY+A ++  G  VA  +++L T  +   +      E+ LLK L + NI+ 
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 65

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEP 149
           L  V   E++  L  + E       +         + +  +K +  Q+L+GL + H+H  
Sbjct: 66  LLDVIHTENK--LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH-- 121

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSWR 198
            V+HRDL   N+ +N   G +K+ D G+A   G  +R          +R
Sbjct: 122 RVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.2 bits (220), Expect = 6e-22
 Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 9/173 (5%)

Query: 28  RYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           +Y   E +G G    V++A ++E    VA  +V+L    DD  +      E+ LLK L +
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKH 60

Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLH 145
           KNI+ LH V   + + TL  + E C     + +   +  +  + +K +  Q+LKGL + H
Sbjct: 61  KNIVRLHDVLHSDKKLTL--VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSWR 198
           +    V+HRDL   N+ +N N G++K+ + G+A   G  +R          +R
Sbjct: 119 SR--NVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYR 168

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.7 bits (219), Expect = 1e-21
 Identities = 30/176 (17%), Positives = 68/176 (38%), Gaps = 7/176 (3%)

Query: 31  ELLGSGAVKKVYRAFD---QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
           ++LG+GA  KV+        + G   A   +K  T        E   +E ++L+ +    
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
            + +   +  +    L+ I +    G L  +  +    +   ++ +  +I+  L +LH  
Sbjct: 90  FL-VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 148

Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSWRRSCTM 203
              +I+RD+   N+ ++ N G V + D G++                +    +  +
Sbjct: 149 --GIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.9 bits (217), Expect = 1e-21
 Identities = 39/185 (21%), Positives = 76/185 (41%), Gaps = 13/185 (7%)

Query: 31  ELLGSGAVKKVYRAFD---QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
             +G G    V++      +   + VA   +K    C   ++ E+   E   ++   + +
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQEALTMRQFDHPH 69

Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYLHT 146
           I+ L  V  +   N +  I E+CT G LR + + +   + + +L  ++ Q+   L YL  
Sbjct: 70  IVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL-- 124

Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSWRRSCTMRIT 206
                +HRD+   NV V+ N   VK+GD G++  +  +       G+      +      
Sbjct: 125 ESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 207 RSLWT 211
           R   +
Sbjct: 184 RRFTS 188

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.8 bits (217), Expect = 1e-21
 Identities = 37/168 (22%), Positives = 66/168 (39%), Gaps = 12/168 (7%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           + +GSG    V+  +      +VA   +K  T  +     E    E  ++  L++  ++ 
Sbjct: 11  QEIGSGQFGLVHLGYWLN-KDKVA---IK--TIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
           L+ V  ++    +  + E    G L +Y R +    + + L      + +G+ YL   E 
Sbjct: 65  LYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL--EEA 120

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSW 197
           CVIHRDL   N  V  N   +K+ D G+   V           +    
Sbjct: 121 CVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 167

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.8 bits (217), Expect = 1e-21
 Identities = 38/156 (24%), Positives = 73/156 (46%), Gaps = 14/156 (8%)

Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
           +  E LG+G   +V+  +      +VA   +K           +   +E  L+K L ++ 
Sbjct: 16  KLVERLGAGQFGEVWMGYYNG-HTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQHQR 69

Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLH 145
           ++ L+ V   E    +  ITE   +G+L ++ K    +  ++  L   + QI +G+ ++ 
Sbjct: 70  LVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
                 IHRDL  +N+ V+ +T   KI D G+A ++
Sbjct: 127 ER--NYIHRDLRAANILVS-DTLSCKIADFGLARLI 159

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 88.0 bits (217), Expect = 2e-21
 Identities = 35/175 (20%), Positives = 61/175 (34%), Gaps = 13/175 (7%)

Query: 27  GRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA 84
            RY     +GSG+   +Y   D   G EVA     ++T         +L  E ++ K + 
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQ 60

Query: 85  NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
               I         + +    + E+        +    R  S+K +   + Q++  + Y+
Sbjct: 61  GGVGIPTIRWC-GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119

Query: 145 HTHEPCVIHRDLNCSNVFV--NGNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSW 197
           H+     IHRD+   N  +        V I D G+A     A        R +  
Sbjct: 120 HSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.2 bits (215), Expect = 3e-21
 Identities = 39/155 (25%), Positives = 66/155 (42%), Gaps = 17/155 (10%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           E +G G   +V+R   +  G EVA      R   +     E    E+     L ++NI+ 
Sbjct: 9   ESIGKGRFGEVWRG--KWRGEEVAVKIFSSRE--ERSWFREA---EIYQTVMLRHENILG 61

Query: 91  LHYVWRDEDRN--TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT-- 146
                  ++     L  +++    G+L +Y  ++  V+V+ + K +     GL +LH   
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEI 120

Query: 147 ----HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV 177
                +P + HRDL   N+ V  N G   I DLG+
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGL 154

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 86.1 bits (212), Expect = 6e-21
 Identities = 44/173 (25%), Positives = 76/173 (43%), Gaps = 10/173 (5%)

Query: 28  RYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
           +Y+  E +G G    VY+A +   G   A  +++L    +D  +      E+ +LK L +
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEK--EDEGIPSTTIREISILKELKH 59

Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLH 145
            NI+ L+ V   + R  L  + E       +        +     K +  Q+L G+ Y  
Sbjct: 60  SNIVKLYDVIHTKKR--LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC- 116

Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSSWR 198
            H+  V+HRDL   N+ +N   G++KI D G+A   G  +R+         +R
Sbjct: 117 -HDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYR 167

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.2 bits (215), Expect = 6e-21
 Identities = 46/168 (27%), Positives = 73/168 (43%), Gaps = 9/168 (5%)

Query: 28  RYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
            Y   + +GSGA   V  A D   G +VA    KL          +R + E+RLLK + +
Sbjct: 19  VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMRH 76

Query: 86  KNIISLHYVWRDEDR--NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
           +N+I L  V+  ++   +  +F   +   G       KH  +    ++    Q+LKGL Y
Sbjct: 77  ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 136

Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCW 191
           +H       HRDL   N+ VN +  ++KI D G+A      +      
Sbjct: 137 IHAAGII--HRDLKPGNLAVNED-CELKILDFGLARQADSEMTGYVVT 181

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.9 bits (212), Expect = 8e-21
 Identities = 36/156 (23%), Positives = 69/156 (44%), Gaps = 14/156 (8%)

Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
           R    LG G   +V+          VA   +K  T        E    E +++K L ++ 
Sbjct: 20  RLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSP-----EAFLQEAQVMKKLRHEK 73

Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREY--RKKHRHVSVKALKKWSKQILKGLNYLH 145
           ++ L+ V  +E    +  +TE  + G+L ++   +  +++ +  L   + QI  G+ Y+ 
Sbjct: 74  LVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130

Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
                 +HRDL  +N+ V  N    K+ D G+A ++
Sbjct: 131 RM--NYVHRDLRAANILVGEN-LVCKVADFGLARLI 163

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.2 bits (210), Expect = 1e-20
 Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 11/155 (7%)

Query: 31  ELLGSGAVKKVYRAF---DQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
           E LG G+   V R        + + VA   +K       P  ++    EV  + +L ++N
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK-PDVLSQPEAMDDFIREVNAMHSLDHRN 72

Query: 88  IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHT 146
           +I L+ V        +  +TE+   G+L +  +KH+ H  +  L +++ Q+ +G+ YL  
Sbjct: 73  LIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL-- 127

Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
                IHRDL   N+ +      VKIGD G+   +
Sbjct: 128 ESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRAL 161

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.2 bits (205), Expect = 6e-20
 Identities = 35/149 (23%), Positives = 66/149 (44%), Gaps = 12/149 (8%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
           + LG+G    V     +    +VA   +K     +     +    E +++  L+++ ++ 
Sbjct: 10  KELGTGQFGVVKYGKWRG-QYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 91  LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNYLHTHEP 149
           L+ V   +    +  ITE   +G L  Y ++ RH    + L +  K + + + YL +   
Sbjct: 64  LYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK-- 119

Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDLGVA 178
             +HRDL   N  VN   G VK+ D G++
Sbjct: 120 QFLHRDLAARNCLVNDQ-GVVKVSDFGLS 147

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.7 bits (206), Expect = 6e-20
 Identities = 39/182 (21%), Positives = 74/182 (40%), Gaps = 23/182 (12%)

Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN-K 86
           ++ +++G G   +V +A  +++G+ +    +K                E+ +L  L +  
Sbjct: 13  KFQDVIGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV----------------SVKAL 130
           NII+L      E R  L    E    GNL ++ +K R +                S + L
Sbjct: 72  NIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 131 KKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRC 190
             ++  + +G++YL   +   IHRDL   N+ V  N    KI D G++      +++   
Sbjct: 130 LHFAADVARGMDYL--SQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMG 186

Query: 191 WG 192
             
Sbjct: 187 RL 188

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.5 bits (200), Expect = 6e-19
 Identities = 49/170 (28%), Positives = 74/170 (43%), Gaps = 13/170 (7%)

Query: 28  RYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVK-LRTFCDDPAMIERLFSEVRLLKTLA 84
           RY     +GSGA   V  AFD + G+ VA   VK L          +R + E+RLLK + 
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVA---VKKLSRPFQSIIHAKRTYRELRLLKHMK 75

Query: 85  NKNIISLHYVWRDEDR---NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
           ++N+I L  V+            ++       +L    K  +       +    QIL+GL
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-QFLIYQILRGL 134

Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCW 191
            Y+H+    +IHRDL  SN+ VN    ++KI D G+A      +      
Sbjct: 135 KYIHSA--DIIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMTGYVAT 181

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 80.3 bits (197), Expect = 1e-18
 Identities = 44/215 (20%), Positives = 65/215 (30%), Gaps = 38/215 (17%)

Query: 22  PTGRYGRYNELLGSGAVKKVYRA-----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSE 76
           P      Y   +G GA  +V++A        E    VA   VK+        M      E
Sbjct: 11  PRNNI-EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVA---VKMLKEEASADMQADFQRE 66

Query: 77  VRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH------------ 124
             L+    N NI+ L  V        +  + E    G+L E+ +                
Sbjct: 67  AALMAEFDNPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 125 ------------VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKI 172
                       +S       ++Q+  G+ YL       +HRDL   N  V  N   VKI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGEN-MVVKI 181

Query: 173 GDLGVAAIVGRAIRRIRCWGRRSSWRRSCTMRITR 207
            D G++  +  A             R      I  
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 79.9 bits (196), Expect = 2e-18
 Identities = 29/177 (16%), Positives = 61/177 (34%), Gaps = 14/177 (7%)

Query: 24  GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL 83
             Y +    +G G+   ++   +     +VA   +K   F    +   +L  E R  K L
Sbjct: 5   VHY-KVGRRIGEGSFGVIFEGTNLLNNQQVA---IK---FEPRRSDAPQLRDEYRTYKLL 57

Query: 84  ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
           A    I  +  +  ++      + ++             R  SVK +   +KQ+L  +  
Sbjct: 58  AGCTGIP-NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116

Query: 144 LHTHEPCVIHRDLNCSNVFVN----GNTGQVKIGDLGVAAIVGRAIRRIRCWGRRSS 196
           +H     +++RD+   N  +      N   + + D G+       + +     R   
Sbjct: 117 IHEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.0 bits (196), Expect = 2e-18
 Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 14/172 (8%)

Query: 27  GRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA 84
            RY   + +GSGA   V  A+D      VA  ++       +    +R + E+ L+K + 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVN 74

Query: 85  NKNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKG 140
           +KNIISL  V+      E+   +  + E+  +   +  + +  H   + +     Q+L G
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH---ERMSYLLYQMLCG 131

Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWG 192
           + +LH+    +IHRDL  SN+ V  +   +KI D G+A   G +        
Sbjct: 132 IKHLHSA--GIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVV 180

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.7 bits (193), Expect = 3e-18
 Identities = 36/157 (22%), Positives = 64/157 (40%), Gaps = 13/157 (8%)

Query: 30  NELLGSGAVKKVYRAF----DQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
            +++G+G   +VY+        ++ + VA   +K                E  ++   ++
Sbjct: 12  QKVIGAGEFGEVYKGMLKTSSGKKEVPVA---IKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYL 144
            NII L  V        +  ITE   +G L ++ R+K    SV  L    + I  G    
Sbjct: 69  HNIIRLEGVISKYKP--MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG--MK 124

Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV 181
           +      +HRDL   N+ VN N    K+ D G++ ++
Sbjct: 125 YLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVL 160

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.8 bits (193), Expect = 3e-18
 Identities = 42/203 (20%), Positives = 77/203 (37%), Gaps = 21/203 (10%)

Query: 28  RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD--PAMIERLFSEVRLLKTLAN 85
           +  + LG GA  +V  A             V ++   +    +    L SE+++L  + +
Sbjct: 16  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 75

Query: 86  KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH----------------VSVKA 129
              +        +    L  I E C  GNL  Y +  R+                ++++ 
Sbjct: 76  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135

Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIR 189
           L  +S Q+ KG+ +L +     IHRDL   N+ ++     VKI D G+A  + +    +R
Sbjct: 136 LICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVR 192

Query: 190 CWGRRSSWRRSCTMRITRSLWTY 212
               R   +      I   ++T 
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTI 215

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.4 bits (192), Expect = 6e-18
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 13/170 (7%)

Query: 31  ELLGSGAVKKVYRAFDQEE-GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN---K 86
             +G GA  KV++A D +  G  VA  +V+++T   +  M      EV +L+ L      
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT--GEEGMPLSTIREVAVLRHLETFEHP 70

Query: 87  NIISLHYVW---RDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLN 142
           N++ L  V    R +    L  + E           +     V  + +K    Q+L+GL+
Sbjct: 71  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 130

Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRCWG 192
           +LH+H   V+HRDL   N+ V  + GQ+K+ D G+A I    +       
Sbjct: 131 FLHSH--RVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVV 177

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.5 bits (182), Expect = 1e-16
 Identities = 45/202 (22%), Positives = 71/202 (35%), Gaps = 24/202 (11%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQ----VKLRTFCDDPAMIERLFSEVRLLKTLANK 86
           + LG GA  +V  A       +         VK+         +  L SE+ ++K +   
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 87  NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKAL 130
             I             L  I E  + GNLREY +  R                 +S K L
Sbjct: 79  KNIINLLGA-CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137

Query: 131 KKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRC 190
              + Q+ +G+ YL       IHRDL   NV V  +   +KI D G+A  +       + 
Sbjct: 138 VSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKT 194

Query: 191 WGRRSSWRRSCTMRITRSLWTY 212
              R   +      +   ++T+
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTH 216

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.6 bits (177), Expect = 6e-16
 Identities = 35/159 (22%), Positives = 62/159 (38%), Gaps = 17/159 (10%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF--CDDPAMIERLFSEVRLLKTLANKNI 88
             LG G+   VY    +    +    +V ++T              +E  ++K     ++
Sbjct: 26  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85

Query: 89  ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV----------SVKALKKWSKQIL 138
           + L  V           I E+ T G+L+ Y +  R            S+  + + + +I 
Sbjct: 86  VRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143

Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV 177
            G+ YL+ +    +HRDL   N  V  +   VKIGD G+
Sbjct: 144 DGMAYLNAN--KFVHRDLAARNCMVAED-FTVKIGDFGM 179

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 69.7 bits (169), Expect = 1e-14
 Identities = 38/202 (18%), Positives = 71/202 (35%), Gaps = 22/202 (10%)

Query: 27  GRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA 84
            RY     LG G    V+ A D      VA   V+      D    E    E++LL+ + 
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVN 67

Query: 85  N-----------KNIISLHYVWRDEDRNTLNFITEVCTSGN---LREYRKKHRHVSVKAL 130
           +            +I+ L   +  +  N ++ +      G        + +HR + +  +
Sbjct: 68  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127

Query: 131 KKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRIRC 190
           K+ SKQ+L GL+Y+H     +IH D+   NV +        +  + +A +          
Sbjct: 128 KQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186

Query: 191 WGRRSSWRRSCTMRITRSLWTY 212
                +        +  + W  
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGC 208

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 53.6 bits (128), Expect = 1e-09
 Identities = 29/181 (16%), Positives = 54/181 (29%), Gaps = 29/181 (16%)

Query: 31  ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMI------ERLFSEVRLLKTLA 84
           +L+G G    V+  +  E+  E      K+                              
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 85  NKNIISLH--YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLN 142
            + +  L    V +         + E+          K+   V V+   +    IL+ + 
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAVLMELI-------DAKELYRVRVENPDEVLDMILEEVA 117

Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG---------RAIRRIRCWGR 193
             +     ++H DL+  NV V+     + I D   +  VG         R +R I  +  
Sbjct: 118 KFYHR--GIVHGDLSQYNVLVSEE--GIWIIDFPQSVEVGEEGWREILERDVRNIITYFS 173

Query: 194 R 194
           R
Sbjct: 174 R 174

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	219
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.96
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.26
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.2
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.87
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.69
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.37
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.53

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-43  Score=276.18  Aligned_cols=191  Identities=32%  Similarity=0.644  Sum_probs=160.6

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec--
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD--   97 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--   97 (219)
                      ....++|++++++||+|+||.||+|++..++..||+|.+.....  .....+.+.+|++++++++||||+++++++..  
T Consensus         4 ~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   81 (270)
T d1t4ha_           4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   81 (270)
T ss_dssp             ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred             cCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence            44678999999999999999999999999999999999886543  44556789999999999999999999999854  


Q ss_pred             CCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                      .+...++++|||+++|+|.+++.....+++..+..++.|++.||.|||+++++|+||||||+|||++.+.+.+||+|||+
T Consensus        82 ~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl  161 (270)
T d1t4ha_          82 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  161 (270)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             ccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence            34567899999999999999998878899999999999999999999998777999999999999975456899999999


Q ss_pred             ceeccccce----eeeecccCccccCCCccccccceeeecc
Q 027788          178 AAIVGRAIR----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      |+.......    ++..+.+||-+ . ..++.++||||+||
T Consensus       162 a~~~~~~~~~~~~GT~~Y~aPE~~-~-~~~~~~~DIwSlGv  200 (270)
T d1t4ha_         162 ATLKRASFAKAVIGTPEFMAPEMY-E-EKYDESVDVYAFGM  200 (270)
T ss_dssp             GGGCCTTSBEESCSSCCCCCGGGG-G-TCCCTHHHHHHHHH
T ss_pred             ceeccCCccCCcccCccccCHHHh-C-CCCCCcCchhhHHH
Confidence            986544432    23334444433 3 35888999999994

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-43  Score=272.39  Aligned_cols=182  Identities=20%  Similarity=0.296  Sum_probs=148.2

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++| ++.+.||+|+||.||+|++..+++.||+|+++....   ....+.+.+|+.++++++||||+++++++..  .+.+
T Consensus         5 ~dy-~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~   78 (271)
T d1nvra_           5 EDW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQ   78 (271)
T ss_dssp             TEE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEE
T ss_pred             cce-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCCEeeEeeeecc--Ccee
Confidence            455 788999999999999999999999999999976532   2234668899999999999999999999965  4568


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++|||+++|+|.+++.....+++..+..++.|++.||.|||+++  |+||||||+||+++.+ +.+||+|||+|+....
T Consensus        79 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRY  155 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTT-CCEEECCCTTCEECEE
T ss_pred             EEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCC-CCEEEccchhheeecc
Confidence            899999999999999887778999999999999999999999999  9999999999999865 5899999999997754


Q ss_pred             cce--------eeeecccCccccCCCccccccceeeecc
Q 027788          184 AIR--------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~--------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ...        ++..+.+||-+...+.++.++||||+||
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGv  194 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI  194 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHH
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHH
Confidence            332        2223334433333333456699999994

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-42  Score=269.87  Aligned_cols=186  Identities=24%  Similarity=0.373  Sum_probs=154.5

Q ss_pred             cccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec
Q 027788           18 IETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD   97 (219)
Q Consensus        18 ~~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   97 (219)
                      ..+||..+| .+.++||+|+||.||+|.+..+|+.||+|.++.....    ..+.+.+|+.++++++||||+++++++..
T Consensus        14 ~~~dp~~~Y-~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~   88 (293)
T d1yhwa1          14 SVGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLV   88 (293)
T ss_dssp             BSSCTTTTB-CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             CCCCccccc-EEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh----HHHHHHHHHHHHHhCCCCCEeeEeEEEEE
Confidence            345677777 6668999999999999999999999999998865422    23678899999999999999999999965


Q ss_pred             CCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                      +  +.+|++|||+++|+|.+++.. ..+++..+..++.|++.||.|||+++  ++||||||+|||++.+ +.+||+|||+
T Consensus        89 ~--~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~-~~vkl~DFG~  162 (293)
T d1yhwa1          89 G--DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMD-GSVKLTDFGF  162 (293)
T ss_dssp             T--TEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTT
T ss_pred             C--CEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCC-CcEeeccchh
Confidence            4  568899999999999998765 46999999999999999999999999  9999999999999866 6899999999


Q ss_pred             ceeccccce-eeeeccc----CccccCCCccccccceeeecc
Q 027788          178 AAIVGRAIR-RIRCWGR----RSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~diws~gi  214 (219)
                      |+.+..... .....|+    +++......++.++||||+||
T Consensus       163 a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  204 (293)
T d1yhwa1         163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI  204 (293)
T ss_dssp             CEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHH
T ss_pred             heeeccccccccccccCCCccChhhhcCCCCCchhceehHhH
Confidence            998754432 2222232    223445667888999999994

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-42  Score=265.07  Aligned_cols=183  Identities=20%  Similarity=0.283  Sum_probs=153.9

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+| .+.+.||+|+||.||+|++..+++.||+|+++..... +....+.+.+|+.++++++||||+++++++.+  .+.+
T Consensus         6 ~dy-~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~   81 (263)
T d2j4za1           6 EDF-EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRV   81 (263)
T ss_dssp             GGE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred             hHe-EEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc-ChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--CCEE
Confidence            345 7889999999999999999999999999998754322 12234678899999999999999999999954  4568


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++|||+++|+|.+++.....+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+|.....
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~-~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSA-GELKIADFGWSVHAPS  158 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEECCCCSCSCCCC
T ss_pred             EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCC-CCEeecccceeeecCC
Confidence            899999999999999988788999999999999999999999999  9999999999999866 5899999999987755


Q ss_pred             cce----eeeecccCccccCCCccccccceeeecc
Q 027788          184 AIR----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ...    ++..+.+|| ......++.++||||+||
T Consensus       159 ~~~~~~~Gt~~Y~APE-~~~~~~~~~~~DiwSlGv  192 (263)
T d2j4za1         159 SRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV  192 (263)
T ss_dssp             CCCEETTEEGGGCCHH-HHTTCCCCTTHHHHHHHH
T ss_pred             CcccccCCCCcccCHH-HHcCCCCCchhhhhhHhH
Confidence            432    333344443 445567888999999994

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-42  Score=270.57  Aligned_cols=186  Identities=26%  Similarity=0.448  Sum_probs=154.9

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE   98 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~   98 (219)
                      +.+|...| ++.+.||+|+||.||+|++..++..||+|.++...    ....+.+.+|++++++++||||+++++++..+
T Consensus         7 ~~~p~d~Y-~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~   81 (288)
T d2jfla1           7 DLNPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYE   81 (288)
T ss_dssp             SSCGGGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS----SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             CCCcccCe-EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            34555666 78899999999999999999999999999987542    33456788999999999999999999999654


Q ss_pred             CCceEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788           99 DRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                        +.++++|||+++|+|.+++.. ...+++..+..++.|++.||.|||+++  |+||||||+||+++.+ +.+||+|||+
T Consensus        82 --~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~-~~~Kl~DFG~  156 (288)
T d2jfla1          82 --NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLD-GDIKLADFGV  156 (288)
T ss_dssp             --TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTT
T ss_pred             --CeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCC-CCEEEEechh
Confidence              568899999999999998654 567999999999999999999999999  9999999999999866 5899999999


Q ss_pred             ceeccccce------eeeecccCcccc----CCCccccccceeeecc
Q 027788          178 AAIVGRAIR------RIRCWGRRSSWR----RSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~------~~~~~~~~~~~~----~~~~~~~~~diws~gi  214 (219)
                      |+.......      ++..+.+||.+.    ....|+.++||||+||
T Consensus       157 a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGv  203 (288)
T d2jfla1         157 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGI  203 (288)
T ss_dssp             CEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHH
T ss_pred             hhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHH
Confidence            987654322      333455555432    4566888999999994

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.4e-42  Score=271.01  Aligned_cols=188  Identities=23%  Similarity=0.361  Sum_probs=156.1

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      -||..+| .+.+.||+|+||.||+|++..+++.||||.++.... .+....+.+.+|+.++++++||||+++++++..+ 
T Consensus        11 ~dp~~~y-~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-   87 (309)
T d1u5ra_          11 DDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-   87 (309)
T ss_dssp             SCHHHHE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-
T ss_pred             cCcHHhc-EeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-
Confidence            3455566 666899999999999999999999999999885443 2345567899999999999999999999999654 


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                       +.++++||||++|+|..++.....+++..+..++.|++.||.|||+++  ++||||||+|||++.+ +.+||+|||+|.
T Consensus        88 -~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~-~~~Kl~DFG~a~  163 (309)
T d1u5ra_          88 -HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEP-GLVKLGDFGSAS  163 (309)
T ss_dssp             -TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT-TEEEECCCTTCB
T ss_pred             -CEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCC-CCEEEeeccccc
Confidence             568899999999999877777778999999999999999999999999  9999999999999966 589999999998


Q ss_pred             eccccce--eeeecccCcccc--CCCccccccceeeecc
Q 027788          180 IVGRAIR--RIRCWGRRSSWR--RSCTMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~diws~gi  214 (219)
                      .......  ++..+.+||-+.  ....|+.++||||+||
T Consensus       164 ~~~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGv  202 (309)
T d1u5ra_         164 IMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI  202 (309)
T ss_dssp             SSSSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHH
T ss_pred             ccCCCCccccCccccCHHHHhccCCCCcCchhhhhhHHH
Confidence            7655432  334455555443  2346888999999994

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-41  Score=263.77  Aligned_cols=185  Identities=23%  Similarity=0.367  Sum_probs=142.4

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|+||.||+|++..+|+.||+|.++....  .....+.+.+|+.++++++||||+++++++.++..+.+|++
T Consensus         6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            3788999999999999999999999999999886543  45566789999999999999999999999987666778999


Q ss_pred             eccccCCChHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---CCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          107 TEVCTSGNLREYRKK----HRHVSVKALKKWSKQILKGLNYLHTHE---PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qv~~~l~~lh~~~---~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      |||+++|+|.+++..    ...+++..++.++.|++.||.|||+++   +.|+||||||+||+++.+ +.+||+|||+|+
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DFG~a~  162 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLAR  162 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeecccee
Confidence            999999999998753    357999999999999999999999864   239999999999999866 689999999998


Q ss_pred             eccccce-eeeecccC----ccccCCCccccccceeeecc
Q 027788          180 IVGRAIR-RIRCWGRR----SSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~diws~gi  214 (219)
                      .+..... .....++|    ++......++.++||||+|+
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGv  202 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGC  202 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHH
T ss_pred             ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCH
Confidence            8755432 11222322    23445667888999999993

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-41  Score=266.80  Aligned_cols=183  Identities=18%  Similarity=0.291  Sum_probs=138.6

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      ..|++.+.||+|+||.||+|.+..+++.||+|++......   ...+.+.+|+.+++.++||||+++++++..  .+.+|
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~   83 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPNIVALDDIYES--GGHLY   83 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEE
Confidence            4358999999999999999999999999999999865432   223567899999999999999999999954  46689


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC--CCCcEEEeccccceecc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG--NTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~--~~~~~~l~dfg~a~~~~  182 (219)
                      ++|||+++|+|.+++...+.+++..+..++.|++.||.|||+++  ++||||||+||++..  +.+.+||+|||+|+...
T Consensus        84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            99999999999999988888999999999999999999999999  999999999999953  34689999999998775


Q ss_pred             ccceeeeecccC----ccccCCCccccccceeeecc
Q 027788          183 RAIRRIRCWGRR----SSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       183 ~~~~~~~~~~~~----~~~~~~~~~~~~~diws~gi  214 (219)
                      .........|+|    ++......|+.++||||+||
T Consensus       162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGv  197 (307)
T d1a06a_         162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGV  197 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHH
T ss_pred             CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhH
Confidence            544322333332    23445667889999999994

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.6e-40  Score=267.60  Aligned_cols=185  Identities=21%  Similarity=0.285  Sum_probs=153.7

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ..++| ++.+.||+|+||.||+|++..+|+.||+|+++..    .....+.+.+|+.++++++||||+++++++.  +.+
T Consensus        27 ~~d~Y-~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~   99 (352)
T d1koba_          27 VYDYY-DILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFE--DKY   99 (352)
T ss_dssp             GGGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE--CSS
T ss_pred             cccce-EEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc----chhHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECC
Confidence            33444 8889999999999999999999999999998754    2344567889999999999999999999995  456


Q ss_pred             eEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC-CCCcEEEeccccce
Q 027788          102 TLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG-NTGQVKIGDLGVAA  179 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~-~~~~~~l~dfg~a~  179 (219)
                      .+|++||||++|+|.+++... ..+++..+..++.|++.||.|||+++  |+||||||+|||++. +.+.+||+|||+|.
T Consensus       100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~  177 (352)
T d1koba_         100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLAT  177 (352)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccce
Confidence            789999999999999877654 46999999999999999999999999  999999999999973 34689999999999


Q ss_pred             eccccceeeeecccC----ccccCCCccccccceeeeccc
Q 027788          180 IVGRAIRRIRCWGRR----SSWRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       180 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~diws~gi~  215 (219)
                      ............+++    ++......++.++||||+|++
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  217 (352)
T d1koba_         178 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL  217 (352)
T ss_dssp             ECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHH
T ss_pred             ecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHH
Confidence            887655433333432    234456668889999999943

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-41  Score=265.08  Aligned_cols=181  Identities=20%  Similarity=0.338  Sum_probs=150.9

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|+||.||+|.+..+++.||+|+++..... +....+.+.+|++++++++||||+++++++..  .+.+|++
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~iv   86 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLYFG   86 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEEEEE
T ss_pred             CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc-CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--CCEEEEE
Confidence            48999999999999999999999999999999754322 12334678899999999999999999999954  4668999


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      |||+++|+|.+++...+.+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+|+.+.....
T Consensus        87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNED-MHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEECC----
T ss_pred             EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCC-ceEEecccccceecccCCc
Confidence            999999999999888888999999999999999999999999  9999999999999866 5899999999988754332


Q ss_pred             --------eeeecccCccccCCCccccccceeeecc
Q 027788          187 --------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 --------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                              ++..+.+| +......++.++||||+||
T Consensus       164 ~~~~~~~~GT~~Y~AP-E~~~~~~~~~~~DiwSlGv  198 (288)
T d1uu3a_         164 QARANSFVGTAQYVSP-ELLTEKSACKSSDLWALGC  198 (288)
T ss_dssp             ------CCCCGGGCCH-HHHHTCCCCHHHHHHHHHH
T ss_pred             ccccccccCCccccCc-eeeccCCCCcccceehhhH
Confidence                    22223333 3445567888999999994

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2e-40  Score=266.90  Aligned_cols=185  Identities=22%  Similarity=0.322  Sum_probs=155.0

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ...+| .+.+.||+|+||.||+|++..+|+.||+|++...    .....+.+.+|+.++++++||||+++++++..  .+
T Consensus        24 il~~Y-~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~   96 (350)
T d1koaa2          24 VLDHY-DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DN   96 (350)
T ss_dssp             GGGTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TT
T ss_pred             CccCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CC
Confidence            34566 7889999999999999999999999999998754    34455788999999999999999999999965  45


Q ss_pred             eEEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC-CCcEEEeccccce
Q 027788          102 TLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN-TGQVKIGDLGVAA  179 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~-~~~~~l~dfg~a~  179 (219)
                      .++++|||+++|+|.+++.. .+.+++..+..++.|++.||.|||+++  ++||||||+||+++.+ .+.+||+|||+|+
T Consensus        97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~  174 (350)
T d1koaa2          97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTA  174 (350)
T ss_dssp             EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchhe
Confidence            68899999999999998854 457999999999999999999999999  9999999999999642 3579999999999


Q ss_pred             eccccceeeeecccC----ccccCCCccccccceeeeccc
Q 027788          180 IVGRAIRRIRCWGRR----SSWRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       180 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~diws~gi~  215 (219)
                      .+..........|++    ++......++.++||||+||+
T Consensus       175 ~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvi  214 (350)
T d1koaa2         175 HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL  214 (350)
T ss_dssp             ECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHH
T ss_pred             ecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHH
Confidence            887665544444443    234456668888999999943

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-40  Score=262.19  Aligned_cols=187  Identities=24%  Similarity=0.372  Sum_probs=154.6

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCC--CHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD--DPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ..+|++.+.||+|+||.||+|++..+|+.||+|+++......  .....+.+.+|+.++++++||||+++++++.  +.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~   86 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE--NKT   86 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSS
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECC
Confidence            344589999999999999999999999999999997654322  1223577899999999999999999999995  456


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCC---cEEEeccccc
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG---QVKIGDLGVA  178 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~---~~~l~dfg~a  178 (219)
                      .++++||||++|+|.+++...+.+++..+..++.|++.||.|||+++  ++||||||+||+++.+..   .+|++|||+|
T Consensus        87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhh
Confidence            78999999999999999987778999999999999999999999999  999999999999975432   4899999999


Q ss_pred             eeccccceeeeeccc----CccccCCCccccccceeeecc
Q 027788          179 AIVGRAIRRIRCWGR----RSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       179 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~diws~gi  214 (219)
                      .............++    +++......++.++||||+||
T Consensus       165 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGv  204 (293)
T d1jksa_         165 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV  204 (293)
T ss_dssp             EECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred             hhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhH
Confidence            887655433222222    223345567888999999994

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-41  Score=270.61  Aligned_cols=180  Identities=22%  Similarity=0.414  Sum_probs=152.0

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      +| ++.+.||+|+||.||+|++..+|+.||+|.++...   +....+.+.+|+.++++++||||++++++|..  ...++
T Consensus         7 ~y-~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~   80 (322)
T d1s9ja_           7 DF-EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEIS   80 (322)
T ss_dssp             GE-EEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--SSEEE
T ss_pred             CC-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEE
Confidence            45 77799999999999999999999999999988653   34445788999999999999999999999964  45689


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT-HEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~-~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +||||+++|+|.+++...+.+++..+..++.|++.||.|||+ ++  |+||||||+|||++.+ +.+||+|||+|+....
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLID  157 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTT-CCEEECCCCCCHHHHH
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCC-CCEEEeeCCCccccCC
Confidence            999999999999999877889999999999999999999997 58  9999999999999866 6899999999987654


Q ss_pred             cce----eeeecccCccccCCCccccccceeeecc
Q 027788          184 AIR----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ...    ++..+.+| +......|+.++||||+|+
T Consensus       158 ~~~~~~~GT~~Y~AP-Evl~~~~y~~~~DiWSlGv  191 (322)
T d1s9ja_         158 SMANSFVGTRSYMSP-ERLQGTHYSVQSDIWSMGL  191 (322)
T ss_dssp             HTC---CCSSCCCCH-HHHHCSCCCTTHHHHHHHH
T ss_pred             CccccccCCccccCc-hHHcCCCCCcHHHHHHHHH
Confidence            332    22233333 3344556899999999994

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-40  Score=265.70  Aligned_cols=183  Identities=19%  Similarity=0.315  Sum_probs=154.8

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      +| ++.+.||+|+||.||+|++..+++.||+|+++...... ....+.+.+|+.++++++||||+++++++.  +.+.+|
T Consensus         6 dy-~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~~   81 (337)
T d1o6la_           6 DF-DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQ--THDRLC   81 (337)
T ss_dssp             GE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEE--CSSEEE
T ss_pred             hc-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhCCCCCEEEEEeeec--cccccc
Confidence            45 78899999999999999999999999999998643321 223577889999999999999999999995  456789


Q ss_pred             EEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecccc
Q 027788          105 FITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRA  184 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~  184 (219)
                      ++|||+++|+|..++.....+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+|+.....
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCT
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCC-CCEEEeecccccccccC
Confidence            99999999999999988889999999999999999999999999  9999999999999866 68999999999876543


Q ss_pred             ce------eeeecccCccccCCCccccccceeeeccc
Q 027788          185 IR------RIRCWGRRSSWRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       185 ~~------~~~~~~~~~~~~~~~~~~~~~diws~gi~  215 (219)
                      ..      ++..+.+| +......|+.++|+||+||+
T Consensus       159 ~~~~~~~~GT~~Y~aP-E~~~~~~y~~~~DiwSlGvi  194 (337)
T d1o6la_         159 GATMKTFCGTPEYLAP-EVLEDNDYGRAVDWWGLGVV  194 (337)
T ss_dssp             TCCBCCCEECGGGCCG-GGGSSSCBCTTHHHHHHHHH
T ss_pred             CcccccceeCHHHhhh-hhccCCCCChhhcccchhhH
Confidence            32      22233333 45667778999999999943

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5e-41  Score=263.87  Aligned_cols=182  Identities=25%  Similarity=0.366  Sum_probs=149.6

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      +....-+++.+.||+|+||.||+|++..+++.||||.++...     ...+.+.+|+.++++++||||+++++++..  .
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~   85 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--E   85 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred             EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-----chHHHHHHHHHHHHhCCCCCEecCCccEee--C
Confidence            333344588899999999999999999999999999987432     224678999999999999999999999954  4


Q ss_pred             ceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccc
Q 027788          101 NTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVA  178 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a  178 (219)
                      +.++++|||+++|+|.+++...  ..+++..+..++.|++.||.|||+++  ++||||||+|||++.+ +.+||+|||+|
T Consensus        86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~-~~~Kl~DFG~a  162 (287)
T d1opja_          86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLS  162 (287)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCCT
T ss_pred             CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCC-CcEEEccccce
Confidence            5578899999999999988643  56899999999999999999999999  9999999999999866 58999999999


Q ss_pred             eecccccee-------eeecccCccccCCCccccccceeeec
Q 027788          179 AIVGRAIRR-------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       179 ~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      +........       +..+.+| +......++.++||||+|
T Consensus       163 ~~~~~~~~~~~~~~~g~~~y~aP-E~~~~~~~~~k~DiwS~G  203 (287)
T d1opja_         163 RLMTGDTYTAHAGAKFPIKWTAP-ESLAYNKFSIKSDVWAFG  203 (287)
T ss_dssp             TTCCSSSSEEETTEEECGGGCCH-HHHHHCCCSHHHHHHHHH
T ss_pred             eecCCCCceeeccccccccccCh-HHHcCCCCCchhhhhhHH
Confidence            876554321       1112233 344456688899999999

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.9e-39  Score=253.43  Aligned_cols=186  Identities=19%  Similarity=0.309  Sum_probs=154.0

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCC-----HHHHHHHHHHHHHHHhhC-CCCceEEEEEEec
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-----PAMIERLFSEVRLLKTLA-NKNIISLHYVWRD   97 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~   97 (219)
                      .+| .+.+.||+|+||+||+|++..+++.||+|+++.......     ....+.+.+|+.++++++ ||||+++++++. 
T Consensus         3 ~~y-~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-   80 (277)
T d1phka_           3 ENY-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-   80 (277)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred             ccC-EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc-
Confidence            455 788999999999999999999999999999986543221     223456889999999997 999999999995 


Q ss_pred             CCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788           98 EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus        98 ~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                       +++.+|++|||+++|+|.+++...+.+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+
T Consensus        81 -~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~-~~~kl~DFG~  156 (277)
T d1phka_          81 -TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGF  156 (277)
T ss_dssp             -CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-CCEEECCCTT
T ss_pred             -cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCC-CCeEEccchh
Confidence             45679999999999999999988888999999999999999999999999  9999999999999866 5899999999


Q ss_pred             ceeccccceeeeecc-----cCccc-----cCCCccccccceeeeccc
Q 027788          178 AAIVGRAIRRIRCWG-----RRSSW-----RRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       178 a~~~~~~~~~~~~~~-----~~~~~-----~~~~~~~~~~diws~gi~  215 (219)
                      +..+..........|     +|+.+     ...+.++.++||||+||+
T Consensus       157 a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvi  204 (277)
T d1phka_         157 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI  204 (277)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHH
T ss_pred             eeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchh
Confidence            998766443333222     33322     234557788999999943

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-39  Score=259.28  Aligned_cols=183  Identities=17%  Similarity=0.248  Sum_probs=153.0

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      .-++| .+.+.||+|+||.||+|.+..+++.||+|+++...     .....+.+|+.+++.++||||+++++++..  .+
T Consensus         3 ~~~rY-~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~   74 (321)
T d1tkia_           3 LYEKY-MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFES--ME   74 (321)
T ss_dssp             CTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TT
T ss_pred             Cccce-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CC
Confidence            44666 78899999999999999999999999999987542     223567899999999999999999999954  45


Q ss_pred             eEEEEeccccCCChHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC-CCcEEEeccccce
Q 027788          102 TLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN-TGQVKIGDLGVAA  179 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~-~~~~~l~dfg~a~  179 (219)
                      .+|++||||++|+|.+++...+ .+++..+..++.|++.|+.|||+.+  ++||||||+||+++.+ ...++|+|||+++
T Consensus        75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~  152 (321)
T d1tkia_          75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhh
Confidence            6899999999999999987654 6999999999999999999999999  9999999999999743 2478999999999


Q ss_pred             eccccceeeeecccCc----cccCCCccccccceeeecc
Q 027788          180 IVGRAIRRIRCWGRRS----SWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~diws~gi  214 (219)
                      ............++|.    +......++.++||||+|+
T Consensus       153 ~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGv  191 (321)
T d1tkia_         153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGT  191 (321)
T ss_dssp             ECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHH
T ss_pred             ccccCCcccccccccccccchhccCCCCCchhhcccHHH
Confidence            8766554444444432    3345566888899999994

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.8e-40  Score=261.38  Aligned_cols=181  Identities=20%  Similarity=0.277  Sum_probs=153.0

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      |++.+.||+|+||.||+|++..+|+.||+|+++..... .....+.+.+|+.+++.++||||+++++++..  .+.+|++
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~iv   82 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIFMI   82 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEEEE
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeEee--CCeeeeE
Confidence            48889999999999999999999999999999754321 12335778899999999999999999999954  4678999


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      |||+++|+|..++.....+++..+..++.|++.|+.|||+++  |+||||||+|||++.+ +.+||+|||+|+.......
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~~~~  159 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKN-GHIKITDFGFAKYVPDVTY  159 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTT-SCEEECCCSSCEECSSCBC
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCC-CCEEEecCccceEeccccc
Confidence            999999999999988888999999999999999999999999  9999999999999866 6899999999998765432


Q ss_pred             ---eeeecccCccccCCCccccccceeeecc
Q 027788          187 ---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                         ++..+.+| +......|+.++||||+||
T Consensus       160 ~~~Gt~~Y~AP-E~l~~~~y~~~~DiwSlGv  189 (316)
T d1fota_         160 TLCGTPDYIAP-EVVSTKPYNKSIDWWSFGI  189 (316)
T ss_dssp             CCCSCTTTCCH-HHHTTCCBCTTHHHHHHHH
T ss_pred             cccCcccccCH-HHHcCCCCCchhhccccch
Confidence               22223333 3445667888999999994

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=9.2e-40  Score=264.36  Aligned_cols=186  Identities=18%  Similarity=0.318  Sum_probs=151.8

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccC--CCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC--DDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      .+| ++.++||+|+||.||+|++..+|+.||+|++......  ...........|+.+++.++||||+++++++..  .+
T Consensus         4 ddy-~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~~   80 (364)
T d1omwa3           4 NDF-SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PD   80 (364)
T ss_dssp             TTE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--SS
T ss_pred             HhC-eeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE--CC
Confidence            345 8889999999999999999999999999998754321  112222233345667777889999999999954  45


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      .+|++|||+++|+|.+++.....+++..+..++.|++.||.|||+++  ++||||||+|||++.+ +.+||+|||+|+..
T Consensus        81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~-g~iKl~DFGla~~~  157 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEH-GHVRISDLGLACDF  157 (364)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-SCEEECCCTTCEEC
T ss_pred             EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCC-CcEEEeeeceeeec
Confidence            68899999999999999988888999999999999999999999999  9999999999999865 68999999999987


Q ss_pred             cccce----eeeecccCccccCCCccccccceeeeccc
Q 027788          182 GRAIR----RIRCWGRRSSWRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       182 ~~~~~----~~~~~~~~~~~~~~~~~~~~~diws~gi~  215 (219)
                      .....    ++..+.+|+.+.....|+.++||||+||+
T Consensus       158 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvi  195 (364)
T d1omwa3         158 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM  195 (364)
T ss_dssp             SSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHH
T ss_pred             CCCcccccccccccchhHHhhcCCCCCcccchhHHHHH
Confidence            65432    44445555555666778889999999943

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-39  Score=261.27  Aligned_cols=183  Identities=19%  Similarity=0.289  Sum_probs=153.8

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+| ++.+.||+|+||.||+|++..+|+.||+|+++..... +....+.+.+|+.+++.++||||+++++++..  ...+
T Consensus        41 d~y-~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~  116 (350)
T d1rdqe_          41 DQF-DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNL  116 (350)
T ss_dssp             GGE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred             cCe-EEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHHcCCCcEeeccccccc--cccc
Confidence            455 7779999999999999999999999999998754322 22335778899999999999999999999954  4568


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++||++.+|+|..++...+.+++..+..++.|++.||.|||+++  |+||||||+|||++.+ +.+||+|||+|+....
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~-g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-SCEEECCCTTCEECSS
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCC-CCEEeeeceeeeeccc
Confidence            899999999999999887788999999999999999999999999  9999999999999866 6899999999998765


Q ss_pred             cce---eeeecccCccccCCCccccccceeeecc
Q 027788          184 AIR---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ...   ++..+.+| +......++.++||||+||
T Consensus       194 ~~~~~~Gt~~Y~AP-E~~~~~~~~~~~DiwSlGv  226 (350)
T d1rdqe_         194 RTWTLCGTPEALAP-EIILSKGYNKAVDWWALGV  226 (350)
T ss_dssp             CBCCCEECGGGCCH-HHHTTCCBCTHHHHHHHHH
T ss_pred             ccccccCccccCCH-HHHcCCCCCccccccchhH
Confidence            432   33333333 3445667888999999994

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-40  Score=258.80  Aligned_cols=180  Identities=23%  Similarity=0.413  Sum_probs=143.8

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccCC-CHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEecc
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD-DPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEV  109 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~  109 (219)
                      ++||+|+||+||+|++..+|+.||||+++...... .....+.+.+|+.++++++||||+++++++..  .+.++++|||
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~~ivmE~   81 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISLVFDF   81 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEEEEEC
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCceeehhhh
Confidence            78999999999999999999999999987544321 12233568899999999999999999999954  4558889999


Q ss_pred             ccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce---
Q 027788          110 CTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---  186 (219)
Q Consensus       110 ~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---  186 (219)
                      ++++++..+......+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+|+.......   
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~~~~~  158 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYT  158 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCCC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCC-CccccccCccccccCCCccccc
Confidence            998877776666677999999999999999999999999  9999999999999865 6899999999987755432   


Q ss_pred             ---eeeecccCccccCCCccccccceeeeccc
Q 027788          187 ---RIRCWGRRSSWRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       187 ---~~~~~~~~~~~~~~~~~~~~~diws~gi~  215 (219)
                         ++..+.+|+.......|+.++||||+||+
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  190 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCI  190 (299)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHH
T ss_pred             ceecChhhccHHHHccCCCCChhhhhhhcchH
Confidence               22334444445556667888999999943

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-39  Score=253.33  Aligned_cols=178  Identities=23%  Similarity=0.378  Sum_probs=142.1

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++| .+.+.||+|+||.||+|+..   ..||||+++....  +....+.+.+|+.++++++||||+++++++..   +.+
T Consensus         8 ~~~-~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~   78 (276)
T d1uwha_           8 GQI-TVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQL   78 (276)
T ss_dssp             TCC-CCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSC
T ss_pred             ccE-EEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEE
Confidence            444 78899999999999999753   3699999875543  34556889999999999999999999998743   347


Q ss_pred             EEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          104 NFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +++|||+++|+|.+++... ..+++..+..++.|++.||.|||+++  |+||||||+|||++.+ +.+||+|||+|+...
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~-~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHED-LTVKIGDFGLATVKS  155 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETT-SSEEECCCCCSCC--
T ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCC-CCEEEccccceeecc
Confidence            8899999999999988654 56999999999999999999999999  9999999999999966 589999999998765


Q ss_pred             ccce--------eeeecccCcccc--CCCccccccceeeec
Q 027788          183 RAIR--------RIRCWGRRSSWR--RSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~--------~~~~~~~~~~~~--~~~~~~~~~diws~g  213 (219)
                      ....        ++..|.+||-+.  ....|+.++||||||
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~G  196 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG  196 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHH
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhH
Confidence            4322        222344444333  234578889999999

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-39  Score=254.74  Aligned_cols=181  Identities=21%  Similarity=0.330  Sum_probs=138.3

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCc---EEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGI---EVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR  100 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~---~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~  100 (219)
                      ...+++.++||+|+||.||+|++..++.   .||+|.+....   .....+.+.+|+.++++++||||+++++++..+  
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--   99 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS--   99 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc---CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC--
Confidence            3455899999999999999999876664   57888765432   456668899999999999999999999999544  


Q ss_pred             ceEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          101 NTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      +.++++|||+++|+|.+++... +.+++..+..++.|++.||.|||+++  ++||||||+|||++.+ +.+||+|||+|+
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~-~~~Kl~DFGla~  176 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSN-LVCKVSDFGLSR  176 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCC----
T ss_pred             CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCC-CcEEECCcccce
Confidence            4578899999999999987764 56899999999999999999999999  9999999999999966 589999999998


Q ss_pred             eccccceee-----------eecccCccccCCCccccccceeeec
Q 027788          180 IVGRAIRRI-----------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       180 ~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .........           ..|.+| +......++.++||||||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~t~~y~aP-E~~~~~~~~~~sDvwS~G  220 (299)
T d1jpaa_         177 FLEDDTSDPTYTSALGGKIPIRWTAP-EAIQYRKFTSASDVWSYG  220 (299)
T ss_dssp             -------------------CGGGSCH-HHHHSCCCCHHHHHHHHH
T ss_pred             EccCCCCcceeeecccccCCccccCH-HHHhcCCCCcccccccch
Confidence            775543211           112222 233456788889999999

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-39  Score=252.51  Aligned_cols=180  Identities=23%  Similarity=0.381  Sum_probs=144.1

Q ss_pred             ceeeee-eeeccccceEEEEEEec--CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           25 RYGRYN-ELLGSGAVKKVYRAFDQ--EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        25 ~~~~~~-~~ig~g~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      ++..++ ++||+|+||.||+|...  .+++.||||.++....  ++...+.+.+|+.++++++||||+++++++..+   
T Consensus         6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~---   80 (277)
T d1xbba_           6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEAE---   80 (277)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS---
T ss_pred             hhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC--CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC---
Confidence            344555 46999999999999754  4567899999875432  345567899999999999999999999998543   


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      ..+++|||+++|+|.+++.....+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+|++|||+++..
T Consensus        81 ~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~-~~~kl~DFGla~~~  157 (277)
T d1xbba_          81 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQ-HYAKISDFGLSKAL  157 (277)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEET-TEEEECCCTTCEEC
T ss_pred             CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccccc-Ccccccchhhhhhc
Confidence            26789999999999999988888999999999999999999999999  9999999999999966 58999999999887


Q ss_pred             cccceee---------eecccCccccCCCccccccceeeec
Q 027788          182 GRAIRRI---------RCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .......         ..|.+|+ ......++.++||||||
T Consensus       158 ~~~~~~~~~~~~~~gt~~y~APE-~l~~~~~~~~sDiwS~G  197 (277)
T d1xbba_         158 RADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFG  197 (277)
T ss_dssp             CTTCSEEEC----CCCGGGCCHH-HHHHCEEEHHHHHHHHH
T ss_pred             cccccccccccccCCCceecCch-hhcCCCCCchhhhccch
Confidence            5543211         1122332 23345578899999999

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.7e-38  Score=248.39  Aligned_cols=186  Identities=19%  Similarity=0.257  Sum_probs=153.9

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCC--c
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR--N  101 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~--~  101 (219)
                      ++| ++.+.||+|+||.||+|++..+++.||+|+++.... .+....+.+.+|+.+++.++||||+++++++..++.  .
T Consensus         7 drY-~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           7 DRY-ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT-TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cee-EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc-cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            556 888999999999999999999999999999985443 346667889999999999999999999999865443  4


Q ss_pred             eEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          102 TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      .+|++|||+++++|..++...+.+++..+..++.|++.|+.|||+++  ++||||||+||+++.+ +..+++|||.+...
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~-~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISAT-NAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETT-SCEEECCCTTCEEC
T ss_pred             eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCcc-ccceeehhhhhhhh
Confidence            68899999999999998888788999999999999999999999999  9999999999999966 58999999998766


Q ss_pred             cccce---------eeeecccCccccCCCccccccceeeeccc
Q 027788          182 GRAIR---------RIRCWGRRSSWRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       182 ~~~~~---------~~~~~~~~~~~~~~~~~~~~~diws~gi~  215 (219)
                      .....         ++..+.+|| ......++.++||||+|++
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE-~~~~~~~~~~~DiwSlGvi  203 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPE-QARGDSVDARSDVYSLGCV  203 (277)
T ss_dssp             C----------------TTCCHH-HHTTCCCCHHHHHHHHHHH
T ss_pred             ccccccccccccccCcccccCHH-HHcCCCCCcceecccchHH
Confidence            44332         222333333 3456678889999999943

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-39  Score=254.35  Aligned_cols=183  Identities=19%  Similarity=0.293  Sum_probs=149.6

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHH-hhCCCCceEEEEEEecCCCceEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLK-TLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~-~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      |.+.+.||+|+||.||+|.+..+++.||+|+++......+ ...+.+..|..++. .++||||+++++++..  .+.+|+
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~-~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~yi   80 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLFF   80 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT-TCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccCh-HHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCceeE
Confidence            3788999999999999999999999999999975432211 22356667777664 7899999999999954  466899


Q ss_pred             EeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          106 ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      ||||+++|+|.+++.....+++..+..++.|++.||.|||+++  ++||||||+|||++.+ +.+||+|||+++......
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTT
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCC-Cceeccccchhhhccccc
Confidence            9999999999999988888999999999999999999999999  9999999999999855 689999999998765433


Q ss_pred             e-eeeeccc----CccccCCCccccccceeeeccc
Q 027788          186 R-RIRCWGR----RSSWRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       186 ~-~~~~~~~----~~~~~~~~~~~~~~diws~gi~  215 (219)
                      . .....|+    +++......++.++||||+||+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  192 (320)
T d1xjda_         158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVL  192 (320)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred             ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHH
Confidence            2 2222232    2244556678899999999943

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-38  Score=253.47  Aligned_cols=182  Identities=18%  Similarity=0.225  Sum_probs=147.6

Q ss_pred             CCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEec--C
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRD--E   98 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~--~   98 (219)
                      ..++|.-+.+.||+|+||.||+|++..+++.||+|+++..         ..+.+|+.++.++ +||||++++++|..  .
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~   79 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYA   79 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence            3467755556799999999999999999999999998632         3466799987654 89999999999854  3


Q ss_pred             CCceEEEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC--CCcEEEec
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN--TGQVKIGD  174 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~--~~~~~l~d  174 (219)
                      ....+|++||||++|+|.+++...  ..+++..+..++.|++.|+.|||+++  ++||||||+||+++.+  .+.+||+|
T Consensus        80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccc
Confidence            456789999999999999998764  36899999999999999999999999  9999999999999742  34699999


Q ss_pred             cccceeccccceeeeecccC----ccccCCCccccccceeeecc
Q 027788          175 LGVAAIVGRAIRRIRCWGRR----SSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       175 fg~a~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~diws~gi  214 (219)
                      ||+|+............|+|    ++......|+.++||||+|+
T Consensus       158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGv  201 (335)
T d2ozaa1         158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV  201 (335)
T ss_dssp             CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHH
T ss_pred             cceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhch
Confidence            99998876655433333332    23445566888999999993

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-39  Score=251.15  Aligned_cols=177  Identities=23%  Similarity=0.394  Sum_probs=143.3

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+.+++.+.||+|+||.||+|... ++..||||.++....     ..+.+.+|+.++++++||||+++++++..+   .+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~~   82 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVTQE---PI   82 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC-----CHHHHHHHHHHHHhCCCCCEeEEEeeeccC---Ce
Confidence            344589999999999999999964 678899999874321     236689999999999999999999987432   36


Q ss_pred             EEEeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          104 NFITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      +++|||+++|+|.+++...  ..+++..+..++.|++.|+.|||+++  ++||||||+||+++.+ +.+||+|||+|+..
T Consensus        83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~-~~~Kl~DFGla~~~  159 (272)
T d1qpca_          83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDT-LSCKIADFGLARLI  159 (272)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecc-cceeeccccceEEc
Confidence            7899999999999876432  35899999999999999999999999  9999999999999966 58999999999987


Q ss_pred             ccccee-------eeecccCccccCCCccccccceeeec
Q 027788          182 GRAIRR-------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ......       +..+.+| +......++.++||||||
T Consensus       160 ~~~~~~~~~~~~gt~~y~AP-E~~~~~~~~~~sDvwS~G  197 (272)
T d1qpca_         160 EDNEYTAREGAKFPIKWTAP-EAINYGTFTIKSDVWSFG  197 (272)
T ss_dssp             SSSCEECCTTCCCCTTTSCH-HHHHHCEECHHHHHHHHH
T ss_pred             cCCccccccccCCcccccCh-HHHhCCCCCchhhhhhhH
Confidence            654321       1122333 333445688899999999

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-38  Score=248.98  Aligned_cols=177  Identities=23%  Similarity=0.366  Sum_probs=143.4

Q ss_pred             eeeee-eeccccceEEEEEEec--CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           27 GRYNE-LLGSGAVKKVYRAFDQ--EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        27 ~~~~~-~ig~g~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      +.+.+ +||+|+||.||+|.+.  .++..||||.++...   .....+.+.+|+.++++++||||+++++++..+   .+
T Consensus        10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~   83 (285)
T d1u59a_          10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---AL   83 (285)
T ss_dssp             EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SE
T ss_pred             eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc---CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC---eE
Confidence            35656 5999999999999765  345579999987543   455678899999999999999999999998543   37


Q ss_pred             EEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          104 NFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+|+...
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNR-HYAKISDFGLSKALG  160 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEET-TEEEECCCTTCEECT
T ss_pred             EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccC-Cceeeccchhhhccc
Confidence            899999999999998754 357999999999999999999999999  9999999999999966 589999999999876


Q ss_pred             cccee---------eeecccCccccCCCccccccceeeec
Q 027788          183 RAIRR---------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~~---------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .....         +..|.+| +......++.++||||||
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~ksDVwS~G  199 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAP-ECINFRKFSSRSDVWSYG  199 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCH-HHHHHCEECHHHHHHHHH
T ss_pred             ccccccccccccccCccccCh-HHHhCCCCCccchhhcch
Confidence            54321         1112222 223445688899999999

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-39  Score=248.11  Aligned_cols=175  Identities=19%  Similarity=0.309  Sum_probs=137.7

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      +++.+.||+|+||.||+|... ++..||||.++....     ..+.+.+|+.++++++||||+++++++..+  +.++++
T Consensus         7 ~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--~~~~lv   78 (263)
T d1sm2a_           7 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLV   78 (263)
T ss_dssp             EEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SSCEEE
T ss_pred             cEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC-----cHHHHHHHHHHHHhcCCCCcccccceeccC--CceEEE
Confidence            478899999999999999865 567899999874321     236688999999999999999999999554  457889


Q ss_pred             eccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccc
Q 027788          107 TEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAI  185 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~  185 (219)
                      |||+++|+|.+++... ..+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+++......
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGG-GCEEECSCC---------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCC-CCeEecccchheeccCCC
Confidence            9999999999987654 56889999999999999999999999  9999999999999966 589999999998775543


Q ss_pred             ee-------eeecccCccccCCCccccccceeeec
Q 027788          186 RR-------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       186 ~~-------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ..       +..+.+| +......++.++||||||
T Consensus       156 ~~~~~~~~gt~~y~aP-E~l~~~~~~~k~DVwS~G  189 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASP-EVFSFSRYSSKSDVWSFG  189 (263)
T ss_dssp             ---------CTTSCCH-HHHTTCCCCHHHHHHHHH
T ss_pred             ceeecceecCcccCCh-HHhcCCCCCchhhhcchH
Confidence            21       1123333 334456688899999999

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-39  Score=250.70  Aligned_cols=186  Identities=22%  Similarity=0.358  Sum_probs=146.8

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCC--HHHHHHHHHHHHHHHhhC--CCCceEEEEEEecC
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD--PAMIERLFSEVRLLKTLA--NKNIISLHYVWRDE   98 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~--~~~i~~~~~~~~~~   98 (219)
                      .++| ++.+.||+|+||.||+|++..+++.||+|.++.......  .....++.+|+.++++++  ||||+++++++.. 
T Consensus         3 ~~~Y-~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-   80 (273)
T d1xwsa_           3 ESQY-QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-   80 (273)
T ss_dssp             TTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-
T ss_pred             CCeE-EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee-
Confidence            3555 899999999999999999999999999999875443211  111233568999999997  8999999999954 


Q ss_pred             CCceEEEEeccccC-CChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccc
Q 027788           99 DRNTLNFITEVCTS-GNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGV  177 (219)
Q Consensus        99 ~~~~~~lv~e~~~~-g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~  177 (219)
                       .+.++++||++.+ +++.+++.....+++..+..++.|++.||.|||+++  ++||||||+||+++.+.+.+||+|||+
T Consensus        81 -~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          81 -PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             -SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             -CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECcccc
Confidence             4568899999965 577788877778999999999999999999999999  999999999999986666899999999


Q ss_pred             ceeccccce----eeeecccCccccCCCc-cccccceeeecc
Q 027788          178 AAIVGRAIR----RIRCWGRRSSWRRSCT-MRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~----~~~~~~~~~~~~~~~~-~~~~~diws~gi  214 (219)
                      |+.......    ++..+.+| ++..... ++.++||||+|+
T Consensus       158 a~~~~~~~~~~~~GT~~y~aP-E~~~~~~~~~~~~DiwSlGv  198 (273)
T d1xwsa_         158 GALLKDTVYTDFDGTRVYSPP-EWIRYHRYHGRSAAVWSLGI  198 (273)
T ss_dssp             CEECCSSCBCCCCSCGGGSCH-HHHHHSCBCHHHHHHHHHHH
T ss_pred             ceecccccccccccCCCcCCH-HHHcCCCCCCccccccccee
Confidence            987655432    22222233 3333333 455689999994

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-38  Score=246.89  Aligned_cols=179  Identities=21%  Similarity=0.352  Sum_probs=140.4

Q ss_pred             eeeeeeeeccccceEEEEEEecCCC----cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCc
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRN  101 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~  101 (219)
                      .+.++++||+|+||.||+|....++    ..||||.++...   .......+.+|+.++++++||||+++++++...  .
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~--~   82 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--K   82 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS--S
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc---ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC--C
Confidence            3578899999999999999876554    479999986443   455567789999999999999999999999544  4


Q ss_pred             eEEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecccccee
Q 027788          102 TLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAI  180 (219)
Q Consensus       102 ~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~  180 (219)
                      .++++||++.++++.+.+... ..+++..+..++.|++.|+.|||+++  ++||||||+|||++.+ +.+||+|||+++.
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~-~~~Kl~DFGla~~  159 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN-LVCKVSDFGLSRV  159 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCCCC---
T ss_pred             ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCC-CeEEEcccchhhc
Confidence            578899999999998876544 57999999999999999999999999  9999999999999966 5899999999987


Q ss_pred             ccccce---------eeeecccCccccCCCccccccceeeec
Q 027788          181 VGRAIR---------RIRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       181 ~~~~~~---------~~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ......         ++..|.+| +......++.++||||||
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~AP-E~l~~~~~~~~sDI~S~G  200 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAP-EAISYRKFTSASDVWSFG  200 (283)
T ss_dssp             --------------CCCGGGSCH-HHHHSCCCCHHHHHHHHH
T ss_pred             ccCCCccceEeccCCCCccccCH-HHHccCCCCCcccccccH
Confidence            654332         11123333 344566788899999999

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7.2e-38  Score=250.26  Aligned_cols=181  Identities=19%  Similarity=0.322  Sum_probs=152.1

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC-CCCceEEEEEEecCC
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDED   99 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~   99 (219)
                      ....+| ++.++||+|+||+||+|++..+++.||+|+++...       .+.+.+|+.+++.++ ||||+++++++..+.
T Consensus        32 ~~~d~y-~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~  103 (328)
T d3bqca1          32 GNQDDY-QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPV  103 (328)
T ss_dssp             CCGGGE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred             CCCcCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCCcEEEEEEEecC
Confidence            333455 88899999999999999999999999999987431       356788999999996 999999999998777


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      ...++++|||+++++|..+.   +.+++..+..++.|++.||.|||+++  |+||||||+|||++.+.+.++|+|||+|.
T Consensus       104 ~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         104 SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             TCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             CCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccce
Confidence            77899999999999987653   46999999999999999999999999  99999999999998665568999999998


Q ss_pred             eccccce-----eeeecccCccccCCCccccccceeeecc
Q 027788          180 IVGRAIR-----RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .......     .+..+.+|+.+.....++.++||||+|+
T Consensus       179 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~  218 (328)
T d3bqca1         179 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC  218 (328)
T ss_dssp             ECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred             eccCCCcccccccCccccCcccccCCCCCCcccchhhhhh
Confidence            8765443     3334455555566666888899999993

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-38  Score=250.52  Aligned_cols=180  Identities=27%  Similarity=0.398  Sum_probs=142.7

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCc-----EEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecC
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGI-----EVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDE   98 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~   98 (219)
                      .-+++.+.||+|+||.||+|++..+++     .||+|.+....   .......+.+|+.++.++ +||||+++++++..+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            345899999999999999999765543     68999876443   233446788999999998 899999999999544


Q ss_pred             CCceEEEEeccccCCChHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeC
Q 027788           99 DRNTLNFITEVCTSGNLREYRKKHR-----------------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRD  155 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g~L~~~~~~~~-----------------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~d  155 (219)
                        +.++++|||+++|+|.+++....                       .+++..+..++.|++.||.|||+++  |+|||
T Consensus       114 --~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRD  189 (325)
T d1rjba_         114 --GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRD  189 (325)
T ss_dssp             --SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETT
T ss_pred             --CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecc
Confidence              55888999999999999986532                       3788999999999999999999999  99999


Q ss_pred             CCCCceEEeCCCCcEEEeccccceecccccee--------eeecccCccccCCCccccccceeeec
Q 027788          156 LNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRR--------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       156 l~~~nili~~~~~~~~l~dfg~a~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      |||+||+++.+ +.+||+|||+|+........        +..+.+| +......++.++||||+|
T Consensus       190 lKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP-E~l~~~~~~~~~DiwS~G  253 (325)
T d1rjba_         190 LAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP-ESLFEGIYTIKSDVWSYG  253 (325)
T ss_dssp             CSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCH-HHHHHCCCCHHHHHHHHH
T ss_pred             CchhccccccC-CeEEEeeccccccccCCCceeeeccccCCCccCCh-HHHcCCCCCcceeccchh
Confidence            99999999966 58999999999877654421        1123333 334456688899999999

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-38  Score=251.13  Aligned_cols=182  Identities=25%  Similarity=0.394  Sum_probs=143.4

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      +| ++.+.||+|+||.||+|++..+++.||+|+++....  .....+.+.+|+.++++++||||+++++++..+  +.++
T Consensus         3 ~Y-~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~--~~~~   77 (298)
T d1gz8a_           3 NF-QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTE--NKLY   77 (298)
T ss_dssp             TE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEE
T ss_pred             CC-EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEeccccccc--ccee
Confidence            45 677999999999999999999999999999975432  223346788999999999999999999999654  5689


Q ss_pred             EEeccccCCChHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          105 FITEVCTSGNLREYRK-KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~-~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      ++|||+.++.+..... ....+++..+..++.|++.||.|||+++  |+||||||+||+++.+ +.+||+|||+|+....
T Consensus        78 iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          78 LVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTE-GAIKLADFGLARAFGV  154 (298)
T ss_dssp             EEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECSTTHHHHHCC
T ss_pred             EEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeeccc-CcceeccCCcceeccC
Confidence            9999997544443333 3456999999999999999999999999  9999999999999866 5899999999987755


Q ss_pred             cce------eeeecccCccccCCCccccccceeeecc
Q 027788          184 AIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ...      ++..+.+|+.+.....++.++||||+||
T Consensus       155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGv  191 (298)
T d1gz8a_         155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC  191 (298)
T ss_dssp             CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             CcccceeecccceeeehhhhccccCCCccccccccch
Confidence            432      2223333443455555677899999994

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-37  Score=249.19  Aligned_cols=178  Identities=21%  Similarity=0.329  Sum_probs=144.3

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEec----CCCce
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRD----EDRNT  102 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~----~~~~~  102 (219)
                      |+..++||+|+||+||+|++..+++.||||+++.....        ..+|+.++++++||||++++++|..    ++..+
T Consensus        22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            46779999999999999999999999999998754321        2369999999999999999998854    34457


Q ss_pred             EEEEeccccCCChHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          103 LNFITEVCTSGNLREYR---KKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~---~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      ++++|||++++.+..+.   .....+++..+..++.|++.||.|||+++  |+||||||+|||++.+...+||+|||++.
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchh
Confidence            89999999865444332   34557999999999999999999999999  99999999999998765579999999998


Q ss_pred             ecccccee-----eeecccCccccCCCccccccceeeecc
Q 027788          180 IVGRAIRR-----IRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ........     +..+.+|+.......++.++||||+|+
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~  211 (350)
T d1q5ka_         172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC  211 (350)
T ss_dssp             ECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             hccCCcccccccccccccChHHhhcccCCCcceeecccce
Confidence            87554432     233344444556677899999999994

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-37  Score=243.25  Aligned_cols=182  Identities=27%  Similarity=0.468  Sum_probs=152.2

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+| ++.+.||+|+||+||+|++..+++.||||+++....  .....+.+.+|+.+++.++||||+++++++..  ....
T Consensus         2 ~ry-~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~   76 (292)
T d1unla_           2 QKY-EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKL   76 (292)
T ss_dssp             CSE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred             CCC-EeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC--ChHHHHHHHHHHHHHHhcCcCCEEeecccccc--ccce
Confidence            355 788999999999999999999999999999976543  44566889999999999999999999999954  4567


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +++++++.++++..++...+.+++..+..++.|++.||.|||+++  |+||||||+||+++.+ +.+|++|||.|+....
T Consensus        77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRN-GELKLANFGLARAFGI  153 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTT-CCEEECCCTTCEECCS
T ss_pred             eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccC-CceeeeecchhhcccC
Confidence            889999999999888888888999999999999999999999999  9999999999999866 5899999999998766


Q ss_pred             cceeee-----ecccCcc-ccCCCccccccceeeec
Q 027788          184 AIRRIR-----CWGRRSS-WRRSCTMRITRSLWTYT  213 (219)
Q Consensus       184 ~~~~~~-----~~~~~~~-~~~~~~~~~~~diws~g  213 (219)
                      ......     ....|++ +.....++.++||||+|
T Consensus       154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG  189 (292)
T d1unla_         154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG  189 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHH
T ss_pred             CCccceeeccccchhhhhHhccCCCCCchhhccccc
Confidence            543212     2222223 33445567889999999

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-38  Score=242.26  Aligned_cols=175  Identities=20%  Similarity=0.329  Sum_probs=144.1

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEEEe
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFIT  107 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~  107 (219)
                      ++.++||+|+||.||+|+. +++..||||.++....     ..+.+.+|+.++++++||||+++++++..  .+.++++|
T Consensus         7 ~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~-----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~~~~~iv~   78 (258)
T d1k2pa_           7 TFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFIIT   78 (258)
T ss_dssp             CCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS-----CHHHHHHHHHHHHTCCCTTBCCEEEEECC--SSSEEEEE
T ss_pred             EEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcC-----CHHHHHHHHHHHHhcCCCceeeEEEEEee--CCceEEEE
Confidence            6889999999999999997 5788999999885432     12568899999999999999999999954  45588999


Q ss_pred             ccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccccce
Q 027788          108 EVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR  186 (219)
Q Consensus       108 e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~  186 (219)
                      ||+++|+|..++.. ...+++..+.+++.|++.|+.|||+++  ++||||||+||+++.+ +.+||+|||+++.......
T Consensus        79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTT-CCEEECCCSSCCBCSSSSC
T ss_pred             EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCC-CcEEECcchhheeccCCCc
Confidence            99999999988654 457899999999999999999999999  9999999999999865 5899999999987655432


Q ss_pred             eee--e----cccCccccCCCccccccceeeec
Q 027788          187 RIR--C----WGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       187 ~~~--~----~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ...  .    ...+++......++.++||||||
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G  188 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG  188 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccc
Confidence            111  1    12233444556688899999999

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-37  Score=247.52  Aligned_cols=187  Identities=24%  Similarity=0.383  Sum_probs=148.1

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      .+...+| ++.+.||+|+||+||+|++..+|+.||||+++...   .....+.+.+|+.++++++|||++++++++....
T Consensus         4 ~~i~~rY-~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~   79 (345)
T d1pmea_           4 FDVGPRY-TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPT   79 (345)
T ss_dssp             CCCCTTE-EEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             cCcCCCe-EEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc
Confidence            3455676 78899999999999999999999999999987532   4556678999999999999999999999985432


Q ss_pred             ---CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788          100 ---RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus       100 ---~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                         ...++++ +++.+++|.+++... .+++..+..++.|++.||.|||+++  |+||||||+|||++.+ +.+||+|||
T Consensus        80 ~~~~~~~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~-~~~kl~DfG  154 (345)
T d1pmea_          80 IEQMKDVYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFG  154 (345)
T ss_dssp             TTTCCCEEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCT
T ss_pred             ccccceEEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCC-CCEEEcccC
Confidence               2234545 556689999998754 6999999999999999999999999  9999999999999865 689999999


Q ss_pred             cceeccccce---------eeeecccCccccCCCccccccceeeeccc
Q 027788          177 VAAIVGRAIR---------RIRCWGRRSSWRRSCTMRITRSLWTYTRL  215 (219)
Q Consensus       177 ~a~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~diws~gi~  215 (219)
                      +|........         ++..+.+|+.......++.++||||+|++
T Consensus       155 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~i  202 (345)
T d1pmea_         155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI  202 (345)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHH
T ss_pred             ceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCce
Confidence            9987655432         22234445445566667888999999943

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-38  Score=246.18  Aligned_cols=180  Identities=22%  Similarity=0.352  Sum_probs=140.9

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEE
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~  104 (219)
                      .-+++++.||+|+||.||+|++..+ ..||||.++....  .   .+.+.+|+.++++++||||+++++++...   .++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~--~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~~---~~~   87 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--S---PEAFLQEAQVMKKLRHEKLVQLYAVVSEE---PIY   87 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS--C---HHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC--C---HHHHHHHHHHHHhcccCCEeEEEEEEecC---CeE
Confidence            4459999999999999999997654 6799999875432  1   26688999999999999999999998532   267


Q ss_pred             EEeccccCCChHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          105 FITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       105 lv~e~~~~g~L~~~~~~--~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      ++|||+++|+|..++..  ...+++..+..++.|++.|+.|||.++  ++||||||+||+++.+ +.+||+|||+|+...
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~-~~~kl~DfGla~~~~  164 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIE  164 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG-GCEEECCCCTTC---
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCC-CcEEEcccchhhhcc
Confidence            89999999999987643  356999999999999999999999999  9999999999999866 589999999998765


Q ss_pred             cccee--e-----eecccCccccCCCccccccceeeec--cccc
Q 027788          183 RAIRR--I-----RCWGRRSSWRRSCTMRITRSLWTYT--RLGC  217 (219)
Q Consensus       183 ~~~~~--~-----~~~~~~~~~~~~~~~~~~~diws~g--i~~~  217 (219)
                      .....  .     ..+.+| +......++.++||||||  +|.+
T Consensus       165 ~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~ksDI~S~Giil~el  207 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAP-EAALYGRFTIKSDVWSFGILLTEL  207 (285)
T ss_dssp             -----------CCGGGSCH-HHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             CCCceeeccccccccccCh-HHHhCCCCCcHHhhhcchHHHHHH
Confidence            44321  1     122233 333456678899999999  5543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.9e-38  Score=246.75  Aligned_cols=182  Identities=25%  Similarity=0.371  Sum_probs=148.1

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+| ++.+.||+|+||+||+|++. +++.||+|+++....  +....+.+.+|+.++++++||||+++++++..+  +.+
T Consensus         2 ~~Y-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--~~~   75 (286)
T d1ob3a_           2 EKY-HGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTK--KRL   75 (286)
T ss_dssp             CSE-EEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--SCE
T ss_pred             CCc-eeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC--Cce
Confidence            356 67799999999999999975 789999999976543  233347788999999999999999999999654  457


Q ss_pred             EEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          104 NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      ++++|++.++.+..+......+++..+..++.|++.||.|||+.+  |+||||||+||+++.+ +.+|++|||.|.....
T Consensus        76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~  152 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINRE-GELKIADFGLARAFGI  152 (286)
T ss_dssp             EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC
T ss_pred             eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCC-CCEEecccccceeccc
Confidence            889999987777777676778999999999999999999999999  9999999999999866 5899999999988755


Q ss_pred             cce------eeeecccCccccCCCccccccceeeecc
Q 027788          184 AIR------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       184 ~~~------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +..      ++..+.+|+.......++.++|+||+|+
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv  189 (286)
T d1ob3a_         153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC  189 (286)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred             CccccceecccchhhhHHHHhCCCCCCcceeehhcCc
Confidence            433      2222334444455666788899999994

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.6e-38  Score=246.76  Aligned_cols=183  Identities=23%  Similarity=0.286  Sum_probs=148.1

Q ss_pred             CCCceeeeeeeeccccceEEEEEEec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEe
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQ-----EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWR   96 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   96 (219)
                      |..+| .+.+.||+|+||.||+|+..     .+++.||||.++...   .....+.+.+|+.++++++|||++++++++.
T Consensus        11 p~~~~-~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_          11 PRNNI-EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             CGGGC-EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CHHHc-EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc---ChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            34455 88899999999999999864     456889999987543   4556688999999999999999999999995


Q ss_pred             cCCCceEEEEeccccCCChHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCee
Q 027788           97 DEDRNTLNFITEVCTSGNLREYRKKHR------------------------HVSVKALKKWSKQILKGLNYLHTHEPCVI  152 (219)
Q Consensus        97 ~~~~~~~~lv~e~~~~g~L~~~~~~~~------------------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~  152 (219)
                      ..  +.++++||++++|+|.+++....                        .+++..+..++.|++.|+.|||+++  ++
T Consensus        87 ~~--~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iv  162 (301)
T d1lufa_          87 VG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FV  162 (301)
T ss_dssp             SS--SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred             cC--CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eE
Confidence            44  45778999999999999885422                        3788899999999999999999999  99


Q ss_pred             eeCCCCCceEEeCCCCcEEEeccccceeccccceee---eec----ccCccccCCCccccccceeeec
Q 027788          153 HRDLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIRRI---RCW----GRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       153 h~dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~~~---~~~----~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ||||||+||+++.+ +.+||+|||+|+.........   ...    ..+++......++.++||||||
T Consensus       163 HrDlKp~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~G  229 (301)
T d1lufa_         163 HRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG  229 (301)
T ss_dssp             CSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred             eeEEcccceEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccch
Confidence            99999999999966 589999999998775543211   111    2233444566788899999999

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-37  Score=246.62  Aligned_cols=189  Identities=19%  Similarity=0.367  Sum_probs=147.9

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED   99 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~   99 (219)
                      .+..++| ++.+.||+|+||+||+|++..+|+.||||++.....  .......+.+|+.++++++|||++++++++....
T Consensus         6 ~~~~~rY-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~   82 (318)
T d3blha1           6 CDEVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKA   82 (318)
T ss_dssp             SCBGGGE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred             CCccCCE-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence            3456888 788999999999999999999999999999876543  2333466789999999999999999998885432


Q ss_pred             ------CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEe
Q 027788          100 ------RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIG  173 (219)
Q Consensus       100 ------~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~  173 (219)
                            .+.++++||++.++.+.........+++..+..++.|++.|+.|||+++  |+||||||+||+++.+ +.+|++
T Consensus        83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~-~~~kl~  159 (318)
T d3blha1          83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLA  159 (318)
T ss_dssp             --------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-SCEEEC
T ss_pred             ccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCC-CcEEee
Confidence                  3468899999987777665555667999999999999999999999999  9999999999999866 589999


Q ss_pred             ccccceeccccce----------eeeecccCccccCCCccccccceeeecc
Q 027788          174 DLGVAAIVGRAIR----------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       174 dfg~a~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      |||++........          ++..+.+|+.......++.++||||+|+
T Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGv  210 (318)
T d3blha1         160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGC  210 (318)
T ss_dssp             CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCc
Confidence            9999987654332          2223334444445556888999999994

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-37  Score=247.05  Aligned_cols=186  Identities=25%  Similarity=0.374  Sum_probs=147.3

Q ss_pred             CCCCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC-
Q 027788           21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED-   99 (219)
Q Consensus        21 ~~~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~-   99 (219)
                      +...+| ++.+.||+|+||.||+|.+..+|+.||||.++...  ......+.+.+|+.+++.++||||++++++|...+ 
T Consensus        15 ~~~~~Y-~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~   91 (346)
T d1cm8a_          15 EVRAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET   91 (346)
T ss_dssp             CCBSSE-EEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred             ecCCcE-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh--cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence            355666 77799999999999999999999999999987543  24566788999999999999999999999996543 


Q ss_pred             ---CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccc
Q 027788          100 ---RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLG  176 (219)
Q Consensus       100 ---~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg  176 (219)
                         ...++++|||+ +.+|..+... ..+++..+..++.|++.||.|||+++  |+||||||+|||++.+ +.+|++|||
T Consensus        92 ~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~-~~~kl~Dfg  166 (346)
T d1cm8a_          92 LDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFG  166 (346)
T ss_dssp             TTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTT-CCEEECCCT
T ss_pred             ccccceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccc-ccccccccc
Confidence               23578999999 4677776553 57999999999999999999999999  9999999999999966 589999999


Q ss_pred             cceeccccce---eeeecccCccccCCCccccccceeeecc
Q 027788          177 VAAIVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       177 ~a~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +|+.......   ++..+.+|+.+.....++.++||||+|+
T Consensus       167 ~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGv  207 (346)
T d1cm8a_         167 LARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC  207 (346)
T ss_dssp             TCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHH
T ss_pred             ceeccCCccccccccccccCHHHHcCCCCCCccchhhcchH
Confidence            9988765443   3334445555555556778899999993

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-37  Score=245.12  Aligned_cols=177  Identities=27%  Similarity=0.444  Sum_probs=139.2

Q ss_pred             eeeeeeeccccceEEEEEEecCCCc----EEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGI----EVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      |++.+.||+|+||.||+|.+..+|+    .||+|.++...   .....+.+.+|+.++++++||||+++++++..++   
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~---   84 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTST---   84 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS---
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence            3788999999999999999887776    47777665332   2334578999999999999999999999997543   


Q ss_pred             EEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          103 LNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      .+++++++.+++|.+.+.. ...+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+|+..
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~-~~~kl~DFGla~~~  161 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTP-QHVKITDFGLAKLL  161 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEET-TEEEECCCSHHHHT
T ss_pred             eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCC-CCeEeeccccceec
Confidence            5678899989999887655 457999999999999999999999999  9999999999999966 58999999999877


Q ss_pred             ccccee--------eeecccCccccCCCccccccceeeec
Q 027788          182 GRAIRR--------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ......        +..|.+|+ ......++.++||||||
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE-~l~~~~~~~~sDvwS~G  200 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALE-SILHRIYTHQSDVWSYG  200 (317)
T ss_dssp             TTTCC--------CCTTTSCHH-HHHHCCCCHHHHHHHHH
T ss_pred             ccccccccccccccCccccChH-HHhcCCCChhhhhhhHH
Confidence            554321        11233333 33445688899999999

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-37  Score=239.64  Aligned_cols=179  Identities=21%  Similarity=0.341  Sum_probs=135.5

Q ss_pred             eeeeeeeeccccceEEEEEEecCC---CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCce
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEE---GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNT  102 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~  102 (219)
                      .+++.+.||+|+||.||+|++..+   +..||+|.++...   .....+.+.+|+.++++++||||+++++++..   +.
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~   81 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP   81 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SS
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---Ce
Confidence            458999999999999999987654   3568888765332   45666889999999999999999999999843   34


Q ss_pred             EEEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          103 LNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      ++++|||+++|+|.+++.. ...+++..+..++.|++.|+.|||+++  ++||||||+||+++.+ +.+||+|||+|+..
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~-~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGLSRYM  158 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET-TEEEECC-------
T ss_pred             EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCC-CcEEEccchhheec
Confidence            7889999999999987654 457899999999999999999999999  9999999999999966 58999999999876


Q ss_pred             ccccee--eee----cccCccccCCCccccccceeeec
Q 027788          182 GRAIRR--IRC----WGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       182 ~~~~~~--~~~----~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      ......  ...    ...+++......++.++||||||
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlG  196 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG  196 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHH
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccch
Confidence            543321  111    11222334456688899999999

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-37  Score=241.02  Aligned_cols=179  Identities=21%  Similarity=0.337  Sum_probs=139.1

Q ss_pred             eeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceEEE
Q 027788           26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNF  105 (219)
Q Consensus        26 ~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~~l  105 (219)
                      -+++.+.||+|+||.||+|..  .|..||||.++.+      ...+.+.+|++++++++||||+++++++..+ .+.+++
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~l   78 (262)
T d1byga_           8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI   78 (262)
T ss_dssp             GEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEE
T ss_pred             HeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcEEE
Confidence            358889999999999999987  4778999998733      2346788999999999999999999988643 345789


Q ss_pred             EeccccCCChHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          106 ITEVCTSGNLREYRKKH--RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       106 v~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                      +|||+++|+|.+++...  ..+++..++.++.|++.|+.|||+.+  ++||||||+||+++.+ +.+|++|||+++....
T Consensus        79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASS  155 (262)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-SCEEECCCCC------
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCC-CCEeecccccceecCC
Confidence            99999999999998643  35899999999999999999999999  9999999999999966 5899999999987654


Q ss_pred             cce---eeeecccCccccCCCccccccceeeec--cccc
Q 027788          184 AIR---RIRCWGRRSSWRRSCTMRITRSLWTYT--RLGC  217 (219)
Q Consensus       184 ~~~---~~~~~~~~~~~~~~~~~~~~~diws~g--i~~~  217 (219)
                      ...   .+..+.+| +......++.++||||||  +|.+
T Consensus       156 ~~~~~~~~~~y~aP-E~l~~~~~t~~sDIwSfG~il~el  193 (262)
T d1byga_         156 TQDTGKLPVKWTAP-EALREKKFSTKSDVWSFGILLWEI  193 (262)
T ss_dssp             ------CCTTTSCH-HHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             CCccccccccCCCh-HHHhCCCCChHHHHHhHHHHHHHH
Confidence            332   22223333 334456788899999999  4543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-37  Score=243.07  Aligned_cols=179  Identities=22%  Similarity=0.358  Sum_probs=142.2

Q ss_pred             eeeeeeeccccceEEEEEEecCCCcE--EEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEEecCCCceE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEGIE--VAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++++++||+|+||.||+|++..++..  ||||.++...   .....+.+.+|+++++++ +||||+++++++..+  +.+
T Consensus        12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~~   86 (309)
T d1fvra_          12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GYL   86 (309)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TEE
T ss_pred             cEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc---ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--Cee
Confidence            37889999999999999999888875  5666654332   233457789999999998 799999999999654  568


Q ss_pred             EEEeccccCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCC
Q 027788          104 NFITEVCTSGNLREYRKKH----------------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT  167 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~----------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~  167 (219)
                      ++||||+++|+|.+++...                ..+++..+..++.|++.|+.|+|+.+  ++||||||+|||++.+ 
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~-  163 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN-  163 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG-
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCC-
Confidence            8999999999999988643                46899999999999999999999999  9999999999999866 


Q ss_pred             CcEEEeccccceeccccceeeeeccc----CccccCCCccccccceeeec
Q 027788          168 GQVKIGDLGVAAIVGRAIRRIRCWGR----RSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       168 ~~~~l~dfg~a~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~diws~g  213 (219)
                      +.+||+|||+|+............++    +++......++.++||||||
T Consensus       164 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfG  213 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG  213 (309)
T ss_dssp             GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHH
T ss_pred             CceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhH
Confidence            58999999999876554432222222    22344566788899999999

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-37  Score=245.44  Aligned_cols=185  Identities=19%  Similarity=0.298  Sum_probs=147.2

Q ss_pred             CceeeeeeeeccccceEEEEEEec---CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCC-CCceEEEEEEecCC
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQ---EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN-KNIISLHYVWRDED   99 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~~~~~~~~~~   99 (219)
                      .+| ++.+.||+|+||+||+|++.   .+|+.||+|.++......+....+.+.+|++++++++| |||+++++.+..  
T Consensus        24 ~~y-~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--  100 (322)
T d1vzoa_          24 ENF-ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--  100 (322)
T ss_dssp             GGE-EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred             hce-EEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--
Confidence            445 88899999999999999874   46899999998755432222334667889999999987 799999999854  


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      ...++++|||+.+++|.+++.....+++..+..++.|++.|+.|+|+.+  ++||||||+||+++.+ +.++|+|||+++
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~-~~vkL~DFG~a~  177 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSN-GHVVLTDFGLSK  177 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-SCEEESCSSEEE
T ss_pred             CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCC-CCEEEeeccchh
Confidence            4568899999999999999988888999999999999999999999999  9999999999999966 689999999998


Q ss_pred             eccccce-------eeeecccCccccCCC-ccccccceeeecc
Q 027788          180 IVGRAIR-------RIRCWGRRSSWRRSC-TMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~-------~~~~~~~~~~~~~~~-~~~~~~diws~gi  214 (219)
                      .+.....       ++..+.+|+.+.... .++.++||||+||
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~  220 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV  220 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHH
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHH
Confidence            7654332       122222333333333 3567899999994

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-36  Score=238.90  Aligned_cols=179  Identities=20%  Similarity=0.352  Sum_probs=144.2

Q ss_pred             eeeeeeeccccceEEEEEEecCCC---cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEEG---IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      .+++++||+|+||+||+|+...++   ..||||.++..   ......+++.+|++++++++||||+++++++...+ +.+
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~  104 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSP  104 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT-TEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC-Cce
Confidence            345789999999999999976543   36899988643   25667788999999999999999999999886443 467


Q ss_pred             EEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          104 NFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +++|||+++++|.+++... ...++..+..++.|++.|+.|+|+.+  ++||||||+|||++.+ +.+||+|||+++...
T Consensus       105 ~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~-~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMY  181 (311)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTT-CCEEECSSGGGCCTT
T ss_pred             EEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCC-CCEEEecccchhhcc
Confidence            8899999999999987754 45778889999999999999999999  9999999999999865 589999999998765


Q ss_pred             cccee----------eeecccCccccCCCccccccceeeec
Q 027788          183 RAIRR----------IRCWGRRSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~~----------~~~~~~~~~~~~~~~~~~~~diws~g  213 (219)
                      .....          +..+.+| +......++.++||||||
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~ksDI~SfG  221 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMAL-ESLQTQKFTTKSDVWSFG  221 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCH-HHHHHCCCCHHHHHHHHH
T ss_pred             ccccccceecccccccccccCh-HHHhcCCCCChhHhhhhH
Confidence            44321          1122232 344556688899999999

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-36  Score=237.27  Aligned_cols=180  Identities=24%  Similarity=0.375  Sum_probs=135.0

Q ss_pred             eeeeeeeccccceEEEEEEecCC---CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           27 GRYNELLGSGAVKKVYRAFDQEE---GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      |++.+.||+|+||.||+|+...+   ...||+|.++..... +....+.+.+|+.++++++||||+++++++..+   .+
T Consensus        10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---~~   85 (273)
T d1u46a_          10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---PM   85 (273)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SC
T ss_pred             eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---ch
Confidence            48889999999999999986433   247899998755432 345567899999999999999999999999532   36


Q ss_pred             EEEeccccCCChHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccceecc
Q 027788          104 NFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVG  182 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~  182 (219)
                      +++|||++++++.+.+.. ...+++..+..++.|++.||.|||+++  ++||||||+||+++.+ +.+||+|||+++...
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~-~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATR-DLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEET-TEEEECCCTTCEECC
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccc-cceeeccchhhhhcc
Confidence            789999999999987654 356999999999999999999999999  9999999999999976 589999999999875


Q ss_pred             ccceeee---eccc-----CccccCCCccccccceeeec
Q 027788          183 RAIRRIR---CWGR-----RSSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       183 ~~~~~~~---~~~~-----~~~~~~~~~~~~~~diws~g  213 (219)
                      .......   ..+.     +++......++.++||||||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~G  201 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG  201 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHH
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhH
Confidence            5433111   1111     22333455678889999999

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-36  Score=238.11  Aligned_cols=187  Identities=24%  Similarity=0.316  Sum_probs=137.4

Q ss_pred             cCCCCceeeeeeeeccccceEEEEEEecC-----CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEE
Q 027788           20 TDPTGRYGRYNELLGSGAVKKVYRAFDQE-----EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHY   93 (219)
Q Consensus        20 ~~~~~~~~~~~~~ig~g~~g~V~~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~   93 (219)
                      ++.....|++.++||+|+||.||+|++..     +++.||+|.++...   .....+.+..|...+.++ .|+||+.+++
T Consensus         8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            33333445899999999999999998653     44689999987543   345557788888888877 5789999988


Q ss_pred             EEecCCCceEEEEeccccCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCC
Q 027788           94 VWRDEDRNTLNFITEVCTSGNLREYRKKH----------------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLN  157 (219)
Q Consensus        94 ~~~~~~~~~~~lv~e~~~~g~L~~~~~~~----------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~  157 (219)
                      ++..+ ...++++|||+++|+|.+++...                ..+++..+..++.|++.||.|||+++  ++|||||
T Consensus        85 ~~~~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlK  161 (299)
T d1ywna1          85 ACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLA  161 (299)
T ss_dssp             EECST-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCC
T ss_pred             eeccC-CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCC
Confidence            87543 35678899999999999998643                23789999999999999999999999  9999999


Q ss_pred             CCceEEeCCCCcEEEeccccceeccccce--------eeeecccCccccCCCccccccceeeecc
Q 027788          158 CSNVFVNGNTGQVKIGDLGVAAIVGRAIR--------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       158 ~~nili~~~~~~~~l~dfg~a~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      |+||+++.+ +.+||+|||+|+.......        ++..+.+|+ ......++.++||||+|+
T Consensus       162 p~NILl~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE-~l~~~~~~~~sDiwS~Gv  224 (299)
T d1ywna1         162 ARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE-TIFDRVYTIQSDVWSFGV  224 (299)
T ss_dssp             GGGEEECGG-GCEEECC------CCSCTTSCCTTSCCCGGGGCCHH-HHHHCCCCHHHHHHHHHH
T ss_pred             ccceeECCC-CcEEEccCcchhhccccccccccCceeeCccccchh-HhhcCCCCcccceeehHH
Confidence            999999866 5899999999987644332        122233333 334456788999999993

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-35  Score=233.88  Aligned_cols=187  Identities=25%  Similarity=0.364  Sum_probs=149.1

Q ss_pred             ccCCCCceeeeeeeeccccceEEEEEEe-----cCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEE
Q 027788           19 ETDPTGRYGRYNELLGSGAVKKVYRAFD-----QEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLH   92 (219)
Q Consensus        19 ~~~~~~~~~~~~~~ig~g~~g~V~~a~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~   92 (219)
                      ..+....-+.+.+.||+|+||.||+|+.     ..+++.||||.++...   .......+.+|+.+++++ +||||++++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~   93 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLL   93 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            4443334448899999999999999975     3567789999987543   455667899999999999 699999999


Q ss_pred             EEEecCCCceEEEEeccccCCChHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCeeee
Q 027788           93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHR------------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHR  154 (219)
Q Consensus        93 ~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~------------------~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~  154 (219)
                      +++...  +.++++|||+++|+|.+++....                  .+++..+..++.|++.|+.|||+++  ++||
T Consensus        94 g~~~~~--~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHr  169 (311)
T d1t46a_          94 GACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHR  169 (311)
T ss_dssp             EEECSS--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred             EEEeeC--CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence            999544  45788999999999999886432                  4889999999999999999999999  9999


Q ss_pred             CCCCCceEEeCCCCcEEEeccccceeccccce---eeeecccC----ccccCCCccccccceeeec
Q 027788          155 DLNCSNVFVNGNTGQVKIGDLGVAAIVGRAIR---RIRCWGRR----SSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       155 dl~~~nili~~~~~~~~l~dfg~a~~~~~~~~---~~~~~~~~----~~~~~~~~~~~~~diws~g  213 (219)
                      ||||+||+++.+ +.++++|||+++.......   .....+++    ++......++.++||||||
T Consensus       170 DLKp~NIl~~~~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G  234 (311)
T d1t46a_         170 DLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG  234 (311)
T ss_dssp             CCSGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred             cccccccccccc-CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchH
Confidence            999999999966 5899999999987754332   11122222    1233456678889999999

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-35  Score=235.29  Aligned_cols=185  Identities=26%  Similarity=0.385  Sum_probs=143.8

Q ss_pred             CceeeeeeeeccccceEEEEEEecCC-CcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh---CCCCceEEEEEEec--
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEE-GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL---ANKNIISLHYVWRD--   97 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~~~~i~~~~~~~~~--   97 (219)
                      .+| ++.+.||+|+||.||+|++.++ ++.||+|.++......  .....+.+|+.+++.+   +||||+++++++..  
T Consensus         7 ~~Y-~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           7 QQY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CCE-EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc--hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            456 7889999999999999999766 6679999997654321  1223455678777766   79999999998853  


Q ss_pred             -CCCceEEEEeccccCCChHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEecc
Q 027788           98 -EDRNTLNFITEVCTSGNLREYRK-KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL  175 (219)
Q Consensus        98 -~~~~~~~lv~e~~~~g~L~~~~~-~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~df  175 (219)
                       +....++++||+++++++..... ....+++..+..++.|++.||.|||+++  |+||||||+|||++.+ +.+||+||
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~-~~~kl~df  160 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADF  160 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECSC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCC-CCeeecch
Confidence             34467899999998776654443 3456899999999999999999999999  9999999999999865 58999999


Q ss_pred             ccceeccccceeeeecccC----ccccCCCccccccceeeecc
Q 027788          176 GVAAIVGRAIRRIRCWGRR----SSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       176 g~a~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~diws~gi  214 (219)
                      |+++............|++    ++......|+.++||||+|+
T Consensus       161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~  203 (305)
T d1blxa_         161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGC  203 (305)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHH
T ss_pred             hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHH
Confidence            9998775554433333332    23445667889999999994

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-36  Score=240.57  Aligned_cols=185  Identities=26%  Similarity=0.385  Sum_probs=146.4

Q ss_pred             CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCC---
Q 027788           23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDED---   99 (219)
Q Consensus        23 ~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~---   99 (219)
                      ..+| ++.+.||+|+||.||+|++..+|+.||||+++...  .+....+.+.+|+.+++.++|||++++++++....   
T Consensus        17 ~~rY-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          17 PERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             ETTE-EEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred             CCCe-EEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence            3466 78899999999999999999999999999987543  24555678899999999999999999999886432   


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      ....+++++++.+|+|.+++.. ..+++..+..++.|++.||.|||+++  |+||||||+||+++.+ +.++++|||++.
T Consensus        94 ~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~-~~~kl~dfg~a~  169 (348)
T d2gfsa1          94 EFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGLAR  169 (348)
T ss_dssp             TCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT-CCEEECCC----
T ss_pred             cCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccccc-ccccccccchhc
Confidence            1223445667778999998754 47999999999999999999999999  9999999999999866 689999999998


Q ss_pred             eccccce---eeeecccCccccCCCccccccceeeecc
Q 027788          180 IVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      .......   ++..+.+|+.......++.++||||+|+
T Consensus       170 ~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv  207 (348)
T d2gfsa1         170 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC  207 (348)
T ss_dssp             CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHH
T ss_pred             ccCcccccccccccccCchhhcCCccCCcccchhhhhH
Confidence            7655442   3333445555566666778899999994

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-35  Score=234.72  Aligned_cols=182  Identities=27%  Similarity=0.349  Sum_probs=141.4

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCC-------cEEEEEEeeecccCCCHHHHHHHHHHHHHHHhh-CCCCceEEEEEE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEG-------IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANKNIISLHYVW   95 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~   95 (219)
                      .+-|.+.+.||+|+||.||+|+...++       ..||||.++...   .......+.+|...+.++ +||||+++++++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc---ChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            344488899999999999999875543       479999987543   455567888999999888 799999999999


Q ss_pred             ecCCCceEEEEeccccCCChHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCC
Q 027788           96 RDEDRNTLNFITEVCTSGNLREYRKKH----------------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCS  159 (219)
Q Consensus        96 ~~~~~~~~~lv~e~~~~g~L~~~~~~~----------------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~  159 (219)
                      ..  .+.++++|||+++|+|.+++...                ..+++..+..++.|++.||.|||+++  ++||||||+
T Consensus        89 ~~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~  164 (299)
T d1fgka_          89 TQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAAR  164 (299)
T ss_dssp             CS--SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred             cc--CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeeccc
Confidence            54  45588899999999999998643                24799999999999999999999999  999999999


Q ss_pred             ceEEeCCCCcEEEeccccceeccccceee--------eecccCccccCCCccccccceeeecc
Q 027788          160 NVFVNGNTGQVKIGDLGVAAIVGRAIRRI--------RCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       160 nili~~~~~~~~l~dfg~a~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      |||++.+ +.+||+|||+++.........        ..+.+| +......|+.++||||||+
T Consensus       165 NiLl~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP-E~l~~~~y~~k~DiwS~Gv  225 (299)
T d1fgka_         165 NVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAP-EALFDRIYTHQSDVWSFGV  225 (299)
T ss_dssp             GEEECTT-CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCH-HHHHHCCCCHHHHHHHHHH
T ss_pred             ceeecCC-CCeEeccchhhccccccccccccccCCCChhhhhh-hHhcCCCCCchhhhHHhHH
Confidence            9999866 589999999998775544211        112222 2334567888999999993

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-35  Score=236.78  Aligned_cols=181  Identities=24%  Similarity=0.327  Sum_probs=140.8

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecC----C
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDE----D   99 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~----~   99 (219)
                      .+| ++.++||+|+||+||+|++..+|+.||||+++....  .....+++.+|+.++++++||||++++++|..+    .
T Consensus        17 ~~Y-~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          17 KRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             TTE-EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             CCe-EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc--CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence            455 888999999999999999999999999999985543  455667899999999999999999999999654    3


Q ss_pred             CceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEeccccce
Q 027788          100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDLGVAA  179 (219)
Q Consensus       100 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~dfg~a~  179 (219)
                      ...+|++|||+.++.+. .+  ...+++..++.++.|++.|+.|||+++  ++||||||+||+++.+ +.++++|||+++
T Consensus        94 ~~~~~iv~Ey~~~~l~~-~~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~-~~~kl~df~~~~  167 (355)
T d2b1pa1          94 FQDVYLVMELMDANLCQ-VI--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLAR  167 (355)
T ss_dssp             CCEEEEEEECCSEEHHH-HH--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTT-CCEEECCCCC--
T ss_pred             CceeEEEEeccchHHHH-hh--hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccc-cceeeechhhhh
Confidence            46889999999765444 33  346899999999999999999999999  9999999999999966 589999999998


Q ss_pred             eccccceeee-----ecccCccccCCCccccccceeeecc
Q 027788          180 IVGRAIRRIR-----CWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       180 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      ..........     .+.+| +......++.++||||+|+
T Consensus       168 ~~~~~~~~~~~~~t~~y~aP-E~l~~~~~~~~~DiwSlG~  206 (355)
T d2b1pa1         168 TAGTSFMMTPYVVTRYYRAP-EVILGMGYKENVDIWSVGC  206 (355)
T ss_dssp             -------------CCTTCCH-HHHTTCCCCTTHHHHHHHH
T ss_pred             ccccccccccccccccccCh-hhhcCCCCCCCcccccccc
Confidence            7766554322     33333 3345567888999999993

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-35  Score=232.32  Aligned_cols=184  Identities=20%  Similarity=0.281  Sum_probs=145.1

Q ss_pred             CCCceeeeeeeeccccceEEEEEEec-----CCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEe
Q 027788           22 PTGRYGRYNELLGSGAVKKVYRAFDQ-----EEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWR   96 (219)
Q Consensus        22 ~~~~~~~~~~~ig~g~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   96 (219)
                      +....+.+.+.||+|+||.||+|++.     .++..||||.++...   .......+.+|+.++++++||||+++++++.
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc---ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            33344488899999999999999874     345789999987432   4455577899999999999999999999996


Q ss_pred             cCCCceEEEEeccccCCChHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCC
Q 027788           97 DEDRNTLNFITEVCTSGNLREYRKKH----------RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN  166 (219)
Q Consensus        97 ~~~~~~~~lv~e~~~~g~L~~~~~~~----------~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~  166 (219)
                      .+  +.++++|||+++|+|.+++...          ..++...+..++.|++.||.|||.++  ++||||||+|||++.+
T Consensus        94 ~~--~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          94 QG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED  169 (308)
T ss_dssp             SS--SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTT
T ss_pred             cC--CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCC
Confidence            54  4578899999999999986532          24688999999999999999999999  9999999999999966


Q ss_pred             CCcEEEeccccceecccccee---eeecccCc----cccCCCccccccceeeec
Q 027788          167 TGQVKIGDLGVAAIVGRAIRR---IRCWGRRS----SWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       167 ~~~~~l~dfg~a~~~~~~~~~---~~~~~~~~----~~~~~~~~~~~~diws~g  213 (219)
                       +++||+|||+|+........   ....+++.    +......++.++|+||||
T Consensus       170 -~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G  222 (308)
T d1p4oa_         170 -FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG  222 (308)
T ss_dssp             -CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred             -ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHH
Confidence             58999999999877554431   11122221    122345577789999999

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-35  Score=231.59  Aligned_cols=178  Identities=24%  Similarity=0.323  Sum_probs=136.8

Q ss_pred             ceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHH--HHHHHHhhCCCCceEEEEEEecCCC--
Q 027788           25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKNIISLHYVWRDEDR--  100 (219)
Q Consensus        25 ~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~--E~~~l~~l~~~~i~~~~~~~~~~~~--  100 (219)
                      +-+.+.+.||+|+||.||+|+.  +|+.||||.++.+.     .  +.+..  |+..+..++||||+++++++..++.  
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-----~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~   73 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----E--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTW   73 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-----H--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----h--hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence            3457889999999999999985  68899999886432     1  23334  4445567899999999999976543  


Q ss_pred             ceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCeeeeCCCCCceEEeCCCCcEEEec
Q 027788          101 NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH------EPCVIHRDLNCSNVFVNGNTGQVKIGD  174 (219)
Q Consensus       101 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~------~~~i~h~dl~~~nili~~~~~~~~l~d  174 (219)
                      ..++++|||+++|+|.++++.. .+++.....++.|++.|+.|+|..      .+.|+||||||+||+++.+ +.+||+|
T Consensus        74 ~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~D  151 (303)
T d1vjya_          74 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIAD  151 (303)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECC
T ss_pred             eEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC-CCeEEEe
Confidence            3688999999999999999765 688999999999999999999974      1239999999999999866 5899999


Q ss_pred             cccceeccccce----------eeeecccCccccC-----CCccccccceeeec
Q 027788          175 LGVAAIVGRAIR----------RIRCWGRRSSWRR-----SCTMRITRSLWTYT  213 (219)
Q Consensus       175 fg~a~~~~~~~~----------~~~~~~~~~~~~~-----~~~~~~~~diws~g  213 (219)
                      ||+++.......          ++..+.+||.+..     ...++.++||||||
T Consensus       152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~G  205 (303)
T d1vjya_         152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG  205 (303)
T ss_dssp             CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred             cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhH
Confidence            999998755432          1222233332221     12356679999999

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-34  Score=227.70  Aligned_cols=179  Identities=21%  Similarity=0.227  Sum_probs=138.3

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCceEEEEEEecCCCceE
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTL  103 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~~  103 (219)
                      ++| ++.+.||+|+||.||+|++..+++.||||++......      +.+..|+++++.++|++++..+..+.. +.+..
T Consensus         7 ~rY-~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~i~~~l~~~~~i~~~~~~~~-~~~~~   78 (299)
T d1ckia_           7 NRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYN   78 (299)
T ss_dssp             TTE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS------CCHHHHHHHHHHSTTSTTCCCEEEEEE-ETTEE
T ss_pred             CEE-EEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC------HHHHHHHHHHHHccCCCcccEEEEEEe-cCCEE
Confidence            455 8999999999999999999999999999998765322      346789999999998876665544433 34567


Q ss_pred             EEEeccccCCChHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC--CCCcEEEecccccee
Q 027788          104 NFITEVCTSGNLREYR-KKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG--NTGQVKIGDLGVAAI  180 (219)
Q Consensus       104 ~lv~e~~~~g~L~~~~-~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~--~~~~~~l~dfg~a~~  180 (219)
                      +++||+++ +++...+ .....+++..+..++.|++.||.|||+++  ++||||||+||+++.  ....++++|||+|+.
T Consensus        79 ~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          79 VMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             EEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             EEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCccee
Confidence            88999995 5665554 44567999999999999999999999999  999999999999863  223699999999998


Q ss_pred             ccccce-------------eeeecccCccccCCCccccccceeeecc
Q 027788          181 VGRAIR-------------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       181 ~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      +.....             ++..+.+| +.....+++.++||||||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aP-E~~~~~~~~~~~DiwSlG~  201 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASI-NTHLGIEQSRRDDLESLGY  201 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCH-HHHTTBCCCHHHHHHHHHH
T ss_pred             ccccccccceeccccCCcCCCccccCH-HHHhCCCCCChhhEEecCH
Confidence            754331             12222222 2344556888999999993

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5e-34  Score=224.44  Aligned_cols=179  Identities=17%  Similarity=0.198  Sum_probs=142.3

Q ss_pred             CceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCC-CCceEEEEEEecCCCce
Q 027788           24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN-KNIISLHYVWRDEDRNT  102 (219)
Q Consensus        24 ~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~~~~~~~~~~~~~  102 (219)
                      +..|++.+.||+|+||.||+|++..+++.||+|+++.....      ..+..|++.++.++| +|++.+++++..  ...
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~   75 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA------PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLH   75 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS------CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc------HHHHHHHHHHHHhcCCCCCCEEEEEeec--CCc
Confidence            33348999999999999999999999999999988754321      235678899999976 899898888854  455


Q ss_pred             EEEEeccccCCChHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeC----CCCcEEEecccc
Q 027788          103 LNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG----NTGQVKIGDLGV  177 (219)
Q Consensus       103 ~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~----~~~~~~l~dfg~  177 (219)
                      .+++||++ +++|.+++... ..++...+..++.|++.++.+||+++  ++||||||+||+++.    ..+.++|+|||+
T Consensus        76 ~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          76 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             cEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccce
Confidence            78899999 57998887654 46999999999999999999999999  999999999999963    235799999999


Q ss_pred             ceeccccce-------------eeeecccCccccCCCccccccceeeecc
Q 027788          178 AAIVGRAIR-------------RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       178 a~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      |+.......             ++..+.+| +......++.++||||+|+
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aP-E~~~~~~~~~~~DiwSlG~  201 (293)
T d1csna_         153 VKFYRDPVTKQHIPYREKKNLSGTARYMSI-NTHLGREQSRRDDLEALGH  201 (293)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCH-HHHTTCCCCHHHHHHHHHH
T ss_pred             eEEcccCccccceeecccCceEEchhhcCH-HHhcCCCCChHHHHHHhhH
Confidence            998754321             12223333 3344567888999999993

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.96  E-value=3e-30  Score=208.22  Aligned_cols=189  Identities=24%  Similarity=0.328  Sum_probs=142.1

Q ss_pred             ccccCC--CCceeeeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC----------
Q 027788           17 FIETDP--TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA----------   84 (219)
Q Consensus        17 ~~~~~~--~~~~~~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~----------   84 (219)
                      +..+++  .+|| ++.++||+|+||+||+|++..+|+.||||+++..     ....+.+.+|+.+++.++          
T Consensus         4 ~~~g~~~~~~rY-~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~   77 (362)
T d1q8ya_           4 AFKGEPYKDARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSM   77 (362)
T ss_dssp             CCTTCEETTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHH
T ss_pred             CCCCCCccCCcE-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccchHHHHHHHHHHHHhcchhhhhhhhc
Confidence            344553  3566 8889999999999999999999999999998743     344466778999888875          


Q ss_pred             -CCCceEEEEEEecCCCceEEEEeccccCCCh-HHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCeeeeCCCCC
Q 027788           85 -NKNIISLHYVWRDEDRNTLNFITEVCTSGNL-REYR--KKHRHVSVKALKKWSKQILKGLNYLHT-HEPCVIHRDLNCS  159 (219)
Q Consensus        85 -~~~i~~~~~~~~~~~~~~~~lv~e~~~~g~L-~~~~--~~~~~~~~~~~~~i~~qv~~~l~~lh~-~~~~i~h~dl~~~  159 (219)
                       |+||+++++++........+++++++..+.. ....  .....+++..+..++.|++.|+.|||+ .+  |+||||||+
T Consensus        78 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~  155 (362)
T d1q8ya_          78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPE  155 (362)
T ss_dssp             HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGG
T ss_pred             CcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChh
Confidence             4789999888876666666667766644332 2222  233578899999999999999999997 78  999999999


Q ss_pred             ceEEeCCCC-----cEEEeccccceeccccce---eeeecccCccccCCCccccccceeeecc
Q 027788          160 NVFVNGNTG-----QVKIGDLGVAAIVGRAIR---RIRCWGRRSSWRRSCTMRITRSLWTYTR  214 (219)
Q Consensus       160 nili~~~~~-----~~~l~dfg~a~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~diws~gi  214 (219)
                      |||++.+..     .++++|||.+........   ++..+.+|+. .....++.++|+||+|+
T Consensus       156 NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~DiwSlG~  217 (362)
T d1q8ya_         156 NVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEV-LLGAPWGCGADIWSTAC  217 (362)
T ss_dssp             GEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHH-HHTCCCCTHHHHHHHHH
T ss_pred             HeeeeccCcccccceeeEeecccccccccccccccccccccChhh-ccccCCCccccccchHH
Confidence            999974421     389999999987654432   2333444443 33556788999999994

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=8e-26  Score=166.65  Aligned_cols=167  Identities=19%  Similarity=0.164  Sum_probs=119.6

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccC----------C--C--HHHHHHHHHHHHHHHhhCCCCceEEEE
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC----------D--D--PAMIERLFSEVRLLKTLANKNIISLHY   93 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~----------~--~--~~~~~~~~~E~~~l~~l~~~~i~~~~~   93 (219)
                      .++++||+|+||.||+|++. +|+.||+|+++.....          .  .  .........|...+.++.|.+++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            57899999999999999874 7899999987532110          0  0  011233456888899999999988776


Q ss_pred             EEecCCCceEEEEeccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCCCeeeeCCCCCceEEeCCCCcEEEe
Q 027788           94 VWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIG  173 (219)
Q Consensus        94 ~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~~~i~h~dl~~~nili~~~~~~~~l~  173 (219)
                      ..  ..    +++||++++..+..       ++......++.|++.++.+||+++  ++||||||+||+++.+  .++++
T Consensus        82 ~~--~~----~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~--~~~li  144 (191)
T d1zara2          82 WE--GN----AVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE--GIWII  144 (191)
T ss_dssp             EE--TT----EEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT--EEEEC
T ss_pred             ec--CC----EEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC--CEEEE
Confidence            54  22    57999998765543       334445678999999999999999  9999999999999843  58999


Q ss_pred             ccccceeccccceeeeecccC---ccccCCCccccccceeeec
Q 027788          174 DLGVAAIVGRAIRRIRCWGRR---SSWRRSCTMRITRSLWTYT  213 (219)
Q Consensus       174 dfg~a~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~diws~g  213 (219)
                      |||.|.....+..........   ..+. .+.|+.++|+||..
T Consensus       145 DFG~a~~~~~~~~~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~  186 (191)
T d1zara2         145 DFPQSVEVGEEGWREILERDVRNIITYF-SRTYRTEKDINSAI  186 (191)
T ss_dssp             CCTTCEETTSTTHHHHHHHHHHHHHHHH-HHHHCCCCCHHHHH
T ss_pred             ECCCcccCCCCCcHHHHHHHHHHHHHHH-cCCCCCcccHHHHH
Confidence            999998776554321111100   1122 35677889999975

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.26  E-value=5e-06  Score=66.05  Aligned_cols=80  Identities=18%  Similarity=0.161  Sum_probs=47.6

Q ss_pred             eeeccccceEEEEEEecCCCcEEEEEEeeecccC---CCHHHHHHHHHHHHHHHhhCC---CCceEEEEEEecCCCceEE
Q 027788           31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC---DDPAMIERLFSEVRLLKTLAN---KNIISLHYVWRDEDRNTLN  104 (219)
Q Consensus        31 ~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~E~~~l~~l~~---~~i~~~~~~~~~~~~~~~~  104 (219)
                      +.||.|....||+......++.+++|........   .-+....+...|.+.++.+..   ..+.+++.+.  ++..  +
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~--~  107 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMA--V  107 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTT--E
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCC--E
Confidence            5789999999999987777888999975432110   001123455678888876642   3345555443  3332  4


Q ss_pred             EEeccccCCC
Q 027788          105 FITEVCTSGN  114 (219)
Q Consensus       105 lv~e~~~~g~  114 (219)
                      ++||++++..
T Consensus       108 lvmE~L~~~~  117 (392)
T d2pula1         108 TVMEDLSHLK  117 (392)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEeccCCcc
Confidence            6999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.20  E-value=5.8e-06  Score=61.58  Aligned_cols=142  Identities=17%  Similarity=0.098  Sum_probs=82.1

Q ss_pred             eeeeeeccccceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCC-CCceEEEEEEecCCCceEEEE
Q 027788           28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN-KNIISLHYVWRDEDRNTLNFI  106 (219)
Q Consensus        28 ~~~~~ig~g~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv  106 (219)
                      ++.+..+-++.+.||+..  ..+..+.+|.........    ...+.+|...++.+.. --+.+++.+...  .+..+++
T Consensus        17 ~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~lv   88 (263)
T d1j7la_          17 RCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT----TYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLL   88 (263)
T ss_dssp             EEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS----TTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEE
T ss_pred             EEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc----hhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceEEE
Confidence            343443334447899875  345567788765332211    1335678888877742 224566665533  3456789


Q ss_pred             eccccCCChHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 027788          107 TEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE--------------------------------------  148 (219)
Q Consensus       107 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qv~~~l~~lh~~~--------------------------------------  148 (219)
                      |+++++..+......  ....   ..+..++...+..||+..                                      
T Consensus        89 ~~~l~G~~~~~~~~~--~~~~---~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T d1j7la_          89 MSEADGVLCSEEYED--EQSP---EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHTTT--CSCH---HHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred             EEecccccccccccc--cccH---HHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence            999988777543211  1111   122333333444444321                                      


Q ss_pred             -------------------CCeeeeCCCCCceEEeCCCCcEEEeccccceeccc
Q 027788          149 -------------------PCVIHRDLNCSNVFVNGNTGQVKIGDLGVAAIVGR  183 (219)
Q Consensus       149 -------------------~~i~h~dl~~~nili~~~~~~~~l~dfg~a~~~~~  183 (219)
                                         +.++|+|+.+.|++++.+ +...++||+.+..-..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDwe~a~~g~~  216 (263)
T d1j7la_         164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSGRADK  216 (263)
T ss_dssp             CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEEEEH
T ss_pred             chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCC-ceEEEeechhcccCCH
Confidence                               137899999999999844 3346999998876443

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.87  E-value=3.4e-05  Score=56.97  Aligned_cols=74  Identities=14%  Similarity=0.033  Sum_probs=46.4

Q ss_pred             eeccccc-eEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCC--ceEEEEEEecCCCceEEEEec
Q 027788           32 LLGSGAV-KKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN--IISLHYVWRDEDRNTLNFITE  108 (219)
Q Consensus        32 ~ig~g~~-g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~--i~~~~~~~~~~~~~~~~lv~e  108 (219)
                      .+..|.. +.||+.. ...+..+.+|......       ...+..|...++.+....  +.+++.+...  .+..+++|+
T Consensus        17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~-------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~   86 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLG   86 (255)
T ss_dssp             ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEE
T ss_pred             EcCCcccCCeEEEEE-eCCCCEEEEEeCCccC-------HhHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEE
Confidence            4455554 6789886 3556678888754321       123567888887775433  4556666543  345678999


Q ss_pred             cccCCCh
Q 027788          109 VCTSGNL  115 (219)
Q Consensus       109 ~~~~g~L  115 (219)
                      +++|.++
T Consensus        87 ~i~G~~~   93 (255)
T d1nd4a_          87 EVPGQDL   93 (255)
T ss_dssp             CCSSEET
T ss_pred             eeecccc
Confidence            9987554

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.69  E-value=0.011  Score=46.20  Aligned_cols=74  Identities=15%  Similarity=0.130  Sum_probs=46.8

Q ss_pred             eeeeeeeccccceEEEEEEecC-------CCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhCCCCc-eEEEEEEecC
Q 027788           27 GRYNELLGSGAVKKVYRAFDQE-------EGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI-ISLHYVWRDE   98 (219)
Q Consensus        27 ~~~~~~ig~g~~g~V~~a~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i-~~~~~~~~~~   98 (219)
                      ..+ +.|+.|-.-.+|+.....       ....|.+++.- ..    ... -...+|..+++.+.-.++ .++++++  +
T Consensus        45 l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~----~~~-idr~~E~~i~~~ls~~gl~Pkll~~~--~  115 (395)
T d1nw1a_          45 LRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP----ETE-SHLVAESVIFTLLSERHLGPKLYGIF--S  115 (395)
T ss_dssp             EEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC----CCH-HHHHHHHHHHHHHHHTTSSSCEEEEE--T
T ss_pred             eEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc----chh-hHHHHHHHHHHHHHhCCCCCeEEEEc--C
Confidence            356 678889999999987542       23567776644 21    112 234478888887753333 4677776  3


Q ss_pred             CCceEEEEeccccCC
Q 027788           99 DRNTLNFITEVCTSG  113 (219)
Q Consensus        99 ~~~~~~lv~e~~~~g  113 (219)
                      +    .++++|+++.
T Consensus       116 ~----g~I~efi~g~  126 (395)
T d1nw1a_         116 G----GRLEEYIPSR  126 (395)
T ss_dssp             T----EEEECCCCEE
T ss_pred             C----ceEEEEeccc
Confidence            3    4588998754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.37  E-value=0.0039  Score=47.44  Aligned_cols=41  Identities=12%  Similarity=0.215  Sum_probs=28.4

Q ss_pred             ceEEEEEEecCCCcEEEEEEeeecccCCCHHHHHHHHHHHHHHHhhC
Q 027788           38 VKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA   84 (219)
Q Consensus        38 ~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   84 (219)
                      -..||++. ..+|..+++|+......     ..+.+..|...+..|.
T Consensus        35 EN~vy~v~-~~dg~~~VlK~~rp~~~-----s~~~i~~E~~~l~~L~   75 (325)
T d1zyla1          35 ENRVYQFQ-DEDRRRFVVKFYRPERW-----TADQILEEHQFALQLV   75 (325)
T ss_dssp             SSEEEEEC-CTTCCCEEEEEECTTTS-----CHHHHHHHHHHHHHHH
T ss_pred             cceeEEEE-cCCCCEEEEEEeCCCCC-----CHHHHHHHHHHHHHHH
Confidence            36899987 46788899998653211     2245667888887775

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.53  E-value=0.013  Score=44.11  Aligned_cols=30  Identities=37%  Similarity=0.339  Sum_probs=25.1

Q ss_pred             eeeeCCCCCceEEeCCCCcEEEeccccceec
Q 027788          151 VIHRDLNCSNVFVNGNTGQVKIGDLGVAAIV  181 (219)
Q Consensus       151 i~h~dl~~~nili~~~~~~~~l~dfg~a~~~  181 (219)
                      ++|+|+.++|++++.+ ....++||+.+..-
T Consensus       185 iIHgDl~~dNvl~~~~-~v~gvIDF~~~~~~  214 (316)
T d2ppqa1         185 VIHADLFQDNVFFLGD-ELSGLIDFYFACND  214 (316)
T ss_dssp             EECSCCCGGGEEEETT-EEEEECCCTTCEEE
T ss_pred             cccCCcchhhhhcccc-cceeEecccccccc
Confidence            8999999999999865 34579999988653